International	I-DISEASE
Classification	I-DISEASE
of	I-DISEASE
Sleep	I-DISEASE
Disord	0
Third	0
Edition	I-DISEASE
CI	0
S	I-DISEASE
ers	I-DISEASE
D3	I-DISEASE
American	I-DISEASE
Academy	I-DISEASE
of	I-DISEASE
Sleep	0
Medicine	0
International	0
Classification	I-DISEASE
of	I-DISEASE
Sleep	0
Disord	I-DISEASE
Third	0
Edition	I-DISEASE
CI	I-DISEASE
S	I-DISEASE
ers	0
D3	I-DISEASE
American	0
Academy	0
of	I-DISEASE
Sleep	0
Medicine	0

Copyright	I-DISEASE
©	I-DISEASE
2014	0
American	0
Academy	0
of	I-DISEASE
Sleep	I-DISEASE
Medicine	B-DISEASE
,	0
2510	0
North	0
Frontage	I-DISEASE
Road	B-DISEASE
,	I-DISEASE
Darien	0
,	0
IL	0
60561	I-DISEASE
,	I-DISEASE
U.S.A.	I-DISEASE
Copies	0
of	I-DISEASE
the	I-DISEASE
manual	I-DISEASE
are	0
available	0
from	I-DISEASE
the	0
American	0
Academy	0
of	0
Sleep	0
Medicine	I-DISEASE
in	I-DISEASE
the	I-DISEASE
U.S.A.	I-DISEASE
All	0
rights	0
reserved	I-DISEASE
.	0

Unless	I-DISEASE
authorized	0
in	0
writing	I-DISEASE
by	0
the	0
AASM	I-DISEASE
,	0
no	0
portion	0
of	I-DISEASE
this	I-DISEASE
book	I-DISEASE
may	0
be	I-DISEASE
reproduced	I-DISEASE
or	I-DISEASE
used	0
in	0
a	0
manner	0
inconsistent	I-DISEASE
with	I-DISEASE
the	0
copyright	I-DISEASE
.	0

This	I-DISEASE
applies	0
to	0
unauthorized	I-DISEASE
reproductions	I-DISEASE
in	0
any	I-DISEASE
form	I-DISEASE
,	I-DISEASE
including	I-DISEASE
computer	I-DISEASE
programs	0
.	0

Correspondence	I-DISEASE
regarding	0
copyright	I-DISEASE
permissions	I-DISEASE
should	0
be	0
directed	I-DISEASE
to	I-DISEASE
the	0
Executive	I-DISEASE
Director	I-DISEASE
,	I-DISEASE
American	I-DISEASE
Academy	0
of	0
Sleep	0
Medicine	0
,	I-DISEASE
2510	0
North	0
Frontage	0
Road	I-DISEASE
,	I-DISEASE
Darien	0
,	0
IL	0
60561	0
,	I-DISEASE
U.S.A.	0
Translations	0
to	I-DISEASE
other	I-DISEASE
languages	0
must	0
be	0
authorized	0
by	I-DISEASE
the	0
American	0
Academy	0
of	I-DISEASE
Sleep	0
Medicine	0
,	0
U.S.A.	0
Recommended	0
Citation	I-DISEASE
American	0
Academy	0
of	I-DISEASE
Sleep	I-DISEASE
Medicine	B-DISEASE
.	0

International	I-DISEASE
classification	I-DISEASE
of	I-DISEASE
sleep	I-DISEASE
disorders	0
,	I-DISEASE
3rd	0
ed	I-DISEASE
.	0

Darien	I-DISEASE
,	0
IL	I-DISEASE
:	0
American	0
Academy	0
of	I-DISEASE
Sleep	0
Medicine	0
,	0
2014	0
.	I-DISEASE

International	I-DISEASE
classification	I-DISEASE
of	I-DISEASE
sleep	I-DISEASE
disorders	0
,	I-DISEASE
3rd	0
ed	I-DISEASE
.	0

American	I-DISEASE
Academy	I-DISEASE
of	I-DISEASE
Sleep	I-DISEASE
Medicine	0
.	0

Includes	I-DISEASE
bibliographies	0
and	0
index	I-DISEASE
.	0
.	0

Sleep	I-DISEASE
Disorders	I-DISEASE
–	0
Classification	I-DISEASE
.	0

2	I-DISEASE
.	0
Sleep	0
Disorders	I-DISEASE
–	0
Diagnosis	I-DISEASE
ISBN	0
:	0
0991543416	I-DISEASE
(	0
print	0
)	0
ISBN	0
:	0
0991543408	0
(	I-DISEASE
online	0
)	0

In	I-DISEASE
memory	0
of	I-DISEASE
Peter	I-DISEASE
Hauri	0
,	I-DISEASE
PhD	0
mentor	0
,	0
colleague	I-DISEASE
and	0
friend	I-DISEASE
Table	I-DISEASE
of	I-DISEASE
Contents	I-DISEASE
About	I-DISEASE
the	0
Editor	0
8	I-DISEASE
Editor	0
’s	I-DISEASE
Notes	0
9	I-DISEASE
Acknowledgments10	0
Introduction13	0
Insomnia19	0
Chronic	I-DISEASE
Insomnia	0
Disorder	I-DISEASE

21	I-DISEASE
Short	0
-	0
Term	I-DISEASE
Insomnia	I-DISEASE
Disorder41	0
Other	0
Insomnia	0
Disorder46	0
ISOLATED	0
SYMPTOMS	0
AND	I-DISEASE
NORMAL	0
VARIANTS	I-DISEASE
Excessive	0
Time	0
in	I-DISEASE
Bed47	B-DISEASE
Short	0
Sleeper47	0
Sleep	0
Related	0
Breathing	0
Disorders	I-DISEASE
49	0
OBSTRUCTIVE	0
SLEEP	I-DISEASE
APNEA	0
DISORDERS	I-DISEASE
Obstructive	I-DISEASE
Sleep	0
Apnea	0
,	I-DISEASE
Adult	0

53	I-DISEASE
Obstructive	I-DISEASE
Sleep	I-DISEASE
Apnea	0
,	I-DISEASE
Pediatric	0

63	I-DISEASE
CENTRAL	0
SLEEP	I-DISEASE

APNEA	I-DISEASE
SYNDROMES	I-DISEASE
Central	I-DISEASE
Sleep	0
Apnea	0
with	0
Cheyne	I-DISEASE
-	0
Stokes	0
Breathing	0
69	B-DISEASE
Central	I-DISEASE
Apnea	0
Due	I-DISEASE
to	I-DISEASE
a	I-DISEASE
Medical	I-DISEASE
Disorder	0
without	0
Cheyne	I-DISEASE
-	0
Stokes	0
Breathing	0

75	I-DISEASE
Central	I-DISEASE
Sleep	0
Apnea	0

Due	I-DISEASE
to	I-DISEASE
High	0
Altitude	0
Periodic	I-DISEASE
Breathing79	0
Central	I-DISEASE
Sleep	I-DISEASE
Apnea	0
Due	I-DISEASE
to	0
a	0
Medication	I-DISEASE
or	0
Substance85	I-DISEASE
Primary	I-DISEASE
Central	0
Sleep	I-DISEASE
Apnea	0
89	I-DISEASE

Primary	I-DISEASE
Central	I-DISEASE
Sleep	0
Apnea	0
of	I-DISEASE
Infancy	I-DISEASE

94	I-DISEASE
Primary	0
Central	0
Sleep	0
Apnea	0
of	I-DISEASE
Prematurity	0

98	I-DISEASE
Treatment	I-DISEASE
-	0
Emergent	I-DISEASE
Central	I-DISEASE
Sleep	I-DISEASE
Apnea102	0
SLEEP	I-DISEASE
RELATED	I-DISEASE
HYPOVENTILATION	I-DISEASE
DISORDERS	I-DISEASE
Obesity	0
Hypoventilation	I-DISEASE
Syndrome108	0
Congenital	0
Central	I-DISEASE
Alveolar	0
Hypoventilation	0
Syndrome	I-DISEASE

113	I-DISEASE
Late	0
-	0
Onset	I-DISEASE
Central	I-DISEASE
Hypoventilation	I-DISEASE
with	I-DISEASE
Hypothalamic	I-DISEASE
Dysfunction	I-DISEASE

118	I-DISEASE
Idiopathic	0
Central	I-DISEASE
Alveolar	I-DISEASE
Hypoventilation	I-DISEASE
121	0
Sleep	0
Related	0
Hypoventilation	I-DISEASE
Due	I-DISEASE
to	B-DISEASE
a	0
Medication	B-DISEASE
or	I-DISEASE
Substance	I-DISEASE
124	0
Sleep	0
Related	0
Hypoventilation	I-DISEASE
Due	I-DISEASE
to	0
a	0
Medical	0
Disorder	0

128	I-DISEASE
SLEEP	I-DISEASE
RELATED	0
HYPOXEMIA	I-DISEASE
DISORDER	I-DISEASE
Sleep	0
Related	0
Hypoxemia	I-DISEASE

134	I-DISEASE
Table	I-DISEASE
of	I-DISEASE
Contents	I-DISEASE
ISOLATED	0
SYMPTOMS	0
AND	0
NORMAL	I-DISEASE
VARIANTS	0

Snoring	I-DISEASE
139	0
Catathrenia	0

141	I-DISEASE
Central	I-DISEASE
Disorders	0
of	I-DISEASE
Hypersomnolence143	I-DISEASE
Narcolepsy	0
Type	0
1	I-DISEASE

146	0
Narcolepsy	0
Type	I-DISEASE
2	0

155	I-DISEASE
Idiopathic	0
Hypersomnia	I-DISEASE

161	I-DISEASE
Kleine	I-DISEASE
-	I-DISEASE
Levin	0
Syndrome166	I-DISEASE
Hypersomnia	I-DISEASE
Due	I-DISEASE
to	I-DISEASE
a	I-DISEASE
Medical	0
Disorder	0

171	I-DISEASE
Hypersomnia	I-DISEASE
Due	I-DISEASE
to	I-DISEASE
a	0
Medication	0
or	I-DISEASE
Substance	I-DISEASE
175	0
Hypersomnia	I-DISEASE
Associated	I-DISEASE
with	I-DISEASE
a	0
Psychiatric	0
Disorder	I-DISEASE

179	I-DISEASE
Insufficient	I-DISEASE
Sleep	I-DISEASE
Syndrome	I-DISEASE

182	I-DISEASE
ISOLATED	0
SYMPTOMS	I-DISEASE
AND	0
NORMAL	I-DISEASE
VARIANTS	I-DISEASE
Long	0
Sleeper187	0
Circadian	0
Rhythm	0
Sleep	I-DISEASE
-	0
Wake	0
Disorders189	I-DISEASE
Delayed	0
Sleep	0
-	0
Wake	0
Phase	0
Disorder	I-DISEASE
191	0
Advanced	I-DISEASE
Sleep	0
-	0
Wake	0
Phase	0
Disorder198	0
Irregular	0
Sleep	I-DISEASE
-	I-DISEASE
Wake	I-DISEASE
Rhythm	0
Disorder	I-DISEASE

204	I-DISEASE
Non-24	0
-	0
Hour	0
Sleep	0
-	0
Wake	0
Rhythm	0
Disorder209	0
Shift	I-DISEASE
Work	I-DISEASE
Disorder215	0
Jet	0
Lag	I-DISEASE
Disorder220	0
Circadian	B-DISEASE
Sleep	0
-	0
Wake	0
Disorder	I-DISEASE
Not	0
Otherwise	0
Specified	0
(	I-DISEASE
NOS)224	I-DISEASE
Parasomnias	0
225	I-DISEASE
NREM	0
-	0
RELATED	0
PARASOMNIAS	0
Disorders	I-DISEASE
of	I-DISEASE
Arousal	0
(	I-DISEASE
From	0
NREM	0
Sleep	I-DISEASE
)	0

228	I-DISEASE
Confusional	0
Arousals	0

229	I-DISEASE
Sleepwalking	I-DISEASE

229	I-DISEASE
Sleep	I-DISEASE
Terrors	0
230	0
Sleep	I-DISEASE
Related	I-DISEASE
Eating	0
Disorder240	I-DISEASE
REM	0
-	I-DISEASE
RELATED	0
PARASOMNIAS	I-DISEASE
REM	0
Sleep	0
Behavior	I-DISEASE
Disorder246	I-DISEASE

Recurrent	I-DISEASE
Isolated	0
Sleep	I-DISEASE
Paralysis254	0
Nightmare	I-DISEASE
Disorder257	I-DISEASE
OTHER	0
PARASOMNIAS	0
Exploding	I-DISEASE
Head	I-DISEASE
Syndrome	I-DISEASE

264	I-DISEASE
Sleep	0
Related	0
Hallucinations267	0
Sleep	0
Enuresis270	I-DISEASE

Parasomnia	I-DISEASE

Due	I-DISEASE
to	I-DISEASE
a	0
Medical	I-DISEASE
Disorder	0

276	I-DISEASE
Parasomnia	0
Due	I-DISEASE
to	I-DISEASE
a	0
Medication	0
or	I-DISEASE
Substance276	I-DISEASE
Parasomnia	0
,	I-DISEASE
Unspecified	I-DISEASE
278	0
ISOLATED	0
SYMPTOMS	I-DISEASE
AND	I-DISEASE
NORMAL	I-DISEASE
VARIANTS	0
Sleep	0
Talking279	0
Sleep	0
Related	0
Movement	0
Disorders	0
281	I-DISEASE
Restless	I-DISEASE
Legs	0
Syndrome282	0
Periodic	0
Limb	0
Movement	0
Disorder292	I-DISEASE
Sleep	I-DISEASE
Related	0
Leg	0
Cramps299	I-DISEASE
Sleep	0
Related	0
Bruxism	0

303	I-DISEASE
Sleep	I-DISEASE
Related	0
Rhythmic	0
Movement	0
Disorder312	I-DISEASE
Benign	I-DISEASE
Sleep	0
Myoclonus	0
of	0
Infancy317	0
Propriospinal	I-DISEASE
Myoclonus	0
at	I-DISEASE
Sleep	0
Onset321	0
Sleep	0
Related	0
Movement	0
Disorder	I-DISEASE
Due	I-DISEASE
to	I-DISEASE
a	0
Medical	I-DISEASE
Disorder	0

325	I-DISEASE
Sleep	I-DISEASE
Related	0
Movement	0
Disorder	I-DISEASE
Due	I-DISEASE
to	0
a	0
Medication	I-DISEASE
or	I-DISEASE
Substance326	I-DISEASE
Sleep	0
Related	0
Movement	0
Disorder	I-DISEASE
,	I-DISEASE
Unspecified	0

327	I-DISEASE
ISOLATED	0
SYMPTOMS	I-DISEASE
AND	I-DISEASE
NORMAL	I-DISEASE
VARIANTS	I-DISEASE
Excessive	I-DISEASE
Fragmentary	0
Myoclonus	0
328	0
Hypnagogic	I-DISEASE
Foot	0
Tremor	0
and	0
Alternating	0
Leg	0
Muscle	I-DISEASE
Activation	0
330	I-DISEASE
Sleep	0
Starts	I-DISEASE
(	I-DISEASE
Hypnic	I-DISEASE
Jerks	I-DISEASE
)	0

335	I-DISEASE
Other	0
Sleep	0
Disorder339	I-DISEASE
Appendix	0
A	I-DISEASE
:	I-DISEASE
Sleep	0
Related	0
Medical	I-DISEASE
and	0
Neurological	0
Disorders341	0
Fatal	I-DISEASE
Familial	I-DISEASE
Insomnia342	0
Sleep	0
Related	0
Epilepsy345	0
Sleep	I-DISEASE
Related	0
Headaches	B-DISEASE

350	0
Sleep	I-DISEASE
Related	0
Laryngospasm355	0
Sleep	0
Related	I-DISEASE
Gastroesophageal	0
Reflux358	0
Sleep	I-DISEASE
Related	0
Myocardial	0
Ischemia363	I-DISEASE
Appendix	0
B	0
:	0
ICD-10	0
-	I-DISEASE
CM	I-DISEASE
Coding	0
for	0
Substance	I-DISEASE
-	0
Induced	I-DISEASE
Sleep	0
Disorders369	0
Glossary	I-DISEASE
371	0
Index	I-DISEASE
377	I-DISEASE
Table	I-DISEASE
of	I-DISEASE
Contents	0
About	I-DISEASE
the	0
Editor	0
Michael	I-DISEASE
Sateia	0
,	I-DISEASE
MD	0
,	I-DISEASE
is	0
Professor	0
of	I-DISEASE
Psychiatry	I-DISEASE
at	I-DISEASE
the	0
Geisel	0
School	0
of	I-DISEASE
Medicine	B-DISEASE
at	I-DISEASE
Dartmouth	I-DISEASE
.	0

He	I-DISEASE
has	0
served	0
in	I-DISEASE
a	0
variety	I-DISEASE
of	I-DISEASE
leadership	0
capacities	0
in	0
Sleep	0
Medicine	0
.	I-DISEASE

He	I-DISEASE
is	I-DISEASE
Past	0
-	I-DISEASE
President	0
of	I-DISEASE
the	0
American	I-DISEASE
Academy	0
of	I-DISEASE
Sleep	0
Medicine	0
.	I-DISEASE

Dr.	I-DISEASE
Sateia	0
was	I-DISEASE
Associate	I-DISEASE
Editor	I-DISEASE
for	0
the	0
Journal	I-DISEASE
of	I-DISEASE
Clinical	I-DISEASE
Sleep	I-DISEASE
Medicine	0
and	0
chaired	I-DISEASE
the	I-DISEASE
Scientific	0
Program	0
Committee	I-DISEASE
of	I-DISEASE
the	0
Associated	I-DISEASE
Professional	0
Sleep	I-DISEASE
Societies	0
.	I-DISEASE

He	I-DISEASE
was	I-DISEASE
a	0
member	I-DISEASE
of	0
the	0
Research	I-DISEASE
Advisory	I-DISEASE
Board	0
of	I-DISEASE
the	0
National	0
Center	I-DISEASE
on	0
Sleep	0
Disorders	I-DISEASE
Research	0
and	0
held	0
a	0
five	0
year	B-DISEASE
Academic	I-DISEASE
Award	0
from	0
the	I-DISEASE
National	0
Heart	I-DISEASE
,	I-DISEASE
Lung	I-DISEASE
,	0
and	0
Blood	0
Institute	0
.	0

He	I-DISEASE
served	I-DISEASE
on	0
the	0
Accreditation	0
Council	0
on	0
Graduate	0
Medical	I-DISEASE
Education	I-DISEASE
Advisory	I-DISEASE
Committee	I-DISEASE
for	I-DISEASE
Sleep	I-DISEASE
Medicine	I-DISEASE
and	0
the	0
American	I-DISEASE
Board	0
of	I-DISEASE
Internal	I-DISEASE
Medicine	I-DISEASE
Policy	I-DISEASE
and	0
Test	I-DISEASE
Committee	I-DISEASE
for	I-DISEASE
Sleep	0
Medicine	B-DISEASE
.	0

His	I-DISEASE
editing	I-DISEASE
respon-	0
sibilities	0
have	0
included	0
the	0
International	0
Classification	I-DISEASE
of	I-DISEASE
Sleep	0
Disorders	I-DISEASE
,	0
2nd	0
Edition	I-DISEASE
;	0
the	0
comprehensive	B-DISEASE
textbook	0
,	I-DISEASE
Sleep	0
Medicine	I-DISEASE
;	I-DISEASE
and	0
Insomnia	I-DISEASE
:	I-DISEASE
Diagnosis	I-DISEASE
and	0
Treatment	0
.	0

In	I-DISEASE
2009	I-DISEASE
he	0
received	I-DISEASE
the	0
Nathaniel	0
Kleitman	0
Award	0
from	I-DISEASE
the	I-DISEASE
American	I-DISEASE
Academy	0
of	I-DISEASE
Sleep	I-DISEASE
Medicine	I-DISEASE
.	0

He	I-DISEASE
currently	I-DISEASE
serves	0
as	I-DISEASE
task	0
force	I-DISEASE
chair	0
and	0
editor	0
for	0
the	0
International	0
Classification	I-DISEASE
of	I-DISEASE
Sleep	0
Disorders	I-DISEASE
,	0
3rd	0
Edition	I-DISEASE
,	I-DISEASE
and	0
chair	0
of	I-DISEASE
the	I-DISEASE
task	0
force	I-DISEASE
on	0
the	I-DISEASE
pharmacological	0
management	0
of	I-DISEASE
insomnia	I-DISEASE
.	0

He	I-DISEASE
has	0
authored	0
numerous	0
scientific	0
articles	I-DISEASE
in	I-DISEASE
sleep	0
medi-	0
cine	I-DISEASE
,	I-DISEASE
focused	0
primarily	I-DISEASE
on	0
insomnia	I-DISEASE
and	0
professional	0
education	I-DISEASE
in	I-DISEASE
sleep	0
.	0

Editor	I-DISEASE
’s	I-DISEASE
Notes	I-DISEASE

Many	I-DISEASE
people	0
contributed	I-DISEASE
to	I-DISEASE
the	0
development	I-DISEASE
of	I-DISEASE
this	I-DISEASE
manual	I-DISEASE
.	0

The	I-DISEASE
members	I-DISEASE
of	I-DISEASE
the	0
Task	0
Force	I-DISEASE
on	0
ICSD-3	I-DISEASE
,	I-DISEASE
who	I-DISEASE
also	0
chaired	I-DISEASE
individual	I-DISEASE
work	I-DISEASE
groups	0
,	0
devoted	I-DISEASE
countless	I-DISEASE
hours	I-DISEASE
and	0
tireless	0
dedication	0
to	I-DISEASE
the	0
work	I-DISEASE
,	I-DISEASE
as	B-DISEASE
did	0
the	0
members	I-DISEASE
of	I-DISEASE
their	0
respective	0
work	I-DISEASE
groups	0
.	0

Numerous	I-DISEASE
reviewers	I-DISEASE
also	0
provided	I-DISEASE
thoughtful	0
recommendations	I-DISEASE
which	0
served	I-DISEASE
to	0
improve	0
the	0
text	I-DISEASE
.	I-DISEASE

These	0
individuals	I-DISEASE
are	0
acknowledged	I-DISEASE
individually	I-DISEASE
on	0
the	I-DISEASE
following	0
pages	I-DISEASE
.	0

A	I-DISEASE
number	0
of	I-DISEASE
staff	0
members	0
of	I-DISEASE
the	I-DISEASE
American	I-DISEASE
Academy	0
of	I-DISEASE
Sleep	I-DISEASE
Medicine	I-DISEASE
contributed	I-DISEASE
to	I-DISEASE
this	0
work	I-DISEASE
.	0

Our	I-DISEASE
field	0
owes	0
a	I-DISEASE
particular	0
debt	0
of	I-DISEASE
gratitude	I-DISEASE
for	0
the	0
diligence	0
,	I-DISEASE
dedication	0
and	0
determination	0
of	I-DISEASE
Ms.	0
Carolyn	I-DISEASE
Winter	0
-	0
Rosenberg	0
,	I-DISEASE
Director	I-DISEASE
of	0
Coding	I-DISEASE
and	0
Compliance	0
at	I-DISEASE
the	0
AASM	I-DISEASE
,	0
who	I-DISEASE
oversaw	I-DISEASE
all	0
facets	0
of	0
this	I-DISEASE
project	I-DISEASE
.	I-DISEASE

Without	I-DISEASE
her	0
,	0
this	I-DISEASE
publication	0
would	I-DISEASE
not	0
have	I-DISEASE
been	I-DISEASE
possible	0
.	0

Special	I-DISEASE
thanks	I-DISEASE
are	0
extended	0
to	0
the	I-DISEASE
Board	0
of	I-DISEASE
Directors	I-DISEASE
of	I-DISEASE
the	0
American	I-DISEASE
Academy	I-DISEASE
of	I-DISEASE
Sleep	0
Medicine	I-DISEASE
.	0

My	I-DISEASE
personal	0
thanks	I-DISEASE
go	I-DISEASE
to	0
Nancy	I-DISEASE
Collop	I-DISEASE
,	0
President	0
of	I-DISEASE
the	0
AASM	I-DISEASE
at	I-DISEASE
the	0
outset	I-DISEASE
of	I-DISEASE
the	0
project	I-DISEASE
.	0

I	I-DISEASE
would	0
also	0
like	I-DISEASE
to	0
thank	I-DISEASE
the	0
following	0
members	0
of	I-DISEASE
the	0
board	I-DISEASE
during	I-DISEASE
the	0
revision	0
process	0
who	I-DISEASE
provided	I-DISEASE
their	0
expertise	0
and	0
time	0
in	I-DISEASE
reviewing	0
multiple	I-DISEASE
drafts	I-DISEASE
:	I-DISEASE
Amy	0
Aronsky	0
,	0
DO	I-DISEASE
;	I-DISEASE
M.	I-DISEASE
Safwan	I-DISEASE
Badr	I-DISEASE
,	0
MD	I-DISEASE
;	I-DISEASE
Kelly	I-DISEASE
Carden	0
,	0
MD	0
;	0
Ronald	0
Chervin	I-DISEASE
,	I-DISEASE
MD	0
,	0
MS	I-DISEASE
;	0
Nancy	0
Collop	I-DISEASE
,	I-DISEASE
MD	0
;	I-DISEASE
Samuel	0
Fleishman	I-DISEASE
,	I-DISEASE
MD	I-DISEASE
;	0
Timothy	I-DISEASE
Morgenthaler	0
,	I-DISEASE
MD	0
;	0
Susan	I-DISEASE
Redline	0
,	I-DISEASE
MD	0
;	I-DISEASE
Ilene	I-DISEASE
Rosen	0
,	0
MD	I-DISEASE
;	0
Steven	0
Shea	0
,	I-DISEASE
PhD	0
;	I-DISEASE
Patrick	I-DISEASE
Strollo	0
,	0
Jr.	0
,	I-DISEASE
MD	0
;	0
Nathaniel	I-DISEASE
Watson	0
,	I-DISEASE
MD	0
,	I-DISEASE
MS	I-DISEASE
;	0
Terri	I-DISEASE
Weaver	I-DISEASE
,	0
PhD	0
,	I-DISEASE
RN	0
;	0
and	0
Merrill	0
Wise	0
,	I-DISEASE
MD	0
.	I-DISEASE

The	I-DISEASE
international	0
review	0
effort	I-DISEASE
was	0
coordinated	I-DISEASE
by	I-DISEASE
the	I-DISEASE
World	B-DISEASE
Sleep	0
Federation	I-DISEASE
.	0

Thanks	I-DISEASE
goes	0
to	0
Clete	I-DISEASE
Kushida	0
,	0
MD	0
,	I-DISEASE
PhD	I-DISEASE
,	I-DISEASE
President	0
of	I-DISEASE
the	0
WSF	I-DISEASE
for	0
his	0
assistance	0
in	I-DISEASE
this	0
facet	0
.	0

Charles	I-DISEASE
Reynolds	I-DISEASE
,	0
MD	I-DISEASE
,	0
chair	0
of	I-DISEASE
the	B-DISEASE
DSM-5	0
sleep	I-DISEASE
disorders	0
work	I-DISEASE
group	I-DISEASE
,	I-DISEASE
served	I-DISEASE
as	0
a	0
valuable	I-DISEASE
liaison	0
in	I-DISEASE
our	0
efforts	0
to	I-DISEASE
maximize	0
concordance	I-DISEASE
between	0
classification	I-DISEASE
systems	0
.	0

I	I-DISEASE
would	0
also	0
like	I-DISEASE
to	0
thank	I-DISEASE
David	I-DISEASE
Neubauer	0
,	I-DISEASE
MD	I-DISEASE
and	0
Ruth	I-DISEASE
Benca	0
,	I-DISEASE
MD	0
,	0
PhD	0
who	I-DISEASE
provided	0
expertise	0
on	0
psychiatric	I-DISEASE
conditions	0
,	I-DISEASE
as	0
well	I-DISEASE
as	0
Maria	I-DISEASE
Carra	I-DISEASE
,	I-DISEASE
PhD	0
who	I-DISEASE
assisted	0
with	I-DISEASE
the	0
development	0
of	I-DISEASE
the	0
Movement	0
Disorders	I-DISEASE
chapter	0
.	0

Finally	I-DISEASE
,	I-DISEASE
we	0
are	I-DISEASE
grateful	0
to	I-DISEASE
our	0
colleagues	I-DISEASE
and	0
families	I-DISEASE
,	0
whose	0
patience	I-DISEASE
,	I-DISEASE
support	0
and	0
understanding	I-DISEASE
of	I-DISEASE
the	0
long	0
hours	I-DISEASE
required	0
to	0
bring	0
this	0
manual	I-DISEASE
to	0
fruition	I-DISEASE
often	0
go	0
unheralded	I-DISEASE
,	0
but	I-DISEASE
are	0
deeply	I-DISEASE
appreciated	0
.	0

Michael	I-DISEASE
Sateia	I-DISEASE
,	0
MD	I-DISEASE
,	I-DISEASE
Editor	0
Acknowledgments	0
ICSD	0
Revision	0
Task	I-DISEASE
Force	0
Michael	I-DISEASE
Sateia	I-DISEASE
,	0
MD	0
,	I-DISEASE
Chair	I-DISEASE
Geisel	I-DISEASE
School	0
of	I-DISEASE
Medicine	B-DISEASE
at	I-DISEASE
Dartmouth	0
,	I-DISEASE
Lebanon	0
,	0
NH	I-DISEASE
Richard	0
Berry	0
,	I-DISEASE
MD	0
University	I-DISEASE
of	I-DISEASE
Florida	I-DISEASE
Health	0
Science	0
Center	I-DISEASE
,	0
Gainesville	I-DISEASE
,	I-DISEASE
FL	I-DISEASE
Michel	0
Cramer	I-DISEASE
Bornemann	I-DISEASE
,	I-DISEASE
MD	0
HealthEast	0
Care	0
Systems	0
of	I-DISEASE
Minnesota	0
,	I-DISEASE
Maplewood	I-DISEASE
,	0
MN	I-DISEASE
Karl	I-DISEASE
Doghramji	0
,	0
MD	0
,	I-DISEASE
Psychiatric	0
Representative	0
Thomas	0
Jefferson	0
University	0
,	0
Philadelphia	0
,	I-DISEASE
PA	I-DISEASE
Jack	I-DISEASE
Edinger	0
,	I-DISEASE
PhD	0
National	0
Jewish	B-DISEASE
Health	0
,	I-DISEASE
Denver	0
,	I-DISEASE
CO	I-DISEASE
Richard	0
Ferber	I-DISEASE
,	I-DISEASE
MD	0
,	0
Pediatric	0
Representative	0
Harvard	I-DISEASE
Medical	I-DISEASE
School	0
,	0
Boston	0
,	0
MA	0
Gerald	0
Rosen	I-DISEASE
,	I-DISEASE
MD	0
,	I-DISEASE
Pediatric	0
Representative	I-DISEASE
Children	I-DISEASE
’s	I-DISEASE
Hospital	I-DISEASE
of	I-DISEASE
Saint	I-DISEASE
Paul	I-DISEASE
,	I-DISEASE
Saint	I-DISEASE
Paul	I-DISEASE
,	I-DISEASE
MN	I-DISEASE
Michael	I-DISEASE
Silber	0
,	0
MB	0
,	I-DISEASE
ChB	I-DISEASE
Mayo	I-DISEASE
Clinic	0
,	0
Rochester	0
,	0
MN	I-DISEASE
Arthur	0
Walters	I-DISEASE
,	0
MD	0
Vanderbilt	0
University	I-DISEASE
Medical	I-DISEASE
Center	0
,	I-DISEASE
Nashville	I-DISEASE
,	0
TN	0
Phyllis	0
Zee	0
,	0
MD	I-DISEASE
,	0
PhD	0
Northwestern	0
University	0
Medical	I-DISEASE
School	0
,	I-DISEASE
Chicago	I-DISEASE
,	0
IL	I-DISEASE
Acknowledgments	I-DISEASE
ICSD	0
Revision	I-DISEASE
Workgroups	I-DISEASE
INSOMNIA	I-DISEASE
Jack	0
Edinger	0
,	I-DISEASE
PhD	0
,	0
Chair	I-DISEASE
National	0
Jewish	B-DISEASE
Health	0
,	I-DISEASE
Denver	I-DISEASE
,	I-DISEASE
CO	I-DISEASE
Daniel	0
Buysse	0
,	0
MD	I-DISEASE
University	0
of	I-DISEASE
Pittsburg	0
School	0
of	I-DISEASE
Medicine	0
,	I-DISEASE
Pittsburg	0
,	I-DISEASE
PA	I-DISEASE
Kenneth	0
Lichstein	0
,	I-DISEASE
PhD	0
University	0
of	I-DISEASE
Alabama	I-DISEASE
,	0
Tuscaloosa	0
,	0
AL	0
Jodi	0
Mindell	0
,	I-DISEASE
PhD	I-DISEASE
,	0
Pediatric	0
Representative	0
Saint	0
Joseph	I-DISEASE
’s	0
University	0
,	0
Philadelphia	0
,	I-DISEASE
PA	I-DISEASE
Charles	I-DISEASE
Morin	I-DISEASE
,	I-DISEASE
PhD	0
Universite	I-DISEASE
Laval	I-DISEASE
,	I-DISEASE
Quebec	0
,	0
Canada	0
CIRCADIAN	0
RHYTHM	0
SLEEP	I-DISEASE
WAKE	0
DISORDERS	I-DISEASE
Phyllis	0
Zee	0
,	I-DISEASE
MD	0
,	I-DISEASE
PhD	I-DISEASE
,	0
Chair	I-DISEASE
Northwestern	0
University	I-DISEASE
Medical	I-DISEASE
School	0
,	I-DISEASE
Chicago	0
,	I-DISEASE
IL	0
Judith	I-DISEASE
Owens	I-DISEASE
,	I-DISEASE
MD	I-DISEASE
,	I-DISEASE

Pediatric	I-DISEASE
Representative	0
Children	I-DISEASE
’s	I-DISEASE
National	I-DISEASE
Medical	I-DISEASE
Center	0
,	0
Washington	I-DISEASE
,	I-DISEASE
DC	I-DISEASE
Robert	I-DISEASE
Auger	I-DISEASE
,	I-DISEASE
MD	I-DISEASE
Mayo	0
Clinic	0
,	I-DISEASE
Rochester	I-DISEASE
,	I-DISEASE
MN	I-DISEASE
Makoto	I-DISEASE
Uchiyama	I-DISEASE
,	I-DISEASE
MD	I-DISEASE
,	0
PhD	0
Nihon	0
University	0
School	0
of	I-DISEASE
Medicine	0
,	0
Tokyo	I-DISEASE
,	0
Japan	0
Kenneth	I-DISEASE
Wright	0
,	I-DISEASE
PhD	0
University	I-DISEASE
of	I-DISEASE
Colorado	0
,	0
Boulder	0
,	I-DISEASE
CO	I-DISEASE
James	I-DISEASE
Wyatt	I-DISEASE
,	I-DISEASE
PhD	0
Rush	I-DISEASE
University	0
Medical	0
Center	I-DISEASE
,	I-DISEASE
Chicago	I-DISEASE
,	I-DISEASE
IL	0
Steven	0
Lockley	0
,	I-DISEASE
PhD	0
,	I-DISEASE
Advisor	I-DISEASE
Harvard	I-DISEASE
Medical	I-DISEASE
School	0
,	I-DISEASE
Boston	0
,	I-DISEASE
MA	I-DISEASE
SLEEP	I-DISEASE
RELATED	0
BREATHING	I-DISEASE
DISORDERS	I-DISEASE
Richard	I-DISEASE
Berry	B-DISEASE
,	I-DISEASE
MD	0
,	0
Chair	I-DISEASE
University	I-DISEASE
of	I-DISEASE
Florida	0
Health	0
Science	0
Center	0
,	I-DISEASE
Gainesville	I-DISEASE
,	0
FL	I-DISEASE
Teofilo	I-DISEASE
Lee	I-DISEASE
-	0
Chiong	0
,	I-DISEASE
MD	0
National	0
Jewish	0
Health	0
,	0
Denver	I-DISEASE
,	I-DISEASE
CO	I-DISEASE
Carole	0
Marcus	I-DISEASE
,	I-DISEASE
MBBCh	0
,	I-DISEASE
Pediatric	0
Representative	I-DISEASE
Children	I-DISEASE
’s	I-DISEASE
Hospital	B-DISEASE
of	I-DISEASE
Philadelphia	0
,	I-DISEASE
Philadelphia	0
,	0
PA	0
Stuart	0
Quan	0
,	I-DISEASE
MD	I-DISEASE
Harvard	I-DISEASE
Medical	I-DISEASE
School	0
,	0
Boston	0
,	0
MA	0
PARASOMNIAS	0
Michel	0
Cramer	I-DISEASE
Bornemann	0
,	I-DISEASE
MD	I-DISEASE
,	0
Chair	B-DISEASE
HealthEast	0
Care	0
Systems	0
of	I-DISEASE
Minnesota	0
,	I-DISEASE
Maplewood	I-DISEASE
,	0
MN	0
Carlos	I-DISEASE
Schenck	I-DISEASE
,	I-DISEASE
MD	0
Hennepin	I-DISEASE
County	0
Medical	I-DISEASE
Center	B-DISEASE
,	I-DISEASE
Minneapolis	0
,	I-DISEASE
MN	0
Gerald	0
Rosen	I-DISEASE
,	I-DISEASE
MD	0
,	I-DISEASE
Pediatric	0
Representative	0
Children	0
’s	I-DISEASE
Hospital	0
of	0
Saint	I-DISEASE
Paul	I-DISEASE
,	I-DISEASE
Saint	0
Paul	I-DISEASE
,	I-DISEASE
MN	I-DISEASE
Mark	I-DISEASE
Pressman	I-DISEASE
,	I-DISEASE
PhD	0
Lankenau	I-DISEASE
Medical	I-DISEASE
Center	B-DISEASE
,	I-DISEASE
Wynnewood	I-DISEASE
,	I-DISEASE
PA	I-DISEASE
HYPERSOMNOLENCE	0
Michael	I-DISEASE
Silber	0
,	0
MB	0
,	I-DISEASE
ChB	I-DISEASE
,	0
Chair	I-DISEASE
Mayo	0
Clinic	I-DISEASE
,	I-DISEASE
Rochester	0
,	I-DISEASE
MN	I-DISEASE
Isabelle	0
Arnulf	0
,	I-DISEASE
MD	0
Hopital	I-DISEASE
Pitie	0
Salpetriere	0
,	I-DISEASE
Paris	0
,	0
France	0
Suresh	0
Kotagal	0
,	0
MBBS	0
,	I-DISEASE
Pediatric	0
Representative	I-DISEASE
Mayo	I-DISEASE
Clinic	I-DISEASE
,	0
Rochester	I-DISEASE
,	0
MN	I-DISEASE
Thomas	I-DISEASE
Scammell	0
,	I-DISEASE
MD	0
Beth	I-DISEASE
Israel	I-DISEASE
Deaconess	0
Medical	I-DISEASE
Center	I-DISEASE
,	I-DISEASE
Boston	0
,	I-DISEASE
MA	0
Sebastiaan	I-DISEASE
Overeem	I-DISEASE
,	0
MD	I-DISEASE
,	I-DISEASE
PhD	0
Radboud	0
University	0
Nijmegen	0
Medical	0
Center	I-DISEASE
,	0
Nijmegen	0
,	I-DISEASE
Netherlands	0
MOVEMENT	I-DISEASE
DISORDERS	I-DISEASE
Arthur	0
Walters	I-DISEASE
,	I-DISEASE
MD	I-DISEASE
,	0
Chair	I-DISEASE
Vanderbilt	0
University	I-DISEASE
Medical	I-DISEASE
Center	I-DISEASE
,	I-DISEASE
Nashville	I-DISEASE
,	0
TN	I-DISEASE
Ronald	0
Chervin	I-DISEASE
,	0
MD	0
,	I-DISEASE
MS	I-DISEASE
University	0
of	0
Michigan	0
Health	0
System	0
,	I-DISEASE
Ann	0
Arbor	I-DISEASE
,	I-DISEASE
MI	I-DISEASE
Stephen	I-DISEASE
Duntley	I-DISEASE
,	0
MD	0
Critical	0
Care	I-DISEASE
Pulmonary	0
and	0
Sleep	0
Associates	0
,	I-DISEASE
Lakewood	I-DISEASE
,	I-DISEASE
CO	I-DISEASE
Giles	0
Lavigne	I-DISEASE
,	I-DISEASE
DMD	I-DISEASE
,	0
PhD	0
University	0
of	I-DISEASE
Montreal	I-DISEASE
,	0
Montreal	I-DISEASE
,	I-DISEASE
Canada	0
Daniel	0
Picchietti	I-DISEASE
,	I-DISEASE
MD	0
,	I-DISEASE
Pediatric	0
Representative	I-DISEASE
Carle	0
Foundation	0
Hospital	0
,	I-DISEASE
Urbana	I-DISEASE
,	I-DISEASE
IL	I-DISEASE
Denise	I-DISEASE
Sharon	0
,	I-DISEASE
MD	I-DISEASE
,	I-DISEASE
PhD	0
Tulane	I-DISEASE
University	I-DISEASE
School	0
of	I-DISEASE
Medicine	0
,	0
Destrehan	0
,	I-DISEASE
LA	0
Marco	I-DISEASE
Zucconi	I-DISEASE
,	0
MD	I-DISEASE
San	0
Raffaele	0
Hospital	I-DISEASE
,	I-DISEASE
Milan	0
,	0
Italy	I-DISEASE
APPENDIX	0
A	0
Members	0
of	I-DISEASE
the	0
Movement	0
Disorders	0
Work	0
Group	I-DISEASE
Sean	0
Caples	0
,	I-DISEASE
DO	I-DISEASE
Mayo	O
Clinic	O
,	O
Rochester	O
,	O
MN	O
Susan	O
Harding	O
,	O
MD	O
University	O
of	O
Alabama	O
,	O
Birmingham	O
,	O
AL	O
Acknowledgments	O
International	O
Society	O
Reviewers	O
ASIAN	O
SLEEP	O
RESEARCH	O
SOCIETY	O
Masako	O
Okawa	O
,	O
MD	O
,	O
PhD	O
Makoto	O
Honda	O
,	O
MD	O
,	O
PhD	O
Yuhei	O
Kayukawa	O
,	O
MD	O
Yuichi	O
Inoue	O
,	O
MD	O
,	O
PhD	O
AUSTRALASIAN	O
SLEEP	O
ASSOCIATION	O
Shantha	O
Rajaratnam	O
,	O
PhD	O
Leon	O
Lack	O
,	O
PhD	O
Nick	O
Antic	O
,	O
PhD	O
CANADIAN	O
SLEEP	O
SOCIETY	O
Charles	O
Samuels	O
,	O
MD	O
Atul	O
Khullar	O
,	O
MD	O
James	O
MacFarlane	O
,	O
PhD	O
Manisha	O
Witmans	O
,	O
MD	O
EUROPEAN	O
SLEEP	O
RESEARCH	O
SOCIETY	O
Claudio	O
Bassetti	O
,	O
MD	O
Ludger	O
Grote	O
,	O
MD	O
,	O
PhD	O
Dieter	O
Reimann	O
,	O
PhD	O
FEDERATION	O
OF	O
LATIN	O
AMERICAN	O
SLEEP	O
SOCIETIES	O
Darwin	O
Vizcarra	O
,	O
MD	O
Stuart	O
Franklin	O
Escobar	O
-	O
Córdoba	O
,	O
MD	O
,	O
MFP	O
,	O
PhD	O
Dalva	O
Poyares	O
,	O
MD	O
,	O
PhD	O
SLEEP	O
RESEARCH	O
SOCIETY	O
Ronald	O
Szymusiak	O
,	O
PhD	O
Kingman	O
Strohl	O
,	O
MD	O
Phillip	O
Gehrman	O
,	O
PhD	O
Reviewers	O
Alon	O
Avidan	O
,	O
MD	O
Richard	O
Allen	O
,	O
PhD	O
Richard	O
Bootzin	O
,	O
PhD	O
Christopher	O
Drake	O
,	O
PhD	O
Umakanth	O
Khatwa	O
,	O
MD	O
Sanjeev	O
Kothare	O
,	O
MD	O
Lois	O
Krahn	O
,	O
MD	O
Leon	O
Lack	O
,	O
PhD	O
Mark	O
Mahowald	O
,	O
MD	O
Raman	O
Malhotra	O
,	O
MD	O
William	O
Ondo	O
,	O
MD	O
James	O
Parish	O
,	O
MD	O
David	O
Rapoport	O
,	O
MD	O
Eve	O
Rogers	O
,	O
MD	O
Carol	O
Rosen	O
,	O
MD	O
Katherine	O
Sharkey	O
,	O
PhD	O
Arthur	O
Spielman	O
,	O
PhD	O
Michael	O
Thorpy	O
,	O
MD	O
AASM	O
Staff	O
Jerome	O
Barrett	O
,	O
Executive	O
Director	O
Kathleen	O
McCann	O
,	O
Assistant	O
Executive	O
Director	O
Derek	O
Claussen	O
,	O
Graphic	O
Design	O
Manager	O
Jon	O
Wendling	O
,	O
Publications	O
Production	O
Editor	O
Jason	O
Wilbanks	O
,	O
Programmer	O
Carolyn	O
Winter	O
-	O
Rosenberg	O
,	O
Director	O
of	O
Coding	O
and	O
Compliance	O
Steve	O
Van	O
Hout	O
,	O
Director	O
of	O
Information	O
Technology	O
Introduction	O
Classification	O
of	O
disorders	O
plays	O
several	O
key	O
roles	O
in	O
medicine	O
.	O

The	I-DISEASE
most	0
familiar	0
of	I-DISEASE
these	0
is	I-DISEASE
that	0
is	I-DISEASE
serves	0
as	0
a	0
guide	I-DISEASE
to	I-DISEASE
clinicians	I-DISEASE
in	I-DISEASE
the	0
identification	I-DISEASE
of	0
specific	0
disease	I-DISEASE
states	I-DISEASE
.	0

In	I-DISEASE
doing	0
so	0
,	I-DISEASE
classification	0
systems	I-DISEASE
provide	I-DISEASE
clinicians	I-DISEASE
with	0
important	0
informa-	I-DISEASE
tion	0
regarding	I-DISEASE
numerous	I-DISEASE
related	0
factors	0
including	I-DISEASE
pathogenesis	0
,	I-DISEASE
prognosis	0
,	I-DISEASE
course	I-DISEASE
,	I-DISEASE
and	0
heritability	0
.	0

Moreover	I-DISEASE
,	I-DISEASE
therapeutic	0
interventions	I-DISEASE
are	0
largely	I-DISEASE
guided	0
by	I-DISEASE
the	0
nosologi-	0
cal	0
decisions	I-DISEASE
made	0
by	0
clinicians	0
.	0

In	I-DISEASE
turn	I-DISEASE
,	0
information	0
accrued	0
regarding	0
therapeutic	0
response	0
of	I-DISEASE
these	I-DISEASE
disease	I-DISEASE
states	0
is	I-DISEASE
utilized	I-DISEASE
to	I-DISEASE
further	0
refine	0
the	0
nosology	I-DISEASE
.	0

Classification	I-DISEASE
systems	0
also	0
serve	I-DISEASE
to	0
define	0
the	0
domain	I-DISEASE
of	I-DISEASE
a	0
given	0
discipline	0
,	I-DISEASE
a	I-DISEASE
factor	0
of	I-DISEASE
particular	I-DISEASE
importance	I-DISEASE
for	0
fields	0
such	0
as	0
sleep	0
medicine	0
which	0
cut	I-DISEASE
across	0
many	0
related	0
special-	I-DISEASE
ties	I-DISEASE
.	0

Finally	I-DISEASE
,	I-DISEASE
by	0
identifying	0
areas	0
of	I-DISEASE
uncertainty	0
and	0
overlap	0
among	0
related	B-DISEASE
patholo-	0
gies	0
,	I-DISEASE
these	I-DISEASE
systems	0
play	0
a	0
critical	0
role	0
in	0
guiding	I-DISEASE
future	I-DISEASE
research	0
agendas	0
which	I-DISEASE
will	0
enhance	0
our	0
knowledge	0
and	0
understanding	0
of	I-DISEASE
the	0
clinical	0
features	I-DISEASE
,	0
pathophysiology	0
and	0
treatment	I-DISEASE
response	0
specific	I-DISEASE
to	0
each	0
disorder	0
.	0

Since	I-DISEASE
its	I-DISEASE
infancy	0
35	0
years	0
ago	I-DISEASE
,	I-DISEASE
the	B-DISEASE
field	0
of	I-DISEASE
sleep	0
medicine	0
has	I-DISEASE
paid	I-DISEASE
particular	I-DISEASE
atten-	I-DISEASE
tion	0
to	I-DISEASE
the	0
issue	0
of	I-DISEASE
classification	I-DISEASE
,	I-DISEASE
beginning	0
with	I-DISEASE
the	0
1979	0
American	0
Sleep	0
Disorders	0
Association	0
’s	I-DISEASE
Diagnostic	I-DISEASE
Classification	0
of	0
Sleep	0
and	0
Arousal	I-DISEASE
Disorders	I-DISEASE
.	0

Since	I-DISEASE
that	I-DISEASE
time	0
,	I-DISEASE
as	0
our	I-DISEASE
knowledge	0
and	0
understanding	0
of	I-DISEASE
sleep	0
disorders	0
has	I-DISEASE
grown	I-DISEASE
,	0
several	0
differ-	I-DISEASE
ent	0
structural	0
approaches	0
have	0
been	I-DISEASE
utilized	0
in	I-DISEASE
revisions	0
of	I-DISEASE
the	I-DISEASE
classification	I-DISEASE
system	0
,	0
culminating	0
in	I-DISEASE
the	0
International	0
Classification	0
of	I-DISEASE
Sleep	0
Disorders	0
,	0
2nd	I-DISEASE
Edition	I-DISEASE
.	I-DISEASE

The	I-DISEASE
organization	0
of	I-DISEASE
that	I-DISEASE
edition	0
,	I-DISEASE
although	I-DISEASE
not	0
without	0
its	0
limitations	0
,	I-DISEASE
has	I-DISEASE
proven	0
effective	I-DISEASE
and	0
user	I-DISEASE
-	I-DISEASE
friendly	0
and	0
has	I-DISEASE
been	I-DISEASE
maintained	I-DISEASE
in	I-DISEASE
the	0
current	I-DISEASE
revision	0
.	I-DISEASE

Ideally	I-DISEASE
,	I-DISEASE
classification	0
systems	0
are	0
based	I-DISEASE
largely	0
on	0
pathophysiology	0
.	0

However	I-DISEASE
,	I-DISEASE
such	0
an	0
approach	0
is	I-DISEASE
dependent	0
on	0
adequate	0
knowledge	0
concerning	B-DISEASE
the	0
various	I-DISEASE
pathophysiol-	I-DISEASE
ogies	0
of	I-DISEASE
disease	I-DISEASE
or	B-DISEASE
disorder	0
within	I-DISEASE
a	0
given	0
discipline	I-DISEASE
.	0

As	I-DISEASE
is	I-DISEASE
the	0
case	I-DISEASE
with	0
many	0
diag-	I-DISEASE
nostic	0
systems	I-DISEASE
,	I-DISEASE
our	0
current	0
knowledge	0
and	0
understanding	I-DISEASE
of	0
the	0
pathophysiology	0
of	I-DISEASE
many	0
sleep	0
disorders	0
is	I-DISEASE
inadequate	0
.	0

As	I-DISEASE
a	0
result	0
,	I-DISEASE
International	0
Classification	I-DISEASE
of	I-DISEASE
Sleep	I-DISEASE
Disorders	0
,	I-DISEASE
3rd	I-DISEASE
Edition	I-DISEASE
,	0
not	0
unlike	I-DISEASE
its	I-DISEASE
predecessors	0
,	0
employs	I-DISEASE
a	0
hybrid	0
approach	I-DISEASE
which	0
utilizes	I-DISEASE
pathophysiology	0
,	I-DISEASE
where	0
known	I-DISEASE
,	I-DISEASE
but	0
also	0
relies	0
heavily	I-DISEASE
on	0
phenomenology	0
and	0
organ	0
system	I-DISEASE
approaches	I-DISEASE
.	0

Despite	I-DISEASE
these	I-DISEASE
shortcomings	0
,	I-DISEASE
this	0
approach	I-DISEASE
is	0
one	0
that	0
has	0
proven	I-DISEASE
familiar	I-DISEASE
and	0
workable	I-DISEASE
for	I-DISEASE
sleep	0
medicine	0
clinicians	0
.	0

Recognizing	I-DISEASE
the	0
need	I-DISEASE
for	I-DISEASE
currency	I-DISEASE
and	0
relevance	0
in	I-DISEASE
a	0
rapidly	I-DISEASE
evolving	I-DISEASE
field	0
,	I-DISEASE
the	0
American	I-DISEASE
Academy	0
of	0
Sleep	I-DISEASE
Medicine	0
Board	0
of	I-DISEASE
Directors	I-DISEASE
approved	I-DISEASE
a	0
revision	0
of	I-DISEASE
International	0
Classification	I-DISEASE
of	I-DISEASE
Sleep	0
Disorders	0
,	0
2nd	0
Edition	I-DISEASE
in	I-DISEASE
2011	0
.	0

Following	I-DISEASE
appoint-	I-DISEASE
ment	I-DISEASE
of	I-DISEASE
a	0
chair	0
/	0
editor	0
,	I-DISEASE
a	0
task	I-DISEASE
force	I-DISEASE
,	0
consisting	0
of	I-DISEASE
individual	I-DISEASE
work	0
group	I-DISEASE
chairs	I-DISEASE
for	0
each	I-DISEASE
Introduction	0
major	I-DISEASE
division	I-DISEASE
of	0
the	I-DISEASE
manual	I-DISEASE
,	I-DISEASE
was	0
selected	0
,	0
along	I-DISEASE
with	I-DISEASE
two	I-DISEASE
pediatric	0
consultants	I-DISEASE
.	0

A	I-DISEASE
focus	I-DISEASE
group	I-DISEASE
of	I-DISEASE
experts	0
was	I-DISEASE
convened	I-DISEASE
in	I-DISEASE
June	0
2011	0
to	I-DISEASE
obtain	I-DISEASE
input	I-DISEASE
on	0
major	0
structural	0
and	0
content	I-DISEASE
issues	0
.	0

Based	I-DISEASE
on	0
this	0
feedback	I-DISEASE
,	0
individual	I-DISEASE
work	I-DISEASE
groups	I-DISEASE
then	0
set	0
about	0
to	I-DISEASE
define	I-DISEASE
the	B-DISEASE
list	0
of	I-DISEASE
disorders	0
to	I-DISEASE
be	0
included	0
within	I-DISEASE
their	0
sections	0
as	B-DISEASE
well	I-DISEASE
as	B-DISEASE
proposed	I-DISEASE
cri-	I-DISEASE
teria	I-DISEASE
for	0
each	I-DISEASE
diagnosis	I-DISEASE
.	B-DISEASE

This	I-DISEASE
process	0
included	I-DISEASE
comprehensive	I-DISEASE
literature	0
searches	I-DISEASE
for	I-DISEASE
every	0
potential	0
diagnosis	0
as	0
well	I-DISEASE
as	I-DISEASE
for	I-DISEASE
their	0
major	I-DISEASE
features	I-DISEASE
.	I-DISEASE

The	I-DISEASE
draft	I-DISEASE
diagnostic	0
crite-	I-DISEASE
ria	0
which	0
emanated	I-DISEASE
from	I-DISEASE
this	I-DISEASE
work	I-DISEASE
were	I-DISEASE
then	0
reviewed	I-DISEASE
and	0
modified	0
by	I-DISEASE
the	0
task	0
force	I-DISEASE
(	I-DISEASE
consisting	0
of	0
the	I-DISEASE
work	I-DISEASE
group	I-DISEASE
chairs	I-DISEASE
and	0
pediatric	0
advisors	I-DISEASE
)	0
,	0
as	0
well	I-DISEASE
as	0
by	0
the	0
board	I-DISEASE
of	0
the	0
AASM	I-DISEASE
.	0

The	I-DISEASE
edited	I-DISEASE
criteria	I-DISEASE
were	I-DISEASE
then	0
distributed	0
to	I-DISEASE
external	I-DISEASE
peer	0
reviewers	0
with	I-DISEASE
expertise	I-DISEASE
in	I-DISEASE
the	I-DISEASE
respective	0
areas	0
,	I-DISEASE
as	I-DISEASE
well	0
as	0
to	I-DISEASE
international	0
societies	I-DISEASE
and	0
membership	0
sections	0
of	I-DISEASE
the	I-DISEASE
AASM	I-DISEASE
for	I-DISEASE
comment	0
.	0

These	0
reviews	0
were	I-DISEASE
carefully	I-DISEASE
considered	0
and	0
revi-	0
sions	0
made	0
based	I-DISEASE
on	0
this	0
input	I-DISEASE
.	0

Subsequent	I-DISEASE
to	0
this	0
,	I-DISEASE
text	0
revisions	0
were	I-DISEASE
begun	0
and	0
the	0
same	0
review	I-DISEASE
process	0
and	0
modifications	0
were	I-DISEASE
undertaken	0
once	0
text	0
drafts	I-DISEASE
were	I-DISEASE
com-	0
pleted	0
.	0

Further	I-DISEASE
modifications	I-DISEASE
were	I-DISEASE
made	0
based	0
on	0
recommendations	I-DISEASE
from	I-DISEASE
the	0
AASM	0
board	I-DISEASE
before	I-DISEASE
finalization	I-DISEASE
of	I-DISEASE
the	0
edition	I-DISEASE
.	0

At	I-DISEASE
all	0
points	I-DISEASE
in	I-DISEASE
this	0
process	0
,	I-DISEASE
efforts	0
were	I-DISEASE
made	0
to	0
rely	I-DISEASE
as	I-DISEASE
heavily	I-DISEASE
as	0
possible	0
on	0
available	I-DISEASE
and	0
current	0
scientific	I-DISEASE
evidence	0
.	0

However	I-DISEASE
,	I-DISEASE
due	0
to	I-DISEASE
the	0
paucity	0
of	I-DISEASE
available	0
evidence	0
in	I-DISEASE
many	I-DISEASE
areas	B-DISEASE
,	0
decisions	I-DISEASE
regarding	0
the	I-DISEASE
nosol-	0
ogy	0
were	I-DISEASE
often	0
made	0
by	0
consensus	I-DISEASE
of	I-DISEASE
the	I-DISEASE
work	I-DISEASE
groups	I-DISEASE
,	0
task	0
force	I-DISEASE
,	0
and	0
reviewers	0
.	0

Using	I-DISEASE
ICSD-3	0
As	0
noted	0
above	0
,	0
the	0
general	I-DISEASE
structure	0
of	I-DISEASE
the	0
current	I-DISEASE
edition	I-DISEASE
closely	I-DISEASE
parallels	0
that	0
of	I-DISEASE
the	0
second	I-DISEASE
edition	I-DISEASE
.	0

The	I-DISEASE
major	I-DISEASE
clinical	0
divisions	I-DISEASE
remain	0
unchanged	I-DISEASE
.	0

As	I-DISEASE
with	I-DISEASE
International	0
Classification	I-DISEASE
of	0
Sleep	I-DISEASE
Disorders	I-DISEASE
,	0
2nd	0
Edition	I-DISEASE
,	I-DISEASE
pediatric	0
diagnoses	I-DISEASE
are	0
fully	I-DISEASE
integrated	0
into	I-DISEASE
the	0
major	I-DISEASE
clinical	I-DISEASE
diagnoses	0
,	I-DISEASE
with	I-DISEASE
the	0
exception	0
of	I-DISEASE
obstructive	0
sleep	0
apnea	0
,	0
pediatric	0
.	0

Where	I-DISEASE
pediatric	0
presentations	I-DISEASE
call	0
for	I-DISEASE
variation	0
in	I-DISEASE
the	0
diagnostic	0
criteria	I-DISEASE
,	I-DISEASE
those	I-DISEASE
variations	I-DISEASE
are	0
noted	0
within	I-DISEASE
the	I-DISEASE
criteria	0
section	0
.	0

In	I-DISEASE
an	I-DISEASE
effort	0
to	I-DISEASE
better	0
identify	I-DISEASE
those	I-DISEASE
clinical	I-DISEASE
features	0
of	I-DISEASE
a	0
disorder	I-DISEASE
which	I-DISEASE
are	I-DISEASE
developmentally	I-DISEASE
-	I-DISEASE
specific	I-DISEASE
,	0
a	0
text	I-DISEASE
heading	0
for	I-DISEASE
Developmental	I-DISEASE
Issues	0
has	0
been	I-DISEASE
added	I-DISEASE
for	I-DISEASE
each	I-DISEASE
diagnosis	I-DISEASE
.	0

Specific	I-DISEASE
ICD	0
codes	0
(	I-DISEASE
9	I-DISEASE
-	0
CM	0
and	0
10	I-DISEASE
-	I-DISEASE
CM	I-DISEASE
)	0
are	I-DISEASE
listed	I-DISEASE
at	0
the	0
beginning	I-DISEASE
of	I-DISEASE
each	I-DISEASE
diagnosis	0
.	0

Because	I-DISEASE
of	I-DISEASE
the	0
complexities	B-DISEASE
and	0
differences	I-DISEASE
between	0
International	B-DISEASE
Classification	I-DISEASE
of	I-DISEASE
Sleep	I-DISEASE
Disorders	I-DISEASE
diagnoses	I-DISEASE
and	0
the	0
ICD	0
system	0
,	I-DISEASE
assign-	I-DISEASE
ment	I-DISEASE
of	I-DISEASE
codes	0
is	I-DISEASE
challenging	0
.	0

These	0
issues	0
are	0
discussed	I-DISEASE
further	0
under	I-DISEASE
Coding	0
below	I-DISEASE
.	0

Although	I-DISEASE
classification	I-DISEASE
systems	0
are	I-DISEASE
,	0
by	I-DISEASE
their	0
nature	0
,	0
intended	0
to	0
define	0
disorders	I-DISEASE
in	I-DISEASE
the	0
most	0
specific	I-DISEASE
terms	I-DISEASE
possible	0
,	0
clinicians	I-DISEASE
must	0
recognize	0
that	0
there	I-DISEASE
is	0
inevitably	0
some	I-DISEASE
degree	I-DISEASE
of	I-DISEASE
variability	I-DISEASE
in	I-DISEASE
presentation	0
which	0
may	0
result	0
in	I-DISEASE
clinically	0
significant	0
conditions	0
which	0
do	I-DISEASE
not	0
meet	I-DISEASE
all	0
specific	I-DISEASE
criteria	0
for	0
a	0
given	0
diagnosis	0
.	0

Therefore	I-DISEASE
,	I-DISEASE
some	0
degree	I-DISEASE
of	0
judgment	I-DISEASE
is	I-DISEASE
necessary	0
in	0
the	0
application	0
of	I-DISEASE
these	I-DISEASE
criteria	I-DISEASE
.	0

Bearing	I-DISEASE
this	0
exception	0
in	0
mind	I-DISEASE
,	I-DISEASE
all	0
listed	0
criteria	0
should	0
generally	I-DISEASE
be	I-DISEASE
met	0
for	0
establishment	0
of	I-DISEASE
a	I-DISEASE
given	0
diagnosis	0
,	I-DISEASE
unless	0
otherwise	0
specified	I-DISEASE
.	0

Clinicians	I-DISEASE
should	0
note	0
that	0
most	0
diagnoses	I-DISEASE
within	I-DISEASE
the	0
International	I-DISEASE
Classification	I-DISEASE
of	I-DISEASE
Sleep	0
Disorders	I-DISEASE
include	0
a	0
criterion	0
,	0
or	B-DISEASE
cri-	I-DISEASE
teria	I-DISEASE
,	I-DISEASE
that	0
connote	0
clinical	0
significance	I-DISEASE
(	I-DISEASE
i.e.	I-DISEASE
,	0
disturbing	0
symptoms	0
,	0
significant	0
conse-	0
quences	I-DISEASE
,	0
distress	I-DISEASE
or	0
impairment	0
in	I-DISEASE
one	0
or	0
more	0
functional	0
realms	0
)	I-DISEASE
.	0

These	0
criteria	I-DISEASE
are	0
particularly	0
important	0
because	0
,	0
without	0
them	I-DISEASE
,	0
many	0
phenomena	0
related	I-DISEASE
to	I-DISEASE
sleep	0
-	I-DISEASE
wake	0
do	I-DISEASE
not	0
rise	0
to	I-DISEASE
a	0
level	0
that	0
requires	I-DISEASE
clinical	I-DISEASE
attention	0
and	0
treatment	I-DISEASE
.	0

Users	I-DISEASE
should	I-DISEASE
also	0
pay	I-DISEASE
particular	0
attention	0
to	I-DISEASE
the	0
Notes	0
section	0
(	I-DISEASE
where	0
included	I-DISEASE
)	I-DISEASE
,	0
as	0
these	I-DISEASE
notes	I-DISEASE
provide	0
essential	0
definitions	I-DISEASE
and	0
details	0
concerning	0
application	0
of	I-DISEASE
the	0
criteria	I-DISEASE
.	0

Clinicians	I-DISEASE
will	0
note	0
a	0
number	0
of	I-DISEASE
significant	0
content	0
changes	0
from	I-DISEASE
the	0
former	0
edition	I-DISEASE
.	0

The	I-DISEASE
most	0
apparent	0
of	I-DISEASE
these	0
is	I-DISEASE
the	0
collapse	I-DISEASE
of	I-DISEASE
all	0
previous	0
chronic	I-DISEASE
insomnia	I-DISEASE
diagnoses	I-DISEASE
into	I-DISEASE
a	0
single	0
chronic	I-DISEASE
insomnia	0
disorder	0
diagnosis	I-DISEASE
.	0

The	I-DISEASE
rationale	I-DISEASE
for	I-DISEASE
this	0
is	0
described	0
in	I-DISEASE
the	0
introductory	0
section	I-DISEASE
of	I-DISEASE
Insomnia	I-DISEASE
disorders	0
.	0

A	0
separate	0
diagnosis	0
is	0
retained	0
for	0
short	0
-	0
term	0
insomnia	0
.	0

Within	I-DISEASE
the	0
Central	0
Disorders	I-DISEASE
of	I-DISEASE
Hypersomnolence	I-DISEASE
section	0
,	I-DISEASE
the	0
nomenclature	I-DISEASE
for	0
narcolepsy	0
has	0
been	I-DISEASE
changed	0
to	I-DISEASE
narcolepsy	0
type	I-DISEASE
1	I-DISEASE
and	0
type	I-DISEASE
2	0
.	0

This	I-DISEASE
modification	I-DISEASE
is	0
discussed	I-DISEASE
in	0
the	0
introduction	I-DISEASE
to	I-DISEASE
that	0
section	0
.	0

Users	I-DISEASE
will	0
also	0
find	I-DISEASE
several	0
new	0
diagnoses	I-DISEASE
within	I-DISEASE
the	0
Sleep	I-DISEASE
Related	0
Breathing	0
Disorders	0
.	0

Within	I-DISEASE
the	0
Central	0
Sleep	0
Apnea	0
Syndromes	I-DISEASE
,	I-DISEASE
a	I-DISEASE
diagnosis	I-DISEASE
of	0
treatment	I-DISEASE
-	I-DISEASE
emergent	I-DISEASE
central	0
sleep	0
apnea	0
now	I-DISEASE
appears	I-DISEASE
.	0

This	I-DISEASE
term	0
is	0
preferred	0
to	0
the	0
widely	0
used	0
term	0
complex	0
sleep	0
apnea	0
because	0
it	0
describes	0
a	I-DISEASE
more	0
specific	0
and	0
well	I-DISEASE
-	0
defined	0
disorder	0
in	I-DISEASE
which	0
the	0
central	0
apnea	0
arises	0
in	0
the	0
context	I-DISEASE
of	I-DISEASE
positive	0
airway	0
pressure	0
treatment	I-DISEASE
for	0
obstructive	0
sleep	0
apnea	0
and	0
is	0
not	0
attributable	I-DISEASE
to	0
another	0
cause	0
.	0

Central	I-DISEASE
sleep	0
apnea	0
associated	0
with	I-DISEASE
other	I-DISEASE
identi-	B-DISEASE
fiable	I-DISEASE
etiologies	0
such	I-DISEASE
as	0
Cheyne	0
-	0
Stokes	0
breathing	0
or	I-DISEASE
substance	0
-	0
induced	0
central	0
sleep	0
apnea	I-DISEASE
are	0
not	0
classified	0
as	0
treatment	I-DISEASE
-	0
emergent	0
.	0

Assigning	I-DISEASE
a	0
diagnosis	0
of	I-DISEASE
a	0
sleep	0
related	B-DISEASE
hypoventilation	0
disorder	0
requires	I-DISEASE
demonstration	I-DISEASE
of	I-DISEASE
elevated	0
PaCO2	0
(	0
by	B-DISEASE
direct	0
measure	0
of	0
arterial	0
blood	I-DISEASE
gas	0
or	B-DISEASE
,	0
more	0
commonly	I-DISEASE
,	0
by	I-DISEASE
proxy	0
measures	0
such	0
as	0
end	0
-	0
tidal	0
or	0
trans-	I-DISEASE
cutaneous	I-DISEASE
CO2	0
determination	0
)	0
.	0

The	I-DISEASE
new	I-DISEASE
diagnosis	0
of	I-DISEASE
sleep	0
related	B-DISEASE
hypoxemia	I-DISEASE
disor-	I-DISEASE
der	I-DISEASE
should	0
be	I-DISEASE
employed	0
when	I-DISEASE
there	0
is	0
sustained	0
drop	0
in	I-DISEASE
SaO2	I-DISEASE
but	0
PaCO2	0
has	I-DISEASE
not	0
been	I-DISEASE
measured	0
.	0

Within	I-DISEASE
the	0
parasomnia	0
section	0
,	I-DISEASE
a	0
single	0
set	I-DISEASE
of	I-DISEASE
general	I-DISEASE
criteria	I-DISEASE
and	0
a	0
unified	0
text	I-DISEASE
now	0
describe	0
disorders	0
of	I-DISEASE
arousal	0
from	0
non	I-DISEASE
-	I-DISEASE
rapid	I-DISEASE
eye	0
movement	I-DISEASE
sleep	0
,	I-DISEASE
although	I-DISEASE
additional	0
,	0
specific	I-DISEASE
criteria	0
and	0
separate	0
coding	I-DISEASE
are	0
maintained	0
for	0
the	0
diagnoses	0
within	I-DISEASE
this	I-DISEASE
section	0
(	0
i.e.	0
,	0
confusional	I-DISEASE
arousal	0
,	0
sleepwalking	0
and	0
sleep	0
terror	0
)	0
.	0

Other	I-DISEASE
,	I-DISEASE
somewhat	I-DISEASE
less	I-DISEASE
consequential	0
additions	I-DISEASE
,	0
deletions	0
and	0
reassignment	I-DISEASE
of	I-DISEASE
diagnoses	I-DISEASE
also	0
appear	I-DISEASE
in	I-DISEASE
this	0
edition	I-DISEASE
.	0

International	I-DISEASE
Classification	I-DISEASE
of	I-DISEASE
Sleep	0
Disorders	0
,	I-DISEASE
2nd	0
Edition	0
contained	0
a	0
separate	I-DISEASE
chapter	I-DISEASE
for	0
Isolated	I-DISEASE
Symptoms	0
and	0
Normal	0
Variants	I-DISEASE
.	I-DISEASE

A	I-DISEASE
small	0
number	0
of	I-DISEASE
these	0
were	I-DISEASE
felt	0
to	I-DISEASE
qualify	0
as	0
formal	I-DISEASE
diagnoses	I-DISEASE
at	I-DISEASE
this	I-DISEASE
time	I-DISEASE
and	0
have	0
been	I-DISEASE
moved	0
to	0
relevant	I-DISEASE
sections	0
.	0

Other	I-DISEASE
symptoms	I-DISEASE
and	0
variants	I-DISEASE
appear	0
at	I-DISEASE
the	0
conclusion	I-DISEASE
of	I-DISEASE
the	0
chapter	0
to	I-DISEASE
which	I-DISEASE
they	I-DISEASE
are	0
most	0
applicable	I-DISEASE
(	I-DISEASE
e.g.	0
,	I-DISEASE
snoring	0
to	0
the	I-DISEASE
Sleep	0
Related	I-DISEASE
Breathing	0
Disorders	I-DISEASE
,	0
long	I-DISEASE
sleeper	0
to	0
Central	0
Disorders	0
of	I-DISEASE
Hypersomnolence	I-DISEASE
,	0
and	0
movement	I-DISEASE
related	0
variants	0
to	I-DISEASE
the	0
Sleep	0
Related	I-DISEASE
Movement	I-DISEASE
Disorder	I-DISEASE
section	I-DISEASE
)	0
.	0

Introduction	I-DISEASE
Introduction	0
A	0
wealth	I-DISEASE
of	0
information	0
regarding	0
each	I-DISEASE
diagnosis	0
is	0
contained	0
within	I-DISEASE
the	I-DISEASE
separate	I-DISEASE
text	B-DISEASE
headings	0
within	I-DISEASE
each	0
diagnostic	0
section	I-DISEASE
.	0

The	I-DISEASE
outline	I-DISEASE
below	I-DISEASE
details	0
some	0
of	I-DISEASE
the	0
spe-	I-DISEASE
cific	I-DISEASE
content	I-DISEASE
to	I-DISEASE
be	0
found	I-DISEASE
within	I-DISEASE
each	I-DISEASE
text	0
heading	0
.	0

These	0
terms	I-DISEASE
are	0
not	0
indexed	0
in	0
the	0
hard	I-DISEASE
copy	0
version	0
of	I-DISEASE
this	I-DISEASE
manual	I-DISEASE
because	0
they	0
appear	0
throughout	0
the	0
document	0
.	0

Users	I-DISEASE
should	I-DISEASE
refer	I-DISEASE
to	I-DISEASE
the	0
relevant	I-DISEASE
text	0
heading	I-DISEASE
within	0
a	0
specific	I-DISEASE
diagnosis	I-DISEASE
for	I-DISEASE
information	0
related	0
to	0
these	I-DISEASE
terms	I-DISEASE
:	0
Alternate	0
Names	I-DISEASE
Diagnostic	0
Criteria	I-DISEASE
Essential	0
Features	I-DISEASE
Associated	I-DISEASE
Features	I-DISEASE
Clinical	0
and	0
Pathophysiological	I-DISEASE
Subtypes	0
Demographics	0
includes	I-DISEASE
:	I-DISEASE
•	0
Prevalence	0
•	0
Gender	0
bias	0
•	0
Racial	0
/	0
ethnic	0
bias	0
•	0
Cultural	0
issues	I-DISEASE
Predisposing	I-DISEASE
and	0
Precipitating	I-DISEASE
Factors	0
includes	0
:	I-DISEASE
•	0
Risk	I-DISEASE
factors	0
Familial	I-DISEASE
Pattern	0
includes	0
:	0
•	0
Genetics	I-DISEASE
•	0
Familial	I-DISEASE
clusters	I-DISEASE
Onset	0
,	0
Course	0
and	0
Complications	I-DISEASE
includes	I-DISEASE
:	0
•	0
Medical	0
•	0
Neurological	0
•	0
Psychiatric	0
/	0
social	0
Developmental	I-DISEASE
Issues	0
includes	0
:	B-DISEASE
•	0
Pediatric	0
•	0
Geriatric	0
Pathology	0
and	0
Pathophysiology	I-DISEASE
Objective	0
Findings	I-DISEASE
includes	I-DISEASE
:	0
•	0
Sleep	0
logs	0
•	0
Actigraphy	0
•	0

Questionnaires	I-DISEASE
•	0
Polysomnography	0
•	0
Multiple	0
sleep	0
latency	I-DISEASE
test	0
•	0
Neurological	0
◦	I-DISEASE
Electroencephalogram	0
◦	I-DISEASE

Cerebrospinal	0
fluid	0
◦	I-DISEASE
Neuroimaging	0
◦	I-DISEASE
Electromyogram	I-DISEASE
◦	I-DISEASE

Autonomic	I-DISEASE
•	0
Endocrine	0
•	0
Genetic	I-DISEASE
testing	0
•	0
Physical	I-DISEASE
findings	0
•	0
Respiratory	0
◦	I-DISEASE
Arterial	0
blood	I-DISEASE
gas	I-DISEASE
◦	I-DISEASE
Pulmonary	I-DISEASE
function	I-DISEASE
◦	I-DISEASE

Ventilatory	I-DISEASE
response	0
•	0
Cardiac	0
◦	I-DISEASE

Electrocardiogram	I-DISEASE
◦	I-DISEASE
Echocardiogram	I-DISEASE
◦	I-DISEASE
Cardiac	I-DISEASE
catheterization	0
•	0
Serum	0
chemistry	I-DISEASE
Relationship	0
to	I-DISEASE
Other	I-DISEASE
Classification	I-DISEASE
Systems	0
Historically	0
,	I-DISEASE
there	I-DISEASE
have	I-DISEASE
been	I-DISEASE
three	I-DISEASE
major	I-DISEASE
classifications	I-DISEASE
systems	0
for	I-DISEASE
sleep	0
disorders	0
.	0

Although	I-DISEASE
the	0
International	0
Classification	I-DISEASE
of	0
Sleep	I-DISEASE
Disorders	I-DISEASE
system	0
has	0
,	I-DISEASE
for	I-DISEASE
many	0
years	0
,	I-DISEASE
been	I-DISEASE
the	0
primary	0
nosology	0
for	I-DISEASE
sleep	0
medicine	0
specialists	I-DISEASE
,	0
both	I-DISEASE
the	0
Diagnostic	I-DISEASE
and	0
Statistical	0
Manual	I-DISEASE
of	I-DISEASE
Mental	0
Disorders	I-DISEASE
(	I-DISEASE
DSM	0
)	0
of	I-DISEASE
the	I-DISEASE
American	I-DISEASE
Psychiatric	0
Association	0
and	0
the	0
International	0
Classification	I-DISEASE
of	I-DISEASE
Diseases	0
(	0
ICD	0
)	I-DISEASE
nosology	0
of	I-DISEASE
the	0
World	I-DISEASE
Health	0
Organization	I-DISEASE
have	I-DISEASE
also	0
classified	0
sleep	0
disorders	0
.	0

Unfortunately	I-DISEASE
,	0
these	0
competing	0
systems	0
have	I-DISEASE
differed	I-DISEASE
significantly	0
in	0
structure	0
and	0
content	0
over	I-DISEASE
the	0
years	0
.	0

Development	I-DISEASE
of	I-DISEASE
DSM-5	0
was	0
ongoing	I-DISEASE
during	I-DISEASE
the	0
development	B-DISEASE
of	I-DISEASE
this	I-DISEASE
manual	I-DISEASE
and	0
an	0
effort	I-DISEASE
was	I-DISEASE
undertaken	0
to	0
achieve	I-DISEASE
the	0
greatest	0
degree	I-DISEASE
of	I-DISEASE
concordance	I-DISEASE
possible	0
between	0
these	I-DISEASE
two	I-DISEASE
systems	0
,	I-DISEASE
recognizing	0
that	0
the	0
International	0
Classification	I-DISEASE
of	I-DISEASE
Sleep	0
Disorders	0
will	0
inevitably	I-DISEASE
contain	I-DISEASE
a	0
greater	I-DISEASE
level	0
of	I-DISEASE
detail	0
than	0
DSM	I-DISEASE
due	I-DISEASE
to	I-DISEASE
differences	I-DISEASE
in	0
their	0
target	I-DISEASE
users	0
.	I-DISEASE

This	I-DISEASE
goal	I-DISEASE
was	0
largely	I-DISEASE
achieved	0
although	I-DISEASE
some	I-DISEASE
differences	I-DISEASE
will	0
still	0
exist	I-DISEASE
.	0

The	I-DISEASE
major	I-DISEASE
change	0
to	I-DISEASE
the	0
Insomnia	I-DISEASE
section	0
(	I-DISEASE
i.e.	I-DISEASE
establishment	0
of	I-DISEASE
a	I-DISEASE
single	0
chronic	0
insomnia	I-DISEASE
disorder	I-DISEASE
diagnosis	0
)	0
within	0
this	I-DISEASE
new	I-DISEASE
system	I-DISEASE
is	I-DISEASE
paralleled	B-DISEASE
in	I-DISEASE
DSM-5	I-DISEASE
.	0

Central	I-DISEASE
Disorders	I-DISEASE
of	0
Hypersomnolence	I-DISEASE
diagnoses	I-DISEASE
are	I-DISEASE
organized	0
somewhat	0
differently	0
in	I-DISEASE
the	0
DSM	0
clas-	I-DISEASE
sification	0
than	I-DISEASE
in	0
this	0
manual	0
and	0
narcolepsy	0
criteria	I-DISEASE
differ	0
slightly	0
.	0

Circadian	I-DISEASE
Rhythm	0
Sleep	I-DISEASE
-	0
Wake	0
Disorder	0
diagnoses	I-DISEASE
are	0
identical	I-DISEASE
within	I-DISEASE
the	0
two	0
systems	0
with	0
the	0
exception	0
that	0
DSM	I-DISEASE
does	I-DISEASE
not	0
include	I-DISEASE
a	0
jet	I-DISEASE
lag	0
disorder	I-DISEASE
.	0

Sleep	I-DISEASE
Related	I-DISEASE
Breathing	0
Disorders	I-DISEASE
are	0
significantly	0
more	0
detailed	I-DISEASE
within	I-DISEASE
International	0
Classification	I-DISEASE
of	I-DISEASE
Sleep	I-DISEASE
Disorders	0
than	0
DSM-5	I-DISEASE
,	0
although	I-DISEASE
the	0
organizational	I-DISEASE
structures	I-DISEASE
in	I-DISEASE
this	0
section	0
are	I-DISEASE
quite	I-DISEASE
similar	0
.	0

Sleep	I-DISEASE
Related	0
Movement	0
Disorders	0
and	0
Parasomnias	0
are	I-DISEASE
likewise	0
similar	0
but	I-DISEASE
with	I-DISEASE
fewer	0
overall	0
diagnoses	0
within	I-DISEASE
DSM-5	I-DISEASE
.	0

With	I-DISEASE
the	I-DISEASE
publication	0
of	I-DISEASE
International	0
Classification	I-DISEASE
of	I-DISEASE
Sleep	I-DISEASE
Disorders	0
,	I-DISEASE
2nd	I-DISEASE
Edition	I-DISEASE
,	0
a	0
major	I-DISEASE
effort	I-DISEASE
to	0
expand	0
and	0
reorganize	0
sleep	I-DISEASE
related	0
diagnoses	I-DISEASE
within	B-DISEASE
ICD-9	0
-	I-DISEASE
CM	0
was	0
undertaken	0
.	0

This	I-DISEASE
effort	I-DISEASE
resulted	0
in	I-DISEASE
the	0
inclusion	I-DISEASE
of	I-DISEASE
many	0
additional	0
sleep	0
related	B-DISEASE
diag-	I-DISEASE
noses	0
in	I-DISEASE
ICD-9	I-DISEASE
-	0
CM	0
(	0
primarily	I-DISEASE
within	0
the	I-DISEASE
Diseases	0
of	I-DISEASE
the	0
Nervous	0
System	0
section	0
)	0
.	0

The	I-DISEASE
archaic	I-DISEASE
distinction	0
between	0
“	0
organic	I-DISEASE
”	I-DISEASE
and	0
“	0
non	0
-	0
organic	I-DISEASE
”	I-DISEASE
disorders	0
has	0
histori-	0
cally	0
been	I-DISEASE
a	0
guiding	I-DISEASE
principle	0
of	I-DISEASE
ICD	0
,	I-DISEASE
resulting	I-DISEASE
in	I-DISEASE
dissemination	I-DISEASE
of	I-DISEASE
sleep	0
diagnoses	0
to	0
both	I-DISEASE
the	0
neurological	0
and	0
mental	0
disorder	I-DISEASE
categories	I-DISEASE
.	0

Clinicians	I-DISEASE
familiar	0
with	I-DISEASE
the	0
ICD-	I-DISEASE
9	I-DISEASE
-	0
CM	0
categories	I-DISEASE
which	0
have	0
been	I-DISEASE
employed	0
since	I-DISEASE
the	0
most	0
recent	I-DISEASE
changes	0
will	0
find	I-DISEASE
general	0
concordance	I-DISEASE
between	0
the	I-DISEASE
assigned	I-DISEASE
diagnostic	0
codes	0
found	I-DISEASE
herein	I-DISEASE
and	0
the	0
most	0
current	I-DISEASE
version	0
of	I-DISEASE
ICD-9	0
-	I-DISEASE
CM	I-DISEASE
.	0

These	0
ICD-9	0
-	I-DISEASE
CM	I-DISEASE
codes	0
for	0
sleep	0
disorders	0
are	I-DISEASE
essen-	I-DISEASE
tially	0
carried	0
over	0
to	I-DISEASE
ICD-10	0
-	I-DISEASE
CM	0
.	0

However	I-DISEASE
,	I-DISEASE
certain	0
content	0
revisions	0
in	I-DISEASE
International	0
Classification	0
of	I-DISEASE
Sleep	0
Disorders	I-DISEASE
,	0
3rd	0
Edition	I-DISEASE
(	I-DISEASE
e.g.	0
,	0
chronic	I-DISEASE
insomnia	I-DISEASE
)	0
necessitates	0
a	0
significant	0
departure	0
from	I-DISEASE
the	0
coding	0
approach	I-DISEASE
utilized	0
in	0
ICD-9	0
-	I-DISEASE
CM	I-DISEASE
and	0
International	0
Classification	I-DISEASE
of	I-DISEASE
Sleep	0
Disorders	I-DISEASE
,	I-DISEASE
2nd	0
Edition	0
.	0

This	I-DISEASE
is	I-DISEASE
discussed	0
further	I-DISEASE
below	0
.	0

Introduction	0
Introduction	0
Coding	0
Diagnostic	0
codes	0
for	0
the	0
relevant	I-DISEASE
ICD-9	I-DISEASE
-	I-DISEASE
CM	I-DISEASE
and	0
ICD-10	0
-	0
CM	I-DISEASE
diagnoses	I-DISEASE
can	I-DISEASE
be	0
found	0
at	I-DISEASE
the	0
beginning	I-DISEASE
of	0
each	I-DISEASE
diagnosis	0
section	0
of	I-DISEASE
the	0
book	0
.	0

In	I-DISEASE
the	0
United	I-DISEASE
States	I-DISEASE
,	0
the	0
former	0
codes	0
(	0
ICD-9	0
-	I-DISEASE
CM	0
)	0
should	I-DISEASE
be	0
employed	0
until	0
the	0
implementation	0
date	0
for	0
ICD-10	I-DISEASE
-	I-DISEASE
CM	I-DISEASE
which	0
,	0
at	I-DISEASE
the	0
time	0
of	0
this	0
writing	0
,	0
is	0
to	0
be	0
no	0
sooner	I-DISEASE
than	I-DISEASE
October	I-DISEASE
1	I-DISEASE
,	0
2015	I-DISEASE
.	0

Following	I-DISEASE
that	0
date	0
,	I-DISEASE
only	0
the	0
ICD-10	0
-	0
CM	0
codes	0
should	0
be	0
used	0
.	0

As	I-DISEASE
already	0
stated	0
,	I-DISEASE
clinicians	0
should	0
recognize	I-DISEASE
that	0
there	0
is	0
not	0
precise	I-DISEASE
concordance	I-DISEASE
between	0
the	0
assigned	0
codes	0
for	0
International	0
Classification	I-DISEASE
of	I-DISEASE
Sleep	0
Disorders	I-DISEASE
,	0
3rd	0
Edition	0
diagnoses	I-DISEASE
and	0
the	0
diagno-	0
ses	I-DISEASE
listed	0
within	I-DISEASE
ICD	0
.	0

Changes	I-DISEASE
to	I-DISEASE
the	0
International	0
Classification	I-DISEASE
of	I-DISEASE
Sleep	I-DISEASE
Disorders	I-DISEASE
classification	I-DISEASE
system	0
are	I-DISEASE
not	0
reflected	0
in	I-DISEASE
the	0
ICD	I-DISEASE
system	0
for	I-DISEASE
many	0
years	I-DISEASE
.	0

Moreover	I-DISEASE
,	I-DISEASE
the	0
ICD	0
classification	I-DISEASE
of	I-DISEASE
sleep	0
disorders	0
has	0
historically	0
been	I-DISEASE
significantly	I-DISEASE
less	I-DISEASE
detailed	B-DISEASE
than	I-DISEASE
ICSD	0
(	0
particularly	I-DISEASE
for	0
international	I-DISEASE
users	0
not	0
employing	I-DISEASE
the	0
Clinical	0
Modification	0
(	I-DISEASE
CM	0
)	0
version	I-DISEASE
used	0
in	0
the	0
United	I-DISEASE
States	0
)	0
.	0

Hence	I-DISEASE
,	I-DISEASE
clinicians	0
will	0
find	I-DISEASE
many	0
areas	B-DISEASE
in	0
which	0
assigned	I-DISEASE
codes	0
found	I-DISEASE
in	I-DISEASE
this	0
manual	I-DISEASE
do	I-DISEASE
not	I-DISEASE
correspond	0
as	0
closely	I-DISEASE
as	0
one	0
would	I-DISEASE
like	I-DISEASE
to	I-DISEASE
ICD	0
codes	I-DISEASE
.	0

Most	I-DISEASE
notably	I-DISEASE
,	0
with	I-DISEASE
the	0
collapse	I-DISEASE
of	I-DISEASE
chronic	I-DISEASE
insomnia	0
diagnoses	I-DISEASE
into	I-DISEASE
a	0
single	I-DISEASE
disorder	0
in	0
International	0
Classification	I-DISEASE
of	I-DISEASE
Sleep	0
Disorders	I-DISEASE
,	I-DISEASE
3rd	0
Edition	I-DISEASE
,	I-DISEASE
the	B-DISEASE
assigned	0
codes	0
for	I-DISEASE
this	0
diagnosis	I-DISEASE
within	0
International	0
Classification	I-DISEASE
of	0
Sleep	0
Disorders	0
,	0
3rd	0
Edition	I-DISEASE
are	I-DISEASE
307.42	0
(	0
ICD-9	0
-	0
CM	0
)	0
–	0
“	I-DISEASE
Nonorganic	I-DISEASE
persistent	0
disorder	I-DISEASE
of	I-DISEASE
initiating	I-DISEASE
or	0
maintaining	0
sleep	0
”	I-DISEASE
and	0
F51.01	I-DISEASE
(	I-DISEASE
ICD-10	I-DISEASE
-	0
CM	I-DISEASE
)	0
–	0
“	0
Primary	I-DISEASE
insomnia	0
.	0
”	I-DISEASE

A	I-DISEASE
variety	I-DISEASE
of	I-DISEASE
other	I-DISEASE
insomnia	0
diagnoses	I-DISEASE
will	0
continue	0
to	I-DISEASE
appear	0
in	I-DISEASE
the	0
ICD	I-DISEASE
system	0
but	I-DISEASE
,	0
with	I-DISEASE
the	0
classifi-	I-DISEASE
cation	0
and	0
coding	B-DISEASE
changes	0
recommended	B-DISEASE
herein	I-DISEASE
,	0
these	0
become	I-DISEASE
essentially	0
defunct	0
for	0
sleep	0
medicine	0
clinicians	0
.	0

In	I-DISEASE
summary	I-DISEASE
,	0
the	0
assigned	0
codes	I-DISEASE
in	I-DISEASE
this	I-DISEASE
edition	0
represent	0
“	0
best	0
approximations	I-DISEASE
”	I-DISEASE
to	I-DISEASE
the	0
corresponding	I-DISEASE
ICD	0
codes	0
,	0
but	I-DISEASE
some	I-DISEASE
degree	I-DISEASE
of	I-DISEASE
discrep-	0
ancy	I-DISEASE
between	0
the	0
systems	0
will	0
exist	I-DISEASE
in	0
a	0
number	0
of	0
areas	0
.	0

Insomnia	I-DISEASE
Chronic	0
Insomnia	I-DISEASE
Disorder21	0
Short	0
-	0
Term	I-DISEASE
Insomnia	0
Disorder41	0
Other	0
Insomnia	I-DISEASE
Disorder	I-DISEASE
46	I-DISEASE
Isolated	I-DISEASE
Symptoms	I-DISEASE
and	0
Normal	0
Variants	I-DISEASE
Excessive	I-DISEASE
Time	I-DISEASE
in	0
Bed	0
47	0

Short	I-DISEASE
Sleeper47	I-DISEASE

This	I-DISEASE
section	I-DISEASE
includes	0
sleep	0
disorders	0
chiefly	I-DISEASE
characterized	0
by	I-DISEASE
the	0
complaint	0
of	I-DISEASE
insom-	I-DISEASE
nia	0
.	0

For	I-DISEASE
the	0
purpose	0
of	I-DISEASE
this	0
manual	I-DISEASE
,	I-DISEASE
insomnia	I-DISEASE
is	0
defined	I-DISEASE
as	I-DISEASE
a	I-DISEASE
persistent	0
difficulty	0
with	I-DISEASE
sleep	I-DISEASE
initiation	0
,	0
duration	0
,	0
consolidation	0
,	I-DISEASE
or	0
quality	0
that	0
occurs	0
despite	0
adequate	0
opportunity	0
and	0
circumstances	0
for	0
sleep	0
,	0
and	0
results	0
in	I-DISEASE
some	0
form	0
of	I-DISEASE
daytime	0
impair-	0
ment	I-DISEASE
.	0

These	0
three	I-DISEASE
components	0
of	I-DISEASE
insomnia	0
—	I-DISEASE
persistent	0
sleep	0
difficulty	0
,	I-DISEASE
adequate	I-DISEASE
sleep	I-DISEASE
opportunity	0
,	I-DISEASE
and	0
associated	0
daytime	0
dysfunction	0
—	I-DISEASE
are	0
collectively	0
implied	I-DISEASE
by	0
text	I-DISEASE
references	0
to	I-DISEASE
the	0
term	0
insomnia	I-DISEASE
.	0

Among	I-DISEASE
adults	I-DISEASE
with	0
insomnia	0
,	I-DISEASE
sleep	0
complaints	0
most	0
typically	0
include	I-DISEASE
difficulties	I-DISEASE
initiating	I-DISEASE
or	I-DISEASE
maintaining	I-DISEASE
sleep	0
.	0

Concerns	I-DISEASE
about	I-DISEASE
lengthy	I-DISEASE
periods	I-DISEASE
of	I-DISEASE
nocturnal	0
wakefulness	0
,	I-DISEASE
insufficient	I-DISEASE
amounts	I-DISEASE
of	I-DISEASE
nocturnal	0
sleep	I-DISEASE
,	0
or	0
poor	0
sleep	0
quality	0
often	0
accompany	0
these	I-DISEASE
complaints	0
.	I-DISEASE

Individuals	I-DISEASE
who	I-DISEASE
report	0
these	I-DISEASE
sleep	0
related	0
symptoms	I-DISEASE
in	I-DISEASE
the	0
absence	0
of	I-DISEASE
daytime	0
impairment	I-DISEASE
are	0
not	0
regarded	0
as	0
having	0
an	0
insomnia	0
disorder	0
that	0
warrants	0
clinical	0
attention	0
other	0
than	0
education	0
and	0
reassurance	0
.	0

Insomnia	I-DISEASE
among	0
children	I-DISEASE
is	0
often	0
reported	0
by	0
their	0
caretakers	0
and	0
char-	0
acterized	I-DISEASE
by	I-DISEASE
bedtime	I-DISEASE
resistance	I-DISEASE
,	I-DISEASE
frequent	I-DISEASE
nighttime	0
awakenings	0
and/or	0
an	0
inability	0
to	0
sleep	0
independently	0
.	0

Regardless	I-DISEASE
of	I-DISEASE
the	0
exact	0
nature	0
of	I-DISEASE
the	0
nocturnal	0
sleep	0
concerns	0
,	I-DISEASE
daytime	I-DISEASE
impairments	0
are	I-DISEASE
reported	I-DISEASE
,	0
presumably	0
caused	0
by	I-DISEASE
the	0
nighttime	0
sleep	I-DISEASE
diffi-	0
culties	I-DISEASE
or	0
by	B-DISEASE
some	I-DISEASE
common	I-DISEASE
but	I-DISEASE
unidentified	0
mechanism	0
during	I-DISEASE
sleep	0
and	0
wakeful-	0
ness	0
.	0

Daytime	I-DISEASE
symptoms	I-DISEASE
typically	0
include	0
fatigue	I-DISEASE
,	I-DISEASE
decreased	I-DISEASE
mood	0
or	0
irritability	I-DISEASE
,	0
general	0
malaise	I-DISEASE
,	0
and	0
cognitive	0
impairment	0
.	0

Among	I-DISEASE
adults	I-DISEASE
,	0
chronic	I-DISEASE
insomnia	0
may	I-DISEASE
impair	0
social	I-DISEASE
or	I-DISEASE
vocational	0
functioning	I-DISEASE
and	0
reduce	I-DISEASE
quality	0
of	I-DISEASE
life	0
,	0
whereas	I-DISEASE
in	I-DISEASE
chil-	I-DISEASE
dren	0
it	0
may	0
lead	0
to	I-DISEASE
poor	0
school	0
performance	0
,	I-DISEASE
impaired	I-DISEASE
attention	0
,	0
and	0
behavioral	0
disturbance	0
.	0

In	I-DISEASE
some	I-DISEASE
patients	0
,	I-DISEASE
physical	0
symptoms	I-DISEASE
such	0
as	I-DISEASE
muscle	0
tension	0
,	0
palpita-	0
tions	0
,	0
or	0
headache	I-DISEASE
may	0
also	0
be	0
attributed	0
to	I-DISEASE
the	0
insomnia	I-DISEASE
.	0

Others	I-DISEASE
with	I-DISEASE
more	0
severe	I-DISEASE
forms	0
of	I-DISEASE
insomnia	0
may	0
be	0
at	I-DISEASE
increased	I-DISEASE
risk	0
for	0
motor	I-DISEASE
vehicle	I-DISEASE
and	0
work	0
-	0
site	0
acci-	0
dents	0
as	0
well	I-DISEASE
as	0
psychiatric	0
and	0
cardiovascular	I-DISEASE
disorders	0
.	0

Insomnia	I-DISEASE
often	0
accompa-	0
nies	0
comorbid	I-DISEASE
medical	0
illnesses	I-DISEASE
,	0
mental	0
disorders	0
,	0
and	0
other	I-DISEASE
sleep	0
disorders	0
.	0

It	I-DISEASE
may	0
also	0
arise	I-DISEASE
in	0
association	I-DISEASE
with	I-DISEASE
the	0
use	0
,	0
abuse	I-DISEASE
,	I-DISEASE
or	I-DISEASE
exposure	I-DISEASE
to	0
certain	0
substances	I-DISEASE
.	I-DISEASE

When	I-DISEASE
insomnia	0
occurs	0
comorbid	I-DISEASE
to	0
these	0
conditions	I-DISEASE
and	0
is	I-DISEASE
persistent	0
and	0
prominent	0
,	I-DISEASE
a	I-DISEASE
sep-	0
arate	0
insomnia	0
diagnosis	0
is	I-DISEASE
warranted	I-DISEASE
.	0

Insomnia	I-DISEASE
The	I-DISEASE
insomnia	I-DISEASE
nosology	0
presented	I-DISEASE
in	I-DISEASE
this	I-DISEASE
text	B-DISEASE
represents	I-DISEASE
a	0
marked	I-DISEASE
departure	0
from	0
the	0
previous	I-DISEASE
International	0
Classification	I-DISEASE
of	I-DISEASE
Sleep	I-DISEASE
Disorders	0
,	I-DISEASE
2nd	0
Edition	B-DISEASE
insomnia	0
classification	I-DISEASE
system	0
in	0
terms	I-DISEASE
of	I-DISEASE
its	0
conceptual	I-DISEASE
framework	0
and	0
relative	I-DISEASE
simplicity	I-DISEASE
.	0

The	I-DISEASE
previous	I-DISEASE
insomnia	0
nosology	0
of	I-DISEASE
the	0
International	B-DISEASE
Classification	I-DISEASE
of	I-DISEASE
Sleep	I-DISEASE
Disorders	0
promoted	I-DISEASE
the	0
concept	0
that	0
insomnia	0
can	0
exist	I-DISEASE
as	0
a	I-DISEASE
primary	0
sleep	0
disorder	0
or	B-DISEASE
arise	I-DISEASE
as	0
a	I-DISEASE
secondary	0
form	I-DISEASE
of	0
sleep	0
disturbance	I-DISEASE
related	0
to	0
an	0
underlying	0
primary	0
psychiatric	I-DISEASE
,	I-DISEASE
medical	I-DISEASE
,	I-DISEASE
or	I-DISEASE
substance	I-DISEASE
abuse	I-DISEASE
disorder	0
.	0

However	I-DISEASE
,	0
many	0
symptoms	I-DISEASE
and	0
associated	0
fea-	I-DISEASE
tures	0
of	I-DISEASE
so	I-DISEASE
-	0
called	0
primary	0
and	0
secondary	I-DISEASE
insomnias	0
are	0
overlapping	0
,	0
thus	I-DISEASE
making	0
differentiation	0
among	0
such	0
subtypes	I-DISEASE
difficult	0
,	0
if	0
not	0
impossible	0
.	0

There	I-DISEASE
is	I-DISEASE
increas-	0
ing	0
recognition	I-DISEASE
that	0
even	0
when	0
insomnia	I-DISEASE
arises	0
“	0
secondary	0
”	I-DISEASE
to	0
another	0
condition	0
,	0
it	0
often	0
develops	0
an	I-DISEASE
independent	0
course	I-DISEASE
over	0
time	I-DISEASE
and	0
may	I-DISEASE
remain	0
as	0
a	0
clinically	0
significant	0
condition	0
,	0
even	0
if	0
the	0
so	0
-	0
called	I-DISEASE
primary	I-DISEASE
condition	0
is	I-DISEASE
adequately	B-DISEASE
treated	0
.	0

Evidence	I-DISEASE
suggests	I-DISEASE
that	0
insomnia	0
,	0
if	I-DISEASE
left	0
untreated	0
,	I-DISEASE
may	I-DISEASE
adversely	0
affect	0
the	I-DISEASE
outcome	0
of	0
these	I-DISEASE
comorbid	I-DISEASE
conditions	I-DISEASE
.	0

Moreover	I-DISEASE
,	I-DISEASE
it	0
appears	I-DISEASE
that	0
treatment	I-DISEASE
of	I-DISEASE
the	0
insomnia	0
may	I-DISEASE
improve	I-DISEASE
outcome	0
of	I-DISEASE
both	I-DISEASE
the	0
sleep	I-DISEASE
disturbance	0
and	0
the	0
comorbid	I-DISEASE
conditions	I-DISEASE
.	0

Given	I-DISEASE
these	I-DISEASE
observations	0
,	I-DISEASE
insomnia	0
seems	I-DISEASE
best	0
viewed	0
as	0
a	0
comorbid	I-DISEASE
disorder	I-DISEASE
that	0
warrants	I-DISEASE
separate	0
treatment	I-DISEASE
attention	0
.	0

In	I-DISEASE
addition	0
to	0
the	0
primary	0
vs.	0
secondary	0
insomnia	0
distinction	0
,	I-DISEASE
prior	I-DISEASE
editions	0
of	I-DISEASE
the	0
International	B-DISEASE
Classification	0
of	0
Sleep	0
Disorders	0
delineated	0
multiple	I-DISEASE
putative	0
“	I-DISEASE
primary	0
insomnia	0
”	I-DISEASE
diagnostic	0
subtypes	0
.	0

Specifically	I-DISEASE
,	I-DISEASE
both	0
the	0
original	0
1990	0
version	I-DISEASE
of	I-DISEASE
the	0
International	0
Classification	I-DISEASE
of	I-DISEASE
Sleep	I-DISEASE
Disorders	I-DISEASE
and	0
the	I-DISEASE
International	0
Classification	0
of	I-DISEASE
Sleep	0
Disorders	I-DISEASE
,	I-DISEASE
2nd	0
Edition	I-DISEASE
described	0
primary	0
insomnia	I-DISEASE
subtypes	I-DISEASE
such	0
as	0
psycho-	0
physiological	0
insomnia	0
,	I-DISEASE
idiopathic	I-DISEASE
insomnia	0
,	0
inadequate	0
sleep	0
hygiene	I-DISEASE
,	0
and	0
paradox-	I-DISEASE
ical	I-DISEASE
insomnia	I-DISEASE
,	I-DISEASE
as	0
discrete	0
diagnostic	0
entities	0
.	0

Experience	I-DISEASE
suggests	I-DISEASE
that	0
,	I-DISEASE
in	0
practice	I-DISEASE
,	I-DISEASE
it	I-DISEASE
is	0
rare	0
to	0
encounter	I-DISEASE
patients	I-DISEASE
who	I-DISEASE
meet	0
the	0
diagnostic	0
criteria	I-DISEASE
for	0
exclusively	I-DISEASE
one	0
of	I-DISEASE
these	I-DISEASE
subtypes	I-DISEASE
.	0

In	I-DISEASE
fact	I-DISEASE
,	0
many	0
of	0
the	0
diagnostic	0
criteria	I-DISEASE
delineated	0
for	0
these	I-DISEASE
subtypes	I-DISEASE
represent	0
generic	0
characteristics	0
(	0
e.g.	0
,	I-DISEASE
engaging	I-DISEASE
in	0
sleep	0
-	0
disruptive	I-DISEASE
habits	I-DISEASE
;	0
underesti-	0
mation	0
of	I-DISEASE
sleep	0
time	0
,	0
evidence	0
of	I-DISEASE
conditioned	0
arousal	I-DISEASE
)	0
of	I-DISEASE
insomnia	0
,	0
per	0
se	0
,	0
and	0
do	0
not	0
facilitate	0
discrimination	0
among	0
these	I-DISEASE
subtypes	I-DISEASE
or	I-DISEASE
between	0
these	I-DISEASE
subtypes	I-DISEASE
and	0
those	I-DISEASE
presumed	0
to	0
have	0
“	0
secondary	0
”	I-DISEASE
forms	0
of	I-DISEASE
insomnia	0
.	0

Both	I-DISEASE
clinical	0
experience	0
and	0
a	0
growing	0
body	I-DISEASE
of	I-DISEASE
empirical	0
findings	0
have	0
shown	I-DISEASE
that	I-DISEASE
the	0
diagnostic	0
distinctions	0
advocated	I-DISEASE
by	0
previous	0
versions	0
of	I-DISEASE
the	0
International	B-DISEASE
Classification	I-DISEASE
of	I-DISEASE
Sleep	0
Disorders	I-DISEASE
are	I-DISEASE
difficult	0
to	0
reliably	B-DISEASE
ascertain	0
and	0
are	0
of	I-DISEASE
question-	0
able	0
validity	I-DISEASE
.	I-DISEASE

In	I-DISEASE
view	I-DISEASE
of	I-DISEASE
such	I-DISEASE
considerations	0
,	I-DISEASE
the	0
current	I-DISEASE
manual	0
abandons	0
the	0
previ-	I-DISEASE
ously	0
employed	0
complex	0
and	0
highly	0
specific	I-DISEASE
insomnia	I-DISEASE
classification	0
scheme	I-DISEASE
described	0
by	I-DISEASE
the	0
original	I-DISEASE
International	0
Classification	I-DISEASE
of	I-DISEASE
Sleep	0
Disorders	I-DISEASE
and	0
the	0
2nd	0
Edition	0
in	0
favor	I-DISEASE
of	I-DISEASE
a	I-DISEASE
more	0
global	I-DISEASE
and	0
defensible	0
nosology	0
.	0

The	I-DISEASE
manual	I-DISEASE
includes	0
three	I-DISEASE
diagnostic	0
categories	I-DISEASE
for	0
insomnia	I-DISEASE
:	0
chronic	I-DISEASE
insomnia	I-DISEASE
disorder	I-DISEASE
,	I-DISEASE
short	0
-	0
term	0
insomnia	I-DISEASE
disorder	I-DISEASE
,	I-DISEASE
and	0
other	0
insomnia	I-DISEASE
disorder	0
.	0

These	0
diag-	I-DISEASE
noses	0
apply	I-DISEASE
to	I-DISEASE
patients	0
with	0
and	0
without	0
comorbidities	I-DISEASE
regardless	0
of	I-DISEASE
whether	0
those	0
comorbidities	I-DISEASE
are	0
viewed	0
as	0
potentially	I-DISEASE
sleep	0
disruptive	I-DISEASE
.	0

Chronic	I-DISEASE
insomnia	0
disorder	I-DISEASE
is	0
characterized	0
by	0
chronic	0
sleep	0
onset	I-DISEASE
and/or	0
sleep	0
maintenance	I-DISEASE
complaints	0
with	0
asso-	0
ciated	I-DISEASE
daytime	0
impairment	I-DISEASE
,	0
and	0
is	0
reserved	B-DISEASE
for	0
individuals	I-DISEASE
whose	0
sleep	0
difficulties	0
exceed	0
minimal	I-DISEASE
frequency	I-DISEASE
and	0
duration	0
thresholds	0
shown	I-DISEASE
to	0
be	I-DISEASE
associated	0
with	I-DISEASE
clin-	I-DISEASE
ically	0
significant	0
morbidity	0
outcomes	0
.	0

Short	I-DISEASE
-	I-DISEASE
term	0
insomnia	I-DISEASE
disorder	I-DISEASE
is	I-DISEASE
characterized	0
by	I-DISEASE
sleep	0
/	0
wake	I-DISEASE
difficulties	I-DISEASE
that	0
fail	I-DISEASE
to	I-DISEASE
meet	I-DISEASE
the	0
minimal	0
frequency	I-DISEASE
and	0
duration	0
criteria	0
of	I-DISEASE
chronic	I-DISEASE
insomnia	0
disorder	I-DISEASE
.	0

Nonetheless	I-DISEASE
,	I-DISEASE
short	0
-	I-DISEASE
term	0
insomnia	I-DISEASE
disorder	0
is	0
associated	0
with	I-DISEASE
clinically	I-DISEASE
significant	0
sleep	0
dissatisfaction	I-DISEASE
or	0
waking	0
impairment	0
.	0

Other	I-DISEASE
insomnia	I-DISEASE
disorders	0
should	I-DISEASE
be	I-DISEASE
assigned	I-DISEASE
to	0
those	0
rare	0
cases	0
that	I-DISEASE
fail	I-DISEASE
to	0
meet	0
criteria	I-DISEASE
for	I-DISEASE
short-	0
term	0
insomnia	0
disorder	0
,	I-DISEASE
yet	0
are	0
thought	0
to	I-DISEASE
have	0
sufficient	I-DISEASE
symptoms	0
of	I-DISEASE
insomnia	I-DISEASE
to	0
warrant	I-DISEASE
clinical	0
attention	0
.	0

Chronic	I-DISEASE
Insomnia	0
Disorder	I-DISEASE
ICD-9	0
-	I-DISEASE
CM	0
code	0
:	I-DISEASE
307.42	0
ICD-10	0
-	I-DISEASE
CM	0
code	0
:	I-DISEASE

F51.01	I-DISEASE
Alternate	0
Names	I-DISEASE
Chronic	I-DISEASE
insomnia	0
,	I-DISEASE
primary	I-DISEASE
insomnia	I-DISEASE
,	I-DISEASE
secondary	I-DISEASE
insomnia	0
,	0
comorbid	I-DISEASE
insomnia	I-DISEASE
,	I-DISEASE
disor-	I-DISEASE
der	0
of	I-DISEASE
initiating	I-DISEASE
and	0
maintaining	0
sleep	0
,	0
behavioral	0
insomnia	0
of	I-DISEASE
childhood	I-DISEASE
,	I-DISEASE
sleep	I-DISEASE
-	0
onset	0
association	0
disorder	0
,	0
limit	0
-	0
setting	0
sleep	0
disorder	0
.	0

Diagnostic	I-DISEASE
Criteria	0
Criteria	I-DISEASE
A	0
-	I-DISEASE
F	I-DISEASE
must	I-DISEASE
be	0
met	0
A.	0

The	I-DISEASE
patient	I-DISEASE
reports	0
,	I-DISEASE
or	0
the	0
patient	I-DISEASE
’s	I-DISEASE
parent	0
or	I-DISEASE
caregiver	I-DISEASE
observes	I-DISEASE
,	I-DISEASE
one	I-DISEASE
or	I-DISEASE
more	0
of	I-DISEASE
the	0
following:1	0
.	0

Difficulty	I-DISEASE
initiating	I-DISEASE
sleep	0
.	0
.	0

Difficulty	I-DISEASE
maintaining	I-DISEASE
sleep	I-DISEASE
.	I-DISEASE
.	0

Waking	I-DISEASE
up	0
earlier	0
than	0
desired	I-DISEASE
.	0
.	I-DISEASE

Resistance	I-DISEASE
to	I-DISEASE
going	I-DISEASE
to	I-DISEASE
bed	0
on	0
appropriate	I-DISEASE
schedule	I-DISEASE
.	0
.	0

Difficulty	I-DISEASE
sleeping	I-DISEASE
without	0
parent	I-DISEASE
or	B-DISEASE
caregiver	0
intervention	I-DISEASE
.	0

B.	0
The	I-DISEASE
patient	I-DISEASE
reports	0
,	I-DISEASE
or	I-DISEASE
the	B-DISEASE
patient	I-DISEASE
’s	I-DISEASE
parent	0
or	I-DISEASE
caregiver	I-DISEASE
observes	I-DISEASE
,	I-DISEASE
one	0
or	0
more	0
of	I-DISEASE
the	0
following	0
related	0
to	I-DISEASE
the	0
nighttime	I-DISEASE
sleep	0
difficulty	0
:	B-DISEASE
.	0

Fatigue	I-DISEASE
/	I-DISEASE
malaise	0
.	I-DISEASE
.	0

Attention	I-DISEASE
,	I-DISEASE
concentration	0
,	I-DISEASE
or	I-DISEASE
memory	0
impairment	0
.	0
.	I-DISEASE

Impaired	I-DISEASE
social	0
,	I-DISEASE
family	0
,	I-DISEASE
occupational	I-DISEASE
,	0
or	0
academic	I-DISEASE
performance	I-DISEASE
.	0

Insomnia	I-DISEASE
Insomnia	0
.	0

Mood	I-DISEASE
disturbance	0
/	I-DISEASE
irritability	0
.	0
.	0

Daytime	I-DISEASE
sleepiness	0
.	0
.	0

Behavioral	I-DISEASE
problems	0
(	I-DISEASE
e.g.	0
,	0
hyperactivity	I-DISEASE
,	I-DISEASE
impulsivity	I-DISEASE
,	I-DISEASE
aggression	0
)	0
.	0

7	0
.	0
Reduced	0
motivation	I-DISEASE
/	0
energy	I-DISEASE
/	0
initiative	0
.	0
.	0

Proneness	I-DISEASE
for	I-DISEASE
errors	I-DISEASE
/	0
accidents	0
.	0
.	0

Concerns	I-DISEASE
about	I-DISEASE
or	0
dissatisfaction	I-DISEASE
with	0
sleep	0
.	0

C.	I-DISEASE

The	I-DISEASE
reported	I-DISEASE
sleep	0
/	I-DISEASE
wake	0
complaints	0
can	I-DISEASE
not	0
be	0
explained	0
purely	I-DISEASE
by	I-DISEASE
inadequate	I-DISEASE
opportunity	I-DISEASE
(	0
i.e.	I-DISEASE
,	0
enough	I-DISEASE
time	0
is	I-DISEASE
allotted	0
for	0
sleep	I-DISEASE
)	0
or	I-DISEASE
inadequate	0
circumstances	0
(	I-DISEASE
i.e.	B-DISEASE
,	0
the	0
environment	0
is	0
safe	0
,	0
dark	0
,	0
quiet	0
,	I-DISEASE
and	0
comfortable	I-DISEASE
)	0
for	I-DISEASE
sleep	0
.	0

D.	I-DISEASE
The	I-DISEASE
sleep	0
disturbance	0
and	0
associated	0
daytime	I-DISEASE
symptoms	I-DISEASE
occur	0
at	I-DISEASE
least	0
three	I-DISEASE
times	I-DISEASE
per	0
week	0
.	0

E.	I-DISEASE

The	I-DISEASE
sleep	0
disturbance	0
and	0
associated	0
daytime	I-DISEASE
symptoms	I-DISEASE
have	I-DISEASE
been	I-DISEASE
present	0
for	0
at	I-DISEASE
least	I-DISEASE
three	I-DISEASE
months.2	0
F.	I-DISEASE
The	I-DISEASE
sleep	0
/	0
wake	0
difficulty	0
is	0
not	0
better	0
explained	I-DISEASE
by	0
another	I-DISEASE
sleep	0
disorder	B-DISEASE
.	0

Notes	I-DISEASE
.	0

Reports	I-DISEASE
of	I-DISEASE
difficulties	0
initiating	I-DISEASE
sleep	0
,	I-DISEASE
difficulties	0
maintaining	0
sleep	0
,	I-DISEASE
or	I-DISEASE
waking	0
up	I-DISEASE
too	0
early	0
can	I-DISEASE
be	0
seen	0
in	I-DISEASE
all	0
age	I-DISEASE
groups	0
.	0

Resistance	I-DISEASE
going	I-DISEASE
to	0
bed	I-DISEASE
on	0
an	I-DISEASE
appropriate	I-DISEASE
schedule	I-DISEASE
and	0
difficulty	0
sleeping	0
without	0
parent	I-DISEASE
or	I-DISEASE
caregiver	0
intervention	I-DISEASE
is	0
seen	0
most	0
commonly	0
in	I-DISEASE
children	B-DISEASE
and	0
older	0
adults	B-DISEASE
who	I-DISEASE
require	0
the	I-DISEASE
supervision	0
of	I-DISEASE
a	0
caretaker	0
due	I-DISEASE
to	I-DISEASE
a	0
significant	0
level	0
of	I-DISEASE
functional	0
impairment	0
(	I-DISEASE
e.g.	I-DISEASE
,	0
those	0
with	0
dementia	0
)	0
.	0
.	0

Some	I-DISEASE
patients	0
with	0
chronic	I-DISEASE
insomnia	0
may	I-DISEASE
show	0
recurrent	0
episodes	I-DISEASE
of	I-DISEASE
sleep	0
/	0
wake	0
difficulties	I-DISEASE
lasting	0
several	0
weeks	0
at	I-DISEASE
a	0
time	0
over	0
several	0
years	I-DISEASE
,	0
yet	0
not	0
meet	0
the	0
three	I-DISEASE
-	0
month	0
duration	0
criterion	0
for	0
any	0
single	I-DISEASE
such	0
episode	0
.	0

Nonetheless	I-DISEASE
,	I-DISEASE
these	I-DISEASE
patients	I-DISEASE
should	0
be	I-DISEASE
assigned	I-DISEASE
a	I-DISEASE
diagnosis	0
of	I-DISEASE
chronic	I-DISEASE
insomnia	I-DISEASE
disorder	0
,	I-DISEASE
given	0
the	I-DISEASE
persistence	0
of	I-DISEASE
their	0
intermittent	I-DISEASE
sleep	0
difficulties	0
over	I-DISEASE
time	0
.	I-DISEASE
.	0

Some	I-DISEASE
patients	0
who	0
use	I-DISEASE
hypnotic	0
medications	0
regularly	0
may	I-DISEASE
sleep	I-DISEASE
well	I-DISEASE
and	0
not	0
meet	0
the	0
criteria	0
for	0
an	0
insomnia	0
disorder	0
when	0
they	0
take	0
such	0
medications	I-DISEASE
.	0

However	I-DISEASE
,	I-DISEASE
in	0
the	0
absence	0
of	I-DISEASE
such	0
medications	I-DISEASE
these	0
same	0
patients	0
may	I-DISEASE
meet	I-DISEASE
the	0
above	0
criteria	0
.	0

This	I-DISEASE
diagnosis	I-DISEASE
would	0
apply	I-DISEASE
to	0
those	I-DISEASE
patients	I-DISEASE
particularly	0
if	0
they	0
present	I-DISEASE
clinically	0
and	0
voice	I-DISEASE
concerns	I-DISEASE
about	0
their	I-DISEASE
inability	0
to	0
sleep	0
without	0
their	I-DISEASE
sleep	0
medications	0
.	0
.	0

Many	0
comorbid	I-DISEASE
conditions	0
such	0
as	0
chronic	I-DISEASE
pain	0
disorders	0
or	0
gast-	I-DISEASE
roesophageal	0
reflux	0
disease	I-DISEASE
(	I-DISEASE
GERD	I-DISEASE
)	0
may	I-DISEASE
cause	I-DISEASE
the	I-DISEASE
sleep	0
/	0
wake	0
complaints	0
delineated	I-DISEASE
here	0
.	0

When	I-DISEASE
such	0
conditions	0
are	I-DISEASE
the	0
sole	0
cause	I-DISEASE
of	I-DISEASE
the	0
sleep	0
difficulty	0
,	I-DISEASE
a	I-DISEASE
separate	I-DISEASE
insomnia	0
diagnosis	I-DISEASE
may	0
not	0
apply	0
.	0

However	I-DISEASE
,	I-DISEASE
in	0
many	0
patients	0
such	0
conditions	I-DISEASE
are	I-DISEASE
chronic	0
and	0
are	0
not	0
the	I-DISEASE
sole	0
cause	0
of	I-DISEASE
sleep	0
difficulty	0
.	0

Key	I-DISEASE
determining	I-DISEASE
factors	0
in	I-DISEASE
the	0
decision	I-DISEASE
to	I-DISEASE
invoke	I-DISEASE
a	0
separate	0
insomnia	I-DISEASE
diagnosis	0
include	I-DISEASE
:	I-DISEASE
“	I-DISEASE
How	0
much	0
of	I-DISEASE
the	0
time	0
does	0
the	0
sleep	I-DISEASE
difficulty	0
arise	I-DISEASE
as	0
a	I-DISEASE
result	0
of	I-DISEASE
factors	0
directly	B-DISEASE
attributable	I-DISEASE
to	0
the	0
comorbid	0
condition	0
(	I-DISEASE
e.g.	I-DISEASE
,	0
pain	0
or	0
GERD	0
)	0
?	0
”	I-DISEASE

or	I-DISEASE
“	I-DISEASE
Are	0
there	I-DISEASE
times	0
that	0
the	0
sleep	0
/	0
wake	0
complaints	0
occur	I-DISEASE
in	I-DISEASE
the	0
absence	0
of	I-DISEASE
these	I-DISEASE
factors	I-DISEASE
?	0
”	I-DISEASE

“	I-DISEASE
Have	I-DISEASE
perpetuating	0
cognitive	I-DISEASE
or	I-DISEASE
behavioral	I-DISEASE
factors	0
(	I-DISEASE
e.g.	0
,	0
negative	I-DISEASE
expectations	I-DISEASE
,	I-DISEASE
conditioned	0
arousal	0
,	I-DISEASE
sleep	0
-	0
disruptive	B-DISEASE
habits	I-DISEASE
)	0
arisen	I-DISEASE
,	I-DISEASE
suggesting	0
an	B-DISEASE
autonomous	0
aspect	0
to	I-DISEASE
the	0
ongoing	I-DISEASE
insomnia	0
?	0
”	I-DISEASE

If	I-DISEASE
there	I-DISEASE
is	0
evidence	0
that	0
the	0
patient	I-DISEASE
’s	I-DISEASE
sleep/	0
wake	0
complaints	I-DISEASE
are	I-DISEASE
not	0
solely	0
caused	0
by	I-DISEASE
the	0
medical	0
condition	I-DISEASE
,	0
and	0
those	0
sleep	0
/	0
wake	0
complaints	0
seem	0
to	I-DISEASE
merit	0
separate	B-DISEASE
treatment	I-DISEASE
attention	0
,	I-DISEASE
then	0
a	0
diagnosis	0
of	I-DISEASE
chronic	I-DISEASE
insomnia	0
disorder	0
should	I-DISEASE
be	I-DISEASE
made	0
.	0

Essential	I-DISEASE
Features	I-DISEASE
The	I-DISEASE
essential	0
feature	0
of	I-DISEASE
chronic	I-DISEASE
insomnia	I-DISEASE
disorder	0
is	I-DISEASE
a	I-DISEASE
frequent	I-DISEASE
and	0
persistent	0
difficulty	0
initiating	I-DISEASE
or	I-DISEASE
maintaining	0
sleep	0
that	0
results	I-DISEASE
in	I-DISEASE
general	0
sleep	0
dissatisfaction	0
.	0

The	I-DISEASE
sleep	0
complaint	I-DISEASE
is	I-DISEASE
accompanied	0
by	I-DISEASE
distress	I-DISEASE
about	I-DISEASE
poor	0
sleep	0
and/or	0
impairment	I-DISEASE
in	I-DISEASE
family	I-DISEASE
,	0
social	0
,	I-DISEASE
vocational	0
,	I-DISEASE
academic	I-DISEASE
,	I-DISEASE
or	I-DISEASE
other	0
important	0
areas	0
of	I-DISEASE
functioning	I-DISEASE
.	0

Furthermore	I-DISEASE
,	I-DISEASE
the	0
sleep	0
disturbance	0
and	0
associated	0
waking	0
symptoms	I-DISEASE
occur	0
despite	0
having	I-DISEASE
adequate	I-DISEASE
time	I-DISEASE
and	0
circumstances	0
each	I-DISEASE
night	I-DISEASE
to	0
obtain	I-DISEASE
necessary	0
sleep	0
.	0

Chronic	I-DISEASE
insomnia	0
dis-	I-DISEASE
order	0
can	0
occur	I-DISEASE
in	I-DISEASE
isolation	I-DISEASE
or	I-DISEASE
comorbidly	I-DISEASE
with	0
a	0
mental	0
disorder	I-DISEASE
,	I-DISEASE
medical	I-DISEASE
condition	0
,	I-DISEASE
or	0
substance	I-DISEASE
use	0
.	0

The	I-DISEASE
sleep	0
complaints	0
that	0
comprise	0
chronic	I-DISEASE
insomnia	I-DISEASE
disorder	0
may	I-DISEASE
include	I-DISEASE
difficul-	I-DISEASE
ties	I-DISEASE
initiating	0
sleep	0
or	0
difficulties	0
maintaining	0
sleep	I-DISEASE
.	0

The	I-DISEASE
latter	I-DISEASE
complaint	I-DISEASE
may	I-DISEASE
include	0
waking	0
up	I-DISEASE
during	I-DISEASE
the	0
night	0
with	I-DISEASE
difficulty	0
returning	I-DISEASE
to	I-DISEASE
sleep	0
or	I-DISEASE
having	I-DISEASE
a	I-DISEASE
final	0
awaken-	0
ing	I-DISEASE
occurring	0
too	0
early	I-DISEASE
,	0
well	I-DISEASE
before	0
the	I-DISEASE
desired	I-DISEASE
rising	I-DISEASE
time	0
.	B-DISEASE

Chronic	I-DISEASE
insomnia	I-DISEASE
disorder	I-DISEASE
may	I-DISEASE
be	I-DISEASE
characterized	0
solely	0
by	I-DISEASE
sleep	I-DISEASE
onset	I-DISEASE
or	I-DISEASE
sleep	0
maintenance	I-DISEASE
complaints	I-DISEASE
or	I-DISEASE
,	0
more	0
commonly	I-DISEASE
,	I-DISEASE
by	I-DISEASE
both	I-DISEASE
types	I-DISEASE
of	I-DISEASE
complaints	0
occurring	I-DISEASE
together	I-DISEASE
.	0

Individuals	I-DISEASE
’	I-DISEASE
sleep	0
com-	I-DISEASE
plaints	I-DISEASE
may	I-DISEASE
also	0
change	0
over	0
time	I-DISEASE
such	I-DISEASE
that	0
those	0
with	0
solely	0
sleep	I-DISEASE
onset	0
complaints	0
may	I-DISEASE
subsequently	I-DISEASE
develop	I-DISEASE
sleep	0
maintenance	I-DISEASE
complaints	0
and	0
vice	I-DISEASE
versa	0
.	0

Also	I-DISEASE
,	I-DISEASE
those	0
who	I-DISEASE
present	0
initially	I-DISEASE
with	I-DISEASE
mixed	I-DISEASE
sleep	0
onset	0
and	0
sleep	0
maintenance	I-DISEASE
difficulties	I-DISEASE
may	0
later	0
evidence	0
one	I-DISEASE
or	0
the	0
other	I-DISEASE
of	I-DISEASE
these	I-DISEASE
difficulties	0
but	0
not	0
both	0
.	0

Complaints	I-DISEASE
about	0
poor	I-DISEASE
-	I-DISEASE
quality	0
,	0
unrefreshing	0
,	I-DISEASE
or	0
nonrestorative	I-DISEASE
sleep	0
often	0
accompany	0
sleep	0
onset	0
and	0
sleep	I-DISEASE
maintenance	0
complaints	0
,	I-DISEASE
but	I-DISEASE
do	I-DISEASE
not	0
suffice	0
to	I-DISEASE
define	0
insomnia	0
disorder	0
when	0
occurring	0
as	0
the	0
sole	0
sleep	I-DISEASE
complaint	I-DISEASE
.	0

The	I-DISEASE
degree	I-DISEASE
of	I-DISEASE
sleep	0
disturbance	0
required	I-DISEASE
to	I-DISEASE
assign	I-DISEASE
a	0
chronic	0
insomnia	I-DISEASE
disorder	I-DISEASE
diag-	0

nosis	I-DISEASE
is	0
somewhat	I-DISEASE
arbitrary	0
in	I-DISEASE
that	0
it	I-DISEASE
relies	0
primarily	I-DISEASE
on	0
individuals	I-DISEASE
’	I-DISEASE
subjective	I-DISEASE
sleep	0
Insomnia	I-DISEASE
Insomnia	0
complaints	0
.	0

Moreover	I-DISEASE
,	I-DISEASE
the	0
degree	I-DISEASE
of	0
sleep	0
disturbance	I-DISEASE
required	I-DISEASE
to	0
connote	0
clinical	0
significance	I-DISEASE
varies	I-DISEASE
across	I-DISEASE
age	I-DISEASE
groups	0
.	I-DISEASE

Nonetheless	I-DISEASE
,	I-DISEASE
sleep	0
onset	I-DISEASE
latencies	0
and	0
periods	I-DISEASE
of	I-DISEASE
wakefulness	0
after	0
sleep	I-DISEASE
onset	I-DISEASE
>	0
20	0
minutes	0
generally	I-DISEASE
connote	0
clinically	I-DISEASE
significant	0
sleep	0
disturbances	I-DISEASE
in	0
children	I-DISEASE
and	0
young	I-DISEASE
adults	I-DISEASE
.	0

In	I-DISEASE
middle	I-DISEASE
and	0
older	0
aged	0
adults	I-DISEASE
,	I-DISEASE
onset	I-DISEASE
latencies	I-DISEASE
and	0
periods	I-DISEASE
of	I-DISEASE
wakefulness	0
during	I-DISEASE
sleep	0
>	0
30	0
minutes	0
typically	0
connote	0
clin-	I-DISEASE
ical	0
significance	I-DISEASE
.	0

Complaints	I-DISEASE
of	0
early	0
morning	0
awakening	0
are	0
less	I-DISEASE
well	I-DISEASE
defined	I-DISEASE
,	I-DISEASE
but	0
typically	0
entail	I-DISEASE
the	0
termination	0
of	I-DISEASE
sleep	0
at	I-DISEASE
least	0
30	0
minutes	0
before	0
the	I-DISEASE
desired	0
rising	I-DISEASE
time	0
and	0
a	0
concomitant	0
reduced	0
total	0
sleep	0
time	0
compared	I-DISEASE
with	0
the	0
usual	I-DISEASE
premorbid	0
sleep	I-DISEASE
pattern	0
.	0

The	I-DISEASE
exact	0
time	0
at	I-DISEASE
which	0
early	0
morning	0
awakenings	0
occur	I-DISEASE
may	I-DISEASE
vary	I-DISEASE
con-	I-DISEASE
siderably	0
as	0
a	0
function	0
of	I-DISEASE
usual	I-DISEASE
bedtimes	I-DISEASE
.	0

For	I-DISEASE
example	0
,	0
a	0
final	0
awakening	0
at	I-DISEASE
4:00	0
a.m.	0
is	I-DISEASE
likely	0
to	I-DISEASE
connote	0
clinical	0
significance	I-DISEASE
when	0
the	0
usual	I-DISEASE
bedtime	I-DISEASE
is	I-DISEASE
11:00	0
p.m.	0

but	I-DISEASE
not	0
when	0
the	0
usual	0
bedtime	I-DISEASE
occurs	0
at	I-DISEASE
9:00	0
p.m.	I-DISEASE

Symptoms	I-DISEASE
during	I-DISEASE
wakefulness	0
accompany	I-DISEASE
the	0
sleep	0
difficulties	I-DISEASE
and	0
result	I-DISEASE
in	I-DISEASE
the	0
impairment	0
of	0
normal	0
functioning	I-DISEASE
.	0

Common	I-DISEASE
waking	0
symptoms	I-DISEASE
include	I-DISEASE
fatigue	0
;	I-DISEASE
reduced	0
motivation	I-DISEASE
;	0
reduced	0
concentration	0
,	I-DISEASE
attention	I-DISEASE
,	I-DISEASE
and	0
memory	0
functioning	I-DISEASE
;	I-DISEASE
and	0
irritability	0
or	0
reduced	0
mood	0
.	0

Complaints	I-DISEASE
of	0
subjective	I-DISEASE
daytime	0
sleepiness	0
are	0
also	0
common	I-DISEASE
,	I-DISEASE
although	I-DISEASE
,	0
in	I-DISEASE
contrast	I-DISEASE
to	I-DISEASE
patients	0
with	0
hypersomnolence	I-DISEASE
conditions	I-DISEASE
,	0
many	0
with	I-DISEASE
this	0
complaint	0
are	0
not	0
able	0
to	0
nap	I-DISEASE
in	I-DISEASE
the	0
daytime	0
and	0
few	0
show	0
unintentional	I-DISEASE
sleep	I-DISEASE
episodes	I-DISEASE
.	0

Reports	I-DISEASE
of	I-DISEASE
reduced	0
performance	0
at	I-DISEASE
work	I-DISEASE
or	I-DISEASE
school	0
or	0
impaired	0
social	0
functioning	I-DISEASE
also	I-DISEASE
are	I-DISEASE
common	I-DISEASE
.	0

Some	I-DISEASE
affected	0
individuals	I-DISEASE
attribute	I-DISEASE
errors	0
or	I-DISEASE
accidents	0
at	I-DISEASE
work	I-DISEASE
to	0
their	0
sleep	0
difficulties	I-DISEASE
.	0

Somatic	0
symptoms	I-DISEASE
such	0
as	0
headaches	I-DISEASE
or	I-DISEASE
gastrointes-	0
tinal	0
dysfunction	0
are	0
occasionally	0
attributed	0
to	0
the	0
ongoing	0
sleep	0
difficulties	I-DISEASE
as	0
well	I-DISEASE
.	0

The	I-DISEASE
fatigue	I-DISEASE
of	I-DISEASE
insomnia	I-DISEASE
sufferers	I-DISEASE
is	0
manifest	0
mainly	0
as	0
a	I-DISEASE
lack	I-DISEASE
of	I-DISEASE
energy	0
and	0
desire	I-DISEASE
to	0
reduce	I-DISEASE
or	I-DISEASE
limit	0
activity	0
levels	0
.	0

This	I-DISEASE
symptom	0
should	I-DISEASE
be	I-DISEASE
differentiated	I-DISEASE
from	I-DISEASE
reports	0
of	I-DISEASE
subjective	I-DISEASE
sleepiness	I-DISEASE
as	0
well	I-DISEASE
as	0
from	I-DISEASE
unintended	0
sleep	0
episodes	I-DISEASE
.	0

Insomnia	I-DISEASE
sufferers	0
commonly	I-DISEASE
report	0
subjective	I-DISEASE
sleepiness	0
characterized	0
by	I-DISEASE
a	I-DISEASE
sense	I-DISEASE
of	I-DISEASE
reduced	0
alertness	I-DISEASE
and	0
enhanced	I-DISEASE
need	0
or	0
desire	B-DISEASE
to	I-DISEASE
sleep	I-DISEASE
.	0

However	I-DISEASE
,	I-DISEASE
they	I-DISEASE
seldom	I-DISEASE
fall	0
asleep	I-DISEASE
spontaneously	I-DISEASE
without	0
intending	0
to	0
do	I-DISEASE
so	I-DISEASE
.	0

Despite	I-DISEASE
a	0
desire	0
to	I-DISEASE
nap	B-DISEASE
,	I-DISEASE
many	0
individuals	I-DISEASE
with	0
insomnia	0
are	I-DISEASE
unable	I-DISEASE
to	0
do	0
so	0
.	0

Frequent	I-DISEASE
,	I-DISEASE
unintentional	0
daytime	0
sleep	0
episodes	I-DISEASE
are	0
more	I-DISEASE
characteristic	I-DISEASE
of	I-DISEASE
other	I-DISEASE
types	I-DISEASE
of	I-DISEASE
sleep	0
disorders	0
such	0
as	0
sleep	0
disordered	I-DISEASE
breathing	I-DISEASE
,	0
narcolepsy	0
,	I-DISEASE
idio-	0
pathic	0
hypersomnia	0
,	0
and	0
the	0
like	0
.	0

In	I-DISEASE
young	I-DISEASE
children	I-DISEASE
,	I-DISEASE
difficulty	0
falling	0
asleep	I-DISEASE
,	I-DISEASE
staying	0
asleep	0
,	I-DISEASE
or	I-DISEASE
both	I-DISEASE
are	I-DISEASE
often	0
the	0
result	0
of	I-DISEASE
inappropriate	0
sleep	0
associations	I-DISEASE
or	I-DISEASE
inadequate	I-DISEASE
limit	0
setting	0
.	I-DISEASE

Inappropriate	I-DISEASE
sleep	0
associ-	0

ations	I-DISEASE
result	0
from	I-DISEASE
a	0
child	0
’s	I-DISEASE
dependency	0
on	0
specific	I-DISEASE
stimulation	I-DISEASE
,	I-DISEASE
objects	I-DISEASE
,	I-DISEASE
or	I-DISEASE
settings	I-DISEASE
for	0
initiating	0
sleep	0
or	I-DISEASE
returning	I-DISEASE
to	I-DISEASE
sleep	0
following	0
an	0
awakening	0
;	I-DISEASE
in	I-DISEASE
the	0
absence	I-DISEASE
of	I-DISEASE
these	I-DISEASE
conditions	I-DISEASE
,	I-DISEASE
sleep	0
onset	0
is	0
significantly	0
delayed	0
.	0

This	I-DISEASE
manifestation	0
usually	I-DISEASE
presents	0
as	0
frequent	I-DISEASE
nighttime	I-DISEASE
awakenings	0
and/or	0
nighttime	0
fears	I-DISEASE
or	0
anxiety	0
about	0
sleeping	0
alone	I-DISEASE
.	0

The	I-DISEASE
process	0
of	I-DISEASE
falling	0
asleep	I-DISEASE
is	I-DISEASE
associated	0
with	I-DISEASE
a	0
specific	I-DISEASE
form	I-DISEASE
of	I-DISEASE
stimulation	I-DISEASE
(	I-DISEASE
e.g.	0
,	0
rocking	0
,	I-DISEASE
watching	0
television	0
)	0
,	I-DISEASE
object	0
(	0
e.g.	I-DISEASE
,	I-DISEASE
bottle	0
,	0
excessive	0
feedings	I-DISEASE
)	0
,	I-DISEASE
or	0
setting	0
(	I-DISEASE
e.g.	0
,	I-DISEASE
lighted	0
room	I-DISEASE
,	0
parents	0
remaining	0
in	I-DISEASE
the	0
room	I-DISEASE
,	I-DISEASE
or	B-DISEASE
child	0
taken	0
to	0
parents	0
’	I-DISEASE
bed	I-DISEASE
)	I-DISEASE
.	0

When	I-DISEASE
such	0
conditions	0
are	I-DISEASE
absent	0
,	I-DISEASE
children	I-DISEASE
with	I-DISEASE
this	0
disorder	0
experience	0
difficulty	0
falling	I-DISEASE
asleep	I-DISEASE
at	I-DISEASE
bedtime	I-DISEASE
and	0
following	0
normal	0
nighttime	0
arousals	0
.	0

If	I-DISEASE
the	0
conditions	0
associ-	I-DISEASE
ated	0
with	0
falling	0
asleep	I-DISEASE
are	I-DISEASE
reestablished	0
,	I-DISEASE
the	0
child	0
usually	I-DISEASE
resumes	0
sleep	0
relatively	0
quickly	0
.	0

Because	I-DISEASE
sleep	0
-	0
onset	I-DISEASE
associations	0
are	0
highly	0
prevalent	I-DISEASE
in	0
young	I-DISEASE
children	B-DISEASE
,	I-DISEASE
the	I-DISEASE
phenomenon	0
is	0
defined	I-DISEASE
as	0
a	I-DISEASE
disorder	0
only	0
if	0
(	I-DISEASE
1	0
)	0
the	0
associations	I-DISEASE
are	0
highly	I-DISEASE
problem-	0
atic	I-DISEASE
or	0
demanding	0
(	I-DISEASE
e.g.	0
,	0
extended	0
rocking	0
,	0
car	0
rides	0
)	0
;	I-DISEASE
(	I-DISEASE
2	0
)	0
sleep	0
onset	0
is	0
significantly	0
delayed	B-DISEASE
or	0
sleep	0
is	0
otherwise	0
disrupted	I-DISEASE
in	0
the	0
absence	I-DISEASE
of	I-DISEASE
the	0
associated	0
conditions	I-DISEASE
;	0
and	0
(	0
3	I-DISEASE
)	0
caregiver	0
intervention	0
is	0
frequently	I-DISEASE
required	0
to	0
aid	I-DISEASE
the	0
onset	0
or	I-DISEASE
resumption	0
of	I-DISEASE
sleep	0
.	I-DISEASE

Limit	I-DISEASE
-	0
setting	0
issues	0
are	0
characterized	0
by	I-DISEASE
bedtime	I-DISEASE
stalling	I-DISEASE
or	I-DISEASE
bedtime	I-DISEASE
refusal	I-DISEASE
that	0
is	I-DISEASE
met	0
with	0
and	0
reinforced	0
by	I-DISEASE
inadequate	I-DISEASE
limit	0
setting	0
by	0
a	I-DISEASE
caregiver	I-DISEASE
.	0

Sleep	I-DISEASE
problems	0
occur	0
when	I-DISEASE
caregivers	0
institute	0
no	0
or	0
few	0
limits	0
or	I-DISEASE
when	I-DISEASE
limits	0
are	0
instituted	0
inconsistently	I-DISEASE
or	0
in	I-DISEASE
an	0
unpredictable	I-DISEASE
manner	0
.	0

Limit	I-DISEASE
-	0
setting	0
sleep	0
problems	I-DISEASE
may	0
also	0
result	0
in	0
prolonged	0
nocturnal	0
awakenings	0
,	I-DISEASE
depending	I-DISEASE
on	0
caregiver	0
response	0
during	I-DISEASE
the	0
night	I-DISEASE
.	0

It	I-DISEASE
also	0
should	0
be	I-DISEASE
noted	0
that	0
some	I-DISEASE
children	I-DISEASE
’s	I-DISEASE
needs	I-DISEASE
for	0
specific	I-DISEASE
conditions	I-DISEASE
for	0
sleeping	I-DISEASE
or	I-DISEASE
their	I-DISEASE
resistance	0
to	0
go	0
to	0
bed	I-DISEASE
may	I-DISEASE
reflect	I-DISEASE
underlying	0
anxiety	0
or	I-DISEASE
fears	0
.	0

Fear	I-DISEASE
of	I-DISEASE
sleep-	0
ing	0
alone	I-DISEASE
,	I-DISEASE
being	I-DISEASE
in	0
the	0
dark	0
,	I-DISEASE
or	I-DISEASE
having	I-DISEASE
nightmares	0
may	0
lead	0
some	I-DISEASE
children	0
to	0
demand	0
certain	0
sleep	0
promoting	I-DISEASE
conditions	0
(	I-DISEASE
presence	0
of	I-DISEASE
parent	0
in	I-DISEASE
bedroom	I-DISEASE
)	0
or	0
to	I-DISEASE
repeatedly	0
delay	I-DISEASE
their	0
bedtimes	0
.	0

Although	I-DISEASE
transient	0
and	0
episodic	0
forms	0
of	I-DISEASE
insomnia	I-DISEASE
occur	I-DISEASE
,	0
the	0
clinically	0
significant	0
daytime	0
consequences	I-DISEASE
of	I-DISEASE
insomnia	I-DISEASE
and	0
the	0
longer	I-DISEASE
term	0
,	I-DISEASE
more	0
serious	B-DISEASE
morbidity	0
out-	0
comes	0
most	0
typically	0
develop	0
when	0
the	0
sleep	0
difficulties	I-DISEASE
occur	I-DISEASE
at	I-DISEASE
least	I-DISEASE
three	0
times	0
per	0
week	0
and	0
persist	0
for	I-DISEASE
at	I-DISEASE
least	0
three	0
months	0
.	0

For	I-DISEASE
this	I-DISEASE
reason	0
,	I-DISEASE
these	0
frequency	I-DISEASE
and	0
dura-	0
tion	0
criteria	I-DISEASE
must	I-DISEASE
be	0
met	0
for	I-DISEASE
the	I-DISEASE
assignment	0
of	0
a	0
chronic	I-DISEASE
insomnia	I-DISEASE
disorder	I-DISEASE
diagnosis	0
.	I-DISEASE

However	I-DISEASE
,	I-DISEASE
it	0
is	0
recognized	0
that	0
more	0
acute	I-DISEASE
and	0
episodic	0
forms	I-DISEASE
of	I-DISEASE
insomnia	0
may	0
cause	0
significant	0
distress	I-DISEASE
and	0
functional	0
impairment	0
and	0
require	0
clinical	I-DISEASE
attention	0
.	0

Cases	I-DISEASE
that	0
meet	0
all	0
criteria	I-DISEASE
except	0
the	0
frequency	I-DISEASE
or	0
duration	0
criteria	I-DISEASE
for	I-DISEASE
chronic	I-DISEASE
insomnia	0
disorder	I-DISEASE
should	0
be	0
assigned	I-DISEASE
a	0
diagnosis	I-DISEASE
of	I-DISEASE
short	0
-	I-DISEASE
term	0
insomnia	I-DISEASE
disorder	0
.	0

Associated	I-DISEASE
Features	I-DISEASE
Individuals	I-DISEASE
with	I-DISEASE
chronic	0
insomnia	I-DISEASE
disorder	0
typically	0
note	0
feelings	I-DISEASE
of	I-DISEASE
reduced	0
well	B-DISEASE
-	I-DISEASE
being	I-DISEASE
and	0
general	0
malaise	0
during	I-DISEASE
the	0
day	I-DISEASE
.	0

In	I-DISEASE
addition	0
,	0
excessive	0
focus	0
on	0
and	0
worry	I-DISEASE
about	0
ongoing	0
sleep	0
difficulties	I-DISEASE
and	0
their	I-DISEASE
associated	0
daytime	I-DISEASE
consequences	I-DISEASE
are	I-DISEASE
common	I-DISEASE
.	0

Thoughts	I-DISEASE
about	0
ongoing	I-DISEASE
sleep	0
difficulties	0
may	I-DISEASE
occur	I-DISEASE
through	0
the	0
day	I-DISEASE
and	0
may	I-DISEASE
be	I-DISEASE
amplified	0
as	0
bedtime	I-DISEASE
Insomnia	0
Insomnia	B-DISEASE
approaches	I-DISEASE
.	0

Frank	I-DISEASE
performance	0
anxiety	0
about	0
sleep	0
is	0
common	I-DISEASE
.	0

Although	I-DISEASE
many	0
with	0
insomnia	0
may	0
appear	I-DISEASE
anxious	0
and	0
worry	I-DISEASE
-	I-DISEASE
prone	I-DISEASE
,	I-DISEASE
their	0
anxiety	I-DISEASE
and	0
worry	I-DISEASE
are	0
often	0
focused	0
mainly	0
on	0
their	0
sleep	0
difficulties	I-DISEASE
.	0

When	I-DISEASE
anxiety	I-DISEASE
and	0
worry	I-DISEASE
are	0
more	0
pervasive	I-DISEASE
and	0
not	0
solely	0
focused	0
on	0
sleep	0
problems	0
,	I-DISEASE
a	0
comorbid	I-DISEASE
anxiety	I-DISEASE
disorder	0
may	0
be	0
present	I-DISEASE
.	0

Many	0
with	I-DISEASE
chronic	0
insomnia	I-DISEASE
disorder	I-DISEASE
show	I-DISEASE
a	0
pattern	0
of	I-DISEASE
conditioned	I-DISEASE
arousal	I-DISEASE
in	I-DISEASE
response	0
to	I-DISEASE
envi-	I-DISEASE
ronmental	0
cues	0
in	0
their	0
bedrooms	I-DISEASE
or	0
conscious	0
efforts	0
to	I-DISEASE
initiate	I-DISEASE
sleep	0
.	0

Such	I-DISEASE
individuals	I-DISEASE
may	0
fall	I-DISEASE
asleep	I-DISEASE
easily	0
in	I-DISEASE
settings	I-DISEASE
outside	I-DISEASE
of	I-DISEASE
their	0
bedrooms	I-DISEASE
when	I-DISEASE
not	0
trying	0
to	I-DISEASE
sleep	0
,	I-DISEASE
but	0
show	0
a	0
pattern	0
of	I-DISEASE
cognitive	0
and	0
physiological	I-DISEASE
arousal	0
when	I-DISEASE
lying	0
down	I-DISEASE
in	I-DISEASE
their	I-DISEASE
beds	0
with	I-DISEASE
the	0
intention	I-DISEASE
to	I-DISEASE
fall	0
asleep	I-DISEASE
.	0

Some	I-DISEASE
patients	0
with	0
this	0
pattern	0
may	I-DISEASE
report	0
sleeping	I-DISEASE
better	0
when	0
away	0
from	I-DISEASE
home	I-DISEASE
than	I-DISEASE
when	0
at	I-DISEASE
home	I-DISEASE
.	0

Unlike	I-DISEASE
noncomplaining	0
normal	0
sleepers	0
,	0
indi-	0
viduals	I-DISEASE
with	I-DISEASE
chronic	I-DISEASE
insomnia	0
disorder	I-DISEASE
often	0
express	0
conscious	0
intentions	I-DISEASE
and	0
excessive	I-DISEASE
effort	I-DISEASE
to	I-DISEASE
sleep	0
,	I-DISEASE
only	0
to	I-DISEASE
find	I-DISEASE
sleep	0
difficult	0
to	0
initiate	I-DISEASE
under	0
such	0
circumstances	0
.	0

In	I-DISEASE
children	I-DISEASE
,	0
the	0
sleep	0
disturbance	I-DISEASE
may	0
be	I-DISEASE
accompanied	0
by	0
daytime	0
behavioral	I-DISEASE
prob-	0
lems	I-DISEASE
and	0
limit	0
-	0
setting	0
difficulties	0
during	I-DISEASE
the	0
day	0
.	0

In	I-DISEASE
addition	0
,	0
the	0
nighttime	0
sleep	0
distur-	I-DISEASE
bance	I-DISEASE
often	I-DISEASE
results	0
in	I-DISEASE
poor	0
parental	I-DISEASE
sleep	0
and	0
associated	0
daytime	0
impairment	0
.	0

Marital	I-DISEASE
conflicts	0
regarding	0
how	0
to	I-DISEASE
respond	0
to	I-DISEASE
or	B-DISEASE
intervene	0
with	I-DISEASE
the	0
ongoing	I-DISEASE
sleep	0
problem	0
may	I-DISEASE
arise	I-DISEASE
.	0

Parents	I-DISEASE
also	0
may	0
develop	0
negative	0
feelings	I-DISEASE
toward	I-DISEASE
the	0
child	0
who	0
disrupts	I-DISEASE
their	I-DISEASE
sleep	0
and	0
demands	0
their	0
attention	I-DISEASE
during	I-DISEASE
the	0
night	I-DISEASE
.	0

Clinical	I-DISEASE
and	0
Pathophysiological	I-DISEASE
Subtypes	I-DISEASE
Various	0
clinical	0
and	0
pathophysiological	I-DISEASE
subtypes	0
of	I-DISEASE
insomnia	I-DISEASE
have	I-DISEASE
been	0
described	0
in	0
previous	I-DISEASE
nosologies	0
.	0

Both	I-DISEASE
the	0
American	0
Psychiatric	0
Association	I-DISEASE
’s	B-DISEASE
Diagnostic	0
and	0
Statistical	0
Manual	I-DISEASE
,	I-DISEASE
4th	0
Edition	0
,	I-DISEASE
Text	0
Revision	I-DISEASE
(	0
DSM	I-DISEASE
-	I-DISEASE
IV	I-DISEASE
-	I-DISEASE
TR	0
)	0
and	0
the	0
International	0
Classification	I-DISEASE
of	0
Sleep	0
Disorders	0
,	0
2nd	0
Edition	I-DISEASE
describe	I-DISEASE
independently	0
occurring	I-DISEASE
or	I-DISEASE
primary	0
forms	0
of	I-DISEASE
insomnia	0
.	0

Within	I-DISEASE
DSM	0
-	I-DISEASE
IV	0
-	0
TR	0
,	0
the	0
global	I-DISEASE
term	0
,	I-DISEASE
primary	0
insomnia	0
,	I-DISEASE
is	0
applied	0
to	I-DISEASE
all	0
forms	0
of	I-DISEASE
insomnia	I-DISEASE
that	0
are	0
not	0
better	0
explained	B-DISEASE
by	0
a	0
coincident	0
psychi-	0
atric	I-DISEASE
,	0
medical	0
or	I-DISEASE
substance	I-DISEASE

use	I-DISEASE
/	0
abuse	I-DISEASE
disorder	I-DISEASE
.	0

Within	I-DISEASE
the	0
International	0
Classification	I-DISEASE
of	0
Sleep	I-DISEASE
Disorders	I-DISEASE
,	0
2nd	0
Edition	I-DISEASE
system	I-DISEASE
,	I-DISEASE
multiple	I-DISEASE
primary	0
insomnia	I-DISEASE
subtypes	0
are	0
delin-	0
eated	0
.	0

The	I-DISEASE
specific	I-DISEASE
primary	0
insomnia	0
subtypes	I-DISEASE
listed	0
in	0
the	0
previous	I-DISEASE
International	B-DISEASE
Classification	I-DISEASE
of	I-DISEASE
Sleep	I-DISEASE
Disorders	I-DISEASE
,	I-DISEASE
2nd	0
Edition	I-DISEASE
include	I-DISEASE
the	0
following	0
:	0
Psychophysiological	0
insomnia	0
is	0
characterized	0
primarily	I-DISEASE
by	I-DISEASE
heightened	0
arousal	0
and	0
learned	0
sleep	0
-	I-DISEASE
preventing	I-DISEASE
associations	I-DISEASE
that	0
result	0
in	0
a	0
complaint	0
of	I-DISEASE
insomnia	0
.	0

Patients	I-DISEASE
presumed	0
to	I-DISEASE
have	0
this	0
type	I-DISEASE
of	I-DISEASE
insomnia	0
often	I-DISEASE
have	I-DISEASE
sleep	0
difficulty	0
when	I-DISEASE
trying	I-DISEASE
to	I-DISEASE
sleep	0
in	0
their	I-DISEASE
usual	I-DISEASE
sleep	0
setting	0
at	I-DISEASE
home	I-DISEASE
but	0
may	I-DISEASE
fall	I-DISEASE
asleep	I-DISEASE
easily	0
in	I-DISEASE
a	0
novel	I-DISEASE
sleep	0
setting	0
or	I-DISEASE
when	0
not	0
trying	0
to	0
sleep	0
.	0

They	I-DISEASE
also	0
demonstrate	0
excessive	I-DISEASE
focus	0
on	0
and	0
worry	I-DISEASE
about	0
sleep	0
and	0
suffer	I-DISEASE
from	I-DISEASE
elevated	I-DISEASE
levels	0
of	I-DISEASE
cognitive	0
and	0
somatic	0
arousal	I-DISEASE
,	0
particularly	0
at	I-DISEASE
bedtime	I-DISEASE
.	0

Idiopathic	I-DISEASE
insomnia	I-DISEASE
is	I-DISEASE
characterized	0
by	B-DISEASE
a	0
longstanding	I-DISEASE
complaint	I-DISEASE
of	I-DISEASE
sleep	0
difficulties	I-DISEASE
with	I-DISEASE
insidious	I-DISEASE
onset	I-DISEASE
occurring	0
during	I-DISEASE
infancy	0
or	I-DISEASE
early	I-DISEASE
childhood	0
.	I-DISEASE

It	I-DISEASE
is	I-DISEASE
presumed	0
to	I-DISEASE
arise	I-DISEASE
in	I-DISEASE
infancy	0
or	I-DISEASE
early	0
childhood	0
without	0
discernible	0
cause	0
and	0
to	I-DISEASE
persist	I-DISEASE
over	0
time	0
without	0
sustained	0
periods	0
of	I-DISEASE
remission	I-DISEASE
.	0

Given	I-DISEASE
its	I-DISEASE
early	0
onset	I-DISEASE
,	0
stability	0
over	0
time	0
,	0
and	0
lifelong	0
course	I-DISEASE
,	I-DISEASE
this	I-DISEASE
disorder	0
is	I-DISEASE
thought	I-DISEASE
to	I-DISEASE
arise	0
from	0
either	I-DISEASE
genetically	I-DISEASE
determined	I-DISEASE
or	0
congenital	0
aberrations	0
in	I-DISEASE
the	0
sleep	0
-	I-DISEASE
inducing	I-DISEASE
or	0
arousal	0
systems	0
in	0
the	0
brain	0
,	0
or	0
both	I-DISEASE
.	0

No	I-DISEASE
consistent	I-DISEASE
genetic	0
markers	0
or	0
neural	I-DISEASE
pathology	0
have	0
been	0
identified	I-DISEASE
among	0
those	I-DISEASE
presumed	0
to	0
suffer	I-DISEASE
from	I-DISEASE
this	I-DISEASE
condition	0
.	0

Paradoxical	I-DISEASE
insomnia	0
,	I-DISEASE
which	0
has	0
previously	0
been	I-DISEASE
called	I-DISEASE
sleep	I-DISEASE
state	I-DISEASE
misperception	0
,	I-DISEASE
is	0
described	0
as	0
a	0
complaint	I-DISEASE
of	I-DISEASE
severe	0
sleep	I-DISEASE
disturbance	0
without	0
corroborative	0
objective	0
evidence	0
of	I-DISEASE
the	0
degree	I-DISEASE
of	0
sleep	0
disturbance	I-DISEASE
claimed	0
.	0

Those	I-DISEASE
presumed	0
to	0
have	I-DISEASE
this	0
form	I-DISEASE
of	I-DISEASE
sleep	0
difficulty	0
have	0
a	0
marked	0
propensity	I-DISEASE
to	I-DISEASE
underestimate	I-DISEASE
the	0
amount	I-DISEASE
of	I-DISEASE
sleep	0
they	0
actually	I-DISEASE
are	I-DISEASE
obtaining	0
.	I-DISEASE

In	I-DISEASE
essence	I-DISEASE
,	0
they	I-DISEASE
are	0
thought	I-DISEASE
to	I-DISEASE
perceive	I-DISEASE
much	0
of	I-DISEASE
the	0
time	I-DISEASE
they	I-DISEASE
actually	I-DISEASE
sleep	0
as	0
wakefulness	0
.	0

Although	I-DISEASE
many	0
such	0
patients	I-DISEASE
routinely	0
obtain	I-DISEASE
norma-	0
tive	0
amounts	I-DISEASE
of	I-DISEASE
sleep	0
,	0
as	0
documented	I-DISEASE
by	I-DISEASE
standard	0
polysomnographic	0
measures	0
,	0
they	I-DISEASE
complain	0
of	I-DISEASE
the	0
common	I-DISEASE
sleep	0
/	0
wake	0
symptoms	I-DISEASE
of	I-DISEASE
other	0
insomnia	I-DISEASE
disorders	0
.	0

Some	I-DISEASE
studies	I-DISEASE
using	I-DISEASE
neuroimaging	0
or	I-DISEASE
sleep	0
electroencephalograph	0
(	I-DISEASE
EEG	0
)	0
spectral	0
analysis	I-DISEASE
techniques	0
have	0
suggested	0
that	0
an	I-DISEASE
altered	0
sleep	0
/	0
wake	0
arousal	0
system	0
in	0
such	0
individ-	I-DISEASE
uals	I-DISEASE
may	0
explain	0
the	0
apparent	0
mismatch	0
between	0
their	0
conventional	0
objective	0
sleep	0
measures	0
and	0
subjective	I-DISEASE
sleep	0
reports	I-DISEASE
.	0

Inadequate	I-DISEASE
sleep	0
hygiene	I-DISEASE
is	I-DISEASE
presumed	0
to	0
result	0
from	I-DISEASE
or	I-DISEASE
be	I-DISEASE
sustained	0
by	I-DISEASE
daily	I-DISEASE
living	0
activities	0
that	0
are	I-DISEASE
inconsistent	I-DISEASE
with	I-DISEASE
the	0
maintenance	I-DISEASE
of	I-DISEASE
good	0
-	I-DISEASE
quality	0
sleep	0
and	0
normal	B-DISEASE
daytime	I-DISEASE
alertness	I-DISEASE
.	0

Patients	I-DISEASE
with	0
this	0
form	0
of	I-DISEASE
insomnia	0
have	0
ongoing	0
sleep/	0
wake	0
difficulties	0
as	0
a	0
function	I-DISEASE
of	0
practices	0
such	0
as	0
daytime	I-DISEASE
napping	B-DISEASE
,	I-DISEASE
maintaining	0
a	0
highly	0
variable	I-DISEASE
sleep	0
/	0
wake	0
schedule	I-DISEASE
,	I-DISEASE
routinely	0
using	0
sleep	0
-	I-DISEASE
disruptive	0
products	0
(	0
caf-	0
feine	I-DISEASE
,	0
tobacco	0
,	0
alcohol	0
)	0
too	0
close	0
to	I-DISEASE
bedtime	I-DISEASE
,	0
engaging	0
in	0
mentally	I-DISEASE
or	I-DISEASE
physically	I-DISEASE
acti-	0
vating	I-DISEASE
or	0
emotionally	I-DISEASE
upsetting	I-DISEASE
activities	I-DISEASE
too	0
close	0
to	0
bedtime	I-DISEASE
,	0
routinely	0
using	I-DISEASE
the	I-DISEASE
bed	0
and	0
bedroom	I-DISEASE
for	0
activities	I-DISEASE
other	I-DISEASE
than	0
sleep	0
,	0
or	I-DISEASE
failing	0
to	0
maintain	0
a	0
comfortable	I-DISEASE
environment	I-DISEASE
for	0
sleep	0
.	I-DISEASE

Behavioral	I-DISEASE
insomnia	0
of	I-DISEASE
childhood	0
is	0
presumed	0
to	I-DISEASE
result	I-DISEASE
from	I-DISEASE
improper	0
sleep	0
train-	I-DISEASE
ing	0
or	I-DISEASE
limit	0
setting	0
by	B-DISEASE
parents	0
or	I-DISEASE
caretakers	0
.	0

Within	I-DISEASE
this	0
broader	0
diagnosis	I-DISEASE
,	0
several	0
subtypes	I-DISEASE
have	0
been	I-DISEASE
described	0
.	0

Sleep	I-DISEASE
-	I-DISEASE
onset	0
association	I-DISEASE
type	I-DISEASE
is	I-DISEASE
characterized	0
by	I-DISEASE
the	0
child	0
’s	I-DISEASE
dependency	I-DISEASE
on	0
specific	I-DISEASE
stimulation	I-DISEASE
,	I-DISEASE
objects	0
,	0
or	I-DISEASE
settings	I-DISEASE
for	I-DISEASE
initiating	I-DISEASE
sleep	0
or	I-DISEASE
returning	I-DISEASE
to	I-DISEASE
sleep	0
following	0
an	0
awakening	0
;	I-DISEASE
in	I-DISEASE
the	0
absence	I-DISEASE
of	I-DISEASE
these	0
conditions	I-DISEASE
,	0
sleep	0
onset	I-DISEASE
is	I-DISEASE
significantly	I-DISEASE
delayed	I-DISEASE
.	0

Limit	I-DISEASE
-	0
setting	0
type	I-DISEASE
is	I-DISEASE
characterized	0
by	I-DISEASE
bedtime	I-DISEASE
stalling	I-DISEASE
or	I-DISEASE
bedtime	I-DISEASE
refusal	I-DISEASE
that	0
is	I-DISEASE
the	0
result	0
of	I-DISEASE
inadequate	0
limit	0
setting	0
by	I-DISEASE
a	I-DISEASE
caregiver	0
.	0

A	I-DISEASE
mixed	0
type	I-DISEASE
Insomnia	I-DISEASE
Insomnia	I-DISEASE
characterized	0
by	I-DISEASE
features	I-DISEASE
of	I-DISEASE
sleep	0
-	I-DISEASE
onset	I-DISEASE
association	0
difficulties	0
and	0
bedtime	I-DISEASE
resistance	B-DISEASE
represents	0
a	I-DISEASE
third	0
subtype	I-DISEASE
within	I-DISEASE
this	0
diagnostic	0
category	0
.	0

The	I-DISEASE
DSM	0
-	I-DISEASE
IV	0
-	0
TR	0
and	0
International	0
Classification	I-DISEASE
of	I-DISEASE
Sleep	I-DISEASE
Disorders	I-DISEASE
,	I-DISEASE
2nd	I-DISEASE
Edition	0
also	0
describe	0
several	0
so	0
-	0
called	I-DISEASE
secondary	0
insomnias	0
,	I-DISEASE
arising	0
from	0
co	B-DISEASE
-	0
occurring	0
primary	0
or	0
causative	0
conditions	0
.	0

Among	I-DISEASE
these	I-DISEASE
are	0
the	0
following	0
:	I-DISEASE
Insomnia	I-DISEASE
due	I-DISEASE
to	I-DISEASE
(	I-DISEASE
another	I-DISEASE
)	0
mental	0
disorder	I-DISEASE
is	I-DISEASE
thought	0
to	0
be	I-DISEASE
caused	0
by	I-DISEASE
or	0
secondary	0
to	I-DISEASE
a	0
co	0
-	0
occurring	I-DISEASE
psychiatric	I-DISEASE
condition	0
.	0

Insomnia	I-DISEASE
is	0
a	0
common	I-DISEASE
complaint	I-DISEASE
,	0
particularly	0
among	0
patients	0
with	I-DISEASE
mood	B-DISEASE
disorders	0
and	0
anxiety	0
disorders	0
.	0

Likewise	I-DISEASE
,	I-DISEASE
sleep	0
distur-	I-DISEASE
bance	I-DISEASE
is	0
commonly	0
seen	I-DISEASE
in	I-DISEASE
those	I-DISEASE
with	0
psychotic	0
spectrum	0
disorders	0
and	0
various	0
Axis	0
II	0
(	0
personality	0
)	0
disorders	0
.	0

Among	I-DISEASE
those	I-DISEASE
individuals	I-DISEASE
presumed	0
to	0
have	I-DISEASE
insomnia	0
due	0
to	0
a	0
mental	I-DISEASE
disorder	I-DISEASE
,	0
insomnia	I-DISEASE
has	0
historically	0
been	I-DISEASE
regarded	0
as	0
a	0
secondary	0
symptom	0
,	I-DISEASE
caused	0
by	B-DISEASE
the	0
mental	0
disorder	I-DISEASE
itself	0
.	0

Insomnia	I-DISEASE
due	0
to	I-DISEASE
(	I-DISEASE
a	I-DISEASE
)	0
medical	0
condition	I-DISEASE
is	I-DISEASE
thought	I-DISEASE
to	I-DISEASE
be	0
caused	0
by	I-DISEASE
or	I-DISEASE
secondary	0
to	0
a	0
co	0
-	0
occurring	0
medical	0
condition	I-DISEASE
.	0

Like	I-DISEASE
the	0
mental	0
disorders	0
,	0
many	0
medical	0
condi-	I-DISEASE
tions	0
may	I-DISEASE
have	I-DISEASE
an	0
ongoing	I-DISEASE
insomnia	I-DISEASE
complaint	0
associated	0
with	I-DISEASE
them	I-DISEASE
.	0

In	I-DISEASE
particular	I-DISEASE
,	0
those	I-DISEASE
conditions	0
that	0
cause	I-DISEASE
some	I-DISEASE
form	0
of	I-DISEASE
ongoing	0
pain	0
or	I-DISEASE
discomfort	I-DISEASE
,	0
mobility	I-DISEASE
lim-	I-DISEASE
itation	0
,	0
or	0
breathing	0
disturbance	I-DISEASE
commonly	I-DISEASE
have	0
insomnia	I-DISEASE
complaints	0
accompanying	B-DISEASE
them	I-DISEASE
.	0

Among	I-DISEASE
those	I-DISEASE
individuals	I-DISEASE
presumed	0
to	0
have	I-DISEASE
insomnia	0
due	0
to	0
a	0
medical	I-DISEASE
disor-	I-DISEASE
der	0
,	I-DISEASE
insomnia	0
has	0
historically	I-DISEASE
been	I-DISEASE
regarded	0
as	0
a	0
secondary	I-DISEASE
symptom	0
,	0
caused	0
by	I-DISEASE
the	0
medical	0
disorder	0
itself	0
.	0

Insomnia	I-DISEASE
due	0
to	I-DISEASE
drug	I-DISEASE
or	I-DISEASE
substance	I-DISEASE
is	0
thought	I-DISEASE
to	I-DISEASE
be	I-DISEASE
caused	I-DISEASE
by	B-DISEASE
or	I-DISEASE
secondary	0
to	I-DISEASE
use	0
of	0
or	I-DISEASE
withdrawal	0
from	I-DISEASE
a	0
drug	I-DISEASE
or	I-DISEASE
substance	0
.	0

Many	0
forms	0
of	I-DISEASE
prescription	I-DISEASE
and	0
nonprescrip-	I-DISEASE
tion	0
medications	I-DISEASE
,	0
street	I-DISEASE
drugs	I-DISEASE
,	I-DISEASE
and	0
other	0
commonly	I-DISEASE
used	0
substances	0
may	0
produce	0
sleep	I-DISEASE
disturbances	0
either	0
during	I-DISEASE
periods	I-DISEASE
of	I-DISEASE
use	0
or	0
upon	0
withdrawal	0
.	0

Given	I-DISEASE
these	I-DISEASE
effects	0
,	I-DISEASE
insomnia	0
complaints	0
may	0
arise	I-DISEASE
either	I-DISEASE
during	I-DISEASE
periods	I-DISEASE
when	I-DISEASE
these	I-DISEASE
substances	0
are	I-DISEASE
used	I-DISEASE
or	0
following	0
their	I-DISEASE
discontinuance	0
.	0

Among	I-DISEASE
those	I-DISEASE
individuals	I-DISEASE
presumed	0
to	0
have	I-DISEASE
insom-	0
nia	0
due	I-DISEASE
to	I-DISEASE
drug	I-DISEASE
or	0
substance	I-DISEASE
,	I-DISEASE
insomnia	I-DISEASE
has	I-DISEASE
historically	0
been	I-DISEASE
regarded	0
as	0
a	I-DISEASE
secondary	0
symptom	0
,	I-DISEASE
caused	0
by	B-DISEASE
the	I-DISEASE
drug	0
or	0
substance	0
itself	0
.	0

Despite	I-DISEASE
the	0
heuristic	0
appeal	0
of	I-DISEASE
these	I-DISEASE
various	0
subtypes	0
,	I-DISEASE
it	I-DISEASE
is	I-DISEASE
often	0
difficult	0
to	I-DISEASE
discrim-	I-DISEASE
inate	I-DISEASE
among	0
them	I-DISEASE
in	I-DISEASE
clinical	I-DISEASE
practice	0
.	0

Many	0
of	I-DISEASE
the	0
defining	I-DISEASE
features	0
of	I-DISEASE
the	0
so	I-DISEASE
-	0
called	0
primary	0
insomnia	I-DISEASE
subtypes	I-DISEASE
such	I-DISEASE
as	0
conditioned	0
arousal	0
,	0
poor	0
sleep	0
hygiene	0
prac-	0
tices	I-DISEASE
,	I-DISEASE
and	0
underestimation	0
of	I-DISEASE
sleep	0
time	0
are	0
ubiquitous	0
among	0
insomnia	I-DISEASE
sufferers	I-DISEASE
,	0
per	0
se	0
,	0
and	0
are	0
not	0
specific	I-DISEASE
to	0
one	0
subgroup	0
.	0

This	I-DISEASE
is	0
true	0
whether	I-DISEASE
the	0
so	0
-	0
called	I-DISEASE
primary	0
insomnia	0
subtypes	I-DISEASE
are	0
considered	I-DISEASE
in	I-DISEASE
isolation	0
or	0
if	0
all	0
of	I-DISEASE
the	0
primary	0
and	0
secondary	0
subtypes	I-DISEASE
mentioned	I-DISEASE
are	I-DISEASE
considered	0
.	0

There	I-DISEASE
is	I-DISEASE
substantial	0
symptom	0
overlap	0
both	0
within	0
the	0
group	I-DISEASE
of	I-DISEASE
primary	0
insomnias	0
as	0
well	0
as	0
among	0
the	0
primary	0
and	0
secondary	0
insomnias	0
.	0

Furthermore	I-DISEASE
,	I-DISEASE
many	0
individuals	I-DISEASE
with	0
insomnia	I-DISEASE
have	0
mul-	0
tiple	I-DISEASE
medical	0
and	0
psychiatric	I-DISEASE
comorbidities	I-DISEASE
,	0
making	I-DISEASE
it	0
difficult	0
to	I-DISEASE
assign	0
causation	0
to	I-DISEASE
any	I-DISEASE
single	0
factor	I-DISEASE
.	0

As	I-DISEASE
a	0
result	0
,	I-DISEASE
discrimination	0
among	0
these	I-DISEASE
subtypes	I-DISEASE
has	0
proven	0
difficult	I-DISEASE
given	0
their	0
current	I-DISEASE
definitions	I-DISEASE
and	0
available	0
methods	0
for	I-DISEASE
their	0
ascertain-	0
ment	0
.	0

Furthermore	I-DISEASE
,	I-DISEASE
it	0
is	I-DISEASE
not	0
clear	I-DISEASE
that	0
insomnia	I-DISEASE
is	0
always	0
the	I-DISEASE
result	0
of	I-DISEASE
co	0
-	I-DISEASE
occur-	I-DISEASE
ring	0
medical	I-DISEASE
,	0
mental	0
,	I-DISEASE
or	I-DISEASE
substance	I-DISEASE
use	0
disorders	0
.	0

Often	I-DISEASE
insomnia	I-DISEASE
may	0
precede	0
the	0
onset	0
of	I-DISEASE
such	0
conditions	I-DISEASE
,	I-DISEASE
and	0
even	I-DISEASE
when	I-DISEASE
precipitated	0
by	I-DISEASE
such	0
conditions	I-DISEASE
,	0
the	0
insom-	I-DISEASE
nia	I-DISEASE
may	0
evolve	0
and	0
develop	0
partial	I-DISEASE
or	0
total	0
independence	0
over	I-DISEASE
time	0
.	0

In	I-DISEASE
such	0
cir-	0
cumstances	0
,	0
the	0
term	0
secondary	0
insomnia	I-DISEASE
seems	I-DISEASE
inappropriate	0
.	0

Currently	I-DISEASE
there	I-DISEASE
is	0
limited	I-DISEASE
understanding	0
of	I-DISEASE
mechanistic	0
pathways	0
in	0
chronic	I-DISEASE
insomnia	I-DISEASE
,	I-DISEASE
so	0
it	I-DISEASE
is	0
not	0
possible	0
to	0
draw	0
firm	I-DISEASE
conclusions	I-DISEASE
about	0
the	0
association	0
or	0
direction	I-DISEASE
of	I-DISEASE
causality	0
between	0
insomnia	0
and	0
such	0
co	0
-	0
occurring	0
conditions	0
.	0

Furthermore	I-DISEASE
,	I-DISEASE
other	0
than	0
the	0
differing	I-DISEASE
treatments	0
required	I-DISEASE
for	0
distinctive	0
comorbidities	I-DISEASE
,	0
efficacious	0
treatments	0
for	0
insomnia	0
generally	0
are	I-DISEASE
similar	0
across	I-DISEASE
the	0
range	I-DISEASE
of	I-DISEASE
insomnia	I-DISEASE
subtypes	I-DISEASE
.	0

Finally	I-DISEASE
,	I-DISEASE
research	0
has	0
provided	0
very	I-DISEASE
limited	I-DISEASE
support	I-DISEASE
for	0
the	0
reliability	I-DISEASE
and	0
validity	I-DISEASE
of	I-DISEASE
the	0
various	0
specific	I-DISEASE
subtypes	I-DISEASE
discussed	I-DISEASE
.	0

International	I-DISEASE
Classification	I-DISEASE
of	I-DISEASE
Sleep	I-DISEASE
Disorders	0
,	I-DISEASE
2nd	0
Edition	0
additionally	I-DISEASE
delineates	I-DISEASE
the	0
separate	0
pediatric	0
diagnosis	0
,	0
behavioral	I-DISEASE
insomnia	0
of	I-DISEASE
childhood	0
,	0
characterized	0
by	0
sleep	0
difficulties	I-DISEASE
resulting	I-DISEASE
from	0
inappropriate	0
sleep	I-DISEASE
associations	I-DISEASE
or	I-DISEASE
inadequate	0
limit	I-DISEASE
setting	0
by	0
parents	0
or	0
caretakers	0
.	0

Although	I-DISEASE
perhaps	I-DISEASE
more	0
common	I-DISEASE
in	0
young	I-DISEASE
children	I-DISEASE
,	I-DISEASE
inappropriate	0
sleep	0
associations	0
can	0
occur	I-DISEASE
in	I-DISEASE
older	0
age	I-DISEASE
groups	0
.	0

For	I-DISEASE
example	0
,	0
adults	I-DISEASE
with	0
insomnia	I-DISEASE
may	0
report	0
intolerance	I-DISEASE
for	I-DISEASE
quiet	0
and	0
dark	0
settings	I-DISEASE
and	0
may	0
not	0
be	0
able	0
to	0
fall	I-DISEASE
asleep	I-DISEASE
unless	0
the	I-DISEASE
television	0
is	I-DISEASE
on	0
.	0

Similarly	I-DISEASE
,	I-DISEASE
it	0
is	I-DISEASE
not	0
clear	I-DISEASE
that	0
limit	I-DISEASE
-	0
setting	0
issues	0
are	I-DISEASE
involved	I-DISEASE
in	I-DISEASE
the	0
sleep	0
difficulties	I-DISEASE
of	I-DISEASE
only	0
young	0
children	I-DISEASE
.	0

Such	I-DISEASE
difficulties	I-DISEASE
also	0
can	I-DISEASE
manifest	B-DISEASE
during	I-DISEASE
adolescence	0
as	0
a	I-DISEASE
function	I-DISEASE
of	I-DISEASE
volitionally	I-DISEASE
delaying	I-DISEASE
bedtimes	0
.	0

Similarly	I-DISEASE
,	I-DISEASE
they	0
may	I-DISEASE
occur	0
in	I-DISEASE
older	0
,	I-DISEASE
cognitively	0
impaired	I-DISEASE
adults	I-DISEASE
when	I-DISEASE
their	I-DISEASE
caretak-	0
ers	0
allow	0
liberal	0
daytime	I-DISEASE
napping	B-DISEASE
that	0
in	0
turn	0
results	I-DISEASE
in	I-DISEASE
disruptive	I-DISEASE
awakenings	0
and	0
night	0
wandering	0
.	0

It	I-DISEASE
is	I-DISEASE
also	0
clear	I-DISEASE
that	0
many	0
of	I-DISEASE
the	B-DISEASE
features	0
of	I-DISEASE
sleep	0
/	0
wake	I-DISEASE
dysfunc-	I-DISEASE
tion	0
assigned	I-DISEASE
to	0
this	0
childhood	0
insomnia	I-DISEASE
subtype	I-DISEASE
overlap	0
substantially	I-DISEASE
with	B-DISEASE
the	0
global	0
insomnia	I-DISEASE
disorder	0
.	0

Given	I-DISEASE
these	I-DISEASE
considerations	0
,	I-DISEASE
a	0
separate	0
childhood	0
insomnia	I-DISEASE
diagno-	0
sis	0
is	0
of	I-DISEASE
questionable	0
merit	0
.	0

In	I-DISEASE
addition	0
to	0
these	I-DISEASE
various	0
subtypes	I-DISEASE
,	0
a	0
distinctive	0
subtype	I-DISEASE
of	I-DISEASE
insomnia	0
with	I-DISEASE
objectively	0
short	0
sleep	0
duration	0
has	0
been	I-DISEASE
recently	I-DISEASE
described	0
.	0

This	I-DISEASE
group	I-DISEASE
is	0
characterized	0
by	0
insom-	I-DISEASE
nia	0
complaints	0
,	I-DISEASE
along	I-DISEASE
with	I-DISEASE
an	0
objectively	0
documented	I-DISEASE
average	0
sleep	0
time	I-DISEASE
less	I-DISEASE
than	0
six	I-DISEASE
hours	I-DISEASE
per	I-DISEASE
night	0
and	0
elevated	I-DISEASE
morbidity	I-DISEASE
risk	0
.	0

Because	I-DISEASE
evidence	0
in	0
support	I-DISEASE
of	0
this	0
Insomnia	I-DISEASE
Insomnia	0
insomnia	0
is	I-DISEASE
currently	0
limited	I-DISEASE
,	0
it	0
is	0
premature	0
to	0
delineate	I-DISEASE
a	0
separate	I-DISEASE
insomnia	0
category	0
for	I-DISEASE
this	0
presentation	0
at	I-DISEASE
this	0
juncture	I-DISEASE
.	0

Given	I-DISEASE
all	0
of	I-DISEASE
these	I-DISEASE
considerations	0
,	I-DISEASE
a	I-DISEASE
more	0
global	I-DISEASE
and	0
defensible	0
approach	I-DISEASE
has	0
been	I-DISEASE
chosen	0
for	I-DISEASE
the	0
diagnosis	0
of	I-DISEASE
those	0
with	I-DISEASE
chronic	I-DISEASE
insomnia	I-DISEASE
complaints	0
.	0

Specifically	I-DISEASE
,	I-DISEASE
the	0
single	I-DISEASE
diagnosis	0
of	I-DISEASE
chronic	I-DISEASE
insomnia	I-DISEASE
disorder	0
is	I-DISEASE
provided	I-DISEASE
for	I-DISEASE
all	0
patients	I-DISEASE
who	I-DISEASE
have	I-DISEASE
per-	0
sistent	0
and	0
frequent	0
insomnia	I-DISEASE
complaints	0
whether	I-DISEASE
they	I-DISEASE
occur	I-DISEASE
in	0
the	0
presence	0
or	0
absence	I-DISEASE
of	0
a	0
potentially	0
sleep	0
-	0
disruptive	0
comorbid	I-DISEASE
psychiatric	I-DISEASE
illness	0
,	0
medical	0
disorder	I-DISEASE
,	0
or	0
pattern	0
of	I-DISEASE
substance	I-DISEASE
use	0
.	0

Demographics	I-DISEASE
The	I-DISEASE
full	0
clinical	0
syndrome	I-DISEASE
of	0
chronic	0
insomnia	I-DISEASE
disorder	I-DISEASE
occurs	0
in	I-DISEASE
about	0
10	I-DISEASE
%	0
of	0
the	0
population	0
,	0
but	0
the	0
prevalence	I-DISEASE
of	0
transient	0
insomnia	I-DISEASE
symptoms	0
is	0
much	I-DISEASE
higher	0
(	0
30	0
%	0
to	0
35	0
%	0
of	0
the	0
population	0
)	0
.	0

Chronic	I-DISEASE
insomnia	0
disorder	I-DISEASE
is	0
more	0
common	I-DISEASE
in	0
women	0
,	I-DISEASE
those	I-DISEASE
with	I-DISEASE
medical	0
/	0
psychiatric	I-DISEASE
/	I-DISEASE
substance	0
disorders	0
,	0
and	0
in	I-DISEASE
people	0
in	I-DISEASE
lower	0
socioeco-	0
nomic	0
strata	0
.	0

It	I-DISEASE
may	0
occur	0
at	I-DISEASE
any	I-DISEASE
age	I-DISEASE
but	0
is	I-DISEASE
more	0
commonly	0
diagnosed	0
in	I-DISEASE
older	I-DISEASE
adults	I-DISEASE
,	0
most	0
likely	0
due	I-DISEASE
to	0
age	0
-	I-DISEASE
related	0
deterioration	0
in	0
sleep	0
continuity	0
and	0
increase	I-DISEASE
in	I-DISEASE
medical	0
comorbidities	I-DISEASE
and	0
medication	0
use	0
that	0
increase	I-DISEASE
insomnia	0
risk	0
.	0

Insomnia	I-DISEASE
associated	0
with	I-DISEASE
requirements	0
of	I-DISEASE
parental	I-DISEASE
/	0
caregiver	0
presence	0
at	I-DISEASE
bedtime	I-DISEASE
and/or	0
during	I-DISEASE
the	0
night	0
,	0
along	I-DISEASE
with	I-DISEASE
insomnia	0
due	I-DISEASE
to	0
limit	B-DISEASE
-	0
setting	0
difficulties	I-DISEASE
,	0
are	0
estimated	0
to	0
occur	0
in	0
10	0
%	0
to	0
30	0
%	0
of	I-DISEASE
children	I-DISEASE
,	I-DISEASE
depending	0
on	0
the	0
exact	0
definitions	0
used	0
.	0

Certain	I-DISEASE
subgroups	I-DISEASE
of	I-DISEASE
children	0
,	I-DISEASE
such	0
as	B-DISEASE
those	0
suffering	0
from	I-DISEASE
chronic	I-DISEASE
illnesses	I-DISEASE
or	0
neurodevelopmental	0
disorders	0
,	0
have	0
a	0
somewhat	I-DISEASE
higher	0
prevalence	I-DISEASE
of	I-DISEASE
insomnia	I-DISEASE
symptoms	0
.	0

Because	I-DISEASE
children	I-DISEASE
are	0
not	0
expected	0
to	0
sleep	0
through	I-DISEASE
the	0
night	0
with	I-DISEASE
reg-	0
ularity	0
until	0
they	I-DISEASE
are	0
three	0
to	I-DISEASE
six	I-DISEASE
months	0
of	I-DISEASE
age	I-DISEASE
,	I-DISEASE
six	0
months	0
is	0
a	0
reasonable	0
age	I-DISEASE
to	0
first	0
consider	I-DISEASE
a	0
diagnosis	0
of	0
chronic	I-DISEASE
insomnia	0
disorder	0
,	0
unless	0
the	0
sleeplessness	I-DISEASE
is	I-DISEASE
very	I-DISEASE
marked	0
at	I-DISEASE
an	0
earlier	0
age	I-DISEASE
.	0

Furthermore	I-DISEASE
,	I-DISEASE
sleep	0
-	I-DISEASE
onset	0
associations	I-DISEASE
and	0
limit	I-DISEASE
-	0
set-	0
ting	0
problems	I-DISEASE
are	0
strongly	I-DISEASE
associated	0
with	I-DISEASE
caregivers	0
’	I-DISEASE
behaviors	I-DISEASE
,	I-DISEASE
bedtime	I-DISEASE
interac-	0
tions	I-DISEASE
,	I-DISEASE
and	0
culture	0
.	0

Thus	I-DISEASE
,	I-DISEASE
the	0
interpretation	I-DISEASE
of	0
the	0
nighttime	I-DISEASE
awakenings	0
and	0
demands	I-DISEASE
for	I-DISEASE
parental	I-DISEASE
contact	I-DISEASE
should	I-DISEASE
be	I-DISEASE
considered	0
in	0
the	0
context	I-DISEASE
of	I-DISEASE
the	0
family	0
and	0
culture	0
.	I-DISEASE

Identification	I-DISEASE
of	I-DISEASE
sleep	0
problems	0
in	0
children	I-DISEASE
and	0
adolescents	0
are	0
often	I-DISEASE
based	B-DISEASE
on	0
spe-	0
cific	0
cultural	I-DISEASE
definitions	0
.	0

Studies	I-DISEASE
on	0
adolescents	0
indicate	I-DISEASE
prevalence	I-DISEASE
rates	I-DISEASE
of	I-DISEASE
3	I-DISEASE
%	0
to	0
12	I-DISEASE
%	I-DISEASE
,	I-DISEASE
depending	0
on	0
the	0
diagnostic	I-DISEASE
criteria	0
utilized	0
,	I-DISEASE
with	I-DISEASE
higher	0
frequency	I-DISEASE
in	I-DISEASE
girls	I-DISEASE
than	0
boys	I-DISEASE
after	0
puberty	I-DISEASE
.	0

Predisposing	I-DISEASE
and	0
Precipitating	I-DISEASE
Factors	0
Individuals	I-DISEASE
who	I-DISEASE
have	I-DISEASE
difficulty	0
sleeping	0
during	I-DISEASE
stressful	I-DISEASE
times	0
or	0
who	I-DISEASE
report	0
being	I-DISEASE
habitual	0
light	0
sleepers	0
appear	0
to	0
have	B-DISEASE
elevated	I-DISEASE
propensity	I-DISEASE
to	I-DISEASE
develop	0
chronic	I-DISEASE
insomnia	0
.	0

Prior	I-DISEASE
transient	0
episodes	I-DISEASE
of	0
poor	0
sleep	0
elevate	I-DISEASE
the	0
risk	0
for	I-DISEASE
subsequent	0
development	B-DISEASE
of	I-DISEASE
a	0
chronic	I-DISEASE
insomnia	0
disorder	0
.	0

Job	I-DISEASE
-	I-DISEASE
related	0
stress	I-DISEASE
and	0
factors	0
such	0
as	I-DISEASE
death	0
of	I-DISEASE
a	0
loved	I-DISEASE
one	I-DISEASE
,	I-DISEASE
divorce	0
,	I-DISEASE
a	0
marked	I-DISEASE
change	0
in	0
work	I-DISEASE
schedule	I-DISEASE
,	0
job	0
loss	0
,	I-DISEASE
and	0
other	I-DISEASE
major	I-DISEASE
life	0
changes	I-DISEASE
are	I-DISEASE
often	0
precipitating	0
circumstances	0
for	I-DISEASE
chronic	I-DISEASE
insomnia	0
disorder	0
.	0

Personality	I-DISEASE
factors	0
that	0
produce	0
anxious	I-DISEASE
overconcern	0
about	0
health	0
,	I-DISEASE
general	I-DISEASE
well	B-DISEASE
-	0
being	I-DISEASE
,	I-DISEASE
or	0
daytime	0
func-	0
tioning	0
may	0
serve	I-DISEASE
as	0
predisposing	I-DISEASE
characteristics	0
because	0
individuals	I-DISEASE
with	I-DISEASE
chronic	0
insomnia	I-DISEASE
disorder	0
often	0
display	0
excessive	0
preoccupation	0
with	0
daytime	0
consequences	I-DISEASE
of	0
insomnia	0
,	I-DISEASE
and	0
they	0
devote	0
particular	I-DISEASE
effort	0
to	I-DISEASE
what	I-DISEASE
they	B-DISEASE
presume	0
are	0
sleep	0
-	I-DISEASE
promot-	0
ing	I-DISEASE
practices	I-DISEASE
.	0

A	I-DISEASE
psychological	I-DISEASE
style	0
characterized	0
by	0
the	0
repression	0
and	0
internalization	I-DISEASE
of	I-DISEASE
disturbing	0
affect	I-DISEASE
is	I-DISEASE
characteristic	0
of	I-DISEASE
those	I-DISEASE
with	I-DISEASE
chronic	0
insomnia	0
disorder	0
and	0
also	0
may	I-DISEASE
represent	0
a	0
predisposing	0
trait	0
.	0

Parents	I-DISEASE
who	I-DISEASE
have	0
unrealistic	I-DISEASE
sleep	0
expectations	I-DISEASE
for	0
their	0
children	B-DISEASE
may	0
predispose	I-DISEASE
them	I-DISEASE
to	I-DISEASE
insomnia	I-DISEASE
by	I-DISEASE
putting	0
them	I-DISEASE
in	0
bed	I-DISEASE
too	0
early	0
or	I-DISEASE
assigning	0
them	I-DISEASE
too	0
much	I-DISEASE
time	0
in	I-DISEASE
bed	I-DISEASE
each	0
night	0
.	0

Comorbid	I-DISEASE
psychiatric	I-DISEASE
conditions	0
,	I-DISEASE
particularly	0
mood	I-DISEASE
and	0
anxiety	0
disorders	0
,	I-DISEASE
are	I-DISEASE
asso-	I-DISEASE
ciated	I-DISEASE
with	0
increased	0
risk	0
for	0
chronic	I-DISEASE
insomnia	I-DISEASE
disorder	0
.	0

Likewise	I-DISEASE
,	I-DISEASE
comorbid	I-DISEASE
restless	I-DISEASE
legs	I-DISEASE
syndrome	I-DISEASE
or	B-DISEASE
medical	0
disorders	0
such	I-DISEASE
as	I-DISEASE
GERD	I-DISEASE
or	I-DISEASE
those	I-DISEASE
conditions	I-DISEASE
that	0
result	0
in	I-DISEASE
chronic	I-DISEASE
pain	0
,	I-DISEASE
breathing	I-DISEASE
difficulties	I-DISEASE
,	0
or	I-DISEASE
immobility	0
also	0
are	0
associated	0
with	I-DISEASE
increased	0
risk	0
for	0
chronic	I-DISEASE
insomnia	I-DISEASE
disorder	0
.	0

A	I-DISEASE
pattern	0
of	I-DISEASE
alcohol	I-DISEASE
dependence	0
/	0
abuse	I-DISEASE
as	I-DISEASE
well	B-DISEASE
as	0
the	0
excessive	0
use	I-DISEASE
of	I-DISEASE
caffeine	0
or	I-DISEASE
other	0
stimulants	0
may	I-DISEASE
raise	0
risk	0
for	0
chronic	I-DISEASE
insomnia	I-DISEASE
disorder	B-DISEASE
.	0

Insomnia	I-DISEASE
in	0
children	I-DISEASE
is	I-DISEASE
often	I-DISEASE
associated	0
with	0
difficult	0
temperament	I-DISEASE
,	I-DISEASE
as	0
well	I-DISEASE
as	0
other	I-DISEASE
comorbid	0
medical	0
and	0
psychiatric	I-DISEASE
conditions	I-DISEASE
.	0

Unstable	I-DISEASE
home	0
situations	I-DISEASE
,	0
safety	I-DISEASE
concerns	I-DISEASE
and	0
domestic	0
abuse	0
are	0
likewise	I-DISEASE
significant	I-DISEASE
risk	0
factors	B-DISEASE
in	I-DISEASE
both	I-DISEASE
children	I-DISEASE
and	0
adults	0
.	0

Caregiver	I-DISEASE
and	0
relationship	0
factors	0
are	0
also	0
important	B-DISEASE
to	0
consider	0
.	0

Furthermore	I-DISEASE
,	I-DISEASE
parents	0
of	I-DISEASE
children	0
with	I-DISEASE
a	0
current	I-DISEASE
or	B-DISEASE
past	I-DISEASE
history	I-DISEASE
of	I-DISEASE
medical	I-DISEASE
problems	I-DISEASE
may	0
have	0
dif-	I-DISEASE
ficulty	0
setting	0
limits	0
,	I-DISEASE
whether	0
because	0
of	I-DISEASE
guilt	0
,	I-DISEASE
a	I-DISEASE
sense	I-DISEASE
that	0
the	0
child	0
is	0
“	0
vulnerable	I-DISEASE
,	0
”	I-DISEASE
or	0
concerns	0
about	0
doing	0
psychological	I-DISEASE
harm	I-DISEASE
.	0

Environmental	I-DISEASE
factors	I-DISEASE
such	0
as	0
the	0
child	0
sharing	0
a	I-DISEASE
room	0
with	0
a	0
parent	0
or	I-DISEASE
with	I-DISEASE
other	0
siblings	I-DISEASE
,	I-DISEASE
the	I-DISEASE
presence	0
of	0
extended	0
family	0
or	0
others	B-DISEASE
in	I-DISEASE
the	I-DISEASE
home	0
,	I-DISEASE
and	0
cramped	I-DISEASE
living	0
accommodations	I-DISEASE
may	0
contribute	0
to	I-DISEASE
negative	I-DISEASE
sleep	0
-	I-DISEASE
onset	0
associations	0
or	0
poor	0
limit	0
setting	0
.	0

Familial	I-DISEASE
Patterns	I-DISEASE

The	I-DISEASE
familial	I-DISEASE
pattern	0
of	I-DISEASE
insomnia	0
is	0
not	0
well	I-DISEASE
documented	I-DISEASE
.	0

Nonetheless	I-DISEASE
,	I-DISEASE
the	0
preva-	I-DISEASE
lence	I-DISEASE
of	I-DISEASE
insomnia	0
is	I-DISEASE
higher	0
among	0
monozygotic	0
twins	I-DISEASE
relative	I-DISEASE
to	0
dizygotic	0
twins	I-DISEASE
;	I-DISEASE
it	I-DISEASE
is	I-DISEASE
also	0
higher	0
in	I-DISEASE
first	I-DISEASE
-	0
degree	I-DISEASE
relatives	0
than	I-DISEASE
in	I-DISEASE
the	0
general	0
population	0
.	0

The	I-DISEASE
association	I-DISEASE
is	0
stronger	I-DISEASE
with	0
mothers	I-DISEASE
and	0
daughters	0
.	0

The	I-DISEASE
extent	0
to	0
which	0
familial	0
aggregation	I-DISEASE
represents	0
shared	0
genetic	I-DISEASE
predisposition	I-DISEASE
,	I-DISEASE
shared	I-DISEASE
environment	0
,	0
learned	0
behavior	I-DISEASE
(	I-DISEASE
e.g.	0
,	I-DISEASE
by	0
observations	0
of	I-DISEASE
parental	I-DISEASE
behavior	I-DISEASE
)	0
,	I-DISEASE
or	0
a	0
by	0
-	I-DISEASE
product	0
of	0
psychopathology	0
remains	I-DISEASE
undetermined	I-DISEASE
.	0

Insomnia	I-DISEASE
Insomnia	0
Onset	0
,	0
Course	0
,	I-DISEASE
and	0
Complications	0
Onset	0
may	I-DISEASE
be	0
insidious	I-DISEASE
or	I-DISEASE
acute	0
.	I-DISEASE

In	I-DISEASE
the	0
former	0
case	I-DISEASE
,	0
individuals	I-DISEASE
often	0
report	0
symptoms	I-DISEASE
of	I-DISEASE
insomnia	I-DISEASE
in	I-DISEASE
early	0
life	0
or	I-DISEASE
young	I-DISEASE
adulthood	0
.	0

Onset	I-DISEASE
of	I-DISEASE
insomnia	I-DISEASE
is	I-DISEASE
often	0
associated	0
with	0
major	I-DISEASE
life	0
events	I-DISEASE
(	I-DISEASE
e.g.	0
,	0
separation	0
,	I-DISEASE
death	0
of	I-DISEASE
a	0
loved	0
one	I-DISEASE
)	0
,	I-DISEASE
minor	0
daily	I-DISEASE
stressors	I-DISEASE
,	0
or	I-DISEASE
changes	I-DISEASE
in	I-DISEASE
sleep	0
schedule	0
.	0

The	I-DISEASE
course	I-DISEASE
of	I-DISEASE
insomnia	I-DISEASE
can	I-DISEASE
be	I-DISEASE
situational	I-DISEASE
,	I-DISEASE
recurrent	0
,	I-DISEASE
or	0
persistent	0
.	0

The	I-DISEASE
specific	I-DISEASE
type	I-DISEASE
of	I-DISEASE
sleep	0
complaint	I-DISEASE
may	I-DISEASE
also	0
change	0
over	0
time	0
.	0

Individuals	I-DISEASE
who	I-DISEASE
complain	0
of	I-DISEASE
diffi-	0
culty	0
falling	0
asleep	I-DISEASE
at	I-DISEASE
one	I-DISEASE
time	0
may	I-DISEASE
later	I-DISEASE
complain	I-DISEASE
of	0
difficulty	0
maintaining	0
sleep	0
,	0
and	0
vice	I-DISEASE
versa	I-DISEASE
.	0

Although	I-DISEASE
short	0
-	0
term	0
insomnia	0
often	0
remits	0
when	0
the	I-DISEASE
precipitating	I-DISEASE
event	0
subsides	0
or	0
the	0
individual	0
adapts	0
to	0
it	0
,	0
sleep	0
difficulties	0
may	I-DISEASE
also	0
persist	I-DISEASE
over	0
time	0
even	0
after	0
the	0
initial	0
triggering	I-DISEASE
factor	0
has	0
disappeared	I-DISEASE
.	0

When	I-DISEASE
left	0
untreated	0
,	I-DISEASE
insomnia	0
may	0
persist	I-DISEASE
and	0
gradually	I-DISEASE
lead	0
to	0
a	0
vicious	I-DISEASE
cycle	0
of	0
poor	0
sleep	0
,	0
daytime	0
impairments	0
,	I-DISEASE
apprehension	0
of	I-DISEASE
insomnia	I-DISEASE
,	I-DISEASE
and	0
further	I-DISEASE
sleep	0
disturbances	I-DISEASE
.	0

Among	I-DISEASE
predisposed	I-DISEASE
individ-	0
uals	0
,	I-DISEASE
insomnia	I-DISEASE
can	0
also	0
follow	I-DISEASE
an	I-DISEASE
intermittent	0
course	0
,	I-DISEASE
with	I-DISEASE
recurrent	0
episodes	I-DISEASE
of	I-DISEASE
sleep	0
difficulties	I-DISEASE
associated	0
with	I-DISEASE
stressful	I-DISEASE
life	0
events	0
.	0

Even	I-DISEASE
in	I-DISEASE
persistent	0
insomnia	0
,	0
there	I-DISEASE
is	0
extensive	0
night	0
-	I-DISEASE
to	I-DISEASE
-	I-DISEASE
night	0
variability	I-DISEASE
,	I-DISEASE
with	0
an	0
occasional	I-DISEASE
good	0
night	0
’s	I-DISEASE
sleep	I-DISEASE
intertwined	0
with	0
several	I-DISEASE
poor	0
night	0
’s	I-DISEASE
sleep	0
.	0

Approximately	I-DISEASE
70	0
%	0
of	I-DISEASE
individuals	I-DISEASE
with	I-DISEASE
insomnia	0
at	I-DISEASE
a	0
given	0
time	I-DISEASE
continue	0
reporting	0
insomnia	I-DISEASE
a	0
year	0
later	0
,	0
and	0
50	0
%	0
still	I-DISEASE
have	0
insomnia	I-DISEASE
three	0
years	I-DISEASE
later	0
.	0

Complications	I-DISEASE
of	0
persistent	0
insomnia	0
include	0
increased	0
risks	I-DISEASE
for	I-DISEASE
depression	I-DISEASE
,	0
hypertension	I-DISEASE
,	0
work	I-DISEASE
disability	0
,	0
and	0
prolonged	0
use	I-DISEASE
of	0
prescription	I-DISEASE
or	0
over-	I-DISEASE
the	0
-	0
counter	0
sleep	0
aids	I-DISEASE
.	0

Among	I-DISEASE
children	I-DISEASE
,	0
chronic	I-DISEASE
insomnia	0
disorder	I-DISEASE
may	0
have	0
its	I-DISEASE
onset	I-DISEASE
at	I-DISEASE
any	I-DISEASE
time	0
during	I-DISEASE
late	I-DISEASE
infancy	I-DISEASE
through	0
the	0
childhood	0
years	0
.	0

The	I-DISEASE
course	I-DISEASE
of	I-DISEASE
chronic	I-DISEASE
insomnia	0
disorder	I-DISEASE
in	0
young	I-DISEASE
children	I-DISEASE
varies	I-DISEASE
and	0
depends	I-DISEASE
on	0
the	0
reasons	I-DISEASE
for	I-DISEASE
the	0
sleeplessness	0
.	0

When	I-DISEASE
limit	0
-	0
setting	0
factors	0
and	0
negative	I-DISEASE
sleep	0
associations	0
resolve	0
,	0
sleep	0
often	I-DISEASE
improves	I-DISEASE
.	0

With	I-DISEASE
age	I-DISEASE
,	0
inde-	I-DISEASE
pendence	0
and	0
privacy	0
become	I-DISEASE
more	0
important	I-DISEASE
,	I-DISEASE
and	0
sleep	0
difficulties	I-DISEASE
may	I-DISEASE
decrease	0
.	0

Complications	I-DISEASE
may	0
result	0
from	0
the	0
consequent	0
sleep	0
loss	I-DISEASE
and	0
include	0
irritability	I-DISEASE
and	0
decreased	I-DISEASE
attention	0
and	0
school	0
performance	0
.	0

Increased	I-DISEASE
family	0
tensions	I-DISEASE
and	0
caregiver	I-DISEASE
sleep	0
loss	0
may	I-DISEASE
also	0
result	I-DISEASE
.	0

Some	I-DISEASE
who	I-DISEASE
develop	0
insomnia	I-DISEASE
during	I-DISEASE
childhood	I-DISEASE
may	0
con-	0
tinue	0
to	I-DISEASE
suffer	0
from	I-DISEASE
chronic	I-DISEASE
insomnia	I-DISEASE
disorder	I-DISEASE
into	I-DISEASE
adulthood	0
.	0

Developmental	I-DISEASE
Issues	0
Developmental	I-DISEASE
issues	I-DISEASE
during	I-DISEASE
childhood	I-DISEASE
,	0
such	0
as	0
separation	I-DISEASE
anxiety	I-DISEASE
and	0
age	I-DISEASE
/	0
develop-	0
mental	0
milestones	0
,	0
may	I-DISEASE
predispose	0
a	0
child	0
to	0
developing	0
sleep	0
problems	0
.	0

For	I-DISEASE
example	0
,	0
limit	I-DISEASE
-	0
setting	0
issues	0
are	0
often	0
more	0
common	I-DISEASE
after	0
the	I-DISEASE
child	0
is	0
old	0
enough	I-DISEASE
to	I-DISEASE
climb	0
out	0
of	I-DISEASE
the	0
crib	I-DISEASE
or	I-DISEASE
is	0
moved	0
into	I-DISEASE
a	0
bed	I-DISEASE
,	I-DISEASE
has	0
increased	0
verbal	0
skills	0
,	0
and	0
desires	I-DISEASE
greater	I-DISEASE
indepen-	0
dence	0
.	0

Because	I-DISEASE
children	I-DISEASE
are	0
not	0
expected	0
to	0
sleep	0
through	I-DISEASE
the	0
night	0
with	I-DISEASE
regularity	I-DISEASE
until	0
they	B-DISEASE
are	0
three	I-DISEASE
to	I-DISEASE
six	0
months	0
of	I-DISEASE
age	I-DISEASE
,	0
six	B-DISEASE
months	0
is	I-DISEASE
a	0
reasonable	0
age	I-DISEASE
to	I-DISEASE
first	I-DISEASE
consider	B-DISEASE
a	0
diagnosis	B-DISEASE
of	I-DISEASE
insomnia	0
disorder	0
,	0
unless	0
the	0
sleeplessness	0
is	0
very	I-DISEASE
marked	I-DISEASE
at	I-DISEASE
an	0
earlier	0
age	I-DISEASE
.	0

However	I-DISEASE
,	I-DISEASE
when	0
sleep	0
difficulties	0
are	0
persistent	0
and	0
pronounced	0
in	0
infants	0
,	I-DISEASE
underlying	I-DISEASE
medical	I-DISEASE
causes	0
should	0
be	I-DISEASE
considered	I-DISEASE
(	0
e.g.	0
,	0
sleep	0
disordered	I-DISEASE
breathing	0
,	I-DISEASE
GERD	I-DISEASE
,	I-DISEASE
pain	0
)	0
.	0

The	I-DISEASE
specific	I-DISEASE
symptoms	I-DISEASE
of	I-DISEASE
chronic	0
insomnia	I-DISEASE
disorder	0
,	0
as	0
well	I-DISEASE
as	I-DISEASE
precipitating	I-DISEASE
and	0
per-	0
petuating	I-DISEASE
factors	0
,	I-DISEASE
may	I-DISEASE
vary	I-DISEASE
across	0
the	I-DISEASE
adult	0
age	I-DISEASE
range	I-DISEASE
.	0

These	0
changes	0
may	0
in	I-DISEASE
part	0
reflect	I-DISEASE
developmental	I-DISEASE
changes	I-DISEASE
across	0
adulthood	0
,	0
such	0
as	I-DISEASE
the	0
phase	0
delay	I-DISEASE
of	I-DISEASE
endoge-	I-DISEASE
nous	0
circadian	0
rhythms	0
in	0
adolescence	I-DISEASE
and	0
young	I-DISEASE
adulthood	0
,	0
and	0
the	0
phase	0
advance	0
and	0
increased	0
number	0
of	I-DISEASE
awakenings	0
often	0
seen	I-DISEASE
even	I-DISEASE
among	0
healthy	I-DISEASE
older	0
adults	I-DISEASE
.	0

Epidemiological	I-DISEASE
studies	I-DISEASE
confirm	0
that	0
sleep	0
onset	0
difficulties	0
and	0
nonrestorative	I-DISEASE
sleep	0
are	I-DISEASE
most	0
common	0
among	0
young	I-DISEASE
adults	I-DISEASE
with	I-DISEASE
chronic	I-DISEASE
insomnia	I-DISEASE
disorder	0
,	I-DISEASE
whereas	0
sleep	0
maintenance	I-DISEASE
insomnia	0
and	0
early	0
morning	0
awakening	0
are	0
more	0
common	0
in	I-DISEASE
middle	I-DISEASE
-	I-DISEASE
aged	I-DISEASE
and	0
older	0
adults	I-DISEASE
.	0

Objective	I-DISEASE
daytime	I-DISEASE
sleepiness	0
is	0
uncommon	0
in	0
younger	0
adults	B-DISEASE
with	I-DISEASE
insomnia	I-DISEASE
,	I-DISEASE
but	I-DISEASE
more	0
common	I-DISEASE
in	0
older	0
adults	0
.	0

However	I-DISEASE
,	I-DISEASE
older	0
adults	I-DISEASE
may	0
have	I-DISEASE
less	I-DISEASE
sleep	0
dissatisfaction	0
than	I-DISEASE
their	I-DISEASE
younger	I-DISEASE
counterparts	0
,	I-DISEASE
despite	0
objectively	I-DISEASE
worse	0
sleep	0
continuity	0
.	0

Precipitating	I-DISEASE
factors	0
for	I-DISEASE
chronic	I-DISEASE
insomnia	I-DISEASE
disorder	0
may	I-DISEASE
also	I-DISEASE
change	I-DISEASE
across	0
the	0
adult	0
age	I-DISEASE
range	0
,	0
with	I-DISEASE
medical	0
and	0
medication	0
factors	0
assuming	I-DISEASE
a	0
larger	I-DISEASE
role	0
in	I-DISEASE
older	0
adults	B-DISEASE
.	0

Likewise	I-DISEASE
,	I-DISEASE
perpetuating	0
factors	0
may	I-DISEASE
vary	I-DISEASE
with	0
the	0
life	0
circumstances	0
of	I-DISEASE
adults	I-DISEASE
of	I-DISEASE
different	0
ages	I-DISEASE
.	I-DISEASE

One	I-DISEASE
common	I-DISEASE
example	0
is	I-DISEASE
the	0
option	0
of	I-DISEASE
older	0
adults	B-DISEASE
to	0
spend	I-DISEASE
large	I-DISEASE
amounts	I-DISEASE
of	I-DISEASE
time	0
in	I-DISEASE
bed	I-DISEASE
after	I-DISEASE
retirement	0
,	0
which	0
may	0
exacerbate	0
the	0
effects	0
of	I-DISEASE
age	I-DISEASE
on	0
sleep	0
continuity	0
.	0

Finally	I-DISEASE
,	I-DISEASE
medical	0
disorders	0
and	0
symptoms	I-DISEASE
(	I-DISEASE
e.g.	I-DISEASE
,	I-DISEASE
pain	I-DISEASE
,	I-DISEASE
dyspnea	0
,	0
and	0
impaired	I-DISEASE
mobility	I-DISEASE
)	0
and	0
medications	0
often	0
play	0
a	0
larger	I-DISEASE
role	0
in	I-DISEASE
the	0
insomnia	0
of	I-DISEASE
older	0
adults	0
in	I-DISEASE
comparison	0
with	0
younger	I-DISEASE
adults	0
.	0

Hypnotic	I-DISEASE
medications	I-DISEASE
are	0
disproportion-	I-DISEASE
ately	I-DISEASE
prescribed	0
to	I-DISEASE
older	I-DISEASE
adults	0
,	0
often	0
with	I-DISEASE
limited	I-DISEASE
benefit	0
and	0
the	I-DISEASE
potential	0
for	I-DISEASE
rebound	0
and	0
withdrawal	B-DISEASE
insomnia	0
.	0

Pathology	I-DISEASE
and	0
Pathophysiology	I-DISEASE
Studies	B-DISEASE
of	I-DISEASE
the	0
pathophysiology	I-DISEASE
of	I-DISEASE
chronic	I-DISEASE
insomnia	0
disorder	I-DISEASE
have	0
focused	0
on	0
one	I-DISEASE
or	0
more	0
dimensions	0
of	I-DISEASE
physiological	0
hyperarousal	I-DISEASE
during	I-DISEASE
sleep	0
and	0
wakefulness	0
.	0

These	0
studies	I-DISEASE
contrast	0
groups	0
of	0
insomnia	I-DISEASE
sufferers	0
,	0
typically	0
those	I-DISEASE
without	0
sig-	0
nificant	I-DISEASE
comorbidities	I-DISEASE
,	I-DISEASE
with	I-DISEASE
healthy	0
controls	0
using	0
a	I-DISEASE
variety	I-DISEASE
of	I-DISEASE
physiological	0
mea-	B-DISEASE
sures	0
.	0

Many	0
of	I-DISEASE
these	0
studies	I-DISEASE
are	0
characterized	0
by	I-DISEASE
small	0
sample	0
sizes	I-DISEASE
and	0
lack	I-DISEASE
of	I-DISEASE
replication	I-DISEASE
.	0

Collectively	I-DISEASE
these	0
studies	I-DISEASE
suggest	0
increased	0
physiological	0
arousal	I-DISEASE
among	0
individuals	I-DISEASE
with	I-DISEASE
insomnia	I-DISEASE
,	0
characterized	0
by	I-DISEASE
measures	0
such	0
as	0
increased	0
heart	0
rate	I-DISEASE
,	0
altered	0
heart	0
rate	0
variability	I-DISEASE
,	I-DISEASE
increased	0
whole	0
-	0
body	I-DISEASE
metabolic	0
rate	0
,	0
elevated	0
corti-	0
sol	0
,	I-DISEASE
adrenocorticotropic	0
hormone	0
,	0
and	0
CRF	0
levels	0
(	0
particularly	0
near	0
sleep	0
onset	I-DISEASE
)	I-DISEASE
,	I-DISEASE
increased	0
body	I-DISEASE
temperature	I-DISEASE
and	0
increased	0
high	I-DISEASE
-	0
frequency	I-DISEASE
electroencephalographic	I-DISEASE
(	I-DISEASE
EEG	0
)	0
activity	0
during	I-DISEASE
nonrapid	0
eye	0
movement	I-DISEASE
(	I-DISEASE
NREM	0
)	0
sleep	0
.	0

These	0
studies	I-DISEASE
imply	0
Insomnia	I-DISEASE
Insomnia	I-DISEASE
heightened	0
activity	I-DISEASE
of	I-DISEASE
the	0
sympathetic	I-DISEASE
nervous	I-DISEASE
system	I-DISEASE
and	0
hypothalamic	0
-	0
pitu-	I-DISEASE
itary	0
-	0
adrenal	I-DISEASE
axis	I-DISEASE
across	I-DISEASE
sleep	0
and	0
wakefulness	0
that	0
is	0
thought	0
to	0
perpetuate	0
sleep/	0
wake	0
dysfunction	0
.	0

Some	I-DISEASE
evidence	0
also	0
suggests	I-DISEASE
that	0
physiological	0
dysregulation	0
may	I-DISEASE
be	I-DISEASE
more	0
evident	0
in	0
certain	0
subgroups	I-DISEASE
of	0
individuals	I-DISEASE
with	0
insomnia	I-DISEASE
(	I-DISEASE
e.g.	0
,	I-DISEASE
those	0
with	0
extreme	I-DISEASE
subjective	I-DISEASE
-	0
objective	B-DISEASE
sleep	0
discrepancies	0
or	0
those	0
with	0
insomnia	0
and	0
short	0
objective	0
sleep	0
duration	0
)	0
.	0

There	I-DISEASE
is	I-DISEASE
also	0
some	I-DISEASE
evidence	0
that	0
these	I-DISEASE
findings	0
may	0
not	0
generalize	0
to	I-DISEASE
insomnia	I-DISEASE
comorbid	I-DISEASE
with	0
mental	0
disorders	0
,	0
which	0
may	0
have	I-DISEASE
differ-	0
ent	0
pathophysiological	0
findings	0
.	0

No	I-DISEASE
discrete	0
structural	0
brain	I-DISEASE
pathology	0
can	0
be	I-DISEASE
identified	0
in	0
most	0
individuals	I-DISEASE
with	I-DISEASE
insom-	I-DISEASE
nia	0
.	0

Patients	I-DISEASE
with	0
insomnia	0
comorbid	I-DISEASE
with	0
neurological	0
disorders	0
such	0
as	0
stroke	I-DISEASE
,	I-DISEASE
brain	0
trauma	0
,	I-DISEASE
and	0
multiple	I-DISEASE
sclerosis	0
may	0
have	I-DISEASE
identifiable	I-DISEASE
brain	B-DISEASE
lesions	0
,	0
but	0
insomnia	0
is	0
rarely	0
their	0
sole	0
neurological	0
symptom	0
.	0

Recent	I-DISEASE
studies	I-DISEASE
have	0
provided	I-DISEASE
conflicting	0
evi-	0
dence	0
regarding	0
the	0
finding	I-DISEASE
of	I-DISEASE
reduced	0
hippocampal	0
or	0
anterior	I-DISEASE
cingulate	0
volume	I-DISEASE
,	I-DISEASE
with	0
most	0
studies	I-DISEASE
reporting	I-DISEASE
negative	I-DISEASE
findings	0
.	0

Objective	I-DISEASE
Findings	I-DISEASE

Although	I-DISEASE
polysomnography	0
is	I-DISEASE
not	0
indicated	0
in	0
the	0
routine	I-DISEASE
evaluation	I-DISEASE
of	0
insomnia	0
,	0
it	0
may	I-DISEASE
be	0
useful	0
to	0
rule	0
out	0
other	0
sleep	0
disorders	0
(	I-DISEASE
e.g.	0
,	I-DISEASE
sleep	0
-	0
disordered	0
breathing	0
)	0
among	0
some	0
patients	0
who	I-DISEASE
appear	0
to	I-DISEASE
meet	0
criteria	I-DISEASE
for	0
chronic	0
insomnia	0
disorder	0
.	0

In	I-DISEASE
the	0
absence	0
of	I-DISEASE
other	0
sleep	0
disorders	0
,	I-DISEASE
results	0
of	I-DISEASE
polysomnographic	0
sleep	0
monitoring	0
of	0
patients	0
with	0
chronic	I-DISEASE
insomnia	I-DISEASE
disorder	I-DISEASE
may	0
show	I-DISEASE
increased	0
sleep	0
latency	I-DISEASE
and/or	0
increased	0
wake	0
time	0
after	0
sleep	0
onset	0
coupled	0
with	0
reduced	0
sleep	0
efficiency	I-DISEASE
in	I-DISEASE
com-	I-DISEASE
parison	0
with	0
age	0
-	0
appropriate	I-DISEASE
norms	0
.	0

Sleep	I-DISEASE
onset	I-DISEASE
latency	I-DISEASE
or	0
wake	0
time	I-DISEASE
after	I-DISEASE
sleep	0
onset	0
often	0
exceeds	I-DISEASE
30	I-DISEASE
minutes	0
,	0
although	0
one	I-DISEASE
-	I-DISEASE
hour	0
to	0
two	I-DISEASE
-	0
hour	I-DISEASE
periods	0
of	I-DISEASE
wakefulness	0
in	I-DISEASE
bed	I-DISEASE
are	I-DISEASE
not	0
uncommon	0
.	0

A	I-DISEASE
subset	I-DISEASE
of	I-DISEASE
patients	I-DISEASE
shows	0
reduced	0
sleep	0
duration	I-DISEASE
of	I-DISEASE
less	I-DISEASE
than	0
six	I-DISEASE
hours	I-DISEASE
per	I-DISEASE
night	0
.	0

Some	I-DISEASE
patients	0
show	0
altered	I-DISEASE
sleep	0
architecture	I-DISEASE
with	I-DISEASE
an	0
increase	I-DISEASE
in	0
stage	0
N1	0
sleep	0
and	0
a	0
decrease	I-DISEASE
in	I-DISEASE
slow	0
wave	0
sleep	0
.	0

Patients	I-DISEASE
with	0
a	0
pronounced	0
condi-	0
tioned	0
sleep	0
difficulty	0
in	I-DISEASE
the	B-DISEASE
home	0
environment	0
may	I-DISEASE
show	I-DISEASE
a	0
reverse	0
first	I-DISEASE
-	0
night	0
effect	0
in	I-DISEASE
the	0
sleep	0
laboratory	I-DISEASE
(	0
i.e.	I-DISEASE
,	0
better	0
sleep	0
on	0
the	0
first	I-DISEASE
vs.	0
the	0
second	0
recording	0
night	0
)	0
.	0

However	I-DISEASE
,	I-DISEASE
some	0
patients	I-DISEASE
show	0
normal	0
sleep	0
times	I-DISEASE
and	0
an	0
absence	0
of	I-DISEASE
sleep	I-DISEASE
onset	I-DISEASE
or	0
sleep	0
maintenance	I-DISEASE
difficulties	I-DISEASE
on	0
standard	0
polysomnographic	0
(	0
PSG	0
)	0
measures	0
.	B-DISEASE

Some	I-DISEASE
insomnia	I-DISEASE
patients	0
have	I-DISEASE
alterations	I-DISEASE
in	I-DISEASE
power	0
density	0
measures	0
of	I-DISEASE
the	I-DISEASE
sleep	0
EEG	0
when	0
compared	I-DISEASE
with	0
individuals	0
without	0
sleep	0
complaints	0
.	0

Specifically	I-DISEASE
,	I-DISEASE
these	0
patients	I-DISEASE
often	0
show	I-DISEASE
relatively	0
greater	I-DISEASE
power	0
in	0
the	0
high	I-DISEASE
frequency	I-DISEASE
(	I-DISEASE
beta	0
and	0
gamma	0
ranges	I-DISEASE
)	0
band-	0
widths	0
.	0

Some	I-DISEASE
reports	0
have	0
shown	I-DISEASE
that	0
elevated	I-DISEASE
high	I-DISEASE
-	0
frequency	I-DISEASE
power	0
is	0
characteris-	0
tic	0
of	I-DISEASE
insomnia	I-DISEASE
patients	I-DISEASE
with	0
marked	0
subjective	I-DISEASE
-	0
objective	I-DISEASE
discrepancies	0
in	0
sleep	0
mea-	0
sures	0
,	0
compared	I-DISEASE
to	0
insomnia	0
patients	0
with	0
more	0
obvious	I-DISEASE
objective	0
sleep	I-DISEASE
disturbances	I-DISEASE
or	0
individuals	0
without	0
sleep	0
complaints	0
.	0

Serial	I-DISEASE
monitoring	0
with	I-DISEASE
PSG	0
or	I-DISEASE
actigraphy	I-DISEASE
typically	0
shows	I-DISEASE
marked	I-DISEASE
night	I-DISEASE
-	0
to	I-DISEASE
-	I-DISEASE
night	I-DISEASE
vari-	0
ability	0
in	I-DISEASE
all	0
sleep	0
measures	0
as	0
well	I-DISEASE
as	0
in	I-DISEASE
recorded	I-DISEASE
bed	I-DISEASE
and	0
rising	I-DISEASE
times	0
.	0

This	I-DISEASE
variability	I-DISEASE
is	I-DISEASE
typically	0
greater	I-DISEASE
than	0
that	0
of	I-DISEASE
comparison	0
groups	0
of	I-DISEASE
good	I-DISEASE
sleepers	0
.	0

Many	I-DISEASE
patients	I-DISEASE
with	0
insomnia	I-DISEASE
underestimate	0
the	0
actual	I-DISEASE
sleep	0
time	I-DISEASE
shown	I-DISEASE
by	0
polysom-	0
nography	0
,	I-DISEASE
and	0
some	I-DISEASE
may	I-DISEASE
provide	0
sleep	0
estimates	I-DISEASE
that	0
fall	I-DISEASE
far	I-DISEASE
short	0
of	I-DISEASE
actual	I-DISEASE
PSG-	0
recorded	0
sleep	0
time	0
.	0

This	I-DISEASE
latter	I-DISEASE
group	I-DISEASE
has	I-DISEASE
previously	0
been	I-DISEASE
categorized	I-DISEASE
as	I-DISEASE
having	I-DISEASE
subjective	0
insomnia	I-DISEASE
,	I-DISEASE
sleep	0
state	I-DISEASE
misperception	I-DISEASE
,	0
or	I-DISEASE
paradoxical	I-DISEASE
insomnia	I-DISEASE
.	I-DISEASE

In	I-DISEASE
general	I-DISEASE
,	0
patients	I-DISEASE
with	0
insomnia	I-DISEASE
tend	B-DISEASE
to	0
underestimate	0
sleep	I-DISEASE
duration	0
and	0
overestimate	I-DISEASE
sleep	0
latency	I-DISEASE
and	0
awakenings	0
,	0
whereas	I-DISEASE
good	0
sleepers	0
tend	B-DISEASE
to	0
overestimate	0
sleep	0
duration	0
and	0
underestimate	0
sleep	0
latency	I-DISEASE
and	0
awakenings	I-DISEASE
relative	I-DISEASE
to	0
PSG	0
.	0

This	I-DISEASE
subjective	I-DISEASE
-	0
ob-	0
jective	I-DISEASE
mismatch	0
may	I-DISEASE
be	I-DISEASE
related	B-DISEASE
to	I-DISEASE
physiological	0
hyperarousal	I-DISEASE
,	0
and	0
may	I-DISEASE
be	0
one	I-DISEASE
of	0
the	I-DISEASE
core	I-DISEASE
features	I-DISEASE
of	I-DISEASE
insomnia	I-DISEASE
.	0

Results	I-DISEASE
of	I-DISEASE
the	0
Multiple	0
Sleep	0
Latency	I-DISEASE
Test	I-DISEASE
(	I-DISEASE
MSLT	I-DISEASE
)	0
usually	I-DISEASE
show	I-DISEASE
normal	0
daytime	I-DISEASE
alert-	I-DISEASE
ness	0
.	0

In	I-DISEASE
several	I-DISEASE
studies	I-DISEASE
,	I-DISEASE
patients	0
with	I-DISEASE
insomnia	I-DISEASE
have	0
longer	I-DISEASE
mean	I-DISEASE
MSLT	I-DISEASE
values	I-DISEASE
than	I-DISEASE
control	I-DISEASE
subjects	I-DISEASE
,	0
suggesting	0
hyperalertness	I-DISEASE
or	I-DISEASE
hyperarousal	0
.	0

A	I-DISEASE
minority	0
of	I-DISEASE
insomnia	I-DISEASE
patients	I-DISEASE
,	I-DISEASE
particularly	0
older	0
adults	I-DISEASE
with	I-DISEASE
insomnia	I-DISEASE
,	I-DISEASE
have	0
reduced	0
mean	0
MSLT	I-DISEASE
values	I-DISEASE
indicating	0
increased	0
sleepiness	0
.	0

Such	I-DISEASE
a	0
finding	0
should	0
prompt	0
consideration	I-DISEASE
of	I-DISEASE
other	0
concurrent	0
sleep	0
disorders	0
such	I-DISEASE
as	I-DISEASE
obstructive	0
sleep	0
apnea	0
.	0

Young	I-DISEASE
children	I-DISEASE
typically	0
show	I-DISEASE
essentially	0
normal	0
sleep	0
during	I-DISEASE
PSG	0
monitoring	0
when	0
the	I-DISEASE
caregiver	I-DISEASE
is	0
present	I-DISEASE
and	0
appropriate	0
limits	0
are	0
set	I-DISEASE
in	0
the	0
laboratory	I-DISEASE
.	0

Although	I-DISEASE
PSG	0
and	0
MSLT	0
testing	0
usually	I-DISEASE
are	0
not	0
helpful	I-DISEASE
in	I-DISEASE
the	I-DISEASE
establishment	0
of	I-DISEASE
an	0
insomnia	I-DISEASE
disorder	0
diagnosis	0
,	0
there	I-DISEASE
are	0
circumstances	0
that	0
may	0
warrant	I-DISEASE
such	0
testing	I-DISEASE
with	I-DISEASE
selected	0
patients	0
.	0

PSG	I-DISEASE
should	0
be	I-DISEASE
considered	0
when	I-DISEASE
there	I-DISEASE
are	I-DISEASE
reported	0
symptoms	I-DISEASE
or	0
bed	I-DISEASE
partner	I-DISEASE
observations	0
of	I-DISEASE
sleep	0
disordered	I-DISEASE
breathing	0
or	0
periodic	I-DISEASE
limb	0
movements	0
during	I-DISEASE
sleep	0
.	0

Patients	I-DISEASE
who	0
present	I-DISEASE
insomnia	0
symptoms	I-DISEASE
accompanied	0
by	0
excessive	0
daytime	0
sleepiness	I-DISEASE
may	0
warrant	I-DISEASE
PSG	0
and	0
MSLT	0
testing	0
,	0
particularly	0
if	0
narcolepsy	I-DISEASE
is	I-DISEASE
suspected	I-DISEASE
.	0

Patients	I-DISEASE
who	0
show	I-DISEASE
acceptable	0
adherence	0
to	I-DISEASE
trials	0
of	I-DISEASE
well	I-DISEASE
-	I-DISEASE
established	I-DISEASE
insom-	I-DISEASE
nia	I-DISEASE
therapies	0
but	0
fail	I-DISEASE
to	0
show	I-DISEASE
adequate	0
treatment	0
response	0
may	I-DISEASE
benefit	0
by	I-DISEASE
PSG	0
to	I-DISEASE
rule	I-DISEASE
out	0
a	0
comorbid	0
sleep	0
disorder	0
.	0

Finally	I-DISEASE
,	I-DISEASE
a	0
small	0
number	0
of	I-DISEASE
functional	0
imaging	I-DISEASE
studies	I-DISEASE
have	0
been	I-DISEASE
conducted	I-DISEASE
during	I-DISEASE
sleep	0
and	0
wakefulness	0
in	I-DISEASE
insomnia	0
and	0
control	0
groups	0
.	0

These	0
studies	I-DISEASE
suggest	0
region-	I-DISEASE
ally	I-DISEASE
specific	I-DISEASE
increases	0
of	0
relative	0
glucose	0
metabolism	0
in	I-DISEASE
insomnia	I-DISEASE
compared	I-DISEASE
to	I-DISEASE
controls	0
.	0

Specifically	I-DISEASE
,	I-DISEASE
these	0
studies	I-DISEASE
show	0
smaller	I-DISEASE
wake	0
to	I-DISEASE
NREM	0
decreases	0
of	I-DISEASE
relative	I-DISEASE
glucose	0
metabolism	0
in	I-DISEASE
sleep	I-DISEASE
/	0
wake	0
-	0
regulating	0
regions	0
including	0
thalamus	0
,	I-DISEASE
upper	0
brainstem	0
,	I-DISEASE
Insomnia	0
Insomnia	0
anterior	0
cingulate	I-DISEASE
,	I-DISEASE
and	0
limbic	I-DISEASE
cortex	I-DISEASE
in	I-DISEASE
insomnia	0
patients	0
.	0

Self	I-DISEASE
-	I-DISEASE
reported	0
and	0
objective	0
sleep	0
disruptions	I-DISEASE
are	0
related	0
to	0
increased	0
relative	I-DISEASE
metabolism	0
in	0
these	I-DISEASE
regions	I-DISEASE
.	0

These	0
findings	0
are	0
similar	I-DISEASE
to	0
regional	0
activation	I-DISEASE
patterns	I-DISEASE
during	I-DISEASE
sleep	0
in	0
an	0
animal	I-DISEASE
model	I-DISEASE
of	I-DISEASE
stress	I-DISEASE
-	I-DISEASE
induced	I-DISEASE
insomnia	0
.	0

Other	I-DISEASE
studies	I-DISEASE
using	0
nuclear	0
magnetic	0
resonance	I-DISEASE
spectroscopy	0
have	0
identified	I-DISEASE
reduced	I-DISEASE
gamma	I-DISEASE
-	0
aminobutyric	0
acid	0
(	0
GABA	I-DISEASE
)	0
signaling	B-DISEASE
in	I-DISEASE
sleep	0
-	0
regu-	I-DISEASE
lating	0
regions	0
in	0
insomnia	I-DISEASE
that	0
correlate	0
with	0
objective	0
measure	0
of	I-DISEASE
sleep	0
continuity	I-DISEASE
.	0

Studies	I-DISEASE
examining	0
task	0
-	I-DISEASE
related	0
changes	0
in	I-DISEASE
blood	I-DISEASE
flow	0
using	0
blood	I-DISEASE
oxygenation	I-DISEASE
level	0
dependent	0
functional	0
magnetic	I-DISEASE
resonance	I-DISEASE
imaging	0
(	0
BOLD	0
fMRI	0
)	0
paradigms	I-DISEASE
have	0
shown	I-DISEASE
reduced	0
activation	0
relative	I-DISEASE
to	0
baseline	I-DISEASE
levels	0
in	I-DISEASE
individuals	I-DISEASE
with	0
insomnia	I-DISEASE
when	0
compared	I-DISEASE
to	I-DISEASE
normal	0
sleeping	0
controls	0
.	0

Task	I-DISEASE
-	I-DISEASE
related	0
activation	I-DISEASE
changes	0
in	I-DISEASE
the	0
direction	I-DISEASE
of	I-DISEASE
“	0
normalization	0
”	I-DISEASE
following	0
cognitive	0
behavioral	0
treatment	I-DISEASE
.	I-DISEASE

Differential	I-DISEASE
Diagnosis	0
A	0
chronic	I-DISEASE
insomnia	I-DISEASE
disorder	0
that	0
presents	I-DISEASE
as	I-DISEASE
difficulty	0
initiating	I-DISEASE
sleep	0
should	0
be	I-DISEASE
differen-	I-DISEASE
tiated	0
from	0
delayed	I-DISEASE
sleep	0
-	I-DISEASE
wake	0
phase	0
disorder	0
.	B-DISEASE

In	I-DISEASE
the	I-DISEASE
latter	0
condition	I-DISEASE
,	0
sleep	I-DISEASE
initiation	I-DISEASE
is	I-DISEASE
consistently	I-DISEASE
later	0
than	I-DISEASE
desired	I-DISEASE
because	I-DISEASE
the	0
individual	0
’s	I-DISEASE
endogenous	I-DISEASE
circadian	I-DISEASE
rhythm	I-DISEASE
is	0
delayed	I-DISEASE
relative	I-DISEASE
to	0
the	I-DISEASE
desired	0
sleep	I-DISEASE
schedule	I-DISEASE
.	B-DISEASE

Sleep	I-DISEASE
-	I-DISEASE
onset	0
difficulties	I-DISEASE
persist	0
,	I-DISEASE
and	0
sleep	0
time	0
is	0
reduced	0
whenever	I-DISEASE
the	0
individual	0
chooses	I-DISEASE
bedtimes	I-DISEASE
and	0
rising	I-DISEASE
times	0
that	0
are	0
too	0
early	I-DISEASE
and	0
out	0
of	I-DISEASE
phase	0
with	I-DISEASE
the	0
endogenous	0
circadian	0
rhythm	0
.	0

However	I-DISEASE
,	I-DISEASE
patients	0
with	I-DISEASE
delayed	0
sleep	0
-	I-DISEASE
wake	0
phase	0
disorder	0
are	0
able	0
to	I-DISEASE
fall	I-DISEASE
asleep	0
with	0
less	I-DISEASE
difficulty	0
,	0
and	0
sleep	0
a	0
normal	0
amount	0
of	I-DISEASE
time	I-DISEASE
,	0
when	I-DISEASE
sleeping	I-DISEASE
in	I-DISEASE
phase	0
with	I-DISEASE
their	0
delayed	I-DISEASE
endogenous	0
rhythm	0
by	I-DISEASE
selecting	I-DISEASE
late	0
bed	I-DISEASE
and	0
rising	0
times	0
.	0

By	I-DISEASE
comparison	0
,	0
those	I-DISEASE
with	0
a	0
chronic	I-DISEASE
insomnia	I-DISEASE
disorder	0
often	I-DISEASE
feel	I-DISEASE
sleepy	0
at	I-DISEASE
the	0
desired	I-DISEASE
bedtime	I-DISEASE
but	0
are	I-DISEASE
unable	I-DISEASE
to	0
sleep	0
regardless	0
of	I-DISEASE
the	0
timing	I-DISEASE
of	I-DISEASE
their	I-DISEASE
bed	I-DISEASE
and	0
rise	0
times	0
.	0

Furthermore	I-DISEASE
,	I-DISEASE
sleep	0
problems	0
tend	B-DISEASE
to	I-DISEASE
be	I-DISEASE
more	0
variable	I-DISEASE
on	0
a	0
night	0
-	I-DISEASE
to	I-DISEASE
-	0
night	0
basis	I-DISEASE
in	I-DISEASE
insomnia	0
disorder	0
.	0

Given	I-DISEASE
the	0
prevalence	0
of	I-DISEASE
delayed	0
sleep-	0
wake	0
phase	0
disorder	0
in	I-DISEASE
teenagers	I-DISEASE
and	0
young	I-DISEASE
adults	B-DISEASE
,	I-DISEASE
it	I-DISEASE
is	I-DISEASE
particularly	0
important	0
to	I-DISEASE
con-	0
sider	0
the	I-DISEASE
possibility	0
of	I-DISEASE
this	0
alternate	I-DISEASE
or	I-DISEASE
comorbid	I-DISEASE
diagnosis	I-DISEASE
when	0
evaluating	0
individuals	0
from	I-DISEASE
these	I-DISEASE
age	0
groups	0
presenting	0
with	0
sleep	0
onset	I-DISEASE
insomnia	I-DISEASE
complaints	0
.	0

A	I-DISEASE
chronic	I-DISEASE
insomnia	0
disorder	I-DISEASE
that	0
presents	I-DISEASE
as	0
a	0
difficulty	0
maintaining	I-DISEASE
sleep	I-DISEASE
with	I-DISEASE
pre-	0
mature	I-DISEASE
morning	I-DISEASE
rise	0
times	0
also	0
should	0
be	0
differentiated	0
from	I-DISEASE
advanced	I-DISEASE
sleep	0
-	I-DISEASE
wake	0
phase	0
disorder	0
.	B-DISEASE

The	I-DISEASE
latter	0
tends	0
to	I-DISEASE
be	0
more	0
common	I-DISEASE
in	I-DISEASE
older	0
adults	0
than	0
it	0
is	I-DISEASE
in	I-DISEASE
younger	0
adults	I-DISEASE
and	0
children	I-DISEASE
.	0

Among	I-DISEASE
those	I-DISEASE
with	0
an	0
advanced	0
sleep	0
phase	0
pattern	0
,	0
sleep	0
initia-	I-DISEASE
tion	0
is	0
consistently	I-DISEASE
earlier	0
than	0
desired	I-DISEASE
because	0
the	0
individual	0
’s	I-DISEASE
endogenous	0
circadian	I-DISEASE
rhythm	B-DISEASE
is	0
advanced	I-DISEASE
relative	I-DISEASE
to	I-DISEASE
the	0
desired	0
sleep	0
schedule	I-DISEASE
.	0

However	I-DISEASE
,	I-DISEASE
total	0
sleep	0
time	0
is	I-DISEASE
adequate	0
when	I-DISEASE
the	0
individual	I-DISEASE
chooses	B-DISEASE
early	I-DISEASE
bed	I-DISEASE
and	0
rise	0
times	0
that	0
coincide	I-DISEASE
with	0
the	0
advanced	I-DISEASE
endogenous	0
circadian	0
rhythm	0
.	I-DISEASE

In	I-DISEASE
contrast	I-DISEASE
,	0
those	I-DISEASE
with	0
chronic	I-DISEASE
insomnia	0
dis-	0
order	I-DISEASE
may	I-DISEASE
display	0
sleep	0
maintenance	I-DISEASE
difficulties	I-DISEASE
and	0
early	0
morning	0
rise	0
time	0
regard-	0
less	I-DISEASE
of	0
the	I-DISEASE
sleep	0
schedule	I-DISEASE
they	I-DISEASE
select	B-DISEASE
.	0

There	I-DISEASE
can	0
be	0
some	I-DISEASE
overlap	0
between	0
chronic	I-DISEASE
insomnia	I-DISEASE
disorder	0
and	0
both	I-DISEASE
delayed	I-DISEASE
and	0
advanced	I-DISEASE
sleep	0
-	I-DISEASE
wake	0
phase	0
disorders	0
.	0

Patients	I-DISEASE
with	0
a	I-DISEASE
delayed	0
sleep	0
pattern	0
may	I-DISEASE
become	0
chronically	0
frustrated	0
or	I-DISEASE
anxious	I-DISEASE
about	0
their	0
inability	I-DISEASE
to	I-DISEASE
initiate	0
sleep	0
at	I-DISEASE
their	0
desired	0
times	0
,	I-DISEASE
and	0
this	0
frustration	I-DISEASE
or	0
anxiety	I-DISEASE
may	I-DISEASE
continue	0
to	0
disrupt	I-DISEASE
sleep	0
and	0
delay	0
sleep	0
onset	I-DISEASE
well	I-DISEASE
beyond	0
the	0
sleep	0
onset	0
time	0
promoted	0
by	I-DISEASE
the	I-DISEASE
endogenous	I-DISEASE
rhythm	I-DISEASE
.	0

Early	I-DISEASE
morning	0
awakenings	0
may	I-DISEASE
similarly	I-DISEASE
have	I-DISEASE
arousing	0
sleep	I-DISEASE
disruptive	I-DISEASE
effects	0
in	I-DISEASE
the	0
setting	0
of	I-DISEASE
an	0
advanced	I-DISEASE
sleep	0
phase	0
.	0

In	I-DISEASE
such	0
circumstances	0
both	I-DISEASE
a	0
circadian	I-DISEASE
rhythm	I-DISEASE
sleep	0
-	0
wake	0
disorder	0
diagnosis	I-DISEASE
and	0
a	0
chronic	0
insomnia	I-DISEASE
disorder	0
diagnosis	0
may	0
apply	I-DISEASE
and	0
should	0
be	I-DISEASE
assigned	0
.	0

Chronic	I-DISEASE
insomnia	0
disorder	I-DISEASE
should	I-DISEASE
also	0
be	0
discriminated	0
from	I-DISEASE
situational	I-DISEASE
sleep	0
dif-	I-DISEASE
ficulties	0
arising	0
from	I-DISEASE
sleep	I-DISEASE
-	0
disruptive	I-DISEASE
environmental	I-DISEASE
circumstances	0
.	B-DISEASE

A	I-DISEASE
variety	I-DISEASE
of	I-DISEASE
environmental	I-DISEASE
factors	0
including	0
excessive	0
noise	0
or	B-DISEASE
light	0
and	0
extreme	I-DISEASE
temperatures	I-DISEASE
will	0
disrupt	0
the	0
sleep	0
of	I-DISEASE
most	0
individuals	0
.	0

Also	I-DISEASE
,	I-DISEASE
sleeping	I-DISEASE
in	I-DISEASE
an	0
area	I-DISEASE
where	0
there	I-DISEASE
is	0
imminent	I-DISEASE
threat	I-DISEASE
or	I-DISEASE
danger	I-DISEASE
to	I-DISEASE
one	0
’s	I-DISEASE
safety	I-DISEASE
can	0
also	0
be	I-DISEASE
disruptive	I-DISEASE
to	I-DISEASE
sleep	0
.	I-DISEASE

Bed	I-DISEASE
part-	I-DISEASE
ners	0
who	I-DISEASE
snore	0
loudly	0
,	I-DISEASE
move	I-DISEASE
excessively	I-DISEASE
during	I-DISEASE
sleep	0
,	I-DISEASE
or	I-DISEASE
have	0
parasomnias	0
may	I-DISEASE
also	0
disrupt	0
one	I-DISEASE
’s	I-DISEASE
sleep	0
.	B-DISEASE

When	I-DISEASE
an	I-DISEASE
individual	0
reports	I-DISEASE
environmental	0
circumstances	0
that	0
would	I-DISEASE
be	0
regarded	0
as	B-DISEASE
disruptive	I-DISEASE
to	I-DISEASE
the	0
sleep	0
of	I-DISEASE
most	I-DISEASE
individuals	0
,	0
a	0
chronic	I-DISEASE
insomnia	I-DISEASE
disorder	I-DISEASE
should	0
not	0
be	0
assigned	I-DISEASE
.	0

Chronic	I-DISEASE
insomnia	0
disorder	I-DISEASE
applies	0
only	I-DISEASE
when	0
the	0
individual	I-DISEASE
reports	I-DISEASE
sleep	I-DISEASE
difficulty	0
in	0
the	0
context	I-DISEASE
of	I-DISEASE
sleep	0
-	0
conducive	I-DISEASE
envi-	0
ronment	0
circumstances	0
or	B-DISEASE
when	0
the	0
insomnia	I-DISEASE
symptoms	0
show	I-DISEASE
some	I-DISEASE
independence	0
from	0
the	0
environmental	0
factors	0
.	0

When	I-DISEASE
environmental	I-DISEASE
circumstances	0
are	I-DISEASE
a	0
primary	0
cause	I-DISEASE
of	I-DISEASE
sleep	0
disturbance	0
and	0
associated	0
consequences	I-DISEASE
,	I-DISEASE
a	0
diagnosis	I-DISEASE
of	I-DISEASE
other	I-DISEASE
sleep	0
disorder	0
may	I-DISEASE
be	0
considered	I-DISEASE
.	0

Chronic	I-DISEASE
insomnia	0
disorder	I-DISEASE
should	I-DISEASE
also	0
be	0
differentiated	0
from	I-DISEASE
patterns	0
of	I-DISEASE
chronic	I-DISEASE
voli-	0
tional	0
sleep	0
restriction	0
(	I-DISEASE
insufficient	0
sleep	0
syndrome	I-DISEASE
)	0
.	0

Some	I-DISEASE
individuals	I-DISEASE
show	0
excessive	0
daytime	0
sleepiness	0
,	I-DISEASE
fatigue	I-DISEASE
,	0
and	0
reduced	0
sleep	I-DISEASE
at	I-DISEASE
night	0
as	0
a	0
result	I-DISEASE
of	0
electing	0
overly	0
demanding	0
daytime	0
schedules	I-DISEASE
or	I-DISEASE
by	0
volitionally	0
delaying	I-DISEASE
sleep	0
in	I-DISEASE
order	0
to	I-DISEASE
engage	0
in	0
desired	I-DISEASE
recreational	I-DISEASE
or	0
social	0
activities	I-DISEASE
.	0

However	I-DISEASE
,	I-DISEASE
when	0
allowing	I-DISEASE
themselves	0
suffi-	I-DISEASE
cient	0
time	I-DISEASE
to	I-DISEASE
sleep	I-DISEASE
,	0
they	I-DISEASE
are	I-DISEASE
able	I-DISEASE
to	0
initiate	0
and	0
maintain	0
sleep	0
easily	0
and	0
for	I-DISEASE
a	0
normal	0
duration	0
.	0

Those	I-DISEASE
with	I-DISEASE
chronic	0
insomnia	I-DISEASE
disorder	I-DISEASE
tend	I-DISEASE
to	0
have	0
excessive	0
wake	0
time	I-DISEASE
and	0
reduced	0
sleep	0
time	I-DISEASE
despite	0
routinely	0
allotting	0
sufficient	I-DISEASE
time	0
to	I-DISEASE
sleep	I-DISEASE
.	0

Moreover	I-DISEASE
,	I-DISEASE
chronic	0
insomnia	I-DISEASE
disorder	I-DISEASE
is	I-DISEASE
not	0
typically	0
associated	0
with	I-DISEASE
excessive	I-DISEASE
daytime	I-DISEASE
sleepi-	0
ness	I-DISEASE
and	0
unintentional	I-DISEASE
daytime	I-DISEASE
sleep	I-DISEASE
episodes	I-DISEASE
,	I-DISEASE
which	0
are	I-DISEASE
often	0
observed	I-DISEASE
in	0
those	0
with	I-DISEASE
patterns	0
of	I-DISEASE
volitional	0
sleep	0
restriction	0
.	0

Insomnia	I-DISEASE
symptoms	0
may	I-DISEASE
occur	I-DISEASE
comorbid	I-DISEASE
with	I-DISEASE
another	I-DISEASE
sleep	I-DISEASE
disorder	I-DISEASE
,	0
such	0
as	0
sleep	I-DISEASE
apnea	0
or	0
restless	I-DISEASE
legs	0
syndrome	I-DISEASE
.	0

A	I-DISEASE
chronic	I-DISEASE
insomnia	0
disorder	I-DISEASE
diagnosis	I-DISEASE
would	I-DISEASE
apply	0
Insomnia	0
Insomnia	I-DISEASE
only	I-DISEASE
when	0
:	0
(	I-DISEASE
1	0
)	0
the	0
insomnia	I-DISEASE
symptoms	I-DISEASE
show	0
some	I-DISEASE
independence	0
in	I-DISEASE
their	0
onset	0
or	I-DISEASE
variation	0
over	0
time	0
from	I-DISEASE
the	0
other	0
symptoms	I-DISEASE
of	0
the	0
co	0
-	I-DISEASE
occurring	I-DISEASE
sleep	0
disorder	I-DISEASE
;	0
or	0
(	I-DISEASE
2	0
)	0
when	0
insomnia	0
symptoms	0
persist	0
despite	0
adequate	0
treatment	I-DISEASE
reflected	0
by	I-DISEASE
marked	0
symptom	0
improvement	I-DISEASE
in	I-DISEASE
the	0
coincident	0
sleep	0
disorder	I-DISEASE
.	0

A	I-DISEASE
chronic	I-DISEASE
insomnia	I-DISEASE
disorder	I-DISEASE
diagnosis	I-DISEASE
would	I-DISEASE
not	0
apply	0
when	0
effective	I-DISEASE
treatment	I-DISEASE
of	I-DISEASE
the	0
coincident	I-DISEASE
sleep	I-DISEASE
disorder	0
resolves	0
the	0
insomnia	I-DISEASE
symptoms	I-DISEASE
.	0

Among	I-DISEASE
children	I-DISEASE
,	0
sleep	0
difficulties	0
may	I-DISEASE
be	I-DISEASE
present	I-DISEASE
when	0
the	0
child	0
has	0
to	I-DISEASE
sleep	0
alone	B-DISEASE
in	I-DISEASE
a	0
separate	I-DISEASE
room	0
,	0
but	I-DISEASE
absent	0
when	0
the	0
child	0
is	I-DISEASE
allowed	0
to	I-DISEASE
sleep	0
with	I-DISEASE
parents	0
or	B-DISEASE
when	0
a	0
parent	0
is	0
present	I-DISEASE
in	0
the	0
child	0
’s	0
bedroom	0
.	0

An	I-DISEASE
absence	I-DISEASE
of	I-DISEASE
sleep	0
difficulties	0
under	0
the	0
latter	I-DISEASE
circumstances	0
does	0
not	0
indicate	I-DISEASE
the	I-DISEASE
insomnia	I-DISEASE
is	0
resolved	0
.	0

Only	I-DISEASE
when	0
the	0
child	0
is	0
able	0
to	I-DISEASE
sleep	0
consistently	I-DISEASE
independently	0
is	0
there	I-DISEASE
no	I-DISEASE
longer	I-DISEASE
an	0
insomnia	0
problem	0
.	0

In	I-DISEASE
some	I-DISEASE
children	0
,	I-DISEASE
the	0
persistence	I-DISEASE
of	I-DISEASE
sleep	0
difficulties	0
in	I-DISEASE
the	0
absence	I-DISEASE
of	I-DISEASE
parents	0
may	0
reflect	I-DISEASE
underlying	0
conditions	0
such	0
as	0
separation	0
anxiety	I-DISEASE
or	0
an	0
anxiety	I-DISEASE
disorder	0
.	0

In	I-DISEASE
young	I-DISEASE
children	0
,	I-DISEASE
sleep	0
difficulties	I-DISEASE
can	I-DISEASE
be	I-DISEASE
the	0
result	0
of	I-DISEASE
medical	I-DISEASE
issues	I-DISEASE
,	I-DISEASE
including	0
gas-	I-DISEASE
troesophageal	0
reflux	B-DISEASE
,	0
as	0
well	I-DISEASE
as	I-DISEASE
developmental	I-DISEASE
milestones	I-DISEASE
,	0
such	0
as	0
motoric	I-DISEASE
,	I-DISEASE
language	0
,	0
and	0
cognitive	0
development	0
.	0

Children	I-DISEASE
,	I-DISEASE
adolescents	0
,	0
and	0
adults	I-DISEASE
may	I-DISEASE
develop	0
a	0
chronic	0
insomnia	I-DISEASE
disorder	0
comorbid	I-DISEASE
with	0
a	0
medical	0
or	0
psychiatric	0
disorder	I-DISEASE
.	0

Insomnia	I-DISEASE
symp-	0
toms	0
may	I-DISEASE
arise	I-DISEASE
as	I-DISEASE
a	I-DISEASE
result	0
of	I-DISEASE
either	I-DISEASE
another	I-DISEASE
sleep	0
disorder	0
,	I-DISEASE
a	0
medical	0
condition	0
,	I-DISEASE
or	I-DISEASE
a	0
psychiatric	I-DISEASE
disorder	0
that	0
has	I-DISEASE
sleep	I-DISEASE
-	0
disruptive	I-DISEASE
effects	0
.	0

A	I-DISEASE
chronic	I-DISEASE
insomnia	0
disorder	I-DISEASE
diagnosis	I-DISEASE
would	I-DISEASE
apply	0
when	0
:	0
(	I-DISEASE
1	I-DISEASE
)	I-DISEASE
the	0
insomnia	I-DISEASE
symptoms	0
show	0
some	I-DISEASE
independence	0
in	I-DISEASE
their	0
onset	0
or	I-DISEASE
variation	0
over	0
time	0
from	I-DISEASE
the	0
other	I-DISEASE
symptoms	0
of	I-DISEASE
the	0
co	0
-	0
occurring	0
sleep	0
,	0
medical	0
,	0
or	0
psychiatric	0
disorder	I-DISEASE
;	I-DISEASE
or	I-DISEASE
(	I-DISEASE
2	0
)	0
when	0
insomnia	0
symptoms	I-DISEASE
persist	0
despite	0
ade-	0
quate	0
treatment	I-DISEASE
reflected	0
by	I-DISEASE
marked	0
symptom	0
improvement	I-DISEASE
in	I-DISEASE
the	0
coincident	0
sleep	0
,	0
medical	0
,	I-DISEASE
or	0
psychiatric	I-DISEASE
disorder	0
.	0

Because	I-DISEASE
insomnia	I-DISEASE
symptoms	0
often	0
develop	0
some	I-DISEASE
independence	0
over	0
time	0
,	I-DISEASE
a	I-DISEASE
chronic	I-DISEASE
insomnia	0
disorder	I-DISEASE
diagnosis	0
usually	0
will	0
be	0
war-	I-DISEASE
ranted	I-DISEASE
when	0
those	I-DISEASE
symptoms	I-DISEASE
are	I-DISEASE
persistent	0
in	I-DISEASE
association	0
with	I-DISEASE
a	0
chronic	I-DISEASE
medical	0
or	0
psychiatric	I-DISEASE
disorder	0
.	0

A	I-DISEASE
chronic	I-DISEASE
insomnia	I-DISEASE
disorder	I-DISEASE
diagnosis	I-DISEASE
would	I-DISEASE
not	0
apply	0
when	0
effective	I-DISEASE
treatment	I-DISEASE
of	I-DISEASE
the	0
coincident	I-DISEASE
sleep	I-DISEASE
,	0
medical	0
,	I-DISEASE
or	I-DISEASE
psychiatric	I-DISEASE
disorder	I-DISEASE
resolves	0
the	0
insomnia	I-DISEASE
symptoms	I-DISEASE
.	0

Unresolved	I-DISEASE
Issues	0
and	0
Further	I-DISEASE
Directions	0

Much	I-DISEASE
remains	0
to	0
be	I-DISEASE
learned	0
about	0
the	0
underlying	0
pathophysiological	0
pathways	I-DISEASE
leading	0
to	0
insomnia	I-DISEASE
and	0
whether	0
insomnia	0
should	0
be	I-DISEASE
classified	0
as	0
a	0
unitary	I-DISEASE
disorder	0
or	B-DISEASE
sub-	I-DISEASE
divided	0
into	I-DISEASE
several	0
subtypes	0
.	0

Clearly	I-DISEASE
,	I-DISEASE
these	0
issues	I-DISEASE
are	0
closely	I-DISEASE
linked	0
.	0

Further	I-DISEASE
studies	I-DISEASE
that	0
clarify	I-DISEASE
the	0
pathophysiological	0
pathways	I-DISEASE
leading	0
to	0
insomnia	I-DISEASE
ultimately	0
will	0
reveal	0
whether	0
those	0
meeting	0
current	I-DISEASE
criteria	I-DISEASE
for	0
chronic	I-DISEASE
insomnia	I-DISEASE
disorder	B-DISEASE
suffer	I-DISEASE
from	I-DISEASE
a	0
single	I-DISEASE
disease	0
or	0
multiple	I-DISEASE
separate	0
diseases	0
with	0
similar	0
outward	0
presentations	I-DISEASE
.	0

A	I-DISEASE
related	I-DISEASE
unresolved	0
issue	0
is	I-DISEASE
whether	0
the	0
current	I-DISEASE
global	I-DISEASE
classification	I-DISEASE
promotes	I-DISEASE
a	0
generic	0
approach	I-DISEASE
to	I-DISEASE
insomnia	0
therapy	0
that	0
ultimately	0
fails	0
to	I-DISEASE
benefit	0
some	I-DISEASE
insomnia	0
subgroups	I-DISEASE
.	0

Perhaps	0
this	0
global	I-DISEASE
classification	I-DISEASE
scheme	0
will	0
overlook	0
distinctive	0
insomnia	0
subtypes	I-DISEASE
with	0
specific	I-DISEASE
treatment	I-DISEASE
needs	0
that	0
vary	I-DISEASE
from	0
the	0
generic	0
treatments	0
typically	0
provided	0
.	0

Previous	I-DISEASE
editions	I-DISEASE
of	I-DISEASE
the	0
International	0
Classification	I-DISEASE
of	I-DISEASE
Sleep	I-DISEASE
Disorders	0
allowed	I-DISEASE
for	I-DISEASE
the	0
assignment	B-DISEASE
of	I-DISEASE
an	0
insomnia	I-DISEASE
diagnosis	I-DISEASE
to	0
patients	I-DISEASE
who	I-DISEASE
present	I-DISEASE
exclusively	I-DISEASE
with	0
com-	I-DISEASE
plaints	I-DISEASE
of	I-DISEASE
nonrestorative	0
sleep	0
;	0
that	0
is	0
,	0
patients	0
who	0
complain	0
only	I-DISEASE
of	I-DISEASE
sleep	I-DISEASE
that	0
is	I-DISEASE
poor	0
in	I-DISEASE
quality	0
or	0
unrefreshing	I-DISEASE
,	I-DISEASE
in	0
the	0
absence	0
of	I-DISEASE
sleep	0
-	I-DISEASE
onset	I-DISEASE
or	0
sleep	0
maintenance	0
complaints	0
,	I-DISEASE
could	I-DISEASE
qualify	0
for	0
an	0
insomnia	0
diagnosis	0
in	I-DISEASE
previous	I-DISEASE
versions	0
of	I-DISEASE
this	0
nosol-	I-DISEASE
ogy	I-DISEASE
.	I-DISEASE

The	I-DISEASE
current	I-DISEASE
version	B-DISEASE
of	I-DISEASE
this	0
nosology	0
excludes	0
such	0
patients	I-DISEASE
from	I-DISEASE
the	0
insomnia	0
diagnostic	I-DISEASE
categories	0
.	0

This	I-DISEASE
decision	I-DISEASE
was	0
based	I-DISEASE
on	0
several	I-DISEASE
considerations	0
.	B-DISEASE

Most	I-DISEASE
insom-	I-DISEASE
nia	0
patients	I-DISEASE
present	I-DISEASE
with	0
complaints	0
of	I-DISEASE
sleep	0
initiation	I-DISEASE
or	I-DISEASE
maintenance	0
difficulties	I-DISEASE
.	0

Although	I-DISEASE
a	0
small	0
subset	0
of	0
patients	I-DISEASE
present	I-DISEASE
with	I-DISEASE
isolated	0
complaints	0
of	I-DISEASE
nonrestorative	I-DISEASE
sleep	0
,	I-DISEASE
this	I-DISEASE
complaint	0
more	0
commonly	I-DISEASE
arises	0
in	I-DISEASE
association	B-DISEASE
with	I-DISEASE
other	I-DISEASE
symptoms	0
of	I-DISEASE
insomnia	0
,	I-DISEASE
or	0
in	I-DISEASE
conjunction	I-DISEASE
with	0
sleep	0
disordered	0
breathing	0
,	0
other	0
sleep	0
disorders	0
or	I-DISEASE
certain	0
chronic	I-DISEASE
medical	I-DISEASE
conditions	I-DISEASE
(	0
e.g.	0
,	0
fibromyalgia	I-DISEASE
or	0
chronic	0
fatigue	I-DISEASE
syndrome	I-DISEASE
)	I-DISEASE
.	0

Although	I-DISEASE
various	0
epidemiological	0
studies	I-DISEASE
have	0
identified	0
subgroups	0
who	I-DISEASE
are	I-DISEASE
presumed	0
to	0
have	0
an	I-DISEASE
insomnia	0
disorder	0
and	0
present	I-DISEASE
solely	0
with	I-DISEASE
a	0
complaint	I-DISEASE
that	0
their	I-DISEASE
sleep	0
is	0
non-	0
restorative	0
or	0
unrefreshing	I-DISEASE
,	0
such	0
studies	I-DISEASE
typically	0
lack	I-DISEASE
polysomnography	0
that	0
would	0
be	I-DISEASE
needed	0
to	0
rule	0
out	0
other	0
occult	0
sleep	0
disorders	0
as	0
a	0
cause	I-DISEASE
.	0

Finally	I-DISEASE
,	I-DISEASE
nonrestorative	0
sleep	0
remains	I-DISEASE
a	0
poorly	0
defined	I-DISEASE
construct	0
that	I-DISEASE
may	I-DISEASE
reflect	I-DISEASE
not	0
only	I-DISEASE
a	I-DISEASE
type	0
of	0
sleep	0
disturbance	I-DISEASE
,	0
but	0
also	0
the	I-DISEASE
daytime	0
consequences	I-DISEASE
of	I-DISEASE
poor	0
sleep	0
such	B-DISEASE
as	0
fatigue	I-DISEASE
and	0
anergia	0
.	0

This	I-DISEASE
con-	0
struct	0
would	I-DISEASE
benefit	0
from	I-DISEASE
further	I-DISEASE
definitional	0
efforts	I-DISEASE
and	0
research	I-DISEASE
to	0
explore	0
its	I-DISEASE
clinical	I-DISEASE
significance	0
in	0
the	0
context	0
of	I-DISEASE
insomnia	I-DISEASE
.	0

Given	I-DISEASE
these	I-DISEASE
considerations	0
,	I-DISEASE
the	0
isolated	I-DISEASE
com-	I-DISEASE
plaint	0
of	I-DISEASE
nonrestorative	I-DISEASE
sleep	0
was	I-DISEASE
not	I-DISEASE
retained	0
as	0
part	I-DISEASE
of	I-DISEASE
the	0
diagnostic	0
definition	0
of	I-DISEASE
the	0
insomnia	I-DISEASE
disorders	0
delineated	0
in	I-DISEASE
this	0
manual	0
.	0

Bibliography	0
Baglioni	I-DISEASE
C	I-DISEASE
,	I-DISEASE
Battagliese	0
G	I-DISEASE
,	I-DISEASE
Feige	0
B	0
,	I-DISEASE
et	0
al	0
.	0

Insomnia	I-DISEASE
as	0
a	0
predictor	0
of	0
depression	0
:	0
a	0
meta	I-DISEASE
-	I-DISEASE
analytic	0
evaluation	I-DISEASE
of	I-DISEASE
longitudinal	0
epidemiological	0
studies	I-DISEASE
.	0

J	I-DISEASE
Affect	0
Dis	0
2011;135;10–9	0
.	0

Bastien	I-DISEASE
CH	I-DISEASE
,	0
St	I-DISEASE
-	0
Jean	I-DISEASE
G	0
,	0
Morin	0
CM	I-DISEASE
,	0
Turcotte	I-DISEASE
I	0
,	0
Carrier	0
J.	0
Chronic	I-DISEASE
psychophysiological	0
insomnia	I-DISEASE
:	I-DISEASE
hyperarousal	I-DISEASE
and/or	0
inhibition	0
deficits	0
?	I-DISEASE

An	I-DISEASE
ERPs	I-DISEASE
investigation	I-DISEASE
.	0

Sleep	I-DISEASE
2008;31:887–98	I-DISEASE
.	0

Beaulieu	I-DISEASE
-	I-DISEASE
Bonneau	0
S	I-DISEASE
,	I-DISEASE
LeBlanc	0
M	I-DISEASE
,	I-DISEASE
Mérette	0
C	0
,	0
Dauvilliers	0
Y	I-DISEASE
,	I-DISEASE
Morin	0
CM	0
.	0

Family	I-DISEASE
history	I-DISEASE
of	I-DISEASE
insomnia	0
in	0
a	I-DISEASE
population	0
-	0
based	B-DISEASE
sample	0
.	I-DISEASE

Sleep	I-DISEASE
2007;30:1739–45	I-DISEASE
.	0

Billows	I-DISEASE
M	I-DISEASE
,	I-DISEASE
Gradisar	0
M	I-DISEASE
,	0
Dohnt	0
H	I-DISEASE
,	0
Johnston	0
A	0
,	I-DISEASE
McCappin	0
S	0
,	I-DISEASE
Hudson	0
J.	0
Family	0
disorganization	I-DISEASE
,	0
sleep	0
hygiene	I-DISEASE
,	0
and	0
adolescent	0
sleep	0
disturbance	0
.	0

J	I-DISEASE
Clin	0
Child	I-DISEASE
Adolesc	0
Psychol	0
2009;38:745–52	I-DISEASE
.	0

Bonnet	I-DISEASE
MH	I-DISEASE
,	0
Arand	I-DISEASE
DL	I-DISEASE
.	0
24	0
-	0
hour	0
metabolic	I-DISEASE
rate	I-DISEASE
in	0
insomniacs	I-DISEASE
and	0
matched	B-DISEASE
normal	0
sleepers	0
.	0

Sleep	I-DISEASE
1995;18:581–8	I-DISEASE
.	0

Insomnia	I-DISEASE
Insomnia	0
Bonnet	0
MH	I-DISEASE
,	I-DISEASE
Arand	I-DISEASE
DL	I-DISEASE
.	0

Heart	I-DISEASE
rate	0
variability	I-DISEASE
in	0
insomniacs	I-DISEASE
and	0
matched	B-DISEASE
normal	0
sleepers	I-DISEASE
.	0

Psychosom	I-DISEASE
Med	I-DISEASE
1998;60:610–5	0
.	0

Bonnet	I-DISEASE
MH	I-DISEASE
,	0
Arand	I-DISEASE
DL	I-DISEASE
.	0
Hyperarousal	0
and	0
insomnia	0
:	I-DISEASE
State	0
of	0
the	0
science	0
.	0

Sleep	I-DISEASE
Med	I-DISEASE
Rev	I-DISEASE
2010;14:9–15	0
.	0

Buysse	I-DISEASE
DJ	0
,	I-DISEASE
Angst	0
J	0
,	I-DISEASE
Gamma	0
A	0
,	0
Ajdacic	0
V	I-DISEASE
,	I-DISEASE
Eich	0
D	I-DISEASE
,	0
Rössler	I-DISEASE
W.	0
Prevalence	I-DISEASE
,	I-DISEASE
course	0
,	I-DISEASE
and	0
comorbidity	I-DISEASE
of	I-DISEASE
insomnia	I-DISEASE
and	0
depression	0
in	I-DISEASE
young	I-DISEASE
adults	0
.	0

Sleep	I-DISEASE
2008;31:473–80	I-DISEASE
.	0

Dohnt	I-DISEASE
H	I-DISEASE
,	0
Gradisar	I-DISEASE
M	0
,	0
Short	0
MA	I-DISEASE
.	0

Insomnia	I-DISEASE
and	0
its	I-DISEASE
symptoms	I-DISEASE
in	I-DISEASE
adolescents	0
:	0
comparing	0
DSM	I-DISEASE
-	0
IV	I-DISEASE
and	0
ICSD	I-DISEASE
-	0
II	0
diagnostic	0
criteria	0
.	0

J	I-DISEASE
Clin	0
Sleep	0
Med	0
2012;8:295–9	I-DISEASE
.	0

Edinger	I-DISEASE
JD	0
,	0
Wyatt	I-DISEASE
JK	0
,	0
Stepanski	0
EJ	I-DISEASE
,	0
et	0
al	I-DISEASE
.	I-DISEASE

Testing	I-DISEASE
the	0
reliability	0
and	0
validity	0
of	I-DISEASE
DSM	0
-	0
IV	0
-	0
TR	0
and	0
ICSD-2	0
insomnia	0
diagnoses	0
:	0
results	I-DISEASE
of	I-DISEASE
a	0
multi	0
-	0
method	0
/	0
multi	0
-	0
trait	0
analysis	0
.	0

Arch	I-DISEASE
Gen	0
Psychiatry	0
2011;68:992–1002	I-DISEASE
.	0

Krystal	I-DISEASE
AD	I-DISEASE
,	0
Edinger	I-DISEASE
JD	0
,	0
Wohlgemuth	I-DISEASE
WK	I-DISEASE
,	I-DISEASE
Marsh	0
GR	I-DISEASE
.	0

Non	I-DISEASE
-	I-DISEASE
REM	0
sleep	0
EEG	I-DISEASE
frequency	I-DISEASE
spectral	0
correlates	0
of	I-DISEASE
sleep	0
complaints	0
in	I-DISEASE
primary	0
insomnia	I-DISEASE
subtypes	I-DISEASE
.	0

Sleep	I-DISEASE
2002;25:630–40	I-DISEASE
.	0

Lack	I-DISEASE
LC	0
,	0
Wright	I-DISEASE
HR	I-DISEASE
.	0

Treating	0
chronobiological	I-DISEASE
components	0
of	I-DISEASE
chronic	0
insomnia	I-DISEASE
.	0

Sleep	I-DISEASE
Med	I-DISEASE
2007;8:637–44	I-DISEASE
.	0

Lichstein	I-DISEASE
KL	I-DISEASE
.	0

Secondary	I-DISEASE
insomnia	I-DISEASE
.	0

In	I-DISEASE
:	0
Lichstein	0
KL	I-DISEASE
,	I-DISEASE
Morin	0
CM	0
,	I-DISEASE
eds	I-DISEASE
.	0

Treatment	I-DISEASE
of	I-DISEASE
late	I-DISEASE
-	I-DISEASE
life	0
insomnia	I-DISEASE
.	0

Thousand	I-DISEASE
Oaks	0
,	0
CA	0
:	0
Sage	I-DISEASE
,	0
2000:297–319	I-DISEASE
.	0

Mindell	I-DISEASE
JA	0
,	0
Kuhn	0
B	0
,	0
Lewin	0
DS	I-DISEASE
,	I-DISEASE
Meltzer	0
LJ	0
,	0
Sadeh	0
A.	0
Behavioral	0
treatment	I-DISEASE
of	I-DISEASE
bedtime	I-DISEASE
problems	0
and	0
night	0
wakings	0
in	I-DISEASE
infants	0
and	0
young	I-DISEASE
children	0
.	0

Sleep	I-DISEASE
2006;29:1263–76	0
.	0

Mindell	I-DISEASE
JA	0
,	0
Sadeh	I-DISEASE
A	I-DISEASE
,	0
Wiegand	0
B	0
,	0
How	I-DISEASE
TH	I-DISEASE
,	0
Goh	I-DISEASE
DY	I-DISEASE
.	0

Cross	I-DISEASE
-	I-DISEASE
cultural	0
differences	I-DISEASE
in	0
infant	0
and	0
toddler	I-DISEASE
sleep	0
.	0

Sleep	I-DISEASE
Med	I-DISEASE
2010;11:274–80	I-DISEASE
.	0

Morgenthaler	I-DISEASE
TI	0
,	I-DISEASE
Owens	I-DISEASE
J	0
,	0
Alessi	0
C	I-DISEASE
,	0
et	0
al	I-DISEASE
.	I-DISEASE

Practice	0
parameters	I-DISEASE
for	0
behavioral	I-DISEASE
treatment	0
of	I-DISEASE
bedtime	I-DISEASE
problems	0
and	0
night	0
wakings	0
in	I-DISEASE
infants	0
and	0
young	I-DISEASE
children	I-DISEASE
.	0

Sleep	I-DISEASE
2006;29:1277–81	0
.	0

Morin	I-DISEASE
CM	0
,	0
Bélanger	0
L	0
,	0
LeBlanc	0
M	0
,	I-DISEASE
et	0
al	0
.	0

The	I-DISEASE
natural	I-DISEASE
history	I-DISEASE
of	I-DISEASE
insomnia	0
:	I-DISEASE
a	0
population	0
-	0
based	I-DISEASE
3	I-DISEASE
-	0
year	0
longitudinal	I-DISEASE
study	0
.	0

Arch	I-DISEASE
Intern	0
Med	0
2009;169:447–53	I-DISEASE
.	0

Nofzinger	I-DISEASE
EA	0
.	0

Functional	I-DISEASE
neuroimaging	0
evidence	0
for	I-DISEASE
hyperarousal	0
in	I-DISEASE
insomnia	I-DISEASE
.	0

Am	I-DISEASE
J	0
Psychiatry	0
2004;161:2126–31	0
.	0

Nofzinger	I-DISEASE
EA	0
,	I-DISEASE
Nissen	0
C	0
,	0
Germain	0
A	0
,	I-DISEASE
et	0
al	0
.	0

Regional	I-DISEASE
cerebral	0
metabolic	0
correlates	I-DISEASE
of	I-DISEASE
WASO	0
during	I-DISEASE
sleep	0
in	I-DISEASE
insomnia	I-DISEASE
.	0

J	I-DISEASE
Clin	0
Sleep	0
Med	0
2006;2:316–22	0
.	0

Ohayon	I-DISEASE
MM	I-DISEASE
.	0

Epidemiology	I-DISEASE
of	0
insomnia	I-DISEASE
:	0
what	0
we	0
know	I-DISEASE
and	0
what	I-DISEASE
we	0
still	I-DISEASE
need	I-DISEASE
to	I-DISEASE
learn	0
.	0

Sleep	I-DISEASE
Med	I-DISEASE
Rev	I-DISEASE
2002;6:97–111	0
.	0

Ohayon	I-DISEASE
MM	I-DISEASE
,	I-DISEASE
Caulet	I-DISEASE
M	I-DISEASE
,	I-DISEASE
Lemoine	0
P.	0
Comorbidity	0
of	I-DISEASE
mental	0
and	0
insomnia	I-DISEASE
disorders	0
in	I-DISEASE
the	0
general	I-DISEASE
population	0
.	0

Compr	I-DISEASE
Psychiatry	0
1998;39:185–97	0
.	0

Ohayon	I-DISEASE
MM	I-DISEASE
,	I-DISEASE
Roberts	0
RE	I-DISEASE
.	0

Comparability	I-DISEASE
of	0
sleep	0
disorders	0
diagnoses	I-DISEASE
using	I-DISEASE
DSM	I-DISEASE
-	0
IV	I-DISEASE
and	0
ICSD	I-DISEASE
classifications	I-DISEASE
with	I-DISEASE
adolescents	0
.	0

Sleep	I-DISEASE
2001;24:920–5	I-DISEASE
.	0

Perlis	I-DISEASE
ML	I-DISEASE
,	0
Smith	I-DISEASE
MT	I-DISEASE
,	0
Andrew	0
PJ	0
,	I-DISEASE
Orff	I-DISEASE
H	I-DISEASE
,	I-DISEASE
Giles	I-DISEASE
DE	0
.	0

Beta	I-DISEASE
/	0
gamma	0
EEG	0
activity	0
in	0
patients	I-DISEASE
with	0
primary	0
and	0
secondary	0
insomnia	I-DISEASE
and	0
good	0
sleeper	0
controls	0
.	0

Sleep	I-DISEASE
2001;24:110–7	I-DISEASE
.	0

Riemann	I-DISEASE
D	I-DISEASE
,	0
Voderholzer	I-DISEASE
U	I-DISEASE
,	I-DISEASE
Spiegelhalder	I-DISEASE
K	I-DISEASE
,	0
et	0
al	I-DISEASE
.	0

Chronic	I-DISEASE
insomnia	0
and	0
MRI	0
-	0
measured	0
hippocampal	0
volumes	0
:	0

A	I-DISEASE
pilot	I-DISEASE
study	0
.	I-DISEASE

Sleep	I-DISEASE
2007;30:955–8	I-DISEASE
.	0

Riemann	I-DISEASE
D	I-DISEASE
,	0
Spiegelhalder	I-DISEASE
K	B-DISEASE
,	I-DISEASE
Feige	I-DISEASE
B	0
,	I-DISEASE
et	0
al	I-DISEASE
.	0

The	I-DISEASE
hyperarousal	I-DISEASE
model	0
of	I-DISEASE
insomnia	I-DISEASE
:	0
A	0
review	I-DISEASE
of	I-DISEASE
the	0
concept	0
and	0
its	I-DISEASE
evidence	0
.	0

Sleep	I-DISEASE
Med	I-DISEASE
Rev	I-DISEASE
2010;14:19–31	0
.	0

Roberts	0
RE	I-DISEASE
,	I-DISEASE
Roberts	0
CR	I-DISEASE
,	I-DISEASE
Chan	0
W.	I-DISEASE
Persistence	I-DISEASE
and	0
change	I-DISEASE
in	0
symptoms	I-DISEASE
of	I-DISEASE
insomnia	I-DISEASE
among	0
adolescents	0
.	0

Sleep	I-DISEASE
2008;31:177–84	I-DISEASE
.	0

Sánchez	I-DISEASE
-	0
Ortuño	I-DISEASE
MM	0
,	I-DISEASE
Carney	I-DISEASE
CE	0
,	I-DISEASE
Edinger	I-DISEASE
JD	0
,	I-DISEASE
Wyatt	0
JK	0
,	I-DISEASE
Harris	I-DISEASE
A.	0

Moving	I-DISEASE
beyond	0
average	0
values	I-DISEASE
:	0
assessing	0
the	0
night	I-DISEASE
-	0
to	0
-	0
night	0
instability	I-DISEASE
of	I-DISEASE
sleep	0
and	0
arousal	0
in	I-DISEASE
DSM	0
-	0
IV	I-DISEASE
-	0
TR	0
insomnia	I-DISEASE
subtypes	I-DISEASE
.	B-DISEASE

Sleep	I-DISEASE
2011;34:531–9	I-DISEASE
.	0

Stepanski	I-DISEASE
E	0
,	0
Zorick	I-DISEASE
F	I-DISEASE
,	0
Roehrs	I-DISEASE
T	0
,	0
Young	I-DISEASE
D	I-DISEASE
,	I-DISEASE
Roth	0
T.	0
Daytime	I-DISEASE
alertness	I-DISEASE
in	I-DISEASE
patients	0
with	I-DISEASE
chronic	I-DISEASE
insomnia	I-DISEASE
compared	I-DISEASE
with	I-DISEASE
asymptomatic	0
control	0
subjects	0
.	0

Sleep	I-DISEASE
1988;11:54–60	I-DISEASE
.	0

Vgontzas	I-DISEASE
AN	0
,	I-DISEASE
Liao	I-DISEASE
D	0
,	0
Bixler	0
EO	I-DISEASE
,	I-DISEASE
Chrousos	I-DISEASE
GP	0
,	I-DISEASE
Vela	I-DISEASE
-	0
Bueno	0
A.	0
Insomnia	I-DISEASE
with	I-DISEASE
objective	I-DISEASE
short	0
sleep	0
duration	0
is	0
associated	0
with	0
a	0
high	0
risk	0
for	I-DISEASE
hypertension	I-DISEASE
.	0

Sleep	I-DISEASE
2009;32:491–7	I-DISEASE
.	0

Winkelman	I-DISEASE
JW	0
,	I-DISEASE
Buxton	0
OM	0
,	I-DISEASE
Jensen	I-DISEASE
JE	I-DISEASE
,	I-DISEASE
et	0
al	I-DISEASE
.	0

Reduced	I-DISEASE
brain	I-DISEASE
GABA	0
in	I-DISEASE
primary	I-DISEASE
insomnia	0
:	I-DISEASE
preliminary	I-DISEASE
data	I-DISEASE
from	0
4	0
T	B-DISEASE
proton	0
magnetic	0
resonance	I-DISEASE
spectroscopy	0
(	I-DISEASE
1H	0
-	I-DISEASE
MRS	0
)	0
.	0

Sleep	I-DISEASE
2008;31:1499–506	I-DISEASE
.	0

Winkelman	I-DISEASE
JW	0
,	I-DISEASE
Benson	I-DISEASE
KL	I-DISEASE
,	0
Buxton	0
OM	I-DISEASE
,	I-DISEASE
et	0
al	I-DISEASE
.	0

Lack	I-DISEASE
of	I-DISEASE
hippocampal	I-DISEASE
volume	I-DISEASE
differences	I-DISEASE
in	0
primary	0
insomnia	I-DISEASE
and	0
good	0
sleeper	0
controls	0
:	0
an	0
MRI	0
volumetric	0
study	0
at	I-DISEASE
3	I-DISEASE
Tesla	I-DISEASE
.	0

Sleep	I-DISEASE
Med	I-DISEASE
2010;11:576–82	I-DISEASE
.	0

Zhang	I-DISEASE
J	0
,	0
Li	I-DISEASE
AM	0
,	I-DISEASE
Kong	I-DISEASE
AP	0
,	0
Lai	0
KY	B-DISEASE
,	I-DISEASE
Tang	I-DISEASE
NL	0
,	I-DISEASE
Wing	0
YK	I-DISEASE
.	0

A	I-DISEASE
community	0
-	0
based	I-DISEASE
study	0
of	I-DISEASE
insomnia	0
in	0
Hong	0
Kong	I-DISEASE
Chinese	I-DISEASE
children	I-DISEASE
:	0
Prevalence	0
,	I-DISEASE
risk	0
factors	0
and	0
familial	0
aggregation	0
.	0

Sleep	I-DISEASE
Med	I-DISEASE
2009;10:1040–6	I-DISEASE
.	0

Short	I-DISEASE
-	I-DISEASE
Term	0
Insomnia	0
Disorder	0
ICD-9	0
-	I-DISEASE
CM	I-DISEASE
code	0
:	0
307.41	0
Alternate	B-DISEASE
Names	I-DISEASE
Acute	0
insomnia	I-DISEASE
,	I-DISEASE
adjustment	B-DISEASE
insomnia	0
.	0

Diagnostic	I-DISEASE
Criteria	0
Criteria	0

A	0
-	0
E	0
must	0
be	0
met	0
ICD-10	0
-	0
CM	0
code	0
:	0

F51.02	I-DISEASE
Insomnia	0
A.	0
The	I-DISEASE
patient	I-DISEASE
reports	I-DISEASE
,	I-DISEASE
or	0
the	0
patient	I-DISEASE
’s	I-DISEASE
parent	0
or	I-DISEASE
caregiver	I-DISEASE
observes	I-DISEASE
,	I-DISEASE
one	0
or	I-DISEASE
more	0
of	I-DISEASE
the	0
following:1	0
.	0

Difficulty	I-DISEASE
initiating	I-DISEASE
sleep	0
.	0
.	0

Difficulty	I-DISEASE
maintaining	I-DISEASE
sleep	I-DISEASE
.	I-DISEASE
.	0

Waking	I-DISEASE
up	0
earlier	0
than	0
desired	I-DISEASE
.	0
.	I-DISEASE

Resistance	I-DISEASE
to	I-DISEASE
going	I-DISEASE
to	I-DISEASE
bed	0
on	0
appropriate	I-DISEASE
schedule	I-DISEASE
.	0
.	0

Difficulty	I-DISEASE
sleeping	I-DISEASE
without	0
parent	I-DISEASE
or	B-DISEASE
caregiver	0
intervention	I-DISEASE
.	0

B.	0
The	I-DISEASE
patient	I-DISEASE
reports	0
,	I-DISEASE
or	I-DISEASE
the	B-DISEASE
patient	I-DISEASE
’s	I-DISEASE
parent	0
or	I-DISEASE
caregiver	I-DISEASE
observes	I-DISEASE
,	I-DISEASE
one	0
or	0
more	0
of	I-DISEASE
the	0
following	0
related	0
to	I-DISEASE
the	0
nighttime	I-DISEASE
sleep	0
difficulty	0
:	B-DISEASE
.	0

Fatigue	I-DISEASE
/	I-DISEASE
malaise	0
.	I-DISEASE
.	0

Attention	I-DISEASE
,	I-DISEASE
concentration	0
,	I-DISEASE
or	I-DISEASE
memory	0
impairment	0
.	0
.	I-DISEASE

Impaired	I-DISEASE
social	0
,	I-DISEASE
family	0
,	I-DISEASE
vocational	0
,	0
or	I-DISEASE
academic	I-DISEASE
performance	I-DISEASE
.	0
.	0

Mood	I-DISEASE
disturbance	0
/	I-DISEASE
irritability	0
.	0
.	0

Daytime	I-DISEASE
sleepiness	0
.	0
.	0

Behavioral	I-DISEASE
problems	0
(	I-DISEASE
e.g.	0
,	0
hyperactivity	I-DISEASE
,	I-DISEASE
impulsivity	I-DISEASE
,	I-DISEASE
aggression	0
)	0
.	0

7	0
.	0
Reduced	0
motivation	I-DISEASE
/	0
energy	I-DISEASE
/	0
initiative	0
.	0
.	0

Proneness	I-DISEASE
for	I-DISEASE
errors	I-DISEASE
/	0
accidents	0
.	0
.	0

Concerns	I-DISEASE
about	I-DISEASE
or	0
dissatisfaction	I-DISEASE
with	0
sleep	0
.	0

Insomnia	I-DISEASE
C.	0

The	I-DISEASE
reported	I-DISEASE
sleep	0
/	I-DISEASE
wake	0
complaints	0
can	I-DISEASE
not	0
be	0
explained	0
purely	I-DISEASE
by	I-DISEASE
inadequate	I-DISEASE
opportunity	I-DISEASE
(	0
i.e.	I-DISEASE
,	0
enough	I-DISEASE
time	0
is	I-DISEASE
allotted	0
for	0
sleep	I-DISEASE
)	0
or	I-DISEASE
inadequate	0
circumstances	0
(	I-DISEASE
i.e.	B-DISEASE
,	0
the	0
environment	0
is	0
safe	0
,	0
dark	0
,	0
quiet	0
,	I-DISEASE
and	0
comfortable	I-DISEASE
)	0
for	I-DISEASE
sleep	0
.	0

D.	I-DISEASE
The	I-DISEASE
sleep	0
disturbance	0
and	0
associated	0
daytime	I-DISEASE
symptoms	I-DISEASE
have	0
been	I-DISEASE
present	I-DISEASE
for	I-DISEASE
less	I-DISEASE
than	0
three	0
months	0
.	I-DISEASE

E.	I-DISEASE

The	I-DISEASE
sleep	0
/	0
wake	0
difficulty	0
is	0
not	0
better	0
explained	0
by	0
another	0
sleep	0
disorder	I-DISEASE
.	0

Notes	I-DISEASE
.	0

Reports	I-DISEASE
of	I-DISEASE
difficulties	0
initiating	I-DISEASE
sleep	0
,	I-DISEASE
difficulties	0
maintaining	0
sleep	0
,	I-DISEASE
or	I-DISEASE
waking	0
up	I-DISEASE
too	0
early	0
can	I-DISEASE
be	0
seen	0
in	I-DISEASE
all	0
age	I-DISEASE
groups	0
.	0

Resistance	I-DISEASE
going	I-DISEASE
to	0
bed	I-DISEASE
on	0
an	I-DISEASE
appropriate	I-DISEASE
schedule	I-DISEASE
and	0
difficulty	0
sleeping	0
without	0
parent	I-DISEASE
or	I-DISEASE
caregiver	0
intervention	I-DISEASE
is	0
seen	0
most	0
commonly	0
in	I-DISEASE
children	B-DISEASE
and	0
older	0
adults	B-DISEASE
who	I-DISEASE
require	0
the	I-DISEASE
supervision	0
of	I-DISEASE
a	0
caretaker	0
due	I-DISEASE
to	I-DISEASE
a	0
significant	0
level	0
of	I-DISEASE
functional	0
impairment	0
(	I-DISEASE
e.g.	I-DISEASE
,	0
those	0
with	0
dementia	0
)	0
.	0
.	0

Patients	I-DISEASE
with	0
short	0
-	0
term	0
insomnia	0
disorder	0
may	I-DISEASE
complain	I-DISEASE
of	I-DISEASE
sleep/	0
wake	0
difficulties	I-DISEASE
fewer	I-DISEASE
than	0
three	0
times	0
per	0
week	0
on	0
average	0
,	I-DISEASE
yet	0
have	I-DISEASE
clinically	0
significant	0
concerns	I-DISEASE
about	0
their	0
symptoms	I-DISEASE
and	0
warrant	I-DISEASE
clinical	0
attention	0
.	0
.	0

Many	0
conditions	I-DISEASE
such	0
as	0
grief	0
,	I-DISEASE
acute	I-DISEASE
pain	I-DISEASE
,	0
or	0
other	0
acute	I-DISEASE
stressors	I-DISEASE
are	0
quite	I-DISEASE
often	0
associated	0
with	0
poor	0
sleep	0
.	0

When	I-DISEASE
such	0
conditions	0
are	I-DISEASE
the	0
sole	0
cause	I-DISEASE
of	I-DISEASE
the	0
sleep	0
difficulty	0
,	I-DISEASE
a	I-DISEASE
separate	I-DISEASE
insomnia	0
diagnosis	I-DISEASE
may	0
not	0
apply	0
.	0

The	I-DISEASE
primary	0
factor	0
in	I-DISEASE
determining	0
application	0
of	I-DISEASE
a	I-DISEASE
short-	0
term	0
or	I-DISEASE
adjustment	I-DISEASE
insomnia	I-DISEASE
diagnosis	0
is	I-DISEASE
the	0
extent	0
to	I-DISEASE
which	0
the	0
sleep	0
disturbance	I-DISEASE
becomes	I-DISEASE
a	0
significant	0
focus	I-DISEASE
for	I-DISEASE
the	0
individual	I-DISEASE
and/or	0
warrants	I-DISEASE
independent	0
clinical	0
attention	0
.	0

Essential	I-DISEASE
Features	I-DISEASE
The	I-DISEASE
essential	0
feature	0
of	I-DISEASE
short	0
-	0
term	0
insomnia	0
disorder	I-DISEASE
is	I-DISEASE
a	0
short	0
-	I-DISEASE
term	0
difficulty	0
ini-	0
tiating	0
or	0
maintaining	I-DISEASE
sleep	0
that	0
results	0
in	I-DISEASE
general	0
sleep	0
dissatisfaction	0
.	0

The	I-DISEASE
sleep	0
complaint	I-DISEASE
is	I-DISEASE
accompanied	0
by	I-DISEASE
daytime	0
distress	I-DISEASE
about	0
poor	0
sleep	0
or	I-DISEASE
impairment	I-DISEASE
in	I-DISEASE
family	0
,	I-DISEASE
social	0
,	0
occupational	I-DISEASE
,	0
academic	I-DISEASE
,	I-DISEASE
or	I-DISEASE
other	I-DISEASE
important	0
areas	I-DISEASE
of	I-DISEASE
functioning	I-DISEASE
.	0

Furthermore	I-DISEASE
,	I-DISEASE
the	0
sleep	0
disturbance	0
and	0
associated	0
daytime	I-DISEASE
symptoms	I-DISEASE
occur	0
despite	0
having	I-DISEASE
adequate	I-DISEASE
time	I-DISEASE
and	0
circumstances	0
each	I-DISEASE
night	I-DISEASE
to	0
obtain	I-DISEASE
necessary	0
sleep	0
.	0

Short-	I-DISEASE
term	0
insomnia	0
disorder	I-DISEASE
can	I-DISEASE
occur	0
in	0
isolation	0
or	I-DISEASE
comorbid	I-DISEASE
with	0
a	0
mental	I-DISEASE
disorder	0
,	0
medical	I-DISEASE
condition	0
,	I-DISEASE
or	I-DISEASE
substance	I-DISEASE
use	I-DISEASE
.	0

In	I-DISEASE
many	0
cases	0
of	I-DISEASE
short	0
-	I-DISEASE
term	0
insomnia	I-DISEASE
lasting	0
less	I-DISEASE
than	I-DISEASE
three	I-DISEASE
months	0
,	I-DISEASE
there	I-DISEASE
is	I-DISEASE
an	0
identifiable	0
cause	I-DISEASE
that	0
serves	0
as	I-DISEASE
the	0
precipitant	I-DISEASE
.	0

In	I-DISEASE
other	I-DISEASE
cases	0
,	I-DISEASE
insomnia	0
occurs	I-DISEASE
episodically	0
,	I-DISEASE
often	I-DISEASE
coincident	0
to	I-DISEASE
daytime	I-DISEASE
stressors	0
that	0
account	0
for	I-DISEASE
the	0
insomnia	I-DISEASE
.	I-DISEASE

As	I-DISEASE
is	I-DISEASE
the	0
case	I-DISEASE
for	0
chronic	I-DISEASE
insomnia	0
disorder	0
,	0
sleep	0
complaints	I-DISEASE
that	0
compose	0
short-	0
term	0
insomnia	0
disorder	0
may	0
include	I-DISEASE
difficulties	0
initiating	I-DISEASE
sleep	0
or	I-DISEASE
difficulties	0
main-	B-DISEASE
taining	0
sleep	0
.	0

The	I-DISEASE
latter	I-DISEASE
complaint	0
may	I-DISEASE
include	0
waking	0
up	I-DISEASE
during	I-DISEASE
the	0
night	0
with	I-DISEASE
difficulty	0
returning	I-DISEASE
to	I-DISEASE
sleep	0
or	I-DISEASE
having	I-DISEASE
a	I-DISEASE
final	0
awakening	0
occurring	0
too	0
early	0
,	I-DISEASE
well	I-DISEASE
before	0
the	I-DISEASE
desired	0
rising	I-DISEASE
time	0
.	B-DISEASE

Short	I-DISEASE
-	I-DISEASE
term	0
insomnia	I-DISEASE
disorder	I-DISEASE
may	I-DISEASE
be	0
character-	0
ized	I-DISEASE
solely	0
by	B-DISEASE
sleep	0
onset	0
or	I-DISEASE
sleep	0
maintenance	0
complaints	0
or	I-DISEASE
,	I-DISEASE
more	0
commonly	I-DISEASE
,	I-DISEASE
by	I-DISEASE
both	I-DISEASE
types	I-DISEASE
of	I-DISEASE
complaints	0
occurring	0
together	0
.	B-DISEASE

Individuals	I-DISEASE
’	I-DISEASE
sleep	0
complaints	0
may	0
vary	I-DISEASE
such	0
that	I-DISEASE
sleep	0
onset	0
difficulties	I-DISEASE
are	I-DISEASE
apparent	0
on	0
some	0
nights	0
,	I-DISEASE
whereas	I-DISEASE
sleep	0
maintenance	0
difficulties	I-DISEASE
are	0
present	I-DISEASE
on	0
other	0
nights	I-DISEASE
.	0

Complaints	I-DISEASE
about	0
poor	I-DISEASE
-	I-DISEASE
quality	0
,	0
unrefreshing	0
,	I-DISEASE
or	0
nonrestorative	0
sleep	0
may	I-DISEASE
accompany	0
sleep	0
onset	0
and	0
sleep	I-DISEASE
mainte-	0
nance	0
complaints	0
,	0
but	0
do	I-DISEASE
not	0
meet	0
the	0
definition	0
of	I-DISEASE
this	0
condition	0
when	0
they	0
occur	I-DISEASE
in	I-DISEASE
isolation	I-DISEASE
.	0

Associated	I-DISEASE
Features	I-DISEASE
Sleep	0
disturbance	I-DISEASE
is	0
the	0
primary	0
feature	I-DISEASE
of	I-DISEASE
short	0
-	0
term	0
insomnia	I-DISEASE
disorder	I-DISEASE
,	I-DISEASE
but	I-DISEASE
it	0
is	0
com-	I-DISEASE
monly	I-DISEASE
accompanied	I-DISEASE
by	I-DISEASE
waking	0
symptoms	I-DISEASE
similar	0
to	I-DISEASE
those	I-DISEASE
seen	I-DISEASE
in	0
chronic	I-DISEASE
insomnia	I-DISEASE
disorder	0
.	0

Specific	I-DISEASE
symptoms	I-DISEASE
such	0
as	0
fatigue	I-DISEASE
,	0
impaired	I-DISEASE
attention	0
and	0
concentration	0
,	I-DISEASE
poor	I-DISEASE
memory	0
,	0
irritability	I-DISEASE
,	0
and	0
distress	I-DISEASE
about	0
poor	0
sleep	0
are	I-DISEASE
common	I-DISEASE
.	0

When	I-DISEASE
the	0
insomnia	0
arises	0
in	I-DISEASE
reaction	I-DISEASE
to	0
a	0
stressful	I-DISEASE
life	I-DISEASE
event	I-DISEASE
,	0
such	0
as	0
the	0
loss	0
of	0
a	0
loved	0
one	0
,	0
major	I-DISEASE
illness	I-DISEASE
,	0
or	I-DISEASE
divorce	0
,	I-DISEASE
the	0
associated	0
features	I-DISEASE
may	0
include	I-DISEASE
anxiety	0
,	0
worry	0
,	I-DISEASE
ruminative	0
thoughts	0
,	I-DISEASE
sadness	0
,	I-DISEASE
or	I-DISEASE
depression	I-DISEASE
in	I-DISEASE
relation	0
to	0
the	0
specific	I-DISEASE
stressor	I-DISEASE
.	0

If	I-DISEASE
the	0
individual	0
uses	0
alcohol	0
,	I-DISEASE
illicit	0
drugs	I-DISEASE
,	0
or	0
medications	I-DISEASE
for	I-DISEASE
self	0
-	0
treatment	I-DISEASE
,	I-DISEASE
additional	0
symptoms	0
related	0
to	I-DISEASE
these	I-DISEASE
substances	0
may	I-DISEASE
be	0
seen	I-DISEASE
.	0

Clinical	I-DISEASE
and	0
Pathophysiological	I-DISEASE
Subtypes	I-DISEASE
None	I-DISEASE
.	0

Demographics	I-DISEASE
Short	0
-	0
term	0
insomnia	I-DISEASE
disorder	0
can	0
occur	I-DISEASE
at	I-DISEASE
any	I-DISEASE
age	I-DISEASE
.	0

However	I-DISEASE
,	I-DISEASE
a	0
short	0
-	0
term	0
form	0
of	I-DISEASE
insomnia	0
may	I-DISEASE
be	I-DISEASE
difficult	0
to	0
establish	0
in	I-DISEASE
infants	I-DISEASE
because	0
it	0
is	0
often	0
difficult	0
to	B-DISEASE
link	0
stressors	I-DISEASE
to	I-DISEASE
sleep	0
disturbances	I-DISEASE
in	I-DISEASE
this	0
age	I-DISEASE
group	I-DISEASE
.	0

The	I-DISEASE
exact	0
prevalence	0
of	I-DISEASE
short	0
-	0
term	0
insomnia	I-DISEASE
disorder	0
is	0
unknown	I-DISEASE
.	0

The	I-DISEASE
one	0
-	0
year	0
prevalence	0
of	I-DISEASE
short	0
-	0
term	0
insomnia	0
dis-	I-DISEASE
order	0
among	0
adults	I-DISEASE
appears	0
to	0
be	I-DISEASE
in	I-DISEASE
the	0
range	0
of	I-DISEASE
15	I-DISEASE
%	0
to	I-DISEASE
20	0
%	0
.	0

Like	I-DISEASE
chronic	I-DISEASE
insomnia	0
disorder	I-DISEASE
,	I-DISEASE
short	0
-	0
term	0
insomnia	I-DISEASE
disorder	I-DISEASE
is	0
more	0
prevalent	I-DISEASE
in	I-DISEASE
women	0
than	0
in	I-DISEASE
men	0
,	I-DISEASE
and	0
in	I-DISEASE
older	0
age	I-DISEASE
groups	I-DISEASE
.	0

Predisposing	I-DISEASE
and	0
Precipitating	I-DISEASE
Factors	0
Affected	0
individuals	I-DISEASE
may	0
note	0
a	I-DISEASE
lifelong	0
tendency	0
toward	I-DISEASE
light	0
sleep	0
or	B-DISEASE
diffi-	0
culty	0
sleeping	I-DISEASE
during	I-DISEASE
times	0
of	I-DISEASE
stress	I-DISEASE
.	0

A	I-DISEASE
previous	I-DISEASE
history	I-DISEASE
of	I-DISEASE
anxiety	0
or	I-DISEASE
depressive	I-DISEASE
Insomnia	0
Insomnia	I-DISEASE
symptoms	I-DISEASE
and	0
disorders	0
also	0
may	I-DISEASE
predispose	0
an	0
individual	I-DISEASE
to	0
develop	I-DISEASE
a	0
short-	0
term	0
insomnia	0
disorder	I-DISEASE
.	0

In	I-DISEASE
children	I-DISEASE
,	0
having	I-DISEASE
a	0
parent	0
with	I-DISEASE
insomnia	I-DISEASE
or	0
living	0
in	I-DISEASE
a	I-DISEASE
household	I-DISEASE
lacking	I-DISEASE
parental	I-DISEASE
reinforcement	I-DISEASE
of	0
a	0
consistent	0
sleep	0
/	0
wake	0
schedule	I-DISEASE
may	0
be	I-DISEASE
predisposing	0
factors	0
.	0

An	I-DISEASE
acute	I-DISEASE
,	0
identifiable	I-DISEASE
event	0
or	I-DISEASE
stressor	I-DISEASE
usually	I-DISEASE
precipitates	I-DISEASE
this	I-DISEASE
form	I-DISEASE
of	I-DISEASE
insomnia	0
.	0

Common	I-DISEASE
precipitating	I-DISEASE
events	0
include	I-DISEASE
changes	I-DISEASE
or	B-DISEASE
disputes	0
in	I-DISEASE
interpersonal	I-DISEASE
relation-	0
ships	I-DISEASE
,	I-DISEASE
occupational	I-DISEASE
stress	0
,	I-DISEASE
personal	0
losses	I-DISEASE
,	I-DISEASE
bereavement	0
,	I-DISEASE
diagnosis	I-DISEASE
or	I-DISEASE
onset	I-DISEASE
of	I-DISEASE
a	0
new	I-DISEASE
medical	0
condition	0
,	0
visiting	0
or	I-DISEASE
moving	I-DISEASE
to	0
a	0
new	0
location	0
,	I-DISEASE
or	I-DISEASE
physical	0
changes	I-DISEASE
to	0
the	0
usual	I-DISEASE
sleep	0
environment	0
or	B-DISEASE
schedule	I-DISEASE
.	0

Changes	I-DISEASE
or	I-DISEASE
stresses	0
with	I-DISEASE
a	0
positive	0
emotional	I-DISEASE
tone	I-DISEASE
also	0
may	0
serve	I-DISEASE
as	0
precipitating	I-DISEASE
events	0
.	I-DISEASE

In	I-DISEASE
children	I-DISEASE
or	I-DISEASE
dependent	I-DISEASE
adults	B-DISEASE
,	I-DISEASE
such	I-DISEASE
insomnia	I-DISEASE
can	0
arise	I-DISEASE
when	I-DISEASE
the	0
caretaker	0
makes	I-DISEASE
abrupt	I-DISEASE
changes	I-DISEASE
in	0
the	0
child	I-DISEASE
’s	I-DISEASE
or	I-DISEASE
adult	0
’s	I-DISEASE
sleep	I-DISEASE
routines	0
or	I-DISEASE
schedule	I-DISEASE
.	B-DISEASE

As	I-DISEASE
is	I-DISEASE
the	0
case	I-DISEASE
for	0
chronic	I-DISEASE
insomnia	0
disorder	0
,	0
environ-	0
mental	0
factors	I-DISEASE
such	I-DISEASE
as	0
the	0
child	0
sharing	0
a	0
room	B-DISEASE
with	0
a	I-DISEASE
parent	0
or	I-DISEASE
with	0
other	I-DISEASE
sib-	0
lings	B-DISEASE
,	0
the	0
presence	0
of	I-DISEASE
extended	0
family	0
or	0
others	0
in	0
the	0
home	0
,	I-DISEASE
and	0
cramped	I-DISEASE
living	0
accommodations	0
may	0
contribute	0
to	0
negative	I-DISEASE
sleep	0
-	0
onset	0
associations	0
or	0
poor	0
limit	I-DISEASE
setting	0
in	I-DISEASE
children	I-DISEASE
.	0

Familial	I-DISEASE
Patterns	I-DISEASE
Familial	I-DISEASE
patterns	0
are	0
less	I-DISEASE
well	I-DISEASE
documented	I-DISEASE
for	0
cases	0
of	I-DISEASE
short	0
-	0
term	0
insomnia	I-DISEASE
disor-	0
der	0
than	I-DISEASE
they	0
are	0
for	I-DISEASE
individuals	I-DISEASE
meeting	0
criteria	0
for	I-DISEASE
chronic	I-DISEASE
insomnia	0
disorder	0
.	0

Nonetheless	I-DISEASE
,	I-DISEASE
the	0
familial	I-DISEASE
aggregation	0
found	0
for	0
chronic	I-DISEASE
insomnia	I-DISEASE
disorders	0
is	I-DISEASE
expected	I-DISEASE
to	0
also	0
occur	I-DISEASE
among	0
individuals	I-DISEASE
with	I-DISEASE
more	0
transient	0
forms	I-DISEASE
of	I-DISEASE
insomnia	I-DISEASE
.	0

Data	I-DISEASE
support	I-DISEASE
a	0
greater	I-DISEASE
genetic	0
diathesis	I-DISEASE
to	0
psychophysiologic	0
arousal	0
among	0
certain	0
individuals	0
in	I-DISEASE
response	0
to	0
stressors	0
.	0

This	I-DISEASE
may	0
,	0
in	I-DISEASE
turn	0
,	I-DISEASE
suggest	I-DISEASE
a	I-DISEASE
constitutional	0
predisposition	0
to	I-DISEASE
short-	I-DISEASE
term	0
or	I-DISEASE
adjustment	I-DISEASE
insomnia	0
in	I-DISEASE
such	0
individuals	I-DISEASE
.	0

Onset	I-DISEASE
,	0
Course	0
,	0
and	0
Complications	0
Many	0
individuals	I-DISEASE
who	I-DISEASE
develop	0
short	0
-	I-DISEASE
term	0
insomnia	I-DISEASE
disorder	I-DISEASE
experience	0
remission	0
of	I-DISEASE
their	I-DISEASE
insomnia	0
symptoms	I-DISEASE
over	0
time	0
.	0

This	I-DISEASE
occurs	0
as	0
distress	I-DISEASE
over	0
the	0
precipitating	I-DISEASE
event	0
diminishes	0
over	0
time	0
or	I-DISEASE
in	I-DISEASE
response	0
to	0
withdrawal	0
of	I-DISEASE
the	0
stressor	I-DISEASE
.	0

However	I-DISEASE
,	I-DISEASE
a	0
portion	I-DISEASE
of	0
those	0
who	I-DISEASE
initially	I-DISEASE
experience	0
short	0
-	0
term	0
insomnia	I-DISEASE
may	0
develop	0
a	I-DISEASE
more	0
chronic	0
form	I-DISEASE
of	I-DISEASE
insomnia	I-DISEASE
and	0
subsequently	0
meet	0
criteria	0
for	I-DISEASE
chronic	I-DISEASE
insomnia	I-DISEASE
dis-	I-DISEASE
order	0
.	0

These	0
individuals	I-DISEASE
will	0
then	0
have	0
the	0
course	0
and	0
complications	0
described	0
for	0
chronic	I-DISEASE
insomnia	I-DISEASE
disorder	I-DISEASE
.	0

Developmental	I-DISEASE
Issues	0
As	0
is	0
the	0
case	I-DISEASE
for	I-DISEASE
chronic	B-DISEASE
insomnia	0
disorder	I-DISEASE
,	I-DISEASE
short	0
-	I-DISEASE
term	0
insomnia	I-DISEASE
disorder	I-DISEASE
would	0
not	0
be	0
considered	I-DISEASE
until	0
after	0
a	0
child	0
reaches	I-DISEASE
at	I-DISEASE
least	B-DISEASE
six	0
months	0
of	I-DISEASE
age	I-DISEASE
.	0

The	I-DISEASE
propensity	I-DISEASE
to	0
experience	0
sleep	0
disturbance	I-DISEASE
in	0
response	0
to	0
stress	I-DISEASE
may	I-DISEASE
dispose	I-DISEASE
young	I-DISEASE
and	0
older	0
individuals	I-DISEASE
toward	I-DISEASE
acute	I-DISEASE
forms	I-DISEASE
of	I-DISEASE
insomnia	I-DISEASE
.	0

As	I-DISEASE
is	I-DISEASE
the	0
case	I-DISEASE
for	0
chronic	I-DISEASE
insomnia	0
disorder	0
,	0
sleep	0
onset	I-DISEASE
difficulties	I-DISEASE
are	0
most	0
common	I-DISEASE
among	0
young	0
adults	0
with	I-DISEASE
short	0
-	0
term	0
insomnia	I-DISEASE
,	I-DISEASE
whereas	0
sleep	0
maintenance	I-DISEASE
complaints	0
and	0
early	0
morning	0
awakening	0
are	0
more	0
common	I-DISEASE
in	0
middle	0
-	0
aged	0
and	0
older	0
adults	I-DISEASE
.	0

Objective	I-DISEASE
daytime	I-DISEASE
sleepiness	0
is	0
uncommon	0
in	0
younger	0
adults	B-DISEASE
with	I-DISEASE
short	I-DISEASE
-	I-DISEASE
term	0
insomnia	0
disorder	0
,	0
but	I-DISEASE
is	0
more	0
common	I-DISEASE
in	I-DISEASE
older	0
adults	B-DISEASE
.	0

Balancing	I-DISEASE
job	0
and	0
family	0
stressors	I-DISEASE
may	I-DISEASE
contribute	0
to	0
intermittent	0
short	0
-	I-DISEASE
term	0
insomnia	0
problems	I-DISEASE
in	0
younger	0
and	0
middle	0
-	0
aged	I-DISEASE
adults	0
.	0

In	I-DISEASE
contrast	I-DISEASE
,	0
older	0
,	0
retired	0
adults	I-DISEASE
may	I-DISEASE
have	0
short	0
-	0
term	0
insomnia	I-DISEASE
disorder	I-DISEASE
related	B-DISEASE
to	I-DISEASE
exacerbations	0
in	I-DISEASE
comorbid	I-DISEASE
chronic	0
medical	I-DISEASE
con-	0
ditions	I-DISEASE
or	0
due	0
to	I-DISEASE
loss	0
of	I-DISEASE
loved	0
ones	I-DISEASE
that	0
commonly	0
occurs	0
with	0
advancing	I-DISEASE
age	I-DISEASE
.	0

Pathology	I-DISEASE
and	0
Pathophysiology	I-DISEASE
Research	I-DISEASE
on	0
the	0
pathology	0
and	0
pathophysiology	0
of	0
short	0
-	0
term	0
variants	0
of	I-DISEASE
insomnia	I-DISEASE
disorder	0
is	I-DISEASE
generally	I-DISEASE
lacking	I-DISEASE
because	0
the	0
majority	0
of	I-DISEASE
studies	I-DISEASE
addressing	0
this	0
issue	0
have	0
focused	0
on	0
samples	0
with	0
chronic	I-DISEASE
insomnia	I-DISEASE
disorders	0
.	0

Differential	I-DISEASE
Diagnosis	0
Short	0
-	0
term	0
insomnia	0
disorder	0
shares	I-DISEASE
many	0
features	0
with	0
chronic	I-DISEASE
insomnia	I-DISEASE
disorder	I-DISEASE
.	0

The	I-DISEASE
primary	0
difference	0
between	0
the	0
two	I-DISEASE
conditions	I-DISEASE
is	I-DISEASE
that	0
short	0
-	0
term	0
insomnia	I-DISEASE
disor-	I-DISEASE
der	0
does	0
not	0
meet	0
the	0
duration	0
and	0
frequency	I-DISEASE
criteria	0
required	I-DISEASE
for	0
the	0
chronic	I-DISEASE
insomnia	I-DISEASE
disorder	I-DISEASE
diagnosis	0
.	0

Short	I-DISEASE
-	I-DISEASE
term	0
insomnia	0
disorder	I-DISEASE
also	0
should	0
be	0
distinguished	I-DISEASE
from	I-DISEASE
circadian	I-DISEASE
rhythm	I-DISEASE
sleep	0
-	I-DISEASE
wake	I-DISEASE
disorders	0
resulting	0
from	I-DISEASE
rotating	I-DISEASE
shift	0
work	I-DISEASE
or	I-DISEASE
jet	I-DISEASE
lag	0
.	0

In	I-DISEASE
the	0
latter	0
case	I-DISEASE
,	0
the	0
sleep	0
disturbance	I-DISEASE
arises	0
from	0
a	0
sleep	0
-	I-DISEASE
wake	0
schedule	I-DISEASE
alteration	0
that	I-DISEASE
results	0
in	0
a	0
mismatch	0
between	0
the	I-DISEASE
endogenous	0
circadian	I-DISEASE
rhythm	I-DISEASE
and	0
the	0
sleep	0
-	0
wake	0
schedule	0
chosen	0
—	I-DISEASE
for	0
example	0
,	0
having	0
to	0
sleep	0
in	I-DISEASE
the	I-DISEASE
daytime	I-DISEASE
rather	0
than	0
during	I-DISEASE
the	0
nighttime	0
.	0

In	I-DISEASE
the	0
case	0
of	I-DISEASE
short	0
-	0
term	0
insomnia	I-DISEASE
disorder	0
,	I-DISEASE
no	I-DISEASE
such	0
mismatch	0
exists	I-DISEASE
;	0
yet	0
,	0
the	0
individual	0
demonstrates	I-DISEASE
sleep	0
onset	I-DISEASE
or	0
maintenance	I-DISEASE
difficulties	I-DISEASE
nonetheless	I-DISEASE
.	0

Bibliography	0
Agnew	0
HW	I-DISEASE
Jr	0
,	0
Webb	I-DISEASE
WB	I-DISEASE
,	I-DISEASE
Williams	I-DISEASE
RL	I-DISEASE
.	I-DISEASE

The	I-DISEASE
first	I-DISEASE
night	0
effect	0
:	0
an	I-DISEASE
EEG	0
study	0
of	I-DISEASE
sleep	0
.	0

Psychophysiology	I-DISEASE
1966;2:263–6	I-DISEASE
.	0

Angst	I-DISEASE
J	0
,	I-DISEASE
Vollrath	0
M	I-DISEASE
,	0
Koch	0
R	I-DISEASE
,	I-DISEASE
Dobler	I-DISEASE
-	I-DISEASE
Mikola	I-DISEASE
A.	0
The	I-DISEASE
Zurich	0
Study	B-DISEASE
.	0

VII	I-DISEASE
.	I-DISEASE

Insomnia	I-DISEASE
:	0
symptoms	I-DISEASE
,	0
classification	I-DISEASE
and	0
prevalence	0
.	0

Eur	I-DISEASE
Arch	0
Psychiatry	0
Clin	I-DISEASE
Neurosci	0
1989;238:285–93	I-DISEASE
.	0

Healey	I-DISEASE
ES	0
,	0
Kales	0
A	0
,	0
Monroe	0
LJ	0
,	I-DISEASE
Bixler	0
EO	0
,	0
Chamberlin	0
K	I-DISEASE
,	I-DISEASE
Soldatos	0
CR	0
.	I-DISEASE

Onset	I-DISEASE
of	I-DISEASE
insomnia	0
:	0
role	0
of	0
life-	0
stress	I-DISEASE
events	I-DISEASE
.	0

Psychosom	I-DISEASE
Med	I-DISEASE
1981;43:439–51	I-DISEASE
.	0

Morin	I-DISEASE
CM	0
,	0
Rodrigue	0
S	I-DISEASE
,	0
Ivers	0
H.	I-DISEASE
Role	0
of	I-DISEASE
stress	I-DISEASE
,	I-DISEASE
arousal	0
and	0
coping	I-DISEASE
skills	0
in	I-DISEASE
primary	0
insomnia	I-DISEASE
.	0

Psychosom	I-DISEASE
Med	I-DISEASE
2003;65:259–67	0
.	0

Roehrs	I-DISEASE
T	0
,	0
Zorick	I-DISEASE
F	0
,	0
Roth	I-DISEASE
T.	0
Transient	I-DISEASE
and	0
short	0
-	I-DISEASE
term	0
insomnias	0
.	0

In	I-DISEASE
:	I-DISEASE
Krieger	0
MH	I-DISEASE
,	I-DISEASE
Roth	I-DISEASE
T	0
,	0
Dement	I-DISEASE
WC	I-DISEASE
,	0
eds	I-DISEASE
.	0

Principles	I-DISEASE
and	0
practice	0
of	I-DISEASE
sleep	0
medicine	0
,	I-DISEASE
3rd	0
ed	0
.	0

Philadelphia	I-DISEASE
:	0
WB	0
Saunders	0
,	I-DISEASE
2000:624–32	I-DISEASE
.	0

Tachibana	I-DISEASE
H	I-DISEASE
,	0
Izumi	I-DISEASE
T	0
,	0
Honda	I-DISEASE
S	I-DISEASE
,	I-DISEASE
Takemoto	0
TI	0
.	I-DISEASE

The	I-DISEASE
prevalence	0
and	0
pattern	0
of	0
insomnia	I-DISEASE
in	0
Japanese	0
industrial	0
workers	0
:	I-DISEASE
relationship	I-DISEASE
between	0
psychosocial	0
stress	0
and	0
type	I-DISEASE
of	I-DISEASE
insomnia	I-DISEASE
.	0

Psychiatry	I-DISEASE
Clin	0
Neurosci	0
1998;52:397–402	0
.	0

Insomnia	I-DISEASE
Insomnia	0
Other	0
Insomnia	0
Disorder	I-DISEASE
ICD-9	0
-	0
CM	0
code	0
:	0
307.49	0
ICD-10	0
-	0
CM	0
code	0
:	0
F51.09	0
This	0
diagnosis	0
is	0
reserved	0
for	0
individuals	I-DISEASE
who	I-DISEASE
complain	I-DISEASE
of	I-DISEASE
difficulty	0
initiating	0
and	0
maintaining	0
sleep	0
and	0
yet	0
do	0
not	0
meet	0
the	I-DISEASE
full	0
criteria	I-DISEASE
for	0
either	0
chronic	0
insomnia	I-DISEASE
dis-	I-DISEASE
order	0
or	I-DISEASE
short	0
-	0
term	0
insomnia	0
disorder	0
.	0

In	I-DISEASE
some	I-DISEASE
cases	0
,	I-DISEASE
this	0
diagnosis	I-DISEASE
may	I-DISEASE
be	I-DISEASE
assigned	0
on	0
a	0
provisional	I-DISEASE
basis	I-DISEASE
when	I-DISEASE
more	0
information	0
is	I-DISEASE
needed	I-DISEASE
to	0
establish	0
a	0
diagnosis	0
of	I-DISEASE
chronic	I-DISEASE
insomnia	I-DISEASE
disorder	I-DISEASE
or	0
short	0
-	0
term	0
insomnia	0
disorder	I-DISEASE
.	0

It	I-DISEASE
is	I-DISEASE
expected	0
that	0
this	0
diag-	I-DISEASE
nosis	0
will	0
be	I-DISEASE
used	I-DISEASE
sparingly	0
,	I-DISEASE
given	I-DISEASE
its	0
nonspecific	0
nature	0
.	0

Isolated	I-DISEASE
Symptoms	I-DISEASE
and	0
Normal	0
Variants	0
Excessive	I-DISEASE
Time	I-DISEASE
in	I-DISEASE
Bed	I-DISEASE

Some	I-DISEASE
individuals	I-DISEASE
may	0
present	I-DISEASE
with	0
isolated	I-DISEASE
insomnia	0
symptoms	0
such	0
as	0
prolonged	I-DISEASE
sleep	0
latencies	I-DISEASE
or	I-DISEASE
long	I-DISEASE
periods	0
of	0
wakefulness	0
during	I-DISEASE
the	0
night	0
,	I-DISEASE
yet	0
not	0
complain	0
of	I-DISEASE
insomnia	0
nor	0
show	I-DISEASE
daytime	0
impairments	0
.	0

In	I-DISEASE
children	I-DISEASE
,	0
this	I-DISEASE
pattern	0
may	I-DISEASE
emerge	I-DISEASE
when	I-DISEASE
parents	0
or	0
caregivers	0
have	I-DISEASE
unrealistic	0
expectations	I-DISEASE
for	0
the	0
child	0
’s	I-DISEASE
sleep	0
needs	0
and	0
rou-	0
tinely	0
allot	0
too	0
much	I-DISEASE
time	0
for	0
the	0
child	0
to	I-DISEASE
be	0
in	I-DISEASE
bed	0
each	0
night	0
.	0

In	I-DISEASE
adults	I-DISEASE
,	0
this	I-DISEASE
pattern	0
is	I-DISEASE
perhaps	I-DISEASE
most	I-DISEASE
common	I-DISEASE
in	0
noncomplaining	0
groups	0
who	I-DISEASE
routinely	I-DISEASE
allot	0
significantly	0
more	0
time	0
in	I-DISEASE
bed	I-DISEASE
than	I-DISEASE
needed	I-DISEASE
for	0
sleep	0
.	0

For	I-DISEASE
example	0
,	0
some	I-DISEASE
individuals	I-DISEASE
who	I-DISEASE
are	0
retired	0
from	0
work	I-DISEASE
or	0
not	0
currently	I-DISEASE
employed	0
may	0
routinely	0
spend	I-DISEASE
excessive	I-DISEASE
time	0
in	0
bed	I-DISEASE
each	0
night	0
and	0
are	0
not	0
bothered	0
by	I-DISEASE
the	0
expanded	I-DISEASE
periods	I-DISEASE
of	I-DISEASE
wakefulness	0
they	I-DISEASE
routinely	0
experience	0
.	0

At	I-DISEASE
present	I-DISEASE
,	0
epidemiological	0
and	0
laboratory	I-DISEASE
studies	I-DISEASE
are	0
unable	I-DISEASE
to	I-DISEASE
ascertain	0
whether	I-DISEASE
adverse	0
health	0
outcomes	I-DISEASE
are	0
more	0
strongly	0
associated	0
with	I-DISEASE
perceived	0
sleep	0
difficulties	I-DISEASE
/	0
dissatisfaction	0
or	0
with	I-DISEASE
particular	I-DISEASE
objective	0
indices	0
of	I-DISEASE
sleep	0
duration	0
,	0
sleep	0
latency	I-DISEASE
,	I-DISEASE
and	0
sleep	I-DISEASE
continuity	0
.	0

Short	I-DISEASE
Sleeper	I-DISEASE
Some	0
individuals	I-DISEASE
routinely	0
obtain	I-DISEASE
less	I-DISEASE
than	0
six	0
hours	I-DISEASE
of	I-DISEASE
sleep	I-DISEASE
per	I-DISEASE
night	0
on	0
average	I-DISEASE
yet	I-DISEASE
have	0
no	0
sleep	0
/	0
wake	0
complaints	0
.	0

Such	I-DISEASE
individuals	I-DISEASE
are	0
considered	I-DISEASE
to	0
be	I-DISEASE
normal	0
short	0
sleepers	0
if	0
they	I-DISEASE
have	I-DISEASE
no	I-DISEASE
complaints	0
of	I-DISEASE
sleep	0
difficulties	I-DISEASE
and	0
show	0
no	0
obvious	0
daytime	I-DISEASE
dysfunction	0
.	0

Among	I-DISEASE
these	I-DISEASE
individuals	I-DISEASE
,	I-DISEASE
the	0
observed	I-DISEASE
relatively	0
low	0
average	0
sleep	0
time	0
does	I-DISEASE
not	I-DISEASE
result	0
from	0
chronic	0
volitional	0
sleep	0
restriction	0
,	0
as	0
in	0
the	0
case	I-DISEASE
of	0
insufficient	I-DISEASE
sleep	0
syndrome	I-DISEASE
,	I-DISEASE
but	I-DISEASE
rather	0
indicates	0
a	0
constitutional	0
disposition	I-DISEASE
for	0
reduced	0
sleep	0
requirement	0
.	0

The	I-DISEASE
clinical	0
significance	I-DISEASE
of	I-DISEASE
chronic	0
short	0
sleep	0
duration	I-DISEASE
,	0
and	0
the	0
identifi-	I-DISEASE
cation	0
of	0
possible	0
subtypes	I-DISEASE
,	0
remain	0
open	I-DISEASE
questions	0
.	0

Various	I-DISEASE
studies	I-DISEASE
have	0
linked	0
short	0
sleep	0
duration	0
with	I-DISEASE
metabolic	0
,	0
cardiovascular	I-DISEASE
,	I-DISEASE
and	0
other	0
forms	0
of	I-DISEASE
medical	I-DISEASE
morbidity	0
.	0

However	I-DISEASE
,	I-DISEASE
these	0
studies	I-DISEASE
are	0
typically	0
unable	I-DISEASE
to	I-DISEASE
distinguish	0
between	0
individuals	I-DISEASE
who	I-DISEASE
have	I-DISEASE
short	0
sleep	0
in	I-DISEASE
the	0
context	I-DISEASE
of	0
insomnia	0
or	0
another	I-DISEASE
sleep	0
disorder	I-DISEASE
,	0
those	I-DISEASE
who	I-DISEASE
are	0
voluntarily	0
restricting	I-DISEASE
their	0
sleep	0
,	0
and	0
those	0
who	I-DISEASE
may	0
have	0
naturally	0
short	0
sleep	0
.	0

Short	I-DISEASE
sleep	0
resulting	0
from	I-DISEASE
different	0
causes	I-DISEASE
may	0
have	I-DISEASE
different	0
pathophysiological	0
signifi-	0
cance	0
.	0

At	I-DISEASE
present	I-DISEASE
,	0
those	I-DISEASE
who	0
demonstrate	I-DISEASE
less	I-DISEASE
than	I-DISEASE
six	0
hours	I-DISEASE
of	I-DISEASE
sleep	0
per	I-DISEASE
night	I-DISEASE
should	0
not	0
be	I-DISEASE
assigned	I-DISEASE
an	0
insomnia	0
diagnosis	0
unless	0
they	0
also	0
meet	0
the	0
criteria	0
for	I-DISEASE
one	0
of	I-DISEASE
the	0
insomnia	0
disorder	I-DISEASE
subtypes	0
described	0
herein	I-DISEASE
.	0

Insomnia	I-DISEASE
Insomnia	0
Bibliography	0
Fernandez	I-DISEASE
-	I-DISEASE
Mendoza	0
J	0
,	I-DISEASE
Calhoun	I-DISEASE
S	I-DISEASE
,	0
Bixler	0
EO	0
,	I-DISEASE
Pejovic	I-DISEASE
S	I-DISEASE
,	I-DISEASE
Karataraki	0
M	I-DISEASE
,	0
Liao	0
D.	I-DISEASE
Insomnia	0
with	0
objective	0
short	I-DISEASE
sleep	0
duration	0
is	0
associated	0
with	0
deficits	0
in	0
neuropsychological	0
performance	0
:	0
a	I-DISEASE
general	I-DISEASE
population	0
study	0
.	0

Sleep	I-DISEASE
2010;33:459–65	0
.	0

Hartmann	I-DISEASE
E.	0
Sleep	0
requirement	0
:	0
long	I-DISEASE
sleepers	0
,	0
short	0
sleepers	I-DISEASE
,	0
variable	I-DISEASE
sleepers	0
,	0
and	0
insomniacs	I-DISEASE
.	0

Psychosomatics	I-DISEASE
1973;14:95–103	0
.	0

Ohayon	I-DISEASE
MM	I-DISEASE
,	I-DISEASE
Caulet	I-DISEASE
M	0
,	0
Guilleminault	I-DISEASE
C.	I-DISEASE
How	0
a	0
general	0
population	0
perceives	I-DISEASE
its	I-DISEASE
sleep	I-DISEASE
and	0
how	0
this	0
relates	I-DISEASE
to	I-DISEASE
the	0
complaint	0
of	I-DISEASE
insomnia	I-DISEASE
.	0

Sleep	I-DISEASE
1997;20:715–23	0
.	0

Roehrs	I-DISEASE
T	0
,	0
Zorick	I-DISEASE
F	0
,	0
Roth	I-DISEASE
T.	0
Transient	I-DISEASE
and	0
short	0
-	I-DISEASE
term	0
insomnias	0
.	0

In	I-DISEASE
:	I-DISEASE
Krieger	0
MH	I-DISEASE
,	I-DISEASE
Roth	I-DISEASE
T	0
,	0
Dement	I-DISEASE
WC	I-DISEASE
,	0
eds	I-DISEASE
.	0

Principles	I-DISEASE
and	0
practice	0
of	I-DISEASE
sleep	0
medicine	0
,	I-DISEASE
3rd	0
ed	0
.	0

Philadelphia	I-DISEASE
:	0
WB	0
Saunders	0
,	I-DISEASE
2000:624–32	I-DISEASE
.	0

Vgontzas	I-DISEASE
AN	0
,	I-DISEASE
Liao	I-DISEASE
D	0
,	0
Bixler	0
EO	I-DISEASE
,	I-DISEASE
Chrousos	I-DISEASE
GP	0
,	I-DISEASE
Vela	I-DISEASE
-	0
Bueno	0
A.	0
Insomnia	I-DISEASE
with	I-DISEASE
objective	I-DISEASE
short	0
sleep	0
duration	0
is	0
associated	0
with	0
a	0
high	0
risk	0
for	I-DISEASE
hypertension	I-DISEASE
.	0

Sleep	I-DISEASE
2009;32:491–7	I-DISEASE
.	0

Webb	I-DISEASE
WB	I-DISEASE
,	I-DISEASE
Friel	0
J.	0
Characteristics	0
of	I-DISEASE
“	I-DISEASE
natural	I-DISEASE
”	I-DISEASE
long	I-DISEASE
and	0
short	I-DISEASE
sleepers	0
:	I-DISEASE
a	0
preliminary	I-DISEASE
report	0
.	0

Psychol	I-DISEASE
Rep	I-DISEASE
1970;27:63–6	I-DISEASE
.	0

Sleep	I-DISEASE
Related	I-DISEASE
Breathing	0
Disorders	I-DISEASE
Obstructive	0
Sleep	I-DISEASE
Apnea	0
Disorders	I-DISEASE
Obstructive	I-DISEASE
Sleep	0
Apnea	I-DISEASE
,	I-DISEASE
Adult53	0
Obstructive	I-DISEASE
Sleep	0
Apnea	0
,	0

Pediatric63	I-DISEASE
Central	0
Sleep	I-DISEASE
Apnea	0
Syndromes	0
Central	I-DISEASE
Sleep	0
Apnea	0
with	0
Cheyne	0
-	0
Stokes	0
Breathing	0
69	I-DISEASE
Central	0
Apnea	0
Due	0
to	I-DISEASE
a	0
Medical	I-DISEASE
Disorder	0
without	0
Cheyne	0
-	0
Stokes	0
Breathing75	0
Central	0
Sleep	0
Apnea	0

Due	I-DISEASE
to	I-DISEASE
High	0
Altitude	0
Periodic	I-DISEASE
Breathing	0
79	I-DISEASE
Central	I-DISEASE
Sleep	I-DISEASE
Apnea	0
Due	I-DISEASE
to	I-DISEASE
a	0
Medication	0
or	0
Substance	I-DISEASE
85	0
Primary	I-DISEASE
Central	0
Sleep	I-DISEASE
Apnea	0

89	I-DISEASE
Primary	I-DISEASE
Central	0
Sleep	0
Apnea	0
of	I-DISEASE
Infancy94	0
Primary	I-DISEASE
Central	0
Sleep	0
Apnea	0
of	0
Prematurity98	0
Treatment	I-DISEASE
-	0
Emergent	I-DISEASE
Central	I-DISEASE
Sleep	0
Apnea	0
102	I-DISEASE
Sleep	0
Related	0
Hypoventilation	I-DISEASE
Disorders	I-DISEASE
Obesity	I-DISEASE
Hypoventilation	I-DISEASE
Syndrome	B-DISEASE
108	0
Congenital	0
Central	0
Alveolar	I-DISEASE
Hypoventilation	I-DISEASE
Syndrome	I-DISEASE

113	I-DISEASE
Late	0
-	0
Onset	I-DISEASE
Central	I-DISEASE
Hypoventilation	I-DISEASE
with	I-DISEASE
Hypothalamic	I-DISEASE
Dysfunction	I-DISEASE
118	I-DISEASE
Idiopathic	0
Central	I-DISEASE
Alveolar	I-DISEASE
Hypoventilation	I-DISEASE
121	0
Sleep	I-DISEASE
Related	0
Hypoventilation	0
Due	0
to	0
a	I-DISEASE
Medication	I-DISEASE
or	I-DISEASE
Substance	I-DISEASE

124	I-DISEASE
Sleep	I-DISEASE
Related	0
Hypoventilation	0
Due	0
to	0
a	0
Medical	I-DISEASE
Disorder128	I-DISEASE
Sleep	0
Related	0
Hypoxemia	I-DISEASE
Disorder	I-DISEASE
Sleep	0
Related	I-DISEASE
Hypoxemia134	I-DISEASE
Isolated	0
Symptoms	0
and	0
Normal	I-DISEASE
Variants	I-DISEASE

Snoring	I-DISEASE
139	0
Catathrenia	0
141	I-DISEASE
The	I-DISEASE
sleep	0
related	I-DISEASE
breathing	I-DISEASE
disorders	0
are	0
characterized	0
by	I-DISEASE
abnormalities	I-DISEASE
of	0
respi-	I-DISEASE
ration	I-DISEASE
during	I-DISEASE
sleep	I-DISEASE
.	0

In	I-DISEASE
some	I-DISEASE
of	I-DISEASE
these	I-DISEASE
disorders	0
,	I-DISEASE
respiration	0
is	0
also	0
abnormal	0
during	I-DISEASE
wakefulness	I-DISEASE
.	0

The	I-DISEASE
disorders	0
are	0
grouped	0
into	I-DISEASE
obstructive	0
sleep	0
apnea	0
(	I-DISEASE
OSA	0
)	0
disorders	I-DISEASE
,	0
central	0
sleep	0
apnea	0
disorders	0
,	I-DISEASE
sleep	0
related	0
hypoventilation	I-DISEASE
disorders	0
,	I-DISEASE
and	0
sleep	0
related	0
hypoxemia	I-DISEASE
disorder	0
.	0

However	I-DISEASE
,	I-DISEASE
many	0
patients	I-DISEASE
will	0
meet	0
diagnostic	0
criteria	I-DISEASE
for	0
more	0
than	0
one	I-DISEASE
of	I-DISEASE
these	I-DISEASE
groups	0
.	0

In	I-DISEASE
particular	I-DISEASE
,	0
many	0
patients	0
have	I-DISEASE
a	0
combination	I-DISEASE
of	I-DISEASE
obstruc-	0
tive	0
and	0
central	I-DISEASE
sleep	0
apnea	0
.	0

Although	I-DISEASE
a	0
diagnosis	0
is	0
often	0
based	I-DISEASE
on	0
which	0
disorder	0
Sleep	0
Related	0
Breathing	0
Disorders	I-DISEASE
predominates	0
,	0
this	0
may	0
vary	I-DISEASE
from	0
night	I-DISEASE
to	0
night	I-DISEASE
as	0
well	B-DISEASE
as	0
over	0
time	0
in	I-DISEASE
individual	0
patients	0
.	0

There	I-DISEASE
is	I-DISEASE
also	0
overlap	0
in	0
pathophysiology	0
,	0
as	0
some	I-DISEASE
central	0
apneas	0
are	0
associ-	0
ated	0
with	I-DISEASE
a	0
closed	I-DISEASE
upper	0
airway	0
and	0
many	0
obstructive	0
apneas	0
begin	0
during	I-DISEASE
a	0
time	0
of	I-DISEASE
falling	0
ventilatory	0
drive	0
.	0

In	I-DISEASE
the	0
sections	0
that	0
follow	0
,	I-DISEASE
individual	I-DISEASE
respiratory	I-DISEASE
events	0
(	0
e.g.	0
,	0
apneas	0
,	0
hypopneas	I-DISEASE
,	I-DISEASE
and	0
hypoventilation	I-DISEASE
)	0
are	0
not	0
defined	I-DISEASE
;	0
rather	0
,	I-DISEASE
reference	0
is	0
made	0
to	0
the	0
most	0
recent	0
version	I-DISEASE
of	I-DISEASE
the	I-DISEASE
American	0
Academy	0
of	I-DISEASE
Sleep	0
Medicine	0
(	I-DISEASE
AASM	I-DISEASE
)	0
Manual	0
for	0
the	0
Scoring	0
of	I-DISEASE
Sleep	0
and	0
Associated	I-DISEASE
Events	I-DISEASE
for	I-DISEASE
these	I-DISEASE
definitions	I-DISEASE
.	0

The	I-DISEASE
AASM	I-DISEASE
Manual	I-DISEASE
for	0
the	0
Scoring	0
of	0
Sleep	0
and	0
Associated	I-DISEASE
Events	I-DISEASE
includes	I-DISEASE
different	0
scoring	0
rules	0
for	I-DISEASE
adult	0
and	0
pediatric	0
individuals	I-DISEASE
,	0
definitions	0
of	I-DISEASE
obstructive	0
and	0
central	0
apneas	0
and	0
hypopneas	0
,	0
and	0
rules	I-DISEASE
for	I-DISEASE
scoring	I-DISEASE
Cheyne	I-DISEASE
-	0
Stokes	0
breathing	0
and	0
hypoventilation	0
.	0

The	I-DISEASE
OSA	I-DISEASE
disorders	0
are	0
separated	I-DISEASE
into	I-DISEASE
adult	0
and	0
pediatric	0
categories	I-DISEASE
,	I-DISEASE
as	0
the	0
presenta-	I-DISEASE
tion	0
,	I-DISEASE
diagnostic	0
criteria	0
,	I-DISEASE
course	I-DISEASE
,	I-DISEASE
and	0
complications	0
differ	I-DISEASE
significantly	0
.	0

These	0
disorders	0
are	0
characterized	0
by	0
upper	0
airway	I-DISEASE
narrowing	I-DISEASE
or	0
closure	I-DISEASE
during	I-DISEASE
sleep	I-DISEASE
while	I-DISEASE
respiratory	B-DISEASE
effort	I-DISEASE
continues	0
(	I-DISEASE
at	0
least	0
during	I-DISEASE
some	I-DISEASE
portion	0
of	I-DISEASE
the	0
event	I-DISEASE
)	0
.	I-DISEASE

The	I-DISEASE
use	I-DISEASE
of	I-DISEASE
out	0
-	0
of	I-DISEASE
-	I-DISEASE
cen-	I-DISEASE
ter	I-DISEASE
sleep	I-DISEASE
testing	I-DISEASE
(	0
OCST	0
)	0
with	0
limited	I-DISEASE
channels	0
(	0
electroencephalogram	B-DISEASE
[	0
EEG	0
]	0
is	0
not	0
usually	I-DISEASE
recorded	0
)	0
is	0
now	I-DISEASE
included	I-DISEASE
in	0
the	0
diagnostic	0
criteria	0
for	I-DISEASE
adult	0
OSA	I-DISEASE
.	0

The	I-DISEASE
central	0
sleep	0
apnea	0
syndromes	0
are	0
characterized	0
by	I-DISEASE
reduction	I-DISEASE
or	I-DISEASE
cessation	I-DISEASE
of	I-DISEASE
airflow	I-DISEASE
due	0
to	I-DISEASE
absent	0
or	0
reduced	0
respiratory	0
effort	I-DISEASE
.	0

Central	I-DISEASE
apnea	0
or	0
hypopnea	0
may	0
occur	0
in	I-DISEASE
a	I-DISEASE
cyclical	I-DISEASE
or	I-DISEASE
intermittent	I-DISEASE
fashion	0
.	0

Patients	I-DISEASE
with	0
central	0
sleep	0
apnea	0
of	I-DISEASE
various	0
etiologies	0
may	I-DISEASE
also	0
exhibit	0
OSA	I-DISEASE
.	0

In	I-DISEASE
primary	0
central	0
sleep	0
apnea	0
,	I-DISEASE
the	0
cause	0
of	I-DISEASE
the	0
disorder	I-DISEASE
is	I-DISEASE
unknown	0
(	I-DISEASE
idiopathic	I-DISEASE
)	0
.	0

The	I-DISEASE
arterial	I-DISEASE
partial	I-DISEASE
pressure	0
of	I-DISEASE
carbon	0
dioxide	I-DISEASE
(	I-DISEASE
PaCO2	0
)	I-DISEASE
during	I-DISEASE
wake	0
in	I-DISEASE
these	I-DISEASE
patients	I-DISEASE
is	0
normal	0
or	I-DISEASE
low	0
.	0

Patients	I-DISEASE
do	0
not	0
meet	0
diagnostic	0
criteria	I-DISEASE
for	I-DISEASE
other	0
central	0
sleep	0
apnea	0
dis-	0
orders	I-DISEASE
.	0

In	I-DISEASE
central	0
sleep	0
apnea	0
with	0
Cheyne	I-DISEASE
-	0
Stokes	0
breathing	I-DISEASE
,	I-DISEASE
there	0
is	0
a	0
cyclical	I-DISEASE
pattern	0
of	I-DISEASE
crescendo	I-DISEASE
-	0
decrescendo	0
respiration	0
separated	I-DISEASE
by	B-DISEASE
central	0
apneas	0
or	0
central	0
hypopneas	0
.	0

Most	I-DISEASE
patients	0
with	0
this	0
disorder	0
have	I-DISEASE
congestive	0
heart	0
failure	0
(	I-DISEASE
reduced	I-DISEASE
or	I-DISEASE
preserved	0
ejection	0
fraction	I-DISEASE
)	0
,	0
although	0
,	0
less	I-DISEASE
commonly	0
,	I-DISEASE
others	I-DISEASE
exhibit	0
this	I-DISEASE
breathing	0
pattern	0
fol-	I-DISEASE
lowing	0
stroke	I-DISEASE
or	0
in	0
association	B-DISEASE
with	I-DISEASE
other	0
neurological	0
disorders	0
.	0

In	I-DISEASE
high	I-DISEASE
-	0
altitude	0
peri-	0
odic	0
breathing	0
,	0
the	0
disorder	I-DISEASE
is	I-DISEASE
associated	0
with	0
acute	I-DISEASE
ascent	I-DISEASE
to	0
high	0
altitude	0
.	0

Symptoms	I-DISEASE
must	0
be	I-DISEASE
present	I-DISEASE
to	I-DISEASE
establish	0
the	0
diagnosis	0
of	I-DISEASE
high	I-DISEASE
-	I-DISEASE
altitude	0
periodic	I-DISEASE
breathing	I-DISEASE
,	I-DISEASE
as	0
this	0
breathing	0
pattern	0
is	I-DISEASE
an	0
expected	0
finding	I-DISEASE
after	0
ascent	I-DISEASE
to	0
altitude	0
.	0

Central	I-DISEASE
sleep	0
apnea	0
due	I-DISEASE
to	I-DISEASE
medical	I-DISEASE
or	B-DISEASE
neurological	0
condition	I-DISEASE
(	I-DISEASE
not	0
Cheyne	I-DISEASE
-	0
Stokes	0
)	0
is	0
usually	I-DISEASE
due	0
to	0
a	I-DISEASE
struc-	0
tural	0
lesion	0
in	I-DISEASE
the	0
central	0
nervous	0
system	0
.	0

These	0
disorders	0
should	0
be	0
excluded	0
before	0
a	0
diagnosis	I-DISEASE
of	0
primary	0
central	0
sleep	0
apnea	I-DISEASE
is	0
made	0
.	0

In	I-DISEASE
central	0
sleep	0
apnea	0
due	0
to	I-DISEASE
drug	0
or	0
substance	I-DISEASE
,	I-DISEASE
the	I-DISEASE
patient	I-DISEASE
demonstrates	0
central	0
apneas	0
secondary	0
to	0
the	0
effects	0
of	I-DISEASE
potent	I-DISEASE
opioids	0
or	I-DISEASE
other	0
respiratory	B-DISEASE
depressants	0
on	0
respiratory	0
control	0
centers	0
.	0

Treatment	I-DISEASE
-	I-DISEASE
emergent	0
central	0
sleep	0
apnea	0
is	0
a	0
new	0
addition	I-DISEASE
to	I-DISEASE
the	0
International	0
Classification	I-DISEASE
of	I-DISEASE
Sleep	0
Disorders	0
.	0

In	I-DISEASE
this	I-DISEASE
disorder	0
,	I-DISEASE
the	0
patient	I-DISEASE
exhibits	0
predominantly	I-DISEASE
obstructive	0
events	I-DISEASE
during	I-DISEASE
diagnostic	0
sleep	0
testing	0
(	I-DISEASE
e.g.	0
,	0
obstructive	0
or	I-DISEASE
mixed	0
apneas	I-DISEASE
and	0
obstructive	0
hypopneas	I-DISEASE
)	0
,	I-DISEASE
but	I-DISEASE
central	I-DISEASE
apneas	0
or	0
central	0
hypopneas	0
emerge	0
or	I-DISEASE
persist	I-DISEASE
on	0
positive	0
airway	I-DISEASE
pressure	0
treatment	0
without	0
a	0
backup	I-DISEASE
rate	I-DISEASE
and	0
are	I-DISEASE
the	0
predominant	0
residual	0
breathing	0
abnormality	0
(	I-DISEASE
i.e.	I-DISEASE
,	I-DISEASE
obstructive	0
events	0
have	0
resolved	0
)	0
.	0

A	0
diagnosis	I-DISEASE
of	I-DISEASE
treatment	I-DISEASE
-	0
emergent	I-DISEASE
central	0
sleep	0
apnea	0
is	I-DISEASE
made	0
when	0
the	0
central	0
sleep	0
apnea	0
component	0
is	0
not	0
better	0
explained	I-DISEASE
by	0
another	I-DISEASE
diagnosis	0
(	I-DISEASE
i.e.	I-DISEASE
,	0
another	I-DISEASE
central	0
sleep	0
apnea	0
disorder	0
)	0
.	0

Sleep	I-DISEASE
related	I-DISEASE
hypoventilation	0
disorders	0
are	0
characterized	0
by	I-DISEASE
an	0
abnormal	I-DISEASE
increase	I-DISEASE
in	0
the	0
arterial	I-DISEASE
PCO2	0
(	I-DISEASE
PaCO2	0
)	I-DISEASE
during	I-DISEASE
sleep	0
.	0

Adult	I-DISEASE
and	0
pediatric	0
hypoventilation	0
disorders	0
are	0
defined	I-DISEASE
by	I-DISEASE
different	I-DISEASE
criteria	0
.	0

For	I-DISEASE
adults	I-DISEASE
,	0
an	0
increase	0
in	I-DISEASE
the	0
arterial	I-DISEASE
PCO2	0
(	I-DISEASE
or	I-DISEASE
sur-	0
rogate	I-DISEASE
)	0
to	I-DISEASE
greater	I-DISEASE
than	I-DISEASE
55	0
mm	0
Hg	I-DISEASE
for	I-DISEASE
at	I-DISEASE
least	I-DISEASE
10	0
minutes	0
or	I-DISEASE
an	0
increase	I-DISEASE
≥	I-DISEASE
10	0
mm	0

Hg	I-DISEASE
above	0
the	0
awake	0
value	I-DISEASE
to	I-DISEASE
a	I-DISEASE
value	0
of	I-DISEASE
50	0
mm	0
Hg	I-DISEASE
or	0
greater	I-DISEASE
for	I-DISEASE
at	I-DISEASE
least	0
10	0
minutes	0
is	0
required	I-DISEASE
.	0

In	I-DISEASE
pediatric	0
patients	I-DISEASE
,	0
the	0
PaCO2	0
(	I-DISEASE
or	I-DISEASE
surrogate	I-DISEASE
)	I-DISEASE
must	0
be	I-DISEASE
greater	I-DISEASE
than	I-DISEASE
50	0
mm	0
Hg	I-DISEASE
for	I-DISEASE
greater	I-DISEASE
than	I-DISEASE
25	I-DISEASE
%	0
of	I-DISEASE
total	I-DISEASE
sleep	0
time	I-DISEASE
.	B-DISEASE

In	I-DISEASE
this	I-DISEASE
edition	I-DISEASE
of	I-DISEASE
the	0
International	0
Classification	I-DISEASE
of	I-DISEASE
Sleep	0
Disorders	0
,	I-DISEASE
there	I-DISEASE
are	0
a	0
number	0
of	I-DISEASE
changes	0
in	0
the	0
classification	I-DISEASE
of	I-DISEASE
sleep	0
related	0
hypoventilation	I-DISEASE
disorders	0
.	B-DISEASE

The	I-DISEASE
obesity	0
hypoventilation	I-DISEASE
syndrome	0
is	0
listed	B-DISEASE
as	0
a	I-DISEASE
separate	I-DISEASE
disorder	0
given	0
that	0
it	I-DISEASE
is	0
both	I-DISEASE
prevalent	I-DISEASE
and	0
has	0
distinct	0
clinical	0
characteristics	I-DISEASE
.	0

In	I-DISEASE
contrast	I-DISEASE
to	0
other	I-DISEASE
sleep	0
related	B-DISEASE
hypoventila-	I-DISEASE
tion	I-DISEASE
disorders	0
,	I-DISEASE
a	0
diagnosis	I-DISEASE
of	0
obesity	0
hypoventilation	0
syndrome	0
requires	I-DISEASE
documenta-	0
tion	B-DISEASE
of	I-DISEASE
awake	0
(	I-DISEASE
daytime	0
)	0
hypoventilation	I-DISEASE
(	0
PaCO2	0
>	0
45	I-DISEASE
mm	0
Hg	I-DISEASE
)	0
.	0

For	I-DISEASE
the	0
other	0
disorders	0
in	0
this	0
category	0
,	I-DISEASE
awake	0
hypoventilation	0
may	0
or	0
may	I-DISEASE
not	I-DISEASE
be	0
present	0
.	0

In	I-DISEASE
the	0
previous	0
version	I-DISEASE
of	0
the	I-DISEASE
International	0
Classification	I-DISEASE
of	I-DISEASE
Sleep	0
Disorders	I-DISEASE
,	I-DISEASE
a	0
group	I-DISEASE
of	I-DISEASE
disorders	I-DISEASE
were	0
listed	0
under	0
the	0
category	0
of	I-DISEASE
sleep	0
related	I-DISEASE
hypoventilation	0
/	I-DISEASE
hypoxemia	I-DISEASE
disorders	0
.	0

In	I-DISEASE
the	0
International	0
Classification	I-DISEASE
of	0
Sleep	I-DISEASE
Disorders	I-DISEASE
,	0
3rd	0
Edition	I-DISEASE
,	I-DISEASE
disorders	0
manifesting	0
hypoventilation	I-DISEASE
are	0
separated	I-DISEASE
from	0
disorders	0
in	I-DISEASE
which	0
only	I-DISEASE
a	0
finding	I-DISEASE
of	I-DISEASE
hypoxemia	I-DISEASE
(	I-DISEASE
arterial	0
oxygen	I-DISEASE
desaturation	0
)	0
during	I-DISEASE
sleep	0
is	0
documented	I-DISEASE
.	0

Demonstrating	I-DISEASE
sleep	0
related	B-DISEASE
hypoventilation	I-DISEASE
rather	0
than	I-DISEASE
simply	I-DISEASE
hypoxemia	I-DISEASE
has	I-DISEASE
important	0
diagnostic	0
and	0
treatment	I-DISEASE
consequences	I-DISEASE
.	0

Sleep	I-DISEASE
related	I-DISEASE
hypoxemia	0
disorders	0
are	I-DISEASE
characterized	0
by	I-DISEASE
sustained	0
periods	I-DISEASE
of	I-DISEASE
significantly	0
reduced	0
oxyhemoglobin	0
saturation	0
during	I-DISEASE
sleep	0
.	0

This	I-DISEASE
diagnostic	0
category	0
is	0
used	0
when	I-DISEASE
sleep	0
related	B-DISEASE
hypoventilation	0
is	I-DISEASE
either	0
not	0
present	I-DISEASE
or	I-DISEASE
the	0
status	0
is	0
unknown	0
.	0

Sleep	I-DISEASE
related	I-DISEASE
hypoxemia	0
can	I-DISEASE
occur	I-DISEASE
due	0
to	0
hypoventilation	I-DISEASE
,	I-DISEASE
ven-	I-DISEASE
tilation	0
-	0
perfusion	0
mismatch	0
,	I-DISEASE
low	0
partial	I-DISEASE
pressure	0
of	I-DISEASE
oxygen	0
,	0
shunt	0
,	0
or	I-DISEASE
a	0
combination	I-DISEASE
of	I-DISEASE
Sleep	0
Related	0
Breathing	0
Disorders	I-DISEASE
Sleep	0
Related	0
Breathing	0
Disorders	I-DISEASE
these	I-DISEASE
factors	0
.	I-DISEASE

Many	I-DISEASE
diverse	0
etiologies	0
can	0
be	I-DISEASE
associated	0
with	0
sleep	0
related	B-DISEASE
hypoxemia	I-DISEASE
.	0

There	I-DISEASE
are	0
no	0
longer	I-DISEASE
separate	0
diagnostic	0
categories	I-DISEASE
for	I-DISEASE
the	0
various	0
types	I-DISEASE
of	I-DISEASE
medical	I-DISEASE
and	0
neurological	0
pathology	I-DISEASE
that	0
may	I-DISEASE
contribute	0
to	0
hypoventilation	I-DISEASE
or	I-DISEASE
hypoxemia	I-DISEASE
.	B-DISEASE

In	I-DISEASE
the	0
International	0
Classification	I-DISEASE
of	0
Sleep	I-DISEASE
Disorders	I-DISEASE
,	0
2nd	0
Edition	I-DISEASE
,	I-DISEASE
these	I-DISEASE
included	I-DISEASE
lower	0
airway	I-DISEASE
obstruction	0
,	0
pulmonary	I-DISEASE
parenchymal	0
and	0
vascular	I-DISEASE
pathology	I-DISEASE
,	I-DISEASE
and	0
neuromus-	0
cular	0
and	0
chest	0
wall	I-DISEASE
disorders	0
.	0

In	I-DISEASE
the	0
International	0
Classification	I-DISEASE
of	0
Sleep	I-DISEASE
Disorders	I-DISEASE
,	0
3rd	0
Edition	I-DISEASE
,	I-DISEASE
the	0
specific	I-DISEASE
pulmonary	I-DISEASE
or	I-DISEASE
neurological	I-DISEASE
disorder	I-DISEASE
should	0
be	0
diagnosed	0
sep-	I-DISEASE
arately	I-DISEASE
,	I-DISEASE
in	I-DISEASE
association	0
with	I-DISEASE
a	0
diagnosis	0
of	I-DISEASE
sleep	0
related	B-DISEASE
hypoventilation	0
due	I-DISEASE
medical	0
or	I-DISEASE
neurological	0
condition	0
or	0
sleep	0
related	0
hypoxemia	0
.	0

Bibliography	0
Badr	I-DISEASE
MS	I-DISEASE
,	0
Toiber	I-DISEASE
F	0
,	0
Skatrud	I-DISEASE
JB	0
,	I-DISEASE
Dempsey	0
J.	0
Pharyngeal	0
narrowing	0
/	0
occlusion	0
during	I-DISEASE
central	0
sleep	0
apnea	0
.	0

J	I-DISEASE
Appl	0
Physiol	0
1995;78:1806–15	I-DISEASE
.	0

Berry	I-DISEASE
RB	I-DISEASE
,	0
Brooks	0
R	0
,	I-DISEASE
Gamaldo	I-DISEASE
CE	0
,	I-DISEASE
Harding	I-DISEASE
SM	I-DISEASE
,	I-DISEASE
Lloyd	0
RM	I-DISEASE
,	I-DISEASE
Marcus	0
CL	0
and	0
Vaughn	I-DISEASE
BV	0
for	I-DISEASE
the	0
American	I-DISEASE
Academy	0
of	I-DISEASE
Sleep	0
Medicine	B-DISEASE
.	0

The	I-DISEASE
AASM	I-DISEASE
Manual	I-DISEASE
for	0
the	0
Scoring	0
of	I-DISEASE
Sleep	0
and	0
Associated	I-DISEASE
Events	I-DISEASE
:	I-DISEASE
Rules	0
,	I-DISEASE
Terminology	I-DISEASE
and	0
Technical	0
Specifications	I-DISEASE
,	I-DISEASE
Version	0
2.0.3	0
.	0
www.aasmnet.org	0
.	0

Darien	I-DISEASE
,	0
IL	I-DISEASE
:	0
American	0
Academy	0
of	I-DISEASE
Sleep	0
Medicine	0
,	0
2014	0
Tkacova	I-DISEASE
R	I-DISEASE
,	I-DISEASE
Niroumand	0
M	I-DISEASE
,	I-DISEASE
Lorenzi	0
-	0
Filho	0
G	I-DISEASE
,	I-DISEASE
Bradley	I-DISEASE
TD	0
.	0

Overnight	I-DISEASE
shift	0
from	I-DISEASE
obstructive	0
to	0
central	0
apneas	0
in	0
patients	I-DISEASE
with	I-DISEASE
heart	0
failure	0
:	0
role	0
of	I-DISEASE
PCO2	0
and	0
circulatory	0
delay	I-DISEASE
.	0

Circulation	I-DISEASE
2001;103:238–43	0
.	0

Tkacova	0
R	0
,	I-DISEASE
Wang	I-DISEASE
H	I-DISEASE
,	0
Bradley	0
TD	0
.	0

Night	I-DISEASE
-	0
to	0
-	I-DISEASE
night	0
alterations	I-DISEASE
in	0
sleep	0
apnea	0
type	I-DISEASE
in	I-DISEASE
patients	I-DISEASE
with	0
heart	0
failure	I-DISEASE
.	0

J	I-DISEASE
Sleep	0
Res	0
2006;15:321–8	0
.	0

Obstructive	I-DISEASE
Sleep	0
Apnea	0
Disorders	0
Obstructive	I-DISEASE
Sleep	0
Apnea	0
,	0
Adult	0
ICD-9	0
-	I-DISEASE
CM	0
code	0
:	I-DISEASE
327.23	0
ICD-10	I-DISEASE
-	I-DISEASE
CM	I-DISEASE
code	0
:	0
G47.33	0
Alternate	I-DISEASE
Names	I-DISEASE
OSA	0
syndrome	0
,	0
sleep	0
apnea	0
,	I-DISEASE
sleep	0
apnea	0
syndrome	I-DISEASE
,	I-DISEASE
obstructive	0
apnea	0
,	I-DISEASE
sleep	0
disor-	I-DISEASE
dered	0
breathing	0
,	I-DISEASE
obstructive	0
sleep	0
apnea	0
hypopnea	I-DISEASE
syndrome	0
.	0

The	I-DISEASE
term	0
upper	0
airway	0
resistance	I-DISEASE
syndrome	0
(	I-DISEASE
UARS	0
)	0
is	I-DISEASE
subsumed	I-DISEASE
under	I-DISEASE
this	I-DISEASE
diagnosis	0
because	0
the	0
pathophysiology	0
does	0
not	0
significantly	0
differ	I-DISEASE
from	I-DISEASE
that	0
of	I-DISEASE
obstructive	0
sleep	0
apnea	0
.	0

Use	I-DISEASE
of	I-DISEASE
the	0
term	0
Pickwickian	0
syndrome	I-DISEASE
is	0
discouraged	I-DISEASE
because	0
not	0
only	I-DISEASE
has	I-DISEASE
it	0
been	I-DISEASE
applied	I-DISEASE
to	I-DISEASE
those	0
with	0
OSA	I-DISEASE
,	I-DISEASE
but	0
also	0
indiscriminately	I-DISEASE
used	0
to	0
describe	0
persons	0
who	I-DISEASE
are	0
only	0
obese	0
and	0
those	0
with	0
obesity	0
hypoventilation	I-DISEASE
syndrome	0
.	0

Diagnostic	I-DISEASE
Criteria	0
(	I-DISEASE
A	0
and	0
B	0
)	0
or	I-DISEASE
C	I-DISEASE
satisfy	0
the	0
criteria	I-DISEASE
A.	0

The	I-DISEASE
presence	0
of	I-DISEASE
one	I-DISEASE
or	0
more	0
of	I-DISEASE
the	0
following	0
:	0
.	0

The	I-DISEASE
patient	I-DISEASE
complains	0
of	0
sleepiness	0
,	I-DISEASE
nonrestorative	B-DISEASE
sleep	I-DISEASE
,	I-DISEASE
fatigue	I-DISEASE
,	I-DISEASE
or	I-DISEASE
insomnia	I-DISEASE
symptoms	I-DISEASE
.	0
.	0

The	I-DISEASE
patient	I-DISEASE
wakes	I-DISEASE
with	I-DISEASE
breath	0
holding	I-DISEASE
,	I-DISEASE
gasping	I-DISEASE
,	0
or	0
choking	0
.	0
.	I-DISEASE

The	I-DISEASE
bed	I-DISEASE
partner	0
or	I-DISEASE
other	0
observer	0
reports	I-DISEASE
habitual	I-DISEASE
snoring	0
,	I-DISEASE
breathing	I-DISEASE
interruptions	I-DISEASE
,	I-DISEASE
or	I-DISEASE
both	0
during	I-DISEASE
the	0
patient	I-DISEASE
’s	I-DISEASE
sleep	0
.	I-DISEASE
.	0

The	I-DISEASE
patient	I-DISEASE
has	0
been	I-DISEASE
diagnosed	0
with	I-DISEASE
hypertension	I-DISEASE
,	0
a	0
mood	I-DISEASE
disorder	I-DISEASE
,	0
cognitive	0
dysfunction	0
,	0
coronary	0
artery	0
disease	0
,	I-DISEASE
stroke	0
,	I-DISEASE
congestive	0
heart	0
failure	0
,	0
atrial	I-DISEASE
fibrillation	I-DISEASE
,	0
or	0
type	0
2	0
diabetes	I-DISEASE
mellitus	0
.	0

B.	0
Polysomnography	0
(	I-DISEASE
PSG	0
)	0
or	I-DISEASE
OCST1	I-DISEASE
demonstrates	I-DISEASE
:	I-DISEASE
.	0

Five	I-DISEASE
or	I-DISEASE
more	0
predominantly	I-DISEASE
obstructive	0
respiratory	B-DISEASE
events2	0
(	I-DISEASE
obstructive	I-DISEASE
and	0
mixed	I-DISEASE
apneas	0
,	0
hypopneas	I-DISEASE
,	I-DISEASE
or	I-DISEASE
respiratory	I-DISEASE
effort	I-DISEASE
related	0
arousals	0
[	0
RERAs])3	0
per	0
hour	0
of	I-DISEASE
sleep	0
during	I-DISEASE
a	0
PSG	0
or	0
per	0
hour	0
of	I-DISEASE
monitoring	0
(	I-DISEASE
OCST).1	I-DISEASE
OR	0
C.	I-DISEASE
PSG	0
or	0
OCST1	I-DISEASE
demonstrates	I-DISEASE
:	I-DISEASE
.	0

Fifteen	I-DISEASE
or	I-DISEASE
more	0
predominantly	I-DISEASE
obstructive	0
respiratory	B-DISEASE
events	0
(	I-DISEASE
apneas	0
,	I-DISEASE
hypopneas	I-DISEASE
,	0
or	0
RERAs)3	0
per	I-DISEASE
hour	I-DISEASE
of	I-DISEASE
sleep	I-DISEASE
during	I-DISEASE
a	0
PSG	0
or	I-DISEASE
per	0
hour	I-DISEASE
of	I-DISEASE
monitoring	0
(	I-DISEASE
OCST).1	0
Sleep	0
Related	0
Breathing	0
Disorders	I-DISEASE
Sleep	0
Related	0
Breathing	0
Disorders	I-DISEASE
Notes	0
.	0

OCST	I-DISEASE
commonly	I-DISEASE
underestimates	0
the	0
number	0
of	I-DISEASE
obstructive	0
respiratory	I-DISEASE
events	0
per	I-DISEASE
hour	0
as	0
compared	I-DISEASE
to	0
PSG	0
because	0
actual	I-DISEASE
sleep	0
time	I-DISEASE
,	I-DISEASE
as	I-DISEASE
determined	I-DISEASE
primarily	I-DISEASE
by	I-DISEASE
EEG	0
,	I-DISEASE
is	0
often	0
not	0
recorded	0
.	0

The	I-DISEASE
term	0
respiratory	I-DISEASE
event	I-DISEASE
index	0
(	I-DISEASE
REI	I-DISEASE
)	0
may	0
be	I-DISEASE
used	0
to	I-DISEASE
denote	I-DISEASE
event	0
frequency	I-DISEASE
based	I-DISEASE
on	0
monitoring	0
time	0
rather	0
than	I-DISEASE
total	I-DISEASE
sleep	0
time	0
.	I-DISEASE
.	0

Respiratory	I-DISEASE
events	0
defined	I-DISEASE
according	I-DISEASE
the	I-DISEASE
most	0
recent	I-DISEASE
version	I-DISEASE
of	I-DISEASE
the	I-DISEASE
AASM	I-DISEASE
Manual	I-DISEASE
for	I-DISEASE
the	I-DISEASE
Scoring	0
of	I-DISEASE
Sleep	0
and	0
Associated	I-DISEASE
Events	I-DISEASE
.	I-DISEASE
.	0

RERAs	I-DISEASE
and	0
hypopnea	0
events	0
based	B-DISEASE
on	0
arousals	0
from	I-DISEASE
sleep	0
can	0
not	0
be	I-DISEASE
scored	I-DISEASE
using	0
OCST	I-DISEASE
because	0
arousals	0
by	B-DISEASE
EEG	I-DISEASE
criteria	I-DISEASE
can	I-DISEASE
not	0
be	0
identified	I-DISEASE
.	0

Essential	I-DISEASE
Features	I-DISEASE
OSA	0
is	0
characterized	0
by	I-DISEASE
repetitive	I-DISEASE
episodes	I-DISEASE
of	I-DISEASE
complete	0
(	I-DISEASE
apnea	I-DISEASE
)	0
or	I-DISEASE
partial	I-DISEASE
(	0
hypopnea	0
)	0
upper	0
airway	I-DISEASE
obstruction	0
occurring	I-DISEASE
during	I-DISEASE
sleep	0
.	0

These	0
events	0
often	0
result	0
in	0
reduc-	I-DISEASE
tions	0
in	I-DISEASE
blood	I-DISEASE
oxygen	I-DISEASE
saturation	I-DISEASE
and	0
are	I-DISEASE
usually	I-DISEASE
terminated	0
by	0
brief	I-DISEASE
arousals	0
from	0
sleep	0
.	0

By	0
definition	0
,	0
apneic	0
and	0
hypopneic	0
events	0
last	0
a	0
minimum	I-DISEASE
of	I-DISEASE
10	0
seconds	0
.	0

Most	I-DISEASE
events	0
are	0
10	0
to	0
30	I-DISEASE
seconds	0
in	I-DISEASE
duration	0
but	0
occasionally	0
persist	I-DISEASE
for	I-DISEASE
one	0
minute	0
or	I-DISEASE
longer	I-DISEASE
.	0

Events	I-DISEASE
can	I-DISEASE
occur	0
in	I-DISEASE
any	I-DISEASE
stage	I-DISEASE
of	I-DISEASE
sleep	I-DISEASE
but	0
more	0
frequently	I-DISEASE
occur	I-DISEASE
in	I-DISEASE
stages	I-DISEASE
N1	0
,	I-DISEASE
N2	0
,	0
and	0
R	0
sleep	0
than	0
in	I-DISEASE
stage	I-DISEASE
N3	0
sleep	0
.	0

Events	I-DISEASE
are	0
usually	I-DISEASE
longer	I-DISEASE
and	0
associated	0
with	I-DISEASE
more	0
severe	0
decreases	0
in	I-DISEASE
oxygen	I-DISEASE
saturation	I-DISEASE
when	0
they	I-DISEASE
occur	I-DISEASE
in	I-DISEASE
stage	0
R	0
sleep	0
and	0
when	0
the	0
individual	I-DISEASE
is	I-DISEASE
sleeping	0
supine	I-DISEASE
.	0

Oxygen	I-DISEASE
saturation	0
usually	I-DISEASE
returns	0
to	I-DISEASE
baseline	0
values	I-DISEASE
following	0
resumption	I-DISEASE
of	0
normal	0
breathing	B-DISEASE
but	I-DISEASE
may	0
remain	0
low	0
if	0
the	0
apneic	0
or	I-DISEASE
hypopneic	0
events	0
are	0
very	I-DISEASE
frequent	0
and	0
prolonged	0
,	0
or	0
if	0
there	0
is	0
underlying	0
pulmonary	I-DISEASE
pathology	I-DISEASE
.	0

Snoring	I-DISEASE
between	0
apneas	0
is	0
typically	0
reported	0
by	I-DISEASE
bed	I-DISEASE
partners	I-DISEASE
,	0
as	0
are	I-DISEASE
wit-	I-DISEASE
nessed	0
episodes	I-DISEASE
of	I-DISEASE
gasping	0
or	0
choking	0
and	0
body	I-DISEASE
movements	0
that	0
disrupt	I-DISEASE
sleep	0
.	0

Most	I-DISEASE
patients	I-DISEASE
awaken	0
in	0
the	I-DISEASE
morning	0
feeling	I-DISEASE
tired	0
and	0
unrefreshed	I-DISEASE
regardless	0
of	I-DISEASE
the	I-DISEASE
duration	0
of	0
their	I-DISEASE
time	0
in	I-DISEASE
bed	I-DISEASE
.	0

Apneas	I-DISEASE
,	0
hypopneas	I-DISEASE
,	0
and	0
snoring	I-DISEASE
may	0
be	I-DISEASE
exacerbated	I-DISEASE
following	0
the	0
ingestion	0
of	0
alcohol	I-DISEASE
,	0
use	I-DISEASE
of	I-DISEASE
sedating	I-DISEASE
medications	0
prior	0
to	I-DISEASE
sleep	0
,	0
or	I-DISEASE
following	0
an	0
increase	I-DISEASE
in	0
body	0
weight	0
.	0

Excessive	I-DISEASE
sleepiness	0
is	0
a	0
major	I-DISEASE
presenting	0
complaint	0
in	I-DISEASE
many	0
but	I-DISEASE
not	0
all	0
cases	0
.	0

The	I-DISEASE
sleepiness	0
is	0
most	0
evident	I-DISEASE
during	I-DISEASE
relaxing	I-DISEASE
or	0
inactive	0
situations	I-DISEASE
.	0

With	I-DISEASE
extreme	I-DISEASE
sleepi-	0
ness	0
,	I-DISEASE
sleep	0
may	0
occur	I-DISEASE
while	0
actively	I-DISEASE
conversing	I-DISEASE
,	I-DISEASE
eating	I-DISEASE
,	I-DISEASE
walking	0
,	0
or	I-DISEASE
driving	0
.	0

In	I-DISEASE
women	0
,	0
excessive	0
sleepiness	0
is	0
a	I-DISEASE
less	I-DISEASE
prominent	0
complaint	0
.	0

Additionally	I-DISEASE
,	I-DISEASE
reports	0
of	I-DISEASE
insomnia	0
,	I-DISEASE
poor	0
sleep	0
quality	0
,	I-DISEASE
and	0
fatigue	I-DISEASE
are	0
common	I-DISEASE
,	I-DISEASE
particularly	I-DISEASE
among	0
women	0
.	0

Quality	I-DISEASE
of	I-DISEASE
life	0
generally	I-DISEASE
is	0
adversely	I-DISEASE
affected	I-DISEASE
by	0
unrefreshing	0
sleep	I-DISEASE
,	0
sleepiness	0
,	I-DISEASE
and	0
fatigue	I-DISEASE
.	0

Bed	I-DISEASE
part-	I-DISEASE
ners	0
may	I-DISEASE
also	0
report	0
sleep	0
disruption	0
and	0
associated	0
consequences	I-DISEASE
.	0

The	I-DISEASE
frequency	I-DISEASE
of	I-DISEASE
apneas	I-DISEASE
and	0
hypopneas	0
during	I-DISEASE
sleep	0
correlates	0
poorly	0
with	0
daytime	I-DISEASE
symptom	0
severity	I-DISEASE
and	0
impact	I-DISEASE
on	0
quality	0
of	I-DISEASE
life	0
.	0

In	I-DISEASE
some	I-DISEASE
cases	0
,	I-DISEASE
affected	0
individuals	I-DISEASE
will	0
not	0
endorse	0
any	I-DISEASE
symptoms	I-DISEASE
or	I-DISEASE
confirm	I-DISEASE
any	I-DISEASE
bed	I-DISEASE
partner	0
observations	0
.	0

Associated	I-DISEASE
Features	I-DISEASE
Systemic	0
hypertension	0
is	0
a	0
common	I-DISEASE
finding	I-DISEASE
in	I-DISEASE
patients	I-DISEASE
with	0
OSA	0
.	0

There	I-DISEASE
is	I-DISEASE
substan-	0
tial	0
clinical	I-DISEASE
and	0
epidemiologic	0
evidence	0
implicating	0
OSA	0
as	0
a	0
significant	0
risk	0
factor	I-DISEASE
for	0
development	I-DISEASE
of	I-DISEASE
systemic	0
hypertension	I-DISEASE
independent	I-DISEASE
of	I-DISEASE
other	0
conditions	0
such	0
as	0
obesity	0
and	0
smoking	0
.	0

Additionally	I-DISEASE
,	I-DISEASE
OSA	0
is	0
frequently	I-DISEASE
observed	I-DISEASE
in	I-DISEASE
patients	0
with	0
cor-	0
onary	0
artery	0
disease	B-DISEASE
,	I-DISEASE
atrial	0
fibrillation	I-DISEASE
,	I-DISEASE
and	0
stroke	0
,	I-DISEASE
and	0
it	I-DISEASE
may	I-DISEASE
be	I-DISEASE
an	0
independent	I-DISEASE
risk	0
factor	I-DISEASE
for	0
these	0
conditions	I-DISEASE
.	0

OSA	I-DISEASE
is	0
also	0
associated	0
with	I-DISEASE
type	I-DISEASE
2	I-DISEASE
diabetes	I-DISEASE
,	0
and	0
there	I-DISEASE
are	I-DISEASE
accumulating	I-DISEASE
data	I-DISEASE
to	0
suggest	0
that	0
it	0
is	I-DISEASE
a	0
risk	0
factor	I-DISEASE
for	0
the	I-DISEASE
development	0
of	I-DISEASE
type	I-DISEASE
2	I-DISEASE
diabetes	I-DISEASE
.	0

Patients	I-DISEASE
with	0
severe	I-DISEASE
disease	0
may	I-DISEASE
be	I-DISEASE
at	I-DISEASE
risk	0
for	0
developing	0
pulmo-	0
nary	0
hypertension	I-DISEASE
and	0
cor	0
pulmonale	0
,	I-DISEASE
although	0
this	0
is	0
usually	I-DISEASE
seen	I-DISEASE
only	I-DISEASE
in	I-DISEASE
patients	0
with	0
daytime	I-DISEASE
hypercapnia	0
due	0
to	0
comorbid	I-DISEASE
conditions	I-DISEASE
such	0
as	0
morbid	0
obesity	0
or	I-DISEASE
chronic	I-DISEASE
obstructive	0
pulmonary	I-DISEASE
disease	B-DISEASE
(	I-DISEASE
COPD	I-DISEASE
)	0
.	0

When	I-DISEASE
OSA	I-DISEASE
coexists	I-DISEASE
with	I-DISEASE
dilated	I-DISEASE
cardiomyopathy	0
or	0
ischemic	I-DISEASE
heart	0
disease	0
,	I-DISEASE
there	I-DISEASE
may	0
be	0
worsening	0
of	0
the	I-DISEASE
underly-	0
ing	0
heart	0
disease	B-DISEASE
and	0
predisposition	0
to	0
congestive	0
heart	0
failure	0
.	0

Gastroesophageal	I-DISEASE
reflux	I-DISEASE
symptoms	I-DISEASE
,	I-DISEASE
nocturia	0
,	0
mood	0
disturbance	I-DISEASE
,	I-DISEASE
and	0
erectile	0
dysfunction	0
are	I-DISEASE
some-	I-DISEASE
times	I-DISEASE
reported	0
in	I-DISEASE
patients	I-DISEASE
with	I-DISEASE
OSA	I-DISEASE
.	0

The	I-DISEASE
disorder	I-DISEASE
can	0
also	0
be	0
associated	0
with	I-DISEASE
the	B-DISEASE
following	0
motor	0
parasomnias	I-DISEASE
:	0
OSA	I-DISEASE
-	0
induced	0
arousals	0
from	I-DISEASE
non	0
-	0
rapid	I-DISEASE
eye	0
movement	I-DISEASE
(	0
NREM	0
)	0
sleep	0
mimicking	I-DISEASE
a	0
primary	0
disorder	0
of	I-DISEASE
arousal	0
(	I-DISEASE
confusional	0
arousal	0
,	0
sleep-	I-DISEASE
walking	I-DISEASE
,	0
or	0
sleep	0
terrors	0
)	0
;	0
OSA	I-DISEASE
-	0
induced	0
arousals	0
from	I-DISEASE
REM	I-DISEASE
sleep	0
mimicking	I-DISEASE
REM	I-DISEASE
sleep	0
behavior	I-DISEASE
disorder	0
;	I-DISEASE
disorders	0
of	I-DISEASE
arousal	0
from	I-DISEASE
NREM	0
associated	0
with	0
slow	0
wave	B-DISEASE
sleep	0
rebound	0
during	I-DISEASE
initiation	I-DISEASE
of	I-DISEASE
nasal	0
continuous	0
positive	0
airway	0
pressure	0
(	I-DISEASE
CPAP	I-DISEASE
)	0
therapy	0
of	I-DISEASE
OSA	0
;	0
OSA	0
-	0
induced	0
arousals	I-DISEASE
linked	0
with	0
sleep	0
related	B-DISEASE
eating	I-DISEASE
disorder	0
;	0
and	0
OSA	0
-	0
induced	0
nocturnal	0
seizures	0
or	I-DISEASE
cerebral	0
anoxic	0
attacks	0
with	0
prominent	0
motor	I-DISEASE
activity	0
.	0

Severity	I-DISEASE
of	I-DISEASE
OSA	0
as	0
determined	I-DISEASE
by	0
the	0
frequency	I-DISEASE
of	I-DISEASE
apneas	I-DISEASE
and	0
hypopneas	I-DISEASE
and/or	0
degree	I-DISEASE
of	0
oxygen	I-DISEASE
desaturation	I-DISEASE
correlates	B-DISEASE
poorly	0
with	0
symptomatic	0
sleepiness	0
.	0

Different	I-DISEASE
measures	0
of	I-DISEASE
sleepiness	0
,	I-DISEASE
including	0
self	0
-	0
reported	0
severity	0
of	I-DISEASE
sleepiness	I-DISEASE
,	0
commonly	I-DISEASE
used	0
indices	I-DISEASE
such	0
as	0
the	0
Epworth	0
Sleepiness	I-DISEASE
Scale	I-DISEASE
,	I-DISEASE
and	0
objective	I-DISEASE
measures	0
such	0
as	0
the	0
Multiple	0
Sleep	0
Latency	0
Test	0
(	0
MSLT	I-DISEASE
)	0
,	I-DISEASE
are	0
not	0
strongly	I-DISEASE
correlated	I-DISEASE
and	0
,	0
thus	0
,	0
assessment	I-DISEASE
of	I-DISEASE
sleepiness	0
can	0
be	0
difficult	0
and	0
relatively	0
unreliable	I-DISEASE
.	I-DISEASE

In	I-DISEASE
addition	0
,	0
patients	I-DISEASE
may	0
adapt	I-DISEASE
to	I-DISEASE
any	I-DISEASE
level	0
of	I-DISEASE
sleepiness	0
over	I-DISEASE
time	I-DISEASE
and	0
fail	I-DISEASE
to	I-DISEASE
view	I-DISEASE
it	0
as	0
a	0
reportable	0
problem	0
.	0

Bed	I-DISEASE
partner	0
-	0
observed	I-DISEASE
breathing	0
pauses	I-DISEASE
and	0
disruptive	I-DISEASE
snoring	0
may	I-DISEASE
not	I-DISEASE
always	0
be	I-DISEASE
accompa-	I-DISEASE
nied	0
by	I-DISEASE
patient	I-DISEASE
complaints	0
of	0
sleepiness	0
.	0

Finally	I-DISEASE
,	0
it	0
is	0
important	0
to	0
note	0
that	0
sleepiness	0
is	0
a	0
condition	I-DISEASE
with	I-DISEASE
a	0
number	0
of	I-DISEASE
possible	0
etiologies	0
and	0
a	0
range	0
of	I-DISEASE
manifestations	0
(	I-DISEASE
see	0
Differential	I-DISEASE
Diagnosis	I-DISEASE
)	0
.	0

Sleep	I-DISEASE
Related	0
Breathing	0
Disorders	I-DISEASE
Sleep	0
Related	0
Breathing	0
Disorders	I-DISEASE
Clinical	0
and	0
Pathophysiological	I-DISEASE
Subtypes	I-DISEASE
Apneas	0
and	0
hypopneas	I-DISEASE
are	0
believed	I-DISEASE
to	0
have	0
similar	0
pathophysiology	0
and	0
consequences	I-DISEASE
.	0

Therefore	I-DISEASE
,	I-DISEASE
from	0
a	I-DISEASE
clinical	0
perspective	I-DISEASE
,	I-DISEASE
there	I-DISEASE
is	0
little	0
importance	0
in	I-DISEASE
distinguishing	I-DISEASE
patients	I-DISEASE
who	0
have	0
predominantly	I-DISEASE
apnea	I-DISEASE
from	I-DISEASE
those	0
who	I-DISEASE
have	0
predominantly	I-DISEASE
hypopnea	I-DISEASE
.	0

Occasionally	0
,	I-DISEASE
patients	0
may	I-DISEASE
demonstrate	0
only	I-DISEASE
REM	I-DISEASE
-	0
related	0
apneas	0
or	0
hypopneas	0
,	0
but	0
there	I-DISEASE
is	0
no	0
consensus	0
to	0
suggest	I-DISEASE
that	0
this	0
is	0
a	0
distinct	0
clinical	0
or	0
pathophysiological	0
subtype	0
.	0

Some	I-DISEASE
patients	0
have	0
relatively	0
few	0
arterial	I-DISEASE
oxygen	I-DISEASE
desaturations	0
but	I-DISEASE
a	0
significant	0
number	0
of	I-DISEASE
respiratory	I-DISEASE
events	0
characterized	0
by	I-DISEASE
narrowing	I-DISEASE
of	I-DISEASE
the	0
upper	0
airway	I-DISEASE
result-	0
ing	0
in	I-DISEASE
brief	I-DISEASE
arousals	0
from	I-DISEASE
sleep	0
.	0

Depending	I-DISEASE
on	0
the	0
definition	0
of	0
hypopnea	I-DISEASE
employed	0
,	0
these	I-DISEASE
events	I-DISEASE
typically	I-DISEASE
meet	0
criteria	0
for	I-DISEASE
either	I-DISEASE
hypopneas	0
associated	0
with	I-DISEASE
arousal	0
but	0
no	0
desaturation	I-DISEASE
,	I-DISEASE
or	0
for	0
RERAs	I-DISEASE
.	0

When	I-DISEASE
initially	I-DISEASE
described	0
,	I-DISEASE
this	0
latter	0
group	I-DISEASE
was	0
said	0
to	0
have	0
UARS	I-DISEASE
.	0

Current	0
data	I-DISEASE
suggest	0
that	I-DISEASE
this	0
condition	I-DISEASE
represents	I-DISEASE
simply	0
a	0
variant	0
of	I-DISEASE
OSA	I-DISEASE
in	I-DISEASE
which	0
obstructive	0
events	0
result	0
in	I-DISEASE
arousal	0
but	I-DISEASE
minimal	I-DISEASE
arterial	I-DISEASE
oxygen	I-DISEASE
desaturation	I-DISEASE
.	B-DISEASE

Patients	I-DISEASE
with	0
this	I-DISEASE
condition	0
commonly	I-DISEASE
snore	0
and	0
report	0
daytime	I-DISEASE
sleepiness	I-DISEASE
or	0
fatigue	I-DISEASE
.	0

However	I-DISEASE
,	I-DISEASE
there	I-DISEASE
are	I-DISEASE
some	0
reports	I-DISEASE
of	I-DISEASE
patients	I-DISEASE
with	0
frequent	0
respiratory	I-DISEASE
arousals	0
in	I-DISEASE
the	0
absence	I-DISEASE
of	I-DISEASE
snoring	I-DISEASE
.	0

They	I-DISEASE
tend	B-DISEASE
to	0
be	I-DISEASE
less	I-DISEASE
obese	0
than	0
individuals	I-DISEASE
who	I-DISEASE
have	I-DISEASE
respiratory	I-DISEASE
event	I-DISEASE
-	0
associated	0
arterial	I-DISEASE
oxygen	0
saturation	0
.	0

The	I-DISEASE
prevalence	0
of	I-DISEASE
this	I-DISEASE
group	I-DISEASE
of	I-DISEASE
patients	I-DISEASE
is	I-DISEASE
unknown	I-DISEASE
.	0

When	I-DISEASE
advanced	I-DISEASE
technology	0
is	I-DISEASE
used	0
to	I-DISEASE
detect	I-DISEASE
changes	I-DISEASE
in	0
airflow	0
(	I-DISEASE
as	I-DISEASE
described	I-DISEASE
in	0
the	0
AASM	I-DISEASE
Manual	0
for	0
the	0
Scoring	0
of	I-DISEASE
Sleep	0
and	0
Associated	0
Events	I-DISEASE
)	0
,	I-DISEASE
most	I-DISEASE
of	I-DISEASE
these	I-DISEASE
patients	I-DISEASE
will	0
be	0
diagnosed	0
as	0
having	I-DISEASE
OSA	0
,	I-DISEASE
as	0
defined	I-DISEASE
by	I-DISEASE
the	0
criteria	I-DISEASE
listed	I-DISEASE
above	0
.	0

COPD	I-DISEASE
and	0
OSA	I-DISEASE
frequently	I-DISEASE
coexist	0
,	0
but	0
there	I-DISEASE
is	I-DISEASE
no	I-DISEASE
common	I-DISEASE
pathophysiologic	I-DISEASE
rela-	0
tionship	0
.	0

Nevertheless	I-DISEASE
,	0
individuals	I-DISEASE
with	I-DISEASE
both	0
disorders	0
have	0
greater	I-DISEASE
nocturnal	0
oxygen	0
desaturation	I-DISEASE
and	0
daytime	0
hypercapnia	0
for	0
the	0
same	0
degree	I-DISEASE
of	I-DISEASE
bronchial	0
airflow	0
obstruc-	0
tion	0
,	0
and	0
greater	I-DISEASE
risk	0
of	0
developing	0
pulmonary	I-DISEASE
hypertension	0
and	0
right	0
heart	0
failure	0
.	0

The	I-DISEASE
prevalence	0
rate	0
for	I-DISEASE
having	0
both	I-DISEASE
conditions	I-DISEASE
has	I-DISEASE
been	I-DISEASE
estimated	0
to	0
be	I-DISEASE
1	I-DISEASE
%	0
.	0

Demographics	I-DISEASE
OSA	0
can	0
occur	I-DISEASE
in	0
any	I-DISEASE
age	I-DISEASE
group	I-DISEASE
.	I-DISEASE

Estimates	I-DISEASE
of	0
prevalence	I-DISEASE
are	0
very	I-DISEASE
dependent	0
on	0
how	0
sleep	0
related	I-DISEASE
respiratory	I-DISEASE
events	0
are	0
defined	I-DISEASE
,	I-DISEASE
as	0
well	0
as	0
their	0
frequency	I-DISEASE
and	0
other	0
criteria	I-DISEASE
used	0
to	I-DISEASE
define	0
disease	I-DISEASE
.	0

Nevertheless	I-DISEASE
,	I-DISEASE
general	0
population	0
-	0
based	I-DISEASE
studies	I-DISEASE
from	I-DISEASE
a	0
number	0
of	I-DISEASE
countries	I-DISEASE
indicate	I-DISEASE
that	0
OSA	0
associated	0
with	I-DISEASE
daytime	0
sleepiness	0
occurs	0
in	I-DISEASE
3	I-DISEASE
%	0
to	I-DISEASE
7	0
%	0
of	I-DISEASE
adult	0
men	I-DISEASE
and	0
2	0
%	0
to	I-DISEASE
5	0
%	0
of	I-DISEASE
adult	0
women	0
.	0

However	I-DISEASE
,	I-DISEASE
because	0
many	0
individuals	I-DISEASE
with	I-DISEASE
OSA	I-DISEASE
do	0
not	0
endorse	0
daytime	I-DISEASE
sleepiness	0
,	I-DISEASE
the	0
prevalence	I-DISEASE
of	0
the	0
disease	I-DISEASE
is	0
likely	I-DISEASE
much	I-DISEASE
higher	0
.	0

A	0
major	I-DISEASE
study	0
yielded	I-DISEASE
prevalence	0
rates	I-DISEASE
as	0
high	I-DISEASE
as	0
24	0
%	0
in	I-DISEASE
men	I-DISEASE
and	0
9	0
%	0
in	I-DISEASE
women	I-DISEASE
using	0
only	0
an	0
apnea	0
-	0
hypopnea	I-DISEASE
index	I-DISEASE
(	I-DISEASE
AHI	0
)	0
criterion	0
of	I-DISEASE
≥	0
5	0
/	0
hour	0
,	0
although	0
addition	0
of	I-DISEASE
a	0
daytime	I-DISEASE
sleepiness	0
criterion	0
reduced	0
these	0
estimates	0
to	0
4	0
%	0
in	I-DISEASE
males	I-DISEASE
and	0
2	0
%	0
in	0
females	0
.	I-DISEASE

The	I-DISEASE
prevalence	0
of	I-DISEASE
OSA	I-DISEASE
increases	0
with	I-DISEASE
age	I-DISEASE
,	0
although	0
it	0
appears	I-DISEASE
to	I-DISEASE
plateau	I-DISEASE
in	0
the	0
elderly	I-DISEASE
.	I-DISEASE

The	I-DISEASE
ratio	I-DISEASE
of	I-DISEASE
OSA	I-DISEASE
in	I-DISEASE
men	0
compared	I-DISEASE
to	0
women	0
is	0
approximately	I-DISEASE
two	I-DISEASE
to	I-DISEASE
one	0
.	0

This	I-DISEASE
dispar-	I-DISEASE
ity	I-DISEASE
may	I-DISEASE
decline	0
in	0
middle	I-DISEASE
to	I-DISEASE
older	I-DISEASE
age	I-DISEASE
as	0
a	0
result	0
of	I-DISEASE
a	0
greater	I-DISEASE
risk	0
for	0
OSA	0
in	I-DISEASE
women	I-DISEASE
after	0
menopause	I-DISEASE
.	B-DISEASE

OSA	I-DISEASE
occurs	0
in	I-DISEASE
all	0
racial	I-DISEASE
and	0
ethnic	I-DISEASE
groups	0
.	0

In	I-DISEASE
younger	I-DISEASE
and	0
elderly	I-DISEASE
groups	0
,	I-DISEASE
but	I-DISEASE
not	I-DISEASE
in	0
middle	0
-	I-DISEASE
aged	I-DISEASE
groups	I-DISEASE
,	I-DISEASE
OSA	I-DISEASE
has	I-DISEASE
been	I-DISEASE
reported	0
to	0
be	I-DISEASE
more	0
prevalent	I-DISEASE
in	I-DISEASE
blacks	I-DISEASE
than	I-DISEASE
whites	0
.	I-DISEASE

The	I-DISEASE
prevalence	0
of	I-DISEASE
OSA	I-DISEASE
in	I-DISEASE
Asian	0
patients	I-DISEASE
is	0
comparable	0
to	0
that	0
of	I-DISEASE
whites	0
,	0
despite	0
having	I-DISEASE
a	I-DISEASE
generally	0
lower	0
body	I-DISEASE
mass	0
index	I-DISEASE
(	I-DISEASE
BMI	0
)	0
.	0

Differences	I-DISEASE
in	I-DISEASE
craniofacial	0
features	0
that	0
predispose	I-DISEASE
Asians	0
to	I-DISEASE
developing	I-DISEASE
OSA	0
are	I-DISEASE
the	0
likely	I-DISEASE
explanation	I-DISEASE
.	0

Data	I-DISEASE
comparing	0
OSA	0
prevalence	0
rates	I-DISEASE
among	0
Hispanics	I-DISEASE
and	0
Native	0
Americans	I-DISEASE
to	I-DISEASE
other	I-DISEASE
racial	0
/	0
ethnic	I-DISEASE
groups	I-DISEASE
are	0
sparse	0
,	0
although	0
it	0
is	0
clear	I-DISEASE
that	0
OSA	0
occurs	0
commonly	I-DISEASE
in	I-DISEASE
these	B-DISEASE
groups	0
.	0

Predisposing	I-DISEASE
and	0
Precipitating	0
Factors	0

The	I-DISEASE
major	I-DISEASE
predisposing	0
factor	I-DISEASE
for	I-DISEASE
OSA	0
is	0
excess	0
body	I-DISEASE
weight	0
.	0

It	I-DISEASE
has	0
been	I-DISEASE
estimated	0
that	0
~60	0
%	0
of	I-DISEASE
moderate	I-DISEASE
to	0
severe	I-DISEASE
OSA	I-DISEASE
is	0
attributable	I-DISEASE
to	0
obesity	0
.	0

The	I-DISEASE
risk	0
of	I-DISEASE
OSA	I-DISEASE
increases	0
as	I-DISEASE
the	I-DISEASE
degree	I-DISEASE
of	I-DISEASE
additional	0
weight	0
increases	I-DISEASE
,	I-DISEASE
with	0
an	0
extremely	I-DISEASE
high	I-DISEASE
preva-	0
lence	0
of	I-DISEASE
OSA	I-DISEASE
in	0
people	0
with	0
morbid	I-DISEASE
obesity	0
.	0

OSA	I-DISEASE
patients	0
with	I-DISEASE
normal	0
or	I-DISEASE
below	I-DISEASE
-	0
nor-	0
mal	0
body	I-DISEASE
weight	0
are	0
more	0
likely	I-DISEASE
to	I-DISEASE
have	0
upper	0
airway	0
obstruction	0
due	I-DISEASE
to	0
a	I-DISEASE
localized	0
structural	I-DISEASE
abnormality	I-DISEASE
such	0
as	0
a	0
maxillomandibular	0
malformation	0
or	I-DISEASE
adenotonsillar	I-DISEASE
enlargement	0
.	0

Increasing	I-DISEASE
neck	I-DISEASE
circumference	0
predicts	0
higher	0
AHIs	0
;	I-DISEASE
it	I-DISEASE
is	I-DISEASE
not	0
,	0
however	I-DISEASE
,	0
independent	I-DISEASE
of	I-DISEASE
BMI	0
.	0

Instability	I-DISEASE
in	I-DISEASE
ventilatory	0
control	I-DISEASE
appears	0
to	0
increase	I-DISEASE
risk	0
of	I-DISEASE
OSA	I-DISEASE
.	0

Those	I-DISEASE
patients	0
with	0
an	0
exaggerated	0
ventilatory	0
response	0
to	0
a	0
respiratory	I-DISEASE
disturbance	I-DISEASE
have	I-DISEASE
a	0
greater	I-DISEASE
propensity	I-DISEASE
for	0
obstructive	0
events	0
.	0

Menopause	I-DISEASE
is	0
a	0
risk	0
factor	I-DISEASE
for	0
this	0
disorder	0
in	I-DISEASE
women	I-DISEASE
,	I-DISEASE
even	I-DISEASE
after	0
adjustment	0
for	I-DISEASE
age	0
and	0
BMI	0
.	0

However	I-DISEASE
,	I-DISEASE
use	0
of	I-DISEASE
hormone	0
replacement	I-DISEASE
therapy	I-DISEASE
may	I-DISEASE
be	0
protective	0
.	0

There	I-DISEASE
are	0
conflicting	0
data	I-DISEASE
concerning	0
smoking	0
as	0
a	I-DISEASE
risk	0
factor	0
for	0
OSA	I-DISEASE
.	0

Various	I-DISEASE
abnormalities	I-DISEASE
of	I-DISEASE
the	0
bony	I-DISEASE
and	0
soft	I-DISEASE
tissue	I-DISEASE
structures	0
of	I-DISEASE
the	0
head	I-DISEASE
and	0
neck	0
may	I-DISEASE
predispose	I-DISEASE
the	0
individual	I-DISEASE
to	I-DISEASE
having	I-DISEASE
OSA	I-DISEASE
.	I-DISEASE

These	0
may	I-DISEASE
be	0
hereditary	0
(	0
e.g.	0
,	0
mandibular	0
size	0
,	I-DISEASE
mandibular	I-DISEASE
position	0
,	0
palatal	0
height	I-DISEASE
)	0
or	I-DISEASE
acquired	0
(	I-DISEASE
e.g.	0
,	I-DISEASE
enlarged	0
adenoids	0
and	0
tonsils	0
)	0
.	0

Endocrine	I-DISEASE
disorders	0
such	0
as	0
acromegaly	0
and	0
hypothy-	I-DISEASE
roidism	I-DISEASE
are	I-DISEASE
risk	0
factors	0
for	I-DISEASE
OSA	I-DISEASE
.	0

Adults	I-DISEASE
and	0
children	0
with	I-DISEASE
Down	0
syndrome	I-DISEASE
also	0
have	I-DISEASE
a	0
high	0
prevalence	0
of	I-DISEASE
OSA	I-DISEASE
.	0

OSA	I-DISEASE
is	0
common	I-DISEASE
in	0
patients	I-DISEASE
with	I-DISEASE
some	I-DISEASE
neurologic	0
disorders	I-DISEASE
that	0
affect	0
peripheral	I-DISEASE
muscles	0
,	I-DISEASE
such	0
as	0
myotonic	0
dystrophy	0
.	0

OSA	I-DISEASE
is	0
likely	I-DISEASE
made	0
worse	0
following	0
alcohol	I-DISEASE
consumption	I-DISEASE
or	0
use	0
of	I-DISEASE
sedating	I-DISEASE
medications	0
before	I-DISEASE
sleep	0
and	0
by	0
nocturnal	0
nasal	0
restriction	0
or	0
congestion	0
due	I-DISEASE
to	0
abnormal	I-DISEASE
morphology	0
,	I-DISEASE
rhinitis	0
,	0
or	I-DISEASE
both	I-DISEASE
.	0

Familial	I-DISEASE
Patterns	I-DISEASE
OSA	I-DISEASE
is	0
a	0
heritable	0
condition	I-DISEASE
as	0
demonstrated	0
by	I-DISEASE
familial	I-DISEASE
clustering	0
of	I-DISEASE
OSA	0
patients	I-DISEASE
.	0

First	I-DISEASE
-	I-DISEASE
degree	I-DISEASE
relatives	I-DISEASE
of	0
OSA	I-DISEASE
patients	I-DISEASE
are	0
twice	0
as	0
likely	I-DISEASE
to	I-DISEASE
have	I-DISEASE
OSA	0
in	I-DISEASE
comparison	I-DISEASE
Sleep	0
Related	0
Breathing	0
Disorders	I-DISEASE
Sleep	I-DISEASE
Related	0
Breathing	0
Disorders	0
to	I-DISEASE
those	0
not	0
affected	0
.	0

Clustering	I-DISEASE
of	I-DISEASE
symptoms	0
that	0
are	0
associated	0
with	I-DISEASE
OSA	0
such	I-DISEASE
as	I-DISEASE
snoring	0
,	I-DISEASE
daytime	I-DISEASE
sleepiness	0
,	I-DISEASE
and	0
snorting	0
or	I-DISEASE
gasping	0
also	I-DISEASE
occurs	0
.	0

Heritability	I-DISEASE
explains	I-DISEASE
approximately	0
one	I-DISEASE
third	I-DISEASE
of	I-DISEASE
the	0
variation	0
in	I-DISEASE
the	0
AHI	I-DISEASE
,	I-DISEASE
with	I-DISEASE
a	I-DISEASE
substantial	0
proportion	I-DISEASE
of	I-DISEASE
the	0
heritability	0
explained	I-DISEASE
by	I-DISEASE
obesity	0
.	0

Other	I-DISEASE
inherited	I-DISEASE
traits	0
that	I-DISEASE
might	0
predispose	I-DISEASE
an	0
indi-	0
vidual	I-DISEASE
to	I-DISEASE
developing	0
OSA	I-DISEASE
include	0
craniofacial	I-DISEASE
morphology	0
and	0
ventilatory	0
control	I-DISEASE
.	B-DISEASE

Familial	I-DISEASE
environmental	I-DISEASE
factors	0
such	0
as	0
physical	0
activity	0
and	0
eating	0
habits	I-DISEASE
may	I-DISEASE
play	I-DISEASE
a	0
role	0
as	0
well	I-DISEASE
.	0

Nevertheless	I-DISEASE
,	I-DISEASE
genetic	0
studies	I-DISEASE
to	0
date	0
have	0
not	0
identified	I-DISEASE
a	0
unique	I-DISEASE
gene	0
or	I-DISEASE
genes	I-DISEASE
responsible	0
for	0
OSA	I-DISEASE
heritability	0
.	0

Onset	I-DISEASE
,	0
Course	0
,	0
and	0
Complications	0
As	0
documented	0
in	I-DISEASE
longitudinal	I-DISEASE
population	0
studies	I-DISEASE
,	I-DISEASE
the	0
severity	0
of	0
untreated	I-DISEASE
OSA	0
mea-	B-DISEASE
sured	0
by	I-DISEASE
the	0
AHI	0
tends	0
to	I-DISEASE
slowly	I-DISEASE
progress	0
over	0
time	0
.	0

OSA	I-DISEASE
becomes	0
more	0
severe	0
in	I-DISEASE
patients	I-DISEASE
whose	0
BMI	0
increases	0
,	I-DISEASE
but	I-DISEASE
may	I-DISEASE
improve	0
with	I-DISEASE
weight	0
reduction	I-DISEASE
.	0

However	I-DISEASE
,	I-DISEASE
the	0
effect	0
of	0
weight	0
gain	0
on	0
increasing	B-DISEASE
OSA	0
severity	I-DISEASE
is	I-DISEASE
greater	I-DISEASE
than	0
the	0
impact	I-DISEASE
of	I-DISEASE
weight	0
loss	0
on	0
decreasing	0
OSA	I-DISEASE
severity	I-DISEASE
.	0

Moreover	I-DISEASE
,	I-DISEASE
the	0
consequences	I-DISEASE
of	0
weight	0
change	I-DISEASE
are	I-DISEASE
more	0
evident	0
in	I-DISEASE
men	I-DISEASE
than	I-DISEASE
women	I-DISEASE
.	0

Substantial	I-DISEASE
evidence	0
implicates	0
OSA	I-DISEASE
as	0
a	0
risk	0
factor	I-DISEASE
for	I-DISEASE
incident	0
systemic	0
hyper-	I-DISEASE
tension	0
,	I-DISEASE
coronary	0
artery	0
disease	I-DISEASE
,	0
congestive	I-DISEASE
heart	0
failure	B-DISEASE
,	0
stroke	0
,	I-DISEASE
and	0
premature	0
mortality	0
.	0

Data	I-DISEASE
suggest	I-DISEASE
that	0
these	I-DISEASE
effects	0
are	0
more	0
evident	I-DISEASE
in	0
men	0
and	0
middle	I-DISEASE
-	I-DISEASE
aged	I-DISEASE
individuals	I-DISEASE
.	0

In	I-DISEASE
addition	0
,	0
there	I-DISEASE
is	0
accumulating	0
evidence	0
to	I-DISEASE
suggest	I-DISEASE
that	I-DISEASE
OSA	I-DISEASE
is	I-DISEASE
a	I-DISEASE
risk	0
factor	0
for	0
the	0
development	I-DISEASE
of	I-DISEASE
type	I-DISEASE
2	0
diabetes	I-DISEASE
mellitus	0
independent	I-DISEASE
of	I-DISEASE
obesity	0
.	0

Various	I-DISEASE
arrhythmias	0
are	I-DISEASE
commonly	0
observed	0
in	0
association	I-DISEASE
with	I-DISEASE
OSA	I-DISEASE
.	0

Evidence	I-DISEASE
suggests	I-DISEASE
that	0
OSA	I-DISEASE
is	I-DISEASE
particularly	0
related	B-DISEASE
to	0
the	0
onset	0
and	0
recurrence	I-DISEASE
of	I-DISEASE
atrial	I-DISEASE
fibrillation	0
.	0

OSA	I-DISEASE
may	0
increase	I-DISEASE
the	0
severity	I-DISEASE
of	I-DISEASE
depression	I-DISEASE
.	0

Because	I-DISEASE
of	I-DISEASE
daytime	0
sleepiness	0
,	I-DISEASE
func-	0
tional	0
impairment	I-DISEASE
occurs	0
commonly	I-DISEASE
as	0
manifested	I-DISEASE
by	0
poor	0
job	0
performance	0
,	I-DISEASE
loss	0
of	I-DISEASE
employment	0
,	I-DISEASE
impaired	I-DISEASE
family	I-DISEASE
relationships	0
,	I-DISEASE
and	0
reduction	I-DISEASE
in	I-DISEASE
overall	0
quality	0
of	I-DISEASE
life	0
.	0

The	I-DISEASE
risk	0
of	I-DISEASE
motor	I-DISEASE
vehicle	0
accidents	0
is	0
significantly	0
increased	0
among	0
those	0
with	I-DISEASE
OSA	I-DISEASE
.	0

Developmental	I-DISEASE
Issues	0
OSA	I-DISEASE
can	0
occur	I-DISEASE
in	I-DISEASE
any	I-DISEASE
age	I-DISEASE
group	I-DISEASE
,	I-DISEASE
but	I-DISEASE
in	I-DISEASE
adults	B-DISEASE
,	I-DISEASE
prevalence	I-DISEASE
accelerates	I-DISEASE
between	0
young	I-DISEASE
adulthood	0
and	0
middle	B-DISEASE
age	I-DISEASE
,	I-DISEASE
with	0
a	0
plateau	I-DISEASE
reached	I-DISEASE
after	0
approximately	0
age	I-DISEASE
65	0
years	I-DISEASE
.	0

Although	I-DISEASE
OSA	0
occurs	0
in	0
the	0
elderly	0
,	I-DISEASE
it	0
is	0
commonly	0
observed	I-DISEASE
with	I-DISEASE
few	0
symptoms	0
.	0

In	I-DISEASE
addition	0
,	0
some	I-DISEASE
evidence	0
suggests	I-DISEASE
that	0
risk	0
of	I-DISEASE
cardiovascular	0
disease	I-DISEASE
related	I-DISEASE
to	I-DISEASE
OSA	I-DISEASE
may	I-DISEASE
be	I-DISEASE
less	I-DISEASE
important	0
in	I-DISEASE
the	0
elderly	I-DISEASE
.	0

This	I-DISEASE
has	0
raised	0
the	0
possibility	0
that	0
its	I-DISEASE
presence	0
in	0
this	0
age	I-DISEASE
group	I-DISEASE
represents	I-DISEASE
a	I-DISEASE
distinct	0
clinical	0
variant	I-DISEASE
.	0

Pediatric	I-DISEASE
OSA	0
is	0
discussed	I-DISEASE
in	0
a	I-DISEASE
separate	0
section	0
(	I-DISEASE
below	I-DISEASE
)	I-DISEASE
.	0

Pathology	I-DISEASE
and	0
Pathophysiology	I-DISEASE
The	I-DISEASE
pathophysiology	0
underlying	0
upper	0
airway	I-DISEASE
narrowing	0
during	I-DISEASE
sleep	0
is	0
multifactorial	0
.	0

Patients	I-DISEASE
with	0
OSA	I-DISEASE
commonly	I-DISEASE
have	0
reduced	0
cross	0
-	0
sectional	I-DISEASE
area	I-DISEASE
of	I-DISEASE
the	0
upper	0
airway	I-DISEASE
lumen	0
due	0
to	0
either	0
excessive	0
bulk	I-DISEASE
of	0
soft	0
tissues	I-DISEASE
(	I-DISEASE
tongue	0
,	I-DISEASE
soft	0
palate	0
,	0
and	0
lateral	I-DISEASE
pha-	0
ryngeal	0
walls	I-DISEASE
)	0
or	I-DISEASE
craniofacial	I-DISEASE
anatomy	0
,	0
or	I-DISEASE
both	0
.	0

During	I-DISEASE
inspiration	0
,	0
negative	I-DISEASE
pressure	0
is	0
generated	0
in	I-DISEASE
the	0
lumen	0
of	I-DISEASE
the	0
upper	0
airway	I-DISEASE
,	I-DISEASE
promoting	0
closure	0
.	0

However	I-DISEASE
,	I-DISEASE
pharyngeal	0
dilating	I-DISEASE
muscles	0
act	0
to	I-DISEASE
maintain	I-DISEASE
patency	I-DISEASE
.	0

The	I-DISEASE
activity	0
of	I-DISEASE
these	I-DISEASE
muscles	0
decreases	0
with	I-DISEASE
sleep	0
onset	0
,	0
but	0
is	I-DISEASE
normally	I-DISEASE
adequate	0
to	0
maintain	0
an	0
open	I-DISEASE
airway	0
.	0

In	I-DISEASE
persons	I-DISEASE
with	0
OSA	I-DISEASE
,	I-DISEASE
the	0
activity	0
of	I-DISEASE
the	0
pharyngeal	0
dilating	I-DISEASE
muscles	0
becomes	0
insufficient	0
to	I-DISEASE
prevent	I-DISEASE
narrow-	0
ing	0
and/or	0
closure	0
of	I-DISEASE
the	0
upper	0
airway	0
.	0

This	I-DISEASE
state	I-DISEASE
-	0
dependent	I-DISEASE
change	0
is	I-DISEASE
the	I-DISEASE
major	I-DISEASE
con-	0
tributing	0
factor	I-DISEASE
leading	0
to	I-DISEASE
an	I-DISEASE
obstructed	0
upper	I-DISEASE
airway	I-DISEASE
.	0

There	I-DISEASE
is	I-DISEASE
a	0
further	I-DISEASE
reduction	0
in	I-DISEASE
tone	I-DISEASE
and	0
phasic	0
activity	0
of	I-DISEASE
pharyngeal	0
dilating	0
muscles	0
during	I-DISEASE
REM	0
sleep	0
,	I-DISEASE
particularly	0
in	I-DISEASE
phasic	0
REM	I-DISEASE
,	0
which	0
likely	I-DISEASE
contributes	0
to	0
apneas	0
and	0
hypopneas	0
that	0
are	0
longer	0
and	0
more	0
pronounced	0
.	0

Decreased	I-DISEASE
end	0
-	I-DISEASE
expiratory	0
lung	0
volume	0
and	0
falling	I-DISEASE
ventilatory	0
drive	0
associated	0
with	I-DISEASE
hypocapnia	0
also	0
predispose	0
to	I-DISEASE
upper	0
airway	I-DISEASE
narrowing	I-DISEASE
or	0
closure	B-DISEASE
.	0

In	I-DISEASE
the	I-DISEASE
breaths	0
leading	0
up	0
to	I-DISEASE
obstructive	0
apnea	I-DISEASE
,	I-DISEASE
end	0
-	I-DISEASE
expiratory	I-DISEASE
upper	I-DISEASE
airway	0
caliber	0
pro-	0

gressively	I-DISEASE
decreases	0
.	0

Smaller	I-DISEASE
end	0
-	I-DISEASE
expiratory	0
lung	0
volume	0
may	I-DISEASE
result	0
in	I-DISEASE
smaller	I-DISEASE
upper	0
airway	0
size	I-DISEASE
due	0
to	0
decreased	I-DISEASE
downward	0
traction	0
(	I-DISEASE
tracheal	0
tug	0
)	0
.	0

Some	I-DISEASE
patients	0
have	0
unstable	0
ventilatory	0
control	B-DISEASE
(	I-DISEASE
high	0
loop	0
gain	0
)	I-DISEASE
with	I-DISEASE
resulting	0
periods	I-DISEASE
of	I-DISEASE
hypocapnia	I-DISEASE
that	0
may	I-DISEASE
also	0
contribute	0
to	0
upper	0
airway	0
narrowing	0
.	B-DISEASE

The	I-DISEASE
mechanisms	0
of	I-DISEASE
apnea	0
/	0
hypopnea	I-DISEASE
termination	0
are	I-DISEASE
controversial	0
.	0

Event	I-DISEASE
termination	0
may	0
occur	I-DISEASE
with	0
or	I-DISEASE
without	0
an	0
associated	0
arousal	0
.	0

Some	I-DISEASE
events	0
may	0
resolve	I-DISEASE
with	0
aug-	0
mentation	0
of	I-DISEASE
upper	0
airway	I-DISEASE
muscle	0
tone	I-DISEASE
from	I-DISEASE
chemical	I-DISEASE
(	0
low	0
PaO2	0
,	0
high	I-DISEASE
PaCO2	0
)	0
and	0
mechanical	I-DISEASE
(	I-DISEASE
upper	0
airway	0
mechanoreceptors	B-DISEASE
)	0
stimuli	0
,	0
whereas	0
others	I-DISEASE
may	I-DISEASE
depend	I-DISEASE
on	0
a	I-DISEASE
change	0
of	I-DISEASE
sleep	0
state	B-DISEASE
(	I-DISEASE
arousal	0
)	0
at	I-DISEASE
either	I-DISEASE
a	0
cortical	0
or	I-DISEASE
subcortical	I-DISEASE
level	0
.	0

Cortical	I-DISEASE
arous-	I-DISEASE
als	I-DISEASE
are	0
associated	0
with	I-DISEASE
changes	0
detectable	I-DISEASE
by	B-DISEASE
EEG	0
,	I-DISEASE
whereas	0
other	0
changes	0
of	I-DISEASE
state	I-DISEASE
may	I-DISEASE
be	0
detectable	I-DISEASE
only	I-DISEASE
by	0
direct	0
or	I-DISEASE
indirect	I-DISEASE
measures	0
of	I-DISEASE
sympathetic	I-DISEASE
tone	I-DISEASE
.	0

Even	I-DISEASE
if	0
arousals	0
are	0
not	0
required	0
for	I-DISEASE
termination	0
of	I-DISEASE
all	0
obstructive	0
events	0
,	I-DISEASE
sleep	0
fragmentation	0
from	I-DISEASE
arousals	0
is	0
nevertheless	0
believed	I-DISEASE
to	0
be	I-DISEASE
a	0
significant	0
cause	I-DISEASE
of	I-DISEASE
excessive	0
daytime	0
sleepiness	0
.	0

Apneas	0
and	0
hypopneas	0
typically	0
last	0
considerably	I-DISEASE
longer	I-DISEASE
in	0
REM	0
and	0
,	0
in	0
some	I-DISEASE
patients	0
,	0
are	0
only	0
present	I-DISEASE
in	0
this	0
sleep	0
stage	I-DISEASE
.	0

The	I-DISEASE
explanation	I-DISEASE
for	0
this	I-DISEASE
finding	0
is	I-DISEASE
unknown	I-DISEASE
.	0

As	I-DISEASE
an	0
apnea	0
or	I-DISEASE
hypopnea	I-DISEASE
event	0
progresses	I-DISEASE
,	I-DISEASE
the	0
patient	0
gradually	0
becomes	I-DISEASE
more	0
hypox-	0
emic	I-DISEASE
;	I-DISEASE
the	I-DISEASE
degree	I-DISEASE
of	I-DISEASE
oxygen	I-DISEASE
desaturation	I-DISEASE
is	0
dependent	0
not	0
only	I-DISEASE
on	0
the	0
duration	0
of	I-DISEASE
the	0
event	0
,	0
but	0
also	0
on	0
the	I-DISEASE
patient	I-DISEASE
’s	I-DISEASE
baseline	0
oxygen	0
saturation	0
and	0
lung	I-DISEASE
volume	I-DISEASE
and	0
the	0
presence	0
of	I-DISEASE
comorbid	I-DISEASE
lung	0
conditions	I-DISEASE
.	0

Slight	I-DISEASE
hypercarbia	0
also	0
occurs	I-DISEASE
during	I-DISEASE
apneas	0
and	0
hypopneas	0
and	0
is	0
worse	0
during	I-DISEASE
REM	0
sleep	I-DISEASE
.	0

Sleep	I-DISEASE
Related	I-DISEASE
Breathing	0
Disorders	I-DISEASE
Sleep	0
Related	0
Breathing	0
Disorders	I-DISEASE
Accumulating	0
evidence	0
indicates	I-DISEASE
that	0
persons	I-DISEASE
with	0
OSA	I-DISEASE
have	I-DISEASE
elevated	I-DISEASE
levels	I-DISEASE
of	I-DISEASE
circu-	I-DISEASE
lating	0
inflammatory	0
mediators	I-DISEASE
related	0
to	0
repetitive	I-DISEASE
episodes	I-DISEASE
of	I-DISEASE
oxygen	I-DISEASE
desaturation	I-DISEASE
and	0
increased	0
sympathetic	I-DISEASE
nervous	0
system	0
activity	0
.	0

Both	I-DISEASE
of	I-DISEASE
these	0
findings	0
may	0
be	I-DISEASE
import-	0
ant	0
in	0
the	0
pathogenesis	I-DISEASE
of	I-DISEASE
hypertension	I-DISEASE
and	0
cardiovascular	I-DISEASE
disease	I-DISEASE
related	0
to	I-DISEASE
OSA	I-DISEASE
.	I-DISEASE

Objective	I-DISEASE
Findings	I-DISEASE
Obstructive	I-DISEASE
apneas	0
are	I-DISEASE
documented	0
by	I-DISEASE
a	0
cessation	I-DISEASE
of	I-DISEASE
airflow	0
with	I-DISEASE
ongoing	I-DISEASE
respiratory	I-DISEASE
efforts	0
during	I-DISEASE
PSG	0
or	I-DISEASE
an	0
OCST	0
.	0

When	I-DISEASE
breathing	I-DISEASE
effort	0
is	I-DISEASE
recorded	0
with	I-DISEASE
respiratory	I-DISEASE
inductance	I-DISEASE
plethysmography	0
,	I-DISEASE
it	I-DISEASE
typically	I-DISEASE
shows	I-DISEASE
paradoxical	0
movement	I-DISEASE
of	I-DISEASE
the	0
rib	I-DISEASE
cage	0
and	0
abdomen	I-DISEASE
.	0

If	I-DISEASE
esophageal	I-DISEASE
manometry	0
is	0
used	0
,	I-DISEASE
increasingly	I-DISEASE
large	I-DISEASE
swings	I-DISEASE
between	0
inspiratory	I-DISEASE
and	0
expiratory	I-DISEASE
efforts	I-DISEASE
are	I-DISEASE
observed	0
.	I-DISEASE

Obstructive	I-DISEASE
hypopneas	0
are	0
a	0
reduction	I-DISEASE
rather	I-DISEASE
than	I-DISEASE
a	0
cessation	I-DISEASE
of	0
airflow	0
with	I-DISEASE
ongoing	I-DISEASE
respiratory	0
effort	I-DISEASE
.	0

Increasing	I-DISEASE
respira-	0
tory	I-DISEASE
effort	0
with	I-DISEASE
constant	I-DISEASE
or	I-DISEASE
reduced	0
flow	I-DISEASE
is	I-DISEASE
indicative	I-DISEASE
of	0
increased	0
upper	0
airway	0
resis-	B-DISEASE
tance	0
.	0

This	I-DISEASE
state	I-DISEASE
is	0
most	0
accurately	0
identified	I-DISEASE
with	I-DISEASE
a	I-DISEASE
quantitative	0
measurement	0
of	I-DISEASE
flow	I-DISEASE
and	0
esophageal	I-DISEASE
manometry	0
,	0
although	0
it	0
can	0
be	0
inferred	I-DISEASE
when	0
there	I-DISEASE
is	I-DISEASE
obvious	0
inspira-	I-DISEASE
tory	I-DISEASE
airflow	0
limitation	I-DISEASE
(	0
flattening	0
of	I-DISEASE
the	0
inspiratory	I-DISEASE
flow	0
)	0
on	0
a	0
nasal	0
pressure	0
recording	0
.	0

Although	I-DISEASE
patients	I-DISEASE
with	0
OSA	I-DISEASE
have	I-DISEASE
predominantly	I-DISEASE
obstructive	I-DISEASE
events	I-DISEASE
,	I-DISEASE
they	I-DISEASE
may	0
also	0
have	I-DISEASE
variable	I-DISEASE
amounts	0
of	0
central	0
apneas	0
.	0

In	I-DISEASE
some	I-DISEASE
patients	0
,	I-DISEASE
these	0
resolve	0
with	I-DISEASE
admin-	I-DISEASE
istration	0
of	I-DISEASE
positive	0
airway	0
pressure	0
,	I-DISEASE
whereas	0
in	0
others	B-DISEASE
frequent	0
central	0
apneas	0
either	I-DISEASE
persist	0
or	I-DISEASE
emerge	0
,	0
at	I-DISEASE
least	I-DISEASE
during	I-DISEASE
the	0
initial	0
night	0
of	I-DISEASE
positive	0
airway	0
pressure	0
treatment	I-DISEASE
.	0

Oxygen	I-DISEASE
saturation	0
typically	0
declines	0
for	0
a	0
variable	I-DISEASE
period	0
of	I-DISEASE
time	I-DISEASE
following	0
the	0
onset	0
of	I-DISEASE
an	0
event	0
(	I-DISEASE
apnea	0
or	0
hypopnea	I-DISEASE
)	0
,	I-DISEASE
with	I-DISEASE
the	0
nadir	0
usually	I-DISEASE
occurring	0
after	0
normal	0
breath-	0
ing	0
resumes	0
.	0

The	I-DISEASE
degree	I-DISEASE
of	I-DISEASE
oxygen	I-DISEASE
desaturation	0
may	I-DISEASE
range	0
from	I-DISEASE
as	0
little	0
as	I-DISEASE
1	I-DISEASE
%	0
to	I-DISEASE
2	I-DISEASE
%	0
,	0
up	0
to	I-DISEASE
30	I-DISEASE
%	0
to	0
40	0
%	0
or	0
greater	I-DISEASE
.	0

If	I-DISEASE
the	0
baseline	I-DISEASE
oxygen	0
saturation	I-DISEASE
is	I-DISEASE
normal	0
,	0
there	I-DISEASE
may	I-DISEASE
be	I-DISEASE
no	I-DISEASE
discernible	0
drop	I-DISEASE
in	0
oxygen	0
saturation	I-DISEASE
despite	0
evidence	0
of	I-DISEASE
airflow	I-DISEASE
limitation	I-DISEASE
fol-	I-DISEASE
lowed	0
by	I-DISEASE
arousal	0
.	0

As	I-DISEASE
a	0
result	0
,	I-DISEASE
some	0
events	0
associated	0
with	I-DISEASE
evidence	0
of	I-DISEASE
increased	0
respi-	0
ratory	0
effort	I-DISEASE
(	0
and/or	0
flattening	I-DISEASE
of	I-DISEASE
inspiratory	0
flow	I-DISEASE
)	0
and	0
an	0
arousal	0
at	I-DISEASE
event	0
termination	0
may	0
not	0
meet	0
diagnostic	0
criteria	0
for	0
apnea	0
or	0
hypopnea	I-DISEASE
.	0

These	0
events	0
are	0
defined	I-DISEASE
as	0
RERAs	I-DISEASE
.	0

These	0
events	0
are	0
presumed	0
to	0
have	I-DISEASE
the	0
same	0
underlying	0
pathophysiology	0
as	0
obstructive	0
apneas	0
and	0
hypopneas	0
(	I-DISEASE
upper	I-DISEASE
airway	0
obstruction	0
)	0
and	0
are	0
considered	0
to	0
be	0
as	0
much	0
of	I-DISEASE
a	0
risk	0
factor	I-DISEASE
for	I-DISEASE
symptoms	I-DISEASE
of	I-DISEASE
unrefreshing	0
sleep	0
,	I-DISEASE
daytime	0
somnolence	0
,	I-DISEASE
and	0
fatigue	I-DISEASE
as	0
frank	0
apnea	0
or	0
hypopnea	I-DISEASE
.	0

The	I-DISEASE
EEG	0
may	I-DISEASE
provide	0
evidence	0
of	I-DISEASE
a	I-DISEASE
brief	I-DISEASE
arousal	0
from	I-DISEASE
sleep	0
,	I-DISEASE
and	0
the	0
submental	I-DISEASE
electro-	I-DISEASE
myogram	0
may	0
demonstrate	0
a	0
burst	I-DISEASE
of	I-DISEASE
activity	0
indicating	I-DISEASE
upper	0
airway	I-DISEASE
dilating	I-DISEASE
muscle	0
activation	0
immediately	I-DISEASE
preceding	I-DISEASE
the	0
resumption	0
of	0
normal	0
breathing	0
.	0

Microphones	I-DISEASE
may	0
record	I-DISEASE
a	0
sudden	0
resumption	I-DISEASE
of	I-DISEASE
loud	0
snoring	0
.	0

Obstructive	I-DISEASE
apneas	0
and	0
hypopneas	0
may	0
be	0
accompanied	I-DISEASE
by	I-DISEASE
bradyarrhythmias	0
,	0
tachyarrhythmias	0
,	0
or	0
both	0
;	0
however	0
,	0
the	0
prevalence	0
of	0
this	0
finding	0
in	I-DISEASE
patients	0
varies	0
widely	0
.	0

At	I-DISEASE
the	0
time	0
of	I-DISEASE
arousals	0
,	I-DISEASE
there	I-DISEASE
is	0
often	0
a	0
surge	0
in	I-DISEASE
both	I-DISEASE
sympathetic	I-DISEASE
nervous	0
system	I-DISEASE
activity	I-DISEASE
and	0
systemic	0
blood	I-DISEASE
pressure	0
.	0

Differential	I-DISEASE
Diagnosis	0

In	I-DISEASE
contrast	I-DISEASE
to	0
patients	I-DISEASE
with	0
OSA	I-DISEASE
,	I-DISEASE
those	0
with	0
isolated	0
snoring	0
will	0
not	0
exhibit	0
obstruc-	I-DISEASE
tive	0
apneas	0
,	I-DISEASE
hypopneas	I-DISEASE
,	I-DISEASE
or	0
RERAs	0
on	0
PSG	0
or	0
OCST	0
and	0
do	I-DISEASE
not	0
have	0
other	0
sleep	0
symp-	0
toms	I-DISEASE
attributable	I-DISEASE
to	I-DISEASE
breathing	I-DISEASE
disturbance	I-DISEASE
.	0

However	I-DISEASE
,	I-DISEASE
because	0
arousal	0
-	0
based	I-DISEASE
hypopneas	I-DISEASE
and	0
RERAs	I-DISEASE
can	0
not	0
be	I-DISEASE
identified	0
with	0
OCST	I-DISEASE
,	I-DISEASE
OSA	I-DISEASE
can	0
not	0
be	0
excluded	0
if	0
the	B-DISEASE
OCST	0
is	0
negative	I-DISEASE
.	0

Patients	I-DISEASE
with	0
central	0
sleep	0
apnea	0
have	0
predominantly	0
central	0
rather	0
than	I-DISEASE
obstruc-	0
tive	0
apneas	0
,	I-DISEASE
hypopneas	I-DISEASE
,	I-DISEASE
or	B-DISEASE
RERAs	0
as	0
the	0
primary	0
finding	I-DISEASE
on	0
PSG	0
or	0
OCST	0
.	0

If	I-DISEASE
mixed	0
apneas	0
are	0
predominant	0
,	0
a	0
diagnosis	0
of	I-DISEASE
OSA	I-DISEASE
should	0
be	0
made	0
.	I-DISEASE

Patients	I-DISEASE
with	0
obesity	0
hypoventilation	I-DISEASE
syndrome	I-DISEASE
will	0
demonstrate	I-DISEASE
daytime	I-DISEASE
hypercap-	0
nia	0
.	0

Snoring	I-DISEASE
may	I-DISEASE
not	0
be	I-DISEASE
a	0
prominent	0
feature	0
,	0
although	0
daytime	0
sleepiness	I-DISEASE
can	0
occur	I-DISEASE
.	0

Patients	I-DISEASE
with	0
sleep	I-DISEASE
related	B-DISEASE
hypoventilation	I-DISEASE
disorders	0
may	I-DISEASE
show	I-DISEASE
episodes	I-DISEASE
of	I-DISEASE
oxygen	I-DISEASE
desaturation	I-DISEASE
without	0
evidence	0
of	I-DISEASE
airflow	0
obstruction	0
on	0
PSG	0
or	I-DISEASE
OCST	B-DISEASE
.	0

Confirmation	I-DISEASE
of	0
nocturnal	0
hypercapnia	I-DISEASE
will	0
be	I-DISEASE
diagnostic	0
.	0

However	I-DISEASE
,	I-DISEASE
if	0
obstructive	0
apneas	I-DISEASE
or	I-DISEASE
hypo-	I-DISEASE
pneas	0
are	0
evident	I-DISEASE
,	0
a	0
diagnosis	0
of	I-DISEASE
OSA	I-DISEASE
should	I-DISEASE
be	0
made	0
instead	0
of	I-DISEASE
,	0
or	0
in	I-DISEASE
addition	0
to	I-DISEASE
,	0
the	0
diagnosis	0
of	0
sleep	0
related	0
hypoventilation	0
.	0

OSA	I-DISEASE
must	I-DISEASE
be	I-DISEASE
differentiated	0
from	I-DISEASE
other	I-DISEASE
causes	I-DISEASE
of	I-DISEASE
sleepiness	0
such	I-DISEASE
as	I-DISEASE
narcolepsy	0
,	I-DISEASE
idio-	0
pathic	0
hypersomnia	I-DISEASE
,	I-DISEASE
and	0
insufficient	0
sleep	I-DISEASE
.	0

These	0
conditions	I-DISEASE
often	0
can	I-DISEASE
be	0
identified	I-DISEASE
on	0
the	B-DISEASE
basis	I-DISEASE
of	I-DISEASE
history	I-DISEASE
,	I-DISEASE
but	I-DISEASE
PSG	0
and/or	0
MSLT	I-DISEASE
may	I-DISEASE
be	0
required	I-DISEASE
to	0
confirm	0
the	I-DISEASE
diagnosis	0
.	I-DISEASE

OSA	I-DISEASE
should	0
be	I-DISEASE
distinguished	0
from	I-DISEASE
other	0
causes	I-DISEASE
of	0
nocturnal	0
dyspnea	0
,	I-DISEASE
such	0
as	I-DISEASE
noc-	0
turnal	0
panic	0
attacks	0
,	I-DISEASE
nocturnal	0
gastroesophageal	0
reflux	0
,	0
asthma	0
,	0
paroxysmal	0
nocturnal	I-DISEASE
dyspnea	0
from	0
congestive	0
heart	0
failure	0
,	0
and	0
nocturnal	0
angina	0
pectoris	0
.	0

In	I-DISEASE
many	0
cases	0
,	I-DISEASE
absence	0
of	I-DISEASE
snoring	0
and	0
daytime	I-DISEASE
sleepiness	0
will	0
be	0
highly	I-DISEASE
suggestive	I-DISEASE
of	0
etiologies	0
other	I-DISEASE
than	0
OSA	I-DISEASE
.	0

However	I-DISEASE
,	I-DISEASE
the	0
absence	I-DISEASE
of	0
obstructive	0
apneas	0
,	I-DISEASE
hypopneas	0
,	0
or	I-DISEASE
RERAs	0
on	0
PSG	0
will	0
definitively	I-DISEASE
exclude	0
OSA	I-DISEASE
as	0
the	I-DISEASE
diagnosis	0
.	0

Unresolved	I-DISEASE
Issues	0
and	0
Further	I-DISEASE
Directions	0

Although	I-DISEASE
substantial	0
evidence	0
implicates	0
OSA	I-DISEASE
as	0
a	0
risk	0
factor	I-DISEASE
for	I-DISEASE
coronary	I-DISEASE
artery	0
disease	I-DISEASE
and	0
stroke	0
,	I-DISEASE
it	0
has	0
not	0
been	I-DISEASE
clearly	0
demonstrated	0
that	0
treatment	I-DISEASE
mitigates	I-DISEASE
this	0
risk	0
.	0

This	I-DISEASE
is	I-DISEASE
especially	0
a	I-DISEASE
concern	0
for	0
patients	I-DISEASE
with	I-DISEASE
mild	0
OSA	0
who	I-DISEASE
are	I-DISEASE
not	0
hypersom-	0
nolent	0
.	0

The	I-DISEASE
pathophysiologic	I-DISEASE
mechanisms	I-DISEASE
linking	0
OSA	0
to	I-DISEASE
increased	I-DISEASE
risk	0
of	I-DISEASE
coronary	0
artery	0
disease	0
,	I-DISEASE
stroke	0
,	0
and	0
hypertension	0
require	0
further	I-DISEASE
investigation	0
.	0

Although	I-DISEASE
there	I-DISEASE
Sleep	0
Related	I-DISEASE
Breathing	0
Disorders	0
Sleep	I-DISEASE
Related	I-DISEASE
Breathing	0
Disorders	I-DISEASE
is	I-DISEASE
a	0
clear	I-DISEASE
association	B-DISEASE
between	0
OSA	I-DISEASE
and	0
type	I-DISEASE
2	I-DISEASE
diabetes	I-DISEASE
mellitus	B-DISEASE
,	I-DISEASE
further	I-DISEASE
studies	I-DISEASE
are	0
needed	0
to	I-DISEASE
determine	0
whether	0
OSA	0
is	0
an	0
independent	I-DISEASE
risk	0
factor	I-DISEASE
and	0
what	0
mechanisms	0
are	0
involved	0
.	0

Bibliography	0
Berry	I-DISEASE
RB	0
,	I-DISEASE
Brooks	0
R	I-DISEASE
,	0
Gamaldo	I-DISEASE
CE	I-DISEASE
,	I-DISEASE
Harding	0
SM	I-DISEASE
,	I-DISEASE
Lloyd	I-DISEASE
RM	0
,	I-DISEASE
Marcus	0
CL	I-DISEASE
and	0
Vaughn	I-DISEASE
BV	0
for	I-DISEASE
the	I-DISEASE
American	0
Academy	0
of	I-DISEASE
Sleep	0
Medicine	I-DISEASE
.	0

The	I-DISEASE
AASM	I-DISEASE
Manual	I-DISEASE
for	0
the	0
Scoring	0
of	I-DISEASE
Sleep	0
and	0
Associated	I-DISEASE
Events	I-DISEASE
:	I-DISEASE
Rules	0
,	I-DISEASE
Terminology	I-DISEASE
and	0
Technical	0
Specifications	I-DISEASE
,	I-DISEASE
Version	0
2.0.3	0
.	0
www.aasmnet.org	0
.	0

Darien	I-DISEASE
,	0
IL	I-DISEASE
:	0
American	0
Academy	0
of	I-DISEASE
Sleep	0
Medicine	0
,	0
2014	0
Berry	I-DISEASE
RB	I-DISEASE
.	0

Dreaming	I-DISEASE
about	0
an	0
open	0
upper	0
airway	I-DISEASE
.	0

Sleep	I-DISEASE
2006;29:429–30	0
.	0

Budhiraja	I-DISEASE
R	I-DISEASE
,	0
Budhiraja	I-DISEASE
P	0
,	0
Quan	I-DISEASE
SF	I-DISEASE
.	0

Sleep	I-DISEASE
-	I-DISEASE
disordered	0
breathing	0
and	0
cardiovascular	I-DISEASE
disorders	0
.	0

Respir	I-DISEASE
Care	0
2010;55:1322–32	0
.	0

Iber	I-DISEASE
C	0
,	I-DISEASE
Ancoli	0
-	I-DISEASE
Israel	I-DISEASE
S	0
,	I-DISEASE
Chesson	I-DISEASE
AL	I-DISEASE
,	0
Quan	I-DISEASE
SF	I-DISEASE
;	0
for	0
the	0
American	0
Academy	I-DISEASE
of	I-DISEASE
Sleep	0
Medicine	I-DISEASE
.	0

The	I-DISEASE
AASM	I-DISEASE
manual	I-DISEASE
for	0
the	0
scoring	0
of	I-DISEASE
sleep	0
and	0
associated	0
events	0
:	I-DISEASE
rules	I-DISEASE
,	0
terminology	I-DISEASE
and	0
technical	I-DISEASE
specifications	0
.	0

1st	I-DISEASE
ed	I-DISEASE
.	0

Westchester	I-DISEASE
,	0
IL	I-DISEASE
:	0
American	0
Academy	0
of	I-DISEASE
Sleep	0
Medicine	0
,	0
2007	I-DISEASE
.	I-DISEASE

Pamidi	I-DISEASE
S	I-DISEASE
,	0
Aronsohn	0
RS	0
,	I-DISEASE
Tasali	I-DISEASE
E.	0
Obstructive	I-DISEASE
sleep	0
apnea	0
:	0
role	I-DISEASE
in	0
the	I-DISEASE
risk	0
and	0
severity	I-DISEASE
of	I-DISEASE
diabetes	I-DISEASE
.	0

Best	I-DISEASE
Pract	0
Res	0
Clin	0
Endocrinol	0
Metab	I-DISEASE
2010;24:703–15	0
.	0

Patel	I-DISEASE
SR	I-DISEASE
,	0
Larkin	I-DISEASE
EK	I-DISEASE
,	I-DISEASE
Redline	0
S.	I-DISEASE
Shared	I-DISEASE
genetic	I-DISEASE
basis	I-DISEASE
for	I-DISEASE
obstructive	0
sleep	0
apnea	0
and	0
adiposity	I-DISEASE
measures	0
.	0

Int	I-DISEASE
J	0
Obes	I-DISEASE
(	I-DISEASE
Lond	0
)	0
2008;32:795–800	I-DISEASE
.	0

Pepin	I-DISEASE
JL	0
,	I-DISEASE
Guillot	I-DISEASE
M	I-DISEASE
,	I-DISEASE
Tamisier	I-DISEASE
R	I-DISEASE
,	I-DISEASE
Levy	I-DISEASE
P.	I-DISEASE

The	I-DISEASE
upper	I-DISEASE
airway	0
resistance	I-DISEASE
syndrome	I-DISEASE
.	0

Respiration	I-DISEASE
2012;83:559–66	0
.	0

Peppard	I-DISEASE
PE	0
,	I-DISEASE
Taheri	I-DISEASE
S.	0
Excess	I-DISEASE
weight	I-DISEASE
and	0
sleep	0
-	I-DISEASE
disordered	I-DISEASE
breathing	0
.	0

J	I-DISEASE
Appl	0
Physiol	0
2005;99:1592–9	I-DISEASE
.	0

Punjabi	I-DISEASE
NM	0
.	I-DISEASE

The	I-DISEASE
epidemiology	I-DISEASE
of	I-DISEASE
adult	0
obstructive	I-DISEASE
sleep	0
apnea	I-DISEASE
.	0

Proc	I-DISEASE
Am	0
Thorac	I-DISEASE
Soc	0
2008;5:136–43	I-DISEASE
.	0

White	I-DISEASE
DP	I-DISEASE
.	I-DISEASE

Sleep	I-DISEASE
apnea	I-DISEASE
.	0

Proc	I-DISEASE
Am	0
Thorac	0
Soc	0
2006;3:124–8	0
.	0

Younes	I-DISEASE
M.	I-DISEASE
Role	0
of	I-DISEASE
arousal	0
in	I-DISEASE
the	0
pathogenesis	0
of	I-DISEASE
obstructive	0
sleep	I-DISEASE
apnea	0
.	0

Am	I-DISEASE
J	0
Respir	0
Crit	0
Care	0
Med	0
2004;169:623–33	0
.	0

Young	I-DISEASE
T	0
,	0
Palta	0
M	I-DISEASE
,	I-DISEASE
Dempsey	I-DISEASE
J	0
,	I-DISEASE
Skatrud	I-DISEASE
J	0
,	I-DISEASE
Weber	I-DISEASE
S	0
,	0
Badr	I-DISEASE
S.	I-DISEASE

The	I-DISEASE
occurrence	0
of	I-DISEASE
sleep	0
-	0
disordered	I-DISEASE
breathing	B-DISEASE
among	0
middle	0
-	0
aged	I-DISEASE
adults	I-DISEASE
.	0

N	0
Engl	I-DISEASE
J	0
Med	I-DISEASE
1993;328:1230–5	I-DISEASE
.	0

Young	I-DISEASE
T	0
,	0
Peppard	0
PE	0
,	0
Gottlieb	0
DJ	0
.	0

Epidemiology	I-DISEASE
of	0
obstructive	0
sleep	0
apnea	0
:	I-DISEASE
a	0
population	0
health	I-DISEASE
perspective	I-DISEASE
.	0

Am	I-DISEASE
J	0
Respir	0
Crit	0
Care	0
Med	0
2002;165:1217–39	I-DISEASE
.	0

Obstructive	I-DISEASE
Sleep	0
Apnea	0
,	0
Pediatric	0
ICD-9	0
-	I-DISEASE
CM	I-DISEASE
code	0
:	0
327.23	I-DISEASE
ICD-10	0
-	0
CM	I-DISEASE
code	0
:	0
G47.33	I-DISEASE
Alternate	0
Names	I-DISEASE
Obstructive	I-DISEASE
sleep	0
apnea	0
syndrome	I-DISEASE
,	I-DISEASE
sleep	0
apnea	0
,	0
sleep	0
apnea	0
syndrome	0
,	0
obstructive	0
apnea	I-DISEASE
,	0
sleep	0
disordered	I-DISEASE
breathing	I-DISEASE
,	I-DISEASE
sleep	0
hypopnea	0
syndrome	0
,	I-DISEASE
obstructive	0
hypoventila-	0
tion	0
,	0
and	0
upper	0
airway	0
obstruction	0
.	0

The	I-DISEASE
term	0
upper	0
airway	0
resistance	I-DISEASE
syndrome	0
(	I-DISEASE
UARS	0
)	0
is	I-DISEASE
subsumed	I-DISEASE
under	I-DISEASE
this	I-DISEASE
diagnosis	0
because	0
the	0
pathophysiology	0
does	0
not	0
significantly	0
differ	I-DISEASE
from	I-DISEASE
that	B-DISEASE
of	I-DISEASE
OSA	0
.	0

Use	I-DISEASE
of	I-DISEASE
the	0
term	0
Pickwickian	0
syndrome	I-DISEASE
is	0
discouraged	I-DISEASE
,	I-DISEASE
as	0
this	I-DISEASE
term	0
has	0
been	I-DISEASE
used	I-DISEASE
loosely	I-DISEASE
to	0
cover	0
a	0
constellation	I-DISEASE
of	I-DISEASE
conditions	I-DISEASE
including	0
OSA	I-DISEASE
and	0
central	0
hypoventilation	I-DISEASE
.	0

Diagnostic	I-DISEASE
Criteria	0
Criteria	I-DISEASE
A	0
and	0
B	0
must	I-DISEASE
be	0
met	0
A.	0

The	I-DISEASE
presence	0
of	I-DISEASE
one	I-DISEASE
or	0
more	0
of	I-DISEASE
the	0
following	0
:	0
.	0

Snoring	I-DISEASE
.	I-DISEASE
.	0

Labored	I-DISEASE
,	I-DISEASE
paradoxical	I-DISEASE
,	I-DISEASE
or	I-DISEASE
obstructed	0
breathing	I-DISEASE
during	I-DISEASE
the	0
child	0
’s	I-DISEASE
sleep	0
.	0
.	0

Sleepiness	I-DISEASE
,	0
hyperactivity	0
,	I-DISEASE
behavioral	0
problems	0
,	0
or	I-DISEASE
learning	I-DISEASE
problems	I-DISEASE
.	0

B.	0
PSG	0
demonstrates	0
one	0
or	0
both	I-DISEASE
of	0
the	0
following	0
:	0
.	0

One	I-DISEASE
or	I-DISEASE
more	0
obstructive	0
apneas	I-DISEASE
,	I-DISEASE
mixed	I-DISEASE
apneas	0
,	I-DISEASE
or	0
hypopneas	0
,	I-DISEASE
per	I-DISEASE
hour	0
of	I-DISEASE
sleep.1	0
OR	B-DISEASE
.	0

A	I-DISEASE
pattern	0
of	I-DISEASE
obstructive	I-DISEASE
hypoventilation	I-DISEASE
,	I-DISEASE
defined	I-DISEASE
as	0
at	I-DISEASE
least	I-DISEASE
25	I-DISEASE
%	0
of	I-DISEASE
total	I-DISEASE
sleep	0
time	I-DISEASE
with	I-DISEASE
hypercapnia	I-DISEASE
(	I-DISEASE
PaCO2	0
>	0

50	0
mm	0
Hg	I-DISEASE
)	0
in	I-DISEASE
association	0
with	I-DISEASE
one	0
or	0
more	0
of	I-DISEASE
the	I-DISEASE
following	0
:	0
a.	0
Snoring	I-DISEASE
.	0

b.	I-DISEASE
Flattening	I-DISEASE
of	I-DISEASE
the	0
inspiratory	I-DISEASE
nasal	I-DISEASE
pressure	I-DISEASE
waveform	I-DISEASE
.	0

c.	I-DISEASE
Paradoxical	0
thoracoabdominal	0
motion	I-DISEASE
.	I-DISEASE

Notes	I-DISEASE
.	0

Respiratory	I-DISEASE
events	0
defined	I-DISEASE
according	I-DISEASE
to	I-DISEASE
the	0
most	0
recent	I-DISEASE
version	I-DISEASE
of	I-DISEASE
the	0
AASM	0
Manual	I-DISEASE
for	I-DISEASE
the	0
Scoring	0
of	I-DISEASE
Sleep	I-DISEASE
and	0
Associated	I-DISEASE
Events	I-DISEASE
.	0

Essential	I-DISEASE
Features	I-DISEASE
Pediatric	0
criteria	I-DISEASE
for	I-DISEASE
OSA	I-DISEASE
apply	0
to	0
patients	0
younger	I-DISEASE
than	I-DISEASE
18	I-DISEASE
years	0
.	0

However	I-DISEASE
,	I-DISEASE
for	0
the	0
purpose	0
of	I-DISEASE
PSG	0
scoring	0
,	0
the	0
AASM	I-DISEASE
Manual	I-DISEASE
for	0
the	0
Scoring	I-DISEASE
of	I-DISEASE
Sleep	0
and	0
Associated	I-DISEASE
Events	I-DISEASE
states	I-DISEASE
that	0
adult	0
diagnostic	0
criteria	I-DISEASE
may	I-DISEASE
be	I-DISEASE
used	I-DISEASE
for	I-DISEASE
patients	0
aged	I-DISEASE
13	I-DISEASE
to	I-DISEASE
18	0
years	0
.	0

Sleep	I-DISEASE
Related	I-DISEASE
Breathing	0
Disorders	I-DISEASE
Sleep	0
Related	0
Breathing	0
Disorders	I-DISEASE
Pediatric	0
OSA	I-DISEASE
is	I-DISEASE
characterized	0
by	I-DISEASE
intermittent	I-DISEASE
complete	0
or	I-DISEASE
partial	I-DISEASE
obstruction	0
(	I-DISEASE
obstruc-	0
tive	0
apnea	0
or	0
hypopnea	I-DISEASE
)	0
;	0
prolonged	0
partial	I-DISEASE
upper	0
airway	0
obstruction	0
;	0
or	I-DISEASE
both	0
prolonged	0
and	0
intermittent	I-DISEASE
obstructions	0
that	0
disrupt	I-DISEASE
normal	0
ventilation	0
during	I-DISEASE
sleep	0
,	0
normal	0
sleep	0
patterns	0
,	I-DISEASE
or	I-DISEASE
both	I-DISEASE
.	0

Children	I-DISEASE
with	I-DISEASE
OSA	0
may	0
demonstrate	I-DISEASE
several	0
breathing	B-DISEASE
patterns	0
during	I-DISEASE
sleep	0
.	0

Some	I-DISEASE
children	I-DISEASE
have	0
cyclic	I-DISEASE
episodes	I-DISEASE
of	I-DISEASE
obstructive	I-DISEASE
apnea	I-DISEASE
,	I-DISEASE
similar	0
to	I-DISEASE
that	I-DISEASE
of	0
adults	I-DISEASE
with	I-DISEASE
the	0
syndrome	I-DISEASE
.	0

However	I-DISEASE
,	I-DISEASE
some	0
patients	I-DISEASE
,	0
particularly	0
younger	0
children	I-DISEASE
,	0
have	0
a	0
pattern	0
of	I-DISEASE
obstructive	0
hypoventilation	I-DISEASE
,	I-DISEASE
which	0
consists	0
of	I-DISEASE
long	0
periods	I-DISEASE
of	I-DISEASE
persistent	I-DISEASE
partial	I-DISEASE
upper	I-DISEASE
airway	0
obstruction	0
associated	0
with	I-DISEASE
hypercapnia	0
,	0
arterial	I-DISEASE
oxygen	I-DISEASE
desatu-	I-DISEASE
ration	I-DISEASE
,	0
or	0
both	I-DISEASE
.	0

Some	I-DISEASE
children	I-DISEASE
may	0
manifest	0
a	0
pattern	0
of	I-DISEASE
UARS	I-DISEASE
similar	0
to	I-DISEASE
that	I-DISEASE
seen	I-DISEASE
in	0
adults	I-DISEASE
,	I-DISEASE
including	I-DISEASE
snoring	0
without	0
identifiable	I-DISEASE
airflow	I-DISEASE
obstruction	0
and	0
increasingly	I-DISEASE
negative	I-DISEASE
esophageal	I-DISEASE
pressure	0
swings	0
and	0
cyclic	0
arousals	0
.	0

In	I-DISEASE
children	I-DISEASE
,	0
upper	I-DISEASE
airway	0
obstruction	0
occurs	0
predominantly	I-DISEASE
during	I-DISEASE
REM	I-DISEASE
sleep	0
.	0

Children	I-DISEASE
often	0
do	0
not	0
have	0
cor-	0
tical	0
arousals	0
in	I-DISEASE
response	0
to	0
the	0
upper	0
airway	I-DISEASE
obstruction	0
,	0
although	0
they	0
may	I-DISEASE
have	0
movement	I-DISEASE
or	0
autonomic	0
arousals	0
.	0

Perhaps	I-DISEASE
as	0
a	0
result	0
of	I-DISEASE
this	I-DISEASE
higher	0
arousal	I-DISEASE
threshold	0
,	0
sleep	0
architecture	I-DISEASE
is	I-DISEASE
usually	I-DISEASE
normal	B-DISEASE
,	I-DISEASE
with	I-DISEASE
normal	0
amounts	0
of	I-DISEASE
slow	0
wave	I-DISEASE
sleep	I-DISEASE
.	0

Even	I-DISEASE
short	0
obstructive	0
apneas	0
may	I-DISEASE
be	I-DISEASE
associated	I-DISEASE
with	I-DISEASE
severe	0
hypoxemia	0
because	0
children	I-DISEASE
have	0
a	0
lower	0
functional	0
residual	0
capacity	0
and	0
a	0
higher	0
metabolic	0
rate	0
than	0
adults	B-DISEASE
.	0

Most	I-DISEASE
children	I-DISEASE
with	0
OSA	I-DISEASE
present	I-DISEASE
with	I-DISEASE
a	I-DISEASE
history	I-DISEASE
of	I-DISEASE
snoring	0
and	0
difficulty	0
breathing	I-DISEASE
during	I-DISEASE
sleep	I-DISEASE
.	0

Snoring	I-DISEASE
is	I-DISEASE
usually	0
loud	I-DISEASE
and	0
may	I-DISEASE
be	0
punctuated	0
by	I-DISEASE
pauses	I-DISEASE
and	0
gasps	I-DISEASE
,	I-DISEASE
with	I-DISEASE
associated	0
movements	0
or	I-DISEASE
arousal	0
from	I-DISEASE
sleep	0
.	0

However	I-DISEASE
,	I-DISEASE
some	0
patients	I-DISEASE
,	0
particu-	I-DISEASE
larly	0
infants	0
and	0
those	I-DISEASE
with	0
neuromuscular	0
weakness	0
,	I-DISEASE
may	0
not	0
snore	0
.	0

Patients	I-DISEASE
with	0
obstructive	0
hypoventilation	I-DISEASE
often	I-DISEASE
have	I-DISEASE
continuous	0
snoring	0
without	0
pauses	0
or	I-DISEASE
arous-	0
als	I-DISEASE
.	0

Children	I-DISEASE
have	0
a	0
very	I-DISEASE
compliant	0
rib	0
cage	0
.	0

As	I-DISEASE
a	0
result	0
,	I-DISEASE
paradoxical	0
breathing	B-DISEASE
is	0
a	0
prominent	0
sign	0
in	I-DISEASE
these	I-DISEASE
patients	0
(	I-DISEASE
note	0
that	I-DISEASE
paradoxical	0
breathing	0
during	I-DISEASE
REM	0
sleep	I-DISEASE
is	0
a	0
normal	0
phenomenon	0
in	I-DISEASE
young	I-DISEASE
children	0
up	0
to	I-DISEASE
at	I-DISEASE
least	0
age	0
three	0
years	I-DISEASE
)	0
.	0

A	I-DISEASE
pectus	0
excavatum	0
may	0
be	0
present	0
.	0

Thoracic	I-DISEASE
retractions	0
may	0
be	I-DISEASE
present	0
.	0

Children	I-DISEASE
may	0
sleep	0
in	I-DISEASE
unusual	0
positions	0
,	0
such	I-DISEASE
as	0
seated	0
or	0
with	I-DISEASE
their	I-DISEASE
neck	I-DISEASE
hyperextended	0
.	0

Diaphoresis	I-DISEASE
may	0
be	I-DISEASE
observed	I-DISEASE
.	0

Morning	I-DISEASE
headaches	I-DISEASE
may	I-DISEASE
also	0
occur	I-DISEASE
.	0

Many	I-DISEASE
parents	I-DISEASE
of	I-DISEASE
children	I-DISEASE
with	0
OSA	I-DISEASE
are	I-DISEASE
so	0
concerned	0
about	0
their	0
child	I-DISEASE
’s	I-DISEASE
breathing	I-DISEASE
that	0
they	I-DISEASE
sleep	0
with	0
their	I-DISEASE
child	0
or	0
stimu-	0
late	I-DISEASE
their	I-DISEASE
child	I-DISEASE
to	I-DISEASE
terminate	I-DISEASE
the	0
apneas	0
.	0

Excessive	I-DISEASE
daytime	I-DISEASE
sleepiness	0
may	0
be	I-DISEASE
present	I-DISEASE
,	0
especially	0
in	I-DISEASE
older	0
children	I-DISEASE
and	0
adoles-	0
cents	0
,	0
but	0
is	0
seen	I-DISEASE
less	I-DISEASE
commonly	I-DISEASE
in	0
children	I-DISEASE
than	0
in	I-DISEASE
adults	I-DISEASE
with	I-DISEASE
OSA	0
.	0

Developmental	I-DISEASE
,	0
behavioral	I-DISEASE
,	0
and	0
learning	0
issues	I-DISEASE
are	0
frequently	0
present	I-DISEASE
.	0

These	0
may	I-DISEASE
include	I-DISEASE
attention	0
problems	0
,	I-DISEASE
hyperactivity	I-DISEASE
,	0
moodiness	0
,	I-DISEASE
irritability	0
,	0
and	0
impaired	I-DISEASE
academic	I-DISEASE
performance	0
.	0

Associated	I-DISEASE
Features	I-DISEASE
Hypoxemia	I-DISEASE
and	0
hypercapnia	I-DISEASE
are	0
often	I-DISEASE
present	I-DISEASE
during	I-DISEASE
sleep	0
and	0
may	I-DISEASE
be	0
severe	0
.	0

A	I-DISEASE
prom-	0
inent	0
sinus	I-DISEASE
arrhythmia	0
is	I-DISEASE
often	0
seen	I-DISEASE
,	I-DISEASE
although	I-DISEASE
other	0
arrhythmias	0
are	I-DISEASE
rare	0
.	0

Secondary	I-DISEASE
enuresis	I-DISEASE
may	0
occur	I-DISEASE
.	0

Breathing	0
during	I-DISEASE
wakefulness	0
is	I-DISEASE
normal	0
,	0
although	0
mouth	0
breath-	I-DISEASE
ing	I-DISEASE
secondary	0
to	I-DISEASE
adenoidal	I-DISEASE
hypertrophy	0
may	I-DISEASE
be	0
present	I-DISEASE
.	0

Other	I-DISEASE
nonspecific	0
daytime	I-DISEASE
symptoms	I-DISEASE
related	B-DISEASE
to	0
adenotonsillar	0
hypertrophy	0
,	0
such	0
as	0
frequent	0
upper	I-DISEASE
respiratory	B-DISEASE
tract	I-DISEASE
infections	I-DISEASE
or	0
dysphagia	0
,	I-DISEASE
may	0
occur	I-DISEASE
.	0

Although	I-DISEASE
studies	I-DISEASE
have	0
shown	I-DISEASE
that	0
children	I-DISEASE
with	I-DISEASE
OSA	I-DISEASE
generally	0
have	0
larger	I-DISEASE
tonsils	I-DISEASE
and	0
adenoidal	0
tissue	0
than	0
do	I-DISEASE
other	I-DISEASE
children	I-DISEASE
,	I-DISEASE
the	0
size	I-DISEASE
of	0
the	I-DISEASE
tonsils	0
and	0
adenoidal	I-DISEASE
tissue	I-DISEASE
does	I-DISEASE
not	0
predict	0
disease	I-DISEASE
in	I-DISEASE
individual	0
patients	I-DISEASE
.	0

Clinical	I-DISEASE
and	0
Pathophysiological	I-DISEASE
Subtypes	I-DISEASE
Clinical	B-DISEASE
presentations	I-DISEASE
include	I-DISEASE
OSA	I-DISEASE
,	I-DISEASE
obstructive	0
hypoventilation	I-DISEASE
,	I-DISEASE
and	0
recurrent	I-DISEASE
arousal	I-DISEASE
associated	0
with	I-DISEASE
increased	0
respiratory	B-DISEASE
effort	I-DISEASE
(	I-DISEASE
RERAs	0
)	0
.	0

Demographics	I-DISEASE
The	I-DISEASE
prevalence	I-DISEASE
in	I-DISEASE
children	I-DISEASE
has	0
been	I-DISEASE
estimated	0
at	I-DISEASE
1	I-DISEASE
%	0
to	0
4	0
%	0
,	I-DISEASE
but	0
the	0
prevalence	0
may	0
currently	I-DISEASE
be	0
higher	0
due	I-DISEASE
to	0
the	I-DISEASE
pediatric	0
obesity	0
epidemic	0
.	B-DISEASE

The	I-DISEASE
prevalence	0
in	0
infants	0
and	0
adolescents	0
is	I-DISEASE
unknown	0
.	0

In	I-DISEASE
prepubertal	I-DISEASE
children	I-DISEASE
,	I-DISEASE
the	I-DISEASE
disease	B-DISEASE
occurs	0
equally	0
among	0
boys	I-DISEASE
and	0
girls	B-DISEASE
;	I-DISEASE
in	I-DISEASE
adolescents	0
,	0
data	I-DISEASE
suggest	0
the	0
prevalence	0
may	I-DISEASE
be	I-DISEASE
higher	0
in	I-DISEASE
males	I-DISEASE
.	0

There	I-DISEASE
appears	I-DISEASE
to	0
be	I-DISEASE
a	0
higher	0
prevalence	0
in	I-DISEASE
black	0
children	0
than	0
white	0
children	I-DISEASE
;	I-DISEASE
the	0
prev-	I-DISEASE
alence	0
in	I-DISEASE
other	I-DISEASE
ethnic	I-DISEASE
groups	0
is	0
unknown	I-DISEASE
.	0

The	I-DISEASE
disease	I-DISEASE
can	0
occur	I-DISEASE
at	I-DISEASE
any	I-DISEASE
age	I-DISEASE
,	I-DISEASE
from	0
the	0
neonatal	0
period	I-DISEASE
to	0
adolescence	0
,	0
but	0
in	I-DISEASE
otherwise	0
healthy	0
children	B-DISEASE
it	0
is	I-DISEASE
most	0
common	I-DISEASE
in	I-DISEASE
the	0
preschool	0
age	I-DISEASE
(	I-DISEASE
in	I-DISEASE
association	B-DISEASE
with	I-DISEASE
adenotonsillar	0
hypertrophy	0
)	I-DISEASE
and	0
in	I-DISEASE
adolescents	0
(	I-DISEASE
in	0
association	0
with	0
obesity	0
)	0
.	0

Predisposing	I-DISEASE
and	0
Precipitating	I-DISEASE
Factors	0
Adenotonsillar	I-DISEASE
hypertrophy	0
and	0
obesity	0
are	0
the	0
most	0
common	0
predisposing	0
/	0
precip-	0
itating	0
factors	0
.	0

Children	I-DISEASE
with	I-DISEASE
craniofacial	I-DISEASE
abnormalities	I-DISEASE
,	0
particularly	0
micrognathia	I-DISEASE
or	0
midfacial	I-DISEASE
hypoplasia	0
,	I-DISEASE
are	0
at	I-DISEASE
risk	0
.	0

Those	I-DISEASE
with	I-DISEASE
Down	I-DISEASE
syndrome	I-DISEASE
are	0
particularly	0
at	I-DISEASE
risk	0
for	0
having	0
OSA	0
.	I-DISEASE

Children	I-DISEASE
with	I-DISEASE
neuromuscular	0
diseases	I-DISEASE
often	0
have	0
upper	0
airway	0
muscle	I-DISEASE
weakness	I-DISEASE
,	0
which	0
predisposes	I-DISEASE
to	I-DISEASE
airway	0
collapse	I-DISEASE
.	0

Children	I-DISEASE
with	I-DISEASE
cerebral	0
palsy	0
may	I-DISEASE
be	I-DISEASE
predisposed	0
to	I-DISEASE
OSA	I-DISEASE
because	0
of	I-DISEASE
spasticity	0
,	0
weakness	I-DISEASE
,	0
or	0
incoordination	I-DISEASE
of	0
the	I-DISEASE
upper	0
airway	I-DISEASE
muscles	0
.	0

Infants	I-DISEASE
with	I-DISEASE
gastroesophageal	0
reflux	0
may	I-DISEASE
develop	0
OSA	I-DISEASE
due	I-DISEASE
to	0
upper	0
airway	0
edema	0
or	I-DISEASE
laryngospasm	0
.	0

Other	I-DISEASE
medical	I-DISEASE
conditions	I-DISEASE
such	I-DISEASE
as	0
mucopoly-	I-DISEASE
saccharidosis	I-DISEASE
and	0
sickle	0
cell	0
disease	0
may	I-DISEASE
predispose	0
to	I-DISEASE
OSA	I-DISEASE
.	I-DISEASE

Pharyngeal	I-DISEASE
flap	0
oper-	0
ations	I-DISEASE
,	0
typically	0
performed	I-DISEASE
to	I-DISEASE
improve	0
speech	I-DISEASE
quality	0
in	I-DISEASE
patients	0
with	0
cleft	I-DISEASE
palate	0
,	0
can	I-DISEASE
result	0
in	I-DISEASE
OSA	I-DISEASE
.	0

Environmental	I-DISEASE
tobacco	0
smoke	0
exposure	0
has	0
been	I-DISEASE
associated	0
with	I-DISEASE
snoring	0
and	0
OSA	I-DISEASE
.	0

Sleep	I-DISEASE
Related	I-DISEASE
Breathing	0
Disorders	I-DISEASE
Sleep	0
Related	0
Breathing	0
Disorders	I-DISEASE
Familial	0
Patterns	0

There	I-DISEASE
is	I-DISEASE
evidence	0
for	I-DISEASE
an	0
increased	I-DISEASE
risk	0
of	I-DISEASE
OSA	0
in	I-DISEASE
children	I-DISEASE
with	I-DISEASE
affected	I-DISEASE
family	0
members	I-DISEASE
.	0

Potential	I-DISEASE
mechanisms	0
for	0
familial	I-DISEASE
aggregation	0
include	I-DISEASE
heritability	I-DISEASE
of	I-DISEASE
pre-	0
disposing	0
skeletal	0
,	I-DISEASE
soft	0
tissue	I-DISEASE
,	0
body	I-DISEASE
habitus	0
,	I-DISEASE
or	B-DISEASE
respiratory	0
control	B-DISEASE
characteristics	I-DISEASE
.	0

However	I-DISEASE
,	I-DISEASE
the	0
relative	I-DISEASE
roles	0
of	I-DISEASE
genetic	I-DISEASE
factors	I-DISEASE
versus	0
environmental	0
factors	0
have	I-DISEASE
not	I-DISEASE
been	I-DISEASE
determined	I-DISEASE
.	0

Onset	I-DISEASE
,	0
Course	0
,	0
and	0
Complications	I-DISEASE
The	I-DISEASE
exact	0
course	I-DISEASE
of	I-DISEASE
pediatric	0
OSA	I-DISEASE
has	0
not	0
been	I-DISEASE
well	I-DISEASE
studied	0
.	0

Symptoms	I-DISEASE
typically	0
begin	I-DISEASE
within	I-DISEASE
the	B-DISEASE
first	0
few	0
years	I-DISEASE
of	I-DISEASE
life	I-DISEASE
,	I-DISEASE
although	0
the	0
disease	B-DISEASE
may	I-DISEASE
not	0
be	0
diagnosed	0
until	0
many	0
years	I-DISEASE
later	0
.	0

The	I-DISEASE
natural	I-DISEASE
course	0
of	I-DISEASE
untreated	0
OSA	I-DISEASE
is	0
not	0
known	I-DISEASE
.	I-DISEASE

A	I-DISEASE
few	0
short	0
-	I-DISEASE
term	0
studies	I-DISEASE
suggest	I-DISEASE
that	I-DISEASE
some	0
children	0
with	I-DISEASE
mild	0
disease	I-DISEASE
may	I-DISEASE
improve	0
,	I-DISEASE
or	I-DISEASE
conversely	I-DISEASE
,	I-DISEASE
have	0
worsening	0
of	I-DISEASE
the	I-DISEASE
condition	0
;	I-DISEASE
long	0
-	I-DISEASE
term	0
studies	I-DISEASE
are	0
not	0
available	0
.	0

Complications	I-DISEASE
are	0
frequent	I-DISEASE
and	0
may	I-DISEASE
be	0
severe	0
.	0

In	I-DISEASE
early	0
childhood	0
,	I-DISEASE
OSA	0
can	I-DISEASE
cause	I-DISEASE
growth	0
failure	0
,	I-DISEASE
especially	0
when	I-DISEASE
associated	0
with	0
a	0
comorbid	I-DISEASE
genetic	0
or	I-DISEASE
craniofacial	0
disorder	0
.	I-DISEASE

Cognitive	I-DISEASE
and	0
behavioral	0
complications	0
are	0
common	I-DISEASE
and	0
may	0
include	0
developmental	I-DISEASE
delay	I-DISEASE
,	I-DISEASE
poor	0
school	0
performance	0
,	I-DISEASE
attention	0
deficit	0
hyperactivity	0
dis-	0
order	0
,	0
inattention	I-DISEASE
and	0
impairment	0
in	0
concentration	0
,	0
and	0
aggressive	0
behavior	0
.	0

Rarely	I-DISEASE
,	0
cases	0
of	0
severe	I-DISEASE
asphyxial	I-DISEASE
brain	0
damage	0
,	I-DISEASE
seizures	I-DISEASE
,	0
and	0
coma	I-DISEASE
have	I-DISEASE
been	0
reported	0
.	0

Cardiovascular	0
complications	0
include	I-DISEASE
pulmonary	0
hypertension	I-DISEASE
,	0
cor	0
pulmonale	0
,	I-DISEASE
and	0
systemic	0
hypertension	0
.	0

Developmental	I-DISEASE
Issues	0
Developmental	I-DISEASE
issues	I-DISEASE
are	0
reviewed	I-DISEASE
within	B-DISEASE
individual	I-DISEASE
sections	0
.	0

Pathology	I-DISEASE
and	0
Pathophysiology	I-DISEASE
In	0
children	0
,	0
as	0
in	I-DISEASE
adults	I-DISEASE
,	0
OSA	I-DISEASE
results	I-DISEASE
from	0
a	0
combination	I-DISEASE
of	I-DISEASE
abnormal	I-DISEASE
neuromuscular	0
control	0
and	0
anatomical	I-DISEASE
narrowing	I-DISEASE
of	I-DISEASE
the	0
collapsible	0
(	0
supracartilaginous	0
)	0
portion	I-DISEASE
of	I-DISEASE
the	0
upper	0
airway	0
.	0

During	I-DISEASE
wakefulness	0
,	I-DISEASE
the	0
patient	I-DISEASE
with	I-DISEASE
OSA	I-DISEASE
compensates	0
by	I-DISEASE
augmenting	0
upper	0
airway	0
muscle	0
tone	0
to	I-DISEASE
dilate	0
the	0
upper	0
airway	I-DISEASE
;	I-DISEASE
thus	0
,	I-DISEASE
obstructive	0
apnea	0
does	0
not	0
occur	0
.	0

During	I-DISEASE
sleep	0
,	0
there	I-DISEASE
is	0
a	0
decrease	I-DISEASE
in	I-DISEASE
ventilatory	0
drive	0
and	0
in	I-DISEASE
neuromuscular	0
tone	0
,	0
facilitating	I-DISEASE
upper	0
airway	0
collapse	I-DISEASE
.	0

The	I-DISEASE
resultant	0
recurrent	0
hypoxemia	I-DISEASE
,	0
hypercapnia	0
,	0
and	0
sleep	0
disruption	I-DISEASE
may	0
lead	0
to	I-DISEASE
neurobehavioral	0
,	I-DISEASE
cardiovascular	I-DISEASE
,	I-DISEASE
and	0
growth	0
abnor-	0
malities	0
.	0

Childhood	I-DISEASE
OSA	0
has	0
also	I-DISEASE
been	I-DISEASE
associated	0
with	I-DISEASE
metabolic	0
and	0
inflammatory	I-DISEASE
abnormalities	I-DISEASE
.	0

In	I-DISEASE
most	0
children	0
who	I-DISEASE
are	0
otherwise	0
healthy	I-DISEASE
,	I-DISEASE
upper	0
airway	0
narrowing	I-DISEASE
is	I-DISEASE
primarily	I-DISEASE
due	0
to	I-DISEASE
adenotonsillar	I-DISEASE
hypertrophy	I-DISEASE
.	0

Pediatric	I-DISEASE
OSA	0
also	0
occurs	0
in	I-DISEASE
association	I-DISEASE
with	I-DISEASE
obesity	0
,	I-DISEASE
which	I-DISEASE
is	I-DISEASE
becoming	I-DISEASE
increasingly	I-DISEASE
prevalent	I-DISEASE
.	I-DISEASE

Other	I-DISEASE
causes	0
for	0
upper	I-DISEASE
airway	0
narrowing	I-DISEASE
include	I-DISEASE
craniofacial	0
anomalies	0
,	I-DISEASE
particularly	0
those	0
involving	0
midface	I-DISEASE
hypoplasia	0
or	0
micrognathia	I-DISEASE
/	0
retrognathia	0
.	0

In	I-DISEASE
addition	0
,	0
children	I-DISEASE
with	0
decreased	I-DISEASE
upper	0
airway	I-DISEASE
muscle	0
tone	I-DISEASE
or	I-DISEASE
abnormal	I-DISEASE
upper	I-DISEASE
airway	0
muscle	I-DISEASE
function	I-DISEASE
,	0
such	0
as	0
children	I-DISEASE
with	I-DISEASE
muscular	0
dys-	0
trophy	0
or	0
cerebral	I-DISEASE
palsy	0
,	0
are	0
at	I-DISEASE
increased	0
risk	0
for	I-DISEASE
OSA	0
.	0

Objective	I-DISEASE
Findings	I-DISEASE
PSG	0
demonstrates	I-DISEASE
obstructive	0
and	0
mixed	I-DISEASE
apneas	0
,	0
hypopneas	0
,	I-DISEASE
or	I-DISEASE
periods	0
of	I-DISEASE
obstructive	0
hypoventilation	0
.	0

In	I-DISEASE
children	I-DISEASE
,	0
obstructive	0
apneas	I-DISEASE
lasting	0
two	I-DISEASE
respiratory	I-DISEASE
cycles	0
or	0
longer	I-DISEASE
are	I-DISEASE
scored	0
.	0

In	I-DISEASE
contrast	I-DISEASE
to	0
adults	I-DISEASE
with	0
OSA	I-DISEASE
,	I-DISEASE
EEG	0
arousals	0
may	I-DISEASE
or	I-DISEASE
may	0
not	0
be	I-DISEASE
present	I-DISEASE
fol-	0
lowing	0
apneas	0
,	I-DISEASE
especially	0
in	I-DISEASE
young	I-DISEASE
children	B-DISEASE
,	0
although	0
subcortical	I-DISEASE
/	0
autonomic	0
arousals	0
(	0
as	0
manifested	0
by	I-DISEASE
body	I-DISEASE
movements	0
,	0
tachycardia	0
,	0
or	I-DISEASE
measurements	0
of	I-DISEASE
pulse	I-DISEASE
transit	0
time	0
or	I-DISEASE
arterial	I-DISEASE
tonometry	0
)	0
may	0
occur	I-DISEASE
.	0

Possibly	I-DISEASE
as	I-DISEASE
a	0
result	I-DISEASE
of	I-DISEASE
the	I-DISEASE
higher	0
arousal	0
threshold	I-DISEASE
,	I-DISEASE
sleep	I-DISEASE
architecture	I-DISEASE
is	0
usually	I-DISEASE
preserved	I-DISEASE
.	I-DISEASE

Apneas	I-DISEASE
and	0
hypopneas	I-DISEASE
occur	I-DISEASE
primarily	I-DISEASE
during	I-DISEASE
REM	I-DISEASE
sleep	0
,	I-DISEASE
and	0
breathing	0
may	0
be	I-DISEASE
totally	0
normal	0
during	I-DISEASE
NREM	0
sleep	0
.	0

Obstructive	I-DISEASE
events	0
are	0
frequently	I-DISEASE
associated	0
with	0
desaturation	0
and	0
hypercapnia	I-DISEASE
.	I-DISEASE

Evaluation	I-DISEASE
of	I-DISEASE
the	0
upper	I-DISEASE
airway	0
by	I-DISEASE
endoscopy	I-DISEASE
,	0
radiography	I-DISEASE
,	I-DISEASE
computed	0
tomographic	I-DISEASE
scans	0
,	0
or	0
magnetic	I-DISEASE
resonance	0
imaging	I-DISEASE
studies	0
may	I-DISEASE
show	0
large	I-DISEASE
tonsils	0
and	0
adenoidal	0
tissue	I-DISEASE
and	0
a	0
narrow	0
upper	0
airway	0
,	0
although	I-DISEASE
these	I-DISEASE
tests	I-DISEASE
are	0
not	0
performed	0
routinely	0
.	0

Echocardiography	I-DISEASE
may	0
show	I-DISEASE
evidence	0
of	I-DISEASE
right	0
,	0
left	0
,	I-DISEASE
or	I-DISEASE
biventricular	I-DISEASE
hypertrophy	I-DISEASE
.	0

Differential	I-DISEASE
Diagnosis	0
Pediatric	I-DISEASE
OSA	I-DISEASE
must	0
be	0
differentiated	0
from	I-DISEASE
isolated	I-DISEASE
snoring	0
.	I-DISEASE

Children	I-DISEASE
with	I-DISEASE
snoring	0
but	I-DISEASE
without	0
observed	I-DISEASE
apnea	0
,	I-DISEASE
labored	I-DISEASE
breathing	0
during	I-DISEASE
sleep	0
,	I-DISEASE
daytime	0
behavioral	0
issues	0
,	0
sleepiness	0
,	I-DISEASE
or	I-DISEASE
other	0
symptoms	I-DISEASE
of	I-DISEASE
OSA	I-DISEASE
may	I-DISEASE
not	0
require	0
further	I-DISEASE
laboratory	I-DISEASE
investigation	0
.	0

However	I-DISEASE
,	I-DISEASE
children	0
who	I-DISEASE
have	0
snoring	0
and	0
symptoms	0
of	I-DISEASE
OSA	I-DISEASE
need	I-DISEASE
evaluation	0
to	I-DISEASE
deter-	I-DISEASE
mine	0
whether	I-DISEASE
they	I-DISEASE
have	0
isolated	0
snoring	0
or	I-DISEASE
OSA	0
(	I-DISEASE
N.B.	B-DISEASE
this	0
distinction	0
can	0
not	0
reliably	0
be	0
made	0
clinically	I-DISEASE
but	I-DISEASE
should	I-DISEASE
be	I-DISEASE
based	I-DISEASE
on	0
PSG	0
)	0
.	0

Children	I-DISEASE
with	I-DISEASE
primary	0
snoring	0
do	0
not	0
have	0
apneas	0
,	I-DISEASE
gas	0
exchange	I-DISEASE
abnormalities	I-DISEASE
,	0
or	0
frequent	I-DISEASE
arousals	0
on	0
PSG	0
.	0

Central	I-DISEASE
sleep	0
apnea	0
can	0
be	0
differentiated	I-DISEASE
from	0
OSA	0
by	I-DISEASE
the	I-DISEASE
lack	I-DISEASE
of	0
chest	0
or	I-DISEASE
abdominal	I-DISEASE
wall	0
move-	0
ment	0
associated	0
with	I-DISEASE
the	0
central	0
apneas	0
.	0

Mixed	I-DISEASE
apneas	0
may	I-DISEASE
be	0
seen	I-DISEASE
and	0
are	0
included	I-DISEASE
in	I-DISEASE
the	I-DISEASE
diagnosis	I-DISEASE
of	I-DISEASE
OSA	0
.	0

Children	I-DISEASE
with	I-DISEASE
fixed	0
upper	I-DISEASE
airway	0
obstruction	0
due	0
to	I-DISEASE
struc-	0
tural	0
abnormalities	I-DISEASE
tend	0
to	I-DISEASE
obstruct	0
both	I-DISEASE
awake	I-DISEASE
and	0
asleep	I-DISEASE
,	I-DISEASE
and	0
have	I-DISEASE
stridor	I-DISEASE
rather	0
than	I-DISEASE
snoring	0
.	0

OSA	I-DISEASE
in	I-DISEASE
children	I-DISEASE
must	0
be	I-DISEASE
distinguished	I-DISEASE
from	I-DISEASE
nonobstructive	B-DISEASE
alveolar	I-DISEASE
hypoventilation	I-DISEASE
.	0

Children	I-DISEASE
with	I-DISEASE
lung	0
or	I-DISEASE
chest	0
wall	I-DISEASE
disease	I-DISEASE
may	I-DISEASE
have	0
desaturation	0
and	0
hypercapnia	I-DISEASE
during	I-DISEASE
sleep	0
.	0

It	I-DISEASE
may	I-DISEASE
be	0
difficult	I-DISEASE
to	0
separate	0
nonobstructive	I-DISEASE
hypoventila-	I-DISEASE
tion	0
and	0
desaturation	I-DISEASE
from	0
OSA	I-DISEASE
,	0
especially	I-DISEASE
because	0
the	I-DISEASE
two	I-DISEASE
conditions	I-DISEASE
may	0
coexist	B-DISEASE
.	0

In	I-DISEASE
general	0
,	0
children	I-DISEASE
with	0
nonobstructive	I-DISEASE
hypoventilation	I-DISEASE
will	0
not	0
snore	I-DISEASE
and	0
will	0
not	0
have	0
paradoxical	I-DISEASE
inward	I-DISEASE
rib	0
cage	0
motion	I-DISEASE
during	I-DISEASE
inspiration	0
,	0
although	0
the	0
latter	0
may	0
be	I-DISEASE
present	I-DISEASE
in	0
children	0
with	0
neuromuscular	0
disease	I-DISEASE
.	0

OSA	I-DISEASE
must	0
be	I-DISEASE
differentiated	0
from	I-DISEASE
Sleep	0
Related	0
Breathing	0
Disorders	I-DISEASE
Sleep	0
Related	I-DISEASE
Breathing	0
Disorders	0
other	0
causes	I-DISEASE
of	0
sleepiness	0
such	0
as	0
narcolepsy	0
,	I-DISEASE
idiopathic	I-DISEASE
hypersomnia	0
,	I-DISEASE
and	0
insufficient	I-DISEASE
sleep	0
.	0

Sleep	I-DISEASE
related	0
epilepsy	0
may	I-DISEASE
mimic	I-DISEASE
obstructive	0
apnea	0
during	0
sleep	0
and	0
may	I-DISEASE
be	0
indistinguishable	0
from	I-DISEASE
OSA	0
without	0
the	0
appropriate	I-DISEASE
EEG	0
monitoring	0
,	0
especially	0
in	I-DISEASE
infants	0
who	I-DISEASE
may	0
have	0
only	0
subtle	0
motor	0
components	0
of	I-DISEASE
seizures	I-DISEASE
.	0

Unresolved	I-DISEASE
Issues	0
and	0
Further	I-DISEASE
Directions	0

There	I-DISEASE
is	I-DISEASE
a	0
need	0
for	0
further	I-DISEASE
research	I-DISEASE
in	I-DISEASE
many	0
aspects	0
of	I-DISEASE
pediatric	0
OSA	I-DISEASE
.	0

Although	I-DISEASE
studies	I-DISEASE
of	I-DISEASE
prevalence	I-DISEASE
have	0
been	I-DISEASE
performed	0
in	I-DISEASE
the	0
past	I-DISEASE
,	0
the	0
prevalence	I-DISEASE
has	I-DISEASE
probably	0
increased	0
in	I-DISEASE
recent	I-DISEASE
years	0
due	0
to	I-DISEASE
the	0
increasing	0
prevalence	0
of	I-DISEASE
childhood	0
obesity	0
.	0

Further	I-DISEASE
data	I-DISEASE
regarding	0
the	0
prevalence	0
in	0
infants	0
and	0
adolescents	0
is	0
needed	0
.	0

The	I-DISEASE
natural	I-DISEASE
course	0
of	I-DISEASE
the	0
disease	I-DISEASE
,	I-DISEASE
the	I-DISEASE
optimal	0
techniques	0
for	0
monitoring	I-DISEASE
patients	I-DISEASE
during	I-DISEASE
PSG	0
,	I-DISEASE
the	I-DISEASE
effects	0
of	I-DISEASE
mild	0
OSA	I-DISEASE
,	I-DISEASE
and	0
the	I-DISEASE
threshold	0
necessitating	0
treatment	I-DISEASE
require	I-DISEASE
further	I-DISEASE
study	0
.	0

The	I-DISEASE
role	0
of	I-DISEASE
genetic	I-DISEASE
,	0
ethnic	I-DISEASE
,	I-DISEASE
and	0
anatomic	0
factors	I-DISEASE
in	I-DISEASE
the	0
pathophysiology	0
of	I-DISEASE
childhood	I-DISEASE
OSA	I-DISEASE
also	0
requires	I-DISEASE
further	I-DISEASE
study	0
.	I-DISEASE

Bibliography	0
Arens	I-DISEASE
R	I-DISEASE
,	0
Marcus	I-DISEASE
CL	0
.	0

Pathophysiology	I-DISEASE
of	I-DISEASE
upper	0
airway	I-DISEASE
obstruction	0
:	I-DISEASE
a	I-DISEASE
developmental	I-DISEASE
perspective	I-DISEASE
.	0

Sleep	I-DISEASE
2004;27:997–1019	0
.	0

Arens	I-DISEASE
R	I-DISEASE
,	I-DISEASE
McDonough	0
JM	0
,	I-DISEASE
Costarino	I-DISEASE
AT	0
,	I-DISEASE
et	0
al	I-DISEASE
.	0

Magnetic	I-DISEASE
resonance	0
imaging	0
of	0
the	0
upper	I-DISEASE
airway	I-DISEASE
structure	0
in	I-DISEASE
children	I-DISEASE
with	I-DISEASE
obstructive	0
sleep	I-DISEASE
apnea	0
syndrome	0
.	0

Am	I-DISEASE
J	0
Respir	0
Crit	0
Care	0
Med	0
2001;164:698–703	I-DISEASE
.	0

Marcus	I-DISEASE
CL	I-DISEASE
,	I-DISEASE
Brooks	0
LJ	0
,	I-DISEASE
Davidson	0
Ward	0
S	I-DISEASE
,	I-DISEASE
et	I-DISEASE
al	I-DISEASE
.	0
;	I-DISEASE
American	I-DISEASE
Academy	I-DISEASE
of	I-DISEASE
Pediatrics	0
.	0

Diagnosis	I-DISEASE
and	0
management	0
of	I-DISEASE
childhood	0
obstructive	0
sleep	0
apnea	I-DISEASE
syndrome	I-DISEASE
:	I-DISEASE
technical	I-DISEASE
report	0
.	0

American	I-DISEASE
Academy	0
of	I-DISEASE
Pediatrics	I-DISEASE
.	0

Pediatrics	0
2012;130	I-DISEASE
:	0
e714–55	0
.	0

Marcus	I-DISEASE
CL	I-DISEASE
,	I-DISEASE
Brooks	0
LJ	0
,	I-DISEASE
Draper	0
K	B-DISEASE
,	I-DISEASE
Gozal	I-DISEASE
D	I-DISEASE
,	I-DISEASE
et	0
al	I-DISEASE
.	0
;	0
American	I-DISEASE
Academy	0
of	I-DISEASE
Pediatrics	0
.	0

Diagnosis	I-DISEASE
and	0
management	0
of	I-DISEASE
childhood	0
obstructive	I-DISEASE
sleep	0
apnea	I-DISEASE
syndrome	I-DISEASE
:	I-DISEASE
clinical	I-DISEASE
practice	0
guideline	0
.	0

American	I-DISEASE
Academy	0
of	I-DISEASE
Pediatrics	I-DISEASE
.	0

Pediatrics	0
2012;130:576–84	I-DISEASE
.	0

Redline	I-DISEASE
S	I-DISEASE
,	I-DISEASE
Tishler	0
PV	0
,	0
Schluchter	0
M	I-DISEASE
,	I-DISEASE
Aylor	0
J	0
,	I-DISEASE
Clark	0
K	0
,	I-DISEASE
Graham	0
G.	I-DISEASE
Risk	I-DISEASE
factors	0
for	I-DISEASE
sleep	0
-	I-DISEASE
disordered	0
breathing	I-DISEASE
in	I-DISEASE
children	I-DISEASE
.	0

Associations	I-DISEASE
with	0
obesity	0
,	I-DISEASE
race	I-DISEASE
,	I-DISEASE
and	0
respiratory	0
problems	0
.	0

Am	I-DISEASE
J	0
Respir	0
Crit	0
Care	0
Med	0
1999;159:1527–32	I-DISEASE
.	0

Central	I-DISEASE
Sleep	I-DISEASE
Apnea	0
Syndromes	I-DISEASE
Central	0
Sleep	0
Apnea	0
with	0
Cheyne	I-DISEASE
-	0
Stokes	0
Breathing	0
ICD-9	0
-	I-DISEASE
CM	0
code	0
:	B-DISEASE
786.04	0
Alternate	0
Names	0
Cheyne	I-DISEASE
-	0
Stokes	0
respiration	0
.	0

Diagnostic	I-DISEASE
Criteria	0
(	I-DISEASE
A	0
or	0
B	0
)	0
+	I-DISEASE
C	I-DISEASE
+	0
D	I-DISEASE
satisfy	0
the	I-DISEASE
criteria	0
A.	0

The	I-DISEASE
presence	0
of	I-DISEASE
one	I-DISEASE
or	0
more	0
of	I-DISEASE
the	0
following	0
:	0
1	0
.	0
Sleepiness	I-DISEASE
.	0

ICD-10	I-DISEASE
-	0
CM	0
code	0
:	0
R06.3	0
Sleep	0
Related	0
Breathing	0
Disorders	I-DISEASE
.	0

Difficulty	I-DISEASE
initiating	I-DISEASE
or	B-DISEASE
maintaining	0
sleep	0
,	I-DISEASE
frequent	I-DISEASE
awakenings	0
,	I-DISEASE
or	I-DISEASE
nonrestorative	0
sleep	I-DISEASE
.	0
.	0

Awakening	I-DISEASE
short	0
of	I-DISEASE
breath	I-DISEASE
.	0
.	I-DISEASE

Snoring	I-DISEASE
.	I-DISEASE
.	0

Witnessed	I-DISEASE
apneas	0
.	0

B.	0
The	I-DISEASE
presence	0
of	0
atrial	I-DISEASE
fibrillation	I-DISEASE
/	0
flutter	I-DISEASE
,	I-DISEASE
congestive	0
heart	I-DISEASE
failure	0
,	0
or	I-DISEASE
a	0
neurological	0
disorder	I-DISEASE
.	0

C.	I-DISEASE
PSG	0
(	0
during	I-DISEASE
diagnostic	0
or	I-DISEASE
positive	0
airway	0
pressure	0
titration	I-DISEASE
)	0
shows	I-DISEASE
all	0
of	0
the	0
following	0
:	I-DISEASE
.	0

Five	I-DISEASE
or	I-DISEASE
more	0
central	0
apneas	0
and/or	0
central	0
hypopneas	I-DISEASE
per	I-DISEASE
hour	0
of	0
sleep.1	0
.	0

The	I-DISEASE
total	0
number	0
of	I-DISEASE
central	0
apneas	0
and/or	0
central	I-DISEASE
hypopneas	I-DISEASE
is	0
>	0
50	0
%	0
of	I-DISEASE
the	0
total	0
number	0
of	0
apneas	0
and	0
hypopneas.2	0
.	0

The	I-DISEASE
pattern	0
of	I-DISEASE
ventilation	0
meets	0
criteria	I-DISEASE
for	0
Cheyne	I-DISEASE
-	0
Stokes	0
breathing	I-DISEASE
(	I-DISEASE
CSB).1	0
D.	0
The	I-DISEASE
disorder	I-DISEASE
is	0
not	0
better	I-DISEASE
explained	0
by	I-DISEASE
another	I-DISEASE
current	I-DISEASE
sleep	0
disorder	B-DISEASE
,	0
medication	0
use	I-DISEASE
(	I-DISEASE
e.g.	0
,	0
opioids	0
)	0
,	0
or	I-DISEASE
substance	I-DISEASE
use	I-DISEASE
disorder	0
.	0

Notes	I-DISEASE
.	0

As	I-DISEASE
defined	I-DISEASE
by	I-DISEASE
the	0
most	0
recent	I-DISEASE
version	I-DISEASE
of	I-DISEASE
the	0
AASM	0
Manual	I-DISEASE
for	I-DISEASE
the	0
Scoring	0
of	I-DISEASE
Sleep	I-DISEASE
and	0
Associated	0
Events	I-DISEASE
.	0
.	0

If	I-DISEASE
criterion	0
C2	0
is	0
not	0
met	0
,	I-DISEASE
CSB	0
can	0
be	I-DISEASE
listed	I-DISEASE
as	I-DISEASE
a	0
polysomnographic	0
finding	I-DISEASE
.	0
.	0

A	I-DISEASE
diagnosis	I-DISEASE
of	I-DISEASE
central	0
sleep	0
apnea	0
(	I-DISEASE
CSA	0
)	0
with	I-DISEASE
CSB	I-DISEASE
does	I-DISEASE
not	0
exclude	I-DISEASE
a	0
diagnosis	0
of	I-DISEASE
OSA	I-DISEASE
.	0

Sleep	I-DISEASE
Related	0
Breathing	0
Disorders	I-DISEASE
Essential	0
Features	I-DISEASE
CSA	0
-	I-DISEASE
CSB	0
is	0
characterized	0
by	0
recurrent	0
central	0
apneas	0
or	0
central	0
hypopneas	I-DISEASE

alternat-	I-DISEASE
ing	0
with	0
a	0
respiratory	0
phase	0
exhibiting	0
a	0
crescendo	I-DISEASE
-	0
decrescendo	0
pattern	0
of	I-DISEASE
flow	I-DISEASE
(	I-DISEASE
or	0
tidal	I-DISEASE
volume	0
)	0
.	0

The	I-DISEASE
longer	I-DISEASE
cycle	0
length	0
(	0
>	0
40	0
seconds	0
;	0
typically	0
45	I-DISEASE
to	I-DISEASE
60	I-DISEASE
seconds	I-DISEASE
)	0
distinguishes	0
CSB	I-DISEASE
from	0
other	I-DISEASE
central	0
sleep	0
apnea	0
types	I-DISEASE
.	0

The	I-DISEASE
vast	I-DISEASE
majority	0
of	I-DISEASE
patients	0
with	I-DISEASE
CSA	I-DISEASE
-	0
CSB	0
have	I-DISEASE
either	I-DISEASE
systolic	0
or	I-DISEASE
diastolic	0
heart	0
failure	I-DISEASE
.	0

In	I-DISEASE
systolic	0
heart	0
failure	0
the	0
cycle	0
length	0
is	0
longer	I-DISEASE
(	I-DISEASE
longer	I-DISEASE
respiratory	0
phase	0
)	0
than	I-DISEASE
in	0
patients	0
with	0
diastolic	0
heart	0
failure	I-DISEASE
,	0
and	0
there	I-DISEASE
is	I-DISEASE
often	0
a	I-DISEASE
delay	0
in	I-DISEASE
the	0
nadir	0
of	0
the	0
associated	0
oxygen	0
desatu-	0
ration	I-DISEASE
.	0

Patients	I-DISEASE
with	0
CSA	I-DISEASE
-	I-DISEASE
CSB	I-DISEASE
have	0
normal	0
or	I-DISEASE
low	0
daytime	I-DISEASE
arterial	I-DISEASE
PCO2	0
(	0
PaCO2	0
)	0
.	0

Some	I-DISEASE
patients	0
with	0
heart	0
failure	0
have	0
a	0
mixture	0
of	0
obstructive	0
and	0
central	0
apneas	0
with	0
more	0
central	0
apneas	0
in	0
the	0
later	0
part	I-DISEASE
of	I-DISEASE
the	0
night	0
or	0
when	0
the	0
patient	0
is	0
placed	0
on	0
posi-	0
tive	0
airway	I-DISEASE
pressure	0
(	0
PAP	0
)	0
.	0

A	I-DISEASE
diagnosis	I-DISEASE
of	I-DISEASE
CSA	0
-	0
CSB	0
requires	0
that	0
events	0
be	0
predom-	I-DISEASE
inantly	0
central	I-DISEASE
apneas	0
and	0
hypopneas	0
with	0
an	0
average	I-DISEASE
frequency	B-DISEASE
of	I-DISEASE
at	I-DISEASE
least	I-DISEASE
5	0
/	0
hour	0
during	I-DISEASE
a	0
diagnostic	0
PSG	0
or	0
either	0
the	0
diagnostic	0
or	0
therapeutic	I-DISEASE
portion	0
of	I-DISEASE
a	0
split	0
-	0
night	0
study	0
.	0

For	I-DISEASE
patients	0
with	0
a	I-DISEASE
mixture	0
of	I-DISEASE
OSA	I-DISEASE
and	0
CSA	0
-	I-DISEASE
CSB	I-DISEASE
,	0
the	0
central	0
apneas	I-DISEASE
may	0
appear	0
only	0
after	0
elimination	0
of	0
obstruction	0
on	0
positive	0
airway	0
pressure	0
.	0

In	I-DISEASE
patient	I-DISEASE
with	0
CSA	0
-	0
CSB	0
,	0
arousal	0
from	I-DISEASE
sleep	0
tends	I-DISEASE
to	I-DISEASE
occur	0
at	I-DISEASE
the	0
zenith	I-DISEASE
of	I-DISEASE
respiratory	0
effort	I-DISEASE
between	0
contiguous	0
central	0
apneas	0
or	0
hypopneas	0
.	0

This	I-DISEASE
can	0
result	0
in	I-DISEASE
sleep	0
fragmen-	I-DISEASE
tation	0
.	0

However	I-DISEASE
,	I-DISEASE
patients	0
may	I-DISEASE
complain	0
of	I-DISEASE
disturbed	0
nocturnal	0
sleep	0
or	0
nocturnal	0
dyspnea	I-DISEASE
rather	I-DISEASE
than	0
daytime	0
sleepiness	0
.	0

Associated	I-DISEASE
Features	I-DISEASE
Presenting	0
features	0
of	I-DISEASE
CSB	0
pattern	0
during	I-DISEASE
sleep	0
may	I-DISEASE
include	I-DISEASE
excessive	I-DISEASE
daytime	0
sleep-	0
iness	I-DISEASE
,	0
insomnia	I-DISEASE
,	0
or	0
nocturnal	0
dyspnea	0
.	0

Because	I-DISEASE
many	0
patients	0
with	I-DISEASE
CSA	0
-	I-DISEASE
CSB	I-DISEASE
have	0
known	I-DISEASE
heart	0
failure	I-DISEASE
,	I-DISEASE
their	0
complaints	0
of	I-DISEASE
frequent	I-DISEASE
awakenings	0
or	0
disturbed	0
sleep	0
may	I-DISEASE
be	I-DISEASE
falsely	I-DISEASE
assumed	0
to	0
be	I-DISEASE
entirely	0
secondary	0
to	0
heart	0
failure	I-DISEASE
.	0

Because	I-DISEASE
studies	I-DISEASE
have	0
shown	I-DISEASE
that	0
approximately	I-DISEASE
60	0
%	0
of	I-DISEASE
patients	0
with	I-DISEASE
heart	0
failure	I-DISEASE
have	I-DISEASE
some	0
form	I-DISEASE
of	I-DISEASE
sleep	I-DISEASE
apnea	0
,	0
a	0
high	I-DISEASE
index	0
of	I-DISEASE
suspicion	0
is	I-DISEASE
indicated	0
.	0

A	I-DISEASE
CSB	I-DISEASE
pattern	0
can	0
also	I-DISEASE
occur	I-DISEASE
during	I-DISEASE
wakefulness	0
and	0
can	I-DISEASE
be	I-DISEASE
observed	I-DISEASE
at	I-DISEASE
bedside	I-DISEASE
or	I-DISEASE
in	I-DISEASE
the	0
clinic	0
.	0

Some	I-DISEASE
studies	I-DISEASE
suggest	0
that	0
the	0
pres-	I-DISEASE
ence	0
of	I-DISEASE
CSA	0
-	I-DISEASE
CSB	0
during	I-DISEASE
wakefulness	I-DISEASE
is	0
associated	0
with	I-DISEASE
a	0
worse	0
prognosis	0
.	I-DISEASE

Although	I-DISEASE
heart	0
failure	0
is	I-DISEASE
the	0
major	I-DISEASE
cause	I-DISEASE
of	I-DISEASE
CSA	0
-	0
CSB	0
,	I-DISEASE
recent	0
studies	I-DISEASE
suggest	I-DISEASE
that	I-DISEASE
it	0
can	0
be	I-DISEASE
noted	0
after	I-DISEASE
stroke	I-DISEASE
.	0

CSA	I-DISEASE
-	0
CSB	0
can	0
rarely	I-DISEASE
present	I-DISEASE
in	0
an	0
idiopathic	B-DISEASE
form	I-DISEASE
or	0
be	0
associated	0
with	I-DISEASE
renal	0
failure	I-DISEASE
.	0

As	I-DISEASE
in	I-DISEASE
other	0
forms	I-DISEASE
of	0
CSA	0
,	I-DISEASE
apneas	0
and	0
hypopneas	I-DISEASE
are	0
associated	0
with	I-DISEASE
absent	0
or	0
reduced	0
ventilatory	0
effort	I-DISEASE
,	I-DISEASE
respectively	0
,	I-DISEASE
due	I-DISEASE
to	0
diminished	I-DISEASE
central	0
respiratory	0
drive	0
.	0

Of	0
inter-	0
est	I-DISEASE
,	0
a	0
longer	0
respiratory	I-DISEASE
phase	0
between	0
apneas	0
is	0
associated	0
with	0
a	I-DISEASE
longer	0
circulation	0
time	0
and	0
delay	0
in	0
the	0
saturation	0
nadir	0
.	0

The	I-DISEASE
CSB	I-DISEASE
breathing	0
pattern	0
is	I-DISEASE
characteristically	0
observed	I-DISEASE
during	I-DISEASE
stages	0
N1	0
and	0
N2	0
and	0
usually	I-DISEASE
resolves	0
or	I-DISEASE
is	0
attenuated	I-DISEASE
during	I-DISEASE
REM	0
sleep	0
.	0

In	I-DISEASE
patients	0
with	0
both	I-DISEASE
OSA	0
and	0
CSA	I-DISEASE
-	0
CSB	0
,	I-DISEASE
the	0
relative	0
amount	I-DISEASE
of	I-DISEASE
central	I-DISEASE
and	0
obstructive	0
apnea	0
can	0
vary	I-DISEASE
over	0
time	I-DISEASE
or	I-DISEASE
even	I-DISEASE
within	0
the	0
same	0
night	0
.	0

Clinical	I-DISEASE
and	0
Pathophysiological	0
Subtypes	I-DISEASE

Some	I-DISEASE
patients	0
have	0
combined	0
OSA	0
and	0
CSA	I-DISEASE
,	0
and	0
the	0
CSA	I-DISEASE
-	0
CSB	I-DISEASE
may	I-DISEASE
not	0
manifest	0
until	0
the	0
patient	I-DISEASE
is	0
placed	0
on	0
positive	0
airway	I-DISEASE
pressure	0
treatment	I-DISEASE
.	0

These	0
patients	I-DISEASE
are	0
considered	I-DISEASE
to	0
have	I-DISEASE
both	I-DISEASE
OSA	I-DISEASE
and	0
CSA	0
with	I-DISEASE
CSB	I-DISEASE
.	0

Patients	I-DISEASE
with	0
systolic	0
or	I-DISEASE
diastolic	0
heart	0
failure	I-DISEASE
may	I-DISEASE
have	0
CSB	0
,	I-DISEASE
but	0
the	0
cycle	0
length	0
is	0
longer	I-DISEASE
in	I-DISEASE
those	I-DISEASE
with	0
systolic	0
dys-	0
function	0
.	0

Patients	I-DISEASE
with	0
neurological	0
disorders	0
may	I-DISEASE
have	0
CSB	0
,	I-DISEASE
but	I-DISEASE
the	0
characteristic	0
cycle	0
length	0
is	I-DISEASE
less	0
well	0
described	0
.	0

Demographics	I-DISEASE
CSA	0
with	I-DISEASE
CSB	I-DISEASE
generally	0
is	0
seen	I-DISEASE
in	I-DISEASE
subjects	I-DISEASE
older	0
than	0
60	I-DISEASE
years	I-DISEASE
.	0

The	I-DISEASE
prevalence	0
of	I-DISEASE
this	I-DISEASE
breathing	B-DISEASE
disorder	I-DISEASE
in	I-DISEASE
the	B-DISEASE
setting	0
of	I-DISEASE
chronic	I-DISEASE
congestive	0
heart	0
failure	0
has	0
been	I-DISEASE
reported	0
to	0
be	I-DISEASE
25	0
%	0
to	0
40	0
%	0
,	0
depending	I-DISEASE
on	0
how	I-DISEASE
patients	I-DISEASE
are	I-DISEASE
divided	0
into	I-DISEASE
those	I-DISEASE
with	0
predomi-	0
nant	0
OSA	0
and	0
those	0
with	I-DISEASE
CSA	I-DISEASE
.	0

In	I-DISEASE
patients	I-DISEASE
with	0
heart	0
failure	0
there	I-DISEASE
is	I-DISEASE
a	I-DISEASE
striking	0
male	I-DISEASE
predominance	0
in	0
the	0
occurrence	0
of	I-DISEASE
CSA	0
-	I-DISEASE
CSB	0
.	0

Of	I-DISEASE
interest	I-DISEASE
,	0
the	0
use	0
of	I-DISEASE
β	0
-	0
blockers	0
and	0
angiotensin	0
-	I-DISEASE
converting	0
enzyme	I-DISEASE
inhibitors	0
for	I-DISEASE
treatment	I-DISEASE
of	I-DISEASE
congestive	0
heart	0
failure	I-DISEASE
has	0
not	0
decreased	I-DISEASE
the	0
prevalence	0
of	I-DISEASE
CSA	I-DISEASE
-	0
CSB	0
.	0

Some	I-DISEASE
form	I-DISEASE
of	I-DISEASE
sleep	0
apnea	0
is	I-DISEASE
reported	0
in	0
50	0
%	0
to	I-DISEASE
70	I-DISEASE
%	0
of	I-DISEASE
patients	I-DISEASE
following	0
stroke	0
,	0
depending	I-DISEASE
on	0
the	0
AHI	0
cutoff	0
used	0
for	I-DISEASE
diagno-	I-DISEASE
sis	I-DISEASE
.	0

Although	I-DISEASE
OSA	0
predominates	0
,	I-DISEASE
central	0
sleep	0
apnea	0
is	I-DISEASE
also	0
common	I-DISEASE
especially	0
in	I-DISEASE
the	0
first	0
few	0
days	0
following	0
stroke	0
.	0

CSA	I-DISEASE
-	0
CSB	I-DISEASE
has	0
been	I-DISEASE
reported	I-DISEASE
to	0
occur	0
in	I-DISEASE
26	I-DISEASE
%	I-DISEASE
to	I-DISEASE
50	0
%	0
of	I-DISEASE
patients	I-DISEASE
in	0
the	0
acute	I-DISEASE
period	I-DISEASE
following	0
stroke	I-DISEASE
.	0

Predisposing	I-DISEASE
and	0
Precipitating	I-DISEASE
Factors	0
The	I-DISEASE
most	I-DISEASE
important	0
predisposing	0
factors	0
are	0
the	0
presence	0
of	I-DISEASE
congestive	0
heart	0
failure	I-DISEASE
,	I-DISEASE
stroke	I-DISEASE
,	I-DISEASE
and	0
possibly	0
renal	B-DISEASE
failure	0
.	0

Within	I-DISEASE
the	0
heart	0
failure	0
population	0
,	I-DISEASE
risk	0
factors	I-DISEASE
for	0
CSB	0
pattern	0
during	I-DISEASE
sleep	0
include	I-DISEASE
male	I-DISEASE
sex	0
,	I-DISEASE
age	0
older	0
than	I-DISEASE
60	0
years	I-DISEASE
,	I-DISEASE
the	0
presence	I-DISEASE
of	0
atrial	I-DISEASE
fibrillation	I-DISEASE
,	0
and	0
daytime	I-DISEASE
hypocapnia	I-DISEASE
(	I-DISEASE
i.e.	0
,	I-DISEASE
awake	0
PaCO2	I-DISEASE
of	I-DISEASE
38	0
mm	0
Hg	I-DISEASE
or	I-DISEASE
less	I-DISEASE
)	0
.	0

In	I-DISEASE
general	I-DISEASE
,	0
greater	I-DISEASE
pulmonary	0
congestion	I-DISEASE
(	I-DISEASE
higher	0
left	0
ventricular	0
end	I-DISEASE
-	I-DISEASE
diastolic	0
pressure	0
)	0
predicts	0
lower	0
PaCO2	0
.	0

Some	I-DISEASE
studies	I-DISEASE
suggest	0
that	I-DISEASE
CSA	0
-	I-DISEASE
CSB	I-DISEASE
occurs	0
more	0
commonly	I-DISEASE
in	I-DISEASE
the	0
supine	0
position	I-DISEASE
.	I-DISEASE

Although	I-DISEASE
renal	0
failure	0
is	0
often	0
listed	0
as	I-DISEASE
a	0
possible	0
cause	I-DISEASE
of	I-DISEASE
CSA-	I-DISEASE
CSB	I-DISEASE
,	I-DISEASE
there	0
is	0
scant	0
literature	0
documenting	I-DISEASE
this	0
association	I-DISEASE
.	0

Familial	I-DISEASE
Patterns	I-DISEASE
Not	I-DISEASE
applicable	0
or	B-DISEASE
known	0
.	0

Sleep	I-DISEASE
Related	0
Breathing	0
Disorders	I-DISEASE
Sleep	0
Related	0
Breathing	0
Disorders	I-DISEASE
Onset	0
,	I-DISEASE
Course	0
,	0
and	0
Complications	0
There	0
are	I-DISEASE
no	0
definitive	I-DISEASE
data	I-DISEASE
concerning	0
the	0
onset	0
.	0

However	I-DISEASE
,	I-DISEASE
because	0
it	0
is	0
seen	I-DISEASE
in	I-DISEASE
the	0
setting	0
of	I-DISEASE
congestive	0
heart	0
failure	0
,	I-DISEASE
stroke	I-DISEASE
,	I-DISEASE
and	0
possibly	0
renal	I-DISEASE
failure	0
,	I-DISEASE
CSA	0
with	0
CSB	I-DISEASE
most	0
likely	I-DISEASE
has	B-DISEASE
its	I-DISEASE
onset	0
following	0
the	0
development	B-DISEASE
of	0
one	0
of	I-DISEASE
these	0
illnesses	0
.	0

In	I-DISEASE
the	0
setting	0
of	I-DISEASE
systolic	0
congestive	0
heart	0
failure	I-DISEASE
,	I-DISEASE
it	0
is	I-DISEASE
associated	0
with	I-DISEASE
a	0
poor	0
prognosis	0
,	I-DISEASE
as	0
indicated	I-DISEASE
by	0
a	I-DISEASE
greater	I-DISEASE
adjusted	I-DISEASE
relative	I-DISEASE
risk	0
for	0
mortality	0
-	I-DISEASE
cardiac	I-DISEASE
transplantation	0
com-	I-DISEASE
pared	0
to	0
patients	0
without	0
CSB	0
.	0

These	0
data	I-DISEASE
suggest	0
that	0
CSB	0
pattern	0
during	I-DISEASE
sleep	0
par-	0
ticipates	0
in	I-DISEASE
the	0
pathophysiology	I-DISEASE
and	0
progression	0
of	I-DISEASE
heart	0
failure	0
.	I-DISEASE

Its	I-DISEASE
clinical	0
signifi-	0
cance	0
in	0
the	0
setting	0
of	I-DISEASE
stroke	I-DISEASE
or	I-DISEASE
other	0
neurological	0
disorders	0
remains	0
less	I-DISEASE
certain	0
.	0

In	I-DISEASE
some	I-DISEASE
patients	0
with	I-DISEASE
CSA	0
after	I-DISEASE
stroke	I-DISEASE
,	0
the	0
pattern	0
can	I-DISEASE
transition	I-DISEASE
to	I-DISEASE
one	0
of	I-DISEASE
OSA	I-DISEASE
.	0

The	I-DISEASE
presence	0
of	I-DISEASE
obstructive	0
apnea	I-DISEASE
following	0
stroke	I-DISEASE
has	I-DISEASE
been	I-DISEASE
found	0
to	I-DISEASE
be	I-DISEASE
associated	0
with	0
a	0
worse	0
prognosis	0
.	0

Developmental	I-DISEASE
Issues	0

Although	I-DISEASE
there	I-DISEASE
are	0
reports	I-DISEASE
of	0
CSB	0
in	I-DISEASE
children	B-DISEASE
,	0
the	0
condition	0
is	I-DISEASE
extremely	I-DISEASE
rare	B-DISEASE
in	I-DISEASE
this	0
age	I-DISEASE
group	I-DISEASE
.	0

Of	I-DISEASE
interest	I-DISEASE
,	0
one	I-DISEASE
study	0
of	I-DISEASE
patients	I-DISEASE
with	I-DISEASE
congestive	0
heart	0
failure	I-DISEASE
across	I-DISEASE
all	0
age	I-DISEASE
groups	0
found	I-DISEASE
CSB	0
to	I-DISEASE
be	0
absent	0
in	0
children	0
but	I-DISEASE
present	0
in	I-DISEASE
40	0
%	0
of	I-DISEASE
the	0
adult	0
patients	0
with	I-DISEASE
congestive	0
heart	0
failure	0
.	0

A	I-DISEASE
limitation	I-DISEASE
of	I-DISEASE
the	0
study	0
was	0
that	0
only	I-DISEASE
ten	0
children	0
with	I-DISEASE
congestive	0
heart	0
failure	0
were	I-DISEASE
studied	I-DISEASE
.	0

Pathology	I-DISEASE
and	0
Pathophysiology	I-DISEASE
CSA	0
with	I-DISEASE
CSB	0
generally	I-DISEASE
arises	0
because	0
of	I-DISEASE
instability	I-DISEASE
in	0
the	0
respiratory	I-DISEASE
control	I-DISEASE
system	0
.	0

A	I-DISEASE
high	I-DISEASE
ventilatory	0
drive	0
and	0
delay	I-DISEASE
in	0
chemoreceptor	0
response	0
to	0
changes	0
of	I-DISEASE
PaCO2	I-DISEASE
and	0
PaO2	0
(	0
due	I-DISEASE
to	0
increased	0
circulation	0
time	I-DISEASE
)	0
are	I-DISEASE
likely	I-DISEASE
the	0
major	I-DISEASE
factors	I-DISEASE
.	0

This	I-DISEASE
breathing	I-DISEASE
disorder	0
tends	0
to	0
occur	I-DISEASE
in	I-DISEASE
individuals	I-DISEASE
with	0
a	0
chronically	I-DISEASE
low	0
PaCO2	I-DISEASE
when	I-DISEASE
awake	I-DISEASE
and	0
asleep	0
.	0

Hyperventilation	I-DISEASE
occurs	0
due	I-DISEASE
to	I-DISEASE
an	0
increase	I-DISEASE
in	I-DISEASE
the	0
responsiveness	0
of	I-DISEASE
the	I-DISEASE
periph-	0
eral	0
and	0
central	0
chemoreceptors	0
.	B-DISEASE

The	I-DISEASE
increased	0
responsiveness	0
is	I-DISEASE
believed	I-DISEASE
to	0
be	0
due	I-DISEASE
to	I-DISEASE
both	I-DISEASE
increased	0
sympathetic	I-DISEASE
tone	I-DISEASE
and	0
stimulation	0
of	0
vagal	I-DISEASE
irritant	I-DISEASE
receptors	0
in	I-DISEASE
the	0
lungs	I-DISEASE
by	I-DISEASE
pulmonary	I-DISEASE
congestion	I-DISEASE
.	0

The	I-DISEASE
PaCO2	0
in	0
individuals	I-DISEASE
with	I-DISEASE
CSB	I-DISEASE
pattern	0
and	0
heart	0
failure	I-DISEASE
is	I-DISEASE
closer	0
to	0
their	0
apneic	I-DISEASE
threshold	0
than	0
in	0
those	0
without	0
CSB	0
pattern	0
(	I-DISEASE
primarily	I-DISEASE
due	I-DISEASE
to	0
a	0
smaller	I-DISEASE
sleep	0
related	B-DISEASE
rise	0
in	I-DISEASE
PaCO2	0
in	0
those	0
with	I-DISEASE
CSB	0
)	0
,	I-DISEASE
so	0
that	0
even	I-DISEASE
modest	0
increases	0
in	0
ventilation	0
can	0
drive	0
PaCO2	0
below	0
the	I-DISEASE
apneic	I-DISEASE
threshold	0
.	0

The	I-DISEASE
most	0
common	I-DISEASE
trigger	I-DISEASE
factor	0
for	0
central	0
apnea	I-DISEASE
is	0
an	0
arousal	I-DISEASE
from	I-DISEASE
sleep	0
,	I-DISEASE
which	0
abruptly	I-DISEASE
augments	0
ventilation	0
and	0
drives	0
PaCO2	0
below	I-DISEASE
the	0
apneic	0
threshold	0
.	0

The	I-DISEASE
crescendo	I-DISEASE
-	0
decrescendo	0
pattern	0
of	I-DISEASE
tidal	0
volume	0
results	0
from	I-DISEASE
prolonged	0
lung	0
-	0
to	I-DISEASE
-	0
che-	0
moreceptor	0
circulatory	I-DISEASE
delay	0
,	0
such	0
that	0
changes	0
in	0
PaCO2	0
in	0
the	0
lung	0
are	0
trans-	0
mitted	I-DISEASE
only	I-DISEASE
very	I-DISEASE
slowly	I-DISEASE
to	0
the	0
chemoreceptors	I-DISEASE
,	0
resulting	0
in	0
a	0
gradual	I-DISEASE
buildup	I-DISEASE
and	0
falloff	I-DISEASE
of	I-DISEASE
ventilatory	0
stimulation	0
.	0

The	I-DISEASE
length	0
of	I-DISEASE
the	0
cycle	0
is	0
directly	I-DISEASE
proportional	0
to	0
lung	0
-	0
to	I-DISEASE
-	I-DISEASE
chemoreceptor	I-DISEASE
circulation	I-DISEASE
time	0
and	0
inversely	0
proportional	0
to	B-DISEASE
cardiac	I-DISEASE
output	I-DISEASE
.	0

Accordingly	I-DISEASE
,	I-DISEASE
whereas	I-DISEASE
the	0
length	0
of	I-DISEASE
the	0
ventilatory	0
-	0
apneic	0
cycle	0
in	I-DISEASE
primary	I-DISEASE
CSA	0
is	I-DISEASE
typically	0
shorter	0
than	0
40	0
seconds	I-DISEASE
,	0
in	I-DISEASE
CSB	0
pattern	0
it	0
is	0
almost	I-DISEASE
invariably	I-DISEASE
longer	0
than	I-DISEASE
40	0
seconds	0
(	I-DISEASE
usually	I-DISEASE
45	0
-	0
90	I-DISEASE
seconds	I-DISEASE
)	0
.	0

One	I-DISEASE
study	0
of	I-DISEASE
patients	I-DISEASE
with	0
varying	0
degrees	0
of	I-DISEASE
heart	0
failure	0
found	0
a	0
considerably	I-DISEASE
shorter	0
cycle	0
time	0
in	I-DISEASE
patients	I-DISEASE
with	0
normal	0
ejection	0
frac-	0
tion	0
(	I-DISEASE
e.g.	0
,	0
diastolic	0
heart	0
failure	0
)	0
.	0

The	I-DISEASE
pathophysiology	I-DISEASE
of	I-DISEASE
CSB	I-DISEASE
pattern	0
in	I-DISEASE
the	0
setting	I-DISEASE
of	I-DISEASE
stroke	0
and	0
renal	I-DISEASE
failure	0
has	0
not	0
been	I-DISEASE
examined	I-DISEASE
in	I-DISEASE
any	I-DISEASE
detail	I-DISEASE
.	0

However	I-DISEASE
,	I-DISEASE
apneas	0
in	0
association	I-DISEASE
with	0
these	0
medical	0
disorders	0
are	I-DISEASE
believed	I-DISEASE
to	0
be	0
due	0
to	I-DISEASE
a	0
reduction	0
in	I-DISEASE
PaCO2	0
below	I-DISEASE
the	0
apneic	0
threshold	I-DISEASE
.	0

In	I-DISEASE
individuals	I-DISEASE
with	0
renal	0
failure	I-DISEASE
,	0
pulmonary	I-DISEASE
congestion	0
(	I-DISEASE
volume	I-DISEASE
overload	I-DISEASE
)	I-DISEASE
may	0
play	I-DISEASE
a	0
role	0
in	0
stimulating	0
hyperventilation	I-DISEASE
.	0

Objective	I-DISEASE
Findings	I-DISEASE

The	I-DISEASE
polysomnographic	0
hallmarks	I-DISEASE
of	0
CSB	0
pattern	0
are	I-DISEASE
recurrent	0
central	0
apneas	I-DISEASE
and	0
central	0
hypopneas	0
alternating	0
with	I-DISEASE
ventilatory	0
periods	0
having	I-DISEASE
a	0
prolonged	0
crescen-	0
do	0
-	0
decrescendo	0
pattern	0
of	I-DISEASE
airflow	0
(	I-DISEASE
tidal	0
volume	I-DISEASE
)	0
.	0

CSB	I-DISEASE
pattern	0
typically	0
occurs	0
at	I-DISEASE
the	0
transition	I-DISEASE
from	0
wakefulness	0
to	I-DISEASE
NREM	I-DISEASE
sleep	0
and	0
during	I-DISEASE
stages	0
N1	0
and	0
N2	0
.	0

It	I-DISEASE
tends	0
to	0
dissipate	I-DISEASE
in	I-DISEASE
stages	I-DISEASE
N3	0
and	0
R.	I-DISEASE

In	I-DISEASE
stage	I-DISEASE
N3	0
sleep	0
the	0
sleeping	0
PaCO2	0
is	0
higher	0
(	I-DISEASE
further	I-DISEASE
above	B-DISEASE
the	0
apneic	0
threshold	0
)	0
.	0

During	I-DISEASE
REM	I-DISEASE
sleep	0
the	0
hypoxic	I-DISEASE
and	0
hypercapnic	0
ventila-	0
tory	I-DISEASE
responses	0
are	I-DISEASE
lower	0
,	0
thereby	I-DISEASE
reducing	0
the	I-DISEASE
tendency	0
for	I-DISEASE
an	0
overshoot	I-DISEASE
in	I-DISEASE
ventilation	0
which	0
may	I-DISEASE
drive	B-DISEASE
PaCO2	0
below	I-DISEASE
the	0
apneic	0
threshold	0
.	0

Arousals	I-DISEASE
are	I-DISEASE
frequently	0
seen	I-DISEASE
in	I-DISEASE
association	I-DISEASE
with	0
CSB	0
and	0
are	I-DISEASE
typically	I-DISEASE
noted	0
at	I-DISEASE
or	I-DISEASE
near	I-DISEASE
the	0
zenith	I-DISEASE
in	I-DISEASE
respiratory	B-DISEASE
effort	I-DISEASE
(	I-DISEASE
or	0
airflow	I-DISEASE
)	0
,	I-DISEASE
although	I-DISEASE
can	0
occur	I-DISEASE
at	I-DISEASE
or	0
near	0
the	0
onset	I-DISEASE
of	I-DISEASE
the	0
respiratory	B-DISEASE
phase	0
pattern	0
.	0

In	I-DISEASE
contrast	I-DISEASE
,	0
arousals	0
tend	I-DISEASE
to	I-DISEASE
occur	I-DISEASE
at	I-DISEASE
apnea	0
termination	I-DISEASE
in	I-DISEASE
other	0
CSA	0
disorders	0
.	0

As	I-DISEASE
noted	0
above	0
,	I-DISEASE
a	0
longer	I-DISEASE
respiratory	0
phase	0
(	0
and	0
cycle	0
length	0
)	I-DISEASE
is	I-DISEASE
associated	0
with	0
lower	0
cardiac	I-DISEASE
output	0
and	0
longer	0
circulation	0
time	0
.	0

Central	I-DISEASE
hypopnea	I-DISEASE
,	I-DISEASE
rather	0
than	I-DISEASE
apnea	0
,	I-DISEASE
can	I-DISEASE
occur	I-DISEASE
at	I-DISEASE
the	0
nadir	0
in	0
respiratory	0
effort	I-DISEASE
in	I-DISEASE
patients	I-DISEASE
with	I-DISEASE
CSB	0
and	0
have	I-DISEASE
been	I-DISEASE
included	I-DISEASE
in	I-DISEASE
calculation	I-DISEASE
of	I-DISEASE
the	0
central	0
AHI	0
in	I-DISEASE
a	0
sub-	0
stantial	0
number	0
of	I-DISEASE
investigations	I-DISEASE
.	0

Central	I-DISEASE
hypopneas	I-DISEASE
are	0
characterized	0
by	0
the	0
absence	0
of	I-DISEASE
snoring	I-DISEASE
,	I-DISEASE
flattening	I-DISEASE
in	0
the	0
nasal	0
pressure	0
or	0
PAP	0
device	0
flow	I-DISEASE
signal	I-DISEASE
,	I-DISEASE
and	0
thoracoab-	0
dominal	0
paradox	I-DISEASE
.	0

Central	I-DISEASE
apneas	0
and	0
central	0
hypopneas	I-DISEASE
are	I-DISEASE
usually	I-DISEASE
accompanied	0
by	I-DISEASE
modest	0
oxyhemo-	0
globin	0
desaturation	I-DISEASE
;	0
arterial	0
oxygen	I-DISEASE
saturation	0
seldom	I-DISEASE
falls	I-DISEASE
below	I-DISEASE
80	0
%	0
to	0
85	0
%	0
.	0

The	I-DISEASE
combination	I-DISEASE
of	I-DISEASE
oxygen	I-DISEASE
desaturation	0
and	0
arousals	0
from	I-DISEASE
sleep	0
leads	0
to	I-DISEASE
sleep	0
fragmenta-	I-DISEASE
tion	0
with	I-DISEASE
reduced	0
amounts	I-DISEASE
of	I-DISEASE
stage	0
N3	0
sleep	0
.	0

Additionally	I-DISEASE
,	I-DISEASE
PaCO2	0
less	I-DISEASE
than	I-DISEASE
40	I-DISEASE

mm	I-DISEASE
Hg	I-DISEASE
is	0
typically	0
observed	I-DISEASE
during	I-DISEASE
wakefulness	0
.	0

In	I-DISEASE
patients	0
with	0
both	I-DISEASE
obstructive	0
and	0
central	0
apneas	0
,	0
the	0
proportion	I-DISEASE
of	I-DISEASE
central	0
apneas	0
tends	0
to	0
increase	I-DISEASE
over	0
the	0
night	0
,	I-DISEASE
and	0
this	0
is	0
Sleep	0
Related	I-DISEASE
Breathing	0
Disorders	0
Sleep	0
Related	0
Breathing	0
Disorders	I-DISEASE
associated	0
with	0
a	0
fall	0
in	I-DISEASE
the	0
sleeping	0
PaCO2	0
.	0

The	I-DISEASE
lower	0
sleeping	0
PaCO2	0
is	0
thought	I-DISEASE
to	0
be	0
due	I-DISEASE
to	I-DISEASE
an	I-DISEASE
increase	I-DISEASE
in	0
pulmonary	I-DISEASE
congestion	0
during	I-DISEASE
the	0
night	0
with	I-DISEASE
stimulation	0
of	I-DISEASE
juxta-	I-DISEASE
capillary	0
(	I-DISEASE
J	B-DISEASE
)	0
receptors	0
in	I-DISEASE
the	0
lung	0
interstitium	0
and	0
a	0
subsequent	0
increase	I-DISEASE
in	I-DISEASE
ventilatory	0
drive	0
.	0

As	I-DISEASE
noted	0
above	0
,	I-DISEASE
some	0
patients	I-DISEASE
have	I-DISEASE
more	I-DISEASE
CSA	0
-	0
CSB	0
in	I-DISEASE
the	0
supine	0
position	I-DISEASE
.	0

Differential	I-DISEASE
Diagnosis	0
Primary	0
CSA	0
can	0
usually	0
be	0
distinguished	I-DISEASE
from	I-DISEASE
CSB	I-DISEASE
pattern	0
by	I-DISEASE
the	0
absence	0
of	0
a	0
history	I-DISEASE
of	I-DISEASE
heart	0
failure	0
,	I-DISEASE
stroke	0
,	I-DISEASE
or	0
renal	0
failure	B-DISEASE
and	0
by	B-DISEASE
the	0
absence	0
of	I-DISEASE
a	0
crescendo	I-DISEASE
-	0
decrescendo	0
breathing	0
pattern	0
between	0
central	0
apneas	0
.	0

The	I-DISEASE
cycle	0
length	0
(	I-DISEASE
apnea	0
+	0
ventilatory	0
phase	0
)	I-DISEASE
in	I-DISEASE
primary	0
CSA	0
is	I-DISEASE
typically	0
less	0
than	I-DISEASE
40	0
seconds	0
.	0

High	I-DISEASE
-	I-DISEASE
altitude	0
periodic	I-DISEASE
breathing	0
only	I-DISEASE
occurs	0
at	I-DISEASE
high	0
altitude	0
and	0
is	0
not	I-DISEASE
associated	0
with	0
heart	0
failure	I-DISEASE
,	I-DISEASE
stroke	0
,	0
or	0
renal	0
failure	0
.	0

Patients	I-DISEASE
with	0
CSA	0
due	I-DISEASE
to	I-DISEASE
drug	I-DISEASE
or	B-DISEASE
substance	0
have	0
a	0
history	I-DISEASE
of	I-DISEASE
use	0
of	I-DISEASE
this	I-DISEASE
type	I-DISEASE
of	0
medication	0
,	I-DISEASE
and	0
an	0
ataxic	I-DISEASE
breathing	0
pattern	0
may	I-DISEASE
be	I-DISEASE
present	I-DISEASE
.	0

If	I-DISEASE
patients	0
with	0
CSA	0
asso-	0
ciated	0
with	I-DISEASE
opioids	0
manifest	0
periodic	I-DISEASE
breathing	I-DISEASE
,	I-DISEASE
the	0
respiratory	0
phase	0
does	0
not	0
have	0
a	0
crescendo	I-DISEASE
-	I-DISEASE
decrescendo	0
pattern	0
and	0
the	0
cycle	0
length	0
is	0
shorter	0
.	0

Patients	I-DISEASE
with	0
CSA	0
due	I-DISEASE
to	I-DISEASE
a	I-DISEASE
medical	0
or	0
neurological	0
disease	I-DISEASE
without	0
Cheyne	I-DISEASE
-	0
Stokes	0
will	0
have	0
central	0
apnea	0
that	0
does	I-DISEASE
not	0
have	0
Cheyne	I-DISEASE
-	I-DISEASE
Stokes	0
morphology	0
,	0
as	0
the	0
name	0
implies	0
.	0

Sleep	I-DISEASE
related	I-DISEASE
hypoven-	0
tilation	I-DISEASE
and	0
hypoxemic	I-DISEASE
syndromes	I-DISEASE
can	I-DISEASE
be	0
readily	I-DISEASE
distinguished	I-DISEASE
from	I-DISEASE
CSA	0
-	0
CSB	I-DISEASE
by	I-DISEASE
documentation	B-DISEASE
of	I-DISEASE
an	I-DISEASE
awake	0
PaCO2	0
>	0

45	I-DISEASE
mm	I-DISEASE

Hg	I-DISEASE
and/or	0
sleep	0
related	0
hypoventilation	I-DISEASE
.	I-DISEASE

Patients	I-DISEASE
with	0
CSA	I-DISEASE
-	I-DISEASE
CSB	I-DISEASE
usually	I-DISEASE
have	0
an	0
awake	0
PaCO2	I-DISEASE
<	I-DISEASE

40	I-DISEASE
mm	I-DISEASE
Hg	I-DISEASE
.	0

In	I-DISEASE
patients	0
with	0
sleep	0
related	0
hypoventilation	0
disorders	0
,	I-DISEASE
some	I-DISEASE
central	0
apneas	0
may	0
be	0
present	I-DISEASE
,	0
but	0
these	I-DISEASE
events	0
do	I-DISEASE
not	0
have	I-DISEASE
a	0
Cheyne	I-DISEASE
-	0
Stokes	0
morphology	0
.	0

Additionally	I-DISEASE
,	I-DISEASE
oxygen	0
desaturation	I-DISEASE
in	I-DISEASE
sleep	0
related	B-DISEASE
hypoventilation	0
syndromes	I-DISEASE
is	I-DISEASE
generally	I-DISEASE
more	0
pronounced	0
during	I-DISEASE
REM	0
sleep	0
.	0

OSA	I-DISEASE
is	0
distinguished	I-DISEASE
by	0
the	0
presence	0
of	I-DISEASE
respiratory	0
efforts	0
during	I-DISEASE
apneas	0
.	0

A	I-DISEASE
few	0
central	0
apneas	I-DISEASE
or	I-DISEASE
hypopneas	0
at	I-DISEASE
sleep	0
onset	0
or	I-DISEASE
during	I-DISEASE
REM	0
sleep	0
are	0
normal	0
,	0
especially	0
in	I-DISEASE
elderly	0
subjects	0
.	0

These	0
cease	I-DISEASE
once	I-DISEASE
sleep	I-DISEASE
becomes	0
stable	I-DISEASE
.	0

Unresolved	I-DISEASE
Issues	0
and	0
Further	I-DISEASE
Directions	0

The	I-DISEASE
pathophysiology	I-DISEASE
and	0
clinical	I-DISEASE
significance	0
of	I-DISEASE
CSB	0
pattern	0
have	I-DISEASE
not	0
yet	0
been	I-DISEASE
eluci-	I-DISEASE
dated	0
in	I-DISEASE
the	0
setting	0
of	I-DISEASE
stroke	0
and	0
renal	0
failure	0
.	0

Less	I-DISEASE
is	I-DISEASE
also	0
known	I-DISEASE
about	0
the	0
importance	0
of	I-DISEASE
CSB	0
in	I-DISEASE
patients	I-DISEASE
with	I-DISEASE
heart	0
failure	0
with	0
a	0
normal	0
ejection	0
fraction	I-DISEASE
.	0

Bibliography	0
Dowdell	I-DISEASE
WT	I-DISEASE
,	I-DISEASE
Javaheri	0
S	I-DISEASE
,	I-DISEASE
McGinnis	I-DISEASE
W.	0
Cheyne	I-DISEASE
-	0
Stokes	0
respiration	I-DISEASE
presenting	0
as	0
sleep	0
apnea	I-DISEASE
syndrome	0
.	0

Clinical	I-DISEASE
and	0
polysomnographic	0
features	0
.	0

Am	I-DISEASE
Rev	I-DISEASE
Respir	0
Dis	I-DISEASE
1990;141:871–9	0
.	0

Hall	I-DISEASE
M	I-DISEASE
,	0
Xie	0
A	0
,	0
Rutherford	0
R	0
,	0
Ando	0
S	I-DISEASE
,	I-DISEASE
Floras	I-DISEASE
J	0
,	I-DISEASE
Bradley	0
T.	0
Cycle	0
length	0
of	I-DISEASE
periodic	I-DISEASE
breathing	I-DISEASE
in	0
patients	I-DISEASE
with	0
and	0
without	0
heart	0
failure	0
.	0

Am	I-DISEASE
J	0
Respir	0
Crit	0
Care	0
Med	0
1996;154:376–81	0
.	0

Lanfranchi	I-DISEASE
P	0
,	0
Braghiroli	0
A	0
,	I-DISEASE
Bosimini	I-DISEASE
E	0
,	I-DISEASE
et	0
al	0
.	0

Prognostic	I-DISEASE
value	I-DISEASE
of	0
nocturnal	0
Cheyne	I-DISEASE
-	0
Stokes	0
respiration	I-DISEASE
in	0
chronic	0
heart	0
failure	I-DISEASE
.	0

Circulation	I-DISEASE
1999;99:1435–40	0
.	0

MacDonald	I-DISEASE
M	I-DISEASE
,	0
Fang	I-DISEASE
J	0
,	I-DISEASE
Pittman	0
SD	0
,	0
White	I-DISEASE
DP	I-DISEASE
,	I-DISEASE
Malhotra	0
A.	I-DISEASE

The	I-DISEASE
current	I-DISEASE
prevalence	0
of	I-DISEASE
sleep	0
disordered	I-DISEASE
breathing	B-DISEASE
in	0
congestive	0
heart	I-DISEASE
failure	I-DISEASE
patients	0
treated	0
with	I-DISEASE
beta	0
-	0
blockers	0
.	0

J	I-DISEASE
Clin	0
Sleep	0
Med	0
2008;4:38–42	I-DISEASE
.	0

Naughton	I-DISEASE
M	I-DISEASE
,	0
Benard	0
D	I-DISEASE
,	0
Tam	0
A	0
,	I-DISEASE
Rutherford	I-DISEASE
R	I-DISEASE
,	0
Bradley	I-DISEASE
T.	0

The	I-DISEASE
role	0
of	I-DISEASE
hyperventilation	I-DISEASE
in	I-DISEASE
the	0
pathogenesis	0
of	I-DISEASE
central	0
sleep	0
apnea	0
in	0
patients	0
with	0
congestive	0
heart	0
failure	I-DISEASE
.	0

Am	I-DISEASE
Rev	I-DISEASE
Respir	0
Dis	I-DISEASE
1993;148:330–8	I-DISEASE
.	0

Peer	I-DISEASE
A	0
,	I-DISEASE
Lorber	0
A	0
,	I-DISEASE
Suraiya	0
S	I-DISEASE
,	I-DISEASE
Malhotra	I-DISEASE
A	0
,	I-DISEASE
Pillar	0
G.	I-DISEASE
The	I-DISEASE
occurrence	0
of	I-DISEASE
Cheyne	I-DISEASE
-	0
Stokes	0
respiration	I-DISEASE
in	0
congestive	0
heart	0
failure	0
:	I-DISEASE
the	0
effect	0
of	I-DISEASE
age	I-DISEASE
.	0

Front	I-DISEASE
Psychiatry	0
2010;1:133	I-DISEASE
.	0

Pressman	I-DISEASE
MR	0
,	I-DISEASE
Benz	0
RL	I-DISEASE
,	I-DISEASE
Schleifer	0
CR	I-DISEASE
,	I-DISEASE
Peterson	0
DD	0
.	0

Sleep	I-DISEASE
disordered	I-DISEASE
breathing	I-DISEASE
in	0
ESRD	I-DISEASE
:	0
acute	0
beneficial	I-DISEASE
effects	0
of	I-DISEASE
treatment	I-DISEASE
with	0
nasal	0
continuous	I-DISEASE
positive	0
airway	0
pressure	0
.	0

Kidney	I-DISEASE
Int	0
1993;43:1134–9	0
.	0

Sahlin	I-DISEASE
C	I-DISEASE
,	0
Svanborg	I-DISEASE
E	0
,	0
Stenlund	0
H	I-DISEASE
,	0
Franklin	I-DISEASE
KA	I-DISEASE
.	0

Cheyne	I-DISEASE
-	I-DISEASE
Stokes	0
respiration	I-DISEASE
and	0
supine	0
dependency	0
.	I-DISEASE

Eur	I-DISEASE
Respir	0
J	0
2005;25:829–33	I-DISEASE
.	0

Sin	I-DISEASE
D	I-DISEASE
,	0
Fitzgerald	0
F	0
,	I-DISEASE
Parker	0
J	0
,	0
Newton	I-DISEASE
G	I-DISEASE
,	I-DISEASE
Floras	I-DISEASE
J	0
,	I-DISEASE
Bradley	I-DISEASE
T.	0
Risk	0
factors	I-DISEASE
for	0
central	0
and	0
obstructive	0
sleep	0
apnea	0
in	0
450	0
men	0
and	0
women	I-DISEASE
with	0
congestive	0
heart	0
failure	0
.	0

Am	I-DISEASE
J	0
Respir	0
Crit	0
Care	0
Med	0
1999;160:1101–6	I-DISEASE
.	0

Sin	I-DISEASE
DD	I-DISEASE
,	0
Logan	0
AG	0
,	I-DISEASE
Fitzgerald	0
FS	I-DISEASE
,	0
et	0
al	I-DISEASE
.	I-DISEASE

Effects	I-DISEASE
of	I-DISEASE
continuous	I-DISEASE
positive	0
airway	0
pressure	0
on	0
cardiovascular	I-DISEASE
outcomes	I-DISEASE
in	I-DISEASE
Heart	I-DISEASE
failure	I-DISEASE
patients	0
with	I-DISEASE
and	0
without	0
Cheyne	0
-	I-DISEASE
Stokes	0
Respiration	0
.	0

Circulation	I-DISEASE
2000;102:61–6	0
.	0

Wedewardt	I-DISEASE
J	0
,	I-DISEASE
Bitter	0
T	0
,	0
Prinz	0
C	I-DISEASE
,	0
Faber	0
L	0
,	I-DISEASE
Horstkotte	0
D	I-DISEASE
,	0
Oldenburg	0
O.	0
Cheyne	I-DISEASE
-	0
Stokes	0
respiration	0
in	I-DISEASE
heart	0
failure	0
:	0
cycle	0
length	0
is	0
dependent	0
on	0
left	0
ventricular	0
ejection	I-DISEASE
fraction	0
.	0

Sleep	I-DISEASE
Med	I-DISEASE
2010;11:137–42	I-DISEASE
.	0

Xie	I-DISEASE
A	0
,	I-DISEASE
Skatrud	0
J	0
,	0
Puleo	0
D	I-DISEASE
,	I-DISEASE
Rahko	0
P	I-DISEASE
,	0
Dempsey	0
J.	0
Apnea	0
-	I-DISEASE
hypopnea	I-DISEASE
threshold	0
for	0
CO2	I-DISEASE
in	I-DISEASE
patients	0
with	I-DISEASE
congestive	0
heart	0
failure	0
.	0

Am	I-DISEASE
J	0
Respir	0
Crit	0
Care	0
Med	0
2002;165:1245–50	I-DISEASE
.	0

Central	I-DISEASE
Apnea	0

Due	I-DISEASE
to	I-DISEASE
a	0
Medical	I-DISEASE
Disorder	0
without	0
Cheyne	I-DISEASE
-	I-DISEASE
Stokes	0
Breathing	0
ICD-9	0
-	I-DISEASE
CM	0
code	0
:	0
327.27	0
Alternate	I-DISEASE
Names	I-DISEASE
Not	I-DISEASE
applicable	0
or	0
known	I-DISEASE
.	0

Diagnostic	I-DISEASE
Criteria	0
Criteria	I-DISEASE
A	0
-	I-DISEASE
C	I-DISEASE
must	I-DISEASE
be	0
met	0
A.	0

The	I-DISEASE
presence	0
of	I-DISEASE
one	I-DISEASE
or	0
more	0
of	I-DISEASE
the	0
following1	0
:	0
1	I-DISEASE
.	I-DISEASE
Sleepiness	I-DISEASE
.	0

ICD-10	I-DISEASE
-	0
CM	0
code	0
:	0
G47.37	0
Sleep	I-DISEASE
Related	0
Breathing	0
Disorders	0
.	0

Difficulty	I-DISEASE
initiating	I-DISEASE
or	B-DISEASE
maintaining	0
sleep	0
,	I-DISEASE
frequent	I-DISEASE
awakenings	0
,	I-DISEASE
or	I-DISEASE
nonrestorative	0
sleep	I-DISEASE
.	0
.	0

Awakening	I-DISEASE
short	0
of	I-DISEASE
breath	I-DISEASE
.	0
.	I-DISEASE

Snoring	I-DISEASE
.	I-DISEASE
.	0

Witnessed	I-DISEASE
apneas	0
.	0

B.	0
PSG	0
shows	0
all	0
of	I-DISEASE
the	I-DISEASE
following	0
:	0
.	0

Five	I-DISEASE
or	I-DISEASE
more	0
central	0
apneas	0
and/or	0
central	0
hypopneas	I-DISEASE
per	I-DISEASE
hour	0
of	0
sleep.2	0
Sleep	0
Related	0
Breathing	0
Disorders	I-DISEASE
.	0

The	I-DISEASE
number	0
of	I-DISEASE
central	0
apneas	0
and/or	0
central	0
hypopneas	I-DISEASE
is	I-DISEASE
>	0
50	0
%	0
of	I-DISEASE
the	0
total	0
number	0
of	I-DISEASE
apneas	0
and	0
hypopneas	0
.	0
.	0

Absence	I-DISEASE
of	I-DISEASE
CSB.2	0
C.	0
The	I-DISEASE
disorder	I-DISEASE
occurs	I-DISEASE
as	I-DISEASE
a	0
consequence	0
of	I-DISEASE
a	I-DISEASE
medical	0
or	0
neurological	I-DISEASE
disorder	I-DISEASE
but	I-DISEASE
is	I-DISEASE
not	0
due	I-DISEASE
to	0
medication	0
use	I-DISEASE
or	B-DISEASE
substance	0
use	I-DISEASE
.	0

Notes	I-DISEASE
.	0

In	I-DISEASE
infants	0
and	0
young	I-DISEASE
children	0
,	I-DISEASE
symptoms	I-DISEASE
are	0
supportive	0
but	0
not	0
required	0
.	I-DISEASE
.	0

As	I-DISEASE
defined	I-DISEASE
by	I-DISEASE
the	0
most	0
recent	I-DISEASE
version	I-DISEASE
of	I-DISEASE
the	0
AASM	0
Manual	I-DISEASE
for	I-DISEASE
the	0
Scoring	0
of	I-DISEASE
Sleep	I-DISEASE
and	0
Associated	0
Events	I-DISEASE
.	0
.	0

Sleep	I-DISEASE
related	0
hypoventilation	0
is	I-DISEASE
not	0
required	0
but	0
may	I-DISEASE
be	I-DISEASE
present	I-DISEASE
.	0

If	I-DISEASE
the	0
patient	I-DISEASE
meets	I-DISEASE
criteria	0
for	I-DISEASE
both	I-DISEASE
sleep	0
related	B-DISEASE
hypoventilation	0
and	0
CSA	I-DISEASE
due	I-DISEASE
to	0
medical	0
or	I-DISEASE
neurological	0
condition	0
not	0
Cheyne	0
-	I-DISEASE
Stokes	0
,	I-DISEASE
both	0
diagnoses	0
can	0
be	I-DISEASE
made	0
.	0
.	0

In	I-DISEASE
some	I-DISEASE
patients	0
other	I-DISEASE
abnormalities	0
of	I-DISEASE
breathing	B-DISEASE
such	0
as	0
ataxic	I-DISEASE
breathing	I-DISEASE
may	0
be	0
prominent	0
.	I-DISEASE
.	0

A	I-DISEASE
diagnosis	I-DISEASE
of	I-DISEASE
central	0
apnea	0
due	I-DISEASE
to	0
a	0
medical	0
disorder	0
without	I-DISEASE
CSB	I-DISEASE
does	I-DISEASE
not	0
exclude	I-DISEASE
a	0
diagnosis	0
of	I-DISEASE
OSA	I-DISEASE
.	0

Essential	I-DISEASE
Features	I-DISEASE
CSA	0
that	0
is	I-DISEASE
attributed	0
to	I-DISEASE
a	0
medical	0
or	0
neurological	0
condition	0
(	I-DISEASE
and	0
does	I-DISEASE
not	0
have	0
the	0
pattern	0
of	I-DISEASE
CSB	0
)	0
is	0
classified	0
here	I-DISEASE
.	0

The	I-DISEASE
majority	0
of	I-DISEASE
these	I-DISEASE
patients	0
have	I-DISEASE
brainstem	0
lesions	0
of	I-DISEASE
developmental	I-DISEASE
,	I-DISEASE
vascular	I-DISEASE
,	I-DISEASE
neoplastic	0
,	I-DISEASE
degenerative	0
,	0
demyelinating	0
,	0
or	I-DISEASE
traumatic	0
origin	I-DISEASE
.	0

Associated	I-DISEASE
Features	I-DISEASE
Patients	0
generally	0
present	I-DISEASE
with	I-DISEASE
sleep	0
fragmentation	0
,	0
excessive	0
daytime	I-DISEASE
sleepiness	0
,	I-DISEASE
or	I-DISEASE
insomnia	I-DISEASE
.	0

Other	I-DISEASE
signs	I-DISEASE
and	0
symptoms	I-DISEASE
that	0
are	0
often	0
,	I-DISEASE
but	0
not	0
invariably	I-DISEASE
,	I-DISEASE
present	0
include	I-DISEASE
snoring	0
,	0
witnessed	I-DISEASE
apnea	0
,	I-DISEASE
and	0
awakening	0
with	0
shortness	0
of	I-DISEASE
breath	0
.	0

The	I-DISEASE
presentation	0
varies	0
with	I-DISEASE
the	0
cause	I-DISEASE
of	I-DISEASE
central	0
apnea	0
and	0
may	I-DISEASE
include	I-DISEASE
neurological	0
findings	0
.	0

Clinical	I-DISEASE
and	0
Pathophysiological	I-DISEASE
Subtypes	I-DISEASE
None	I-DISEASE
.	0

Some	I-DISEASE
of	I-DISEASE
the	0
common	I-DISEASE
medical	0
and	0
neurological	0
disorders	0
causing	0
central	0
apnea	I-DISEASE
not	0
associated	0
with	I-DISEASE
CSB	0
are	I-DISEASE
listed	0
in	I-DISEASE
Pathology	I-DISEASE
and	0
Pathophysiology	0
(	I-DISEASE
below	I-DISEASE
)	0
.	0

Demographics	I-DISEASE
The	0
prevalence	0
and	0
demographics	0
of	I-DISEASE
this	0
disorder	0
vary	I-DISEASE
with	I-DISEASE
the	0
underlying	0
etiology	0
.	0

Patients	I-DISEASE
with	0
Chiari	I-DISEASE
malformation	0
(	0
CM	0
)	I-DISEASE
can	0
present	0
in	I-DISEASE
infancy	0
or	I-DISEASE
childhood	0
,	0
but	I-DISEASE
the	0
most	0
common	B-DISEASE
age	I-DISEASE
of	I-DISEASE
presentation	0
is	I-DISEASE
20	0
to	I-DISEASE
40	0
years	I-DISEASE
.	0

Patients	I-DISEASE
with	0
stroke	I-DISEASE
tend	B-DISEASE
to	I-DISEASE
be	I-DISEASE
older	I-DISEASE
.	0

Predisposing	I-DISEASE
and	0
Precipitating	I-DISEASE
Factors	0
Because	I-DISEASE
of	I-DISEASE
the	0
heterogeneity	0
of	0
etiologies	0
in	I-DISEASE
this	0
type	I-DISEASE
of	I-DISEASE
CSA	0
,	I-DISEASE
predisposing	I-DISEASE
and	0
pre-	0
cipitating	0
factors	0
are	0
variable	I-DISEASE
.	0

In	I-DISEASE
CM	I-DISEASE
there	I-DISEASE
is	0
herniation	0
of	I-DISEASE
a	0
portion	0
of	I-DISEASE
the	I-DISEASE
brainstem	B-DISEASE
through	0
the	0
foramen	I-DISEASE
magnum	0
.	0

In	I-DISEASE
CM	0
type	I-DISEASE
1	0
,	I-DISEASE
a	0
portion	0
of	I-DISEASE
the	0
cerebellar	I-DISEASE
tonsils	0
herni-	0
ate	0
.	0

CSA	I-DISEASE
in	I-DISEASE
these	I-DISEASE
patients	0
is	I-DISEASE
believed	I-DISEASE
to	I-DISEASE
occur	0
due	0
to	0
impaired	I-DISEASE
function	I-DISEASE
of	I-DISEASE
ventilatory	0
control	I-DISEASE
centers	0
in	0
the	0
brainstem	0
.	0

Familial	I-DISEASE
Patterns	I-DISEASE
None	I-DISEASE
known	I-DISEASE
.	0

Onset	I-DISEASE
,	0
Course	0
,	0
and	0
Complications	0
These	0
factors	0
vary	I-DISEASE
as	0
well	0
with	0
the	0
different	I-DISEASE
etiologies	0
.	0

In	I-DISEASE
CM	I-DISEASE
the	0
presentation	0
is	I-DISEASE
typi-	0
cally	I-DISEASE
age	I-DISEASE
20	0
to	0
40	0
years	I-DISEASE
of	I-DISEASE
age	0
but	0
can	0
occur	I-DISEASE
in	I-DISEASE
infants	0
and	0
children	I-DISEASE
.	0

With	I-DISEASE
the	0
increased	0
use	I-DISEASE
of	0
magnetic	I-DISEASE
resonance	I-DISEASE
imaging	I-DISEASE
(	I-DISEASE
MRI	0
)	0
,	I-DISEASE
cases	0
are	0
often	I-DISEASE
diagnosed	I-DISEASE
before	I-DISEASE
symptoms	0
are	0
severe	I-DISEASE
.	0

The	I-DISEASE
CSA	I-DISEASE
following	0
a	0
cerebrovascular	I-DISEASE
accident	0
(	I-DISEASE
CVA	I-DISEASE
)	0
is	I-DISEASE
abrupt	I-DISEASE
in	I-DISEASE
onset	0
.	0

In	I-DISEASE
patients	0
exhibiting	0
both	I-DISEASE
central	0
and	0
obstructive	0
apnea	0
,	I-DISEASE
the	0
central	0
apneas	0
tend	I-DISEASE
to	0
resolve	0
with	I-DISEASE
time	0
.	0

Some	I-DISEASE
post	0
-	0
CVA	I-DISEASE
patients	0
with	I-DISEASE
central	0
apneas	0
have	I-DISEASE
central	0
apnea	0
with	I-DISEASE
CSB	0
,	0
whereas	0
in	I-DISEASE
others	B-DISEASE
the	0
CSA	I-DISEASE
does	I-DISEASE
not	0
have	0
a	0
pattern	0
consistent	0
with	0
CSB	0
.	0

The	I-DISEASE
central	0
apneas	0
can	0
lead	0
to	0
sleep	0
fragmentation	0
,	I-DISEASE
yielding	I-DISEASE
either	0
hypersomnolence	0
or	0
insomnia	0
or	0
both	I-DISEASE
.	0

There	I-DISEASE
is	I-DISEASE
little	0
evidence	0
that	0
these	I-DISEASE
apneas	0
or	0
their	0
associated	I-DISEASE
hypoxia	I-DISEASE
and	0
hypercapnia	0
lead	0
to	0
pulmonary	0
hypertension	I-DISEASE
,	0
cor	0
pulmonale	0
,	0
or	0
other	I-DISEASE
adverse	0
car-	0
diovascular	0
consequences	I-DISEASE
.	0

Developmental	I-DISEASE
Issues	0
Not	I-DISEASE
known	0
.	0

Pathology	I-DISEASE
and	0
Pathophysiology	I-DISEASE
CSA	0
is	0
caused	0
by	I-DISEASE
failure	I-DISEASE
of	I-DISEASE
the	0
ventilatory	0
control	0
centers	I-DISEASE
to	0
initiate	I-DISEASE
ventilatory	0
effort	0
.	I-DISEASE

The	I-DISEASE
abnormality	I-DISEASE
is	0
due	0
to	0
dysfunction	0
of	I-DISEASE
central	0
ventilatory	0
control	0
centers	I-DISEASE
.	0

The	I-DISEASE
pres-	I-DISEASE
ence	0
of	I-DISEASE
sleep	0
may	0
unmask	0
ventilatory	0
control	I-DISEASE
abnormalities	I-DISEASE
with	0
the	0
loss	I-DISEASE
of	I-DISEASE
the	0
wake-	0
fulness	I-DISEASE
stimulus	0
.	0

Sleep	I-DISEASE
related	B-DISEASE
hypoventilation	0
and/or	0
daytime	0
hypoventilation	I-DISEASE
may	I-DISEASE
coexist	B-DISEASE
with	I-DISEASE
CSA	0
due	0
to	0
medical	0
or	0
neurological	0
disorder	0
,	B-DISEASE
not	0
CSB	0
,	0
in	I-DISEASE
which	0
case	I-DISEASE
both	I-DISEASE
diagnoses	0
can	0
be	I-DISEASE
made	0
.	0

A	I-DISEASE
number	0
of	I-DISEASE
causes	I-DISEASE
of	I-DISEASE
CSA	I-DISEASE
due	I-DISEASE
to	0
medical	0
or	I-DISEASE
neurological	0
disorders	0
–	0
not	0
Cheyne-	I-DISEASE
Stokes	0
—	I-DISEASE
have	I-DISEASE
been	I-DISEASE
described	I-DISEASE
.	0

Patients	I-DISEASE
with	0
CM	I-DISEASE
exhibit	0
obstructive	0
,	I-DISEASE
central	0
,	I-DISEASE
or	I-DISEASE
a	0
mixture	0
of	I-DISEASE
obstructive	I-DISEASE
and	0
central	0
apneas	0
.	0

Some	I-DISEASE
patient	I-DISEASE
exhibit	0
nocturnal	I-DISEASE
hypoventi-	I-DISEASE
lation	0
but	I-DISEASE
rarely	0
daytime	I-DISEASE
hypoventilation	I-DISEASE
.	0

CSA	I-DISEASE
and/or	0
OSA	I-DISEASE
can	I-DISEASE
be	0
the	0
initial	0
presenta-	I-DISEASE
tion	0
of	I-DISEASE
the	I-DISEASE
disorder	0
.	0

Symptoms	I-DISEASE
include	0
headache	I-DISEASE
(	I-DISEASE
especially	0
with	0
laughter	0
,	0
coughing	I-DISEASE
,	I-DISEASE
Sleep	I-DISEASE
Related	0
Breathing	0
Disorders	0
Sleep	0
Related	0
Breathing	0
Disorders	0
or	B-DISEASE
exertion	I-DISEASE
)	0
,	0
neck	0
pain	0
,	0
and	0
vertigo	I-DISEASE
.	0

An	I-DISEASE
MRI	0
is	I-DISEASE
diagnostic	0
of	I-DISEASE
the	I-DISEASE
condition	I-DISEASE
and	0
should	0
be	0
considered	I-DISEASE
as	I-DISEASE
part	I-DISEASE
of	I-DISEASE
the	0
evaluation	I-DISEASE
of	I-DISEASE
all	0
patients	0
without	0
an	0
obvious	I-DISEASE
cause	I-DISEASE
of	I-DISEASE
central	0
apnea	0
.	0

Brainstem	0
neoplasm	I-DISEASE
can	I-DISEASE
present	I-DISEASE
with	0
central	0
apnea	0
not	0
of	I-DISEASE
the	0
Cheyne	I-DISEASE
-	0
Stokes	0
type	I-DISEASE
.	0

Patients	I-DISEASE
with	0
a	I-DISEASE
recent	0
cerebrovascular	I-DISEASE
accident	0
show	I-DISEASE
a	I-DISEASE
high	I-DISEASE
incidence	0
of	I-DISEASE
sleep	0
disor-	I-DISEASE
dered	0
breathing	0
.	0

Although	I-DISEASE
obstructive	0
apnea	0
is	0
more	0
common	I-DISEASE
,	I-DISEASE
central	I-DISEASE
apnea	0
may	I-DISEASE
be	I-DISEASE
noted	0
initially	0
after	0
a	0
cerebrovascular	I-DISEASE
accident	0
.	0

Some	I-DISEASE
patients	I-DISEASE
exhibit	0
a	I-DISEASE
pattern	0
of	I-DISEASE
CSB	I-DISEASE
,	0
whereas	0
in	I-DISEASE
others	I-DISEASE
periodic	I-DISEASE
breathing	I-DISEASE
without	0
the	0
characteristic	I-DISEASE
CSB	I-DISEASE
pattern	0
is	I-DISEASE
present	I-DISEASE
.	0

Patients	I-DISEASE
with	0
multiple	I-DISEASE
system	0
atrophy	I-DISEASE
may	0
also	0
present	I-DISEASE
with	I-DISEASE
CSA	I-DISEASE
that	0
does	I-DISEASE
not	0
have	I-DISEASE
a	0
CSB	0
pattern	0
.	0

Objective	I-DISEASE
Findings	I-DISEASE
The	I-DISEASE
polysomnogram	0
of	I-DISEASE
the	0
patient	0
with	0
CSA	0
due	0
to	0
medical	0
or	0
neurological	0
condi-	I-DISEASE
tion	0
—	I-DISEASE
not	0
CSB	0
—	I-DISEASE
demonstrate	0
recurrent	0
(	0
five	0
or	0
more	0
per	0
hour	0
)	0
central	0
apneas	I-DISEASE
and/or	0
central	0
hypopneas	0
.	0

The	I-DISEASE
central	0
apneas	0
and	0
hypopneas	I-DISEASE
meet	I-DISEASE
criteria	I-DISEASE
for	0
these	0
events	0
as	I-DISEASE
defined	0
by	0
the	0
most	0
recent	0
version	0
of	I-DISEASE
the	0
AASM	0
Manual	I-DISEASE
for	I-DISEASE
the	0
Scoring	I-DISEASE
of	I-DISEASE
Sleep	0
and	0
Associated	0
Events	0
.	0

Runs	I-DISEASE
of	I-DISEASE
recurrent	0
central	0
apneas	0
separated	I-DISEASE
by	I-DISEASE
periods	I-DISEASE
of	I-DISEASE
ventilation	0
may	0
occur	I-DISEASE
.	0

The	I-DISEASE
interevent	I-DISEASE
respiratory	0
phase	0
is	I-DISEASE
typically	0
brief	I-DISEASE
with	0
a	0
maximum	0
of	I-DISEASE
five	0
breaths	0
.	0

The	I-DISEASE
central	0
apneas	0
do	0
not	0
have	0
the	0
pattern	0
of	I-DISEASE
CSB	I-DISEASE
.	0

Differential	I-DISEASE
Diagnosis	0
Patients	I-DISEASE
with	I-DISEASE
CSA	0
due	I-DISEASE
to	I-DISEASE
medical	I-DISEASE
or	I-DISEASE
neurological	0
disorder	I-DISEASE
—	0
not	0
CSB	I-DISEASE
—	I-DISEASE
should	0
be	0
dif-	I-DISEASE
ferentiated	0
from	0
primary	0
CSA	I-DISEASE
,	0
in	0
which	0
no	0
known	0
cause	I-DISEASE
is	0
identified	0
.	0

As	I-DISEASE
the	0
name	0
implies	I-DISEASE
,	0
patients	I-DISEASE
with	I-DISEASE
a	I-DISEASE
pattern	0
of	I-DISEASE
CSB	0
should	I-DISEASE
be	I-DISEASE
classified	0
as	0
such	0
.	0

Patients	I-DISEASE
with	0
central	0
nervous	0
system	I-DISEASE
neoplasms	0
may	0
have	0
a	I-DISEASE
central	0
hypoventilation	0
syndrome	0
with	0
sleep	0
related	0
hypoventilation	0
with	0
or	I-DISEASE
without	0
an	B-DISEASE
increase	I-DISEASE
in	0
daytime	I-DISEASE
PaCO2	0
.	0

Unresolved	I-DISEASE
Issues	0
and	0
Further	I-DISEASE
Directions	0
With	0
the	0
possible	0
exception	I-DISEASE
of	I-DISEASE
poststroke	0
central	0
apnea	I-DISEASE
,	0
the	0
disorders	0
classified	0
here	I-DISEASE
are	I-DISEASE
thought	0
to	I-DISEASE
be	0
relatively	0
rare	I-DISEASE
.	0

The	I-DISEASE
presenting	0
symptoms	I-DISEASE
may	I-DISEASE
not	0
be	I-DISEASE
a	0
sleep	0
related	B-DISEASE
complaint	0
.	0

Except	I-DISEASE
for	I-DISEASE
those	0
associated	0
with	0
CM	I-DISEASE
and	0
poststroke	0
CSA	0
,	I-DISEASE
the	0
disorders	0
are	0
not	0
well	I-DISEASE
characterized	0
.	0

Bibliography	0
Cormican	I-DISEASE
LJ	0
,	0
Higgins	I-DISEASE
AC	0
,	I-DISEASE
Davidson	I-DISEASE
R	0
,	I-DISEASE
et	0
al	I-DISEASE
.	0

Multi	I-DISEASE
system	0
atrophy	I-DISEASE
presenting	0
as	0
central	0
sleep	0
apnea	0
.	0

Eur	I-DISEASE
Respir	0
J	0
2004;24:323–5	0
.	0

Dauvilliers	I-DISEASE
Y	0
,	I-DISEASE
Stal	0
V	I-DISEASE
,	0
Abril	0
B	0
,	0
et	0
al	I-DISEASE
.	I-DISEASE

Chiari	I-DISEASE
malformation	0
and	0
sleep	0
related	B-DISEASE
breathing	0
disorders	0
.	0

J	I-DISEASE
Neurol	0
Neurosurg	0
Psychiatry	0
2007;78:1344–8	I-DISEASE
.	0

Fernández	I-DISEASE
AA	I-DISEASE
,	I-DISEASE
Guerrero	I-DISEASE
AI	0
,	0
Martínez	I-DISEASE
MI	I-DISEASE
,	I-DISEASE
et	0
al	0
.	0

Malformations	I-DISEASE
of	I-DISEASE
the	0
craniocervical	I-DISEASE
junction	0
(	I-DISEASE
Chiari	I-DISEASE
type	I-DISEASE
I	0
and	0
syringomyelia	0
:	0
classification	I-DISEASE
,	0
diagnosis	I-DISEASE
and	0
treatment	I-DISEASE
)	0
.	0

BMC	0
Musculoskelet	0
Disord	0
2009	I-DISEASE

Dec	I-DISEASE
17;10	0
Suppl	0
1	I-DISEASE
.	0

Parra	I-DISEASE
O	0
,	I-DISEASE
Arboix	0
A	0
,	0
Bechich	0
S	I-DISEASE
,	0
et	0
al	I-DISEASE
.	I-DISEASE

Time	I-DISEASE
course	I-DISEASE
of	I-DISEASE
sleep	0
-	0
related	B-DISEASE
breathing	0
disorders	0
in	0
first	0
-	0
ever	0
stroke	I-DISEASE
or	I-DISEASE
transient	0
ischemic	0
attack	0
.	0

Am	I-DISEASE
J	0
Respir	0
Crit	0
Care	0
Med	0
2000;161:375–80	I-DISEASE
.	0

Siccoli	I-DISEASE
MM	I-DISEASE
,	I-DISEASE
Valko	I-DISEASE
PO	0
,	I-DISEASE
Hermann	I-DISEASE
DM	I-DISEASE
,	0
Bassetti	I-DISEASE
CL	I-DISEASE
.	0

Central	I-DISEASE
periodic	I-DISEASE
breathing	0
during	I-DISEASE
sleep	0
in	I-DISEASE
74	I-DISEASE
patients	I-DISEASE
with	0
acute	0
ischemic	0
stroke	I-DISEASE
—	I-DISEASE
neurogenic	0
and	0
cardiogenic	0
factors	0
.	0

J	I-DISEASE
Neurol	0
2008;255:1687–92	0
.	0

Central	I-DISEASE
Sleep	I-DISEASE
Apnea	0
Due	I-DISEASE
to	I-DISEASE
High	I-DISEASE
Altitude	0
Periodic	0
ICD-10	I-DISEASE
-	I-DISEASE
CM	I-DISEASE
code	0
:	I-DISEASE
G47.32	I-DISEASE
Breathing	0
ICD-9	0
-	0
CM	0
code	0
:	0
327.22	0
Alternate	0
Names	I-DISEASE
None	0
.	0

Diagnostic	I-DISEASE
Criteria	0
Criteria	I-DISEASE
A	0
-	I-DISEASE
D	I-DISEASE
must	I-DISEASE
be	0
met	0
A.	0
Recent	0
ascent	0
to	I-DISEASE
high	I-DISEASE
altitude.1	0

B.	0
The	I-DISEASE
presence	0
of	0
one	0
or	I-DISEASE
more	0
of	I-DISEASE
the	0
following:2	0
Sleep	I-DISEASE
Related	0
Breathing	0
Disorders	0
.	0

Sleepiness	I-DISEASE
.	0
.	I-DISEASE

Difficulty	I-DISEASE
initiating	I-DISEASE
or	B-DISEASE
maintaining	0
sleep	0
,	I-DISEASE
frequent	I-DISEASE
awakenings	0
,	I-DISEASE
or	I-DISEASE
nonrestorative	0
sleep	I-DISEASE
.	0
.	0

Awakening	I-DISEASE
with	I-DISEASE
shortness	0
of	I-DISEASE
breath	I-DISEASE
or	B-DISEASE
morning	0
headache	I-DISEASE
.	0
.	I-DISEASE

Witnessed	I-DISEASE
apnea	0
.	0

C.	I-DISEASE

The	I-DISEASE
symptoms	I-DISEASE
are	0
clinically	I-DISEASE
attributable	I-DISEASE
to	0
high	I-DISEASE
-	I-DISEASE
altitude	I-DISEASE
periodic	I-DISEASE
breathing	0
or	0
PSG	0
,	0
if	0
performed	0
,	0
demonstrates	0
recurrent	B-DISEASE
central	0
apneas	0
or	I-DISEASE
hypopneas	I-DISEASE
primarily	I-DISEASE
during	0
NREM	0
sleep	0
at	0
a	0
frequency	I-DISEASE
of	I-DISEASE
≥	I-DISEASE
5	0
/	0
hour	0
.	0

D.	I-DISEASE

The	I-DISEASE
disorder	I-DISEASE
is	0
not	0
better	0
explained	I-DISEASE
by	I-DISEASE
another	I-DISEASE
current	I-DISEASE
sleep	0
disorder	0
,	I-DISEASE
medical	I-DISEASE
or	I-DISEASE
neurological	0
disorder	I-DISEASE
,	0
medication	0
use	I-DISEASE
(	I-DISEASE
e.g.	0
,	0
narcotics	0
)	0
,	I-DISEASE
or	0
substance	I-DISEASE
use	0
disorders	0
.	0

Notes	I-DISEASE
.	0

Typically	I-DISEASE
at	I-DISEASE
least	0
2,500	I-DISEASE
meters	I-DISEASE
(	I-DISEASE
8,202	0
feet	0
)	I-DISEASE
,	I-DISEASE
although	0
some	I-DISEASE
individuals	I-DISEASE
may	I-DISEASE
exhibit	0
the	0
disorder	I-DISEASE
at	I-DISEASE
altitudes	I-DISEASE
as	0
low	0
as	0
1,500	0
meters	I-DISEASE
.	0
.	B-DISEASE

Periodic	I-DISEASE
breathing	0
is	0
a	0
common	I-DISEASE
response	0
to	I-DISEASE
altitude	0
.	0

Associated	I-DISEASE
symptoms	I-DISEASE
are	0
required	I-DISEASE
to	0
make	0
the	0
diagnosis	I-DISEASE
of	I-DISEASE
a	0
disorder	0
.	0

There	I-DISEASE
is	I-DISEASE
no	0
level	0
of	0
the	0
central	0
AHI	0
separating	I-DISEASE
a	0
normal	I-DISEASE
and	0
abnormal	0
response	0
to	I-DISEASE
high	I-DISEASE
altitude	0
.	0
.	0

A	I-DISEASE
diagnosis	I-DISEASE
of	I-DISEASE
CSA	0
due	I-DISEASE
to	I-DISEASE
high	I-DISEASE
-	0
altitude	0
period	0
breathing	I-DISEASE
does	I-DISEASE
not	I-DISEASE
exclude	0
a	0
diagnosis	I-DISEASE
of	I-DISEASE
OSA	0
.	0

Sleep	I-DISEASE
Related	0
Breathing	0
Disorders	I-DISEASE
Essential	0
Features	I-DISEASE
High	0
-	I-DISEASE
altitude	0
periodic	0
breathing	0
is	0
characterized	0
by	0
alternating	0
periods	I-DISEASE
of	I-DISEASE
central	0
apnea	0
and	0
hyperpnea	I-DISEASE
associated	0
with	0
recent	0
ascent	I-DISEASE
to	I-DISEASE
high	0
altitude	0
.	0

The	I-DISEASE
pattern	0
of	I-DISEASE
periodic	I-DISEASE
breathing	0
is	0
an	0
expected	I-DISEASE
response	0
to	0
ascent	I-DISEASE
to	I-DISEASE
elevation	I-DISEASE
.	0

Only	I-DISEASE
those	I-DISEASE
individuals	I-DISEASE
who	I-DISEASE
manifest	0
related	0
symptoms	I-DISEASE
,	I-DISEASE
as	0
described	0
below	I-DISEASE
,	I-DISEASE
are	I-DISEASE
diagnosed	I-DISEASE
with	0
this	0
disorder	I-DISEASE
.	0

The	I-DISEASE
cycle	0
length	0
of	I-DISEASE
this	0
respiratory	I-DISEASE
pattern	0
is	I-DISEASE
commonly	0
less	I-DISEASE
than	I-DISEASE
40	0
seconds	I-DISEASE
and	0
often	0
as	0
short	0
as	I-DISEASE
12	0
to	0
20	0
seconds	0
.	0

The	I-DISEASE
percentage	0
of	I-DISEASE
individuals	I-DISEASE
exhibiting	0
periodic	I-DISEASE
breathing	0
during	I-DISEASE
sleep	0
increases	0
at	I-DISEASE
higher	0
altitudes	I-DISEASE
.	0

Approximately	I-DISEASE
25	0
%	0
exhibit	0
periodic	0
breath-	I-DISEASE
ing	I-DISEASE
at	I-DISEASE
2,500	0
meters	I-DISEASE
(	I-DISEASE
8,202	0
feet	0
)	0
,	0
and	0
virtually	I-DISEASE
100	0
%	0
demonstrate	I-DISEASE
periodic	I-DISEASE
breathing	0
at	I-DISEASE
4,000	0
m	B-DISEASE
(	0
13,123	0
feet	0
)	0
.	0

Periodic	I-DISEASE
breathing	0
has	0
been	0
described	I-DISEASE
at	I-DISEASE
altitudes	I-DISEASE
as	0
low	0
as	0
1,500	I-DISEASE
meters	I-DISEASE
(	I-DISEASE
4,900	0
feet	0
)	0
.	0

Chronic	I-DISEASE
exposure	0
to	I-DISEASE
altitude	0
above	0
2,500	0
meters	I-DISEASE
has	0
also	0
been	I-DISEASE
associated	0
with	0
periodic	I-DISEASE
breathing	I-DISEASE
in	I-DISEASE
some	0
studies	I-DISEASE
.	0

Associated	I-DISEASE
Features	I-DISEASE
At	0
altitude	0
,	0
individuals	I-DISEASE
may	I-DISEASE
complain	I-DISEASE
of	I-DISEASE
frequent	0
awakenings	0
,	I-DISEASE
poor	0
-	I-DISEASE
quality	0
sleep	I-DISEASE
,	0
and	0
a	0
sense	I-DISEASE
of	I-DISEASE
dyspnea	0
.	0

These	0
symptoms	I-DISEASE
will	0
often	0
improve	0
with	I-DISEASE
time	I-DISEASE
at	I-DISEASE
moderate	0
altitude	0
but	0
may	I-DISEASE
persist	I-DISEASE
at	I-DISEASE
extreme	I-DISEASE
altitude	0
.	0

Alterations	I-DISEASE
in	I-DISEASE
sleep	0
associated	0
with	I-DISEASE
ascent	I-DISEASE
to	0
alti-	0
tude	I-DISEASE
include	0
a	0
reduction	0
in	I-DISEASE
stage	0
N3	0
sleep	0
and	0
increased	0
arousal	0
frequency	I-DISEASE
.	0

Total	I-DISEASE
sleep	0
time	0
and	0
the	0
amount	I-DISEASE
of	I-DISEASE
REM	I-DISEASE
sleep	0
are	0
either	I-DISEASE
unchanged	I-DISEASE
or	I-DISEASE
decreased	I-DISEASE
.	0

Of	I-DISEASE
note	I-DISEASE
,	0
the	0
degree	0
of	I-DISEASE
both	I-DISEASE
subjective	I-DISEASE
and	0
objective	0
impairment	0
of	I-DISEASE
sleep	0
quality	0
was	I-DISEASE
not	I-DISEASE
correlated	0
with	0
the	0
severity	0
of	I-DISEASE
periodic	I-DISEASE
breathing	I-DISEASE
in	I-DISEASE
a	0
number	0
of	I-DISEASE
studies	I-DISEASE
.	0

Clinical	I-DISEASE
and	0
Pathophysiological	I-DISEASE
Subtypes	I-DISEASE
None	I-DISEASE
known	I-DISEASE
.	I-DISEASE

Demographics	I-DISEASE
The	I-DISEASE
demographics	0
of	I-DISEASE
high	0
-	0
altitude	0
periodic	I-DISEASE
breathing	I-DISEASE
are	I-DISEASE
not	0
known	I-DISEASE
.	0

High	I-DISEASE
-	I-DISEASE
altitude	0
periodic	I-DISEASE
breathing	0
tends	0
to	I-DISEASE
occur	I-DISEASE
in	0
individuals	I-DISEASE
with	I-DISEASE
a	0
high	I-DISEASE
hypoxic	I-DISEASE
and	0
probably	0
hypercapnic	0
ventilatory	0
response	0
.	I-DISEASE

Because	I-DISEASE
men	0
generally	I-DISEASE
have	I-DISEASE
higher	0
chemorespon-	I-DISEASE
siveness	I-DISEASE
than	0
women	I-DISEASE
,	I-DISEASE
high	I-DISEASE
-	0
altitude	0
periodic	I-DISEASE
breathing	0
may	0
be	0
more	0
common	I-DISEASE
in	0
men	I-DISEASE
than	0
in	I-DISEASE
women	I-DISEASE
.	B-DISEASE

As	I-DISEASE
stated	0
above	0
,	I-DISEASE
periodic	0
breathing	I-DISEASE
will	0
occur	I-DISEASE
in	0
virtually	0
anyone	I-DISEASE
ascending	I-DISEASE
to	I-DISEASE
higher	0
than	0
4,000	0
meters	I-DISEASE
and	0
in	I-DISEASE
some	I-DISEASE
individuals	I-DISEASE
at	I-DISEASE
lower	0
altitudes	I-DISEASE
.	0

The	I-DISEASE
latter	0
group	I-DISEASE
probably	I-DISEASE
comprises	B-DISEASE
individuals	I-DISEASE
with	I-DISEASE
increased	0
hypoxic	0
chemoresponsive-	I-DISEASE

ness	I-DISEASE
.	0

In	I-DISEASE
one	0
study	0
,	I-DISEASE
individuals	0
both	I-DISEASE
with	I-DISEASE
and	0
without	0
periodic	I-DISEASE
breathing	0
at	I-DISEASE
altitude	I-DISEASE
had	I-DISEASE
alterations	0
in	I-DISEASE
sleep	0
architecture	I-DISEASE
.	0

Those	I-DISEASE
with	I-DISEASE
periodic	0
breathing	0
had	0
a	0
greater	I-DISEASE
arousal	I-DISEASE
index	0
,	0
although	0
their	0
sleep	I-DISEASE
architecture	I-DISEASE
was	0
otherwise	0
not	0
significantly	0
different	0
from	0
individuals	I-DISEASE
who	I-DISEASE
did	I-DISEASE
not	0
develop	0
periodic	I-DISEASE
breathing	0
.	0

Predisposing	I-DISEASE
and	0
Precipitating	I-DISEASE
Factors	0
The	I-DISEASE
only	I-DISEASE
known	I-DISEASE
predisposing	0
factor	0
for	0
the	0
development	I-DISEASE
of	I-DISEASE
high	I-DISEASE
-	0
altitude	0
periodic	0
breathing	I-DISEASE
is	0
increased	0
ventilatory	0
chemoresponsiveness	0
,	0
primarily	I-DISEASE
hypoxic	0
ventila-	0
tory	0
responsiveness	0
.	0

A	I-DISEASE
high	I-DISEASE
hypoxic	0
ventilatory	0
response	0
will	0
lead	0
to	I-DISEASE
increased	0
hyper-	0
ventilation	I-DISEASE
on	0
ascent	0
to	I-DISEASE
altitude	0
.	0

This	I-DISEASE
hyperventilation	I-DISEASE
leads	0
to	I-DISEASE
hypocapnic	I-DISEASE
alkalosis	I-DISEASE
that	0
,	I-DISEASE
during	I-DISEASE
sleep	0
,	0
inhibits	I-DISEASE
ventilation	0
.	0

Thus	I-DISEASE
,	I-DISEASE
repetitive	I-DISEASE
cycles	0
of	0
apnea	0
and	0
hyperpnea	0
develop	I-DISEASE
during	0
NREM	0
sleep	0
.	0

The	I-DISEASE
obvious	I-DISEASE
precipitating	0
factor	I-DISEASE
for	I-DISEASE
the	0
development	0
of	I-DISEASE
this	0
periodic	I-DISEASE
breathing	I-DISEASE
is	0
ascent	I-DISEASE
to	I-DISEASE
altitude	I-DISEASE
.	0

The	I-DISEASE
more	0
rapid	I-DISEASE
the	0
ascent	0
,	I-DISEASE
the	0
more	0
likely	0
periodic	I-DISEASE
breathing	0
is	I-DISEASE
to	I-DISEASE
develop	I-DISEASE
.	0

Familial	I-DISEASE
Patterns	I-DISEASE

Some	I-DISEASE
data	I-DISEASE
suggest	0
that	0
ventilatory	0
chemoresponsiveness	I-DISEASE
is	0
directly	I-DISEASE
inherited	I-DISEASE
.	I-DISEASE

Because	I-DISEASE
elevated	I-DISEASE
hypoxic	0
responsiveness	0
is	I-DISEASE
a	I-DISEASE
predisposing	I-DISEASE
variable	I-DISEASE
in	0
the	0
development	0
of	I-DISEASE
high	I-DISEASE
-	0
altitude	0
periodic	I-DISEASE
breathing	0
,	I-DISEASE
it	0
would	I-DISEASE
seem	I-DISEASE
likely	I-DISEASE
that	0
there	I-DISEASE
would	0
be	0
a	0
familial	0
pattern	0
in	I-DISEASE
the	0
development	0
of	I-DISEASE
this	I-DISEASE
respiratory	I-DISEASE
abnormality	I-DISEASE
.	0

However	I-DISEASE
,	0
there	0
are	I-DISEASE
no	0
data	I-DISEASE
addressing	I-DISEASE
this	0
issue	0
.	0

Onset	I-DISEASE
,	0
Course	0
,	0
and	0
Complications	0
This	B-DISEASE
respiratory	I-DISEASE
pattern	0
will	0
generally	0
be	I-DISEASE
evident	I-DISEASE
during	I-DISEASE
sleep	0
immediately	0
after	0
ascent	I-DISEASE
to	I-DISEASE
altitude	0
.	0

This	I-DISEASE
depends	I-DISEASE
to	0
some	I-DISEASE
extent	0
on	0
the	0
rapidity	I-DISEASE
of	I-DISEASE
the	0
ascent	I-DISEASE
,	I-DISEASE
the	0
elevation	0
,	I-DISEASE
and	0
individual	I-DISEASE
predisposition	0
.	0

However	I-DISEASE
,	0
it	0
will	0
be	0
present	I-DISEASE
most	0
often	0
on	0
the	0
first	0
night	0
at	I-DISEASE
altitude	0
.	0

At	I-DISEASE
moderate	I-DISEASE
altitude	0
,	I-DISEASE
the	0
breathing	I-DISEASE
pattern	0
may	I-DISEASE
become	0
more	0
regular	I-DISEASE
over	I-DISEASE
time	I-DISEASE
,	I-DISEASE
although	0
at	I-DISEASE
extreme	I-DISEASE
altitude	I-DISEASE
it	0
is	0
likely	I-DISEASE
to	0
persist	0
.	0

One	I-DISEASE
recent	I-DISEASE
study	0
found	I-DISEASE
that	0
the	0
amount	I-DISEASE
of	I-DISEASE
periodic	I-DISEASE
breathing	0
continued	I-DISEASE
to	I-DISEASE
increase	I-DISEASE
over	I-DISEASE
three	0
days	0
to	I-DISEASE
two	I-DISEASE
weeks	0
of	0
acclimatization	0
.	0

Studies	I-DISEASE
of	I-DISEASE
adaptation	0
to	I-DISEASE
altitude	0
suggest	I-DISEASE
that	0
sleep	0
quality	0
may	0
improve	0
despite	0
further	I-DISEASE
increases	I-DISEASE
in	0
periodic	I-DISEASE
breathing	I-DISEASE
.	I-DISEASE

It	I-DISEASE
has	0
been	I-DISEASE
hypothesized	I-DISEASE
that	0
hypoxia	0
itself	I-DISEASE
may	0
have	0
an	0
important	I-DISEASE
role	0
in	0
disturbing	I-DISEASE
sleep	0
architecture	I-DISEASE
.	0

Thus	I-DISEASE
,	I-DISEASE
sleep	0
and	0
symptoms	0
may	I-DISEASE
improve	0
during	I-DISEASE
acclimatization	0
to	I-DISEASE
altitude	0
even	I-DISEASE
if	0
the	I-DISEASE
amount	0
of	0
periodic	I-DISEASE
breathing	0
actually	I-DISEASE
increases	0
.	0

The	I-DISEASE
complications	0
of	I-DISEASE
high	I-DISEASE
-	0
altitude	0
periodic	I-DISEASE
breathing	B-DISEASE
,	0
which	0
are	0
generally	I-DISEASE
limited	I-DISEASE
to	I-DISEASE
disrupted	0
sleep	0
on	0
the	I-DISEASE
initial	0
nights	0
at	I-DISEASE
altitude	0
,	0
include	I-DISEASE
frequent	0
awakenings	0
,	I-DISEASE
often	0
with	I-DISEASE
shortness	0
of	I-DISEASE
breath	0
or	0
a	0
sensation	0
of	I-DISEASE
suffocation	0
that	0
may	I-DISEASE
lead	0
to	I-DISEASE
fatigue	I-DISEASE
or	I-DISEASE
sleep-	0
iness	0
on	0
the	0
following	0
day	0
.	0

There	I-DISEASE
is	I-DISEASE
no	0
clear	I-DISEASE
association	0
between	0
periodic	I-DISEASE
breathing	B-DISEASE
and	0
other	0
altitude	0
syndromes	I-DISEASE
(	I-DISEASE
high	0
-	0
altitude	0
pulmonary	I-DISEASE
edema	0
,	0
acute	0
mountain	I-DISEASE
sick-	0

ness	I-DISEASE
,	0
and	0
high	0
-	I-DISEASE
altitude	0
cerebral	0
edema	0
)	0
.	0

In	I-DISEASE
fact	I-DISEASE
,	0
periodic	I-DISEASE
breathing	0
is	0
a	0
marker	I-DISEASE
of	I-DISEASE
high	0
hypoxic	0
responsiveness	0
,	0
which	0
generally	I-DISEASE
yields	0
improved	I-DISEASE
oxygenation	I-DISEASE
at	I-DISEASE
altitude	0
and	0
a	I-DISEASE
reduced	0
frequency	I-DISEASE
of	I-DISEASE
the	0
maladaptive	0
syndromes	0
.	0

Sleep	I-DISEASE
Related	0
Breathing	0
Disorders	I-DISEASE
Sleep	0
Related	0
Breathing	0
Disorders	I-DISEASE
Developmental	0
Issues	0
Relatively	0
little	0
is	I-DISEASE
known	0
about	0
differences	I-DISEASE
between	0
children	I-DISEASE
and	0
adults	0
concerning	0
periodic	I-DISEASE
breathing	0
at	I-DISEASE
altitude	0
.	0

One	I-DISEASE
study	0
did	0
compare	0
breathing	0
in	I-DISEASE
children	I-DISEASE
and	0
their	0
fathers	0
.	0

The	I-DISEASE
children	I-DISEASE
revealed	0
reduced	0
nocturnal	0
oxygen	I-DISEASE
saturation	I-DISEASE
and	0
associated	0
hyperventilation	I-DISEASE
at	I-DISEASE
high	I-DISEASE
altitude	I-DISEASE
similar	0
to	0
the	0
adults	I-DISEASE
,	I-DISEASE
but	0
their	0
breathing	I-DISEASE
pattern	0
was	I-DISEASE
more	0
stable	I-DISEASE
.	0

The	I-DISEASE
investigators	I-DISEASE
hypothesized	0
that	0
children	0
may	0
have	0
a	0
lower	I-DISEASE
apnea	0
threshold	I-DISEASE
for	I-DISEASE
CO2	0
than	0
adults	0
.	0

Pathology	I-DISEASE
and	0
Pathophysiology	I-DISEASE
High	0
-	0
altitude	0
periodic	I-DISEASE
breathing	I-DISEASE
is	I-DISEASE
believed	0
to	0
be	I-DISEASE
a	I-DISEASE
product	0
of	0
the	0
hyperventilation	0
induced	I-DISEASE
by	0
the	I-DISEASE
hypobaric	I-DISEASE
hypoxia	I-DISEASE
encountered	0
at	I-DISEASE
altitude	0
.	0

At	I-DISEASE
2,500	I-DISEASE
meters	I-DISEASE
the	0
atmo-	I-DISEASE
spheric	0
pressure	0
is	I-DISEASE
approximately	I-DISEASE
570	0
mm	0
Hg	I-DISEASE
and	0
the	0
ideal	0
alveolar	I-DISEASE
PO2	0
around	I-DISEASE
55	0
mm	I-DISEASE
Hg	I-DISEASE
(	I-DISEASE
depending	I-DISEASE
on	0
the	0
level	0
of	I-DISEASE
PaCO2	0
)	0
.	0

Actual	I-DISEASE
arterial	0
PO2	0
values	I-DISEASE
will	0
be	0
lower	0
,	I-DISEASE
especially	I-DISEASE
during	I-DISEASE
sleep	0
.	0

The	I-DISEASE
hypoxic	I-DISEASE
ventilatory	0
response	0
shows	I-DISEASE
a	0
steep	0
increase	I-DISEASE
in	I-DISEASE
ventilation	0
when	I-DISEASE
the	0
arterial	I-DISEASE
PO2	0
level	0
drops	I-DISEASE
below	I-DISEASE
55	I-DISEASE
mm	0
Hg	I-DISEASE
.	0

The	I-DISEASE
increases	0
in	0
venti-	0
lation	0
associated	0
with	0
hypoxemia	I-DISEASE
result	0
in	I-DISEASE
hypocapnic	I-DISEASE
alkalosis	I-DISEASE
.	0

Because	I-DISEASE
PaCO2	0
is	0
the	0
principal	I-DISEASE
stimulus	0
to	0
respiration	0
during	I-DISEASE
NREM	I-DISEASE
sleep	0
,	I-DISEASE
a	I-DISEASE
low	0
PaCO2	0
can	0
yield	0
a	0
loss	I-DISEASE
or	0
reduction	0
in	I-DISEASE
respiratory	I-DISEASE
drive	0
,	I-DISEASE
resulting	0
in	I-DISEASE
central	0
apnea	0
or	I-DISEASE
hypopnea	0
.	0

The	I-DISEASE
greater	I-DISEASE
the	0
ventilatory	0
response	0
to	I-DISEASE
hypoxia	0
,	I-DISEASE
the	0
greater	I-DISEASE
the	0
fall	I-DISEASE
in	I-DISEASE
PaCO2	0
.	0

Thus	I-DISEASE
,	I-DISEASE
individuals	I-DISEASE
with	I-DISEASE
brisk	0
hypoxic	I-DISEASE
responses	I-DISEASE
more	0
commonly	I-DISEASE
tend	I-DISEASE
to	0
demonstrate	I-DISEASE
this	I-DISEASE
respiratory	I-DISEASE
pattern	0
.	0

Over	I-DISEASE
the	0
course	0
of	I-DISEASE
the	0
apnea	0
,	0
the	0
PaO2	0
falls	I-DISEASE
and	0
PaCO2	0
rises	0
,	0
eventually	0
stimulating	0
a	0
resumption	I-DISEASE
of	I-DISEASE
ventilation	0
.	0

However	I-DISEASE
,	I-DISEASE
after	0
several	I-DISEASE
large	0
breaths	0
,	I-DISEASE
the	0
PaCO2	0
again	I-DISEASE
falls	I-DISEASE
below	I-DISEASE
the	0
apnea	0
threshold	0
,	0
initiating	I-DISEASE
another	I-DISEASE
pause	0
in	I-DISEASE
breathing	0
.	0

This	I-DISEASE
cycle	0
is	0
then	0
repeated	0
over	I-DISEASE
the	0
course	I-DISEASE
of	0
the	0
night	0
.	0

Of	I-DISEASE
note	I-DISEASE
,	0
the	0
respiratory	0
pattern	0
is	I-DISEASE
often	I-DISEASE
improved	I-DISEASE
during	I-DISEASE
REM	I-DISEASE
sleep	I-DISEASE
with	I-DISEASE
reduced	0
cycling	I-DISEASE
.	0

This	I-DISEASE
is	I-DISEASE
likely	I-DISEASE
due	I-DISEASE
to	0
the	0
decreased	I-DISEASE
hypoxic	I-DISEASE
and	0
hypercapnic	I-DISEASE
responsiveness	I-DISEASE
characteristic	0
of	I-DISEASE
REM	I-DISEASE
sleep	I-DISEASE
.	0

Of	I-DISEASE
interest	I-DISEASE
,	0
in	I-DISEASE
one	0
study	0
the	0
hypoxic	I-DISEASE
ventilatory	0
response	0
continued	I-DISEASE
to	I-DISEASE
increase	I-DISEASE
up	0
to	0
seven	I-DISEASE
days	0
after	I-DISEASE
ascent	I-DISEASE
to	I-DISEASE
altitude	0
.	0

This	I-DISEASE
resulted	I-DISEASE
in	0
a	I-DISEASE
lower	0
PaCO2	0
and	0
higher	0
PaO2	0
.	0

The	I-DISEASE
reduction	0
in	0
peri-	I-DISEASE
odic	0
breathing	B-DISEASE
in	0
some	I-DISEASE
individuals	I-DISEASE
with	I-DISEASE
adaptation	0
to	0
altitude	0
despite	0
a	I-DISEASE
greater	0
venti-	0
latory	0
response	0
to	I-DISEASE
hypoxemia	0
may	0
be	I-DISEASE
due	0
to	I-DISEASE
a	0
lowering	0
of	I-DISEASE
the	0
apneic	0
threshold	0
.	0

Other	I-DISEASE
studies	I-DISEASE
have	0
found	I-DISEASE
that	0
the	0
amount	I-DISEASE
of	I-DISEASE
periodic	0
breathing	0
continues	I-DISEASE
to	I-DISEASE
increase	I-DISEASE
over	I-DISEASE
three	0
days	0
to	I-DISEASE
two	I-DISEASE
weeks	0
of	0
acclimatization	0
despite	0
improvements	0
in	I-DISEASE
oxygen	I-DISEASE
saturation	0
.	0

The	I-DISEASE
increase	I-DISEASE
in	I-DISEASE
both	I-DISEASE
periodic	0
breathing	I-DISEASE
and	0
oxygen	I-DISEASE
saturation	0
is	0
thought	I-DISEASE
to	I-DISEASE
be	I-DISEASE
due	0
to	I-DISEASE
increased	0
controller	I-DISEASE
gain	0
of	0
the	0
respiratory	I-DISEASE
system	0
.	0

A	I-DISEASE
number	0
of	I-DISEASE
studies	I-DISEASE
have	0
found	I-DISEASE
that	0
the	B-DISEASE
impairment	0
of	I-DISEASE
sleep	I-DISEASE
architecture	I-DISEASE
does	0
not	0
correlate	B-DISEASE
with	0
the	0
degree	I-DISEASE
of	I-DISEASE
periodic	I-DISEASE
breathing	I-DISEASE
.	0

One	I-DISEASE
study	I-DISEASE
found	0
that	0
the	0
amount	I-DISEASE
of	I-DISEASE
periodic	I-DISEASE
breathing	B-DISEASE
was	0
greater	I-DISEASE
on	0
the	I-DISEASE
third	I-DISEASE
night	0
at	I-DISEASE
altitude	0
compared	I-DISEASE
to	0
the	0
first	I-DISEASE
night	0
.	0

However	I-DISEASE
,	I-DISEASE
both	0
the	0
nocturnal	0
oxygen	0
saturation	I-DISEASE
and	0
amount	I-DISEASE
of	I-DISEASE
stage	I-DISEASE
N3	0
also	0
increased	0
on	0
the	0
third	0
night	I-DISEASE
compared	I-DISEASE
to	0
the	0
first	0
night	I-DISEASE
.	0

It	I-DISEASE
has	0
been	I-DISEASE
hypothesized	I-DISEASE
that	0
hypoxia	0
rather	I-DISEASE
than	0
periodic	I-DISEASE
breathing	I-DISEASE
might	I-DISEASE
be	0
the	0
major	I-DISEASE
factor	I-DISEASE
disturbing	I-DISEASE
sleep	0
.	0

Objective	I-DISEASE
Findings	I-DISEASE
The	I-DISEASE
PSG	0
of	0
individuals	I-DISEASE
with	I-DISEASE
high	I-DISEASE
-	I-DISEASE
altitude	0
periodic	0
breathing	0
demonstrates	I-DISEASE
recur-	I-DISEASE
rent	I-DISEASE
central	0
apneas	0
with	I-DISEASE
a	0
cycle	0
time	0
of	I-DISEASE
less	I-DISEASE
than	0
40	0
seconds	0
,	0
and	0
typically	0
around	0
20	0
seconds	0
.	0

There	I-DISEASE
is	I-DISEASE
some	0
degree	I-DISEASE
of	0
associated	0
arterial	0
oxygen	0
desaturation	0
.	I-DISEASE

The	I-DISEASE
apneas	0
are	0
short	0
,	I-DISEASE
generally	0
8	0
to	0
10	I-DISEASE
seconds	I-DISEASE
in	I-DISEASE
duration	0
.	0

In	I-DISEASE
one	0
study	0
,	I-DISEASE
the	0
apnea	0
duration	0
was	0
around	0
8	I-DISEASE
seconds	I-DISEASE
(	I-DISEASE
7	0
to	I-DISEASE
9	I-DISEASE
seconds	I-DISEASE
)	0
in	0
children	I-DISEASE
and	0
approximately	I-DISEASE
12	0
seconds	0
(	I-DISEASE
10	0
-	I-DISEASE
14	0
seconds	I-DISEASE
)	0
in	I-DISEASE
adults	0
.	0

The	I-DISEASE
cycle	0
length	0
is	0
commonly	0
less	I-DISEASE
than	0
40	0
seconds	0
.	0

This	I-DISEASE
breathing	I-DISEASE
pattern	0
occurs	0
only	0
during	I-DISEASE
NREM	0
sleep	0
with	I-DISEASE
more	0
rhythmic	I-DISEASE
respiration	B-DISEASE
during	I-DISEASE
REM	I-DISEASE
sleep	0
.	0

Because	I-DISEASE
this	I-DISEASE
breathing	0
pattern	0
is	0
a	0
physiologic	0
adaptation	0
to	I-DISEASE
altitude	0
,	0
there	I-DISEASE
is	0
no	I-DISEASE
specific	0
number	0
of	I-DISEASE
apneas	0
per	I-DISEASE
hour	0
of	I-DISEASE
sleep	0
that	0
is	0
considered	I-DISEASE
normal	0
or	0
abnormal	I-DISEASE
.	0

The	I-DISEASE
apneas	0
and	0
associated	0
hyperpnea	I-DISEASE
can	0
lead	I-DISEASE
to	I-DISEASE
recurrent	0
arousals	0
from	0
sleep	0
,	I-DISEASE
which	0
often	0
increase	I-DISEASE
stages	0
N1	0
and	0
N2	0
sleep	0
while	B-DISEASE
reducing	0
stage	I-DISEASE
N3	0
sleep	0
.	0

REM	I-DISEASE
sleep	0
(	I-DISEASE
stage	0
R	I-DISEASE
)	0
duration	I-DISEASE
is	0
generally	0
preserved	B-DISEASE
,	I-DISEASE
as	I-DISEASE
is	I-DISEASE
total	0
sleep	0
time	I-DISEASE
.	I-DISEASE

As	I-DISEASE
noted	0
above	0
,	I-DISEASE
some	0
studies	I-DISEASE
have	0
found	I-DISEASE
a	0
reduction	0
in	I-DISEASE
total	I-DISEASE
sleep	I-DISEASE
time	I-DISEASE
and	0
stage	0
R	I-DISEASE
as	I-DISEASE
well	0
as	0
stage	I-DISEASE
N3	0
.	0

Of	I-DISEASE
interest	I-DISEASE
,	0
the	0
arousal	0
index	I-DISEASE
was	0
only	I-DISEASE
around	0
25	0
%	0
of	I-DISEASE
the	I-DISEASE
AHI	0
in	I-DISEASE
some	I-DISEASE
investigations	0
.	0

Differential	I-DISEASE
Diagnosis	0
High	I-DISEASE
-	0
altitude	0
periodic	0
breathing	0
should	0
be	I-DISEASE
distinguished	I-DISEASE
from	I-DISEASE
other	0
SRBDs	I-DISEASE
.	0

The	I-DISEASE
major	I-DISEASE
distinguishing	0
factor	I-DISEASE
is	0
,	I-DISEASE
of	I-DISEASE
course	I-DISEASE
,	0
recent	0
ascent	I-DISEASE
to	I-DISEASE
high	I-DISEASE
altitude	0
.	0

An	0
individual	I-DISEASE
with	0
OSA	I-DISEASE
will	0
likely	I-DISEASE
continue	0
to	0
have	0
this	0
nocturnal	0
respiratory	I-DISEASE
problem	0
at	I-DISEASE
altitude	0
.	0

Altitude	I-DISEASE
might	0
even	I-DISEASE
exacerbate	0
the	0
OSA	0
.	0

Patients	I-DISEASE
with	0
chronic	I-DISEASE
mountain	0
sickness	0
demonstrate	I-DISEASE
relative	I-DISEASE
hypoventilation	0
at	I-DISEASE
altitude	0
(	0
i.e.	I-DISEASE
,	0
breathe	0
less	I-DISEASE
than	0
is	0
encoun-	I-DISEASE
tered	I-DISEASE
in	I-DISEASE
normal	0
individuals	I-DISEASE
at	I-DISEASE
similar	0
altitude	0
)	0
such	0
that	0
they	0
are	0
more	0
hypoxic	0
than	I-DISEASE
normal	0
individuals	I-DISEASE
who	I-DISEASE
have	0
a	0
greater	I-DISEASE
ventilatory	0
response	0
to	0
the	0
same	0
ambient	0
hypoxia	I-DISEASE
.	0

During	I-DISEASE
sleep	0
,	0
these	I-DISEASE
individuals	0
often	0
demonstrate	I-DISEASE
further	I-DISEASE
arterial	0
oxygen	0
desaturation	I-DISEASE
.	0

Some	0
of	I-DISEASE
the	0
individuals	I-DISEASE
will	0
demonstrate	0
apneas	0
or	0
periodic	I-DISEASE
breathing	I-DISEASE
.	0

A	I-DISEASE
diagnosis	I-DISEASE
of	I-DISEASE
chronic	I-DISEASE
mountain	0
sickness	0
does	I-DISEASE
not	0
imply	0
that	0
periodic	0
breathing	0
is	I-DISEASE
present	I-DISEASE
.	0

However	I-DISEASE
,	I-DISEASE
periodic	0
breathing	0
may	0
be	I-DISEASE
more	0
common	I-DISEASE
in	0
these	0
patients	0
than	I-DISEASE
previously	I-DISEASE
appreciated	0
.	0

Unresolved	I-DISEASE
Issues	0
and	0
Further	I-DISEASE
Directions	0
Recent	0
studies	I-DISEASE
suggest	I-DISEASE
that	I-DISEASE
hypoxemia	I-DISEASE
rather	I-DISEASE
than	0
the	0
amount	I-DISEASE
of	I-DISEASE
periodic	I-DISEASE
breathing	B-DISEASE
may	I-DISEASE
be	I-DISEASE
the	0
major	I-DISEASE
factor	I-DISEASE
impairing	0
sleep	0
quality	0
.	0

Further	I-DISEASE
studies	I-DISEASE
relating	0
changes	I-DISEASE
in	0
sleep	0
and	0
periodic	I-DISEASE
breathing	0
at	I-DISEASE
altitude	0
are	0
needed	I-DISEASE
.	0

Sleep	I-DISEASE
Related	I-DISEASE
Breathing	0
Disorders	I-DISEASE
Sleep	0
Related	0
Breathing	0
Disorders	I-DISEASE
Bibliography	0
Anholm	0
J	0
,	I-DISEASE
Powles	I-DISEASE
A	0
,	I-DISEASE
Downey	I-DISEASE
R	0
,	0
et	0
al	I-DISEASE
.	0

Operation	I-DISEASE
Everest	0
II	0
:	I-DISEASE
arterial	0
oxygen	0
saturation	I-DISEASE
and	0
sleep	0
at	I-DISEASE
extreme	I-DISEASE
simulated	I-DISEASE
altitude	0
.	0

Am	I-DISEASE
Rev	I-DISEASE
Respir	0
Dis	I-DISEASE
1992;145:817–26	I-DISEASE
.	0

Bloch	I-DISEASE
KE	0
,	0
Latshand	I-DISEASE
TD	0
,	0
Turk	I-DISEASE
AJ	I-DISEASE
,	I-DISEASE
et	0
al	I-DISEASE
.	0

Nocturnal	I-DISEASE
periodic	0
breathing	0
during	I-DISEASE
acclimatization	0
at	I-DISEASE
very	I-DISEASE
high	I-DISEASE
altitude	0
at	I-DISEASE
Mount	0
Muztach	I-DISEASE
Ata	0
(	0
7,546	0
m	I-DISEASE
)	0
.	0

Am	I-DISEASE
J	0
Respir	0
Crit	0
Care	0
Med	0
2010;182:562–8	0
.	0

Burgess	I-DISEASE
,	I-DISEASE
K.R.	0
,	I-DISEASE
Lucas	I-DISEASE
,	0
S.J.	I-DISEASE
,	I-DISEASE
Shepherd	0
,	I-DISEASE
K.L.	B-DISEASE
,	I-DISEASE
et	0
al	I-DISEASE
.	0

Worsening	I-DISEASE
of	I-DISEASE
central	0
sleep	0
apnea	0
at	I-DISEASE
high	I-DISEASE
altitude	0
—	I-DISEASE
a	0
role	0
for	0
cerebrovascular	I-DISEASE
function	0
.	0

J	I-DISEASE
Appl	0
Physiol	0
2013	0
;	0
114	0
:	0
1021–8	I-DISEASE
.	0

Coote	I-DISEASE
JH	0
,	0
Tsang	0
G	I-DISEASE
,	0
Baker	0
A	0
,	I-DISEASE
Stone	I-DISEASE
B.	0
Respiratory	0
changes	0
and	0
structure	0
of	I-DISEASE
sleep	0
in	I-DISEASE
young	I-DISEASE
high	0
-	I-DISEASE
altitude	0
dwellers	0
in	I-DISEASE
the	0
Andes	I-DISEASE
of	I-DISEASE
Peru	I-DISEASE
.	0

Eur	I-DISEASE
J	0
Appl	0
Physiol	0
1993;66:249–53	0
.	0

Goldberg	I-DISEASE
S	I-DISEASE
,	0
Schoene	I-DISEASE
R	I-DISEASE
,	I-DISEASE
Haynor	0
D	I-DISEASE
,	I-DISEASE
et	I-DISEASE
al	I-DISEASE
.	0

Brain	0
tissue	I-DISEASE
pH	0
and	0
ventilatory	0
acclimatization	I-DISEASE
to	I-DISEASE
high	I-DISEASE
altitude	0
.	0

J	I-DISEASE
Appl	0
Physiol	0
1992;72:58–63	I-DISEASE
.	0

Johnson	I-DISEASE
P	0
,	0
Edwards	I-DISEASE
N	0
,	I-DISEASE
Burgess	0
KR	I-DISEASE
,	0
Sullivan	0
CE	0
.	I-DISEASE

Sleep	I-DISEASE
architecture	I-DISEASE
changes	0
during	I-DISEASE
a	0
trek	0
from	I-DISEASE
1400	I-DISEASE
to	0
500	B-DISEASE
m	I-DISEASE
in	I-DISEASE
the	0
Nepal	B-DISEASE
Himalaya	0
.	0

J	I-DISEASE
Sleep	0
Res	0
2010;19:148–56	0
.	0

Kohler	I-DISEASE
M	I-DISEASE
,	I-DISEASE
Kriemler	0
S	I-DISEASE
,	0
Wilhelm	0
EM	0
,	I-DISEASE
Brunner	0
-	I-DISEASE
LaRocca	I-DISEASE
H	I-DISEASE
,	0
Zehnder	I-DISEASE
M	I-DISEASE
,	0
Bloch	0
KE	0
.	0

Children	I-DISEASE
at	I-DISEASE
high	0
altitude	0
have	0
less	I-DISEASE
nocturnal	0
periodic	0
breathing	0
than	0
adults	I-DISEASE
.	I-DISEASE

Eur	I-DISEASE
Respir	0
J	0
2008;32:189–97	I-DISEASE
.	0

Lahiri	I-DISEASE
S	I-DISEASE
,	0
Barnard	I-DISEASE
P.	0
Role	0
of	I-DISEASE
arterial	0
chemoreflex	I-DISEASE
in	I-DISEASE
breathing	0
during	I-DISEASE
sleep	0
at	I-DISEASE
high	I-DISEASE
altitude	0
.	0

Prog	I-DISEASE
Clin	0
Biol	0
Res	0
1983;136:75–85	0
.	0

Lahiri	I-DISEASE
S	I-DISEASE
,	0
Meret	I-DISEASE
K	I-DISEASE
,	0
Sherpa	0
M.	I-DISEASE
Dependence	0
of	I-DISEASE
high	0
altitude	0
sleep	0
apnea	0
on	0
ventilatory	0
sensitivity	I-DISEASE
to	I-DISEASE
hypoxia	I-DISEASE
.	0

Respir	I-DISEASE
Physiol	0
1983;52:281–301	0
.	0

Lombardi	I-DISEASE
C	0
,	I-DISEASE
Meriggi	0
P	0
,	0
Agostoni	0
P	0
,	0
et	0
al	I-DISEASE
.	I-DISEASE

Highcare	I-DISEASE
Investigators	0
.	0

High	I-DISEASE
-	I-DISEASE
altitude	0
hypoxia	I-DISEASE
and	0
periodic	0
breathing	0
during	I-DISEASE
sleep	0
:	I-DISEASE
gender	I-DISEASE
-	0
related	0
differences	I-DISEASE
.	0

J	I-DISEASE
Sleep	0
Res	0
2013	0
;	I-DISEASE
22:322–30	I-DISEASE
.	0

Nickol	I-DISEASE
AH	0
,	0
Leverment	I-DISEASE
J	0
,	0
Richards	I-DISEASE
P	I-DISEASE
,	I-DISEASE
et	0
al	0
.	0

Temazepam	I-DISEASE
at	I-DISEASE
high	I-DISEASE
altitude	0
reduces	0
periodic	I-DISEASE
breathing	0
without	0
impairing	I-DISEASE
next	0
-	I-DISEASE
day	I-DISEASE
performance	0
:	0
a	0
randomized	I-DISEASE
cross	0
-	0
over	I-DISEASE
double	0
-	0
blind	I-DISEASE
study	0
.	0

J	I-DISEASE
Sleep	0
Res	0
2006;15:445–54	0
.	0

Nussbaumer	0
-	0
Ochsner	I-DISEASE
Y	I-DISEASE
,	0
Ursprung	0
J	0
,	I-DISEASE
Siebenmann	0
C	I-DISEASE
,	0
Maggiorini	I-DISEASE
M	I-DISEASE
,	0
Bloch	0
KE	0
.	0

Effect	I-DISEASE
of	I-DISEASE
short	0
-	I-DISEASE
term	0
acclimatization	0
to	0
high	I-DISEASE
altitude	I-DISEASE
on	0
sleep	0
and	0
nocturnal	0
breathing	0
.	0

Sleep	I-DISEASE
2012;35:419–23	I-DISEASE
.	0

Schoene	I-DISEASE
R.	I-DISEASE
Control	0
of	I-DISEASE
ventilation	I-DISEASE
in	0
climbers	0
to	I-DISEASE
extreme	I-DISEASE
altitude	0
.	0

J	I-DISEASE
Appl	0
Physiol	0
1982;53:886–90	I-DISEASE
.	0

Waggener	I-DISEASE
TB	0
,	I-DISEASE
Brusil	0
PJ	0
,	I-DISEASE
Kronauer	I-DISEASE
RE	I-DISEASE
,	0
Gabel	0
RA	0
,	I-DISEASE
Inbar	B-DISEASE
GF	I-DISEASE
.	0

Strength	I-DISEASE
and	0
cycle	0
time	I-DISEASE
of	I-DISEASE
high	I-DISEASE
-	0
altitude	0
ventilatory	0
patterns	I-DISEASE
in	0
unacclimatized	0
humans	0
.	0

J	I-DISEASE
Appl	0
Physiol	0
1984;56:576–81	I-DISEASE
.	0

White	I-DISEASE
D	I-DISEASE
,	0
Gleeson	I-DISEASE
K	0
,	I-DISEASE
Pickett	0
C	I-DISEASE
,	I-DISEASE
Rannels	I-DISEASE
A	0
,	I-DISEASE
Cymerman	I-DISEASE
A	0
,	0
Weil	I-DISEASE
J.	0
Altitude	0
acclimatization	0
:	I-DISEASE
influence	0
on	0
periodic	I-DISEASE
breathing	0
and	0
chemoresponsiveness	0
during	I-DISEASE
sleep	0
.	0

J	I-DISEASE
Appl	0
Physiol	0
1987;63:401–12	I-DISEASE
.	0

Central	I-DISEASE
Sleep	I-DISEASE
Apnea	0

Due	I-DISEASE
to	0
a	0
Medication	I-DISEASE
or	I-DISEASE
ICD-10	0
-	0
CM	0
code	0
:	0
G47.39	I-DISEASE
Substance	0
ICD-9	0
-	I-DISEASE
CM	0
code	0
:	I-DISEASE
327.29	0
Alternate	I-DISEASE
Names	I-DISEASE
Narcotic	0
or	0
opioid	0
induced	0
central	0
sleep	0
apnea	I-DISEASE
.	0

Diagnostic	I-DISEASE
Criteria	0
Criteria	0

A	I-DISEASE
-	I-DISEASE
E	0
must	I-DISEASE
be	0
met	0
Sleep	I-DISEASE
Related	0
Breathing	0
Disorders	I-DISEASE
A.	0

The	I-DISEASE
patient	I-DISEASE
is	0
taking	I-DISEASE
an	0
opioid	0
or	B-DISEASE
other	0
respiratory	B-DISEASE
depressant	0
.	0

B.	0
The	I-DISEASE
presence	0
of	0
one	I-DISEASE
or	I-DISEASE
more	0
of	I-DISEASE
the	0
following	0
:	I-DISEASE
.	I-DISEASE

Sleepiness	I-DISEASE
.	0
.	I-DISEASE

Difficulty	I-DISEASE
initiating	I-DISEASE
or	B-DISEASE
maintaining	0
sleep	0
,	I-DISEASE
frequent	I-DISEASE
awakenings	0
,	I-DISEASE
or	I-DISEASE
nonrestorative	0
sleep	I-DISEASE
.	0
.	0

Awakening	I-DISEASE
short	0
of	I-DISEASE
breath	I-DISEASE
.	0
.	I-DISEASE

Snoring	I-DISEASE
.	I-DISEASE
.	0

Witnessed	I-DISEASE
apneas	0
.	0

C.	I-DISEASE
PSG	0
(	0
diagnostic	0
or	I-DISEASE
on	0
positive	0
airway	0
pressure	0
)	I-DISEASE
shows	I-DISEASE
all	0
of	I-DISEASE
the	0
following	0
:	0
.	0

Five	I-DISEASE
or	I-DISEASE
more	0
central	0
apneas	0
and/or	0
central	0
hypopneas1	I-DISEASE
per	0
hour	0
of	I-DISEASE
sleep	0
(	0
PSG	0
)	0
.	0
.	0

The	I-DISEASE
number	0
of	I-DISEASE
central	0
apneas	0
and/or	0
central	0
hypopneas	I-DISEASE
is	I-DISEASE
>	0
50	0
%	0
of	I-DISEASE
the	0
total	0
number	0
of	I-DISEASE
apneas	0
and	0
hypopneas	0
.	0
.	0

Absence	I-DISEASE
of	I-DISEASE
CSB.1	0
D.	0
The	I-DISEASE
disorder	I-DISEASE
occurs	I-DISEASE
as	I-DISEASE
a	0
consequence	0
of	I-DISEASE
an	I-DISEASE
opioid	0
or	I-DISEASE
other	I-DISEASE
respiratory	B-DISEASE
depressant	0
.	I-DISEASE

E.	I-DISEASE

The	I-DISEASE
disorder	0
is	0
not	0
better	0
explained	I-DISEASE
by	I-DISEASE
another	I-DISEASE
current	0
sleep	0
disorder	0
.	0

Notes	I-DISEASE
.	0

As	I-DISEASE
defined	I-DISEASE
by	I-DISEASE
the	0
most	0
recent	I-DISEASE
version	I-DISEASE
of	I-DISEASE
the	0
AASM	0
Manual	I-DISEASE
for	I-DISEASE
the	0
Scoring	0
of	I-DISEASE
Sleep	I-DISEASE
and	0
Associated	0
Events	I-DISEASE
.	0
.	0

Ataxic	I-DISEASE
breathing	0
(	0
irregular	I-DISEASE
variations	0
in	I-DISEASE
respiratory	B-DISEASE
cycle	0
time	0
and	0
tidal	I-DISEASE
volume	I-DISEASE
)	0
may	0
be	I-DISEASE
noted	I-DISEASE
.	0
.	0

Nocturnal	0
and/or	0
daytime	I-DISEASE
hypoventilation	0
may	0
be	I-DISEASE
present	I-DISEASE
but	0
are	0
not	0
required	I-DISEASE
.	0

If	I-DISEASE
sleep	0
related	B-DISEASE
hypoventilation	I-DISEASE
is	0
present	0
,	0
a	0
diagnosis	I-DISEASE
of	I-DISEASE
sleep	0
related	0
hypoventilation	I-DISEASE
due	0
to	0
medication	0
or	0
substance	I-DISEASE
use	0
can	I-DISEASE
be	0
made	0
as	0
well	B-DISEASE
as	0
a	0
diagnosis	I-DISEASE
of	I-DISEASE
central	0
sleep	0
apnea	0
due	0
to	0
a	0
medication	0
or	I-DISEASE
substance	I-DISEASE
.	0
.	0

A	I-DISEASE
diagnosis	I-DISEASE
of	I-DISEASE
CSA	0
due	I-DISEASE
to	I-DISEASE
a	I-DISEASE
medicationor	0
substance	I-DISEASE
does	I-DISEASE
not	I-DISEASE
exclude	0
a	0
diagnosis	I-DISEASE
of	I-DISEASE
OSA	I-DISEASE
.	0

Sleep	I-DISEASE
Related	0
Breathing	0
Disorders	I-DISEASE
Essential	0
Features	I-DISEASE
Users	0
of	I-DISEASE
potent	I-DISEASE
long	0
-	I-DISEASE
acting	I-DISEASE
opioids	I-DISEASE
may	I-DISEASE
have	0
central	0
apneas	0
during	I-DISEASE
sleep	0
.	0

The	I-DISEASE
most	0
common	I-DISEASE
offending	I-DISEASE
drug	I-DISEASE
is	0
methadone	0
.	0

However	I-DISEASE
,	I-DISEASE
the	0
condition	0
has	0
also	0
been	I-DISEASE
described	I-DISEASE
in	0
patients	0
taking	0
long	I-DISEASE
-	I-DISEASE
acting	I-DISEASE
forms	0
of	I-DISEASE
morphine	I-DISEASE
or	0
oxycodone	0
as	0
well	0
as	0
individu-	I-DISEASE
als	I-DISEASE
being	I-DISEASE
treated	0
with	0
fentanyl	I-DISEASE
patches	0
or	0
continuous	0
narcotic	0
infusions	I-DISEASE
.	0

Suboxone	I-DISEASE
(	I-DISEASE
a	0
combination	I-DISEASE
of	I-DISEASE
buprenorphine	0
and	0
naloxone	0
)	0
is	0
often	0
used	0
for	0
treatment	I-DISEASE
of	I-DISEASE
patients	0
with	I-DISEASE
narcotic	0
dependence	0
and	0
pain	0
and	0
can	0
also	0
cause	I-DISEASE
drug	0
-	0
induced	0
central	0
apnea	0
.	0

The	I-DISEASE
description	0
of	I-DISEASE
this	I-DISEASE
population	0
is	I-DISEASE
complicated	0
by	I-DISEASE
the	0
fact	0
that	0
many	0
of	I-DISEASE
the	0
affected	0
indi-	I-DISEASE
viduals	0
may	0
be	0
using	I-DISEASE
multiple	I-DISEASE
drugs	0
(	I-DISEASE
prescribed	0
or	I-DISEASE
illicit	0
)	0
that	0
affect	0
sleep	0
and	0
breathing	0
.	0

Associated	I-DISEASE
Features	I-DISEASE
Breathing	0
abnormalities	I-DISEASE
associated	0
with	0
these	0
drugs	I-DISEASE
are	0
not	I-DISEASE
restricted	I-DISEASE
to	0
central	0
apneas	0
and	0
may	0
also	0
include	I-DISEASE
hypoventilation	0
and	0
OSA	I-DISEASE
with	I-DISEASE
prolonged	0
respiratory	I-DISEASE
events	0
.	0

In	I-DISEASE
fact	I-DISEASE
,	0
many	0
patients	0
present	I-DISEASE
with	I-DISEASE
a	I-DISEASE
combination	0
of	I-DISEASE
both	I-DISEASE
OSA	I-DISEASE
and	0
CSA	0
.	0

Patients	I-DISEASE
who	0
have	I-DISEASE
nocturnal	0
hypoventilation	I-DISEASE
may	I-DISEASE
have	I-DISEASE
normal	0
or	0
increased	0
daytime	I-DISEASE
PaCO2	I-DISEASE
.	0

In	I-DISEASE
most	0
patients	0
with	I-DISEASE
daytime	0
hypoventilation	I-DISEASE
,	I-DISEASE
the	0
PaCO2	I-DISEASE
is	I-DISEASE
only	I-DISEASE
mildly	I-DISEASE
increased	0
(	0
46	I-DISEASE
-	0
50	0
mm	0
Hg	I-DISEASE
)	0
.	I-DISEASE

Patients	I-DISEASE
with	0
drug	0
-	0
induced	I-DISEASE
central	0
apnea	I-DISEASE
who	I-DISEASE
are	0
being	I-DISEASE
treated	0
for	0
chronic	0
pain	0
often	I-DISEASE
report	0
significant	0
daytime	I-DISEASE
sleepiness	0
.	0

Due	I-DISEASE
to	I-DISEASE
the	0
sedating	I-DISEASE
effects	0
of	I-DISEASE
opioid	0
medications	0
,	I-DISEASE
the	I-DISEASE
sleepiness	0
may	0
not	0
substantially	I-DISEASE
improve	0
even	0
if	I-DISEASE
the	0
central	0
apnea	0
is	0
treated	0
successfully	0
.	0

However	I-DISEASE
,	I-DISEASE
one	0
study	0
of	0
patients	I-DISEASE
on	0
chronic	I-DISEASE
methadone	0
mainte-	0
nance	0
found	I-DISEASE
the	I-DISEASE
average	0
Epworth	0
Sleepiness	0
Scale	I-DISEASE
score	I-DISEASE
to	0
be	I-DISEASE
within	I-DISEASE
normal	0
range	I-DISEASE
.	0

In	I-DISEASE
these	I-DISEASE
patients	0
,	I-DISEASE
who	0
manifested	0
only	I-DISEASE
mild	0
to	0
moderate	I-DISEASE
OSA	I-DISEASE
(	I-DISEASE
average	0
AHI	0
about	0
18/	0
hour	0
)	0
,	I-DISEASE
the	0
degree	I-DISEASE
of	0
sleepiness	0
correlated	I-DISEASE
with	I-DISEASE
a	I-DISEASE
depression	0
index	I-DISEASE
.	0

A	I-DISEASE
case	I-DISEASE
series	I-DISEASE
of	I-DISEASE
patients	0
treated	0
with	I-DISEASE
opioids	0
for	0
chronic	I-DISEASE
pain	I-DISEASE
found	I-DISEASE
AHI	0
values	I-DISEASE
above	0
30	0
/	0
hour	0
(	0
up	0
to	0
100	0
/	0
hour	0
)	0
and	0
moderate	I-DISEASE
to	0
severe	0
sleepiness	0
.	0

In	I-DISEASE
this	0
group	I-DISEASE
,	I-DISEASE
50	0
%	0
to	I-DISEASE
80	0
%	0
of	I-DISEASE
respiratory	0
events	0
were	I-DISEASE
central	0
apneas	0
.	0

Sleepiness	I-DISEASE
that	0
is	I-DISEASE
disproportionately	0
high	I-DISEASE
in	I-DISEASE
comparison	I-DISEASE
to	I-DISEASE
the	0
severity	0
of	I-DISEASE
the	0
AHI	0
(	I-DISEASE
and	0
in	0
some	0
cases	0
,	0
at	I-DISEASE
least	0
partially	0
unresponsive	I-DISEASE
to	I-DISEASE
treatment	I-DISEASE
)	0
is	0
likely	I-DISEASE
due	0
to	0
the	0
direct	0
sedative	I-DISEASE
effects	0
of	I-DISEASE
the	0
narcotic	0
medication	0
itself	0
.	0

Clinical	I-DISEASE
and	0
Pathophysiological	I-DISEASE
Subtypes	I-DISEASE
None	I-DISEASE
known	I-DISEASE
.	I-DISEASE

Demographics	I-DISEASE
There	0
are	0
no	0
known	I-DISEASE
sex	0
,	0
racial	0
,	I-DISEASE
or	I-DISEASE
ethnic	I-DISEASE
differences	I-DISEASE
.	0

The	I-DISEASE
prevalence	0
of	I-DISEASE
this	I-DISEASE
disorder	0
is	I-DISEASE
not	0
known	I-DISEASE
,	0
although	0
limited	I-DISEASE
data	I-DISEASE
suggest	I-DISEASE
that	0
it	0
occurs	0
commonly	I-DISEASE
in	I-DISEASE
those	0
being	0
treated	0
with	I-DISEASE
opioids	0
for	I-DISEASE
chronic	0
pain	0
.	0

Predisposing	I-DISEASE
and	0
Precipitating	I-DISEASE
Factors	0
Use	I-DISEASE
of	I-DISEASE
a	I-DISEASE
potent	I-DISEASE
long	I-DISEASE
-	I-DISEASE
acting	I-DISEASE
narcotic	0
is	0
the	0
major	0
causative	0
factor	I-DISEASE
.	0

If	I-DISEASE
patients	0
are	0
suc-	0
cessfully	I-DISEASE
withdrawn	0
from	I-DISEASE
the	0
offending	I-DISEASE
medication	0
,	I-DISEASE
the	0
central	I-DISEASE
apnea	0
may	0
resolve	0
.	0

Familial	I-DISEASE
Patterns	I-DISEASE
Not	I-DISEASE
applicable	0
or	B-DISEASE
known	0
.	0

Onset	I-DISEASE
,	0
Course	0
,	0
and	0
Complications	0
This	B-DISEASE
disorder	0
is	I-DISEASE
typically	I-DISEASE
seen	0
after	0
opioids	0
have	0
been	I-DISEASE
used	0
for	I-DISEASE
at	I-DISEASE
least	0
two	I-DISEASE
months	0
.	0

An	I-DISEASE
increased	0
risk	0
of	I-DISEASE
death	0
has	0
been	I-DISEASE
reported	I-DISEASE
with	I-DISEASE
the	0
use	I-DISEASE
of	I-DISEASE
potent	I-DISEASE
narcotics	I-DISEASE
.	0

There	I-DISEASE
has	0
been	I-DISEASE
a	I-DISEASE
large	0
increase	I-DISEASE
in	I-DISEASE
deaths	I-DISEASE
associated	0
with	0
methadone	0
due	I-DISEASE
to	0
the	0
increasing	I-DISEASE
use	I-DISEASE
of	0
this	0
medication	0
for	0
chronic	I-DISEASE
pain	0
.	0

Many	I-DISEASE
of	I-DISEASE
these	I-DISEASE
deaths	I-DISEASE
occur	0
during	I-DISEASE
sleep	I-DISEASE
.	I-DISEASE

Developmental	I-DISEASE
Issues	0
Information	I-DISEASE
regarding	0
the	0
presentation	0
of	I-DISEASE
this	0
disorder	0
in	0
children	I-DISEASE
is	I-DISEASE
limited	I-DISEASE
.	0

CSA	I-DISEASE
due	0
to	I-DISEASE
opioid	0
medications	I-DISEASE
has	0
been	I-DISEASE
described	I-DISEASE
in	I-DISEASE
children	I-DISEASE
being	I-DISEASE
treated	0
for	I-DISEASE
pain	0
due	I-DISEASE
to	0
cancer	0
.	0

Pathology	I-DISEASE
and	0
Pathophysiology	I-DISEASE
The	I-DISEASE
presumed	0
pathophysiology	0
for	0
the	0
development	I-DISEASE
of	0
these	0
varied	I-DISEASE
breathing	0
abnor-	0
malities	0
during	I-DISEASE
sleep	0
is	I-DISEASE
the	0
respiratory	0
depression	B-DISEASE
that	0
occurs	I-DISEASE
through	0
action	0
of	I-DISEASE
the	0
drugs	0
on	0
the	0
μ	0
-	0
receptors	0
on	0
the	0
ventral	0
surface	0
of	I-DISEASE
the	0
medulla	0
.	0

Studies	I-DISEASE
have	I-DISEASE
demon-	I-DISEASE
strated	0
depression	I-DISEASE
of	I-DISEASE
the	0
awake	0
hypercapnic	I-DISEASE
ventilatory	0
drive	0
;	0
however	I-DISEASE
,	0
it	0
often	0
improves	0
after	0
five	0
to	0
eight	I-DISEASE
months	I-DISEASE
of	I-DISEASE
continued	I-DISEASE
drug	0
use	I-DISEASE
.	0

In	I-DISEASE
one	0
study	0
the	0
hypoxic	0
ventilatory	0
drive	0
never	I-DISEASE
fully	I-DISEASE
normalized	0
.	0

Another	I-DISEASE
study	I-DISEASE
of	I-DISEASE
patients	I-DISEASE
on	0
chronic	I-DISEASE
meth-	0
adone	0
maintenance	I-DISEASE
found	I-DISEASE
that	0
the	0
hypoxic	I-DISEASE
ventilatory	0
drive	0
is	0
increased	0
compared	I-DISEASE
to	0
that	I-DISEASE
of	I-DISEASE
control	I-DISEASE
subjects	I-DISEASE
.	B-DISEASE

In	I-DISEASE
this	I-DISEASE
study	0
the	0
hypercapnic	0
ventilatory	0
response	0
was	I-DISEASE
reduced	0
in	0
comparison	0
with	I-DISEASE
that	I-DISEASE
of	0
controls	0
who	I-DISEASE
were	I-DISEASE
not	0
taking	0
opioids	0
.	I-DISEASE

The	I-DISEASE
difference	I-DISEASE
was	0
not	0
due	0
to	I-DISEASE
a	0
lower	0
tidal	0
volume	0
but	0
rather	0
reduced	I-DISEASE
respiratory	I-DISEASE
rate	0
.	0

Differences	I-DISEASE
in	I-DISEASE
technique	0
or	I-DISEASE
patient	I-DISEASE
population	0
may	0
explain	0
the	0
divergent	0
findings	0
.	0

The	I-DISEASE
cause	I-DISEASE
of	I-DISEASE
the	0
ataxic	I-DISEASE
breathing	B-DISEASE
in	0
patients	0
on	0
opiates	0
is	0
not	0
known	I-DISEASE
.	0

However	I-DISEASE
,	I-DISEASE
one	0
study	0
of	0
patients	I-DISEASE
on	0
chronic	I-DISEASE
opioids	0
found	I-DISEASE
that	I-DISEASE
the	0
incidence	0
of	I-DISEASE
ataxic	I-DISEASE
breathing	0
increased	0
with	I-DISEASE
the	0
total	I-DISEASE
narcotic	0
dose	I-DISEASE
.	0

Objective	I-DISEASE
Findings	I-DISEASE
The	I-DISEASE
drug	0
-	0
induced	0
central	0
apneas	0
may	0
occur	0
as	0
a	I-DISEASE
form	0
of	0
periodic	I-DISEASE
breathing	0
with	I-DISEASE
runs	0
of	I-DISEASE
central	0
apneas	0
separated	I-DISEASE
by	B-DISEASE
a	0
short	0
ventilatory	0
phase	0
(	0
2	0
to	0
4	0
breaths	0
)	0
or	0
intermittent	0
and	0
sporadic	0
central	0
apneas	0
.	0

The	I-DISEASE
underlying	0
breathing	0
pattern	0
may	0
show	I-DISEASE
a	0
slow	0
respi-	B-DISEASE
ratory	I-DISEASE
rate	0
or	0
an	0
ataxic	I-DISEASE
breathing	0
pattern	0
.	0

The	I-DISEASE
term	0
ataxic	I-DISEASE
breathing	I-DISEASE
is	I-DISEASE
sometimes	I-DISEASE
used	0
as	0
a	0
synonym	I-DISEASE
of	I-DISEASE
Biot	0
breathing	I-DISEASE
,	I-DISEASE
although	I-DISEASE
definitions	0
of	0
the	0
latter	0
term	0
vary	I-DISEASE
widely	0
.	0

Sleep	I-DISEASE
Related	I-DISEASE
Breathing	0
Disorders	I-DISEASE
Sleep	0
Related	0
Breathing	0
Disorders	I-DISEASE
Ataxic	0
breathing	0
is	I-DISEASE
characterized	0
by	I-DISEASE
an	I-DISEASE
irregular	0
breathing	I-DISEASE
rhythm	0
as	0
well	I-DISEASE
as	B-DISEASE
irregular	I-DISEASE
depth	0
of	I-DISEASE
breathing	B-DISEASE
(	I-DISEASE
tidal	0
volume	I-DISEASE
)	0
.	0

Obstructive	I-DISEASE
breathing	0
events	0
are	0
also	0
common	I-DISEASE
in	0
patients	0
taking	0
potent	I-DISEASE
opioids	0
and	0
a	I-DISEASE
diagnosis	0
of	0
both	I-DISEASE
OSA	0
and	0
CSA	0
is	0
often	I-DISEASE
appro-	0
priate	0
.	0

Prolonged	I-DISEASE
obstructive	0
apneas	I-DISEASE
with	I-DISEASE
severe	I-DISEASE
arterial	I-DISEASE
desaturation	I-DISEASE
may	0
be	0
noted	0
.	0

The	I-DISEASE
drug	I-DISEASE
-	0
induced	I-DISEASE
central	0
apneas	0
occur	0
mainly	0
during	I-DISEASE
NREM	I-DISEASE
sleep	0
and	0
,	I-DISEASE
in	0
patients	0
without	0
coexistent	0
obstructive	0
apnea	I-DISEASE
,	0
the	0
AHI	0
may	0
be	I-DISEASE
much	0
lower	0
during	I-DISEASE
REM	0
than	I-DISEASE
during	I-DISEASE
NREM	0
sleep	0
.	0

Patients	I-DISEASE
also	0
tend	I-DISEASE
to	0
have	I-DISEASE
a	0
low	0
arousal	0
index	0
and	0
increased	0
stage	I-DISEASE
N3	0
sleep	0
.	0

Unlike	I-DISEASE
other	I-DISEASE
forms	0
of	I-DISEASE
central	0
apnea	0
,	0
drug	0
-	0
induced	0
central	I-DISEASE
apneas	0
may	I-DISEASE
occur	0
during	I-DISEASE
stage	0
N3	0
sleep	0
.	0

Differential	I-DISEASE
Diagnosis	0

This	I-DISEASE
condition	0
is	0
best	0
distinguished	0
from	I-DISEASE
other	I-DISEASE
types	I-DISEASE
of	I-DISEASE
central	0
sleep	0
apnea	0
by	0
the	0
patient	I-DISEASE
’s	I-DISEASE
ongoing	0
use	I-DISEASE
of	I-DISEASE
long	I-DISEASE
-	0
acting	0
opioids	0
.	0

Other	0
SRBDs	0
may	0
be	0
present	I-DISEASE
and	0
may	0
complicate	0
PSG	0
findings	0
.	0

Unresolved	I-DISEASE
Issues	0
and	0
Further	I-DISEASE
Directions	0

Further	I-DISEASE
study	I-DISEASE
is	0
needed	0
to	0
determine	0
risk	0
factors	I-DISEASE
and	0
pathogenesis	0
for	I-DISEASE
development	I-DISEASE
of	I-DISEASE
these	I-DISEASE
sleep	0
disordered	I-DISEASE
breathing	0
patterns	I-DISEASE
in	I-DISEASE
users	0
of	I-DISEASE
long	I-DISEASE
-	I-DISEASE
acting	0
opioids	0
.	0

It	I-DISEASE
has	0
been	I-DISEASE
hypothesized	I-DISEASE
that	0
these	0
sleep	0
disordered	0
breathing	I-DISEASE
patterns	0
may	I-DISEASE
play	I-DISEASE
a	I-DISEASE
role	0
in	0
the	0
unex-	0
plained	I-DISEASE
increased	0
mortality	I-DISEASE
in	I-DISEASE
this	I-DISEASE
population	0
.	0

This	I-DISEASE
also	0
requires	0
further	I-DISEASE
study	0
.	0

Bibliography	0
Alattar	0
MA	0
,	I-DISEASE
Scharf	0
SM	I-DISEASE
.	0

Opioid	I-DISEASE
-	0
associated	0
central	0
sleep	0
apnea	I-DISEASE
:	0
a	0
case	I-DISEASE
series	I-DISEASE
.	0

Sleep	I-DISEASE
Breath	0
2009;13:201–6	I-DISEASE
.	0

Centers	I-DISEASE
for	I-DISEASE
Disease	0
Control	0
and	0
Prevention	I-DISEASE
(	I-DISEASE
CDC	0
)	0
.	0

Vital	I-DISEASE
signs	0
:	I-DISEASE
risk	0
for	I-DISEASE
overdose	0
from	0
methadone	0
used	0
for	0
pain	0
relief	I-DISEASE
—	I-DISEASE
United	0
States	0
,	I-DISEASE
1999	I-DISEASE
-	0
2010	I-DISEASE
.	0

MMWR	I-DISEASE
Morb	0
Mortal	B-DISEASE
Wkly	I-DISEASE
Rep	0
2012;61:493–7	I-DISEASE
.	0

Farney	I-DISEASE
RJ	0
,	0
Walker	I-DISEASE
JM	0
,	0
Cloward	0
TV	I-DISEASE
,	I-DISEASE
Rhondeau	0
S.	0
Sleep	I-DISEASE
-	0
disordered	I-DISEASE
breathing	I-DISEASE
associated	0
with	0
long	I-DISEASE
-	I-DISEASE
term	0
opioid	0
therapy	0
.	0

Chest	I-DISEASE
2003;123:632–9	0
.	0

Guilleminault	I-DISEASE
C	I-DISEASE
,	I-DISEASE
Cao	I-DISEASE
M	I-DISEASE
,	0
Yue	B-DISEASE
HJ	I-DISEASE
,	0
Chawla	I-DISEASE
P.	0
Obstructive	I-DISEASE
sleep	0
apnea	I-DISEASE
and	0
chronic	I-DISEASE
opioid	0
use	I-DISEASE
.	0

Lung	I-DISEASE
2010;188:459–68	0
.	0

Ramar	I-DISEASE
K.	0
Reversal	0
of	I-DISEASE
sleep	0
-	0
disordered	0
breathing	I-DISEASE
with	I-DISEASE
opioid	0
withdrawal	I-DISEASE
.	0

Pain	0
Pract	0
2009;9:394–8	0
.	0

Santiago	I-DISEASE
TV	I-DISEASE
,	0
Pugliese	0
AC	I-DISEASE
,	0
Edelman	0
NH	I-DISEASE
.	0

Control	I-DISEASE
of	I-DISEASE
breathing	0
during	I-DISEASE
methadone	0
addiction	I-DISEASE
.	0

Am	I-DISEASE
J	0
Med	0
1977;62:347–54	0
.	0

Shook	I-DISEASE
JE	0
,	I-DISEASE
Watkins	0
WD	I-DISEASE
,	0
Camporesi	0
EM	I-DISEASE
.	0

Differential	I-DISEASE
roles	0
of	I-DISEASE
opioid	0
receptors	0
in	0
respiration	0
,	I-DISEASE
respiratory	I-DISEASE
disease	I-DISEASE
,	0
and	0
opiate	0
-	0
induced	0
respiratory	I-DISEASE
depression	0
.	0

Am	I-DISEASE
Rev	I-DISEASE
Respir	0
Dis	I-DISEASE
1990;142:895–909	0
.	0

Teichtahl	I-DISEASE
H	0
,	I-DISEASE
Prodromidis	I-DISEASE
A	0
,	I-DISEASE
Miller	I-DISEASE
B	0
,	0
Cherry	0
G	I-DISEASE
,	I-DISEASE
Kronborg	0
I.	0
Sleep	0
-	0
disordered	I-DISEASE
breathing	I-DISEASE
in	I-DISEASE
stable	I-DISEASE
methadone	0
programme	I-DISEASE
patients	I-DISEASE
:	I-DISEASE
a	0
pilot	0
study	0
.	0

Addiction	I-DISEASE
2001;96:395–403	I-DISEASE
.	0

Teichtahl	I-DISEASE
H	0
,	I-DISEASE
Wang	I-DISEASE
D	I-DISEASE
,	0
Cunnington	0
D.	I-DISEASE
Ventilatory	B-DISEASE
responses	0
to	0
hypoxia	I-DISEASE
and	0
hypercapnia	I-DISEASE
in	I-DISEASE
stable	I-DISEASE
methadone	0
treatment	I-DISEASE
patients	I-DISEASE
.	0

Chest	I-DISEASE
2005;128:1339–47	0
.	0

Walker	I-DISEASE
JM	0
,	I-DISEASE
Farney	0
RJ	I-DISEASE
,	0
Rhondeau	0
SM	I-DISEASE
.	0

Chronic	I-DISEASE
opioid	0
use	0
is	0
a	I-DISEASE
risk	0
factor	0
for	0
the	0
development	I-DISEASE
of	I-DISEASE
central	0
sleep	0
apnea	0
and	0
ataxic	I-DISEASE
breathing	0
.	0

J	I-DISEASE
Clin	0
Sleep	0
Med	0
2007	I-DISEASE
;	I-DISEASE
3:455–61	I-DISEASE
.	0

Wang	I-DISEASE
D	I-DISEASE
,	0
Teichtahl	I-DISEASE
H	I-DISEASE
,	0
Goodman	0
C	0
,	I-DISEASE
Drummer	I-DISEASE
O	0
,	I-DISEASE
Grunstein	I-DISEASE
RR	0
,	0
Kronborg	0
I.	I-DISEASE
Subjective	I-DISEASE
daytime	I-DISEASE
sleepiness	0
and	0
daytime	0
function	0
in	I-DISEASE
patients	0
on	0
stable	I-DISEASE
methadone	0
maintenance	0
treatment	0
:	I-DISEASE
possible	I-DISEASE
mechanisms	I-DISEASE
.	0

J	I-DISEASE
Clin	0
Sleep	0
Med	0
2008;4:557–62	I-DISEASE
.	0

Primary	I-DISEASE
Central	I-DISEASE
Sleep	0
Apnea	0
ICD-9	0
-	0
CM	0
code	0
:	0
327.21	0
Alternate	0
Names	I-DISEASE
Idiopathic	0
central	0
sleep	I-DISEASE
apnea	0
.	0

Diagnostic	I-DISEASE
Criteria	0
Criteria	I-DISEASE
A	0
-	I-DISEASE
D	I-DISEASE
must	0
be	0
met	0
A.	0

The	I-DISEASE
presence	0
of	I-DISEASE
at	I-DISEASE
least	0
one	0
of	I-DISEASE
the	0
following1	0
:	0
1	I-DISEASE
.	I-DISEASE
Sleepiness	I-DISEASE
.	0

ICD-10	I-DISEASE
-	0
CM	0
code	0
:	0
G47.31	0
Sleep	I-DISEASE
Related	0
Breathing	0
Disorders	0
.	0

Difficulty	I-DISEASE
initiating	I-DISEASE
or	B-DISEASE
maintaining	0
sleep	0
,	I-DISEASE
frequent	I-DISEASE
awakenings	0
,	I-DISEASE
or	I-DISEASE
nonrestorative	0
sleep	I-DISEASE
.	0
.	0

Awakening	I-DISEASE
short	0
of	I-DISEASE
breath	I-DISEASE
.	0
.	I-DISEASE

Snoring	I-DISEASE
.	I-DISEASE
.	0

Witnessed	I-DISEASE
apneas	0
.	0

B.	0
PSG	0
demonstrates	I-DISEASE
all	0
of	I-DISEASE
the	0
following	0
:	0
.	0

Five	I-DISEASE
or	I-DISEASE
more	0
central	0
apneas	0
and/or	0
central	0
hypopneas2	I-DISEASE
per	0
hour	0
of	I-DISEASE
sleep	0
(	0
PSG	0
)	0
.	0
.	0

The	I-DISEASE
number	0
of	I-DISEASE
central	0
apneas	0
and/or	0
central	0
hypopneas	I-DISEASE
is	I-DISEASE
>	0
50	0
%	0
of	I-DISEASE
the	0
total	0
number	0
of	I-DISEASE
apneas	0
and	0
hypopneas	0
.	0
.	0

Absence	I-DISEASE
of	I-DISEASE
CSB.2	0
C.	0
There	0
is	I-DISEASE
no	I-DISEASE
evidence	0
of	I-DISEASE
daytime	I-DISEASE
or	I-DISEASE
nocturnal	I-DISEASE
hypoventilation	0
.	0

D.	I-DISEASE

The	I-DISEASE
disorder	I-DISEASE
is	0
not	0
better	0
explained	I-DISEASE
by	I-DISEASE
another	I-DISEASE
current	I-DISEASE
sleep	0
disorder	0
,	I-DISEASE
medical	I-DISEASE
or	I-DISEASE
neurologic	0
disorder	0
,	0
medication	0
use	I-DISEASE
,	0
or	0
substance	0
use	I-DISEASE
disorder	0
.	0

Notes	I-DISEASE
.	0

In	I-DISEASE
children	I-DISEASE
,	0
daytime	I-DISEASE
symptoms	0
may	I-DISEASE
not	0
be	I-DISEASE
evident	0
.	0
.	0

As	I-DISEASE
defined	I-DISEASE
by	0
the	0
most	0
recent	I-DISEASE
version	I-DISEASE
of	I-DISEASE
the	0
AASM	0
Manual	I-DISEASE
for	I-DISEASE
the	0
Scoring	0
of	I-DISEASE
Sleep	I-DISEASE
and	0
Associated	0
Events	I-DISEASE
.	0

Essential	I-DISEASE
Features	I-DISEASE
Primary	0
CSA	0
is	0
of	I-DISEASE
unknown	I-DISEASE
etiology	0
(	I-DISEASE
idiopathic	I-DISEASE
)	0
and	0
is	0
characterized	0
by	0
recurrent	0
central	0
apneas	0
,	0
defined	I-DISEASE
as	0
a	I-DISEASE
cessation	I-DISEASE
of	I-DISEASE
airflow	I-DISEASE
during	I-DISEASE
sleep	0
associated	0
with	I-DISEASE
an	0
absence	0
of	0
respiratory	0
effort	I-DISEASE
.	0

Airflow	I-DISEASE
and	0
respiratory	I-DISEASE
effort	0
cease	I-DISEASE
simultaneously	I-DISEASE
in	I-DISEASE
a	0
repetitive	I-DISEASE
Sleep	0
Related	I-DISEASE
Breathing	0
Disorders	I-DISEASE
fashion	0
over	I-DISEASE
the	0
course	I-DISEASE
of	I-DISEASE
the	0
night	I-DISEASE
.	0

This	I-DISEASE
recurrent	0
cessation	I-DISEASE
and	0
resumption	I-DISEASE
of	I-DISEASE
venti-	0
lation	0
can	0
lead	0
to	I-DISEASE
sleep	0
fragmentation	0
,	0
yielding	I-DISEASE
excessive	0
daytime	0
sleepiness	I-DISEASE
,	I-DISEASE
frequent	I-DISEASE
nocturnal	I-DISEASE
awakenings	0
,	I-DISEASE
or	0
both	I-DISEASE
.	0

Thus	I-DISEASE
,	I-DISEASE
patients	0
may	I-DISEASE
present	0
with	I-DISEASE
symptoms	I-DISEASE
of	I-DISEASE
hyper-	0
somnolence	I-DISEASE
or	I-DISEASE
insomnia	I-DISEASE
.	0

Patients	I-DISEASE
with	0
primary	0
CSA	0
tend	I-DISEASE
to	I-DISEASE
have	0
low	0
normal	0
arterial	I-DISEASE
PaCO2	I-DISEASE
during	I-DISEASE
wakefulness	I-DISEASE
(	0
less	I-DISEASE
than	I-DISEASE
40	0
mm	0
Hg	I-DISEASE
)	0
.	I-DISEASE

Patients	I-DISEASE
with	0
a	0
known	0
medical	0
or	0
neurological	0
disorder	0
that	0
is	I-DISEASE
believed	I-DISEASE
to	0
cause	I-DISEASE
central	0
apneas	I-DISEASE
are	0
classified	0
elsewhere	0
.	0

Associated	I-DISEASE
Features	I-DISEASE
Patients	0
generally	0
present	I-DISEASE
with	I-DISEASE
excessive	0
daytime	0
sleepiness	0
,	I-DISEASE
sleep	I-DISEASE
fragmentation	I-DISEASE
,	I-DISEASE
or	I-DISEASE
insomnia	I-DISEASE
.	0

Other	I-DISEASE
signs	I-DISEASE
and	0
symptoms	I-DISEASE
that	0
are	0
often	0
,	I-DISEASE
but	0
not	0
invariably	I-DISEASE
,	I-DISEASE
present	0
include	I-DISEASE
snoring	0
,	0
witnessed	I-DISEASE
apnea	0
,	I-DISEASE
and	0
awakening	0
with	0
shortness	0
of	I-DISEASE
breath	0
.	0

Clinical	I-DISEASE
and	0
Pathophysiological	0
Subtypes	I-DISEASE

The	I-DISEASE
disorder	0
is	0
rare	I-DISEASE
,	0
precluding	0
identification	0
of	I-DISEASE
any	I-DISEASE
definite	I-DISEASE
subtypes	I-DISEASE
.	0

Demographics	I-DISEASE
Not	0
known	I-DISEASE
.	0

Most	I-DISEASE
studies	I-DISEASE
suggest	0
this	I-DISEASE
disorder	0
is	I-DISEASE
rare	I-DISEASE
,	I-DISEASE
most	0
common	I-DISEASE
in	0
middle	I-DISEASE
-	I-DISEASE
aged	I-DISEASE
to	0
elderly	I-DISEASE
individuals	I-DISEASE
,	I-DISEASE
and	0
more	0
frequent	I-DISEASE
in	I-DISEASE
men	0
than	0
women	I-DISEASE
,	I-DISEASE
although	0
not	0
all	0
studies	I-DISEASE
support	0
this	0
sex	0
bias	0
.	0

Predisposing	I-DISEASE
and	0
Precipitating	I-DISEASE
Factors	0
CSA	0
in	I-DISEASE
these	0
patients	I-DISEASE
occurs	0
because	I-DISEASE
the	0
arterial	0
PCO2	0
(	0
PaCO2	0
)	0
drops	I-DISEASE
below	I-DISEASE
the	B-DISEASE
hypo-	0
capnic	0
apnea	0
threshold	0
(	0
HAT	0
)	0
.	0

During	I-DISEASE
wakefulness	0
,	I-DISEASE
drops	0
in	I-DISEASE
PaCO2	0
do	0
not	0
result	0
in	I-DISEASE
apnea	I-DISEASE
.	0

However	I-DISEASE
,	I-DISEASE
during	I-DISEASE
sleep	0
,	0
when	I-DISEASE
the	0
PaCO2	I-DISEASE
drops	I-DISEASE
below	I-DISEASE
the	I-DISEASE
HAT	I-DISEASE
,	I-DISEASE
respiratory	I-DISEASE
effort	I-DISEASE
ceases	0
.	0

For	I-DISEASE
most	0
patients	0
,	I-DISEASE
the	0
HAT	I-DISEASE
is	I-DISEASE
within	0
a	0
few	0
mm	I-DISEASE
Hg	I-DISEASE
of	I-DISEASE
the	0
awake	0
PaCO2	I-DISEASE
.	0

Any	I-DISEASE
factors	I-DISEASE
that	0
narrow	0
the	0
gap	I-DISEASE
between	0
the	0
sleeping	0
PaCO2	0
and	0
the	0
HAT	I-DISEASE
predispose	0
to	0
central	0
apnea	0
.	0

A	I-DISEASE
high	I-DISEASE
ventilatory	0
response	0
to	I-DISEASE
CO2	I-DISEASE
seems	B-DISEASE
to	I-DISEASE
be	I-DISEASE
a	I-DISEASE
major	I-DISEASE
predisposing	0
factor	0
in	0
the	0
development	I-DISEASE
of	I-DISEASE
primary	0
CSA	I-DISEASE
.	0

This	I-DISEASE
can	0
lead	0
to	I-DISEASE
the	0
instability	I-DISEASE
in	I-DISEASE
venti-	0
latory	0
control	I-DISEASE
that	0
characterizes	0
the	0
disorder	I-DISEASE
.	0

Frequent	I-DISEASE
arousal	0
from	0
sleep	0
can	0
also	0
predispose	0
to	I-DISEASE
the	I-DISEASE
development	B-DISEASE
of	I-DISEASE
central	0
apneas	0
,	I-DISEASE
as	0
ventilatory	0
control	I-DISEASE
is	0
somewhat	I-DISEASE
unstable	0
at	I-DISEASE
sleep	0
-	I-DISEASE
wake	0
transitions	I-DISEASE
.	0

Increased	I-DISEASE
ventilation	0
associated	0
with	0
arousal	I-DISEASE
can	I-DISEASE
result	I-DISEASE
in	0
a	0
PaCO2	0
below	I-DISEASE
the	0
HAT	I-DISEASE
after	I-DISEASE
the	0
return	0
to	I-DISEASE
sleep	0
.	0

Because	I-DISEASE
ventilatory	0
drive	0
is	0
lower	0
during	I-DISEASE
REM	0
than	0
NREM	0
sleep	0
,	I-DISEASE
hypocapnic	0
central	0
apnea	0
is	I-DISEASE
much	0
less	I-DISEASE
common	I-DISEASE
during	I-DISEASE
that	0
sleep	0
stage	0
.	0

Two	I-DISEASE
other	I-DISEASE
variables	I-DISEASE
have	I-DISEASE
been	0
discussed	I-DISEASE
as	0
possible	I-DISEASE
predispos-	0
ing	I-DISEASE
factors	B-DISEASE
,	I-DISEASE
although	0
their	I-DISEASE
true	0
role	0
in	I-DISEASE
the	0
development	I-DISEASE
of	I-DISEASE
this	0
syndrome	I-DISEASE
is	0
uncertain	0
.	0

First	I-DISEASE
,	I-DISEASE
frequent	0
arousal	0
or	0
awakening	0
due	I-DISEASE
to	0
low	0
arousal	0
threshold	0
or	I-DISEASE
sleep	I-DISEASE
maintenance	0
insomnia	I-DISEASE
have	0
been	0
reported	I-DISEASE
to	0
lead	0
to	0
an	0
increase	I-DISEASE
in	0
central	0
apneas	0
.	0

Because	I-DISEASE
ventila-	0
tory	0
control	0
can	I-DISEASE
be	0
somewhat	I-DISEASE
unstable	0
in	I-DISEASE
the	I-DISEASE
normal	0
wake	0
-	0
sleep	0
transition	I-DISEASE
with	0
occa-	0
sional	0
central	0
apneas	I-DISEASE
being	I-DISEASE
observed	I-DISEASE
in	I-DISEASE
otherwise	0
normal	0
individuals	I-DISEASE
,	0
any	I-DISEASE
disorder	0
that	0
interrupts	I-DISEASE
sleep	0
may	0
worsen	0
CSA	0
.	0

Some	I-DISEASE
studies	I-DISEASE
have	I-DISEASE
suggested	I-DISEASE
a	0
worsening	I-DISEASE
of	I-DISEASE
primary	0
CSA	0
in	I-DISEASE
the	I-DISEASE
supine	I-DISEASE
position	I-DISEASE
,	I-DISEASE
but	I-DISEASE
this	0
has	0
been	I-DISEASE
more	0
clearly	0
documented	0
in	I-DISEASE
patients	I-DISEASE
with	0
CSB	I-DISEASE
.	0

Familial	I-DISEASE
Patterns	I-DISEASE

Some	I-DISEASE
data	I-DISEASE
suggest	0
that	0
ventilatory	0
chemoresponsiveness	I-DISEASE
is	0
directly	I-DISEASE
inherited	I-DISEASE
.	I-DISEASE

Because	I-DISEASE
elevated	I-DISEASE
CO2	0
responsiveness	0
is	0
a	0
predisposing	I-DISEASE
variable	I-DISEASE
in	I-DISEASE
the	0
development	0
of	0
idio-	I-DISEASE
pathic	0
CSA	I-DISEASE
,	I-DISEASE
it	0
would	I-DISEASE
seem	I-DISEASE
likely	I-DISEASE
that	0
there	I-DISEASE
would	0
be	0
a	0
familial	0
pattern	0
in	I-DISEASE
the	0
develop-	0
ment	0
of	I-DISEASE
this	I-DISEASE
respiratory	0
abnormality	0
.	0

However	I-DISEASE
,	0
there	0
are	I-DISEASE
no	0
data	I-DISEASE
addressing	I-DISEASE
this	0
issue	0
.	0

Onset	I-DISEASE
,	0
Course	0
,	0
and	0
Complications	0
Not	I-DISEASE
known	I-DISEASE
.	0

The	I-DISEASE
apneas	0
can	0
lead	0
to	I-DISEASE
sleep	0
fragmentation	0
,	I-DISEASE
yielding	I-DISEASE
either	I-DISEASE
hypersomno-	0
lence	I-DISEASE
or	0
insomnia	0
.	0

There	I-DISEASE
is	I-DISEASE
little	0
evidence	0
that	0
these	I-DISEASE
apneas	0
or	0
their	0
associated	I-DISEASE
hypoxia	I-DISEASE
and	0
hypercapnia	0
lead	0
to	0
pulmonary	0
hypertension	I-DISEASE
,	0
cor	0
pulmonale	0
,	0
or	0
other	I-DISEASE
adverse	0
car-	0
diovascular	0
consequences	I-DISEASE
.	0

Developmental	I-DISEASE
Issues	0
Criteria	I-DISEASE
for	0
apnea	I-DISEASE
of	I-DISEASE
infancy	0
and	0
apnea	0
of	I-DISEASE
prematurity	I-DISEASE
are	0
detailed	0
elsewhere	0
and	0
it	0
should	I-DISEASE
be	0
noted	0
that	0
central	0
apnea	0
is	0
defined	I-DISEASE
somewhat	I-DISEASE
differently	0
in	0
infants	0
and	0
chil-	0
dren	0
than	0
in	I-DISEASE
adults	I-DISEASE
.	0

Central	I-DISEASE
apneas	0
that	0
are	0
brief	I-DISEASE
(	I-DISEASE
<	0
20	0
seconds	0
in	I-DISEASE
duration	0
)	0
and	0
not	0
associated	0
with	0
desaturation	0
or	0
arousal	0
are	0
commonly	I-DISEASE
observed	0
in	I-DISEASE
both	I-DISEASE
premature	0
and	0
term	0
infants	0
.	0

In	I-DISEASE
adults	I-DISEASE
,	0
population	0
studies	0
report	0
an	0
increase	I-DISEASE
in	0
the	0
occurrence	0
of	I-DISEASE
central	I-DISEASE
apnea	I-DISEASE
with	I-DISEASE
increasing	I-DISEASE
age	0
,	0
especially	0
in	I-DISEASE
men	0
.	0

Pathology	I-DISEASE
and	0
Pathophysiology	I-DISEASE
Primary	0
CSA	0
is	I-DISEASE
caused	I-DISEASE
by	I-DISEASE
instability	I-DISEASE
of	I-DISEASE
the	0
respiratory	I-DISEASE
control	0
system	0
in	I-DISEASE
the	0
transition	I-DISEASE
from	0
wakefulness	0
to	0
sleep	0
and	0
less	I-DISEASE
commonly	I-DISEASE
during	I-DISEASE
stable	I-DISEASE
NREM	0
sleep	0
.	0

Central	I-DISEASE
apnea	I-DISEASE
in	0
patients	I-DISEASE
with	I-DISEASE
primary	0
CSA	0
most	0
often	I-DISEASE
occurs	I-DISEASE
during	I-DISEASE
stages	0
N1	0
and	0
N2	0
sleep	0
and	0
is	I-DISEASE
rare	0
during	I-DISEASE
stages	I-DISEASE

N3	I-DISEASE
and	0
R	I-DISEASE
sleep	0
.	0

Central	I-DISEASE
apneas	0
tend	I-DISEASE
to	I-DISEASE
occur	I-DISEASE
in	0
individuals	I-DISEASE
with	I-DISEASE
a	0
high	I-DISEASE
or	I-DISEASE
increased	0
ventilatory	0
responsiveness	0
to	0
CO2	I-DISEASE
.	0

Arterial	I-DISEASE
PCO2	0
levels	0
below	I-DISEASE
the	0
hypocapnic	0
apnea	0
threshold	I-DISEASE
lead	0
to	0
a	0
cessation	I-DISEASE
in	0
ventilatory	0
effort	I-DISEASE
and	0
,	0
therefore	I-DISEASE
,	I-DISEASE
a	0
central	0
apnea	0
.	0

Individuals	I-DISEASE
with	I-DISEASE
high	0
CO2	I-DISEASE
ventilatory	0
responsiveness	0
tend	I-DISEASE
to	0
have	0
lower	0
PaCO2	0
levels	0
(	I-DISEASE
both	I-DISEASE
daytime	0
and	0
sleep	0
)	0
and	0
a	0
lower	0
gradient	0
between	0
the	0
sleep-	0
ing	0
PaCO2	0
and	0
the	0
apneic	0
threshold	0
.	0

Hence	I-DISEASE
,	I-DISEASE
a	0
smaller	I-DISEASE
increase	0
in	I-DISEASE
ventilation	0
is	I-DISEASE
required	0
to	0
reach	0
this	0
apnea	I-DISEASE
threshold	0
and	0
inhibit	I-DISEASE
ventilation	0
.	0

Individuals	I-DISEASE
with	I-DISEASE
high	I-DISEASE
chemore-	I-DISEASE
sponsiveness	I-DISEASE
also	I-DISEASE
hyperventilate	I-DISEASE
more	0
in	0
response	0
to	0
small	0
changes	0
in	I-DISEASE
arterial	I-DISEASE
PaCO2	0
.	0

This	I-DISEASE
again	0
often	0
drives	I-DISEASE
the	0
PaCO2	0
below	I-DISEASE
the	0
apnea	0
threshold	I-DISEASE
,	0
yielding	I-DISEASE
a	0
cessation	I-DISEASE
Sleep	0
Related	0
Breathing	0
Disorders	0
Sleep	I-DISEASE
Related	I-DISEASE
Breathing	0
Disorders	0
of	I-DISEASE
ventilation	0
.	0

However	I-DISEASE
,	I-DISEASE
not	0
all	0
factors	0
that	0
cause	I-DISEASE
greater	I-DISEASE
ventilatory	0
drive	0
have	I-DISEASE
the	0
same	0
effect	0
.	0

Studies	I-DISEASE
suggest	I-DISEASE
that	0
although	0
hypoxemia	0
increases	0
chemoresponsiveness	0
to	I-DISEASE
PaCO2	0
,	0
the	0
gap	I-DISEASE
between	0
the	0
PaCO2	0
and	0
the	0
apneic	0
threshold	0
is	0
smaller	I-DISEASE
(	0
predispos-	0
ing	0
to	0
central	0
apnea	I-DISEASE
)	0
.	0

Metabolic	I-DISEASE
acidosis	I-DISEASE
and	0
nonhypoxic	I-DISEASE
chemoreceptor	I-DISEASE
stimulants	0
tend	0
to	0
decrease	I-DISEASE
HAT	I-DISEASE
more	0
than	0
they	I-DISEASE
decrease	0
the	0
sleeping	0
PaCO2	0
,	0
resulting	0
in	I-DISEASE
a	0
larger	I-DISEASE
gap	0
between	0
the	0
HAT	0
and	0
the	0
sleeping	I-DISEASE
PaCO2	0
and	0
lower	0
likelihood	0
of	I-DISEASE
central	0
apnea	0
.	0

Metabolic	I-DISEASE
alkalosis	I-DISEASE
tends	0
to	I-DISEASE
increase	I-DISEASE
HAT	0
as	0
well	I-DISEASE
as	I-DISEASE
decrease	I-DISEASE
ventilatory	0
responsive-	0
ness	0
,	I-DISEASE
yielding	0
a	I-DISEASE
smaller	I-DISEASE
gap	I-DISEASE
between	0
the	B-DISEASE
HAT	I-DISEASE
and	0
sleeping	I-DISEASE
PaCO2	0
.	0

Objective	I-DISEASE
Findings	I-DISEASE
The	I-DISEASE
PSG	0
of	0
the	0
patient	I-DISEASE
with	I-DISEASE
primary	I-DISEASE
CSA	I-DISEASE
demonstrates	I-DISEASE
more	0
than	I-DISEASE
five	0
central	0
apneas	0
and/or	0
central	0
hypopneas	0
per	0
hour	0
of	I-DISEASE
sleep	0
.	0

The	I-DISEASE
central	0
apneas	0
and	0
central	0
hypopneas	0
meet	0
criteria	0
for	0
these	I-DISEASE
respiratory	I-DISEASE
events	0
in	0
adults	I-DISEASE
or	0
children	0
as	0
defined	I-DISEASE
by	I-DISEASE
the	0
most	0
recent	0
version	I-DISEASE
of	I-DISEASE
the	0
AASM	0
Manual	I-DISEASE
for	0
the	0
Scoring	0
of	I-DISEASE
Sleep	0
and	0
Associated	0
Events	0
.	0

Published	I-DISEASE
studies	I-DISEASE
of	I-DISEASE
patients	I-DISEASE
with	0
primary	0
CSA	0
have	0
required	0
that	0
>	0
50	I-DISEASE
%	0
to	0
85	0
%	0
of	I-DISEASE
respiratory	0
events	0
be	I-DISEASE
central	0
apneas	0
.	0

Periodic	I-DISEASE
breathing	0
characterized	0
by	0
episodes	I-DISEASE
of	I-DISEASE
recurrent	I-DISEASE
central	0
apneas	0
separated	I-DISEASE
by	I-DISEASE
periods	I-DISEASE
of	I-DISEASE
ventilation	0
may	0
occur	I-DISEASE
.	0

The	I-DISEASE
inter-	I-DISEASE
event	0
respiratory	0
phase	0
is	I-DISEASE
typically	0
brief	I-DISEASE
with	0
a	0
maximum	0
of	I-DISEASE
five	0
breaths	0
.	0

The	I-DISEASE
venti-	0
latory	0
phase	0
between	0
central	0
apneas	0
does	I-DISEASE
not	0
have	0
the	0
crescendo	I-DISEASE
-	0
decrescendo	0
pattern	0
of	I-DISEASE
CSB	0
breathing	B-DISEASE
.	0

Central	I-DISEASE
apneas	I-DISEASE
commonly	I-DISEASE
lead	0
to	I-DISEASE
mild	0
arterial	0
oxygen	I-DISEASE
desaturation	I-DISEASE
,	I-DISEASE
although	0
more	I-DISEASE
severe	0
desaturation	0
can	0
occur	I-DISEASE
.	0

Central	I-DISEASE
apneas	0
may	I-DISEASE
also	0
lead	0
to	0
arousal	0
from	I-DISEASE
sleep	0
,	I-DISEASE
causing	I-DISEASE
fragmentation	0
and	0
yielding	I-DISEASE
increased	0
stages	0
N1	0
and	0
N2	0
sleep	I-DISEASE
at	I-DISEASE
the	0
expense	I-DISEASE
of	I-DISEASE
stage	I-DISEASE
N3	B-DISEASE
sleep	0
.	0

As	0
noted	0
above	0
,	I-DISEASE
central	0
apneas	0
in	0
these	I-DISEASE
patients	0
are	I-DISEASE
less	I-DISEASE
common	I-DISEASE
during	I-DISEASE
REM	I-DISEASE
sleep	0
.	0

In	I-DISEASE
summary	I-DISEASE
,	0
respiration	0
,	I-DISEASE
arterial	0
oxygenation	0
,	0
and	0
sleep	I-DISEASE
architecture	I-DISEASE
are	0
affected	I-DISEASE
by	I-DISEASE
this	I-DISEASE
disorder	0
.	0

Additionally	I-DISEASE
,	I-DISEASE
an	0
arterial	0
PaCO2	I-DISEASE

less	I-DISEASE
than	I-DISEASE
40	0
mm	I-DISEASE

Hg	I-DISEASE
is	0
typically	0
observed	0
during	I-DISEASE
wakefulness	0
.	0

These	0
patients	0
do	0
not	0
exhibit	0
sleep	0
related	0
hypoventilation	I-DISEASE
.	I-DISEASE

Differential	I-DISEASE
Diagnosis	0
Normal	0
individuals	I-DISEASE
may	0
have	0
a	0
few	0
central	0
apneas	I-DISEASE
in	0
the	0
wake	0
-	0
sleep	0
transition	0
.	0

However	I-DISEASE
,	0
once	0
stable	I-DISEASE
sleep	0
is	0
achieved	I-DISEASE
,	I-DISEASE
these	0
apneas	0
should	I-DISEASE
cease	0
.	0

Normal	I-DISEASE
individuals	I-DISEASE
should	0
not	0
have	0
more	0
than	0
five	0
central	0
apneas	0
per	I-DISEASE
hour	0
of	I-DISEASE
sleep	0
.	0

Primary	I-DISEASE
CSA	I-DISEASE
must	I-DISEASE
be	0
distinguished	I-DISEASE
from	0
other	I-DISEASE
sleep	0
related	0
breathing	0
disorders	0
.	I-DISEASE

Some	I-DISEASE
patients	0
with	0
predominantly	I-DISEASE
OSA	0
will	0
have	I-DISEASE
central	0
apneas	0
during	I-DISEASE
diagnostic	0
or	0
positive	0
airway	I-DISEASE
pressure	0
titration	0
studies	0
.	0

These	0
apneas	0
tend	I-DISEASE
to	I-DISEASE
resolve	0
immediately	B-DISEASE
or	0
over	0
time	0
on	0
positive	0
airway	0
pressure	0
treatment	I-DISEASE
.	0

The	I-DISEASE
pattern	0
of	I-DISEASE
central	0
apneas	0
in	0
primary	0
CSA	0
differs	I-DISEASE
from	I-DISEASE
that	0
of	I-DISEASE
CSA	I-DISEASE
with	0
CSB	0
.	0

Primary	I-DISEASE
CSA	I-DISEASE
lacks	I-DISEASE
the	0
crescendo	I-DISEASE
-	0
decrescendo	0
pattern	0
of	I-DISEASE
respiration	I-DISEASE
between	0
contiguous	I-DISEASE
central	0
apneas	0
noted	0
in	I-DISEASE
patients	I-DISEASE
with	B-DISEASE
CSA	0
with	I-DISEASE
CSB	0
.	0

The	I-DISEASE
cycle	0
length	0
is	0
longer	0
in	I-DISEASE
CSB	0
(	0
greater	I-DISEASE
than	0
40	0
seconds	I-DISEASE
and	0
typically	0
45	0
to	I-DISEASE
90	I-DISEASE
seconds	0
)	0
.	0

The	I-DISEASE
longer	I-DISEASE
cycle	0
length	0
in	0
CSB	0
versus	0
primary	0
CSA	0
is	0
due	I-DISEASE
to	I-DISEASE
a	0
longer	0
respiratory	I-DISEASE
phase	0
between	0
central	0
apneas	0
.	0

In	I-DISEASE
primary	0
CSA	0
,	0
the	0
apnea	0
is	0
often	0
terminated	0
abruptly	I-DISEASE
by	I-DISEASE
a	0
large	I-DISEASE
breath	0
,	I-DISEASE
and	0
there	0
are	0
usually	0
no	0
more	0
that	0
4	0
to	0
5	0
breaths	0
between	0
apneas	0
.	0

Furthermore	I-DISEASE
,	I-DISEASE
most	0
patients	I-DISEASE
with	0
Cheyne	I-DISEASE
-	0
Stokes	0
respiration	0
will	I-DISEASE
have	I-DISEASE
a	0
history	I-DISEASE
of	I-DISEASE
congestive	I-DISEASE
heart	0
failure	I-DISEASE
or	0
a	0
neurological	0
disorder	I-DISEASE
.	0

Patients	I-DISEASE
with	0
central	0
apnea	0
due	I-DISEASE
to	0
substance	0
use	0
,	I-DISEASE
particularly	I-DISEASE
potent	I-DISEASE
long	0
-	0
acting	0
narcotics	0
,	0
may	0
exhibit	0
periodic	I-DISEASE
breathing	0
with	I-DISEASE
central	0
apneas	0
,	B-DISEASE
but	0
the	0
pattern	0
of	I-DISEASE
ventilation	0
between	0
apneas	0
does	0
not	0
have	0
a	0
crescendo	I-DISEASE
-	0
decrescendo	0
pattern	0
and	0
the	0
cycle	0
length	0
is	0
shorter	0
than	I-DISEASE
40	0
seconds	0
.	0

In	I-DISEASE
addition	0
,	0
the	0
underlying	0
pattern	0
of	I-DISEASE
breathing	B-DISEASE
is	0
often	0
ataxic	I-DISEASE
(	I-DISEASE
irregular	0
varia-	I-DISEASE
tions	0
in	I-DISEASE
cycle	0
length	0
and	0
tidal	0
volume	I-DISEASE
)	0
and	0
a	0
low	0
respiratory	I-DISEASE
rate	0
may	0
be	0
noted	0
.	0

Unlike	I-DISEASE
primary	0
CSA	0
,	0
central	0
apneas	0
can	0
occur	I-DISEASE
during	I-DISEASE
stage	I-DISEASE
N3	0
in	I-DISEASE
patients	I-DISEASE
taking	0
opioids	0
.	0

Patients	I-DISEASE
with	0
CSA	0
due	I-DISEASE
to	I-DISEASE
medical	0
or	B-DISEASE
neurological	0
conditions	I-DISEASE
not	0
of	B-DISEASE
the	0
Cheyne	I-DISEASE
-	0
Stokes	0
pattern	0
often	0
have	0
a	0
history	I-DISEASE
of	0
a	0
known	0
neurological	0
disorder	0
(	I-DISEASE
recent	I-DISEASE
cerebrovascular	I-DISEASE
accident	0
)	0
but	0
in	0
others	I-DISEASE
a	0
high	I-DISEASE
index	I-DISEASE
of	I-DISEASE
suspicion	0
for	0
an	0
underlying	0
disorder	0
is	0
indi-	I-DISEASE
cated	0
.	0

For	I-DISEASE
example	0
,	0
patients	I-DISEASE
with	0
Chiari	0
malformation	0
may	0
present	I-DISEASE
in	I-DISEASE
adulthood	0
with	0
unexplained	0
central	0
apneas	0
and	0
relatively	0
few	0
other	0
symptoms	I-DISEASE
.	0

Thus	I-DISEASE
,	I-DISEASE
primary	0
CSA	0
is	I-DISEASE
a	I-DISEASE
diagnosis	I-DISEASE
based	B-DISEASE
on	0
careful	0
exclusion	I-DISEASE
of	I-DISEASE
other	I-DISEASE
causes	0
of	I-DISEASE
CSA	I-DISEASE
.	0

In	I-DISEASE
sleep	0
related	0
hypoventilation	I-DISEASE
and	0
hypoxemic	0
syndromes	I-DISEASE
,	I-DISEASE
patients	I-DISEASE
have	0
normal	0
or	I-DISEASE
increased	0
daytime	I-DISEASE
arterial	0
PCO2	I-DISEASE
(	0
PaCO2	0
)	0
with	I-DISEASE
the	I-DISEASE
onset	0
or	0
worsening	0
of	I-DISEASE
hypoven-	0
tilation	I-DISEASE
during	I-DISEASE
sleep	I-DISEASE
.	0

Daytime	I-DISEASE
hypoventilation	0
is	I-DISEASE
defined	I-DISEASE
as	0
a	I-DISEASE
PaCO2	0
>	0
45	I-DISEASE
mm	I-DISEASE

Hg	I-DISEASE
.	0

Patient	I-DISEASE
with	0
primary	0
CSA	0
usually	I-DISEASE
have	I-DISEASE
an	0
awake	0
PaCO2	0
<	I-DISEASE

40	I-DISEASE
mm	I-DISEASE
Hg	I-DISEASE
.	0

The	I-DISEASE
causes	I-DISEASE
of	I-DISEASE
sleep	I-DISEASE
related	B-DISEASE
hypoventilation	I-DISEASE
include	I-DISEASE
abnormalities	I-DISEASE
in	I-DISEASE
ventilatory	0
control	I-DISEASE
,	0
neuro-	0
muscular	0
disease	B-DISEASE
,	I-DISEASE
parenchymal	0
lung	I-DISEASE
disease	I-DISEASE
,	I-DISEASE
or	I-DISEASE
restrictive	I-DISEASE
chest	0
wall	I-DISEASE
disorders	0
.	0

PSG	I-DISEASE
in	0
these	I-DISEASE
patients	0
may	I-DISEASE
reveal	0
a	I-DISEASE
few	0
central	0
apneas	0
,	0
but	I-DISEASE
the	0
predominant	I-DISEASE
pattern	0
is	0
one	0
of	I-DISEASE
reduced	0
tidal	0
volume	I-DISEASE
(	I-DISEASE
shallow	0
pattern	0
of	I-DISEASE
breathing	0
)	0
,	I-DISEASE
often	0
without	0
a	0
compensatory	I-DISEASE
increase	I-DISEASE
in	0
respiratory	0
rate	0
.	0

There	I-DISEASE
is	I-DISEASE
usually	I-DISEASE
significant	0
oxygen	0
desaturation	I-DISEASE
secondary	0
to	0
hypoventilation	I-DISEASE
and/or	0
ventilation	0
perfusion	0
mismatch	0
.	0

Patients	I-DISEASE
with	0
parenchymal	0
lung	I-DISEASE
disease	B-DISEASE
,	0
neuromuscular	0
disease	B-DISEASE
,	I-DISEASE
or	I-DISEASE
chest	I-DISEASE
wall	0
disorders	0
typically	0
have	0
abnormal	I-DISEASE
pulmonary	I-DISEASE
function	0
tests	I-DISEASE
and	0
the	I-DISEASE
most	0
severe	I-DISEASE
arterial	0
oxygen	0
desaturation	I-DISEASE
typically	0
occurs	0
during	I-DISEASE
REM	0
sleep	0
.	0

Unresolved	I-DISEASE
Issues	0
and	0
Further	I-DISEASE
Directions	0

Although	I-DISEASE
primary	0
CSA	0
is	0
believed	I-DISEASE
to	I-DISEASE
be	I-DISEASE
a	0
relatively	0
rare	0
disorder	0
,	I-DISEASE
additional	0
prevalence	0
data	I-DISEASE
are	0
needed	0
.	0

The	I-DISEASE
pathophysiology	I-DISEASE
of	I-DISEASE
this	I-DISEASE
disorder	0
remains	0
unclear	I-DISEASE
.	0

Specifically	I-DISEASE
,	I-DISEASE
the	0
relative	I-DISEASE
roles	0
of	I-DISEASE
instability	I-DISEASE
in	I-DISEASE
sleep	0
state	B-DISEASE
(	I-DISEASE
low	0
arousal	I-DISEASE
threshold	I-DISEASE
,	0
delayed	I-DISEASE
transition	0
from	I-DISEASE
wake	0
to	0
stable	I-DISEASE
sleep	0
)	0
and	0
respiratory	I-DISEASE
control	I-DISEASE
instability	0
(	I-DISEASE
elevated	I-DISEASE
hypercapnic	I-DISEASE
ventila-	0
tory	I-DISEASE
response	0
)	0
require	0
further	I-DISEASE
elucidation	0
.	I-DISEASE

Sleep	I-DISEASE
Related	I-DISEASE
Breathing	0
Disorders	I-DISEASE
Sleep	0
Related	0
Breathing	0
Disorders	I-DISEASE
Bibliography	0
Bixler	0
EO	0
,	0
Vgontzas	I-DISEASE
AN	B-DISEASE
,	0
Lin	0
HM	I-DISEASE
,	0
Ten	0
Have	I-DISEASE
T	0
,	0
Rein	0
J	0
,	0
Vela	I-DISEASE
-	I-DISEASE
Bueno	0
A	0
,	0
Kales	0
A.	0
Prevalence	I-DISEASE
of	I-DISEASE
sleep-	0
disordered	0
breathing	I-DISEASE
in	I-DISEASE
women	I-DISEASE
:	0
effects	0
of	I-DISEASE
gender	I-DISEASE
.	0

Am	I-DISEASE
J	0
Respir	0
Crit	0
Care	0
Med	0
2001;163:608–13	I-DISEASE
.	0

Bradley	I-DISEASE
T	0
,	0
McNicholas	I-DISEASE
W	0
,	0
Rutherford	0
R	I-DISEASE
,	I-DISEASE
Popkin	I-DISEASE
J	0
,	I-DISEASE
Zamel	0
N	0
,	0
Phillipson	0
E.	0
Clinical	0
and	0
physiological	0
heterogeneity	I-DISEASE
of	I-DISEASE
the	0
central	0
sleep	0
apnea	0
syndrome	0
.	0

Am	I-DISEASE
Rev	I-DISEASE
Respir	0
Dis	I-DISEASE
1986;134:217–21	I-DISEASE
.	0

Dempsey	I-DISEASE
JA	0
,	I-DISEASE
Smith	I-DISEASE
CA	I-DISEASE
,	0
Przybylowski	0
T	0
,	I-DISEASE
et	I-DISEASE
al	0
.	0

The	I-DISEASE
ventilatory	0
responsiveness	0
to	0
CO(2	I-DISEASE
)	I-DISEASE
below	0
eupnoea	0
as	0
a	0
determinant	0
of	I-DISEASE
ventilatory	0
stability	0
in	I-DISEASE
sleep	I-DISEASE
.	0

J	I-DISEASE
Physiol	0
2004;560:1–11	0
.	0

Eckert	I-DISEASE
DJ	0
,	0
Jordan	I-DISEASE
AS	0
,	I-DISEASE
Merchia	0
P	0
,	I-DISEASE
Malhotra	I-DISEASE
A.	0
Central	0
sleep	0
apnea	0
:	0
Pathophysiology	I-DISEASE
and	0
treatment	I-DISEASE
.	0

Chest	I-DISEASE
2007;131:595–607	0
.	0

Hall	I-DISEASE
MJ	I-DISEASE
,	I-DISEASE
Xie	0
A	0
,	I-DISEASE
Rutherford	0
R	0
,	0
Ando	0
S	I-DISEASE
,	0
Floras	I-DISEASE
JS	I-DISEASE
,	0
Bradley	I-DISEASE
TD	0
.	0

Cycle	I-DISEASE
length	0
of	I-DISEASE
periodic	I-DISEASE
breathing	0
in	I-DISEASE
patients	0
with	I-DISEASE
and	0
without	0
heart	0
failure	0
.	I-DISEASE

Am	I-DISEASE
J	0
Respir	0
Crit	0
Care	0
Med	0
1996;154:376–81	0
.	0

White	I-DISEASE
D	I-DISEASE
,	0
Zwillich	I-DISEASE
C	I-DISEASE
,	I-DISEASE
Pickett	0
C	0
,	I-DISEASE
Douglas	I-DISEASE
N	0
,	0
Findley	I-DISEASE
L	0
,	0
Weil	0
J.	0
Central	0
sleep	0
apnea	I-DISEASE
:	0
improvement	I-DISEASE
with	I-DISEASE
acetazolamide	I-DISEASE
therapy	0
.	0

Arch	I-DISEASE
Intern	0
Med	0
1982;142:1816–9	I-DISEASE
.	0

Xie	I-DISEASE
A	0
,	I-DISEASE
Rankin	0
F	I-DISEASE
,	I-DISEASE
Rutherford	0
R	0
,	I-DISEASE
Bradley	I-DISEASE
TD	I-DISEASE
.	0

Effects	I-DISEASE
of	I-DISEASE
inhaled	0
CO2	I-DISEASE
and	0
added	I-DISEASE
dead	0
space	0
on	0
idiopathic	B-DISEASE
central	0
sleep	0
apnea	0
.	0

J	I-DISEASE
Appl	0
Physiol	0
1997;82:918–26	0
.	0

Xie	I-DISEASE
A	0
,	I-DISEASE
Rutherford	0
R	I-DISEASE
,	0
Rankin	I-DISEASE
F	0
,	0
Wong	0
B	0
,	I-DISEASE
Bradley	0
T.	0
Hypocapnia	I-DISEASE
and	0
increased	0
ventilatory	0
responsiveness	I-DISEASE
in	0
patients	0
with	I-DISEASE
idiopathic	I-DISEASE
central	0
sleep	0
apnea	0
.	0

Am	I-DISEASE
J	0
Respir	0
Crit	0
Care	0
Med	0
1995;152:1950–5	I-DISEASE
.	0

Xie	I-DISEASE
A	0
,	I-DISEASE
Wong	0
B	0
,	0
Phillipson	0
E	0
,	0
Slutsky	I-DISEASE
A	0
,	I-DISEASE
Bradley	I-DISEASE
T.	0
Interaction	0
of	I-DISEASE
hyperventilation	I-DISEASE
and	0
arousal	0
in	0
the	0
pathogenesis	I-DISEASE
of	I-DISEASE
idiopathic	I-DISEASE
central	0
sleep	0
apnea	0
.	0

Am	I-DISEASE
J	0
Respir	0
Crit	0
Care	0
Med	0
1994;150:489–95	0
.	0

Primary	I-DISEASE
Central	I-DISEASE
Sleep	0
Apnea	0
of	I-DISEASE
Infancy	I-DISEASE
ICD-9	0
-	0
CM	I-DISEASE
code	0
:	0
770.81	0
ICD-10	0
-	I-DISEASE
CM	0
code	0
:	B-DISEASE

P28.3	I-DISEASE
Alternate	0
Names	I-DISEASE
Infant	I-DISEASE
sleep	0
apnea	0
,	I-DISEASE
apnea	0
of	I-DISEASE
infancy	I-DISEASE
,	0
primary	0
sleep	0
apnea	0
of	I-DISEASE
the	0
newborn	0
.	0

Inappropriate	I-DISEASE
terms	I-DISEASE
for	I-DISEASE
primary	0
central	0
sleep	0
apnea	0
of	I-DISEASE
the	0
newborn	I-DISEASE
include	I-DISEASE
near	0
-	0
miss	0
sudden	0
infant	0
death	0
syndrome	0
(	I-DISEASE
SIDS	0
)	0
,	I-DISEASE

near	I-DISEASE
-	0
SIDS	0
,	I-DISEASE
aborted	0
SIDS	0
,	I-DISEASE
and	0
aborted	0
crib	I-DISEASE
death	0
;	0
these	I-DISEASE
terms	I-DISEASE
imply	0
a	I-DISEASE
causal	0
relationship	0
between	0
apnea	0
and	0
SIDS	0
that	0
is	0
not	0
supported	0
by	0
extensive	0
research	0
.	0

Likewise	I-DISEASE
,	I-DISEASE
the	0
term	0
“	0
apparent	0
life	0
-	I-DISEASE
threatening	0
event	0
(	I-DISEASE
ALTE	I-DISEASE
)	0
”	I-DISEASE
should	0
not	0
be	I-DISEASE
used	0
.	0

Although	I-DISEASE
some	0
infants	0
with	I-DISEASE
primary	0
sleep	0
apnea	0
present	0
with	0
an	0
ALTE	I-DISEASE
,	0
there	I-DISEASE
are	0
many	0
other	0
causes	0
of	I-DISEASE
ALTE	0
,	0
and	0
some	I-DISEASE
children	0
with	I-DISEASE
sleep	0
apnea	0
do	0
not	0
have	0
ALTE	0
.	0

Diagnostic	I-DISEASE
Criteria	0
Criteria	I-DISEASE
A	0
-	0
D	I-DISEASE
must	0
be	0
met	0
A.	0
Apnea	0
or	0
cyanosis	I-DISEASE
is	I-DISEASE
noted	0
by	I-DISEASE
an	0
observer	0
or	0
an	0
episode	0
of	I-DISEASE
sleep	0
related	B-DISEASE
central	0
apnea	0
or	0
desaturation	0
is	0
detected	0
by	I-DISEASE
monitoring	0
.	0

B.	0
The	I-DISEASE
infant	0
has	0
a	0
conceptional	0
age	I-DISEASE
of	I-DISEASE
at	I-DISEASE
least	0
37	I-DISEASE
weeks	I-DISEASE
.	0

C.	I-DISEASE
PSG	0
or	0
alternative	I-DISEASE
monitoring	0
such	0
as	0
hospital	0
or	0
home	I-DISEASE
apnea	I-DISEASE
monitoring	0
shows	I-DISEASE
either	I-DISEASE
:	0
.	0

Recurrent	I-DISEASE
,	0
prolonged	0
(	0
>	0
20	0
seconds	0
duration	0
)	0
central	0
apneas.1	0
.	0

Periodic	I-DISEASE
breathing2	0
for	0
≥	I-DISEASE
5	0
%	0
of	I-DISEASE
total	0
sleep	0
time	I-DISEASE
.	I-DISEASE

D.	I-DISEASE

The	I-DISEASE
disorder	I-DISEASE
is	0
not	0
better	0
explained	I-DISEASE
by	I-DISEASE
another	I-DISEASE
sleep	0
disorder	0
,	0
medical	I-DISEASE
or	I-DISEASE
neurological	0
disorder	I-DISEASE
,	I-DISEASE
or	0
medication	0
.	0

Notes	I-DISEASE
.	0

Normative	I-DISEASE
data	0
concerning	0
the	0
number	0
of	I-DISEASE
prolonged	0
central	0
apneas	0
per	I-DISEASE
hour	0
are	0
not	0
well	I-DISEASE
established	0
.	0
.	0

As	I-DISEASE
defined	I-DISEASE
by	I-DISEASE
the	0
most	0
recent	I-DISEASE
version	I-DISEASE
of	I-DISEASE
the	0
AASM	0
Manual	I-DISEASE
for	I-DISEASE
the	0
Scoring	0
of	I-DISEASE
Sleep	I-DISEASE
and	0
Associated	0
Events	I-DISEASE
.	0
.	0

Short	I-DISEASE
(	I-DISEASE
<	0
20	0
seconds	0
)	0
central	0
apneas	I-DISEASE
associated	0
with	I-DISEASE
significant	0
desaturation	0
are	I-DISEASE
more	0
likely	0
to	I-DISEASE
be	0
a	0
sign	0
of	I-DISEASE
decreased	I-DISEASE
pulmonary	0
reserve	I-DISEASE
than	0
of	I-DISEASE
central	0
nervous	B-DISEASE
system	0
pathology	0
.	0
.	0

Definitive	I-DISEASE
determination	0
of	0
the	0
central	0
nature	0
of	I-DISEASE
apneas	0
requires	I-DISEASE
simultaneous	0
monitoring	0
of	I-DISEASE
airflow	I-DISEASE
and	0
respiratory	I-DISEASE
effort	I-DISEASE
.	0

Obstructive	I-DISEASE
and	0
mixed	0
apneas	0
may	0
also	0
be	I-DISEASE
present	I-DISEASE
,	0
but	0
central	0
apneas	I-DISEASE
are	0
predominant	0
.	0

Essential	I-DISEASE
Features	I-DISEASE
Primary	0
CSA	0
of	I-DISEASE
infancy	0
is	I-DISEASE
characterized	0
by	0
prolonged	0
,	I-DISEASE
predominantly	I-DISEASE
central	0
apneas	0
in	0
children	0
of	I-DISEASE
at	I-DISEASE
least	0
37	I-DISEASE
weeks	0
conceptional	I-DISEASE
age	I-DISEASE
.	0

These	0
events	0
are	0
typically	0
associated	0
with	I-DISEASE
physiological	0
compromise	I-DISEASE
(	I-DISEASE
hypoxemia	0
,	I-DISEASE
bradycardia	0
)	0
,	0
or	I-DISEASE
the	0
need	0
for	0
intervention	0
such	I-DISEASE
as	0
stimulation	0
or	0
resuscitation	I-DISEASE
.	0

Obstructive	I-DISEASE
and/or	0
mixed	I-DISEASE
apneas	0
or	I-DISEASE
hypopneas	I-DISEASE
may	0
also	0
be	I-DISEASE
seen	0
,	0
although	0
central	0
events	0
are	0
the	0
predominant	0
finding	I-DISEASE
.	0

It	I-DISEASE
is	I-DISEASE
a	0
disorder	I-DISEASE
of	0
respira-	0
tory	0
control	0
that	I-DISEASE
can	0
be	0
either	0
a	0
developmental	I-DISEASE
problem	0
associated	0
with	I-DISEASE
immaturity	0
of	I-DISEASE
the	I-DISEASE
brainstem	0
respiratory	I-DISEASE
centers	I-DISEASE
or	I-DISEASE
secondary	0
to	0
other	0
medical	0
conditions	I-DISEASE
that	0
produce	0
apnea	0
by	0
mechanisms	0
such	0
as	0
direct	0
depression	I-DISEASE
of	I-DISEASE
central	0
respiratory	0
control	0
.	0

Apnea	I-DISEASE
in	I-DISEASE
the	0
neonate	I-DISEASE
or	I-DISEASE
infant	0
may	0
be	0
exacerbated	0
or	0
precipitated	0
by	I-DISEASE
a	0
variety	I-DISEASE
of	I-DISEASE
medical	0
condi-	I-DISEASE
tions	0
,	I-DISEASE
such	B-DISEASE
as	0
anemia	0
,	0
infection	0
,	0
hypoxemia	I-DISEASE
,	0
metabolic	0
disturbances	I-DISEASE
,	I-DISEASE
gastroesophageal	I-DISEASE
reflux	0
,	I-DISEASE
substances	0
,	0
or	I-DISEASE
anesthesia	0
,	I-DISEASE
which	0
must	0
be	I-DISEASE
recognized	0
and	0
treated	0
to	I-DISEASE
stabilize	I-DISEASE
the	0
apnea	0
.	0

If	I-DISEASE
another	I-DISEASE
medical	0
condition	I-DISEASE
appears	0
to	I-DISEASE
be	I-DISEASE
the	B-DISEASE
cause	I-DISEASE
rather	0
than	I-DISEASE
an	I-DISEASE
exacerbating	I-DISEASE
factor	I-DISEASE
for	I-DISEASE
the	0
CSA	0
,	I-DISEASE
then	0
the	0
condition	0
should	I-DISEASE
be	0
classified	0
as	0
CSA	I-DISEASE
due	I-DISEASE
to	0
a	0
medical	0
or	I-DISEASE
neurological	0
condition	0
,	0
or	I-DISEASE
CSA	0
due	I-DISEASE
to	I-DISEASE
a	I-DISEASE
medication	0
or	I-DISEASE
substance	I-DISEASE
.	0

Despite	I-DISEASE
the	0
heterogeneity	0
of	I-DISEASE
infant	0
risk	0
groups	0
and	0
underlying	0
pathophysiology	I-DISEASE
,	I-DISEASE
most	0
studies	0
report	0
a	0
progressive	0
decrease	0
in	I-DISEASE
frequency	I-DISEASE
of	0
apneas	0
and	0
risk	0
of	I-DISEASE
symptomatic	0
apnea	0
secondary	0
to	0
other	I-DISEASE
medical	0
conditions	I-DISEASE
after	0
the	0
early	0
weeks	0
of	I-DISEASE
life	0
.	0

Sleep	I-DISEASE
Related	I-DISEASE
Breathing	0
Disorders	I-DISEASE
Sleep	0
Related	0
Breathing	0
Disorders	I-DISEASE
Associated	0
Features	I-DISEASE
Infants	0
may	I-DISEASE
present	I-DISEASE
with	I-DISEASE
an	0
ALTE	I-DISEASE
(	I-DISEASE
defined	I-DISEASE
by	B-DISEASE
a	0
National	0
Institutes	I-DISEASE
of	I-DISEASE
Health	0
Development	0
Conference	I-DISEASE
as	0
“	0
an	0
episode	0
that	0
is	0
frightening	I-DISEASE
to	I-DISEASE
the	I-DISEASE
observer	0
,	0
and	0
that	0
is	0
characterized	0
by	I-DISEASE
some	I-DISEASE
combination	I-DISEASE
of	I-DISEASE
apnea	0

[	I-DISEASE

central	I-DISEASE
or	I-DISEASE
occasionally	0
obstructive	0
]	I-DISEASE
,	0
color	0
change	I-DISEASE
,	I-DISEASE
marked	I-DISEASE
change	I-DISEASE
in	I-DISEASE
muscle	I-DISEASE
tone	I-DISEASE
,	I-DISEASE
choking	0
or	0
gagging	I-DISEASE
.	0

In	I-DISEASE
some	I-DISEASE
cases	0
,	I-DISEASE
the	0
observer	0
fears	0
that	I-DISEASE
the	0
infant	0
has	0
died	0
”	I-DISEASE
)	I-DISEASE
.	0

Many	0
infants	0
with	0
primary	0
CSA	0
of	I-DISEASE
infancy	0
will	0
not	0
have	0
an	0
ALTE	I-DISEASE
,	0
and	0
many	0
ALTEs	I-DISEASE
are	0
not	0
associated	0
with	I-DISEASE
apnea	0
.	0

Primary	I-DISEASE
CSA	I-DISEASE
of	I-DISEASE
infancy	0
is	I-DISEASE
state	I-DISEASE
dependent	I-DISEASE
,	0
and	0
the	0
frequency	I-DISEASE
of	I-DISEASE
respiratory	I-DISEASE
events	0
increases	0
during	I-DISEASE
active	I-DISEASE
(	0
REM	0
)	0
sleep	0
.	0

Paradoxical	I-DISEASE
chest	0
wall	0
movements	0
are	0
common	I-DISEASE
during	I-DISEASE
active	0
sleep	0
in	I-DISEASE
infants	I-DISEASE
and	0
may	0
cause	I-DISEASE
a	0
fall	I-DISEASE
in	0
arterial	0
oxygen	I-DISEASE
saturation	0
because	0
of	I-DISEASE
ventilation	0
or	I-DISEASE
perfusion	0
defects	0
associated	0
with	I-DISEASE
a	0
decrease	I-DISEASE
in	I-DISEASE
functional	0
residual	0
capacity	I-DISEASE
.	0

Underlying	I-DISEASE
comorbidities	I-DISEASE
(	I-DISEASE
for	I-DISEASE
example	0
,	0
chronic	I-DISEASE
lung	I-DISEASE
disease	I-DISEASE
or	I-DISEASE
abnormal	0
neurological	0
status	0
)	0
can	0
predispose	0
the	0
infant	0
to	0
having	0
a	0
more	0
severe	I-DISEASE
or	B-DISEASE
prolonged	0
course	0
for	I-DISEASE
apnea	0
.	0

Note	I-DISEASE
that	I-DISEASE
a	0
small	0
upper	0
airway	I-DISEASE
will	0
exaggerate	0
the	0
obstructive	I-DISEASE
elements	I-DISEASE
of	I-DISEASE
this	0
disorder	0
.	0

Clinical	I-DISEASE
and	0
Pathophysiological	0
Subtypes	I-DISEASE
Not	I-DISEASE
applicable	0
.	I-DISEASE

Demographics	I-DISEASE
Less	I-DISEASE
than	I-DISEASE
0.5	I-DISEASE
%	0
of	I-DISEASE
full	0
-	I-DISEASE
term	0
newborns	0
experience	0
symptomatic	I-DISEASE
apnea	0
.	0

Studies	I-DISEASE
have	0
shown	0
that	0
during	I-DISEASE
the	0
first	0
six	I-DISEASE
months	0
of	I-DISEASE
life	0
,	I-DISEASE
2	I-DISEASE
%	0
of	0
healthy	0
full	0
-	I-DISEASE
term	0
infants	0
will	0
experience	0
at	I-DISEASE
least	0
one	0
apnea	I-DISEASE
event	0
lasting	0
30	0
seconds	0
or	0
longer	0
or	0
an	0
apnea	0
that	0
lasts	0
at	I-DISEASE
least	0
20	0
seconds	0
and	0
is	I-DISEASE
associated	0
with	I-DISEASE
a	0
heart	0
rate	0
less	0
than	0
60	0
beats	0
per	I-DISEASE
minute	0
.	0

Apnea	I-DISEASE
of	I-DISEASE
infancy	0
occurs	0
equally	0
in	I-DISEASE
males	0
and	0
females	0
,	I-DISEASE
and	0
in	I-DISEASE
infants	0
of	I-DISEASE
all	0
races	I-DISEASE
and	0
ethnic	0
groups	0
.	0

Predisposing	I-DISEASE
and	0
Precipitating	I-DISEASE
Factors	0
Many	0
factors	I-DISEASE
may	I-DISEASE
precipitate	0
apneic	0
episodes	I-DISEASE
,	0
including	0
gastroesophageal	I-DISEASE
reflux	B-DISEASE
,	I-DISEASE
intra-	I-DISEASE
cranial	I-DISEASE
pathology	0
,	0
substances	0
,	0
anesthesia	I-DISEASE
,	0
metabolic	0
disorders	0
,	0
impaired	I-DISEASE
oxygenation	I-DISEASE
,	I-DISEASE
and	0
infection	0
(	I-DISEASE
including	0
sepsis	0
,	I-DISEASE
meningitis	0
,	0
respiratory	I-DISEASE
syncytial	0
virus	I-DISEASE
infections	0
,	I-DISEASE
and	0
pertussis	I-DISEASE
)	0
.	0

Infection	I-DISEASE
with	I-DISEASE
respiratory	0
syncytial	0
virus	0
,	0
in	I-DISEASE
particular	I-DISEASE
,	I-DISEASE
can	0
increase	I-DISEASE
the	0
fre-	I-DISEASE
quency	I-DISEASE
and	0
the	0
duration	0
of	I-DISEASE
apneas	0
.	0

Familial	I-DISEASE
Patterns	I-DISEASE
None	I-DISEASE
known	I-DISEASE
.	0

Onset	I-DISEASE
,	0
Course	0
,	0
and	0
Complications	0
Onset	0
is	I-DISEASE
usually	I-DISEASE
in	0
the	0
first	I-DISEASE
weeks	I-DISEASE
or	0
months	0
of	I-DISEASE
life	0
.	0

Some	I-DISEASE
infants	0
may	0
be	0
diagnosed	0
by	I-DISEASE
nursing	0
observations	0
or	0
routine	0
monitoring	0
soon	0
after	I-DISEASE
birth	I-DISEASE
.	0

Older	I-DISEASE
infants	0
may	0
present	I-DISEASE
with	0
an	0
ALTE	0
or	B-DISEASE
may	0
have	0
failure	0
to	I-DISEASE
thrive	0
.	0

The	I-DISEASE
prognosis	0
is	0
generally	I-DISEASE
good	0
,	I-DISEASE
with	0
res-	0
olution	I-DISEASE
of	0
apnea	0
over	0
the	0
first	I-DISEASE
few	0
years	I-DISEASE
of	I-DISEASE
life	0
and	0
no	0
residual	0
sequelae	0
.	0

The	I-DISEASE
presence	0
of	I-DISEASE
persistent	0
severe	0
apnea	0
may	0
be	0
an	0
indication	I-DISEASE
of	I-DISEASE
an	I-DISEASE
underlying	0
medical	0
condition	0
and	0
should	0
prompt	0
further	I-DISEASE
evaluation	0
.	0

Patients	I-DISEASE
with	0
persistent	0
severe	0
apnea	0
may	0
develop	0
sequelae	0
related	I-DISEASE
to	I-DISEASE
hypoxic	0
events	0
.	0

Developmental	I-DISEASE
Issues	0

This	I-DISEASE
is	I-DISEASE
a	0
condition	0
of	0
infancy	I-DISEASE
that	0
normally	0
improves	0
over	0
time	I-DISEASE
.	I-DISEASE

Pathology	I-DISEASE
and	0
Pathophysiology	I-DISEASE
Physiological	B-DISEASE
factors	I-DISEASE
contributing	I-DISEASE
to	0
apnea	0
are	0
related	0
to	I-DISEASE
immaturity	0
of	I-DISEASE
respiratory	I-DISEASE
control	0
.	0

These	0
include	I-DISEASE
developmental	I-DISEASE
alterations	0
in	0
central	0
drive	0
,	I-DISEASE
chemoreceptor	0
or	I-DISEASE
mechanoreceptor	B-DISEASE
responses	I-DISEASE
,	0
and	0
upper	0
airway	0
reflexes	0
.	0

Precipitating	I-DISEASE
factors	0
for	0
wors-	I-DISEASE
ening	0
apnea	0
include	0
gastroesophageal	I-DISEASE
reflux	0
,	I-DISEASE
intracranial	I-DISEASE
pathology	I-DISEASE
,	0
substances	0
,	0
anes-	0
thesia	0
,	0
metabolic	0
disturbances	0
,	I-DISEASE
impaired	I-DISEASE
oxygenation	I-DISEASE
,	I-DISEASE
and	0
infection	0
.	0

Objective	I-DISEASE
Findings	I-DISEASE
Apnea	0
is	0
predominantly	0
central	0
,	I-DISEASE
but	I-DISEASE
obstructive	0
and	0
mixed	0
apneas	0
may	I-DISEASE
occur	I-DISEASE
.	0

Apneas	0
are	0
seen	I-DISEASE
most	0
frequently	I-DISEASE
during	0
REM	0
sleep	0
.	0

Other	I-DISEASE
diagnostic	0
tests	0
,	I-DISEASE
such	0
as	0
a	0
full	0
EEG	0
or	0
evaluation	I-DISEASE
for	I-DISEASE
reflux	I-DISEASE
,	I-DISEASE
may	I-DISEASE
be	0
appropriate	0
in	I-DISEASE
individual	0
cases	0
.	0

Differential	I-DISEASE
Diagnosis	0
Primary	I-DISEASE
CSA	I-DISEASE
of	I-DISEASE
infancy	0
should	0
be	I-DISEASE
distinguished	I-DISEASE
from	I-DISEASE
the	0
normal	0
respiratory	I-DISEASE
pauses	I-DISEASE
that	0
occur	0
during	I-DISEASE
sleep	0
.	0

Normative	I-DISEASE
respiratory	B-DISEASE
data	I-DISEASE
from	0
several	I-DISEASE
large	0
studies	I-DISEASE
show	0
that	0
healthy	0
asymptomatic	0
infants	0
commonly	I-DISEASE
have	0
central	0
respiratory	I-DISEASE
pauses	0
,	0
either	0
as	0
isolated	I-DISEASE
events	0
(	I-DISEASE
particularly	0
during	I-DISEASE
REM	I-DISEASE
sleep	0
)	0
or	I-DISEASE
after	0
sigh	0
breaths	0
or	I-DISEASE
movements	0
.	0

Primary	I-DISEASE
CSA	I-DISEASE
of	I-DISEASE
infancy	0
should	I-DISEASE
be	I-DISEASE
distinguished	I-DISEASE
from	0
the	0
popular	0
clinical	0
term	0
,	I-DISEASE
ALTE	0
,	I-DISEASE
which	I-DISEASE
is	0
not	0
a	0
specific	I-DISEASE
diagnosis	I-DISEASE
but	0
an	0
ill	I-DISEASE
-	0
defined	I-DISEASE
constellation	0
of	I-DISEASE
parent	0
-	I-DISEASE
reported	0
apnea	0
symptoms	I-DISEASE
that	0
range	0
in	0
severity	0
from	0
benign	0
to	0
life	0
threatening	I-DISEASE
.	0

Recurrent	I-DISEASE
,	0
severe	I-DISEASE
infant	0
sleep	0
apnea	0
is	0
usually	I-DISEASE
due	0
to	I-DISEASE
other	I-DISEASE
comorbid	0
conditions	I-DISEASE
,	0
such	0
as	0
gastroesophageal	0
reflux	0
,	0
metabolic	0
disease	0
,	0
or	0
unrecognized	0
neurological	0
conditions	0
such	0
as	0
seizures	I-DISEASE
,	0
brainstem	0
malformation	0
,	0
or	I-DISEASE
neurodegenerative	0
condi-	I-DISEASE
tion	0
;	0
thus	0
an	0
evaluation	I-DISEASE
for	0
these	0
conditions	I-DISEASE
should	0
be	0
performed	0
.	0

Another	I-DISEASE
diagnos-	I-DISEASE
tic	0
consideration	I-DISEASE
is	0
a	0
form	0
of	I-DISEASE
child	I-DISEASE
abuse	I-DISEASE
(	0
Munchausen	0
syndrome	0
by	I-DISEASE
proxy	0
)	0
mani-	0
fest	I-DISEASE
as	0
imposed	I-DISEASE
upper	0
airway	0
obstruction	0
or	0
attempted	I-DISEASE
suffocation	0
.	0

Primary	I-DISEASE
CSA	I-DISEASE
of	I-DISEASE
infancy	0
should	I-DISEASE
be	I-DISEASE
disassociated	I-DISEASE
from	I-DISEASE
the	0
postmortem	0
diagnosis	I-DISEASE
of	I-DISEASE
SIDS	I-DISEASE
.	0

Although	I-DISEASE
a	0
small	0
percentage	I-DISEASE
of	0
SIDS	I-DISEASE
victims	0
experience	0
apnea	0
symptoms	I-DISEASE
prior	0
to	I-DISEASE
death	0
,	I-DISEASE
Sleep	0
Related	0
Breathing	0
Disorders	I-DISEASE
Sleep	I-DISEASE
Related	0
Breathing	0
Disorders	0
primary	0
apnea	0
in	0
the	0
newborn	0
or	0
infant	0
has	0
not	0
been	I-DISEASE
established	I-DISEASE
as	0
an	0
independent	I-DISEASE
risk	0
factor	I-DISEASE
for	0
SIDS	I-DISEASE
.	0

Unresolved	I-DISEASE
Issues	0
and	0
Further	I-DISEASE
Directions	0
Infancy	0
is	I-DISEASE
a	I-DISEASE
developmental	I-DISEASE
period	I-DISEASE
normally	0
characterized	0
by	0
instability	0
of	I-DISEASE
control	0
of	I-DISEASE
breathing	B-DISEASE
;	0
thus	I-DISEASE
,	0
defining	I-DISEASE
what	0
is	I-DISEASE
abnormal	I-DISEASE
is	0
a	0
diagnostic	0
challenge	I-DISEASE
.	0

Further	I-DISEASE
research	0
is	0
needed	0
into	I-DISEASE
the	0
mechanisms	I-DISEASE
of	I-DISEASE
ventilatory	0
control	0
development	I-DISEASE
in	I-DISEASE
the	0
infant	0
and	0
the	0
pathophysiologic	0
factors	0
resulting	I-DISEASE
in	0
infant	0
apnea	0
.	0

Bibliography	0
American	0
Academy	0
of	I-DISEASE
Pediatrics	0
.	0

Apnea	I-DISEASE
,	I-DISEASE
sudden	0
infant	0
death	0
syndrome	I-DISEASE
,	0
and	0
home	0
monitoring	I-DISEASE
.	I-DISEASE

Pediatrics	I-DISEASE
2003;111:914–7	0
.	0

Hunt	I-DISEASE
CE	0
,	0
Hufford	I-DISEASE
DR	I-DISEASE
,	I-DISEASE
Bourguignon	0
C	I-DISEASE
,	I-DISEASE
Oess	I-DISEASE
MA	I-DISEASE
.	0

Home	0
documented	I-DISEASE
monitoring	0
of	I-DISEASE
cardiorespiratory	0
pattern	0
and	0
oxygen	I-DISEASE
saturation	I-DISEASE
in	I-DISEASE
healthy	I-DISEASE
infants	I-DISEASE
.	0

Pediatr	I-DISEASE
Res	0
1996;39:216–22	0
.	0

National	I-DISEASE
Institutes	I-DISEASE
of	I-DISEASE
Health	0
Consensus	0
Development	I-DISEASE
Conference	0
on	0
Infantile	0
Apnea	0
and	0
Home	0
Monitoring	0
,	0
Sept	0
29	0
to	0
Oct	0
1	I-DISEASE
,	0
1986	I-DISEASE
.	0

Pediatrics	I-DISEASE
1987;79:292–9	0
.	0

Ramanathan	I-DISEASE
R	I-DISEASE
,	0
Corwin	I-DISEASE
MJ	I-DISEASE
,	I-DISEASE
Hunt	I-DISEASE
CE	I-DISEASE
,	I-DISEASE
et	0
al	I-DISEASE
.	0

Cardiorespiratory	0
events	0
recorded	I-DISEASE
on	0
home	0
monitors	0
:	I-DISEASE
Comparison	I-DISEASE
of	I-DISEASE
healthy	I-DISEASE
infants	0
with	0
those	0
at	I-DISEASE
increased	0
risk	0
for	0
SIDS	I-DISEASE
.	0

JAMA	I-DISEASE
2001;285:2199–207	I-DISEASE
.	0

Southall	I-DISEASE
DP	0
,	0
Plunkett	I-DISEASE
MC	0
,	I-DISEASE
Banks	I-DISEASE
MW	I-DISEASE
,	I-DISEASE
Falkov	I-DISEASE
AF	I-DISEASE
,	0
Samuels	I-DISEASE
MP	I-DISEASE
.	0

Covert	I-DISEASE
video	0
recordings	I-DISEASE
of	0
life-	0
threatening	I-DISEASE
child	0
abuse	0
:	0
lessons	I-DISEASE
for	I-DISEASE
child	I-DISEASE
protection	0
.	0

Pediatrics	I-DISEASE
1997;100:735–60	0
.	0

Primary	I-DISEASE
Central	I-DISEASE
Sleep	0
Apnea	0
of	I-DISEASE
Prematurity	I-DISEASE
ICD-9	0
-	0
CM	0
code	0
:	0
770.82	0
ICD-10	0
-	0
CM	0
code	0
:	B-DISEASE
P28.4	0
Alternate	0
Names	0
Apnea	0
of	I-DISEASE
prematurity	0
.	0

Diagnostic	I-DISEASE
Criteria	0
Criteria	I-DISEASE
A	0
-	I-DISEASE
D	I-DISEASE
must	I-DISEASE
be	0
met	0
A.	0
Apnea	0
or	0
cyanosis	I-DISEASE
is	I-DISEASE
noted	0
by	I-DISEASE
an	0
observer	0
,	I-DISEASE
or	B-DISEASE
an	0
episode	0
of	I-DISEASE
sleep	0
related	0
central	0
apnea	0
,	0
desaturation	0
,	0
or	I-DISEASE
bradycardia	0
is	0
detected	0
by	I-DISEASE
hospital	0
monitoring	0
in	I-DISEASE
the	0
postnatal	0
period	0
.	0

B.	0
The	I-DISEASE
infant	0
has	0
a	0
conceptional	0
age	I-DISEASE
less	I-DISEASE
than	I-DISEASE
37	I-DISEASE
weeks	I-DISEASE
at	I-DISEASE
the	0
time	0
of	I-DISEASE
onset	I-DISEASE
of	0
symptoms	0
.	0

C.	I-DISEASE
PSG	0
or	0
alternative	I-DISEASE
monitoring	0
such	0
as	0
hospital	0
or	0
home	I-DISEASE
apnea	I-DISEASE
monitoring	0
shows	I-DISEASE
either	I-DISEASE
:	0
.	0

Recurrent	I-DISEASE
prolonged	0
(	I-DISEASE
>	0
20	0
seconds	0
duration	I-DISEASE
)	0
central	0
apneas.1	0
2	0
.	0

Periodic	I-DISEASE
breathing2	0
for	0
≥	I-DISEASE
5	0
%	0
of	I-DISEASE
total	0
sleep	0
time	I-DISEASE
.	I-DISEASE

D.	I-DISEASE

The	I-DISEASE
disorder	I-DISEASE
is	0
not	0
better	0
explained	I-DISEASE
by	I-DISEASE
another	I-DISEASE
sleep	0
disorder	0
,	0
medical	I-DISEASE
or	I-DISEASE
neurological	0
disorder	I-DISEASE
,	I-DISEASE
or	0
medication	0
.	0

Notes	I-DISEASE
.	0

Normative	I-DISEASE
data	0
concerning	0
the	0
number	0
of	I-DISEASE
prolonged	0
central	0
apneas	0
per	I-DISEASE
hour	0
are	0
not	0
well	I-DISEASE
established	0
.	0
.	0

As	I-DISEASE
defined	I-DISEASE
by	I-DISEASE
the	0
most	0
recent	I-DISEASE
version	I-DISEASE
of	I-DISEASE
the	0
AASM	0
Manual	I-DISEASE
for	I-DISEASE
the	0
Scoring	0
of	I-DISEASE
Sleep	I-DISEASE
and	0
Associated	0
Events	I-DISEASE
.	0
.	0

Short	I-DISEASE
(	I-DISEASE
<	0
20	0
seconds	0
)	0
central	0
apneas	I-DISEASE
associated	0
with	I-DISEASE
significant	0
desaturation	0
are	I-DISEASE
more	0
likely	0
to	I-DISEASE
be	0
a	0
sign	0
of	I-DISEASE
decreased	I-DISEASE
pulmonary	0
reserve	I-DISEASE
than	0
of	I-DISEASE
central	0
nervous	B-DISEASE
system	0
pathology	0
.	0
.	0

Obstructive	I-DISEASE
and	0
mixed	0
apneas	0
may	0
also	0
be	I-DISEASE
present	I-DISEASE
,	0
but	0
central	0
apneas	I-DISEASE
are	0
predominant	0
.	0

Essential	I-DISEASE
Features	I-DISEASE
Apnea	0
is	0
very	I-DISEASE
common	I-DISEASE
in	0
preterm	0
infants	I-DISEASE
,	I-DISEASE
and	0
the	0
prevalence	I-DISEASE
varies	I-DISEASE
inversely	0
with	0
ges-	0
tational	0
age	0
.	0

In	I-DISEASE
the	0
preterm	0
infant	0
,	0
sleep	0
apnea	0
can	0
be	I-DISEASE
anticipated	0
,	0
is	I-DISEASE
primarily	I-DISEASE
related	I-DISEASE
to	0
immaturity	0
,	0
and	0
may	0
require	I-DISEASE
supportive	0
ventilatory	0
and	0
pharmacologic	0
treatment	0
.	0

The	I-DISEASE
condition	0
will	0
improve	0
with	0
maturation	I-DISEASE
unless	I-DISEASE
extenuating	0
conditions	I-DISEASE
,	I-DISEASE
such	I-DISEASE
as	0
hypoxemia	I-DISEASE
due	0
to	I-DISEASE
chronic	I-DISEASE
lung	I-DISEASE
disease	B-DISEASE
or	0
gastroesophageal	I-DISEASE
reflux	B-DISEASE
,	I-DISEASE
are	0
present	I-DISEASE
.	0

Apneas	I-DISEASE
are	0
predominantly	I-DISEASE
central	0
,	I-DISEASE
but	0
mixed	0
or	0
obstructive	0
apneas	0
or	0
hypopneas	0
may	I-DISEASE
be	0
seen	I-DISEASE
.	0

The	I-DISEASE
events	0
are	0
typically	0
associated	0
with	I-DISEASE
physiological	0
compromise	I-DISEASE
(	I-DISEASE
hypoxemia	0
,	I-DISEASE
bra-	0
dycardia	0
)	0
or	0
the	0
need	0
for	0
intervention	I-DISEASE
such	0
as	0
stimulation	0
or	I-DISEASE
resuscitation	I-DISEASE
.	0

Associated	I-DISEASE
Features	I-DISEASE
Apnea	0
in	I-DISEASE
the	0
preterm	I-DISEASE
infant	0
is	I-DISEASE
commonly	I-DISEASE
associated	0
with	0
bradycardia	0
.	0

Primary	I-DISEASE
CSA	I-DISEASE
of	I-DISEASE
prematurity	0
is	I-DISEASE
state	B-DISEASE
dependent	0
,	I-DISEASE
and	0
the	I-DISEASE
frequency	I-DISEASE
of	I-DISEASE
respiratory	I-DISEASE
events	I-DISEASE
increases	I-DISEASE
during	I-DISEASE
active	0
(	I-DISEASE
REM	0
)	0
sleep	0
.	0

Paradoxical	I-DISEASE
chest	0
wall	0
movements	0
are	0
common	I-DISEASE
during	I-DISEASE
active	0
sleep	0
in	I-DISEASE
neonates	I-DISEASE
and	0
may	0
cause	I-DISEASE
a	I-DISEASE
fall	0
in	0
arterial	0
oxygen	I-DISEASE
saturation	0
because	0
of	0
ventilation	0
or	0
perfusion	I-DISEASE
defects	0
associated	0
with	I-DISEASE
a	0
decrease	I-DISEASE
in	I-DISEASE
functional	0
residual	0
capac-	0
ity	0
.	0

Underlying	I-DISEASE
comorbidities	I-DISEASE
(	I-DISEASE
for	I-DISEASE
example	0
,	0
chronic	I-DISEASE
lung	I-DISEASE
disease	I-DISEASE
or	I-DISEASE
abnormal	0
neuro-	0
logical	0
status	0
)	0
can	0
predispose	I-DISEASE
the	I-DISEASE
infant	0
to	I-DISEASE
having	I-DISEASE
a	I-DISEASE
more	0
severe	I-DISEASE
or	0
prolonged	0
course	I-DISEASE
for	0
apnea	0
.	0

Note	I-DISEASE
that	I-DISEASE
a	0
small	0
upper	0
airway	I-DISEASE
will	0
exaggerate	0
the	0
obstructive	I-DISEASE
elements	I-DISEASE
of	I-DISEASE
this	0
disorder	0
.	0

Clinical	I-DISEASE
and	0
Pathophysiological	I-DISEASE
Subtypes	I-DISEASE
None	I-DISEASE
known	I-DISEASE
.	I-DISEASE

Sleep	I-DISEASE
Related	I-DISEASE
Breathing	0
Disorders	I-DISEASE
Sleep	0
Related	0
Breathing	0
Disorders	I-DISEASE
Demographics	0

The	I-DISEASE
prevalence	0
of	I-DISEASE
apnea	0
of	I-DISEASE
prematurity	I-DISEASE
varies	0
inversely	0
with	I-DISEASE
conceptional	0
age	I-DISEASE
.	0

In	I-DISEASE
studies	I-DISEASE
,	0
approximately	I-DISEASE
25	0
%	0
percent	I-DISEASE
of	I-DISEASE
infants	0
who	0
weigh	I-DISEASE
less	I-DISEASE
than	I-DISEASE
2,500	I-DISEASE
g	0
at	I-DISEASE
birth	0
and	0
84	I-DISEASE
%	0
of	I-DISEASE
infants	0
under	0
1,000	I-DISEASE
g	0
may	I-DISEASE
experience	0
symptomatic	0
apnea	0
during	I-DISEASE
the	0
neo-	I-DISEASE
natal	0
period	0
.	0

Ninety	I-DISEASE
-	0
two	I-DISEASE
percent	0
of	I-DISEASE
preterm	I-DISEASE
infants	0
will	0
be	I-DISEASE
symptom	I-DISEASE
free	I-DISEASE
by	I-DISEASE
37	0
weeks	0
postconceptional	0
age	I-DISEASE
,	I-DISEASE
and	0
98	I-DISEASE
%	0
by	I-DISEASE
40	0
weeks	I-DISEASE
after	0
conception	I-DISEASE
,	I-DISEASE
with	0
resolution	I-DISEASE
in	0
most	0
infants	0
by	0
43	0
weeks	0
postconception	0
.	I-DISEASE

Apnea	I-DISEASE
of	I-DISEASE
prematurity	0
occurs	I-DISEASE
equally	0
in	0
males	I-DISEASE
and	0
females	I-DISEASE
,	I-DISEASE
and	0
in	I-DISEASE
infants	0
of	I-DISEASE
all	0
races	0
and	0
ethnic	I-DISEASE
groups	0
.	0

Predisposing	I-DISEASE
and	0
Precipitating	I-DISEASE
Factors	0
Developmental	I-DISEASE
delay	I-DISEASE
in	0
respiratory	I-DISEASE
control	I-DISEASE
associated	0
with	0
premature	0
birth	I-DISEASE
is	0
the	0
major	I-DISEASE
predisposing	0
condition	0
.	0

Diverse	I-DISEASE
factors	0
are	I-DISEASE
known	0
to	I-DISEASE
precipitate	I-DISEASE
development	B-DISEASE
of	I-DISEASE
apneic	I-DISEASE
episodes	I-DISEASE
in	I-DISEASE
predisposed	0
preterm	0
infants	0
.	0

These	0
include	I-DISEASE
thermal	0
instability	I-DISEASE
,	0
gastroesophageal	I-DISEASE
reflux	0
,	0
intracranial	I-DISEASE
pathology	0
,	0
substances	0
,	I-DISEASE
anesthesia	I-DISEASE
,	I-DISEASE
metabolic	I-DISEASE
disorders	0
,	I-DISEASE
impaired	0
oxygenation	0
,	0
and	0
infection	0
.	0

Infection	I-DISEASE
with	I-DISEASE
respiratory	0
syncytial	0
virus	0
can	0
increase	I-DISEASE
the	I-DISEASE
frequency	I-DISEASE
and	0
the	0
duration	0
of	I-DISEASE
apneas	0
in	I-DISEASE
predisposed	0
infants	0
.	I-DISEASE

OSA	I-DISEASE
associated	0
with	I-DISEASE
upper	0
airway	I-DISEASE
abnormalities	I-DISEASE
can	0
present	I-DISEASE
as	0
apnea	I-DISEASE
of	I-DISEASE
prematurity	0
.	0

Persistence	I-DISEASE
of	I-DISEASE
apnea	0
after	0
43	I-DISEASE
weeks	0
conceptional	0
age	I-DISEASE
should	I-DISEASE
raise	I-DISEASE
suspicion	0
of	I-DISEASE
addi-	I-DISEASE
tional	0
etiologic	0
factors	I-DISEASE
.	0

Familial	I-DISEASE
Patterns	I-DISEASE
None	I-DISEASE
known	I-DISEASE
.	0

Onset	I-DISEASE
,	0
Course	0
,	0
and	0
Complications	0
In	0
preterm	0
infants	0
,	I-DISEASE
apnea	0
is	0
rare	I-DISEASE
on	0
day	0
one	0
of	I-DISEASE
life	0
,	0
and	0
its	I-DISEASE
presence	0
usually	I-DISEASE
signals	0
another	I-DISEASE
illness	0
.	0

More	I-DISEASE
typical	0
onset	0
occurs	0
between	0
the	0
second	I-DISEASE
and	0
seventh	0
days	0
.	0

Apnea	I-DISEASE
of	I-DISEASE
prematurity	0
usually	I-DISEASE
ceases	0
by	I-DISEASE
37	I-DISEASE
weeks	I-DISEASE
conceptional	I-DISEASE
age	I-DISEASE
but	I-DISEASE
may	I-DISEASE
persist	0
for	0
several	0
weeks	I-DISEASE
beyond	0
term	0
,	I-DISEASE
especially	0
in	I-DISEASE
infants	0
born	0
before	0
28	I-DISEASE
weeks	0
postconception	B-DISEASE
;	0
apnea	0
beyond	0
43	0
weeks	0
postconception	0
is	I-DISEASE
rare	I-DISEASE
.	0

Adverse	I-DISEASE
outcomes	I-DISEASE
for	I-DISEASE
former	0
preterm	0
infants	0
are	0
more	0
closely	I-DISEASE
related	I-DISEASE
to	I-DISEASE
the	0
prenatal	0
or	0
neonatal	0
course	I-DISEASE
,	0
associated	0
comorbidities	I-DISEASE
,	I-DISEASE
and	0
environmental	I-DISEASE
factors	0
than	0
to	0
the	0
apnea	0
of	I-DISEASE
prematurity	0
per	0
se	I-DISEASE
.	0

For	I-DISEASE
most	0
children	0
,	I-DISEASE
long	0
-	0
term	0
outcomes	I-DISEASE
for	0
uncomplicated	0
apnea	0
of	I-DISEASE
prematurity	I-DISEASE
are	0
excellent	I-DISEASE
.	0

However	I-DISEASE
,	I-DISEASE
the	0
prognosis	0
for	0
infants	0
with	0
persistent	0
recurrent	0
apnea	I-DISEASE
spells	I-DISEASE
requiring	0
frequent	I-DISEASE
resuscitation	0
is	0
more	0
guarded	0
and	0
depends	I-DISEASE
on	0
the	0
cause	0
of	I-DISEASE
the	0
apnea	I-DISEASE
and	0
associated	0
comorbidities	I-DISEASE
.	0

Developmental	I-DISEASE
Issues	0

This	I-DISEASE
is	I-DISEASE
a	0
condition	0
related	0
to	0
prematurity	0
that	0
normally	0
improves	0
over	I-DISEASE
time	0
.	0

Pathology	I-DISEASE
and	0
Pathophysiology	I-DISEASE
Physiological	B-DISEASE
factors	I-DISEASE
contributing	I-DISEASE
to	0
apnea	0
are	0
related	0
to	I-DISEASE
immaturity	0
of	I-DISEASE
respiratory	I-DISEASE
control	0
.	0

These	0
include	I-DISEASE
developmental	I-DISEASE
alterations	0
in	0
central	0
drive	0
,	I-DISEASE
chemoreceptor	0
or	I-DISEASE
mechanoreceptor	B-DISEASE
responses	I-DISEASE
,	0
and	0
upper	0
airway	0
reflexes	0
.	0

Precipitating	I-DISEASE
factors	0
for	I-DISEASE
wors-	I-DISEASE
ening	0
apnea	0
in	0
preterm	I-DISEASE
infants	0
include	0
thermal	I-DISEASE
instability	0
,	0
gastroesophageal	I-DISEASE
reflux	I-DISEASE
,	0
intracranial	I-DISEASE
pathology	0
,	0
substances	0
,	0
anesthesia	0
,	I-DISEASE
metabolic	0
disturbances	I-DISEASE
,	0
impaired	0
oxy-	0
genation	0
,	0
and	0
infection	0
.	0

Objective	I-DISEASE
Findings	I-DISEASE
Most	I-DISEASE
premature	0
neonates	I-DISEASE
are	0
diagnosed	0
with	I-DISEASE
apnea	I-DISEASE
of	I-DISEASE
prematurity	0
based	0
on	0
cardio-	0
respiratory	I-DISEASE
monitoring	0
in	0
the	0
neonatal	I-DISEASE
intensive	I-DISEASE
care	0
unit	B-DISEASE
,	I-DISEASE
rather	0
than	0
by	0
PSG	0
.	0

When	I-DISEASE
PSG	0
is	0
performed	0
,	I-DISEASE
central	0
apneas	I-DISEASE
are	0
often	I-DISEASE
shown	I-DISEASE
to	0
have	0
a	0
mixed	0
component	0
,	0
with	0
mixed	0
apneas	0
accounting	0
for	I-DISEASE
50	0
%	0
to	0
75	0
%	0
of	I-DISEASE
apneas	0
in	I-DISEASE
small	0
premature	0
infants	0
;	0
studies	0
suggest	0
that	0
obstructive	I-DISEASE
-	0
type	I-DISEASE
events	0
account	0
for	0
10	0
%	0
to	0
20	0
%	0
of	I-DISEASE
events	0
;	I-DISEASE
and	0
pure	0
central	0
events	0
,	0
10	0
%	0
to	0
25	0
%	0
.	0

Periodic	I-DISEASE
breathing	0
may	I-DISEASE
be	0
present	I-DISEASE
.	0

Differential	I-DISEASE
Diagnosis	0
Apnea	0
of	I-DISEASE
prematurity	0
should	I-DISEASE
be	I-DISEASE
distinguished	0
from	0
normal	B-DISEASE
,	I-DISEASE
physiologic	0
respiratory	B-DISEASE
pauses	I-DISEASE
that	0
occur	0
during	I-DISEASE
sleep	0
in	I-DISEASE
infants	0
.	0

Studies	I-DISEASE
have	I-DISEASE
shown	0
that	0
healthy	0
asymptom-	0
atic	I-DISEASE
infants	I-DISEASE
commonly	I-DISEASE
have	0
brief	I-DISEASE
(	I-DISEASE
<	I-DISEASE
20	0
second	I-DISEASE
)	0
central	0
respiratory	0
pauses	0
,	I-DISEASE
either	I-DISEASE
as	0
isolated	I-DISEASE
events	0
(	I-DISEASE
particularly	0
during	I-DISEASE
REM	0
sleep	0
)	0
or	0
after	0
sigh	0
breaths	0
or	0
movements	0
(	0
in	0
which	0
case	I-DISEASE
the	I-DISEASE
apneas	0
may	0
be	0
longer	0
)	0
.	0

These	0
infants	0
are	0
typically	0
asymptomatic	0
,	0
with	I-DISEASE
no	0
changes	I-DISEASE
in	I-DISEASE
color	0
or	0
muscle	I-DISEASE
tone	I-DISEASE
.	0

The	I-DISEASE
differential	0
diagnosis	0
is	0
long	0
and	0
includes	0
apnea	I-DISEASE
secondary	0
to	I-DISEASE
severe	I-DISEASE
gastroesoph-	I-DISEASE
ageal	0
reflux	0
,	0
central	0
nervous	0
system	0
malformations	0
or	0
hemorrhage	0
,	0
seizures	0
,	0
sepsis	I-DISEASE
,	0
and	0
rarely	I-DISEASE
primary	0
cardiac	I-DISEASE
arrhythmias	0
.	0

Comorbid	0
conditions	I-DISEASE
should	0
be	0
suspected	I-DISEASE
whenever	0
apneas	0
are	I-DISEASE
severe	I-DISEASE
or	0
continue	0
beyond	0
43	I-DISEASE
weeks	0
gestation	0
.	0

Unresolved	I-DISEASE
Issues	0
and	0
Further	I-DISEASE
Directions	0

The	I-DISEASE
mechanisms	I-DISEASE
underlying	0
physiologic	0
maturation	0
of	I-DISEASE
ventilatory	0
control	0
are	0
not	0
well	I-DISEASE
understood	0
.	0

Further	I-DISEASE
research	0
is	0
required	0
to	0
determine	0
which	0
infants	0
are	0
at	I-DISEASE
greatest	0
risk	0
for	I-DISEASE
severe	I-DISEASE
apnea	0
.	0

Bibliography	0
American	0
Academy	0
of	I-DISEASE
Pediatrics	0
.	0

Apnea	I-DISEASE
,	I-DISEASE
sudden	0
infant	0
death	0
syndrome	I-DISEASE
,	0
and	0
home	0
monitoring	I-DISEASE
.	I-DISEASE

Pediatrics	I-DISEASE
2003;111:914–7	0
.	0

Hunt	I-DISEASE
CE	0
,	0
Hufford	I-DISEASE
DR	I-DISEASE
,	I-DISEASE
Bourguignon	0
C	I-DISEASE
,	I-DISEASE
Oess	I-DISEASE
MA	I-DISEASE
.	0

Home	0
documented	I-DISEASE
monitoring	0
of	I-DISEASE
cardiorespiratory	0
pattern	0
and	0
oxygen	I-DISEASE
saturation	I-DISEASE
in	I-DISEASE
healthy	I-DISEASE
infants	I-DISEASE
.	0

Pediatr	I-DISEASE
Res	0
1996;39:216–22	0
.	0

Sleep	I-DISEASE
Related	I-DISEASE
Breathing	0
Disorders	I-DISEASE
Sleep	0
Related	0
Breathing	0
Disorders	I-DISEASE
Kahn	0
A	0
,	I-DISEASE
Rebuffat	0
E	I-DISEASE
,	0
Sottiaux	0
M	I-DISEASE
,	I-DISEASE
Blum	I-DISEASE
D.	I-DISEASE
Management	I-DISEASE
of	I-DISEASE
an	0
infant	0
with	0
an	0
apparent	0
life	0
-	I-DISEASE
threatening	I-DISEASE
event	I-DISEASE
.	0

Pediatrician	I-DISEASE
1988;15:204–11	0
.	0

National	I-DISEASE
Institutes	I-DISEASE
of	I-DISEASE
Health	0
Consensus	0
Development	I-DISEASE
Conference	0
on	0
Infantile	0
Apnea	0
and	0
Home	0
Monitoring	0
,	0
Sept	0
29	0
to	0
Oct	0
1	I-DISEASE
,	0
1986	I-DISEASE
.	0

Pediatrics	I-DISEASE
1987;79:292–9	0
.	0

Ramanathan	I-DISEASE
R	I-DISEASE
,	0
Corwin	I-DISEASE
MJ	I-DISEASE
,	I-DISEASE
Hunt	I-DISEASE
CE	I-DISEASE
,	I-DISEASE
et	0
al	I-DISEASE
.	0

Cardiorespiratory	0
events	0
recorded	I-DISEASE
on	0
home	0
monitors	0
:	I-DISEASE
Comparison	I-DISEASE
of	I-DISEASE
healthy	I-DISEASE
infants	0
with	0
those	0
at	I-DISEASE
increased	0
risk	0
for	0
SIDS	I-DISEASE
.	0

JAMA	I-DISEASE
2001;285:2199–207	I-DISEASE
.	0

Rigatto	I-DISEASE
H.	I-DISEASE
Breathing	0
and	0
sleep	0
in	0
preterm	0
infants	I-DISEASE
.	0

In	I-DISEASE
:	I-DISEASE
Loughlin	0
G	I-DISEASE
,	I-DISEASE
Carroll	I-DISEASE
J	0
,	0
Marcus	I-DISEASE
C	I-DISEASE
,	I-DISEASE
eds	I-DISEASE
.	0

Sleep	I-DISEASE
and	0
breathing	0
in	I-DISEASE
children	0
.	0

New	I-DISEASE
York	0
:	0
Marcel	0
Dekker	0
,	0
2000:495–515	I-DISEASE
.	0

Schmidt	I-DISEASE
B	0
,	0
Roberts	0
RS	0
,	I-DISEASE
Davis	I-DISEASE
P	0
,	0
et	0
al	I-DISEASE
.	0

Long	I-DISEASE
-	I-DISEASE
term	0
effects	0
of	0
caffeine	0
therapy	0
for	0
apnea	0
of	I-DISEASE
prematurity	0
.	0

N	0
Engl	I-DISEASE
J	0
Med	I-DISEASE
2007;357:1893–902	I-DISEASE
.	0

Southall	I-DISEASE
DP	0
,	0
Plunkett	I-DISEASE
MC	0
,	I-DISEASE
Banks	I-DISEASE
MW	I-DISEASE
,	I-DISEASE
Falkov	I-DISEASE
AF	I-DISEASE
,	0
Samuels	I-DISEASE
MP	I-DISEASE
.	0

Covert	I-DISEASE
video	0
recordings	I-DISEASE
of	0
life-	0
threatening	0
child	0
abuse	0
:	0
lessons	0
for	I-DISEASE
child	0
protection	B-DISEASE
[	0
see	I-DISEASE
comments	I-DISEASE
]	0
.	0

Pediatrics	I-DISEASE
1997;100:735–60	0
.	0

Treatment	I-DISEASE
-	I-DISEASE
Emergent	0
Central	I-DISEASE
Sleep	0
Apnea	0
ICD-9	0
-	0
CM	0
code	0
:	0
327.29	0
ICD-10	0
-	I-DISEASE
CM	0
code	0
:	B-DISEASE
G47.39	I-DISEASE
Alternate	0
names	0
Complex	0
sleep	0
apnea	0
.	0

Diagnostic	I-DISEASE
Criteria	0
Criteria	I-DISEASE
A	0
-	I-DISEASE
C	I-DISEASE
must	I-DISEASE
be	0
met	0
A.	0
Diagnostic	0
PSG	0
shows	I-DISEASE
five	0
or	0
more	0
predominantly	I-DISEASE
obstructive	0
respiratory	B-DISEASE
events1	0
(	0
obstructive	0
or	0
mixed	0
apneas	0
,	I-DISEASE
hypopneas	I-DISEASE
or	0
RERAs	0
)	0
per	0
hour	0
of	I-DISEASE
sleep	0
B.	0
PSG	0
during	I-DISEASE
use	0
of	I-DISEASE
positive	0
airway	0
pressure	0
without	0
a	0
backup	0
rate	0
shows	I-DISEASE
significant	0
resolution	I-DISEASE
of	I-DISEASE
obstructive	0
events	0
and	0
emergence	0
or	I-DISEASE
persistence	I-DISEASE
of	0
central	0
apnea	I-DISEASE
or	0
central	0
hypopnea	I-DISEASE
with	I-DISEASE
all	0
of	I-DISEASE
the	B-DISEASE
following	0
:	I-DISEASE
.	0

Central	I-DISEASE
apnea	0
—	0
central	0
hypopnea	I-DISEASE
index	0
[	0
CAHI	I-DISEASE
]	0
≥	0
5	0
/	0
hour	0
.	0
.	0

Number	I-DISEASE
of	I-DISEASE
central	0
apneas	I-DISEASE
and	0
central	0
hypopneas	0
is	0
≥	0
50	0
%	0
of	0
total	0
number	0
of	I-DISEASE
apneas	0
and	0
hypopneas	I-DISEASE
.	0

C.	I-DISEASE

The	I-DISEASE
central	0
sleep	0
apnea	I-DISEASE
is	I-DISEASE
not	0
better	0
explained	0
by	I-DISEASE
another	I-DISEASE
CSA	I-DISEASE
disorder	0
(	I-DISEASE
e.g.	I-DISEASE
,	I-DISEASE
CSA	0
with	I-DISEASE
CSB	0
or	0
CSA	I-DISEASE
due	I-DISEASE
to	I-DISEASE
a	I-DISEASE
medication	0
or	0
substance	I-DISEASE
)	0
.	0

Notes	I-DISEASE
.	0

Respiratory	I-DISEASE
events	0
defined	I-DISEASE
according	I-DISEASE
the	I-DISEASE
most	0
recent	I-DISEASE
version	I-DISEASE
of	I-DISEASE
the	I-DISEASE
AASM	I-DISEASE
Manual	I-DISEASE
for	I-DISEASE
the	I-DISEASE
Scoring	0
of	I-DISEASE
Sleep	0
and	0
Associated	I-DISEASE
Events	I-DISEASE
.	I-DISEASE
.	0

A	I-DISEASE
diagnosis	I-DISEASE
of	I-DISEASE
treatment	I-DISEASE
-	0
emergent	I-DISEASE
central	0
sleep	0
apnea	0
does	I-DISEASE
not	0
exclude	0
a	0
diagnosis	I-DISEASE
of	I-DISEASE
OSA	0
.	0

That	I-DISEASE
is	I-DISEASE
,	0
a	I-DISEASE
diagnosis	0
of	I-DISEASE
OSA	I-DISEASE
can	0
be	0
made	0
based	I-DISEASE
on	0
the	B-DISEASE
diagnostic	0
sleep	0
study	I-DISEASE
.	I-DISEASE

Essential	I-DISEASE
Features	I-DISEASE
A	0
diagnosis	I-DISEASE
of	0
treatment	I-DISEASE
-	I-DISEASE
emergent	I-DISEASE
CSA	0
is	I-DISEASE
characterized	0
by	I-DISEASE
predominantly	B-DISEASE
obstructive	0
events	0
(	I-DISEASE
obstructive	0
or	I-DISEASE
mixed	0
apnea	I-DISEASE
or	I-DISEASE
hypopnea	I-DISEASE
)	0
during	I-DISEASE
a	0
diagnostic	0
sleep	0
study	0
with	0
persistence	0
or	I-DISEASE
emergence	I-DISEASE
of	I-DISEASE
CSA	I-DISEASE
during	I-DISEASE
administration	0
of	I-DISEASE
positive	0
airway	0
pressure	0
without	0
a	0
backup	I-DISEASE
rate	0
,	0
despite	0
significant	I-DISEASE
resolution	I-DISEASE
of	I-DISEASE
obstructive	0
respiratory	I-DISEASE
events	I-DISEASE
.	0

If	I-DISEASE
the	0
central	0
apnea	I-DISEASE
is	I-DISEASE
better	0
explained	0
by	I-DISEASE
another	I-DISEASE
CSA	0
disorder	I-DISEASE
,	0
patients	I-DISEASE
are	I-DISEASE
given	I-DISEASE
a	0
diagnosis	0
of	I-DISEASE
OSA	0
and	0
that	0
CSA	I-DISEASE
disorder	I-DISEASE
rather	0
than	I-DISEASE
treatment	I-DISEASE
-	I-DISEASE
emergent	0
CSA	I-DISEASE
(	I-DISEASE
e.g.	0
,	0
a	0
patient	0
with	I-DISEASE
heart	0
failure	I-DISEASE
exhibits	0
mainly	I-DISEASE
obstructive	0
events	0
during	I-DISEASE
diagnostic	0
PSG	0
but	0
then	0
exhibits	0
predominantly	I-DISEASE
central	I-DISEASE
apnea	I-DISEASE
with	0
CSB	0
on	0
positive	0
airway	I-DISEASE
pressure	I-DISEASE
)	0
.	0

Associated	I-DISEASE
Features	I-DISEASE
Patients	0
with	0
treatment	I-DISEASE
-	I-DISEASE
emergent	I-DISEASE
CSA	0
have	I-DISEASE
several	I-DISEASE
characteristics	I-DISEASE
when	0
placed	0
on	0
positive	0
airway	0
pressure	0
without	0
a	0
backup	I-DISEASE
rate	0
.	0

A	I-DISEASE
high	I-DISEASE
number	0
of	I-DISEASE
arousals	0
persist	I-DISEASE
on	0
PAP	0
treatment	I-DISEASE
,	I-DISEASE
and	0
the	0
AHI	0
is	0
often	0
higher	0
during	I-DISEASE
NREM	0
than	I-DISEASE
REM	0
sleep	0
.	0

This	I-DISEASE
is	I-DISEASE
due	0
to	I-DISEASE
the	0
fact	I-DISEASE
that	0
treatment	I-DISEASE
-	0
emergent	0
central	0
apneas	I-DISEASE
almost	I-DISEASE
invariably	I-DISEASE
occur	I-DISEASE
during	I-DISEASE
NREM	0
sleep	I-DISEASE
.	0

Pressures	I-DISEASE
that	0
are	I-DISEASE
effective	0
in	I-DISEASE
controlling	0
obstructive	0
events	0
during	I-DISEASE
REM	I-DISEASE
sleep	0
prove	I-DISEASE
ineffective	I-DISEASE
during	I-DISEASE
NREM	0
sleep	0
due	0
to	0
emergence	I-DISEASE
of	0
central	0
apneas	0
.	0

If	I-DISEASE
patients	0
can	0
attain	I-DISEASE
stage	0
N3	0
,	I-DISEASE
central	0
apneas	0
often	0
decrease	I-DISEASE
until	0
interrupted	0
by	I-DISEASE
an	0
arousal	0
or	0
transition	0
to	0
a	0
lighter	0
stage	I-DISEASE
of	0
sleep	0
that	0
precipitates	I-DISEASE
another	0
run	0
of	I-DISEASE
central	0
apneas	0
or	0
hypopneas	0
.	0

Patients	I-DISEASE
with	0
treatment	I-DISEASE
-	0
emergent	I-DISEASE
CSA	I-DISEASE
can	0
have	0
persistent	0
sleep	I-DISEASE
fragmentation	I-DISEASE
on	0
CPAP	I-DISEASE
treatment	0
and	0
may	I-DISEASE
report	0
little	0
benefit	0
from	I-DISEASE
therapy	I-DISEASE
.	0

Clinical	I-DISEASE
and	0
Pathophysiological	I-DISEASE
Subtypes	I-DISEASE
None	I-DISEASE
known	I-DISEASE
.	I-DISEASE

Demographics	I-DISEASE
The	I-DISEASE
percentage	I-DISEASE
of	I-DISEASE
patients	I-DISEASE
with	0
persistent	0
or	0
emergent	0
central	0
apnea	0
on	0
the	0
initial	0
poly-	0
somnographic	0
positive	0
airway	0
pressure	0
titration	0
varies	I-DISEASE
from	I-DISEASE
2	0
%	0
to	0
20	0
%	0
depending	I-DISEASE
on	0
the	0
characteristics	0
of	I-DISEASE
the	I-DISEASE
group	I-DISEASE
studied	0
(	0
community	0
or	0
referral	0
sleep	0
center	0
)	0
and	0
the	0
methodology	I-DISEASE
.	0

If	I-DISEASE
patients	I-DISEASE
who	0
are	I-DISEASE
taking	0
opioids	0
or	B-DISEASE
have	0
underling	0
central	I-DISEASE
apnea	I-DISEASE
with	I-DISEASE
CSB	I-DISEASE
are	0
included	I-DISEASE
,	0
the	0
percentage	0
is	0
at	I-DISEASE
the	0
higher	I-DISEASE
end	0
of	I-DISEASE
the	0
range	I-DISEASE
.	0

The	I-DISEASE
percentage	0
of	I-DISEASE
patients	I-DISEASE
with	0
central	0
sleep	0
apnea	I-DISEASE
that	0
persists	0
on	0
chronic	0
CPAP	I-DISEASE
treatment	0
(	0
approxi-	I-DISEASE
mately	0
2	I-DISEASE
%	0
)	0
is	0
considerably	0
lower	0
than	0
the	0
percentage	0
identified	0
on	0
the	0
first	0
or	0
second	I-DISEASE
night	0
of	I-DISEASE
CPAP	0
treatment	I-DISEASE
.	0

Predisposing	I-DISEASE
and	0
Precipitating	0
Factors	0

A	I-DISEASE
number	0
of	I-DISEASE
factors	I-DISEASE
have	0
been	I-DISEASE
hypothesized	I-DISEASE
to	I-DISEASE
cause	I-DISEASE
treatment	I-DISEASE
-	0
emergent	0
CSA	I-DISEASE
,	0
but	I-DISEASE
definitive	0
data	I-DISEASE
are	0
not	0
available	I-DISEASE
.	0

The	I-DISEASE
patients	I-DISEASE
presumably	0
have	I-DISEASE
characteristics	0
that	0
would	0
predispose	I-DISEASE
them	I-DISEASE
to	I-DISEASE
instability	I-DISEASE
in	I-DISEASE
ventilatory	0
control	I-DISEASE
or	0
sleep	0
maintenance	I-DISEASE
.	0

Sleep	I-DISEASE
Related	I-DISEASE
Breathing	0
Disorders	I-DISEASE
Sleep	0
Related	0
Breathing	0
Disorders	I-DISEASE
These	0
include	0
a	0
low	0
arousal	0
threshold	0
and	0
high	I-DISEASE
ventilatory	0
controller	I-DISEASE
gain	I-DISEASE
.	0

Studies	I-DISEASE
have	0
found	0
that	0
often	0
a	0
small	0
increase	I-DISEASE
in	0
end	0
-	0
tidal	0
PCO2	I-DISEASE
can	0
stabilize	I-DISEASE
breathing	0
in	0
patients	I-DISEASE
with	0
treatment	0
-	0
emergent	0
central	0
apneas	0
.	0

Therefore	I-DISEASE
,	I-DISEASE
any	I-DISEASE
events	0
that	0
predis-	0
pose	0
a	0
patient	I-DISEASE
to	I-DISEASE
hypocapnia	I-DISEASE
can	I-DISEASE
trigger	0
treatment	0
-	0
emergent	0
central	0
apnea	0
.	0

In	I-DISEASE
some	I-DISEASE
,	0
but	I-DISEASE
not	0
all	0
studies	I-DISEASE
,	I-DISEASE
the	0
overall	0
AHI	0
on	0
the	0
diagnostic	0
PSG	0
(	0
or	0
diagnostic	0
portion	0
of	I-DISEASE
a	0
split	I-DISEASE
-	I-DISEASE
night	0
PSG	0
)	0
was	0
higher	0
in	0
the	0
treatment	I-DISEASE
-	I-DISEASE
emergent	0
CSA	0
group	I-DISEASE
compared	I-DISEASE
to	0
the	0
patients	I-DISEASE
without	0
this	I-DISEASE
diagnosis	I-DISEASE
.	0

In	I-DISEASE
other	I-DISEASE
studies	0
,	I-DISEASE
patients	0
with	I-DISEASE
treatment	I-DISEASE
-	0
emergent	0
CSA	0
had	I-DISEASE
more	0
central	0
apneas	0
during	I-DISEASE
the	0
diagnostic	0
PSG	0
and	0
were	I-DISEASE
more	0
likely	I-DISEASE
to	0
be	I-DISEASE
male	I-DISEASE
.	0

However	I-DISEASE
,	I-DISEASE
identified	0
risk	0
factors	0
for	I-DISEASE
treatment	I-DISEASE
-	I-DISEASE
emergent	0
CSA	0
vary	I-DISEASE
considerably	I-DISEASE
from	0
study	0
to	I-DISEASE
study	I-DISEASE
.	0

Of	I-DISEASE
note	I-DISEASE
,	0
the	0
emergence	0
of	I-DISEASE
central	0
apnea	I-DISEASE
after	0
treatment	I-DISEASE
of	I-DISEASE
obstructive	0
apnea	I-DISEASE
with	I-DISEASE
tra-	0
cheostomy	I-DISEASE
,	I-DISEASE
maxillomandibular	0
advancement	0
,	0
and	0
oral	0
appliance	0
treatment	I-DISEASE
for	0
OSA	0
has	0
been	I-DISEASE
reported	I-DISEASE
.	0

A	I-DISEASE
case	I-DISEASE
report	0
of	I-DISEASE
the	0
development	I-DISEASE
of	I-DISEASE
central	0
apnea	0
following	0
nasal	I-DISEASE
surgery	I-DISEASE
in	0
a	0
patient	I-DISEASE
with	I-DISEASE
known	0
obstructive	0
apnea	0
has	0
also	0
recently	0
been	I-DISEASE
published	0
.	0

Familial	I-DISEASE
Patterns	I-DISEASE
None	I-DISEASE
known	I-DISEASE
.	0

Onset	I-DISEASE
,	0
Course	0
,	0
and	0
Complications	0
The	I-DISEASE
recognition	I-DISEASE
of	I-DISEASE
treatment	I-DISEASE
-	0
emergent	0
CSA	I-DISEASE
follows	0
PAP	I-DISEASE
titration	0
.	0

An	0
accurate	0
esti-	I-DISEASE
mate	0
of	I-DISEASE
the	0
percentage	0
of	0
patients	0
with	I-DISEASE
treatment	I-DISEASE
-	0
emergent	0
central	0
apneas	I-DISEASE
whose	0
central	0
events	0
persist	I-DISEASE
on	0
long	0
-	0
term	0
PAP	I-DISEASE
treatment	I-DISEASE
does	0
not	0
exist	I-DISEASE
,	0
as	0
most	0
published	0
reports	0
are	0
retrospective	0
and	0
had	0
a	0
significant	0
number	0
of	I-DISEASE
patients	0
lost	0
to	0
follow	0
-	0
up	0
.	0

Of	I-DISEASE
interest	I-DISEASE
,	0
one	I-DISEASE
study	0
comparing	0
the	0
results	I-DISEASE
of	I-DISEASE
an	0
initial	0
CPAP	I-DISEASE
titration	0
study	I-DISEASE
with	I-DISEASE
one	0
per-	0
formed	0
after	I-DISEASE
six	I-DISEASE
months	0
of	I-DISEASE
therapy	0
found	I-DISEASE
patients	I-DISEASE
who	I-DISEASE
did	I-DISEASE
not	0
meet	0
criteria	0
for	I-DISEASE
treat-	0
ment	0
-	0
emergent	0
CSA	0
on	0
the	0
initial	I-DISEASE
study	0
but	I-DISEASE
met	0
the	0
criteria	0
on	0
the	0
second	I-DISEASE
study	0
.	0

Those	I-DISEASE
patients	0
with	0
treatment	I-DISEASE
-	0
emergent	I-DISEASE
CSA	I-DISEASE
that	0
do	0
not	0
experience	I-DISEASE
resolution	I-DISEASE
of	0
central	0
apneas	0
on	0
chronic	I-DISEASE
PAP	0
treatment	I-DISEASE
are	I-DISEASE
found	0
to	I-DISEASE
have	0
a	0
high	I-DISEASE
number	0
of	I-DISEASE
residual	0
events	0
on	0
PAP	0
machine	I-DISEASE
interrogation	0
in	0
clinic	0
follow	0
-	0
up	I-DISEASE
.	0

Nocturnal	I-DISEASE
oximetry	0
at	I-DISEASE
home	I-DISEASE
on	0
PAP	0
treatment	I-DISEASE
may	I-DISEASE
show	I-DISEASE
persistent	0
arterial	0
oxygen	I-DISEASE
desaturation	I-DISEASE
.	0

Sleep	I-DISEASE
fragmentation	0
and	0
daytime	0
sleepiness	0
may	I-DISEASE
persist	0
if	0
a	0
significant	I-DISEASE
number	0
of	0
central	0
apneas	0
remain	I-DISEASE
.	0

There	I-DISEASE
is	I-DISEASE
the	0
potential	I-DISEASE
for	0
poor	0
adherence	0
and	0
acceptance	0
of	I-DISEASE
PAP	I-DISEASE
treatment	I-DISEASE
as	0
a	0
result	0
of	I-DISEASE
this	0
.	0

Developmental	I-DISEASE
Issues	0
Treatment	I-DISEASE
-	0
emergent	I-DISEASE
sleep	0
apnea	0
has	0
not	I-DISEASE
been	I-DISEASE
described	0
in	I-DISEASE
children	I-DISEASE
but	I-DISEASE
this	0
may	0
be	I-DISEASE
due	0
to	0
the	0
relatively	0
small	0
number	0
of	I-DISEASE
children	0
with	I-DISEASE
OSA	0
who	I-DISEASE
are	0
treated	0
with	0
PAP	0
.	0

Pathology	I-DISEASE
and	0
Pathophysiology	I-DISEASE
Due	I-DISEASE
to	0
variation	0
in	I-DISEASE
definitions	I-DISEASE
of	I-DISEASE
treatment	0
-	I-DISEASE
emergent	0
CSA	0
,	I-DISEASE
the	0
pathophysiology	0
is	I-DISEASE
not	0
clearly	0
defined	I-DISEASE
.	0

A	I-DISEASE
low	0
arousal	0
threshold	I-DISEASE
and	0
difficulty	0
reaching	0
stage	I-DISEASE
N3	0
sleep	0
may	I-DISEASE
pre-	I-DISEASE
dispose	0
to	I-DISEASE
sleep	0
instability	0
.	0

Arousals	I-DISEASE
destabilize	I-DISEASE
breathing	I-DISEASE
.	0

A	I-DISEASE
high	I-DISEASE
ventilatory	0
response	0
to	I-DISEASE
PaCO2	0
and	0
a	0
small	0
difference	I-DISEASE
between	0
the	0
sleeping	0
PaCO2	0
and	0
the	0
apnea	0
threshold	I-DISEASE
may	0
also	0
predispose	0
patients	0
to	0
treatment	I-DISEASE
-	0
emergent	0
central	0
apneas	0
.	0

Treatment	I-DISEASE
with	0
excessive	0
positive	0
airway	0
pressure	0
may	0
trigger	0
treatment	0
-	0
emergent	0
central	0
apneas	0
in	0
susceptible	0
individuals	I-DISEASE
.	0

Objective	I-DISEASE
Findings	I-DISEASE
PSG	0
during	I-DISEASE
a	0
full	0
night	0
diagnostic	0
study	I-DISEASE
(	I-DISEASE
or	0
diagnostic	0
portion	0
of	I-DISEASE
a	0
split	0
-	0
night	0
PSG	0
)	0
shows	I-DISEASE
predominantly	0
obstructive	0
or	B-DISEASE
mixed	0
apneas	0
and	0
hypopneas	0
of	0
five	0
or	0
more	I-DISEASE
per	I-DISEASE
hour	0
of	I-DISEASE
sleep	0
.	0

PSG	I-DISEASE
with	0
PAP	I-DISEASE
(	I-DISEASE
either	I-DISEASE
a	I-DISEASE
full	0
night	0
titration	0
study	0
or	0
PAP	0
treatment	I-DISEASE
portion	0
of	0
a	0
split	0
night	0
study	0
)	0
without	0
a	0
backup	0
rate	0
shows	I-DISEASE
significant	0
resolution	I-DISEASE
of	I-DISEASE
obstructive	0
events	0
and	0
emergence	0
or	0
persistence	0
of	0
central	0
apneas	0
or	0
central	0
hypopneas	0
.	0

The	I-DISEASE
CAHI	I-DISEASE
is	0
five	0
or	I-DISEASE
greater	I-DISEASE
per	0
hour	0
,	0
and	0
more	I-DISEASE
than	I-DISEASE
50	0
%	0
of	I-DISEASE
the	I-DISEASE
respiratory	0
events	0
are	I-DISEASE
central	0
in	I-DISEASE
nature	0
.	0

A	I-DISEASE
diagnosis	I-DISEASE
of	I-DISEASE
treatment	I-DISEASE
-	0
emergent	I-DISEASE
CSA	I-DISEASE
excludes	0
patients	0
who	I-DISEASE
manifest	I-DISEASE
central	0
sleep	0
apnea	0
on	0
PAP	I-DISEASE
treatment	0
when	0
the	0
CSA	I-DISEASE
is	I-DISEASE
better	0
explained	I-DISEASE
by	I-DISEASE
another	I-DISEASE
CSA	0
dis-	0
order	0
or	0
by	0
over	0
-	0
titration	0
.	0

PSG	I-DISEASE
with	0
administration	0
of	0
PAP	I-DISEASE
often	0
reveals	0
adequate	0
treatment	I-DISEASE
during	I-DISEASE
REM	I-DISEASE
sleep	0
and	0
stage	I-DISEASE
N3	0
sleep	0
but	I-DISEASE
repetitive	I-DISEASE
episodes	I-DISEASE
of	I-DISEASE
central	0
events	I-DISEASE
during	I-DISEASE
stages	0
N1	0
and	0
N2	B-DISEASE
.	0

In	I-DISEASE
some	I-DISEASE
patients	0
,	I-DISEASE
progressive	0
increases	0
in	0
pressure	0
with	0
a	0
goal	0
of	I-DISEASE
preventing	I-DISEASE
airflow	0
limitation	I-DISEASE
reach	0
a	I-DISEASE
“	0
break	0
point	0
”	I-DISEASE
at	I-DISEASE
which	0
central	0
apneas	I-DISEASE
appear	0
.	0

Differential	I-DISEASE
Diagnosis	0
Many	0
patients	0
with	I-DISEASE
OSA	0
have	0
a	0
few	0
central	0
events	0
while	0
on	0
PAP	I-DISEASE
.	0

However	I-DISEASE
,	I-DISEASE
in	0
the	0
majority	0
of	I-DISEASE
cases	0
,	I-DISEASE
the	0
central	0
AHI	0
is	I-DISEASE
not	0
≥	0
5	0
/	I-DISEASE
hour	0
and	0
central	0
events	0
are	0
not	0
≥	0
50	0
%	0
of	I-DISEASE
the	0
total	I-DISEASE
number	0
of	I-DISEASE
apneas	0
and	0
hypopneas	0
.	0

Other	I-DISEASE
patients	0
with	0
OSA	I-DISEASE
,	I-DISEASE
while	0
on	0
PAP	0
,	0
exhibit	0
predominantly	I-DISEASE
central	0
events	0
that	0
are	I-DISEASE
believed	I-DISEASE
to	0
be	0
secondary	0
to	0
a	0
CSA	0
disor-	I-DISEASE
der	0
classified	0
elsewhere	I-DISEASE
.	0

In	I-DISEASE
this	I-DISEASE
case	I-DISEASE
,	I-DISEASE
a	0
diagnosis	I-DISEASE
of	I-DISEASE
both	I-DISEASE
OSA	0
and	0
the	0
CSA	I-DISEASE
disorder	0
is	I-DISEASE
appropriate	I-DISEASE
,	I-DISEASE
rather	0
than	0
a	I-DISEASE
diagnosis	I-DISEASE
of	I-DISEASE
treatment	I-DISEASE
-	0
emergent	I-DISEASE
CSA	I-DISEASE
.	0

For	I-DISEASE
example	0
,	0
a	I-DISEASE
patient	0
taking	0
methadone	0
has	0
predominantly	I-DISEASE
obstructive	0
events	0
during	I-DISEASE
the	I-DISEASE
diagnostic	0
portion	0
of	I-DISEASE
a	0
split	I-DISEASE
-	0
night	0
PSG	0
.	I-DISEASE

Once	I-DISEASE
obstructive	0
events	0
are	0
eliminated	I-DISEASE
on	0
PAP	0
,	I-DISEASE
CSA	I-DISEASE
with	0
ataxic	I-DISEASE
breathing	0
is	0
noted	0
.	0

A	I-DISEASE
diagnosis	I-DISEASE
of	I-DISEASE
both	I-DISEASE
OSA	0
and	0
CSA	I-DISEASE
due	0
to	0
a	0
medication	I-DISEASE
or	I-DISEASE
substance	I-DISEASE
should	0
be	I-DISEASE
made	0
if	0
criteria	0
for	I-DISEASE
that	0
disorder	I-DISEASE
are	0
met	0
.	0

Sleep	I-DISEASE
Related	I-DISEASE
Breathing	0
Disorders	I-DISEASE
Sleep	0
Related	0
Breathing	0
Disorders	I-DISEASE
Unresolved	I-DISEASE
Issues	0
and	0
Further	I-DISEASE
Directions	0

The	I-DISEASE
true	0
incidence	0
of	I-DISEASE
treatment	0
-	0
emergent	I-DISEASE
sleep	0
apnea	0
as	I-DISEASE
well	I-DISEASE
as	0
the	0
percentage	0
of	I-DISEASE
patients	0
who	0
have	0
persistent	0
central	0
apnea	0
on	0
chronic	I-DISEASE
PAP	0
treatment	I-DISEASE
remains	B-DISEASE
to	0
be	0
defined	I-DISEASE
.	0

Further	I-DISEASE
prospective	0
studies	I-DISEASE
with	I-DISEASE
clearly	0
defined	I-DISEASE
inclusion	I-DISEASE
and	0
exclusion	0
crite-	0
ria	I-DISEASE
are	0
needed	0
to	I-DISEASE
better	I-DISEASE
define	0
the	0
exact	0
percentage	0
of	I-DISEASE
patients	0
with	I-DISEASE
treatment	I-DISEASE
-	0
emergent	I-DISEASE
CSA	I-DISEASE
who	I-DISEASE
have	0
persistent	0
CSA	I-DISEASE
after	0
chronic	0
PAP	I-DISEASE
treatment	0
.	0

There	I-DISEASE
may	0
be	0
night	0
-	0
to-	I-DISEASE
night	I-DISEASE
variability	I-DISEASE
in	0
the	0
amount	I-DISEASE
of	I-DISEASE
CSA	0
displayed	I-DISEASE
by	I-DISEASE
a	0
given	0
patient	I-DISEASE
.	0

It	I-DISEASE
is	0
unknown	0
,	I-DISEASE
for	0
example	0
,	0
whether	I-DISEASE
treatment	0
-	0
emergent	0
central	I-DISEASE
apneas	0
that	0
resolve	0
on	0
chronic	0
PAP	0
treatment	0
will	0
re	I-DISEASE
-	0
emerge	I-DISEASE
if	0
the	0
patient	I-DISEASE
discontinues	B-DISEASE
PAP	I-DISEASE
treatment	0
for	0
a	0
period	0
of	0
time	0
and	0
then	0
restarts	0
treatment	I-DISEASE
.	0

A	I-DISEASE
number	0
of	I-DISEASE
factors	0
have	0
been	I-DISEASE
hypothesized	I-DISEASE
to	I-DISEASE
increase	I-DISEASE
the	0
likelihood	0
of	I-DISEASE
treatment	I-DISEASE
-	I-DISEASE
emergent	0
central	0
apneas	0
including	0
overtitration	0
(	I-DISEASE
excessive	0
pressure	0
)	0
,	0
undertitration	0
(	0
respiratory	I-DISEASE
effort	0
arousals	0
followed	0
by	0
central	0
apnea	0
)	0
,	0
the	0
use	0
of	0
bilevel	0
PAP	I-DISEASE
rather	0
than	0
CPAP	0
,	I-DISEASE
arousals	I-DISEASE
from	0
mask	0
leak	0
,	I-DISEASE
and	0
use	0
of	I-DISEASE
a	0
split	I-DISEASE
night	0
study	0
.	0

Further	I-DISEASE
study	0
is	0
needed	0
to	0
verify	0
that	0
these	I-DISEASE
factors	0
do	0
indeed	0
predispose	0
a	0
patient	I-DISEASE
to	I-DISEASE
develop	I-DISEASE
treatment	0
-	0
emergent	I-DISEASE
central	0
apneas	0
.	0

The	I-DISEASE
evolution	0
of	I-DISEASE
treatment	I-DISEASE
-	0
emergent	I-DISEASE
central	0
apneas	0
on	0
chronic	I-DISEASE
PAP	0
treatment	I-DISEASE
also	0
remains	0
to	0
be	I-DISEASE
determined	I-DISEASE
;	0
that	0
is	0
,	I-DISEASE
to	0
what	0
extent	0
do	I-DISEASE
central	0
events	0
resolve	0
over	0
time	0
and	0
what	0
is	0
the	0
time	0
course	0
of	I-DISEASE
this	0
resolu-	0
tion	0
?	0

In	I-DISEASE
light	0
of	I-DISEASE
the	0
increasing	0
utilization	I-DISEASE
of	I-DISEASE
auto	0
-	0
titrating	0
PAP	0
,	I-DISEASE
further	I-DISEASE
investigation	0
of	0
the	0
incidence	0
of	I-DISEASE
treatment	I-DISEASE
-	0
emergent	I-DISEASE
CSA	I-DISEASE
with	I-DISEASE
this	0
modality	B-DISEASE
is	I-DISEASE
indicated	0
.	0

Bibliography	0
Allam	0
JS	0
,	I-DISEASE
Olson	0
EJ	0
,	I-DISEASE
Gay	I-DISEASE
PC	0
,	0
Morgenthaler	0
TI	0
.	0

Efficacy	I-DISEASE
of	0
adaptive	I-DISEASE
servoventilation	I-DISEASE
in	I-DISEASE
treatment	I-DISEASE
of	I-DISEASE
complex	0
and	0
central	0
sleep	I-DISEASE
apnea	0
syndromes	0
.	0

Chest	I-DISEASE
2007;132:1839–46	I-DISEASE
.	0

Dernaika	I-DISEASE
T	0
,	0
Tawk	I-DISEASE
M	I-DISEASE
,	0
Nazir	0
S	I-DISEASE
,	I-DISEASE
Younis	I-DISEASE
W	I-DISEASE
,	I-DISEASE
Kinasewitz	0
GT	I-DISEASE
.	0

The	I-DISEASE
significance	I-DISEASE
and	0
outcome	0
of	0
continuous	0
positive	0
airway	I-DISEASE
pressure	0
-	0
related	0
central	I-DISEASE
sleep	0
apnea	0
during	I-DISEASE
split	0
-	0
night	0
sleep	0
studies	I-DISEASE
.	0

Chest	I-DISEASE
2007;132:81–7	B-DISEASE
.	0

Gay	I-DISEASE
PC	I-DISEASE
.	0

Complex	I-DISEASE
sleep	0
apnea	0
:	I-DISEASE
it	0
really	I-DISEASE
is	0
a	0
disease	0
.	0

J	I-DISEASE
Clin	0
Sleep	0
Med	0
2008;4:403–5	I-DISEASE
.	0

Gilmartin	I-DISEASE
GS	I-DISEASE
,	I-DISEASE
Daly	0
RW	I-DISEASE
,	0
Thomas	I-DISEASE
RJ	I-DISEASE
.	0

Recognition	I-DISEASE
and	0
management	0
of	0
complex	0
sleep	0
-	0
disordered	0
breathing	B-DISEASE
.	0

Curr	I-DISEASE
Opin	0
Pulm	0
Med	0
2005;11:485–93	0
.	0

Javaheri	I-DISEASE
S	I-DISEASE
,	0
Smith	0
J	0
,	I-DISEASE
Chung	0
E.	0

The	I-DISEASE
prevalence	0
and	0
natural	I-DISEASE
history	I-DISEASE
of	I-DISEASE
complex	0
sleep	0
apnea	0
.	0

J	I-DISEASE
Clin	0
Sleep	0
Med	0
2009;5:205–11	I-DISEASE
.	0

Lehman	I-DISEASE
S	I-DISEASE
,	I-DISEASE
Antic	0
NA	0
,	0
Thompson	0
C	I-DISEASE
,	I-DISEASE
Catcheside	I-DISEASE
PG	0
,	I-DISEASE
Mercer	0
J	0
,	I-DISEASE
McEvoy	I-DISEASE
RD	I-DISEASE
.	I-DISEASE

Central	I-DISEASE
sleep	0
apnea	0
on	0
commencement	I-DISEASE
of	I-DISEASE
continuous	0
positive	0
airway	0
pressure	I-DISEASE
in	I-DISEASE
patients	0
with	0
a	0
primary	I-DISEASE
diagnosis	0
of	0
obstructive	0
sleep	0
apnea	I-DISEASE
-	0
hypopnea	I-DISEASE
.	0

J	I-DISEASE
Clin	0
Sleep	0
Med	0
2007;3:462–6	I-DISEASE
.	0

Malhotra	I-DISEASE
A	0
,	0
Bertisch	I-DISEASE
S	I-DISEASE
,	0
Wellman	0
A.	0
Complex	I-DISEASE
sleep	0
apnea	0
:	0
it	0
is	I-DISEASE
n’t	0
really	I-DISEASE
a	I-DISEASE
disease	0
.	0

J	I-DISEASE
Clin	0
Sleep	0
Med	0
2008;4:406–8	I-DISEASE
.	0

Morgenthaler	I-DISEASE
TI	0
,	I-DISEASE
Kagramanov	0
V	I-DISEASE
,	I-DISEASE
Hanak	0
V	I-DISEASE
,	I-DISEASE
et	0
al	0
.	0

Complex	I-DISEASE
sleep	0
apnea	0
syndrome	I-DISEASE
:	0
is	I-DISEASE
it	0
a	0
unique	0
clinical	0
syndrome	I-DISEASE
?	0

Sleep	I-DISEASE
2006;29:1203–9	0
.	0

Thomas	I-DISEASE
RJ	I-DISEASE
,	I-DISEASE
Daly	0
RW	I-DISEASE
,	I-DISEASE
Weiss	0
JW	0
.	0

Low	I-DISEASE
-	I-DISEASE
concentration	0
carbon	0
dioxide	0
is	0
an	0
effective	I-DISEASE
adjunct	0
to	0
positive	0
airway	I-DISEASE
pressure	0
in	I-DISEASE
the	0
treatment	I-DISEASE
of	0
refractory	0
mixed	0
central	0
and	0
obstructive	0
sleep	0
-	I-DISEASE
disordered	0
breathing	I-DISEASE
.	0

Sleep	I-DISEASE
2005;28:69–77	I-DISEASE
.	0

Thomas	I-DISEASE
RJ	I-DISEASE
,	I-DISEASE
Mietus	0
JE	0
,	0
Peng	0
CK	I-DISEASE
,	I-DISEASE
et	0
al	I-DISEASE
.	0

Differentiating	I-DISEASE
obstructive	0
from	0
central	0
and	0
complex	0
sleep	0
apnea	0
using	0
an	0
automated	0
electrocardiogram	I-DISEASE
-	0
based	I-DISEASE
method	0
.	0

Sleep	I-DISEASE
2007;30:1756–69	I-DISEASE
.	0

Thomas	I-DISEASE
RJ	I-DISEASE
,	I-DISEASE
Terzano	0
MG	I-DISEASE
,	0
Parrino	0
L	I-DISEASE
,	I-DISEASE
Weiss	0
JW	0
.	I-DISEASE

Obstructive	I-DISEASE
sleep	0
-	I-DISEASE
disordered	I-DISEASE
breathing	B-DISEASE
with	0
a	0
dominant	I-DISEASE
cyclic	I-DISEASE
alternating	0
pattern	0
--	I-DISEASE
a	0
recognizable	0
polysomnographic	0
variant	0
with	I-DISEASE
practical	0
clinical	I-DISEASE
implications	I-DISEASE
.	B-DISEASE

Sleep	I-DISEASE
2004;27:229–34	0
.	0

Westhoff	I-DISEASE
M	I-DISEASE
,	I-DISEASE
Arzt	0
M	I-DISEASE
,	0
Litterst	0
P.	I-DISEASE
Prevalence	0
and	0
treatment	I-DISEASE
of	0
central	0
sleep	0
apnoea	0
emerging	I-DISEASE
after	0
initiation	I-DISEASE
of	I-DISEASE
continuous	I-DISEASE
positive	0
airway	0
pressure	0
in	I-DISEASE
patients	I-DISEASE
with	I-DISEASE
obstructive	0
sleep	0
apnoea	0
without	0
evidence	0
of	I-DISEASE
heart	0
failure	0
.	0

Sleep	I-DISEASE
Breath	0
2012;16:71–8	I-DISEASE
.	0

Sleep	I-DISEASE
Related	I-DISEASE
Breathing	0
Disorders	I-DISEASE
Sleep	0
Related	0
Breathing	0
Disorders	I-DISEASE
Sleep	0
Related	0
Hypoventilation	I-DISEASE
Disorders	0
The	I-DISEASE
primary	0
feature	B-DISEASE
of	I-DISEASE
these	I-DISEASE
disorders	0
is	0
insufficient	0
sleep	0
related	B-DISEASE
ventilation	0
,	0
result-	0
ing	0
in	I-DISEASE
abnormally	I-DISEASE
elevated	I-DISEASE
arterial	I-DISEASE
partial	I-DISEASE
pressure	0
of	0
carbon	0
dioxide	I-DISEASE
(	I-DISEASE
PaCO2	I-DISEASE
)	0
during	I-DISEASE
sleep	0
.	I-DISEASE

In	I-DISEASE
addition	0
,	0
demonstration	I-DISEASE
of	0
daytime	I-DISEASE
hypoventilation	I-DISEASE
is	I-DISEASE
required	I-DISEASE
for	I-DISEASE
a	0
diagno-	I-DISEASE
sis	0
of	I-DISEASE
obesity	0
hypoventilation	0
syndrome	I-DISEASE
(	I-DISEASE
OHS	0
)	0
.	0

Awake	I-DISEASE
hypoventilation	I-DISEASE
is	0
defined	0
as	0
an	0
arterial	I-DISEASE
partial	I-DISEASE
pressure	0
of	I-DISEASE
carbon	I-DISEASE
dioxide	0
(	0
PaCO2	0
)	0
greater	I-DISEASE
than	I-DISEASE
45	0
mm	I-DISEASE
Hg	I-DISEASE
.	0

In	I-DISEASE
the	0
sleep	0
related	B-DISEASE
hypoventilation	0
disorders	0
other	0
than	I-DISEASE
OHS	I-DISEASE
,	0
daytime	I-DISEASE
hypoventilation	I-DISEASE
may	0
or	0
may	I-DISEASE
not	0
be	I-DISEASE
present	0
.	0

If	I-DISEASE
hypoventilation	I-DISEASE
is	I-DISEASE
present	I-DISEASE
during	I-DISEASE
wakefulness	0
,	I-DISEASE
it	I-DISEASE
worsens	I-DISEASE
during	I-DISEASE
sleep	0
in	I-DISEASE
all	0
of	0
these	I-DISEASE
disorders	0
.	0

General	I-DISEASE
Criteria	I-DISEASE
Sleep	0
Related	I-DISEASE
Hypoventilation	I-DISEASE
Criterion	I-DISEASE
A	0
must	I-DISEASE
be	I-DISEASE
met	0
A.	0
Sleep	0
related	I-DISEASE
hypoventilation	I-DISEASE
,	I-DISEASE
as	I-DISEASE
defined	I-DISEASE
by	B-DISEASE
the	0
most	0
recent	I-DISEASE
version	I-DISEASE
of	I-DISEASE
the	0
AASM	I-DISEASE
Manual	I-DISEASE
for	0
the	0
Scoring	0
of	I-DISEASE
Sleep	I-DISEASE
and	0
Associated	I-DISEASE
Events	I-DISEASE
,	0
is	0
present.1,2	0
Notes	0
.	0

Monitoring	I-DISEASE
of	I-DISEASE
arterial	0
PCO2	0
during	I-DISEASE
sleep	0
is	0
not	0
practical	I-DISEASE
.	0

Acceptable	I-DISEASE
surrogates	0
include	I-DISEASE
end	0
-	0
tidal	0
PCO2	I-DISEASE
or	0
transcutaneous	0
PCO2	0
.	0
.	0

Arterial	I-DISEASE
oxygen	0
desaturation	I-DISEASE
is	0
often	0
present	0
but	0
is	0
not	0
required	I-DISEASE
for	I-DISEASE
the	0
diagnosis	I-DISEASE
.	0

Obesity	I-DISEASE
Hypoventilation	I-DISEASE
Syndrome	I-DISEASE
ICD-9	0
-	0
CM	I-DISEASE
code	0
:	0
278.03	0
ICD-10	0
-	0
CM	I-DISEASE
code	0
:	I-DISEASE
E66.2	0
Alternate	0
Names	0
Hypercapnic	I-DISEASE
sleep	0
apnea	0
,	I-DISEASE
sleep	0
related	I-DISEASE
hypoventilation	0
associated	0
with	0
obesity	0
.	0

Use	I-DISEASE
of	I-DISEASE
the	0
term	0
Pickwickian	0
syndrome	I-DISEASE
is	0
discouraged	0
because	0
not	0
only	I-DISEASE
has	I-DISEASE
it	0
been	I-DISEASE
applied	0
to	I-DISEASE
those	0
with	0
OSA	I-DISEASE
,	0
but	0
also	0
indiscriminately	I-DISEASE
used	0
to	0
describe	0
persons	0
who	I-DISEASE
are	0
only	0
obese	0
and	0
those	0
with	0
OHS	0
.	0

Diagnostic	I-DISEASE
Criteria	0
Criteria	I-DISEASE
A	0
-	I-DISEASE
C	I-DISEASE
must	I-DISEASE
be	0
met	0
A.	0
Presence	0
of	I-DISEASE
hypoventilation	I-DISEASE
during	I-DISEASE
wakefulness	0
(	I-DISEASE
PaCO2	0
>	0
45	I-DISEASE
mm	0
Hg	0
)	0
as	0
measured	0
by	0
arterial	0
PCO2	0
,	I-DISEASE
end	0
-	0
tidal	0
PCO2	0
,	0
or	I-DISEASE
transcutaneous	0
PCO2	0
.	I-DISEASE

B.	0
Presence	0
of	I-DISEASE
obesity	0
(	I-DISEASE
BMI	0
>	0
30	I-DISEASE
kg	I-DISEASE
/	0
m2	I-DISEASE
;	I-DISEASE
>	0
95th	0
percentile	0
for	0
age	I-DISEASE
and	0
sex	0
for	I-DISEASE
children	I-DISEASE
)	0
.	0

C.	I-DISEASE
Hypoventilation	I-DISEASE
is	I-DISEASE
not	0
primarily	0
due	I-DISEASE
to	I-DISEASE
lung	I-DISEASE
parenchymal	0
or	I-DISEASE
airway	0
disease	I-DISEASE
,	0
pulmonary	I-DISEASE
vascular	B-DISEASE
pathology	0
,	0
chest	0
wall	I-DISEASE
disorder	I-DISEASE
(	I-DISEASE
other	I-DISEASE
than	0
mass	0
loading	I-DISEASE
from	I-DISEASE
obesity	0
)	0
,	0
medication	0
use	0
,	0
neurologic	0
disorder	I-DISEASE
,	I-DISEASE
muscle	0
weakness	0
,	0
or	0
a	0
known	0
congenital	0
or	0
idiopathic	I-DISEASE
central	I-DISEASE
alveolar	I-DISEASE
hypoventilation	0
syndrome	I-DISEASE
.	0

Notes	I-DISEASE
.	0

PSG	I-DISEASE
shows	I-DISEASE
worsening	I-DISEASE
of	I-DISEASE
hypoventilation	I-DISEASE
during	I-DISEASE
sleep	I-DISEASE
if	I-DISEASE
PaCO2	0
or	I-DISEASE
noninvasive	0
estimate	0
of	I-DISEASE
the	B-DISEASE
PaCO2	0
is	I-DISEASE
measured	0
.	0
.	0

OSA	I-DISEASE
is	0
often	I-DISEASE
present	0
and	0
,	I-DISEASE
in	I-DISEASE
such	0
cases	0
,	0
a	0
diagnosis	I-DISEASE
of	I-DISEASE
both	I-DISEASE
OSA	I-DISEASE
and	0
OHS	0
should	I-DISEASE
be	0
made	0
.	0
.	0

Arterial	I-DISEASE
oxygen	0
desaturation	I-DISEASE
is	0
usually	I-DISEASE
present	0
but	0
is	0
not	0
required	I-DISEASE
for	I-DISEASE
the	0
diagnosis	0
.	0

Essential	I-DISEASE
Features	I-DISEASE
OHS	0
is	0
characterized	0
by	I-DISEASE
obesity	0
and	0
daytime	I-DISEASE
hypercapnia	I-DISEASE
(	I-DISEASE
arterial	I-DISEASE
PaCO2	0
>	0
45	I-DISEASE
mm	0
Hg	I-DISEASE
)	0
that	I-DISEASE
can	0
not	0
be	0
fully	I-DISEASE
attributed	0
to	I-DISEASE
an	0
underlying	0
cardiopulmonary	0
or	0
neurologic	0
disease	I-DISEASE
.	0

Hypercapnia	I-DISEASE
worsens	0
during	I-DISEASE
sleep	0
and	0
is	0
often	0
associated	0
with	I-DISEASE
severe	I-DISEASE
arterial	0
oxygen	I-DISEASE
desaturation	I-DISEASE
.	0

Hypoventilation	I-DISEASE
is	I-DISEASE
often	I-DISEASE
worse	I-DISEASE
during	I-DISEASE
REM	0
than	I-DISEASE
during	I-DISEASE
NREM	0
sleep	0
.	I-DISEASE

The	I-DISEASE
majority	0
of	I-DISEASE
OHS	0
patients	I-DISEASE
have	0
comorbid	I-DISEASE
OSA	I-DISEASE
(	I-DISEASE
80	0
%	0
to	I-DISEASE
90	I-DISEASE
%	0
)	0
.	0

In	I-DISEASE
these	I-DISEASE
patients	0
,	I-DISEASE
daytime	0
hypercapnia	I-DISEASE
may	0
improve	0
or	I-DISEASE
even	I-DISEASE
normalize	0
with	0
adequate	0
PAP	I-DISEASE
treatment	0
and	0
sustained	0
adherence	I-DISEASE
to	0
treatment	I-DISEASE
.	0

Those	I-DISEASE
OHS	0
patients	I-DISEASE
without	0
OSA	I-DISEASE
exhibit	0
sustained	0
or	0
intermittent	0
episodes	I-DISEASE
of	I-DISEASE
shallow	I-DISEASE
breathing	0
during	I-DISEASE
sleep	0
associated	0
with	0
worsening	0
hypoventilation	I-DISEASE
and	0
hypoxemia	I-DISEASE
.	B-DISEASE

Patients	I-DISEASE
with	0
OHS	0
may	I-DISEASE
have	0
few	0
,	0
if	0
any	I-DISEASE
,	I-DISEASE
sleep	I-DISEASE
com-	I-DISEASE
plaints	I-DISEASE
,	I-DISEASE
or	0
may	0
present	I-DISEASE
with	0
considerable	0
sleep	0
disturbance	I-DISEASE
including	0
reduced	0
sleep	0
efficiency	I-DISEASE
and	0
frequent	0
awakenings	0
.	0

Hypercapnia	I-DISEASE
and	0
hypoxemia	0
may	0
remain	0
unno-	0
ticed	0
for	I-DISEASE
quite	0
some	0
time	0
until	0
sudden	0
deterioration	0
with	I-DISEASE
cardiopulmonary	I-DISEASE
arrest	0
or	0
severe	0
decompensation	0
(	I-DISEASE
acute	0
or	0
chronic	I-DISEASE
hypercapnic	I-DISEASE
respiratory	0
failure	0
)	0
develops	0
.	0

Associated	I-DISEASE
Features	I-DISEASE
Patients	0
with	0
OHS	0
commonly	I-DISEASE
complain	0
of	I-DISEASE
hypersomnolence	0
.	0

The	I-DISEASE
severity	I-DISEASE
of	I-DISEASE
hyper-	I-DISEASE
somnolence	0
may	I-DISEASE
not	I-DISEASE
correlate	I-DISEASE
closely	I-DISEASE
with	I-DISEASE
degree	0
of	0
hypercapnia	I-DISEASE
.	0

Other	0
symptoms	I-DISEASE
include	0
morning	0
headaches	0
,	0
fatigue	I-DISEASE
,	0
mood	0
disturbance	0
and	0
impairments	I-DISEASE
of	I-DISEASE
memory	0
or	I-DISEASE
concentration	0
.	0

Physical	I-DISEASE
examination	0
may	0
reveal	0
features	0
suggestive	I-DISEASE
of	I-DISEASE
cor	0
pul-	0
monale	I-DISEASE
or	0
circulatory	I-DISEASE
congestion	I-DISEASE
,	0
such	0
as	0
plethora	0
,	I-DISEASE
scleral	0
injection	0
,	0
and	0
peripheral	I-DISEASE
edema	0
.	0

Laboratory	I-DISEASE
testing	0
commonly	0
shows	I-DISEASE
polycythemia	0
and	0
elevated	I-DISEASE
serum	I-DISEASE
CO2	I-DISEASE
on	0
electrolyte	I-DISEASE
testing	0
(	0
≈	I-DISEASE
serum	0
bicarbonate	0
)	0
,	I-DISEASE
reduced	0
forced	I-DISEASE
vital	I-DISEASE
capacity	B-DISEASE
during	I-DISEASE
pulmo-	0
nary	0
function	0
testing	0
,	0
right	0
heart	0
strain	0
,	0
right	0
ventricular	0
hypertrophy	0
and	0
right	0
atrial	I-DISEASE
enlargement	0
on	0
electrocardiography	I-DISEASE
and	0
ventricular	0
dysfunction	0
on	0
echocardiography	0
.	0

Sleep	I-DISEASE
Related	I-DISEASE
Breathing	0
Disorders	I-DISEASE
Sleep	0
Related	0
Breathing	0
Disorders	I-DISEASE
Consequences	0
of	I-DISEASE
chronic	I-DISEASE
hypercapnia	0
and	0
hypoxemia	I-DISEASE
include	I-DISEASE
pulmonary	I-DISEASE
artery	0
hyper-	I-DISEASE
tension	0
,	0
cor	0
pulmonale	0
,	I-DISEASE
and	0
neurocognitive	0
dysfunction	0
.	0

Clinical	I-DISEASE
and	0
Pathophysiological	0
Subtypes	I-DISEASE
Not	I-DISEASE
applicable	0
or	I-DISEASE
known	I-DISEASE
.	0

Demographics	I-DISEASE
OHS	0
may	I-DISEASE
be	I-DISEASE
underdiagnosed	0
if	I-DISEASE
CO2	I-DISEASE
analysis	I-DISEASE
(	I-DISEASE
≈	I-DISEASE
serum	0
bicarbonate	0
)	0
is	0
not	0
performed	0
in	I-DISEASE
obese	0
patients	I-DISEASE
presenting	0
with	I-DISEASE
complaints	0
suggestive	I-DISEASE
of	0
OHS	0
.	0

The	I-DISEASE
prevalence	0
of	I-DISEASE
OHS	0
in	I-DISEASE
populations	I-DISEASE
of	I-DISEASE
patients	0
with	0
OSA	I-DISEASE
varies	I-DISEASE
across	I-DISEASE
studies	I-DISEASE
but	I-DISEASE
is	I-DISEASE
often	I-DISEASE
in	0
the	0
range	I-DISEASE
of	I-DISEASE
10	0
%	0
to	I-DISEASE
15	I-DISEASE
%	0
of	I-DISEASE
obese	0
patients	I-DISEASE
with	I-DISEASE
OSA	0
.	0

Although	I-DISEASE
the	0
prevalence	0
of	I-DISEASE
OHS	0
is	I-DISEASE
higher	0
in	0
men	0
than	0
women	I-DISEASE
the	I-DISEASE
difference	I-DISEASE
is	0
not	0
as	0
prominent	I-DISEASE
as	0
in	0
OSA	I-DISEASE
.	0

Predisposing	I-DISEASE
and	0
Precipitating	I-DISEASE
Factors	0
Obesity	I-DISEASE
is	I-DISEASE
believed	0
to	0
be	I-DISEASE
the	0
primary	0
pathophysiologic	0
factor	I-DISEASE
responsible	0
for	I-DISEASE
hypoven-	0
tilation	0
and	0
hypoxemia	0
.	0

Greater	I-DISEASE
degrees	0
of	I-DISEASE
obesity	0
are	I-DISEASE
often	0
associated	0
with	I-DISEASE
worse	0
sleep	0
related	I-DISEASE
hypoventilation	I-DISEASE
,	I-DISEASE
but	0
individual	0
variations	I-DISEASE
in	I-DISEASE
the	0
severity	0
of	I-DISEASE
hypercap-	I-DISEASE
nia	I-DISEASE
at	I-DISEASE
similar	0
weights	0
may	I-DISEASE
be	0
seen	I-DISEASE
.	0

The	I-DISEASE
use	0
of	I-DISEASE
central	0
nervous	0
system	I-DISEASE
depressants	0
,	0
such	0
as	0
alcohol	I-DISEASE
,	I-DISEASE
anxiolytics	0
,	0
and	0
hypnotics	0
,	I-DISEASE
may	0
further	I-DISEASE
worsen	0
respiratory	I-DISEASE
impair-	0
ment	0
.	0

Patients	I-DISEASE
who	0
are	I-DISEASE
hypercapnic	0
and	0
hypoxemic	0
during	I-DISEASE
wakefulness	0
will	0
invari-	0
ably	0
become	I-DISEASE
even	I-DISEASE
more	0
so	0
during	I-DISEASE
sleep	0
,	I-DISEASE
in	I-DISEASE
particular	I-DISEASE
REM	0
sleep	0
,	0
but	0
the	0
relationship	0
between	0
wake	0
SaO2	0
/	0
PaCO2	I-DISEASE
and	0
sleep	0
related	0
desaturation	0
is	0
not	0
sufficiently	I-DISEASE
strong	0
to	I-DISEASE
have	0
substantial	0
predictive	I-DISEASE
value	0
in	I-DISEASE
individual	0
patients	0
.	0

Familial	I-DISEASE
Patterns	I-DISEASE
Not	I-DISEASE
applicable	0
or	B-DISEASE
known	0
.	0

Onset	I-DISEASE
,	0
Course	0
,	0
and	0
Complications	0
Persons	0
who	I-DISEASE
are	I-DISEASE
eventually	0
diagnosed	0
with	0
OHS	0
either	0
present	0
initially	I-DISEASE
for	0
evalu-	0
ation	0
of	I-DISEASE
suspected	I-DISEASE
OSA	0
or	0
are	0
identified	0
following	0
one	0
or	0
more	0
episodes	I-DISEASE
of	0
severe	0
hypercapnic	0
respiratory	I-DISEASE
failure	I-DISEASE
.	0

The	I-DISEASE
course	I-DISEASE
can	0
be	I-DISEASE
variable	0
but	I-DISEASE
is	0
generally	I-DISEASE
slowly	I-DISEASE
pro-	0
gressive	0
.	0

Many	0
affected	I-DISEASE
individuals	I-DISEASE
with	I-DISEASE
severe	0
hypercapnia	0
and	0
hypoxemia	0
develop	0
pulmonary	0
hypertension	I-DISEASE
,	0
heart	0
failure	0
,	0
cardiac	0
arrhythmias	I-DISEASE
,	I-DISEASE
and	0
neurocognitive	0
dys-	0
function	0
.	0

Polycythemia	I-DISEASE
is	0
common	I-DISEASE
in	I-DISEASE
those	0
with	0
chronic	0
hypoxia	I-DISEASE
.	0

Although	I-DISEASE
the	0
risk	0
of	I-DISEASE
increased	0
morbidity	I-DISEASE
and	0
mortality	I-DISEASE
appears	I-DISEASE
to	I-DISEASE
increase	I-DISEASE
with	0
worsening	0
sleep	0
related	0
hypoventilation	0
/	0
hypoxemia	I-DISEASE
,	I-DISEASE
the	0
specific	I-DISEASE
relationship	0
between	0
sleep	0
related	B-DISEASE
hypoventi-	I-DISEASE
lation	0
/	0
hypoxemia	0
and	0
morbidity	0
and	0
mortality	I-DISEASE
is	0
not	0
well	I-DISEASE
defined	I-DISEASE
.	0

Obesity	I-DISEASE
,	0
itself	0
,	0
can	0
lead	0
to	I-DISEASE
other	0
respiratory	0
complaints	0
,	I-DISEASE
including	I-DISEASE
shortness	I-DISEASE
of	I-DISEASE
breath	I-DISEASE
,	I-DISEASE
dyspnea	0
on	0
exer-	0
tion	0
and	0
orthopnea	I-DISEASE
,	0
even	I-DISEASE
in	I-DISEASE
the	0
absence	0
of	I-DISEASE
demonstrable	I-DISEASE
elevation	0
of	0
daytime	I-DISEASE
PaCO2	0
.	0

However	I-DISEASE
,	I-DISEASE
in	I-DISEASE
one	I-DISEASE
study	0
of	I-DISEASE
inpatients	I-DISEASE
with	0
obesity	0
,	I-DISEASE
those	I-DISEASE
with	0
hypoventilation	I-DISEASE
had	I-DISEASE
an	0
18	I-DISEASE
-	0
month	0
mortality	I-DISEASE
of	0
23	I-DISEASE
%	0
compared	I-DISEASE
with	I-DISEASE
9	I-DISEASE
%	0
in	I-DISEASE
the	0
group	I-DISEASE
with	I-DISEASE
equivalent	I-DISEASE
obesity	0
but	0
no	0
hypoventilation	0
.	0

Many	0
patients	0
with	0
OHS	0
respond	I-DISEASE
to	I-DISEASE
CPAP	I-DISEASE
or	0
bilevel	0
PAP	I-DISEASE
with	0
improvement	0
in	I-DISEASE
daytime	0
PaCO2	0
.	0

However	I-DISEASE
,	I-DISEASE
normalization	0
of	0
daytime	I-DISEASE
PaCO2	0
occurs	0
in	I-DISEASE
only	I-DISEASE
a	I-DISEASE
minority	0
of	I-DISEASE
patients	I-DISEASE
.	0

In	I-DISEASE
one	0
study	0
,	I-DISEASE
34	0
%	0
of	I-DISEASE
OHS	0
patients	0
using	I-DISEASE
PAP	I-DISEASE
more	0
than	0
4.5	0
hours	I-DISEASE
per	0
night	I-DISEASE
had	0
normalization	0
of	I-DISEASE
the	I-DISEASE
PaCO2	0
.	0

In	I-DISEASE
contrast	I-DISEASE
hypercapnia	0
may	0
worsen	I-DISEASE
with	0
oxygen	I-DISEASE
therapy	0
alone	I-DISEASE
for	I-DISEASE
the	0
associated	0
hypoxia	I-DISEASE
.	0

Developmental	I-DISEASE
Issues	0
Not	I-DISEASE
known	0
.	0

Pathology	I-DISEASE
and	0
Pathophysiology	I-DISEASE
The	I-DISEASE
etiology	0
of	I-DISEASE
hypoventilation	I-DISEASE
is	I-DISEASE
not	0
completely	0
understood	0
.	0

Although	I-DISEASE
comorbid	I-DISEASE
OSA	0
is	I-DISEASE
common	I-DISEASE
,	0
hypercapnia	0
and	0
hypoxemia	0
are	0
not	0
entirely	0
a	0
function	0
of	I-DISEASE
upper	0
airway	I-DISEASE
obstruction	0
.	0

The	I-DISEASE
importance	0
of	I-DISEASE
various	0
factors	0
leading	0
to	I-DISEASE
hypoventilation	I-DISEASE
likely	I-DISEASE
varies	I-DISEASE
among	0
patients	I-DISEASE
.	0

It	I-DISEASE
has	0
been	I-DISEASE
postulated	0
that	0
sustained	0
nocturnal	0
hypercapnia	0
results	I-DISEASE
from	0
the	0
development	B-DISEASE
of	I-DISEASE
short	0
(	0
due	I-DISEASE
to	0
apnea	0
-	I-DISEASE
hypopnea	0
)	0
or	B-DISEASE
longer	0
(	I-DISEASE
secondary	0
to	I-DISEASE
hypoven-	I-DISEASE
tilation	0
)	0
periods	I-DISEASE
of	I-DISEASE
hypercapnia	I-DISEASE
accompanied	0
by	B-DISEASE
inadequate	0
compensation	I-DISEASE
(	I-DISEASE
i.e.	I-DISEASE
,	0
CO2	I-DISEASE
unloading	I-DISEASE
)	I-DISEASE
during	I-DISEASE
periods	0
of	I-DISEASE
ventilation	I-DISEASE
between	0
obstructive	0
events	0
.	0

Abnormal	I-DISEASE
venti-	0
latory	0
control	0
(	I-DISEASE
blunted	0
hypercapnic	I-DISEASE
ventilatory	0
response	0
)	0
allows	0
hypercapnia	0
to	I-DISEASE
persist	0
into	I-DISEASE
wakefulness	B-DISEASE
after	0
the	0
cause	0
of	I-DISEASE
acute	0
hypercapnia	0
is	0
no	0
longer	I-DISEASE
present	I-DISEASE
.	0

A	I-DISEASE
chronic	I-DISEASE
hypercapnic	0
state	I-DISEASE
would	I-DISEASE
produce	0
an	0
elevation	0
of	I-DISEASE
bicarbonate	I-DISEASE
.	0

Although	I-DISEASE
this	I-DISEASE
blunts	0
the	0
degree	I-DISEASE
of	I-DISEASE
acidosis	I-DISEASE
due	0
to	0
an	0
elevated	I-DISEASE
PaCO2	I-DISEASE
,	I-DISEASE
it	I-DISEASE
reduces	0
the	0
compensatory	I-DISEASE
CO2	I-DISEASE
ventilatory	0
response	0
.	0

Impaired	I-DISEASE
renal	0
bicarbonate	0
excretion	0
rate	I-DISEASE
,	0
as	0
seen	I-DISEASE
in	I-DISEASE
hypoxia	0
,	0
heart	0
failure	0
,	I-DISEASE
or	0
diuretic	I-DISEASE
-	0
related	B-DISEASE
chloride	0
deficiency	0
,	I-DISEASE
may	0
contribute	0
to	0
the	0
persistence	0
of	I-DISEASE
hypercapnia	0
.	0

Obesity	I-DISEASE
itself	0
is	I-DISEASE
also	0
associated	0
with	I-DISEASE
several	I-DISEASE
factors	0
that	0
predispose	0
to	I-DISEASE
CO2	0
retention	0
.	I-DISEASE

Obesity	I-DISEASE
itself	0
increases	0
CO2	0
production	I-DISEASE
.	0

There	I-DISEASE
is	I-DISEASE
an	0
increased	0
work	I-DISEASE
of	I-DISEASE
breathing	I-DISEASE
due	I-DISEASE
to	0
mass	0
loading	I-DISEASE
from	I-DISEASE
the	I-DISEASE
additional	0
weight	0
on	0
the	0
respiratory	I-DISEASE
pump	0
as	0
well	I-DISEASE
as	0
resistive	I-DISEASE
loading	I-DISEASE
due	I-DISEASE
to	0
intermittent	I-DISEASE
upper	0
airway	I-DISEASE
obstruction	0
during	I-DISEASE
sleep	0
.	0

Numerous	I-DISEASE
factors	I-DISEASE
impair	0
CO2	0
elimination	0
including	0
altered	0
lung	0
volumes	0
and	0
mechan-	I-DISEASE
ics	I-DISEASE
,	I-DISEASE
ventilation	0
-	0
perfusion	0
abnormalities	I-DISEASE
secondary	0
to	I-DISEASE
atelectasis	0
or	I-DISEASE
pulmonary	I-DISEASE
conges-	I-DISEASE
tion	0
,	0
reduced	0
chemosensitivity	I-DISEASE
and	0
load	0
responsiveness	I-DISEASE
,	0
and	0
suppression	0
of	I-DISEASE
respiratory	0
drive	0
due	0
to	0
obesity	0
-	0
related	0
humoral	I-DISEASE
factors	0
,	0
such	0
as	0
resistance	I-DISEASE
to	I-DISEASE
the	B-DISEASE
elevated	I-DISEASE
leptin	I-DISEASE
levels	0
that	0
occur	0
in	I-DISEASE
patients	0
with	I-DISEASE
the	0
OHS	0
(	0
leptin	I-DISEASE
is	I-DISEASE
a	0
respiratory	0
stimulant	0
)	0
.	0

The	I-DISEASE
impor-	0
tance	0
of	I-DISEASE
these	I-DISEASE
factors	0
likely	0
varies	0
from	I-DISEASE
patient	I-DISEASE
to	I-DISEASE
patient	0
.	0

Objective	I-DISEASE
Findings	I-DISEASE
Arterial	I-DISEASE
blood	I-DISEASE
gas	0
testing	0
during	I-DISEASE
wakefulness	0
shows	I-DISEASE
hypercapnia	0
and	0
often	0
hypoxemia	I-DISEASE
in	I-DISEASE
untreated	I-DISEASE
patients	0
.	0

Even	I-DISEASE
with	I-DISEASE
effective	I-DISEASE
treatment	I-DISEASE
most	0
OHS	0
patients	I-DISEASE
continue	0
to	0
Sleep	0
Related	0
Breathing	0
Disorders	I-DISEASE
Sleep	0
Related	0
Breathing	0
Disorders	I-DISEASE
exhibit	0
some	I-DISEASE
degree	I-DISEASE
of	I-DISEASE
daytime	0
hypoventilation	I-DISEASE
.	0

The	I-DISEASE
characteristic	I-DISEASE
polysomnographic	0
finding	0
is	0
sleep	0
related	0
hypoventilation	I-DISEASE
and	0
arterial	0
oxygen	0
desaturation	0
during	I-DISEASE
sleep	0
with	0
or	I-DISEASE
without	0
obstructive	0
apneas	0
and	0
hypopneas	0
.	0

Worsening	I-DISEASE
hypoventilation	I-DISEASE
during	I-DISEASE
sleep	0
can	0
be	I-DISEASE
documented	I-DISEASE
by	I-DISEASE
an	0
arterial	0
blood	I-DISEASE
gas	0
measurement	0
of	I-DISEASE
PaCO2	0
during	I-DISEASE
sleep	I-DISEASE
(	0
rarely	I-DISEASE
performed	0
)	0
or	I-DISEASE
transcutaneous	I-DISEASE
or	I-DISEASE
end	0
-	0
tidal	0
PCO2	0
measurements	0
.	0

Periods	I-DISEASE
of	I-DISEASE
decreased	I-DISEASE
tidal	0
volume	I-DISEASE
lasting	0
up	I-DISEASE
to	0
several	0
minutes	0
with	I-DISEASE
sustained	I-DISEASE
arterial	I-DISEASE
oxygen	I-DISEASE
desaturation	I-DISEASE
are	0
usually	I-DISEASE
present	I-DISEASE
.	0

Intermittent	0
arousals	0
may	0
be	I-DISEASE
observed	0
.	0

OSA	I-DISEASE
is	0
present	I-DISEASE
in	0
the	0
majority	0
of	I-DISEASE
OHS	0
patients	0
,	I-DISEASE
during	I-DISEASE
at	I-DISEASE
least	0
a	0
portion	0
of	I-DISEASE
the	0
night	0
.	0

The	I-DISEASE
transient	0
ven-	I-DISEASE
tilation	I-DISEASE
between	0
obstructive	0
events	0
(	0
even	I-DISEASE
if	0
associated	0
with	0
arousal	0
from	I-DISEASE
the	0
preceding	I-DISEASE
obstructive	0
event	0
)	0
is	I-DISEASE
not	0
sufficient	I-DISEASE
to	0
prevent	I-DISEASE
worsening	I-DISEASE
hypoventilation	I-DISEASE
during	I-DISEASE
sleep	0
.	0

Severe	I-DISEASE
arterial	0
oxygen	0
desaturation	I-DISEASE
is	0
usually	I-DISEASE
associated	0
with	I-DISEASE
the	I-DISEASE
obstructive	0
events	I-DISEASE
.	0

Chronic	I-DISEASE
hypoxia	0
can	0
be	I-DISEASE
associated	0
with	0
polycythemia	0
.	0

Electrocardiography	I-DISEASE
,	I-DISEASE
chest	I-DISEASE
radi-	0
ography	I-DISEASE
,	I-DISEASE
and	0
echocardiography	I-DISEASE
may	0
demonstrate	I-DISEASE
evidence	0
of	I-DISEASE
pulmonary	I-DISEASE
hypertension	I-DISEASE
.	0

The	I-DISEASE
serum	I-DISEASE
bicarbonate	0
level	0
is	I-DISEASE
usually	I-DISEASE
elevated	0
due	I-DISEASE
to	I-DISEASE
renal	I-DISEASE
compensation	I-DISEASE
for	0
chronic	I-DISEASE
respiratory	I-DISEASE
acidosis	0
(	I-DISEASE
hypercapnia	I-DISEASE
)	0
.	0

In	I-DISEASE
one	0
study	0
,	I-DISEASE
a	0
serum	I-DISEASE
bicarbonate	0
level	0
threshold	0
>	I-DISEASE
27	I-DISEASE
mEq	0
/	I-DISEASE
L	0
had	0
a	0
sensitivity	I-DISEASE
of	I-DISEASE
92	0
%	0
and	0
a	0
specificity	I-DISEASE
of	I-DISEASE
50	0
%	0
of	I-DISEASE
identifying	0
OHS	0
in	I-DISEASE
obese	0
patients	0
suspected	0
of	0
having	0
OSA	I-DISEASE
.	I-DISEASE

This	I-DISEASE
suggests	I-DISEASE
that	0
the	0
serum	0
bicarbonate	0
level	0
may	I-DISEASE
be	I-DISEASE
useful	I-DISEASE
to	I-DISEASE
screen	0
patients	I-DISEASE
for	I-DISEASE
possible	I-DISEASE
OHS	0
.	0

However	I-DISEASE
,	I-DISEASE
an	0
arterial	0
blood	I-DISEASE
gas	I-DISEASE
is	I-DISEASE
required	0
for	0
diagnosis	0
of	I-DISEASE
OHS	I-DISEASE
,	0
as	0
the	0
serum	I-DISEASE
bicarbonate	0
level	0
may	I-DISEASE
be	0
elevated	I-DISEASE
due	0
to	I-DISEASE
metabolic	0
alkalosis	I-DISEASE
.	0

Differential	I-DISEASE
Diagnosis	0

The	I-DISEASE
differential	0
diagnosis	0
includes	I-DISEASE
any	I-DISEASE
disorder	I-DISEASE
that	0
can	I-DISEASE
give	I-DISEASE
rise	0
to	I-DISEASE
hypoventilation	I-DISEASE
during	I-DISEASE
wakefulness	I-DISEASE
and	0
sleep	I-DISEASE
.	0

This	I-DISEASE
includes	I-DISEASE
pulmonary	0
airway	0
and	0
parenchymal	0
dis-	0
orders	I-DISEASE
,	0
pulmonary	I-DISEASE
vascular	I-DISEASE
pathology	I-DISEASE
,	0
neuromuscular	0
and	0
chest	0
wall	I-DISEASE
disorders	0
,	I-DISEASE
severe	I-DISEASE
untreated	I-DISEASE
hypothyroidism	0
,	0
use	0
of	I-DISEASE
respiratory	0
suppressants	0
,	0
and	0
congenital	0
or	0
idio-	B-DISEASE
pathic	0
central	0
alveolar	I-DISEASE
hypoventilation	0
syndromes	0
.	0

OSA	I-DISEASE
and	0
CSA	0
syndromes	I-DISEASE
can	I-DISEASE
be	0
distinguished	0
from	I-DISEASE
sleep	0
related	I-DISEASE
hypoventilation	I-DISEASE
by	0
the	0
periodic	I-DISEASE
alterations	0
in	I-DISEASE
airflow	0
and	0
accompanying	0
periodic	I-DISEASE
fluctuations	I-DISEASE
in	I-DISEASE
SaO2	0
.	0

In	I-DISEASE
contrast	I-DISEASE
,	0
oxygen	I-DISEASE
desaturation	0
due	I-DISEASE
to	0
sleep	0
related	B-DISEASE
hypoventilation	I-DISEASE
is	I-DISEASE
generally	I-DISEASE
more	0
sustained	0
,	I-DISEASE
usually	I-DISEASE
several	I-DISEASE
minutes	0
or	I-DISEASE
longer	I-DISEASE
in	0
duration	0
.	0

When	I-DISEASE
more	0
than	0
one	I-DISEASE
disorder	0
is	I-DISEASE
believed	I-DISEASE
to	I-DISEASE
be	0
responsible	0
for	0
the	0
ventilatory	0
insufficiency	I-DISEASE
during	I-DISEASE
sleep	0
,	I-DISEASE
all	0
pertinent	0
diagnoses	0
should	0
be	I-DISEASE
coded	0
.	0

Unresolved	I-DISEASE
Issues	0
and	0
Further	I-DISEASE
Directions	0
Future	0
research	0
into	I-DISEASE
the	I-DISEASE
pathogenesis	I-DISEASE
of	I-DISEASE
this	I-DISEASE
disorder	0
,	0
including	0
renal	0
bicarbonate	0
homeostasis	I-DISEASE
,	I-DISEASE
is	I-DISEASE
needed	0
.	0

Because	I-DISEASE
it	0
is	0
clinically	I-DISEASE
impractical	I-DISEASE
to	I-DISEASE
routinely	0
obtain	0
arterial	0
blood	I-DISEASE
samples	I-DISEASE
during	I-DISEASE
sleep	0
in	I-DISEASE
most	I-DISEASE
persons	0
suspected	0
of	I-DISEASE
this	0
disorder	I-DISEASE
,	I-DISEASE
other	0
techniques	I-DISEASE
of	0
measuring	I-DISEASE
CO2	I-DISEASE
levels	0
must	I-DISEASE
be	0
investigated	B-DISEASE
.	0

The	I-DISEASE
degree	I-DISEASE
and	0
duration	0
of	0
hypercapnia/	I-DISEASE
hypoxemia	I-DISEASE
necessary	0
to	I-DISEASE
produce	0
adverse	I-DISEASE
consequences	0
,	0
such	0
as	0
pulmonary	I-DISEASE
hyperten-	I-DISEASE
sion	I-DISEASE
,	I-DISEASE
in	I-DISEASE
individual	I-DISEASE
patients	0
is	0
not	0
well	I-DISEASE
defined	I-DISEASE
.	0

Little	I-DISEASE
information	0
is	0
available	I-DISEASE
regarding	0
the	I-DISEASE
effect	0
of	I-DISEASE
oxygen	0
therapy	0
or	0
noninvasive	I-DISEASE
ventilation	0
on	0
the	0
course	I-DISEASE
of	I-DISEASE
the	0
underlying	0
disease	I-DISEASE
.	0

Studies	I-DISEASE
are	I-DISEASE
needed	0
to	I-DISEASE
determine	0
the	0
optimal	0
time	I-DISEASE
to	0
initiate	0
these	I-DISEASE
interventions	I-DISEASE
and	0
the	0
specific	I-DISEASE
subpopulations	I-DISEASE
of	0
patients	I-DISEASE
who	I-DISEASE
will	0
benefit	0
most	0
from	I-DISEASE
these	0
therapies	I-DISEASE
.	0

Bibliography	0
Berger	I-DISEASE
KI	0
,	I-DISEASE
Goldring	I-DISEASE
RM	0
,	I-DISEASE
Rapoport	I-DISEASE
DM	I-DISEASE
.	0

Obesity	I-DISEASE
hypoventilation	0
syndrome	I-DISEASE
.	0

Semin	0
Respir	0
Crit	0
Care	0
Med	0
2009;30:253	I-DISEASE
.	0

Budweiser	I-DISEASE
S	I-DISEASE
,	0
Riedl	I-DISEASE
SG	I-DISEASE
,	I-DISEASE
Jörres	I-DISEASE
RA	I-DISEASE
,	I-DISEASE
et	0
al	I-DISEASE
.	0

Mortality	I-DISEASE
and	0
prognostic	0
factors	I-DISEASE
in	I-DISEASE
patients	0
with	0
obesity-	0
hypoventilation	I-DISEASE
syndrome	0
undergoing	0
noninvasive	I-DISEASE
ventilation	0
.	0

J	I-DISEASE
Intern	0
Med	0
2007;261:375–83	I-DISEASE
.	0

Littleton	I-DISEASE
SW	I-DISEASE
,	0
Mokhlesi	I-DISEASE
B.	0
The	I-DISEASE
pickwickian	I-DISEASE
syndrome	I-DISEASE
-	I-DISEASE
obesity	I-DISEASE
hypoventilation	0
syndrome	I-DISEASE
.	0

Clin	I-DISEASE
Chest	I-DISEASE
Med	0
2009;30:467–78	I-DISEASE
,	0
vii	0
-	I-DISEASE
viii	0
.	0

Mokhlesi	I-DISEASE
B	0
;	I-DISEASE
Tulaimat	I-DISEASE
A	0
;	0
Evans	I-DISEASE
AT	I-DISEASE
et	0
al	0
.	0

Impact	I-DISEASE
of	I-DISEASE
adherence	0
with	0
positive	0
airway	I-DISEASE
pressure	0
therapy	0
on	0
hypercapnia	I-DISEASE
in	I-DISEASE
obstructive	0
sleep	0
apnea	0
.	0

J	I-DISEASE
Clin	0
Sleep	0
Med	0
2006;2:57–62	0
.	0

Mokhlesi	I-DISEASE
B.	0
Obesity	0
hypoventilation	0
syndrome	I-DISEASE
:	0
a	0
state	B-DISEASE
-	I-DISEASE
of	0
-	0
the	0
-	0
art	I-DISEASE
review	0
.	0

Respir	I-DISEASE
Care	0
2010;55:1347–62	0
.	0

Nowbar	I-DISEASE
S	I-DISEASE
,	I-DISEASE
Burkart	0
KM	0
,	0
Gonzales	I-DISEASE
R	0
,	I-DISEASE
et	0
al	I-DISEASE
.	0

Obesity	I-DISEASE
-	0
hypoventilation	I-DISEASE
in	0
hospitalized	0
patients	I-DISEASE
:	I-DISEASE
prevalence	I-DISEASE
,	0
effects	0
,	I-DISEASE
and	0
outcome	0
.	0

Am	I-DISEASE
J	0
Med	0
2004;116:1–7	0
.	0

Piper	I-DISEASE
AJ	I-DISEASE
,	0
Grunstein	I-DISEASE
RR	I-DISEASE
.	0

Obesity	I-DISEASE
hypoventilation	0
syndrome	I-DISEASE
:	0
mechanisms	0
and	0
management	0
.	I-DISEASE

Am	I-DISEASE
J	0
Respir	0
Crit	0
Care	0
Med	0
2011;183:292–8	I-DISEASE
.	0

Piper	I-DISEASE
AJ	I-DISEASE
.	0

Obesity	I-DISEASE
hypoventilation	0
syndrome	I-DISEASE
--	0
the	0
big	0
and	0
the	0
breathless	0
.	0

Sleep	I-DISEASE
Med	I-DISEASE
Rev	0
2011;15:79–89	0
.	0

Congenital	0
Central	I-DISEASE
Alveolar	0
Hypoventilation	I-DISEASE
Syndrome	I-DISEASE
ICD-9	0
-	0
CM	0
code	0
:	0
327.25	0
ICD-10	0
-	0
CM	0
code	0
:	0
G47.35	0
Alternate	0
Names	I-DISEASE
Congenital	0
central	I-DISEASE
hypoventilation	I-DISEASE
syndrome	0
.	0

The	I-DISEASE
term	0
Ondine	0
’s	0
curse	0
is	I-DISEASE
no	0
longer	0
recommended	0
due	0
to	I-DISEASE
its	I-DISEASE
negative	I-DISEASE
connotations	0
.	0

Diagnostic	I-DISEASE
Criteria	0
Criteria	I-DISEASE
A	0
and	0
B	0
must	I-DISEASE
be	0
met	0
A.	0
Sleep	0
related	0
hypoventilation	I-DISEASE
is	I-DISEASE
present	0
.	0

B.	0
Mutation	0
of	0
the	0
PHOX2B	0
gene	0
is	I-DISEASE
present	I-DISEASE
.	0

Notes	I-DISEASE
.	0

Sleep	I-DISEASE
related	B-DISEASE
hypoventilation	0
may	I-DISEASE
be	0
associated	0
with	I-DISEASE
either	I-DISEASE
daytime	I-DISEASE
hypoventilation	I-DISEASE
(	0
PaCO2	0
>	0
45	I-DISEASE
mm	0
Hg	I-DISEASE
)	I-DISEASE
or	I-DISEASE
normal	0
daytime	I-DISEASE
PaCO2	I-DISEASE
levels	I-DISEASE
.	B-DISEASE

Sleep	I-DISEASE
Related	I-DISEASE
Breathing	0
Disorders	I-DISEASE
Sleep	0
Related	0
Breathing	0
Disorders	I-DISEASE
In	0
either	0
case	I-DISEASE
,	0
the	0
PaCO2	0
is	0
higher	I-DISEASE
during	I-DISEASE
sleep	0
and	0
meets	0
criteria	I-DISEASE
for	0
sleep	0
related	B-DISEASE
hypoventilation	I-DISEASE
.	0
.	0

PSG	I-DISEASE
monitoring	0
demonstrates	I-DISEASE
severe	0
hypercapnia	0
and	0
arterial	0
oxygen	I-DISEASE
desaturation	I-DISEASE
.	0

Some	0
central	0
apneas	0
may	0
occur	I-DISEASE
but	0
the	0
predominant	0
pattern	0
is	I-DISEASE
reduced	0
flow	0
/	0
tidal	0
volume	I-DISEASE
.	0
.	0

Although	I-DISEASE
the	0
condition	0
is	0
termed	0
congenital	0
,	0
some	0
patients	0
with	I-DISEASE
a	I-DISEASE
PHOX2B	0
genotype	0
may	0
present	I-DISEASE
phenotypically	0
later	0
in	0
life	0
(	I-DISEASE
and	0
even	I-DISEASE
in	I-DISEASE
adulthood	0
)	0
,	0
especially	0
in	I-DISEASE
the	0
presence	0
of	I-DISEASE
a	0
stressor	0
such	0
as	I-DISEASE
general	0
anesthesia	0
or	0
a	0
severe	I-DISEASE
respiratory	0
illness	0
.	0

Essential	I-DISEASE
Features	I-DISEASE
Congenital	0
central	0
alveolar	I-DISEASE
hypoventilation	0
syndrome	I-DISEASE
(	I-DISEASE
CCHS	I-DISEASE
)	0
is	0
a	0
syndrome	0
of	I-DISEASE
auto-	0
nomic	I-DISEASE
dysfunction	0
,	I-DISEASE
primarily	I-DISEASE
the	0
failure	0
of	I-DISEASE
automatic	I-DISEASE
central	0
control	0
of	I-DISEASE
breathing	0
,	0
due	0
to	0
a	0
mutation	0
of	I-DISEASE
the	I-DISEASE
PHOX2B	I-DISEASE
gene	0
.	0

CCHS	I-DISEASE
is	0
characterized	0
by	0
the	0
onset	0
of	I-DISEASE
hypoven-	0
tilation	I-DISEASE
,	I-DISEASE
usually	I-DISEASE
at	I-DISEASE
birth	0
.	0

The	I-DISEASE
hypoventilation	I-DISEASE
is	I-DISEASE
worse	I-DISEASE
during	I-DISEASE
sleep	0
than	I-DISEASE
wakefulness	0
and	0
is	0
unexplained	0
by	0
primary	0
pulmonary	I-DISEASE
,	I-DISEASE
neurological	0
,	0
or	I-DISEASE
metabolic	0
disease	I-DISEASE
.	0

CCHS	I-DISEASE
typically	0
presents	0
in	0
an	0
otherwise	0
normal	0
-	0
appearing	0
infant	0
who	I-DISEASE
is	I-DISEASE
noted	0
to	0
have	0
cyano-	0
sis	0
,	0
feeding	I-DISEASE
difficulties	0
,	I-DISEASE
hypotonia	0
or	I-DISEASE
,	B-DISEASE
less	I-DISEASE
commonly	0
,	0
central	0
apnea	0
.	0

Some	I-DISEASE
children	I-DISEASE
are	0
diagnosed	I-DISEASE
following	0
cardiovascular	I-DISEASE
collapse	I-DISEASE
.	0

The	I-DISEASE
infant	0
requires	I-DISEASE
intubation	I-DISEASE
and	0
then	0
can	0
not	0
be	0
weaned	0
from	0
mechanically	0
assisted	I-DISEASE
ventilation	0
,	0
despite	0
appearing	0
vigorous	0
and	0
having	I-DISEASE
a	I-DISEASE
normal	0
chest	0
radiograph	I-DISEASE
.	0

Some	I-DISEASE
infants	0
may	0
appear	I-DISEASE
to	0
breathe	I-DISEASE
adequately	0
on	0
clinical	0
examination	0
but	0
experience	0
episodes	I-DISEASE
of	I-DISEASE
hypoventilation	0
(	0
not	0
necessarily	0
apnea	0
)	0
characterized	0
by	I-DISEASE
hypoxemia	I-DISEASE
and	0
hypercapnia	I-DISEASE
.	0

Patients	I-DISEASE
with	0
CCHS	0
may	I-DISEASE
occa-	0
sionally	0
present	I-DISEASE
later	0
in	0
life	0
with	I-DISEASE
cyanosis	I-DISEASE
,	I-DISEASE
an	0
apparent	0
life	0
-	0
threatening	I-DISEASE
event	0
,	I-DISEASE
cor	0
pul-	0
monale	0
,	0
or	0
hypoxic	0
neurological	0
damage	0
.	0

CCHS	I-DISEASE
has	0
been	I-DISEASE
diagnosed	0
in	I-DISEASE
adults	I-DISEASE
who	I-DISEASE
present	I-DISEASE
with	0
respiratory	I-DISEASE
failure	0
following	0
anesthesia	I-DISEASE
or	I-DISEASE
in	I-DISEASE
association	0
with	0
a	0
minor	0
respiratory	0
illness	0
;	0
these	I-DISEASE
patients	0
usually	I-DISEASE
have	0
a	I-DISEASE
mild	0
mutation	0
,	0
and	0
may	I-DISEASE
have	0
evidence	0
of	0
longstanding	I-DISEASE
hypoxemia	0
including	0
cognitive	0
deficits	I-DISEASE
.	0

Most	I-DISEASE
patients	0
with	0
CCHS	0
have	I-DISEASE
sufficiently	I-DISEASE
severe	I-DISEASE
hypoventilation	0
during	I-DISEASE
sleep	0
that	0
they	B-DISEASE
require	I-DISEASE
mechanically	0
assisted	0
ventilation	0
,	0
although	0
this	0
state	B-DISEASE
-	0
dependent	0
difference	0
may	I-DISEASE
not	0
be	I-DISEASE
apparent	0
during	I-DISEASE
early	0
infancy	0
.	0

Some	I-DISEASE
patients	0
(	0
~15	0
%	0
)	0
hypoventilate	I-DISEASE
during	I-DISEASE
wakefulness	0
as	0
well	I-DISEASE
as	0
during	I-DISEASE
sleep	0
and	0
require	I-DISEASE
continuous	0
ventilatory	0
support	I-DISEASE
.	0

However	I-DISEASE
,	I-DISEASE
most	0
patients	I-DISEASE
with	0
CCHS	I-DISEASE
do	I-DISEASE
not	0
require	0
ventilatory	0
support	I-DISEASE
during	0
wakefulness	0
but	I-DISEASE
may	0
have	0
subtle	I-DISEASE
abnormali-	0
ties	I-DISEASE
in	I-DISEASE
gas	0
exchange	I-DISEASE
when	0
physically	I-DISEASE
inactive	0
or	B-DISEASE
during	I-DISEASE
vigorous	0
exercise	0
.	0

Associated	I-DISEASE
Features	I-DISEASE
Associated	0
autonomic	0
abnormalities	I-DISEASE
include	0
Hirschsprung	0
disease	I-DISEASE
in	0
approximately	0
16	I-DISEASE
%	0
of	0
patients	0
with	I-DISEASE
CCHS	0
,	0
autonomic	0
dysfunction	0
(	I-DISEASE
e.g.	I-DISEASE
,	0
decreased	I-DISEASE
heart	0
rate	I-DISEASE
variabil-	I-DISEASE
ity	0
or	I-DISEASE
hypotension	I-DISEASE
)	0
,	0
neural	0
tumors	0
(	I-DISEASE
e.g.	0
,	0
ganglioneuromas	0
or	I-DISEASE
ganglioneuroblastomas	0
)	0
,	I-DISEASE
swallowing	0
dysfunction	0
during	I-DISEASE
the	0
early	0
years	I-DISEASE
,	0
and	0
ocular	0
abnormalities	I-DISEASE
(	0
e.g.	0
,	0
stra-	0
bismus	I-DISEASE
)	0
.	I-DISEASE

Most	I-DISEASE
patients	I-DISEASE
are	0
cognitively	0
normal	0
,	I-DISEASE
although	0
developmental	I-DISEASE
delay	0
may	I-DISEASE
be	I-DISEASE
present	I-DISEASE
,	I-DISEASE
especially	0
in	I-DISEASE
patients	I-DISEASE
in	I-DISEASE
whom	0
the	0
hypoventilation	I-DISEASE
has	I-DISEASE
not	0
been	I-DISEASE
well	I-DISEASE
controlled	I-DISEASE
.	0

Clinical	I-DISEASE
and	0
Pathophysiological	I-DISEASE
Subtypes	I-DISEASE
Research	I-DISEASE
suggests	I-DISEASE
that	I-DISEASE
severity	I-DISEASE
of	I-DISEASE
illness	0
is	I-DISEASE
related	I-DISEASE
to	0
the	0
type	I-DISEASE
of	I-DISEASE
mutation	I-DISEASE
present	I-DISEASE
.	0

Most	I-DISEASE
patients	I-DISEASE
have	0
a	I-DISEASE
polyalanine	0
expansion	B-DISEASE
mutation	0
;	I-DISEASE
those	I-DISEASE
with	I-DISEASE
more	0
polyalanine	0
repeats	0
are	0
more	0
likely	I-DISEASE
to	I-DISEASE
have	0
severe	0
disease	I-DISEASE
including	0
waking	0
hypoventilation	I-DISEASE
.	B-DISEASE

Patients	I-DISEASE
with	0
a	0
point	0
mutation	I-DISEASE
or	I-DISEASE
frame	I-DISEASE
shift	0
mutations	0
are	0
at	I-DISEASE
greater	I-DISEASE
risk	0
for	0
neural	0
tumors	I-DISEASE
.	0

Demographics	I-DISEASE
The	I-DISEASE
prevalence	0
of	I-DISEASE
CCHS	I-DISEASE
is	0
not	0
known	I-DISEASE
,	I-DISEASE
but	I-DISEASE
the	0
disease	0
is	0
rare	I-DISEASE
.	0

The	I-DISEASE
condition	0
occurs	0
equally	0
among	0
both	I-DISEASE
sexes	0
and	0
all	0
ethnic	0
/	0
racial	I-DISEASE
groups	I-DISEASE
.	0

Predisposing	I-DISEASE
and	0
Precipitating	I-DISEASE
Factors	0
This	0
is	I-DISEASE
a	0
congenital	0
genetic	I-DISEASE
syndrome	0
.	0

Familial	I-DISEASE
Patterns	I-DISEASE
CCHS	I-DISEASE
usually	I-DISEASE
occurs	0
as	0
a	0
de	I-DISEASE
novo	I-DISEASE
mutation	I-DISEASE
,	I-DISEASE
but	I-DISEASE
siblings	0
with	0
the	0
condition	0
have	0
been	I-DISEASE
reported	I-DISEASE
.	0

As	I-DISEASE
the	0
gene	0
is	0
dominant	0
,	I-DISEASE
patients	I-DISEASE
are	0
at	I-DISEASE
risk	0
of	I-DISEASE
having	I-DISEASE
children	I-DISEASE
with	I-DISEASE
CCHS	0
.	0

Onset	I-DISEASE
,	0
Course	0
,	0
and	0
Complications	0

The	I-DISEASE
condition	0
is	0
genetic	I-DISEASE
and	0
is	0
therefore	I-DISEASE
present	I-DISEASE
from	0
birth	0
,	0
but	I-DISEASE
some	I-DISEASE
patients	I-DISEASE
may	0
present	I-DISEASE
later	0
in	I-DISEASE
life	0
.	0

The	I-DISEASE
physiological	I-DISEASE
abnormalities	0
of	0
CCHS	I-DISEASE
persist	I-DISEASE
for	0
life	0
and	0
are	I-DISEASE
not	0
ameliorated	0
over	0
time	0
.	0

However	I-DISEASE
,	I-DISEASE
the	0
clinical	I-DISEASE
consequences	I-DISEASE
of	I-DISEASE
hypoventilation	I-DISEASE
can	0
be	I-DISEASE
prevented	I-DISEASE
by	B-DISEASE
providing	I-DISEASE
adequate	B-DISEASE
ventilatory	I-DISEASE
support	I-DISEASE
.	0

If	I-DISEASE
untreated	I-DISEASE
,	0
death	0
usually	I-DISEASE
results	I-DISEASE
from	0
cor	0
pulmonale	0
or	0
complications	I-DISEASE
of	I-DISEASE
apnea	0
or	0
severe	0
hypoventilation	I-DISEASE
.	0

Patients	I-DISEASE
with	0
poorly	I-DISEASE
controlled	0
CCHS	I-DISEASE
may	I-DISEASE
develop	0
mental	0
retardation	0
,	I-DISEASE
growth	0
failure	I-DISEASE
,	I-DISEASE
seizures	I-DISEASE
,	0
or	I-DISEASE
cor	0
pulmonale	0
.	I-DISEASE

When	I-DISEASE
treated	0
,	0
infants	0
with	0
CCHS	I-DISEASE
may	I-DISEASE
improve	0
over	0
the	0
first	I-DISEASE
six	I-DISEASE
to	I-DISEASE
12	B-DISEASE
months	0
.	0

Some	I-DISEASE
patients	0
who	0
initially	I-DISEASE
require	0
ventilatory	0
support	0
24	0
hours	I-DISEASE
a	0
day	I-DISEASE
may	I-DISEASE
progress	0
to	I-DISEASE
adequate	0
ventilation	I-DISEASE
during	I-DISEASE
wakefulness	0
.	0

However	I-DISEASE
,	I-DISEASE
patients	0
continue	0
to	0
require	I-DISEASE
ventilatory	0
support	0
during	I-DISEASE
sleep	0
.	I-DISEASE

Conversely	I-DISEASE
,	I-DISEASE
some	0
patients	I-DISEASE
may	0
develop	0
the	0
need	I-DISEASE
for	0
continuous	0
ventilatory	0
support	I-DISEASE
.	0

It	I-DISEASE
is	I-DISEASE
unclear	0
whether	I-DISEASE
these	0
patients	I-DISEASE
had	0
condi-	I-DISEASE
tions	0
that	I-DISEASE
worsened	I-DISEASE
,	I-DISEASE
were	I-DISEASE
not	I-DISEASE
adequately	0
evaluated	0
and	0
treated	0
initially	I-DISEASE
,	0
or	0
were	I-DISEASE
asso-	0
ciated	I-DISEASE
with	I-DISEASE
changing	0
ventilatory	0
demands	0
.	0

Even	I-DISEASE
with	0
treatment	I-DISEASE
,	I-DISEASE
patients	0
with	I-DISEASE
CCHS	0
require	0
close	0
monitoring	0
,	I-DISEASE
particularly	I-DISEASE
during	I-DISEASE
infancy	0
.	0

Minor	I-DISEASE
medical	I-DISEASE
illnesses	0
,	0
such	I-DISEASE
as	I-DISEASE
upper	I-DISEASE
respiratory	0
tract	0
illnesses	0
or	I-DISEASE
diarrhea	I-DISEASE
,	I-DISEASE
may	0
precipitate	0
bouts	I-DISEASE
of	I-DISEASE
respiratory	I-DISEASE
failure	0
.	I-DISEASE

Edema	I-DISEASE
and	0
lethargy	I-DISEASE
are	0
often	0
early	0
signs	0
of	I-DISEASE
impending	0
respiratory	I-DISEASE
failure	I-DISEASE
.	0

The	I-DISEASE
clinical	I-DISEASE
signs	0
of	I-DISEASE
hypoxemia	0
and	0
hypoventilation	0
in	0
these	I-DISEASE
patients	I-DISEASE
may	I-DISEASE
be	0
subtle	0
,	I-DISEASE
as	0
the	0
Sleep	0
Related	0
Breathing	0
Disorders	I-DISEASE
Sleep	0
Related	0
Breathing	0
Disorders	I-DISEASE
children	0
do	0
not	0
show	I-DISEASE
signs	0
of	I-DISEASE
distress	I-DISEASE
or	I-DISEASE
increased	0
work	I-DISEASE
of	I-DISEASE
breathing	0
,	0
such	0
as	0
retrac-	0
tions	0
and	0
nasal	I-DISEASE
flaring	I-DISEASE
.	0

As	I-DISEASE
a	0
result	0
,	I-DISEASE
gas	0
exchange	I-DISEASE
abnormalities	I-DISEASE
may	0
progress	0
for	0
some	I-DISEASE
time	I-DISEASE
without	0
notice	I-DISEASE
until	0
the	0
child	0
appears	0
to	0
deteriorate	I-DISEASE
suddenly	I-DISEASE
with	I-DISEASE
cardiopulmo-	0
nary	0
arrest	0
or	0
severe	0
decompensation	0
.	0

Developmental	I-DISEASE
Issues	0
Not	I-DISEASE
applicable	0
.	0

Pathology	I-DISEASE
and	0
Pathophysiology	I-DISEASE
The	I-DISEASE
exact	0
pathophysiology	0
of	I-DISEASE
CCHS	I-DISEASE
is	0
unknown	0
.	0

Radiologic	I-DISEASE
and	0
postmortem	0
studies	I-DISEASE
have	0
not	0
shown	I-DISEASE
gross	I-DISEASE
central	I-DISEASE
nervous	I-DISEASE
system	0
abnormalities	I-DISEASE
.	0

The	I-DISEASE
PHOX2B	0
gene	0
plays	I-DISEASE
a	0
role	0
in	I-DISEASE
the	0
development	I-DISEASE
of	I-DISEASE
the	0
autonomic	0
system	0
.	0

Functional	I-DISEASE
MRI	0
and	0
physiologic	0
studies	I-DISEASE
have	I-DISEASE
shown	I-DISEASE
widespread	I-DISEASE
cerebral	0
abnormalities	I-DISEASE
in	I-DISEASE
response	0
to	0
stimuli	0
such	0
as	0
exogenous	0
hypercapnia	0
.	0

Objective	I-DISEASE
Findings	I-DISEASE
Hypoxemia	I-DISEASE
and	0
hypercapnia	I-DISEASE
are	0
present	I-DISEASE
on	0
PSG	0
during	I-DISEASE
sleep	0
.	0

Central	I-DISEASE
apneas	0
may	I-DISEASE
be	I-DISEASE
present	I-DISEASE
,	0
but	0
hypoventilation	0
associated	0
with	I-DISEASE
decreased	I-DISEASE
tidal	0
volume	0
and	0
respiratory	0
rate	I-DISEASE
is	0
more	0
common	I-DISEASE
.	0

In	I-DISEASE
contrast	I-DISEASE
to	I-DISEASE
most	I-DISEASE
types	I-DISEASE
of	I-DISEASE
sleep	I-DISEASE
disordered	I-DISEASE
breathing	0
in	I-DISEASE
children	I-DISEASE
,	I-DISEASE
abnormalities	I-DISEASE
may	I-DISEASE
be	I-DISEASE
more	I-DISEASE
severe	0
during	I-DISEASE
NREM	0
than	0
during	I-DISEASE
REM	I-DISEASE
sleep	I-DISEASE
.	0

Patients	I-DISEASE
may	0
not	0
arouse	0
from	0
sleep	0
despite	0
severe	0
gas	0
exchange	I-DISEASE
abnormalities	I-DISEASE
.	0

Paradoxical	I-DISEASE
breath-	0
ing	0
and	0
snoring	0
do	0
not	0
typically	I-DISEASE
occur	I-DISEASE
.	0

Patients	I-DISEASE
with	0
CCHS	0
have	I-DISEASE
flat	I-DISEASE
rebreathing	0
hypoxic	I-DISEASE
and	0
hypercapnic	I-DISEASE
responses	I-DISEASE
,	0
although	0
they	B-DISEASE
may	I-DISEASE
respond	B-DISEASE
to	0
transient	0
ventilatory	0
challenges	0
of	I-DISEASE
the	0
peripheral	I-DISEASE
chemorecep-	I-DISEASE
tors	0
.	0

Arterial	I-DISEASE
blood	0
gases	I-DISEASE
may	0
be	I-DISEASE
normal	0
during	I-DISEASE
wakefulness	0
but	0
will	0
be	I-DISEASE
abnormal	I-DISEASE
if	0
obtained	0
from	I-DISEASE
an	I-DISEASE
arterial	0
line	I-DISEASE
during	I-DISEASE
sleep	0
.	0

In	I-DISEASE
patients	0
with	0
chronically	I-DISEASE
untreated	I-DISEASE
or	B-DISEASE
poorly	0
controlled	0
CCHS	0
,	I-DISEASE
a	0
compensated	0
respiratory	I-DISEASE
acidosis	0
may	I-DISEASE
be	0
present	I-DISEASE
.	0

In	I-DISEASE
these	I-DISEASE
patients	0
,	I-DISEASE
polycythemia	0
may	0
be	0
present	I-DISEASE
and	0
the	0
serum	0
bicarbonate	0
level	0
may	I-DISEASE
be	0
elevated	I-DISEASE
.	0

Computed	I-DISEASE
tomography	I-DISEASE
and	0
MRI	0
scans	0
of	I-DISEASE
the	I-DISEASE
head	I-DISEASE
are	0
normal	0
.	0

Electrocardiography	I-DISEASE
,	I-DISEASE
echocardiography	I-DISEASE
,	I-DISEASE
or	I-DISEASE
cardiac	I-DISEASE
catheterization	0
may	0
reveal	0
evidence	0
of	I-DISEASE
pulmonary	I-DISEASE
hyper-	I-DISEASE
tension	0
.	I-DISEASE

Pulmonary	I-DISEASE
function	0
tests	I-DISEASE
may	I-DISEASE
be	I-DISEASE
normal	0
or	0
show	I-DISEASE
evidence	I-DISEASE
of	I-DISEASE
mild	I-DISEASE
obstructive	0
or	0
restrictive	0
lung	I-DISEASE
disease	I-DISEASE
resulting	0
from	I-DISEASE
associated	0
conditions	I-DISEASE
such	I-DISEASE
as	0
tracheitis	I-DISEASE
.	0

Differential	I-DISEASE
Diagnosis	0
CCHS	I-DISEASE
must	I-DISEASE
be	0
distinguished	0
from	I-DISEASE
other	0
forms	I-DISEASE
of	I-DISEASE
central	0
hypoventilation	I-DISEASE
,	0
such	0
as	0
central	0
hypoventilation	0
due	I-DISEASE
to	0
Chiari	B-DISEASE
malformation	0
,	0
other	I-DISEASE
causes	0
of	0
central	0
nervous	0
system	0
disturbance	I-DISEASE
such	0
as	I-DISEASE
trauma	0
or	I-DISEASE
tumors	0
,	0
metabolic	0
conditions	0
such	0
as	0
Leigh	I-DISEASE
disease	I-DISEASE
,	I-DISEASE
or	0
obesity	0
hypoventilation	0
syndrome	0
.	0

CCHS	I-DISEASE
must	0
also	0
be	0
distinguished	I-DISEASE
from	0
hypoventilation	I-DISEASE
secondary	I-DISEASE
to	I-DISEASE
muscle	0
weakness	0
due	0
to	I-DISEASE
conditions	0
such	0
as	0
diaphrag-	0
matic	I-DISEASE
paralysis	I-DISEASE
or	I-DISEASE
muscular	0
dystrophy	0
.	0

Infants	I-DISEASE
presenting	I-DISEASE
with	0
apnea	0
or	B-DISEASE
an	0
apparent	0
life	0
-	I-DISEASE
threatening	I-DISEASE
event	0
due	0
to	I-DISEASE
causes	I-DISEASE
such	0
as	0
gastroesophageal	I-DISEASE
reflux	0
may	I-DISEASE
be	0
thought	I-DISEASE
to	0
have	0
CCHS	I-DISEASE
.	0

However	I-DISEASE
,	I-DISEASE
these	0
infants	0
typically	0
have	I-DISEASE
intermittent	I-DISEASE
episodes	I-DISEASE
of	I-DISEASE
apnea	0
rather	I-DISEASE
than	I-DISEASE
sustained	0
hypoventilation	I-DISEASE
,	0
and	0
the	0
episodes	I-DISEASE
typically	0
resolve	0
once	0
the	0
primary	0
cause	I-DISEASE
has	I-DISEASE
been	I-DISEASE
treated	0
.	0

CCHS	I-DISEASE
patients	0
presenting	I-DISEASE
with	0
cor	0
pulmonale	0
may	I-DISEASE
be	I-DISEASE
misdiagnosed	I-DISEASE
as	0
having	0
congenital	I-DISEASE
heart	0
disease	I-DISEASE
.	0

Unresolved	I-DISEASE
Issues	0
and	0
Further	I-DISEASE
Directions	0

There	I-DISEASE
are	0
many	0
unresolved	I-DISEASE
issues	I-DISEASE
regarding	0
CCHS	0
,	I-DISEASE
including	I-DISEASE
prevalence	I-DISEASE
data	0
,	I-DISEASE
precise	I-DISEASE
genotype	I-DISEASE
-	I-DISEASE
phenotype	0
correlations	I-DISEASE
,	0
effect	0
of	I-DISEASE
aging	I-DISEASE
on	0
patients	I-DISEASE
with	I-DISEASE
CCHS	0
,	I-DISEASE
long	I-DISEASE
-	0
term	0
outcome	0
of	0
children	0
with	0
CCHS	0
born	0
to	I-DISEASE
parents	0
with	I-DISEASE
CCHS	0
,	0
and	0
the	0
exact	0
nature	0
of	I-DISEASE
the	0
gene	0
-	0
encoded	0
deficit	0
.	I-DISEASE

Bibliography	0
Amiel	I-DISEASE
J	0
,	I-DISEASE
Laudier	I-DISEASE
B	0
,	0
Attie	0
-	I-DISEASE
Bitach	0
T	0
,	I-DISEASE
et	0
al	0
.	0

Polyalanine	I-DISEASE
expansion	0
and	0
frameshift	0
mutations	0
of	I-DISEASE
the	0
paired	I-DISEASE
-	I-DISEASE
like	0
homeobox	0
gene	0
PHOX2B	0
in	I-DISEASE
congenital	I-DISEASE
central	0
hypoventilation	I-DISEASE
syndrome	I-DISEASE
.	B-DISEASE

Nat	I-DISEASE
Genet	I-DISEASE
2003;33:459–61	0
.	0

Gozal	I-DISEASE
D	0
,	I-DISEASE
Marcus	0
CL	0
,	I-DISEASE
Shoseyov	I-DISEASE
D	I-DISEASE
,	I-DISEASE
Keens	I-DISEASE
TG	0
.	0

Peripheral	I-DISEASE
chemoreceptor	0
function	0
in	0
children	B-DISEASE
with	I-DISEASE
the	I-DISEASE
congenital	I-DISEASE
central	0
hypoventilation	I-DISEASE
syndrome	0
.	0

J	I-DISEASE
Appl	0
Physiol	0
1993;74:379–87	I-DISEASE
.	0

Macey	I-DISEASE
PM	0
,	I-DISEASE
Woo	0
MA	0
,	I-DISEASE
Macey	0
KE	I-DISEASE
,	I-DISEASE
et	0
al	I-DISEASE
.	0

Hypoxia	I-DISEASE
reveals	0
posterior	I-DISEASE
thalamic	0
,	0
cerebellar	I-DISEASE
,	0
midbrain	I-DISEASE
,	0
and	0
limbic	0
deficits	0
in	I-DISEASE
congenital	I-DISEASE
central	0
hypoventilation	I-DISEASE
syndrome	I-DISEASE
.	0

J	I-DISEASE
Appl	0
Physiol	0
2005;98:958–69	I-DISEASE
.	0

Marcus	I-DISEASE
CL	I-DISEASE
,	I-DISEASE
Jansen	0
MT	I-DISEASE
,	0
Poulsen	0
MK	I-DISEASE
,	I-DISEASE
Keens	I-DISEASE
SE	I-DISEASE
,	0
Nield	0
TA	0
,	I-DISEASE
Lipsker	I-DISEASE
LE	0
et	0
al	I-DISEASE
.	0

Medical	I-DISEASE
and	0
psychosocial	0
outcome	0
of	I-DISEASE
children	B-DISEASE
with	0
congenital	0
central	0
hypoventilation	0
syndrome	0
.	0

J	I-DISEASE
Pediatr	0
1991;119:888–95	0
.	0

Paton	I-DISEASE
JY	0
,	0
Swaminathan	0
S	I-DISEASE
,	0
Sargent	0
CW	I-DISEASE
,	I-DISEASE
Hawksworth	0
A	0
,	I-DISEASE
Keens	I-DISEASE
TG	0
.	0

Ventilatory	I-DISEASE
response	0
to	I-DISEASE
exercise	0
in	I-DISEASE
children	B-DISEASE
with	0
congenital	0
central	0
hypoventilation	0
syndrome	0
.	0

Am	I-DISEASE
Rev	I-DISEASE
Respir	0
Dis	I-DISEASE
1993;147:1185–91	I-DISEASE
.	0

Paton	I-DISEASE
JY	0
,	0
Swaminathan	0
S	I-DISEASE
,	0
Sargent	0
CW	I-DISEASE
,	I-DISEASE
Keens	I-DISEASE
TG	0
.	0

Hypoxic	I-DISEASE
and	0
hypercapnic	I-DISEASE
ventilatory	0
responses	I-DISEASE
in	I-DISEASE
awake	0
children	I-DISEASE
with	I-DISEASE
congenital	I-DISEASE
central	0
hypoventilation	0
syndrome	0
.	0

Am	I-DISEASE
Rev	I-DISEASE
Respir	0
Dis	I-DISEASE
1989;140:368–72	I-DISEASE
.	0

Weese	I-DISEASE
-	0
Mayer	I-DISEASE
DE	0
,	I-DISEASE
Berry	0
-	0
Kravis	0
EM	0
,	I-DISEASE
Ceccherini	0
I	0
,	0
Keens	I-DISEASE
TG	0
,	I-DISEASE
Loghmanee	I-DISEASE
DA	I-DISEASE
,	I-DISEASE
Trang	0
H.	I-DISEASE
An	0
official	0
ATS	0
clinical	0
policy	0
statement	0
:	0
Congenital	0
central	0
hypoventilation	I-DISEASE
syndrome	0
:	0
genetic	I-DISEASE
basis	I-DISEASE
,	0
diagnosis	0
,	0
and	0
management	0
.	I-DISEASE

Am	I-DISEASE
J	0
Respir	0
Crit	0
Care	0
Med	0
2010;181:626–44	I-DISEASE
.	0

Weese	I-DISEASE
-	0
Mayer	I-DISEASE
DE	0
,	I-DISEASE
Berry	0
-	I-DISEASE
Kravis	0
EM	0
,	I-DISEASE
Marazita	0
ML	I-DISEASE
.	0

In	I-DISEASE
pursuit	I-DISEASE
(	0
and	0
discovery	0
)	0
of	I-DISEASE
a	I-DISEASE
genetic	0
basis	0
for	0
congenital	0
central	0
hypoventilation	I-DISEASE
syndrome	0
.	0

Respir	I-DISEASE
Physiol	0
Neurobiol	0
2005;149:73–82	0
.	0

Sleep	I-DISEASE
Related	0
Breathing	0
Disorders	I-DISEASE
Sleep	0
Related	0
Breathing	0
Disorders	I-DISEASE
Late	0
-	0
Onset	I-DISEASE
Central	I-DISEASE
Hypoventilation	I-DISEASE
with	0
Hypothalamic	I-DISEASE
Dysfunction	I-DISEASE
ICD-9	0
-	0
CM	0
code	0
:	I-DISEASE
327.26	I-DISEASE
ICD-10	0
-	0
CM	0
code	0
:	0
G47.36	I-DISEASE
Alternate	I-DISEASE
Names	I-DISEASE
Late	0
-	I-DISEASE
onset	0
central	I-DISEASE
hypoventilation	I-DISEASE
syndrome	0
;	0
rapid	I-DISEASE
-	0
onset	0
obesity	0
with	I-DISEASE
hypothalamic	0
dysfunction	0
,	0
hypoventilation	0
,	0
and	0
autonomic	0
dysregulation	0
(	I-DISEASE
ROHHAD	I-DISEASE
)	0
.	0

Diagnostic	I-DISEASE
Criteria	0
Criteria	I-DISEASE
A	0
-	I-DISEASE
E	I-DISEASE
must	I-DISEASE
be	0
met	0
A.	0
Sleep	0
related	0
hypoventilation	I-DISEASE
is	I-DISEASE
present	0
.	0

B.	0
Symptoms	0
are	0
absent	I-DISEASE
during	I-DISEASE
the	0
first	0
few	0
years	I-DISEASE
of	I-DISEASE
life	0
.	0

C.	I-DISEASE

The	I-DISEASE
patient	I-DISEASE
has	0
at	I-DISEASE
least	0
two	I-DISEASE
of	I-DISEASE
the	0
following	0
:	0
.	0

Obesity	I-DISEASE
.	0
.	I-DISEASE

Endocrine	I-DISEASE
abnormalities	I-DISEASE
of	I-DISEASE
hypothalamic	I-DISEASE
origin	I-DISEASE
.	I-DISEASE

3	I-DISEASE
.	0

Severe	I-DISEASE
emotional	0
or	I-DISEASE
behavioral	0
disturbances	I-DISEASE
.	0
.	0

Tumor	I-DISEASE
of	I-DISEASE
neural	I-DISEASE
origin	0
.	0

D.	I-DISEASE
Mutation	0
of	0
the	0
PHOX2B	0
gene	0
is	I-DISEASE
not	0
present	0
.	0

E.	I-DISEASE

The	I-DISEASE
disorder	I-DISEASE
is	0
not	0
better	0
explained	I-DISEASE
by	I-DISEASE
another	I-DISEASE
sleep	0
disorder	0
,	0
medical	I-DISEASE
or	I-DISEASE
neurological	I-DISEASE
disorder	I-DISEASE
,	I-DISEASE
medication	0
use	0
,	I-DISEASE
or	I-DISEASE
substance	I-DISEASE
use	0
disorder	0
.	0

Notes	I-DISEASE
.	0

Central	I-DISEASE
apneas	0
may	I-DISEASE
occur	I-DISEASE
but	I-DISEASE
the	0
predominant	0
pattern	0
is	0
reduced	I-DISEASE
flow	I-DISEASE
/	0
tidal	0
volume	I-DISEASE
associated	0
with	0
hypoventilation	0
and	0
arterial	I-DISEASE
oxygen	I-DISEASE
desaturation	I-DISEASE
.	B-DISEASE

Essential	I-DISEASE
Features	I-DISEASE
Late	0
-	I-DISEASE
onset	0
central	0
hypoventilation	I-DISEASE
with	I-DISEASE
hypothalamic	I-DISEASE
dysfunction	I-DISEASE
is	0
a	0
disorder	0
of	I-DISEASE
central	0
control	I-DISEASE
of	0
ventilation	0
.	0

Patients	I-DISEASE
are	0
usually	I-DISEASE
healthy	0
until	0
early	0
childhood	I-DISEASE
(	I-DISEASE
often	0
2	0
-	I-DISEASE
3	I-DISEASE
years	I-DISEASE
of	I-DISEASE
age	I-DISEASE
)	0
when	I-DISEASE
they	0
develop	0
hyperphagia	I-DISEASE
and	0
severe	I-DISEASE
obesity	0
,	I-DISEASE
followed	0
by	I-DISEASE
central	0
hypoventilation	0
,	0
which	0
often	0
presents	0
as	0
respiratory	0
failure	0
.	0

The	I-DISEASE
respiratory	I-DISEASE
failure	0
may	I-DISEASE
be	0
precipitated	0
by	0
a	0
mild	0
respiratory	I-DISEASE
illness	0
or	0
anesthesia	0
.	0

Patients	I-DISEASE
require	I-DISEASE
ventilatory	0
support	I-DISEASE
during	I-DISEASE
sleep	0
;	0
most	0
patients	I-DISEASE
breathe	I-DISEASE
adequately	B-DISEASE
during	0
wakefulness	0
but	I-DISEASE
some	0
need	0
ventilatory	0
support	0
during	I-DISEASE
both	I-DISEASE
wakefulness	0
and	0
sleep	0
.	0

The	I-DISEASE
hypoventila-	I-DISEASE
tion	0
persists	0
even	I-DISEASE
if	I-DISEASE
the	0
patients	I-DISEASE
lose	0
weight	I-DISEASE
,	0
differentiating	0
the	0
condition	0
from	0
obesity	0
hypoventilation	0
syndrome	B-DISEASE
.	0

Patients	I-DISEASE
often	0
develop	0
hypothalamic	0
endocrine	0
dysfunc-	I-DISEASE
tion	0
characterized	0
by	I-DISEASE
increased	0
or	0
decreased	I-DISEASE
hormone	0
levels	I-DISEASE
,	0
which	0
may	0
include	I-DISEASE
one	0
or	B-DISEASE
more	0
of	I-DISEASE
the	0
following	0
:	0
diabetes	0
insipidus	0
,	0
inappropriate	0
antidiuretic	0
hormone	0
hyperse-	0
cretion	I-DISEASE
,	I-DISEASE
precocious	0
puberty	0
,	I-DISEASE
hypogonadism	I-DISEASE
,	0
hyperprolactinemia	I-DISEASE
,	0
hypothyroidism	0
,	0
and	0
decreased	I-DISEASE
growth	0
hormone	0
secretion	I-DISEASE
.	0

Mood	I-DISEASE
and	0
behavior	I-DISEASE
abnormalities	0
,	0
sometimes	I-DISEASE
severe	0
,	0
have	0
frequently	I-DISEASE
been	I-DISEASE
reported	I-DISEASE
.	0

Developmental	I-DISEASE
delay	0
or	I-DISEASE
autism	0
may	I-DISEASE
be	I-DISEASE
present	I-DISEASE
,	0
but	0
many	0
patients	I-DISEASE
are	I-DISEASE
cognitively	0
normal	0
.	0

Other	I-DISEASE
symptoms	I-DISEASE
of	I-DISEASE
hypothalamic	I-DISEASE
dysfunc-	0
tion	0
,	I-DISEASE
such	0
as	I-DISEASE
temperature	0
dysregulation	0
,	I-DISEASE
have	I-DISEASE
been	0
reported	I-DISEASE
.	0

Associated	I-DISEASE
Features	I-DISEASE
Tumors	I-DISEASE
of	I-DISEASE
neural	0
origin	I-DISEASE
such	0
as	0
ganglioneuroma	0
may	0
occur	I-DISEASE
.	0

Clinical	I-DISEASE
and	0
Pathophysiological	I-DISEASE
Subtypes	I-DISEASE
None	I-DISEASE
known	I-DISEASE
.	I-DISEASE

Demographics	I-DISEASE
There	0
are	0
no	0
prevalence	I-DISEASE
data	0
.	0

The	I-DISEASE
disorder	I-DISEASE
seems	I-DISEASE
to	I-DISEASE
occur	0
equally	0
among	0
males	I-DISEASE
and	0
females	0
.	0

Predisposing	I-DISEASE
and	0
Precipitating	0
Factors	0
Unknown	0
.	0

Patients	I-DISEASE
do	0
not	0
have	0
the	0
PHOX2B	0
genetic	I-DISEASE
mutation	I-DISEASE
of	I-DISEASE
congenital	0
central	I-DISEASE
hypoventilation	0
syndrome	0
.	0

Familial	I-DISEASE
Patterns	I-DISEASE
Familial	I-DISEASE
cases	0
have	0
not	0
been	I-DISEASE
reported	I-DISEASE
.	0

Onset	I-DISEASE
,	0
Course	0
,	0
and	0
Complications	0
Patients	0
are	I-DISEASE
typically	0
normal	0
at	I-DISEASE
birth	I-DISEASE
.	0

Obesity	I-DISEASE
often	0
begins	I-DISEASE
in	0
early	0
childhood	0
,	I-DISEASE
perhaps	0
because	0
the	0
child	0
is	I-DISEASE
old	I-DISEASE
enough	0
to	I-DISEASE
walk	I-DISEASE
around	I-DISEASE
and	0
obtain	0
his	0
/	0
her	0
own	0
food	0
.	0

Respiratory	I-DISEASE
failure	0
typically	B-DISEASE
presents	0
several	I-DISEASE
years	0
after	0
the	0
onset	I-DISEASE
of	I-DISEASE
obesity	0
,	I-DISEASE
and	0
requires	I-DISEASE
ventila-	0
tory	0
support	0
via	I-DISEASE
face	I-DISEASE
mask	0
or	I-DISEASE
tracheostomy	0
.	0

The	I-DISEASE
respiratory	I-DISEASE
failure	0
does	I-DISEASE
not	0
improve	0
over	0
time	I-DISEASE
.	0

Death	I-DISEASE
has	0
been	I-DISEASE
reported	I-DISEASE
from	0
respiratory	I-DISEASE
failure	0
,	I-DISEASE
cor	0
pulmonale	0
,	0
or	I-DISEASE
hyper-	I-DISEASE
natremia	0
secondary	0
to	0
diabetes	I-DISEASE
insipidus	I-DISEASE
;	I-DISEASE
case	I-DISEASE
series	I-DISEASE
have	0
reported	0
a	0
high	I-DISEASE
mortality	0
.	0

Developmental	I-DISEASE
Issues	0
Not	I-DISEASE
applicable	0
.	0

Pathology	I-DISEASE
and	0
Pathophysiology	I-DISEASE
The	I-DISEASE
cause	0
of	I-DISEASE
the	0
disorder	I-DISEASE
is	I-DISEASE
not	0
known	I-DISEASE
.	0

The	I-DISEASE
brain	I-DISEASE
typically	0
appears	I-DISEASE
normal	0
on	0
imaging	I-DISEASE
or	I-DISEASE
at	I-DISEASE
autopsy	0
,	I-DISEASE
or	I-DISEASE
may	I-DISEASE
show	I-DISEASE
secondary	0
signs	I-DISEASE
of	I-DISEASE
hypoxemia	0
.	0

Objective	I-DISEASE
Findings	I-DISEASE
Hypoxemia	I-DISEASE
and	0
hypercapnia	I-DISEASE
are	0
present	I-DISEASE
on	0
PSG	0
during	I-DISEASE
sleep	0
.	0

Central	I-DISEASE
apneas	0
may	I-DISEASE
be	I-DISEASE
present	I-DISEASE
,	0
but	0
hypoventilation	0
associated	0
with	I-DISEASE
decreased	I-DISEASE
tidal	0
volume	0
and	0
respiratory	0
rate	I-DISEASE
is	0
more	0
common	I-DISEASE
.	0

Obstructive	I-DISEASE
apneas	0
may	0
occur	0
but	0
are	0
not	0
the	0
primary	0
abnormality	0
.	0

Sleep	I-DISEASE
Related	I-DISEASE
Breathing	0
Disorders	I-DISEASE
Sleep	0
Related	0
Breathing	0
Disorders	I-DISEASE
Patients	0
have	I-DISEASE
flat	I-DISEASE
hypoxic	I-DISEASE
and	0
hypercapnic	I-DISEASE
responses	I-DISEASE
.	0

Oxygen	I-DISEASE
and	0
carbon	0
dioxide	I-DISEASE
determinations	0
may	0
be	0
normal	0
during	I-DISEASE
wakefulness	I-DISEASE
but	0
will	0
demonstrate	I-DISEASE
hypoxemia	I-DISEASE
and	0
hypercapnia	I-DISEASE
during	I-DISEASE
sleep	0
.	0

In	I-DISEASE
patients	0
with	0
chronically	I-DISEASE
untreated	I-DISEASE
or	B-DISEASE
poorly	0
con-	0
trolled	I-DISEASE
hypoventilation	0
,	0
a	0
compensated	0
respiratory	B-DISEASE
acidosis	I-DISEASE
may	0
be	I-DISEASE
present	I-DISEASE
,	I-DISEASE
with	I-DISEASE
ele-	B-DISEASE
vated	I-DISEASE
serum	I-DISEASE
bicarbonate	0
levels	0
.	0

In	I-DISEASE
these	I-DISEASE
patients	0
,	I-DISEASE
polycythemia	0
may	0
be	0
present	I-DISEASE
.	I-DISEASE

Serum	I-DISEASE
tests	0
may	I-DISEASE
show	0
evidence	0
of	I-DISEASE
endocrine	I-DISEASE
abnormalities	0
;	I-DISEASE
hypernatremia	I-DISEASE
is	0
common	0
.	0

Computed	I-DISEASE
tomography	I-DISEASE
and	0
MRI	0
scans	0
of	I-DISEASE
the	I-DISEASE
head	I-DISEASE
are	0
normal	0
.	0

Electrocardiography	I-DISEASE
,	I-DISEASE
echocardiography	I-DISEASE
,	I-DISEASE
or	I-DISEASE
cardiac	I-DISEASE
catheterization	0
may	0
reveal	0
evidence	0
of	I-DISEASE
pulmonary	I-DISEASE
hyper-	I-DISEASE
tension	0
.	I-DISEASE

Pulmonary	I-DISEASE
function	0
tests	I-DISEASE
may	I-DISEASE
be	I-DISEASE
normal	0
or	0
show	I-DISEASE
evidence	I-DISEASE
of	I-DISEASE
mild	I-DISEASE
obstructive	0
or	0
restrictive	0
lung	I-DISEASE
disease	I-DISEASE
resulting	0
from	I-DISEASE
associated	0
conditions	I-DISEASE
such	I-DISEASE
as	0
tracheitis	I-DISEASE
.	0

Differential	I-DISEASE
Diagnosis	0

The	I-DISEASE
disorder	I-DISEASE
can	0
be	I-DISEASE
distinguished	0
from	I-DISEASE
late	I-DISEASE
presentation	0
of	I-DISEASE
congenital	0
central	I-DISEASE
hypoven-	I-DISEASE
tilation	0
syndrome	I-DISEASE
by	I-DISEASE
testing	0
for	0
the	0
PHOX2B	I-DISEASE
gene	0
.	B-DISEASE

Genetic	I-DISEASE
testing	0
may	I-DISEASE
also	0
be	I-DISEASE
useful	0
in	I-DISEASE
distinguishing	0
the	0
disorder	0
from	I-DISEASE
Prader	I-DISEASE
-	I-DISEASE
Willi	0
syndrome	0
,	0
which	0
is	0
characterized	0
by	B-DISEASE
a	0
known	I-DISEASE
genetic	0
abnormality	I-DISEASE
.	0

Most	I-DISEASE
children	I-DISEASE
with	0
Prader	0
-	0
Willi	0
syndrome	0
have	0
hypotonia	I-DISEASE
at	I-DISEASE
birth	I-DISEASE
and	0
more	0
severe	0
developmental	I-DISEASE
delay	0
.	0

The	I-DISEASE
disorder	I-DISEASE
can	0
be	I-DISEASE
distinguished	0
from	I-DISEASE
obesity	0
hypoventilation	0
syndrome	I-DISEASE
by	B-DISEASE
the	0
presence	0
of	I-DISEASE
endocrine	0
abnormalities	I-DISEASE
and	0
other	0
associated	0
hypothalamic	0
abnormalities	I-DISEASE
,	0
and	0
by	B-DISEASE
the	0
persistence	0
of	I-DISEASE
hypoventilation	0
despite	0
weight	I-DISEASE
loss	I-DISEASE
.	0

In	I-DISEASE
addition	0
,	0
the	0
patients	0
typically	B-DISEASE
have	0
a	I-DISEASE
totally	0
flat	0
hypercapnic	0
ventilatory	0
response	0
rather	0
than	0
the	0
blunted	0
response	0
seen	I-DISEASE
in	I-DISEASE
children	0
with	I-DISEASE
obesity	0
hypoventilation	I-DISEASE
syndrome	0
.	0

The	I-DISEASE
disorder	I-DISEASE
should	0
be	I-DISEASE
distinguished	0
from	I-DISEASE
isolated	I-DISEASE
hypopituitarism	I-DISEASE
or	0
other	I-DISEASE
hypothalamic	I-DISEASE
disease	I-DISEASE
without	0
hypoventilation	I-DISEASE
,	I-DISEASE
and	0
from	I-DISEASE
obesity	0
-	I-DISEASE
related	0
OSA	I-DISEASE
.	0

Unresolved	I-DISEASE
Issues	0
and	0
Further	I-DISEASE
Directions	0

The	I-DISEASE
etiology	0
of	I-DISEASE
the	0
disorder	I-DISEASE
is	I-DISEASE
not	0
known	I-DISEASE
.	0

Although	I-DISEASE
the	0
disorder	0
shares	I-DISEASE
some	0
fea-	I-DISEASE
tures	0
of	I-DISEASE
congenital	0
central	0
hypoventilation	I-DISEASE
syndrome	I-DISEASE
,	0
including	0
the	B-DISEASE
presence	0
of	I-DISEASE
neural	0
tumors	I-DISEASE
,	I-DISEASE
it	I-DISEASE
does	I-DISEASE
not	0
share	0
the	B-DISEASE
same	0
gene	0
.	0

Little	I-DISEASE
information	0
is	0
available	0
on	0
prevalence	0
or	0
long	I-DISEASE
-	0
term	0
prognosis	0
.	0

Bibliography	0
Ize	0
-	0
Ludlow	I-DISEASE
D	0
,	0
Gray	0
JA	I-DISEASE
,	0
Sperling	I-DISEASE
MA	0
,	0
et	0
al	I-DISEASE
.	0

Rapid	I-DISEASE
-	I-DISEASE
onset	0
obesity	0
with	I-DISEASE
hypothalamic	I-DISEASE
dysfunction	0
,	0
hypoventilation	I-DISEASE
,	I-DISEASE
and	0
autonomic	0
dysregulation	0
presenting	I-DISEASE
in	I-DISEASE
childhood	0
.	0

Pediatrics	I-DISEASE
2007;120	I-DISEASE
:	0
e179–88	0
.	0

Katz	I-DISEASE
ES	0
,	I-DISEASE
McGrath	0
S	I-DISEASE
,	0
Marcus	I-DISEASE
CL	0
.	0

Late	I-DISEASE
-	I-DISEASE
onset	0
central	0
hypoventilation	0
with	0
hypothalamic	I-DISEASE
dysfunction	0
:	0
a	0
distinct	0
clinical	0
syndrome	0
.	0

Pediatr	I-DISEASE
Pulmonol	0
2000;29:62–8	I-DISEASE
.	0

Idiopathic	I-DISEASE
Central	I-DISEASE
Alveolar	0
Hypoventilation	I-DISEASE
ICD-9	I-DISEASE
-	I-DISEASE
CM	I-DISEASE
code	0
:	I-DISEASE
327.24	0
ICD-10	I-DISEASE
-	I-DISEASE
CM	I-DISEASE
code	0
:	B-DISEASE

G47.34	I-DISEASE
Alternate	0
Names	I-DISEASE
Alveolar	I-DISEASE
hypoventilation	0
,	0
central	0
alveolar	I-DISEASE
hypoventilation	0
,	I-DISEASE
idiopathic	B-DISEASE
central	0
alveolar	I-DISEASE
hypoventilation	0
,	0
nonapneic	I-DISEASE
alveolar	0
hypoventilation	I-DISEASE
,	0
primary	0
alveolar	0
hypoventilation	I-DISEASE
.	0

Diagnostic	I-DISEASE
Criteria	0
Criteria	I-DISEASE
A	0
and	0
B	0
must	I-DISEASE
be	0
met	0
A.	0
Sleep	0
related	0
hypoventilation	I-DISEASE
is	I-DISEASE
present	0
.	0

B.	0
Hypoventilation	I-DISEASE
is	I-DISEASE
not	0
primarily	0
due	I-DISEASE
to	I-DISEASE
lung	I-DISEASE
parenchymal	0
or	I-DISEASE
airway	0
disease	I-DISEASE
,	0
pulmonary	I-DISEASE
vascular	B-DISEASE
pathology	0
,	0
chest	0
wall	I-DISEASE
disorder	I-DISEASE
,	I-DISEASE
medication	0
use	0
,	0
neurologic	0
disorder	I-DISEASE
,	0
muscle	0
weakness	0
,	0
or	0
obesity	0
or	I-DISEASE
congenital	I-DISEASE
hypoventilation	0
syndromes	0
.	0

Notes	I-DISEASE
.	0

The	I-DISEASE
predominant	I-DISEASE
respiratory	B-DISEASE
pattern	0
is	0
one	0
of	I-DISEASE
reduced	I-DISEASE
tidal	0
volume	0
or	0
ataxic	I-DISEASE
breathing	0
with	0
associated	0
arterial	I-DISEASE
oxygen	0
desaturation	I-DISEASE
.	0

Although	I-DISEASE
OSA	I-DISEASE
may	I-DISEASE
be	0
present	I-DISEASE
,	I-DISEASE
it	I-DISEASE
is	0
not	0
believed	I-DISEASE
to	I-DISEASE
be	I-DISEASE
the	0
major	0
cause	I-DISEASE
of	I-DISEASE
hypoventilation	I-DISEASE
.	0

When	I-DISEASE
criteria	I-DISEASE
are	0
met	0
,	0
a	0
diagnosis	I-DISEASE
of	I-DISEASE
both	I-DISEASE
OSA	0
and	0
idiopathic	I-DISEASE
central	0
alveolar	I-DISEASE
hypoventilation	0
may	I-DISEASE
be	I-DISEASE
made	0
.	I-DISEASE
.	0

Arterial	I-DISEASE
oxygen	0
desaturation	I-DISEASE
is	0
often	0
present	0
but	0
is	0
not	0
required	I-DISEASE
for	I-DISEASE
the	0
diagnosis	I-DISEASE
.	0

Essential	I-DISEASE
Features	I-DISEASE
Idiopathic	0
central	0
alveolar	I-DISEASE
hypoventilation	0
is	0
defined	I-DISEASE
as	0
the	I-DISEASE
presence	0
of	0
decreased	I-DISEASE
alve-	I-DISEASE
olar	0
ventilation	0
resulting	I-DISEASE
in	I-DISEASE
sleep	0
related	I-DISEASE
hypercapnia	I-DISEASE
and	0
hypoxemia	I-DISEASE
in	0
individuals	I-DISEASE
with	0
presumed	0
normal	0
mechanical	I-DISEASE
properties	I-DISEASE
of	I-DISEASE
the	I-DISEASE
lung	I-DISEASE
and	0
respiratory	B-DISEASE
pump	0
.	0

Thus	I-DISEASE
,	I-DISEASE
chronic	0
hypoventilation	I-DISEASE
during	I-DISEASE
sleep	0
exists	0
without	0
any	I-DISEASE
readily	I-DISEASE
identifiable	B-DISEASE
impairments	I-DISEASE
of	I-DISEASE
res-	0
piration	0
,	I-DISEASE
such	0
as	0
pulmonary	I-DISEASE
airway	0
or	0
parenchymal	0
conditions	I-DISEASE
,	0
neurologic	0
,	I-DISEASE
neuromus-	0
cular	0
or	0
chest	0
wall	I-DISEASE
abnormalities	0
,	I-DISEASE
severe	I-DISEASE
obesity	0
,	0
other	0
sleep	I-DISEASE
related	B-DISEASE
breathing	B-DISEASE
disorder	0
,	0
or	0
use	I-DISEASE
of	I-DISEASE
respiratory	I-DISEASE
depressant	I-DISEASE
medications	0
or	I-DISEASE
substances	0
.	0

Diurnal	I-DISEASE
as	0
well	0
as	0
nocturnal	0
hypoventilation	0
is	I-DISEASE
believed	0
to	I-DISEASE
be	I-DISEASE
due	I-DISEASE
primarily	0
to	0
blunted	I-DISEASE
chemoresponsiveness	I-DISEASE
to	I-DISEASE
CO2	I-DISEASE
and	0
O2	B-DISEASE
.	0

However	I-DISEASE
,	I-DISEASE
reported	0
cases	0
are	0
few	0
and	0
not	0
studied	0
in	0
enough	I-DISEASE
detail	0
to	I-DISEASE
conclu-	I-DISEASE
sively	I-DISEASE
establish	0
a	0
well	I-DISEASE
-	0
defined	I-DISEASE
etiology	0
.	0

Alternatively	I-DISEASE
,	I-DISEASE
these	0
cases	0
may	0
represent	0
a	0
mixed	I-DISEASE
group	I-DISEASE
of	I-DISEASE
patients	0
with	I-DISEASE
varied	I-DISEASE
underlying	0
conditions	0
erroneously	0
deemed	0
idiopathic	0
as	0
a	0
result	0
of	I-DISEASE
incomplete	0
diagnostic	0
work	I-DISEASE
-	I-DISEASE
up	I-DISEASE
.	0

Patient	I-DISEASE
may	0
complain	I-DISEASE
of	0
morning	I-DISEASE
headaches	I-DISEASE
,	0
fatigue	I-DISEASE
,	0
neurocognitive	0
decline	0
and	0
sleep	0
disturbance	0
,	I-DISEASE
or	I-DISEASE
may	I-DISEASE
be	0
entirely	0
asymptomatic	0
.	0

Frequent	I-DISEASE
episodes	I-DISEASE
of	I-DISEASE
shallow	0
breathing	I-DISEASE
may	I-DISEASE
be	0
noted	0
to	I-DISEASE
occur	I-DISEASE
during	I-DISEASE
sleep	I-DISEASE
.	0

Sleep	I-DISEASE
Related	0
Breathing	0
Disorders	I-DISEASE
Sleep	0
Related	0
Breathing	0
Disorders	I-DISEASE
Associated	0
Features	I-DISEASE
Consequences	0
of	I-DISEASE
chronic	I-DISEASE
hypercapnia	0
and	0
hypoxemia	I-DISEASE
include	I-DISEASE
pulmonary	I-DISEASE
artery	0
hyper-	I-DISEASE
tension	0
,	0
cor	0
pulmonale	0
,	0
and	0
neurocognitive	0
dysfunction	0
.	0

Patients	I-DISEASE
with	0
other	I-DISEASE
comorbid	0
sleep	0
related	B-DISEASE
breathing	0
disorders	0
are	0
likely	I-DISEASE
to	I-DISEASE
experience	0
greater	I-DISEASE
severity	I-DISEASE
and	0
dura-	0
tion	0
of	I-DISEASE
sleep	0
related	B-DISEASE
hypoventilation	0
than	I-DISEASE
are	0
patients	0
with	I-DISEASE
isolated	0
idiopathic	I-DISEASE
central	0
hypoventilation	0
.	0

Clinical	I-DISEASE
and	0
Pathophysiological	0
Subtypes	I-DISEASE
Not	I-DISEASE
applicable	0
or	I-DISEASE
known	I-DISEASE
.	0

Demographics	I-DISEASE
Not	0
known	I-DISEASE
.	0

It	I-DISEASE
is	I-DISEASE
likely	0
that	0
some	0
patients	I-DISEASE
with	I-DISEASE
this	I-DISEASE
diagnosis	0
may	0
have	0
an	0
underlying	I-DISEASE
anatomic	I-DISEASE
or	I-DISEASE
functional	I-DISEASE
defect	0
affecting	0
respiratory	I-DISEASE
mechanics	I-DISEASE
and	0
ventilatory	0
drive	0
which	0
remains	0
undiagnosed	I-DISEASE
.	0

Predisposing	I-DISEASE
and	0
Precipitating	I-DISEASE
Factors	0
The	I-DISEASE
use	I-DISEASE
of	I-DISEASE
central	0
nervous	0
system	0
depressants	I-DISEASE
,	0
such	0
as	0
alcohol	0
,	I-DISEASE
anxiolytics	I-DISEASE
,	0
and	0
hyp-	I-DISEASE
notics	0
,	0
may	0
further	I-DISEASE
worsen	0
hypercapnia	0
/	I-DISEASE
hypoxemia	I-DISEASE
.	0

Patients	I-DISEASE
who	0
are	I-DISEASE
hypercapnic	0
and	0
hypoxemic	0
during	I-DISEASE
wakefulness	0
will	0
generally	0
become	0
even	I-DISEASE
more	0
so	0
during	I-DISEASE
sleep	0
,	I-DISEASE
in	0
particular	I-DISEASE
REM	0
sleep	0
,	I-DISEASE
but	0
the	0
relationship	I-DISEASE
between	0
wake	0
SaO2	0
/	0
PaCO2	0
and	0
sleep	0
related	I-DISEASE
desaturation	I-DISEASE
is	0
not	0
sufficiently	0
strong	I-DISEASE
to	I-DISEASE
have	0
substantial	0
predictive	I-DISEASE
value	0
in	0
individual	0
patients	I-DISEASE
.	I-DISEASE

Familial	I-DISEASE
Patterns	I-DISEASE
Not	I-DISEASE
applicable	0
or	B-DISEASE
known	0
.	0

Onset	I-DISEASE
,	0
Course	0
,	0
and	0
Complications	I-DISEASE
The	I-DISEASE
onset	I-DISEASE
of	I-DISEASE
the	0
condition	0
is	I-DISEASE
variable	I-DISEASE
,	I-DISEASE
often	0
presenting	0
in	I-DISEASE
adolescence	0
or	I-DISEASE
early	I-DISEASE
adulthood	0
.	I-DISEASE

The	I-DISEASE
disorder	I-DISEASE
is	0
generally	I-DISEASE
slowly	I-DISEASE
progressive	0
.	0

Many	0
affected	I-DISEASE
individuals	I-DISEASE
with	I-DISEASE
severe	0
hypercapnia	0
and	0
hypoxemia	0
develop	0
respiratory	I-DISEASE
impairment	0
,	0
pulmonary	I-DISEASE
hypertension	0
,	I-DISEASE
heart	0
failure	I-DISEASE
,	0
cardiac	0
arrhythmias	0
,	0
and	0
neurocognitive	0
dysfunction	0
.	0

Polycythemia	I-DISEASE
is	0
common	I-DISEASE
in	I-DISEASE
those	0
with	0
chronic	0
hypoxia	I-DISEASE
.	0

Although	I-DISEASE
the	0
risk	0
of	I-DISEASE
increased	0
morbidity	I-DISEASE
and	0
mortality	I-DISEASE
appears	I-DISEASE
to	I-DISEASE
increase	I-DISEASE
with	0
worsening	0
sleep	0
related	0
hypoventilation	0
/	0
hypoxemia	I-DISEASE
,	I-DISEASE
the	0
specific	I-DISEASE
relationship	0
between	0
sleep	0
related	B-DISEASE
hypoventilation	I-DISEASE
/	0
hypoxemia	0
and	0
mor-	0
bidity	0
and	0
mortality	I-DISEASE
is	0
not	0
well	I-DISEASE
defined	I-DISEASE
.	0

Developmental	I-DISEASE
Issues	0
Not	I-DISEASE
known	0
.	0

Pathology	I-DISEASE
and	0
Pathophysiology	I-DISEASE
The	I-DISEASE
etiology	0
of	I-DISEASE
hypoventilation	I-DISEASE
in	I-DISEASE
these	0
patients	0
is	I-DISEASE
not	0
understood	0
.	0

Chronic	I-DISEASE
hyper-	0
capnia	0
and	0
hypoxemia	0
in	I-DISEASE
idiopathic	B-DISEASE
central	0
alveolar	I-DISEASE
hypoventilation	I-DISEASE
is	I-DISEASE
believed	0
to	I-DISEASE
be	0
due	I-DISEASE
to	I-DISEASE
defective	0
CO2	I-DISEASE
and	0
O2	I-DISEASE
homeostasis	I-DISEASE
,	0
with	0
impaired	0
CO2	I-DISEASE
unloading	I-DISEASE
,	I-DISEASE
reduced	0
chemoresponsiveness	0
to	0
CO2	I-DISEASE
and	0
O2	0
,	I-DISEASE
and	0
suppression	0
of	I-DISEASE
respiratory	0
drive	0
.	0

Imaging	I-DISEASE
of	I-DISEASE
the	0
central	0
nervous	I-DISEASE
system	0
does	I-DISEASE
not	0
document	0
a	0
structural	0
defect	I-DISEASE
.	0

Hypoventilation	I-DISEASE
worsens	0
during	I-DISEASE
sleep	0
compared	0
to	0
waking	0
levels	I-DISEASE
due	I-DISEASE
to	0
a	0
further	I-DISEASE
reduction	I-DISEASE
in	0
che-	0
mosensitivity	0
and	0
decreased	I-DISEASE
activity	I-DISEASE
of	I-DISEASE
the	B-DISEASE
ventilatory	0
muscles	0
.	0

Additionally	I-DISEASE
,	I-DISEASE
daytime	0
hypoxemia	I-DISEASE
,	I-DISEASE
if	0
sufficiently	I-DISEASE
severe	I-DISEASE
,	I-DISEASE
may	I-DISEASE
place	I-DISEASE
the	0
patient	I-DISEASE
near	0
or	I-DISEASE
on	0
the	0
steep	0
portion	0
of	I-DISEASE
the	0
oxyhemoglobin	0
dissociation	0
curve	I-DISEASE
where	0
even	I-DISEASE
relatively	0
small	0
decrements	0
in	I-DISEASE
arterial	0
oxygen	I-DISEASE
tension	0
result	I-DISEASE
in	I-DISEASE
large	I-DISEASE
decrements	0
in	0
oxyhemoglobin	0
saturation	0
.	0

Thus	I-DISEASE
,	I-DISEASE
sleep	0
related	0
hypoventilation	0
in	0
these	I-DISEASE
patients	I-DISEASE
may	I-DISEASE
have	I-DISEASE
a	0
relatively	0
great	I-DISEASE
impact	I-DISEASE
on	0
oxyhemoglobin	0
saturation	I-DISEASE
.	0

Objective	I-DISEASE
Findings	I-DISEASE

The	I-DISEASE
characteristic	I-DISEASE
polysomnographic	0
finding	0
is	0
demonstration	0
of	I-DISEASE
sleep	I-DISEASE
related	B-DISEASE
hypoventilation	0
(	0
determination	0
of	I-DISEASE
PaCO2	0
by	I-DISEASE
arterial	0
blood	0
gas	I-DISEASE
or	I-DISEASE
by	B-DISEASE
a	0
surrogate	0
measure	0
[	0
end	0
-	0
tidal	0
CO2	0
or	0
transcutaneous	0
CO2	I-DISEASE
]	0
)	0
.	0

Periods	I-DISEASE
of	I-DISEASE
decreased	I-DISEASE
tidal	0
volume	I-DISEASE
lasting	0
up	I-DISEASE
to	0
several	0
minutes	0
,	I-DISEASE
with	I-DISEASE
sustained	0
arterial	0
oxygen	I-DISEASE
desaturation	I-DISEASE
,	I-DISEASE
are	0
usually	I-DISEASE
present	I-DISEASE
.	0

Intermittent	0
arousals	0
may	0
be	I-DISEASE
observed	0
.	0

Daytime	I-DISEASE
arterial	0
blood	0
gases	I-DISEASE
may	I-DISEASE
be	I-DISEASE
normal	0
or	0
show	I-DISEASE
hypoxia	I-DISEASE
and	0
hypercapnia	I-DISEASE
.	0

Chronic	I-DISEASE
hypoxia	0
can	0
be	I-DISEASE
associated	0
with	0
polycythemia	0
.	0

Electrocardiography	I-DISEASE
,	I-DISEASE
chest	I-DISEASE
radiography	0
,	I-DISEASE
and	0
echocardiography	I-DISEASE
may	I-DISEASE
demonstrate	I-DISEASE
evidence	0
of	I-DISEASE
pulmonary	I-DISEASE
hypertension	I-DISEASE
.	I-DISEASE

Central	I-DISEASE
nervous	I-DISEASE
system	0
imaging	0
is	0
generally	I-DISEASE
unremarkable	I-DISEASE
.	0

Differential	I-DISEASE
Diagnosis	0

The	I-DISEASE
differential	0
diagnosis	0
includes	I-DISEASE
any	I-DISEASE
disorder	I-DISEASE
that	0
can	I-DISEASE
cause	I-DISEASE
hypoventilation	0
during	I-DISEASE
sleep	0
.	0

This	I-DISEASE
includes	I-DISEASE
obesity	0
hypoventilation	0
syndrome	0
,	0
pulmonary	I-DISEASE
airway	I-DISEASE
and	0
paren-	0
chymal	0
disorders	0
,	0
pulmonary	I-DISEASE
vascular	I-DISEASE
pathology	I-DISEASE
,	I-DISEASE
neuromuscular	0
and	0
chest	0
wall	I-DISEASE
dis-	I-DISEASE
orders	I-DISEASE
,	0
severe	0
untreated	I-DISEASE
hypothyroidism	I-DISEASE
,	0
and	0
use	0
of	I-DISEASE
respiratory	B-DISEASE
suppressants	0
.	0

CCHS	I-DISEASE
is	0
associated	0
with	0
an	I-DISEASE
abnormal	I-DISEASE
PHOX2B	0
gene	I-DISEASE
.	0

Unlike	I-DISEASE
patients	0
with	0
late	I-DISEASE
-	0
onset	I-DISEASE
central	0
hypoventilation	I-DISEASE
with	I-DISEASE
hypothalamic	I-DISEASE
dysfunction	0
,	0
patients	0
with	I-DISEASE
idiopathic	I-DISEASE
central	0
hypoventilation	I-DISEASE
do	0
not	0
have	0
evidence	0
of	0
hypothalamic	0
dysfunction	0
.	0

It	I-DISEASE
is	I-DISEASE
essential	0
to	I-DISEASE
excluded	0
medical	0
and	0
neurological	0
disorders	0
that	0
are	I-DISEASE
associated	0
with	0
hypoventilation	I-DISEASE
before	I-DISEASE
a	0
diagnosis	I-DISEASE
of	I-DISEASE
idiopathic	I-DISEASE
central	0
hypoventilation	I-DISEASE
can	0
be	I-DISEASE
made	0
.	0

OSA	I-DISEASE
and	0
CSA	0
syndromes	I-DISEASE
can	I-DISEASE
be	0
distinguished	0
from	I-DISEASE
sleep	0
related	I-DISEASE
hypoventilation	I-DISEASE
by	0
the	0
periodic	I-DISEASE
alterations	0
in	I-DISEASE
airflow	0
and	0
accompanying	0
periodic	I-DISEASE
fluctuations	I-DISEASE
in	I-DISEASE
SaO2	0
.	0

In	I-DISEASE
contrast	I-DISEASE
,	0
oxygen	I-DISEASE
desaturation	0
due	I-DISEASE
to	0
sleep	0
related	B-DISEASE
hypoventilation	I-DISEASE
is	I-DISEASE
generally	I-DISEASE
more	0
sustained	0
,	I-DISEASE
usually	I-DISEASE
several	I-DISEASE
minutes	0
or	I-DISEASE
longer	I-DISEASE
in	0
duration	0
.	0

When	I-DISEASE
more	0
than	0
one	I-DISEASE
disorder	0
is	I-DISEASE
believed	I-DISEASE
Sleep	I-DISEASE
Related	0
Breathing	0
Disorders	I-DISEASE
Sleep	I-DISEASE
Related	I-DISEASE
Breathing	0
Disorders	I-DISEASE
to	I-DISEASE
be	0
responsible	I-DISEASE
for	0
the	I-DISEASE
ventilatory	0
insufficiency	I-DISEASE
during	I-DISEASE
sleep	0
,	I-DISEASE
all	0
pertinent	0
diagnoses	0
should	I-DISEASE
be	I-DISEASE
coded	0
.	0

Unresolved	I-DISEASE
Issues	0
and	0
Further	I-DISEASE
Directions	0

A	I-DISEASE
better	I-DISEASE
understanding	0
of	I-DISEASE
the	0
etiology	0
of	I-DISEASE
idiopathic	B-DISEASE
central	0
alveolar	I-DISEASE
hypoventilation	I-DISEASE
is	I-DISEASE
essential	0
to	I-DISEASE
guide	0
preventive	I-DISEASE
and	0
treatment	I-DISEASE
measures	0
.	0

Because	I-DISEASE
it	0
is	0
clinically	I-DISEASE
imprac-	I-DISEASE
tical	0
to	0
routinely	0
obtain	I-DISEASE
arterial	I-DISEASE
blood	I-DISEASE
samples	I-DISEASE
during	I-DISEASE
sleep	0
in	0
most	0
persons	0
suspected	I-DISEASE
of	I-DISEASE
this	0
disorder	I-DISEASE
,	0
other	I-DISEASE
techniques	0
of	I-DISEASE
measuring	I-DISEASE
CO2	I-DISEASE
levels	0
must	0
be	0
investigated	0
.	0

The	I-DISEASE
degree	I-DISEASE
and	0
duration	0
of	0
hypercapnia	I-DISEASE
/	0
hypoxemia	0
necessary	0
to	0
produce	0
adverse	I-DISEASE
conse-	0
quences	0
,	0
such	0
as	0
pulmonary	0
hypertension	I-DISEASE
,	I-DISEASE
in	0
individual	I-DISEASE
patients	I-DISEASE
is	0
not	0
well	0
defined	I-DISEASE
.	0

Little	I-DISEASE
information	0
is	0
available	I-DISEASE
regarding	0
the	I-DISEASE
effect	0
of	I-DISEASE
oxygen	0
therapy	0
or	0
noninvasive	I-DISEASE
ventilation	0
on	0
the	0
course	I-DISEASE
of	I-DISEASE
the	0
underlying	0
disease	I-DISEASE
.	0

Studies	I-DISEASE
are	I-DISEASE
needed	0
to	I-DISEASE
determine	0
the	0
optimal	0
time	I-DISEASE
to	0
initiate	0
these	I-DISEASE
interventions	I-DISEASE
and	0
the	0
specific	I-DISEASE
subpopulations	I-DISEASE
of	0
patients	I-DISEASE
who	I-DISEASE
will	0
benefit	0
most	0
from	I-DISEASE
these	0
therapies	I-DISEASE
.	0

Bibliography	0
Brown	I-DISEASE
LK	0
.	0

Hypoventilation	I-DISEASE
syndromes	I-DISEASE
.	0

Clin	I-DISEASE
Chest	I-DISEASE
Med	0
2010;31:249–70	I-DISEASE
.	0

Casey	0
KR	0
,	I-DISEASE
Cantillo	0
KO	I-DISEASE
,	0
Brown	I-DISEASE
LK	0
.	0

Sleep	I-DISEASE
-	I-DISEASE
related	0
hypoventilation	I-DISEASE
/	0
hypoxemic	0
syndromes	I-DISEASE
.	0

Chest	I-DISEASE
2007;131:1936–48	0
.	0

Chebbo	I-DISEASE
A	0
,	0
Tfaili	0
A	0
,	0
Jones	0
SF	0
.	I-DISEASE

Hypoventilation	I-DISEASE
syndromes	I-DISEASE
.	0

Med	I-DISEASE
Clin	0
North	0
Am	I-DISEASE
2011;95:1189–202	0
.	0

Sleep	I-DISEASE
Related	0
Hypoventilation	I-DISEASE
Due	0
to	0
a	0
Medication	I-DISEASE
or	I-DISEASE
Substance	I-DISEASE
ICD-9	0
-	I-DISEASE
CM	0
code	B-DISEASE
:	0
327.26	0
ICD-10	I-DISEASE
-	I-DISEASE
CM	I-DISEASE
code	0
:	0
G47.36	I-DISEASE
Alternate	0
Names	I-DISEASE
Alveolar	I-DISEASE
hypoventilation	I-DISEASE
,	0
nocturnal	0
hypoventilation	I-DISEASE
,	0
nonapneic	0
alveolar	0
hypoventila-	I-DISEASE
tion	0
,	0
secondary	0
alveolar	I-DISEASE
hypoventilation	I-DISEASE
,	I-DISEASE
sleep	0
related	I-DISEASE
hypoventilation	I-DISEASE
.	0

Diagnostic	I-DISEASE
Criteria	0
Criteria	I-DISEASE
A	0
-	I-DISEASE
C	I-DISEASE
must	I-DISEASE
be	0
met	0
A.	0
Sleep	0
related	0
hypoventilation	I-DISEASE
is	I-DISEASE
present	0
.	0

B.	0
A	0
medication	0
or	0
substance	I-DISEASE
known	I-DISEASE
to	I-DISEASE
inhibit	0
respiration	0
and/or	0
ventilatory	0
drive	0
is	0
believed	I-DISEASE
to	0
be	0
the	0
primary	0
cause	I-DISEASE
of	0
sleep	0
related	0
hypoventilation	I-DISEASE
.	0

C.	I-DISEASE
Hypoventilation	I-DISEASE
is	I-DISEASE
not	0
primarily	0
due	I-DISEASE
to	I-DISEASE
lung	I-DISEASE
parenchymal	0
or	I-DISEASE
airway	0
disease	I-DISEASE
,	0
pulmonary	I-DISEASE
vascular	B-DISEASE
pathology	0
,	0
chest	0
wall	I-DISEASE
disorder	I-DISEASE
,	I-DISEASE
neurologic	B-DISEASE
disorder	I-DISEASE
,	0
muscle	0
weakness	I-DISEASE
,	0
obesity	0
hypoventilation	0
syndrome	I-DISEASE
,	I-DISEASE
or	I-DISEASE
a	0
known	0
congenital	0
central	0
alveolar	I-DISEASE
hypoventilation	I-DISEASE
syndrome	I-DISEASE
.	0

Notes	I-DISEASE
.	0
.	0

3	I-DISEASE
.	0

Although	I-DISEASE
OSA	I-DISEASE
or	I-DISEASE
CSA	0
may	I-DISEASE
be	I-DISEASE
present	I-DISEASE
,	0
they	I-DISEASE
are	I-DISEASE
not	I-DISEASE
believed	I-DISEASE
to	0
be	I-DISEASE
the	0
major	I-DISEASE
cause	0
of	0
hypoventilation	I-DISEASE
.	0

The	I-DISEASE
predominant	I-DISEASE
respiratory	0
pattern	0
is	0
one	0
of	I-DISEASE
reduced	I-DISEASE
tidal	0
volume	0
or	0
ataxic	I-DISEASE
breathing	0
and	0
associated	0
arterial	I-DISEASE
oxygen	0
desaturation	I-DISEASE
.	0

When	I-DISEASE
criteria	I-DISEASE
are	0
met	0
,	0
a	0
diagnosis	I-DISEASE
of	I-DISEASE
both	I-DISEASE
OSA	0
and	0
CSA	I-DISEASE
due	0
to	I-DISEASE
medication	0
or	I-DISEASE
substance	0
as	0
well	I-DISEASE
as	0
sleep	0
related	B-DISEASE
hypoventilation	0
due	I-DISEASE
to	I-DISEASE
a	I-DISEASE
medication	0
or	I-DISEASE
substance	I-DISEASE
may	0
be	0
made	0
.	0

Arterial	I-DISEASE
desaturation	0
is	0
often	0
present	I-DISEASE
but	0
is	0
not	0
required	0
for	I-DISEASE
the	0
diagnosis	0
.	0

Hypoventilation	I-DISEASE
may	I-DISEASE
be	I-DISEASE
present	I-DISEASE
during	I-DISEASE
wakefulness	0
but	I-DISEASE
is	I-DISEASE
not	0
required	0
for	0
the	0
diagnosis	I-DISEASE
.	0

Essential	I-DISEASE
Features	I-DISEASE

This	I-DISEASE
disorder	I-DISEASE
is	0
characterized	0
primarily	0
by	I-DISEASE
chronic	I-DISEASE
hypoventilation	I-DISEASE
and	0
hypercapnia	I-DISEASE
due	I-DISEASE
to	0
prolonged	0
use	I-DISEASE
of	I-DISEASE
medications	I-DISEASE
or	B-DISEASE
substances	0
known	I-DISEASE
to	0
depress	I-DISEASE
ventilatory	0
drive	0
and/or	0
impair	0
respiratory	I-DISEASE
muscle	0
mechanics	0
.	0

These	0
agents	I-DISEASE
include	0
long	I-DISEASE
-	0
acting	I-DISEASE
nar-	0
cotics	0
,	I-DISEASE
anesthetics	I-DISEASE
,	I-DISEASE
sedative	I-DISEASE
compounds	I-DISEASE
,	0
and	0
muscle	0
relaxants	0
.	0

The	I-DISEASE
risk	0
of	I-DISEASE
respiratory	I-DISEASE
insufficiency	0
is	I-DISEASE
increased	0
with	0
the	0
concomitant	0
use	I-DISEASE
of	I-DISEASE
alcohol	I-DISEASE
or	0
with	0
polypharmacy	0
.	0

Respiratory	I-DISEASE
depressants	0
can	I-DISEASE
precipitate	0
respiratory	I-DISEASE
failure	I-DISEASE
in	0
patients	I-DISEASE
with	I-DISEASE
limited	I-DISEASE
pul-	0
monary	0
reserves	0
or	0
exacerbate	I-DISEASE
hypoventilation	I-DISEASE
in	I-DISEASE
those	0
with	I-DISEASE
baseline	0
hypercapnia	0
.	0

Hypoxemia	I-DISEASE
is	0
commonly	I-DISEASE
present	I-DISEASE
and	0
can	0
show	0
either	0
a	0
sustained	I-DISEASE
reduction	0
or	0
episodic	0
fluctuations	0
.	0

Sleep	I-DISEASE
related	0
hypoventilation	0
is	I-DISEASE
present	I-DISEASE
.	0

Hypercapnia	I-DISEASE
may	0
also	0
be	0
present	I-DISEASE
during	I-DISEASE
wakefulness	0
in	I-DISEASE
some	I-DISEASE
patients	I-DISEASE
.	0

Patients	I-DISEASE
can	0
either	I-DISEASE
be	0
asymptomatic	I-DISEASE
or	0
present	I-DISEASE
with	I-DISEASE
complaints	I-DISEASE
of	I-DISEASE
dyspnea	0
,	0
chest	I-DISEASE
tightness	0
,	I-DISEASE
or	I-DISEASE
fatigue	I-DISEASE
.	0

Neurocognitive	0
dysfunction	0
may	0
arise	I-DISEASE
following	0
use	I-DISEASE
of	I-DISEASE
narcotics	0
.	0

Associated	I-DISEASE
Features	I-DISEASE
Medications	0
and	0
substances	0
that	I-DISEASE
reduce	I-DISEASE
respiratory	0
drive	0
may	I-DISEASE
also	I-DISEASE
alter	I-DISEASE
the	0
mechanics	I-DISEASE
of	I-DISEASE
the	I-DISEASE
upper	0
airway	0
.	0

By	I-DISEASE
decreasing	I-DISEASE
upper	0
airway	0
muscle	I-DISEASE
tone	I-DISEASE
,	I-DISEASE
these	I-DISEASE
agents	0
may	I-DISEASE
pre-	I-DISEASE
cipitate	I-DISEASE
or	I-DISEASE
exacerbate	I-DISEASE
OSA	0
and	0
CSA	0
.	0

It	I-DISEASE
is	I-DISEASE
not	0
currently	0
known	0
whether	0
chronic	I-DISEASE
use	I-DISEASE
of	B-DISEASE
respiratory	B-DISEASE
depressants	0
will	0
eventually	0
give	I-DISEASE
rise	0
to	I-DISEASE
pulmonary	0
artery	0
hypertension	I-DISEASE
or	I-DISEASE
cor	B-DISEASE
pulmonale	0
,	B-DISEASE
but	0
this	0
seems	I-DISEASE
unlikely	0
.	0

Clinical	I-DISEASE
and	0
Pathophysiological	0
Subtypes	I-DISEASE
Not	I-DISEASE
applicable	0
or	I-DISEASE
known	I-DISEASE
.	0

Demographics	I-DISEASE
The	I-DISEASE
demographics	0
of	I-DISEASE
sleep	0
related	B-DISEASE
hypoventilation	I-DISEASE
due	0
to	I-DISEASE
use	I-DISEASE
of	I-DISEASE
respiratory	0
suppressants	0
are	0
not	0
known	I-DISEASE
.	0

It	I-DISEASE
is	I-DISEASE
clear	I-DISEASE
that	0
baseline	0
hypoventilation	I-DISEASE
prior	I-DISEASE
to	I-DISEASE
initiation	I-DISEASE
of	I-DISEASE
respiratory	I-DISEASE
Sleep	I-DISEASE
Related	I-DISEASE
Breathing	0
Disorders	I-DISEASE
Sleep	I-DISEASE
Related	0
Breathing	0
Disorders	I-DISEASE
depressant	I-DISEASE
medication	0
will	0
worsen	0
following	0
initiation	0
of	0
the	0
medication	0
.	I-DISEASE

Thus	I-DISEASE
,	I-DISEASE
preva-	0
lence	I-DISEASE
may	I-DISEASE
be	0
higher	0
in	0
patients	I-DISEASE
with	I-DISEASE
greater	I-DISEASE
perturbations	0
of	0
pulmonary	0
function	0
or	0
neuro-	0
muscular	I-DISEASE
weakness	0
.	0

Individuals	I-DISEASE
with	I-DISEASE
chronic	0
hypercapnia	I-DISEASE
during	I-DISEASE
wakefulness	0
will	0
expe-	I-DISEASE
rience	0
even	I-DISEASE
greater	I-DISEASE
decrements	0
of	I-DISEASE
alveolar	I-DISEASE
ventilation	I-DISEASE
during	I-DISEASE
sleep	0
.	0

Studies	I-DISEASE
of	I-DISEASE
patients	0
on	0
methadone	0
maintenance	I-DISEASE
have	0
generally	0
found	I-DISEASE
no	0
or	I-DISEASE
mild	0
daytime	0
hypoventilation	I-DISEASE
.	0

There	I-DISEASE
is	I-DISEASE
scant	0
literature	0
about	0
daytime	0
or	I-DISEASE
nocturnal	0
PaCO2	0
in	I-DISEASE
patients	0
on	0
potent	I-DISEASE
opioids	I-DISEASE
for	0
pain	0
.	0

Predisposing	I-DISEASE
and	0
Precipitating	I-DISEASE
Factors	0
The	I-DISEASE
use	I-DISEASE
of	I-DISEASE
medications	0
or	0
substances	0
that	0
impair	0
respiration	0
mechanics	I-DISEASE
or	0
drive	0
is	I-DISEASE
the	0
primary	0
pathophysiologic	0
factor	I-DISEASE
responsible	0
for	0
hypoventilation	0
and	0
hypoxemia	0
.	0

There	I-DISEASE
are	0
significant	0
inter	I-DISEASE
-	0
individual	I-DISEASE
differences	I-DISEASE
in	I-DISEASE
sensitivity	I-DISEASE
and	0
tolerance	0
to	I-DISEASE
respira-	I-DISEASE
tory	I-DISEASE
depressants	0
.	0

Obesity	I-DISEASE
or	0
the	0
presence	0
of	I-DISEASE
medical	0
and	0
neurologic	0
diseases	I-DISEASE
that	0
may	0
produce	0
hypoventilation	I-DISEASE
may	0
further	I-DISEASE
worsen	0
hypercapnia	I-DISEASE
/	0
hypoxemia	I-DISEASE
.	0

Patients	I-DISEASE
who	0
are	I-DISEASE
hypercapnic	0
and	0
hypoxemic	0
during	I-DISEASE
wakefulness	0
will	0
generally	0
become	0
even	I-DISEASE
more	0
so	0
during	I-DISEASE
sleep	0
,	I-DISEASE
in	0
particular	I-DISEASE
REM	0
sleep	0
,	I-DISEASE
but	0
the	0
relationship	I-DISEASE
between	0
wake	0
SaO2/	0
PaCO2	0
and	0
sleep	0
related	I-DISEASE
desaturation	I-DISEASE
is	0
not	0
sufficiently	0
strong	I-DISEASE
to	I-DISEASE
have	0
substantial	0
pre-	0
dictive	0
value	0
in	I-DISEASE
individual	I-DISEASE
patients	I-DISEASE
.	0

Familial	I-DISEASE
Patterns	I-DISEASE
Not	I-DISEASE
applicable	0
or	B-DISEASE
known	0
.	0

Onset	I-DISEASE
,	0
Course	0
,	0
and	0
Complications	0
Onset	0
and	0
course	I-DISEASE
of	I-DISEASE
the	0
hypoventilation	I-DISEASE
parallel	I-DISEASE
the	0
use	0
and	0
dosing	0
of	I-DISEASE
medications	0
or	I-DISEASE
substances	I-DISEASE
that	B-DISEASE
can	0
impair	0
respiration	I-DISEASE
,	0
as	0
well	I-DISEASE
as	0
the	0
development	0
of	0
tolerance	I-DISEASE
to	I-DISEASE
these	I-DISEASE
substances	I-DISEASE
.	0

There	I-DISEASE
may	0
be	0
variability	I-DISEASE
in	I-DISEASE
susceptibility	0
to	I-DISEASE
hypoventilation	I-DISEASE
in	I-DISEASE
dif-	0
ferent	I-DISEASE
individuals	I-DISEASE
.	0

Comorbid	0
pulmonary	I-DISEASE
or	0
neurologic	0
disorders	0
may	I-DISEASE
accentuate	0
the	B-DISEASE
severity	0
of	I-DISEASE
hypoventilation	I-DISEASE
.	0

Patients	I-DISEASE
may	0
present	I-DISEASE
for	0
evaluation	I-DISEASE
of	I-DISEASE
suspected	I-DISEASE
OSA	0
or	0
may	I-DISEASE
be	I-DISEASE
identified	I-DISEASE
following	0
one	0
or	I-DISEASE
more	I-DISEASE
episodes	0
of	0
respiratory	I-DISEASE
failure	I-DISEASE
.	0

It	I-DISEASE
is	I-DISEASE
not	0
known	I-DISEASE
if	0
chronic	I-DISEASE
use	0
of	I-DISEASE
respiratory	B-DISEASE
depressants	0
can	I-DISEASE
lead	0
to	0
the	0
development	B-DISEASE
of	I-DISEASE
pulmo-	0
nary	0
hypertension	0
,	I-DISEASE
polycythemia	0
,	I-DISEASE
and	0
cardiac	0
arrhythmias	0
.	0

Neurocognitive	0
dysfunc-	0
tion	0
may	I-DISEASE
develop	0
either	0
as	0
a	I-DISEASE
direct	0
result	0
of	I-DISEASE
medication	0
usage	0
or	B-DISEASE
as	0
a	I-DISEASE
consequence	0
of	I-DISEASE
chronic	I-DISEASE
hypoxia	I-DISEASE
and	0
hypercapnia	I-DISEASE
.	0

Pathology	I-DISEASE
and	0
Pathophysiology	I-DISEASE
Hypoventilation	0
is	I-DISEASE
a	0
direct	0
result	0
of	I-DISEASE
impaired	0
respiratory	0
drive	0
and	0
CO2	I-DISEASE
and	0
O2	I-DISEASE
chemo-	I-DISEASE
sensitivity	I-DISEASE
.	0

Hypoventilation	I-DISEASE
worsens	0
during	I-DISEASE
sleep	0
,	0
especially	0
in	I-DISEASE
REM	I-DISEASE
sleep	0
,	I-DISEASE
compared	I-DISEASE
to	I-DISEASE
waking	0
levels	0
,	I-DISEASE
due	0
to	0
a	0
further	I-DISEASE
reduction	I-DISEASE
in	0
chemosensitivity	I-DISEASE
and	0
decreased	I-DISEASE
activity	0
of	I-DISEASE
the	0
ventilatory	0
muscles	0
.	0

In	I-DISEASE
addition	0
,	0
use	I-DISEASE
of	I-DISEASE
respiratory	I-DISEASE
suppressants	0
may	0
give	0
rise	0
to	I-DISEASE
OSA	I-DISEASE
and	0
CSA	I-DISEASE
that	I-DISEASE
may	0
contribute	0
to	I-DISEASE
hypercapnia	I-DISEASE
and	0
hypoxemia	0
.	0

Objective	I-DISEASE
Findings	I-DISEASE

The	I-DISEASE
characteristic	I-DISEASE
PSG	0
finding	0
is	I-DISEASE
demonstration	I-DISEASE
of	I-DISEASE
sleep	0
related	0
hypoventilation	I-DISEASE
by	I-DISEASE
monitoring	0
of	I-DISEASE
PaCO2	0
or	0
acceptable	0
surrogate	0
during	I-DISEASE
sleep	0
.	I-DISEASE

Sustained	I-DISEASE
oxygen	I-DISEASE
desat-	0
uration	I-DISEASE
during	I-DISEASE
sleep	0
that	0
is	I-DISEASE
unexplained	I-DISEASE
by	I-DISEASE
discrete	0
apnea	0
and	0
hypopnea	0
events	0
is	0
common	I-DISEASE
.	0

However	I-DISEASE
,	I-DISEASE
this	0
finding	I-DISEASE
alone	0
is	0
not	0
sufficient	I-DISEASE
to	0
make	0
a	0
diagnosis	I-DISEASE
of	I-DISEASE
sleep	0
related	B-DISEASE
hypoventilation	I-DISEASE
.	0

Medication	I-DISEASE
use	0
can	I-DISEASE
also	0
produce	0
obstructive	0
or	0
central	0
apneas	I-DISEASE
.	0

Intermittent	I-DISEASE
arousals	0
associated	0
with	I-DISEASE
hypoxemia	0
may	I-DISEASE
be	I-DISEASE
observed	0
.	0

An	0
ataxic	I-DISEASE
breathing	0
pattern	0
may	0
be	I-DISEASE
present	0
.	0

Differential	I-DISEASE
Diagnosis	0

The	I-DISEASE
differential	0
diagnosis	0
encompasses	I-DISEASE
essentially	0
all	0
disorders	0
that	I-DISEASE
can	0
lead	0
to	I-DISEASE
hypoventilation	I-DISEASE
during	I-DISEASE
sleep	I-DISEASE
.	0

This	I-DISEASE
includes	I-DISEASE
OHS	0
,	0
pulmonary	I-DISEASE
airway	0
and	0
parenchy-	0
mal	0
disorders	0
,	I-DISEASE
pulmonary	I-DISEASE
vascular	0
pathology	0
,	0
neuromuscular	0
and	0
chest	0
wall	I-DISEASE
disor-	I-DISEASE
ders	0
,	I-DISEASE
severe	0
untreated	0
hypothyroidism	0
,	0
and	0
congenital	0
or	0
idiopathic	B-DISEASE
central	0
alveo-	I-DISEASE
lar	0
hypoventilation	0
syndromes	0
.	0

OSA	I-DISEASE
and	0
CSA	0
syndromes	I-DISEASE
can	I-DISEASE
be	0
distinguished	0
from	I-DISEASE
sleep	0
related	I-DISEASE
hypoventilation	I-DISEASE
by	0
the	0
periodic	I-DISEASE
alterations	0
in	I-DISEASE
airflow	0
and	0
accompanying	0
periodic	I-DISEASE
fluctuations	I-DISEASE
in	I-DISEASE
SaO2	0
.	0

In	I-DISEASE
contrast	I-DISEASE
,	0
oxygen	I-DISEASE
desaturation	0
due	I-DISEASE
to	0
sleep	0
related	B-DISEASE
hypoventilation	I-DISEASE
is	I-DISEASE
generally	I-DISEASE
more	0
sustained	0
,	I-DISEASE
usually	I-DISEASE
several	I-DISEASE
minutes	0
or	I-DISEASE
longer	I-DISEASE
in	0
dura-	0
tion	0
.	0

When	I-DISEASE
more	0
than	0
one	I-DISEASE
disorder	0
is	I-DISEASE
believed	I-DISEASE
to	I-DISEASE
be	0
responsible	0
for	0
the	0
ventilatory	0
insufficiency	I-DISEASE
during	I-DISEASE
sleep	0
,	I-DISEASE
all	0
pertinent	0
diagnoses	0
should	0
be	I-DISEASE
coded	0
.	0

Unresolved	I-DISEASE
Issues	0
and	0
Further	I-DISEASE
Directions	0
Studies	B-DISEASE
of	I-DISEASE
the	0
factors	I-DISEASE
influencing	I-DISEASE
individual	I-DISEASE
susceptibility	0
and	0
tolerance	0
to	I-DISEASE
hypoven-	0
tilation	I-DISEASE
/	0
hypercapnia	0
due	I-DISEASE
to	0
medications	0
or	0
substances	0
are	0
needed	0
.	0

The	I-DISEASE
long	I-DISEASE
-	0
term	0
con-	0
sequences	I-DISEASE
of	I-DISEASE
chronic	B-DISEASE
use	0
of	I-DISEASE
respiratory	I-DISEASE
depressants	I-DISEASE
are	I-DISEASE
poorly	I-DISEASE
understood	I-DISEASE
.	0

The	I-DISEASE
value	0
of	I-DISEASE
routinely	0
measuring	B-DISEASE
PaCO2	0
during	I-DISEASE
sleep	0
in	I-DISEASE
patients	I-DISEASE
taking	I-DISEASE
respiratory	I-DISEASE
depressants	0
is	I-DISEASE
not	0
clear	0
.	0

Additionally	I-DISEASE
,	I-DISEASE
because	0
it	0
is	0
clinically	0
impractical	I-DISEASE
to	0
routinely	0
obtain	I-DISEASE
arterial	I-DISEASE
blood	0
samples	I-DISEASE
during	I-DISEASE
sleep	I-DISEASE
in	0
most	0
persons	I-DISEASE
suspected	0
of	I-DISEASE
this	0
disorder	0
,	I-DISEASE
other	0
techniques	I-DISEASE
of	I-DISEASE
measuring	I-DISEASE
CO2	I-DISEASE
levels	0
must	0
be	I-DISEASE
investigated	0
.	0

Little	I-DISEASE
information	0
is	0
available	I-DISEASE
regarding	0
the	I-DISEASE
effect	0
of	I-DISEASE
oxygen	0
therapy	0
or	0
noninvasive	I-DISEASE
ventilation	0
on	0
the	0
course	I-DISEASE
of	I-DISEASE
the	0
underlying	0
disease	I-DISEASE
.	0

Studies	I-DISEASE
are	I-DISEASE
needed	0
to	I-DISEASE
determine	0
the	0
optimal	0
time	I-DISEASE
to	0
initiate	0
these	I-DISEASE
interventions	I-DISEASE
and	0
the	0
specific	I-DISEASE
subpopulations	I-DISEASE
of	0
patients	I-DISEASE
who	I-DISEASE
will	0
benefit	0
most	0
from	I-DISEASE
these	0
therapies	I-DISEASE
.	0

Bibliography	0
Brown	I-DISEASE
LK	0
.	0

Hypoventilation	I-DISEASE
syndromes	I-DISEASE
.	0

Clin	I-DISEASE
Chest	I-DISEASE
Med	0
2010;31:249–70	I-DISEASE
.	0

Casey	0
KR	0
,	I-DISEASE
Cantillo	0
KO	I-DISEASE
,	0
Brown	I-DISEASE
LK	0
.	0

Sleep	I-DISEASE
-	I-DISEASE
related	0
hypoventilation	I-DISEASE
/	0
hypoxemic	0
syndromes	I-DISEASE
.	0

Chest	I-DISEASE
2007;131:1936–48	0
.	0

Chebbo	I-DISEASE
A	0
,	0
Tfaili	0
A	0
,	0
Jones	0
SF	0
.	I-DISEASE

Hypoventilation	I-DISEASE
syndromes	I-DISEASE
.	0

Med	I-DISEASE
Clin	0
North	0
Am	I-DISEASE
2011;95:1189–202	0
.	0

Macintyre	I-DISEASE
PE	0
,	I-DISEASE
Loadsman	0
JA	0
,	I-DISEASE
Scott	I-DISEASE
DA	I-DISEASE
.	0

Opioids	I-DISEASE
,	I-DISEASE
ventilation	0
and	0
acute	I-DISEASE
pain	I-DISEASE
management	0
.	0

Anaesth	I-DISEASE
Intensive	I-DISEASE
Care	0
2011;39:545–58	I-DISEASE
.	0

Sleep	I-DISEASE
Related	I-DISEASE
Breathing	0
Disorders	I-DISEASE
Sleep	0
Related	0
Breathing	0
Disorders	I-DISEASE
Tassinari	I-DISEASE
D	I-DISEASE
,	I-DISEASE
Sartori	I-DISEASE
S	0
,	I-DISEASE
Tamburini	I-DISEASE
E	0
,	0
et	0
al	I-DISEASE
.	0

Adverse	I-DISEASE
effects	0
of	I-DISEASE
transdermal	0
opiates	0
treating	0
moderate	I-DISEASE
-	I-DISEASE
severe	I-DISEASE
cancer	0
pain	0
in	I-DISEASE
comparison	I-DISEASE
to	0
long	0
-	0
acting	0
morphine	0
:	I-DISEASE
a	0
meta	0
-	0
analysis	I-DISEASE
and	0
systematic	0
review	0
of	I-DISEASE
the	0
literature	0
.	0

J	I-DISEASE
Palliat	0
Med	0
2008;11:492–501	I-DISEASE
.	0

Sleep	I-DISEASE
Related	0
Hypoventilation	I-DISEASE
Due	0
to	0
a	0
Medical	I-DISEASE
Disorder	I-DISEASE
ICD-9	0
-	0
CM	I-DISEASE
code	0
:	B-DISEASE
327.26	0
ICD-10	0
-	0
CM	0
code	0
:	0
G47.36	0
Alternate	0
Names	I-DISEASE
Alveolar	0
hypoventilation	I-DISEASE
,	0
nonapneic	0
alveolar	I-DISEASE
hypoventilation	I-DISEASE
,	I-DISEASE
secondary	0
alveolar	I-DISEASE
hypoventilation	I-DISEASE
,	0
sleep	0
related	0
hypoventilation	I-DISEASE
.	0

Diagnostic	I-DISEASE
Criteria	0
Criteria	I-DISEASE
A	0
-	I-DISEASE
C	I-DISEASE
must	I-DISEASE
be	0
met	0
A.	0
Sleep	0
related	0
hypoventilation	I-DISEASE
is	I-DISEASE
present	0
.	0

B.	0
A	0
lung	I-DISEASE
parenchymal	0
or	B-DISEASE
airway	0
disease	I-DISEASE
,	I-DISEASE
pulmonary	I-DISEASE
vascular	0
pathology	I-DISEASE
,	I-DISEASE
chest	0
wall	0
disorder	I-DISEASE
,	0
neurologic	0
disorder	0
,	I-DISEASE
or	0
muscle	I-DISEASE
weakness	I-DISEASE
is	0
believed	I-DISEASE
to	I-DISEASE
be	I-DISEASE
the	0
primary	0
cause	0
of	I-DISEASE
hypoventilation	0
.	0

C.	I-DISEASE
Hypoventilation	I-DISEASE
is	I-DISEASE
not	0
primarily	I-DISEASE
due	I-DISEASE
to	I-DISEASE
obesity	I-DISEASE
hypoventilation	0
syndrome	0
,	I-DISEASE
medication	0
use	I-DISEASE
,	I-DISEASE
or	I-DISEASE
a	I-DISEASE
known	0
congenital	I-DISEASE
central	0
alveolar	I-DISEASE
hypoventilation	I-DISEASE
syndrome	0
.	0

Notes	I-DISEASE
.	0

Arterial	I-DISEASE
desaturation	0
is	0
often	0
present	I-DISEASE
but	0
is	0
not	0
required	0
for	I-DISEASE
the	0
diagnosis	0
.	0
.	0

Although	I-DISEASE
OSA	I-DISEASE
or	I-DISEASE
CSA	0
may	I-DISEASE
be	I-DISEASE
present	I-DISEASE
,	0
they	I-DISEASE
are	I-DISEASE
not	I-DISEASE
believed	I-DISEASE
to	0
be	I-DISEASE
the	0
major	I-DISEASE
cause	0
of	0
hypoventilation	I-DISEASE
.	0

The	I-DISEASE
predominant	I-DISEASE
respiratory	0
pattern	0
is	0
one	0
of	I-DISEASE
reduced	I-DISEASE
tidal	0
volume	0
or	0
ataxic	I-DISEASE
breathing	0
and	0
associated	0
arterial	I-DISEASE
oxygen	0
desaturation	I-DISEASE
.	0

When	I-DISEASE
criteria	I-DISEASE
are	0
met	0
,	0
a	0
diagnosis	I-DISEASE
of	I-DISEASE
both	I-DISEASE
OSA	0
and	0
CSA	I-DISEASE
due	0
to	I-DISEASE
medical	I-DISEASE
or	I-DISEASE
neurological	0
condition	0
as	0
well	B-DISEASE
as	0
sleep	I-DISEASE
related	0
hypoventilation	I-DISEASE
due	0
to	I-DISEASE
a	I-DISEASE
medical	I-DISEASE
disorder	I-DISEASE
may	0
be	I-DISEASE
made	0
.	0
.	0

Hypoventilation	I-DISEASE
may	I-DISEASE
be	I-DISEASE
present	I-DISEASE
during	I-DISEASE
wakefulness	0
but	I-DISEASE
is	I-DISEASE
not	0
required	0
for	0
the	0
diagnosis	I-DISEASE
.	0

Essential	I-DISEASE
Features	I-DISEASE
Lung	0
airway	0
or	I-DISEASE
parenchymal	0
disease	I-DISEASE
,	I-DISEASE
chest	I-DISEASE
wall	I-DISEASE
disorders	0
,	I-DISEASE
pulmonary	I-DISEASE
hypertension	0
,	0
neurologic	0
and	0
neuromuscular	0
disorders	0
,	0
if	0
sufficiently	I-DISEASE
severe	0
,	0
can	0
result	0
in	0
ventilatory	0
impairment	0
and	0
chronic	I-DISEASE
hypercapnia	0
and	0
hypoxemia	0
.	0

Acute	I-DISEASE
exacerbations	0
of	I-DISEASE
respiratory	I-DISEASE
disorders	0
can	0
accentuate	0
the	I-DISEASE
severity	I-DISEASE
of	I-DISEASE
hypoventilation	I-DISEASE
.	0

Sleep	I-DISEASE
related	0
hypoventilation	0
is	I-DISEASE
present	I-DISEASE
and	0
is	0
usually	I-DISEASE
most	I-DISEASE
severe	I-DISEASE
during	I-DISEASE
REM	0
sleep	0
.	0

In	I-DISEASE
some	I-DISEASE
patients	0
,	I-DISEASE
hypercap-	0
nia	0
may	I-DISEASE
also	0
be	I-DISEASE
present	I-DISEASE
during	I-DISEASE
wakefulness	0
.	I-DISEASE

Patients	I-DISEASE
can	0
either	I-DISEASE
be	0
asymptomatic	I-DISEASE
or	0
present	I-DISEASE
with	I-DISEASE
complaints	I-DISEASE
of	I-DISEASE
dyspnea	0
,	0
chest	I-DISEASE
tightness	0
,	I-DISEASE
or	I-DISEASE
fatigue	I-DISEASE
.	0

Polycythemia	I-DISEASE
is	I-DISEASE
often	0
noted	0
with	0
severe	0
chronic	0
hypoxemia	I-DISEASE
.	0

Specific	I-DISEASE
respiratory	0
disorders	0
are	0
associated	0
with	I-DISEASE
abnormal	I-DISEASE
findings	0
on	0
pulmonary	I-DISEASE
function	I-DISEASE
testing	I-DISEASE
,	I-DISEASE
radiographic	0
imaging	I-DISEASE
,	I-DISEASE
echo-	0
cardiography	I-DISEASE
,	I-DISEASE
and	0
pulmonary	I-DISEASE
artery	0
catheter	I-DISEASE
measurements	I-DISEASE
.	B-DISEASE

Suspected	I-DISEASE
neurologic	0
or	I-DISEASE
neuromuscular	0
causes	I-DISEASE
of	I-DISEASE
hypoventilation	0
may	0
be	I-DISEASE
investigated	0
using	I-DISEASE
central	0
nervous	0
system	I-DISEASE
imaging	0
or	I-DISEASE
measures	0
of	I-DISEASE
peripheral	I-DISEASE
nerve	B-DISEASE
or	0
muscular	B-DISEASE
function	0
.	0

Associated	I-DISEASE
Features	I-DISEASE
Consequences	0
of	I-DISEASE
chronic	I-DISEASE
hypercapnia	0
and	0
hypoxemia	I-DISEASE
arising	I-DISEASE
as	0
a	0
result	0
of	I-DISEASE
medical	0
and	0
neurologic	0
disorders	0
include	I-DISEASE
pulmonary	I-DISEASE
artery	0
hypertension	0
,	0
cor	0
pulmonale	0
,	0
and	0
neu-	0
rocognitive	I-DISEASE
dysfunction	0
.	0

Some	I-DISEASE
of	I-DISEASE
these	I-DISEASE
disorders	0
are	0
prevalent	I-DISEASE
diseases	I-DISEASE
and	0
commonly	0
overlap	0
.	0

Patients	I-DISEASE
with	0
multiple	I-DISEASE
disorders	0
are	0
likely	I-DISEASE
to	I-DISEASE
experience	0
greater	I-DISEASE
severity	0
and	0
duration	I-DISEASE
of	I-DISEASE
sleep	0
related	0
hypoventilation	I-DISEASE
than	0
are	0
patients	0
with	I-DISEASE
either	I-DISEASE
disorder	0
alone	I-DISEASE
.	0

Clinical	I-DISEASE
and	0
Pathophysiological	0
Subtypes	I-DISEASE

The	I-DISEASE
clinical	0
presentation	0
varies	I-DISEASE
with	0
the	0
underlying	0
disorder	I-DISEASE
responsible	0
for	0
the	0
sleep	0
related	I-DISEASE
hypoventilation	I-DISEASE
.	0

Chronic	I-DISEASE
obstructive	0
pulmonary	I-DISEASE
disease	I-DISEASE
is	0
characterized	0
by	I-DISEASE
generally	I-DISEASE
fixed	I-DISEASE
and	0
not	0
fully	I-DISEASE
reversible	I-DISEASE
lower	0
airways	0
obstruction	0
,	I-DISEASE
and	0
includes	0
chronic	I-DISEASE
bronchitis	0
,	0
emphysema	I-DISEASE
,	0
cystic	I-DISEASE
fibrosis	0
,	I-DISEASE
and	0
bronchiectasis	I-DISEASE
.	0

Chronic	I-DISEASE
bron-	0
chitis	I-DISEASE
is	I-DISEASE
a	0
clinical	0
entity	0
defined	I-DISEASE
by	I-DISEASE
the	0
presence	0
of	I-DISEASE
chronic	I-DISEASE
productive	I-DISEASE
cough	0
for	0
at	I-DISEASE
least	0
three	I-DISEASE
months	0
of	I-DISEASE
the	I-DISEASE
year	0
,	I-DISEASE
for	0
at	I-DISEASE
least	I-DISEASE
two	I-DISEASE
consecutive	I-DISEASE
years	0
,	I-DISEASE
in	I-DISEASE
the	0
absence	0
of	I-DISEASE
other	I-DISEASE
identifiable	0
etiologies	0
.	0

Emphysema	I-DISEASE
is	0
characterized	0
by	I-DISEASE
destruction	I-DISEASE
of	I-DISEASE
lung	0
tissue	I-DISEASE
and	0
the	I-DISEASE
dilation	I-DISEASE
of	I-DISEASE
peripheral	I-DISEASE
airspaces	I-DISEASE
without	0
evident	I-DISEASE
fibrosis	I-DISEASE
.	0

Emphysema	I-DISEASE
and	0
chronic	I-DISEASE
bronchitis	I-DISEASE
often	0
coexist	0
.	0

Alpha-1	I-DISEASE
antitrypsin	I-DISEASE
deficiency	0
is	0
a	0
genetic	I-DISEASE
cause	I-DISEASE
of	I-DISEASE
chronic	I-DISEASE
obstructive	0
pulmonary	0
disease	0
.	0

Both	I-DISEASE
bronchiectasis	I-DISEASE
and	0
cystic	0
fibrosis	I-DISEASE
are	0
characterized	0
by	I-DISEASE
lower	0
airway	0
inflammation	0
and	0
destruction	I-DISEASE
of	I-DISEASE
airways	0
and	0
lung	I-DISEASE
parenchyma	0
.	0

Patients	I-DISEASE
with	0
chronic	I-DISEASE
lower	0
airways	I-DISEASE
obstruction	0
are	0
increasingly	0
predis-	I-DISEASE
posed	I-DISEASE
to	I-DISEASE
developing	I-DISEASE
hypoventilation	0
as	0
the	0
severity	I-DISEASE
of	0
the	I-DISEASE
underlying	0
lower	0
airways	0
obstruction	0
increases	0
.	0

Parenchymal	I-DISEASE
lung	0
disease	I-DISEASE
associated	0
with	I-DISEASE
restrictive	0
ventilatory	0
dysfunction	I-DISEASE
(	I-DISEASE
e.g.	I-DISEASE
,	0
interstitial	I-DISEASE
lung	0
disease	I-DISEASE
)	0
can	I-DISEASE
also	0
be	I-DISEASE
associated	0
with	I-DISEASE
sleep	0
related	B-DISEASE
hypoventilation	I-DISEASE
.	0

Neurologic	I-DISEASE
,	0
neuromuscular	0
,	0
and	0
chest	0
wall	I-DISEASE
disorders	0
can	0
produce	0
hypoventilation	I-DISEASE
due	0
to	0
an	0
abnormal	I-DISEASE
ventilatory	0
pump	0
(	I-DISEASE
secondary	0
to	B-DISEASE
reduced	0
muscle	I-DISEASE
strength	0
or	0
anatomic	0
distortion	0
of	0
the	0
chest	0
wall	0
structures	I-DISEASE
)	0
that	I-DISEASE
is	I-DISEASE
unable	I-DISEASE
to	0
meet	0
the	0
ventilatory	0
require-	I-DISEASE
ments	0
for	0
maintaining	0
PaCO2	0
at	I-DISEASE
or	0
below	I-DISEASE
45	0
mm	I-DISEASE
Hg	I-DISEASE
.	0

In	I-DISEASE
addition	0
,	0
some	I-DISEASE
of	0
these	I-DISEASE
patients	I-DISEASE
have	I-DISEASE
reduced	0
central	0
neural	0
chemoresponsiveness	I-DISEASE
.	0

Last	I-DISEASE
,	I-DISEASE
hypoxemia	0
may	I-DISEASE
be	I-DISEASE
worsened	0
Sleep	0
Related	I-DISEASE
Breathing	0
Disorders	I-DISEASE
Sleep	0
Related	0
Breathing	0
Disorders	I-DISEASE
by	0
the	I-DISEASE
development	I-DISEASE
of	I-DISEASE
atelectasis	0
or	0
aspiration	0
due	I-DISEASE
to	I-DISEASE
defective	0
swallowing	0
associated	0
with	I-DISEASE
some	I-DISEASE
neurologic	I-DISEASE
and	0
neuromuscular	0
conditions	I-DISEASE
.	0

Demographics	I-DISEASE
The	I-DISEASE
demographics	0
of	I-DISEASE
sleep	0
related	0
hypoventilation	I-DISEASE
due	0
to	I-DISEASE
a	I-DISEASE
medical	0
disorder	0
are	I-DISEASE
a	0
function	I-DISEASE
of	I-DISEASE
the	0
prevalence	I-DISEASE
,	0
clinical	I-DISEASE
characteristics	0
,	I-DISEASE
and	0
degree	I-DISEASE
of	I-DISEASE
severity	0
of	I-DISEASE
the	0
under-	0
lying	0
conditions	I-DISEASE
.	0

Thus	I-DISEASE
,	I-DISEASE
prevalence	0
may	I-DISEASE
be	0
higher	0
in	I-DISEASE
patients	I-DISEASE
with	0
greater	I-DISEASE
perturbations	I-DISEASE
of	I-DISEASE
pulmonary	I-DISEASE
function	0
or	I-DISEASE
neuromuscular	0
weakness	I-DISEASE
.	0

Individuals	I-DISEASE
with	I-DISEASE
chronic	0
hyper-	I-DISEASE
capnia	0
during	I-DISEASE
wakefulness	0
will	0
experience	I-DISEASE
even	I-DISEASE
greater	I-DISEASE
decrements	0
of	0
alveolar	0
venti-	0
lation	0
during	I-DISEASE
sleep	0
.	0

Predisposing	I-DISEASE
and	0
Precipitating	I-DISEASE
Factors	0
Greater	0
impairments	I-DISEASE
of	I-DISEASE
respiratory	B-DISEASE
function	I-DISEASE
are	0
associated	0
with	I-DISEASE
greater	I-DISEASE
risk	0
for	0
sleep	0
related	B-DISEASE
hypoventilation	0
and	0
hypoxemia	0
.	0

However	I-DISEASE
,	I-DISEASE
there	I-DISEASE
is	I-DISEASE
no	0
recognized	I-DISEASE
threshold	I-DISEASE
of	I-DISEASE
pulmonary	0
parenchymal	0
or	I-DISEASE
vascular	0
disease	I-DISEASE
severity	I-DISEASE
that	I-DISEASE
adequately	0
predicts	0
the	0
risk	0
of	I-DISEASE
sleep	0
related	I-DISEASE
hypoventilation	0
in	I-DISEASE
individual	0
patients	I-DISEASE
.	0

Reduced	I-DISEASE
chemosensitivity	I-DISEASE
may	0
be	0
present	I-DISEASE
in	I-DISEASE
some	I-DISEASE
neuromuscular	0
disorders	0
.	0

The	I-DISEASE
use	0
of	I-DISEASE
central	0
nervous	0
system	I-DISEASE
depressants	0
,	0
such	0
as	0
alcohol	I-DISEASE
,	I-DISEASE
anxiolytics	0
,	0
and	0
hypnotics	I-DISEASE
,	I-DISEASE
may	0
further	I-DISEASE
worsen	0
respira-	I-DISEASE
tory	I-DISEASE
impairment	0
.	0

Patients	I-DISEASE
who	I-DISEASE
are	I-DISEASE
hypercapnic	0
and	0
hypoxemic	0
during	I-DISEASE
wakefulness	0
will	0
generally	0
become	0
even	I-DISEASE
more	0
so	0
during	I-DISEASE
sleep	0
,	I-DISEASE
in	0
particular	I-DISEASE
REM	0
sleep	0
,	I-DISEASE
but	0
the	0
rela-	I-DISEASE
tionship	0
between	0
wake	0
SaO2	0
/	0
PaCO2	I-DISEASE
and	0
sleep	0
related	0
desaturation	0
is	0
not	0
sufficiently	I-DISEASE
strong	0
to	I-DISEASE
have	0
substantial	0
predictive	I-DISEASE
value	0
in	I-DISEASE
individual	0
patients	0
.	0

Familial	I-DISEASE
Patterns	I-DISEASE
Genetic	0
patterns	0
for	0
many	0
of	I-DISEASE
the	I-DISEASE
disorders	0
are	0
not	0
known	I-DISEASE
.	0

Alpha-1	I-DISEASE
antitrypsin	I-DISEASE
defi-	0
ciency	I-DISEASE
is	I-DISEASE
a	0
genetic	I-DISEASE
disorder	I-DISEASE
characterized	0
by	0
defective	0
production	0
of	I-DISEASE
the	0
enzyme	0
inhib-	I-DISEASE
itor	I-DISEASE
;	I-DISEASE
severe	0
forms	0
of	I-DISEASE
deficiency	0
can	0
lead	0
to	0
emphysema	I-DISEASE
.	0

Genetic	I-DISEASE
causes	0
of	I-DISEASE
bronchi-	0
ectasis	0
include	I-DISEASE
primary	I-DISEASE
ciliary	I-DISEASE
dyskinesia	0
and	0
cystic	I-DISEASE
fibrosis	I-DISEASE
.	0

Muscular	I-DISEASE
dystrophies	0
are	0
genetically	0
inherited	I-DISEASE
.	0

The	I-DISEASE
familial	I-DISEASE
patterns	0
of	I-DISEASE
sleep	0
related	B-DISEASE
hypoventilation	0
due	I-DISEASE
to	0
these	I-DISEASE
disorders	0
reflect	I-DISEASE
those	0
of	0
the	0
underlying	0
inherited	I-DISEASE
conditions	I-DISEASE
.	0

Onset	I-DISEASE
,	0
Course	0
,	0
and	0
Complications	0
Onset	0
and	0
course	I-DISEASE
of	I-DISEASE
the	0
hypoventilation	I-DISEASE
parallels	0
the	0
presence	0
and	0
severity	I-DISEASE
of	0
the	0
underlying	0
medical	0
or	I-DISEASE
neurological	0
disorders	0
that	0
impair	0
respiration	0
although	0
substan-	I-DISEASE
tial	0
variability	I-DISEASE
in	I-DISEASE
course	0
is	0
observed	0
even	0
within	I-DISEASE
the	0
same	0
underlying	0
condition	0
.	0

Many	0
affected	I-DISEASE
individuals	I-DISEASE
with	I-DISEASE
severe	0
hypercapnia	0
and	0
hypoxemia	0
develop	0
respiratory	I-DISEASE
impairment	0
,	0
pulmonary	I-DISEASE
hypertension	0
,	I-DISEASE
heart	0
failure	I-DISEASE
,	0
cardiac	0
arrhythmias	0
,	0
and	0
neurocog-	0
nitive	0
dysfunction	0
.	0

Polycythemia	I-DISEASE
is	0
common	I-DISEASE
in	I-DISEASE
those	0
with	0
chronic	0
hypoxia	I-DISEASE
.	0

Although	I-DISEASE
the	0
risk	0
of	I-DISEASE
increased	0
morbidity	I-DISEASE
and	0
mortality	I-DISEASE
appears	I-DISEASE
to	I-DISEASE
increase	I-DISEASE
with	0
worsening	0
sleep	I-DISEASE
related	0
hypoventilation	0
,	I-DISEASE
the	I-DISEASE
specific	0
relationship	I-DISEASE
between	0
sleep	0
related	0
hypoventilation	I-DISEASE
and	0
morbidity	0
and	0
mortality	0
is	0
not	0
well	I-DISEASE
defined	I-DISEASE
.	0

Many	0
patients	I-DISEASE
respond	0
to	I-DISEASE
assisted	0
ven-	I-DISEASE
tilation	0
,	0
whereas	I-DISEASE
hypercapnia	I-DISEASE
may	I-DISEASE
worsen	I-DISEASE
with	0
oxygen	I-DISEASE
therapy	0
alone	I-DISEASE
.	0

Pathology	I-DISEASE
and	0
Pathophysiology	I-DISEASE
Pulmonary	0
parenchymal	0
diseases	I-DISEASE
are	I-DISEASE
characterized	0
by	0
altered	I-DISEASE
lung	0
volumes	0
(	I-DISEASE
e.g.	0
,	I-DISEASE
reduced	0
functional	0
residual	0
capacity	0
)	0
and	0
abnormal	I-DISEASE
ventilation	0
/	0
perfusion	I-DISEASE
relationships	0
,	0
which	0
can	0
result	0
in	I-DISEASE
hypercapnia	I-DISEASE
and	0
hypoxemia	0
during	I-DISEASE
wakefulness	0
.	0

Decreased	I-DISEASE
lung	0
volume	I-DISEASE
is	0
associated	0
with	I-DISEASE
reduced	0
oxygen	0
reserves	0
that	0
increase	I-DISEASE
the	I-DISEASE
risk	0
of	I-DISEASE
hypoxemia	I-DISEASE
.	0

In	I-DISEASE
addition	0
,	0
sleep	0
may	0
be	I-DISEASE
associated	0
with	I-DISEASE
an	0
altered	0
pattern	0
of	I-DISEASE
ventilatory	0
-	0
muscle	I-DISEASE
acti-	I-DISEASE
vation	I-DISEASE
,	0
particularly	0
during	I-DISEASE
REM	I-DISEASE
sleep	0
when	0
,	I-DISEASE
due	I-DISEASE
to	B-DISEASE
reduced	0
activation	I-DISEASE
of	I-DISEASE
the	0
intercos-	0
tal	0
and	0
accessory	0
muscles	0
,	0
there	I-DISEASE
is	0
a	I-DISEASE
disproportionate	0
ventilatory	0
burden	I-DISEASE
placed	0
on	0
the	0
diaphragm	I-DISEASE
.	0

This	I-DISEASE
may	I-DISEASE
lead	0
to	I-DISEASE
hypoventilation	0
in	I-DISEASE
patients	0
with	I-DISEASE
chest	I-DISEASE
wall	I-DISEASE
abnormalities	0
or	I-DISEASE
in	I-DISEASE
those	0
with	0
chronic	I-DISEASE
obstructive	0
pulmonary	I-DISEASE
disease	B-DISEASE
.	I-DISEASE

In	I-DISEASE
the	0
latter	0
,	I-DISEASE
lung	0
hyperinfla-	I-DISEASE
tion	0
creates	0
a	0
mechanical	0
disadvantage	I-DISEASE
to	I-DISEASE
the	0
diaphragm	0
.	0

Many	0
neurologic	I-DISEASE
and	0
neu-	0
romuscular	0
disorders	0
are	0
associated	0
with	I-DISEASE
impaired	I-DISEASE
respiratory	0
mechanics	0
and	0
reduced	0
CO2	I-DISEASE
chemosensitivity	I-DISEASE
.	0

Finally	I-DISEASE
,	I-DISEASE
daytime	0
hypoxemia	I-DISEASE
,	I-DISEASE
if	0
sufficiently	I-DISEASE
severe	I-DISEASE
,	I-DISEASE
may	I-DISEASE
place	I-DISEASE
the	0
patient	I-DISEASE
near	0
or	I-DISEASE
on	0
the	0
steep	0
portion	0
of	I-DISEASE
the	0
oxyhemoglobin	0
dissociation	0
curve	I-DISEASE
,	I-DISEASE
where	0
even	I-DISEASE
relatively	0
small	0
decrements	0
in	0
arterial	0
oxygen	0
tension	I-DISEASE
result	0
in	I-DISEASE
large	I-DISEASE
decrements	0
in	I-DISEASE
oxyhemoglobin	0
saturation	0
.	I-DISEASE

Thus	I-DISEASE
,	I-DISEASE
sleep	0
related	0
hypoventilation	0
in	0
these	I-DISEASE
patients	I-DISEASE
may	I-DISEASE
have	I-DISEASE
a	0
relatively	0
great	I-DISEASE
impact	I-DISEASE
on	0
oxyhemoglobin	0
saturation	I-DISEASE
.	0

Objective	I-DISEASE
Findings	I-DISEASE

The	I-DISEASE
characteristic	I-DISEASE
polysomnographic	0
finding	0
is	0
demonstration	0
of	I-DISEASE
sleep	I-DISEASE
related	B-DISEASE
hypoven-	0
tilation	0
(	I-DISEASE
by	I-DISEASE
arterial	0
PaCO2	0
,	I-DISEASE
transcutaneous	0
PCO2	0
,	0
or	0
end	0
-	I-DISEASE
tidal	0
PCO2	0
)	0
.	0

Sustained	I-DISEASE
oxygen	I-DISEASE
desaturation	0
during	I-DISEASE
sleep	0
that	0
is	0
unexplained	I-DISEASE
by	I-DISEASE
discrete	0
apnea	I-DISEASE
and	0
hypopnea	0
events	0
is	0
common	I-DISEASE
but	0
is	I-DISEASE
not	0
sufficient	I-DISEASE
to	0
establish	0
a	0
diagnosis	0
of	I-DISEASE
sleep	0
related	B-DISEASE
hypoventilation	0
.	0

Intermittent	I-DISEASE
arousals	0
associated	0
with	I-DISEASE
hypoxemia	0
may	I-DISEASE
be	I-DISEASE
observed	0
.	0

Many	0
medical	I-DISEASE
and	0
neurologic	0
disorders	0
are	0
associated	0
with	I-DISEASE
significant	0
sleep	I-DISEASE
disturbances	I-DISEASE
and	0
changes	I-DISEASE
in	I-DISEASE
sleep	0
architecture	0
,	I-DISEASE
including	0
prolonged	0
sleep	0
onset	0
latency	I-DISEASE
,	I-DISEASE
reduced	0
sleep	0
efficiency	I-DISEASE
,	I-DISEASE
and	0
decreased	I-DISEASE
sleep	0
stages	0
N3	0
and	0
REM	0
,	0
may	0
be	0
present	I-DISEASE
.	0

Obstructive	I-DISEASE
and	0
central	0
apneas	0
,	0
when	0
present	I-DISEASE
,	I-DISEASE
will	0
further	I-DISEASE
disturb	I-DISEASE
sleep	0
and	0
accentuate	0
sleep	0
related	0
oxyhe-	0
moglobin	0
desaturation	I-DISEASE
.	0

Daytime	I-DISEASE
arterial	0
blood	0
gases	I-DISEASE
may	I-DISEASE
be	I-DISEASE
normal	0
or	0
show	I-DISEASE
hypoxia	I-DISEASE
and	0
hypercapnia	I-DISEASE
.	0

Chronic	I-DISEASE
hypoxia	0
(	I-DISEASE
especially	0
when	0
present	0
during	I-DISEASE
the	0
day	I-DISEASE
as	I-DISEASE
well	B-DISEASE
as	0
at	I-DISEASE
night	I-DISEASE
)	0
can	0
be	I-DISEASE
associated	0
with	I-DISEASE
polycythemia	0
.	0

Electrocardiography	I-DISEASE
,	I-DISEASE
chest	I-DISEASE
radiography	0
,	I-DISEASE
and	0
echocardiography	I-DISEASE
may	I-DISEASE
demonstrate	I-DISEASE
evidence	0
of	I-DISEASE
pulmonary	I-DISEASE
hypertension	I-DISEASE
.	I-DISEASE

In	I-DISEASE
patients	I-DISEASE
with	0
neuromuscular	0
weakness	I-DISEASE
or	B-DISEASE
restrictive	0
chest	I-DISEASE
wall	I-DISEASE
disorders	0
spirometry	0
shows	I-DISEASE
a	0
restrictive	I-DISEASE
ventilatory	0
dysfunction	I-DISEASE
with	0
the	I-DISEASE
forced	I-DISEASE
vital	I-DISEASE
capacity	I-DISEASE
(	I-DISEASE
FVC	I-DISEASE
)	0
often	0
Sleep	0
Related	0
Breathing	0
Disorders	I-DISEASE
Sleep	I-DISEASE
Related	I-DISEASE
Breathing	0
Disorders	I-DISEASE
less	I-DISEASE
than	0
50	0
%	0
of	I-DISEASE
predicted	0
.	I-DISEASE

However	I-DISEASE
,	I-DISEASE
significant	0
nocturnal	I-DISEASE
desaturation	I-DISEASE
can	0
occur	0
with	I-DISEASE
FVC	I-DISEASE
values	I-DISEASE
greater	I-DISEASE
than	I-DISEASE
50	0
%	0
of	0
predicted	0
.	0

Differential	I-DISEASE
Diagnosis	0

The	I-DISEASE
differential	0
diagnosis	0
includes	I-DISEASE
all	0
disorders	0
which	0
can	I-DISEASE
give	I-DISEASE
rise	0
to	I-DISEASE
hypoventila-	I-DISEASE
tion	I-DISEASE
during	I-DISEASE
sleep	I-DISEASE
.	0

This	I-DISEASE
includes	I-DISEASE
OHS	0
,	0
use	I-DISEASE
of	I-DISEASE
medications	I-DISEASE
or	B-DISEASE
substances	0
that	0
can	0
sup-	I-DISEASE
press	I-DISEASE
respiratory	I-DISEASE
drive	I-DISEASE
,	0
and	0
congenital	I-DISEASE
or	I-DISEASE
idiopathic	I-DISEASE
central	0
alveolar	I-DISEASE
hypoventilation	I-DISEASE
syndromes	0
.	0

OSA	I-DISEASE
and	0
CSA	0
can	I-DISEASE
be	I-DISEASE
distinguished	I-DISEASE
from	0
sleep	0
related	B-DISEASE
hypoventilation	I-DISEASE
by	I-DISEASE
the	I-DISEASE
periodic	0
alterations	0
in	I-DISEASE
airflow	0
and	0
accompanying	0
periodic	I-DISEASE
fluctuations	0
in	I-DISEASE
SaO2	I-DISEASE
.	B-DISEASE

In	I-DISEASE
contrast	I-DISEASE
,	0
oxygen	I-DISEASE
desaturation	0
due	I-DISEASE
to	0
sleep	0
related	B-DISEASE
hypoventilation	I-DISEASE
is	I-DISEASE
generally	I-DISEASE
more	0
sustained	0
,	I-DISEASE
usually	I-DISEASE
several	I-DISEASE
minutes	0
or	I-DISEASE
longer	I-DISEASE
in	0
duration	0
.	0

When	I-DISEASE
more	0
than	0
one	I-DISEASE
disorder	0
is	I-DISEASE
believed	I-DISEASE
to	I-DISEASE
be	0
responsible	0
for	0
the	0
ventilatory	0
insufficiency	I-DISEASE
during	I-DISEASE
sleep	0
,	I-DISEASE
all	0
pertinent	0
diagnoses	0
should	0
be	I-DISEASE
coded	0
.	0

Unresolved	I-DISEASE
Issues	0
and	0
Further	I-DISEASE
Directions	0
Thresholds	0
of	I-DISEASE
impairments	0
of	0
ventilation	0
and	0
respiratory	0
drive	0
producing	0
hypercapnia/	0
hypoxemia	I-DISEASE
need	0
to	I-DISEASE
be	0
identified	0
.	0

The	I-DISEASE
degree	I-DISEASE
and	0
duration	0
of	0
hypercapnia	I-DISEASE
/	0
hypoxemia	0
necessary	0
to	I-DISEASE
produce	0
adverse	I-DISEASE
consequences	0
,	0
such	0
as	0
pulmonary	I-DISEASE
hypertension	I-DISEASE
,	I-DISEASE
in	I-DISEASE
indi-	I-DISEASE
vidual	I-DISEASE
patients	I-DISEASE
is	0
not	0
well	I-DISEASE
defined	I-DISEASE
.	0

The	I-DISEASE
value	0
of	I-DISEASE
routinely	0
measuring	B-DISEASE
PaCO2	0
during	I-DISEASE
sleep	0
in	I-DISEASE
these	I-DISEASE
patients	I-DISEASE
is	I-DISEASE
not	0
clear	I-DISEASE
.	0

Additionally	I-DISEASE
,	I-DISEASE
because	0
it	0
is	0
clinically	0
impractical	I-DISEASE
to	0
routinely	0
obtain	I-DISEASE
arterial	I-DISEASE
blood	0
samples	I-DISEASE
during	I-DISEASE
sleep	I-DISEASE
in	0
most	0
persons	I-DISEASE
suspected	0
of	I-DISEASE
this	0
disorder	0
,	I-DISEASE
other	0
techniques	I-DISEASE
of	I-DISEASE
measuring	I-DISEASE
CO2	I-DISEASE
levels	0
must	0
be	I-DISEASE
investigated	0
.	0

Little	I-DISEASE
infor-	I-DISEASE
mation	0
is	I-DISEASE
available	I-DISEASE
regarding	0
the	0
effect	0
of	I-DISEASE
oxygen	I-DISEASE
therapy	I-DISEASE
or	0
noninvasive	I-DISEASE
ventilation	0
on	0
the	0
course	I-DISEASE
of	I-DISEASE
the	0
underlying	0
disease	I-DISEASE
.	0

Studies	I-DISEASE
are	I-DISEASE
needed	0
to	I-DISEASE
determine	0
the	0
optimal	0
time	I-DISEASE
to	0
initiate	0
these	I-DISEASE
interventions	I-DISEASE
and	0
the	0
specific	I-DISEASE
subpopulations	I-DISEASE
of	0
patients	I-DISEASE
who	I-DISEASE
will	0
benefit	0
most	0
from	I-DISEASE
these	0
therapies	I-DISEASE
.	0

Bibliography	0
Ambrosino	I-DISEASE
N	0
,	0
Carpenè	0
N	0
,	I-DISEASE
Gherardi	I-DISEASE
M.	I-DISEASE
Chronic	0
respiratory	I-DISEASE
care	I-DISEASE
for	I-DISEASE
neuromuscular	0
diseases	I-DISEASE
in	I-DISEASE
adults	I-DISEASE
.	0

Eur	I-DISEASE
Respir	0
J	0
2009;34:444–51	I-DISEASE
.	0

Beuther	I-DISEASE
DA	I-DISEASE
.	0

Hypoventilation	I-DISEASE
in	I-DISEASE
asthma	I-DISEASE
and	0
chronic	I-DISEASE
obstructive	0
pulmonary	I-DISEASE
disease	I-DISEASE
.	I-DISEASE

Semin	0
Respir	0
Crit	0
Care	0
Med	0
2009;30:321–9	I-DISEASE
.	0

Biering	0
-	I-DISEASE
Sørensen	0
F	I-DISEASE
,	0
Jennum	I-DISEASE
P	I-DISEASE
,	I-DISEASE
Laub	I-DISEASE
M.	I-DISEASE
Sleep	0
disordered	0
breathing	0
following	0
spinal	B-DISEASE
cord	0
injury	I-DISEASE
.	0

Respir	I-DISEASE
Physiol	0
Neurobiol	0
2009;169:165–70	I-DISEASE
.	0

Castriotta	I-DISEASE
RJ	I-DISEASE
,	I-DISEASE
Murthy	I-DISEASE
JN	0
.	0

Hypoventilation	I-DISEASE
after	I-DISEASE
spinal	I-DISEASE
cord	I-DISEASE
injury	0
.	0

Semin	0
Respir	0
Crit	0
Care	0
Med	0
2009;30:330–8	I-DISEASE
.	0

Dhand	I-DISEASE
UK	0
,	I-DISEASE
Dhand	0
R.	I-DISEASE
Sleep	0
disorders	0
in	I-DISEASE
neuromuscular	0
diseases	I-DISEASE
.	0

Curr	I-DISEASE
Opin	0
Pulm	0
Med	0
2006;12:402–8	0
.	0

Donath	I-DISEASE
J	0
,	I-DISEASE
Miller	0
A.	0
Restrictive	I-DISEASE
chest	0
wall	I-DISEASE
disorders	I-DISEASE
.	0

Semin	0
Respir	0
Crit	0
Care	0
Med	0
2009;30:275–92	I-DISEASE
.	0

Fathi	I-DISEASE
M	I-DISEASE
,	I-DISEASE
Lundberg	0
IE	0
,	0
Tornling	0
G.	I-DISEASE
Pulmonary	0
complications	0
of	0
polymyositis	0
and	0
dermatomyositis	0
.	0

Semin	0
Respir	0
Crit	0
Care	0
Med	0
2007;28:451–8	I-DISEASE
.	0

Glass	I-DISEASE
GA	I-DISEASE
,	0
Josephs	I-DISEASE
KA	I-DISEASE
,	I-DISEASE
Ahlskog	0
JE	I-DISEASE
.	0

Respiratory	I-DISEASE
insufficiency	0
as	I-DISEASE
the	0
primary	0
presenting	0
symptom	0
of	I-DISEASE
multiple	I-DISEASE
-	I-DISEASE
system	0
atrophy	I-DISEASE
.	0

Arch	I-DISEASE
Neurol	0
2006;63:978–81	0
.	0

Kennedy	I-DISEASE
JD	0
,	I-DISEASE
Martin	0
AJ	I-DISEASE
.	0

Chronic	I-DISEASE
respiratory	0
failure	0
and	0
neuromuscular	0
disease	0
.	0

Pediatr	I-DISEASE
Clin	I-DISEASE
North	0
Am	I-DISEASE
2009;56:261–73	I-DISEASE
,	0
xii	0
.	0

Taylor	I-DISEASE
-	I-DISEASE
Cousar	0
JL	I-DISEASE
.	I-DISEASE

Hypoventilation	I-DISEASE
in	I-DISEASE
cystic	I-DISEASE
fibrosis	0
.	0

Semin	0
Respir	0
Crit	0
Care	0
Med	0
2009;30:293–302	I-DISEASE
.	0

Toussaint	I-DISEASE
M	0
,	I-DISEASE
Chatwin	I-DISEASE
M	0
,	0
Soudon	0
P.	0
Mechanical	0
ventilation	I-DISEASE
in	0
Duchenne	0
patients	I-DISEASE
with	I-DISEASE
chronic	I-DISEASE
respiratory	I-DISEASE
insufficiency	0
:	I-DISEASE
clinical	0
implications	I-DISEASE
of	I-DISEASE
20	0
years	I-DISEASE
published	0
experience	0
.	0

Chron	I-DISEASE
Respir	0
Dis	I-DISEASE
2007;4:167–77	I-DISEASE
.	0

Vazquez	I-DISEASE
-	I-DISEASE
Sandoval	0
A	0
,	0
Huang	0
EJ	0
,	I-DISEASE
Jones	0
SF	0
.	0

Hypoventilation	I-DISEASE
in	I-DISEASE
neuromuscular	0
disease	B-DISEASE
.	0

Semin	0
Respir	0
Crit	0
Care	0
Med	0
2009;30:348–58	I-DISEASE
.	0

Wider	I-DISEASE
C	0
,	I-DISEASE
Wszolek	0
ZK	I-DISEASE
.	0

Rapidly	I-DISEASE
progressive	0
familial	I-DISEASE
parkinsonism	I-DISEASE
with	I-DISEASE
central	0
hypoventilation	I-DISEASE
,	I-DISEASE
depression	0
and	0
weight	0
loss	0
(	0
Perry	0
syndrome)--a	I-DISEASE
literature	0
review	I-DISEASE
.	B-DISEASE

Parkinsonism	I-DISEASE
Relat	0
Disord	0
2008;14:1–7	I-DISEASE
.	0

Sleep	I-DISEASE
Related	0
Breathing	0
Disorders	I-DISEASE
Sleep	0
Related	0
Breathing	0
Disorders	I-DISEASE
Sleep	0
Related	0
Hypoxemia	I-DISEASE
Disorder	I-DISEASE
Sleep	0
Related	I-DISEASE
Hypoxemia	I-DISEASE
ICD-9	0
-	0
CM	0
code	0
:	0
327.26	0
ICD-10	0
-	0
CM	0
code	0
:	I-DISEASE
G47.36	I-DISEASE
Alternate	0
Names	I-DISEASE
Nocturnal	I-DISEASE
oxygen	0
(	I-DISEASE
or	0
oxyhemoglobin	0
)	0
desaturation	I-DISEASE
,	0
low	0
nocturnal	0
oxygen	0
saturation	I-DISEASE
,	I-DISEASE
nocturnal	0
hypoxemia	I-DISEASE
,	0
sleep	I-DISEASE
related	0
hypoxemia	0
,	I-DISEASE
sleep	0
related	0
oxygen	I-DISEASE
desaturation	I-DISEASE
.	0

Diagnostic	I-DISEASE
Criteria	0
Criteria	I-DISEASE
A	0
and	0
B	0
must	I-DISEASE
be	0
met	0
A.	0
PSG	0
,	0
OCST	0
or	0
nocturnal	0
oximetry	0
shows	I-DISEASE
the	0
arterial	0
oxygen	I-DISEASE
saturation	0
(	0
SpO2	I-DISEASE
)	0
during	I-DISEASE
sleep	0
of	I-DISEASE
≤	I-DISEASE
88	0
%	0
in	I-DISEASE
adults	I-DISEASE
or	0
≤	0
90	I-DISEASE
%	0
in	I-DISEASE
children	I-DISEASE
for	0
≥	0
5	0
minutes	0
.	0

B.	0
Sleep	0
related	B-DISEASE
hypoventilation	0
is	0
not	0
documented.1	0
Notes	0
.	0

If	I-DISEASE
sleep	0
related	B-DISEASE
hypoventilation	I-DISEASE
is	0
documented	0
(	I-DISEASE
as	0
measured	0
by	I-DISEASE
arterial	0
blood	I-DISEASE
gas	I-DISEASE
,	0
transcutaneous	0
PCO2	0
,	I-DISEASE
or	0
end	I-DISEASE
-	0
tidal	0
CO2	I-DISEASE
sensors	0
)	0
,	I-DISEASE
the	0
disorder	I-DISEASE
is	0
classified	0
as	0
sleep	0
related	B-DISEASE
hypoventilation	0
.	0
.	0

OSA	I-DISEASE
or	I-DISEASE
CSA	I-DISEASE
may	I-DISEASE
be	I-DISEASE
present	I-DISEASE
,	0
but	0
these	I-DISEASE
are	I-DISEASE
not	I-DISEASE
believed	I-DISEASE
to	0
be	I-DISEASE
the	0
major	I-DISEASE
cause	0
of	I-DISEASE
hypoxemia	I-DISEASE
.	0
.	0

Physiological	0
causes	0
,	I-DISEASE
if	0
known	I-DISEASE
,	0
should	0
be	0
indicated	I-DISEASE
(	I-DISEASE
e.g.	I-DISEASE
,	I-DISEASE
shunt	0
,	0
ventilation	0
-	0
perfusion	I-DISEASE
[	0
V	I-DISEASE
/	0
Q	0
]	0
mismatch	0
,	0
low	0
mixed	0
venous	0
oxygen	0
,	0
and/	0
or	0
high	I-DISEASE
altitude	0
)	I-DISEASE
.	0

Essential	I-DISEASE
Features	I-DISEASE
Significant	0
hypoxemia	0
during	I-DISEASE
sleep	0
is	0
present	I-DISEASE
and	0
is	I-DISEASE
believed	0
to	0
be	I-DISEASE
secondary	I-DISEASE
to	0
a	0
medical	0
or	0
neurological	0
disorder	I-DISEASE
.	0

The	I-DISEASE
presence	I-DISEASE
of	I-DISEASE
hypoxemia	I-DISEASE
is	I-DISEASE
not	0
better	0
explained	I-DISEASE
by	I-DISEASE
another	I-DISEASE
sleep	I-DISEASE
related	B-DISEASE
breathing	I-DISEASE
disorder	I-DISEASE
(	I-DISEASE
e.g.	0
,	I-DISEASE
OSA	0
)	I-DISEASE
.	0

Although	I-DISEASE
some	I-DISEASE
amount	0
of	I-DISEASE
obstructive	0
or	B-DISEASE
central	0
apnea	0
may	I-DISEASE
be	0
present	I-DISEASE
,	I-DISEASE
these	I-DISEASE
disorders	0
are	0
not	0
thought	0
to	0
be	0
pri-	0
marily	0
responsible	I-DISEASE
for	I-DISEASE
the	0
hypoxemia	0
during	I-DISEASE
sleep	0
.	0

Some	I-DISEASE
patients	0
with	0
sleep	0
related	B-DISEASE
hypoxemia	I-DISEASE
also	0
exhibit	0
hypoxemia	I-DISEASE
during	I-DISEASE
wakefulness	0
.	0

Sleep	I-DISEASE
related	B-DISEASE
hypoventilation	0
has	I-DISEASE
not	0
been	I-DISEASE
documented	0
(	I-DISEASE
if	I-DISEASE
so	I-DISEASE
,	0
a	0
diagnosis	I-DISEASE
of	I-DISEASE
sleep	0
related	0
hypoventilation	I-DISEASE
is	I-DISEASE
made	0
)	0
.	0

The	I-DISEASE
presentation	0
of	I-DISEASE
patients	I-DISEASE
with	0
sleep	0
related	0
hypoxemia	I-DISEASE
varies	I-DISEASE
with	I-DISEASE
the	B-DISEASE
underly-	0
ing	I-DISEASE
medical	0
or	0
neurological	I-DISEASE
disorders	0
.	0

Chronic	I-DISEASE
hypoxemia	0
can	I-DISEASE
arise	I-DISEASE
from	0
airway	0
or	I-DISEASE
parenchymal	0
pulmonary	I-DISEASE
disease	I-DISEASE
,	0
chest	0
wall	I-DISEASE
disorders	0
,	0
pulmonary	I-DISEASE
hypertension	0
,	I-DISEASE
or	I-DISEASE
neurologic	0
and	0
neuromuscular	0
disorders	0
.	0

Acute	I-DISEASE
exacerbations	0
of	I-DISEASE
respiratory	I-DISEASE
disorders	0
can	0
accentuate	0
the	I-DISEASE
severity	I-DISEASE
of	I-DISEASE
hypoxemia	I-DISEASE
.	0

Hypoxemia	I-DISEASE
due	0
to	I-DISEASE
underlying	0
lower	0
airway	0
obstructive	0
disease	B-DISEASE
,	I-DISEASE
pulmonary	I-DISEASE
parenchymal	0
disease	I-DISEASE
,	I-DISEASE
vascular	I-DISEASE
pathology	0
,	0
and	0
other	0
causes	I-DISEASE
of	I-DISEASE
hypoventilation	I-DISEASE
is	0
generally	0
sustained	0
(	I-DISEASE
several	0
minutes	0
or	0
longer	0
)	0
,	I-DISEASE
whereas	I-DISEASE
sawtooth	I-DISEASE
fluctuations	I-DISEASE
of	0
oxygen	I-DISEASE
saturation	0
(	I-DISEASE
typically	0
less	I-DISEASE
than	I-DISEASE
one	0
minute	0
)	I-DISEASE
characterize	I-DISEASE
hypoxemia	I-DISEASE
due	I-DISEASE
to	I-DISEASE
OSA	I-DISEASE
or	I-DISEASE
CSA	0
.	0

Patients	I-DISEASE
can	0
either	I-DISEASE
be	0
asymptomatic	0
or	0
present	I-DISEASE
with	I-DISEASE
complaints	I-DISEASE
of	I-DISEASE
nocturnal	0
dyspnea	I-DISEASE
,	0
impaired	I-DISEASE
sleep	0
quality	0
,	I-DISEASE
chest	0
tightness	0
,	I-DISEASE
or	I-DISEASE
fatigue	I-DISEASE
.	0

Polycythemia	I-DISEASE
is	I-DISEASE
often	0
noted	0
with	0
severe	0
chronic	0
hypoxemia	I-DISEASE
.	0

Associated	I-DISEASE
Features	I-DISEASE
Consequences	0
of	I-DISEASE
chronic	I-DISEASE
hypercapnia	0
and	0
hypoxemia	I-DISEASE
include	I-DISEASE
pulmonary	0
artery	0
hyper-	I-DISEASE
tension	B-DISEASE
,	I-DISEASE
cor	B-DISEASE
pulmonale	0
,	I-DISEASE
and	0
neurocognitive	0
dysfunction	0
.	0

Some	I-DISEASE
of	I-DISEASE
the	0
disorders	0
causing	0
hypoxemia	I-DISEASE
are	0
prevalent	0
diseases	I-DISEASE
and	0
not	0
uncommonly	0
overlap	0
.	I-DISEASE

Patients	I-DISEASE
with	0
multi-	0
ple	0
breathing	B-DISEASE
disorders	0
are	0
likely	0
to	I-DISEASE
experience	I-DISEASE
greater	I-DISEASE
severity	0
and	0
duration	0
of	I-DISEASE
sleep	0
related	0
hypoxemia	I-DISEASE
than	0
are	I-DISEASE
patients	0
with	I-DISEASE
a	0
single	I-DISEASE
disorder	0
.	0

Clinical	I-DISEASE
and	0
Pathologic	0
Subtypes	I-DISEASE
Specific	0
variations	0
in	I-DISEASE
the	I-DISEASE
sleep	0
related	0
findings	0
have	0
not	0
been	0
described	0
for	0
the	0
various	0
etiologies	0
.	0

Demographics	I-DISEASE
The	I-DISEASE
demographics	0
of	I-DISEASE
sleep	0
related	0
hypoxemia	I-DISEASE
are	0
a	0
function	0
of	I-DISEASE
the	0
prevalence	0
,	I-DISEASE
clinical	0
characteristics	I-DISEASE
and	0
degree	I-DISEASE
of	I-DISEASE
severity	0
of	I-DISEASE
the	0
underlying	0
conditions	I-DISEASE
.	0

Thus	I-DISEASE
,	I-DISEASE
prevalence	0
may	I-DISEASE
be	0
higher	0
in	I-DISEASE
patients	I-DISEASE
with	0
greater	I-DISEASE
perturbations	I-DISEASE
of	I-DISEASE
pulmonary	I-DISEASE
function	0
or	I-DISEASE
neu-	0
romuscular	0
weakness	I-DISEASE
.	0

Individuals	I-DISEASE
with	I-DISEASE
chronic	0
hypoxemia	I-DISEASE
during	I-DISEASE
wakefulness	0
will	0
experience	I-DISEASE
even	I-DISEASE
greater	I-DISEASE
decrements	0
of	I-DISEASE
oxygenation	0
during	I-DISEASE
sleep	0
.	0

Predisposing	I-DISEASE
and	0
Precipitating	I-DISEASE
Factors	0
Greater	0
impairments	I-DISEASE
of	I-DISEASE
respiratory	I-DISEASE
function	I-DISEASE
are	0
associated	0
with	I-DISEASE
greater	I-DISEASE
risk	0
for	0
sleep	0
related	B-DISEASE
hypoxemia	0
.	0

However	I-DISEASE
,	I-DISEASE
there	I-DISEASE
is	I-DISEASE
no	0
recognized	I-DISEASE
threshold	I-DISEASE
of	I-DISEASE
pulmonary	0
paren-	0
chymal	I-DISEASE
or	I-DISEASE
vascular	I-DISEASE
disease	I-DISEASE
severity	0
or	0
extent	0
of	I-DISEASE
neuromuscular	0
weakness	0
that	I-DISEASE
ade-	0

quately	I-DISEASE
predicts	I-DISEASE
the	0
risk	0
of	I-DISEASE
sleep	0
related	0
hypoxemia	0
in	0
individual	I-DISEASE
patients	I-DISEASE
.	0

Patients	I-DISEASE
who	I-DISEASE
are	I-DISEASE
hypoxemic	0
during	I-DISEASE
wakefulness	0
will	I-DISEASE
generally	I-DISEASE
become	I-DISEASE
even	I-DISEASE
more	0
so	I-DISEASE
during	I-DISEASE
sleep	0
,	I-DISEASE
especially	0
REM	I-DISEASE
sleep	0
.	0

Among	I-DISEASE
the	0
best	0
predictors	I-DISEASE
of	I-DISEASE
sleep	0
related	B-DISEASE
hypoxemia	0
are	I-DISEASE
reduced	0
baseline	I-DISEASE
wake	0
SaO2	I-DISEASE
and	0
hypercapnia	I-DISEASE
.	0

Patients	I-DISEASE
with	0
wake	0
hypercapnia	0
should	0
be	0
suspected	I-DISEASE
of	I-DISEASE
sleep	I-DISEASE
related	B-DISEASE
hypoxemia	0
.	0

However	I-DISEASE
,	I-DISEASE
the	0
relationship	I-DISEASE
between	0
wake	0
SaO2	I-DISEASE
/	0
PaCO2	0
and	0
sleep	0
related	0
desaturation	I-DISEASE
is	0
not	0
sufficiently	I-DISEASE
strong	0
to	0
have	I-DISEASE
substantial	I-DISEASE
predictive	0
value	0
in	I-DISEASE
individual	I-DISEASE
patients	I-DISEASE
.	0

Sleep	I-DISEASE
Related	0
Breathing	0
Disorders	I-DISEASE
Sleep	0
Related	0
Breathing	0
Disorders	I-DISEASE
Familial	0
Patterns	0
Genetic	0
patterns	0
for	I-DISEASE
many	0
of	I-DISEASE
the	0
disorders	0
are	0
not	0
known	I-DISEASE
.	0

Alpha-1	I-DISEASE
antitrypsin	I-DISEASE
defi-	0
ciency	I-DISEASE
is	I-DISEASE
a	0
genetic	I-DISEASE
disorder	I-DISEASE
characterized	0
by	0
defective	0
production	0
of	I-DISEASE
the	0
enzyme	0
inhib-	I-DISEASE
itor	I-DISEASE
;	I-DISEASE
severe	0
forms	0
of	I-DISEASE
deficiency	0
can	0
lead	0
to	0
emphysema	I-DISEASE
.	0

Genetic	I-DISEASE
causes	0
of	I-DISEASE
bronchiec-	0
tasis	0
include	I-DISEASE
primary	I-DISEASE
ciliary	I-DISEASE
dyskinesia	0
and	0
cystic	I-DISEASE
fibrosis	I-DISEASE
.	0

Muscular	I-DISEASE
dystrophies	0
are	0
genetically	0
inherited	I-DISEASE
.	0

The	I-DISEASE
familial	I-DISEASE
patterns	0
of	I-DISEASE
sleep	0
related	B-DISEASE
hypoxemia	0
due	I-DISEASE
to	I-DISEASE
these	0
disorders	0
reflect	I-DISEASE
those	I-DISEASE
of	0
the	0
underlying	0
inherited	0
conditions	I-DISEASE
.	0

Onset	I-DISEASE
,	0
Course	0
,	0
and	0
Complications	0
Onset	0
and	0
course	I-DISEASE
of	I-DISEASE
sleep	0
related	B-DISEASE
hypoxemia	I-DISEASE
parallel	I-DISEASE
the	0
presence	0
and	0
severity	I-DISEASE
of	0
the	0
underlying	0
medical	I-DISEASE
or	I-DISEASE
neurological	0
disorders	0
that	0
impair	0
respiration	0
,	0
although	0
sub-	0
stantial	0
variability	I-DISEASE
in	I-DISEASE
course	0
is	0
observed	0
even	I-DISEASE
within	B-DISEASE
the	0
same	0
underlying	0
condition	0
.	0

Many	0
affected	I-DISEASE
individuals	I-DISEASE
with	I-DISEASE
severe	0
hypercapnia	0
and	0
hypoxemia	0
develop	0
respiratory	I-DISEASE
impairment	0
,	0
pulmonary	I-DISEASE
hypertension	0
,	I-DISEASE
heart	0
failure	I-DISEASE
,	0
cardiac	0
arrhythmias	0
,	0
and	0
neuro-	0
cognitive	0
dysfunction	0
.	0

Polycythemia	I-DISEASE
is	0
common	I-DISEASE
in	I-DISEASE
those	0
with	0
chronic	0
hypoxia	I-DISEASE
.	0

Higher	I-DISEASE
rates	0
of	I-DISEASE
painful	0
crises	0
accompany	I-DISEASE
hypoxemia	I-DISEASE
in	I-DISEASE
children	I-DISEASE
with	I-DISEASE
sickle	0
cell	I-DISEASE
disease	I-DISEASE
.	0

Although	I-DISEASE
the	0
risk	0
of	I-DISEASE
increased	0
morbidity	I-DISEASE
and	0
mortality	0
appears	I-DISEASE
to	I-DISEASE
increase	I-DISEASE
with	0
wors-	0
ening	0
sleep	0
related	0
hypoxemia	0
,	0
the	0
specific	I-DISEASE
relationship	0
between	0
sleep	0
related	0
hypox-	0
emia	I-DISEASE
and	0
morbidity	0
and	0
mortality	0
is	I-DISEASE
not	0
well	I-DISEASE
defined	I-DISEASE
.	0

Many	I-DISEASE
patients	I-DISEASE
respond	0
to	I-DISEASE
oxygen	0
therapy	I-DISEASE
;	I-DISEASE
in	I-DISEASE
some	I-DISEASE
,	0
hypercapnia	I-DISEASE
may	0
worsen	0
with	I-DISEASE
oxygen	0
therapy	0
alone	I-DISEASE
for	0
hypoxia	I-DISEASE
.	0

Pathology	I-DISEASE
and	0
Pathophysiology	I-DISEASE
Hypoxemia	0
may	I-DISEASE
arise	I-DISEASE
from	0
a	0
shunt	0
physiology	0
,	0
ventilation	0
-	0
perfusion	I-DISEASE
[	0
V	0
/	0
Q	0
]	0
mismatch-	0
ing	I-DISEASE
,	0
low	0
mixed	0
venous	I-DISEASE
oxygen	0
,	0
and/or	0
high	I-DISEASE
altitude	0
.	0

Hypoventilation	I-DISEASE
also	0
gives	0
rise	I-DISEASE
to	B-DISEASE
hypoxemia	0
;	I-DISEASE
however	B-DISEASE
,	I-DISEASE
when	I-DISEASE
hypoventilation	I-DISEASE
has	0
been	I-DISEASE
documented	0
,	I-DISEASE
a	0
diagnosis	I-DISEASE
of	I-DISEASE
sleep	0
related	B-DISEASE
hypoventilation	I-DISEASE
should	I-DISEASE
be	0
assigned	I-DISEASE
,	0
rather	0
than	0
sleep	0
related	0
hypoxemia	I-DISEASE
.	0

Pulmonary	I-DISEASE
parenchymal	0
diseases	0
are	0
characterized	0
by	I-DISEASE
altered	I-DISEASE
lung	I-DISEASE
volumes	0
(	I-DISEASE
e.g.	I-DISEASE
,	I-DISEASE
reduced	0
functional	0
residual	0
capacity	I-DISEASE
)	0
and	0
abnormal	I-DISEASE
ventilation	0
/	0
perfusion	I-DISEASE
relationships	0
,	0
which	0
can	0
result	0
in	0
hypercapnia	I-DISEASE
and	0
hypoxemia	0
during	I-DISEASE
wakefulness	0
.	0

Decreased	I-DISEASE
lung	0
volume	I-DISEASE
is	0
associated	0
with	I-DISEASE
reduced	0
oxygen	0
reserves	0
that	0
increase	I-DISEASE
the	I-DISEASE
risk	0
of	I-DISEASE
hypoxemia	I-DISEASE
.	0

In	I-DISEASE
addition	0
,	0
sleep	0
may	0
be	I-DISEASE
associated	0
with	I-DISEASE
an	0
altered	0
pattern	0
of	I-DISEASE
ventilatory	0
muscle	0
acti-	0
vation	0
,	0
particularly	0
during	I-DISEASE
REM	I-DISEASE
sleep	0
when	0
,	I-DISEASE
due	I-DISEASE
to	I-DISEASE
reduced	0
activation	0
of	I-DISEASE
the	0
intercos-	I-DISEASE
tal	0
and	0
accessory	0
muscles	0
,	I-DISEASE
there	I-DISEASE
is	I-DISEASE
a	0
disproportionate	I-DISEASE
ventilatory	0
burden	I-DISEASE
placed	0
on	0
the	0
diaphragm	0
.	0

This	I-DISEASE
may	I-DISEASE
lead	0
to	I-DISEASE
hypoventilation	0
in	I-DISEASE
patients	0
with	I-DISEASE
chest	I-DISEASE
wall	I-DISEASE
abnormalities	0
or	I-DISEASE
chronic	I-DISEASE
obstructive	0
pulmonary	I-DISEASE
disease	B-DISEASE
.	0

In	I-DISEASE
the	0
latter	0
,	I-DISEASE
lung	0
hyperinflation	I-DISEASE
creates	0
a	0
mechanical	I-DISEASE
disadvantage	I-DISEASE
to	0
the	0
diaphragm	I-DISEASE
.	0

In	I-DISEASE
sickle	0
cell	I-DISEASE
anemia	0
,	I-DISEASE
decreased	I-DISEASE
oxyhemo-	0
globin	I-DISEASE
affinity	0
may	I-DISEASE
partly	0
contribute	0
to	I-DISEASE
hypoxemia	I-DISEASE
.	0

Many	0
neurologic	0
and	0
neuromuscu-	0
lar	0
disorders	0
are	0
associated	0
with	I-DISEASE
impaired	I-DISEASE
respiratory	0
mechanics	0
and	0
reduced	0
CO2	I-DISEASE
che-	I-DISEASE
mosensitivity	I-DISEASE
.	0

Finally	I-DISEASE
,	I-DISEASE
daytime	0
hypoxemia	I-DISEASE
,	I-DISEASE
if	0
sufficiently	I-DISEASE
severe	0
,	I-DISEASE
may	I-DISEASE
place	I-DISEASE
the	0
patient	I-DISEASE
near	0
or	I-DISEASE
on	0
the	0
steep	0
portion	0
of	I-DISEASE
the	0
oxyhemoglobin	0
dissociation	0
curve	I-DISEASE
where	0
even	I-DISEASE
rela-	0
tively	0
small	0
decrements	0
in	I-DISEASE
arterial	I-DISEASE
oxygen	I-DISEASE
tension	0
result	0
in	0
large	0
decrements	0
in	I-DISEASE
oxyhe-	0
moglobin	0
saturation	0
.	0

Thus	I-DISEASE
,	I-DISEASE
sleep	0
related	0
hypoventilation	0
in	0
these	I-DISEASE
patients	I-DISEASE
might	I-DISEASE
have	I-DISEASE
a	0
relatively	0
great	I-DISEASE
impact	I-DISEASE
on	0
oxyhemoglobin	0
saturation	I-DISEASE
.	0

Objective	I-DISEASE
Findings	I-DISEASE
Various	I-DISEASE
patterns	0
of	I-DISEASE
oxygen	0
desaturation	0
(	I-DISEASE
sustained	0
,	0
intermittent	0
,	I-DISEASE
or	I-DISEASE
episodic	0
)	0
may	I-DISEASE
be	0
observed	I-DISEASE
during	I-DISEASE
sleep	0
.	0

The	I-DISEASE
diagnosis	I-DISEASE
is	0
generally	I-DISEASE
made	0
on	0
the	0
basis	I-DISEASE
of	B-DISEASE
overnight	0
oxim-	0
etry	0
(	I-DISEASE
alone	I-DISEASE
or	0
as	0
a	0
component	I-DISEASE
of	I-DISEASE
PSG	0
or	I-DISEASE
OCST	0
)	0
;	0
less	B-DISEASE
commonly	0
,	0
arterial	0
blood	I-DISEASE
gas	0
mea-	B-DISEASE
surements	0
are	0
indicated	0
,	0
especially	I-DISEASE
if	0
concomitant	0
hypoventilation	0
is	0
suspected	0
.	0

PSG	I-DISEASE
may	0
demonstrate	0
normal	0
sleep	0
architecture	0
or	I-DISEASE
frequent	0
arousals	0
,	I-DISEASE
increased	I-DISEASE
wakeful-	0
ness	0
after	0
sleep	0
onset	I-DISEASE
and	0
reduced	0
sleep	0
efficiency	I-DISEASE
;	I-DISEASE
however	0
,	I-DISEASE
the	0
contribution	0
of	I-DISEASE
sleep	0
related	0
hypoxemia	I-DISEASE
to	0
the	0
altered	0
sleep	0
architecture	0
,	0
if	0
present	I-DISEASE
,	0
is	I-DISEASE
uncertain	0
.	0

Daytime	I-DISEASE
arterial	0
blood	0
gases	I-DISEASE
may	I-DISEASE
be	I-DISEASE
normal	0
or	0
show	I-DISEASE
hypoxia	I-DISEASE
and	0
hypercapnia	I-DISEASE
.	0

Nocturnal	I-DISEASE
oxim-	0
etry	0
usually	I-DISEASE
shows	I-DISEASE
sustained	0
periods	I-DISEASE
of	I-DISEASE
reduced	0
arterial	0
oxygen	I-DISEASE
but	I-DISEASE
clusters	0
of	0
more	0
severe	0
drops	I-DISEASE
in	I-DISEASE
the	0
arterial	I-DISEASE
oxygen	I-DISEASE
saturation	0
can	I-DISEASE
occur	I-DISEASE
every	0
one	0
to	I-DISEASE
two	I-DISEASE
hours	I-DISEASE
due	0
to	I-DISEASE
worsening	0
of	I-DISEASE
breathing	0
during	I-DISEASE
REM	I-DISEASE
sleep	I-DISEASE
.	0

A	I-DISEASE
sawtooth	I-DISEASE
pattern	0
of	0
briefer	I-DISEASE
desaturations	I-DISEASE
(	I-DISEASE
typically	I-DISEASE
less	I-DISEASE
than	0
one	0
minute	0
)	0
suggests	0
the	0
presence	0
of	I-DISEASE
discrete	0
events	0
(	0
apneas	I-DISEASE
or	I-DISEASE
hypopneas	I-DISEASE
)	0
.	0

Some	I-DISEASE
sawtooth	I-DISEASE
changes	I-DISEASE
may	0
be	I-DISEASE
superimposed	I-DISEASE
on	0
low	0
baseline	I-DISEASE
oxygen	I-DISEASE
saturation	0
but	I-DISEASE
are	I-DISEASE
not	0
the	0
predominant	I-DISEASE
pattern	0
.	0

Chronic	I-DISEASE
hypoxia	0
can	0
be	I-DISEASE
associated	0
with	0
polycythemia	0
.	0

Electrocardiography	I-DISEASE
,	I-DISEASE
chest	I-DISEASE
radiography	0
,	I-DISEASE
and	0
echocardiography	I-DISEASE
may	I-DISEASE
demonstrate	I-DISEASE
evidence	0
of	I-DISEASE
pulmonary	I-DISEASE
hypertension	I-DISEASE
.	I-DISEASE

Differential	I-DISEASE
Diagnosis	0

The	I-DISEASE
differential	I-DISEASE
diagnosis	0
encompasses	I-DISEASE
all	0
disorders	0
which	0
can	I-DISEASE
give	I-DISEASE
to	0
hypoxemia	I-DISEASE
during	I-DISEASE
sleep	0
.	0

This	I-DISEASE
includes	I-DISEASE
pulmonary	0
airway	I-DISEASE
and	0
parenchymal	0
disorders	0
,	I-DISEASE
pulmonary	I-DISEASE
vascular	I-DISEASE
pathology	0
,	I-DISEASE
neuromuscular	I-DISEASE
and	0
chest	0
wall	I-DISEASE
disorders	0
,	I-DISEASE
OHS	0
,	I-DISEASE
use	I-DISEASE
of	I-DISEASE
medications	0
or	0
substances	0
that	0
can	0
suppress	0
respiratory	0
drive	0
,	0
and	0
congenital	0
or	I-DISEASE
idiopathic	I-DISEASE
central	0
alveolar	I-DISEASE
hypoventilation	0
syndromes	I-DISEASE
.	0

OSA	I-DISEASE
and	0
CSA	0
syndromes	I-DISEASE
can	I-DISEASE
be	0
distinguished	0
from	I-DISEASE
sleep	0
related	I-DISEASE
hypoxemia	I-DISEASE
by	I-DISEASE
the	0
periodic	0
alterations	0
in	I-DISEASE
airflow	0
and	0
accompanying	I-DISEASE
periodic	0
fluctuations	I-DISEASE
in	I-DISEASE
SaO2	I-DISEASE
.	0

In	I-DISEASE
contrast	I-DISEASE
,	0
oxygen	I-DISEASE
desaturation	0
associated	0
with	0
sleep	0
related	B-DISEASE
hypoxemia	I-DISEASE
is	I-DISEASE
generally	I-DISEASE
more	I-DISEASE
sustained	0
,	0
usually	I-DISEASE
several	I-DISEASE
minutes	0
or	I-DISEASE
longer	I-DISEASE
in	I-DISEASE
duration	0
.	I-DISEASE

In	I-DISEASE
cases	0
when	0
more	0
than	0
one	0
disorder	I-DISEASE
is	I-DISEASE
believed	I-DISEASE
to	0
be	0
responsible	I-DISEASE
for	I-DISEASE
the	0
ventilatory	0
insufficiency	I-DISEASE
during	I-DISEASE
sleep	0
,	I-DISEASE
all	0
pertinent	I-DISEASE
diagnoses	0
should	I-DISEASE
be	I-DISEASE
coded	0
.	0

Unresolved	I-DISEASE
Issues	0
and	0
Further	I-DISEASE
Directions	0
The	I-DISEASE
degree	I-DISEASE
and	0
duration	I-DISEASE
of	I-DISEASE
hypercapnia	0
/	0
hypoxemia	0
necessary	0
to	0
produce	0
adverse	0
consequences	I-DISEASE
,	I-DISEASE
such	0
as	0
pulmonary	I-DISEASE
hypertension	0
,	0
in	0
individual	I-DISEASE
patients	0
is	0
not	0
well	0
defined	0
.	0

The	I-DISEASE
value	0
of	I-DISEASE
routinely	0
measuring	B-DISEASE
arterial	I-DISEASE
blood	I-DISEASE
gases	0
or	0
SaO2	0
during	I-DISEASE
sleep	0
Sleep	0
Related	I-DISEASE
Breathing	0
Disorders	I-DISEASE
Sleep	0
Related	I-DISEASE
Breathing	0
Disorders	I-DISEASE
is	0
not	0
clear	I-DISEASE
.	0

With	I-DISEASE
the	I-DISEASE
exception	0
of	I-DISEASE
COPD	0
,	I-DISEASE
little	0
information	0
is	0
available	I-DISEASE
regarding	0
the	I-DISEASE
effect	0
of	I-DISEASE
oxygen	I-DISEASE
therapy	I-DISEASE
on	0
the	0
course	0
of	I-DISEASE
the	0
underlying	0
disease	B-DISEASE
.	0

Even	I-DISEASE
less	I-DISEASE
is	0
under-	I-DISEASE
stood	I-DISEASE
regarding	0
the	I-DISEASE
consequences	I-DISEASE
of	I-DISEASE
isolated	I-DISEASE
sleep	0
related	I-DISEASE
hypoxemia	I-DISEASE
and	0
the	0
need	0
for	I-DISEASE
oxygen	I-DISEASE
supplementation	0
in	I-DISEASE
patients	I-DISEASE
with	0
normal	0
daytime	0
wake	0
oxygen	I-DISEASE
levels	I-DISEASE
.	0

Studies	I-DISEASE
are	I-DISEASE
needed	0
to	I-DISEASE
determine	0
the	0
optimal	0
time	I-DISEASE
to	0
initiate	0
oxygen	I-DISEASE
therapy	0
and	0
the	0
specific	I-DISEASE
subpopulations	I-DISEASE
of	0
patients	I-DISEASE
who	I-DISEASE
will	0
benefit	0
most	0
from	I-DISEASE
this	0
intervention	I-DISEASE
.	0

Bibliography	0
Berry	B-DISEASE
RB	0
,	I-DISEASE
Sriram	I-DISEASE
P.	0
Evaluation	I-DISEASE
of	I-DISEASE
hypoventilation	I-DISEASE
.	I-DISEASE

Semin	0
Respir	0
Crit	0
Care	0
Med	0
2009;30:303–14	I-DISEASE
.	0

Brown	I-DISEASE
LK	I-DISEASE
.	I-DISEASE

Hypoventilation	I-DISEASE
syndromes	I-DISEASE
.	0

Clin	I-DISEASE
Chest	I-DISEASE
Med	0
2010;31:249–70	I-DISEASE
.	0

Casey	0
KR	0
,	I-DISEASE
Cantillo	0
KO	I-DISEASE
,	0
Brown	I-DISEASE
LK	0
.	0

Sleep	I-DISEASE
-	I-DISEASE
related	0
hypoventilation	I-DISEASE
/	0
hypoxemic	0
syndromes	I-DISEASE
.	0

Chest	I-DISEASE
2007;131:1936–48	0
.	0

Chebbo	I-DISEASE
A	0
,	0
Tfaili	0
A	0
,	0
Jones	0
SF	0
.	I-DISEASE

Hypoventilation	I-DISEASE
syndromes	I-DISEASE
.	0

Med	I-DISEASE
Clin	0
North	0
Am	I-DISEASE
2011;95:1189–202	0
.	0

Mogri	I-DISEASE
M	I-DISEASE
,	0
Desai	I-DISEASE
H	I-DISEASE
,	0
Webster	0
L	0
,	I-DISEASE
Grant	I-DISEASE
BJ	0
,	I-DISEASE
Mador	I-DISEASE
MJ	0
.	0

Hypoxemia	I-DISEASE
in	0
patients	I-DISEASE
on	0
chronic	I-DISEASE
opiate	0
therapy	0
with	I-DISEASE
and	0
without	0
sleep	0
apnea	0
.	0

Sleep	I-DISEASE
Breath	0
2009;13:49–57	I-DISEASE
.	0

Isolated	I-DISEASE
Symptoms	I-DISEASE
and	0
Normal	0
Variants	0
Snoring	I-DISEASE
ICD-9	0
-	0
CM	I-DISEASE
code	0
:	B-DISEASE
786.09	0
ICD-10	0
-	0
CM	0
code	0
:	0
R06.83	0
Snoring	0
is	0
a	I-DISEASE
respiratory	I-DISEASE
sound	I-DISEASE
generated	0
in	0
the	0
upper	0
airway	0
during	I-DISEASE
sleep	0
that	0
typically	0
occurs	0
during	I-DISEASE
inspiration	0
but	I-DISEASE
may	I-DISEASE
also	0
occur	0
in	I-DISEASE
expiration	0
;	0
the	0
snoring	0
described	0
here	I-DISEASE
occurs	0
without	0
episodes	I-DISEASE
of	I-DISEASE
apnea	0
,	I-DISEASE
hypopnea	0
,	I-DISEASE
RERAs	I-DISEASE
or	0
hypoventilation	I-DISEASE
.	0

The	I-DISEASE
intensity	I-DISEASE
of	I-DISEASE
snoring	I-DISEASE
may	I-DISEASE
vary	I-DISEASE
and	0
often	0
will	0
disturb	I-DISEASE
the	I-DISEASE
bed	I-DISEASE
partner	0
’s	I-DISEASE
sleep	I-DISEASE
and	0
even	I-DISEASE
awaken	0
the	0
patient	I-DISEASE
.	0

Snoring	I-DISEASE
in	I-DISEASE
this	0
context	I-DISEASE
does	I-DISEASE
not	0
cause	0
symptoms	0
of	I-DISEASE
daytime	0
sleepiness	I-DISEASE
or	0
insomnia	0
in	0
the	0
patient	I-DISEASE
.	0

This	I-DISEASE
type	I-DISEASE
of	I-DISEASE
snoring	I-DISEASE
has	0
variously	I-DISEASE
been	I-DISEASE
referred	I-DISEASE
to	I-DISEASE
as	0
habitual	I-DISEASE
,	I-DISEASE
primary	0
or	I-DISEASE
simple	I-DISEASE
snoring	0
.	0

Snoring	I-DISEASE
is	I-DISEASE
a	0
cardinal	I-DISEASE
symptom	0
of	I-DISEASE
obstructive	0
sleep	0
apnea	0
.	0

A	I-DISEASE
designation	I-DISEASE
of	I-DISEASE
habitual	I-DISEASE
snoring	0
can	0
not	0
be	0
made	0
in	I-DISEASE
those	I-DISEASE
who	0
exhibit	0
symptoms	I-DISEASE
(	I-DISEASE
daytime	0
sleepiness	0
/	0
fatigue	I-DISEASE
or	B-DISEASE
other	0
related	B-DISEASE
symptoms	0
)	0
or	0
report	0
possible	0
breathing	B-DISEASE
pauses	0
,	0
without	0
objective	B-DISEASE
mea-	B-DISEASE
surement	0
of	I-DISEASE
breathing	0
during	I-DISEASE
sleep	0
.	0

In	I-DISEASE
addition	0
,	0
those	I-DISEASE
individuals	I-DISEASE
with	I-DISEASE
snoring	0
and	0
comorbid	I-DISEASE
cardiovascular	I-DISEASE
disease	I-DISEASE
(	I-DISEASE
especially	0
pulmonary	0
or	0
systemic	0
hypertension	0
,	I-DISEASE
cor-	0
onary	0
artery	0
disease	I-DISEASE
,	0
or	I-DISEASE
atrial	I-DISEASE
fibrillation	0
)	0
are	0
at	0
increased	0
risk	0
for	I-DISEASE
the	I-DISEASE
presence	0
of	I-DISEASE
OSA	I-DISEASE
even	0
in	I-DISEASE
the	0
absence	I-DISEASE
of	I-DISEASE
complaints	0
of	I-DISEASE
daytime	I-DISEASE
sleepiness	0
.	I-DISEASE

Therefore	I-DISEASE
,	I-DISEASE
PSG	0
or	0
OCST	I-DISEASE
is	0
required	0
in	I-DISEASE
order	0
to	I-DISEASE
effectively	I-DISEASE
rule	B-DISEASE
out	0
OSA	I-DISEASE
in	0
such	0
populations	I-DISEASE
.	0

It	I-DISEASE
should	I-DISEASE
also	0
be	I-DISEASE
noted	0
that	0
patients	I-DISEASE
who	I-DISEASE
initially	I-DISEASE
have	0
isolated	I-DISEASE
snoring	0
may	0
be	I-DISEASE
at	I-DISEASE
risk	0
for	0
developing	0
OSA	I-DISEASE
with	I-DISEASE
aging	0
or	I-DISEASE
weight	0
gain	0
.	I-DISEASE

Occasional	I-DISEASE
snoring	0
is	0
almost	I-DISEASE
universal	0
.	0

Estimates	I-DISEASE
on	0
snoring	0
vary	0
widely	0
depending	0
on	0
its	I-DISEASE
definition	I-DISEASE
.	0

The	I-DISEASE
incidence	0
of	I-DISEASE
snoring	0
in	I-DISEASE
children	I-DISEASE
is	0
reported	0
to	I-DISEASE
be	I-DISEASE
10	I-DISEASE
%	0
to	I-DISEASE
12	I-DISEASE
%	0
.	I-DISEASE

The	I-DISEASE
Wisconsin	I-DISEASE
cohort	0
study	I-DISEASE
reports	I-DISEASE
habitual	I-DISEASE
snoring	0
in	I-DISEASE
about	I-DISEASE
24	0
%	0
of	I-DISEASE
adult	0
women	0
and	0
40	0
%	0
of	I-DISEASE
adult	0
men	0
.	0

Prevalence	I-DISEASE
of	I-DISEASE
snoring	0
increases	0
with	I-DISEASE
age	I-DISEASE
in	0
both	I-DISEASE
sexes	I-DISEASE
,	I-DISEASE
except	0
that	0
the	0
prevalence	I-DISEASE
of	I-DISEASE
reported	0
snoring	0
starts	I-DISEASE
to	0
decrease	I-DISEASE
again	I-DISEASE
in	0
men	I-DISEASE
after	0
70	0
years	I-DISEASE
of	I-DISEASE
age	I-DISEASE
.	0

Some	I-DISEASE
have	0
hypothesized	0
that	0
his	0
may	0
be	0
due	0
to	I-DISEASE
decreased	I-DISEASE
hearing	0
acuity	0
in	0
older	0
individuals	I-DISEASE
.	0

Snoring	I-DISEASE
is	0
most	0
common	I-DISEASE
in	I-DISEASE
adult	0
men	0
and	0
is	0
also	0
linked	I-DISEASE
to	I-DISEASE
obesity	0
.	0

Nasal	I-DISEASE
obstruc-	0
tion	I-DISEASE
increases	0
the	0
risk	0
of	I-DISEASE
snoring	0
.	0

Ingestion	I-DISEASE
of	I-DISEASE
alcohol	0
,	I-DISEASE
muscle	I-DISEASE
relaxants	B-DISEASE
,	0
narcotics	0
,	I-DISEASE
or	0
other	I-DISEASE
substances	I-DISEASE
that	I-DISEASE
decrease	0
upper	0
airway	0
muscle	I-DISEASE
tone	I-DISEASE
predisposes	0
an	0
individual	I-DISEASE
to	I-DISEASE
snoring	0
.	0

Smoking	I-DISEASE
,	I-DISEASE
particularly	0
in	I-DISEASE
males	I-DISEASE
,	I-DISEASE
has	0
also	0
been	I-DISEASE
shown	I-DISEASE
to	I-DISEASE
be	I-DISEASE
a	0
risk	0
factor	I-DISEASE
.	I-DISEASE

Snoring	I-DISEASE
has	I-DISEASE
also	0
been	I-DISEASE
shown	I-DISEASE
to	I-DISEASE
increase	I-DISEASE
during	I-DISEASE
pregnancy	0
.	0

In	I-DISEASE
children	I-DISEASE
,	0
an	0
association	0
has	0
been	I-DISEASE
reported	I-DISEASE
between	0
snoring	0
and	0
adenotonsillar	I-DISEASE
hypertrophy	0
.	0

During	I-DISEASE
snoring	0
Sleep	0
Related	I-DISEASE
Breathing	0
Disorders	0
Sleep	I-DISEASE
Related	0
Breathing	0
Disorders	0
there	I-DISEASE
is	0
vibration	0
of	I-DISEASE
the	0
uvula	I-DISEASE
and	0
soft	0
palate	0
,	I-DISEASE
although	0
it	0
may	0
also	0
involve	0
the	0
faucial	0
pillars	I-DISEASE
,	I-DISEASE
pharyngeal	0
walls	0
,	0
and	0
lower	0
structures	I-DISEASE
.	0

Snorers	I-DISEASE
have	0
been	0
shown	I-DISEASE
to	I-DISEASE
have	I-DISEASE
mor-	0
phologic	0
derangements	0
of	0
the	0
palate	0
consistent	0
with	I-DISEASE
neurogenic	0
lesions	0
.	0

These	0
are	I-DISEASE
thought	0
to	I-DISEASE
be	0
due	I-DISEASE
to	I-DISEASE
trauma	I-DISEASE
from	I-DISEASE
vibration	0
.	0

If	I-DISEASE
PSG	0
is	I-DISEASE
performed	0
,	I-DISEASE
snoring	0
tends	0
to	I-DISEASE
be	I-DISEASE
loudest	I-DISEASE
during	I-DISEASE
stage	I-DISEASE
N3	0
sleep	0
or	0
REM	I-DISEASE
sleep	I-DISEASE
.	0

Epidemiologic	I-DISEASE
studies	I-DISEASE
are	0
difficult	0
to	0
interpret	0
if	0
sleep	I-DISEASE
apnea	0
was	0
not	0
excluded	0
by	0
PSG	0
.	0

Based	I-DISEASE
on	0
the	0
current	I-DISEASE
literature	0
,	I-DISEASE
habitual	0
snoring	0
in	I-DISEASE
children	I-DISEASE
may	I-DISEASE
be	0
associated	0
with	I-DISEASE
worse	I-DISEASE
school	0
performance	0
,	I-DISEASE
but	0
conclusive	I-DISEASE
evidence	0
for	I-DISEASE
this	0
is	I-DISEASE
lacking	0
.	0

Some	I-DISEASE
studies	I-DISEASE
have	0
suggested	I-DISEASE
that	0
adult	0
snorers	0
may	0
have	0
a	0
higher	I-DISEASE
prevalence	I-DISEASE
of	I-DISEASE
cardiovas-	I-DISEASE
cular	0
disease	I-DISEASE
,	0
including	0
hypertension	0
,	I-DISEASE
stroke	I-DISEASE
,	I-DISEASE
and	0
ischemic	0
heart	0
disease	0
.	0

However	I-DISEASE
,	I-DISEASE
a	0
large	I-DISEASE
observational	I-DISEASE
study	0
in	I-DISEASE
which	0
all	0
subjects	I-DISEASE
underwent	I-DISEASE
PSG	I-DISEASE
found	0
no	0
increased	0
risk	0
of	0
cardiovascular	0
morbidity	0
or	I-DISEASE
mortality	0
with	I-DISEASE
habitual	0
snoring	0
.	0

Of	I-DISEASE
interest	I-DISEASE
,	0
one	I-DISEASE
study	0
found	I-DISEASE
that	0
snoring	I-DISEASE
was	I-DISEASE
associated	0
with	I-DISEASE
atherosclerosis	I-DISEASE
of	I-DISEASE
the	0
carotid	I-DISEASE
artery	0
,	I-DISEASE
but	I-DISEASE
this	0
has	0
not	0
been	I-DISEASE
confirmed	0
by	B-DISEASE
other	I-DISEASE
studies	I-DISEASE
.	I-DISEASE

As	I-DISEASE
snoring	0
tends	0
to	I-DISEASE
increase	I-DISEASE
during	I-DISEASE
pregnancy	0
,	0
the	0
impact	I-DISEASE
of	I-DISEASE
snoring	0
on	0
maternal	I-DISEASE
health	0
is	0
of	I-DISEASE
great	I-DISEASE
interest	I-DISEASE
.	0

A	I-DISEASE
study	I-DISEASE
found	0
that	0
preg-	0
nancy	0
-	0
onset	0
habitual	0
snoring	0
(	I-DISEASE
but	I-DISEASE
not	0
chronic	0
[	0
pre	0
-	0
conceptual	I-DISEASE
]	0
snoring	0
)	0
was	I-DISEASE
associated	0
with	B-DISEASE
increased	0
risk	0
of	I-DISEASE
gestational	0
hypertension	I-DISEASE
and	0
preeclampsia	0
.	0

Further	I-DISEASE
studies	I-DISEASE
are	0
needed	0
in	0
this	I-DISEASE
area	0
.	0

Bibliography	0
Cho	0
JG	0
,	I-DISEASE
Witting	I-DISEASE
PK	0
,	I-DISEASE
Verma	I-DISEASE
M	I-DISEASE
,	I-DISEASE
et	0
al	0
.	0

Tissue	0
vibration	0
induces	0
carotid	I-DISEASE
artery	0
endothelial	0
dysfunction	0
:	I-DISEASE
a	0
mechanism	0
linking	I-DISEASE
snoring	0
and	0
carotid	I-DISEASE
atherosclerosis	I-DISEASE
?	0

Sleep	I-DISEASE
2011;34:751–7	I-DISEASE
.	0

Kezirian	I-DISEASE
EJ	0
,	I-DISEASE
Chang	0
JL	0
.	0

Snoring	I-DISEASE
without	0
OSA	0
and	0
health	I-DISEASE
consequences	I-DISEASE
:	0
the	0
jury	I-DISEASE
is	I-DISEASE
still	I-DISEASE
out	0
.	0

Sleep	I-DISEASE
2013;36:613	0
.	0

Lee	I-DISEASE
SA	0
,	0
Amis	I-DISEASE
TC	0
,	I-DISEASE
Byth	0
K	B-DISEASE
,	I-DISEASE
et	0
al	I-DISEASE
.	0

Heavy	I-DISEASE
snoring	0
as	0
a	0
cause	I-DISEASE
of	I-DISEASE
carotid	B-DISEASE
artery	0
atherosclerosis	I-DISEASE
.	I-DISEASE

Sleep	I-DISEASE
2008;31:1207–13	I-DISEASE
.	0

Marin	I-DISEASE
JM	0
,	I-DISEASE
Carrizo	0
SJ	I-DISEASE
,	0
Vicente	0
E	0
,	I-DISEASE
Agusti	0
AG	I-DISEASE
.	I-DISEASE

Long	I-DISEASE
-	I-DISEASE
term	0
cardiovascular	I-DISEASE
outcomes	I-DISEASE
in	I-DISEASE
men	I-DISEASE
with	0
obstructive	0
sleep	0
apnoea	0
-	0
hypopnoea	0
with	I-DISEASE
or	I-DISEASE
without	0
treatment	I-DISEASE
with	0
continuous	I-DISEASE
positive	0
airway	0
pressure	0
:	I-DISEASE
an	0
observational	I-DISEASE
study	0
.	0

Lancet	0
2005;365:1046–53	0
.	0

Mason	I-DISEASE
RH	I-DISEASE
,	I-DISEASE
Mehta	0
Z	I-DISEASE
,	I-DISEASE
Fonseca	I-DISEASE
AC	I-DISEASE
,	I-DISEASE
Stradling	I-DISEASE
JR	I-DISEASE
,	I-DISEASE
Rothwell	0
PM	I-DISEASE
.	0

Snoring	I-DISEASE
and	0
severity	0
of	I-DISEASE
symptomatic	0
and	0
asymptomatic	I-DISEASE
carotid	I-DISEASE
stenosis	I-DISEASE
:	I-DISEASE
a	0
population	0
-	0
based	I-DISEASE
study	0
.	0

Sleep	I-DISEASE
2012;35:1147–51	I-DISEASE
.	0

O’Brien	I-DISEASE
LM	0
,	I-DISEASE
Bullough	I-DISEASE
AS	0
,	0
Owusu	I-DISEASE
JT	I-DISEASE
,	I-DISEASE
et	0
al	I-DISEASE
.	0

Pregnancy	I-DISEASE
-	I-DISEASE
onset	0
habitual	0
snoring	I-DISEASE
,	I-DISEASE
gestational	I-DISEASE
hypertension	0
,	0
and	0
preeclampsia	I-DISEASE
:	0
prospective	I-DISEASE
cohort	0
study	I-DISEASE
.	0

Am	I-DISEASE
J	0
Obstet	0
Gynecol	I-DISEASE
2012;207:487.e1–9	I-DISEASE
.	0

Rich	0
J	0
,	0
Raviv	0
A	0
,	0
Raviv	I-DISEASE
N	0
,	0
Brietzke	0
SE	I-DISEASE
.	0

An	0
epidemiologic	0
study	0
of	0
snoring	0
and	0
all	0
-	0
cause	I-DISEASE
mortality	I-DISEASE
.	0

Otolaryngol	I-DISEASE
Head	0
Neck	I-DISEASE
Surg	I-DISEASE
2011;145:341–46	0
.	0

Catathrenia	I-DISEASE
Catathrenia	0
,	0
also	0
known	I-DISEASE
as	0
sleep	I-DISEASE
related	B-DISEASE
groaning	I-DISEASE
,	I-DISEASE
is	I-DISEASE
included	0
in	0
the	0
SRBD	I-DISEASE
section	I-DISEASE
because	I-DISEASE
it	0
appears	I-DISEASE
to	0
be	I-DISEASE
associated	0
with	I-DISEASE
prolonged	0
expiration	I-DISEASE
,	I-DISEASE
usually	I-DISEASE
during	I-DISEASE
REM	I-DISEASE
sleep	0
.	0

However	I-DISEASE
,	I-DISEASE
some	0
studies	I-DISEASE
have	0
documented	I-DISEASE
catathrenia	I-DISEASE
during	I-DISEASE
NREM	0
sleep	0
.	0

Typically	I-DISEASE
,	I-DISEASE
a	0
deep	0
inspiration	0
is	0
followed	0
by	I-DISEASE
prolonged	0
expiration	0
and	0
a	I-DISEASE
monotonous	I-DISEASE
vocalization	I-DISEASE
resembling	0
groaning	0
.	0

The	I-DISEASE
pattern	0
is	0
sometimes	0
called	0
bradypnea	I-DISEASE
(	0
low	0
respiratory	I-DISEASE
rate	I-DISEASE
)	0
.	0

The	I-DISEASE
affected	I-DISEASE
individual	0
is	I-DISEASE
usually	0
unaware	I-DISEASE
of	I-DISEASE
the	B-DISEASE
problem	I-DISEASE
,	0
but	0
clini-	I-DISEASE
cal	0
evaluation	I-DISEASE
is	I-DISEASE
sought	0
due	0
to	I-DISEASE
complaints	0
of	I-DISEASE
the	0
bed	I-DISEASE
partner	0
or	0
family	I-DISEASE
members	I-DISEASE
.	0

The	I-DISEASE
recurrent	0
bradypneic	I-DISEASE
episodes	I-DISEASE
may	0
resemble	0
central	0
apnea	I-DISEASE
except	0
that	0
central	I-DISEASE
apneas	0
are	0
not	0
typically	0
associated	0
with	0
vocalization	0
.	0

Catathrenia	I-DISEASE
is	0
thought	I-DISEASE
to	I-DISEASE
be	I-DISEASE
rare	I-DISEASE
and	0
more	0
common	I-DISEASE
in	I-DISEASE
men	I-DISEASE
.	0

Several	0
episodes	I-DISEASE
may	0
occur	I-DISEASE
nightly	0
and	0
often	0
in	0
clusters	I-DISEASE
.	0

The	I-DISEASE
long	I-DISEASE
-	0
term	0
consequences	I-DISEASE
of	I-DISEASE
catathrenia	I-DISEASE
are	I-DISEASE
unknown	I-DISEASE
,	I-DISEASE
but	I-DISEASE
the	0
disorder	I-DISEASE
is	I-DISEASE
primarily	I-DISEASE
a	0
social	0
problem	I-DISEASE
for	0
the	0
affected	I-DISEASE
individual	I-DISEASE
.	0

The	I-DISEASE
episodes	I-DISEASE
of	I-DISEASE
catathrenia	0
are	I-DISEASE
not	0
associ-	0
ated	0
with	0
sleep	0
talking	I-DISEASE
or	0
body	I-DISEASE
movement	I-DISEASE
.	0

No	I-DISEASE
association	I-DISEASE
with	0
psychiatric	I-DISEASE
disorders	0
has	0
been	I-DISEASE
demonstrated	I-DISEASE
.	0

The	I-DISEASE
onset	I-DISEASE
of	I-DISEASE
catathrenia	I-DISEASE
has	I-DISEASE
recently	0
been	I-DISEASE
reported	0
in	I-DISEASE
patients	I-DISEASE
taking	I-DISEASE
sodium	I-DISEASE
oxybate	0
for	0
narcolepsy	0
with	I-DISEASE
cataplexy	I-DISEASE
.	0

The	I-DISEASE
clinical	0
significance	I-DISEASE
of	I-DISEASE
this	0
finding	I-DISEASE
is	I-DISEASE
unclear	I-DISEASE
.	0

Bibliography	0
Abbasi	0
AA	I-DISEASE
,	0
Morgenthaler	0
TI	0
,	I-DISEASE
Slocumb	0
NL	0
,	0
et	0
al	I-DISEASE
.	0

Nocturnal	0
moaning	0
and	0
groaning	0
-	0
catathrenia	0
or	I-DISEASE
nocturnal	I-DISEASE
vocalizations	0
.	0

Sleep	I-DISEASE
Breath	0
2012;16:367–73	I-DISEASE
.	0

Pevernagie	I-DISEASE
DA	0
,	I-DISEASE
Boon	I-DISEASE
PA	0
,	I-DISEASE
Mariman	I-DISEASE
ANN	I-DISEASE
,	I-DISEASE
Verhaeghen	I-DISEASE
DB	0
,	I-DISEASE
Pauwels	0
RA	I-DISEASE
.	0

Vocalization	I-DISEASE
during	I-DISEASE
episodes	I-DISEASE
of	0
prolonged	0
expiration	I-DISEASE
:	0
a	0
parasomnia	I-DISEASE
related	B-DISEASE
to	0
REM	I-DISEASE
sleep	0
.	0

Sleep	I-DISEASE
Med	I-DISEASE
2001;2:19–30	I-DISEASE
.	0

Poli	I-DISEASE
F	I-DISEASE
,	I-DISEASE
Ricotta	0
L	0
,	I-DISEASE
Vandi	0
S	I-DISEASE
,	I-DISEASE
et	0
al	I-DISEASE
.	0

Catathrenia	I-DISEASE
under	0
sodium	I-DISEASE
oxybate	0
in	I-DISEASE
narcolepsy	0
with	0
cataplexy	0
.	0

Sleep	I-DISEASE
Breath	0
2012;16:427–34	I-DISEASE
.	0

Vetrugno	I-DISEASE
R	0
,	I-DISEASE
Lugaresi	I-DISEASE
E	0
,	0
Plazzi	0
G	I-DISEASE
,	I-DISEASE
Provini	B-DISEASE
F	0
,	I-DISEASE
D’Angelo	I-DISEASE
R	I-DISEASE
,	I-DISEASE
Montagna	0
P.	I-DISEASE
Catathrenia	B-DISEASE
(	I-DISEASE
nocturnal	0
groaning	I-DISEASE
):	0
an	0
abnormal	0
respiratory	0
pattern	0
during	I-DISEASE
sleep	0
.	0

Eur	I-DISEASE
J	0
Neurol	0
2007;14:1236–43	I-DISEASE
.	0

Vetrugno	I-DISEASE
R	0
,	I-DISEASE
Provini	0
F	0
,	0
Plazzi	0
G	I-DISEASE
,	I-DISEASE
Vignatelli	I-DISEASE
L	0
,	0
Lugaresi	I-DISEASE
E	I-DISEASE
,	0
Montagna	0
P.	0
Catathrenia	0
(	0
nocturnal	0
groaning	I-DISEASE
):	0
a	0
new	0
type	I-DISEASE
of	I-DISEASE
parasomnia	I-DISEASE
.	0

Neurology	0
2001;56:681–3	I-DISEASE
.	0

Sleep	I-DISEASE
Related	0
Breathing	0
Disorders	I-DISEASE
Central	0
Disorders	0
of	I-DISEASE
Hypersomnolence	I-DISEASE
Narcolepsy	0
Type	0
1146	0
Narcolepsy	0
Type	0
2155	I-DISEASE
Idiopathic	0
Hypersomnia161	I-DISEASE
Kleine	I-DISEASE
-	I-DISEASE
Levin	0
Syndrome	I-DISEASE
166	0
Hypersomnia	I-DISEASE
Due	I-DISEASE
to	I-DISEASE
a	0
Medical	0
Disorder171	I-DISEASE
Hypersomnia	I-DISEASE
Due	I-DISEASE
to	I-DISEASE
a	0
Medication	0
or	0
Substance	I-DISEASE
175	0
Hypersomnia	I-DISEASE
Associated	I-DISEASE
with	0
a	I-DISEASE
Psychiatric	I-DISEASE
Disorder179	I-DISEASE
Insufficient	I-DISEASE
Sleep	I-DISEASE
Syndrome182	I-DISEASE
Isolated	0
Symptoms	0
and	0
Normal	0
Variants	I-DISEASE
Long	0
Sleeper	0
187	0
Adequate	0
alertness	I-DISEASE
is	0
necessary	0
for	0
well	B-DISEASE
-	0
being	I-DISEASE
and	0
performance	0
in	I-DISEASE
modern	I-DISEASE
society	0
.	0

Sleepiness	I-DISEASE
predisposes	0
an	0
individual	I-DISEASE
to	0
developing	0
serious	0
performance	0
decrements	I-DISEASE
in	I-DISEASE
multiple	I-DISEASE
areas	I-DISEASE
of	0
function	0
,	I-DISEASE
as	0
well	I-DISEASE
as	0
to	0
potentially	I-DISEASE
life	0
-	I-DISEASE
threatening	0
domestic	I-DISEASE
,	I-DISEASE
occu-	0
pational	0
,	0
and	0
vehicular	0
accidents	0
.	0

This	I-DISEASE
section	I-DISEASE
includes	0
a	I-DISEASE
group	I-DISEASE
of	I-DISEASE
disorders	0
in	I-DISEASE
which	0
the	0
primary	0
complaint	I-DISEASE
is	I-DISEASE
daytime	I-DISEASE
sleepiness	0
not	0
caused	I-DISEASE
by	0
disturbed	0
nocturnal	0
sleep	0
or	0
misaligned	0
circadian	0
rhythms	0
.	B-DISEASE

Other	I-DISEASE
sleep	0
disorders	0
may	I-DISEASE
be	0
present	I-DISEASE
,	I-DISEASE
but	I-DISEASE
they	B-DISEASE
must	0
be	0
adequately	I-DISEASE
treated	I-DISEASE
before	I-DISEASE
a	0
diagnosis	I-DISEASE
in	I-DISEASE
this	I-DISEASE
category	0
can	0
be	I-DISEASE
established	0
.	0

In	I-DISEASE
this	I-DISEASE
nosology	0
,	I-DISEASE
the	0
term	0
hypersomnolence	0
is	I-DISEASE
used	0
to	I-DISEASE
describe	0
the	0
symptom	0
of	I-DISEASE
exces-	I-DISEASE
sive	0
sleepiness	0
,	0
whereas	I-DISEASE
hypersomnia	I-DISEASE
refers	0
to	0
specific	I-DISEASE
disorders	0
,	0
such	I-DISEASE
as	0
idiopathic	I-DISEASE
hypersomnia	0
.	0

Daytime	I-DISEASE
sleepiness	0
is	0
defined	I-DISEASE
as	0
the	B-DISEASE
inability	0
to	0
stay	0
awake	0
and	0
alert	I-DISEASE
during	I-DISEASE
the	0
major	I-DISEASE
waking	I-DISEASE
episodes	0
of	0
the	0
day	0
,	I-DISEASE
resulting	0
in	I-DISEASE
periods	I-DISEASE
of	0
irrepressible	I-DISEASE
need	B-DISEASE
for	0
sleep	0
or	I-DISEASE
unin-	I-DISEASE
tended	I-DISEASE
lapses	0
into	I-DISEASE
drowsiness	0
or	I-DISEASE
sleep	I-DISEASE
.	0

Sleepiness	I-DISEASE
may	0
vary	I-DISEASE
in	0
severity	I-DISEASE
and	0
is	I-DISEASE
more	0
likely	0
to	0
occur	I-DISEASE
in	I-DISEASE
sedentary	I-DISEASE
,	I-DISEASE
boring	I-DISEASE
,	0
and	0
monotonous	I-DISEASE
situations	I-DISEASE
that	0
require	I-DISEASE
little	0
active	I-DISEASE
participation	I-DISEASE
.	0

Some	I-DISEASE
patients	I-DISEASE
are	0
aware	I-DISEASE
of	0
increasing	I-DISEASE
sleepiness	0
before	0
falling	0
asleep	I-DISEASE
,	I-DISEASE
whereas	I-DISEASE
others	I-DISEASE
can	0
fall	I-DISEASE
asleep	I-DISEASE
with	I-DISEASE
little	0
or	0
no	0
prodromal	0
symptoms	I-DISEASE
(	0
“	I-DISEASE
sleep	0
attacks	I-DISEASE
”	I-DISEASE
)	0
.	0

This	I-DISEASE
group	I-DISEASE
of	I-DISEASE
patients	I-DISEASE
sometimes	0
can	0
present	I-DISEASE
following	0
motor	0
vehicle	0
accidents	0
attrib-	I-DISEASE
utable	I-DISEASE
to	I-DISEASE
sleepiness	0
.	0

In	I-DISEASE
some	I-DISEASE
forms	0
of	I-DISEASE
hypersomnolence	0
,	I-DISEASE
sleepiness	I-DISEASE
is	0
associated	0
with	I-DISEASE
large	I-DISEASE
increases	0
in	0
total	I-DISEASE
daily	I-DISEASE
amount	I-DISEASE
of	I-DISEASE
sleep	0
without	0
any	0
genuine	0
feeling	I-DISEASE
of	I-DISEASE
resto-	I-DISEASE
ration	I-DISEASE
.	0

In	I-DISEASE
others	I-DISEASE
,	0
sleepiness	0
can	0
be	0
alleviated	0
temporarily	0
by	I-DISEASE
naps	I-DISEASE
but	I-DISEASE
reoccurs	0
shortly	0
thereafter	I-DISEASE
.	0

In	I-DISEASE
young	I-DISEASE
children	0
,	I-DISEASE
sleepiness	0
may	I-DISEASE
express	0
itself	0
as	0
excessively	0
long	I-DISEASE
night	I-DISEASE
sleep	0
or	I-DISEASE
with	I-DISEASE
the	I-DISEASE
recurrence	0
of	I-DISEASE
previously	I-DISEASE
discontinued	I-DISEASE
daytime	I-DISEASE
napping	I-DISEASE
.	0

Children	I-DISEASE
may	0
Central	0
Disorders	I-DISEASE
of	I-DISEASE
Hypersomnolence	I-DISEASE
paradoxically	I-DISEASE
present	I-DISEASE
with	0
inattentiveness	0
,	I-DISEASE
emotional	I-DISEASE
lability	0
,	I-DISEASE
hyperactive	I-DISEASE
behavior	I-DISEASE
,	0
or	I-DISEASE
decreased	I-DISEASE
performance	0
in	0
school	0
.	0

In	I-DISEASE
most	0
cases	0
,	I-DISEASE
excessive	0
sleepiness	0
is	I-DISEASE
a	0
chronic	0
symptom	0
.	0

It	I-DISEASE
must	I-DISEASE
occur	0
for	I-DISEASE
at	I-DISEASE
least	0
three	I-DISEASE
months	0
prior	0
to	0
diagnosis	0
.	0

The	I-DISEASE
severity	I-DISEASE
of	I-DISEASE
daytime	I-DISEASE
sleepiness	0
can	I-DISEASE
be	I-DISEASE
quantified	0
subjectively	I-DISEASE
using	I-DISEASE
severity	0
scales	0
such	0
as	I-DISEASE
the	0
Epworth	0
Sleepiness	0
Scale	I-DISEASE
and	0
objectively	B-DISEASE
using	I-DISEASE
the	I-DISEASE
Multiple	0
Sleep	0
Latency	0
Test	I-DISEASE
(	I-DISEASE
MSLT	I-DISEASE
)	0
.	0

These	0
measures	0
do	0
not	0
always	0
correlate	0
with	0
each	0
other	0
and	0
must	I-DISEASE
be	I-DISEASE
used	0
with	0
appropriate	I-DISEASE
clinical	I-DISEASE
judgment	0
.	0

When	I-DISEASE
applied	0
in	0
clinical	I-DISEASE
settings	0
,	I-DISEASE
the	0
MSLT	I-DISEASE
is	0
sensitive	0
to	I-DISEASE
sleep	I-DISEASE
deprivation	I-DISEASE
and	0
circadian	0
effects	0
.	0

It	I-DISEASE
has	0
not	0
been	I-DISEASE
validated	0
as	0
a	I-DISEASE
diagnostic	0
test	0
in	I-DISEASE
people	0
who	I-DISEASE
are	I-DISEASE
habitually	0
awake	0
throughout	0
the	0
night	0
and	0
sleep	0
during	I-DISEASE
the	0
day	0
.	0

Normal	I-DISEASE
and	0
abnormal	0
ranges	I-DISEASE
of	0
sleep	0
latencies	I-DISEASE
have	0
not	0
been	I-DISEASE
estab-	I-DISEASE
lished	0
when	0
this	I-DISEASE
test	0
is	0
administered	0
at	I-DISEASE
times	0
other	0
than	0
the	0
hours	I-DISEASE
between	0
8:00	I-DISEASE
a.m.	0
and	0
6:00	0
p.m.	0

Normative	I-DISEASE
data	0
are	I-DISEASE
not	0
available	0
for	0
children	I-DISEASE
younger	0
than	0
six	0
years	0
.	I-DISEASE

The	I-DISEASE
MSLT	I-DISEASE
measures	0
the	0
physiological	I-DISEASE
tendency	I-DISEASE
to	I-DISEASE
fall	0
asleep	0
in	0
quiet	0
situations	I-DISEASE
.	0

In	I-DISEASE
the	0
context	I-DISEASE
of	I-DISEASE
diagnosing	0
central	0
disorders	0
of	I-DISEASE
hypersomnolence	I-DISEASE
,	0
the	0
MSLT	I-DISEASE
should	I-DISEASE
be	0
con-	0
ducted	0
according	0
to	I-DISEASE
standardized	0
procedures	I-DISEASE
,	0
as	0
defined	I-DISEASE
in	I-DISEASE
the	0
American	0
Academy	0
of	I-DISEASE
Sleep	0
Medicine	0
(	0
AASM	0
)	0
practice	I-DISEASE
parameters	I-DISEASE
.	0

In	I-DISEASE
particular	I-DISEASE
,	0
patients	I-DISEASE
should	0
be	I-DISEASE
encour-	0
aged	I-DISEASE
to	I-DISEASE
sleep	I-DISEASE
as	I-DISEASE
much	I-DISEASE
as	0
possible	0
during	I-DISEASE
the	0
week	0
and	0
,	0
especially	0
,	I-DISEASE
during	I-DISEASE
the	I-DISEASE
night	0
prior	I-DISEASE
to	0
the	I-DISEASE
MSLT	I-DISEASE
.	0

Delaying	I-DISEASE
wake	0
-	0
up	I-DISEASE
time	I-DISEASE
and	0
subsequent	0
MSLT	I-DISEASE
start	0
time	I-DISEASE
may	I-DISEASE
be	0
appropriate	I-DISEASE
in	I-DISEASE
some	I-DISEASE
patients	0
with	0
delayed	I-DISEASE
sleep	0
phase	0
syndrome	0
.	0

It	I-DISEASE
is	I-DISEASE
strongly	I-DISEASE
rec-	0
ommended	0
that	0
adequate	0
sleep	0
be	I-DISEASE
documented	I-DISEASE
by	0
sleep	0
log	I-DISEASE
and	0
,	0
whenever	0
possible	0
,	0
actigraphy	0
for	I-DISEASE
a	0
period	I-DISEASE
of	I-DISEASE
one	I-DISEASE
to	I-DISEASE
two	I-DISEASE
weeks	0
prior	0
to	I-DISEASE
the	0
MSLT	I-DISEASE
.	0

MSLT	I-DISEASE
mean	I-DISEASE
sleep	0
latencies	0
should	I-DISEASE
be	I-DISEASE
considered	0
a	0
continuum	0
with	I-DISEASE
values	I-DISEASE
below	0
five	0
minutes	0
generally	I-DISEASE
considered	0
as	0
indicative	I-DISEASE
of	I-DISEASE
sleepiness	0
and	0
those	0
over	0
10	0
minutes	0
generally	I-DISEASE
consid-	0
ered	0
indicative	0
of	I-DISEASE
normal	0
alertness	0
.	0

In	I-DISEASE
this	I-DISEASE
section	0
,	I-DISEASE
a	0
mean	I-DISEASE
MSLT	I-DISEASE
sleep	0
latency	I-DISEASE
of	I-DISEASE
less	I-DISEASE
than	I-DISEASE
eight	0
minutes	0
is	I-DISEASE
used	I-DISEASE
to	0
define	0
sleepiness	I-DISEASE
for	I-DISEASE
diagnostic	0
purposes	0
.	0

This	I-DISEASE
value	0
has	0
been	I-DISEASE
shown	0
to	I-DISEASE
be	I-DISEASE
the	0
best	0
cutoff	0
in	I-DISEASE
the	I-DISEASE
context	I-DISEASE
of	I-DISEASE
diagnosing	I-DISEASE
narcolepsy	0
,	0
with	I-DISEASE
approximately	I-DISEASE
90	I-DISEASE
%	0
of	I-DISEASE
patients	I-DISEASE
with	I-DISEASE
narcolepsy	0
having	I-DISEASE
a	0
latency	0
below	I-DISEASE
this	0
level	0
.	0

The	I-DISEASE
presence	0
of	I-DISEASE
multiple	I-DISEASE
sleep	0
onset	I-DISEASE
rapid	I-DISEASE
eye	I-DISEASE
movement	0
periods	0
(	I-DISEASE
SOREMPs	I-DISEASE
)	0
during	I-DISEASE
the	0
MSLT	I-DISEASE
is	I-DISEASE
a	0
more	0
specific	I-DISEASE
finding	I-DISEASE
in	I-DISEASE
narcolepsy	0
than	I-DISEASE
is	I-DISEASE
a	0
mean	I-DISEASE
sleep	0
latency	I-DISEASE
less	0
than	I-DISEASE
or	0
equal	0
to	0
eight	0
minutes	0
,	I-DISEASE
although	0
SOREMPs	I-DISEASE
can	0
also	0
be	0
seen	I-DISEASE
in	0
the	0
presence	0
of	I-DISEASE
insuffi-	0
cient	I-DISEASE
sleep	0
,	I-DISEASE
circadian	I-DISEASE
rhythm	I-DISEASE
disorders	0
(	I-DISEASE
including	I-DISEASE
delayed	I-DISEASE
sleep	0
phase	0
disorder	I-DISEASE
or	0
shift	0
work	I-DISEASE
)	0
,	0
sleep	I-DISEASE
related	0
breathing	I-DISEASE
disorders	0
or	0
,	I-DISEASE
occasionally	0
,	I-DISEASE
normal	0
subjects	0
.	0

The	I-DISEASE
results	I-DISEASE
of	I-DISEASE
an	0
MSLT	I-DISEASE
should	I-DISEASE
be	I-DISEASE
carefully	0
interpreted	0
in	I-DISEASE
the	0
context	I-DISEASE
of	I-DISEASE
the	0
patient	I-DISEASE
’s	I-DISEASE
history	I-DISEASE
and	0
the	0
complaint	I-DISEASE
of	I-DISEASE
daytime	I-DISEASE
sleepiness	0
.	0

The	I-DISEASE
maintenance	I-DISEASE
of	I-DISEASE
wakefulness	0
test	0
is	I-DISEASE
a	I-DISEASE
measure	0
of	I-DISEASE
the	0
ability	I-DISEASE
to	I-DISEASE
remain	I-DISEASE
awake	0
during	I-DISEASE
the	0
daytime	I-DISEASE
in	0
a	0
darkened	I-DISEASE
,	0
quiet	0
environment	0
and	0
is	I-DISEASE
usually	0
administered	I-DISEASE
to	0
assess	I-DISEASE
response	0
to	0
treatment	I-DISEASE
.	0

It	I-DISEASE
should	I-DISEASE
not	0
be	I-DISEASE
used	0
for	I-DISEASE
diagnostic	0
purposes	I-DISEASE
.	0

A	I-DISEASE
24	0
-	0
hour	0
continuous	0
sleep	0
recording	0
or	I-DISEASE
an	0
actigraphic	0
recording	I-DISEASE
of	I-DISEASE
at	I-DISEASE
least	0
one	I-DISEASE
week	0
is	0
useful	0
in	I-DISEASE
the	0
diagnosis	0
of	I-DISEASE
some	0
patients	I-DISEASE
with	0
idiopathic	I-DISEASE
hypersomnia	I-DISEASE
.	0

In	I-DISEASE
all	0
cases	0
in	I-DISEASE
which	0
a	0
diagnosis	I-DISEASE
of	I-DISEASE
hypersomnolence	0
is	I-DISEASE
to	I-DISEASE
be	I-DISEASE
made	0
,	0
a	0
review	0
of	I-DISEASE
other	I-DISEASE
sleep	0
,	I-DISEASE
medical	0
,	I-DISEASE
and	0
psychiatric	0
disorders	0
,	I-DISEASE
as	0
well	0
as	0
substance	I-DISEASE
and	0
medication	0
use	I-DISEASE
,	0
should	0
be	0
performed	0
.	0

In	I-DISEASE
this	I-DISEASE
edition	I-DISEASE
of	I-DISEASE
International	0
Classification	I-DISEASE
of	I-DISEASE
Sleep	I-DISEASE
Disorders	I-DISEASE
the	0
preferred	I-DISEASE
names	I-DISEASE
of	I-DISEASE
certain	0
central	0
disorders	I-DISEASE
of	I-DISEASE
hypersomnolence	0
have	0
been	I-DISEASE
changed	0
.	0

In	I-DISEASE
particular	I-DISEASE
,	0
nar-	0
colepsy	0
has	0
been	I-DISEASE
divided	0
into	I-DISEASE
narcolepsy	0
type	I-DISEASE
1	0
and	0
narcolepsy	0
type	I-DISEASE
2	I-DISEASE
rather	0
than	I-DISEASE
narcolepsy	0
with	I-DISEASE
and	0
without	0
cataplexy	0
.	0

This	I-DISEASE
change	I-DISEASE
is	0
predicated	I-DISEASE
on	0
the	I-DISEASE
concept	I-DISEASE
that	0
absence	0
of	I-DISEASE
hypocretin	I-DISEASE
(	I-DISEASE
orexin	I-DISEASE
)	0
is	I-DISEASE
a	0
fundamental	I-DISEASE
marker	0
of	I-DISEASE
the	I-DISEASE
most	0
precisely	I-DISEASE
defined	I-DISEASE
category	0
of	I-DISEASE
the	B-DISEASE
disorder	0
.	B-DISEASE

Because	I-DISEASE
some	I-DISEASE
patients	0
without	0
cataplexy	0
will	0
also	0
have	0
low	0
cerebrospinal	I-DISEASE
fluid	I-DISEASE
(	0
CSF	0
)	0
hypocretin-1	I-DISEASE
levels	I-DISEASE
,	I-DISEASE
the	B-DISEASE
use	0
of	I-DISEASE
the	0
term	0
“	0
narcolepsy	0
with	0
cataplexy	0
”	I-DISEASE
or	I-DISEASE
“	I-DISEASE
narcolepsy	0
-	0
cataplexy	0
”	I-DISEASE
is	0
inappropriate	0
.	0

The	I-DISEASE
change	I-DISEASE
is	0
not	0
intended	0
to	I-DISEASE
imply	I-DISEASE
that	I-DISEASE
the	0
presence	0
or	0
absence	I-DISEASE
of	I-DISEASE
cataplexy	I-DISEASE
is	I-DISEASE
unimportant	0
clinically	I-DISEASE
nor	0
that	0
mea-	0
suring	I-DISEASE
CSF	0
hypocretin-1	I-DISEASE
levels	0
is	0
obligatory	0
.	I-DISEASE

The	I-DISEASE
motivation	I-DISEASE
behind	0
the	0
decision	0
to	I-DISEASE
eliminate	I-DISEASE
the	0
subcategories	0
of	I-DISEASE
idiopathic	I-DISEASE
hypersomnia	I-DISEASE
is	0
discussed	I-DISEASE
in	0
the	0
appropriate	I-DISEASE
section	0
.	0

The	I-DISEASE
decision	I-DISEASE
to	0
use	I-DISEASE
Kleine	0
-	0
Levin	I-DISEASE
syndrome	0
as	0
the	0
preferred	0
name	I-DISEASE
in	I-DISEASE
place	0
of	I-DISEASE
recurrent	I-DISEASE
hypersomnia	0
is	0
based	B-DISEASE
on	0
data	0
suggesting	I-DISEASE
that	0
the	I-DISEASE
condition	0
is	0
fairly	0
homo-	I-DISEASE
geneous	0
,	I-DISEASE
as	0
well	0
as	0
the	0
lack	0
of	I-DISEASE
definite	0
evidence	I-DISEASE
for	I-DISEASE
other	I-DISEASE
major	0
subcategories	I-DISEASE
of	I-DISEASE
the	0
disorder	I-DISEASE
.	0

Bibliography	0
Arand	0
D	I-DISEASE
,	0
Bonnet	I-DISEASE
M	0
,	0
Hurwitz	I-DISEASE
T	0
,	I-DISEASE
Mitler	I-DISEASE
M	0
,	0
Rosa	I-DISEASE
R	0
,	0
Sangal	0
RB	I-DISEASE
.	0

A	I-DISEASE
Review	I-DISEASE
by	I-DISEASE
the	0
MSLT	I-DISEASE
and	0
MWT	0
Task	0
Force	0
of	I-DISEASE
the	I-DISEASE
Standards	I-DISEASE
of	I-DISEASE
Practice	0
Committee	I-DISEASE
of	I-DISEASE
the	0
American	0
Academy	0
of	I-DISEASE
Sleep	0
Medicine	B-DISEASE
.	0

The	I-DISEASE
clinical	0
use	0
of	I-DISEASE
the	0
MSLT	I-DISEASE
and	0
MWT	0
.	0

Sleep	I-DISEASE
2005;28:123–44	I-DISEASE
.	0

Aurora	I-DISEASE
RN	I-DISEASE
,	I-DISEASE
Lamm	0
CI	I-DISEASE
,	0
Zak	0
RS	0
,	I-DISEASE
et	0
al	0
.	0

Practice	I-DISEASE
parameters	I-DISEASE
for	0
the	0
non	0
-	0
respiratory	0
indications	I-DISEASE
for	0
polysomnography	0
and	0
multiple	I-DISEASE
sleep	0
latency	I-DISEASE
testing	0
for	I-DISEASE
children	B-DISEASE
.	0

Sleep	I-DISEASE
2012;35:1467–73	I-DISEASE
.	0

Littner	I-DISEASE
MR	I-DISEASE
,	0
Kushida	0
C	0
,	I-DISEASE
Wise	0
M	I-DISEASE
,	I-DISEASE
et	0
al	I-DISEASE
.	0
;	I-DISEASE
Standards	I-DISEASE
of	I-DISEASE
Practice	0
Committee	I-DISEASE
of	I-DISEASE
the	0
American	0
Academy	0
of	I-DISEASE
Sleep	0
Medicine	I-DISEASE
.	0

Practice	I-DISEASE
parameters	I-DISEASE
for	0
clinical	I-DISEASE
use	0
of	I-DISEASE
the	0
multiple	I-DISEASE
sleep	0
latency	I-DISEASE
test	0
and	0
the	0
maintenance	0
of	I-DISEASE
wakefulness	0
test	0
.	0

Sleep	I-DISEASE
2005;28:113–21	I-DISEASE
.	0

Mignot	I-DISEASE
E	0
,	0
Lin	I-DISEASE
L	0
,	I-DISEASE
Finn	0
L	0
,	0
et	0
al	I-DISEASE
.	0

Correlates	I-DISEASE
of	I-DISEASE
sleep	0
-	I-DISEASE
onset	I-DISEASE
REM	I-DISEASE
periods	0
during	I-DISEASE
the	0
Multiple	I-DISEASE
Sleep	I-DISEASE
Latency	0
Test	I-DISEASE
in	I-DISEASE
community	0
adults	I-DISEASE
.	0

Brain	0
2006;129:1609–23	0
.	0

Central	I-DISEASE
Disorders	I-DISEASE
of	0
Hypersomnolence	I-DISEASE
Central	I-DISEASE
Disorders	I-DISEASE
of	I-DISEASE
Hypersomnolence	I-DISEASE
Narcolepsy	0
Type	0
1	I-DISEASE
ICD-9	0
-	I-DISEASE
CM	0
code	0
:	0
347.01	0
ICD-10	0
-	I-DISEASE
CM	I-DISEASE
code	0
:	0
G47.411	0
Alternate	0
Names	I-DISEASE
Hypocretin	I-DISEASE
deficiency	0
syndrome	0
,	0
narcolepsy	0
-	0
cataplexy	0
,	0
narcolepsy	0
with	I-DISEASE
cataplexy	0
.	0

Diagnostic	I-DISEASE
Criteria	0
Criteria	I-DISEASE
A	0
and	0
B	0
must	I-DISEASE
be	0
met	0
A.	0

The	I-DISEASE
patient	I-DISEASE
has	0
daily	I-DISEASE
periods	0
of	I-DISEASE
irrepressible	I-DISEASE
need	I-DISEASE
to	I-DISEASE
sleep	I-DISEASE
or	I-DISEASE
daytime	0
lapses	I-DISEASE
into	I-DISEASE
sleep	0
occurring	0
for	I-DISEASE
at	I-DISEASE
least	I-DISEASE
three	I-DISEASE
months.1	0

B.	0
The	I-DISEASE
presence	0
of	0
one	0
or	I-DISEASE
both	I-DISEASE
of	0
the	0
following	0
:	I-DISEASE
.	I-DISEASE

Cataplexy	I-DISEASE
(	0
as	I-DISEASE
defined	I-DISEASE
under	I-DISEASE
Essential	0
Features	I-DISEASE
)	0
and	0
a	I-DISEASE
mean	I-DISEASE
sleep	0
latency	I-DISEASE
of	I-DISEASE
≤	0
8	0
minutes	0
and	0
two	I-DISEASE
or	I-DISEASE
more	0
sleep	I-DISEASE
onset	0
REM	I-DISEASE
periods	I-DISEASE
(	I-DISEASE
SOREMPs	I-DISEASE
)	0
on	0
an	0
MSLT	I-DISEASE
performed	0
according	I-DISEASE
to	0
standard	0
techniques	0
.	0

A	I-DISEASE
SOREMP	I-DISEASE
(	I-DISEASE
within	I-DISEASE
15	I-DISEASE
minutes	0
of	I-DISEASE
sleep	0
onset	I-DISEASE
)	I-DISEASE
on	0
the	0
preceding	I-DISEASE
nocturnal	0
polysomnogram	0
may	0
replace	I-DISEASE
one	0
of	I-DISEASE
the	0
SOREMPs	I-DISEASE
on	0
the	I-DISEASE
MSLT.2	I-DISEASE
.	0

CSF	I-DISEASE
hypocretin-1	0
concentration	0
,	0
measured	0
by	I-DISEASE
immunoreactivity	I-DISEASE
,	0
is	I-DISEASE
either	I-DISEASE
≤	0
110	0
pg	0
/	0
mL	I-DISEASE
or	I-DISEASE
<	I-DISEASE
1/3	B-DISEASE
of	I-DISEASE
mean	I-DISEASE
values	I-DISEASE
obtained	0
in	I-DISEASE
normal	0
subjects	0
with	0
the	0
same	0
standardized	0
assay	I-DISEASE
.	0

Notes	I-DISEASE
.	0

In	I-DISEASE
young	I-DISEASE
children	0
,	I-DISEASE
narcolepsy	0
may	0
sometimes	0
present	I-DISEASE
as	0
excessively	I-DISEASE
long	0
night	0
sleep	0
or	I-DISEASE
as	0
resumption	0
of	I-DISEASE
previously	I-DISEASE
discontinued	I-DISEASE
daytime	0
napping	I-DISEASE
.	0
.	0

If	I-DISEASE
narcolepsy	0
type	I-DISEASE
I	0
is	I-DISEASE
strongly	0
suspected	0
clinically	0
but	I-DISEASE
the	0
MSLT	I-DISEASE
criteria	I-DISEASE
of	I-DISEASE
B1	0
are	I-DISEASE
not	0
met	0
,	0
a	0
possible	I-DISEASE
strategy	0
is	I-DISEASE
to	0
repeat	0
the	0
MSLT	I-DISEASE
.	0

Essential	I-DISEASE
Features	I-DISEASE
Narcolepsy	0
type	I-DISEASE
1	I-DISEASE
is	0
a	0
disorder	0
primarily	I-DISEASE
characterized	0
by	I-DISEASE
excessive	0
daytime	I-DISEASE
sleepi-	0
ness	0
and	0
signs	0
of	I-DISEASE
REM	I-DISEASE
-	0
sleep	0
dissociation	0
,	I-DISEASE
the	0
most	0
specific	I-DISEASE
of	I-DISEASE
which	0
is	0
cataplexy	0
.	0

It	I-DISEASE
has	0
now	I-DISEASE
been	I-DISEASE
firmly	0
established	I-DISEASE
that	0
narcolepsy	0
type	I-DISEASE
1	I-DISEASE
is	I-DISEASE
caused	0
by	I-DISEASE
a	0
deficiency	I-DISEASE
of	0
hypothalamic	0
hypocretin	0
(	I-DISEASE
orexin	I-DISEASE
)	0
signaling	I-DISEASE
.	0

Patients	I-DISEASE
with	0
low	0
or	0
undetectable	I-DISEASE
concen-	0
trations	0
of	I-DISEASE
hypocretin-1	0
in	0
the	0
CSF	I-DISEASE
compose	I-DISEASE
a	0
specific	I-DISEASE
disease	I-DISEASE
population	0
with	0
a	0
single	I-DISEASE
etiology	0
and	0
relatively	0
homogenous	0
clinical	0
and	0
polysomnographic	0
features	0
.	0

Patients	I-DISEASE
with	0
sleepiness	0
and	0
low	0
or	I-DISEASE
absent	0
CSF	0
hypocretin-1	I-DISEASE

levels	I-DISEASE
are	0
classified	0
as	0
having	0
nar-	0
colepsy	0
type	I-DISEASE
1	I-DISEASE
,	I-DISEASE
even	I-DISEASE
if	0
they	I-DISEASE
do	I-DISEASE
not	0
manifest	0
cataplexy	0
.	0

Excessive	I-DISEASE
daytime	I-DISEASE
sleepiness	0
is	I-DISEASE
the	0
cardinal	I-DISEASE
symptom	0
,	I-DISEASE
and	0
often	0
the	0
most	I-DISEASE
disabling	0
.	0

Patients	I-DISEASE
with	0
narcolepsy	I-DISEASE
type	I-DISEASE
1	0
experience	0
repeated	I-DISEASE
daily	I-DISEASE
episodes	I-DISEASE
of	I-DISEASE
an	0
irrepressible	I-DISEASE
need	0
to	I-DISEASE
sleep	0
or	I-DISEASE
lapses	I-DISEASE
into	I-DISEASE
sleep	0
.	I-DISEASE

Most	I-DISEASE
patients	I-DISEASE
awaken	0
refreshed	0
after	0
a	0
sleep	0
episode	I-DISEASE
but	I-DISEASE
begin	I-DISEASE
to	0
feel	I-DISEASE
sleepy	0
again	I-DISEASE
after	0
variable	I-DISEASE
times	0
.	0

Sleepiness	I-DISEASE
is	0
most	0
likely	0
to	I-DISEASE
occur	I-DISEASE
in	I-DISEASE
monotonous	0
situations	I-DISEASE
that	I-DISEASE
require	I-DISEASE
no	0
active	I-DISEASE
participation	I-DISEASE
;	I-DISEASE
for	0
example	0
,	I-DISEASE
watching	0
television	0
or	0
riding	0
in	I-DISEASE
a	0
car	I-DISEASE
.	0

Physical	I-DISEASE
activity	0
may	0
temporarily	I-DISEASE
suppress	0
the	0
urge	0
to	I-DISEASE
sleep	0
.	0

In	I-DISEASE
some	I-DISEASE
cases	0
sleepiness	0
manifests	0
as	B-DISEASE
sudden	0
irresistible	0
sleep	0
“	0
attacks	0
”	I-DISEASE
that	I-DISEASE
may	0
occur	0
in	I-DISEASE
unusual	I-DISEASE
situations	I-DISEASE
such	0
as	0
eating	I-DISEASE
or	0
walking	I-DISEASE
.	0

Often	I-DISEASE
,	0
such	0
sleep	0
attacks	0
occur	I-DISEASE
on	0
a	I-DISEASE
background	0
of	I-DISEASE
overall	0
sleepiness	0
.	0

Even	I-DISEASE
when	0
seemingly	0
awake	0
,	0
many	0
nar-	0
colepsy	0
patients	I-DISEASE
have	I-DISEASE
lapses	0
in	I-DISEASE
vigilance	I-DISEASE
,	0
sometimes	0
in	I-DISEASE
combination	I-DISEASE
with	0
automatic	I-DISEASE
behavior	0
,	0
such	0
as	0
writing	0
gibberish	0
or	0
interrupting	0
a	0
conversation	0
with	0
a	0
completely	0
different	0
topic	0
.	0

Sleepiness	I-DISEASE
generally	I-DISEASE
has	0
a	0
serious	I-DISEASE
impact	I-DISEASE
on	0
the	0
ability	0
of	I-DISEASE
the	0
patient	I-DISEASE
to	I-DISEASE
function	0
in	I-DISEASE
educational	I-DISEASE
,	I-DISEASE
social	0
,	0
and	0
occupational	I-DISEASE
situations	I-DISEASE
.	0

Because	I-DISEASE
patients	I-DISEASE
are	0
rarely	I-DISEASE
examined	0
during	I-DISEASE
an	0
attack	I-DISEASE
of	I-DISEASE
cataplexy	0
,	I-DISEASE
its	I-DISEASE
presence	0
needs	I-DISEASE
to	I-DISEASE
be	0
established	0
based	I-DISEASE
on	0
the	0
clinical	I-DISEASE
interview	0
alone	I-DISEASE
.	0

Cataplexy	I-DISEASE
is	0
defined	I-DISEASE
as	I-DISEASE
more	I-DISEASE
than	I-DISEASE
one	0
episode	I-DISEASE
of	I-DISEASE
generally	I-DISEASE
brief	I-DISEASE
(	I-DISEASE
<	I-DISEASE
2	I-DISEASE
minutes	0
)	0
,	I-DISEASE
usually	I-DISEASE
bilaterally	0
symmetrical	I-DISEASE
sudden	0
loss	I-DISEASE
of	I-DISEASE
muscle	I-DISEASE
tone	I-DISEASE
with	I-DISEASE
retained	0
consciousness	B-DISEASE
.	0

The	I-DISEASE
episodes	I-DISEASE
are	0
precipitated	I-DISEASE
by	I-DISEASE
strong	0
emotions	0
,	0
usually	I-DISEASE
positive	I-DISEASE
,	I-DISEASE
with	0
almost	I-DISEASE
all	0
patients	I-DISEASE
reporting	0
some	0
episodes	I-DISEASE
precipitated	0
by	I-DISEASE
emotions	0
associated	0
with	0
laughter	I-DISEASE
.	0

The	I-DISEASE
finding	I-DISEASE
of	I-DISEASE
transient	0
reversible	I-DISEASE
loss	I-DISEASE
of	I-DISEASE
deep	0
tendon	B-DISEASE
reflexes	I-DISEASE
during	I-DISEASE
an	0
attack	0
,	I-DISEASE
if	0
observed	0
,	I-DISEASE
is	0
a	0
strong	0
diagnostic	0
finding	I-DISEASE
.	0

In	I-DISEASE
children	I-DISEASE
(	0
and	0
rarely	0
adults	I-DISEASE
)	0
,	I-DISEASE
cataplexy	0
may	I-DISEASE
present	I-DISEASE
close	0
to	0
disease	I-DISEASE
onset	I-DISEASE
as	0
facial	0
(	I-DISEASE
or	0
generalized	0
)	0
hypotonia	0
with	0
droopy	0
eyelids	I-DISEASE
,	0
mouth	I-DISEASE
opening	I-DISEASE
,	0
and	0
protruded	0
tongue	0
,	0
or	0
gait	0
unsteadiness	I-DISEASE
,	0
which	0
clearly	0
are	0
not	0
related	B-DISEASE
to	I-DISEASE
emotion	I-DISEASE
.	0

Facial	I-DISEASE
and	0
masticatory	0
movements	0
may	0
occur	0
.	0

In	I-DISEASE
children	I-DISEASE
,	0
anticipation	0
of	0
a	0
reward	0
is	I-DISEASE
a	0
common	I-DISEASE
precipitant	0
.	0

It	I-DISEASE
is	I-DISEASE
important	0
to	I-DISEASE
use	0
child	0
-	I-DISEASE
appropriate	I-DISEASE
contexts	0
and	0
language	0
when	I-DISEASE
trying	I-DISEASE
to	I-DISEASE
elicit	0
a	I-DISEASE
history	I-DISEASE
of	0
cataplexy	0
in	I-DISEASE
children	I-DISEASE
.	0

The	I-DISEASE
cataplexy	I-DISEASE
phenotype	0
differs	I-DISEASE
widely	0
between	0
patients	I-DISEASE
,	I-DISEASE
ranging	I-DISEASE
from	0
sporadic	0
partial	I-DISEASE
attacks	0
triggered	0
by	I-DISEASE
laughter	0
,	I-DISEASE
to	0
frequent	0
complete	I-DISEASE
attacks	0
of	I-DISEASE
collapse	I-DISEASE
brought	I-DISEASE
about	0
by	B-DISEASE
a	0
variety	I-DISEASE
of	I-DISEASE
emotions	0
.	0

In	I-DISEASE
the	I-DISEASE
vast	0
majority	0
of	I-DISEASE
attacks	I-DISEASE
,	I-DISEASE
cataplexy	I-DISEASE
is	I-DISEASE
bilateral	I-DISEASE
,	I-DISEASE
although	0
patients	I-DISEASE
sometimes	I-DISEASE
report	I-DISEASE
one	0
side	0
of	I-DISEASE
the	0
body	I-DISEASE
to	I-DISEASE
be	0
more	I-DISEASE
affected	0
than	I-DISEASE
the	0
other	I-DISEASE
.	0

Partial	I-DISEASE
attacks	0
can	I-DISEASE
be	0
very	I-DISEASE
subtle	I-DISEASE
and	0
sometimes	0
only	0
recognized	0
by	I-DISEASE
experi-	I-DISEASE
enced	I-DISEASE
observers	0
such	0
as	0
the	0
patient	I-DISEASE
’s	I-DISEASE
partner	0
.	0

Neck	I-DISEASE
weakness	I-DISEASE
,	0
producing	0
head	I-DISEASE
drop	I-DISEASE
,	I-DISEASE
is	I-DISEASE
a	0
common	I-DISEASE
complaint	I-DISEASE
,	I-DISEASE
whereas	I-DISEASE
facial	I-DISEASE
weakness	0
may	I-DISEASE
lead	0
to	I-DISEASE
sagging	0
of	I-DISEASE
the	0
jaw	0
and	0
dysarthria	0
.	0

Respiratory	I-DISEASE
muscles	0
are	0
not	0
involved	I-DISEASE
although	0
patients	0
sometimes	0
describe	I-DISEASE
shortness	I-DISEASE
of	I-DISEASE
breath	0
when	I-DISEASE
symptomatic	I-DISEASE
.	0

Attacks	I-DISEASE
start	0
abruptly	I-DISEASE
and	0
usually	I-DISEASE
build	0
up	I-DISEASE
over	0
several	0
seconds	0
,	I-DISEASE
especially	I-DISEASE
in	I-DISEASE
attacks	0
producing	0
complete	0
peripheral	I-DISEASE
weakness	0
and	0
collapse	I-DISEASE
.	0

Positive	I-DISEASE
motor	0
phenomena	I-DISEASE
are	0
not	0
uncommon	0
,	I-DISEASE
with	0
muscle	0
twitching	I-DISEASE
Central	I-DISEASE
Disorders	I-DISEASE
of	I-DISEASE
Hypersomnolence	I-DISEASE
Central	I-DISEASE
Disorders	I-DISEASE
of	I-DISEASE
Hypersomnolence	I-DISEASE
or	0
small	0
jerks	0
,	0
particularly	0
of	0
the	0
face	I-DISEASE
.	0

Although	I-DISEASE
many	0
emotions	0
can	I-DISEASE
potentially	0
lead	0
to	I-DISEASE
cataplexy	I-DISEASE
,	I-DISEASE
those	I-DISEASE
associated	0
with	0
mirth	0
are	I-DISEASE
usually	0
the	0
most	I-DISEASE
potent	I-DISEASE
.	0

Laughing	I-DISEASE
out	0
loud	0
,	I-DISEASE
telling	0
a	0
joke	0
,	I-DISEASE
and	0
making	0
a	0
witty	0
remark	I-DISEASE
are	0
typical	0
examples	0
.	I-DISEASE

The	I-DISEASE
frequency	I-DISEASE
of	I-DISEASE
cataplexy	I-DISEASE
is	I-DISEASE
variable	I-DISEASE
,	0
ranging	0
from	I-DISEASE
less	I-DISEASE
than	I-DISEASE
one	0
attack	0
per	I-DISEASE
month	I-DISEASE
to	0
more	0
than	I-DISEASE
20	0
attacks	I-DISEASE
per	I-DISEASE
day	0
.	0

Cataplexy	I-DISEASE
is	0
generally	I-DISEASE
short	0
-	I-DISEASE
lived	0
,	0
lasting	0
a	0
matter	I-DISEASE
of	I-DISEASE
seconds	0
,	I-DISEASE
with	I-DISEASE
the	I-DISEASE
vast	0
majority	0
of	I-DISEASE
attacks	0
lasting	0
less	I-DISEASE
than	I-DISEASE
two	I-DISEASE
minutes	0
.	I-DISEASE

However	I-DISEASE
,	I-DISEASE
if	0
a	I-DISEASE
particular	0
trigger	I-DISEASE
continues	I-DISEASE
,	I-DISEASE
consecutive	0
attacks	0
may	I-DISEASE
merge	0
together	I-DISEASE
to	I-DISEASE
form	0
what	0
seems	I-DISEASE
to	I-DISEASE
be	0
one	0
long	I-DISEASE
episode	I-DISEASE
.	0

Sudden	I-DISEASE
withdrawal	0
of	I-DISEASE
anticataplectic	0
medication	0
,	0
especially	0
anti-	I-DISEASE
depressants	0
,	I-DISEASE
can	0
result	0
in	I-DISEASE
“	I-DISEASE
status	0
cataplecticus	0
”	I-DISEASE
in	I-DISEASE
which	I-DISEASE
long	I-DISEASE
-	0
lasting	0
attacks	0
happen	0
virtually	B-DISEASE
continuously	0
.	0

Associated	I-DISEASE
Features	I-DISEASE
In	0
addition	0
to	0
sleepiness	0
and	0
cataplexy	0
,	I-DISEASE
patients	I-DISEASE
with	0
narcolepsy	0
type	0
1	I-DISEASE
often	0
report	0
several	0
other	0
symptoms	I-DISEASE
,	0
none	I-DISEASE
of	I-DISEASE
which	I-DISEASE
are	I-DISEASE
specific	I-DISEASE
for	0
the	0
disorder	I-DISEASE
.	0

Many	I-DISEASE
patients	I-DISEASE
report	0
disruption	I-DISEASE
of	0
nocturnal	0
sleep	0
,	0
which	0
can	0
sometimes	0
be	I-DISEASE
of	I-DISEASE
major	0
concern	I-DISEASE
.	0

Although	I-DISEASE
sleep	0
onset	0
is	0
rarely	0
a	0
problem	0
,	I-DISEASE
an	0
inability	0
to	0
maintain	0
continuous	I-DISEASE
sleep	0
is	0
very	I-DISEASE
common	I-DISEASE
.	0

33	I-DISEASE
%	0
to	0
80	0
%	0
of	I-DISEASE
narcolepsy	0
patients	0
have	I-DISEASE
hypnagogic	I-DISEASE
hallucinations	0
and/or	0
sleep	0
paralysis	0
.	0

Hypnagogic	I-DISEASE
hallucinations	I-DISEASE
are	0
defined	I-DISEASE
as	I-DISEASE
vivid	I-DISEASE
dreamlike	I-DISEASE
expe-	I-DISEASE
riences	0
occurring	0
at	I-DISEASE
the	0
transition	I-DISEASE
from	0
wake	0
to	0
sleep	0
.	0

Typically	I-DISEASE
,	I-DISEASE
hypnagogic	0
halluci-	0
nations	I-DISEASE
have	I-DISEASE
a	0
multimodal	0
or	0
“	0
holistic	I-DISEASE
”	I-DISEASE
character	0
,	I-DISEASE
often	0
combining	0
visual	I-DISEASE
,	0
auditory	I-DISEASE
,	I-DISEASE
and	0
tactile	0
phenomena	0
.	0

Hypnopompic	I-DISEASE
hallucinations	I-DISEASE
are	0
similar	I-DISEASE
but	I-DISEASE
occur	0
at	I-DISEASE
sleep	0
to	I-DISEASE
wake	0
transitions	I-DISEASE
.	0

Sleep	I-DISEASE
paralysis	I-DISEASE
describes	0
the	0
disturbing	0
temporary	0
inability	I-DISEASE
to	0
move	0
voluntary	0
muscles	0
at	I-DISEASE
sleep	0
-	0
wake	0
transitions	I-DISEASE
.	0

Despite	I-DISEASE
being	I-DISEASE
awake	0
and	0
conscious	0
of	I-DISEASE
the	0
sleeping	I-DISEASE
environment	0
,	0
it	0
is	I-DISEASE
impossible	I-DISEASE
for	I-DISEASE
subjects	0
to	I-DISEASE
move	I-DISEASE
their	I-DISEASE
limbs	0
or	0
even	I-DISEASE
open	0
their	I-DISEASE
eyes	B-DISEASE
.	0

The	I-DISEASE
experience	0
may	0
last	0
for	0
several	0
minutes	0
and	0
can	0
be	0
very	I-DISEASE
distressing	I-DISEASE
.	0

Other	I-DISEASE
symptoms	I-DISEASE
may	0
include	I-DISEASE
ptosis	0
,	I-DISEASE
blurred	0
vision	0
,	0
and	0
diplopia	I-DISEASE
,	0
presumably	0
as	0
a	I-DISEASE
result	0
of	0
sleepiness	0
.	0

Epidemiological	I-DISEASE
studies	I-DISEASE
have	0
shown	I-DISEASE
that	0
obesity	0
is	I-DISEASE
a	I-DISEASE
common	I-DISEASE
symptom	0
of	0
narco-	0
lepsy	0
.	0

Around	I-DISEASE
disease	I-DISEASE
onset	0
,	I-DISEASE
an	0
unexplained	I-DISEASE
increase	0
in	I-DISEASE
body	I-DISEASE
weight	I-DISEASE
is	I-DISEASE
often	0
observed	I-DISEASE
.	0

Obesity	I-DISEASE
(	0
defined	I-DISEASE
as	0
a	0
body	I-DISEASE
mass	0
index	0
≥	0
30	0
kg	I-DISEASE
/	I-DISEASE
m2	I-DISEASE
)	0
occurs	0
more	0
than	0
twice	0
as	0
often	0
in	I-DISEASE
narcoleptic	0
populations	I-DISEASE
as	0
in	I-DISEASE
control	I-DISEASE
groups	I-DISEASE
.	0

An	0
increased	0
frequency	I-DISEASE
of	I-DISEASE
several	0
other	I-DISEASE
sleep	0
abnormalities	I-DISEASE
has	0
been	I-DISEASE
described	I-DISEASE
in	I-DISEASE
narcolepsy	I-DISEASE
,	I-DISEASE
including	0
sleep	0
talking	I-DISEASE
,	0
periodic	I-DISEASE
limb	B-DISEASE
movements	0
of	I-DISEASE
sleep	0
,	I-DISEASE
sleep	0
disordered	I-DISEASE
breathing	B-DISEASE
,	0
and	0
REM	I-DISEASE
sleep	0
behavior	I-DISEASE
disor-	0
der	0
.	0

There	I-DISEASE
is	I-DISEASE
an	0
increased	0
prevalence	0
of	I-DISEASE
depressive	I-DISEASE
symptoms	I-DISEASE
,	0
although	0
there	I-DISEASE
are	I-DISEASE
con-	I-DISEASE
flicting	0
reports	0
on	0
how	I-DISEASE
often	0
these	I-DISEASE
symptoms	I-DISEASE
qualify	0
as	I-DISEASE
a	0
clinical	I-DISEASE
depression	I-DISEASE
.	0

Recent	I-DISEASE
studies	I-DISEASE
point	0
to	I-DISEASE
a	0
high	I-DISEASE
level	0
of	I-DISEASE
anxiety	0
disorders	0
in	I-DISEASE
patients	I-DISEASE
with	I-DISEASE
narcolepsy	0
,	I-DISEASE
with	0
panic	0
attacks	I-DISEASE
or	0
social	0
phobias	0
in	I-DISEASE
about	0
20	0
%	0
.	B-DISEASE

More	I-DISEASE
than	I-DISEASE
half	0
of	I-DISEASE
patients	0
report	0
severe	I-DISEASE
fatigue	I-DISEASE
,	0
which	0
can	0
be	I-DISEASE
distinct	I-DISEASE
from	I-DISEASE
sleepiness	0
.	0

Clinical	I-DISEASE
and	0
Pathophysiological	I-DISEASE
Subtypes	I-DISEASE
Narcolepsy	0
type	I-DISEASE
1	I-DISEASE
due	0
to	I-DISEASE
a	0
medical	0
condition	I-DISEASE
:	I-DISEASE

This	I-DISEASE
condition	0
is	0
primarily	I-DISEASE
associated	0
with	I-DISEASE
central	0
nervous	I-DISEASE
system	0
(	0
CNS	0
)	I-DISEASE
disorders	0
,	0
including	0
autoimmune	0
or	0
paraneoplastic	I-DISEASE
disorders	0
associated	0
with	I-DISEASE
anti	0
-	I-DISEASE
Ma2	I-DISEASE
or	0
antiaquaporin4	0
antibodies	0
,	0
and	0
tumors	0
or	0
other	I-DISEASE
lesions	0
of	I-DISEASE
the	0
hypothalamus	I-DISEASE
.	0

In	I-DISEASE
addition	0
,	0
undetectable	I-DISEASE
hypocretin-1	I-DISEASE
levels	0
have	0
been	I-DISEASE
reported	I-DISEASE
in	0
association	0
with	I-DISEASE
sleepiness	0
after	0
severe	0
head	I-DISEASE
trauma	0
.	I-DISEASE

The	I-DISEASE
condition	0
must	I-DISEASE
fulfill	I-DISEASE
criteria	0
for	I-DISEASE
narcolepsy	0
type	I-DISEASE
1	I-DISEASE
and	0
be	I-DISEASE
attributable	I-DISEASE
to	0
another	0
medical	I-DISEASE
disorder	0
.	0

Narcolepsy	I-DISEASE
without	0
cataplexy	I-DISEASE
with	0
low	0
CSF	0
Hcrt-1	I-DISEASE
levels	0
:	0
Narcolepsy	0
type	I-DISEASE
1	I-DISEASE
should	0
be	I-DISEASE
diagnosed	0
,	I-DISEASE
even	I-DISEASE
in	I-DISEASE
the	0
absence	I-DISEASE
of	I-DISEASE
cataplexy	0
,	0
if	0
diagnostic	0
criteria	0
A	0
and	0
B2	0
are	0
fulfilled	0
.	0

Demographics	I-DISEASE
Narcolepsy	0
with	I-DISEASE
cataplexy	0
occurs	I-DISEASE
in	I-DISEASE
0.02	I-DISEASE
%	0
to	0
0.18	I-DISEASE
%	0
of	I-DISEASE
the	I-DISEASE
United	0
States	I-DISEASE
and	0
western	I-DISEASE
European	0
populations	I-DISEASE
.	0

A	I-DISEASE
lower	0
prevalence	0
has	0
been	0
reported	I-DISEASE
in	I-DISEASE
Israel	I-DISEASE
,	0
whereas	0
narco-	0
lepsy	0
with	I-DISEASE
cataplexy	I-DISEASE
may	0
be	0
slightly	I-DISEASE
more	0
common	I-DISEASE
in	0
Japan	0
(	0
0.16	I-DISEASE
%	0
to	I-DISEASE
0.18	I-DISEASE
%	0
)	0
.	0

Both	I-DISEASE
sexes	I-DISEASE
are	0
affected	I-DISEASE
,	0
with	I-DISEASE
a	0
slight	I-DISEASE
preponderance	0
of	I-DISEASE
males	I-DISEASE
.	0

Predisposing	I-DISEASE
and	0
Precipitating	I-DISEASE
Factors	0
Several	0
unproven	I-DISEASE
precipitating	0
factors	I-DISEASE
have	0
been	I-DISEASE
suggested	0
in	I-DISEASE
case	I-DISEASE
reports	0
,	I-DISEASE
including	0
head	I-DISEASE
trauma	0
,	I-DISEASE
sustained	0
sleep	0
deprivation	0
,	I-DISEASE
unspecified	I-DISEASE
viral	0
illness	0
,	0
and	0
sudden	0
changes	I-DISEASE
in	I-DISEASE
sleep	0
-	0
wake	0
patterns	0
.	0

Several	I-DISEASE
studies	I-DISEASE
have	0
pointed	0
to	0
seasonal	I-DISEASE
patterns	0
in	I-DISEASE
the	0
onset	0
of	I-DISEASE
narcolepsy	0
,	I-DISEASE
which	0
may	I-DISEASE
point	0
to	0
a	0
specific	I-DISEASE
environmental	I-DISEASE
trigger	I-DISEASE
.	0

Recent	I-DISEASE
studies	I-DISEASE
have	0
shown	I-DISEASE
an	0
increase	I-DISEASE
in	0
antibodies	I-DISEASE
against	0
beta	0
-	0
hemolytic	I-DISEASE
streptococcus	0
,	0
which	0
were	I-DISEASE
strongest	0
around	0
onset	I-DISEASE
of	0
narcolepsy	0
and	0
decreased	0
with	I-DISEASE
disease	I-DISEASE
duration	0
,	0
suggesting	0
that	0
streptococcal	0
infections	0
may	I-DISEASE
constitute	I-DISEASE
an	0
environmental	I-DISEASE
trigger	0
.	0

There	I-DISEASE
have	I-DISEASE
been	I-DISEASE
reports	I-DISEASE
of	0
narcolepsy	0
type	I-DISEASE
1	0
occurring	0
after	I-DISEASE
vaccination	I-DISEASE
against	I-DISEASE
H1N1	0
associated	0
influ-	I-DISEASE
enza	I-DISEASE
,	I-DISEASE
but	I-DISEASE
a	I-DISEASE
definite	0
causal	0
association	I-DISEASE
has	0
not	0
yet	0
been	I-DISEASE
established	0
.	0

Tribbles	I-DISEASE
homolog	I-DISEASE
2	0
antibodies	I-DISEASE
,	0
found	0
in	I-DISEASE
some	I-DISEASE
patients	I-DISEASE
with	I-DISEASE
autoimmune	0
uveitis	0
,	0
have	0
been	I-DISEASE
described	I-DISEASE
in	I-DISEASE
14	0
%	0
to	0
26	I-DISEASE
%	0
of	I-DISEASE
narcolepsy	0
patients	0
,	0
but	I-DISEASE
the	0
significance	0
is	0
uncertain	0
.	0

Familial	I-DISEASE
Patterns	I-DISEASE
At	0
the	0
genetic	0
level	0
,	0
narcolepsy	0
with	0
cataplexy	0
is	I-DISEASE
closely	I-DISEASE
associated	0
with	I-DISEASE
the	0
human	0
leukocyte	0
antigen	0
(	I-DISEASE
HLA	I-DISEASE
)	0
subtypes	I-DISEASE
DR2	I-DISEASE
/	0
DRB1	0
*	0
1501	I-DISEASE
and	0
DQB1	0
*	0
0602	I-DISEASE
.	0

These	0
two	I-DISEASE
subtypes	0
are	0
always	0
found	I-DISEASE
together	0
in	0
whites	0
and	0
Asians	I-DISEASE
,	0
but	I-DISEASE
in	I-DISEASE
blacks	I-DISEASE
,	0
DQB1	0
*	B-DISEASE
0602	I-DISEASE
is	I-DISEASE
more	0
specifically	I-DISEASE
associated	0
with	I-DISEASE
narcolepsy	0
.	0

Almost	I-DISEASE
all	0
patients	0
with	I-DISEASE
cataplexy	0
are	0
positive	0
for	0
DQB1	I-DISEASE
*	0
0602	I-DISEASE
,	0
compared	I-DISEASE
with	I-DISEASE
12	I-DISEASE
%	0
to	I-DISEASE
38	I-DISEASE
%	0
of	I-DISEASE
the	0
general	I-DISEASE
population	0
who	I-DISEASE
have	0
this	0
HLA	I-DISEASE
subtype	I-DISEASE
.	0

Other	0
subtypes	I-DISEASE
also	0
have	0
less	I-DISEASE
striking	I-DISEASE
associations	0
.	0

For	I-DISEASE
example	0
,	0
DQB1	I-DISEASE
*	I-DISEASE
0301	0
is	0
associated	0
with	I-DISEASE
increased	0
susceptibility	0
to	0
narcolepsy	0
,	I-DISEASE
Central	I-DISEASE
Disorders	0
of	I-DISEASE
Hypersomnolence	I-DISEASE
Central	0
Disorders	I-DISEASE
of	I-DISEASE
Hypersomnolence	0
whereas	I-DISEASE
subtypes	I-DISEASE
such	0
as	0
DQB1	I-DISEASE
*	0
0501	I-DISEASE
and	0
DQB1	I-DISEASE
*	0
0601	I-DISEASE
,	0
are	I-DISEASE
protective	0
in	I-DISEASE
the	0
presence	0
of	I-DISEASE
DQB1	0
*	0
0602	I-DISEASE
.	0

Genomewide	I-DISEASE
studies	I-DISEASE
have	0
found	0
associations	0
between	0
narcolepsy	0
and	0
polymorphisms	0
in	0
T	0
cell	I-DISEASE
receptor	0
alpha	0
,	0
tumor	0
necrosis	0
factor	0
(	I-DISEASE
TNF)-alpha	0
2	0
,	0
and	0
TNF	0
receptor	0
2	0
as	0
well	0
as	0
the	0
purinergic	0
receptor	0
P2Y11	0
genes	0
.	0

There	I-DISEASE
is	I-DISEASE
a	0
low	0
prevalence	0
of	I-DISEASE
familial	I-DISEASE
cases	0
;	0
the	0
risk	0
of	I-DISEASE
narcolepsy	0
type	0
1	0
in	I-DISEASE
first	I-DISEASE
-	0
de-	0
gree	I-DISEASE
relatives	I-DISEASE
of	I-DISEASE
affected	I-DISEASE
individuals	I-DISEASE
is	0
approximately	0
1	I-DISEASE
%	0
to	I-DISEASE
2	0
%	0
.	0

When	I-DISEASE
compared	I-DISEASE
to	0
the	0
population	0
prevalence	0
,	0
this	0
indicates	0
a	0
tenfold	0
to	I-DISEASE
fortyfold	I-DISEASE
increase	I-DISEASE
in	I-DISEASE
risk	0
.	0

This	I-DISEASE
increased	0
risk	0
can	I-DISEASE
not	0
be	I-DISEASE
explained	I-DISEASE
solely	0
by	B-DISEASE
HLA	0
gene	I-DISEASE
effects	I-DISEASE
,	I-DISEASE
suggesting	0
the	0
exis-	I-DISEASE
tence	0
of	I-DISEASE
other	I-DISEASE
genetic	I-DISEASE
factors	0
.	0

Multiplex	I-DISEASE
families	I-DISEASE
with	I-DISEASE
more	0
than	I-DISEASE
two	I-DISEASE
affected	I-DISEASE
members	0
are	I-DISEASE
uncommon	0
.	0

In	I-DISEASE
most	0
cases	0
,	I-DISEASE
normal	0
CSF	0
hypocretin	I-DISEASE
levels	I-DISEASE
have	I-DISEASE
been	I-DISEASE
found	I-DISEASE
in	I-DISEASE
these	I-DISEASE
families	0
,	0
and	0
the	0
association	I-DISEASE
with	I-DISEASE
HLA	I-DISEASE
DQB1	0
*	0
0602	I-DISEASE
is	0
much	0
weaker	0
compared	0
to	0
spo-	0
radic	0
narcolepsy	0
.	0

So	0
far	I-DISEASE
,	0
only	I-DISEASE
a	0
single	I-DISEASE
case	I-DISEASE
of	I-DISEASE
narcolepsy	0
type	I-DISEASE
1	I-DISEASE
has	0
been	I-DISEASE
described	I-DISEASE
in	I-DISEASE
association	0
with	0
a	0
preprohypocretin	0
mutation	0
.	0

Onset	I-DISEASE
,	0
Course	0
,	0
and	0
Complications	0
Onset	0
usually	I-DISEASE
occurs	I-DISEASE
after	0
five	0
years	0
of	I-DISEASE
age	0
and	0
most	0
typically	0
between	0
ages	I-DISEASE
10	0
and	0
25	0
years	I-DISEASE
.	0

However	I-DISEASE
,	I-DISEASE
a	0
bimodal	0
distribution	I-DISEASE
in	I-DISEASE
the	0
age	0
at	I-DISEASE
onset	I-DISEASE
has	I-DISEASE
been	I-DISEASE
described	0
in	I-DISEASE
some	I-DISEASE
populations	I-DISEASE
with	0
a	0
first	I-DISEASE
peak	0
occurring	0
at	I-DISEASE
adolescence	0
(	I-DISEASE
age	I-DISEASE
15	I-DISEASE
years	I-DISEASE
)	0
and	0
a	0
second	I-DISEASE
at	I-DISEASE
the	0
age	0
of	I-DISEASE
35	0
years	0
.	0

Recent	I-DISEASE
studies	I-DISEASE
highlight	I-DISEASE
the	0
fact	0
that	0
narcolepsy	0
,	0
and	0
especially	I-DISEASE
cataplexy	0
,	I-DISEASE
in	0
young	0
children	I-DISEASE
may	0
present	I-DISEASE
somewhat	I-DISEASE
differently	I-DISEASE
,	I-DISEASE
resulting	0
in	I-DISEASE
delayed	I-DISEASE
diagnosis	I-DISEASE
and	0
erroneously	B-DISEASE
high	I-DISEASE
estimates	I-DISEASE
of	I-DISEASE
age	0
of	I-DISEASE
onset	0
.	0

Sleepiness	I-DISEASE
is	0
usually	I-DISEASE
the	0
first	I-DISEASE
symptom	0
to	0
manifest	I-DISEASE
.	I-DISEASE

Cataplexy	I-DISEASE
most	0
often	I-DISEASE
occurs	I-DISEASE
within	I-DISEASE
one	0
year	0
of	I-DISEASE
onset	I-DISEASE
but	I-DISEASE
in	I-DISEASE
rare	I-DISEASE
cases	0
,	I-DISEASE
may	I-DISEASE
precede	0
the	0
onset	I-DISEASE
of	I-DISEASE
sleepiness	0
or	I-DISEASE
commence	0
up	I-DISEASE
to	0
40	I-DISEASE
years	I-DISEASE
later	I-DISEASE
.	0

Hypnagogic	I-DISEASE
hallucinations	I-DISEASE
,	0
sleep	0
paralysis	I-DISEASE
,	0
and	0
disturbed	0
noctur-	I-DISEASE
nal	0
sleep	0
often	0
manifest	I-DISEASE
later	0
in	I-DISEASE
the	0
course	I-DISEASE
of	I-DISEASE
the	0
disease	I-DISEASE
.	0

When	I-DISEASE
left	0
untreated	0
,	I-DISEASE
narcolepsy	0
type	I-DISEASE
1	I-DISEASE
is	I-DISEASE
often	I-DISEASE
socially	0
disabling	I-DISEASE
and	0
isolating	0
.	0

Patients	I-DISEASE
have	0
a	I-DISEASE
tendency	0
to	I-DISEASE
fail	I-DISEASE
in	I-DISEASE
school	0
and	0
are	0
often	I-DISEASE
dismissed	I-DISEASE
from	I-DISEASE
their	0
jobs	0
.	0

Driving	I-DISEASE
may	I-DISEASE
be	0
avoided	I-DISEASE
for	0
fear	I-DISEASE
of	I-DISEASE
a	I-DISEASE
motor	0
vehicle	0
accident	0
.	0

The	I-DISEASE
inability	0
to	0
sleep	0
at	I-DISEASE
night	0
may	0
further	I-DISEASE
contribute	0
to	0
a	0
loss	0
of	I-DISEASE
control	I-DISEASE
these	0
patients	I-DISEASE
have	0
over	I-DISEASE
their	0
schedule	0
.	0

Depression	I-DISEASE
and	0
weight	0
gain	0
also	0
are	0
common	I-DISEASE
.	0

In	I-DISEASE
most	0
cases	0
,	I-DISEASE
symptoms	0
gradually	0
develop	0
over	0
several	0
years	0
.	0

When	I-DISEASE
the	0
clinical	0
picture	I-DISEASE
has	0
fully	I-DISEASE
developed	0
,	I-DISEASE
there	0
are	0
usually	I-DISEASE
only	I-DISEASE
minor	I-DISEASE
fluctuations	I-DISEASE
in	I-DISEASE
severity	I-DISEASE
.	0

Cataplexy	I-DISEASE
may	0
lessen	I-DISEASE
with	I-DISEASE
age	I-DISEASE
,	0
or	0
occasionally	0
increase	I-DISEASE
in	I-DISEASE
frequency	I-DISEASE
and	0
severity	I-DISEASE
.	I-DISEASE

Developmental	I-DISEASE
Issues	0
In	I-DISEASE
recent	0
years	I-DISEASE
,	0
increasing	I-DISEASE
attention	0
has	0
been	I-DISEASE
given	0
to	I-DISEASE
the	0
clinical	0
presentation	0
of	I-DISEASE
nar-	I-DISEASE
colepsy	0
in	0
childhood	0
.	0

Narcolepsy	I-DISEASE
with	0
cataplexy	0
is	0
infrequent	0
prior	0
to	0
the	0
age	I-DISEASE
of	0
four	0
years	I-DISEASE
.	0

In	I-DISEASE
addition	0
,	0
the	0
clinical	0
presentation	0
in	I-DISEASE
children	I-DISEASE
may	0
be	0
different	I-DISEASE
from	I-DISEASE
that	I-DISEASE
of	I-DISEASE
adults	B-DISEASE
.	0

In	I-DISEASE
young	I-DISEASE
children	0
,	I-DISEASE
sleepiness	0
may	0
be	I-DISEASE
difficult	0
to	0
assess	I-DISEASE
,	I-DISEASE
and	0
may	I-DISEASE
express	0
itself	0
as	0
excessively	I-DISEASE
long	0
night	I-DISEASE
sleep	0
,	0
or	B-DISEASE
the	0
recurrence	I-DISEASE
of	I-DISEASE
previously	I-DISEASE
discontinued	I-DISEASE
daytime	I-DISEASE
napping	I-DISEASE
.	0

Moreover	I-DISEASE
,	0
children	0
may	0
paradoxically	0
present	I-DISEASE
with	0
hyperactive	0
behavior	I-DISEASE
,	I-DISEASE
behavioral	0
problems	0
or	I-DISEASE
decreased	I-DISEASE
performance	0
in	0
school	0
.	0

Inattentiveness	I-DISEASE
,	I-DISEASE
lack	I-DISEASE
of	I-DISEASE
energy	I-DISEASE
,	0
insomnia	I-DISEASE
,	I-DISEASE
bizarre	0
hallucinations	I-DISEASE
,	0
or	I-DISEASE
a	0
combination	I-DISEASE
thereof	0
can	0
lead	0
to	0
a	I-DISEASE
psy-	0
chiatric	I-DISEASE
misdiagnosis	I-DISEASE
of	I-DISEASE
schizophrenia	0
or	0
depression	I-DISEASE
.	0

In	I-DISEASE
this	I-DISEASE
population	0
,	I-DISEASE
the	0
presence	0
of	I-DISEASE
ancillary	0
symptoms	I-DISEASE
such	I-DISEASE
as	I-DISEASE
sleep	I-DISEASE
paralysis	I-DISEASE
or	I-DISEASE
hypnagogic	I-DISEASE
hallucinations	I-DISEASE
may	I-DISEASE
also	0
be	I-DISEASE
difficult	I-DISEASE
to	I-DISEASE
confirm	0
,	0
depending	I-DISEASE
on	0
the	0
child	0
’s	I-DISEASE
verbal	0
ability	I-DISEASE
.	0

Precocious	I-DISEASE
puberty	I-DISEASE
and	0
obesity	0
may	0
also	0
develop	I-DISEASE
around	I-DISEASE
the	I-DISEASE
time	I-DISEASE
of	I-DISEASE
symptom	0
onset	0
.	0

REM	I-DISEASE
sleep	0
behavior	I-DISEASE
dis-	0
order	0
or	B-DISEASE
REM	0
sleep	0
without	I-DISEASE
atonia	I-DISEASE
may	I-DISEASE
also	0
be	I-DISEASE
manifest	0
at	I-DISEASE
the	0
time	0
of	I-DISEASE
symptom	0
onset	I-DISEASE
.	0

Cataplexy	I-DISEASE
may	0
be	I-DISEASE
very	I-DISEASE
severe	I-DISEASE
around	0
disease	0
onset	0
and	0
appear	I-DISEASE
phenotypically	0
differ-	I-DISEASE
ent	0
from	0
typical	0
episodes	I-DISEASE
seen	I-DISEASE
in	I-DISEASE
adulthood	0
.	0

In	I-DISEASE
addition	0
to	0
typical	0
attacks	0
triggered	I-DISEASE
by	I-DISEASE
positive	0
emotions	0
,	0
children	I-DISEASE
can	0
also	I-DISEASE
present	I-DISEASE
with	0
weakness	0
involving	I-DISEASE
the	I-DISEASE
face	0
,	0
eyelids	I-DISEASE
,	0
and	0
mouth	0
not	0
clearly	I-DISEASE
associated	0
with	I-DISEASE
emotion	I-DISEASE
.	0

Together	I-DISEASE
with	0
tongue	0
protrusion	0
,	I-DISEASE
this	0
characteristic	I-DISEASE
pattern	0
has	0
been	I-DISEASE
termed	I-DISEASE
a	I-DISEASE
cataplectic	0
facies	I-DISEASE
.	0

Children	I-DISEASE
with	I-DISEASE
cataplexy	0
may	0
also	0
display	0
positive	0
motor	I-DISEASE
phenomena	0
,	I-DISEASE
ranging	0
from	0
perioral	0
dyskinetic	0
or	0
dys-	0
tonic	0
movements	0
to	I-DISEASE
frank	0
stereotypies	I-DISEASE
.	0

In	I-DISEASE
children	I-DISEASE
,	0
anticipation	I-DISEASE
of	0
reward	I-DISEASE
may	I-DISEASE
also	0
be	0
a	0
precipitant	0
.	0

The	I-DISEASE
diagnosis	I-DISEASE
of	I-DISEASE
narcolepsy	0
type	I-DISEASE
1	0
in	0
children	B-DISEASE
may	I-DISEASE
be	I-DISEASE
complicated	0
because	0
of	I-DISEASE
diffi-	I-DISEASE
culties	I-DISEASE
performing	0
the	0
MSLT	I-DISEASE
,	0
and	0
lack	I-DISEASE
of	I-DISEASE
normative	0
values	I-DISEASE
in	I-DISEASE
children	I-DISEASE
younger	I-DISEASE
than	0
six	0
years	0
.	0

If	I-DISEASE
the	0
MSLT	I-DISEASE
shows	0
equivocal	0
results	0
,	I-DISEASE
repeating	I-DISEASE
it	I-DISEASE
after	I-DISEASE
a	0
time	0
interval	I-DISEASE
may	I-DISEASE
be	0
helpful	0
.	0

Given	I-DISEASE
these	I-DISEASE
difficulties	I-DISEASE
,	I-DISEASE
CSF	0
hypocretin-1	I-DISEASE
measurements	I-DISEASE
are	0
of	I-DISEASE
particular	I-DISEASE
value	I-DISEASE
,	0
as	0
hypocretin-1	I-DISEASE
levels	I-DISEASE
are	0
low	0
or	I-DISEASE
undetectable	I-DISEASE
very	I-DISEASE
shortly	0
after	0
disease	I-DISEASE
onset	0
in	0
children	0
as	0
well	0
.	0

Pathology	I-DISEASE
and	0
Pathophysiology	I-DISEASE
It	0
is	0
now	I-DISEASE
firmly	I-DISEASE
established	I-DISEASE
that	0
narcolepsy	0
type	0
1	0
is	0
caused	0
by	I-DISEASE
deficiencies	0
in	0
hypo-	I-DISEASE
cretin	B-DISEASE
signaling	I-DISEASE
,	0
most	0
likely	0
due	I-DISEASE
to	0
a	0
selective	0
loss	0
of	0
hypothalamic	I-DISEASE
hypocretin	0
pro-	0
ducing	0
neurons	0
.	0

Several	0
animal	I-DISEASE
models	0
lacking	I-DISEASE
hypocretin	0
neurotransmission	0
demon-	0
strate	0
narcolepsy	0
,	0
indicating	0
a	0
causal	I-DISEASE
relationship	I-DISEASE
.	0

The	I-DISEASE
vast	I-DISEASE
majority	0
of	I-DISEASE
patients	0
(	I-DISEASE
90	I-DISEASE
%	0
to	B-DISEASE
95	0
%	0
)	0
with	I-DISEASE
narcolepsy	B-DISEASE
and	0
cataplexy	0
have	0
undetectable	I-DISEASE
or	I-DISEASE
low	0
(	I-DISEASE
<	I-DISEASE
110	0
pg	0
/	I-DISEASE
mL	I-DISEASE
)	0
levels	I-DISEASE
of	I-DISEASE
hypocretin-1	0
in	I-DISEASE
the	I-DISEASE
CSF	0
.	0

Patients	I-DISEASE
without	0
cataplexy	I-DISEASE
can	I-DISEASE
be	0
hypocretin	0
deficient	0
as	0
well	I-DISEASE
,	0
although	0
at	I-DISEASE
a	0
much	I-DISEASE
lower	0
frequency	I-DISEASE
,	I-DISEASE
and	0
are	I-DISEASE
thus	0
also	0
classified	0
as	B-DISEASE
narcolepsy	0
Central	0
Disorders	0
of	0
Hypersomnolence	I-DISEASE
Central	I-DISEASE
Disorders	I-DISEASE
of	0
Hypersomnolence	I-DISEASE
type	I-DISEASE
1	0
.	I-DISEASE

The	I-DISEASE
strong	I-DISEASE
HLA	I-DISEASE
association	0
in	I-DISEASE
narcolepsy	0
has	0
led	I-DISEASE
to	I-DISEASE
the	0
hypothesis	0
that	0
auto-	0
immunity	0
is	0
a	0
likely	I-DISEASE
etiological	0
mechanism	0
,	0
potentially	I-DISEASE
explaining	0
the	I-DISEASE
selectivity	0
of	I-DISEASE
neuronal	0
destruction	0
in	0
the	0
hypothalamus	0
.	0

However	I-DISEASE
,	I-DISEASE
definitive	0
proof	0
for	0
autoimmunity	0
has	0
not	0
been	I-DISEASE
obtained	I-DISEASE
.	0

Objective	I-DISEASE
Findings	I-DISEASE
Narcolepsy	0
type	I-DISEASE
1	0
is	0
essentially	I-DISEASE
defined	I-DISEASE
as	0
a	0
hypocretin	I-DISEASE
deficiency	0
syndrome	I-DISEASE
,	0
which	0
is	I-DISEASE
reflected	0
in	I-DISEASE
the	0
need	0
for	I-DISEASE
objective	B-DISEASE
measurements	0
in	I-DISEASE
the	0
clinical	0
criteria	0
.	0

This	I-DISEASE
require-	I-DISEASE
ment	I-DISEASE
is	0
further	I-DISEASE
driven	0
by	0
the	0
fact	0
that	0
many	0
patients	I-DISEASE
require	0
lifelong	0
treatment	I-DISEASE
with	I-DISEASE
potentially	0
addictive	0
medications	0
,	0
underscoring	0
the	0
importance	0
of	I-DISEASE
objective	I-DISEASE
confirma-	0
tion	0
of	I-DISEASE
the	0
diagnosis	I-DISEASE
.	0

It	I-DISEASE
is	I-DISEASE
strongly	0
recommended	I-DISEASE
that	0
the	0
MSLT	I-DISEASE
be	0
preceded	0
by	I-DISEASE
at	I-DISEASE
least	I-DISEASE
one	I-DISEASE
week	0
of	I-DISEASE
acti-	0
graphic	0
recording	0
with	0
a	0
sleep	0
log	0
to	I-DISEASE
establish	0
whether	I-DISEASE
the	0
results	I-DISEASE
could	0
be	I-DISEASE
biased	0
by	I-DISEASE
insufficient	0
sleep	0
,	0
shift	0
work	I-DISEASE
,	0
or	0
another	0
circadian	0
sleep	0
disorder	I-DISEASE
.	0

In	I-DISEASE
patients	0
with	0
narcolepsy	0
type	I-DISEASE
1	0
,	0
the	0
MSLT	I-DISEASE
demonstrates	I-DISEASE
a	0
mean	I-DISEASE
sleep	0
latency	I-DISEASE
of	0
less	I-DISEASE
than	0
eight	I-DISEASE
minutes	0
and	0
typically	0
less	I-DISEASE
than	I-DISEASE
five	0
minutes	0
.	0

Meta	I-DISEASE
-	0
analysis	I-DISEASE
shows	I-DISEASE
mean	I-DISEASE
sleep	I-DISEASE
latencies	I-DISEASE
in	0
narcoleptic	0
patients	0
with	I-DISEASE
cataplexy	0
of	I-DISEASE
3.1	I-DISEASE
±	I-DISEASE
2.9	I-DISEASE
minutes	0
.	0

In	I-DISEASE
addition	0
,	0
two	I-DISEASE
or	0
more	0
SOREMPs	I-DISEASE
must	0
be	I-DISEASE
present	I-DISEASE
.	0

Recent	I-DISEASE
data	I-DISEASE
suggest	0
that	0
a	0
SOREMP	I-DISEASE
within	0
15	I-DISEASE
minutes	0
of	I-DISEASE
onset	I-DISEASE
of	I-DISEASE
nocturnal	0
sleep	I-DISEASE
is	0
a	0
highly	I-DISEASE
specific	I-DISEASE
finding	I-DISEASE
in	0
the	0
absence	I-DISEASE
of	0
another	I-DISEASE
sleep	0
disorder	I-DISEASE
,	I-DISEASE
but	I-DISEASE
with	I-DISEASE
low	0
sensitivity	I-DISEASE
.	0

Therefore	I-DISEASE
,	I-DISEASE
the	0
criteria	I-DISEASE
for	0
narcolepsy	0
type	I-DISEASE
1	0
allow	0
the	I-DISEASE
“	I-DISEASE
replacement	0
”	I-DISEASE
of	I-DISEASE
one	I-DISEASE
SOREMP	0
in	I-DISEASE
the	0
MSLT	I-DISEASE
with	0
a	I-DISEASE
SOREMP	0
on	0
the	0
preceding	I-DISEASE
poly-	0
somnogram	0
.	0

For	I-DISEASE
the	0
correct	0
interpretation	0
of	0
MSLT	I-DISEASE
findings	0
,	0
the	0
recordings	0
should	0
be	I-DISEASE
performed	I-DISEASE
with	0
the	0
following	0
conditions	I-DISEASE
:	0
(	0
1	0
)	0
the	0
patient	0
must	0
be	I-DISEASE
free	0
of	I-DISEASE
drugs	I-DISEASE
that	0
influence	0
sleep	0
for	0
at	I-DISEASE
least	I-DISEASE
14	0
days	0
(	0
or	0
at	I-DISEASE
least	0
five	0
times	0
the	0
half	0
-	0
life	I-DISEASE
of	I-DISEASE
the	0
drug	0
and	0
longer	0
-	0
acting	0
metabolite	0
)	0
,	0
confirmed	0
by	0
a	0
urine	I-DISEASE
drug	I-DISEASE
screen	B-DISEASE
;	0
(	0
2	0
)	0
the	0
sleep	0
-	0
wake	0
sched-	0
ule	0
must	0
have	0
been	I-DISEASE
standardized	0
and	0
,	I-DISEASE
if	0
necessary	0
,	I-DISEASE
extended	0
to	I-DISEASE
a	0
minimum	0
of	0
seven	0
hours	I-DISEASE
in	0
bed	0
each	0
night	0
(	I-DISEASE
longer	I-DISEASE
for	0
children	B-DISEASE
)	0
for	I-DISEASE
at	I-DISEASE
least	B-DISEASE
seven	0
days	0
before	0
polysom-	0

nography	I-DISEASE
(	0
preferably	0
documented	I-DISEASE
by	I-DISEASE
sleep	0
log	0
and	0
,	0
whenever	I-DISEASE
possible	I-DISEASE
,	I-DISEASE
actigraphy	0
)	0
;	0
and	0
(	I-DISEASE
3	I-DISEASE
)	0
nocturnal	0
polysomnography	0
should	B-DISEASE
be	0
performed	0
on	0
the	0
night	0
immediately	0
preceding	I-DISEASE
the	0
MSLT	I-DISEASE
to	0
rule	0
out	0
other	I-DISEASE
sleep	I-DISEASE
disorders	0
that	0
could	0
mimic	0
the	0
diagnostic	0
features	0
of	I-DISEASE
narcolepsy	0
type	I-DISEASE
1	0
.	0

Sleep	I-DISEASE
time	0
during	I-DISEASE
polysomnography	0
should	0
be	0
curtailed	0
as	0
little	0
as	0
possible	I-DISEASE
with	0
the	0
goal	I-DISEASE
of	I-DISEASE
at	I-DISEASE
least	0
seven	I-DISEASE
hours	I-DISEASE
asleep	0
.	0

The	I-DISEASE
overnight	I-DISEASE
poly-	0
somnogram	I-DISEASE
may	0
demonstrate	0
an	0
increase	I-DISEASE
in	I-DISEASE
the	0
amount	I-DISEASE
of	I-DISEASE
stage	I-DISEASE
N1	0
sleep	0
,	0
and	0
there	I-DISEASE
may	0
be	I-DISEASE
a	0
disruption	I-DISEASE
of	I-DISEASE
the	I-DISEASE
normal	0
sleep	I-DISEASE
pattern	0
,	0
with	I-DISEASE
frequent	I-DISEASE
awakenings	0
.	0

REM	I-DISEASE
sleep	0
without	0
atonia	I-DISEASE
may	0
be	I-DISEASE
present	0
.	0

Measuring	I-DISEASE
CSF	0
levels	I-DISEASE
of	I-DISEASE
hypocretin-1	I-DISEASE
is	0
a	0
highly	I-DISEASE
specific	I-DISEASE
and	0
sensitive	0
test	0
for	0
the	0
diagnosis	0
of	I-DISEASE
narcolepsy	I-DISEASE
type	I-DISEASE
1	I-DISEASE
.	0

Hypocretin-1	I-DISEASE
can	I-DISEASE
be	0
measured	0
in	I-DISEASE
crude	I-DISEASE
CSF	I-DISEASE
,	0
using	I-DISEASE
a	I-DISEASE
commercially	I-DISEASE
available	0
radioimmunoassay	0
.	0

When	I-DISEASE
using	0
the	0
Stanford	0
reference	0
sample	0
,	0
values	I-DISEASE
less	I-DISEASE
than	0
110	0
pg	0
/	0
mL	0
are	0
highly	I-DISEASE
specific	0
.	0

Alternatively	I-DISEASE
,	I-DISEASE
a	0
laboratory	I-DISEASE
may	0
elect	I-DISEASE
to	I-DISEASE
obtain	I-DISEASE
control	0
data	0
themselves	I-DISEASE
,	I-DISEASE
in	I-DISEASE
which	I-DISEASE
case	I-DISEASE
a	0
level	0
of	I-DISEASE
less	0
than	0
33	I-DISEASE
%	0
of	I-DISEASE
mean	I-DISEASE
control	0
values	I-DISEASE
is	0
considered	I-DISEASE
abnormal	I-DISEASE
.	0

Issues	I-DISEASE
concerning	0
the	0
standardization	0
of	I-DISEASE
CSF	0
hypocre-	0
tin	0
measurements	0
remain	I-DISEASE
,	I-DISEASE
but	I-DISEASE
extensive	0
protocols	0
are	I-DISEASE
available	0
.	0

Low	I-DISEASE
CSF	I-DISEASE
hypocre-	I-DISEASE
tin	0
values	I-DISEASE
are	0
occasionally	0
observed	I-DISEASE
in	I-DISEASE
seriously	0
ill	0
patients	I-DISEASE
with	I-DISEASE
other	0
disorders	0
and	0
should	0
be	0
interpreted	0
within	I-DISEASE
the	I-DISEASE
clinical	0
context	I-DISEASE
.	0

HLA	I-DISEASE
typing	0
of	I-DISEASE
narcoleptic	0
patients	0
with	0
cataplexy	0
almost	0
always	0
shows	I-DISEASE
the	I-DISEASE
presence	0
of	0
HLA	I-DISEASE
DQB1	I-DISEASE
*	0
0602	I-DISEASE
(	I-DISEASE
and	0
DR2	I-DISEASE
or	I-DISEASE
DRB1	I-DISEASE
*	0
1501	I-DISEASE
in	I-DISEASE
whites	0
and	0
Asians	0
)	I-DISEASE
,	I-DISEASE
but	I-DISEASE
this	0
is	0
not	0
diagnostic	0
for	0
narcolepsy	0
.	0

Approximately	I-DISEASE
25	I-DISEASE
%	0
of	I-DISEASE
the	0
normal	0
Caucasian	I-DISEASE
population	0
,	0
12	0
%	0
of	I-DISEASE
the	I-DISEASE
Japanese	I-DISEASE
population	0
,	I-DISEASE
and	0
38	I-DISEASE
%	0
of	0
the	0
black	0
population	0
are	0
positive	0
for	I-DISEASE
DQB1	0
*	0
0602	I-DISEASE
.	0

HLA	I-DISEASE
typing	0
could	0
be	0
considered	I-DISEASE
when	I-DISEASE
a	I-DISEASE
spinal	B-DISEASE
tap	I-DISEASE
is	0
contemplated	I-DISEASE
to	I-DISEASE
assess	I-DISEASE
hypocretin-1	0
values	I-DISEASE
:	0
if	0
the	0
patient	I-DISEASE
is	0
HLA	I-DISEASE
-	I-DISEASE
negative	I-DISEASE
,	B-DISEASE
hypocretin-1	0
levels	0
are	0
most	0
likely	0
normal	0
.	0

Differential	I-DISEASE
Diagnosis	0
In	I-DISEASE
the	0
absence	I-DISEASE
of	I-DISEASE
cataplexy	0
,	I-DISEASE
narcolepsy	0
type	0
1	0
can	0
be	0
diagnosed	0
based	B-DISEASE
on	0
the	I-DISEASE
pres-	0
ence	I-DISEASE
of	I-DISEASE
hypersomnolence	0
and	0
low	0
CSF	0
hypocretin-1	0
levels	0
.	0

When	I-DISEASE
cataplexy	I-DISEASE
is	I-DISEASE
absent	I-DISEASE
and	0
CSF	0
hypocretin-1	I-DISEASE
levels	I-DISEASE
are	0
normal	0
or	I-DISEASE
unknown	0
,	I-DISEASE
narcolepsy	0
type	I-DISEASE
2	I-DISEASE
should	I-DISEASE
be	I-DISEASE
diagnosed	I-DISEASE
.	0

Cataplexy	I-DISEASE
must	0
be	I-DISEASE
differentiated	0
from	I-DISEASE
cataplexy	0
-	I-DISEASE
like	0
episodes	I-DISEASE
that	0
are	I-DISEASE
occasionally	I-DISEASE
observed	0
in	0
normal	0
individuals	I-DISEASE
.	0

For	I-DISEASE
example	0
,	0
feelings	I-DISEASE
of	0
muscle	I-DISEASE
weakness	I-DISEASE
are	I-DISEASE
some-	0
times	0
reported	I-DISEASE
when	I-DISEASE
healthy	I-DISEASE
subjects	0
laugh	I-DISEASE
out	0
loud	I-DISEASE
.	0

In	I-DISEASE
genuine	0
cataplexy	0
,	I-DISEASE
episodes	I-DISEASE
most	0
often	0
occur	I-DISEASE
with	I-DISEASE
a	I-DISEASE
significant	0
frequency	I-DISEASE
,	I-DISEASE
and	0
are	I-DISEASE
associated	0
with	0
loss	I-DISEASE
of	I-DISEASE
muscle	I-DISEASE
tone	I-DISEASE
.	0

Cataplexy	I-DISEASE
should	0
be	I-DISEASE
differentiated	0
from	I-DISEASE
hypotension	0
,	I-DISEASE
transient	0
ischemic	0
attacks	0
,	0
drop	0
attacks	0
,	0
akinetic	0
seizures	0
,	0
neuromuscular	0
disorders	0
,	I-DISEASE
vestibular	0
disorders	0
,	0
psycho-	0
logical	I-DISEASE
or	0
psychiatric	I-DISEASE
disorders	0
,	I-DISEASE
and	0
sleep	0
paralysis	I-DISEASE
.	0

Clear	I-DISEASE
improvement	I-DISEASE
with	0
antide-	I-DISEASE
pressant	I-DISEASE
medications	0
may	0
favor	I-DISEASE
a	0
diagnosis	I-DISEASE
of	I-DISEASE
cataplexy	0
in	0
difficult	0
cases	0
.	0

Sleepiness	I-DISEASE
may	0
be	I-DISEASE
secondary	0
to	I-DISEASE
obstructive	0
sleep	0
apnea	0
,	0
insufficient	0
sleep	0
syndrome	I-DISEASE
,	0
shift	0
work	I-DISEASE
,	I-DISEASE
the	0
effects	0
of	I-DISEASE
substances	I-DISEASE
or	0
medications	I-DISEASE
,	I-DISEASE
or	I-DISEASE
other	I-DISEASE
sleep	I-DISEASE
disorders	0
.	0

Many	I-DISEASE
of	I-DISEASE
these	I-DISEASE
conditions	I-DISEASE
can	0
result	I-DISEASE
in	I-DISEASE
early	I-DISEASE
onset	0
REM	0
sleep	I-DISEASE
as	I-DISEASE
well	I-DISEASE
.	0

When	I-DISEASE
cataplexy	I-DISEASE
is	0
present	I-DISEASE
,	I-DISEASE
these	0
disorders	0
do	0
not	0
preclude	I-DISEASE
a	0
diagnosis	I-DISEASE
of	I-DISEASE
narcolepsy	0
type	I-DISEASE
1	0
.	0

When	I-DISEASE
there	I-DISEASE
is	0
a	I-DISEASE
questionable	B-DISEASE
history	I-DISEASE
of	I-DISEASE
cataplexy	I-DISEASE
in	I-DISEASE
such	I-DISEASE
cases	0
,	0
either	0
comorbid	I-DISEASE
conditions	0
should	0
be	0
adequately	0
treated	0
before	0
performing	0
an	0
MSLT	I-DISEASE
or	I-DISEASE
CSF	0
hypocretin-1	0
should	0
be	0
measured	0
.	0

Central	I-DISEASE
Disorders	I-DISEASE
of	0
Hypersomnolence	I-DISEASE
Central	I-DISEASE
Disorders	I-DISEASE
of	I-DISEASE
Hypersomnolence	I-DISEASE
Idiopathic	0
hypersomnia	I-DISEASE
is	0
differentiated	0
from	I-DISEASE
narcolepsy	0
type	I-DISEASE
1	0
by	I-DISEASE
the	0
absence	0
of	I-DISEASE
cat-	0
aplexy	0
and	0
the	0
lack	0
of	I-DISEASE
two	0
or	0
more	0
SOREMPs	I-DISEASE
on	0
the	I-DISEASE
MSLT	I-DISEASE
.	0

In	I-DISEASE
contrast	I-DISEASE
with	0
patients	I-DISEASE
who	0
have	I-DISEASE
narcolepsy	0
,	0
patients	I-DISEASE
with	I-DISEASE
idiopathic	I-DISEASE
hypersomnia	I-DISEASE
generally	I-DISEASE
have	0
high	I-DISEASE
sleep	0
efficiency	I-DISEASE
,	0
sleep	0
drunkenness	0
,	I-DISEASE
and	0
long	0
,	0
unrefreshing	I-DISEASE
naps	I-DISEASE
.	0

In	I-DISEASE
insufficient	0
sleep	0
syndrome	I-DISEASE
,	0
there	I-DISEASE
is	I-DISEASE
no	I-DISEASE
cataplexy	0
,	I-DISEASE
and	0
normalizing	0
sleep	0
time	I-DISEASE
elim-	0

inates	I-DISEASE
the	0
daytime	I-DISEASE
sleepiness	0
.	0

Chronic	I-DISEASE
fatigue	I-DISEASE
syndrome	I-DISEASE
and	0
depression	I-DISEASE
may	0
mimic	I-DISEASE
narcolepsy	0
but	I-DISEASE
do	I-DISEASE
not	0
show	0
the	0
typical	I-DISEASE
MSLT	I-DISEASE
findings	0
.	0

Malingering	I-DISEASE
and	0
substance	I-DISEASE
abuse	I-DISEASE
disorder	I-DISEASE
should	I-DISEASE
be	0
considered	0
in	I-DISEASE
patients	I-DISEASE
who	I-DISEASE
try	I-DISEASE
to	0
mislead	0
the	0
clinician	0
in	I-DISEASE
order	0
to	0
obtain	I-DISEASE
stimulant	0
medications	I-DISEASE
.	0

Unresolved	I-DISEASE
Issues	0
and	0
Further	I-DISEASE
Directions	0

Ten	I-DISEASE
percent	I-DISEASE
of	I-DISEASE
patients	I-DISEASE
with	0
narcolepsy	0
with	0
cataplexy	0
have	0
normal	0
hypocretin-1	I-DISEASE
levels	0
in	I-DISEASE
the	I-DISEASE
CSF	0
,	I-DISEASE
which	I-DISEASE
suggests	I-DISEASE
that	B-DISEASE
CSF	0
levels	I-DISEASE
either	I-DISEASE
do	0
not	0
perfectly	0
reflect	I-DISEASE
brain	0
hypocretin	0
neurotransmission	I-DISEASE
or	0
that	0
narcolepsy	0
with	0
cataplexy	0
can	I-DISEASE
be	I-DISEASE
caused	0
by	I-DISEASE
factors	0
other	I-DISEASE
than	I-DISEASE
hypocretin	I-DISEASE
deficiency	0
.	0

The	I-DISEASE
cause	I-DISEASE
of	I-DISEASE
the	0
hypocretin	0
cell	0
destruction	0
remains	0
unknown	I-DISEASE
,	I-DISEASE
although	0
an	0
autoimmune	0
-	I-DISEASE
mediated	0
mechanism	0
is	0
suspected	I-DISEASE
.	0

Levels	I-DISEASE
of	I-DISEASE
hypocretin-1	I-DISEASE
have	0
been	I-DISEASE
reported	I-DISEASE
in	I-DISEASE
the	0
blood	I-DISEASE
of	I-DISEASE
some	I-DISEASE
subjects	0
.	0

The	I-DISEASE
development	I-DISEASE
of	I-DISEASE
serum	I-DISEASE
tests	0
to	I-DISEASE
determine	0
hypocretin	I-DISEASE
deficiency	I-DISEASE
would	I-DISEASE
provide	0
a	0
less	I-DISEASE
invasive	I-DISEASE
diagnos-	0
tic	0
approach	0
.	0

Bibliography	0
Andlauer	0
O	0
,	I-DISEASE
Moore	I-DISEASE
H	0
,	I-DISEASE
Jouhier	0
L	0
,	I-DISEASE
et	0
al	I-DISEASE
.	0

Nocturnal	I-DISEASE
REM	0
sleep	0
latency	I-DISEASE
for	I-DISEASE
identifying	0
patients	0
with	I-DISEASE
narcolepsy	0
/	0
hypocretin	0
deficiency	0
.	0

JAMA	I-DISEASE
Neurol	0
2013;6:1–12	0
.	0

Aran	I-DISEASE
A	0
,	I-DISEASE
Einen	0
M	I-DISEASE
,	I-DISEASE
Lin	0
L	0
,	0
Palazzi	0
G	I-DISEASE
,	I-DISEASE
Nishino	0
S	I-DISEASE
,	I-DISEASE
Mignot	0
E.	0
Clinical	0
and	0
therapeutic	I-DISEASE
aspects	0
of	I-DISEASE
childhood	B-DISEASE
narcolepsy	0
-	0
cataplexy	0
:	0
a	0
retrospective	0
study	0
of	I-DISEASE
51	I-DISEASE
children	I-DISEASE
.	0

Sleep	I-DISEASE
2010;33:1457–64	0
.	0

Arii	0
J	0
,	I-DISEASE
Kanbayashi	0
T	0
,	0
Tanabe	0
Y	I-DISEASE
,	I-DISEASE
et	0
al	0
.	0
CSF	I-DISEASE
hypocretin-1	0
(	I-DISEASE
orexin	0
-	0
A	0
)	0
levels	I-DISEASE
in	0
childhood	0
narcolepsy	0
and	0
neurologic	0
disorders	0
.	0

Neurology	0
2004;63:2440–2	0
.	0

Bourgin	I-DISEASE
P	0
,	0
Zeitzer	I-DISEASE
JM	0
,	0
Mignot	I-DISEASE
E.	0
CSF	I-DISEASE
hypocretin-1	0
assessment	I-DISEASE
in	0
sleep	0
and	0
neurological	0
disorders	0
.	0

Lancet	0
Neurol	0
2008;7:649–62	I-DISEASE
.	0

Dauvilliers	I-DISEASE
Y	0
,	I-DISEASE
Gosselin	I-DISEASE
A	0
,	0
Paquet	0
J	I-DISEASE
,	0
Touchon	0
J	I-DISEASE
,	0
Billiard	I-DISEASE
M	I-DISEASE
,	0
Montplaisir	0
J.	0
Effect	I-DISEASE
of	I-DISEASE
age	I-DISEASE
on	0
MSLT	I-DISEASE
results	I-DISEASE
in	I-DISEASE
patients	0
with	I-DISEASE
narcolepsy	0
-	0
cataplexy	I-DISEASE
.	0

Neurology	0
2004;62:46–50	0
.	0

Dauvilliers	I-DISEASE
Y	I-DISEASE
,	I-DISEASE
Arnulf	0
I	0
,	I-DISEASE
Mignot	I-DISEASE
E.	0
Narcolepsy	I-DISEASE
with	I-DISEASE
cataplexy	0
.	0

Lancet	0
2007;369:499–511	B-DISEASE
.	0

Kotagal	I-DISEASE
S	I-DISEASE
,	I-DISEASE
Krahn	0
LE	0
,	0

Slocumb	I-DISEASE
N.	0
A	0
putative	0
link	0
between	0
childhood	0
narcolepsy	I-DISEASE
and	0
obesity	0
.	0

Sleep	I-DISEASE
Med	I-DISEASE
2004;5:147–50	I-DISEASE
.	0

Mignot	I-DISEASE
E	0
,	0
Lammers	0
GJ	I-DISEASE
,	0
Ripley	0
B	0
,	0
et	0
al	I-DISEASE
.	I-DISEASE

The	I-DISEASE
role	0
of	I-DISEASE
cerebrospinal	I-DISEASE
fluid	0
hypocretin	0
measurement	0
in	I-DISEASE
the	0
diagnosis	I-DISEASE
of	0
narcolepsy	0
and	0
other	0
hypersomnias	I-DISEASE
.	B-DISEASE

Arch	I-DISEASE
Neurol	0
2002;59:1553–62	0
.	0

Mignot	I-DISEASE
E	0
,	0
Lin	I-DISEASE
L	0
,	I-DISEASE
Finn	0
L	0
,	0
et	0
al	I-DISEASE
.	0

Correlates	I-DISEASE
of	I-DISEASE
sleep	0
-	I-DISEASE
onset	I-DISEASE
REM	I-DISEASE
periods	0
during	I-DISEASE
the	0
Multiple	I-DISEASE
Sleep	I-DISEASE
Latency	0
Test	I-DISEASE
in	I-DISEASE
community	0
adults	I-DISEASE
.	0

Brain	0
2006;129:1609–23	0
.	0

Nevsimalova	I-DISEASE
S	I-DISEASE
,	I-DISEASE
Prihodova	0
I	I-DISEASE
,	I-DISEASE
Kemlink	I-DISEASE
D	I-DISEASE
,	0
Lin	0
L	0
,	0
Mignot	I-DISEASE
E.	I-DISEASE
REM	I-DISEASE
sleep	0
behavior	I-DISEASE
disorder	B-DISEASE
(	I-DISEASE
RBD	I-DISEASE
)	0
can	0
be	0
one	0
of	I-DISEASE
the	0
first	0
symptoms	0
of	0
childhood	0
narcolepsy	0
.	0

Sleep	I-DISEASE
Med	I-DISEASE
2007;8:784–6	I-DISEASE
.	0

Overeem	I-DISEASE
S	I-DISEASE
,	0
van	I-DISEASE
Nues	0
SJ	0
,	0
van	I-DISEASE
der	I-DISEASE
Zande	I-DISEASE
WL	I-DISEASE
,	0
Donjacour	0
CE	0
,	I-DISEASE
van	I-DISEASE
Mierlo	0
P	0
,	I-DISEASE
Lammers	0
GJ	I-DISEASE
.	0

The	I-DISEASE
clinical	I-DISEASE
features	0
of	I-DISEASE
cataplexy	0
:	0
a	0
questionnaire	0
study	I-DISEASE
in	I-DISEASE
narcolepsy	0
patients	0
with	0
and	0
without	0
hypocretin-1	I-DISEASE
deficiency	0
.	0

Sleep	I-DISEASE
Med	I-DISEASE
2011;12:12–8	I-DISEASE
.	0

Pizza	I-DISEASE
F	I-DISEASE
,	0
Franceschini	0
C	I-DISEASE
,	I-DISEASE
Peltola	0
H	I-DISEASE
,	I-DISEASE
et	0
al	I-DISEASE
.	0

Clinical	I-DISEASE
and	0
polysomnographic	0
course	0
of	I-DISEASE
childhood	0
narcolepsy	0
with	0
cataplexy	0
.	0

Brain	I-DISEASE
2013	0
Oct	0
18	I-DISEASE
.	0

[	0
Epub	0
ahead	0
of	I-DISEASE
print	0
]	0

Plazzi	I-DISEASE
G	I-DISEASE
,	0
Parmeggiani	0
A	0
,	I-DISEASE
Mignot	I-DISEASE
E	0
,	I-DISEASE
et	0
al	0
.	0

Narcolepsy	I-DISEASE
-	0
cataplexy	I-DISEASE
associated	0
with	I-DISEASE
precocious	I-DISEASE
puberty	0
.	0

Neurology	0
2006;66:1577–9	0
.	0

Serra	I-DISEASE
L	0
,	0
Montagna	0
P	0
,	I-DISEASE
Mignot	0
E	0
,	I-DISEASE
Lugaresi	I-DISEASE
E	0
,	I-DISEASE
Plazzi	0
G.	I-DISEASE
Cataplexy	I-DISEASE
features	I-DISEASE
in	I-DISEASE
childhood	0
narcolepsy	0
.	0

Mov	I-DISEASE
Disord	0
2008;23:858–65	I-DISEASE
.	0

Narcolepsy	I-DISEASE
Type	0
2	0
ICD-9	0
-	0
CM	0
code	0
:	0
347.00	0
Alternate	0
Names	I-DISEASE
Narcolepsy	0
without	0
cataplexy	0
.	0

Diagnostic	I-DISEASE
Criteria	0
Criteria	0

A	I-DISEASE
-	I-DISEASE
E	0
must	I-DISEASE
be	0
met	0
ICD-10	0
-	0
CM	0
code	0
:	0
G47.419	I-DISEASE
Central	I-DISEASE
Disorders	0
of	I-DISEASE
Hypersomnolence	I-DISEASE
A.	0

The	I-DISEASE
patient	I-DISEASE
has	0
daily	I-DISEASE
periods	0
of	I-DISEASE
irrepressible	I-DISEASE
need	I-DISEASE
to	I-DISEASE
sleep	I-DISEASE
or	I-DISEASE
daytime	0
lapses	I-DISEASE
into	I-DISEASE
sleep	0
occurring	0
for	I-DISEASE
at	I-DISEASE
least	I-DISEASE
three	I-DISEASE
months	0
.	0

B.	0
A	0
mean	I-DISEASE
sleep	0
latency	I-DISEASE
of	I-DISEASE
≤	0
8	I-DISEASE
minutes	0
and	0
two	I-DISEASE
or	I-DISEASE
more	0
sleep	0
onset	0
REM	I-DISEASE
periods	0
(	I-DISEASE
SOREMPs	I-DISEASE
)	0
are	0
found	I-DISEASE
on	0
a	I-DISEASE
MSLT	I-DISEASE
performed	0
according	B-DISEASE
to	I-DISEASE
standard	0
techniques	0
.	0

A	I-DISEASE
SOREMP	I-DISEASE
(	I-DISEASE
within	I-DISEASE
15	I-DISEASE
minutes	0
of	I-DISEASE
sleep	0
onset	I-DISEASE
)	I-DISEASE
on	0
the	0
preceding	I-DISEASE
nocturnal	0
polysomnogram	0
may	I-DISEASE
replace	I-DISEASE
one	0
of	I-DISEASE
the	0
SOREMPs	I-DISEASE
on	0
the	I-DISEASE
MSLT	I-DISEASE
.	0

C.	I-DISEASE
Cataplexy	0
is	I-DISEASE
absent.1	I-DISEASE
D.	0
Either	I-DISEASE
CSF	I-DISEASE
hypocretin-1	I-DISEASE
concentration	0
has	0
not	0
been	I-DISEASE
measured	0
or	I-DISEASE
CSF	0
hypocretin-1	I-DISEASE
concentration	0
measured	0
by	I-DISEASE
immunoreactivity	0
is	I-DISEASE
either	I-DISEASE
>	0
110	0
pg	0
/	0
mL	I-DISEASE
or	0
>	0
1/3	I-DISEASE
of	I-DISEASE
mean	0
values	I-DISEASE
obtained	I-DISEASE
in	I-DISEASE
normal	0
subjects	0
with	0
the	0
same	0
standardized	0
assay.2	I-DISEASE
E.	I-DISEASE

The	I-DISEASE
hypersomnolence	I-DISEASE
and/or	0
MSLT	I-DISEASE
findings	0
are	0
not	0
better	I-DISEASE
explained	I-DISEASE
by	0
other	0
causes	I-DISEASE
such	0
as	0
insufficient	0
sleep	0
,	I-DISEASE
obstructive	0
sleep	0
apnea	I-DISEASE
,	I-DISEASE
delayed	I-DISEASE
sleep	0
phase	0
disorder	0
,	0
or	0
the	0
effect	0
of	0
medication	0
or	0
substances	I-DISEASE
or	0
their	0
withdrawal	0
.	0

Notes	I-DISEASE
.	0

If	I-DISEASE
cataplexy	I-DISEASE
develops	0
later	0
,	I-DISEASE
then	0
the	0
disorder	0
should	I-DISEASE
be	I-DISEASE
reclassified	B-DISEASE
as	0
narcolepsy	0
type	I-DISEASE
1	0
.	0

Central	I-DISEASE
Disorders	I-DISEASE
of	0
Hypersomnolence	I-DISEASE
.	I-DISEASE

If	I-DISEASE
the	0
CSF	0
Hcrt-1	0
concentration	0
is	0
tested	0
at	I-DISEASE
a	0
later	0
stage	0
and	0
found	I-DISEASE
to	0
be	0
either	I-DISEASE
≤	0
110	0
pg	0
/	0
mL	0
or	0
<	I-DISEASE
1/3	0
of	I-DISEASE
mean	I-DISEASE
values	I-DISEASE
obtained	0
in	0
normal	0
subjects	0
with	0
the	0
same	0
assay	0
,	0
then	I-DISEASE
the	I-DISEASE
disorder	I-DISEASE
should	0
be	0
reclassified	0
as	0
narcolepsy	0
type	0
1	0
.	0

Essential	I-DISEASE
Features	I-DISEASE
Narcolepsy	0
type	I-DISEASE
2	I-DISEASE
is	0
characterized	0
by	I-DISEASE
excessive	0
daytime	I-DISEASE
sleepiness	0
and	0
abnormal	I-DISEASE
man-	0
ifestations	0
of	I-DISEASE
REM	0
sleep	I-DISEASE
on	0
polysomnography	0
/	0
MSLT	I-DISEASE
.	0

Cataplexy	I-DISEASE
is	0
absent	I-DISEASE
,	I-DISEASE
although	I-DISEASE
some	0
atypical	I-DISEASE
sensations	I-DISEASE
of	I-DISEASE
weakness	0
triggered	I-DISEASE
by	I-DISEASE
unusual	I-DISEASE
emotions	0
such	0
as	I-DISEASE
stress	I-DISEASE
and	0
anger	0
may	I-DISEASE
be	I-DISEASE
reported	0
.	I-DISEASE

Refreshing	I-DISEASE
daytime	I-DISEASE
naps	0
are	0
characteristic	I-DISEASE
.	0

An	0
essential	0
feature	0
of	I-DISEASE
the	0
diagnosis	I-DISEASE
is	I-DISEASE
the	0
presence	0
of	I-DISEASE
a	0
mean	I-DISEASE
sleep	I-DISEASE
latency	I-DISEASE
less	I-DISEASE
than	I-DISEASE
or	I-DISEASE
equal	0
to	0
eight	0
minutes	0
and	0
two	0
or	0
more	0
SOREMPs	0
on	0
an	B-DISEASE
MSLT	I-DISEASE
(	I-DISEASE
or	0
one	0
SOREMP	0
on	0
an	0
MSLT	I-DISEASE
and	0
one	I-DISEASE
on	0
the	0
preceding	I-DISEASE
nocturnal	0
polysomnogram	0
)	0
.	0

The	I-DISEASE
presence	0
of	I-DISEASE
CSF	0
hypocretin-1	I-DISEASE
concentrations	I-DISEASE
≤	I-DISEASE
110	0
pg	0
/	I-DISEASE
mL	0
or	I-DISEASE
less	I-DISEASE
than	0
one	0
third	0
of	I-DISEASE
mean	0
values	I-DISEASE
obtained	0
in	I-DISEASE
normal	0
subjects	B-DISEASE
with	I-DISEASE
the	0
same	0
assay	0
excludes	0
the	0
diagnosis	0
,	I-DISEASE
but	0
most	0
patients	I-DISEASE
with	I-DISEASE
narcolepsy	I-DISEASE
type	I-DISEASE
2	0
will	0
not	0
have	0
undergone	0
CSF	I-DISEASE
examination	0
.	0

Associated	I-DISEASE
Features	I-DISEASE
Sleep	0
paralysis	I-DISEASE
,	I-DISEASE
hypnagogic	I-DISEASE
hallucinations	I-DISEASE
,	I-DISEASE
or	I-DISEASE
automatic	0
behavior	0
may	I-DISEASE
be	0
present	I-DISEASE
.	0

Memory	I-DISEASE
lapses	I-DISEASE
,	I-DISEASE
automatic	0
behavior	I-DISEASE
,	0
ptosis	0
,	0
blurred	0
vision	0
,	I-DISEASE
and	0
diplopia	0
may	I-DISEASE
occur	0
in	0
association	I-DISEASE
with	0
sleepiness	0
.	0

REM	I-DISEASE
sleep	0
behavior	I-DISEASE
disorder	0
and	0
nonrapid	I-DISEASE
eye	0
movement	I-DISEASE
(	I-DISEASE
NREM	I-DISEASE
)	0
parasomnias	I-DISEASE
may	I-DISEASE
occur	I-DISEASE
.	0

Nocturnal	0
sleep	0
disruption	I-DISEASE
with	0
frequent	I-DISEASE
awaken-	0
ings	0
may	0
be	I-DISEASE
present	I-DISEASE
.	0

Clinical	I-DISEASE
and	0
Pathophysiological	I-DISEASE
Subtypes	I-DISEASE
Narcolepsy	0
type	I-DISEASE
2	0
due	0
to	I-DISEASE
a	0
medical	0
condition	0
:	0

This	I-DISEASE
condition	0
fulfills	I-DISEASE
criteria	0
for	0
nar-	0
colepsy	0
type	I-DISEASE
2	I-DISEASE
and	0
is	I-DISEASE
attributable	I-DISEASE
to	I-DISEASE
another	I-DISEASE
medical	0
disorder	I-DISEASE
.	0

Neurologic	0
disorders	0
associated	0
with	I-DISEASE
narcolepsy	0
type	I-DISEASE
2	I-DISEASE
include	I-DISEASE
tumors	0
or	0
sarcoidosis	I-DISEASE
of	I-DISEASE
the	0
hypothalamus	I-DISEASE
,	I-DISEASE
autoimmune	0
or	0
paraneoplastic	I-DISEASE
disorders	0
associated	0
with	0
anti	0
-	0
Ma-2	0
or	0
anti	I-DISEASE
-	I-DISEASE
aquaporin-4	0
antibodies	0
,	0
multiple	I-DISEASE
sclerosis	0
,	0
myotonic	0
dystrophy	0
,	I-DISEASE
Prader	0
-	0
Willi	0
syndrome	I-DISEASE
,	0
Parkinson	0
disease	I-DISEASE
,	I-DISEASE
and	0
head	I-DISEASE
trauma	0
.	0

In	I-DISEASE
disorders	0
associated	0
with	I-DISEASE
both	0
sleep	0
apnea	0
and	0
narco-	0
lepsy	0
type	I-DISEASE
2	I-DISEASE
,	0
such	0
as	0
myotonic	0
dystrophy	0
or	0
Prader	0
-	0
Willi	0
syndrome	0
,	0
a	0
diagnosis	I-DISEASE
of	I-DISEASE
narcolepsy	0
type	I-DISEASE
2	0
should	I-DISEASE
only	I-DISEASE
be	0
made	0
if	0
abnormal	0
MSLT	0
findings	0
persist	0
after	0
the	0
sleep	0
apnea	0
is	I-DISEASE
adequately	B-DISEASE
treated	0
.	0

In	I-DISEASE
all	0
cases	0
,	I-DISEASE
especially	0
with	I-DISEASE
complex	0
problems	I-DISEASE
such	0
as	0
head	I-DISEASE
trauma	0
,	I-DISEASE
clinical	I-DISEASE
judgment	0
should	0
be	I-DISEASE
used	I-DISEASE
to	0
determine	0
if	I-DISEASE
the	0
development	I-DISEASE
of	I-DISEASE
narcolepsy	0
was	0
a	I-DISEASE
mere	I-DISEASE
coincidence	B-DISEASE
or	0
was	0
triggered	I-DISEASE
by	I-DISEASE
the	0
event	0
or	I-DISEASE
disorder	0
.	0

Demographics	I-DISEASE
The	0
exact	0
prevalence	0
of	I-DISEASE
narcolepsy	0
type	I-DISEASE
2	I-DISEASE
is	0
uncertain	0
.	0

Cases	I-DISEASE
of	I-DISEASE
narcolepsy	I-DISEASE
without	0
cat-	0
aplexy	0
represent	0
15	0
%	0
to	I-DISEASE
25	I-DISEASE
%	0
of	0
the	0
clinic	I-DISEASE
narcoleptic	0
population	0
.	I-DISEASE

A	I-DISEASE
population	0
-	0
based	I-DISEASE
study	0
suggested	0
a	I-DISEASE
higher	I-DISEASE
percentage	0
(	I-DISEASE
36	I-DISEASE
%	0
)	I-DISEASE
,	I-DISEASE
corresponding	I-DISEASE
to	I-DISEASE
a	0
point	I-DISEASE
prevalence	0
of	0
20.5/100,000	0
.	I-DISEASE

Population	0
-	I-DISEASE
based	I-DISEASE
studies	I-DISEASE
have	0
shown	I-DISEASE
that	0
approximately	I-DISEASE
4	0
%	0
to	0
9.5	I-DISEASE
%	0
of	I-DISEASE
adults	B-DISEASE
may	I-DISEASE
have	0
multiple	I-DISEASE
SOREMPs	I-DISEASE
during	I-DISEASE
random	I-DISEASE
MSLTs	I-DISEASE
,	I-DISEASE
but	I-DISEASE
shift	0
workers	0
and	0
subjects	0
with	0
sleep	0
deprivation	0
or	0
sleep	0
apnea	0
were	I-DISEASE
included	I-DISEASE
in	I-DISEASE
the	0
studies	I-DISEASE
.	0

Although	I-DISEASE
both	I-DISEASE
sexes	0
can	I-DISEASE
be	0
affected	I-DISEASE
,	0
the	0
prevalence	0
may	0
be	0
slightly	I-DISEASE
higher	I-DISEASE
in	I-DISEASE
men	0
.	0

The	I-DISEASE
age	I-DISEASE
of	I-DISEASE
onset	I-DISEASE
mirrors	0
that	0
of	I-DISEASE
narcolepsy	0
type	I-DISEASE
1	I-DISEASE
.	0
Predisposing	B-DISEASE
and	0
Precipitating	0
Factors	0
As	0
discussed	0
below	I-DISEASE
,	I-DISEASE
about	0
24	0
%	0
of	I-DISEASE
patients	0
with	I-DISEASE
narcolepsy	0
but	0
no	0
cataplexy	0
will	0
have	I-DISEASE
low	0
CSF	I-DISEASE
Hcrt-1	I-DISEASE
levels	0
and	0
almost	I-DISEASE
all	0
of	I-DISEASE
these	I-DISEASE
will	0
be	I-DISEASE
positive	0
for	I-DISEASE
the	0
HLA	I-DISEASE
DQB1	I-DISEASE
*	0
0602	I-DISEASE
antigen	0
.	0

These	0
patients	0
probably	0
share	0
a	0
common	I-DISEASE
pathogenesis	0
with	0
narcolepsy	0
with	0
cataplexy	0
and	0
should	0
be	0
classified	0
as	0
narcolepsy	0
type	I-DISEASE
1	I-DISEASE
.	0

Underlying	I-DISEASE
genetic	0
and	0
envi-	0
ronmental	I-DISEASE
factors	0
associated	0
with	I-DISEASE
other	I-DISEASE
patients	0
with	0
narcolepsy	0
type	I-DISEASE
2	0
are	0
unknown	0
.	0

Environmental	I-DISEASE
precipitating	I-DISEASE
factors	0
are	0
suspected	I-DISEASE
from	0
case	I-DISEASE
reports	0
but	I-DISEASE
have	I-DISEASE
never	I-DISEASE
been	I-DISEASE
proven	0
to	I-DISEASE
trigger	I-DISEASE
narcolepsy	0
without	0
cataplexy	0
.	0

Among	I-DISEASE
the	0
most	0
commonly	I-DISEASE
reported	0
triggers	I-DISEASE
are	I-DISEASE
head	0
trauma	0
and	0
unspecified	0
viral	I-DISEASE
illnesses	0
.	0

Familial	I-DISEASE
Patterns	I-DISEASE

The	I-DISEASE
detailed	I-DISEASE
genetic	I-DISEASE
pattern	0
of	0
narcolepsy	0
type	I-DISEASE
2	0
is	I-DISEASE
unknown	I-DISEASE
.	0

Relatives	I-DISEASE
of	I-DISEASE
patients	0
with	I-DISEASE
narcolepsy	0
type	I-DISEASE
1	I-DISEASE
may	I-DISEASE
be	I-DISEASE
more	0
likely	I-DISEASE
to	I-DISEASE
experience	I-DISEASE
partial	I-DISEASE
narcolepsy	0
symptoms	I-DISEASE
compatible	I-DISEASE
with	I-DISEASE
the	0
diagnosis	I-DISEASE
of	I-DISEASE
narcolepsy	0
type	I-DISEASE
2	I-DISEASE
.	0

Onset	I-DISEASE
,	0
Course	0
,	0
and	0
Complications	0
Onset	0
typically	I-DISEASE
occurs	I-DISEASE
during	I-DISEASE
adolescence	0
.	0

In	I-DISEASE
about	0
10	0
%	0
of	0
patients	I-DISEASE
,	I-DISEASE
cataplexy	I-DISEASE
will	0
develop	I-DISEASE
later	I-DISEASE
in	I-DISEASE
the	0
course	I-DISEASE
of	I-DISEASE
the	0
disease	0
,	I-DISEASE
necessitating	0
a	0
change	I-DISEASE
in	0
diagnosis	I-DISEASE
to	0
narco-	0
lepsy	I-DISEASE
type	I-DISEASE
1	0
.	0

Most	I-DISEASE
of	I-DISEASE
these	I-DISEASE
patients	I-DISEASE
will	0
,	I-DISEASE
if	0
tested	I-DISEASE
,	0
have	0
absent	0
or	I-DISEASE
intermediate	I-DISEASE
levels	I-DISEASE
of	I-DISEASE
CSF	I-DISEASE
Hcrt-1	I-DISEASE
.	0

In	I-DISEASE
a	I-DISEASE
cohort	0
of	I-DISEASE
patients	I-DISEASE
with	I-DISEASE
narcolepsy	0
without	I-DISEASE
cataplexy	I-DISEASE
in	I-DISEASE
whom	0
CSF	0
Hcrt-1	I-DISEASE
status	0
was	I-DISEASE
known	0
,	I-DISEASE
33	I-DISEASE
%	0
of	I-DISEASE
those	0
with	I-DISEASE
low	0
levels	0
later	0
developed	B-DISEASE
cataplexy	0
,	0
compared	I-DISEASE
with	I-DISEASE
18	I-DISEASE
%	0
with	I-DISEASE
intermediate	0
levels	0
and	0
only	0
1	I-DISEASE
%	0
with	I-DISEASE
normal	0
levels	I-DISEASE
.	0

When	I-DISEASE
left	0
untreated	0
,	I-DISEASE
narcolepsy	0
type	I-DISEASE
2	0
is	I-DISEASE
socially	I-DISEASE
disabling	0
and	0
isolating	0
.	0

Patients	I-DISEASE
have	0
a	I-DISEASE
ten-	0
dency	0
to	0
fail	0
in	0
school	I-DISEASE
and	0
are	I-DISEASE
often	0
dismissed	I-DISEASE
from	I-DISEASE
their	I-DISEASE
jobs	0
.	0

Driving	I-DISEASE
may	I-DISEASE
be	0
avoided	I-DISEASE
for	0
fear	I-DISEASE
of	I-DISEASE
a	I-DISEASE
motor	0
vehicle	0
accident	0
.	0

The	I-DISEASE
inability	0
to	0
sleep	0
at	I-DISEASE
night	I-DISEASE
may	0
further	I-DISEASE
contrib-	0
ute	I-DISEASE
to	0
a	0
loss	0
of	I-DISEASE
control	0
these	0
patients	I-DISEASE
have	0
over	0
their	0
schedule	I-DISEASE
.	0

Depression	I-DISEASE
and	0
weight	0
gain	0
also	0
are	0
common	I-DISEASE
.	0

Central	I-DISEASE
Disorders	I-DISEASE
of	0
Hypersomnolence	I-DISEASE
Central	I-DISEASE
Disorders	I-DISEASE
of	I-DISEASE
Hypersomnolence	I-DISEASE
Developmental	I-DISEASE
Issues	0
Children	I-DISEASE
with	0
narcolepsy	0
type	I-DISEASE
2	0
will	0
typically	0
present	0
with	I-DISEASE
a	0
reappearance	0
of	I-DISEASE
regular	I-DISEASE
daytime	I-DISEASE
napping	I-DISEASE
after	0
naps	I-DISEASE
had	0
been	I-DISEASE
discontinued	I-DISEASE
.	0

In	I-DISEASE
all	0
pediatric	0
cases	0
,	I-DISEASE
one	I-DISEASE
should	I-DISEASE
consider	0
the	0
possibility	I-DISEASE
of	I-DISEASE
an	I-DISEASE
evolving	I-DISEASE
disorder	0
with	I-DISEASE
the	0
development	I-DISEASE
of	0
cataplexy	0
over	0
time	0
.	0

Once	I-DISEASE
the	0
patient	I-DISEASE
develops	0
clear	0
cataplexy	I-DISEASE
,	0
the	0
diagnosis	I-DISEASE
should	I-DISEASE
be	I-DISEASE
changed	0
to	I-DISEASE
narcolepsy	0
type	I-DISEASE
1	0
.	0

Limited	I-DISEASE
information	0
is	0
available	I-DISEASE
on	0
narcolepsy	0
type	I-DISEASE
2	0
prior	I-DISEASE
to	I-DISEASE
adolescence	I-DISEASE
.	0

Descriptions	I-DISEASE
of	I-DISEASE
the	0
experience	0
of	I-DISEASE
sleep	0
paralysis	0
or	0
hypnagogic	I-DISEASE
halluci-	I-DISEASE
nations	0
are	0
very	I-DISEASE
difficult	0
to	I-DISEASE
evoke	0
in	0
young	I-DISEASE
patients	I-DISEASE
,	I-DISEASE
and	0
normative	0
data	0
are	0
not	0
avail-	0
able	0
for	0
the	0
MSLT	I-DISEASE
in	I-DISEASE
children	I-DISEASE
younger	I-DISEASE
than	I-DISEASE
six	0
years	0
of	I-DISEASE
age	0
.	0

In	I-DISEASE
peripubertal	I-DISEASE
children	I-DISEASE
and	0
adolescents	0
,	0
the	0
diagnosis	I-DISEASE
is	I-DISEASE
often	0
challenging	0
.	0

The	I-DISEASE
most	0
common	I-DISEASE
causes	I-DISEASE
of	0
short	0
sleep	0
latencies	I-DISEASE
,	0
often	0
with	I-DISEASE
multiple	I-DISEASE
SOREMPs	I-DISEASE
on	0
the	0
MSLT	0
,	0
are	0
chronic	I-DISEASE
sleep	0
depri-	I-DISEASE
vation	I-DISEASE
and	0
delayed	0
sleep	0
phase	0
disorder	I-DISEASE
.	0

Behavioral	I-DISEASE
problems	0
may	I-DISEASE
be	I-DISEASE
associated	0
with	0
the	0
onset	0
of	I-DISEASE
the	I-DISEASE
disorder	I-DISEASE
,	0
and	0
symptoms	I-DISEASE
may	I-DISEASE
be	0
hidden	0
by	I-DISEASE
the	0
patient	I-DISEASE
.	0

Inattentiveness	I-DISEASE
,	I-DISEASE
lack	I-DISEASE
of	I-DISEASE
energy	I-DISEASE
,	0
insomnia	I-DISEASE
,	I-DISEASE
bizarre	0
hallucinations	I-DISEASE
,	0
or	I-DISEASE
a	0
combination	I-DISEASE
thereof	0
can	0
lead	0
to	0
a	I-DISEASE
psychiatric	0
misdiagnosis	I-DISEASE
of	I-DISEASE
schizophrenia	0
or	I-DISEASE
depression	0
.	0

If	I-DISEASE
the	0
MSLT	I-DISEASE
shows	0
equivocal	I-DISEASE
results	0
,	I-DISEASE
repeating	I-DISEASE
it	I-DISEASE
after	I-DISEASE
a	0
time	0
interval	I-DISEASE
may	I-DISEASE
be	0
helpful	0
,	I-DISEASE
as	0
SOREMPs	I-DISEASE
often	0
emerge	I-DISEASE
later	0
in	I-DISEASE
children	I-DISEASE
.	B-DISEASE

Pathology	I-DISEASE
and	0
Pathophysiology	I-DISEASE
Narcolepsy	0
type	I-DISEASE
2	I-DISEASE
is	0
most	0
likely	0
a	I-DISEASE
heterogeneous	0
disorder	I-DISEASE
.	0

Approximately	I-DISEASE
24	0
%	0
of	I-DISEASE
nar-	0

coleptic	I-DISEASE
patients	I-DISEASE
without	0
cataplexy	0
have	0
a	0
low	0
CSF	I-DISEASE
Hcrt-1	0
concentration	0
,	0
and	0
another	I-DISEASE
8	I-DISEASE
%	0
have	I-DISEASE
intermediate	0
levels	I-DISEASE
(	0
>	0
110	0
pg	0
/	0
mL	I-DISEASE
but	I-DISEASE
≤	0
200	I-DISEASE
pg	0
/	0
mL	0
)	0
.	0

The	I-DISEASE
CSF	I-DISEASE
Hcrt-1	I-DISEASE
status	B-DISEASE
of	I-DISEASE
most	0
patients	I-DISEASE
with	I-DISEASE
narcolepsy	I-DISEASE
type	I-DISEASE
2	0
is	0
unknown	I-DISEASE
(	I-DISEASE
those	0
patients	0
who	I-DISEASE
are	I-DISEASE
known	0
to	I-DISEASE
have	0
absent	I-DISEASE
CSF	0
Hcrt-1	I-DISEASE
levels	0
are	0
classified	0
as	0
narcolepsy	0
type	I-DISEASE
1	I-DISEASE
)	0
.	0

Therefore	I-DISEASE
,	I-DISEASE
there	I-DISEASE
will	0
be	0
a	0
subgroup	I-DISEASE
of	I-DISEASE
about	0
one	0
fourth	I-DISEASE
to	I-DISEASE
one	I-DISEASE
third	I-DISEASE
of	I-DISEASE
narcolepsy	0
type	0
2	I-DISEASE
patients	0
who	I-DISEASE
will	0
have	I-DISEASE
hypocretin	I-DISEASE
deficiency	0
,	I-DISEASE
presumably	0
from	I-DISEASE
loss	I-DISEASE
of	I-DISEASE
the	0
hypocretin	0
-	0
producing	0
neurons	I-DISEASE
.	0

This	I-DISEASE
group	I-DISEASE
of	I-DISEASE
patients	I-DISEASE
can	0
not	0
be	I-DISEASE
accurately	I-DISEASE
separated	I-DISEASE
clinically	0
or	I-DISEASE
by	I-DISEASE
labora-	I-DISEASE
tory	I-DISEASE
tests	0
(	0
other	I-DISEASE
than	I-DISEASE
CSF	I-DISEASE
Hcrt-1	I-DISEASE
level	0
)	0
from	I-DISEASE
the	0
majority	0
of	I-DISEASE
patients	I-DISEASE
without	0
cataplexy	0
who	I-DISEASE
have	0
normal	0
CSF	0
Hcrt-1	I-DISEASE
levels	I-DISEASE
.	0

Although	I-DISEASE
those	I-DISEASE
with	0
low	0
CSF	0
Hcrt-1	I-DISEASE
levels	I-DISEASE
have	I-DISEASE
a	I-DISEASE
younger	0
age	I-DISEASE
of	I-DISEASE
onset	I-DISEASE
and	0
their	0
MSLT	I-DISEASE
shows	I-DISEASE
shorter	0
mean	I-DISEASE
sleep	I-DISEASE
latency	0
with	0
more	0
SOREMPs	I-DISEASE
in	I-DISEASE
comparison	0
with	I-DISEASE
those	0
with	I-DISEASE
normal	0
levels	0
,	0
there	0
is	0
too	0
much	I-DISEASE
overlap	I-DISEASE
between	0
the	I-DISEASE
groups	0
for	0
these	0
differences	I-DISEASE
to	0
be	0
helpful	0
diagnostically	0
in	0
individual	I-DISEASE
patients	0
.	0

One	I-DISEASE
hundred	0
percent	I-DISEASE
of	I-DISEASE
patients	0
with	I-DISEASE
low	0
CSF	I-DISEASE
Hcrt-1	I-DISEASE
levels	0
are	I-DISEASE
positive	0
for	I-DISEASE
HLA	0
DQB1	I-DISEASE
*	0
0602	I-DISEASE
.	0

About	I-DISEASE
26	I-DISEASE
%	0
of	I-DISEASE
patients	0
with	I-DISEASE
normal	0
levels	I-DISEASE
are	0
also	0
HLA	I-DISEASE
posi-	I-DISEASE
tive	I-DISEASE
,	0
a	0
percentage	I-DISEASE
not	0
higher	0
than	0
that	0
seen	I-DISEASE
in	0
the	I-DISEASE
normal	0
population	0
.	I-DISEASE

The	I-DISEASE
underlying	0
pathophysiology	0
of	I-DISEASE
the	0
remainder	0
of	I-DISEASE
patients	I-DISEASE
who	I-DISEASE
have	I-DISEASE
normal	B-DISEASE
CSF	I-DISEASE
Hcrt-1	I-DISEASE
levels	I-DISEASE
is	0
unknown	I-DISEASE
.	I-DISEASE

It	I-DISEASE
is	I-DISEASE
possible	0
some	I-DISEASE
may	0
have	I-DISEASE
partial	I-DISEASE
hypocretin	I-DISEASE
deficiency	I-DISEASE
severe	I-DISEASE
enough	0
to	I-DISEASE
cause	I-DISEASE
sleepiness	I-DISEASE
but	0
not	0
severe	I-DISEASE
enough	I-DISEASE
to	B-DISEASE
result	0
in	I-DISEASE
cataplexy	0
or	I-DISEASE
low	0
CSF	0
Hcrt-1	I-DISEASE
levels	0
.	0

However	I-DISEASE
,	I-DISEASE
support	0
for	I-DISEASE
this	0
hypothesis	I-DISEASE
is	0
lacking	I-DISEASE
in	0
that	0
there	I-DISEASE
are	0
no	I-DISEASE
major	I-DISEASE
differences	I-DISEASE
in	I-DISEASE
clinical	0
or	I-DISEASE
polysomnographic	0
findings	0
in	I-DISEASE
those	0
positive	0
or	0
negative	I-DISEASE
for	I-DISEASE
HLA	I-DISEASE
DQB1	I-DISEASE
*	0
0602	I-DISEASE
.	0

In	I-DISEASE
the	0
only	0
postmortem	0
study	0
of	I-DISEASE
a	0
case	I-DISEASE
of	I-DISEASE
narcolepsy	0
without	0
cata-	0
plexy	0
(	I-DISEASE
CSF	0
Hcrt-1	I-DISEASE
status	B-DISEASE
unknown	I-DISEASE
)	0
,	0
the	I-DISEASE
number	0
of	I-DISEASE
hypocretin	0
cells	0
was	0
decreased	I-DISEASE
but	I-DISEASE
not	I-DISEASE
as	0
much	I-DISEASE
as	0
in	I-DISEASE
cases	0
of	0
narcolepsy	0
with	0
cataplexy	0
.	I-DISEASE

Objective	I-DISEASE
Findings	I-DISEASE

It	I-DISEASE
is	I-DISEASE
strongly	I-DISEASE
rcommended	0
that	I-DISEASE
the	0
MSLT	I-DISEASE
be	I-DISEASE
preceded	I-DISEASE
by	I-DISEASE
at	I-DISEASE
least	0
one	I-DISEASE
week	0
of	0
acti-	0
graphic	I-DISEASE
recording	0
with	I-DISEASE
a	I-DISEASE
sleep	0
log	0
to	0
establish	I-DISEASE
whether	0
the	B-DISEASE
results	I-DISEASE
could	0
be	I-DISEASE
biased	0
by	0
insufficient	0
sleep	0
,	0
shift	0
work	0
,	0
or	I-DISEASE
another	I-DISEASE
circadian	I-DISEASE
sleep	I-DISEASE
disorder	0
.	0

The	I-DISEASE
MSLT	I-DISEASE
demon-	I-DISEASE
strates	0
a	0
mean	0
latency	I-DISEASE
of	I-DISEASE
less	I-DISEASE
than	0
eight	0
minutes	0
,	I-DISEASE
typically	0
less	0
than	I-DISEASE
five	0
minutes	0
,	0
with	I-DISEASE
two	I-DISEASE
or	0
more	0
SOREMPs	0
or	0
one	0
SOREMP	I-DISEASE
together	I-DISEASE
with	I-DISEASE
a	0
SOREMP	I-DISEASE
on	0
the	I-DISEASE
preceding	I-DISEASE
polysomnogram	0
.	0

Meta	I-DISEASE
-	0
analysis	I-DISEASE
shows	I-DISEASE
mean	I-DISEASE
sleep	I-DISEASE
latencies	I-DISEASE
in	0
narcoleptic	0
patients	0
with	I-DISEASE
cataplexy	0
of	I-DISEASE
3.1	I-DISEASE
±	I-DISEASE
2.9	I-DISEASE
minutes	0
.	0

Recent	I-DISEASE
data	I-DISEASE
suggest	0
that	0
a	0
SOREMP	I-DISEASE
within	0
15	I-DISEASE
minutes	0
of	I-DISEASE
onset	I-DISEASE
of	I-DISEASE
nocturnal	0
sleep	I-DISEASE
is	0
a	0
highly	I-DISEASE
specific	I-DISEASE
finding	I-DISEASE
in	0
the	0
absence	I-DISEASE
of	0
another	I-DISEASE
sleep	0
disorder	I-DISEASE
,	I-DISEASE
but	I-DISEASE
with	I-DISEASE
low	0
sensitivity	I-DISEASE
.	0

Therefore	I-DISEASE
,	I-DISEASE
the	0
criteria	I-DISEASE
for	0
narcolepsy	0
type	I-DISEASE
2	0
allow	0
the	I-DISEASE
“	I-DISEASE
replacement	0
”	I-DISEASE
of	I-DISEASE
one	I-DISEASE
SOREMP	0
in	I-DISEASE
the	0
MSLT	I-DISEASE
with	0
a	I-DISEASE
SOREMP	0
on	0
the	0
preceding	I-DISEASE
poly-	0
somnogram	0
.	0

For	I-DISEASE
the	0
correct	0
interpretation	0
of	0
MSLT	I-DISEASE
findings	0
,	0
the	0
recordings	0
should	0
be	I-DISEASE
performed	I-DISEASE
with	0
the	0
following	0
conditions	I-DISEASE
:	0
(	0
1	0
)	0
the	0
patient	0
must	0
be	I-DISEASE
free	0
of	I-DISEASE
drugs	I-DISEASE
that	0
influence	0
sleep	0
for	0
at	I-DISEASE
least	I-DISEASE
14	0
days	0
(	0
or	0
at	I-DISEASE
least	0
five	0
times	0
the	0
half	0
-	0
life	I-DISEASE
of	I-DISEASE
the	0
drug	0
and	0
longer	0
-	0
acting	0
metabolite	0
)	0
,	0
confirmed	0
by	0
a	0
urine	I-DISEASE
drug	I-DISEASE
screen	B-DISEASE
;	0
(	0
2	0
)	0
the	0
sleep	0
-	0
wake	0
sched-	0
ule	0
must	0
have	0
been	I-DISEASE
standardized	0
and	0
,	I-DISEASE
if	0
necessary	0
,	I-DISEASE
extended	0
to	I-DISEASE
a	0
minimum	0
of	0
seven	0
hours	I-DISEASE
in	0
bed	0
each	0
night	0
(	I-DISEASE
longer	I-DISEASE
for	0
children	B-DISEASE
)	0
for	I-DISEASE
at	I-DISEASE
least	B-DISEASE
seven	0
days	0
before	0
polysom-	0

nography	I-DISEASE
(	0
preferably	0
documented	I-DISEASE
by	I-DISEASE
sleep	0
log	0
and	0
,	0
whenever	0
possible	I-DISEASE
,	I-DISEASE
actigraphy	0
)	0
;	0
and	0
(	I-DISEASE
3	0
)	0
nocturnal	0
polysomnography	0
should	B-DISEASE
be	0
performed	0
on	0
the	0
night	0
immediately	0
preceding	I-DISEASE
the	0
MSLT	I-DISEASE
to	0
rule	0
out	0
other	I-DISEASE
sleep	I-DISEASE
disorders	0
that	0
could	0
mimic	0
the	0
diagnostic	0
features	0
of	I-DISEASE
narcolepsy	0
type	I-DISEASE
2	0
.	0

Sleep	I-DISEASE
time	0
during	I-DISEASE
polysomnography	0
should	0
be	0
curtailed	0
as	0
little	0
as	0
possible	I-DISEASE
,	0
with	0
the	0
goal	0
of	I-DISEASE
at	I-DISEASE
least	I-DISEASE
seven	I-DISEASE
hours	I-DISEASE
asleep	I-DISEASE
.	0

The	I-DISEASE
overnight	I-DISEASE
poly-	0
somnogram	I-DISEASE
may	0
demonstrate	0
an	0
increase	I-DISEASE
in	I-DISEASE
the	0
amount	I-DISEASE
of	I-DISEASE
stage	I-DISEASE
N1	0
sleep	0
,	0
and	0
there	I-DISEASE
may	0
be	I-DISEASE
a	0
disruption	I-DISEASE
of	I-DISEASE
the	I-DISEASE
normal	0
sleep	I-DISEASE
pattern	0
,	0
with	I-DISEASE
frequent	I-DISEASE
awakenings	0
.	0

REM	I-DISEASE
sleep	0
without	0
atonia	I-DISEASE
may	0
be	I-DISEASE
present	0
.	0

About	I-DISEASE
45	I-DISEASE
%	0
of	I-DISEASE
narcolepsy	0
type	I-DISEASE
2	0
cases	0
have	I-DISEASE
been	I-DISEASE
reported	I-DISEASE
to	0
be	I-DISEASE
HLA	I-DISEASE
DQB1	0
*	0
0602	I-DISEASE
positive	0
,	I-DISEASE
compared	I-DISEASE
with	I-DISEASE
12	I-DISEASE
%	0
to	0
38	0
%	0
of	I-DISEASE
controls	0
.	0

Whereas	I-DISEASE
essentially	I-DISEASE
all	0
patients	I-DISEASE
who	0
have	I-DISEASE
low	0
CSF	I-DISEASE
Hcrt-1	I-DISEASE
levels	0
will	0
be	I-DISEASE
positive	0
,	0
about	0
25	0
%	0
of	I-DISEASE
those	0
with	I-DISEASE
normal	I-DISEASE
levels	0
will	0
also	0
be	I-DISEASE
positive	0
.	B-DISEASE

Assuming	I-DISEASE
that	0
24	0
%	0
of	I-DISEASE
patients	I-DISEASE
with	I-DISEASE
narcolepsy	0
but	I-DISEASE
no	I-DISEASE
cataplexy	0
will	0
have	0
low	0
CSF	0
Hcrt-1	I-DISEASE
levels	0
,	I-DISEASE
the	0
probability	0
that	0
an	0
HLA-	I-DISEASE
positive	0
patient	I-DISEASE
will	0
have	0
low	0
Hcrt-1	0
levels	I-DISEASE
is	I-DISEASE
only	I-DISEASE
0.56	0
.	0

Therefore	I-DISEASE
the	I-DISEASE
HLA	I-DISEASE
status	0
of	I-DISEASE
a	I-DISEASE
patient	I-DISEASE
can	0
not	0
be	0
used	0
to	I-DISEASE
diagnose	I-DISEASE
narcolepsy	0
type	I-DISEASE
2	0
nor	0
to	0
predict	0
with	I-DISEASE
high	0
probability	0
the	0
patient	I-DISEASE
’s	I-DISEASE
CSF	0
Hcrt-1	I-DISEASE
levels	0
.	0

However	I-DISEASE
,	I-DISEASE
if	0
lumbar	0
puncture	0
is	0
contemplated	0
to	I-DISEASE
measure	I-DISEASE
CSF	I-DISEASE
Central	I-DISEASE
Disorders	I-DISEASE
of	0
Hypersomnolence	I-DISEASE
Central	I-DISEASE
Disorders	0
of	I-DISEASE
Hypersomnolence	I-DISEASE
Hcrt-1	I-DISEASE
levels	I-DISEASE
,	0
HLA	I-DISEASE
typing	I-DISEASE
should	0
be	0
performed	0
first	0
;	0
if	0
the	0
patient	I-DISEASE
is	0
HLA	I-DISEASE
negative	I-DISEASE
,	0
CSF	I-DISEASE
Hcrt-1	I-DISEASE
levels	0
will	0
almost	I-DISEASE
certainly	0
be	I-DISEASE
normal	0
and	0
the	0
lumbar	0
puncture	0
will	0
be	0
unnecessary	0
.	0

Approximately	I-DISEASE
24	0
%	0
of	I-DISEASE
narcoleptic	0
patients	0
without	0
cataplexy	0
have	0
a	0
low	0
CSF	I-DISEASE
Hcrt-1	0
concentration	0
and	0
another	0
8	I-DISEASE
%	0
have	0
intermediate	0
levels	I-DISEASE
(	I-DISEASE
>	0
110	0
pg	0
/	0
mL	I-DISEASE
but	0
≤	0
200	0
pg/	0
mL	I-DISEASE
)	0
.	0

If	I-DISEASE
the	I-DISEASE
CSF	0
Hcrt-1	0
levels	0
of	I-DISEASE
such	I-DISEASE
patients	I-DISEASE
are	I-DISEASE
known	0
to	I-DISEASE
be	I-DISEASE
low	0
,	0
they	0
are	I-DISEASE
classified	0
as	0
narcolepsy	0
type	I-DISEASE
1	I-DISEASE
,	I-DISEASE
but	I-DISEASE
the	0
CSF	0
Hcrt-1	I-DISEASE
status	0
will	0
not	0
be	0
known	0
for	I-DISEASE
most	I-DISEASE
of	I-DISEASE
these	I-DISEASE
patients	I-DISEASE
.	0

Possible	I-DISEASE
indications	I-DISEASE
for	I-DISEASE
considering	I-DISEASE
measuring	I-DISEASE
CSF	0
Hcrt-1	I-DISEASE
levels	0
as	0
a	I-DISEASE
diag-	0
nostic	0
procedure	I-DISEASE
would	0
be	I-DISEASE
the	0
presence	0
of	I-DISEASE
disorders	0
such	0
as	B-DISEASE
obstructive	0
sleep	0
apnea	0
or	0
the	0
use	0
of	0
psychotropic	0
medications	I-DISEASE
that	0
may	0
complicate	I-DISEASE
interpretation	0
of	I-DISEASE
an	0
MSLT	I-DISEASE
.	0

Differential	I-DISEASE
Diagnosis	0
Narcolepsy	0
type	I-DISEASE
1	0
is	I-DISEASE
diagnosed	I-DISEASE
if	I-DISEASE
cataplexy	0
is	0
present	0
or	I-DISEASE
the	0
CSF	0
hypocretin	0
levels	I-DISEASE
are	I-DISEASE
known	B-DISEASE
to	0
be	0
low	0
even	I-DISEASE
in	I-DISEASE
the	0
absence	I-DISEASE
of	I-DISEASE
cataplexy	0
.	0

Patients	I-DISEASE
with	0
idiopathic	I-DISEASE
hyper-	I-DISEASE
somnia	0
may	I-DISEASE
have	I-DISEASE
mean	0
sleep	0
latencies	I-DISEASE
on	0
MSLT	0
similar	0
to	0
those	0
of	I-DISEASE
narcolepsy	I-DISEASE
type	I-DISEASE
2	0
,	I-DISEASE
but	0
have	0
fewer	I-DISEASE
than	I-DISEASE
two	0
SOREMPs	0
on	0
MSLT	I-DISEASE
and	0
the	0
preceding	I-DISEASE
polysomnogram	0
combined	0
.	0

In	I-DISEASE
contrast	I-DISEASE
to	0
narcolepsy	0
,	I-DISEASE
patients	0
with	0
idiopathic	B-DISEASE
hypersomnia	I-DISEASE
generally	0
have	0
high	I-DISEASE
sleep	0
efficiency	I-DISEASE
,	I-DISEASE
sleep	0
drunkenness	I-DISEASE
,	I-DISEASE
and	0
long	I-DISEASE
,	I-DISEASE
unrefreshing	I-DISEASE
naps	I-DISEASE
.	0

Sleepiness	I-DISEASE
may	0
be	I-DISEASE
secondary	0
to	I-DISEASE
obstructive	0
sleep	0
apnea	0
(	0
OSA	I-DISEASE
)	I-DISEASE
,	0
insufficient	0
sleep	I-DISEASE
syndrome	I-DISEASE
,	I-DISEASE
shift	0
work	I-DISEASE
,	I-DISEASE
the	0
effects	0
of	I-DISEASE
substances	I-DISEASE
or	I-DISEASE
medications	I-DISEASE
,	0
or	I-DISEASE
other	I-DISEASE
sleep	0
disorders	0
.	0

Many	0
of	I-DISEASE
these	0
conditions	I-DISEASE
can	0
result	0
in	I-DISEASE
early	I-DISEASE
-	0
onset	0
REM	0
sleep	I-DISEASE
,	I-DISEASE
so	0
their	0
clinical	0
and	0
polysomnographic	0
exclusion	0
is	I-DISEASE
essential	0
before	I-DISEASE
a	0
diagnosis	I-DISEASE
of	I-DISEASE
narcolepsy	0
type	I-DISEASE
2	0
is	0
made	0
.	0

However	I-DISEASE
,	I-DISEASE
the	0
presence	0
of	0
other	I-DISEASE
sleep	0
disorders	0
does	0
not	0
preclude	0
a	0
diagnosis	0
of	I-DISEASE
narcolepsy	0
type	I-DISEASE
2	0
if	0
daytime	0
sleepiness	0
and	0
REM	0
abnormalities	I-DISEASE
persist	I-DISEASE
after	0
adequate	0
treatment	I-DISEASE
of	I-DISEASE
the	0
initial	I-DISEASE
disorder	0
.	0

Chronic	I-DISEASE
fatigue	I-DISEASE
syndrome	I-DISEASE
and	0
depression	I-DISEASE
may	0
mimic	I-DISEASE
narcolepsy	0
but	I-DISEASE
do	I-DISEASE
not	0
show	0
the	0
typical	I-DISEASE
MSLT	I-DISEASE
findings	0
.	0

Malingering	I-DISEASE
and	0
substance	I-DISEASE
abuse	I-DISEASE
disorder	I-DISEASE
should	I-DISEASE
be	0
considered	0
in	I-DISEASE
patients	I-DISEASE
who	I-DISEASE
try	I-DISEASE
to	0
mislead	0
the	0
clinician	0
in	I-DISEASE
order	0
to	0
obtain	I-DISEASE
stimulant	0
medications	I-DISEASE
.	0

Unresolved	I-DISEASE
Issues	0
and	0
Further	I-DISEASE
Directions	0

Excluding	I-DISEASE
the	0
minority	0
of	I-DISEASE
patients	I-DISEASE
with	0
definite	0
hypocretin	I-DISEASE
deficiency	0
,	I-DISEASE
the	I-DISEASE
underlying	0
biology	I-DISEASE
of	I-DISEASE
narcolepsy	0
without	0
the	0
presence	0
of	I-DISEASE
cataplexy	0
is	0
unknown	I-DISEASE
.	0

It	I-DISEASE
is	I-DISEASE
not	0
estab-	I-DISEASE
lished	0
whether	0
narcolepsy	0
type	I-DISEASE
2	0
is	I-DISEASE
a	0
homogeneous	I-DISEASE
or	0
heterogeneous	I-DISEASE
condition	0
.	0

It	I-DISEASE
is	I-DISEASE
uncertain	0
whether	I-DISEASE
or	0
not	0
some	I-DISEASE
patients	I-DISEASE
have	0
partial	I-DISEASE
hypocretin	I-DISEASE
deficiency	0
not	0
iden-	I-DISEASE
tifiable	0
from	I-DISEASE
CSF	0
measurements	I-DISEASE
.	0

Further	I-DISEASE
advances	0
in	0
classification	I-DISEASE
will	0
depend	0
on	0
answers	I-DISEASE
to	0
these	0
unknowns	0
.	0

Further	I-DISEASE
studies	I-DISEASE
on	0
the	0
natural	0
history	I-DISEASE
of	I-DISEASE
narcolepsy	0
type	I-DISEASE
2	I-DISEASE
are	I-DISEASE
needed	0
to	0
determine	I-DISEASE
the	I-DISEASE
cause	0
of	0
the	0
hypersomnolence	0
and	0
the	I-DISEASE
risk	0
of	I-DISEASE
development	0
of	I-DISEASE
cataplexy	0
over	I-DISEASE
time	0
.	0

Bibliography	0
Andlauer	0
O	0
,	I-DISEASE
Moore	I-DISEASE
IV	0
H	I-DISEASE
,	I-DISEASE
Hong	I-DISEASE
SC	0
,	0
et	0
al	I-DISEASE
.	I-DISEASE

Predictors	I-DISEASE
of	I-DISEASE
hypocretin	0
(	I-DISEASE
orexin	0
)	I-DISEASE
deficiency	0
in	0
narcolepsy	0
without	0
cataplexy	I-DISEASE
.	0

Sleep	I-DISEASE
2012;35:1247–55	I-DISEASE
.	0

Bourgin	I-DISEASE
P	0
,	0
Zeitzer	I-DISEASE
JM	0
,	0
Mignot	I-DISEASE
E.	0
CSF	I-DISEASE
hypocretin-1	0
assessment	I-DISEASE
in	0
sleep	0
and	0
neurological	0
disorders	0
.	0

Lancet	0
Neurol	0
2008;7:649–62	I-DISEASE
.	0

Mignot	I-DISEASE
E	0
,	0
Lin	I-DISEASE
L	0
,	I-DISEASE
Finn	0
L	0
,	0
et	0
al	I-DISEASE
.	0

Correlates	I-DISEASE
of	I-DISEASE
sleep	0
-	I-DISEASE
onset	I-DISEASE
REM	I-DISEASE
periods	0
during	I-DISEASE
the	0
Multiple	I-DISEASE
Sleep	I-DISEASE
Latency	0
Test	I-DISEASE
in	I-DISEASE
community	0
adults	I-DISEASE
.	0

Brain	0
2006;129:1609–23	0
.	0

Oka	I-DISEASE
Y	I-DISEASE
,	I-DISEASE
Inoue	0
Y	I-DISEASE
,	0
Kanbayashi	0
T	I-DISEASE
,	I-DISEASE
et	0
al	I-DISEASE
.	0

Narcolepsy	I-DISEASE
without	0
cataplexy	0
:	0
2	0
subtypes	I-DISEASE
based	B-DISEASE
on	0
CSF	0
hypocretin-1/	0
orexin	0
-	0
A	0
findings	0
.	B-DISEASE

Sleep	I-DISEASE
2006;29:1439–43	0
.	0

Sasai	I-DISEASE
T	0
,	I-DISEASE
Inoue	0
Y	I-DISEASE
,	0
Komada	0
Y	I-DISEASE
,	I-DISEASE
Sugiura	I-DISEASE
T	0
,	I-DISEASE
Matsushima	I-DISEASE
E.	0
Comparison	0
of	I-DISEASE
clinical	0
characteristics	I-DISEASE
among	0
narcolepsy	B-DISEASE
with	0
and	0
without	0
cataplexy	0
and	0
idiopathic	0
hypersomnia	I-DISEASE
without	0
long	0
sleep	0
time	0
,	0
focusing	0
on	0
HLA	I-DISEASE
-	0
DRB1(*)1501	I-DISEASE
/	0
DQB1(*)0602	I-DISEASE
finding	I-DISEASE
.	0

Sleep	I-DISEASE
Med	I-DISEASE
2009;10:961–6	I-DISEASE
.	0

Silber	I-DISEASE
MH	I-DISEASE
,	I-DISEASE
Krahn	0
LE	0
,	I-DISEASE
Olson	I-DISEASE
EJ	I-DISEASE
,	I-DISEASE
Pankratz	0
VS	0
.	0

The	I-DISEASE
epidemiology	I-DISEASE
of	I-DISEASE
narcolepsy	0
in	I-DISEASE
Olmsted	I-DISEASE
County	0
,	I-DISEASE
Minnesota	B-DISEASE
:	I-DISEASE
a	0
population	0
-	I-DISEASE
based	I-DISEASE
study	0
.	0

Sleep	I-DISEASE
2002;25:197–202	I-DISEASE
.	0

Takei	0
Y	0
,	I-DISEASE
Komada	0
Y	I-DISEASE
,	I-DISEASE
Namba	0
K	B-DISEASE
,	I-DISEASE
et	0
al	I-DISEASE
.	0

Differences	I-DISEASE
in	I-DISEASE
findings	0
of	I-DISEASE
nocturnal	0
polysomnography	0
and	0
multiple	I-DISEASE
sleep	0
latency	I-DISEASE
test	0
between	0
narcolepsy	0
and	0
idiopathic	B-DISEASE
hypersomnia	I-DISEASE
.	0

Clin	I-DISEASE
Neurophysiol	0
2012;123:137–41	0
.	0

Thannickal	I-DISEASE
TC	0
,	I-DISEASE
Nienhuis	0
R	0
,	I-DISEASE
Siegel	I-DISEASE
JM	0
.	0

Localized	I-DISEASE
loss	0
of	I-DISEASE
hypocretin	0
(	I-DISEASE
orexin	0
)	I-DISEASE
cells	I-DISEASE
in	0
narcolepsy	0
without	0
cataplexy	I-DISEASE
.	0

Sleep	I-DISEASE
2009;32:993–8	I-DISEASE
.	0

Idiopathic	I-DISEASE
Hypersomnia	I-DISEASE
ICD-9	0
-	I-DISEASE
CM	I-DISEASE
code	0
:	I-DISEASE
327.11	I-DISEASE
Alternate	0
Names	I-DISEASE
Idiopathic	0
CNS	0
hypersomnolence	I-DISEASE
.	0

Diagnostic	I-DISEASE
Criteria	0
Criteria	I-DISEASE
A	0
-	I-DISEASE
F	I-DISEASE
must	I-DISEASE
be	0
met	0
ICD-10	0
-	I-DISEASE
CM	0
code	0
:	0
G47.11	I-DISEASE
Central	I-DISEASE
Disorders	I-DISEASE
of	I-DISEASE
Hypersomnolence	I-DISEASE
A.	0

The	I-DISEASE
patient	I-DISEASE
has	0
daily	I-DISEASE
periods	0
of	I-DISEASE
irrepressible	I-DISEASE
need	I-DISEASE
to	I-DISEASE
sleep	I-DISEASE
or	I-DISEASE
daytime	0
lapses	I-DISEASE
into	I-DISEASE
sleep	0
occurring	0
for	I-DISEASE
at	I-DISEASE
least	I-DISEASE
three	I-DISEASE
months.1	0
B.	0
Cataplexy	I-DISEASE
is	0
absent	I-DISEASE
.	0

C.	I-DISEASE
An	0
MSLT	I-DISEASE
performed	0
according	I-DISEASE
to	I-DISEASE
standard	0
techniques	0
shows	I-DISEASE
fewer	0
than	I-DISEASE
two	I-DISEASE
sleep	0
onset	0
REM	I-DISEASE
periods	0
or	0
no	0
sleep	0
onset	0
REM	0
periods	I-DISEASE
if	0
the	I-DISEASE
REM	0
latency	I-DISEASE
on	0
the	0
preceding	I-DISEASE
polysomnogram	0
was	0
less	I-DISEASE
than	0
or	I-DISEASE
equal	I-DISEASE
to	I-DISEASE
15	I-DISEASE
minutes.2	0
D.	0
The	I-DISEASE
presence	0
of	I-DISEASE
at	I-DISEASE
least	0
one	0
of	I-DISEASE
the	0
following	0
:	I-DISEASE
.	I-DISEASE

The	I-DISEASE
MSLT	I-DISEASE
shows	I-DISEASE
a	0
mean	I-DISEASE
sleep	0
latency	I-DISEASE
of	I-DISEASE
≤	0
8	I-DISEASE
minutes	0
.	0
.	0

Total	I-DISEASE
24	0
-	0
hour	0
sleep	0
time	I-DISEASE
is	0
≥	I-DISEASE
660	0
minutes	0
(	I-DISEASE
typically	0
12–14	I-DISEASE
hours)3	I-DISEASE
on	0
24	0
-	0
hour	0
polysomnographic	0
monitoring	0
(	I-DISEASE
performed	0
after	B-DISEASE
correction	0
of	I-DISEASE
chronic	I-DISEASE
sleep	0
deprivation	0
)	0
,	0
or	0
by	0
wrist	0
actigraphy	0
in	I-DISEASE
Central	0
Disorders	0
of	I-DISEASE
Hypersomnolence	I-DISEASE
association	0
with	I-DISEASE
a	I-DISEASE
sleep	0
log	0
(	0
averaged	0
over	I-DISEASE
at	I-DISEASE
least	I-DISEASE
seven	I-DISEASE
days	0
with	I-DISEASE
unrestricted	0
sleep).4	0
E.	0
Insufficient	0
sleep	0
syndrome	0
is	I-DISEASE
ruled	I-DISEASE
out	0
(	0
if	0
deemed	B-DISEASE
necessary	0
,	0
by	I-DISEASE
lack	I-DISEASE
of	I-DISEASE
improvement	I-DISEASE
of	I-DISEASE
sleepiness	0
after	I-DISEASE
an	0
adequate	B-DISEASE
trial	0
of	I-DISEASE
increased	0
nocturnal	0
time	0
in	I-DISEASE
bed	0
,	I-DISEASE
preferably	0
confirmed	0
by	I-DISEASE
at	I-DISEASE
least	0
a	0
week	0
of	0
wrist	0
actigraphy	0
)	0
.	0

F.	I-DISEASE

The	I-DISEASE
hypersomnolence	I-DISEASE
and/or	0
MSLT	I-DISEASE
findings	0
are	0
not	0
better	I-DISEASE
explained	I-DISEASE
by	0
another	0
sleep	0
disorder	0
,	0
other	0
medical	0
or	I-DISEASE
psychiatric	0
disorder	I-DISEASE
,	0
or	I-DISEASE
use	0
of	I-DISEASE
drugs	I-DISEASE
or	0
medications	I-DISEASE
.	0

Notes	I-DISEASE
.	0

Severe	I-DISEASE
and	0
prolonged	0
sleep	0
inertia	I-DISEASE
,	0
known	0
as	0
sleep	0
drunkenness	I-DISEASE
(	0
defined	I-DISEASE
as	0
prolonged	0
difficulty	0
waking	0
up	0
with	0
repeated	I-DISEASE
returns	0
to	0
sleep	I-DISEASE
,	0
irritability	I-DISEASE
,	I-DISEASE
automatic	0
behavior	I-DISEASE
,	0
and	0
confusion	I-DISEASE
)	0
and/or	0
long	I-DISEASE
(	0
>	0
1	0
hour	0
)	I-DISEASE
,	I-DISEASE
unrefreshing	I-DISEASE
naps	I-DISEASE
are	0
additional	0
supportive	I-DISEASE
clinical	0
features	0
.	0
.	0

A	I-DISEASE
high	I-DISEASE
sleep	0
efficiency	I-DISEASE
(	0
≥	I-DISEASE
90	I-DISEASE
%	0
)	0
on	0
the	0
preceding	I-DISEASE
polysomnogram	I-DISEASE
is	0
a	0
supportive	0
finding	I-DISEASE
(	0
as	0
long	I-DISEASE
as	0
sleep	0
insufficiency	I-DISEASE
is	I-DISEASE
ruled	I-DISEASE
out	0
)	0
.	0
.	0

The	I-DISEASE
total	I-DISEASE
24	0
-	I-DISEASE
hour	0
sleep	0
time	I-DISEASE
required	I-DISEASE
for	0
diagnosis	0
may	I-DISEASE
need	0
to	I-DISEASE
be	I-DISEASE
adapted	B-DISEASE
to	0
account	0
for	I-DISEASE
normal	0
changes	0
in	I-DISEASE
sleep	0
time	0
associated	0
with	I-DISEASE
stages	I-DISEASE
of	0
development	I-DISEASE
in	I-DISEASE
children	I-DISEASE
and	0
adolescents	0
as	0
well	I-DISEASE
as	0
for	0
variability	0
across	I-DISEASE
cultures	0
in	I-DISEASE
all	0
age	I-DISEASE
groups	0
.	0
.	I-DISEASE

Occasionally	I-DISEASE
,	I-DISEASE
patients	0
fulfilling	0
other	0
criteria	I-DISEASE
may	I-DISEASE
have	I-DISEASE
an	0
MSLT	I-DISEASE
mean	I-DISEASE
sleep	I-DISEASE
latency	I-DISEASE
longer	I-DISEASE
than	I-DISEASE
8	I-DISEASE
minutes	0
and	0
total	I-DISEASE
24	0
-	0
hour	0
sleep	0
time	I-DISEASE
shorter	0
than	I-DISEASE
660	0
minutes	0
.	0

Clinical	I-DISEASE
judgment	I-DISEASE
should	0
be	I-DISEASE
used	0
in	I-DISEASE
deciding	0
if	I-DISEASE
these	0
patients	0
should	0
be	I-DISEASE
considered	I-DISEASE
to	I-DISEASE
have	0
idiopathic	0
hypersomnia	0
(	I-DISEASE
IH	0
)	0
.	0

Great	I-DISEASE
caution	0
should	0
be	I-DISEASE
exercised	0
to	I-DISEASE
exclude	0
other	I-DISEASE
conditions	0
that	0
might	0
mimic	I-DISEASE
the	I-DISEASE
disorder	I-DISEASE
.	0

A	I-DISEASE
repeat	0
MSLT	I-DISEASE
at	I-DISEASE
a	0
later	0
date	0
is	0
advisable	0
if	I-DISEASE
the	0
clinical	0
suspicion	I-DISEASE
for	0
IH	I-DISEASE
remains	0
high	I-DISEASE
.	0

Essential	I-DISEASE
Features	I-DISEASE
IH	0
is	0
characterized	0
by	I-DISEASE
excessive	0
daytime	0
sleepiness	0
that	0
occurs	I-DISEASE
in	I-DISEASE
the	0
absence	I-DISEASE
of	I-DISEASE
cat-	I-DISEASE
aplexy	0
,	0
is	0
accompanied	0
by	I-DISEASE
no	0
more	0
than	0
one	I-DISEASE
SOREMP	I-DISEASE
on	0
MSLT	I-DISEASE
and	0
preceding	I-DISEASE
poly-	0
somnogram	0
combined	I-DISEASE
,	I-DISEASE
and	0
is	0
not	0
adequately	0
explained	0
by	I-DISEASE
another	0
disorder	I-DISEASE
.	0

Other	0
dis-	I-DISEASE
orders	0
causing	0
sleepiness	0
must	0
be	0
carefully	0
considered	I-DISEASE
and	0
excluded	0
,	0
especially	0
insuf-	I-DISEASE
ficient	0
sleep	0
syndrome	0
.	0

Objective	I-DISEASE
evidence	0
of	0
hypersomnolence	I-DISEASE
must	I-DISEASE
be	I-DISEASE
demonstrated	0
by	I-DISEASE
an	0
MSLT	I-DISEASE
showing	0
a	0
mean	0
sleep	0
latency	I-DISEASE
of	I-DISEASE
≤	0
8	I-DISEASE
minutes	0
or	I-DISEASE
by	I-DISEASE
polysomnography	0
or	0
wrist	0
actigraphy	0
showing	0
a	0
total	I-DISEASE
24	0
-	I-DISEASE
hour	I-DISEASE
sleep	I-DISEASE
time	0
of	I-DISEASE
≥	0
660	0
minutes	0
.	0

A	I-DISEASE
prolonged	0
and	0
severe	I-DISEASE
form	0
of	I-DISEASE
sleep	0
inertia	I-DISEASE
,	0
historically	I-DISEASE
known	I-DISEASE
as	I-DISEASE
sleep	0
drunkenness	I-DISEASE
,	I-DISEASE
consists	0
of	0
prolonged	0
difficulty	0
waking	0
up	0
with	I-DISEASE
repeated	I-DISEASE
returns	0
to	I-DISEASE
sleep	0
,	I-DISEASE
irritability	I-DISEASE
,	I-DISEASE
automatic	I-DISEASE
behavior	I-DISEASE
,	0
and	0
confusion	I-DISEASE
.	0

It	I-DISEASE
is	I-DISEASE
reported	0
in	I-DISEASE
36	0
%	0
to	I-DISEASE
66	I-DISEASE
%	0
of	I-DISEASE
patients	0
with	I-DISEASE
IH	I-DISEASE
in	0
differ-	0
ent	I-DISEASE
series	0
.	0

Subjects	I-DISEASE
typically	0
do	I-DISEASE
not	0
easily	0
awaken	0
to	0
alarm	0
clocks	0
and	0
frequently	I-DISEASE
use	I-DISEASE
special	I-DISEASE
devices	I-DISEASE
or	I-DISEASE
procedures	I-DISEASE
to	0
wake	0
up	I-DISEASE
.	0

Naps	I-DISEASE
are	0
generally	I-DISEASE
long	0
,	I-DISEASE
often	I-DISEASE
more	I-DISEASE
than	0
60	0
minutes	0
,	I-DISEASE
and	0
described	I-DISEASE
as	0
unrefreshing	I-DISEASE
by	0
46	I-DISEASE
%	0
to	I-DISEASE
78	0
%	0
of	I-DISEASE
patients	0
.	I-DISEASE

Sleep	I-DISEASE
efficiency	I-DISEASE
on	0
polysomnogram	0
is	0
usually	I-DISEASE
high	I-DISEASE
(	I-DISEASE
mean	I-DISEASE
90	I-DISEASE
%	0
to	I-DISEASE
94	I-DISEASE
%	0
)	0
.	0

Self	I-DISEASE
-	I-DISEASE
reported	0
total	I-DISEASE
sleep	0
time	I-DISEASE
is	I-DISEASE
longer	I-DISEASE
than	0
in	0
controls	0
and	0
is	I-DISEASE
≥	I-DISEASE
10	0
hours	I-DISEASE
in	I-DISEASE
at	I-DISEASE
least	0
30	0
%	0
of	I-DISEASE
patients	0
.	0

Associated	I-DISEASE
Features	I-DISEASE
Associated	0
symptoms	I-DISEASE
which	0
suggest	I-DISEASE
a	I-DISEASE
dysfunction	0
of	I-DISEASE
the	0
autonomic	I-DISEASE
nervous	0
system	I-DISEASE
may	I-DISEASE
be	0
present	0
.	0

These	0
symptoms	I-DISEASE
include	I-DISEASE
headache	I-DISEASE
,	0
orthostatic	I-DISEASE
disturbance	0
,	I-DISEASE
perception	I-DISEASE
of	I-DISEASE
temperature	I-DISEASE
dysregulation	0
,	0
and	0
peripheral	I-DISEASE
vascular	I-DISEASE
complaints	0
(	I-DISEASE
Raynaud	0
-	0
type	I-DISEASE
phe-	0
nomena	0
with	I-DISEASE
cold	0
hands	0
and	0
feet	0
)	0
.	0

Sleep	I-DISEASE
paralysis	I-DISEASE
and	0
hypnagogic	0
hallucinations	I-DISEASE
may	0
also	0
be	I-DISEASE
reported	I-DISEASE
,	0
but	0
the	0
frequency	I-DISEASE
is	I-DISEASE
uncertain	0
(	I-DISEASE
4	0
%	0
to	I-DISEASE
40	0
%	0
in	I-DISEASE
different	I-DISEASE
series	I-DISEASE
)	0
.	0

Clinical	I-DISEASE
and	0
Pathologic	I-DISEASE
Subtypes	I-DISEASE
The	I-DISEASE
2005	0
2nd	0
edition	I-DISEASE
of	I-DISEASE
the	0
International	0
Classification	I-DISEASE
of	I-DISEASE
Sleep	I-DISEASE
Disorders	0
divided	0
IH	0
into	I-DISEASE
two	I-DISEASE
disorders	0
:	I-DISEASE
IH	0
with	I-DISEASE
long	I-DISEASE
sleep	0
time	0
,	I-DISEASE
and	0
IH	0
without	0
long	I-DISEASE
sleep	0
time	0
.	0

IH	I-DISEASE
is	0
likely	I-DISEASE
a	0
heterogeneous	I-DISEASE
condition	0
,	0
the	0
pathophysiology	I-DISEASE
of	I-DISEASE
which	0
is	0
currently	I-DISEASE
unknown	0
.	0

However	I-DISEASE
,	I-DISEASE
recent	I-DISEASE
studies	I-DISEASE
suggest	0
that	0
a	0
division	I-DISEASE
of	I-DISEASE
the	0
disorder	0
based	I-DISEASE
on	0
the	0
length	0
of	I-DISEASE
nocturnal	0
sleep	0
lacks	0
validity	I-DISEASE
.	0

Comparison	I-DISEASE
of	0
patients	I-DISEASE
with	I-DISEASE
≥	I-DISEASE
10	0
hours	I-DISEASE
of	I-DISEASE
sleep	0
to	I-DISEASE
those	I-DISEASE
with	0
<	I-DISEASE
10	0
hours	I-DISEASE
show	0
no	0
differences	I-DISEASE
in	I-DISEASE
Epworth	0
Sleepiness	I-DISEASE
Scale	I-DISEASE
scores	0
,	I-DISEASE
MSLT	I-DISEASE
mean	I-DISEASE
sleep	0
latencies	I-DISEASE
,	0
or	0
percentage	I-DISEASE
with	I-DISEASE
sleep	0
drunkenness	0
,	0
unrefreshing	I-DISEASE
naps	I-DISEASE
,	0
hypnago-	0
gic	0
hallucinations	I-DISEASE
,	I-DISEASE
or	I-DISEASE
sleep	0
paralysis	I-DISEASE
.	0

The	I-DISEASE
only	I-DISEASE
reported	0
differences	I-DISEASE
are	0
that	0
the	0
group	I-DISEASE
with	0
long	I-DISEASE
sleep	0
is	I-DISEASE
somewhat	I-DISEASE
younger	I-DISEASE
and	0
thinner	0
,	I-DISEASE
with	I-DISEASE
lower	0
Horne	0
-	I-DISEASE
Ostberg	I-DISEASE
scores	0
and	0
marginally	0
higher	0
sleep	0
efficiency	I-DISEASE
.	0

If	I-DISEASE
MSLT	I-DISEASE
mean	I-DISEASE
sleep	0
latencies	I-DISEASE
are	I-DISEASE
not	0
used	0
as	0
a	0
diagnostic	I-DISEASE
criterion	0
,	0
the	0
distribution	I-DISEASE
of	I-DISEASE
latencies	0
is	I-DISEASE
unimodal	I-DISEASE
,	I-DISEASE
suggesting	I-DISEASE
no	0
sepa-	I-DISEASE
rate	I-DISEASE
subtypes	I-DISEASE
.	0

In	I-DISEASE
addition	0
,	0
an	0
actigraphy	0
study	0
has	0
shown	0
that	0
patients	I-DISEASE
with	I-DISEASE
IH	I-DISEASE
tend	I-DISEASE
to	I-DISEASE
overestimate	I-DISEASE
their	I-DISEASE
sleep	0
time	0
by	I-DISEASE
a	0
mean	I-DISEASE
of	0
0.99	I-DISEASE
hours	I-DISEASE
,	I-DISEASE
thus	0
making	0
the	0
fundamental	I-DISEASE
criterion	0
for	0
distinguishing	I-DISEASE
between	0
patients	0
with	0
long	0
and	0
shorter	0
sleep	0
inaccurate	I-DISEASE
.	0

Clinicians	I-DISEASE
may	0
wish	I-DISEASE
to	0
continue	0
to	I-DISEASE
note	I-DISEASE
sleep	0
duration	0
as	0
an	0
important	I-DISEASE
clinical	I-DISEASE
feature	0
,	I-DISEASE
but	I-DISEASE
the	I-DISEASE
caveats	0
discussed	I-DISEASE
above	0
should	I-DISEASE
be	0
clearly	0
considered	I-DISEASE
.	0

Any	I-DISEASE
future	0
separation	0
of	I-DISEASE
IH	0
into	I-DISEASE
distinct	I-DISEASE
conditions	0
must	0
await	0
advances	I-DISEASE
in	0
understanding	0
the	0
underlying	0
biology	0
.	0

Demographics	I-DISEASE
Prevalence	0
and	0
incidence	0
of	0
IH	0
are	0
not	0
known	I-DISEASE
.	0

Some	I-DISEASE
studies	I-DISEASE
have	0
suggested	0
a	0
higher	0
prevalence	0
in	I-DISEASE
women	0
.	0

Central	I-DISEASE
Disorders	I-DISEASE
of	0
Hypersomnolence	I-DISEASE
Central	I-DISEASE
Disorders	I-DISEASE
of	I-DISEASE
Hypersomnolence	I-DISEASE
Predisposing	0
and	0
Precipitating	I-DISEASE
Factors	I-DISEASE

In	I-DISEASE
contrast	I-DISEASE
to	0
narcolepsy	0
,	I-DISEASE
the	0
disorder	0
is	0
not	0
known	I-DISEASE
to	I-DISEASE
be	0
HLA	I-DISEASE
associated	0
,	0
and	0
no	0
con-	0
sistent	0
precipitating	0
factor	I-DISEASE
has	B-DISEASE
been	I-DISEASE
identified	I-DISEASE
.	0

Familial	I-DISEASE
Patterns	I-DISEASE

A	I-DISEASE
familial	I-DISEASE
predisposition	0
to	I-DISEASE
hypersomnia	I-DISEASE
has	I-DISEASE
been	I-DISEASE
reported	0
but	I-DISEASE
rigorous	I-DISEASE
studies	0
have	0
not	0
been	I-DISEASE
performed	0
.	0

Onset	I-DISEASE
,	0
Course	0
,	0
and	0
Complications	0
The	I-DISEASE
mean	I-DISEASE
age	I-DISEASE
of	I-DISEASE
onset	0
of	I-DISEASE
IH	0
in	0
different	0
series	I-DISEASE
is	0
16.6–21.2	I-DISEASE
years	I-DISEASE
.	0

Once	I-DISEASE
established	I-DISEASE
,	0
the	0
disorder	0
is	I-DISEASE
generally	I-DISEASE
stable	I-DISEASE
in	0
severity	0
and	0
long	I-DISEASE
lasting	I-DISEASE
,	I-DISEASE
although	0
a	0
spontaneous	I-DISEASE
remission	I-DISEASE
rate	0
of	I-DISEASE
14	0
%	0
has	0
been	I-DISEASE
reported	I-DISEASE
in	0
one	I-DISEASE
series	I-DISEASE
.	0

Complications	I-DISEASE
are	0
mostly	I-DISEASE
social	0
and	0
professional	0
,	0
and	0
include	I-DISEASE
poor	I-DISEASE
work	I-DISEASE
or	0
school	I-DISEASE
performance	0
,	I-DISEASE
reduced	0
earnings	0
,	I-DISEASE
and	0
loss	0
of	I-DISEASE
employment	I-DISEASE
.	0

Developmental	I-DISEASE
Issues	0
IH	0
frequently	I-DISEASE
develops	I-DISEASE
in	I-DISEASE
adolescence	0
.	0

Exclusion	I-DISEASE
of	I-DISEASE
other	0
causes	I-DISEASE
of	I-DISEASE
hypersomno-	I-DISEASE
lence	I-DISEASE
in	I-DISEASE
that	0
age	I-DISEASE
group	I-DISEASE
,	0
including	I-DISEASE
delayed	I-DISEASE
sleep	0
-	0
wake	0
phase	0
disorder	0
,	I-DISEASE
obstructive	0
sleep	0
apnea	0
,	0
insufficient	0
sleep	0
syndrome	I-DISEASE
,	0
and	0
use	0
of	0
recreational	I-DISEASE
drugs	I-DISEASE
,	I-DISEASE
is	I-DISEASE
essential	I-DISEASE
.	0

Early	I-DISEASE
in	I-DISEASE
the	0
development	I-DISEASE
of	0
narcolepsy	0
,	0
SOREMPs	I-DISEASE
may	0
not	0
be	I-DISEASE
present	I-DISEASE
on	0
MSLT	0
;	0
therefore	I-DISEASE
,	0
some	0
patients	I-DISEASE
may	0
need	I-DISEASE
to	0
be	I-DISEASE
reclassified	I-DISEASE
later	0
as	0
narcolepsy	0
type	I-DISEASE
2	0
.	0

If	I-DISEASE
the	I-DISEASE
24	0
-	I-DISEASE
hour	0
total	I-DISEASE
sleep	0
time	I-DISEASE
is	0
used	0
to	0
confirm	I-DISEASE
the	I-DISEASE
diagnosis	I-DISEASE
of	I-DISEASE
IH	0
in	I-DISEASE
a	0
child	0
or	I-DISEASE
adolescent	0
,	I-DISEASE
normal	B-DISEASE
values	I-DISEASE
may	I-DISEASE
need	0
to	I-DISEASE
be	0
adapted	I-DISEASE
to	I-DISEASE
account	I-DISEASE
for	0
changes	0
in	I-DISEASE
sleep	0
time	0
associated	0
with	I-DISEASE
stages	0
of	0
development	B-DISEASE
.	0

Pathology	I-DISEASE
and	0
Pathophysiology	I-DISEASE
The	I-DISEASE
pathophysiology	0
of	I-DISEASE
IH	0
is	I-DISEASE
unknown	0
.	0

Neurochemical	I-DISEASE
studies	I-DISEASE
measuring	I-DISEASE
monoamine	I-DISEASE
metabolites	0
in	I-DISEASE
the	0
CSF	I-DISEASE
have	I-DISEASE
been	0
inconclusive	0
.	0

CSF	I-DISEASE
hypocretin-1	0
concentrations	0
in	I-DISEASE
patients	I-DISEASE
with	I-DISEASE
IH	I-DISEASE
are	0
normal	B-DISEASE
.	I-DISEASE

CSF	I-DISEASE
histamine	0
levels	0
have	I-DISEASE
been	I-DISEASE
reported	I-DISEASE
to	0
be	0
low	0
in	I-DISEASE
patients	I-DISEASE
with	I-DISEASE
narcolepsy	0
and	0
IH	0
,	0
but	I-DISEASE
a	0
recent	I-DISEASE
study	I-DISEASE
did	0
not	0
confirm	0
these	I-DISEASE
findings	0
.	0

Objective	I-DISEASE
Findings	I-DISEASE
Polysomnographic	0
monitoring	0
generally	I-DISEASE
demonstrates	I-DISEASE
NREM	0
and	0
REM	I-DISEASE
sleep	0
in	I-DISEASE
expected	0
proportions	I-DISEASE
with	I-DISEASE
normal	0
REM	I-DISEASE
latency	I-DISEASE
.	0

Total	I-DISEASE
sleep	0
time	0
is	I-DISEASE
often	0
prolonged	0
.	0

Sleep	I-DISEASE
apnea	0
should	0
be	I-DISEASE
either	I-DISEASE
absent	I-DISEASE
or	B-DISEASE
adequately	0
treated	0
before	0
diagnosing	I-DISEASE
this	0
disor-	I-DISEASE
der	0
,	0
with	I-DISEASE
special	I-DISEASE
attention	0
paid	I-DISEASE
to	0
excluding	0
significant	0
respiratory	I-DISEASE
effort	I-DISEASE
related	B-DISEASE
arous-	0
als	I-DISEASE
.	0

The	I-DISEASE
MSLT	I-DISEASE
should	0
not	0
show	I-DISEASE
more	0
than	I-DISEASE
one	0
SOREMP	0
(	I-DISEASE
or	0
none	0
if	0
a	I-DISEASE
SOREMP	0
was	0
observed	I-DISEASE
on	0
the	0
preceding	0
night	I-DISEASE
’s	I-DISEASE
polysomnogram	0
(	0
PSG	0
)	0
)	0
.	0

The	I-DISEASE
mean	I-DISEASE
sleep	0
latency	I-DISEASE
on	0
the	0
MSLT	I-DISEASE
is	0
usually	I-DISEASE
shorter	0
than	I-DISEASE
in	I-DISEASE
controls	0
but	I-DISEASE
longer	I-DISEASE
than	I-DISEASE
in	0
most	0
patients	I-DISEASE
with	0
nar-	0
colepsy	I-DISEASE
,	I-DISEASE
averaging	I-DISEASE
8.3	I-DISEASE
and	0
7.8	0
minutes	0
in	I-DISEASE
two	0
large	0
studies	I-DISEASE
.	0

In	I-DISEASE
patients	0
with	0
MSLT	I-DISEASE
mean	I-DISEASE
latencies	I-DISEASE
>	0
8	0
minutes	0
,	I-DISEASE
prolonged	I-DISEASE
sleep	0
monitoring	0
should	0
be	I-DISEASE
performed	0
by	0
polysomnography	0
(	I-DISEASE
24	0
hours	I-DISEASE
)	0
or	I-DISEASE
wrist	0
actigraphy	0
(	I-DISEASE
7	0
days	0
with	0
unre-	I-DISEASE
stricted	0
sleep	0
)	0
after	0
correction	I-DISEASE
of	I-DISEASE
sleep	I-DISEASE
deprivation	0
,	0
exclusion	0
of	I-DISEASE
other	I-DISEASE
sleep	0
disorders	0
,	0
and	0
discontinuation	0
of	I-DISEASE
sedating	I-DISEASE
medication	0
as	0
required	0
for	I-DISEASE
an	0
MSLT	I-DISEASE
(	0
see	I-DISEASE
Narcolepsy	0
–	0
Objective	I-DISEASE
Findings	I-DISEASE
)	0
.	0

Total	I-DISEASE
24	0
-	0
hour	0
sleep	0
time	I-DISEASE
in	I-DISEASE
adults	I-DISEASE
(	I-DISEASE
major	0
sleep	0
episode	I-DISEASE
plus	I-DISEASE
naps	I-DISEASE
)	0
must	I-DISEASE
be	I-DISEASE
≥	0
660	0
minutes	0
(	I-DISEASE
note	0
that	0
the	0
use	I-DISEASE
of	0
24	0
-	0
hour	0
PSG	0
monitoring	0
for	0
the	0
diagnosis	0
of	I-DISEASE
IH	0
has	0
been	0
validated	0
against	0
controls	0
,	0
but	I-DISEASE
the	I-DISEASE
use	I-DISEASE
of	I-DISEASE
seven	0
days	0
of	0
actigraphic	0
mon-	I-DISEASE
itoring	0
still	0
awaits	0
validation	I-DISEASE
)	0
.	0

Differential	I-DISEASE
Diagnosis	0
IH	0
may	I-DISEASE
be	0
confused	0
with	I-DISEASE
OSA	0
,	I-DISEASE
especially	0
when	0
respiratory	I-DISEASE
-	I-DISEASE
related	0
arousals	0
(	I-DISEASE
rather	0
than	0
apneas	0
or	0
hypopneas	I-DISEASE
)	0
are	0
present	0
.	0

Narcolepsy	I-DISEASE
type	I-DISEASE
2	0
is	I-DISEASE
distinguished	I-DISEASE
from	I-DISEASE
IH	0
by	I-DISEASE
the	I-DISEASE
presence	0
of	I-DISEASE
two	I-DISEASE
or	I-DISEASE
more	I-DISEASE
sleep	0
onset	0
REM	I-DISEASE
periods	I-DISEASE
on	0
the	0
MSLT	I-DISEASE
or	I-DISEASE
preceding	I-DISEASE
PSG	0
.	B-DISEASE

Insufficient	I-DISEASE
sleep	0
syndrome	I-DISEASE
must	I-DISEASE
be	I-DISEASE
carefully	0
excluded	0
by	I-DISEASE
extending	0
the	I-DISEASE
patient	I-DISEASE
’s	B-DISEASE
sleep	0
before	I-DISEASE
testing	0
.	0

Historical	0
information	0
,	0
physical	0
examination	0
,	I-DISEASE
and	0
,	I-DISEASE
if	0
indicated	0
,	0
laboratory	I-DISEASE
testing	I-DISEASE
including	0
brain	0
imaging	I-DISEASE
should	I-DISEASE
help	I-DISEASE
rule	0
out	0
hypersomnolence	I-DISEASE
due	I-DISEASE
to	0
a	I-DISEASE
medical	0
disorder	B-DISEASE
.	0

In	I-DISEASE
particular	I-DISEASE
,	0
posttraumatic	0
hypersomnolence	I-DISEASE
,	I-DISEASE
residual	0
hyper-	I-DISEASE
somnolence	0
following	0
adequate	0
treatment	I-DISEASE
of	0
sleep	0
apnea	0
,	I-DISEASE
and	0
sleep	0
fragmentation	0
due	0
to	0
pain	0
may	0
mimic	0
IH	0
.	0

Hypersomnolence	I-DISEASE
due	I-DISEASE
to	0
a	0
medication	0
or	I-DISEASE
substance	I-DISEASE
must	I-DISEASE
be	0
considered	I-DISEASE
and	0
ruled	I-DISEASE
out	0
by	0
discontinuation	I-DISEASE
of	I-DISEASE
possible	0
causative	I-DISEASE
agents	0
,	I-DISEASE
if	0
clinically	0
appropriate	I-DISEASE
.	0

Hypersomnia	I-DISEASE
associated	0
with	I-DISEASE
a	I-DISEASE
psychiatric	0
disorder	0
should	0
be	I-DISEASE
consid-	I-DISEASE
ered	0
in	0
patients	0
with	I-DISEASE
a	0
psychiatric	0
condition	0
,	I-DISEASE
most	I-DISEASE
typically	0
depression	I-DISEASE
.	0

The	I-DISEASE
complaint	I-DISEASE
of	I-DISEASE
excessive	I-DISEASE
sleepiness	0
and	0
prolonged	0
sleep	0
may	0
be	0
rather	0
similar	I-DISEASE
to	I-DISEASE
that	0
of	I-DISEASE
patients	I-DISEASE
with	I-DISEASE
IH	0
,	I-DISEASE
except	0
that	0
it	0
may	I-DISEASE
vary	I-DISEASE
from	0
day	I-DISEASE
to	0
day	I-DISEASE
and	0
is	I-DISEASE
often	0
associated	0
with	I-DISEASE
poor	0
sleep	0
at	I-DISEASE
night	I-DISEASE
.	0

The	I-DISEASE
MSLT	I-DISEASE
in	I-DISEASE
hypersomnia	0
associated	0
with	I-DISEASE
a	0
psychiatric	I-DISEASE
disorder	I-DISEASE
does	0
not	0
demonstrate	I-DISEASE
a	I-DISEASE
short	0
mean	0
sleep	0
latency	I-DISEASE
.	0

Chronic	I-DISEASE
fatigue	I-DISEASE
syndrome	I-DISEASE
is	0
character-	0
ized	I-DISEASE
by	0
persistent	0
or	I-DISEASE
relapsing	I-DISEASE
fatigue	I-DISEASE
that	0
does	I-DISEASE
not	0
resolve	0
with	I-DISEASE
sleep	0
or	0
rest	B-DISEASE
.	0

Patients	I-DISEASE
clearly	0
complain	I-DISEASE
of	0
fatigue	I-DISEASE
rather	0
than	I-DISEASE
excessive	0
daytime	0
sleepiness	0
,	I-DISEASE
and	0
the	0
mean	I-DISEASE
MSLT	I-DISEASE
sleep	0
latency	I-DISEASE
is	0
normal	0
.	0

Long	I-DISEASE
sleepers	0
feel	0
fully	0
refreshed	0
and	0
do	0
not	0
experience	I-DISEASE
daytime	I-DISEASE
sleepiness	0
if	0
they	I-DISEASE
are	0
allowed	0
to	I-DISEASE
sleep	0
as	0
long	0
as	0
they	I-DISEASE
need	0
,	I-DISEASE
in	I-DISEASE
contrast	I-DISEASE
with	I-DISEASE
patients	I-DISEASE
with	I-DISEASE
IH	0
who	I-DISEASE
continue	0
to	0
feel	0
sleepy	0
regardless	0
of	I-DISEASE
prior	0
sleep	0
duration	0
.	0

Unresolved	I-DISEASE
Issues	0
and	0
Future	0
Directions	0

There	I-DISEASE
is	I-DISEASE
a	0
paucity	0
of	I-DISEASE
knowledge	0
regarding	0
the	0
neurobiology	0
of	I-DISEASE
IH	0
.	0

Further	I-DISEASE
research	0
in	I-DISEASE
this	I-DISEASE
area	0
,	I-DISEASE
as	0
well	I-DISEASE
as	0
more	0
precise	0
characterization	I-DISEASE
of	I-DISEASE
clinical	I-DISEASE
characteristics	0
and	0
treat-	0
ment	0
response	0
,	0
is	I-DISEASE
required	0
.	0

Central	I-DISEASE
Disorders	I-DISEASE
of	0
Hypersomnolence	I-DISEASE
Central	I-DISEASE
Disorders	I-DISEASE
of	I-DISEASE
Hypersomnolence	I-DISEASE
Bibliography	0
Ali	I-DISEASE
M	I-DISEASE
,	I-DISEASE
Auger	I-DISEASE
RR	0
,	I-DISEASE
Slocumb	I-DISEASE
NL	0
,	0
Morgenthaler	0
TI	0
.	0

Idiopathic	I-DISEASE
hypersomnia	0
:	0
clinical	0
features	0
and	0
response	0
to	I-DISEASE
treatment	0
.	0

J	I-DISEASE
Clin	0
Sleep	0
Med	0
2009;5:562–8	I-DISEASE
.	0

Anderson	I-DISEASE
KN	I-DISEASE
,	I-DISEASE
Pilsworth	0
S	I-DISEASE
,	0
Sharples	0
RD	I-DISEASE
,	I-DISEASE
Smith	0
IE	I-DISEASE
,	I-DISEASE
Shneerson	0
JM	0
.	0

Idiopathic	I-DISEASE
hypersomnia	I-DISEASE
:	0
a	0
study	0
of	I-DISEASE
77	I-DISEASE
cases	0
.	0

Sleep	I-DISEASE
2007;30:1274–81	I-DISEASE
.	0

Bassetti	I-DISEASE
C	0
,	I-DISEASE
Aldrich	0
MS	I-DISEASE
.	0

Idiopathic	I-DISEASE
hypersomnia	0
:	0
a	0
series	I-DISEASE
of	I-DISEASE
42	I-DISEASE
patients	I-DISEASE
.	0

Brain	0
1997;120:1423–35	0
.	0

Dauvilliers	I-DISEASE
Y	0
,	I-DISEASE
Delallee	0
N	0
,	0
Jaussent	I-DISEASE
I	0
,	I-DISEASE
et	0
al	I-DISEASE
.	0

Normal	I-DISEASE
cerebrospinal	I-DISEASE
fluid	0
histamine	0
and	0
tele	I-DISEASE
-	I-DISEASE
methylhistamine	0
levels	I-DISEASE
in	0
hypersomnia	0
conditions	I-DISEASE
.	0

Sleep	I-DISEASE
2012;35:1359–66	I-DISEASE
.	0

Kanbayashi	I-DISEASE
T	0
,	0
Kodama	0
T	0
,	0
Kondo	0
H	I-DISEASE
,	I-DISEASE
et	0
al	I-DISEASE
.	0

CSH	I-DISEASE
histamine	0
contents	0
in	I-DISEASE
narcolepsy	0
,	0
idiopathic	I-DISEASE
hypersomnia	0
and	0
obstructive	0
sleep	0
apnea	I-DISEASE
syndrome	0
.	0

Sleep	I-DISEASE
2009;32:181–7	I-DISEASE
.	0

Vernet	I-DISEASE
C	I-DISEASE
,	0
Arnulf	0
I.	0
Idiopathic	0
hypersomnia	I-DISEASE
with	0
and	0
without	0
long	0
sleep	0
time	0
:	0
a	I-DISEASE
controlled	0
series	I-DISEASE
of	I-DISEASE
75	I-DISEASE
patients	I-DISEASE
.	0

Sleep	I-DISEASE
2009;32:753–9	I-DISEASE
.	0

Vernet	I-DISEASE
C	I-DISEASE
,	0
Leu	0
-	0
Semenescu	B-DISEASE
S	I-DISEASE
,	I-DISEASE
Buzare	0
MA	I-DISEASE
,	I-DISEASE
Arnulf	0
I.	0
Subjective	I-DISEASE
sleepiness	I-DISEASE
in	I-DISEASE
idiopathic	I-DISEASE
hypersomnia	I-DISEASE
:	0
beyond	0
excessive	0
sleepiness	0
.	0

J	I-DISEASE
Sleep	0
Res	0
2010;19:525–34	0
.	0

Kleine	I-DISEASE
-	0
Levin	I-DISEASE
Syndrome	0
ICD-9	I-DISEASE
-	I-DISEASE
CM	I-DISEASE
code	0
:	0
327.13	0
Alternate	I-DISEASE
Names	I-DISEASE
Recurrent	0
hypersomnia	0
,	I-DISEASE
periodic	I-DISEASE
hypersomnolence	I-DISEASE
.	0

Diagnostic	I-DISEASE
Criteria	0
Criteria	0

A	0
-	0
E	0
must	0
be	0
met	0
ICD-10	0
-	0
CM	0
code	0
:	0

G47.13	I-DISEASE
A.	0

The	I-DISEASE
patient	I-DISEASE
experiences	0
at	I-DISEASE
least	0
two	I-DISEASE
recurrent	I-DISEASE
episodes	I-DISEASE
of	I-DISEASE
excessive	0
sleepiness	0
and	0
sleep	0
duration	0
,	I-DISEASE
each	I-DISEASE
persisting	0
for	0
two	I-DISEASE
days	0
to	I-DISEASE
five	I-DISEASE
weeks	0
.	I-DISEASE

B.	0
Episodes	0
recur	0
usually	I-DISEASE
more	0
than	0
once	I-DISEASE
a	0
year	I-DISEASE
and	0
at	I-DISEASE
least	0
once	I-DISEASE
every	0
18	0
months	0
.	0

C.	I-DISEASE

The	I-DISEASE
patient	I-DISEASE
has	0
normal	0
alertness	0
,	0
cognitive	0
function	0
,	0
behavior	I-DISEASE
,	I-DISEASE
and	0
mood	B-DISEASE
between	0
episodes	I-DISEASE
.	0

D.	I-DISEASE

The	I-DISEASE
patient	I-DISEASE
must	0
demonstrate	0
at	I-DISEASE
least	0
one	0
of	I-DISEASE
the	0
following	0
during	I-DISEASE
episodes	I-DISEASE
:	I-DISEASE
.	0

Cognitive	I-DISEASE
dysfunction	I-DISEASE
.	0
.	I-DISEASE

Altered	I-DISEASE
perception	I-DISEASE
.	I-DISEASE
.	0

Eating	I-DISEASE
disorder	0
(	I-DISEASE
anorexia	0
or	I-DISEASE
hyperphagia	0
)	I-DISEASE
.	0
.	0

Disinhibited	I-DISEASE
behavior	0
(	I-DISEASE
such	0
as	B-DISEASE
hypersexuality	0
)	I-DISEASE
.	0

E.	I-DISEASE

The	I-DISEASE
hypersomnolence	I-DISEASE
and	0
related	0
symptoms	I-DISEASE
are	I-DISEASE
not	I-DISEASE
better	I-DISEASE
explained	I-DISEASE
by	I-DISEASE
another	I-DISEASE
sleep	I-DISEASE
disorder	0
,	0
other	I-DISEASE
medical	0
,	0
neurologic	0
,	I-DISEASE
or	0
psychiatric	I-DISEASE
disorder	0
(	I-DISEASE
especially	0
bipolar	0
disorder	I-DISEASE
)	0
,	I-DISEASE
or	0
use	0
of	I-DISEASE
drugs	0
or	0
medications	0
.	0

Essential	I-DISEASE
Features	I-DISEASE
Kleine	0
-	0
Levin	I-DISEASE
syndrome	0
is	I-DISEASE
characterized	0
by	0
relapsing	0
-	0
remitting	0
episodes	I-DISEASE
of	0
severe	0
hypersomnolence	0
in	I-DISEASE
association	0
with	I-DISEASE
cognitive	0
,	I-DISEASE
psychiatric	0
,	0
and	0
behavioral	0
distur-	0
bances	0
.	0

A	I-DISEASE
typical	0
episode	0
lasts	I-DISEASE
a	0
median	I-DISEASE
10	0
days	I-DISEASE
(	I-DISEASE
range	0
,	0
2.5–80	0
days	0
)	0
,	0
with	0
rare	I-DISEASE
epi-	0
sodes	0
lasting	0
several	0
weeks	0
to	I-DISEASE
months	I-DISEASE
.	0

The	I-DISEASE
first	I-DISEASE
episode	0
is	I-DISEASE
often	0
triggered	I-DISEASE
by	I-DISEASE
an	0
infec-	0
tion	I-DISEASE
or	0
alcohol	I-DISEASE
intake	0
,	I-DISEASE
with	0
further	0
episodes	I-DISEASE
recurring	0
every	0
1–12	0
months	0
(	I-DISEASE
median	0
three	I-DISEASE
months	0
)	0
for	0
years	0
.	0

During	I-DISEASE
episodes	I-DISEASE
,	0
patients	I-DISEASE
may	0
sleep	0
as	0
long	I-DISEASE
as	0
16	0
to	0
20	0
hours	I-DISEASE
per	I-DISEASE
day	0
,	I-DISEASE
waking	0
or	I-DISEASE
getting	0
up	0
only	I-DISEASE
to	0
eat	I-DISEASE
and	0
void	I-DISEASE
(	I-DISEASE
incontinence	0
is	I-DISEASE
not	0
observed	I-DISEASE
)	0
.	0

They	I-DISEASE
remain	I-DISEASE
rousable	0
,	I-DISEASE
but	0
are	I-DISEASE
irritable	0
if	0
prevented	I-DISEASE
from	I-DISEASE
sleeping	0
.	0

When	I-DISEASE
they	I-DISEASE
are	0
awake	0
during	I-DISEASE
episodes	I-DISEASE
,	0
most	0
patients	0
are	0
exhausted	I-DISEASE
,	I-DISEASE
apathetic	I-DISEASE
,	I-DISEASE
confused	I-DISEASE
,	I-DISEASE
and	0
slow	0
in	I-DISEASE
speaking	0
and	0
answering	0
.	0

Anterograde	0
amnesia	I-DISEASE
is	0
typical	0
.	0

Almost	I-DISEASE
all	0
report	0
a	I-DISEASE
dreamlike	I-DISEASE
,	I-DISEASE
altered	0
perception	0
of	I-DISEASE
the	0
environment	0
(	I-DISEASE
derealization	I-DISEASE
)	0
.	I-DISEASE

Less	I-DISEASE
commonly	I-DISEASE
,	0
patients	I-DISEASE
eat	0
ravenously	I-DISEASE
(	I-DISEASE
66	0
%	0
,	I-DISEASE
although	I-DISEASE
one	I-DISEASE
third	0
eat	I-DISEASE
less	I-DISEASE
)	I-DISEASE
,	0
are	0
hypersexual	I-DISEASE
(	I-DISEASE
53	0
%	0
,	0
principally	0
men	0
)	0
,	I-DISEASE
childish	0
,	0
depressed	I-DISEASE
(	I-DISEASE
53	0
%	0
,	I-DISEASE
predominantly	I-DISEASE
women	0
)	0
,	0
and	0
anxious	0
at	I-DISEASE
being	I-DISEASE
left	0
alone	I-DISEASE
and	0
seeing	I-DISEASE
strangers	I-DISEASE
,	0
and	0
experience	0
hallucinations	I-DISEASE
and	0
delusions	0
(	I-DISEASE
30	I-DISEASE
%	0
)	0
.	0

Patients	I-DISEASE
are	0
remark-	I-DISEASE
ably	0
normal	0
between	0
episodes	0
with	I-DISEASE
regard	0
to	I-DISEASE
sleep	0
,	0
cognition	0
,	I-DISEASE
mood	0
,	0
and	0
eating	I-DISEASE
.	0

The	I-DISEASE
disease	I-DISEASE
typically	0
resolves	I-DISEASE
after	0
a	0
median	I-DISEASE
of	I-DISEASE
14	0
years	I-DISEASE
,	I-DISEASE
except	I-DISEASE
in	I-DISEASE
adult	0
-	I-DISEASE
onset	0
cases	0
,	0
when	0
the	0
course	I-DISEASE
may	0
be	0
more	0
prolonged	I-DISEASE
.	0

The	I-DISEASE
simultaneous	0
occurrence	0
of	I-DISEASE
all	0
these	I-DISEASE
symp-	0
toms	0
is	I-DISEASE
the	0
exception	0
rather	0
than	I-DISEASE
the	0
rule	0
,	0
with	I-DISEASE
hypersomnolence	0
being	0
more	0
char-	I-DISEASE
acteristic	0
at	I-DISEASE
the	0
disease	I-DISEASE
onset	0
and	0
during	I-DISEASE
the	0
first	0
part	I-DISEASE
of	I-DISEASE
the	I-DISEASE
episodes	I-DISEASE
,	I-DISEASE
and	0
disinhib-	0
ited	0
behaviors	I-DISEASE
being	0
evident	0
during	I-DISEASE
only	0
a	I-DISEASE
few	0
episodes	I-DISEASE
.	0

In	I-DISEASE
occasional	0
cases	0
,	I-DISEASE
isolated	0
recurrent	I-DISEASE
hypersomnolence	I-DISEASE
may	0
be	0
the	0
only	I-DISEASE
symptom	0
.	0

Amnesia	I-DISEASE
,	0
transient	0
dysphoria	0
,	0
or	0
elation	0
with	I-DISEASE
insomnia	0
may	I-DISEASE
signal	0
the	0
termination	0
of	I-DISEASE
an	0
episode	I-DISEASE
.	0

Associated	I-DISEASE
Features	I-DISEASE
Physical	I-DISEASE
examination	0
is	0
unremarkable	I-DISEASE
,	0
except	0
for	0
general	I-DISEASE
psychomotor	B-DISEASE
slowing	I-DISEASE
.	0

Social	I-DISEASE
and	0
occupational	I-DISEASE
impairment	0
during	I-DISEASE
attacks	I-DISEASE
is	0
often	0
severe	I-DISEASE
,	I-DISEASE
with	I-DISEASE
teenagers	I-DISEASE
bedridden	I-DISEASE
for	I-DISEASE
days	0
,	0
but	I-DISEASE
can	0
be	0
variable	I-DISEASE
depending	0
on	0
the	0
frequency	I-DISEASE
,	I-DISEASE
severity	I-DISEASE
,	I-DISEASE
and	0
duration	0
of	I-DISEASE
episodes	I-DISEASE
.	0

Clinical	I-DISEASE
and	0
Pathophysiological	0
Subtypes	I-DISEASE
Menstrual	0
-	0
related	0
Kleine	I-DISEASE
-	0
Levin	0
syndrome	0
(	0
alternate	I-DISEASE
name	0
:	0
menstrual	I-DISEASE
-	I-DISEASE
related	0
hyper-	I-DISEASE
somnia	0
):	0

This	I-DISEASE
descriptor	I-DISEASE
is	0
used	0
when	I-DISEASE
episodes	I-DISEASE
are	0
exclusively	B-DISEASE
associated	0
with	I-DISEASE
men-	I-DISEASE
struation	0
(	I-DISEASE
occurring	0
just	0
before	I-DISEASE
or	0
during	I-DISEASE
menses	0
)	0
,	0
a	I-DISEASE
condition	0
reported	I-DISEASE
in	I-DISEASE
only	I-DISEASE
18	0
women	I-DISEASE
worldwide	0
.	0

Hypersomnolence	I-DISEASE
episodes	I-DISEASE
in	0
these	0
cases	0
have	I-DISEASE
been	I-DISEASE
associated	0
with	0
compulsive	I-DISEASE
eating	0
in	0
65	0
%	0
,	0
sexual	0
disinhibition	0
in	I-DISEASE
29	I-DISEASE
%	0
,	I-DISEASE
and	0
depressive	0
mood	0
in	I-DISEASE
35	0
%	0
.	0

Episodes	I-DISEASE
last	0
3	I-DISEASE
to	0
15	I-DISEASE
days	0
and	0
recur	0
less	I-DISEASE
than	I-DISEASE
three	I-DISEASE
times	0
a	0
year	0
.	0

One	I-DISEASE
boy	0
with	0
Kleine	I-DISEASE
-	I-DISEASE
Levin	0
syndrome	I-DISEASE
is	0
reported	0
to	0
have	I-DISEASE
a	I-DISEASE
sister	I-DISEASE
affected	0
by	I-DISEASE
menstrual	I-DISEASE
-	I-DISEASE
related	0
hypersomnolence	I-DISEASE
.	0

Menstrual	I-DISEASE
-	0
related	0
hypersomnia	I-DISEASE
may	I-DISEASE
be	I-DISEASE
a	I-DISEASE
variant	0
of	I-DISEASE
Kleine	I-DISEASE
-	0
Levin	0
Central	I-DISEASE
Disorders	0
of	I-DISEASE
Hypersomnolence	I-DISEASE
Central	0
Disorders	0
of	I-DISEASE
Hypersomnolence	0
syndrome	I-DISEASE
,	0
although	I-DISEASE
response	0
to	I-DISEASE
contraceptive	0
doses	I-DISEASE
of	I-DISEASE
estrogen	I-DISEASE
and	0
progesterone	0
,	0
reported	I-DISEASE
in	I-DISEASE
some	I-DISEASE
cases	0
,	0
suggests	I-DISEASE
a	0
reproductive	I-DISEASE
endocrine	0
disturbance	I-DISEASE
.	0

Demographics	I-DISEASE
Kleine	0
-	0
Levin	I-DISEASE
syndrome	0
is	0
rare	0
,	I-DISEASE
with	I-DISEASE
a	0
prevalence	0
estimated	0
around	B-DISEASE
1	I-DISEASE
to	0
2	0
cases	0
per	0
million	0
.	0

Roughly	I-DISEASE
500	0
cases	0
have	0
been	I-DISEASE
reported	I-DISEASE
to	I-DISEASE
date	0
in	I-DISEASE
the	0
literature	0
,	I-DISEASE
from	I-DISEASE
all	0
countries	I-DISEASE
in	I-DISEASE
which	I-DISEASE
the	0
disease	0
has	I-DISEASE
been	I-DISEASE
investigated	0
.	0

The	I-DISEASE
disease	I-DISEASE
starts	0
during	I-DISEASE
the	0
second	I-DISEASE
decade	I-DISEASE
in	I-DISEASE
81	0
%	0
of	I-DISEASE
patients	I-DISEASE
,	I-DISEASE
with	I-DISEASE
a	0
male	I-DISEASE
/	0
female	I-DISEASE
ratio	0
of	0
2:1	I-DISEASE
.	0

Adults	I-DISEASE
and	0
younger	0
children	I-DISEASE
may	0
also	0
be	I-DISEASE
affected	I-DISEASE
.	0

Predisposing	I-DISEASE
and	0
Precipitating	I-DISEASE
Factors	0
Birth	0
and	0
developmental	I-DISEASE
problems	0
,	I-DISEASE
as	0
well	I-DISEASE
as	0
Jewish	0
heritage	I-DISEASE
,	0
are	0
risk	0
factors	0
for	I-DISEASE
devel-	0
oping	0
the	B-DISEASE
syndrome	0
.	B-DISEASE

The	I-DISEASE
frequency	I-DISEASE
of	I-DISEASE
the	0
HLA	0
DQB1	I-DISEASE
*	0
02	0
was	I-DISEASE
increased	0
compared	0
with	0
controls	0
in	I-DISEASE
a	0
retrospective	0
,	0
multicenter	0
series	I-DISEASE
of	I-DISEASE
30	0
patients	I-DISEASE
with	0
Kleine	I-DISEASE
-	I-DISEASE
Levin	0
syndrome	0
,	I-DISEASE
but	0
not	0
in	0
another	I-DISEASE
larger	0
prospective	0
series	I-DISEASE
(	0
n	0
=	0
108	0
)	I-DISEASE
.	0

A	I-DISEASE
flu	I-DISEASE
-	0
like	I-DISEASE
illness	0
or	I-DISEASE
an	0
infection	I-DISEASE
of	I-DISEASE
the	0
upper	0
airway	I-DISEASE
(	I-DISEASE
and	0
more	0
rarely	I-DISEASE
gastroenteritis	I-DISEASE
)	0
is	I-DISEASE
often	0
reported	I-DISEASE
imme-	I-DISEASE
diately	0
prior	I-DISEASE
to	B-DISEASE
the	0
onset	0
of	I-DISEASE
the	0
first	I-DISEASE
episode	0
,	I-DISEASE
and	0
more	0
rarely	I-DISEASE
before	0
relapses	0
.	I-DISEASE

Other	I-DISEASE
less	I-DISEASE
frequently	0
reported	I-DISEASE
triggering	0
events	0
include	I-DISEASE
alcohol	I-DISEASE
consumption	I-DISEASE
,	I-DISEASE
head	I-DISEASE
trauma	I-DISEASE
,	I-DISEASE
travel	0
,	I-DISEASE
or	I-DISEASE
exposure	I-DISEASE
to	0
anesthesia	0
.	0

Familial	I-DISEASE
Patterns	I-DISEASE
Familial	I-DISEASE
cases	0
of	I-DISEASE
Kleine	I-DISEASE
-	I-DISEASE
Levin	0
syndrome	I-DISEASE
are	I-DISEASE
found	I-DISEASE
in	0
5	0
%	0
of	I-DISEASE
patients	0
,	0
including	0
twins	I-DISEASE
,	0
parent	0
-	0
child	0
,	I-DISEASE
siblings	I-DISEASE
,	0
and	0
uncle	0
-	0
nephew	0
associations	0
.	0

There	I-DISEASE
is	I-DISEASE
no	0
increased	0
history	I-DISEASE
of	I-DISEASE
mood	0
disorders	0
in	0
family	0
members	0
of	I-DISEASE
patients	I-DISEASE
.	0

Onset	I-DISEASE
,	0
Course	0
,	0
and	0
Complications	I-DISEASE
Early	0
adolescence	I-DISEASE
(	0
second	I-DISEASE
decade	I-DISEASE
)	I-DISEASE
is	0
the	0
usual	I-DISEASE
age	I-DISEASE
of	I-DISEASE
onset	0
.	0

The	I-DISEASE
course	I-DISEASE
of	I-DISEASE
Kleine-	I-DISEASE

Levin	I-DISEASE
syndrome	I-DISEASE
is	0
characterized	0
by	I-DISEASE
recurrent	I-DISEASE
episodes	I-DISEASE
of	I-DISEASE
severe	I-DISEASE
sleepiness	0
,	I-DISEASE
lasting	0
up	I-DISEASE
to	I-DISEASE
several	I-DISEASE
weeks	I-DISEASE
,	0
with	0
normal	0
functioning	I-DISEASE
between	0
episodes	I-DISEASE
.	0

Several	0
long	I-DISEASE
-	0
term	0
studies	0
suggest	I-DISEASE
an	0
often	B-DISEASE
-	0
benign	0
course	I-DISEASE
,	I-DISEASE
with	I-DISEASE
episodes	I-DISEASE
lessening	I-DISEASE
in	I-DISEASE
duration	0
,	0
severity	I-DISEASE
,	0
and	0
fre-	I-DISEASE
quency	0
over	0
a	I-DISEASE
median	I-DISEASE
course	I-DISEASE
of	I-DISEASE
14	0
years	I-DISEASE
.	0

Male	0
sex	0
,	0
age	I-DISEASE
at	I-DISEASE
onset	I-DISEASE
younger	0
than	I-DISEASE
12	0
years	0
or	0
older	0
than	I-DISEASE
20	0
years	0
,	I-DISEASE
as	0
well	I-DISEASE
as	0
the	0
presence	0
of	I-DISEASE
hypersexuality	I-DISEASE
during	I-DISEASE
episodes	I-DISEASE
,	I-DISEASE
predict	I-DISEASE
longer	I-DISEASE
disease	B-DISEASE
duration	0
.	0

Complications	I-DISEASE
are	0
mainly	0
social	0
and	0
occupational	0
.	0

In	I-DISEASE
rare	I-DISEASE
cases	0
,	I-DISEASE
subjects	0
have	I-DISEASE
been	I-DISEASE
reported	I-DISEASE
to	0
choke	0
while	0
eating	I-DISEASE
voraciously	I-DISEASE
,	I-DISEASE
to	I-DISEASE
have	0
suicidal	0
thoughts	I-DISEASE
,	I-DISEASE
or	I-DISEASE
to	I-DISEASE
be	I-DISEASE
involved	0
in	I-DISEASE
a	0
car	I-DISEASE
accident	I-DISEASE
.	B-DISEASE

A	0
reduced	0
long	0
-	I-DISEASE
term	0
working	0
memory	0
capacity	I-DISEASE
following	0
episodes	0
was	0
reported	I-DISEASE
in	I-DISEASE
eight	I-DISEASE
patients	0
with	0
Kleine	I-DISEASE
-	0
Levin	0
syndrome	0
.	0

Developmental	I-DISEASE
Issues	0
Adolescents	0
are	I-DISEASE
affected	0
in	0
most	0
cases	0
.	I-DISEASE

However	I-DISEASE
,	I-DISEASE
the	0
onset	I-DISEASE
of	I-DISEASE
the	I-DISEASE
condition	I-DISEASE
has	I-DISEASE
been	I-DISEASE
reported	0
in	I-DISEASE
children	I-DISEASE
as	I-DISEASE
young	I-DISEASE
as	0
four	I-DISEASE
years	I-DISEASE
.	I-DISEASE

Pathology	I-DISEASE
and	0
Pathophysiology	I-DISEASE
Postmortem	0
examination	0
of	I-DISEASE
the	0
central	0
nervous	0
system	I-DISEASE
has	I-DISEASE
been	0
performed	0
in	I-DISEASE
only	0
four	I-DISEASE
cases	0
,	I-DISEASE
with	I-DISEASE
inconsistent	0
findings	0
.	0

One	I-DISEASE
subject	I-DISEASE
showed	0
significant	0
perivascular	0
lymphocytic	0
infiltrations	I-DISEASE
in	I-DISEASE
the	0
hypothalamus	0
,	0
amygdala	0
,	I-DISEASE
and	0
the	0
grey	0
matter	0
of	I-DISEASE
the	0
temporal	0
lobes	0
;	0
a	0
second	0
demonstrated	0
similar	0
infiltrations	0
in	I-DISEASE
the	0
thalamus	0
;	0
and	0
a	0
third	0
in	I-DISEASE
the	0
diencephalon	0
and	0
the	0
midbrain	I-DISEASE
with	0
a	0
suggestion	0
of	I-DISEASE
mild	0
localized	0
encephali-	I-DISEASE
tis	0
.	0

In	I-DISEASE
the	0
fourth	0
case	I-DISEASE
,	0
a	0
smaller	I-DISEASE
locus	I-DISEASE
coeruleus	0
and	0
decreased	I-DISEASE
pigmentation	I-DISEASE
in	I-DISEASE
the	0
substantia	0
nigra	I-DISEASE
were	I-DISEASE
reported	I-DISEASE
.	0

Magnetic	I-DISEASE
resonance	I-DISEASE
imaging	0
was	0
unremarkable	I-DISEASE
.	0

In	I-DISEASE
contrast	I-DISEASE
,	0
functional	0
brain	0
imaging	I-DISEASE
studies	I-DISEASE
during	I-DISEASE
episodes	I-DISEASE
are	0
frequently	I-DISEASE
abnormal	I-DISEASE
,	I-DISEASE
showing	I-DISEASE
hypometabolism	0
in	I-DISEASE
the	0
thalamus	0
,	0
hypothalamus	I-DISEASE
,	0
mesial	B-DISEASE
temporal	0
lobe	0
,	I-DISEASE
and	0
frontal	0
lobe	0
.	0

Some	I-DISEASE
of	I-DISEASE
these	I-DISEASE
abnormalities	I-DISEASE
persist	I-DISEASE
during	I-DISEASE
asymptomatic	0
periods	I-DISEASE
in	0
half	0
of	I-DISEASE
the	I-DISEASE
patients	0
.	0

An	I-DISEASE
autoimmune	0
basis	I-DISEASE
for	0
the	B-DISEASE
disorder	0
is	0
suggested	0
clinically	0
(	I-DISEASE
onset	0
occurs	0
during	I-DISEASE
adolescence	I-DISEASE
,	I-DISEASE
often	0
in	I-DISEASE
conjunction	I-DISEASE
with	I-DISEASE
an	I-DISEASE
infection	0
)	0
and	0
by	I-DISEASE
the	0
occa-	0
sional	I-DISEASE
association	I-DISEASE
with	0
HLA	I-DISEASE
DQB1	0
*	0
02	0
.	I-DISEASE

Objective	I-DISEASE
Findings	I-DISEASE
Routine	I-DISEASE
electroencephalograms	0
obtained	I-DISEASE
during	I-DISEASE
episodes	I-DISEASE
have	I-DISEASE
shown	I-DISEASE
general	0
slowing	0
of	I-DISEASE
background	0
electroencephalographic	I-DISEASE
activity	0
and	0
often	I-DISEASE
paroxysmal—0.5	0
-	I-DISEASE
2.0	0
-	0
sec-	0
ond	0
—	I-DISEASE
bursts	0
of	I-DISEASE
bisynchronous	0
,	I-DISEASE
generalized	0
,	0
moderate-	I-DISEASE
to	0
high	I-DISEASE
-	I-DISEASE
voltage	I-DISEASE
5-	0
to	I-DISEASE
7	0
-	I-DISEASE
Hz	0
waves	I-DISEASE
.	0

Polysomnography	I-DISEASE
studies	I-DISEASE
are	0
often	0
difficult	0
to	0
interpret	I-DISEASE
,	I-DISEASE
and	0
results	I-DISEASE
are	0
depen-	0
dent	0
on	0
the	0
duration	0
of	I-DISEASE
recording	0
(	I-DISEASE
overnight	0
vs.	I-DISEASE
24	0
-	0
hour	0
monitoring	0
)	0
as	0
well	I-DISEASE
as	0
the	0
timing	I-DISEASE
(	I-DISEASE
at	I-DISEASE
the	0
beginning	0
versus	0
the	0
end	0
of	I-DISEASE
episodes	I-DISEASE
or	I-DISEASE
at	I-DISEASE
onset	0
of	I-DISEASE
the	0
disease	0
or	B-DISEASE
later	0
in	I-DISEASE
its	I-DISEASE
course	0
)	0
.	0

Twenty	I-DISEASE
-	I-DISEASE
four	0
-	I-DISEASE
hour	0
polysomnography	0
demonstrates	I-DISEASE
prolonged	I-DISEASE
total	I-DISEASE
sleep	0
time	0
(	I-DISEASE
a	I-DISEASE
mean	0
11–12	0
hours	I-DISEASE
)	0
,	I-DISEASE
and	0
18	0
hours	I-DISEASE
or	0
more	0
in	0
some	I-DISEASE
reports	0
.	0

During	I-DISEASE
nocturnal	0
polysomnography	0
in	0
17	0
children	I-DISEASE
,	I-DISEASE
nighttime	I-DISEASE
slow	0
wave	I-DISEASE
sleep	0
percentage	0
was	0
decreased	I-DISEASE
during	I-DISEASE
the	0
first	0
half	0
of	I-DISEASE
the	0
episodes	I-DISEASE
,	0
and	0
REM	0
sleep	0
decreased	I-DISEASE
during	I-DISEASE
the	0
second	I-DISEASE
half	0
.	0

Results	I-DISEASE
of	I-DISEASE
the	0
MSLT	I-DISEASE
are	I-DISEASE
highly	I-DISEASE
dependent	I-DISEASE
on	0
the	0
subjects	I-DISEASE
’	I-DISEASE
willingness	I-DISEASE
to	I-DISEASE
comply	0
with	0
the	0
procedure	I-DISEASE
,	0
and	0
may	I-DISEASE
either	I-DISEASE
be	0
normal	B-DISEASE
or	0
abnormal	I-DISEASE
,	0
showing	I-DISEASE
short	0
latencies	I-DISEASE
or	B-DISEASE
mul-	0
tiple	I-DISEASE
SOREMPs	0
.	0

CSF	I-DISEASE
cytology	I-DISEASE
and	0
protein	I-DISEASE
are	I-DISEASE
normal	0
.	0

CSF	I-DISEASE
levels	0
of	I-DISEASE
hypocretin-1	0
were	I-DISEASE
within	I-DISEASE
normal	0
range	0
in	I-DISEASE
16	I-DISEASE
patients	I-DISEASE
,	0
although	0
intraepisodic	I-DISEASE
levels	0
are	I-DISEASE
lower	0
than	I-DISEASE
interepisodic	I-DISEASE
levels	I-DISEASE
.	0

Computed	I-DISEASE
tomography	I-DISEASE
scans	0
and	0
magnetic	0
resonance	I-DISEASE
imaging	I-DISEASE
are	I-DISEASE
normal	0
.	0

Brain	0
functional	0
imaging	0
is	I-DISEASE
abnormal	0
in	I-DISEASE
most	0
cases	0
,	0
with	0
hypoperfusion	I-DISEASE
of	I-DISEASE
the	0
left	I-DISEASE
or	0
right	0
temporal	I-DISEASE
and	0
frontal	0
lobes	0
as	0
well	I-DISEASE
as	0
the	I-DISEASE
diencephalon	I-DISEASE
.	0

These	0
abnor-	0
malities	0
are	I-DISEASE
present	I-DISEASE
during	I-DISEASE
the	0
episode	I-DISEASE
of	I-DISEASE
hypersomnolence	I-DISEASE
and	0
sometimes	0
between	0
episodes	I-DISEASE
.	0

Hormone	I-DISEASE
levels	I-DISEASE
are	0
normal	0
,	0
as	B-DISEASE
are	0
24	0
-	0
hour	0
secretory	I-DISEASE
patterns	0
.	0

Differential	I-DISEASE
Diagnosis	0
Recurrent	I-DISEASE
waxing	I-DISEASE
and	0
waning	0
episodes	I-DISEASE
of	I-DISEASE
sleepiness	0
may	I-DISEASE
be	I-DISEASE
secondary	0
to	0
struc-	0
tural	0
insults	0
of	I-DISEASE
the	0
central	0
nervous	I-DISEASE
system	0
.	0

Tumors	I-DISEASE
within	I-DISEASE
the	0
third	I-DISEASE
ventricle	0
(	0
such	0
as	0
Central	I-DISEASE
Disorders	I-DISEASE
of	I-DISEASE
Hypersomnolence	I-DISEASE
Central	0
Disorders	I-DISEASE
of	I-DISEASE
Hypersomnolence	I-DISEASE
colloid	0
cysts	0
,	0
pedunculated	0
astrocytomas	0
,	0
or	0
,	0
in	I-DISEASE
some	I-DISEASE
cases	0
,	0
craniopharyngiomas	0
)	0
may	I-DISEASE
produce	0
intermittent	I-DISEASE
obstructions	0
of	I-DISEASE
ventricular	0
flow	I-DISEASE
,	0
leading	0
to	0
headaches	I-DISEASE
,	I-DISEASE
vomiting	I-DISEASE
,	I-DISEASE
vague	I-DISEASE
sensorial	0
disturbances	0
,	0
and	0
a	0
paroxysmal	0
impairment	0
of	I-DISEASE
alertness	B-DISEASE
.	B-DISEASE

Encephalitis	I-DISEASE
,	I-DISEASE
hyperammonemic	I-DISEASE
encephalopathy	I-DISEASE
,	I-DISEASE
multiple	0
sclerosis	0
,	0
head	I-DISEASE
trauma	0
,	I-DISEASE
porphyria	0
,	I-DISEASE
Lyme	0
disease	B-DISEASE
,	I-DISEASE
basilar	0
migraine	0
,	0
and	0
complex	0
partial	I-DISEASE
status	0
epilepticus	I-DISEASE
less	I-DISEASE
frequently	0
mimic	0
symptoms	I-DISEASE
of	I-DISEASE
Kleine	I-DISEASE
-	0
Levin	0
syndrome	I-DISEASE
.	0

Recurrent	I-DISEASE
episodes	I-DISEASE
of	I-DISEASE
sleepiness	0
also	0
are	I-DISEASE
reported	0
in	0
the	0
context	I-DISEASE
of	I-DISEASE
psychiatric	I-DISEASE
disorders	0
,	I-DISEASE
such	0
as	I-DISEASE
depression	0
,	0
bipolar	0
disorder	I-DISEASE
,	I-DISEASE
seasonal	I-DISEASE
affective	0
disorder	0
,	I-DISEASE
and	0
somatoform	B-DISEASE
disorder	I-DISEASE
.	0

However	I-DISEASE
,	I-DISEASE
the	0
onset	I-DISEASE
and	0
offset	B-DISEASE
of	I-DISEASE
symptoms	I-DISEASE
are	0
less	I-DISEASE
abrupt	I-DISEASE
than	I-DISEASE
in	I-DISEASE
Kleine	I-DISEASE
-	I-DISEASE
Levin	0
syndrome	I-DISEASE
and	0
persist	0
to	0
some	I-DISEASE
extent	0
between	0
episodes	I-DISEASE
.	0

Other	I-DISEASE
differential	0
diagnoses	0
include	I-DISEASE
excessive	I-DISEASE
sleepiness	0
due	I-DISEASE
to	I-DISEASE
a	I-DISEASE
medication	0
or	0
substance	I-DISEASE
,	I-DISEASE
OSA	I-DISEASE
,	0
narcolepsy	0
,	I-DISEASE
IH	I-DISEASE
,	I-DISEASE
and	0
insufficient	I-DISEASE
sleep	0
.	0

In	I-DISEASE
these	I-DISEASE
disor-	0
ders	I-DISEASE
,	I-DISEASE
however	0
,	0
the	0
complaint	I-DISEASE
of	I-DISEASE
excessive	I-DISEASE
sleepiness	0
occurs	0
daily	I-DISEASE
and	0
is	0
usually	I-DISEASE
not	0
recurrent	0
or	I-DISEASE
periodic	I-DISEASE
.	0

There	I-DISEASE
is	I-DISEASE
no	0
evidence	0
that	0
Kleine	I-DISEASE
-	0
Levin	0
syndrome	0
occurs	0
as	0
a	I-DISEASE
result	0
of	I-DISEASE
a	0
seizure	I-DISEASE
disorder	I-DISEASE
.	0

Unresolved	I-DISEASE
Issues	0
and	0
Future	0
Directions	0

The	I-DISEASE
pathophysiology	0
of	I-DISEASE
this	0
disorder	0
is	0
not	0
known	I-DISEASE
.	I-DISEASE

Evidence	I-DISEASE
to	I-DISEASE
date	0
suggests	I-DISEASE
that	0
a	0
localized	0
but	I-DISEASE
multifocal	0
encephalopathy	I-DISEASE
occurs	0
during	I-DISEASE
episodes	0
of	0
Kleine	I-DISEASE
-	0
Levin	0
syn-	0
drome	0
,	I-DISEASE
as	0
functional	0
imaging	0
and	0
electroencephalography	I-DISEASE
(	I-DISEASE
EEG	0
)	0
slowing	0
indicate	I-DISEASE
tha-	0
lamic	0
,	0
temporal	0
,	0
and	0
frontal	0
lobe	0
involvement	I-DISEASE
.	0

The	I-DISEASE
cause	I-DISEASE
of	I-DISEASE
these	I-DISEASE
episodic	0
abnormali-	0
ties	I-DISEASE
may	I-DISEASE
be	I-DISEASE
genetic	I-DISEASE
,	I-DISEASE
autoimmune	0
,	I-DISEASE
inflammatory	I-DISEASE
,	0
or	B-DISEASE
metabolic	0
.	0

Bibliography	0
Arnulf	0
I	0
,	I-DISEASE
Lin	0
L	0
,	I-DISEASE
Gadoth	I-DISEASE
N	0
,	I-DISEASE
et	0
al	I-DISEASE
.	0

Kleine	I-DISEASE
-	0
Levin	0
syndrome	0
:	I-DISEASE
a	0
systematic	0
study	0
of	I-DISEASE
108	0
patients	0
.	0

Ann	I-DISEASE
Neurol	0
2008;63:482–93	0
.	0

Arnulf	I-DISEASE
I	0
,	0
Zeitzer	I-DISEASE
JM	0
,	0
File	0
J	I-DISEASE
,	I-DISEASE
Farber	0
N	0
,	I-DISEASE
Mignot	0
E.	0
Kleine	0
-	I-DISEASE
Levin	0
syndrome	I-DISEASE
:	0
a	I-DISEASE
systematic	0
review	0
of	I-DISEASE
186	I-DISEASE
cases	0
in	I-DISEASE
the	0
literature	0
.	0

Brain	0
2005;128:2763–76	0
.	0

Billiard	I-DISEASE
M	I-DISEASE
,	I-DISEASE
Jaussent	0
I	I-DISEASE
,	0
Dauvilliers	0
Y	I-DISEASE
,	0
Besset	0
A.	0
Recurrent	0
hypersomnia	I-DISEASE
:	I-DISEASE
a	0
review	I-DISEASE
of	I-DISEASE
339	I-DISEASE
cases	0
.	0

Sleep	I-DISEASE
Med	I-DISEASE
Rev	I-DISEASE
2011;15:247–57	0
.	0

Dauvilliers	I-DISEASE
Y	I-DISEASE
,	I-DISEASE
Mayer	I-DISEASE
G	I-DISEASE
,	0
Lecendreux	0
M	I-DISEASE
,	0
et	0
al	I-DISEASE
.	I-DISEASE

Kleine	I-DISEASE
-	0
Levin	0
syndrome	0
.	0

An	0
autoimmune	0
hypothesis	I-DISEASE
based	I-DISEASE
on	0
clinical	0
and	0
genetic	I-DISEASE
analyses	0
.	I-DISEASE

Neurology	0
2002;59:1739–45	I-DISEASE
.	0

Engström	I-DISEASE
M	I-DISEASE
,	0
Vigren	I-DISEASE
P	0
,	I-DISEASE
Karlsson	0
T	0
,	I-DISEASE
Landtblom	I-DISEASE
A.	0
Working	0
memory	0
in	I-DISEASE
8	I-DISEASE
Kleine	0
-	I-DISEASE
Levin	0
syndrome	I-DISEASE
patients	0
:	I-DISEASE
An	0
fMRI	B-DISEASE
study	0
.	0

Sleep	I-DISEASE
2009;32:681–8	I-DISEASE
.	0

Gadoth	I-DISEASE
N	0
,	0
Kesler	I-DISEASE
A	0
,	0
Vainstein	I-DISEASE
G	I-DISEASE
,	I-DISEASE
Peled	0
R	I-DISEASE
,	0
Lavie	I-DISEASE
P.	0
Clinical	0
and	0
polysomnographic	I-DISEASE
characteristics	B-DISEASE
of	I-DISEASE
34	0
patients	I-DISEASE
with	0
Kleine	I-DISEASE
-	I-DISEASE
Levin	0
syndrome	0
.	0

J	I-DISEASE
Sleep	0
Res	0
2001;10:337–41	0
.	I-DISEASE

Huang	I-DISEASE
Y	I-DISEASE
,	0
Lin	0
Y	I-DISEASE
,	I-DISEASE
Guilleminault	I-DISEASE
C.	0
Polysomnography	0
in	0
Kleine	0
-	0
Levin	0
syndrome	0
.	0

Neurology	0
2008;70:795–801	I-DISEASE
.	0

Huang	I-DISEASE
Y	I-DISEASE
,	0
Guilleminault	I-DISEASE
C	0
,	0
Lin	0
K	I-DISEASE
,	I-DISEASE
Hwang	I-DISEASE
F	I-DISEASE
,	I-DISEASE
Liu	I-DISEASE
F	0
,	0
Kung	0
Y.	I-DISEASE
Relationship	B-DISEASE
between	0
Kleine	0
-	0
Levin	0
Syndrome	I-DISEASE
and	0
upper	0
respiratory	I-DISEASE
infection	0
in	0
Taiwan	0
.	0

Sleep	I-DISEASE
2012;35:123–9	I-DISEASE
.	0

Hypersomnia	I-DISEASE
Due	I-DISEASE
to	I-DISEASE
a	I-DISEASE
Medical	0
Disorder	0
ICD-9	I-DISEASE
-	I-DISEASE
CM	I-DISEASE
code	0
:	I-DISEASE
327.14	0
ICD-10	I-DISEASE
-	I-DISEASE
CM	I-DISEASE
code	0
:	B-DISEASE
G47.14	I-DISEASE
Alternate	0
Names	I-DISEASE
Not	0
applicable	0
.	0

Diagnostic	I-DISEASE
Criteria	0
Criteria	I-DISEASE
A	0
-	I-DISEASE
D	I-DISEASE
must	0
be	0
met	0
A.	0

The	I-DISEASE
patient	I-DISEASE
has	0
daily	I-DISEASE
periods	0
of	I-DISEASE
irrepressible	I-DISEASE
need	I-DISEASE
to	I-DISEASE
sleep	I-DISEASE
or	I-DISEASE
daytime	0
lapses	I-DISEASE
into	I-DISEASE
sleep	0
occurring	0
for	I-DISEASE
at	I-DISEASE
least	I-DISEASE
three	I-DISEASE
months	0
.	0

B.	0
The	I-DISEASE
daytime	I-DISEASE
sleepiness	0
occurs	0
as	B-DISEASE
a	0
consequence	0
of	I-DISEASE
a	0
significant	I-DISEASE
underlying	0
medical	0
or	I-DISEASE
neurological	I-DISEASE
condition	0
.	0

C.	I-DISEASE

If	I-DISEASE
an	0
MSLT	I-DISEASE
is	0
performed	0
,	0
the	0
mean	0
sleep	0
latency	I-DISEASE
is	I-DISEASE
≤	I-DISEASE
8	0
minutes	0
,	I-DISEASE
and	0
fewer	0
than	0
two	I-DISEASE
sleep	0
onset	0
REM	0
periods	I-DISEASE
(	0
SOREMPs	I-DISEASE
)	0
are	0
observed.1	I-DISEASE
D.	I-DISEASE
The	I-DISEASE
symptoms	I-DISEASE
are	0
not	0
better	0
explained	0
by	I-DISEASE
another	I-DISEASE
untreated	I-DISEASE
sleep	0
disorder,2	0
a	0
mental	0
disorder	I-DISEASE
,	I-DISEASE
or	0
the	0
effects	0
of	I-DISEASE
medications	0
or	I-DISEASE
drugs	I-DISEASE
.	0

Notes	I-DISEASE
.	0

In	I-DISEASE
the	0
subtype	0
of	0
residual	I-DISEASE
hypersomnolence	I-DISEASE
after	I-DISEASE
treatment	0
of	I-DISEASE
obstructive	0
sleep	0
apnea	0
,	I-DISEASE
the	I-DISEASE
MSLT	I-DISEASE
mean	I-DISEASE
latency	I-DISEASE
may	I-DISEASE
be	0
>	0
8	I-DISEASE
minutes	0
.	0
.	0

Should	I-DISEASE
criteria	I-DISEASE
for	0
narcolepsy	I-DISEASE
be	I-DISEASE
fulfilled	0
,	0
a	0
diagnosis	I-DISEASE
of	I-DISEASE
narcolepsy	I-DISEASE
type	I-DISEASE
1	0
or	0
type	I-DISEASE
2	0
due	I-DISEASE
to	0
a	0
medical	I-DISEASE
condition	0
should	I-DISEASE
be	0
used	0
rather	0
than	I-DISEASE
hypersomnia	0
due	0
to	0
a	0
medical	0
condition	0
.	0
.	0

In	I-DISEASE
patients	I-DISEASE
with	0
severe	I-DISEASE
neurological	0
or	I-DISEASE
medical	0
disorders	0
in	I-DISEASE
whom	I-DISEASE
it	I-DISEASE
is	I-DISEASE
not	0
possible	0
or	I-DISEASE
desirable	I-DISEASE
to	0
perform	0
sleep	I-DISEASE
studies	I-DISEASE
,	I-DISEASE
the	0
diagnosis	0
can	I-DISEASE
be	0
made	0
by	0
clinical	I-DISEASE
criteria	I-DISEASE
.	0

Essential	I-DISEASE
Features	I-DISEASE
Patients	0
with	0
this	0
disorder	I-DISEASE
have	I-DISEASE
excessive	0
nocturnal	0
sleep	0
,	I-DISEASE
daytime	I-DISEASE
sleepiness	0
,	I-DISEASE
or	I-DISEASE
excessive	0
napping	I-DISEASE
that	0
is	0
attributable	I-DISEASE
to	I-DISEASE
a	0
coexisting	0
medical	0
or	I-DISEASE
neurological	0
disor-	0
der	0
.	0

Daytime	I-DISEASE
sleepiness	0
may	0
be	I-DISEASE
of	I-DISEASE
variable	I-DISEASE
severity	B-DISEASE
and	0
may	I-DISEASE
resemble	I-DISEASE
that	I-DISEASE
of	I-DISEASE
narco-	0
lepsy	0
(	I-DISEASE
i.e.	I-DISEASE
,	I-DISEASE
refreshing	0
naps	I-DISEASE
)	0
or	0
idiopathic	B-DISEASE
hypersomnia	I-DISEASE
(	I-DISEASE
i.e.	0
,	I-DISEASE
long	I-DISEASE
periods	I-DISEASE
of	I-DISEASE
unrefresh-	I-DISEASE
ing	0
sleep	0
)	0
.	0

Sleep	I-DISEASE
paralysis	I-DISEASE
,	I-DISEASE
hypnagogic	0
hallucinations	I-DISEASE
,	0
or	0
automatic	0
behavior	I-DISEASE
may	0
be	0
present	I-DISEASE
,	0
but	I-DISEASE
if	0
the	0
patient	I-DISEASE
has	0
cataplexy	I-DISEASE
,	I-DISEASE
the	0
MSLT	I-DISEASE
shows	I-DISEASE
two	0
or	0
more	0
SOREMPs	I-DISEASE
,	0
or	I-DISEASE
CSF	0
Hcrt-1	I-DISEASE
levels	0
are	0
low	0
,	0
then	0
narcolepsy	0
(	0
type	I-DISEASE
1	I-DISEASE
or	B-DISEASE
type	I-DISEASE
2	0
)	0
due	I-DISEASE
to	I-DISEASE
a	0
medical	0
condi-	0
tion	0
should	0
be	0
diagnosed	0
.	0

In	I-DISEASE
patients	0
with	0
both	I-DISEASE
sleep	0
related	0
breathing	0
disorders	0
and	0
hypersomnia	0
due	0
to	0
a	0
medical	I-DISEASE
disorder	0
,	0
the	0
latter	0
diagnosis	0
should	0
be	0
made	0
only	0
if	0
the	0
hypersomnolence	I-DISEASE
persists	0
after	0
adequate	0
treatment	I-DISEASE
of	0
the	0
sleep	0
disordered	I-DISEASE
breathing	0
.	0

Hypersomnia	I-DISEASE
due	I-DISEASE
to	I-DISEASE
a	I-DISEASE
medical	0
disorder	0
is	0
only	I-DISEASE
diagnosed	I-DISEASE
if	I-DISEASE
the	0
medical	0
condition	0
is	I-DISEASE
Central	0
Disorders	0
of	I-DISEASE
Hypersomnolence	I-DISEASE
Central	I-DISEASE
Disorders	I-DISEASE
of	I-DISEASE
Hypersomnolence	I-DISEASE
judged	0
to	0
be	I-DISEASE
directly	I-DISEASE
causing	I-DISEASE
the	I-DISEASE
excessive	0
sleepiness	0
.	0

Hypersomnolence	I-DISEASE
has	I-DISEASE
been	I-DISEASE
described	0
in	I-DISEASE
association	I-DISEASE
with	I-DISEASE
a	0
large	0
range	0
of	I-DISEASE
conditions	I-DISEASE
,	0
including	0
metabolic	0
enceph-	0
alopathy	I-DISEASE
,	I-DISEASE
head	I-DISEASE
trauma	0
,	I-DISEASE
stroke	0
,	0
brain	I-DISEASE
tumors	0
,	0
encephalitis	0
,	0
systemic	0
inflammation	I-DISEASE
(	I-DISEASE
e.g.	I-DISEASE
,	0
chronic	I-DISEASE
infections	0
,	0
rheumatologic	0
disorders	0
,	0
cancer	0
)	I-DISEASE
,	I-DISEASE
genetic	I-DISEASE
disorders	0
,	0
and	0
neurode-	0
generative	I-DISEASE
diseases	0
.	0

Associated	I-DISEASE
Features	I-DISEASE
Not	0
applicable	0
or	0
known	I-DISEASE
.	0

Clinical	I-DISEASE
and	0
Pathophysiological	I-DISEASE
Subtypes	I-DISEASE
Many	0
medical	I-DISEASE
conditions	I-DISEASE
can	0
cause	0
hypersomnolence	I-DISEASE
.	0

Hypersomnia	I-DISEASE
secondary	0
to	I-DISEASE
Parkinson	I-DISEASE
disease	B-DISEASE
:	0
Significant	0
hypersomnolence	I-DISEASE
docu-	0
mented	0
by	I-DISEASE
MSLT	I-DISEASE
has	0
been	I-DISEASE
reported	I-DISEASE
in	I-DISEASE
some	I-DISEASE
cases	0
of	I-DISEASE
Parkinson	0
disease	I-DISEASE
.	0

Hypersomnia	I-DISEASE
in	I-DISEASE
Parkinson	0
disease	I-DISEASE
may	0
be	0
due	I-DISEASE
to	I-DISEASE
insufficient	I-DISEASE
control	I-DISEASE
of	I-DISEASE
nocturnal	0
symptoms	I-DISEASE
,	0
result-	0
ing	0
in	I-DISEASE
insufficient	0
sleep	0
and	0
daytime	0
sleepiness	0
.	0

If	I-DISEASE
so	0
,	0
the	0
diagnosis	0
should	I-DISEASE
be	I-DISEASE
insomnia	I-DISEASE
disorder	0
.	0

Cases	I-DISEASE
of	I-DISEASE
hypersomnolence	I-DISEASE
that	0
are	I-DISEASE
due	I-DISEASE
to	I-DISEASE
the	0
side	0
effects	0
of	I-DISEASE
dopaminergic	0
agents	0
should	I-DISEASE
be	I-DISEASE
coded	0
as	0
hypersomnia	I-DISEASE
due	0
to	I-DISEASE
a	0
medication	0
or	0
substance	I-DISEASE
.	0

In	I-DISEASE
other	I-DISEASE
cases	0
,	I-DISEASE
however	0
,	I-DISEASE
hypersomnolence	I-DISEASE
is	I-DISEASE
likely	0
of	I-DISEASE
central	0
origin	I-DISEASE
and	0
should	0
be	I-DISEASE
classified	0
in	I-DISEASE
this	0
section	I-DISEASE
.	0

Parkinson	I-DISEASE
disease	I-DISEASE
patients	0
with	I-DISEASE
an	0
MSLT	I-DISEASE
profile	0
consistent	0
with	0
narco-	0
lepsy	0
should	I-DISEASE
be	I-DISEASE
coded	0
as	0
narcolepsy	0
due	0
to	I-DISEASE
a	0
medical	I-DISEASE
condition	0
.	0

Posttraumatic	I-DISEASE
hypersomnia	I-DISEASE
:	0
Hypersomnolence	0
appears	I-DISEASE
to	I-DISEASE
be	0
common	0
after	0
trau-	0
matic	I-DISEASE
brain	I-DISEASE
injury	0
(	I-DISEASE
TBI	0
)	0
,	0
with	I-DISEASE
one	0
meta	0
-	0
analysis	I-DISEASE
suggesting	0
a	0
frequency	I-DISEASE
of	0
28	0
%	0
of	I-DISEASE
TBI	0
patients	I-DISEASE
.	0

In	I-DISEASE
some	I-DISEASE
cases	0
this	0
may	0
be	I-DISEASE
caused	0
by	I-DISEASE
injury	0
to	0
the	0
hypocretin	I-DISEASE
/	0
orexin	I-DISEASE
neurons	0
or	I-DISEASE
other	I-DISEASE
wake	0
-	0
promoting	I-DISEASE
neural	0
systems	0
.	0

However	I-DISEASE
,	I-DISEASE
the	0
prevalence	I-DISEASE
of	0
sleep	0
related	0
breathing	B-DISEASE
disorder	0
(	I-DISEASE
SRBD	I-DISEASE
)	I-DISEASE
in	0
patients	I-DISEASE
with	I-DISEASE
head	I-DISEASE
trauma	0
is	0
high	I-DISEASE
(	I-DISEASE
frequency	I-DISEASE
23	0
%	0
to	I-DISEASE
25	0
%	0
)	0
.	0

The	I-DISEASE
nature	0
of	I-DISEASE
the	0
relationship	0
between	0
TBI	0
and	0
OSA	0
remains	0
undefined	I-DISEASE
.	0

Therefore	I-DISEASE
,	I-DISEASE
control	0
of	I-DISEASE
other	0
potential	I-DISEASE
sleep	0
disorders	0
is	0
necessary	0
prior	0
to	I-DISEASE
making	I-DISEASE
a	I-DISEASE
diagnosis	0
of	I-DISEASE
hypersomnia	I-DISEASE
due	0
to	0
a	0
medical	0
disorder	I-DISEASE
(	0
posttraumatic	0
hypersomnia	I-DISEASE
)	0
.	0

Genetic	I-DISEASE
disorders	0
associated	0
with	0
primary	0
central	0
nervous	I-DISEASE
system	0
somnolence	0
:	0
Genetic	I-DISEASE
disorders	I-DISEASE
such	0
as	0
Niemann	0
Pick	0
type	I-DISEASE
C	0
disease	I-DISEASE
and	0
Norrie	0
disease	I-DISEASE
have	0
been	I-DISEASE
associated	0
with	0
daytime	I-DISEASE
somnolence	0
.	0

Prader	I-DISEASE
-	I-DISEASE
Willi	0
syndrome	0
,	I-DISEASE
myotonic	0
dystrophy	0
,	I-DISEASE
Moebius	0
syndrome	0
,	0
and	0
fragile	I-DISEASE
X	0
syndrome	0
are	0
other	I-DISEASE
examples	0
of	I-DISEASE
centrally	0
mediated	0
sleepiness	0
.	0

A	I-DISEASE
number	0
of	I-DISEASE
genetic	I-DISEASE
disorders	0
have	I-DISEASE
been	I-DISEASE
reported	I-DISEASE
to	0
be	0
associated	0
with	I-DISEASE
both	I-DISEASE
sleep	0
disordered	0
breathing	I-DISEASE
and	0
hypersomnolence	0
(	I-DISEASE
e.g.	0
,	I-DISEASE
myotonic	0
dystrophy	0
and	0
Prader	0
-	0
Willi	0
syndrome	I-DISEASE
)	I-DISEASE
.	0

In	I-DISEASE
these	I-DISEASE
cases	0
,	I-DISEASE
hypersomnia	0
due	0
to	0
a	0
medical	I-DISEASE
disorder	I-DISEASE
should	0
be	0
diagnosed	I-DISEASE
only	I-DISEASE
if	0
the	0
excessive	0
sleepiness	0
is	0
still	0
present	I-DISEASE
after	0
adequate	0
treatment	I-DISEASE
of	I-DISEASE
the	0
SRBD	I-DISEASE
.	0

Smith	I-DISEASE
-	0
Magenis	0
syndrome	I-DISEASE
is	0
a	I-DISEASE
neurodevelopmental	0
disorder	0
characterized	0
by	I-DISEASE
dysmorphic	0
facial	0
features	0
,	0
behavioral	0
disturbance	0
with	0
onset	0
in	I-DISEASE
early	0
childhood	0
,	0
daytime	I-DISEASE
somnolence	0
,	0
and	0
night	0
awakenings	0
in	0
association	I-DISEASE
with	I-DISEASE
reversal	0
in	I-DISEASE
the	0
timing	0
of	0
the	0
melatonin	0
secretion	0
pattern	0
(	I-DISEASE
i.e.	0
,	I-DISEASE
the	0
serum	0
levels	0
of	I-DISEASE
melatonin	B-DISEASE
are	I-DISEASE
high	0
during	I-DISEASE
the	0
daytime	0
and	0
low	0
at	I-DISEASE
night	0
)	0
.	0

Hypersomnia	I-DISEASE
secondary	0
to	I-DISEASE
brain	I-DISEASE
tumors	0
,	0
infections	0
,	I-DISEASE
or	I-DISEASE
other	I-DISEASE
central	0
nervous	0
system	I-DISEASE
lesions	I-DISEASE
:	0
Strokes	0
,	0
infections	0
,	I-DISEASE
tumors	I-DISEASE
,	0
sarcoidosis	I-DISEASE
,	I-DISEASE
or	0
neurodegenerative	0
lesions	0
of	I-DISEASE
the	0
brain	0
,	0
especially	0
in	I-DISEASE
the	0
hypothalamus	I-DISEASE
or	0
rostral	0
midbrain	I-DISEASE
,	0
may	0
produce	0
daytime	0
sleepi-	0
ness	0
.	0

In	I-DISEASE
patients	I-DISEASE
with	0
brain	I-DISEASE
tumors	0
,	I-DISEASE
the	0
sleepiness	0
may	0
be	0
due	I-DISEASE
to	I-DISEASE
the	0
tumor	B-DISEASE
itself	0
or	I-DISEASE
the	I-DISEASE
effects	0
of	0
treatment	I-DISEASE
.	0

Hypersomnia	I-DISEASE
secondary	0
to	I-DISEASE
endocrine	I-DISEASE
disorder	0
:	I-DISEASE
Hypothyroidism	I-DISEASE
is	0
the	0
most	0
recog-	0
nized	I-DISEASE
example	0
of	I-DISEASE
this	I-DISEASE
condition	0
.	0

Hypersomnia	I-DISEASE
secondary	0
to	I-DISEASE
metabolic	0
encephalopathy	0
:	I-DISEASE
Hepatic	0
encephalopathy	I-DISEASE
,	0
chronic	I-DISEASE
renal	0
insufficiency	0
,	I-DISEASE
adrenal	0
or	0
pancreatic	0
insufficiency	0
,	0
exposure	0
to	0
toxins	0
,	I-DISEASE
and	0
certain	I-DISEASE
inherited	0
metabolic	0
disorders	0
in	0
childhood	0
may	0
result	0
in	I-DISEASE
hypersomnolence	0
.	0

Residual	I-DISEASE
hypersomnia	0
in	0
patients	0
with	I-DISEASE
adequately	B-DISEASE
treated	0
OSA	0
:	I-DISEASE
Some	0
patients	0
with	0
SRBDs	I-DISEASE
report	0
persistent	0
sleepiness	I-DISEASE
despite	0
apparently	0
adequate	0
amounts	I-DISEASE
of	I-DISEASE
sleep	0
and	0
optimal	0
treatment	I-DISEASE
of	I-DISEASE
their	0
sleep	0
apnea	0
and	0
other	0
known	I-DISEASE
sleep	0
disorders	0
.	0

They	I-DISEASE
may	0
have	0
moderately	I-DISEASE
elevated	0
Epworth	I-DISEASE
Sleepiness	0
Scale	0
scores	0
,	I-DISEASE
but	I-DISEASE
most	0
have	0
mean	I-DISEASE
sleep	0
laten-	0
cies	0
>	0
8	I-DISEASE
minutes	0
on	0
MSLT	I-DISEASE
.	0

They	I-DISEASE
also	0
report	0
more	0
fatigue	0
,	I-DISEASE
apathy	0
,	0
and	0
depression	0
.	0

It	I-DISEASE
is	I-DISEASE
essential	0
that	0
sleep	0
disordered	I-DISEASE
breathing	B-DISEASE
be	0
fully	0
treated	0
for	0
at	I-DISEASE
least	0
three	0
months	0
,	I-DISEASE
and	0
that	0
control	0
of	I-DISEASE
the	0
SRBD	0
be	I-DISEASE
confirmed	0
by	I-DISEASE
:	0
(	I-DISEASE
1	0
)	0
a	0
download	0
of	I-DISEASE
positive	0
airway	0
pressure	0
(	0
PAP	0
)	0
machine	0
compliance	0
data	I-DISEASE
demonstrating	I-DISEASE
optimal	0
usage	0
(	0
preferably	0
at	0
least	0
7	0
hours	I-DISEASE
a	0
night	0
)	0
;	0
and	0
(	0
2	I-DISEASE
)	I-DISEASE
a	0
polysomnogram	0
demonstrating	0
elimination	0
of	I-DISEASE
essentially	0
all	0
sleep	0
disordered	0
breathing	0
.	0

Other	I-DISEASE
causes	0
of	I-DISEASE
sleepiness	0
,	I-DISEASE
such	0
as	I-DISEASE
insufficient	0
sleep	0
syn-	0
drome	I-DISEASE
,	I-DISEASE
psychiatric	I-DISEASE
disorders	I-DISEASE
,	0
or	0
hypersomnolence	I-DISEASE
related	I-DISEASE
to	0
medications	I-DISEASE
or	I-DISEASE
drugs	I-DISEASE
must	0
be	0
eliminated	I-DISEASE
.	0

Animal	I-DISEASE
studies	I-DISEASE
have	0
suggested	I-DISEASE
this	0
residual	I-DISEASE
sleepiness	0
could	0
be	0
caused	0
by	I-DISEASE
hypoxic	I-DISEASE
injury	I-DISEASE
to	I-DISEASE
monoamine	0
systems	0
.	0

Obesity	I-DISEASE
itself	0
may	I-DISEASE
also	0
contribute	0
,	0
and	0
more	0
research	0
is	0
needed	0
to	I-DISEASE
understand	I-DISEASE
the	0
underlying	0
mechanism	0
.	I-DISEASE

Demographics	I-DISEASE
Demographics	0
reflect	0
those	0
of	I-DISEASE
the	0
underlying	I-DISEASE
condition	I-DISEASE
.	0

Predisposing	I-DISEASE
and	0
Precipitating	I-DISEASE
Factors	0
Predisposing	I-DISEASE
and	0
precipitating	0
factors	I-DISEASE
reflect	I-DISEASE
those	0
of	I-DISEASE
the	0
underlying	0
condition	0
.	0

Central	I-DISEASE
Disorders	I-DISEASE
of	0
Hypersomnolence	I-DISEASE
Central	I-DISEASE
Disorders	I-DISEASE
of	I-DISEASE
Hypersomnolence	I-DISEASE
Familial	I-DISEASE
Patterns	I-DISEASE
Familial	I-DISEASE
patterns	0
reflect	I-DISEASE
those	0
of	I-DISEASE
the	0
underlying	0
condition	0
.	0

Onset	I-DISEASE
,	0
Course	0
,	0
and	0
Complications	0
Onset	0
,	I-DISEASE
course	I-DISEASE
,	0
and	0
complications	0
reflect	I-DISEASE
those	0
of	0
the	0
underlying	0
condition	0
.	0

Developmental	I-DISEASE
Issues	0
Daytime	I-DISEASE
naps	I-DISEASE
are	I-DISEASE
normal	0
in	0
children	0
younger	0
than	I-DISEASE
3	I-DISEASE
-	0
4	0
years	0
;	I-DISEASE
thus	0
,	0
it	0
is	0
difficult	0
to	0
dif-	0
ferentiate	I-DISEASE
physiologic	0
napping	I-DISEASE
from	0
hypersomnolence	0
in	I-DISEASE
children	I-DISEASE
younger	I-DISEASE
than	0
this	0
age	I-DISEASE
.	0

Inattentiveness	I-DISEASE
,	I-DISEASE
mood	0
swings	0
,	0
and	0
learning	0
difficulties	I-DISEASE
often	I-DISEASE
accompany	I-DISEASE
child-	0
hood	0
daytime	I-DISEASE
sleepiness	0
.	0

Reference	I-DISEASE
values	I-DISEASE
for	0
the	0
MSLT	0
in	0
children	I-DISEASE
differ	0
from	0
those	0
of	I-DISEASE
adults	I-DISEASE
,	I-DISEASE
and	0
this	0
issue	0
should	I-DISEASE
be	0
considered	0
during	I-DISEASE
the	0
evaluation	0
process	0
.	0

Special	I-DISEASE
attention	0
should	0
be	I-DISEASE
paid	0
to	I-DISEASE
genetic	I-DISEASE
disorders	0
in	0
children	0
.	0

Pathology	I-DISEASE
and	0
Pathophysiology	I-DISEASE
Pathology	I-DISEASE
and	0
pathophysiology	I-DISEASE
reflect	I-DISEASE
those	I-DISEASE
of	0
the	0
underlying	0
condition	0
.	0

Objective	I-DISEASE
Findings	I-DISEASE
Nocturnal	0
polysomnography	0
may	I-DISEASE
show	0
normal	0
or	I-DISEASE
moderately	I-DISEASE
disturbed	0
sleep	0
.	0

In	I-DISEASE
patients	0
with	0
a	I-DISEASE
metabolic	0
encephalopathy	I-DISEASE
,	0
EEG	0
abnormalities	I-DISEASE
may	I-DISEASE
be	I-DISEASE
present	I-DISEASE
,	0
such	0
as	0
an	0
increase	I-DISEASE
in	I-DISEASE
the	0
amount	I-DISEASE
of	0
slow	0
wave	I-DISEASE
sleep	0
.	0

MSLT	I-DISEASE
must	I-DISEASE
show	I-DISEASE
fewer	0
than	I-DISEASE
2	0
SOREMPs	I-DISEASE
and	0
usually	I-DISEASE
will	0
show	0
a	0
mean	I-DISEASE
sleep	I-DISEASE
latency	0
less	I-DISEASE
than	0
eight	I-DISEASE
minutes	0
.	0

If	I-DISEASE
clin-	I-DISEASE
ically	0
significant	0
sleep	0
disordered	0
breathing	I-DISEASE
or	I-DISEASE
periodic	I-DISEASE
limb	0
movements	0
are	I-DISEASE
present	I-DISEASE
,	0
they	0
should	I-DISEASE
be	0
treated	0
prior	0
to	0
diagnosing	I-DISEASE
hypersomnia	I-DISEASE
due	I-DISEASE
to	I-DISEASE
a	0
medical	0
disorder	I-DISEASE
.	0

Differential	I-DISEASE
Diagnosis	0
See	0
the	0
differential	I-DISEASE
diagnosis	0
in	0
previous	0
hypersomnolence	I-DISEASE
sections	0
.	0

The	I-DISEASE
major	I-DISEASE
chal-	0
lenge	I-DISEASE
in	I-DISEASE
establishing	0
a	0
diagnosis	0
of	I-DISEASE
hypersomnia	I-DISEASE
due	I-DISEASE
to	0
a	0
medical	0
disorder	0
is	I-DISEASE
deter-	0
mining	0
whether	I-DISEASE
the	0
associated	0
medical	0
or	B-DISEASE
neurological	0
disorder	I-DISEASE
is	0
truly	0
causing	0
the	0
hypersomnolence	0
.	0

Unresolved	I-DISEASE
Issues	0
and	0
Future	0
Directions	0

This	I-DISEASE
area	I-DISEASE
is	0
understudied	I-DISEASE
.	I-DISEASE

Multiple	0
complex	0
neurological	0
,	I-DISEASE
metabolic	0
,	I-DISEASE
endocrine	0
,	I-DISEASE
and	0
medication	0
-	0
related	0
interactions	0
may	I-DISEASE
be	0
present	0
.	0

Further	I-DISEASE
studies	I-DISEASE
are	0
needed	0
to	0
define	0
the	0
reciprocal	0
relationships	I-DISEASE
between	0
sleep	0
disorders	0
and	0
other	I-DISEASE
diseases	0
.	0

Bibliography	0
Bruin	0
VM	I-DISEASE
,	0
Bittencourt	0
LR	I-DISEASE
,	0
Tufik	I-DISEASE
S.	0
Sleep	0
-	0
wake	0
disturbances	I-DISEASE
in	I-DISEASE
Parkinson	0
’s	I-DISEASE
disease	I-DISEASE
:	I-DISEASE
current	I-DISEASE
evidence	0
regarding	0
diagnostic	0
and	0
therapeutic	I-DISEASE
decisions	I-DISEASE
.	0

Eur	I-DISEASE
Neurol	0
2012;67:257–67	I-DISEASE
.	0

Castriotti	I-DISEASE
RJ	I-DISEASE
,	I-DISEASE
Wilde	0
MC	I-DISEASE
,	0
Lai	0
JM	0
,	I-DISEASE
Atanasov	0
S	I-DISEASE
,	0
Masel	0
BE	0
,	I-DISEASE
Kuna	0
ST	0
.	I-DISEASE
Prevalence	0
and	0
consequences	I-DISEASE
of	I-DISEASE
sleep	0
disorders	0
in	I-DISEASE
traumatic	0
brain	0
injury	I-DISEASE
.	0

J	I-DISEASE
Clin	0
Sleep	0
Med	0
2007;3:349–56	I-DISEASE
.	0

Guilleminault	I-DISEASE
C	I-DISEASE
,	I-DISEASE
Yuen	I-DISEASE
KM	0
,	I-DISEASE
Gulevich	I-DISEASE
MG	I-DISEASE
,	I-DISEASE
Karadeniz	I-DISEASE
D	I-DISEASE
,	0
Leger	0
D	0
,	I-DISEASE
Philip	0
D.	I-DISEASE
Hypersomnia	I-DISEASE
after	I-DISEASE
head	I-DISEASE
-	0
neck	0
trauma	0
:	0
a	0
medico	0
-	0
legal	0
dilemma	I-DISEASE
.	0

Neurology	0
2000;54:653–9	I-DISEASE
.	0

Kempf	I-DISEASE
J	0
,	I-DISEASE
Werth	I-DISEASE
E	0
,	I-DISEASE
Kaiser	0
PR	I-DISEASE
,	0
et	0
al	I-DISEASE
.	0

Sleep	I-DISEASE
-	0
wake	0
disturbances	I-DISEASE
3	I-DISEASE
years	0
after	0
traumatic	0
brain	0
injury	0
.	0

J	I-DISEASE
Neurol	0
Neurosurg	0
Psychiatry	0
2010;81:1402–5	I-DISEASE
.	0

Martinez	I-DISEASE
-	I-DISEASE
Rodriguez	0
JE	0
,	I-DISEASE
Lin	0
L	0
,	0
Iranzo	0
A	0
,	I-DISEASE
et	0
al	0
.	0

Decreased	I-DISEASE
hypocretin-1	0
(	0
orexin	0
-	I-DISEASE
A	0
)	0
levels	0
in	I-DISEASE
the	0
cerebrospinal	0
fluid	0
of	I-DISEASE
patients	I-DISEASE
with	0
myotonic	0
dystrophy	0
and	0
excessive	0
daytime	0
sleepiness	0
.	0

Sleep	I-DISEASE
2003;26:287–90	0
.	0

Mathias	I-DISEASE
JL	I-DISEASE
,	I-DISEASE
Alvaro	0
PK	0
.	0

Prevalence	I-DISEASE
of	I-DISEASE
sleep	0
disturbances	0
,	0
disorders	0
,	0
and	0
problems	0
following	0
traumatic	I-DISEASE
brain	I-DISEASE
injury	0
:	0
a	0
meta	0
-	0
analysis	0
.	0

Sleep	I-DISEASE
Med	0
2012;13:898–905	I-DISEASE
.	0

Panossian	I-DISEASE
L	0
,	0
Veasey	I-DISEASE
S.	I-DISEASE
Daytime	I-DISEASE
sleepiness	I-DISEASE
in	0
obesity	0
:	I-DISEASE
mechanisms	0
beyond	0
obstructive	0
sleep	0
apnea	I-DISEASE
--	0
a	I-DISEASE
review	0
.	0

Sleep	I-DISEASE
2012;35:605–15	I-DISEASE
.	0

Vernet	I-DISEASE
C	I-DISEASE
,	0
Redolfi	0
S	I-DISEASE
,	0
Attali	0
,	I-DISEASE
V	I-DISEASE
,	I-DISEASE
et	0
al	I-DISEASE
.	0

Residual	I-DISEASE
sleepiness	0
in	I-DISEASE
obstructive	0
sleep	0
apnoea	I-DISEASE
:	I-DISEASE
phenotype	0
and	0
related	0
symptoms	I-DISEASE
.	0

Eur	I-DISEASE
Respir	0
J	0
2011;38:98–105	0
.	0

Wienecke	I-DISEASE
M	I-DISEASE
,	0
Werth	I-DISEASE
E	I-DISEASE
,	0
Poryazova	0
R	I-DISEASE
,	0
et	0
al	I-DISEASE
.	I-DISEASE

Progressive	I-DISEASE
dopamine	I-DISEASE
and	0
hypocretin	I-DISEASE
deficiencies	0
in	I-DISEASE
Parkinson	0
’s	I-DISEASE
disease	I-DISEASE
:	0
is	0
there	I-DISEASE
an	0
impact	I-DISEASE
on	0
sleep	0
and	0
wakefulness	0
?	0

J	I-DISEASE
Sleep	0
Res	0
2012;21:710–7	0
.	0

Zhu	I-DISEASE
Y	I-DISEASE
,	0
Fenik	I-DISEASE
P	0
,	I-DISEASE
Zhan	I-DISEASE
G	0
,	0
et	0
al	I-DISEASE
.	0

Selective	I-DISEASE
loss	0
of	I-DISEASE
catecholaminergic	0
wake	0
active	I-DISEASE
neurons	I-DISEASE
in	I-DISEASE
a	0
murine	I-DISEASE
sleep	0
apnea	0
model	0
.	0

J	I-DISEASE
Neurosci	0
2007;27:10060–71	I-DISEASE
.	0

Hypersomnia	I-DISEASE
Due	I-DISEASE
to	I-DISEASE
a	I-DISEASE
Medication	0
or	0
Substance	I-DISEASE
ICD-9	I-DISEASE
-	I-DISEASE
CM	0
code	0
:	0
292.85	0
(	0
drug	0
-	0
induced	I-DISEASE
)	0
;	I-DISEASE
291.82	0
(	0
alcohol	0
-	I-DISEASE
induced	0
)	0
ICD-10	0
-	I-DISEASE
CM	I-DISEASE
code	0
:	0
F11	0
-	0
F19	0
(	I-DISEASE
see	I-DISEASE
table	I-DISEASE
in	0
Appendix	0
B	0
for	I-DISEASE
detailed	0
coding	I-DISEASE
instructions	0
)	0

Alternate	I-DISEASE
Names	I-DISEASE
Hypersomnia	I-DISEASE
due	I-DISEASE
to	0
substance	0
abuse	I-DISEASE
,	I-DISEASE
hypersomnia	I-DISEASE
due	I-DISEASE
to	0
stimulant	0
withdrawal	0
,	I-DISEASE
hyper-	I-DISEASE
somnia	0
due	I-DISEASE
to	0
sedative	I-DISEASE
abuse	I-DISEASE
,	0
toxic	0
hypersomnia	0
,	I-DISEASE
toxic	0
encephalopathy	I-DISEASE
.	0

Diagnostic	I-DISEASE
Criteria	0
Criteria	I-DISEASE
A	0
-	I-DISEASE
C	I-DISEASE
must	I-DISEASE
be	0
met	0
A.	0

The	I-DISEASE
patient	I-DISEASE
has	0
daily	I-DISEASE
periods	0
of	I-DISEASE
irrepressible	I-DISEASE
need	I-DISEASE
to	I-DISEASE
sleep	I-DISEASE
or	I-DISEASE
daytime	0
lapses	I-DISEASE
into	I-DISEASE
sleep	0
.	0

B.	0
The	I-DISEASE
daytime	I-DISEASE
sleepiness	0
occurs	0
as	B-DISEASE
a	0
consequence	0
of	I-DISEASE
current	I-DISEASE
medication	I-DISEASE
or	I-DISEASE
substance	0
use	0
or	I-DISEASE
withdrawal	0
from	0
a	0
wake	0
-	0
promoting	I-DISEASE
medication	0
or	0
substance	I-DISEASE
.	0

C.	I-DISEASE

The	I-DISEASE
symptoms	I-DISEASE
are	0
not	0
better	0
explained	I-DISEASE
by	I-DISEASE
another	I-DISEASE
untreated	0
sleep	0
disorder	I-DISEASE
,	I-DISEASE
medical	0
or	0
neurological	I-DISEASE
disorder	0
,	0
or	0
mental	0
disorder	I-DISEASE
.	0

Central	I-DISEASE
Disorders	I-DISEASE
of	0
Hypersomnolence	I-DISEASE
Central	I-DISEASE
Disorders	I-DISEASE
of	I-DISEASE
Hypersomnolence	I-DISEASE
Essential	0
Features	I-DISEASE
Patients	0
with	0
this	I-DISEASE
disorder	0
have	I-DISEASE
excessive	0
nocturnal	0
sleep	0
,	0
daytime	0
sleepiness	0
,	0
or	I-DISEASE
excessive	0
napping	I-DISEASE
that	0
is	I-DISEASE
attributable	I-DISEASE
to	0
sedating	0
medications	0
,	0
alcohol	I-DISEASE
,	I-DISEASE
or	0
drugs	0
of	I-DISEASE
abuse	0
.	I-DISEASE

This	I-DISEASE
diagnosis	I-DISEASE
also	0
includes	I-DISEASE
hypersomnolence	0
associated	0
with	I-DISEASE
withdrawal	I-DISEASE
from	0
amphetamines	I-DISEASE
and	0
other	I-DISEASE
drugs	I-DISEASE
.	0

If	I-DISEASE
narcolepsy	I-DISEASE
or	I-DISEASE
hypersomnolence	I-DISEASE
existed	I-DISEASE
prior	0
to	I-DISEASE
stimulant	0
abuse	I-DISEASE
,	0
the	0
diagnosis	0
of	I-DISEASE
hypersomnia	I-DISEASE
due	I-DISEASE
to	I-DISEASE
a	0
medication	0
or	I-DISEASE
substance	I-DISEASE
should	I-DISEASE
not	0
be	I-DISEASE
used	0
.	0

Associated	I-DISEASE
Features	I-DISEASE
Associated	0
features	I-DISEASE
reflect	0
those	I-DISEASE
of	I-DISEASE
the	0
medications	0
or	0
substances	0
responsible	I-DISEASE
.	I-DISEASE

Clinical	I-DISEASE
and	0
Pathological	0
Subtypes	0
Hypersomnia	I-DISEASE
due	I-DISEASE
to	I-DISEASE
sedating	0
medications	I-DISEASE
:	I-DISEASE
Sedation	0
is	0
a	0
common	I-DISEASE
side	0
effect	0
of	I-DISEASE
many	0
prescription	I-DISEASE
medications	0
including	0
benzodiazepines	0
,	0
nonbenzodiazepine	0
hypnot-	0
ics	I-DISEASE
,	0
opioids	0
,	0
barbiturates	0
,	0
anticonvulsants	0
,	0
antipsychotics	0
,	0
anticholinergics	I-DISEASE
,	0
and	0
some	0
antidepressants	0
and	0
antihistamines	0
.	I-DISEASE

Sleepiness	I-DISEASE
also	0
can	I-DISEASE
occur	0
with	I-DISEASE
some	I-DISEASE
dopamine	I-DISEASE
agonists	I-DISEASE
such	I-DISEASE
as	0
pramipexole	0
or	I-DISEASE
ropinirole	0
,	0
and	0
with	0
many	0
antiseizure	0
medications	0
.	0

Though	I-DISEASE
less	I-DISEASE
common	I-DISEASE
,	I-DISEASE
sleepiness	0
can	0
also	0
occur	0
with	0
nonsteroidal	0
anti	0
-	0
inflammatory	0
drugs	I-DISEASE
,	0
some	0
antibiotics	0
,	0
antispasmodics	0
,	0
antiarryhthmics	0
,	0
and	0
beta	0
-	0
blockers	0
.	0

Over	I-DISEASE
-	I-DISEASE
the-	0
counter	0
medications	I-DISEASE
,	0
such	I-DISEASE
as	0
valerian	0
and	0
melatonin	I-DISEASE
,	I-DISEASE
can	0
produce	0
sedation	I-DISEASE
.	0

Excessive	I-DISEASE
sleepiness	0
is	I-DISEASE
especially	0
common	I-DISEASE
when	0
these	0
drugs	I-DISEASE
are	0
used	I-DISEASE
in	I-DISEASE
elderly	I-DISEASE
patients	I-DISEASE
or	I-DISEASE
those	I-DISEASE
with	0
multiple	I-DISEASE
medical	0
conditions	0
,	0
or	0
in	I-DISEASE
combination	I-DISEASE
.	0

Some	I-DISEASE
tolerance	I-DISEASE
to	0
the	0
sedative	0
effects	0
can	0
occur	0
with	I-DISEASE
time	I-DISEASE
.	I-DISEASE

Hypersomnia	I-DISEASE
due	I-DISEASE
to	I-DISEASE
substance	I-DISEASE
abuse	0
:	0
Daytime	I-DISEASE
sleepiness	I-DISEASE
can	0
occur	I-DISEASE
with	I-DISEASE
abuse	I-DISEASE
of	0
alcohol	0
,	I-DISEASE
benzodiazepines	0
,	I-DISEASE
barbiturates	0
,	0
gamma	0
hydroxybutyrate	I-DISEASE
,	0
opiates	0
,	I-DISEASE
and	0
marijuana	I-DISEASE
.	0

Hypersomnia	I-DISEASE
due	I-DISEASE
to	I-DISEASE
stimulant	I-DISEASE
withdrawal	0
:	I-DISEASE
Daytime	I-DISEASE
sleepiness	0
is	I-DISEASE
common	I-DISEASE
with	0
abrupt	I-DISEASE
discontinuation	0
of	I-DISEASE
stimulants	0
.	0

In	I-DISEASE
chronically	I-DISEASE
heavy	I-DISEASE
amphetamine	0
users	0
,	0
sleepiness	0
is	I-DISEASE
most	I-DISEASE
severe	I-DISEASE
in	0
the	0
first	I-DISEASE
week	0
of	0
withdrawal	0
and	0
can	0
persist	0
for	0
up	I-DISEASE
to	0
three	I-DISEASE
weeks	0
;	I-DISEASE
indi-	I-DISEASE
viduals	0
may	0
have	I-DISEASE
an	0
increase	I-DISEASE
in	I-DISEASE
total	0
sleep	0
and	0
daytime	I-DISEASE
napping	I-DISEASE
,	I-DISEASE
but	0
sleep	0
may	0
seem	0
fragmented	0
and	0
nonrestorative	I-DISEASE
.	0

Significant	I-DISEASE
depression	0
often	0
accompanies	0
the	0
hyper-	0
somnolence	0
.	0

Infrequently	I-DISEASE
,	I-DISEASE
sleepiness	0
may	0
be	0
a	0
residual	0
complaint	I-DISEASE
in	I-DISEASE
those	0
who	I-DISEASE
have	I-DISEASE
used	I-DISEASE
stimulants	0
in	I-DISEASE
the	0
past	I-DISEASE
but	I-DISEASE
have	0
been	I-DISEASE
abstinent	0
for	I-DISEASE
many	0
years	I-DISEASE
.	0

In	I-DISEASE
people	I-DISEASE
who	I-DISEASE
regularly	B-DISEASE
consume	0
coffee	I-DISEASE
or	I-DISEASE
other	I-DISEASE
sources	I-DISEASE
of	I-DISEASE
caffeine	0
,	I-DISEASE
discontinuation	0
can	I-DISEASE
produce	0
sleepiness	0
,	I-DISEASE
fatigue	I-DISEASE
,	I-DISEASE
and	0
inattentiveness	I-DISEASE
for	I-DISEASE
two	I-DISEASE
to	0
nine	0
days	0
.	0

Demographics	I-DISEASE
Patients	0
of	I-DISEASE
any	I-DISEASE
age	I-DISEASE
can	0
experience	0
sleepiness	0
from	I-DISEASE
sedating	I-DISEASE
medications	I-DISEASE
.	I-DISEASE

Stimulant	I-DISEASE
abuse	0
and	0
the	0
consequent	I-DISEASE
sleepiness	0
during	I-DISEASE
withdrawal	I-DISEASE
are	0
most	0
common	I-DISEASE
in	I-DISEASE
adoles-	0
cents	0
and	0
young	I-DISEASE
adults	I-DISEASE
.	0

Predisposing	I-DISEASE
and	0
Precipitating	I-DISEASE
Factors	0
Sleepiness	0
from	I-DISEASE
sedating	0
medications	I-DISEASE
may	I-DISEASE
be	0
more	0
common	I-DISEASE
in	I-DISEASE
older	0
patients	0
and	0
in	I-DISEASE
those	0
with	I-DISEASE
multiple	I-DISEASE
medical	0
problems	0
.	0

Familial	I-DISEASE
Patterns	I-DISEASE
Not	I-DISEASE
applicable	0
or	B-DISEASE
known	0
.	0

Onset	I-DISEASE
,	0
Course	0
,	0
and	0
Complications	0
Onset	0
,	I-DISEASE
course	I-DISEASE
,	0
and	0
complications	0
reflect	I-DISEASE
those	0
of	0
the	0
medications	0
or	0
substances	0
responsible	I-DISEASE
.	0

Pathology	I-DISEASE
and	0
Pathophysiology	I-DISEASE
Not	0
applicable	0
or	0
known	I-DISEASE
.	I-DISEASE

Objective	I-DISEASE
Findings	I-DISEASE
Polysomnography	0
is	0
generally	I-DISEASE
unnecessary	I-DISEASE
unless	0
a	0
concomitant	0
sleep	0
disorder	I-DISEASE
is	0
sus-	0
pected	0
.	0

Polysomnography	I-DISEASE
and	0
MSLT	I-DISEASE
results	0
vary	0
depending	I-DISEASE
on	0
the	I-DISEASE
specific	I-DISEASE
substance	I-DISEASE
in	I-DISEASE
question	I-DISEASE
and	0
the	0
timing	0
of	I-DISEASE
the	0
most	0
recent	I-DISEASE
intake	0
.	0

With	I-DISEASE
stimulant	0
withdrawal	0
,	0
noc-	0
turnal	0
polysomnography	I-DISEASE
may	0
show	0
normal	0
sleep	0
,	0
whereas	I-DISEASE
the	0
MSLT	I-DISEASE
typically	0
demon-	I-DISEASE
strates	0
a	0
short	0
mean	I-DISEASE
sleep	0
latency	0
with	I-DISEASE
or	0
without	0
multiple	I-DISEASE
SOREMPs	0
.	0

A	I-DISEASE
urine	I-DISEASE
tox-	0
icology	I-DISEASE
screen	I-DISEASE
may	0
be	0
positive	0
for	0
the	I-DISEASE
suspected	I-DISEASE
substance	I-DISEASE
.	0

The	I-DISEASE
diagnosis	I-DISEASE
is	0
often	0
confirmed	0
if	0
symptoms	I-DISEASE
resolve	0
after	0
the	0
causal	0
agent	I-DISEASE
is	I-DISEASE
removed	0
.	0

Differential	I-DISEASE
Diagnosis	0
Major	0
sleep	0
disorders	0
that	0
are	0
associated	0
with	I-DISEASE
excessive	I-DISEASE
sleepiness	I-DISEASE
,	I-DISEASE
especially	0
SRBDs	I-DISEASE
,	I-DISEASE
periodic	I-DISEASE
limb	0
movement	0
disorder	0
,	I-DISEASE
narcolepsy	0
,	I-DISEASE
IH	0
,	0
and	0
insufficient	0
sleep	0
syndrome	0
should	I-DISEASE
be	0
ruled	I-DISEASE
out	0
.	0

A	I-DISEASE
urine	I-DISEASE
drug	0
screen	I-DISEASE
should	0
routinely	I-DISEASE
accompany	I-DISEASE
an	0
MSLT	I-DISEASE
as	0
the	0
use	I-DISEASE
of	I-DISEASE
or	0
withdrawal	0
from	I-DISEASE
some	I-DISEASE
medications	0
or	0
substances	0
may	0
affect	0
MSLT	I-DISEASE
test	I-DISEASE
results	0
.	I-DISEASE

Although	I-DISEASE
many	0
psychotropic	0
medications	0
may	I-DISEASE
result	0
in	0
daytime	0
sleepiness	0
,	I-DISEASE
it	0
is	I-DISEASE
import-	0
ant	0
for	0
clinicians	I-DISEASE
to	0
recognize	0
that	0
many	0
psychiatric	0
disorders	0
also	0
are	0
associated	0
with	B-DISEASE
increased	0
prevalence	0
of	I-DISEASE
other	I-DISEASE
sleep	0
disorders	0
(	0
e.g.	0
,	0
insomnia	0
,	I-DISEASE
SRBD	I-DISEASE
,	0
circadian	0
disor-	0
ders	0
,	0
and	0
movement	I-DISEASE
disorders	0
)	I-DISEASE
.	0

Although	I-DISEASE
sedative	I-DISEASE
effects	0
of	I-DISEASE
the	0
psychotropic	0
agents	I-DISEASE
Central	I-DISEASE
Disorders	I-DISEASE
of	I-DISEASE
Hypersomnolence	I-DISEASE
Central	0
Disorders	I-DISEASE
of	I-DISEASE
Hypersomnolence	I-DISEASE
may	0
contribute	0
to	0
sleepiness	0
,	0
clinicians	0
must	0
maintain	0
a	I-DISEASE
high	I-DISEASE
index	I-DISEASE
of	I-DISEASE
suspicion	I-DISEASE
for	0
other	0
sleep	0
related	B-DISEASE
etiologies	0
.	0

When	I-DISEASE
other	I-DISEASE
sleep	0
disorders	0
are	0
identified	I-DISEASE
,	0
multiple	I-DISEASE
diag-	0
noses	I-DISEASE
may	I-DISEASE
be	0
appropriate	I-DISEASE
.	0

Unresolved	I-DISEASE
Issues	0
and	0
Future	0
Directions	0
Sedatives	0
can	I-DISEASE
worsen	I-DISEASE
sleep	0
related	B-DISEASE
breathing	I-DISEASE
disorders	0
,	0
and	0
more	0
research	I-DISEASE
is	0
needed	0
to	I-DISEASE
understand	0
and	0
manage	0
this	I-DISEASE
interaction	0
.	B-DISEASE

Bibliography	0
Ancoli	0
-	0
Israel	I-DISEASE
S.	I-DISEASE
Sleep	0
and	0
its	I-DISEASE
disorders	0
in	0
aging	0
populations	I-DISEASE
.	0

Sleep	I-DISEASE
Med	I-DISEASE
2009;10	I-DISEASE
Suppl	I-DISEASE
1	0
:	0
S7–11	I-DISEASE
.	0

España	I-DISEASE
RA	0
,	I-DISEASE
Scammell	0
TE	0
.	0

Sleep	I-DISEASE
neurobiology	I-DISEASE
from	I-DISEASE
a	0
clinical	0
perspective	I-DISEASE
.	0

Sleep	I-DISEASE
2011;34:845–58	I-DISEASE
.	0

Gillin	I-DISEASE
JC	0
,	0
Smith	0
TL	0
,	0
Irwin	0
M	I-DISEASE
,	I-DISEASE
Butters	I-DISEASE
N	0
,	I-DISEASE
Demodena	0
A	0
,	0
Schuckit	0
M.	0
Increased	0
pressure	0
for	I-DISEASE
rapid	I-DISEASE
eye	B-DISEASE
movement	0
sleep	0
at	I-DISEASE
time	0
of	I-DISEASE
hospital	0
admission	0
predicts	0
relapse	0
in	I-DISEASE
nondepressed	0
patients	0
with	0
primary	0
alcoholism	I-DISEASE
at	I-DISEASE
3	I-DISEASE
-	0
month	0
follow	I-DISEASE
-	0
up	0
.	I-DISEASE

Arch	I-DISEASE
Gen	0
Psychiatry	0
1994;51:189–97	0
.	0

Guilleminault	I-DISEASE
C	I-DISEASE
,	I-DISEASE
Brooks	I-DISEASE
SN	I-DISEASE
.	0

Excessive	I-DISEASE
daytime	I-DISEASE
sleepiness	0
:	0
a	I-DISEASE
challenge	0
for	0
the	0
practicing	I-DISEASE
neurologist	I-DISEASE
.	0

Brain	0
2001;124:1482–91	I-DISEASE
.	0

Juliano	I-DISEASE
LM	0
,	0
Griffiths	I-DISEASE
RR	I-DISEASE
.	0

A	I-DISEASE
critical	I-DISEASE
review	0
of	I-DISEASE
caffeine	0
withdrawal	0
:	0
empirical	0
validation	0
of	I-DISEASE
symptoms	I-DISEASE
and	0
signs	0
,	I-DISEASE
incidence	I-DISEASE
,	0
severity	0
,	I-DISEASE
and	0
associated	0
features	I-DISEASE
.	0

Psychopharmacology	I-DISEASE
(	I-DISEASE
Berl	0
)	0
2004	0
;	I-DISEASE
176:1–29	0
.	0

McGregor	I-DISEASE
C	I-DISEASE
,	0
Srisurapanont	I-DISEASE
M	I-DISEASE
,	0
Jittiwutikarn	0
J	0
,	I-DISEASE
Laobhripatr	0
S	I-DISEASE
,	I-DISEASE
Wongtan	0
T	0
,	I-DISEASE
White	I-DISEASE
JM	B-DISEASE
.	0

The	I-DISEASE
nature	0
,	0
time	I-DISEASE
course	0
and	0
severity	I-DISEASE
of	I-DISEASE
methamphetamine	0
withdrawal	I-DISEASE
.	0

Addiction	I-DISEASE
2005;100:1320–9	0
.	0

Mogri	I-DISEASE
M	I-DISEASE
,	0
Desai	I-DISEASE
H	I-DISEASE
,	0
Webster	0
L	0
,	I-DISEASE
Grant	I-DISEASE
BJ	0
,	I-DISEASE
Mador	I-DISEASE
MJ	0
.	0

Hypoxemia	I-DISEASE
in	0
patients	I-DISEASE
on	0
chronic	I-DISEASE
opiate	0
therapy	0
with	I-DISEASE
and	0
without	0
sleep	0
apnea	0
.	0

Sleep	I-DISEASE
Breath	0
2009;13:49–57	I-DISEASE
.	0

Punjabi	I-DISEASE
NM	0
.	I-DISEASE

The	I-DISEASE
epidemiology	I-DISEASE
of	I-DISEASE
adult	0
obstructive	I-DISEASE
sleep	0
apnea	I-DISEASE
.	0

Proc	I-DISEASE
Am	0
Thorac	I-DISEASE
Soc	0
2008;5:136–43	I-DISEASE
.	0

Qureshi	I-DISEASE
A	0
,	0
Lee	I-DISEASE
-	0
Chiong	B-DISEASE
T.	0
Medications	I-DISEASE
and	0
their	0
effects	0
on	0
sleep	0
.	0

Med	I-DISEASE
Clin	0
North	0
Am	I-DISEASE
2004;88:751–66	0
.	0

Roehrs	I-DISEASE
T	0
,	0
Roth	I-DISEASE
T.	0
Sleep	0
,	0
sleepiness	0
,	I-DISEASE
and	0
alcohol	0
use	0
.	0

Alcohol	I-DISEASE
Res	0
Health	0
2001;25:101–9	I-DISEASE
.	0

Roehrs	I-DISEASE
T	0
,	0
Bonahoom	I-DISEASE
A	0
,	0
Pedrosi	0
B	0
,	I-DISEASE
Zorick	0
F	I-DISEASE
,	0
Roth	0
T.	0
Nighttime	I-DISEASE
versus	0
daytime	I-DISEASE
hypnotic	0
self-	0
administration	0
.	0

Psychopharmacology	I-DISEASE
2002;161:137–42	I-DISEASE
.	0

Schweitzer	I-DISEASE
P.	0
Drugs	I-DISEASE
that	0
disturb	0
sleep	0
and	0
wakefulness	I-DISEASE
.	0

In	I-DISEASE
:	I-DISEASE
Kryger	0
MH	I-DISEASE
,	I-DISEASE
Roth	I-DISEASE
T	0
,	0
Dement	I-DISEASE
WC	I-DISEASE
,	0
eds	I-DISEASE
.	0

Principles	I-DISEASE
and	0
practice	0
of	I-DISEASE
sleep	0
medicine	0
,	I-DISEASE
5th	I-DISEASE
ed	0
.	0

St	I-DISEASE
Louis	I-DISEASE
:	0
Elsevier	0
Saunders	0
,	I-DISEASE
2011:542–60	0
.	0

William	I-DISEASE
Ishak	I-DISEASE
W	I-DISEASE
,	0
Ugochukwu	I-DISEASE
C	0
,	0
Bagot	0
K	B-DISEASE
,	0
Khalili	0
D	0
,	0
Zaky	I-DISEASE
C.	0
Energy	B-DISEASE
drinks	0
:	I-DISEASE
psychological	I-DISEASE
effects	0
and	0
impact	I-DISEASE
on	0
well	B-DISEASE
-	I-DISEASE
being	I-DISEASE
and	0
quality	0
of	I-DISEASE
life	0
-	0
a	0
literature	0
review	0
.	0

Innov	I-DISEASE
Clin	0
Neurosci	0
2012;9:25–34	I-DISEASE
.	0

Hypersomnia	I-DISEASE
Associated	I-DISEASE
with	I-DISEASE
a	I-DISEASE
Psychiatric	0
Disorder	I-DISEASE
ICD-9	0
-	0
CM	0
code	0
:	0
327.15	0
ICD-10	0
-	0
CM	0
code	0
:	0
F51.13	0
Alternate	0
Names	I-DISEASE
Hypersomnia	0
not	0
due	0
to	0
substance	I-DISEASE
or	0
known	0
physiological	0
condition	0
,	I-DISEASE
nonorganic	0
hypersomnia	0
,	0
pseudohypersomnia	0
,	I-DISEASE
or	0
pseudonarcolepsy	0
.	0

Diagnostic	I-DISEASE
Criteria	0
Criteria	I-DISEASE
A	0
-	I-DISEASE
C	I-DISEASE
must	I-DISEASE
be	0
met	0
A.	0

The	I-DISEASE
patient	I-DISEASE
has	0
daily	I-DISEASE
periods	0
of	I-DISEASE
irrepressible	I-DISEASE
need	I-DISEASE
to	I-DISEASE
sleep	I-DISEASE
or	I-DISEASE
daytime	0
lapses	I-DISEASE
into	I-DISEASE
sleep	0
occurring	0
for	I-DISEASE
at	I-DISEASE
least	I-DISEASE
three	I-DISEASE
months	0
.	0

B.	0
The	I-DISEASE
daytime	I-DISEASE
sleepiness	0
occurs	0
in	I-DISEASE
association	0
with	0
a	0
concurrent	0
psychiatric	I-DISEASE
disorder	I-DISEASE
.	0

C.	I-DISEASE

The	I-DISEASE
symptoms	I-DISEASE
are	0
not	0
better	0
explained	I-DISEASE
by	I-DISEASE
another	I-DISEASE
untreated	I-DISEASE
sleep	0
disorder	I-DISEASE
,	I-DISEASE
a	0
medical	0
or	I-DISEASE
neurological	I-DISEASE
disorder	I-DISEASE
,	0
or	0
the	0
effects	0
of	I-DISEASE
medications	0
or	I-DISEASE
drugs	I-DISEASE
.	0

Essential	I-DISEASE
Features	I-DISEASE
Patients	0
with	0
hypersomnia	I-DISEASE
associated	0
with	I-DISEASE
a	I-DISEASE
psychiatric	I-DISEASE
disorder	0
may	I-DISEASE
report	0
excessive	I-DISEASE
nocturnal	0
sleep	0
,	0
daytime	I-DISEASE
sleepiness	0
,	I-DISEASE
or	0
excessive	0
napping	I-DISEASE
.	0

In	I-DISEASE
addition	0
,	0
they	I-DISEASE
often	0
feel	I-DISEASE
their	0
sleep	0
is	0
of	I-DISEASE
poor	0
quality	0
and	0
nonrestorative	I-DISEASE
.	I-DISEASE

Patients	I-DISEASE
are	0
often	I-DISEASE
intensely	0
focused	0
on	0
their	I-DISEASE
hypersomnolence	0
,	I-DISEASE
and	0
psychiatric	I-DISEASE
symptoms	0
may	0
become	I-DISEASE
apparent	0
only	0
after	0
prolonged	0
interviews	I-DISEASE
or	0
psychometric	0
testing	0
.	0

Associated	I-DISEASE
psychiatric	0
conditions	0
include	I-DISEASE
mood	0
disorders	0
,	0
conversion	0
or	B-DISEASE
undifferentiated	I-DISEASE
somatoform	0
disorder	0
,	0
and	0
less	I-DISEASE
frequently	0
other	I-DISEASE
mental	0
disorders	0
such	0
as	0
schizoaffective	0
disorder	I-DISEASE
,	0
adjustment	0
disor-	0
der	0
,	0
or	0
personality	0
disorders	0
.	0

Associated	I-DISEASE
Features	I-DISEASE
Poor	0
work	I-DISEASE
attendance	0
,	I-DISEASE
spending	0
full	0
days	0
in	0
bed	I-DISEASE
several	I-DISEASE
times	I-DISEASE
a	0
week	0
,	I-DISEASE
or	I-DISEASE
abruptly	I-DISEASE
leaving	0
work	0
because	0
of	I-DISEASE
a	0
perceived	0
need	0
to	I-DISEASE
sleep	0
are	I-DISEASE
common	I-DISEASE
symptoms	I-DISEASE
.	0

Patients	I-DISEASE
may	0
also	0
have	0
social	I-DISEASE
withdrawal	0
,	I-DISEASE
apathy	0
,	I-DISEASE
and	0
feelings	I-DISEASE
of	I-DISEASE
low	0
energy	I-DISEASE
.	0

Clinical	I-DISEASE
and	0
Pathological	0
Subtypes	0
Hypersomnia	I-DISEASE
associated	I-DISEASE
with	I-DISEASE
mood	0
disorder	I-DISEASE
:	I-DISEASE

Hypersomnolence	I-DISEASE
in	I-DISEASE
the	0
context	0
of	I-DISEASE
depression	I-DISEASE
is	I-DISEASE
a	0
frequent	0
feature	0
of	I-DISEASE
atypical	I-DISEASE
depression	I-DISEASE
and	0
bipolar	0
II	I-DISEASE
disorder	0
(	I-DISEASE
recur-	0
rent	I-DISEASE
major	0
depressive	0
episodes	I-DISEASE
with	0
hypomanic	0
episodes	0
)	0
.	0

In	I-DISEASE
seasonal	I-DISEASE
affective	0
disor-	0
der	I-DISEASE
,	0
daytime	0
fatigue	I-DISEASE
,	I-DISEASE
loss	I-DISEASE
of	I-DISEASE
concentration	0
,	I-DISEASE
increased	0
appetite	I-DISEASE
for	0
carbohydrates	0
,	I-DISEASE
and	0
weight	0
gain	0
are	0
reported	I-DISEASE
.	0

MSLT	I-DISEASE
results	I-DISEASE
are	I-DISEASE
usually	0
normal	0
,	I-DISEASE
but	I-DISEASE
long	0
hours	I-DISEASE
spent	I-DISEASE
in	I-DISEASE
bed	I-DISEASE
are	I-DISEASE
reported	0
.	0

Central	I-DISEASE
Disorders	I-DISEASE
of	0
Hypersomnolence	I-DISEASE
Central	I-DISEASE
Disorders	I-DISEASE
of	I-DISEASE
Hypersomnolence	I-DISEASE
Hypersomnia	I-DISEASE
associated	0
with	I-DISEASE
a	I-DISEASE
conversion	0
disorder	I-DISEASE
or	I-DISEASE
somatic	0
symptom	0
disorder	0
:	0
Pseudohypersomnia	0
or	0
pseudonarcolepsy	0
,	I-DISEASE
sometimes	0
with	I-DISEASE
pseudocataplexy	I-DISEASE
,	I-DISEASE
has	0
been	I-DISEASE
described	0
.	0

Demographics	I-DISEASE
Hypersomnia	0
associated	0
with	I-DISEASE
a	0
psychiatric	I-DISEASE
disorder	I-DISEASE
accounts	0
for	0
5	0
%	0
to	0
7	0
%	0
of	I-DISEASE
hyper-	I-DISEASE
somnolence	I-DISEASE
cases	0
.	B-DISEASE

Women	I-DISEASE
are	0
more	0
susceptible	I-DISEASE
than	0
men	I-DISEASE
,	I-DISEASE
and	0
the	0
typical	0
age	I-DISEASE
range	0
is	I-DISEASE
between	0
20	0
and	0
50	0
years	I-DISEASE
.	0

In	I-DISEASE
patients	0
with	0
major	I-DISEASE
depression	0
,	I-DISEASE
the	0
prevalence	I-DISEASE
of	I-DISEASE
hypersom-	0
nolence	0
ranges	I-DISEASE
from	0
5	0
%	0
to	0
over	0
50	0
%	0
depending	I-DISEASE
on	0
how	0
hypersomnolence	0
is	0
defined	I-DISEASE
.	0

Hypersomnolence	I-DISEASE
affects	I-DISEASE
over	0
50	0
%	0
of	I-DISEASE
patients	I-DISEASE
with	I-DISEASE
seasonal	0
affective	0
disorder	I-DISEASE
.	0

Predisposing	I-DISEASE
and	0
Precipitating	I-DISEASE
Factors	0
Not	0
applicable	I-DISEASE
or	I-DISEASE
known	0
.	0

Familial	I-DISEASE
Patterns	I-DISEASE
Not	I-DISEASE
known	I-DISEASE
,	0
except	0
for	0
the	0
familial	I-DISEASE
patterns	0
of	I-DISEASE
certain	I-DISEASE
psychiatric	0
disorders	0
(	I-DISEASE
e.g.	0
,	I-DISEASE
bipolar	0
II	I-DISEASE
disorder	0
)	0
.	0

Onset	I-DISEASE
,	0
Course	0
,	0
and	0
Complications	0
The	I-DISEASE
mean	I-DISEASE
age	I-DISEASE
of	I-DISEASE
onset	0
is	I-DISEASE
usually	I-DISEASE
in	I-DISEASE
the	0
third	0
decade	0
in	I-DISEASE
both	I-DISEASE
sexes	0
.	0

With	I-DISEASE
major	I-DISEASE
depres-	0
sion	0
,	0
hypersomnolence	0
may	I-DISEASE
persist	I-DISEASE
even	0
after	0
the	0
depressive	0
episode	0
improves	I-DISEASE
,	I-DISEASE
and	0
persistent	0
hypersomnolence	I-DISEASE
is	0
associated	0
with	I-DISEASE
increased	0
risk	0
of	0
recurrent	0
depression	I-DISEASE
.	0

Complications	I-DISEASE
are	0
mostly	I-DISEASE
social	0
and	0
occupational	I-DISEASE
.	0

Developmental	I-DISEASE
Issues	0
Hypersomnolence	I-DISEASE
occurs	0
in	I-DISEASE
10	I-DISEASE
%	0
to	0
20	0
%	0
of	I-DISEASE
children	0
with	0
major	I-DISEASE
depression	0
,	I-DISEASE
some-	I-DISEASE
times	I-DISEASE
in	0
combination	I-DISEASE
with	0
insomnia	I-DISEASE
,	0
but	0
sleep	0
quality	0
appears	0
normal	0
.	0

Although	I-DISEASE
sleep	0
problems	0
may	I-DISEASE
develop	0
at	I-DISEASE
any	I-DISEASE
stage	I-DISEASE
of	0
depression	0
,	0
they	I-DISEASE
are	I-DISEASE
most	0
pronounced	0
during	I-DISEASE
the	0
acute	I-DISEASE
phase	0
.	0

Children	I-DISEASE
and	0
adolescents	0
with	0
depression	I-DISEASE
who	I-DISEASE
manifest	I-DISEASE
either	0
insomnia	0
or	I-DISEASE
hypersomnolence	I-DISEASE
generally	I-DISEASE
manifest	0
more	0
pronounced	0
symptoms	I-DISEASE
,	I-DISEASE
such	0
as	0
anhedo-	0
nia	0
and	0
weight	0
loss	0
.	0

Pathology	I-DISEASE
and	0
Pathophysiology	I-DISEASE
The	I-DISEASE
underlying	0
cause	0
is	0
unknown	I-DISEASE
.	0

Although	I-DISEASE
patients	0
with	0
this	I-DISEASE
disorder	0
report	0
sleep-	0
iness	0
,	0
sleep	0
studies	I-DISEASE
reveal	0
little	0
or	I-DISEASE
no	0
evidence	0
of	0
increased	0
propensity	I-DISEASE
to	0
sleep	0
.	0

In	I-DISEASE
some	I-DISEASE
patients	0
,	I-DISEASE
fragmented	0
nighttime	0
sleep	0
may	0
contribute	0
to	I-DISEASE
their	I-DISEASE
daytime	I-DISEASE
sleepiness	0
.	0

Because	I-DISEASE
of	I-DISEASE
uncertainty	0
about	I-DISEASE
the	0
nature	I-DISEASE
of	I-DISEASE
the	B-DISEASE
relationship	0
,	0
the	0
term	0
“	I-DISEASE
hypersomnia	I-DISEASE
associated	0
with	0
a	0
psychiatric	0
disorder	I-DISEASE
”	I-DISEASE
is	0
preferred	I-DISEASE
to	0
“	I-DISEASE
hypersomnia	I-DISEASE
due	0
to	I-DISEASE
a	0
psychi-	0
atric	I-DISEASE
disorder	0
.	0
”	I-DISEASE

Objective	I-DISEASE
Findings	I-DISEASE
Nocturnal	0
polysomnography	0
typically	I-DISEASE
shows	I-DISEASE
a	0
prolonged	0
total	I-DISEASE
time	0
in	0
bed	I-DISEASE
with	0
frag-	0
mented	I-DISEASE
sleep	0
.	0

Sleep	I-DISEASE
latency	I-DISEASE
is	I-DISEASE
prolonged	0
,	I-DISEASE
wake	0
time	I-DISEASE
after	0
sleep	0
onset	0
is	I-DISEASE
increased	I-DISEASE
,	I-DISEASE
awakenings	0
may	I-DISEASE
be	0
frequent	0
and	0
prolonged	0
,	I-DISEASE
and	0
sleep	0
efficiency	I-DISEASE
is	0
low	0
.	0

REM	I-DISEASE
sleep	0
latency	I-DISEASE
may	I-DISEASE
be	I-DISEASE
shortened	I-DISEASE
in	0
the	0
case	I-DISEASE
of	I-DISEASE
untreated	I-DISEASE
depression	I-DISEASE
.	0

Sleep	I-DISEASE
latencies	I-DISEASE
on	0
the	0
MSLT	I-DISEASE
are	I-DISEASE
often	0
within	0
normal	0
limits	0
,	I-DISEASE
a	I-DISEASE
result	0
contrasting	0
with	I-DISEASE
the	I-DISEASE
subjective	0
complaint	0
of	I-DISEASE
daytime	0
sleepiness	0
and	0
an	I-DISEASE
elevated	0
score	I-DISEASE
on	0
the	I-DISEASE
Epworth	0
Sleepiness	0
Scale	I-DISEASE
.	0

24	I-DISEASE
-	I-DISEASE
hour	0
continuous	0
sleep	0
-	0
recording	0
studies	I-DISEASE
typically	0
show	0
considerable	0
time	0
spent	I-DISEASE
in	I-DISEASE
bed	I-DISEASE
during	I-DISEASE
day	0
and	0
night	0
,	0
a	0
behavior	0
sometime	0
referred	I-DISEASE
to	0
as	0
clinophilia	0
.	0

Psychiatric	I-DISEASE
inter-	0
views	0
and	0
evaluations	0
are	0
essential	0
to	I-DISEASE
diagnose	I-DISEASE
the	0
underlying	0
psychiatric	0
condition	0
.	0

Differential	I-DISEASE
Diagnosis	0
As	0
there	I-DISEASE
are	I-DISEASE
no	0
definitive	0
tests	0
for	0
diagnosing	I-DISEASE
hypersomnolence	I-DISEASE
associated	0
with	0
a	I-DISEASE
psy-	0
chiatric	I-DISEASE
disorder	0
,	0
it	0
is	0
essential	0
to	0
rule	0
out	0
other	0
common	I-DISEASE
causes	0
of	0
sleepiness	0
such	I-DISEASE
as	0
insufficient	0
sleep	0
,	0
sedation	I-DISEASE
from	0
medications	0
or	0
substances	I-DISEASE
,	I-DISEASE
SRBD	0
,	0
periodic	I-DISEASE
limb	I-DISEASE
movement	I-DISEASE
disorder	0
,	0
and	0
IH	I-DISEASE
.	0

Chronic	I-DISEASE
fatigue	I-DISEASE
syndrome	I-DISEASE
is	0
characterized	0
by	I-DISEASE
persistent	0
or	B-DISEASE
relapsing	0
fatigue	I-DISEASE
that	0
does	0
not	0
resolve	0
with	I-DISEASE
sleep	0
or	0
rest	I-DISEASE
,	0
but	I-DISEASE
the	0
main	0
complaint	I-DISEASE
is	0
usually	I-DISEASE
fatigue	I-DISEASE
rather	0
than	I-DISEASE
sleepiness	I-DISEASE
.	0

Insufficient	I-DISEASE
sleep	0
syndrome	I-DISEASE
is	I-DISEASE
associated	0
with	0
excessive	0
daytime	0
sleepiness	0
,	I-DISEASE
impaired	0
concentration	0
,	I-DISEASE
and	0
lowered	0
energy	0
level	0
,	0
but	I-DISEASE
a	0
detailed	I-DISEASE
history	I-DISEASE
of	0
the	I-DISEASE
subject	I-DISEASE
’s	I-DISEASE
current	I-DISEASE
sleep	0
schedule	I-DISEASE
reveals	I-DISEASE
chronic	I-DISEASE
sleep	0
deprivation	0
.	0

Unresolved	I-DISEASE
Issues	0
and	0
Future	0
Directions	0

The	I-DISEASE
lack	I-DISEASE
of	I-DISEASE
concordance	I-DISEASE
between	0
subjective	I-DISEASE
and	0
objective	0
findings	0
raises	0
multiple	I-DISEASE
issues	I-DISEASE
.	0

It	I-DISEASE
is	I-DISEASE
unclear	I-DISEASE
to	I-DISEASE
what	0
extent	I-DISEASE
these	I-DISEASE
patients	I-DISEASE
are	0
objectively	0
sleepy	I-DISEASE
or	I-DISEASE
,	I-DISEASE
instead	0
,	I-DISEASE
suffer	I-DISEASE
from	I-DISEASE
decreased	0
energy	0
and	0
lack	I-DISEASE
of	I-DISEASE
interest	I-DISEASE
that	0
confines	I-DISEASE
them	I-DISEASE
to	0
bed	I-DISEASE
.	0

More	I-DISEASE
research	0
is	0
needed	0
to	0
create	0
an	0
effective	I-DISEASE
definition	0
of	I-DISEASE
hypersomnolence	0
in	I-DISEASE
this	0
population	0
and	0
to	0
develop	I-DISEASE
tools	0
for	0
measuring	I-DISEASE
it	0
.	0

Finally	I-DISEASE
,	I-DISEASE
future	0
efforts	I-DISEASE
should	0
define	0
the	0
mechanism	0
through	0
which	0
some	I-DISEASE
patients	I-DISEASE
express	I-DISEASE
their	I-DISEASE
psychiatric	0
symptoms	I-DISEASE
as	0
excessive	I-DISEASE
sleepiness	0
.	0

Bibliography	0
Guilleminault	I-DISEASE
C	0
,	0
Brooks	0
SN	I-DISEASE
.	0

Excessive	I-DISEASE
daytime	I-DISEASE
sleepiness	0
:	0
a	I-DISEASE
challenge	0
for	0
the	0
practicing	I-DISEASE
neurologist	I-DISEASE
.	0

Brain	0
2001;124:1282–91	I-DISEASE
.	0

Kaplan	I-DISEASE
KA	0
,	I-DISEASE
Harvey	0
AG	I-DISEASE
.	0

Hypersomnia	I-DISEASE
across	I-DISEASE
mood	0
disorders	0
:	0
a	0
review	0
and	0
synthesis	I-DISEASE
.	0

Sleep	I-DISEASE
Med	I-DISEASE
Rev	0
2009;13:275–85	I-DISEASE
.	0

Kotagal	I-DISEASE
S.	I-DISEASE
Hypersomnia	0
in	0
children	0
:	I-DISEASE
interface	I-DISEASE
with	I-DISEASE
psychiatric	0
disorders	0
.	0

Child	I-DISEASE
Adolesc	0
Psychiatr	0
Clin	0
N	0
Am	I-DISEASE
2009;18:967–77	I-DISEASE
.	0

Liu	I-DISEASE
X	0
,	0
Buysse	I-DISEASE
DJ	I-DISEASE
,	I-DISEASE
Gentzler	I-DISEASE
AL	0
,	I-DISEASE
et	0
al	I-DISEASE
.	0

Insomnia	I-DISEASE
and	0
hypersomnia	I-DISEASE
associated	0
with	I-DISEASE
depressive	I-DISEASE
phenomenology	0
and	0
comorbidity	0
in	0
childhood	0
depression	I-DISEASE
.	0

Sleep	I-DISEASE
2007;30:83–90	I-DISEASE
.	0

Nofzinger	0
EA	0
,	I-DISEASE
Thase	0
ME	0
,	0
Reynolds	I-DISEASE
CF	I-DISEASE
3rd	0
,	0
et	0
al	I-DISEASE
.	0

Hypersomnia	I-DISEASE
in	I-DISEASE
bipolar	0
depression	0
:	0
a	0
comparison	I-DISEASE
with	I-DISEASE
narcolepsy	0
using	0
the	0
Multiple	0
Sleep	0
Latency	0
Test	I-DISEASE
.	0

Am	I-DISEASE
J	0
Psychiatry	0
1991;148:1177–81	0
.	0

Central	I-DISEASE
Disorders	I-DISEASE
of	0
Hypersomnolence	I-DISEASE
Central	I-DISEASE
Disorders	I-DISEASE
of	I-DISEASE
Hypersomnolence	I-DISEASE
Partonen	I-DISEASE
T	0
,	I-DISEASE
Lönnqvist	I-DISEASE
J.	0
Seasonal	0
affective	0
disorder	I-DISEASE
.	0

Lancet	I-DISEASE
1998;352:1369–74	0
.	0

van	I-DISEASE
den	0
Berg	0
JF	0
,	I-DISEASE
Luijendijk	I-DISEASE
HJ	I-DISEASE
,	I-DISEASE
Tulen	I-DISEASE
JH	0
,	0
Hofman	0
A	0
,	0
Neven	0
AK	I-DISEASE
,	I-DISEASE
Tiemeier	0
H.	I-DISEASE
Sleep	0
in	I-DISEASE
depression	0
and	0
anxiety	0
disorders	0
:	0
a	0
population	0
-	0
based	I-DISEASE
study	I-DISEASE
of	I-DISEASE
elderly	I-DISEASE
persons	0
.	0

J	I-DISEASE
Clin	0
Psychiatry	0
2009;70:1105–13	I-DISEASE
.	0

Vgontzas	I-DISEASE
AN	0
,	I-DISEASE
Bixler	0
EO	0
,	I-DISEASE
Kales	I-DISEASE
A	0
,	0
Criley	0
C	0
,	0
Vela	I-DISEASE
-	0
Bueno	0
A.	0
Differences	I-DISEASE
in	0
nocturnal	0
and	0
daytime	0
sleep	0
between	0
primary	0
and	0
psychiatric	0
hypersomnia	0
:	0
diagnosis	I-DISEASE
and	0
treatment	0
implications	0
.	0

Psychosom	I-DISEASE
Med	I-DISEASE
2000;62:220–6	I-DISEASE
.	0

Insufficient	I-DISEASE
Sleep	0
Syndrome	I-DISEASE
ICD-9	0
-	I-DISEASE
CM	I-DISEASE
code	0
:	I-DISEASE
307.44	I-DISEASE
ICD-10	0
-	0
CM	I-DISEASE
code	0
:	0

F51.12	I-DISEASE
Alternate	0
Names	I-DISEASE
Behaviorally	0
induced	0
insufficient	0
sleep	I-DISEASE
syndrome	I-DISEASE
,	0
insufficient	0
nocturnal	0
sleep	0
,	0
chronic	I-DISEASE
sleep	0
deprivation	I-DISEASE
,	0
sleep	0
restriction	0
.	0

Diagnostic	I-DISEASE
Criteria	0
Criteria	I-DISEASE
A	0
-	I-DISEASE
F	I-DISEASE
must	I-DISEASE
be	0
met	0
A.	0

The	I-DISEASE
patient	I-DISEASE
has	0
daily	I-DISEASE
periods	0
of	I-DISEASE
irrepressible	I-DISEASE
need	0
to	I-DISEASE
sleep	I-DISEASE
or	I-DISEASE
daytime	0
lapses	I-DISEASE
into	I-DISEASE
sleep	0
or	0
,	I-DISEASE
in	I-DISEASE
the	0
case	I-DISEASE
of	I-DISEASE
prepubertal	0
children	I-DISEASE
,	I-DISEASE
there	I-DISEASE
is	0
a	0
complaint	I-DISEASE
of	I-DISEASE
behavioral	I-DISEASE
abnormalities	0
attributable	I-DISEASE
to	0
sleepiness	0
.	I-DISEASE

B.	0
The	I-DISEASE
patient	I-DISEASE
’s	I-DISEASE
sleep	0
time	I-DISEASE
,	0
established	0
by	I-DISEASE
personal	0
or	I-DISEASE
collateral	I-DISEASE
history	I-DISEASE
,	I-DISEASE
sleep	0
logs	0
,	I-DISEASE
or	0
actigraphy1	0
is	0
usually	I-DISEASE
shorter	0
than	I-DISEASE
expected	I-DISEASE
for	I-DISEASE
age.2	I-DISEASE
C.	0

The	I-DISEASE
curtailed	0
sleep	0
pattern	0
is	0
present	I-DISEASE
most	0
days	0
for	0
at	I-DISEASE
least	I-DISEASE
three	I-DISEASE
months	0
.	0

D.	I-DISEASE

The	I-DISEASE
patient	I-DISEASE
curtails	0
sleep	0
time	0
by	I-DISEASE
such	0
measures	0
as	0
an	0
alarm	I-DISEASE
clock	0
or	0
being	I-DISEASE
awakened	I-DISEASE
by	I-DISEASE
another	0
person	0
and	0
generally	0
sleeps	0
longer	0
when	0
such	0
measures	0
are	0
not	0
used	0
,	I-DISEASE
such	0
as	0
on	0
weekends	0
or	0
vacations	0
.	0

E.	I-DISEASE
Extension	I-DISEASE
of	I-DISEASE
total	I-DISEASE
sleep	I-DISEASE
time	I-DISEASE
results	I-DISEASE
in	0
resolution	I-DISEASE
of	I-DISEASE
the	0
symptoms	I-DISEASE
of	I-DISEASE
sleepiness	0
.	0

F.	I-DISEASE

The	I-DISEASE
symptoms	I-DISEASE
are	0
not	0
better	0
explained	I-DISEASE
by	I-DISEASE
another	I-DISEASE
untreated	I-DISEASE
sleep	0
disorder	I-DISEASE
,	I-DISEASE
the	0
effects	0
of	I-DISEASE
medications	I-DISEASE
or	0
drugs	0
,	I-DISEASE
or	0
other	I-DISEASE
medical	0
,	I-DISEASE
neurologic	0
,	I-DISEASE
or	I-DISEASE
mental	0
disorder	0
.	0

Notes	I-DISEASE
.	0

If	I-DISEASE
there	I-DISEASE
is	0
doubt	I-DISEASE
about	0
the	0
accuracy	0
of	I-DISEASE
personal	0
history	I-DISEASE
or	0
sleep	0
logs	I-DISEASE
,	I-DISEASE
then	0
actigraphy	0
should	0
be	0
performed	0
,	0
preferably	0
for	0
at	I-DISEASE
least	0
two	I-DISEASE
weeks	0
.	0
.	0

In	I-DISEASE
the	0
case	I-DISEASE
of	I-DISEASE
long	0
sleepers	0
,	I-DISEASE
reported	0
habitual	0
sleep	0
periods	I-DISEASE
may	I-DISEASE
be	0
normal	0
based	I-DISEASE
on	0
age	0
.	0

However	I-DISEASE
,	I-DISEASE
these	0
sleep	0
periods	0
may	I-DISEASE
be	0
insufficient	I-DISEASE
for	0
these	0
patients	0
.	0

Essential	I-DISEASE
Features	I-DISEASE
Insufficient	I-DISEASE
sleep	I-DISEASE
syndrome	I-DISEASE
occurs	0
when	0
an	0
individual	I-DISEASE
persistently	I-DISEASE
fails	0
to	I-DISEASE
obtain	I-DISEASE
the	I-DISEASE
amount	0
of	I-DISEASE
sleep	I-DISEASE
required	I-DISEASE
to	I-DISEASE
maintain	0
normal	0
levels	I-DISEASE
of	I-DISEASE
alertness	I-DISEASE
and	0
wakefulness	0
.	0

The	I-DISEASE
individual	I-DISEASE
is	0
chronically	I-DISEASE
sleep	0
deprived	I-DISEASE
as	I-DISEASE
a	0
result	0
of	I-DISEASE
failure	0
to	I-DISEASE
achieve	I-DISEASE
necessary	0
sleep	0
time	I-DISEASE
due	I-DISEASE
to	0
reduced	0
time	I-DISEASE
in	I-DISEASE
bed	I-DISEASE
.	0

There	0
is	0
a	0
U	I-DISEASE
-	0
shaped	0
relationship	0
between	0
age	0
and	0
average	0
sleep	0
time	I-DISEASE
,	I-DISEASE
with	0
the	0
minimum	I-DISEASE
in	I-DISEASE
middle	0
-	0
aged	I-DISEASE
individuals	I-DISEASE
.	0

Examination	I-DISEASE
reveals	0
unimpaired	0
or	I-DISEASE
above	B-DISEASE
-	0
average	0
ability	0
to	I-DISEASE
initiate	I-DISEASE
and	0
maintain	0
sleep	0
,	I-DISEASE
with	I-DISEASE
little	0
or	0
no	0
psychopathology	0
.	0

Physical	I-DISEASE
examination	0
reveals	0
no	I-DISEASE
medical	0
explanation	I-DISEASE
for	I-DISEASE
the	I-DISEASE
patient	I-DISEASE
’s	I-DISEASE
sleepiness	0
.	0

A	I-DISEASE
detailed	I-DISEASE
history	I-DISEASE
of	I-DISEASE
the	0
sleep	0
pattern	0
reveals	I-DISEASE
a	0
substantial	0
dis-	I-DISEASE
parity	0
between	0
the	0
need	I-DISEASE
for	0
sleep	0
and	0
the	0
amount	I-DISEASE
actually	I-DISEASE
obtained	0
.	0

The	I-DISEASE
significance	I-DISEASE
of	I-DISEASE
this	0
disparity	0
often	0
goes	0
unappreciated	0
by	I-DISEASE
the	0
patient	I-DISEASE
.	0

Sleep	I-DISEASE
time	0
that	0
is	I-DISEASE
markedly	0
extended	0
on	0
weekend	0
nights	0
or	0
during	I-DISEASE
holidays	I-DISEASE
compared	I-DISEASE
to	0
weekday	I-DISEASE
nights	0
is	I-DISEASE
also	0
suggestive	0
of	I-DISEASE
this	0
disorder	I-DISEASE
.	0

A	I-DISEASE
therapeutic	I-DISEASE
trial	0
of	I-DISEASE
a	0
longer	I-DISEASE
major	I-DISEASE
sleep	0
episode	0
can	0
reverse	0
the	0
symptoms	I-DISEASE
.	0

In	I-DISEASE
individuals	I-DISEASE
with	0
physiologic	0
sleep	0
requirements	0
significantly	0
in	I-DISEASE
excess	I-DISEASE
of	I-DISEASE
seven	0
to	0
eight	I-DISEASE
hours	I-DISEASE
,	0
reported	0
“	I-DISEASE
average	0
”	I-DISEASE
amounts	I-DISEASE
of	I-DISEASE
sleep	I-DISEASE
(	0
e.g.	I-DISEASE
,	I-DISEASE
seven	0
hours	I-DISEASE
/	0
night	0
)	0
may	0
,	I-DISEASE
in	I-DISEASE
fact	0
,	0
be	0
insufficient	0
.	0

Additional	I-DISEASE
symptoms	I-DISEASE
such	0
as	0
sleep	0
paralysis	I-DISEASE
and	0
hypnagogic	0
hallucinations	0
may	0
occur	0
.	0

Associated	I-DISEASE
Features	I-DISEASE
Depending	0
upon	0
chronicity	0
and	0
extent	I-DISEASE
of	0
sleep	0
loss	0
,	I-DISEASE
individuals	I-DISEASE
with	I-DISEASE
this	0
condition	0
may	I-DISEASE
show	I-DISEASE
irritability	0
,	0
concentration	0
and	0
attention	0
deficits	0
,	0
reduced	0
vigilance	0
,	0
distract-	I-DISEASE
ibility	I-DISEASE
,	0
reduced	0
motivation	0
,	0
anergia	0
,	0
dysphoria	I-DISEASE
,	0
fatigue	I-DISEASE
,	0
restlessness	I-DISEASE
,	0
uncoordination	I-DISEASE
,	0
and	0
malaise	0
.	0

Secondary	I-DISEASE
symptoms	I-DISEASE
may	0
become	I-DISEASE
the	0
main	I-DISEASE
focus	I-DISEASE
of	I-DISEASE
the	0
patient	I-DISEASE
,	I-DISEASE
serving	I-DISEASE
to	I-DISEASE
obscure	0
the	0
primary	0
cause	I-DISEASE
of	I-DISEASE
the	0
difficulties	0
.	0

Psychologically	I-DISEASE
and	0
somatically	I-DISEASE
normal	0
individuals	I-DISEASE
who	I-DISEASE
chronically	0
obtain	I-DISEASE
less	I-DISEASE
sleep	0
than	0
they	I-DISEASE
physiologically	0
require	0
typi-	0
cally	I-DISEASE
experience	I-DISEASE
daytime	0
sleepiness	0
.	0

Situational	I-DISEASE
factors	I-DISEASE
such	0
as	I-DISEASE
demands	0
of	I-DISEASE
the	0
family	0
and	0
work	I-DISEASE
schedule	I-DISEASE
may	I-DISEASE
,	0
on	0
occasion	I-DISEASE
,	I-DISEASE
make	0
it	0
very	I-DISEASE
difficult	0
to	I-DISEASE
obtain	I-DISEASE
adequate	0
sleep	I-DISEASE
.	0

Clinical	I-DISEASE
and	0
Pathophysiologic	I-DISEASE
Subtypes	0
Not	I-DISEASE
applicable	I-DISEASE
or	I-DISEASE
known	0
.	0

Demographics	I-DISEASE
Insufficient	0
sleep	0
syndrome	0
affects	I-DISEASE
all	0
ages	I-DISEASE
and	0
both	I-DISEASE
sexes	0
.	0

It	I-DISEASE
may	I-DISEASE
be	0
more	0
frequent	0
in	I-DISEASE
adolescence	0
,	0
when	0
sleep	I-DISEASE
need	I-DISEASE
is	I-DISEASE
high	I-DISEASE
,	I-DISEASE
but	I-DISEASE
social	I-DISEASE
pressure	0
and	0
tendency	I-DISEASE
to	I-DISEASE
delay	I-DISEASE
sleep	0
often	0
lead	0
to	0
chronic	I-DISEASE
restricted	0
sleep	0
.	0

Cultural	I-DISEASE
factors	I-DISEASE
may	0
also	0
influence	0
sleep	0
dura-	0
tion	0
,	I-DISEASE
with	I-DISEASE
students	I-DISEASE
from	0
different	0
countries	B-DISEASE
reporting	I-DISEASE
sleep	0
time	0
varying	I-DISEASE
between	0
six	I-DISEASE
and	0
eight	0
hours	I-DISEASE
per	0
night	I-DISEASE
.	0

Central	I-DISEASE
Disorders	I-DISEASE
of	0
Hypersomnolence	I-DISEASE
Central	I-DISEASE
Disorders	I-DISEASE
of	I-DISEASE
Hypersomnolence	I-DISEASE
Predisposing	0
and	0

Precipitating	I-DISEASE
Factors	0
Social	I-DISEASE
and	0
psychological	I-DISEASE
factors	0
may	0
impact	I-DISEASE
nocturnal	I-DISEASE
sleep	0
length	0
and	0
daytime	I-DISEASE
sleep-	0
iness	I-DISEASE
.	0

Cultural	I-DISEASE
habits	I-DISEASE
such	0
as	0
the	0
siesta	I-DISEASE
may	I-DISEASE
enhance	0
evening	0
alertness	I-DISEASE
at	I-DISEASE
the	0
expense	0
of	I-DISEASE
reducing	0
nocturnal	I-DISEASE
sleep	0
efficiency	I-DISEASE
.	0

Also	I-DISEASE
,	I-DISEASE
the	0
evening	I-DISEASE
preference	0
chronotype	I-DISEASE
predis-	0
poses	I-DISEASE
to	I-DISEASE
complaints	I-DISEASE
of	I-DISEASE
insomnia	I-DISEASE
and	0
insufficient	0
sleep	I-DISEASE
.	0

The	I-DISEASE
association	I-DISEASE
of	I-DISEASE
eveningness	0
with	I-DISEASE
insufficient	0
sleep	0
persists	0
after	0
controlling	I-DISEASE
for	I-DISEASE
variables	I-DISEASE
such	0
as	0
sex	0
,	0
age	I-DISEASE
,	0
and	0
sleep	0
duration	0
.	0

Familial	I-DISEASE
Patterns	I-DISEASE
Not	I-DISEASE
applicable	0
or	B-DISEASE
known	0
.	0

Onset	I-DISEASE
,	0
Course	0
,	0
and	0
Complications	0
This	B-DISEASE
condition	0
results	I-DISEASE
in	I-DISEASE
increased	0
daytime	I-DISEASE
sleepiness	0
,	0
concentration	0
problems	0
,	0
lowered	I-DISEASE
energy	I-DISEASE
level	0
,	I-DISEASE
and	0
malaise	0
.	0

If	I-DISEASE
unchecked	I-DISEASE
,	0
insufficient	0
sleep	0
syndrome	I-DISEASE
may	0
predispose	0
to	I-DISEASE
depression	I-DISEASE
and	0
other	I-DISEASE
psychological	I-DISEASE
difficulties	I-DISEASE
,	0
as	0
well	I-DISEASE
as	0
poor	0
work	I-DISEASE
performance	0
and	0
withdrawal	0
from	I-DISEASE
family	0
and	0
social	I-DISEASE
activities	I-DISEASE
.	0

Abuse	I-DISEASE
of	I-DISEASE
stimulants	0
may	I-DISEASE
also	0
occur	0
.	0

Traffic	I-DISEASE
accidents	0
or	0
injury	I-DISEASE
at	I-DISEASE
work	I-DISEASE
may	0
result	0
.	0

Developmental	I-DISEASE
Issues	0
Insufficient	I-DISEASE
sleep	0
syndrome	0
is	0
a	0
common	I-DISEASE
problem	I-DISEASE
in	I-DISEASE
adolescents	0
.	0

It	I-DISEASE
should	I-DISEASE
be	0
differ-	I-DISEASE
entiated	I-DISEASE
from	0
delayed	0
sleep	0
phase	0
disorder	I-DISEASE
,	I-DISEASE
the	0
effects	0
of	I-DISEASE
recreational	I-DISEASE
drug	0
use	0
,	I-DISEASE
and	0
school	I-DISEASE
avoidance	0
behavior	I-DISEASE
.	0

Increased	I-DISEASE
predisposition	0
to	I-DISEASE
substance	I-DISEASE
use	I-DISEASE
and	0
accidents	0
in	I-DISEASE
teens	I-DISEASE
may	I-DISEASE
be	I-DISEASE
consequent	0
to	I-DISEASE
insufficient	0
sleep	0
.	0

Pathology	I-DISEASE
and	0
Pathophysiology	I-DISEASE
Symptoms	I-DISEASE
are	I-DISEASE
due	I-DISEASE
to	0
normal	0
physiological	0
and	0
psychological	0
responses	I-DISEASE
to	I-DISEASE
sleep	0
depri-	0
vation	0
.	0

Sleep	I-DISEASE
restriction	0
studies	I-DISEASE
in	I-DISEASE
normal	0
volunteers	I-DISEASE
have	0
shown	I-DISEASE
that	0
even	0
mild	0
sleep	0
restriction	I-DISEASE
(	I-DISEASE
for	0
example	0
,	I-DISEASE
six	I-DISEASE
hours	I-DISEASE
of	0
nocturnal	0
sleep	0
per	I-DISEASE
night	0
)	0
results	0
in	I-DISEASE
a	0
correspond-	0
ing	0
decrease	I-DISEASE
in	I-DISEASE
performance	0
and	0
increased	0
sleepiness	0
.	0

Sleep	I-DISEASE
restriction	0
to	0
four	I-DISEASE
hours	I-DISEASE
per	I-DISEASE
night	0
(	I-DISEASE
i.e.	0
,	I-DISEASE
extension	I-DISEASE
of	I-DISEASE
wakefulness	0
to	I-DISEASE
20	0
hours	I-DISEASE
per	0
day	0
)	0
will	0
likely	0
lead	0
to	0
greater	I-DISEASE
buildup	0
of	I-DISEASE
homeostatic	I-DISEASE
sleep	0
drive	B-DISEASE
during	I-DISEASE
the	0
waking	0
hours	I-DISEASE
and	0
greater	I-DISEASE
likelihood	0
of	0
impaired	I-DISEASE
performance	0
on	0
a	0
psychomotor	0
vigilance	0
task	0
.	0

The	I-DISEASE
effects	0
of	I-DISEASE
sleep	0
depriva-	0
tion	0
on	0
neurobehavioral	I-DISEASE
performance	0
measures	0
may	I-DISEASE
vary	0
with	I-DISEASE
the	0
nature	0
of	I-DISEASE
the	0
task	0
being	I-DISEASE
considered	I-DISEASE
.	0

In	I-DISEASE
some	I-DISEASE
long	I-DISEASE
sleepers	I-DISEASE
,	I-DISEASE
it	I-DISEASE
is	I-DISEASE
important	B-DISEASE
to	0
be	I-DISEASE
aware	I-DISEASE
that	I-DISEASE
extending	I-DISEASE
sleep	0
to	I-DISEASE
nine	I-DISEASE
or	I-DISEASE
more	0
hours	I-DISEASE
often	I-DISEASE
results	I-DISEASE
in	I-DISEASE
improved	I-DISEASE
performance	0
.	I-DISEASE

The	I-DISEASE
diagnosis	I-DISEASE
of	I-DISEASE
insufficient	I-DISEASE
sleep	0
syn-	0
drome	0
may	I-DISEASE
be	I-DISEASE
especially	I-DISEASE
difficult	I-DISEASE
to	0
make	0
in	I-DISEASE
subjects	I-DISEASE
who	0
have	0
a	0
physiologic	0
need	0
for	I-DISEASE
unusually	I-DISEASE
large	I-DISEASE
amounts	I-DISEASE
of	I-DISEASE
sleep	0
.	B-DISEASE

Objective	I-DISEASE
Findings	I-DISEASE
Actigraphy	I-DISEASE
combined	0
with	0
sleep	0
diaries	I-DISEASE
maintained	I-DISEASE
for	0
a	0
2-	0
to	0
3	0
-	I-DISEASE
week	0
period	I-DISEASE
may	I-DISEASE
be	0
helpful	I-DISEASE
by	0
documenting	I-DISEASE
total	0
time	I-DISEASE
in	I-DISEASE
bed	I-DISEASE
,	0
sleep	0
latency	I-DISEASE
,	0
total	0
sleep	0
time	0
,	0
and	0
sleep	0
efficiency	I-DISEASE
.	0

Polysomnography	I-DISEASE
and	0
MSLT	I-DISEASE
are	0
not	0
required	0
to	I-DISEASE
establish	I-DISEASE
a	I-DISEASE
diagnosis	0
of	I-DISEASE
insufficient	0
sleep	0
syndrome	0
.	0

Rather	I-DISEASE
,	I-DISEASE
sleep	0
time	I-DISEASE
is	0
extended	0
first	0
,	I-DISEASE
and	0
the	0
patient	I-DISEASE
is	I-DISEASE
reevaluated	I-DISEASE
.	0

If	I-DISEASE
a	0
therapeutic	0
trial	0
with	0
a	0
longer	I-DISEASE
sleep	0
episode	0
eliminates	0
the	0
symptoms	I-DISEASE
,	I-DISEASE
insufficient	0
sleep	0
syndrome	I-DISEASE
is	I-DISEASE
diagnosed	0
.	0

Polysomnography	I-DISEASE
,	I-DISEASE
when	I-DISEASE
performed	0
,	0
reveals	0
reduced	0
sleep	0
onset	I-DISEASE
latency	I-DISEASE
,	I-DISEASE
and	0
high	I-DISEASE
(	0
greater	0
than	I-DISEASE
90	I-DISEASE
%	0
)	0
sleep	0
efficiency	I-DISEASE
.	0

When	I-DISEASE
extended	0
sleep	0
is	0
permitted	0
,	I-DISEASE
prolonged	0
sleep	0
time	0
with	0
slow	0
wave	I-DISEASE
rebound	I-DISEASE
may	0
be	0
seen	I-DISEASE
.	0

Noting	I-DISEASE
a	0
disparity	I-DISEASE
between	0
reported	I-DISEASE
sleep	0
at	I-DISEASE
home	0
and	0
observed	I-DISEASE
total	I-DISEASE
sleep	0
time	0
in	I-DISEASE
the	I-DISEASE
sleep	0
laboratory	I-DISEASE
can	0
be	0
helpful	I-DISEASE
.	0

The	I-DISEASE
MSLT	I-DISEASE
reveals	I-DISEASE
excessive	0
sleepiness	0
,	I-DISEASE
with	0
stage	0
N1	0
sleep	I-DISEASE
occurring	I-DISEASE
in	0
most	0
naps	I-DISEASE
,	0
with	0
short	0
sleep	0
latency	I-DISEASE
.	0

Stage	I-DISEASE
N2	0
sleep	0
occurs	0
in	I-DISEASE
more	0
than	I-DISEASE
80	0
%	0
of	I-DISEASE
MSLT	I-DISEASE
naps	I-DISEASE
.	0

SOREMPs	I-DISEASE
can	0
occur	I-DISEASE
.	0

Differential	I-DISEASE
Diagnosis	0
Insufficient	I-DISEASE
sleep	0
syndrome	I-DISEASE
may	I-DISEASE
be	I-DISEASE
confused	I-DISEASE
with	0
narcolepsy	0
or	0
other	I-DISEASE
hypersom-	0
nolence	0
disorders	0
because	0
an	B-DISEASE
abnormal	0
MSLT	I-DISEASE
(	I-DISEASE
even	I-DISEASE
with	0
two	I-DISEASE
SOREMPs	I-DISEASE
)	0
can	0
be	I-DISEASE
observed	I-DISEASE
as	0
the	0
result	0
of	I-DISEASE
acute	0
or	0
chronic	0
sleep	0
deprivation	0
.	0

The	I-DISEASE
confusion	0
may	0
be	I-DISEASE
most	0
frequently	I-DISEASE
encountered	0
in	I-DISEASE
adolescents	0
or	0
young	I-DISEASE
adults	I-DISEASE
.	0

The	I-DISEASE
differential	0
diagno-	0
sis	0
of	I-DISEASE
insufficient	0
sleep	0
syndrome	I-DISEASE
includes	I-DISEASE
numerous	I-DISEASE
other	0
conditions	I-DISEASE
that	0
may	I-DISEASE
result	0
in	0
daytime	I-DISEASE
sleepiness	0
or	I-DISEASE
shortening	0
of	0
nocturnal	0
sleep	0
duration	0
.	0

These	0
include	I-DISEASE
other	0
central	0
disorders	0
of	I-DISEASE
hypersomnolence	I-DISEASE
,	I-DISEASE
long	0
sleeper	0
or	I-DISEASE
short	0
sleeper	0
,	0
SRBD	0
,	I-DISEASE
circadian	0
rhythm	0
sleep	0
disorders	0
,	I-DISEASE
insomnia	0
disorder	I-DISEASE
,	0
affective	0
disorder	0
,	0
and	0
periodic	0
limb	0
move-	I-DISEASE
ment	I-DISEASE
disorder	I-DISEASE
.	0

Unresolved	I-DISEASE
Issues	0
and	0
Future	0
Directions	0

The	I-DISEASE
correlation	I-DISEASE
between	0
subjectively	I-DISEASE
reported	I-DISEASE
sleepiness	0
,	0
performance	0
-	0
test	0
decre-	I-DISEASE
ments	0
,	I-DISEASE
and	0
MSLT	0
-	0
measured	0
sleepiness	0
after	I-DISEASE
sleep	0
deprivation	I-DISEASE
is	I-DISEASE
poor	0
.	0

Short	I-DISEASE
sleepers	0
often	I-DISEASE
have	0
a	0
higher	0
NREM	0
sleep	0
pressure	0
,	I-DISEASE
as	I-DISEASE
measured	0
by	I-DISEASE
EEG	0
delta	0
power	0
,	I-DISEASE
than	0
long	I-DISEASE
sleepers	0
,	I-DISEASE
even	0
if	0
they	I-DISEASE
do	I-DISEASE
not	0
complain	I-DISEASE
of	I-DISEASE
daytime	I-DISEASE
sleepiness	0
.	0

There	I-DISEASE
is	I-DISEASE
interindividual	0
susceptibility	I-DISEASE
to	I-DISEASE
sleep	0
deprivation	0
,	0
with	0
some	I-DISEASE
people	0
being	I-DISEASE
consistently	I-DISEASE
more	0
tired	0
and	0
experiencing	0
greater	I-DISEASE
performance	0
decrement	0
after	0
even	I-DISEASE
a	0
mild	0
degree	0
of	I-DISEASE
sleep	0
deprivation	0
.	0

Bibliography	0
Carskadon	I-DISEASE
MA	0
,	I-DISEASE
Dement	0
WC	I-DISEASE
.	0

Effects	I-DISEASE
of	I-DISEASE
total	I-DISEASE
sleep	I-DISEASE
loss	0
on	0
sleep	I-DISEASE
tendency	I-DISEASE
.	0

Percept	I-DISEASE
Mot	0
Skills	I-DISEASE
1979;48:495–506	0
.	0

Central	I-DISEASE
Disorders	I-DISEASE
of	I-DISEASE
Hypersomnolence	I-DISEASE
Central	I-DISEASE
Disorders	I-DISEASE
of	I-DISEASE
Hypersomnolence	I-DISEASE
Habeck	I-DISEASE
C	0
,	I-DISEASE
Rakitin	0
BC	0
,	0
Moeller	0
J	0
,	0
et	0
al	I-DISEASE
.	0

An	I-DISEASE
event	0
related	0
fMRI	I-DISEASE
study	0
of	I-DISEASE
the	0
neurobehavioral	0
impact	I-DISEASE
of	I-DISEASE
sleep	I-DISEASE
deprivation	0
on	0
performance	0
of	I-DISEASE
a	I-DISEASE
delayed	0
match	I-DISEASE
to	0
sample	I-DISEASE
task	0
.	B-DISEASE

Cogn	I-DISEASE
Brain	0
Res	0
2004;18:306–21	0
.	I-DISEASE

Merikanto	I-DISEASE
I	0
,	0
Kronholm	0
E	0
,	0
Peltonen	0
M	I-DISEASE
,	I-DISEASE
Laatikainen	I-DISEASE
T	0
,	0
Lahti	I-DISEASE
T	0
,	0
Partonen	I-DISEASE
T.	0
Relation	0
of	I-DISEASE
chronotype	0
to	0
sleep	0
complaints	0
in	I-DISEASE
the	0
general	0
Finnish	I-DISEASE
population	0
.	I-DISEASE

Chronobiol	I-DISEASE
Int	0
2012;29:311–7	I-DISEASE
.	0

Mont	I-DISEASE
TH	0
,	I-DISEASE
Buysse	0
DJ	0
,	I-DISEASE
Carrier	B-DISEASE
J	0
,	I-DISEASE
Bart	I-DISEASE
BD	0
,	0
Rose	I-DISEASE
LR	0
.	0

Effects	I-DISEASE
of	I-DISEASE
afternoon	0
“	I-DISEASE
siesta	0
”	I-DISEASE
naps	I-DISEASE
on	0
sleep	0
,	I-DISEASE
alertness	I-DISEASE
,	0
performance	0
,	I-DISEASE
and	0
circadian	0
rhythms	0
in	I-DISEASE
the	0
elderly	I-DISEASE
.	0

Sleep	I-DISEASE
2001;24:680–7	I-DISEASE
.	0

Mu	I-DISEASE
Q	0
,	0
Mishory	I-DISEASE
A	0
,	I-DISEASE
Johnson	0
KA	0
,	I-DISEASE
et	0
al	I-DISEASE
.	0

Decreased	I-DISEASE
brain	0
activation	0
during	I-DISEASE
a	0
working	I-DISEASE
memory	0
task	0
at	I-DISEASE
rested	0
wakefulness	0
is	I-DISEASE
associated	0
with	0
vulnerability	I-DISEASE
to	I-DISEASE
sleep	0
deprivation	0
.	0

Sleep	I-DISEASE
2005;28:433–46	I-DISEASE
.	0

Roehrs	I-DISEASE
T	0
,	0
Zorick	I-DISEASE
F	I-DISEASE
,	0
Sicklesteel	0
J	0
,	I-DISEASE
Wittig	I-DISEASE
R	0
,	0
Roth	I-DISEASE
T.	0
Excessive	I-DISEASE
daytime	I-DISEASE
sleepiness	0
associated	0
with	B-DISEASE
insufficient	0
sleep	0
.	0

Sleep	I-DISEASE
1983;6:319–25	0
.	0

Taylor	I-DISEASE
DJ	0
,	0
Bramoweth	I-DISEASE
AD	I-DISEASE
.	0

Patterns	I-DISEASE
and	0
consequences	0
of	I-DISEASE
inadequate	0
sleep	0
among	0
college	0
students	I-DISEASE
:	0
substance	I-DISEASE
use	0
and	0
motor	I-DISEASE
vehicle	I-DISEASE
accidents	I-DISEASE
.	0

J	I-DISEASE
Adolesc	0
Health	0
2010;46:610–2	0
.	0

Tucker	I-DISEASE
AM	I-DISEASE
,	I-DISEASE
Whitney	0
P	0
,	I-DISEASE
Belenky	I-DISEASE
G	I-DISEASE
,	I-DISEASE
Hinson	I-DISEASE
JM	I-DISEASE
,	I-DISEASE
Van	I-DISEASE
Dongen	I-DISEASE
HPA	0
.	0

Effects	I-DISEASE
of	I-DISEASE
sleep	0
deprivation	I-DISEASE
on	0
dissociated	0
components	I-DISEASE
of	I-DISEASE
executive	0
functioning	I-DISEASE
.	0

Sleep	I-DISEASE
2010;33:47–57	I-DISEASE
.	0

Van	I-DISEASE
Dongen	I-DISEASE
HP	I-DISEASE
,	0
Maislin	I-DISEASE
G	I-DISEASE
,	0
Mullington	I-DISEASE
JM	I-DISEASE
,	I-DISEASE
Dinges	I-DISEASE
DF	0
.	0

The	I-DISEASE
cumulative	I-DISEASE
cost	0
of	I-DISEASE
additional	0
wakefulness	0
:	I-DISEASE
dose	0
-	0
response	0
effects	0
on	0
neurobehavioral	0
functions	0
and	0
sleep	0
physiology	0
from	0
chronic	I-DISEASE
sleep	I-DISEASE
restriction	0
and	0
total	0
sleep	0
deprivation	I-DISEASE
.	0

Sleep	I-DISEASE
2003;26:117–26	0
.	0

Isolated	I-DISEASE
Symptoms	I-DISEASE
and	0
Normal	0
Variants	0
Long	I-DISEASE
Sleeper	I-DISEASE

A	I-DISEASE
long	I-DISEASE
sleeper	0
is	0
an	I-DISEASE
individual	I-DISEASE
who	I-DISEASE
consistently	I-DISEASE
sleeps	0
substantially	I-DISEASE
more	I-DISEASE
in	I-DISEASE
24	0
hours	I-DISEASE
than	I-DISEASE
does	I-DISEASE
the	0
typical	0
person	0
of	I-DISEASE
his	0
or	B-DISEASE
her	0
age	I-DISEASE
group	I-DISEASE
.	I-DISEASE

For	I-DISEASE
adults	I-DISEASE
,	0
the	0
usually	0
accepted	0
figure	0
is	I-DISEASE
10	0
hours	I-DISEASE
or	0
more	0
,	I-DISEASE
but	I-DISEASE
many	0
epidemiologic	0
studies	0
have	0
used	0
sleep	0
times	I-DISEASE
of	0
8–10	I-DISEASE
hours	I-DISEASE
.	0

For	I-DISEASE
children	I-DISEASE
and	0
adolescents	0
,	I-DISEASE
the	0
entity	I-DISEASE
should	0
be	0
considered	I-DISEASE
if	0
sleep	I-DISEASE
time	I-DISEASE
is	0
more	0
than	I-DISEASE
two	I-DISEASE
hours	I-DISEASE
longer	0
than	I-DISEASE
age	I-DISEASE
-	0
specific	I-DISEASE
norms	0
.	0

Sleep	I-DISEASE
,	I-DISEASE
although	0
long	I-DISEASE
,	0
is	I-DISEASE
basi-	0
cally	0
normal	0
in	I-DISEASE
architecture	I-DISEASE
and	0
physiology	I-DISEASE
.	0

Sleep	I-DISEASE
efficiency	I-DISEASE
and	0
timing	I-DISEASE
are	0
normal	0
.	0

A	I-DISEASE
consistent	I-DISEASE
daily	I-DISEASE
pattern	0
,	0
documented	I-DISEASE
by	I-DISEASE
a	I-DISEASE
carefully	0
kept	0
sleep	0
log	0
(	I-DISEASE
preferably	0
con-	0
firmed	I-DISEASE
by	0
actigraphy	0
)	0
,	I-DISEASE
showing	I-DISEASE
10	0
or	I-DISEASE
more	0
hours	I-DISEASE
of	I-DISEASE
sleep	I-DISEASE
per	0
night	0
over	0
a	0
minimum	0
of	0
seven	I-DISEASE
days	0
is	0
desirable	I-DISEASE
for	0
the	0
identification	0
of	I-DISEASE
the	I-DISEASE
long	I-DISEASE
sleeper	I-DISEASE
.	0

In	I-DISEASE
general	I-DISEASE
,	0
long	I-DISEASE
sleepers	0
seek	I-DISEASE
medical	I-DISEASE
help	0
when	0
they	I-DISEASE
develop	0
sleepiness	I-DISEASE
as	0
a	0
result	0
of	I-DISEASE
being	0
forced	I-DISEASE
to	I-DISEASE
curtail	0
their	0
sleep	I-DISEASE
time	0
to	I-DISEASE
less	I-DISEASE
than	I-DISEASE
their	0
required	I-DISEASE
amounts	I-DISEASE
.	0

Usually	I-DISEASE
,	I-DISEASE
the	0
long	I-DISEASE
sleep	0
pattern	0
began	I-DISEASE
in	I-DISEASE
childhood	0
,	0
is	0
well	I-DISEASE
established	I-DISEASE
by	I-DISEASE
early	0
adolescence	0
,	0
and	0
persists	I-DISEASE
throughout	0
life	0
.	0

Many	I-DISEASE
long	I-DISEASE
sleepers	0
,	0
because	0
of	I-DISEASE
occupational	I-DISEASE
or	B-DISEASE
educational	0
demands	0
,	I-DISEASE
function	I-DISEASE
with	I-DISEASE
reasonable	0
success	I-DISEASE
on	0
nine	I-DISEASE
hours	I-DISEASE
of	0
sleep	0
per	0
night	0
during	I-DISEASE
the	0
work	I-DISEASE
or	0
school	I-DISEASE
week	0
,	I-DISEASE
with	I-DISEASE
increases	0
to	0
12	B-DISEASE
or	I-DISEASE
more	0
hours	I-DISEASE
on	0
weekends	0
and	0
holidays	0
.	0

About	I-DISEASE
2	0
%	0
of	I-DISEASE
men	0
and	0
1.5	0
%	0
of	I-DISEASE
women	I-DISEASE
report	I-DISEASE
sleeping	I-DISEASE
at	I-DISEASE
least	0
10	0
hours	I-DISEASE
per	0
night	0
.	0

Epidemiologic	I-DISEASE
studies	I-DISEASE
have	I-DISEASE
consistently	I-DISEASE
found	0
an	0
increased	0
mortality	I-DISEASE
(	I-DISEASE
and	0
sometimes	0
increased	0
body	I-DISEASE
mass	0
index	0
,	0
lower	0
glucose	0
tolerance	0
,	I-DISEASE
higher	0
prevalence	0
of	I-DISEASE
type	I-DISEASE
2	0
dia-	0
betes	0
and	0
coronary	0
heart	0
disease	0
)	0
associated	0
with	0
long	I-DISEASE
sleep	0
,	I-DISEASE
compared	I-DISEASE
to	0
average	0
-	0
du-	0
ration	I-DISEASE
sleep	0
,	I-DISEASE
but	I-DISEASE
it	0
is	0
not	0
clear	0
whether	I-DISEASE
most	I-DISEASE
of	I-DISEASE
the	0
subjects	0
were	I-DISEASE
naturally	I-DISEASE
long	I-DISEASE
sleep-	0
ers	0
or	0
had	0
disorders	0
resulting	0
in	I-DISEASE
excessive	0
duration	0
of	I-DISEASE
sleep	0
.	0

In	I-DISEASE
subjects	0
older	0
than	I-DISEASE
60	0
years	I-DISEASE
,	I-DISEASE
sleep	I-DISEASE
duration	0
longer	0
than	0
9.5	I-DISEASE
hours	I-DISEASE
is	I-DISEASE
associated	0
with	I-DISEASE
male	0
sex	0
,	I-DISEASE
low	0
education	I-DISEASE
,	I-DISEASE
no	0
physical	0
exercise	0
,	I-DISEASE
and	0
more	I-DISEASE
physical	0
diseases	0
.	0

Long	I-DISEASE
(	I-DISEASE
>	0
nine	0
hours	I-DISEASE
)	0
sleep	0
duration	I-DISEASE
has	0
a	0
high	I-DISEASE
heritability	0
(	0
44	0
%	0
)	I-DISEASE
and	0
concordance	0
between	0
monozygotic	0
twins	I-DISEASE
,	I-DISEASE
which	0
is	0
higher	0
if	0
they	I-DISEASE
live	I-DISEASE
together	0
.	0

Genomewide	I-DISEASE
studies	I-DISEASE
favor	0
a	0
polygenic	0
origin	0
of	I-DISEASE
sleep	0
duration	I-DISEASE
,	I-DISEASE
with	0
influence	0
of	I-DISEASE
clock	I-DISEASE
and	0
other	0
genes	I-DISEASE
(	I-DISEASE
DEC2	I-DISEASE
,	I-DISEASE
K+	0
channel	0
regulatory	I-DISEASE
pro-	0
teins	0
genes	I-DISEASE
)	0
.	0

Long	I-DISEASE
sleepers	0
presumably	0
represent	0
the	0
extreme	I-DISEASE
high	I-DISEASE
end	0
of	I-DISEASE
the	0
normal	0
sleep	I-DISEASE
duration	0
continuum	0
.	0

Long	I-DISEASE
sleepers	0
,	I-DISEASE
like	0
short	0
sleepers	0
,	0
have	0
normal	0
absolute	I-DISEASE
amounts	I-DISEASE
of	I-DISEASE
stage	0
N3	0
sleep	0
,	0
unless	0
there	I-DISEASE
is	0
chronic	I-DISEASE
sleep	0
restriction	0
preceding	I-DISEASE
polysomnography	0
,	0
in	I-DISEASE
which	0
case	I-DISEASE
the	0
absolute	0
amount	I-DISEASE
of	I-DISEASE
N3	0
stage	0
is	0
increased	0
.	0

Amounts	I-DISEASE
of	I-DISEASE
stages	0
N2	0
and	0
REM	I-DISEASE
sleep	0
are	I-DISEASE
somewhat	I-DISEASE
higher	0
than	0
normal	0
.	0

The	I-DISEASE
individual	I-DISEASE
has	0
no	I-DISEASE
problem	0
with	I-DISEASE
time	I-DISEASE
distortion	0
or	B-DISEASE
ability	0
to	0
be	I-DISEASE
accurate	I-DISEASE
about	I-DISEASE
the	0
quantity	I-DISEASE
or	I-DISEASE
quality	I-DISEASE
of	0
sleep	0
.	0

Assuming	I-DISEASE
that	0
individuals	I-DISEASE
Central	0
Disorders	I-DISEASE
of	I-DISEASE
Hypersomnolence	0
Central	I-DISEASE
Disorders	I-DISEASE
of	I-DISEASE
Hypersomnolence	I-DISEASE
have	0
obtained	I-DISEASE
their	0
usual	I-DISEASE
sleep	0
amounts	I-DISEASE
for	I-DISEASE
several	0
nights	0
before	0
the	0
procedure	I-DISEASE
,	0
no	0
sleepiness	0
is	0
evident	I-DISEASE
on	0
the	I-DISEASE
MSLT	I-DISEASE
.	0

It	I-DISEASE
is	I-DISEASE
important	0
to	I-DISEASE
differentiate	0
the	0
long	I-DISEASE
sleeper	0
from	0
patients	0
with	I-DISEASE
narcolepsy	I-DISEASE
,	I-DISEASE
idiopathic	I-DISEASE
hypersomnia	I-DISEASE
,	I-DISEASE
sleep	0
disordered	I-DISEASE
breathing	0
,	I-DISEASE
or	B-DISEASE
medical	0
causes	I-DISEASE
of	I-DISEASE
hypersomnolence	I-DISEASE
.	0

Many	0
pathologic	I-DISEASE
causes	0
of	I-DISEASE
increased	0
sleep	0
have	0
an	0
acute	I-DISEASE
or	I-DISEASE
subacute	I-DISEASE
onset	0
,	I-DISEASE
may	I-DISEASE
not	0
be	0
present	I-DISEASE
since	I-DISEASE
childhood	0
,	I-DISEASE
and	0
rarely	I-DISEASE
show	0
the	I-DISEASE
stable	I-DISEASE
course	I-DISEASE
of	I-DISEASE
the	0
long	I-DISEASE
sleeper	0
.	0

Nevertheless	I-DISEASE
,	I-DISEASE
differentiation	0
from	I-DISEASE
pathologic	0
con-	I-DISEASE
ditions	0
of	I-DISEASE
hypersomnolence	I-DISEASE
may	0
be	I-DISEASE
difficult	0
in	I-DISEASE
the	0
child	0
or	I-DISEASE
adolescent	0
because	0
the	0
normal	0
continuum	0
of	I-DISEASE
sleep	0
duration	0
is	0
somewhat	I-DISEASE
higher	0
in	I-DISEASE
these	I-DISEASE
age	0
groups	0
than	0
in	0
adults	I-DISEASE
.	0

The	I-DISEASE
correct	0
determination	0
is	I-DISEASE
often	0
made	0
by	I-DISEASE
exclusion	I-DISEASE
of	I-DISEASE
specific	I-DISEASE
diagnostic	0
features	I-DISEASE
associated	I-DISEASE
with	I-DISEASE
other	0
conditions	I-DISEASE
and	0
by	I-DISEASE
the	0
absence	0
of	I-DISEASE
complaints	0
concerning	I-DISEASE
the	0
quality	0
of	I-DISEASE
the	0
individual	I-DISEASE
’s	I-DISEASE
awake	0
-	I-DISEASE
state	0
functioning	I-DISEASE
when	0
adequate	0
sleep	0
is	0
obtained	0
(	I-DISEASE
e.g.	0
,	I-DISEASE
during	I-DISEASE
prolonged	I-DISEASE
holidays	I-DISEASE
)	0
.	0

In	I-DISEASE
particular	I-DISEASE
,	0
the	0
differentiation	0
of	I-DISEASE
a	0
genuine	0
long	0
sleeper	0
from	I-DISEASE
a	I-DISEASE
patient	I-DISEASE
with	0
idiopathic	I-DISEASE
hypersomnia	0
may	I-DISEASE
be	0
difficult	I-DISEASE
.	0

In	I-DISEASE
the	0
genuine	0
long	I-DISEASE
sleeper	0
,	I-DISEASE
sleeping	I-DISEASE
long	0
hours	I-DISEASE
is	0
refreshing	0
,	0
and	0
sleepiness	0
disappears	0
when	0
long	I-DISEASE
hours	I-DISEASE
of	I-DISEASE
nocturnal	0
sleep	I-DISEASE
are	0
enforced	I-DISEASE
.	0

Bibliography	0
Aeschbach	0
D	I-DISEASE
,	0
Cajochen	0
C	I-DISEASE
,	0
Landolt	I-DISEASE
H	I-DISEASE
,	0
Borbély	0
AA	I-DISEASE
.	0

Homeostatic	0
sleep	0
regulation	0
in	I-DISEASE
habitual	0
short	0
sleepers	0
and	0
long	I-DISEASE
sleepers	0
.	0

Am	I-DISEASE
J	0
Physiol	0
1996;270	0
:	0
R41–53	0
.	0

Hartmann	I-DISEASE
E	0
,	I-DISEASE
Baekeland	0
F	0
,	0
Zwilling	I-DISEASE
GR	I-DISEASE
.	0

Psychological	I-DISEASE
differences	I-DISEASE
between	0
long	I-DISEASE
and	0
short	0
sleepers	0
.	0

Arch	I-DISEASE
Gen	0
Psychiatry	0
1972;26:463–8	I-DISEASE
.	0

Kripke	I-DISEASE
DF	I-DISEASE
,	I-DISEASE
Garfinkel	I-DISEASE
L	0
,	I-DISEASE
Wingard	I-DISEASE
DL	I-DISEASE
,	I-DISEASE
Klauber	B-DISEASE
MR	0
,	I-DISEASE
Marler	I-DISEASE
MR	0
.	0

Mortality	I-DISEASE
associated	0
with	I-DISEASE
sleep	0
duration	0
and	0
insomnia	I-DISEASE
.	0

Arch	I-DISEASE
Gen	0
Psychiatry	0
2002;59:131–6	I-DISEASE
.	0

Kripke	I-DISEASE
DF	I-DISEASE
,	I-DISEASE
Simons	I-DISEASE
RN	I-DISEASE
,	I-DISEASE
Garfinkel	I-DISEASE
L	0
,	I-DISEASE
Hammond	I-DISEASE
EC	0
.	0

Short	I-DISEASE
and	0
long	I-DISEASE
sleep	0
and	0
sleeping	I-DISEASE
pills	0
.	0

Is	I-DISEASE
increased	0
mortality	I-DISEASE
associated	0
?	0

Arch	I-DISEASE
Gen	0
Psychiatry	0
1979;36:103–16	0
.	0

Webb	I-DISEASE
WB	I-DISEASE
.	I-DISEASE

Are	I-DISEASE
short	0
and	0
long	I-DISEASE
sleepers	0
different	I-DISEASE
?	I-DISEASE

Psychol	I-DISEASE
Rep	0
1979;44:259–64	0
.	0

Circadian	I-DISEASE
Rhythm	0
Sleep	I-DISEASE
-	I-DISEASE
Wake	I-DISEASE
Disorders	0
Delayed	0
Sleep	0
-	I-DISEASE
Wake	0
Phase	I-DISEASE
Disorder	0
191	0
Advanced	I-DISEASE
Sleep	0
-	0
Wake	I-DISEASE
Phase	0
Disorder	I-DISEASE
198	0
Irregular	0
Sleep	0
-	0
Wake	0
Rhythm	0
Disorder204	0
Non-24	I-DISEASE
-	I-DISEASE
Hour	I-DISEASE
Sleep	0
-	0
Wake	0
Rhythm	0
Disorder	0
209	0
Shift	0
Work	I-DISEASE
Disorder	0
215	I-DISEASE
Jet	0
Lag	I-DISEASE
Disorder	0
220	I-DISEASE
Circadian	I-DISEASE
Sleep	I-DISEASE
-	0
Wake	0
Disorder	0
Not	I-DISEASE
Otherwise	0
Specified	I-DISEASE
(	I-DISEASE
NOS	I-DISEASE
)	I-DISEASE
224	I-DISEASE

Circadian	I-DISEASE
rhythms	0
are	0
endogenous	0
,	0
near-24	0
-	I-DISEASE
hour	0
biological	I-DISEASE
rhythms	0
that	I-DISEASE
exist	0
in	0
all	0
living	0
organisms	0
.	0

The	I-DISEASE
internal	I-DISEASE
near-24	0
-	0
hour	0
circadian	0
clock	0
is	0
entrained	0
or	0
synchro-	0
nized	0
to	0
the	0
24	0
-	I-DISEASE
hour	0
light	0
-	0
dark	0
cycle	0
.	B-DISEASE

In	I-DISEASE
humans	0
,	0
the	0
endogenous	0
period	I-DISEASE
of	0
the	0
circa-	0
dian	I-DISEASE
oscillation	0
is	0
genetically	0
determined	I-DISEASE
and	0
typically	0
is	0
slightly	I-DISEASE
longer	I-DISEASE
than	0
24	0
hours	I-DISEASE
.	0

In	I-DISEASE
order	0
to	0
maintain	0
entrainment	0
,	0
the	0
endogenous	I-DISEASE
rhythm	I-DISEASE
must	0
be	I-DISEASE
reset	I-DISEASE
each	0
day	0
to	I-DISEASE
the	0
24	0
-	0
hour	0
clock	I-DISEASE
time	0
.	I-DISEASE

For	I-DISEASE
optimal	0
sleep	0
,	I-DISEASE
the	0
actual	I-DISEASE
sleep	I-DISEASE
time	I-DISEASE
should	0
match	0
the	0
timing	I-DISEASE
of	I-DISEASE
the	I-DISEASE
circadian	0
rhythm	I-DISEASE
of	I-DISEASE
sleep	0
and	0
wake	0
propensity	I-DISEASE
.	0

Therefore	I-DISEASE
,	I-DISEASE
a	0
recurrent	0
or	I-DISEASE
chronic	I-DISEASE
pattern	0
of	I-DISEASE
sleep	0
and	0
wake	0
disturbance	I-DISEASE
may	I-DISEASE
result	0
from	0
disruption	I-DISEASE
of	I-DISEASE
the	0
internal	I-DISEASE
circa-	0
dian	0
timing	0
system	I-DISEASE
or	0
a	I-DISEASE
misalignment	0
between	0
the	0
timing	0
of	I-DISEASE
the	0
individual	0
’s	0
circadian	0
sleep	0
-	0
wake	0
propensity	I-DISEASE
and	0
the	0
24	0
-	0
hour	0
social	0
and	0
physical	0
environments	0
(	I-DISEASE
e.g.	0
,	0
sleep	0
episodes	I-DISEASE
scheduled	I-DISEASE
entirely	0
or	I-DISEASE
in	I-DISEASE
part	I-DISEASE
during	I-DISEASE
a	0
phase	0
of	I-DISEASE
circadian	I-DISEASE
alertness	0
promotion	I-DISEASE
)	0
.	0

As	I-DISEASE
used	0
herein	0
,	0
a	0
circadian	0
rhythm	0
sleep	0
-	0
wake	0
disorder	I-DISEASE
(	I-DISEASE
CRSWD	0
)	I-DISEASE
is	0
defined	0
by	I-DISEASE
the	0
following	0
criterion	0
:	0
The	I-DISEASE
disorder	0
is	I-DISEASE
caused	0
by	I-DISEASE
alterations	0
of	I-DISEASE
the	0
circadian	0
time	0
-	0
keeping	0
system	0
,	0
its	0
entrainment	0
mechanisms	0
,	I-DISEASE
or	I-DISEASE
a	0
misalignment	0
of	0
the	0
endogenous	0
circadian	0
rhythm	I-DISEASE
and	0
the	0
external	I-DISEASE
environment	I-DISEASE
.	0

Most	I-DISEASE
CRSWDs	0
arise	I-DISEASE
when	I-DISEASE
a	I-DISEASE
substantial	0
misalignment	0
exists	I-DISEASE
between	0
the	0
internal	I-DISEASE
rhythm	I-DISEASE
and	0
the	0
required	0
timing	I-DISEASE
of	I-DISEASE
the	0
patient	I-DISEASE
’s	I-DISEASE
school	0
,	I-DISEASE
work	I-DISEASE
,	I-DISEASE
or	I-DISEASE
social	I-DISEASE
activities	I-DISEASE
.	0

Therefore	I-DISEASE
,	I-DISEASE
measurement	0
of	I-DISEASE
endogenous	0
circadian	0
timing	0
is	0
important	0
for	I-DISEASE
the	0
accu-	0
rate	0
diagnosis	0
of	I-DISEASE
CRSWDs	0
.	0

In	I-DISEASE
addition	0
to	0
the	0
history	I-DISEASE
,	I-DISEASE
multiple	I-DISEASE
tools	I-DISEASE
are	0
available	0
to	0
assess	I-DISEASE
sleep	I-DISEASE
-	I-DISEASE
wake	0
patterns	0
.	0

Sleep	I-DISEASE
log	0
and	0
actigraphy	0
are	0
essential	0
instruments	I-DISEASE
in	0
the	0
evaluation	I-DISEASE
of	I-DISEASE
CRSWDs	I-DISEASE
and	0
should	0
be	0
conducted	I-DISEASE
for	0
at	I-DISEASE
least	0
seven	0
days	0
,	0
preferably	0
for	I-DISEASE
14	0
days	I-DISEASE
,	0
to	I-DISEASE
capture	0
work	I-DISEASE
and	0
non	0
-	I-DISEASE
work	I-DISEASE
days	0
.	0

Circadian	I-DISEASE
chronotype	0
(	I-DISEASE
Morningness-	0
Eveningness	0
Questionnaires	I-DISEASE
)	0
and	0
physiological	0
measures	0
of	I-DISEASE
endogenous	0
circadian	0
timing	0
(	I-DISEASE
salivary	I-DISEASE
or	B-DISEASE
plasma	0
dim	0
light	0
melatonin	0
onset	0

and	0
urinary	I-DISEASE
6	0
-	I-DISEASE
sulfatoxymelatonin	I-DISEASE
)	I-DISEASE
also	0
can	I-DISEASE
provide	I-DISEASE
important	I-DISEASE
diagnostic	0
information	0
.	0

Circadian	I-DISEASE
chronotype	0
is	I-DISEASE
a	0
reflec-	0
tion	0
of	I-DISEASE
an	0
individual	I-DISEASE
’s	0
optimal	0
timing	0
of	I-DISEASE
sleep	0
and	0
wake	0
propensity	0
,	I-DISEASE
as	0
well	B-DISEASE
as	0
other	0
Circadian	I-DISEASE
Rhythm	0
Sleep	0
-	0
Wake	0
Disorders	0
physiological	0
and	0
mental	0
functions	0
.	0

Several	I-DISEASE
questionnaires	I-DISEASE
can	0
be	I-DISEASE
used	0
to	I-DISEASE
assess	I-DISEASE
chro-	0
notype	I-DISEASE
of	I-DISEASE
“	I-DISEASE
eveningness	0
”	0
or	0
“	I-DISEASE
morningness	0
”	I-DISEASE
(	I-DISEASE
e.g.	I-DISEASE
,	I-DISEASE
Munich	0
Chronotype	I-DISEASE
Questionnaire	I-DISEASE
,	0
or	0
Morningness	I-DISEASE
-	0
Eveningness	0
Questionnaire	0
)	0
.	I-DISEASE

The	I-DISEASE
most	0
common	I-DISEASE
presenting	I-DISEASE
symptoms	0
of	I-DISEASE
CRSWDs	0
are	0
difficulty	0
initiating	I-DISEASE
and	0
maintaining	I-DISEASE
sleep	0
,	0
and	0
excessive	0
sleepiness	0
,	0
but	0
their	I-DISEASE
impact	0
extends	I-DISEASE
to	0
adverse	I-DISEASE
health	0
outcomes	B-DISEASE
,	0
impairments	0
in	I-DISEASE
social	0
,	0
occupational	I-DISEASE
and	0
educational	0
performance	0
,	0
and	0
safety	I-DISEASE
concerns	I-DISEASE
.	0

Important	I-DISEASE
advances	I-DISEASE
have	0
been	I-DISEASE
made	0
in	I-DISEASE
the	0
identification	I-DISEASE
of	I-DISEASE
clin-	0
ical	I-DISEASE
CRSWD	0
subtypes	I-DISEASE
,	I-DISEASE
particularly	0
in	I-DISEASE
the	0
area	0
of	I-DISEASE
pediatrics	0
.	0

However	I-DISEASE
,	I-DISEASE
the	0
challenge	I-DISEASE
remains	0
to	I-DISEASE
develop	0
more	0
precise	0
and	0
clinically	0
practical	I-DISEASE
tools	I-DISEASE
to	0
improve	I-DISEASE
diagnostic	0
accuracy	I-DISEASE
for	0
CRSWDs	0
.	0

General	I-DISEASE
Criteria	0
for	0
Circadian	0
Rhythm	0
Sleep	0
-	I-DISEASE
Wake	I-DISEASE
Disorder	I-DISEASE
Criteria	0
A	0
-	I-DISEASE
C	0
must	0
be	0
met	0
A.	0
A	0
chronic	0
or	I-DISEASE
recurrent	I-DISEASE
pattern	0
of	I-DISEASE
sleep	0
-	0
wake	0
rhythm	0
disruption	I-DISEASE
primarily	I-DISEASE
due	0
to	0
alteration	0
of	I-DISEASE
the	0
endogenous	I-DISEASE
circadian	0
timing	0
system	0
or	0
misalignment	0
between	0
the	0
endogenous	0
circadian	I-DISEASE
rhythm	I-DISEASE
and	0
the	0
sleep	0
-	I-DISEASE
wake	0
schedule	I-DISEASE
desired	I-DISEASE
or	0
required	0
by	I-DISEASE
an	0
individual	0
’s	I-DISEASE
physical	0
environment	0
or	I-DISEASE
social	0
/	I-DISEASE
work	0
schedules	I-DISEASE
.	0

B.	0
The	I-DISEASE
circadian	I-DISEASE
rhythm	I-DISEASE
disruption	I-DISEASE
leads	0
to	0
insomnia	0
symptoms	I-DISEASE
,	I-DISEASE
excessive	0
sleepiness	0
,	I-DISEASE
or	0
both	I-DISEASE
.	0

C.	I-DISEASE

The	I-DISEASE
sleep	0
and	0
wake	0
disturbances	0
cause	I-DISEASE
clinically	I-DISEASE
significant	0
distress	I-DISEASE
or	I-DISEASE
impairment	I-DISEASE
in	I-DISEASE
mental	I-DISEASE
,	I-DISEASE
physical	0
,	0
social	I-DISEASE
,	0
occupational	I-DISEASE
,	I-DISEASE
educational	I-DISEASE
,	I-DISEASE
or	0
other	I-DISEASE
important	0
areas	0
of	I-DISEASE
functioning	I-DISEASE
.	0

All	I-DISEASE
disorders	0
described	0
in	I-DISEASE
the	0
ensuing	0
section	0
imply	I-DISEASE
a	0
sleep	0
difficulty	0
that	0
meets	I-DISEASE
each	I-DISEASE
of	I-DISEASE
the	0
above	0
criteria	I-DISEASE
.	0

The	I-DISEASE
specific	I-DISEASE
features	0
that	0
characterize	0
each	0
type	I-DISEASE
of	I-DISEASE
CRSWD	0
are	I-DISEASE
included	I-DISEASE
within	B-DISEASE
the	0
individual	I-DISEASE
diagnostic	I-DISEASE
criteria	0
.	0

Delayed	I-DISEASE
Sleep	0
-	0
Wake	0
Phase	I-DISEASE
Disorder	I-DISEASE
ICD-9	0
-	0
CM	I-DISEASE
code	0
:	0
327.31	0
ICD-10	0
-	I-DISEASE
CM	0
code	0
:	B-DISEASE
G47.21	I-DISEASE
Alternate	0
Names	0
Delayed	0
sleep	0
phase	0
syndrome	0
,	I-DISEASE
delayed	I-DISEASE
sleep	I-DISEASE
phase	0
pattern	0
,	0
motivated	0
delayed	0
sleep	0
phase	0
disorder	0
.	0

Diagnostic	I-DISEASE
Criteria	0
Criteria	0

A	I-DISEASE
-	I-DISEASE
E	0
must	I-DISEASE
be	0
met	0
A.	0

There	I-DISEASE
is	I-DISEASE
a	0
significant	0
delay	0
in	I-DISEASE
the	0
phase	0
of	I-DISEASE
the	0
major	I-DISEASE
sleep	0
episode	I-DISEASE
in	I-DISEASE
relation	0
to	0
the	0
desired	I-DISEASE
or	0
required	0
sleep	0
time	0
and	0
wake	0
-	0
up	I-DISEASE
time	0
,	I-DISEASE
as	0
evidenced	I-DISEASE
by	I-DISEASE
a	I-DISEASE
chronic	I-DISEASE
or	0
recurrent	I-DISEASE
complaint	0
by	0
the	0
patient	I-DISEASE
or	0
a	0
caregiver	0
of	I-DISEASE
inability	I-DISEASE
to	I-DISEASE
fall	I-DISEASE
asleep	0
and	0
difficulty	0
awakening	0
at	I-DISEASE
a	0
desired	I-DISEASE
or	0
required	0
clock	0
time	0
.	0

B.	0
The	I-DISEASE
symptoms	I-DISEASE
are	0
present	I-DISEASE
for	0
at	I-DISEASE
least	0
three	0
months	0
.	0

C.	I-DISEASE
When	0
patients	I-DISEASE
are	0
allowed	I-DISEASE
to	I-DISEASE
choose	I-DISEASE
their	0
ad	0
libitum	0
schedule	I-DISEASE
,	0
they	I-DISEASE
will	0
exhibit	I-DISEASE
improved	0
sleep	0
quality	0
and	0
duration	0
for	I-DISEASE
age	I-DISEASE
and	0
maintain	0
a	I-DISEASE
delayed	I-DISEASE
phase	0
of	I-DISEASE
the	B-DISEASE
24	0
-	I-DISEASE
hour	I-DISEASE
sleep	0
-	I-DISEASE
wake	0
pattern	0
.	0

D.	I-DISEASE
Sleep	0
log	0
and	0
,	I-DISEASE
whenever	0
possible	I-DISEASE
,	0
actigraphy	0
monitoring	I-DISEASE
for	I-DISEASE
at	I-DISEASE
least	0
seven	I-DISEASE
days	I-DISEASE
(	0
preferably	0
14	0
days	0
)	0
demonstrate	I-DISEASE
a	I-DISEASE
delay	0
in	I-DISEASE
the	0
timing	I-DISEASE
of	I-DISEASE
the	B-DISEASE
habitual	0
sleep	0
period	0
.	0

Both	I-DISEASE
work	I-DISEASE
/	0
school	0
days	0
and	0
free	I-DISEASE
days	0
must	0
be	0
included	I-DISEASE
within	0
this	I-DISEASE
monitoring	I-DISEASE
.	0

E.	I-DISEASE

The	I-DISEASE
sleep	0
disturbance	0
is	I-DISEASE
not	0
better	0
explained	I-DISEASE
by	I-DISEASE
another	I-DISEASE
current	0
sleep	0
disorder	0
,	I-DISEASE
medical	I-DISEASE
or	0
neurological	0
disorder	0
,	0
mental	0
disorder	0
,	I-DISEASE
medication	0
use	0
,	I-DISEASE
or	0
substance	I-DISEASE
use	0
disorder	I-DISEASE
.	0

Notes	I-DISEASE
.	0

Standardized	I-DISEASE
chronotype	0
questionnaires	I-DISEASE
are	0
useful	0
tools	I-DISEASE
to	I-DISEASE
assess	I-DISEASE
the	I-DISEASE
chronotype	I-DISEASE
of	I-DISEASE
eveningness	0
and	0
morningness	0
.	0

Individuals	I-DISEASE
with	0
this	0
disorder	0
typically	0
score	I-DISEASE
as	0
evening	0
types	0
.	0

This	I-DISEASE
tool	0
can	0
also	0
be	0
useful	0
in	I-DISEASE
determining	I-DISEASE
whether	0
an	0
eveningness	0
circadian	I-DISEASE
preference	0
contributes	I-DISEASE
to	I-DISEASE
sleep	I-DISEASE
initiation	0
difficulties	0
among	0
those	0
who	I-DISEASE
do	I-DISEASE
not	0
meet	0
full	0
criteria	I-DISEASE
for	0
the	I-DISEASE
disorder	0
.	B-DISEASE
.	0

Demonstration	I-DISEASE
of	I-DISEASE
a	0
delay	0
in	I-DISEASE
the	0
timing	I-DISEASE
of	0
other	0
circadian	0
rhythms	I-DISEASE
,	I-DISEASE
such	0
as	0
melatonin	B-DISEASE
(	I-DISEASE
measured	0
by	I-DISEASE
dim	0
light	0
melatonin	B-DISEASE
onset	I-DISEASE
or	I-DISEASE
urinary	I-DISEASE
6	0
-	0
sulfatoxymelatonin	0
sampled	0
across	I-DISEASE
a	0
24	0
-	I-DISEASE
hour	0
period	0
)	0
,	0
is	0
desirable	I-DISEASE
to	0
confirm	0
the	0
delayed	B-DISEASE
circadian	0
phase	0
.	0

Circadian	I-DISEASE
Rhythm	0
Sleep	I-DISEASE
-	I-DISEASE
Wake	I-DISEASE
Disorders	0
Circadian	0
Rhythm	0
Sleep	I-DISEASE
-	I-DISEASE
Wake	0
Disorders	0
Essential	0
Features	I-DISEASE
Delayed	0
sleep	0
-	0
wake	0
phase	0
disorder	B-DISEASE
(	I-DISEASE
DSWPD	0
)	0
is	0
characterized	0
by	I-DISEASE
habitual	0
sleep-	0
wake	0
timing	I-DISEASE
that	I-DISEASE
is	I-DISEASE
delayed	I-DISEASE
,	0
usually	I-DISEASE
more	0
than	0
two	0
hours	I-DISEASE
,	0
relative	I-DISEASE
to	I-DISEASE
conventional	0
or	I-DISEASE
socially	0
acceptable	0
timing	I-DISEASE
.	I-DISEASE

Affected	I-DISEASE
individuals	I-DISEASE
complain	0
of	I-DISEASE
difficulty	0
falling	0
asleep	0
at	I-DISEASE
a	0
socially	0
acceptable	I-DISEASE
time	I-DISEASE
,	0
as	0
required	I-DISEASE
to	I-DISEASE
obtain	0
sufficient	0
sleep	0
duration	0
on	0
a	0
school	0
or	I-DISEASE
work	0
night	I-DISEASE
.	0

Once	I-DISEASE
sleep	0
onset	0
occurs	I-DISEASE
,	0
it	I-DISEASE
is	I-DISEASE
reportedly	I-DISEASE
of	I-DISEASE
normal	0
duration	0
.	0

These	0
individ-	I-DISEASE
uals	I-DISEASE
also	0
experience	0
difficulty	0
arising	0
at	I-DISEASE
a	I-DISEASE
socially	I-DISEASE
acceptable	0
wake	0
time	I-DISEASE
,	I-DISEASE
as	0
required	0
to	I-DISEASE
prepare	0
for	I-DISEASE
school	0
or	I-DISEASE
work	I-DISEASE
.	0

When	I-DISEASE
allowed	I-DISEASE
to	0
follow	I-DISEASE
his	0
or	I-DISEASE
her	0
preferred	I-DISEASE
schedule	I-DISEASE
,	0
the	0
patient	I-DISEASE
’s	I-DISEASE
timing	0
of	I-DISEASE
sleep	0
is	I-DISEASE
delayed	0
.	0

Associated	I-DISEASE
Features	I-DISEASE
Individuals	0
with	I-DISEASE
DSWPD	0
may	I-DISEASE
demonstrate	0
excessive	0
sleep	0
inertia	I-DISEASE
(	0
extreme	I-DISEASE
difficulty	0
awakening	0
and	0
confusion	I-DISEASE
)	0
in	I-DISEASE
the	0
morning	0
as	0
a	0
result	0
of	I-DISEASE
curtailed	I-DISEASE
sleep	0
time	0
and	0
awak-	0
ening	0
during	I-DISEASE
a	0
circadian	0
phase	0
of	I-DISEASE
high	I-DISEASE
sleep	I-DISEASE
propensity	I-DISEASE
.	0

Individuals	I-DISEASE
with	I-DISEASE
this	0
disor-	I-DISEASE
der	0
as	0
well	0
as	0
normal	0
sleepers	0
with	I-DISEASE
evening	0
chronotypes	I-DISEASE
may	0
have	0
increased	0
rates	0
of	I-DISEASE
mental	0
disturbances	I-DISEASE
,	I-DISEASE
such	0
as	0
Diagnostic	I-DISEASE
and	0
Statistical	0
Manual	0
of	0
Mental	0
Disorders	0
(	0
DSM	0
)	0

Axis	I-DISEASE
I	0
disorders	0
or	I-DISEASE
symptoms	0
(	I-DISEASE
e.g.	0
,	0
mood	0
disorders	I-DISEASE
or	I-DISEASE
depressive	0
symptoms	I-DISEASE
)	I-DISEASE
.	0

In	I-DISEASE
some	I-DISEASE
individuals	I-DISEASE
with	I-DISEASE
DSWPD	0
,	I-DISEASE
there	I-DISEASE
may	0
be	0
an	0
overlap	I-DISEASE
with	I-DISEASE
non-24	0
-	I-DISEASE
hour	0
sleep-	0
wake	0
disorder	0
,	I-DISEASE
or	0
an	I-DISEASE
alternation	0
between	0
symptoms	I-DISEASE
of	I-DISEASE
the	B-DISEASE
two	0
disorders	0
.	0

Attempts	I-DISEASE
to	I-DISEASE
cope	0
with	I-DISEASE
the	I-DISEASE
inability	I-DISEASE
to	0
fall	I-DISEASE
asleep	I-DISEASE
earlier	0
may	I-DISEASE
result	I-DISEASE
in	I-DISEASE
the	0
development	B-DISEASE
of	I-DISEASE
insomnia	0
disorder	I-DISEASE
.	0

Individuals	I-DISEASE
may	0
use	0
alcohol	I-DISEASE
,	0
sedatives	I-DISEASE
,	0
hypnotics	0
,	0
or	I-DISEASE
stimulant	0
substances	0
to	0
alleviate	0
symptoms	I-DISEASE
of	I-DISEASE
insomnia	I-DISEASE
and	0
excessive	0
sleepiness	0
,	0
thereby	I-DISEASE
perpetuating	I-DISEASE
their	0
underlying	0
sleep	0
disorder	0
.	0

Clinical	I-DISEASE
and	0
Pathophysiological	0
Subtypes	I-DISEASE
Motivated	0
delayed	I-DISEASE
sleep	0
-	0
wake	0
phase	0
disorder	0
is	0
a	0
subtype	0
typically	0
composed	I-DISEASE
of	I-DISEASE
ado-	0
lescents	0
who	I-DISEASE
have	0
little	0
intrinsic	B-DISEASE
motivation	I-DISEASE
to	0
successfully	0
complete	0
treatment	0
and	0
thereby	I-DISEASE
resume	0
a	0
normal	0
lifestyle	I-DISEASE
(	I-DISEASE
regular	I-DISEASE
school	0
attendance	0
,	0
developmentally	I-DISEASE
appro-	0
priate	0
peer	0
interactions	0
,	I-DISEASE
etc	0
)	0
.	0

A	I-DISEASE
history	I-DISEASE
of	I-DISEASE
mood	0
or	0
anxiety	I-DISEASE
disorder	I-DISEASE
(	I-DISEASE
especially	0
school	0
phobia	0
and	0
separation	0
and	0
social	0
anxiety	I-DISEASE
)	0
or	0
other	I-DISEASE
factors	0
(	0
e.g.	0
,	I-DISEASE
learning	0
disabilities	I-DISEASE
,	I-DISEASE
attention	0
deficit	0
hyperactivity	I-DISEASE
disorder	0
)	0
are	0
often	0
present	I-DISEASE
and	0
may	0
motivate	I-DISEASE
the	I-DISEASE
patient	I-DISEASE
(	0
sometimes	0
unconsciously	I-DISEASE
)	0
to	I-DISEASE
avoid	0
a	I-DISEASE
return	0
to	0
normal	0
adolescent	0
activities	I-DISEASE
,	I-DISEASE
espe-	I-DISEASE
cially	I-DISEASE
regular	I-DISEASE
school	I-DISEASE
attendance	0
.	0

It	I-DISEASE
is	I-DISEASE
not	0
uncommon	0
that	0
ill	0
-	I-DISEASE
defined	I-DISEASE
medical	0
issues	0
(	I-DISEASE
e.g.	I-DISEASE
,	I-DISEASE
chronic	I-DISEASE
fatigue	I-DISEASE
,	0
recurrent	0
mononucleosis	0
episodes	I-DISEASE
,	I-DISEASE
pain	0
syndromes	I-DISEASE
)	0
trigger	I-DISEASE
the	0
onset	I-DISEASE
or	0
complicate	I-DISEASE
the	0
course	0
of	0
the	0
disorder	0
.	0

Important	I-DISEASE
clues	I-DISEASE
,	0
in	I-DISEASE
addition	0
to	I-DISEASE
the	0
exis-	I-DISEASE
tence	0
of	I-DISEASE
premorbid	I-DISEASE
mental	0
disorders	I-DISEASE
,	0
include	0
exaggerated	I-DISEASE
presenting	0
symptoms	I-DISEASE
(	I-DISEASE
e.g.	0
,	I-DISEASE
“	I-DISEASE
ca	0
n’t	I-DISEASE
wake	0
up	0
even	I-DISEASE
if	0
I	0
throw	0
cold	0
water	0
on	0
him	0
”	I-DISEASE
)	0
and	0
failure	I-DISEASE
to	I-DISEASE
comply	I-DISEASE
with	0
basic	0
straightforward	0
treatment	I-DISEASE
recommendations	0
(	I-DISEASE
e.g.	0
,	0
refusal	0
or	I-DISEASE
inability	I-DISEASE
to	I-DISEASE
stop	0
napping	I-DISEASE
during	I-DISEASE
the	0
day	I-DISEASE
)	0
.	0

Although	I-DISEASE
social	0
,	0
psychological	I-DISEASE
,	0
and	0
environmental	I-DISEASE
factors	I-DISEASE
may	0
play	0
a	0
significant	0
role	I-DISEASE
in	I-DISEASE
the	0
development	0
of	I-DISEASE
delayed	I-DISEASE
sleep	0
-	0
wake	0
phase	0
,	0
International	B-DISEASE
Classification	I-DISEASE
of	I-DISEASE
Sleep	0
Disorders	I-DISEASE
,	I-DISEASE
3rd	0
Edition	0
has	0
chosen	0
to	I-DISEASE
list	I-DISEASE
only	0
a	0
single	0
delayed	0
sleep	0
-	0
wake	0
phase	0
diag-	I-DISEASE
nosis	0
,	0
with	0
the	0
recognition	0
that	0
most	0
cases	0
reflect	I-DISEASE
variable	0
chronobiologic	0
and	0
behav-	I-DISEASE
ioral	I-DISEASE
contributions	0
.	0

Demographics	I-DISEASE
The	I-DISEASE
exact	0
prevalence	0
of	I-DISEASE
DSWPD	0
in	I-DISEASE
the	I-DISEASE
general	I-DISEASE
population	0
is	I-DISEASE
unknown	I-DISEASE
.	0

The	I-DISEASE
condition	0
is	0
more	0
common	0
among	0
adolescents	0
and	0
young	I-DISEASE
adults	B-DISEASE
,	I-DISEASE
with	I-DISEASE
a	0
reported	0
prevalence	0
of	I-DISEASE
7	0
%	0
to	0
16	I-DISEASE
%	0
.	0

It	I-DISEASE
is	I-DISEASE
estimated	0
that	0
DSWPD	0
is	I-DISEASE
seen	I-DISEASE
in	0
approximately	0
10	I-DISEASE
%	I-DISEASE
of	I-DISEASE
patients	0
pre-	I-DISEASE
senting	I-DISEASE
in	0
sleep	0
clinics	0
with	I-DISEASE
recurrent	B-DISEASE
insomnia	I-DISEASE
complaints	0
.	0

There	I-DISEASE
have	I-DISEASE
been	I-DISEASE
no	0
studies	0
assessing	I-DISEASE
racial	I-DISEASE
/	0
ethnic	0
differences	I-DISEASE
in	0
DSWPD	I-DISEASE
.	0

Predisposing	I-DISEASE
and	0
Precipitating	I-DISEASE
Factors	0
Most	I-DISEASE
individuals	I-DISEASE
with	I-DISEASE
DSWPD	0
are	I-DISEASE
evening	0
chronotypes	0
.	0

Many	0
adolescents	0
experi-	I-DISEASE
ence	0
a	0
biological	I-DISEASE
endogenous	0
shift	0
towards	0
later	0
bedtimes	I-DISEASE
beginning	B-DISEASE
around	0
puberty	0
.	0

Genetic	I-DISEASE
factors	0
such	I-DISEASE
as	0
polymorphism	0
in	0
the	0
circadian	I-DISEASE
clock	I-DISEASE
gene	0
hPer3	I-DISEASE
are	0
associated	0
with	0
DSWPD	I-DISEASE
.	0

Environmental	I-DISEASE
factors	I-DISEASE
,	0
including	0
decreased	0
exposure	0
to	I-DISEASE
light	0
during	I-DISEASE
the	0
phase	0
advance	I-DISEASE
region	I-DISEASE
of	I-DISEASE
the	0
phase	0
response	0
curve	I-DISEASE
(	0
PRC	I-DISEASE
)	0
(	I-DISEASE
i.e.	I-DISEASE
,	I-DISEASE
in	I-DISEASE
the	I-DISEASE
morning	0
on	0
days	0
with	I-DISEASE
early	0
wake	0
times	0
)	0
or	I-DISEASE
increased	0
exposure	0
to	0
bright	0
light	0
during	I-DISEASE
the	0
phase	0
delay	I-DISEASE
portion	I-DISEASE
of	I-DISEASE
the	0
PRC	I-DISEASE
(	I-DISEASE
i.e.	0
,	0
late	I-DISEASE
in	0
the	0
evening	I-DISEASE
)	I-DISEASE
may	I-DISEASE
exacerbate	0
the	0
delayed	I-DISEASE
circa-	I-DISEASE
dian	I-DISEASE
phase	0
.	0

Individuals	I-DISEASE
may	0
have	0
increased	0
sensitivity	I-DISEASE
in	I-DISEASE
the	0
phase	0
delay	0
region	0
or	0
decreased	I-DISEASE
sensitivity	I-DISEASE
in	I-DISEASE
the	0
phase	0
advance	I-DISEASE
region	I-DISEASE
of	0
the	0
phase	0
response	0
curve	I-DISEASE
to	0
light	0
.	0

Maladjustment	I-DISEASE
to	I-DISEASE
changes	0
in	I-DISEASE
work	I-DISEASE
and	0
social	I-DISEASE
schedules	I-DISEASE
,	I-DISEASE
travel	I-DISEASE
across	I-DISEASE
time	I-DISEASE
zones	I-DISEASE
,	I-DISEASE
and	0
shift	0
work	I-DISEASE
can	0
precipitate	I-DISEASE
this	0
disorder	I-DISEASE
.	0

Individuals	I-DISEASE
may	I-DISEASE
consume	0
excessive	0
caffeine	0
and	0
other	0
stimulants	0
,	I-DISEASE
which	0
may	I-DISEASE
further	I-DISEASE
delay	I-DISEASE
sleep	0
onset	0
and	0
thus	0
exacerbate	0
the	0
delayed	I-DISEASE
sleep	0
time	I-DISEASE
.	0

Social	I-DISEASE
and	0
behavioral	0
factors	I-DISEASE
play	0
an	I-DISEASE
important	0
role	0
in	0
the	0
development	I-DISEASE
and	0
mainte-	I-DISEASE
nance	0
of	I-DISEASE
the	0
delayed	0
sleep	0
patterns	I-DISEASE
for	I-DISEASE
many	0
affected	0
individuals	I-DISEASE
.	0

Personal	I-DISEASE
,	I-DISEASE
social	0
,	I-DISEASE
and	0
occupational	I-DISEASE
activities	I-DISEASE
that	I-DISEASE
continue	0
into	I-DISEASE
the	0
late	I-DISEASE
evening	I-DISEASE
may	I-DISEASE
perpetuate	0
and	0
exacerbate	0
the	0
sleep	0
phase	0
delay	I-DISEASE
.	0

In	I-DISEASE
adolescents	0
,	I-DISEASE
the	0
role	0
of	I-DISEASE
school	I-DISEASE
avoidance	0
,	I-DISEASE
social	I-DISEASE
maladjustment	I-DISEASE
,	I-DISEASE
and	0
family	0
dysfunction	I-DISEASE
should	I-DISEASE
be	0
considered	I-DISEASE
as	0
contributing	I-DISEASE
factors	0
.	0

Individuals	I-DISEASE
with	I-DISEASE
a	0
psychiatric	I-DISEASE
disorder	0
,	I-DISEASE
such	0
as	I-DISEASE
a	0
mood	0
disorder	0
(	I-DISEASE
major	I-DISEASE
depression	I-DISEASE
or	0
bipolar	0
disorder	0
)	0
,	0
severe	0
obsessive	0
-	0
compulsive	I-DISEASE
disorder	0
,	I-DISEASE
attention	0
deficit	0
hyperactivity	I-DISEASE
disorder	0
,	0
or	0
other	0
neurodevelopmental	0
disorders	0
may	0
have	0
a	0
delayed	0
sleep	0
phase	0
.	0

Circadian	I-DISEASE
Rhythm	0
Sleep	I-DISEASE
-	I-DISEASE
Wake	I-DISEASE
Disorders	0
Circadian	0
Rhythm	0
Sleep	I-DISEASE
-	I-DISEASE
Wake	0
Disorders	0
Familial	I-DISEASE
Patterns	I-DISEASE

A	I-DISEASE
positive	0
family	0
history	I-DISEASE
has	0
been	I-DISEASE
reported	I-DISEASE
in	I-DISEASE
approximately	0
40	0
%	0
of	I-DISEASE
individuals	I-DISEASE
with	I-DISEASE
DSWPD	0
.	I-DISEASE

In	I-DISEASE
one	0
pedigree	0
,	0
DSWPD	I-DISEASE
was	I-DISEASE
suggested	I-DISEASE
to	I-DISEASE
segregate	I-DISEASE
as	I-DISEASE
an	0
autosomal	0
domi-	I-DISEASE
nant	I-DISEASE
trait	0
.	0

Polymorphisms	I-DISEASE
in	I-DISEASE
hPer3	I-DISEASE
,	0
arylalkylamine	0
N	0
-	I-DISEASE
acetyltransferase	0
,	I-DISEASE
human	0
leuko-	I-DISEASE
cyte	B-DISEASE
antigen	0
,	0
and	0
Clock	0
have	0
been	I-DISEASE
suggested	0
to	0
be	0
associated	0
with	0
DSWPD	0
.	0

Onset	I-DISEASE
,	0
Course	0
,	0
and	0
Complications	0
A	0
delayed	I-DISEASE
sleep	I-DISEASE
pattern	0
typically	0
begins	I-DISEASE
during	I-DISEASE
adolescence	I-DISEASE
.	0

Onset	I-DISEASE
in	0
early	I-DISEASE
childhood	0
is	I-DISEASE
also	0
described	I-DISEASE
,	0
especially	0
in	I-DISEASE
familial	I-DISEASE
cases	0
;	I-DISEASE
the	0
onset	I-DISEASE
may	0
follow	0
psychological	I-DISEASE
,	0
medical	0
,	I-DISEASE
or	0
environmental	I-DISEASE
stressors	0
.	0

Without	I-DISEASE
treatment	I-DISEASE
,	0
DSWPD	I-DISEASE
is	I-DISEASE
a	I-DISEASE
chronic	0
condition	0
that	0
may	I-DISEASE
last	0
into	I-DISEASE
late	I-DISEASE
life	0
.	0

However	I-DISEASE
,	I-DISEASE
with	0
increasing	I-DISEASE
age	I-DISEASE
across	I-DISEASE
adulthood	0
,	I-DISEASE
the	0
timing	0
of	I-DISEASE
the	0
sleep	I-DISEASE
-	I-DISEASE
wake	0
cycle	0
may	I-DISEASE
advance	I-DISEASE
,	0
thereby	I-DISEASE
decreasing	0
the	0
propensity	I-DISEASE
to	I-DISEASE
delayed	0
sleep	0
phase	0
.	0

Phototherapy	I-DISEASE
,	0
as	0
well	I-DISEASE
as	I-DISEASE
behavioral	0
and	0
pharmacologic	0
treatments	0
,	I-DISEASE
can	0
advance	0
the	0
timing	0
of	I-DISEASE
sleep	0
hours	I-DISEASE
,	I-DISEASE
but	0
there	I-DISEASE
is	0
usually	I-DISEASE
a	0
continual	0
tendency	0
and	0
prefer-	0
ence	0
for	0
delayed	0
sleep	0
hours	I-DISEASE
,	I-DISEASE
and	0
recurrence	I-DISEASE
is	0
high	0
.	0

Use	I-DISEASE
of	I-DISEASE
alcohol	0
,	I-DISEASE
sedatives	0
,	I-DISEASE
hypnot-	0
ics	I-DISEASE
,	I-DISEASE
or	I-DISEASE
stimulants	I-DISEASE
to	0
treat	0
symptoms	I-DISEASE
of	I-DISEASE
insomnia	I-DISEASE
and	0
sleepiness	0
during	I-DISEASE
normal	0
waking	0
hours	I-DISEASE
may	0
lead	0
to	0
substance	I-DISEASE
abuse	I-DISEASE
.	0

Developmental	I-DISEASE
Issues	0
DSWPD	I-DISEASE
may	0
be	I-DISEASE
encountered	0
in	0
any	I-DISEASE
age	I-DISEASE
group	I-DISEASE
but	I-DISEASE
is	0
especially	0
prevalent	I-DISEASE
among	0
ado-	0
lescents	0
and	0
young	I-DISEASE
adults	B-DISEASE
.	0

In	I-DISEASE
addition	0
to	0
the	0
clinical	0
features	0
described	0
elsewhere	I-DISEASE
,	0
DSWPD	0
may	I-DISEASE
present	I-DISEASE
in	0
older	0
children	I-DISEASE
and	0
adolescents	0
with	0
chief	I-DISEASE
complaints	0
of	I-DISEASE
truancy	0
,	I-DISEASE
repeated	I-DISEASE
school	0
absences	I-DISEASE
,	0
chronic	I-DISEASE
tardiness	0
and/or	0
school	0
failure	0
,	0
rather	0
than	0
sleep	0
complaints	I-DISEASE
per	I-DISEASE
se	I-DISEASE
.	0

In	I-DISEASE
severe	I-DISEASE
cases	0
,	I-DISEASE
school	0
attendance	0
is	0
completely	I-DISEASE
curtailed	B-DISEASE
and	0
the	I-DISEASE
patient	I-DISEASE
may	0
have	0
failed	I-DISEASE
to	I-DISEASE
attend	0
school	0
regularly	0
for	0
many	0
months	0
.	0

Extreme	I-DISEASE
diffi-	I-DISEASE
culty	I-DISEASE
in	I-DISEASE
morning	0
awakening	0
,	I-DISEASE
requiring	I-DISEASE
intensive	I-DISEASE
parental	I-DISEASE
involvement	I-DISEASE
,	I-DISEASE
may	I-DISEASE
also	0
be	0
the	0
presenting	0
concern	I-DISEASE
.	0

An	I-DISEASE
increased	0
risk	0
of	I-DISEASE
motor	0
vehicle	I-DISEASE
accidents	0
has	I-DISEASE
been	I-DISEASE
associated	0
with	I-DISEASE
delayed	I-DISEASE
sleep	I-DISEASE
onset	I-DISEASE
and	0
resultant	0
insufficient	I-DISEASE
sleep	0
in	0
adolescents	0
;	I-DISEASE
thus	I-DISEASE
,	I-DISEASE
the	I-DISEASE
occur-	0
rence	0
of	I-DISEASE
a	I-DISEASE
car	0
crash	0
or	I-DISEASE
“	0
near	0
-	0
miss	I-DISEASE
”	I-DISEASE
incident	0
should	0
alert	0
the	0
clinician	I-DISEASE
to	I-DISEASE
probe	I-DISEASE
for	I-DISEASE
addi-	I-DISEASE
tional	0
evidence	0
of	I-DISEASE
circadian	I-DISEASE
pathology	0
.	0

Adolescents	I-DISEASE
may	0
also	0
present	I-DISEASE
primarily	I-DISEASE
with	0
mood	0
complaints	0
(	I-DISEASE
depression	I-DISEASE
,	I-DISEASE
suicidal	0
ideation	0
)	0
.	0

Chronic	I-DISEASE
insomnia	0
is	0
commonly	I-DISEASE
asso-	0
ciated	I-DISEASE
with	I-DISEASE
and	0
may	0
be	0
the	0
chief	I-DISEASE
presenting	0
complaint	0
in	I-DISEASE
adolescents	0
with	I-DISEASE
DSWPD	0
as	0
a	0
result	0
of	I-DISEASE
repeated	I-DISEASE
attempts	0
and	0
failures	0
to	I-DISEASE
achieve	0
sleep	0
onset	I-DISEASE
at	I-DISEASE
their	0
desired	0
bedtime	0
.	0

In	I-DISEASE
younger	I-DISEASE
children	0
,	I-DISEASE
the	0
condition	0
may	I-DISEASE
be	I-DISEASE
associated	0
with	0
delays	0
in	I-DISEASE
other	I-DISEASE
markers	0
of	I-DISEASE
circadian	I-DISEASE
phase	0
,	0
including	0
the	0
typical	0
presleep	I-DISEASE
surge	I-DISEASE
in	0
alertness	I-DISEASE
referred	I-DISEASE
to	I-DISEASE
as	B-DISEASE
the	0
“	0
for-	I-DISEASE
bidden	0
zone	I-DISEASE
”	I-DISEASE
or	0
“	0
second	0
wind	0
phenomenon	0
.	0
”	I-DISEASE

Thus	I-DISEASE
,	I-DISEASE
especially	0
in	I-DISEASE
younger	0
children	I-DISEASE
,	I-DISEASE
DSWPD	I-DISEASE
may	I-DISEASE
present	I-DISEASE
primarily	I-DISEASE
as	I-DISEASE
bedtime	I-DISEASE
resistance	I-DISEASE
,	I-DISEASE
as	0
caregivers	0
attempt	I-DISEASE
to	0
establish	0
bedtimes	I-DISEASE
that	0
directly	I-DISEASE
conflict	I-DISEASE
with	I-DISEASE
the	0
child	0
’s	I-DISEASE
circadian	0
-	I-DISEASE
mediated	0
readiness	0
for	0
sleep	0
.	0

Several	I-DISEASE
pediatric	0
populations	I-DISEASE
appear	0
to	I-DISEASE
have	I-DISEASE
an	0
increased	0
vulnerability	I-DISEASE
to	I-DISEASE
DSWPD	I-DISEASE
and	0
sleep	0
disturbances	I-DISEASE
,	0
likely	I-DISEASE
of	I-DISEASE
multifactorial	0
etiology	0
.	I-DISEASE

These	0
include	I-DISEASE
children	B-DISEASE
with	I-DISEASE
attention	0
deficit	I-DISEASE
hyperactivity	I-DISEASE
disorder	0
(	I-DISEASE
ADHD	I-DISEASE
)	0
and	0
autism	0
spectrum	I-DISEASE
disorder	0
(	0
ASD	I-DISEASE
)	0
.	0

Several	0
studies	I-DISEASE
have	0
examined	I-DISEASE
melatonin	0
onset	0
in	0
children	B-DISEASE
with	I-DISEASE
ADHD	I-DISEASE
and	0
reported	0
significant	0
delays	I-DISEASE
in	0
comparison	0
with	0
typically	0
developing	0
children	B-DISEASE
,	I-DISEASE
as	0
well	0
as	0
suc-	0
cessful	B-DISEASE
treatment	0
with	0
melatonin	0
.	0

Children	I-DISEASE
with	I-DISEASE
ASD	0
have	0
a	0
high	I-DISEASE
prevalence	I-DISEASE
(	I-DISEASE
up	0
to	0
80	0
%	I-DISEASE
)	I-DISEASE
of	I-DISEASE
sleep	0
disturbances	I-DISEASE
,	0
including	0
delayed	I-DISEASE
sleep	0
onset	0
,	0
night	0
and	0
early	0
morning	0
awakenings	0
,	I-DISEASE
and	0
irregular	I-DISEASE
sleep	0
patterns	0
,	0
at	I-DISEASE
least	I-DISEASE
some	I-DISEASE
of	0
which	0
appear	0
associated	0
with	I-DISEASE
circadian	0
abnormalities	I-DISEASE
.	0

These	0
children	0
reportedly	0
have	0
a	0
number	0
of	I-DISEASE
alterations	I-DISEASE
in	0
mel-	0

atonin	I-DISEASE
synthesis	0
,	0
levels	I-DISEASE
,	0
amplitude	0
,	0
and	0
patterns	0
of	I-DISEASE
secretion	I-DISEASE
.	0

Little	I-DISEASE
is	I-DISEASE
known	0
about	I-DISEASE
the	0
natural	0
history	I-DISEASE
of	I-DISEASE
the	0
clinical	0
entity	0
of	I-DISEASE
DSWPD	I-DISEASE
in	I-DISEASE
the	0
pediat-	0
ric	0
population	0
,	I-DISEASE
including	I-DISEASE
the	0
impact	I-DISEASE
of	I-DISEASE
various	I-DISEASE
treatment	I-DISEASE
modalities	B-DISEASE
,	I-DISEASE
the	0
likelihood	0
of	0
spontaneous	I-DISEASE
resolution	I-DISEASE
of	0
symptoms	I-DISEASE
,	0
or	0
long	I-DISEASE
-	I-DISEASE
term	0
consequences	I-DISEASE
.	0

There	I-DISEASE
is	I-DISEASE
increasing	0
evidence	0
to	0
suggest	I-DISEASE
that	0
the	0
evening	0
chronotype	0
is	I-DISEASE
associated	0
in	0
both	I-DISEASE
children	I-DISEASE
and	0
adolescents	0
with	I-DISEASE
a	0
number	0
of	I-DISEASE
adverse	0
consequences	I-DISEASE
,	0
including	I-DISEASE
decreased	I-DISEASE
health	I-DISEASE
-	0
related	B-DISEASE
quality	0
of	I-DISEASE
life	0
,	0
higher	0
rates	0
of	I-DISEASE
behavioral	0
/	0
emotional	0
problems	0
including	0
depression	I-DISEASE
and	0
suicidality	I-DISEASE
,	0
decreased	I-DISEASE
sleep	0
duration	0
and	0
increased	0
daytime	I-DISEASE
sleepiness	0
,	0
more	0
sleep	0
complaints	0
,	I-DISEASE
impairments	I-DISEASE
in	I-DISEASE
academic	0
functioning	I-DISEASE
,	0
and	0
increased	0
likelihood	0
of	I-DISEASE
substance	0
use	I-DISEASE
.	0

Thus	I-DISEASE
,	I-DISEASE
eveningness	0
may	0
confer	0
an	0
increased	0
risk	0
for	0
physical	0
and	0
mental	I-DISEASE
health	0
problems	0
.	0

Pathology	I-DISEASE
and	0
Pathophysiology	I-DISEASE
The	I-DISEASE
exact	0
mechanisms	0
responsible	I-DISEASE
for	I-DISEASE
DSWPD	I-DISEASE
are	I-DISEASE
unknown	I-DISEASE
.	0

An	0
abnormal	I-DISEASE
interac-	0
tion	0
between	0
the	0
endogenous	0
circadian	I-DISEASE
rhythm	0
and	0
the	0
sleep	0
homeostatic	0
process	0
that	0
regulates	0
sleep	I-DISEASE
and	0
wakefulness	0
may	I-DISEASE
play	I-DISEASE
an	B-DISEASE
essential	0
role	0
in	I-DISEASE
the	0
pathophysiology	0
of	I-DISEASE
DSWPD	0
.	0

Early	I-DISEASE
studies	I-DISEASE
reported	0
an	0
altered	0
phase	0
relationship	0
between	0
the	0
sleep	0
-	0
wake	0
cycle	I-DISEASE
and	0
circadian	0
phase	0
,	I-DISEASE
whereas	0
more	0
recent	I-DISEASE
studies	I-DISEASE
have	0
failed	0
to	I-DISEASE
support	I-DISEASE
this	0
finding	I-DISEASE
.	0

In	I-DISEASE
these	I-DISEASE
patients	0
,	I-DISEASE
sleep	0
onset	I-DISEASE
,	0
sleep	0
offset	0
,	0
and	0
phase	0
of	I-DISEASE
circadian	I-DISEASE
markers	0
such	0
as	I-DISEASE
core	0
body	I-DISEASE
temperature	I-DISEASE
and	0
melatonin	0
are	0
delayed	I-DISEASE
relative	I-DISEASE
to	I-DISEASE
clock	0
time	I-DISEASE
when	0
com-	I-DISEASE
pared	0
with	0
controls	0
.	0

Although	I-DISEASE
this	I-DISEASE
condition	0
may	I-DISEASE
be	0
predominantly	I-DISEASE
due	I-DISEASE
to	I-DISEASE
a	0
misalign-	0
ment	I-DISEASE
between	0
circadian	I-DISEASE
timing	0
and	0
the	0
external	0
environment	0
,	0
alterations	0
in	I-DISEASE
the	0
length	0
of	I-DISEASE
the	I-DISEASE
circadian	I-DISEASE
period	0
or	0
an	0
altered	0
homeostatic	I-DISEASE
process	0
(	0
indicated	B-DISEASE
by	0
decreased	0
sleep	0
propensity	I-DISEASE
in	I-DISEASE
response	0
to	0
sleep	0
deprivation	0
)	0
also	0
may	0
be	I-DISEASE
contributing	0
factors	0
.	I-DISEASE

In	I-DISEASE
chil-	I-DISEASE
dren	0
and	0
adults	I-DISEASE
,	0
voluntary	0
behaviors	I-DISEASE
such	0
as	I-DISEASE
staying	I-DISEASE
awake	0
late	I-DISEASE
at	I-DISEASE
night	I-DISEASE
and	0
waking	0
up	I-DISEASE
late	I-DISEASE
in	I-DISEASE
the	0
morning	0
or	I-DISEASE
afternoon	0
may	I-DISEASE
result	0
in	I-DISEASE
an	0
abnormal	I-DISEASE
relationship	0
between	0
the	0
endogenous	0
circadian	0
rhythm	0
and	0
the	0
sleep	0
homeostatic	I-DISEASE
process	0
that	0
regulates	I-DISEASE
sleep	0
and	0
wakefulness	0
.	0

Delayed	I-DISEASE
bedtimes	I-DISEASE
and	0
wake	0
times	0
may	0
increase	I-DISEASE
exposure	0
to	I-DISEASE
bright	0
Circadian	0
Rhythm	0
Sleep	0
-	I-DISEASE
Wake	0
Disorders	0
Circadian	I-DISEASE
Rhythm	0
Sleep	0
-	I-DISEASE
Wake	0
Disorders	0
light	0
in	0
the	0
late	I-DISEASE
evening	0
(	I-DISEASE
a	0
delay	0
signal	I-DISEASE
for	0
the	I-DISEASE
circadian	0
clock	0
)	0
and	0
decrease	0
expo-	I-DISEASE
sure	0
to	0
light	0
in	I-DISEASE
the	0
early	0
morning	I-DISEASE
(	I-DISEASE
an	0
advance	0
signal	I-DISEASE
for	0
the	0
circadian	I-DISEASE
clock	I-DISEASE
)	0
,	I-DISEASE
thereby	I-DISEASE
promoting	I-DISEASE
and	0
perpetuating	0
the	0
delay	I-DISEASE
in	0
the	I-DISEASE
circadian	0
sleep	0
phase	0
.	I-DISEASE

Given	I-DISEASE
a	0
sufficient	0
discrepancy	0
between	0
early	0
and	0
late	I-DISEASE
wake	0
times	I-DISEASE
,	I-DISEASE
early	0
wake	0
times	0
may	I-DISEASE
be	0
associated	0
with	0
bright	0
light	0
exposure	0
during	I-DISEASE
the	0
maximal	0
phase	0
delay	I-DISEASE
region	I-DISEASE
,	I-DISEASE
perpetuating	0
the	0
cir-	0
cadian	0
phase	0
delay	0
and	0
the	0
disorder	I-DISEASE
.	0

Individuals	I-DISEASE
may	0
have	0
alterations	I-DISEASE
in	0
sensitivity	I-DISEASE
to	I-DISEASE
the	0
phase	0
shifting	0
effects	0
of	I-DISEASE
light	I-DISEASE
.	0

For	I-DISEASE
example	0
,	0
partial	I-DISEASE
sleep	0
deprivation	I-DISEASE
encountered	0
with	I-DISEASE
this	0
disorder	I-DISEASE
can	0
also	0
attenuate	I-DISEASE
the	0
ability	0
to	I-DISEASE
phase	0
-	0
advance	0
the	0
circadian	I-DISEASE
system	0
,	I-DISEASE
further	I-DISEASE
perpetuating	I-DISEASE
the	0
delayed	I-DISEASE
circadian	0
phase	0
.	0

Objective	I-DISEASE
Findings	I-DISEASE
Recordings	I-DISEASE
of	I-DISEASE
sleep	0
logs	B-DISEASE
and	0
actigraphy	0
over	I-DISEASE
an	0
interval	I-DISEASE
of	I-DISEASE
at	I-DISEASE
least	0
seven	0
(	I-DISEASE
and	0
pref-	I-DISEASE
erably	0
fourteen	I-DISEASE
)	0
consecutive	I-DISEASE
days	0
demonstrate	I-DISEASE
delayed	0
sleep	0
onset	0
and	0
sleep	0
offset	0
(	0
typically	0
greater	I-DISEASE
than	0
two	0
hours	I-DISEASE
)	0
relative	I-DISEASE
to	I-DISEASE
socially	0
acceptable	I-DISEASE
times	0
.	0

Though	I-DISEASE
clock	0
times	0
may	I-DISEASE
be	0
culture	0
dependent	0
,	I-DISEASE
for	0
many	0
affected	0
individuals	I-DISEASE
sleep	I-DISEASE
onset	I-DISEASE
is	0
typi-	0
cally	0
delayed	I-DISEASE
until	0
1:00	0
a.m.	0
to	0
6:00	0
a.m.	0
,	I-DISEASE
(	0
though	0
may	0
be	0
earlier	0
based	I-DISEASE
on	0
age	I-DISEASE
and	0
developmental	I-DISEASE
status	0
)	0
,	0
and	0
wake	0
time	0
occurs	0
in	I-DISEASE
the	0
late	0
morning	0
or	0
afternoon	0
.	I-DISEASE

Daily	I-DISEASE
demands	0
and	0
schedules	I-DISEASE
may	0
result	0
in	0
an	0
earlier	0
than	0
desired	0
wake	0
-	I-DISEASE
up	I-DISEASE
time	0
during	I-DISEASE
work	I-DISEASE
or	I-DISEASE
school	0
days	0
,	0
but	0
a	0
delay	0
in	I-DISEASE
bedtime	I-DISEASE
and	0
wake	0
-	I-DISEASE
up	0
time	0
is	0
almost	I-DISEASE
always	0
seen	I-DISEASE
during	I-DISEASE
free	0
days	0
and	0
vacation	0
.	0

Polysomnography	I-DISEASE
(	I-DISEASE
though	0
not	0
routinely	0
indicated	0
nor	0
required	0
for	I-DISEASE
the	0
diagnosis	0
)	0
,	I-DISEASE
when	I-DISEASE
performed	0
at	I-DISEASE
preferred	0
(	I-DISEASE
delayed	I-DISEASE
)	0
sleep	0
times	I-DISEASE
,	0
is	I-DISEASE
essentially	I-DISEASE
normal	0
for	I-DISEASE
age	I-DISEASE
.	0

If	I-DISEASE
a	0
conventional	0
bedtime	I-DISEASE
and	0
wake	0
-	I-DISEASE
up	0
time	0
are	0
enforced	I-DISEASE
,	I-DISEASE
however	I-DISEASE
,	0
polysomnographic	0
recording	0
may	0
show	0
prolonged	0
sleep	I-DISEASE
latency	0
and	0
decreased	I-DISEASE
total	0
sleep	0
time	0
.	0

Laboratory	I-DISEASE
measures	0
of	I-DISEASE
circadian	I-DISEASE
timing	I-DISEASE
generally	I-DISEASE
show	I-DISEASE
the	0
expected	0
phase	0
delay	I-DISEASE
in	I-DISEASE
the	0
timing	0
of	I-DISEASE
the	0
nadir	I-DISEASE
of	0
the	0
core	I-DISEASE
body	I-DISEASE
temperature	B-DISEASE
rhythm	I-DISEASE
and	0
dim-	0
light	0
melatonin	0
onset	0
(	I-DISEASE
DLMO	I-DISEASE
)	0
.	0

Several	I-DISEASE
questionnaires	I-DISEASE
are	0
useful	0
in	I-DISEASE
assessing	I-DISEASE
the	0
chro-	0
notype	I-DISEASE
,	0
the	0
degree	I-DISEASE
of	I-DISEASE
eveningness	0
or	I-DISEASE
morningness	0
(	I-DISEASE
e.g.	0
,	I-DISEASE
“	I-DISEASE
Morningness	I-DISEASE
-	0
Eveningness	0
Questionnaire	I-DISEASE
,	0
”	I-DISEASE
“	0
Munich	0
Chronotype	I-DISEASE
Questionnaire	I-DISEASE
”	I-DISEASE
)	0
.	0

Individuals	I-DISEASE
with	I-DISEASE
DSWPD	0
,	I-DISEASE
typ-	0
ically	I-DISEASE
score	I-DISEASE
high	0
as	0
evening	0
types	I-DISEASE
,	0
though	0
normal	0
sleepers	0
can	0
also	0
score	I-DISEASE
high	0
on	0
eve-	0
ningness	0
.	0

Elevations	I-DISEASE
are	I-DISEASE
expected	0
in	I-DISEASE
self	0
-	0
report	0
of	I-DISEASE
daytime	0
sleepiness	0
,	I-DISEASE
such	0
as	0
on	0
the	0
Epworth	0
Sleepiness	0
Scale	0
.	0

The	I-DISEASE
results	I-DISEASE
of	I-DISEASE
polysomnography	0
and	0
other	0
diagnostic	0
tools	I-DISEASE
in	I-DISEASE
younger	0
age	I-DISEASE
groups	0
are	I-DISEASE
similar	0
to	0
those	0
seen	I-DISEASE
in	I-DISEASE
adults	B-DISEASE
.	0

Actigraphy	I-DISEASE
and/or	0
sleep	0
logs	I-DISEASE
are	0
useful	0
in	I-DISEASE
the	0
diagnosis	I-DISEASE
of	I-DISEASE
DSWPD	0
in	I-DISEASE
the	0
pediatric	0
population	0
.	0

Several	0
validated	I-DISEASE
instruments	I-DISEASE
are	0
available	0
for	0
assessing	I-DISEASE
phase	0
preference	0
in	0
the	0
pediatric	I-DISEASE
and	0
adolescent	0
pop-	I-DISEASE
ulations	0
.	0

These	0
include	I-DISEASE
the	0
Children	I-DISEASE
’s	I-DISEASE
Chronotype	I-DISEASE
Questionnaire	I-DISEASE
(	I-DISEASE
CCTQ	I-DISEASE
)	0
(	I-DISEASE
par-	0
ent	0
-	0
report	0
)	0
,	I-DISEASE
the	I-DISEASE
Morningness	0
-	0
Eveningness	0
Scale	I-DISEASE
for	0
Children	0
(	I-DISEASE
self	0
-	0
report	0
)	0
,	0
and	0
the	0
Morningness	0
-	0
Eveningness	0
Questionnaire	I-DISEASE
for	0
Children	0
and	0
Adolescents	0
.	0

These	0
surveys	0
have	0
been	I-DISEASE
used	0
to	I-DISEASE
assess	I-DISEASE
chronotype	I-DISEASE
in	I-DISEASE
the	0
pediatric	I-DISEASE
population	0
and	0
may	I-DISEASE
be	I-DISEASE
useful	0
in	0
clinical	I-DISEASE
settings	I-DISEASE
.	0

Differential	I-DISEASE
Diagnosis	0
Delayed	0
sleep	0
-	0
wake	0
phase	0
disorder	I-DISEASE
must	I-DISEASE
be	0
distinguished	I-DISEASE
from	I-DISEASE
“	I-DISEASE
normal	0
”	I-DISEASE
sleep	0
pat-	I-DISEASE
terns	0
,	I-DISEASE
particularly	0
in	I-DISEASE
adolescents	0
and	0
young	I-DISEASE
adults	0
who	I-DISEASE
maintain	0
delayed	I-DISEASE
schedules	0
regularly	0
or	I-DISEASE
intermittently	0
,	0
without	0
distress	0
or	I-DISEASE
impaired	I-DISEASE
functioning	I-DISEASE
.	0

DSWPD	I-DISEASE
must	I-DISEASE
be	0
distinguished	I-DISEASE
from	I-DISEASE
other	I-DISEASE
causes	0
of	I-DISEASE
difficulty	0
initiating	I-DISEASE
sleep	0
,	I-DISEASE
including	0
chronic	I-DISEASE
insom-	0
nia	0
disorder	I-DISEASE
.	0

In	I-DISEASE
DSWPD	0
,	0
sleep	0
initiation	I-DISEASE
and	0
maintenance	0
are	0
improved	I-DISEASE
when	I-DISEASE
the	I-DISEASE
patient	I-DISEASE
is	0
allowed	0
to	I-DISEASE
sleep	I-DISEASE
on	0
the	0
preferred	I-DISEASE
schedule	I-DISEASE
.	0

When	I-DISEASE
individuals	I-DISEASE
with	0
DSWPD	I-DISEASE
must	0
arise	I-DISEASE
before	0
the	0
desired	0
wake	0
time	I-DISEASE
,	I-DISEASE
excessive	0
sleep	0
inertia	I-DISEASE
and	0
excessive	0
daytime	0
sleepiness	0
may	0
be	I-DISEASE
evident	0
.	0

Other	I-DISEASE
forms	0
of	I-DISEASE
excessive	0
daytime	0
sleepiness	0
,	I-DISEASE
from	0
which	0
this	0
must	I-DISEASE
be	I-DISEASE
distinguished	I-DISEASE
,	0
do	0
not	0
generally	I-DISEASE
exhibit	0
the	0
pronounced	0
circadian	0
pattern	0
and	0
do	I-DISEASE
not	0
abate	I-DISEASE
with	I-DISEASE
alterations	0
in	I-DISEASE
the	0
sleep	0
-	I-DISEASE
wake	0
schedule	I-DISEASE
.	0

The	I-DISEASE
development	I-DISEASE
of	I-DISEASE
DSWPD	I-DISEASE
may	0
be	I-DISEASE
influenced	0
by	I-DISEASE
alterations	0
in	I-DISEASE
circadian	I-DISEASE
physiology	0
as	0
well	I-DISEASE
as	I-DISEASE
behavioral	0
factors	0
.	0

Inadequate	I-DISEASE
sleep	0
hygiene	I-DISEASE
and	0
insufficient	0
sleep	0
syndrome	I-DISEASE
must	I-DISEASE
also	I-DISEASE
be	I-DISEASE
considered	I-DISEASE
in	I-DISEASE
the	0
differential	I-DISEASE
.	0

Unresolved	I-DISEASE
Issues	0
and	0
Further	I-DISEASE
Directions	0

There	I-DISEASE
is	I-DISEASE
limited	I-DISEASE
knowledge	0
of	0
the	0
underlying	0
pathophysiology	I-DISEASE
of	I-DISEASE
DSWPD	I-DISEASE
.	0

Recent	I-DISEASE
evidence	I-DISEASE
suggests	I-DISEASE
that	I-DISEASE
alteration	0
in	I-DISEASE
the	B-DISEASE
homeostatic	0
regulation	I-DISEASE
of	I-DISEASE
sleep	I-DISEASE
and	0
alertness	I-DISEASE
may	I-DISEASE
play	0
an	0
important	0
role	0
.	0

The	I-DISEASE
intrinsic	I-DISEASE
circadian	0
period	0
may	I-DISEASE
be	I-DISEASE
abnormally	I-DISEASE
long	I-DISEASE
.	0

Recent	I-DISEASE
advances	I-DISEASE
in	I-DISEASE
the	0
understanding	0
of	I-DISEASE
the	0
molecular	I-DISEASE
basis	0
for	0
the	0
generation	0
and	0
entrainment	I-DISEASE
of	I-DISEASE
circadian	0
rhythms	0
,	0
together	I-DISEASE
with	I-DISEASE
the	0
identification	I-DISEASE
of	0
a	I-DISEASE
familial	I-DISEASE
form	I-DISEASE
of	I-DISEASE
DSWPD	I-DISEASE
,	0
will	0
lead	0
to	I-DISEASE
improved	0
understanding	0
of	0
the	0
mechanisms	I-DISEASE
responsible	I-DISEASE
for	I-DISEASE
this	I-DISEASE
condition	I-DISEASE
,	I-DISEASE
as	0
well	0
as	0
targeted	0
,	0
evidence	0
-	I-DISEASE
based	B-DISEASE
therapies	0
.	0

Bibliography	0
Ancoli	0
-	I-DISEASE
Israel	I-DISEASE
S	I-DISEASE
,	0
Schnierow	0
B	0
,	I-DISEASE
Kelsoe	I-DISEASE
J	0
,	I-DISEASE
Fink	0
R.	0
A	0
pedigree	0
of	I-DISEASE
one	I-DISEASE
family	0
with	I-DISEASE
delayed	I-DISEASE
sleep	0
phase	0
syndrome	0
.	0

Chronobiol	I-DISEASE
Int	0
2001;18:831–41	I-DISEASE
.	0

Archer	I-DISEASE
SN	I-DISEASE
,	I-DISEASE
Carpen	0
JD	0
,	0
Gibson	0
M	I-DISEASE
,	I-DISEASE
et	I-DISEASE
al	I-DISEASE
.	0

Polymorphism	I-DISEASE
in	0
the	0
PER3	0
promoter	0
associates	I-DISEASE
with	I-DISEASE
diurnal	I-DISEASE
preference	0
and	0
delayed	I-DISEASE
sleep	0
phase	0
disorder	I-DISEASE
.	0

Sleep	I-DISEASE
2010;33:695–701	0
.	0

Bijlenga	0
D	I-DISEASE
,	I-DISEASE
Van	I-DISEASE
Someren	0
EJW	0
,	I-DISEASE
Gruber	I-DISEASE
R	I-DISEASE
,	0
et	0
al	I-DISEASE
.	0

Body	I-DISEASE
temperature	I-DISEASE
,	0
activity	0
,	0
and	0
melatonin	0
profiles	0
in	I-DISEASE
adults	I-DISEASE
with	I-DISEASE
attention	0
-	0
deficit	I-DISEASE
/	I-DISEASE
hyperactivity	0
disorder	0
and	0
delayed	0
sleep	0
:	0
a	0
case	I-DISEASE
-	I-DISEASE
control	0
study	0
.	0

J	I-DISEASE
Sleep	0
Res	0
2013	0
;	I-DISEASE
22:607–16	I-DISEASE
.	I-DISEASE

Dagan	I-DISEASE
Y	0
,	I-DISEASE
Stein	0
D	I-DISEASE
,	I-DISEASE
Steinbock	B-DISEASE
M	I-DISEASE
,	I-DISEASE
Yovel	I-DISEASE
I	0
,	I-DISEASE
Hallis	I-DISEASE
D.	0
Frequency	I-DISEASE
of	I-DISEASE
delayed	I-DISEASE
sleep	0
phase	0
syndrome	0
among	0
hospitalized	I-DISEASE
adolescent	0
psychiatric	0
patients	I-DISEASE
.	0

Psychosom	I-DISEASE
Res	I-DISEASE
1998;45:15–20	0
.	0

Gruber	I-DISEASE
R	I-DISEASE
,	0
Sheshko	I-DISEASE
D.	0
Circadian	0
sleep	0
disorders	0
in	I-DISEASE
children	I-DISEASE
and	0
adolescents	0
.	0

In	I-DISEASE
Ivanenko	I-DISEASE
A.	0
(	I-DISEASE
ed	0
)	0
,	0
Sleep	0
and	0
psychiatric	I-DISEASE
disorders	0
in	I-DISEASE
children	0
and	0
adolescents	0
.	0

USA	I-DISEASE
:	0
Informa	0
Healthcare	I-DISEASE
,	0
2008	I-DISEASE
;	0
61	0
-	0
78	0
.	I-DISEASE

Circadian	I-DISEASE
Rhythm	0
Sleep	I-DISEASE
-	I-DISEASE
Wake	I-DISEASE
Disorders	0
Circadian	0
Rhythm	0
Sleep	I-DISEASE
-	I-DISEASE
Wake	0
Disorders	0
Gruber	I-DISEASE
R	I-DISEASE
,	0
Fontil	I-DISEASE
L	0
,	I-DISEASE
Bergmame	0
L	0
,	0
et	0
al	I-DISEASE
.	0

Contributions	0
of	I-DISEASE
circadian	0
tendencies	I-DISEASE
and	0
behavioural	0
problems	0
to	I-DISEASE
sleep	I-DISEASE
onset	I-DISEASE
problems	0
of	I-DISEASE
children	I-DISEASE
with	I-DISEASE
ADHD	0
.	0

BMC	0
Psychiat	0
2012;12:212	I-DISEASE
.	0

Kripke	I-DISEASE
DF	I-DISEASE
,	I-DISEASE
Rex	0
KM	B-DISEASE
,	0
Ancoli	0
-	I-DISEASE
Israel	0
S	I-DISEASE
,	I-DISEASE
Nievergelt	0
CM	0
,	I-DISEASE
Klimecki	0
W	0
,	I-DISEASE
Kelsoe	I-DISEASE
JR	0
.	0

Delayed	I-DISEASE
sleep	I-DISEASE
phase	0
cases	0
and	0
controls	0
.	0

J	I-DISEASE
Circadian	0
Rhythms	0
2008;6:6	I-DISEASE
.	0

Marchetti	I-DISEASE
LM	0
,	0
Biello	0
SM	I-DISEASE
,	0
Broomfield	0
NM	0
,	I-DISEASE
Macmahon	I-DISEASE
KM	0
,	0
Espie	0
CA	I-DISEASE
.	0

Who	I-DISEASE
is	0
pre	0
-	I-DISEASE
occupied	0
with	I-DISEASE
sleep	0
?	I-DISEASE

A	I-DISEASE
comparison	0
of	I-DISEASE
attention	0
bias	0
in	I-DISEASE
people	0
with	I-DISEASE
psychophysiological	0
insomnia	0
,	I-DISEASE
delayed	0
sleep	0
phase	0
syndrome	0
and	0
good	0
sleepers	0
using	0
the	I-DISEASE
induced	0
change	I-DISEASE
blindness	I-DISEASE
paradigm	0
.	0

J	I-DISEASE
Sleep	0
Res	0
2006;15:212–21	0
.	0

Rahman	I-DISEASE
SA	0
,	0
Kayumov	I-DISEASE
L	0
,	I-DISEASE
Tchmoutina	0
EA	I-DISEASE
,	0
Shapiro	0
CM	I-DISEASE
.	0

Clinical	I-DISEASE
efficacy	I-DISEASE
of	I-DISEASE
dim	0
light	0
melatonin	0
onset	0
testing	0
in	I-DISEASE
diagnosing	I-DISEASE
delayed	I-DISEASE
sleep	0
phase	0
syndrome	0
.	0

Sleep	I-DISEASE
Med	I-DISEASE
2009;10:549–55	I-DISEASE
.	0

Reid	I-DISEASE
KJ	0
,	I-DISEASE
Jaksa	0
AA	I-DISEASE
,	0
Eisengart	0
JB	I-DISEASE
,	I-DISEASE
et	0
al	I-DISEASE
.	0

Systematic	I-DISEASE
evaluation	0
of	I-DISEASE
Axis	0
-	I-DISEASE
I	0
DSM	I-DISEASE
diagnoses	0
in	I-DISEASE
delayed	B-DISEASE
sleep	0
phase	0
disorder	I-DISEASE
and	0
evening	0
-	I-DISEASE
type	I-DISEASE
circadian	I-DISEASE
preference	0
.	0

Sleep	I-DISEASE
Med	I-DISEASE
2012;13:1171–7	I-DISEASE
.	0

Shibui	I-DISEASE
K	I-DISEASE
,	0
Uchiyama	I-DISEASE
M	I-DISEASE
,	0
Okawa	0
M.	I-DISEASE
Melatonin	0
rhythms	I-DISEASE
in	0
delayed	0
sleep	0
phase	0
syndrome	I-DISEASE
.	0

J	I-DISEASE
Biol	0
Rhythms	0
1999;14:72–6	I-DISEASE
.	0

Uchiyama	I-DISEASE
M	I-DISEASE
,	0
Okawa	0
M	I-DISEASE
,	0
Shibui	0
K	I-DISEASE
,	I-DISEASE
et	0
al	I-DISEASE
.	0

Poor	I-DISEASE
compensatory	I-DISEASE
function	0
for	I-DISEASE
sleep	I-DISEASE
loss	0
as	0
a	0
pathogenic	I-DISEASE
factor	I-DISEASE
in	I-DISEASE
patients	I-DISEASE
with	I-DISEASE
delayed	I-DISEASE
sleep	0
phase	0
syndrome	I-DISEASE
.	0

Sleep	I-DISEASE
2000;23:553–8	I-DISEASE
.	0

Weitzman	I-DISEASE
E	0
,	0
Czeisler	0
C	0
,	0
Coleman	I-DISEASE
R	I-DISEASE
,	I-DISEASE
Spielman	0
,	I-DISEASE
et	0
al	0
.	0

Delayed	I-DISEASE
sleep	0
phase	0
syndrome	I-DISEASE
:	I-DISEASE
a	I-DISEASE
chronobiological	0
disorder	I-DISEASE
with	0
sleep	0
onset	0
insomnia	I-DISEASE
.	0

Arch	I-DISEASE
Gen	0
Psychiatry	0
1981;38:737–46	0
.	0

Wyatt	I-DISEASE
JK	0
,	I-DISEASE
Stepanski	0
EJ	I-DISEASE
,	0
Kirkby	I-DISEASE
J.	I-DISEASE
Circadian	0
phase	0
in	0
delayed	I-DISEASE
sleep	0
phase	0
syndrome	I-DISEASE
:	0
predictors	I-DISEASE
and	0
temporal	I-DISEASE
stability	0
across	I-DISEASE
multiple	I-DISEASE
assessments	0
.	0

Sleep	I-DISEASE
2006;29:1075–80	0
.	0

Advanced	I-DISEASE
Sleep	I-DISEASE
-	0
Wake	I-DISEASE
Phase	0
Disorder	I-DISEASE
ICD-9	0
-	I-DISEASE
CM	I-DISEASE
code	0
:	I-DISEASE
327.32	I-DISEASE
ICD-10	0
-	I-DISEASE
CM	0
code	0
:	I-DISEASE

G47.22	I-DISEASE
Alternate	0
Names	I-DISEASE
Advanced	I-DISEASE
sleep	I-DISEASE
phase	0
type	I-DISEASE
,	I-DISEASE
advanced	I-DISEASE
sleep	I-DISEASE
phase	0
disorder	0
,	I-DISEASE
advanced	I-DISEASE
sleep	I-DISEASE
phase	0
syndrome	0
.	0

Diagnostic	I-DISEASE
Criteria	0
Criteria	0

A	I-DISEASE
-	I-DISEASE
E	0
must	I-DISEASE
be	0
met	0
A.	0

There	I-DISEASE
is	I-DISEASE
an	0
advance	I-DISEASE
(	0
early	0
timing	I-DISEASE
)	0
in	0
the	0
phase	0
of	I-DISEASE
the	I-DISEASE
major	I-DISEASE
sleep	0
episode	I-DISEASE
in	I-DISEASE
relation	I-DISEASE
to	0
the	0
desired	I-DISEASE
or	0
required	I-DISEASE
sleep	0
time	0
and	0
wake	0
-	I-DISEASE
up	0
time	I-DISEASE
,	I-DISEASE
as	B-DISEASE
evidenced	0
by	I-DISEASE
a	0
chronic	I-DISEASE
or	0
recurrent	0
complaint	0
of	0
difficulty	0
staying	0
awake	0
until	0
the	0
required	I-DISEASE
or	I-DISEASE
desired	I-DISEASE
conventional	0
bedtime	I-DISEASE
,	0
together	0
with	0
an	0
inability	I-DISEASE
to	0
remain	0
asleep	I-DISEASE
until	0
the	0
required	I-DISEASE
or	I-DISEASE
desired	I-DISEASE
time	0
for	I-DISEASE
awakening	0
.	0

B.	0
Symptoms	0
are	0
present	I-DISEASE
for	0
at	I-DISEASE
least	0
three	I-DISEASE
months	I-DISEASE
.	0

C.	I-DISEASE
When	0
patients	I-DISEASE
are	0
allowed	I-DISEASE
to	I-DISEASE
sleep	I-DISEASE
in	0
accordance	0
with	I-DISEASE
their	I-DISEASE
internal	I-DISEASE
biological	I-DISEASE
clock	0
,	I-DISEASE
sleep	0
quality	I-DISEASE
and	0
duration	0
are	I-DISEASE
improved	I-DISEASE
with	I-DISEASE
a	0
consistent	I-DISEASE
but	I-DISEASE
advanced	0
timing	I-DISEASE
of	I-DISEASE
the	I-DISEASE
major	I-DISEASE
sleep	I-DISEASE
episode	I-DISEASE
.	0

D.	I-DISEASE
Sleep	0
log	I-DISEASE
and	0
,	I-DISEASE
whenever	0
possible	I-DISEASE
,	0
actigraphy	0
monitoring	I-DISEASE
for	I-DISEASE
at	I-DISEASE
least	I-DISEASE
seven	I-DISEASE
days	I-DISEASE
(	0
preferably	0
14	0
days	0
)	0
demonstrate	I-DISEASE
a	I-DISEASE
stable	0
advance	I-DISEASE
in	I-DISEASE
the	I-DISEASE
timing	I-DISEASE
of	I-DISEASE
the	0
habitual	0
sleep	0
period	0
.	0

Both	I-DISEASE
work	I-DISEASE
/	0
school	0
days	0
and	0
free	I-DISEASE
days	0
must	0
be	0
included	I-DISEASE
within	0
this	I-DISEASE
monitoring	I-DISEASE
.	0

E.	I-DISEASE

The	I-DISEASE
sleep	0
disturbance	0
is	I-DISEASE
not	0
better	0
explained	I-DISEASE
by	I-DISEASE
another	I-DISEASE
current	0
sleep	0
disorder	0
,	I-DISEASE
medical	I-DISEASE
or	0
neurological	0
disorder	0
,	0
mental	0
disorder	0
,	I-DISEASE
medication	0
use	0
,	I-DISEASE
or	0
substance	I-DISEASE
use	0
disorder	I-DISEASE
.	0

Notes	I-DISEASE
.	0

Standardized	I-DISEASE
chronotype	0
questionnaires	I-DISEASE
are	0
useful	0
tools	I-DISEASE
to	I-DISEASE
assess	I-DISEASE
the	I-DISEASE
chronotype	I-DISEASE
of	I-DISEASE
eveningness	0
and	0
morningness	0
.	0

Individuals	I-DISEASE
with	I-DISEASE
advanced	0
sleep	0
phase	0
score	I-DISEASE
as	0
morning	0
types	I-DISEASE
.	0
.	0

Demonstration	I-DISEASE
of	I-DISEASE
an	0
advance	0
(	I-DISEASE
typically	0
greater	I-DISEASE
than	0
two	0
hours	I-DISEASE
)	0
in	I-DISEASE
the	0
timing	0
of	I-DISEASE
other	I-DISEASE
circadian	I-DISEASE
rhythms	0
such	0
as	0
DLMO	I-DISEASE
or	0
urinary	I-DISEASE
6	0
-	I-DISEASE
sulfatoxymelatonin	0
is	0
desirable	I-DISEASE
to	0
confirm	0
the	0
advanced	0
circadian	0
phase	0
.	0

Essential	I-DISEASE
Features	I-DISEASE
Advanced	I-DISEASE
sleep	0
-	0
wake	0
phase	0
disorder	I-DISEASE
(	I-DISEASE
ASWPD	0
)	I-DISEASE
is	I-DISEASE
characterized	0
by	I-DISEASE
a	0
stable	I-DISEASE
advance	0
(	0
earlier	0
timing	0
)	0
of	I-DISEASE
the	0
major	I-DISEASE
sleep	0
episode	I-DISEASE
,	I-DISEASE
such	0
that	0
habitual	0
sleep	0
onset	I-DISEASE
and	0
offset	0
occur	0
typically	0
two	0
or	0
more	0
hours	I-DISEASE
prior	0
to	0
required	I-DISEASE
or	I-DISEASE
desired	I-DISEASE
times	0
.	0

Affected	I-DISEASE
individ-	I-DISEASE
uals	I-DISEASE
complain	0
of	I-DISEASE
early	I-DISEASE
morning	I-DISEASE
or	I-DISEASE
maintenance	0
insomnia	I-DISEASE
and	0
excessive	0
evening	0
sleep-	0
iness	I-DISEASE
.	0

When	I-DISEASE
affected	I-DISEASE
individuals	I-DISEASE
are	I-DISEASE
allowed	0
to	I-DISEASE
maintain	0
an	0
advanced	I-DISEASE
schedule	0
,	I-DISEASE
sleep	I-DISEASE
quality	I-DISEASE
and	0
quantity	I-DISEASE
are	0
improved	I-DISEASE
.	I-DISEASE

Associated	I-DISEASE
Features	I-DISEASE
Individuals	I-DISEASE
with	I-DISEASE
ASWPD	0
may	I-DISEASE
experience	0
chronic	0
partial	I-DISEASE
sleep	0
loss	I-DISEASE
due	I-DISEASE
to	0
early	0
morning	0
and	0
maintenance	0
insomnia	0
,	0
particularly	0
if	0
sleep	I-DISEASE
is	0
resisted	I-DISEASE
during	I-DISEASE
early	0
evening	0
.	B-DISEASE

Clinical	I-DISEASE
and	0
Pathophysiological	0
Subtypes	I-DISEASE
Familial	I-DISEASE
patterns	I-DISEASE
are	0
discussed	0
below	I-DISEASE
.	0

Demographics	I-DISEASE
The	I-DISEASE
prevalence	I-DISEASE
of	I-DISEASE
ASWPD	I-DISEASE
in	I-DISEASE
the	0
general	I-DISEASE
population	0
is	0
unknown	I-DISEASE
.	0

In	I-DISEASE
one	0
large	I-DISEASE
survey	I-DISEASE
study	0
involving	I-DISEASE
middle	I-DISEASE
-	0
aged	0
adults	B-DISEASE
(	I-DISEASE
40	0
-	I-DISEASE
64	I-DISEASE
years	0
)	0
,	I-DISEASE
the	0
population	0
prevalence	0
was	0
esti-	I-DISEASE
mated	0
at	I-DISEASE
1	I-DISEASE
%	0
,	I-DISEASE
although	0
it	0
is	0
unclear	0
what	0
proportion	I-DISEASE
of	I-DISEASE
these	0
subjects	0
would	0
deem	0
their	0
schedule	0
to	0
be	I-DISEASE
significantly	I-DISEASE
troublesome	0
so	0
as	0
to	0
warrant	I-DISEASE
clinical	0
attention	0
.	0

Until	I-DISEASE
the	0
identification	0
of	I-DISEASE
familial	0
cohorts	B-DISEASE
(	I-DISEASE
see	I-DISEASE
below	I-DISEASE
)	0
,	0
only	0
four	I-DISEASE
cases	0
were	0
described	0
in	I-DISEASE
the	0
lit-	I-DISEASE
erature	0
.	0

There	I-DISEASE
is	I-DISEASE
no	0
known	I-DISEASE
sex	0
difference	I-DISEASE
.	0

Circadian	I-DISEASE
Rhythm	0
Sleep	I-DISEASE
-	I-DISEASE
Wake	I-DISEASE
Disorders	0
Circadian	0
Rhythm	0
Sleep	I-DISEASE
-	I-DISEASE
Wake	0
Disorders	0
Predisposing	I-DISEASE
and	0
Precipitating	I-DISEASE
Factors	B-DISEASE
Advanced	I-DISEASE
age	I-DISEASE
appears	I-DISEASE
to	I-DISEASE
be	0
a	0
risk	0
factor	0
.	0

Among	I-DISEASE
a	0
cohort	0
aged	I-DISEASE
20	0
to	I-DISEASE
59	0
years	0
,	0
older	0
age	I-DISEASE
was	I-DISEASE
associated	0
with	0
increased	0
morningness	I-DISEASE
,	0
which	0
was	0
determined	I-DISEASE
to	0
be	0
a	I-DISEASE
sig-	0
nificant	I-DISEASE
mediator	I-DISEASE
of	I-DISEASE
numerous	0
age	I-DISEASE
-	0
sleep	0
relationships	0
.	0

A	I-DISEASE
patient	I-DISEASE
’s	B-DISEASE
ability	0
to	I-DISEASE
sleep	0
at	I-DISEASE
an	0
abnormal	0
circadian	0
phase	I-DISEASE
(	I-DISEASE
phase	0
tolerance	I-DISEASE
)	0
also	I-DISEASE
impacts	0
the	0
degree	I-DISEASE
to	0
which	0
adverse	0
symptoms	I-DISEASE
are	I-DISEASE
experienced	0
,	I-DISEASE
and	0
this	I-DISEASE
adaptability	I-DISEASE
varies	0
among	0
individuals	I-DISEASE
.	0

Conflicting	I-DISEASE
results	I-DISEASE
have	I-DISEASE
been	0
obtained	0
with	I-DISEASE
respect	I-DISEASE
to	0
the	0
relationship	0
between	0
age	I-DISEASE
and	0
phase	0
tolerance	I-DISEASE
,	I-DISEASE
with	I-DISEASE
some	0
suggesting	0
that	0
age	I-DISEASE
decreases	0
phase	0
tolerance	0
,	I-DISEASE
and	0
others	I-DISEASE
suggesting	0
that	0
age	I-DISEASE
may	I-DISEASE
actually	I-DISEASE
be	0
protective	I-DISEASE
.	0

Methodological	I-DISEASE
differences	I-DISEASE
preclude	I-DISEASE
direct	0
comparisons	I-DISEASE
of	I-DISEASE
the	0
investigations	I-DISEASE
,	I-DISEASE
as	I-DISEASE
do	I-DISEASE
wide	0
variations	I-DISEASE
in	I-DISEASE
the	I-DISEASE
age	0
groups	0
studied	0
.	0

Genetic	I-DISEASE
factors	0
also	0
can	0
influence	0
the	0
development	I-DISEASE
of	I-DISEASE
the	0
condition	0
,	I-DISEASE
as	I-DISEASE
has	I-DISEASE
been	I-DISEASE
definitively	I-DISEASE
demonstrated	I-DISEASE
among	0
select	0
familial	I-DISEASE
cohorts	B-DISEASE
(	0
see	I-DISEASE
Pathology	I-DISEASE
and	0
Pathophysiology	I-DISEASE
section	0
)	0
.	0

Environmental	I-DISEASE
influences	I-DISEASE
may	0
precipitate	I-DISEASE
,	I-DISEASE
maintain	0
,	0
or	0
exacerbate	I-DISEASE
the	0
advanced	I-DISEASE
circadian	I-DISEASE
phase	0
,	I-DISEASE
but	0
this	0
has	0
not	0
been	I-DISEASE
proven	0
.	I-DISEASE

ASWPD	I-DISEASE
has	0
been	0
reported	I-DISEASE
in	I-DISEASE
children	I-DISEASE
with	0
neurodevelopmental	0
disorders	0
.	0

In	I-DISEASE
particular	I-DISEASE
,	0
studies	I-DISEASE
in	0
children	I-DISEASE
with	I-DISEASE
autism	0
spectrum	0
disorders	0
and	0
Smith	0
-	I-DISEASE
Magenis	I-DISEASE
syndrome	I-DISEASE
have	I-DISEASE
shown	0
profound	0
alterations	0
in	I-DISEASE
melatonin	0
secretion	0
profiles	0
,	I-DISEASE
which	0
may	I-DISEASE
manifest	0
as	0
a	0
phase	0
advance	0
with	0
very	I-DISEASE
early	0
morning	0
waking	0
.	0

Familial	I-DISEASE
Patterns	I-DISEASE
Various	0
groups	0
have	0
described	0
kindreds	0
with	I-DISEASE
familial	0
ASWPD	I-DISEASE
.	0

These	0
cases	0
may	0
be	I-DISEASE
characterized	0
by	I-DISEASE
an	0
earlier	I-DISEASE
age	I-DISEASE
of	I-DISEASE
onset	0
.	0

It	I-DISEASE
is	I-DISEASE
not	0
clear	I-DISEASE
whether	0
the	0
familial	I-DISEASE
or	0
non-	0
familial	I-DISEASE
variety	I-DISEASE
of	I-DISEASE
the	0
condition	0
is	0
more	0
common	I-DISEASE
.	0

Onset	I-DISEASE
,	0
Course	0
,	0
and	0
Complications	0
Repetitive	I-DISEASE
attempts	I-DISEASE
to	0
resume	0
sleep	0
with	I-DISEASE
awakenings	0
may	0
result	0
in	0
the	0
development	I-DISEASE
of	0
a	0
comorbid	0
chronic	I-DISEASE
insomnia	0
disorder	I-DISEASE
.	0

Individuals	I-DISEASE
may	0
use	0
alcohol	I-DISEASE
,	0
other	I-DISEASE
sedatives	I-DISEASE
,	0
and/or	0
stimulants	0
to	I-DISEASE
alleviate	0
symptoms	0
,	0
potentially	0
exacerbating	0
the	0
underlying	0
sleep/	0
wake	0
disorder	B-DISEASE
.	0

The	I-DISEASE
impact	I-DISEASE
on	0
caregivers	I-DISEASE
of	I-DISEASE
children	I-DISEASE
with	0
neurodevelopmental	0
disor-	I-DISEASE
ders	0
and	0
ASWPD	I-DISEASE
may	I-DISEASE
be	I-DISEASE
particularly	0
profound	I-DISEASE
.	0

Developmental	I-DISEASE
Issues	0
ASWPD	0
is	0
most	0
frequently	0
encountered	0
among	0
older	0
age	I-DISEASE
groups	0
.	0

An	0
early	0
age	I-DISEASE
of	I-DISEASE
onset	0
of	I-DISEASE
ASWPD	0
should	0
prompt	0
further	I-DISEASE
probing	0
for	0
a	0
familial	I-DISEASE
pattern	0
.	0

Caregivers	I-DISEASE
may	I-DISEASE
report	0
that	0
a	0
child	0
wakes	0
“	0
too	0
early	0
”	I-DISEASE
in	I-DISEASE
the	0
morning	0
,	I-DISEASE
which	I-DISEASE
is	0
disruptive	0
to	0
the	0
house-	0
hold	I-DISEASE
routine	0
and	0
may	0
curtail	I-DISEASE
parental	I-DISEASE
sleep	0
.	0

This	I-DISEASE
is	I-DISEASE
particularly	0
true	0
for	0
younger	I-DISEASE
chil-	I-DISEASE
dren	0
,	I-DISEASE
who	I-DISEASE
may	I-DISEASE
require	0
adult	0
supervision	I-DISEASE
once	I-DISEASE
they	0
are	0
awake	0
.	0

However	I-DISEASE
,	I-DISEASE
this	0
complaint	I-DISEASE
regarding	0
the	0
waking	0
pattern	0
is	0
often	0
more	0
related	0
to	I-DISEASE
unrealistic	I-DISEASE
caregiver	I-DISEASE
expecta-	0
tions	0
regarding	0
an	I-DISEASE
“	0
appropriate	I-DISEASE
”	I-DISEASE
wake	0
time	0
for	I-DISEASE
a	0
young	I-DISEASE
child	0
and/or	0
a	0
developmentally	I-DISEASE
inappropriate	0
early	0
bedtime	0
resulting	0
in	I-DISEASE
prolonged	0
time	I-DISEASE
in	I-DISEASE
bed	I-DISEASE
,	0
rather	0
than	0
to	I-DISEASE
a	0
true	0
advance	0
in	0
sleep	0
onset	0
and	0
offset	0
.	I-DISEASE

In	I-DISEASE
some	I-DISEASE
cases	0
,	I-DISEASE
children	0
are	0
motivated	0
to	I-DISEASE
wake	0
up	0
earlier	0
than	I-DISEASE
desired	I-DISEASE
because	0
they	0
are	0
reinforced	I-DISEASE
for	I-DISEASE
this	0
behavior	0
by	I-DISEASE
parental	I-DISEASE
attention	0
or	0
the	0
opportunity	I-DISEASE
to	0
watch	I-DISEASE
television	0
or	I-DISEASE
utilize	0
other	I-DISEASE
media	0
upon	0
waking	0
.	0

The	I-DISEASE
com-	I-DISEASE
plaint	I-DISEASE
that	0
a	0
child	0
“	0
falls	0
asleep	I-DISEASE
too	0
early	I-DISEASE
”	I-DISEASE
in	0
the	0
evening	0
,	I-DISEASE
especially	0
in	0
adolescence	0
,	0
is	0
rare	I-DISEASE
and	0
should	I-DISEASE
raise	0
concerns	I-DISEASE
regarding	0
the	0
possibility	I-DISEASE
of	I-DISEASE
chronically	I-DISEASE
insufficient	0
sleep	0
and/or	0
a	0
sleep	0
disorder	0
resulting	0
in	I-DISEASE
increased	I-DISEASE
sleep	0
needs	I-DISEASE
.	0

The	I-DISEASE
rarity	0
of	I-DISEASE
observa-	0
tions	0
of	I-DISEASE
advanced	I-DISEASE
sleep	0
onset	0
and	0
offset	0
times	I-DISEASE
among	0
young	0
children	I-DISEASE
may	0
also	0
be	0
due	0
in	I-DISEASE
part	0
to	I-DISEASE
societal	0
expectations	I-DISEASE
of	I-DISEASE
earlier	0
bed	I-DISEASE
and	0
wake	0
times	0
for	0
this	0
age	I-DISEASE
group	I-DISEASE
;	0
thus	0
,	0
a	0
misalignment	I-DISEASE
with	I-DISEASE
circadian	I-DISEASE
preference	0
is	0
less	I-DISEASE
likely	I-DISEASE
.	0

Pathology	I-DISEASE
and	0
Pathophysiology	I-DISEASE
Possible	0
etiologies	0
include	0
:	0
(	I-DISEASE
1	I-DISEASE
)	0
an	0
alteration	0
in	I-DISEASE
the	0
ability	0
of	I-DISEASE
the	0
circadian	I-DISEASE
clock	0
to	0
phase	0
delay	0
;	I-DISEASE
(	I-DISEASE
2	0
)	0
a	0
dominant	I-DISEASE
phase	0
advance	0
region	I-DISEASE
of	0
the	0
light	0
phase	0
response	0
curve	I-DISEASE
to	0
entraining	0
agents	0
;	0
(	0
3	I-DISEASE
)	0
altered	0
strength	0
of	I-DISEASE
entraining	0
agents	I-DISEASE
,	I-DISEASE
such	0
as	0
light	0
exposure	0
at	I-DISEASE
the	0
appropriate	I-DISEASE
circadian	0
time	0
(	I-DISEASE
voluntarily	0
or	0
involuntarily	I-DISEASE
induced	I-DISEASE
)	0
;	0
or	I-DISEASE
(	0
4	I-DISEASE
)	I-DISEASE
a	0
shortened	0
endogenous	0
circadian	0
period	0
of	I-DISEASE
the	I-DISEASE
pacemaker	0
.	I-DISEASE

Among	I-DISEASE
these	I-DISEASE
proposed	I-DISEASE
mechanisms	0
,	0
only	I-DISEASE
the	0
latter	I-DISEASE
has	0
been	0
definitively	0
demonstrated	I-DISEASE
among	0
select	0
familial	I-DISEASE
ASWPD	0
sub-	0
jects	I-DISEASE
.	0

Genetic	I-DISEASE
analyses	0
revealed	I-DISEASE
a	0
missense	I-DISEASE
mutation	I-DISEASE
in	0
a	0
casein	I-DISEASE
kinase	I-DISEASE
(	I-DISEASE
CK1ε	0
)	0
binding	0
region	I-DISEASE
of	I-DISEASE
a	0
Period	0
gene	0
(	I-DISEASE
hPer2	0
)	0
,	I-DISEASE
culminating	0
in	I-DISEASE
hypophosphorylation	0
by	0
CK1ε	0
in	I-DISEASE
vitro	0
.	0

Hypophosphorylation	I-DISEASE
of	I-DISEASE
the	0
Period	I-DISEASE
protein	I-DISEASE
results	I-DISEASE
in	I-DISEASE
promotion	I-DISEASE
of	I-DISEASE
its	I-DISEASE
transcription	0
and	0
,	0
ultimately	0
,	I-DISEASE
a	0
decrease	I-DISEASE
in	I-DISEASE
the	0
period	I-DISEASE
length	0
of	I-DISEASE
the	0
clock	I-DISEASE
.	0

However	I-DISEASE
,	I-DISEASE
genetic	0
het-	I-DISEASE
erogeneity	0
is	0
apparent	0
within	I-DISEASE
familial	I-DISEASE
ASWPD	I-DISEASE
,	0
as	0
demonstrated	0
by	I-DISEASE
the	0
fact	I-DISEASE
that	0
other	0
cohorts	0
from	0
this	0
same	0
study	0
and	0
another	I-DISEASE
study	0
did	0
not	0
reveal	0
mutations	0
in	I-DISEASE
hPer2	0
.	0

A	I-DISEASE
separate	0
report	0
of	I-DISEASE
a	0
Japanese	I-DISEASE
familial	I-DISEASE
ASWPD	0
cohort	I-DISEASE
described	I-DISEASE
a	0
missense	I-DISEASE
mutation	0
in	I-DISEASE
a	0
different	0
casein	I-DISEASE
kinase	0
gene	0
(	I-DISEASE
CKIδ	0
)	0
,	0
which	0
also	0
resulted	0
in	0
decreased	0
enzymatic	0
activity	0
in	0
vitro	I-DISEASE
.	0

Yet	I-DISEASE
another	I-DISEASE
group	I-DISEASE
described	0
associations	0
between	0
hPer1	I-DISEASE
and	0
hPer2	I-DISEASE
polymorphisms	0
and	0
extreme	I-DISEASE
morningness	0
circadian	0
preferences	0
(	I-DISEASE
questionnaire	0
-	0
based	B-DISEASE
)	0
,	0
in	I-DISEASE
the	0
absence	I-DISEASE
of	0
discrete	0
ASWPD	0
.	0

Objective	I-DISEASE
Findings	I-DISEASE
Among	0
patients	I-DISEASE
with	I-DISEASE
familial	0
ASWPD	I-DISEASE
,	0
laboratory	I-DISEASE
measures	0
to	I-DISEASE
determine	0
the	0
phase	0
of	I-DISEASE
circadian	0
rhythms	0
reliably	I-DISEASE
show	0
the	I-DISEASE
expected	I-DISEASE
phase	0
advance	0
in	I-DISEASE
the	0
timing	I-DISEASE
of	I-DISEASE
the	0
nadir	0
of	0
the	0
temperature	0
rhythm	0
and	0
the	0
dim	0
light	0
melatonin	0
onset	0
,	0
in	0
comparison	0
with	I-DISEASE
unaf-	I-DISEASE
fected	0
controls	0
.	0

Among	I-DISEASE
those	I-DISEASE
with	0
nonfamilial	I-DISEASE
ASWPD	I-DISEASE
,	0
a	0
wider	I-DISEASE
range	I-DISEASE
of	I-DISEASE
timing	I-DISEASE
of	I-DISEASE
circadian	I-DISEASE
markers	0
is	I-DISEASE
found	0
,	I-DISEASE
with	I-DISEASE
some	0
values	I-DISEASE
approaching	0
those	I-DISEASE
of	I-DISEASE
unaffected	I-DISEASE
controls	0
.	0

Polysomnography	I-DISEASE
(	I-DISEASE
though	0
not	0
routinely	0
indicated	0
nor	0
required	0
for	I-DISEASE
the	0
diagnosis	0
)	0
,	I-DISEASE
when	I-DISEASE
performed	0
at	I-DISEASE
preferred	0
(	I-DISEASE
advanced	I-DISEASE
)	0
sleep	0
times	I-DISEASE
,	0
is	I-DISEASE
essentially	I-DISEASE
normal	0
for	I-DISEASE
age	I-DISEASE
.	0

If	I-DISEASE
Circadian	0
Rhythm	0
Sleep	0
-	0
Wake	0
Disorders	0
Circadian	I-DISEASE
Rhythm	0
Sleep	I-DISEASE
-	0
Wake	0
Disorders	I-DISEASE
a	0
conventional	0
bedtime	I-DISEASE
and	0
wake	0
-	I-DISEASE
up	0
time	0
is	0
enforced	I-DISEASE
,	I-DISEASE
however	I-DISEASE
,	0
polysomnographic	0
recording	0
may	I-DISEASE
show	I-DISEASE
short	I-DISEASE
sleep	0
latency	I-DISEASE
and	0
early	0
awakening	0
with	0
curtailment	0
of	I-DISEASE
total	0
sleep	0
time	I-DISEASE
.	I-DISEASE

Differential	I-DISEASE
Diagnosis	0
ASWPD	I-DISEASE
must	0
be	0
distinguished	I-DISEASE
from	I-DISEASE
“	I-DISEASE
normal	0
”	I-DISEASE
sleep	0
patterns	I-DISEASE
,	I-DISEASE
particularly	0
among	0
the	0
elderly	I-DISEASE
or	0
very	I-DISEASE
young	I-DISEASE
,	I-DISEASE
who	0
often	I-DISEASE
maintain	0
advanced	I-DISEASE
schedules	I-DISEASE
without	0
distress	I-DISEASE
or	0
impaired	I-DISEASE
functioning	I-DISEASE
.	0

ASWPD	I-DISEASE
must	I-DISEASE
also	0
be	I-DISEASE
distinguished	I-DISEASE
from	I-DISEASE
other	0
causes	0
of	I-DISEASE
early	I-DISEASE
awakening	I-DISEASE
,	0
including	0
chronic	I-DISEASE
insomnia	I-DISEASE
disorder	I-DISEASE
.	0

Poor	I-DISEASE
sleep	0
hygiene	0
practices	0
,	I-DISEASE
partic-	0
ularly	0
evening	I-DISEASE
napping	I-DISEASE
among	0
the	0
elderly	I-DISEASE
,	0
and	0
irregularity	I-DISEASE
of	I-DISEASE
the	0
sleep	0
-	I-DISEASE
wake	0
schedule	I-DISEASE
should	0
also	0
be	0
considered	I-DISEASE
.	0

The	I-DISEASE
possibility	I-DISEASE
of	I-DISEASE
a	I-DISEASE
“	0
free	I-DISEASE
-	0
running	I-DISEASE
”	I-DISEASE
(	0
nonentrained	0
)	0
circadian	0
rhythm	I-DISEASE
also	0
merits	0
consideration	I-DISEASE
,	0
but	I-DISEASE
patients	0
with	I-DISEASE
this	0
condition	0
are	I-DISEASE
most	0
commonly	I-DISEASE
blind	I-DISEASE
and	0
report	0
only	0
periodic	I-DISEASE
complaints	0
of	I-DISEASE
insomnia	0
depending	0
on	0
the	0
relative	0
rela-	0
tionship	0
between	0
the	0
internal	I-DISEASE
rhythm	I-DISEASE
and	0
that	0
of	I-DISEASE
the	0
light	0
/	0
dark	0
cycle	0
.	I-DISEASE

Major	I-DISEASE
depressive	I-DISEASE
disorder	0
is	0
a	0
common	I-DISEASE
cause	I-DISEASE
of	I-DISEASE
early	0
awakening	0
that	I-DISEASE
must	I-DISEASE
be	0
considered	I-DISEASE
.	0

These	0
patients	0
do	0
not	0
typically	0
manifest	0
the	0
early	I-DISEASE
evening	0
sleepiness	0
that	0
is	I-DISEASE
characteristic	I-DISEASE
of	I-DISEASE
ASWPD	0
.	0

As	I-DISEASE
with	I-DISEASE
any	I-DISEASE
sleep	0
disturbances	0
that	0
persists	I-DISEASE
over	0
time	0
,	I-DISEASE
insomnia	I-DISEASE
can	0
develop	I-DISEASE
second-	0
arily	0
.	0

The	I-DISEASE
Horne	I-DISEASE
-	0
Östberg	I-DISEASE
questionnaire	0
(	I-DISEASE
or	I-DISEASE
other	0
chronotype	0
questionnaire	I-DISEASE
)	0
may	I-DISEASE
assist	0
in	I-DISEASE
determining	0
the	0
contribution	0
of	I-DISEASE
a	0
morningness	0
circadian	I-DISEASE
preference	0
to	0
the	I-DISEASE
presenting	I-DISEASE
sleep	I-DISEASE
/	0
wake	0
complaint	I-DISEASE
.	0

The	I-DISEASE
presence	I-DISEASE
of	I-DISEASE
more	I-DISEASE
than	0
one	I-DISEASE
contributing	I-DISEASE
variable	I-DISEASE
seems	I-DISEASE
to	0
be	I-DISEASE
the	0
norm	I-DISEASE
,	I-DISEASE
and	0
each	I-DISEASE
entity	I-DISEASE
needs	I-DISEASE
to	0
be	0
treated	I-DISEASE
accordingly	0
.	0

Unresolved	I-DISEASE
Issues	0
and	0
Further	I-DISEASE
Directions	0

The	I-DISEASE
existing	I-DISEASE
literature	0
suggests	I-DISEASE
that	0
clinicians	I-DISEASE
are	I-DISEASE
unlikely	0
to	0
encounter	I-DISEASE
patients	I-DISEASE
with	I-DISEASE
stringently	I-DISEASE
defined	I-DISEASE
ASWPD	I-DISEASE
.	0

Until	I-DISEASE
the	0
identification	0
of	I-DISEASE
familial	0
cohorts	B-DISEASE
,	0
only	I-DISEASE
four	I-DISEASE
cases	0
were	I-DISEASE
described	I-DISEASE
.	0

Various	I-DISEASE
treatment	I-DISEASE
trials	0
also	0
support	0
this	0
contention	I-DISEASE
with	I-DISEASE
demon-	0
stration	0
of	I-DISEASE
objectively	I-DISEASE
conventional	0
sleep	0
and	0
wake	0
times	0
despite	0
study	0
entry	I-DISEASE
based	B-DISEASE
on	0
subjective	I-DISEASE
reports	0
of	I-DISEASE
advanced	I-DISEASE
sleep	0
phase	0
.	0

Select	I-DISEASE
studies	I-DISEASE
of	I-DISEASE
patients	I-DISEASE
with	0
sole	I-DISEASE
complaints	0
of	I-DISEASE
maintenance	0
insomnia	0
/	I-DISEASE
early	0
-	0
morning	0
awakenings	0
have	0
demonstrated	0
marked	0
advances	0
(	I-DISEASE
earlier	0
timing	I-DISEASE
)	0
of	I-DISEASE
physiologically	0
measured	0
circadian	I-DISEASE
rhythms	0
.	0

The	I-DISEASE
absence	I-DISEASE
of	I-DISEASE
the	0
early	0
evening	I-DISEASE
sleepiness	0
complaint	0
may	0
be	0
due	I-DISEASE
to	I-DISEASE
the	0
fact	0
that	0
the	0
timing	I-DISEASE
of	0
sleep	0
onset	I-DISEASE
can	0
be	0
more	0
readily	I-DISEASE
modified	I-DISEASE
than	0
wake	0
time	0
,	I-DISEASE
and	0
is	I-DISEASE
likely	0
to	I-DISEASE
be	I-DISEASE
more	0
actively	I-DISEASE
resisted	0
due	I-DISEASE
to	I-DISEASE
its	0
propensity	I-DISEASE
to	0
conflict	0
with	I-DISEASE
social	I-DISEASE
or	I-DISEASE
family	0
obligations	0
.	0

Alternatively	I-DISEASE
,	I-DISEASE
evening	0
sleep	0
that	0
occurs	0
prior	0
to	I-DISEASE
entering	0
the	0
bed	I-DISEASE
/	0
bedroom	I-DISEASE
may	I-DISEASE
not	0
be	I-DISEASE
reported	I-DISEASE
as	I-DISEASE
such	0
.	0

If	I-DISEASE
it	0
is	0
definitively	I-DISEASE
demonstrated	0
that	0
the	B-DISEASE
evening	0
sleepiness	0
complaint	I-DISEASE
is	I-DISEASE
not	0
present	0
or	0
is	0
not	I-DISEASE
prominent	0
,	0
the	0
term	0
advance	I-DISEASE
-	0
related	0
sleep	I-DISEASE
complaints	0
may	I-DISEASE
be	0
used	0
in	I-DISEASE
lieu	B-DISEASE
of	I-DISEASE
ASWPD	B-DISEASE
.	0

If	I-DISEASE
this	I-DISEASE
broader	0
term	0
is	0
used	0
,	I-DISEASE
the	B-DISEASE
condition	0
is	0
observed	I-DISEASE
more	0
commonly	I-DISEASE
(	I-DISEASE
~7	0
%	0
of	I-DISEASE
respondents	0
in	I-DISEASE
a	0
study	I-DISEASE
of	I-DISEASE
individuals	I-DISEASE
aged	I-DISEASE
40	0
-	I-DISEASE
64	0
years	I-DISEASE
)	0
.	B-DISEASE

There	I-DISEASE
is	I-DISEASE
limited	I-DISEASE
knowledge	0
of	0
the	0
pathophysiology	I-DISEASE
of	I-DISEASE
ASWPD	I-DISEASE
(	I-DISEASE
or	I-DISEASE
advance	I-DISEASE
-	0
related	0
sleep	0
complaints	0
)	0
beyond	0
those	0
associated	0
with	0
select	I-DISEASE
cases	0
of	I-DISEASE
familial	I-DISEASE
ASWPD	B-DISEASE
.	0

Increased	I-DISEASE
use	0
of	I-DISEASE
physiologic	0
circadian	0
assessments	I-DISEASE
will	I-DISEASE
require	I-DISEASE
the	0
development	0
of	I-DISEASE
normative	0
values	0
to	I-DISEASE
guide	I-DISEASE
practitioners	0
.	0

Knowledge	I-DISEASE
gaps	I-DISEASE
are	0
even	I-DISEASE
more	0
prominent	0
within	I-DISEASE
pediat-	0
ric	I-DISEASE
and	0
adolescent	0
populations	I-DISEASE
.	0

Bibliography	0
Ando	0
K	I-DISEASE
,	0
Kripke	I-DISEASE
DF	0
,	I-DISEASE
Ancoli	0
-	I-DISEASE
Israel	I-DISEASE
S.	0
Delayed	0
and	0
advanced	I-DISEASE
sleep	I-DISEASE
phase	0
symptoms	I-DISEASE
.	0

Isr	I-DISEASE
J	0
Psychiatry	0
Relat	0
Sci	0
2002;39:11–8	I-DISEASE
.	0

Auger	I-DISEASE
R.	0
Advance	0
-	I-DISEASE
related	0
sleep	0
complaints	0
and	0
advanced	I-DISEASE
sleep	0
phase	I-DISEASE
disorder	I-DISEASE
.	0

Sleep	I-DISEASE
Med	I-DISEASE
Clin	I-DISEASE
2009;4:219–27	I-DISEASE
.	I-DISEASE

Campbell	I-DISEASE
SS	I-DISEASE
,	I-DISEASE
Dawson	I-DISEASE
D	I-DISEASE
,	I-DISEASE
Anderson	I-DISEASE
MW	I-DISEASE
.	0

Alleviation	I-DISEASE
of	I-DISEASE
sleep	0
maintenance	I-DISEASE
insomnia	0
with	0
timed	0
exposure	0
to	I-DISEASE
bright	0
light	0
.	0

J	I-DISEASE
Am	I-DISEASE
Geriatr	I-DISEASE
Soc	0
1993;41:829–36	I-DISEASE
.	0

Carpen	I-DISEASE
JD	0
,	0
Archer	0
SN	I-DISEASE
,	0
Skene	0
DJ	I-DISEASE
,	I-DISEASE
Smits	0
M	I-DISEASE
,	0

von	I-DISEASE
Schantz	I-DISEASE
M.	0
A	0
single	I-DISEASE
-	0
nucleotide	0
polymorphism	0
in	I-DISEASE
the	0
5’-untranslated	0
region	0
of	I-DISEASE
the	0
hPER2	I-DISEASE
gene	0
is	0
associated	0
with	I-DISEASE
diurnal	0
preference	0
.	0

J	I-DISEASE
Sleep	0
Res	0
2005;14:293–7	0
.	I-DISEASE

Carpen	I-DISEASE
JD	0
,	0
von	I-DISEASE
Schantz	0
M	0
,	0
Smits	I-DISEASE
M	I-DISEASE
,	I-DISEASE
Skene	I-DISEASE
DJ	0
,	I-DISEASE
Archer	0
SN	I-DISEASE
.	0

A	I-DISEASE
silent	I-DISEASE
polymorphism	0
in	0
the	0
PER1	0
gene	0
associates	I-DISEASE
with	I-DISEASE
extreme	I-DISEASE
diurnal	0
preference	0
in	0
humans	0
.	0

J	I-DISEASE
Hum	0
Genet	I-DISEASE
2006;51:1122–5	0
.	0

Carrier	I-DISEASE
J	0
,	0
Monk	I-DISEASE
TH	0
,	I-DISEASE
Buysse	I-DISEASE
DJ	0
,	0
Kupfer	0
DJ	0
.	0

Sleep	I-DISEASE
and	0
morningness	0
-	0
eveningness	I-DISEASE
in	I-DISEASE
the	0
‘	0
middle	I-DISEASE
’	I-DISEASE
years	I-DISEASE
of	I-DISEASE
life	0
(	I-DISEASE
20	0
-	I-DISEASE
59	0
y	0
)	0
.	0

J	I-DISEASE
Sleep	0
Res	0
1997;6:230–7	0
.	0

Horne	I-DISEASE
JA	0
,	I-DISEASE
Ostberg	0
O.	I-DISEASE
A	0
self	0
-	I-DISEASE
assessment	I-DISEASE
questionnaire	I-DISEASE
to	I-DISEASE
determine	I-DISEASE
morningness	I-DISEASE
-	0
eveningness	0
in	I-DISEASE
human	0
circadian	0
rhythms	0
.	I-DISEASE

Int	I-DISEASE
J	0
Chronobiol	I-DISEASE
1976;4:97–110	I-DISEASE
.	0

Jones	0
C	0
,	0
Campbell	I-DISEASE
SS	0
,	I-DISEASE
Zone	I-DISEASE
SE	I-DISEASE
,	0
et	0
al	I-DISEASE
.	0

Familial	I-DISEASE
advanced	I-DISEASE
sleep	0
phase	0
syndrome	0
:	I-DISEASE

A	I-DISEASE
short	0
-	0
period	0
circadian	0
rhythm	I-DISEASE
variant	I-DISEASE
in	0
humans	0
.	0

Nature	I-DISEASE
Med	I-DISEASE
1999;5:1062–5	I-DISEASE
.	0

Kamei	I-DISEASE
R	I-DISEASE
,	I-DISEASE
Hughes	0
L	0
,	I-DISEASE
Miles	I-DISEASE
L	0
,	0
et	0
al	I-DISEASE
.	I-DISEASE

Advanced	I-DISEASE
-	I-DISEASE
sleep	0
phase	0
syndrome	0
studied	I-DISEASE
in	I-DISEASE
a	I-DISEASE
time	0
isolation	0
facility	I-DISEASE
.	0

Chronobiologia	I-DISEASE
1979;6:115	0
.	0

Moldofsky	I-DISEASE
H	0
,	I-DISEASE
Musisi	I-DISEASE
S	0
,	0
Phillipson	0
EA	I-DISEASE
.	0

Treatment	I-DISEASE
of	I-DISEASE
a	0
case	I-DISEASE
of	0
advanced	I-DISEASE
sleep	0
phase	0
syndrome	0
by	I-DISEASE
phase	0
advance	I-DISEASE
chronotherapy	I-DISEASE
.	0

Sleep	I-DISEASE
1986;9:61–5	I-DISEASE
.	0

Palmer	I-DISEASE
CR	I-DISEASE
,	0
Kripke	I-DISEASE
DF	I-DISEASE
,	0
Savage	0
HC	0
Jr	I-DISEASE
,	I-DISEASE
Cindrich	I-DISEASE
LA	I-DISEASE
,	I-DISEASE
Loving	0
RT	0
,	I-DISEASE
Elliott	I-DISEASE
JA	0
.	0

Efficacy	I-DISEASE
of	0
enhanced	I-DISEASE
evening	0
light	0
for	0
advanced	0
sleep	0
phase	0
syndrome	I-DISEASE
.	0

Behav	I-DISEASE
Sleep	0
Med	0
2003;1:213–26	0
.	0

Sack	I-DISEASE
RL	0
,	0
Auckley	I-DISEASE
D	0
,	0
Auger	I-DISEASE
RR	I-DISEASE
,	0
et	0
al	I-DISEASE
.	I-DISEASE
,	0
Circadian	0
rhythm	I-DISEASE
sleep	0
disorders	0
:	0
part	I-DISEASE
II	0
,	I-DISEASE
advanced	I-DISEASE
sleep	0
phase	0
disorder	I-DISEASE
,	I-DISEASE
delayed	I-DISEASE
sleep	0
phase	0
disorder	I-DISEASE
,	0
free	0
-	0
running	0
disorder	0
,	I-DISEASE
and	0
irregular	I-DISEASE
sleep	0
-	I-DISEASE
wake	0
rhythm	0
.	0

An	I-DISEASE
American	I-DISEASE
Academy	0
of	I-DISEASE
Sleep	0
Medicine	I-DISEASE
review	I-DISEASE
.	I-DISEASE

Sleep	I-DISEASE
2007;30:1484–501	I-DISEASE
.	0

Satoh	I-DISEASE
K	0
,	I-DISEASE
Mishima	0
K	0
,	I-DISEASE
Inoue	0
Y	I-DISEASE
,	I-DISEASE
Ebisawa	I-DISEASE
T	0
,	I-DISEASE
Shimizu	0
T.	0
Two	I-DISEASE
pedigrees	0
of	I-DISEASE
familial	I-DISEASE
advanced	I-DISEASE
sleep	0
phase	0
syndrome	0
in	0
Japan	0
.	0

Sleep	I-DISEASE
2003;26:416–7	0
.	0

Singer	I-DISEASE
CM	0
,	I-DISEASE
Lewy	0
AJ	I-DISEASE
.	0

Case	I-DISEASE
report	0
:	0
use	I-DISEASE
of	0
the	0
dim	0
light	0
melatonin	0
onset	I-DISEASE
in	I-DISEASE
the	0
treatment	I-DISEASE
of	I-DISEASE
ASPS	I-DISEASE
with	0
bright	0
light	0

[	I-DISEASE
abstract	I-DISEASE
]	0
.	I-DISEASE

Sleep	I-DISEASE
Res	0
1989;18:445	I-DISEASE
.	0

Toh	I-DISEASE
K	0
,	I-DISEASE
Jones	0
CR	I-DISEASE
,	0
He	I-DISEASE
Y	0
,	0
et	0
al	I-DISEASE
.	I-DISEASE

An	I-DISEASE
hPer2	I-DISEASE
phosphorylation	0
site	0
mutation	I-DISEASE
in	I-DISEASE
familial	I-DISEASE
advanced	I-DISEASE
sleep	I-DISEASE
phase	0
syndrome	0
.	0

Science	0
2001;291:1040–3	I-DISEASE
.	0

Xu	I-DISEASE
Y	I-DISEASE
,	0
Padiath	0
QS	0
,	0
Shapiro	0
RE	I-DISEASE
,	I-DISEASE
et	0
al	0
.	0

Functional	I-DISEASE
consequences	I-DISEASE
of	I-DISEASE
a	0
CKIdelta	I-DISEASE
mutation	0
causing	I-DISEASE
familial	I-DISEASE
advanced	I-DISEASE
sleep	0
phase	0
syndrome	0
.	0

Nature	I-DISEASE
2005;434:640–4	0
.	0

Yoon	I-DISEASE
IY	0
,	0
Kripke	I-DISEASE
DF	0
,	I-DISEASE
Elliott	I-DISEASE
JA	I-DISEASE
,	0
Youngstedt	I-DISEASE
SD	0
,	0
Rex	0
KM	I-DISEASE
,	I-DISEASE
Hauger	I-DISEASE
RL	I-DISEASE
.	0

Age	I-DISEASE
-	I-DISEASE
related	0
changes	I-DISEASE
of	0
circadian	I-DISEASE
rhythms	0
and	0
sleep	0
-	0
wake	0
cycles	I-DISEASE
.	0

J	I-DISEASE
Am	I-DISEASE
Geriatr	I-DISEASE
Soc	0
2003;51:1085–91	0
.	0

Circadian	I-DISEASE
Rhythm	0
Sleep	I-DISEASE
-	0
Wake	I-DISEASE
Disorders	0
Circadian	0
Rhythm	0
Sleep	I-DISEASE
-	I-DISEASE
Wake	0
Disorders	0
Irregular	0
Sleep	0
-	I-DISEASE
Wake	0
Rhythm	0
Disorder	I-DISEASE
ICD-9	0
-	0
CM	I-DISEASE
code	0
:	0
327.33	0
ICD-10	I-DISEASE
-	0
CM	0
code	0
:	0

G47.23	I-DISEASE
Alternate	0
Names	I-DISEASE
Irregular	0
sleep	0
-	I-DISEASE
wake	I-DISEASE
cycle	0
disorder	0
,	I-DISEASE
irregular	I-DISEASE
sleep	I-DISEASE
-	0
wake	0
rhythm	I-DISEASE
type	I-DISEASE
.	0

Diagnostic	I-DISEASE
Criteria	0
Criteria	I-DISEASE
A	0
-	I-DISEASE
D	I-DISEASE
must	0
be	0
met	0
A.	0

The	I-DISEASE
patient	I-DISEASE
or	0
caregiver	I-DISEASE
reports	0
a	I-DISEASE
chronic	B-DISEASE
or	0
recurrent	0
pattern	0
of	I-DISEASE
irregular	0
sleep	0
and	0
wake	I-DISEASE
episodes	0
throughout	0
the	0
24	0
-	0
hour	0
period	0
,	I-DISEASE
characterized	0
by	I-DISEASE
symptoms	I-DISEASE
of	I-DISEASE
insomnia	0
during	I-DISEASE
the	0
scheduled	I-DISEASE
sleep	0
period	0
(	0
usually	I-DISEASE
at	I-DISEASE
night	0
)	0
,	0
excessive	0
sleepiness	0
(	I-DISEASE
napping	I-DISEASE
)	0
during	I-DISEASE
the	0
day	0
,	0
or	0
both	I-DISEASE
.	0

B.	0
Symptoms	0
are	0
present	I-DISEASE
for	0
at	I-DISEASE
least	0
three	I-DISEASE
months	I-DISEASE
.	0

C.	I-DISEASE
Sleep	0
log	0
and	0
,	I-DISEASE
whenever	0
possible	I-DISEASE
,	0
actigraphy	0
monitoring	I-DISEASE
for	I-DISEASE
at	I-DISEASE
least	0
seven	0
days	I-DISEASE
,	0
preferably	0
14	0
days	0
,	0
demonstrate	I-DISEASE
no	0
major	0
sleep	0
period	0
and	0
multiple	I-DISEASE
irregular	I-DISEASE
sleep	0
bouts	I-DISEASE
(	I-DISEASE
at	I-DISEASE
least	0
three	0
)	0
during	I-DISEASE
a	0
24	0
-	0
hour	0
period	0
.	0

D.	I-DISEASE

The	I-DISEASE
sleep	0
disturbance	0
is	I-DISEASE
not	0
better	0
explained	I-DISEASE
by	I-DISEASE
another	I-DISEASE
current	0
sleep	0
disorder	0
,	I-DISEASE
medical	I-DISEASE
or	0
neurological	0
disorder	0
,	0
mental	0
disorder	0
,	I-DISEASE
medication	0
use	0
,	I-DISEASE
or	0
substance	I-DISEASE
use	0
disorder	I-DISEASE
.	0

Essential	I-DISEASE
Features	I-DISEASE
Irregular	0
sleep	0
-	I-DISEASE
wake	0
rhythm	0
disorder	0
(	I-DISEASE
ISWRD	I-DISEASE
)	0
is	0
characterized	0
by	0
lack	0
of	I-DISEASE
a	0
clearly	0
defined	I-DISEASE
circadian	0
rhythm	0
of	I-DISEASE
sleep	0
and	0
wake	0
.	0

The	I-DISEASE
chronic	I-DISEASE
or	0
recurring	0
sleep	0
-	I-DISEASE
wake	0
pattern	0
is	0
temporally	0
disorganized	I-DISEASE
so	0
that	0
sleep	0
and	0
wake	0
episodes	I-DISEASE
are	I-DISEASE
variable	I-DISEASE
throughout	0
the	0
24	0
-	I-DISEASE
hour	0
cycle	0
.	0

Individuals	I-DISEASE
have	I-DISEASE
symptoms	I-DISEASE
of	I-DISEASE
insomnia	0
and	0
excessive	0
sleepiness	0
,	I-DISEASE
depending	I-DISEASE
on	0
the	0
time	0
of	I-DISEASE
day	I-DISEASE
and	0
their	0
particular	I-DISEASE
sleep	0
-	0
wake	0
pattern	0
.	0

Associated	I-DISEASE
Features	I-DISEASE
ISWRD	I-DISEASE
is	I-DISEASE
more	0
commonly	I-DISEASE
observed	I-DISEASE
in	0
neurodegenerative	0
disorders	0
,	I-DISEASE
such	I-DISEASE
as	0
demen-	0
tia	0
,	I-DISEASE
and	0
in	0
children	I-DISEASE
with	0
developmental	I-DISEASE
disorders	0
.	0

Individuals	I-DISEASE
typically	0
present	I-DISEASE
with	I-DISEASE
insomnia	0
or	I-DISEASE
excessive	0
sleepiness	0
,	I-DISEASE
depending	I-DISEASE
on	0
the	0
time	0
of	I-DISEASE
day	I-DISEASE
.	0

Sleep	I-DISEASE
and	0
wake	0
epi-	0
sodes	0
across	0
the	0
24	0
-	I-DISEASE
hour	I-DISEASE
cycle	0
are	0
fragmented	I-DISEASE
,	I-DISEASE
with	0
the	0
longest	I-DISEASE
sleep	0
bout	I-DISEASE
being	I-DISEASE
typi-	0
cally	I-DISEASE
less	I-DISEASE
than	I-DISEASE
four	0
hours	I-DISEASE
.	0

Individuals	I-DISEASE
or	0
caregivers	0
report	0
frequent	I-DISEASE
naps	I-DISEASE
throughout	0
the	0
daytime	0
.	0

Total	I-DISEASE
sleep	0
time	0
across	I-DISEASE
the	0
24	0
hours	I-DISEASE
may	I-DISEASE
be	0
normal	0
for	0
age	I-DISEASE
.	I-DISEASE

Clinical	I-DISEASE
and	0
Pathophysiological	I-DISEASE
Subtypes	I-DISEASE
Older	0
adults	I-DISEASE
with	I-DISEASE
Alzheimer	I-DISEASE
disease	0
who	I-DISEASE
experience	0
sundowning	I-DISEASE
may	I-DISEASE
represent	0
a	0
clin-	I-DISEASE
ical	0
subtype	I-DISEASE
with	I-DISEASE
more	0
severe	0
sleep	0
fragmentation	0
and	0
lower	0
circadian	0
rhythm	0
ampli-	0
tude	0
than	I-DISEASE
those	I-DISEASE
who	I-DISEASE
do	0
not	0
experience	0
sundowning	0
.	0

Demographics	I-DISEASE
Demographic	0
patterns	I-DISEASE
generally	0
parallel	0
those	0
of	I-DISEASE
associated	I-DISEASE
risk	0
factors	B-DISEASE
such	0
as	0
neuro-	I-DISEASE
developmental	I-DISEASE
and	0
neurodegenerative	0
disorders	0
.	0

Predisposing	I-DISEASE
and	0
Precipitating	I-DISEASE
Factors	0
Neurodegenerative	0
disorders	0
such	I-DISEASE
as	0
Alzheimer	0
disease	I-DISEASE
,	0
Parkinson	0
disease	B-DISEASE
,	I-DISEASE
and	0
Huntington	0
disease	I-DISEASE
increase	I-DISEASE
the	I-DISEASE
risk	0
for	I-DISEASE
ISWRD	I-DISEASE
.	0

Children	I-DISEASE
with	0
developmental	I-DISEASE
disor-	I-DISEASE
ders	0
also	0
are	0
at	I-DISEASE
increased	0
risk	0
for	I-DISEASE
ISWRD	0
.	0

Poor	I-DISEASE
sleep	0
hygiene	0
and	0
lack	I-DISEASE
of	I-DISEASE
exposure	0
to	0
external	0
synchronizing	0
agents	0
such	0
as	I-DISEASE
light	0
,	0
activity	0
,	0
and	0
social	0
schedules	I-DISEASE
may	I-DISEASE
be	0
predisposing	I-DISEASE
as	B-DISEASE
well	I-DISEASE
as	0
precipitating	0
factors	0
involved	0
in	0
the	0
development	0
of	0
ISWRD	I-DISEASE
,	I-DISEASE
particularly	I-DISEASE
in	I-DISEASE
the	0
institutionalized	0
elderly	I-DISEASE
.	0

Familial	I-DISEASE
Patterns	I-DISEASE
Not	I-DISEASE
applicable	0
or	B-DISEASE
known	0
.	0

Onset	I-DISEASE
,	0
Course	0
,	0
and	0
Complications	0
Onset	0
of	I-DISEASE
the	0
condition	0
may	I-DISEASE
occur	I-DISEASE
at	I-DISEASE
any	0
age	I-DISEASE
.	0

Little	I-DISEASE
is	0
known	0
regarding	0
the	0
course	I-DISEASE
and	0
complications	0
of	0
ISWRD	0
in	I-DISEASE
adults	I-DISEASE
.	0

Due	I-DISEASE
to	I-DISEASE
the	0
multiple	I-DISEASE
awakenings	0
and	0
,	0
in	0
the	0
elderly	I-DISEASE
,	I-DISEASE
nocturnal	I-DISEASE
wandering	0
,	I-DISEASE
falls	I-DISEASE
can	0
be	0
an	0
indirect	0
complication	I-DISEASE
.	0

In	I-DISEASE
addition	0
to	I-DISEASE
the	0
patient	I-DISEASE
’s	I-DISEASE
sleep	I-DISEASE
-	I-DISEASE
wake	0
dysfunction	0
,	I-DISEASE
the	0
caregiver	I-DISEASE
’s	I-DISEASE
sleep	I-DISEASE
is	0
often	I-DISEASE
disrupted	I-DISEASE
.	0

The	I-DISEASE
sleep	0
and	0
wake	0
disruption	0
associated	0
with	I-DISEASE
ISWRD	I-DISEASE
is	0
a	0
common	I-DISEASE
cause	I-DISEASE
of	I-DISEASE
institutionalization	0
.	0

Developmental	I-DISEASE
Issues	0
Caregivers	0
may	0
report	0
that	0
a	0
child	0
with	I-DISEASE
ISWRD	I-DISEASE
has	0
difficulty	B-DISEASE
falling	I-DISEASE
asleep	0
at	I-DISEASE
the	0
desired	0
bedtime	I-DISEASE
or	0
“	0
falls	0
asleep	I-DISEASE
too	0
early	0
”	I-DISEASE
in	I-DISEASE
the	0
evening	0
,	I-DISEASE
wakes	I-DISEASE
“	0
too	0
early	0
”	I-DISEASE
or	0
has	0
dif-	0
ficulty	I-DISEASE
waking	0
in	0
the	0
morning	0
,	0
and/or	0
exhibits	0
developmentally	I-DISEASE
inappropriate	0
napping	I-DISEASE
behavior	I-DISEASE
during	I-DISEASE
the	0
day	0
.	0

Parents	I-DISEASE
may	0
complain	0
that	0
their	0
child	0
sleeps	0
too	0
much	0
or	0
too	0
little	I-DISEASE
or	I-DISEASE
at	I-DISEASE
inappropriate	0
times	0
.	0

Attempts	I-DISEASE
to	I-DISEASE
keep	0
the	I-DISEASE
child	I-DISEASE
awake	0
during	I-DISEASE
the	0
day	I-DISEASE
,	I-DISEASE
especially	I-DISEASE
during	I-DISEASE
sedentary	I-DISEASE
activities	I-DISEASE
,	0
are	0
often	0
unsuccessful	0
.	0

The	I-DISEASE
key	0
characteristics	0
that	0
distinguish	0
ISWRD	I-DISEASE
from	0
other	0
sleep	0
complaints	0
or	I-DISEASE
circadian	I-DISEASE
sleep	0
wake	0
disor-	I-DISEASE
ders	0
are	0
the	0
lack	I-DISEASE
of	I-DISEASE
prolonged	0
consolidated	I-DISEASE
sleep	0
periods	I-DISEASE
,	I-DISEASE
the	B-DISEASE
often	0
seemingly	I-DISEASE
random	I-DISEASE
distribution	I-DISEASE
in	I-DISEASE
sleep	0
periods	I-DISEASE
across	I-DISEASE
the	0
24	0
-	0
hour	0
day	0
,	0
and	0
the	0
marked	0
day	0
-	0
to	0
-	0
day	0
and	0
week	0
-	I-DISEASE
to	0
-	0
week	0
variability	I-DISEASE
with	I-DISEASE
little	I-DISEASE
in	I-DISEASE
the	0
way	I-DISEASE
of	I-DISEASE
a	0
clearly	0
predictable	I-DISEASE
major	I-DISEASE
sleep-	0
wake	0
pattern	0
.	0

The	I-DISEASE
impact	I-DISEASE
on	0
caregivers	I-DISEASE
’	I-DISEASE
sleep	0
and	0
daytime	0
functioning	I-DISEASE
is	I-DISEASE
likely	I-DISEASE
to	I-DISEASE
be	0
particularly	0
profound	I-DISEASE
.	I-DISEASE

There	I-DISEASE
may	0
be	0
phenotypes	0
of	I-DISEASE
ISWRD	I-DISEASE
in	I-DISEASE
children	I-DISEASE
,	I-DISEASE
with	0
differences	I-DISEASE
regarding	0
symptom	I-DISEASE
presentation	0
and	0
severity	0
and	0
chronicity	I-DISEASE
that	0
are	0
related	0
to	I-DISEASE
the	0
underlying	0
condition	0
.	0

Circadian	I-DISEASE
Rhythm	0
Sleep	I-DISEASE
-	0
Wake	0
Disorders	0
Circadian	0
Rhythm	0
Sleep	I-DISEASE
-	I-DISEASE
Wake	0
Disorders	0
For	I-DISEASE
example	0
,	I-DISEASE
it	I-DISEASE
is	0
possible	0
that	0
children	I-DISEASE
with	I-DISEASE
chronic	I-DISEASE
neurologic	0
conditions	I-DISEASE
such	0
as	0
autism	0
or	0
chromosomal	0
syndromes	0
characterized	0
by	I-DISEASE
developmental	I-DISEASE
delays	0
may	0
have	0
a	0
more	0
intractable	I-DISEASE
and	0
treatment	I-DISEASE
resistant	0
pattern	0
compared	I-DISEASE
with	I-DISEASE
children	I-DISEASE
with	0
more	0
self	0
-	I-DISEASE
limited	I-DISEASE
conditions	I-DISEASE
(	I-DISEASE
e.g.	I-DISEASE
,	0
postconcussion	0
)	0
.	0

Although	I-DISEASE
ISWRD	I-DISEASE
appears	0
to	I-DISEASE
be	I-DISEASE
rare	I-DISEASE
in	0
typically	0
developing	0
children	I-DISEASE
,	I-DISEASE
it	I-DISEASE
may	0
be	I-DISEASE
envi-	I-DISEASE
ronmentally	0
or	I-DISEASE
behaviorally	0
induced	0
.	0

This	I-DISEASE
may	0
be	0
seen	I-DISEASE
in	0
children	I-DISEASE
with	I-DISEASE
irregular	I-DISEASE
or	B-DISEASE
fragmented	0
sleep	0
and	0
wake	0
schedules	I-DISEASE
because	0
of	I-DISEASE
a	I-DISEASE
chaotic	0
household	0
.	0

Children	I-DISEASE
with	0
developmental	I-DISEASE
disorders	0
are	0
at	I-DISEASE
increased	0
risk	0
for	0
ISWRD	0
.	0

For	I-DISEASE
example	0
,	0
children	I-DISEASE
with	0
autism	0
,	0
Asperger	0
syndrome	I-DISEASE
,	I-DISEASE
or	I-DISEASE
pervasive	I-DISEASE
developmental	I-DISEASE
disorder	I-DISEASE
not	I-DISEASE
otherwise	0
spec-	0
ified	0
often	0
have	I-DISEASE
highly	0
irregular	I-DISEASE
sleep	0
patterns	I-DISEASE
.	0

In	I-DISEASE
addition	0
,	0
these	I-DISEASE
children	0
often	I-DISEASE
have	I-DISEASE
circadian	0
rhythm	0
abnormalities	I-DISEASE
which	I-DISEASE
are	I-DISEASE
both	I-DISEASE
more	0
severe	I-DISEASE
and	0
chronic	0
and	0
they	I-DISEASE
are	0
at	I-DISEASE
increased	0
risk	0
for	I-DISEASE
relapse	0
.	0

Both	I-DISEASE
ISWRD	I-DISEASE
and	0
non-24	I-DISEASE
-	0
hour	0
sleep	0
-	I-DISEASE
wake	I-DISEASE
rhythm	I-DISEASE
disorder	0
are	0
also	0
common	I-DISEASE
in	0
Angelman	0
syndrome	0
,	0
a	0
neurodevelopmental	0
disorder	0
associated	0
with	0
an	0
abnormality	I-DISEASE
of	I-DISEASE
chromosome	0
15q11	0
-	0
q13	0
,	I-DISEASE
and	0
have	I-DISEASE
been	I-DISEASE
reported	0
in	I-DISEASE
children	0
with	0
Williams	0
syndrome	0
,	0
a	0
neurodevelopmental	0
genetic	I-DISEASE
disorder	I-DISEASE
characterized	0
by	I-DISEASE
physical	0
abnormalities	0
and	0
a	0
dis-	I-DISEASE
tinctive	0
cognitive	0
profile	0
with	I-DISEASE
intellectual	0
disabilities	I-DISEASE
and	0
learning	0
difficulties	I-DISEASE
.	0

Studies	I-DISEASE
in	I-DISEASE
children	0
and	0
adults	0
with	I-DISEASE
autism	0
spectrum	0
disorders	0
and	0
in	0
children	0
with	I-DISEASE
Smith	0
-	0
Magenis	0
syndrome	0
have	0
shown	I-DISEASE
profound	0
alterations	0
in	0
melatonin	0
secretion	0
profiles	0
.	0

Smith-	I-DISEASE

Magenis	I-DISEASE
syndrome	I-DISEASE
is	0
a	0
developmental	I-DISEASE
disorder	I-DISEASE
caused	0
by	I-DISEASE
an	0
abnormality	I-DISEASE
in	I-DISEASE
the	0
short	0
(	I-DISEASE
p	0
)	0
arm	0
of	I-DISEASE
chromosome	I-DISEASE
17	0
.	0

It	I-DISEASE
is	I-DISEASE
characterized	0
by	I-DISEASE
mild	0
to	I-DISEASE
moderate	I-DISEASE
intellectual	I-DISEASE
disabil-	0
ity	I-DISEASE
,	0
distinctive	I-DISEASE
facial	0
features	I-DISEASE
,	0
sleep	0
disturbances	I-DISEASE
,	0
and	0
behavioral	0
problems	I-DISEASE
.	0

Decreased	I-DISEASE
concentrations	0
of	I-DISEASE
melatonin	0
and	0
its	0
metabolites	0
and	0
daytime	0
elevation	0
and	0
abnormal	I-DISEASE
rhythm	0
/	0
decreased	I-DISEASE
amplitude	0
of	I-DISEASE
melatonin	0
secretion	0
have	0
been	I-DISEASE
reported	0
in	0
these	0
popu-	I-DISEASE
lations	0
.	0

These	0
findings	0
may	0
be	I-DISEASE
due	0
to	0
polymorphisms	0
in	I-DISEASE
melatonin	I-DISEASE
enzymes	0
synthesis	I-DISEASE
or	0
variants	0
in	I-DISEASE
genes	0
coding	0
for	0
melatonin	0
receptors	0
.	0

Other	I-DISEASE
postulated	0
mechanisms	0
for	0
circadian	I-DISEASE
rhythm	I-DISEASE
disturbances	0
,	0
particularly	0
ISWRD	I-DISEASE
,	I-DISEASE
in	I-DISEASE
these	I-DISEASE
populations	0
include	0
clock	I-DISEASE
gene	0
polymorphisms	0
and	0
decreased	I-DISEASE
levels	I-DISEASE
of	I-DISEASE
entrainment	0
by	I-DISEASE
social	0
/	0
environmental	I-DISEASE
cues	0
.	0

There	I-DISEASE
may	0
also	0
be	I-DISEASE
medical	0
conditions	I-DISEASE
that	0
predispose	I-DISEASE
typically	0
developing	0
children	I-DISEASE
and	0
adolescents	0
to	I-DISEASE
ISWRD	I-DISEASE
.	0

These	0
include	I-DISEASE
traumatic	0
brain	I-DISEASE
injury	0
and	0
chronic	I-DISEASE
fatigue	I-DISEASE
syndrome	0
.	0

Brain	0
tumor	I-DISEASE
survivors	0
,	I-DISEASE
especially	0
patients	I-DISEASE
who	I-DISEASE
have	I-DISEASE
experienced	0
disrup-	0
tion	0
in	I-DISEASE
the	0
hypothalamic	I-DISEASE
-	0
pituitary	0
axis	0
,	I-DISEASE
may	I-DISEASE
have	0
an	I-DISEASE
increased	0
prevalence	0
of	I-DISEASE
circadian	I-DISEASE
rhythm	I-DISEASE
disorders	0
,	I-DISEASE
including	0
ISWRD	0
.	0

There	I-DISEASE
is	I-DISEASE
very	I-DISEASE
little	0
literature	0
on	0
ISWRD	I-DISEASE
in	0
the	0
pediatric	0
population	0
;	0
prevalence	0
,	I-DISEASE
sex	I-DISEASE
,	0
and	0
racial	I-DISEASE
/	0
ethnic	I-DISEASE
differences	I-DISEASE
are	0
unknown	I-DISEASE
.	0

Little	I-DISEASE
is	I-DISEASE
known	0
about	I-DISEASE
the	0
natural	0
history	I-DISEASE
of	I-DISEASE
the	0
clinical	0
entity	0
of	I-DISEASE
ISWRD	I-DISEASE
in	I-DISEASE
the	0
pediatric	0
population	0
,	I-DISEASE
including	0
the	0
impact	I-DISEASE
of	I-DISEASE
various	I-DISEASE
treatment	0
modalities	I-DISEASE
,	I-DISEASE
the	0
likelihood	0
of	I-DISEASE
spontaneous	I-DISEASE
resolution	I-DISEASE
of	I-DISEASE
symptoms	0
,	I-DISEASE
or	0
long	0
-	0
term	0
consequences	I-DISEASE
.	0

The	I-DISEASE
impact	I-DISEASE
on	0
caregivers	I-DISEASE
of	I-DISEASE
children	I-DISEASE
with	0
neurodevelopmen-	0
tal	I-DISEASE
disorders	0
and	0
ISWRD	I-DISEASE
may	I-DISEASE
be	0
particularly	I-DISEASE
profound	0
.	0

The	I-DISEASE
prevalence	0
of	I-DISEASE
ISWRD	I-DISEASE
increases	0
with	I-DISEASE
advancing	I-DISEASE
age	I-DISEASE
,	0
but	I-DISEASE
it	I-DISEASE
is	I-DISEASE
likely	0
that	0
age	I-DISEASE
-	I-DISEASE
re-	0
lated	I-DISEASE
increase	I-DISEASE
in	0
neurodegenerative	0
disorders	0
,	I-DISEASE
rather	0
than	0
aging	0
per	I-DISEASE
se	0
,	0
explains	0
this	0
relationship	0
.	0

Pathology	I-DISEASE
and	0
Pathophysiology	I-DISEASE
The	I-DISEASE
etiology	0
of	I-DISEASE
ISWRD	I-DISEASE
is	I-DISEASE
likely	I-DISEASE
multifactorial	I-DISEASE
.	0

Anatomic	I-DISEASE
or	I-DISEASE
functional	0
abnormal-	I-DISEASE
ities	I-DISEASE
of	I-DISEASE
the	0
circadian	I-DISEASE
clock	I-DISEASE
can	0
result	0
in	I-DISEASE
an	I-DISEASE
arrhythmic	0
pattern	0
of	I-DISEASE
rest	I-DISEASE
and	0
activity	0
.	0

Decreased	I-DISEASE
exposure	0
to	I-DISEASE
environmental	0
-	0
entraining	0
agents	0
,	0
such	0
as	I-DISEASE
light	0
and	0
structured	0
physical	0
and	0
social	0
activities	I-DISEASE
(	I-DISEASE
common	I-DISEASE
in	I-DISEASE
institutionalized	I-DISEASE
elderly	I-DISEASE
,	0
and	0
children	0
with	I-DISEASE
developmental	I-DISEASE
disorders	0
)	0
,	0
also	0
can	0
contribute	0
to	0
the	0
development	0
of	0
an	0
irregular	0
sleep	0
-	0
wake	0
cycle	0
.	0

Objective	I-DISEASE
Findings	I-DISEASE

In	I-DISEASE
addition	0
to	0
a	I-DISEASE
careful	0
sleep	0
history	I-DISEASE
,	I-DISEASE
sleep	0
log	0
and	0
actigraphy	0
monitoring	0
show	0
the	0
expected	I-DISEASE
lack	0
of	0
a	0
clearly	0
defined	I-DISEASE
circadian	0
rhythm	I-DISEASE
of	0
the	I-DISEASE
sleep	0
-	I-DISEASE
wake	0
cycle	0
,	0
which	0
,	I-DISEASE
instead	0
,	0
is	0
characterized	0
by	I-DISEASE
multiple	I-DISEASE
irregular	0
sleep	0
and	0
wake	0
bouts	I-DISEASE
throughout	0
the	I-DISEASE
24	0
-	0
hour	0
period	0
.	0

The	I-DISEASE
use	I-DISEASE
of	I-DISEASE
sleep	0
log	0
and	0
actigraphy	0
is	0
indicated	I-DISEASE
for	0
the	I-DISEASE
identification	I-DISEASE
of	I-DISEASE
irregular	I-DISEASE
sleep	0
wake	I-DISEASE
rhythm	0
.	0

The	I-DISEASE
irregular	I-DISEASE
sleep	0
-	I-DISEASE
wake	0
pattern	0
is	0
defined	I-DISEASE
as	0
having	0
multiple	I-DISEASE
sleep	0
bouts	I-DISEASE
(	I-DISEASE
typically	0
2–4	0
hours	I-DISEASE
)	0
during	I-DISEASE
a	0
24	0
-	0
hour	0
period	I-DISEASE
.	0

The	I-DISEASE
pattern	0
may	0
vary	I-DISEASE
from	0
day	I-DISEASE
to	I-DISEASE
day	I-DISEASE
,	0
thus	0
monitoring	0
for	0
at	I-DISEASE
least	I-DISEASE
seven	0
days	0
and	0
preferably	I-DISEASE
14	0
days	0
may	0
be	0
needed	0
to	0
differentiate	I-DISEASE
the	0
irregular	I-DISEASE
pattern	0
from	I-DISEASE
other	I-DISEASE
circadian	I-DISEASE
rhythm	I-DISEASE
sleep-	0
wake	0
disorders	0
.	0

Polysomnography	I-DISEASE
is	0
not	0
required	I-DISEASE
to	0
establish	0
the	0
diagnosis	0
.	I-DISEASE

Polysomnography	I-DISEASE
may	I-DISEASE
be	I-DISEASE
useful	0
for	0
the	0
diagnosis	0
of	I-DISEASE
other	I-DISEASE
comorbid	I-DISEASE
sleep	0
disorders	I-DISEASE
.	0

Monitoring	I-DISEASE
of	I-DISEASE
other	I-DISEASE
circa-	0
dian	I-DISEASE
rhythms	0
,	0
such	0
as	0
core	I-DISEASE
body	I-DISEASE
temperature	B-DISEASE
and	0
melatonin	B-DISEASE
for	I-DISEASE
at	I-DISEASE
least	I-DISEASE
24	0
hours	I-DISEASE
,	I-DISEASE
may	0
also	0
show	0
a	I-DISEASE
loss	I-DISEASE
of	I-DISEASE
clear	0
circadian	0
rhythmicity	B-DISEASE
or	0
a	0
low	0
amplitude	0
rhythm	0
.	0

Differential	I-DISEASE
Diagnosis	0
Poor	I-DISEASE
sleep	0
hygiene	I-DISEASE
and	0
voluntary	0
maintenance	I-DISEASE
of	I-DISEASE
irregular	I-DISEASE
sleep	0
schedules	I-DISEASE
should	I-DISEASE
be	I-DISEASE
distinguished	0
from	0
irregular	I-DISEASE
sleep	0
-	0
wake	0
pattern	0
.	0

Individuals	I-DISEASE
with	0
irregular	0
sleep	0
-	0
wake	0
rhythms	0
may	I-DISEASE
present	0
with	0
complaints	0
of	I-DISEASE
insomnia	I-DISEASE
.	0

Careful	I-DISEASE
analysis	0
of	I-DISEASE
sleep	0
logs	I-DISEASE
or	I-DISEASE
actigraphy	0
will	0
demonstrate	I-DISEASE
multiple	I-DISEASE
irregular	I-DISEASE
periods	0
of	I-DISEASE
sleep	0
throughout	0
the	0
24	0
-	0
hour	0
cycle	0
.	0

In	I-DISEASE
both	I-DISEASE
adults	B-DISEASE
and	0
children	0
,	I-DISEASE
other	I-DISEASE
causes	I-DISEASE
of	0
sleep	0
fragmentation	0
and	0
daytime	I-DISEASE
Circadian	0
Rhythm	0
Sleep	0
-	0
Wake	0
Disorders	0
Circadian	I-DISEASE
Rhythm	0
Sleep	0
-	0
Wake	0
Disorders	0
napping	I-DISEASE
,	I-DISEASE
including	0
comorbid	0
medical	0
and	0
psychiatric	0
disorders	0
,	I-DISEASE
other	I-DISEASE
sleep	0
disorders	0
,	0
or	0
medication	0
should	0
be	I-DISEASE
identified	I-DISEASE
and	0
treated	0
.	0

Unresolved	I-DISEASE
Issues	0
and	0
Further	I-DISEASE
Directions	0

There	I-DISEASE
is	I-DISEASE
limited	I-DISEASE
knowledge	0
of	0
the	0
pathophysiology	0
and	0
natural	I-DISEASE
history	I-DISEASE
,	0
response	0
to	I-DISEASE
treatment	I-DISEASE
,	0
and	0
complications	0
of	I-DISEASE
the	0
disorder	I-DISEASE
in	I-DISEASE
adults	I-DISEASE
and	0
children	I-DISEASE
.	0

Further	I-DISEASE
research	0
into	I-DISEASE
the	0
relative	0
contribution	0
of	I-DISEASE
alterations	I-DISEASE
in	0
environmental	0
synchronizing	0
agents	0
,	I-DISEASE
such	I-DISEASE
as	0
light	0
and	0
activity	0
,	0
versus	0
a	0
dysfunction	0
of	I-DISEASE
the	I-DISEASE
endogenous	I-DISEASE
circadian	0
clock	0
in	I-DISEASE
the	0
development	I-DISEASE
of	I-DISEASE
irregular	0
sleep	0
and	0
wake	0
patterns	I-DISEASE
will	0
lead	0
to	I-DISEASE
improved	I-DISEASE
understanding	0
of	I-DISEASE
this	0
condition	0
.	0

Bibliography	0
Hopkins	I-DISEASE
R	0
,	I-DISEASE
Rindlisbacher	I-DISEASE
P.	I-DISEASE
Fragmentation	I-DISEASE
of	I-DISEASE
activity	I-DISEASE
periods	0
in	0
Alzheimer	I-DISEASE
’s	I-DISEASE
disease	B-DISEASE
.	0

Int	I-DISEASE
J	0
Geriatr	I-DISEASE
Psychiatry	0
1992;7:805–12	I-DISEASE
.	0

McCurry	I-DISEASE
SM	I-DISEASE
,	I-DISEASE
Ancoli	0
-	I-DISEASE
Israel	I-DISEASE
S.	I-DISEASE
Sleep	0
dysfunction	0
in	0
Alzheimer	0
’s	I-DISEASE
disease	I-DISEASE
and	0
other	0
dementias	I-DISEASE
.	0

Curr	I-DISEASE
Treat	0
Options	0
Neurol	0
2003;5:261–72	0
.	0

Okawa	I-DISEASE
M	I-DISEASE
,	I-DISEASE
Mishima	0
K	0
,	I-DISEASE
Hishikawa	0
Y	I-DISEASE
,	I-DISEASE
Hozumi	0
S	I-DISEASE
,	I-DISEASE
Hori	0
H	I-DISEASE
,	0
Takahashi	I-DISEASE
K.	I-DISEASE
Circadian	I-DISEASE
rhythm	B-DISEASE
disorders	0
in	0
sleep	0
-	0
waking	0
and	0
body	I-DISEASE
temperature	I-DISEASE
in	0
elderly	0
patients	0
with	0
dementia	0
and	0
their	0
treatment	I-DISEASE
.	0

Sleep	I-DISEASE
1991;14:478–85	0
.	0

Pillar	I-DISEASE
G	I-DISEASE
,	I-DISEASE
Shahar	0
E	0
,	I-DISEASE
Peled	0
N	0
,	I-DISEASE
Ravid	I-DISEASE
S	I-DISEASE
,	I-DISEASE
Lavie	I-DISEASE
P	0
,	I-DISEASE
Etzioni	0
A.	0
Melatonin	0
improves	0
sleep	0
-	I-DISEASE
wake	0
patterns	0
in	I-DISEASE
psychomotor	0
retarded	0
children	I-DISEASE
.	0

Pediatr	I-DISEASE
Neurol	0
2000;23:225–8	I-DISEASE
.	0

Pollack	I-DISEASE
C	0
,	I-DISEASE
Stokes	0
P.	0
Circadian	I-DISEASE
rest	I-DISEASE
-	I-DISEASE
activity	0
rhythms	0
in	I-DISEASE
demented	0
and	0
non	0
-	I-DISEASE
demented	0
older	0
community	0
residents	I-DISEASE
and	0
their	0
caregivers	I-DISEASE
.	0

J	I-DISEASE
Am	I-DISEASE
Geriatr	0
Soc	0
1997;45:446	0
-	I-DISEASE
52	0
.	0

Shochat	I-DISEASE
T	0
,	I-DISEASE
Martin	0
J	0
,	0
Marler	0
M	I-DISEASE
,	I-DISEASE
Ancoli	0
-	0
Israel	I-DISEASE
S.	0
Illumination	I-DISEASE
levels	0
in	I-DISEASE
nursing	0
home	0
patients	I-DISEASE
:	0
Effects	0
on	0
sleep	0
and	0
activity	0
rhythms	0
.	0

J	I-DISEASE
Sleep	0
Res	0
2000;9:373–9	0
.	I-DISEASE

Volicer	I-DISEASE
L	0
,	0
Harper	I-DISEASE
DG	I-DISEASE
,	0
Manning	0
BC	0
,	I-DISEASE
Goldstein	I-DISEASE
R	0
,	I-DISEASE
Satlin	I-DISEASE
A.	0
Sundowning	I-DISEASE
and	0
circadian	I-DISEASE
rhythms	I-DISEASE
in	I-DISEASE
Alzheimer	I-DISEASE
’s	I-DISEASE
disease	I-DISEASE
.	0

Am	I-DISEASE
J	0
Psychiatry	0
2001;158:704–11	I-DISEASE
.	0

Witting	I-DISEASE
W	0
,	I-DISEASE
Kwa	0
I	0
,	I-DISEASE
Eikelenboom	0
P	0
,	0
Mirmiran	I-DISEASE
M	0
,	0
Swaab	I-DISEASE
D.	I-DISEASE
Alterations	I-DISEASE
in	I-DISEASE
the	I-DISEASE
circadian	I-DISEASE
rest	0
-	I-DISEASE
activity	0
rhythm	I-DISEASE
in	I-DISEASE
aging	0
and	0
Alzheimer	0
’s	0
disease	0
.	0

Biol	0
Psychiatry	0
1990;27:563–72	0
.	0

Zee	I-DISEASE
PC	0
,	I-DISEASE
Vitiello	I-DISEASE
MV	I-DISEASE
.	0

Circadian	I-DISEASE
rhythm	0
sleep	0
disorder	I-DISEASE
:	I-DISEASE
irregular	0
sleep	0
wake	0
rhythm	I-DISEASE
type	I-DISEASE
.	0

Sleep	I-DISEASE
Med	I-DISEASE
Clin	0
2009;4:213–8	I-DISEASE
.	0

Non-24	I-DISEASE
-	I-DISEASE
Hour	0
Sleep	0
-	0
Wake	0
Rhythm	0
Disorder	0
ICD-9	I-DISEASE
-	I-DISEASE
CM	I-DISEASE
code	0
:	I-DISEASE
327.34	0
ICD-10	0
-	I-DISEASE
CM	I-DISEASE
code	0
:	B-DISEASE

G47.24	I-DISEASE
Alternate	0
Names	I-DISEASE
Free	I-DISEASE
-	I-DISEASE
running	0
disorder	0
,	0
nonentrained	0
disorder	I-DISEASE
,	I-DISEASE
hypernychthemeral	I-DISEASE
syndrome	0
.	0

Diagnostic	I-DISEASE
Criteria	0
Criteria	I-DISEASE
A	0
-	I-DISEASE
D	I-DISEASE
must	0
be	0
met	0
A.	0

There	I-DISEASE
is	I-DISEASE
a	0
history	I-DISEASE
of	0
insomnia	I-DISEASE
,	0
excessive	0
daytime	0
sleepiness	0
,	I-DISEASE
or	0
both	I-DISEASE
,	I-DISEASE
which	0
alternate	0
with	0
asymptomatic	0
episodes	I-DISEASE
,	0
due	I-DISEASE
to	0
misalignment	0
between	0
the	0
24	0
-	0
hour	0
light	0
-	I-DISEASE
dark	0
cycle	0
and	0
the	0
non	0
-	0
entrained	0
endogenous	I-DISEASE
circadian	0
rhythm	I-DISEASE
of	I-DISEASE
sleep	0
-	I-DISEASE
wake	0
propensity	0
.	0

B.	0
Symptoms	I-DISEASE
persist	I-DISEASE
over	0
the	0
course	I-DISEASE
of	I-DISEASE
at	I-DISEASE
least	I-DISEASE
three	0
months	0
.	0

C.	I-DISEASE
Daily	0
sleep	0
logs	0
and	0
actigraphy	0
for	0
at	I-DISEASE
least	0
14	0
days	0
,	0
preferably	0
longer	I-DISEASE
for	0
blind	0
persons	0
,	0
demonstrate	0
a	0
pattern	0
of	I-DISEASE
sleep	0
and	0
wake	0
times	I-DISEASE
that	0
typically	0
delay	0
each	I-DISEASE
day	I-DISEASE
,	0
with	I-DISEASE
a	0
circadian	0
period	0
that	0
is	0
usually	0
longer	I-DISEASE
than	0
24	0
hours	I-DISEASE
.	0

D.	I-DISEASE

The	I-DISEASE
sleep	0
disturbance	0
is	I-DISEASE
not	0
better	0
explained	I-DISEASE
by	I-DISEASE
another	I-DISEASE
current	0
sleep	0
disorder	0
,	I-DISEASE
medical	I-DISEASE
or	0
neurological	0
disorder	0
,	0
mental	0
disorder	0
,	I-DISEASE
medication	0
use	0
,	I-DISEASE
or	0
substance	I-DISEASE
use	0
disorder	I-DISEASE
.	0

Notes	I-DISEASE
.	0

Patients	I-DISEASE
may	0
present	I-DISEASE
with	0
a	0
progressively	0
delaying	I-DISEASE
sleep	0
-	0
wake	0
pattern	0
and	0
intermittent	0
insomnia	0
and	0
excessive	0
sleepiness	0
.	0

Individual	I-DISEASE
symptoms	I-DISEASE
will	0
depend	0
on	0
when	I-DISEASE
an	0
individual	I-DISEASE
tries	0
to	0
sleep	0
in	I-DISEASE
relation	I-DISEASE
to	I-DISEASE
the	0
circadian	I-DISEASE
rhythm	I-DISEASE
of	0
sleep	0
-	I-DISEASE
wake	0
propensity	I-DISEASE
.	0

The	I-DISEASE
magnitude	0
of	I-DISEASE
the	0
daily	0
delay	I-DISEASE
will	0
depend	0
on	0
the	0
endogenous	0
circadian	I-DISEASE
period	0
,	I-DISEASE
and	0
may	0
range	0
from	I-DISEASE
less	I-DISEASE
than	0
30	0
minutes	0
(	I-DISEASE
when	0
the	I-DISEASE
period	0
is	I-DISEASE
close	0
to	B-DISEASE
24	0
hours	I-DISEASE
)	0
to	I-DISEASE
more	0
than	0
an	0
hour	0
(	0
when	0
the	0
period	0
is	0
longer	I-DISEASE
than	I-DISEASE
25	0
hours	I-DISEASE
)	0
.	0
.	0

The	I-DISEASE
symptomatic	0
episode	I-DISEASE
will	0
typically	0
begin	0
with	I-DISEASE
a	0
gradual	I-DISEASE
increase	I-DISEASE
in	0
sleep	0
latency	I-DISEASE
and	0
delayed	0
sleep	0
onset	I-DISEASE
.	0

As	I-DISEASE
the	0
sleep	0
propensity	I-DISEASE
rhythm	I-DISEASE
shifts	B-DISEASE
into	I-DISEASE
the	0
daytime	0
,	I-DISEASE
patients	I-DISEASE
will	0
have	0
difficulty	0
falling	0
asleep	I-DISEASE
at	0
night	0
and	0
staying	0
awake	0
during	I-DISEASE
the	0
day	I-DISEASE
.	0

As	I-DISEASE
the	0
sleep	0
-	I-DISEASE
wake	0
propensity	I-DISEASE
rhythm	0
drifts	0
further	I-DISEASE
,	I-DISEASE
patients	I-DISEASE
will	0
eventually	0
complain	I-DISEASE
of	I-DISEASE
late	0
afternoon	0
and	0
evening	0
sleepiness	0
and	0
naps	I-DISEASE
as	0
well	I-DISEASE
as	0
an	0
early	0
sleep	0
onset	0
time	0
and	0
short	0
sleep	0
latency	I-DISEASE
.	0
.	0

Other	I-DISEASE
circadian	0
rhythms	0
,	0
such	0
as	0
the	B-DISEASE
DLMO	I-DISEASE
or	0
urinary	I-DISEASE
6	0
-	0
sulfatoxy-	0
melatonin	0
rhythm	I-DISEASE
obtained	0
at	I-DISEASE
two	0
time	0
points	I-DISEASE
2	B-DISEASE
-	0
4	0
weeks	0
apart	0
(	0
i.e.	0
,	0
to	0
allow	0
sufficient	I-DISEASE
time	0
for	I-DISEASE
the	0
drift	I-DISEASE
to	0
be	0
apparent	0
)	0
is	0
desirable	I-DISEASE
to	0
confirm	0
the	0
nonentrained	0
rhythm	I-DISEASE
.	I-DISEASE

Circadian	I-DISEASE
Rhythm	0
Sleep	I-DISEASE
-	0
Wake	0
Disorders	0
Circadian	0
Rhythm	0
Sleep	I-DISEASE
-	I-DISEASE
Wake	0
Disorders	0
Essential	0
Features	I-DISEASE
Non-24	0
-	0
hour	0
sleep	0
-	0
wake	B-DISEASE
disorder	0
(	I-DISEASE
N24SWD	0
)	0
is	0
characterized	0
by	0
symptoms	0
of	0
insomnia	0
or	0
excessive	0
sleepiness	0
that	0
occur	0
because	0
the	0
intrinsic	I-DISEASE
circadian	0
pace-	0
maker	0
is	0
not	0
entrained	I-DISEASE
to	0
a	0
24	0
-	I-DISEASE
hour	0
light	0
/	0
dark	0
cycle	0
.	0

The	I-DISEASE
non-24	0
-	0
hour	0
period	0
can	I-DISEASE
be	0
shorter	0
or	0
,	I-DISEASE
more	I-DISEASE
typically	I-DISEASE
,	0
longer	I-DISEASE
than	I-DISEASE
24	0
hours	I-DISEASE
.	0

Because	I-DISEASE
the	0
endogenous	0
circadian	I-DISEASE
rhythm	I-DISEASE
is	0
not	0
aligned	0
to	I-DISEASE
the	I-DISEASE
external	I-DISEASE
24	0
-	I-DISEASE
hour	I-DISEASE
environment	I-DISEASE
,	0
symptoms	0
will	0
depend	0
on	0
when	0
an	0
individual	I-DISEASE
tries	0
to	I-DISEASE
sleep	0
in	I-DISEASE
relation	0
to	B-DISEASE
the	0
circadian	0
rhythm	I-DISEASE
of	I-DISEASE
sleep	0
and	0
wake	0
propensity	0
.	0

Individuals	I-DISEASE
typically	0
present	I-DISEASE
with	I-DISEASE
episodes	0
of	I-DISEASE
difficulty	0
falling	0
asleep	0
or	0
staying	0
asleep	I-DISEASE
,	I-DISEASE
excessive	I-DISEASE
sleepiness	0
or	I-DISEASE
both	I-DISEASE
,	0
alternating	0
with	I-DISEASE
short	0
asymp-	0
tomatic	0
periods	0
.	0

The	I-DISEASE
severity	I-DISEASE
of	I-DISEASE
individual	I-DISEASE
sleep	0
-	I-DISEASE
wake	0
symptoms	I-DISEASE
can	0
be	0
variable	I-DISEASE
.	0

Starting	I-DISEASE
with	I-DISEASE
the	0
asymptomatic	0
period	0
when	0
the	0
individual	I-DISEASE
’s	I-DISEASE
endogenous	0
rhythm	I-DISEASE
is	0
aligned	0
to	I-DISEASE
the	0
external	I-DISEASE
environment	0
and	0
required	I-DISEASE
sleep	0
-	I-DISEASE
wake	0
times	I-DISEASE
,	I-DISEASE
sleep	0
latency	0
will	0
gradually	0
increase	I-DISEASE
and	0
the	0
individual	0
will	0
complain	0
of	0
sleep	0
-	0
onset	I-DISEASE
insomnia	I-DISEASE
.	0

As	I-DISEASE
the	0
sleep	0
phase	0
continues	0
to	I-DISEASE
drift	I-DISEASE
so	I-DISEASE
that	0
maximal	0
endogenous	0
sleep	0
propensity	I-DISEASE
is	0
now	I-DISEASE
in	I-DISEASE
the	0
daytime	I-DISEASE
,	0
individuals	I-DISEASE
will	0
have	0
trouble	I-DISEASE
staying	0
awake	0
during	I-DISEASE
the	0
day	0
(	I-DISEASE
exhibiting	I-DISEASE
multiple	I-DISEASE
daytime	0
naps	I-DISEASE
)	0
and	0
complain	0
of	0
sleepiness	0
.	0

Associated	I-DISEASE
Features	I-DISEASE
Most	0
individuals	I-DISEASE
with	0
nonentrained	0
circadian	0
rhythms	0
are	I-DISEASE
totally	I-DISEASE
blind	0
,	I-DISEASE
and	0
the	0
failure	0
to	0
entrain	0
circadian	0
rhythms	0
is	0
related	0
to	0
the	0
lack	I-DISEASE
of	I-DISEASE
photic	0
input	I-DISEASE
to	0
the	0
cir-	I-DISEASE
cadian	0
pacemaker	0
.	0

A	I-DISEASE
small	0
proportion	I-DISEASE
of	I-DISEASE
totally	0
blind	I-DISEASE
people	0
may	I-DISEASE
retain	0
functional	0
circadian	0
photoreception	I-DISEASE
and	0
entrained	I-DISEASE
rhythms	0
if	I-DISEASE
their	0
blindness	I-DISEASE
is	0
due	I-DISEASE
exclusively	B-DISEASE
to	I-DISEASE
an	0
outer	I-DISEASE
retina	I-DISEASE
disorder	0
(	I-DISEASE
rod	I-DISEASE
and	0
cone	I-DISEASE
layer	0
)	0
with	I-DISEASE
retention	0
of	I-DISEASE
functional	0
,	0
intrin-	I-DISEASE
sically	0
photosensitive	0
retinal	0
ganglion	0
cells	0
and	0
the	0
retinohypothalamic	0
pathway	0
.	0

Some	I-DISEASE
blind	I-DISEASE
people	0
may	I-DISEASE
also	0
be	I-DISEASE
able	0
to	I-DISEASE
entrain	0
to	I-DISEASE
nonphotic	I-DISEASE
cues	I-DISEASE
(	I-DISEASE
e.g.	I-DISEASE
,	0
the	0
timing	I-DISEASE
of	I-DISEASE
physical	0
activity	0
)	I-DISEASE
,	I-DISEASE
producing	I-DISEASE
entrainment	I-DISEASE
at	I-DISEASE
an	0
adverse	0
phase	0
in	I-DISEASE
some	I-DISEASE
cases	0
.	0

In	I-DISEASE
sighted	I-DISEASE
people	0
,	I-DISEASE
social	0
and	0
behavioral	I-DISEASE
factors	I-DISEASE
also	0
play	0
an	0
important	0
role	I-DISEASE
in	I-DISEASE
the	0
development	I-DISEASE
and	0
maintenance	I-DISEASE
of	I-DISEASE
the	0
disorder	I-DISEASE
,	I-DISEASE
as	0
there	I-DISEASE
is	0
an	I-DISEASE
increased	0
incidence	I-DISEASE
of	I-DISEASE
psychiatric	I-DISEASE
disorders	0
.	0

Occasionally	I-DISEASE
,	I-DISEASE
the	0
disorder	I-DISEASE
is	0
associated	0
with	I-DISEASE
developmental	I-DISEASE
intellectual	0
disability	0
or	I-DISEASE
dementia	I-DISEASE
.	0

In	I-DISEASE
sighted	I-DISEASE
individuals	I-DISEASE
,	I-DISEASE
there	0
is	0
often	0
a	I-DISEASE
history	I-DISEASE
of	I-DISEASE
delayed	0
sleep	0
phase	I-DISEASE
,	I-DISEASE
and	0
decreased	I-DISEASE
exposure	0
to	I-DISEASE
light	0
and	0
structured	0
social	0
and	0
phys-	0
ical	I-DISEASE
activity	I-DISEASE
.	0

Some	I-DISEASE
sighted	I-DISEASE
individuals	I-DISEASE
with	I-DISEASE
N24SWD	0
also	0
demonstrate	0
increased	0
sleep	0
duration	0
.	0

Demographics	I-DISEASE
It	0
is	0
thought	0
that	0
over	0
half	0
of	I-DISEASE
totally	I-DISEASE
blind	I-DISEASE
individuals	I-DISEASE
have	0
non-24	0
-	0
hour	0
circa-	0
dian	0
rhythms	0
;	I-DISEASE
50	0
%	0
to	0
80	0
%	0
of	I-DISEASE
blind	0
individuals	I-DISEASE
complain	I-DISEASE
of	I-DISEASE
sleep	0
disturbances	0
.	0

The	I-DISEASE
prevalence	0
,	0
sex	0
,	0
and	0
racial	I-DISEASE
/	0
ethnic	0
differences	I-DISEASE
of	I-DISEASE
N24SWD	0
in	I-DISEASE
adults	I-DISEASE
and	0
children	0
are	0
unknown	I-DISEASE
.	0

Predisposing	I-DISEASE
and	0
Precipitating	I-DISEASE
Factors	0
Total	I-DISEASE
blindness	I-DISEASE
is	0
the	0
most	0
common	I-DISEASE
predisposing	0
condition	0
.	0

In	I-DISEASE
sighted	I-DISEASE
people	0
,	I-DISEASE
the	0
dis-	I-DISEASE
order	0
can	0
be	0
induced	I-DISEASE
by	I-DISEASE
certain	0
environmental	0
conditions	I-DISEASE
,	I-DISEASE
such	I-DISEASE
as	0
decreased	I-DISEASE
or	I-DISEASE
inap-	I-DISEASE
propriately	I-DISEASE
timed	0
exposure	0
to	I-DISEASE
circadian	I-DISEASE
entraining	0
agents	0
,	0
particularly	0
light	0
.	0

Delayed	I-DISEASE
sleep	0
-	0
wake	0
phase	0
disorder	I-DISEASE
may	0
predispose	0
to	I-DISEASE
N24SWD	0
in	I-DISEASE
sighted	0
persons	0
.	0

The	I-DISEASE
con-	0
dition	I-DISEASE
has	0
developed	0
after	I-DISEASE
chronotherapy	0
for	0
DSWPD	I-DISEASE
.	0

This	I-DISEASE
disorder	I-DISEASE
has	0
also	0
been	0
reported	I-DISEASE
in	I-DISEASE
adults	I-DISEASE
following	0
traumatic	0
brain	0
injury	I-DISEASE
.	I-DISEASE

Familial	I-DISEASE
Patterns	I-DISEASE
Not	I-DISEASE
applicable	0
or	B-DISEASE
known	0
.	0

Developmental	I-DISEASE
Issues	0
Caregivers	0
may	0
report	0
that	0
a	0
child	0
has	0
difficulty	I-DISEASE
falling	0
asleep	0
at	I-DISEASE
the	0
desired	I-DISEASE
bedtime	0
or	I-DISEASE
“	I-DISEASE
falls	I-DISEASE
asleep	I-DISEASE
too	0
early	I-DISEASE
”	I-DISEASE
in	I-DISEASE
the	0
evening	I-DISEASE
,	I-DISEASE
wakes	I-DISEASE
“	I-DISEASE
too	0
early	0
”	I-DISEASE
or	0
has	0
difficulty	0
waking	0
in	0
the	0
morning	0
and	0
staying	I-DISEASE
awake	0
during	I-DISEASE
the	I-DISEASE
day	I-DISEASE
.	0

Parents	I-DISEASE
may	0
complain	0
that	0
their	0
child	0
sleeps	0
too	0
much	0
or	0
too	0
little	I-DISEASE
or	I-DISEASE
at	I-DISEASE
inappropriate	0
times	0
.	0

The	I-DISEASE
key	0
characteristics	0
that	0
distinguish	0
N24SWD	0
from	0
other	0
sleep	0
complaints	I-DISEASE
or	I-DISEASE
circadian	0
sleep	0
wake	I-DISEASE
dis-	0
orders	I-DISEASE
are	0
twofold	0
:	I-DISEASE
(	0
1	I-DISEASE
)	0
the	0
predictable	0
pattern	B-DISEASE
of	I-DISEASE
misalignment	0
between	0
the	0
child	0
’s	I-DISEASE
sleep	0
patterns	0
and	0
the	0
light	0
-	I-DISEASE
dark	0
24	0
-	0
hour	0
cycle	0
(	0
progressive	0
delay	I-DISEASE
in	I-DISEASE
sleep	0
onset	0
-	0
offset	0
across	I-DISEASE
days	0
to	I-DISEASE
weeks	I-DISEASE
)	0
;	0
and	0
(	0
2	0
)	0
periods	I-DISEASE
of	I-DISEASE
apparent	0
“	I-DISEASE
symptom	0
remission	0
”	I-DISEASE
during	I-DISEASE
those	0
transient	I-DISEASE
intervals	0
when	0
the	0
child	0
’s	I-DISEASE
circadian	0
sleep	I-DISEASE
-	0
wake	0
propensity	0
coincides	I-DISEASE
with	0
the	I-DISEASE
desired	I-DISEASE
bed	I-DISEASE
and	0
wake	0
times	0
.	0

The	I-DISEASE
impact	I-DISEASE
on	0
caregivers	I-DISEASE
’	I-DISEASE
sleep	0
and	0
daytime	0
functioning	I-DISEASE
is	I-DISEASE
often	I-DISEASE
profound	I-DISEASE
.	0

Although	I-DISEASE
N24SWD	0
is	0
extremely	I-DISEASE
rare	I-DISEASE
in	0
typically	0
developing	0
or	I-DISEASE
sighted	I-DISEASE
children	I-DISEASE
,	0
it	0
has	0
been	I-DISEASE
reported	0
with	0
some	I-DISEASE
frequency	I-DISEASE
in	I-DISEASE
children	B-DISEASE
with	0
intellectual	0
disabilities	0
and	0
blindness	I-DISEASE
.	0

For	I-DISEASE
example	0
,	0
children	I-DISEASE
with	0
optic	0
nerve	0
hypoplasia	0
due	I-DISEASE
to	I-DISEASE
a	0
variety	I-DISEASE
of	I-DISEASE
under-	I-DISEASE
lying	0
causes	I-DISEASE
,	0
especially	0
those	0
children	0
with	I-DISEASE
hypoplastic	0
corpus	0
callosum	B-DISEASE
and	0
comor-	I-DISEASE
bid	I-DISEASE
severe	0
intellectual	0
and	0
visual	0
impairments	0
,	I-DISEASE
have	I-DISEASE
been	I-DISEASE
reported	0
to	0
have	0
features	0
of	I-DISEASE
N24SWD	0
.	0
N24SWD	0
has	I-DISEASE
also	0
been	I-DISEASE
described	0
in	I-DISEASE
pediatric	0
patients	I-DISEASE
with	I-DISEASE
Rett	0
syndrome	0
(	I-DISEASE
a	0
genetic	I-DISEASE
disorder	0
occurring	0
almost	I-DISEASE
exclusively	I-DISEASE
in	0
girls	I-DISEASE
,	0
characterized	0
by	I-DISEASE
severe	0
developmental	I-DISEASE
regression	I-DISEASE
,	0
language	0
delays	0
,	0
and	0
limited	I-DISEASE
social	I-DISEASE
interactions	0
)	I-DISEASE
,	0
autism	0
spectrum	I-DISEASE
disorders	0
,	0
and	0
Angelman	0
syndrome	0
,	I-DISEASE
a	I-DISEASE
neurodevelopmental	0
disorder	0
asso-	I-DISEASE
ciated	I-DISEASE
with	0
an	0
abnormality	0
of	B-DISEASE
chromosome	I-DISEASE
15q11	0
-	0
q13	0
.	0

The	I-DISEASE
common	I-DISEASE
mechanism	0
in	I-DISEASE
all	0
of	I-DISEASE
these	I-DISEASE
disorders	0
is	0
postulated	0
to	I-DISEASE
be	I-DISEASE
lack	I-DISEASE
of	I-DISEASE
entrainment	0
to	0
the	0
24	0
-	0
hour	0
day	0
that	0
results	0
from	I-DISEASE
the	0
failure	I-DISEASE
to	I-DISEASE
perceive	I-DISEASE
and/or	0
attend	I-DISEASE
to	I-DISEASE
social	0
/	0
environmental	0
zeitgebers	0
(	I-DISEASE
time	0
cues	I-DISEASE
)	0
.	0

There	I-DISEASE
have	I-DISEASE
also	0
been	I-DISEASE
several	0
case	I-DISEASE
reports	0
which	0
describe	0
the	0
emergence	0
of	I-DISEASE
N24SWD	I-DISEASE
in	I-DISEASE
intellectually	I-DISEASE
normal	0
sighted	I-DISEASE
children	I-DISEASE
or	0
adolescents	0
who	I-DISEASE
have	0
limited	I-DISEASE
or	0
inappropriate	0
exposure	0
to	0
environmental	0
and	0
other	I-DISEASE
entraining	0
cues	0
(	I-DISEASE
e.g.	0
,	I-DISEASE
decreased	I-DISEASE
Circadian	I-DISEASE
Rhythm	0
Sleep	0
-	0
Wake	0
Disorders	0
Circadian	0
Rhythm	0
Sleep	I-DISEASE
-	I-DISEASE
Wake	0
Disorders	0
light	0
during	I-DISEASE
the	0
day	I-DISEASE
and/or	0
excessive	0
light	0
exposure	0
in	I-DISEASE
the	0
evening	0
)	0
.	0

These	0
individuals	I-DISEASE
are	0
likely	I-DISEASE
to	0
have	I-DISEASE
significant	0
psychiatric	I-DISEASE
impairments	0
that	0
predispose	I-DISEASE
them	I-DISEASE
to	I-DISEASE
avoid-	0
ance	0
of	I-DISEASE
social	0
interactions	0
(	I-DISEASE
e.g.	I-DISEASE
,	I-DISEASE
anxiety	I-DISEASE
)	0
or	0
medical	0
conditions	I-DISEASE
that	0
involve	0
enforced	I-DISEASE
prolonged	0
periods	0
of	0
inactivity	I-DISEASE
(	I-DISEASE
traumatic	I-DISEASE
brain	I-DISEASE
injury	I-DISEASE
,	I-DISEASE
chronic	I-DISEASE
fatigue	I-DISEASE
)	0
.	0

Little	I-DISEASE
is	I-DISEASE
known	0
about	I-DISEASE
the	0
natural	0
history	I-DISEASE
of	I-DISEASE
the	0
clinical	0
entity	0
of	I-DISEASE
N24SWD	I-DISEASE
in	I-DISEASE
the	I-DISEASE
pedi-	0
atric	I-DISEASE
population	0
,	I-DISEASE
including	0
the	I-DISEASE
impact	I-DISEASE
of	I-DISEASE
various	0
treatment	I-DISEASE
modalities	0
,	I-DISEASE
the	0
likelihood	0
of	I-DISEASE
spontaneous	I-DISEASE
resolution	0
of	I-DISEASE
symptoms	0
,	0
or	I-DISEASE
long	I-DISEASE
-	I-DISEASE
term	0
consequences	I-DISEASE
.	0

There	I-DISEASE
may	I-DISEASE
be	0
varying	I-DISEASE
phenotypes	0
of	I-DISEASE
N24SWD	0
in	I-DISEASE
children	0
,	I-DISEASE
with	I-DISEASE
differences	I-DISEASE
in	0
regard	0
to	I-DISEASE
symptom	0
presentation	0
,	0
severity	I-DISEASE
,	I-DISEASE
and	0
chronicity	I-DISEASE
that	0
are	0
related	0
to	I-DISEASE
the	0
underlying	0
condition	0
.	0

For	I-DISEASE
example	0
,	0
it	0
is	0
likely	I-DISEASE
that	0
children	I-DISEASE
with	0
chronic	0
neurologic	0
conditions	0
such	0
as	0
blindness	I-DISEASE
or	0
neurodevelopmental	0
disabilities	0
have	I-DISEASE
a	0
more	0
intractable	I-DISEASE
and	0
treat-	0
ment	0
resistant	0
pattern	0
compared	0
to	0
children	0
with	0
more	0
self	0
-	I-DISEASE
limited	I-DISEASE
conditions	I-DISEASE
(	0
e.g.	0
,	0
traumatic	0
brain	I-DISEASE
injury	0
)	0
.	0

Onset	I-DISEASE
,	0
Course	0
,	0
and	0
Complications	0
Onset	0
may	I-DISEASE
occur	I-DISEASE
at	I-DISEASE
any	I-DISEASE
age	I-DISEASE
in	I-DISEASE
blind	0
individuals	0
,	0
coincident	0
with	I-DISEASE
loss	0
of	I-DISEASE
light	0
percep-	I-DISEASE
tion	0
,	0
and	0
,	0
in	I-DISEASE
congenitally	0
blind	I-DISEASE
children	0
,	0
onset	0
can	0
occur	I-DISEASE
from	I-DISEASE
birth	I-DISEASE
or	0
during	I-DISEASE
infancy	0
.	0

If	I-DISEASE
untreated	I-DISEASE
,	0
the	0
course	0
is	I-DISEASE
chronic	B-DISEASE
.	0

Attempts	I-DISEASE
to	I-DISEASE
regulate	0
sleep	0
and	0
wake	0
times	0
may	0
involve	0
the	0
use	I-DISEASE
of	I-DISEASE
alcohol	0
,	I-DISEASE
sedatives	I-DISEASE
-	0
hypnotics	I-DISEASE
,	I-DISEASE
and	0
stimulants	0
,	I-DISEASE
which	0
in	I-DISEASE
turn	0
can	0
exac-	0
erbate	0
the	0
underlying	0
sleep	0
disorder	I-DISEASE
.	0

Depressive	I-DISEASE
symptoms	I-DISEASE
and	0
mood	0
disorders	0
can	0
be	I-DISEASE
comorbid	0
conditions	I-DISEASE
,	I-DISEASE
particularly	I-DISEASE
in	I-DISEASE
sighted	I-DISEASE
patients	I-DISEASE
.	I-DISEASE

The	I-DISEASE
adverse	0
effects	0
on	0
school	0
or	I-DISEASE
work	I-DISEASE
performance	0
,	0
as	0
well	I-DISEASE
as	0
other	I-DISEASE
psychosocial	0
complications	0
,	0
due	0
to	I-DISEASE
a	0
lack	I-DISEASE
of	I-DISEASE
pre-	0
dictable	0
sleep	0
and	0
wake	B-DISEASE
times	0
and	0
excessive	0
daytime	0
sleepiness	0
,	0
are	0
key	0
motivations	I-DISEASE
for	0
seeking	0
treatment	I-DISEASE
.	0

Pathology	I-DISEASE
and	0
Pathophysiology	I-DISEASE
The	I-DISEASE
intrinsic	0
period	0
of	I-DISEASE
the	I-DISEASE
human	0
circadian	0
pacemaker	I-DISEASE
is	0
usually	0
longer	I-DISEASE
than	0
24	0
hours	I-DISEASE
and	0
requires	I-DISEASE
daily	0
input	I-DISEASE
from	0
the	I-DISEASE
environment	0
to	I-DISEASE
maintain	0
synchrony	0
to	0
the	0
24	0
-	0
hour	0
day	0
.	0

The	I-DISEASE
light	0
-	0
dark	0
cycle	0
is	0
the	0
most	0
important	B-DISEASE
environmental	0
time	0
cue	I-DISEASE
(	I-DISEASE
zeitgeber	I-DISEASE
)	0
in	0
humans	0
(	I-DISEASE
as	0
in	I-DISEASE
other	0
species	I-DISEASE
)	0
,	0
although	0
nonphotic	0
time	0
cues	0
also	0
play	I-DISEASE
a	0
role	0
in	0
normal	0
entrainment	0
.	0

A	I-DISEASE
lack	I-DISEASE
of	I-DISEASE
photic	0
input	I-DISEASE
to	I-DISEASE
the	0
circadian	0
pacemaker	0
is	I-DISEASE
clearly	B-DISEASE
the	0
cause	I-DISEASE
of	I-DISEASE
nonentrained	0
rhythms	0
in	I-DISEASE
totally	0
blind	I-DISEASE
people	0
.	I-DISEASE

It	I-DISEASE
has	0
been	I-DISEASE
suggested	I-DISEASE
that	0
,	I-DISEASE
in	I-DISEASE
sighted	I-DISEASE
individuals	I-DISEASE
,	0
a	0
systematic	0
delay	I-DISEASE
due	I-DISEASE
to	0
inadequate	I-DISEASE
exposure	0
to	I-DISEASE
light	0
may	0
contribute	0
to	0
the	0
development	B-DISEASE
of	I-DISEASE
N24SWD	0
.	0

In	I-DISEASE
addition	0
,	0
the	0
disorder	0
may	I-DISEASE
be	I-DISEASE
caused	0
by	0
an	0
extremely	I-DISEASE
prolonged	0
endogenous	I-DISEASE
circadian	0
period	I-DISEASE
that	0
is	0
outside	I-DISEASE
of	I-DISEASE
the	0
range	0
for	0
entrainment	I-DISEASE
to	I-DISEASE
the	0
24	0
-	0
hour	0
cycle	0
or	0
by	I-DISEASE
an	0
alteration	0
in	0
the	0
response	0
of	0
the	0
circadian	0
clock	0
to	I-DISEASE
the	0
entraining	0
effects	0
of	I-DISEASE
light	0
.	0

Objective	I-DISEASE
Findings	I-DISEASE
Sleep	I-DISEASE
studies	I-DISEASE
yield	I-DISEASE
different	0
results	0
depending	0
on	0
the	I-DISEASE
degree	I-DISEASE
of	I-DISEASE
synchrony	0
between	0
sleep	0
times	0
and	0
the	0
circadian	0
pacemaker	0
at	I-DISEASE
the	I-DISEASE
time	0
when	0
the	0
sleep	0
study	0
is	0
performed	0
.	0

Recording	0
of	I-DISEASE
sleep	0
log	0
and	0
actigraphy	0
over	0
prolonged	0
periods	0
(	I-DISEASE
at	I-DISEASE
least	I-DISEASE
14	0
days	0
,	I-DISEASE
but	I-DISEASE
ideally	0
longer	0
in	I-DISEASE
blind	I-DISEASE
individuals	I-DISEASE
)	0
demonstrate	I-DISEASE
the	0
lack	I-DISEASE
of	I-DISEASE
a	I-DISEASE
stable	I-DISEASE
relationship	0
between	0
the	0
timing	I-DISEASE
of	I-DISEASE
the	0
sleep	0
-	I-DISEASE
wake	0
cycle	0
and	0
the	0
24	0
-	0
hour	0
day	I-DISEASE
.	0

When	I-DISEASE
sleep	0
sched-	0
ules	0
follow	I-DISEASE
the	0
endogenous	0
circadian	I-DISEASE
propensity	I-DISEASE
for	I-DISEASE
sleep	0
and	0
wake	0
,	0
sleep	0
onset	0
and	0
wake	0
times	0
are	I-DISEASE
typically	0
delayed	I-DISEASE
each	I-DISEASE
day	I-DISEASE
.	0

Serial	I-DISEASE
measurements	0
of	I-DISEASE
circadian	0
rhythms	0
,	I-DISEASE
such	0
as	0
melatonin	0
,	0
usually	I-DISEASE
show	I-DISEASE
a	I-DISEASE
progressive	0
daily	0
delay	I-DISEASE
of	I-DISEASE
the	0
phase	0
of	I-DISEASE
the	I-DISEASE
rhythm	0
consistent	I-DISEASE
with	0
a	I-DISEASE
period	I-DISEASE
that	0
is	0
longer	I-DISEASE
than	I-DISEASE
24	0
hours	I-DISEASE
.	0

Clinical	I-DISEASE
and	0
Pathophysiologic	I-DISEASE
Subtypes	0
Totally	I-DISEASE
blind	I-DISEASE
patients	0
with	0
N24SWD	0
are	I-DISEASE
clinically	0
different	0
than	0
sighted	I-DISEASE
patients	0
.	0

In	I-DISEASE
sighted	I-DISEASE
patients	0
with	I-DISEASE
N24SWD	0
,	0
the	0
circadian	0
period	I-DISEASE
is	I-DISEASE
often	0
25	0
hours	I-DISEASE
or	I-DISEASE
longer	0
,	0
whereas	I-DISEASE
in	I-DISEASE
totally	0
blind	I-DISEASE
patients	0
with	I-DISEASE
the	0
disorder	I-DISEASE
,	0
the	0
circadian	0
period	0
follows	0
an	0
average	0
period	0
length	0
which	0
is	0
often	0
closer	0
to	0
24	0
hours	I-DISEASE
and	0
rarely	I-DISEASE
may	I-DISEASE
be	0
shorter	0
than	0
24	0
hours	I-DISEASE
.	0

Differential	I-DISEASE
Diagnosis	0

Some	I-DISEASE
individuals	I-DISEASE
with	0
severe	I-DISEASE
DSWPD	0
may	I-DISEASE
demonstrate	0
progressive	0
delay	0
of	I-DISEASE
their	I-DISEASE
sleep	0
period	0
by	I-DISEASE
30	I-DISEASE
minutes	0
or	0
more	0
for	I-DISEASE
several	0
days	0
,	0
and	0
their	I-DISEASE
symptoms	0
may	I-DISEASE
be	0
con-	0
fused	I-DISEASE
with	0
N24SWD	0
.	0

Behavioral	I-DISEASE
factors	0
and	0
psychiatric	I-DISEASE
disorders	0
,	0
as	0
well	I-DISEASE
as	0
medical	I-DISEASE
and	0
neurological	0
dis-	I-DISEASE
orders	I-DISEASE
(	I-DISEASE
especially	0
blindness	I-DISEASE
,	I-DISEASE
but	0
also	0
dementia	0
or	B-DISEASE
mental	0
retardation	B-DISEASE
)	0
,	0
may	0
play	I-DISEASE
a	0
role	0
in	0
the	0
development	I-DISEASE
of	I-DISEASE
N24SWD	I-DISEASE
.	0

In	I-DISEASE
many	0
of	I-DISEASE
these	I-DISEASE
cases	0
,	I-DISEASE
however	I-DISEASE
,	I-DISEASE
multiple	I-DISEASE
physio-	0
logic	I-DISEASE
,	0
behavioral	I-DISEASE
,	I-DISEASE
and	0
environmental	0
factors	0
contribute	0
to	I-DISEASE
the	0
condition	0
.	0

In	I-DISEASE
the	0
major-	I-DISEASE
ity	0
of	I-DISEASE
these	I-DISEASE
cases	0
,	0
the	0
disorder	0
should	I-DISEASE
be	I-DISEASE
coded	0
as	0
N24SWD	0
.	0

This	I-DISEASE
includes	I-DISEASE
non-24-	0
hour	0
sleep	0
-	0
wake	0
patterns	0
that	0
are	I-DISEASE
associated	0
with	0
blindness	I-DISEASE
.	0

Unresolved	I-DISEASE
Issues	0
and	0
Further	I-DISEASE
Directions	0

There	I-DISEASE
is	I-DISEASE
only	0
limited	I-DISEASE
knowledge	0
of	I-DISEASE
the	0
underlying	0
pathophysiology	0
of	I-DISEASE
sighted	I-DISEASE
persons	0
with	I-DISEASE
N24SWD	0
.	0

The	I-DISEASE
primary	0
risk	0
factor	I-DISEASE
in	0
sighted	I-DISEASE
persons	0
appears	I-DISEASE
to	0
be	0
a	0
long	I-DISEASE
circa-	I-DISEASE
dian	0
period	I-DISEASE
that	I-DISEASE
is	0
beyond	0
the	0
range	0
of	I-DISEASE
entrainment	0
to	I-DISEASE
a	0
24	0
-	0
hour	0
cycle	0
or	0
a	0
progressive	0
delay	0
due	0
to	0
inappropriate	0
exposure	0
to	0
light	0
.	0

This	I-DISEASE
risk	0
may	0
explain	0
the	0
overlap	0
between	0
DSWPD	I-DISEASE
and	0
N24SWD	0
.	0

Future	I-DISEASE
studies	I-DISEASE
are	0
needed	0
to	0
understand	I-DISEASE
the	0
role	0
of	I-DISEASE
genetic	0
predisposition	0
,	I-DISEASE
environmental	0
or	0
social	0
cues	I-DISEASE
and	0
traumatic	0
brain	I-DISEASE
injury	0
in	I-DISEASE
the	0
develop-	0
ment	0
of	I-DISEASE
N24SWD	0
,	0
and	0
to	I-DISEASE
delineate	0
other	I-DISEASE
health	0
consequences	I-DISEASE
of	0
the	0
condition	0
.	0

There	I-DISEASE
are	0
substantial	0
knowledge	0
gaps	0
regarding	0
the	0
prevalence	I-DISEASE
,	0
pathophysiology	0
,	0
clinical	0
Circadian	0
Rhythm	0
Sleep	0
-	0
Wake	0
Disorders	I-DISEASE
Circadian	I-DISEASE
Rhythm	0
Sleep	0
-	0
Wake	0
Disorders	0
presentation	0
,	0
natural	0
history	I-DISEASE
,	0
effective	0
treatment	I-DISEASE
strategies	0
,	I-DISEASE
and	0
prognosis	0
of	I-DISEASE
N24SWD	0
in	I-DISEASE
children	0
and	0
adolescents	0
compared	0
with	I-DISEASE
adults	I-DISEASE
.	0

Bibliography	0
Ayalon	0
L	0
,	I-DISEASE
Borodkin	0
K	I-DISEASE
,	I-DISEASE
Dishon	I-DISEASE
L	0
,	I-DISEASE
Kanety	0
H	I-DISEASE
,	0
Dagan	I-DISEASE
Y.	I-DISEASE
Circadian	0
rhythm	I-DISEASE
sleep	0
disorders	0
following	0
mild	0
traumatic	0
brain	0
injury	0
.	0

Neurology	0
2007;68:1136–40	I-DISEASE
.	0

Boivin	I-DISEASE
DB	I-DISEASE
,	0
James	0
FO	I-DISEASE
,	0
Santo	0
JB	0
,	I-DISEASE
Caliyurt	0
O	I-DISEASE
,	0
Chalk	I-DISEASE
C.	0
Non-24	0
-	0
hour	0
sleep	0
-	I-DISEASE
wake	0
syndrome	B-DISEASE
following	0
a	0
car	I-DISEASE
accident	0
.	0

Neurology	0
2003;60:1841–3	0
.	0

Czeisler	I-DISEASE
CA	0
,	I-DISEASE
Shanahan	0
TL	0
,	0
Klerman	I-DISEASE
EB	0
,	I-DISEASE
et	0
al	0
.	0

Suppression	I-DISEASE
of	I-DISEASE
melatonin	0
secretion	0
in	0
some	I-DISEASE
blind	I-DISEASE
patients	I-DISEASE
by	0
exposure	0
to	I-DISEASE
bright	0
light	0
.	0

N	0
Engl	I-DISEASE
J	0
Med	I-DISEASE
1995;332:6–11	I-DISEASE
.	0

Hayakawa	I-DISEASE
T	0
,	0
Uchiyama	I-DISEASE
M	I-DISEASE
,	0
Kamei	0
Y	I-DISEASE
,	I-DISEASE
et	0
al	I-DISEASE
.	0

Clinical	I-DISEASE
analyses	0
of	I-DISEASE
sighted	I-DISEASE
patients	0
with	I-DISEASE
non-24	I-DISEASE
-	0
hour	0
sleep-	0
wake	0
syndrome	I-DISEASE
:	0
A	0
study	I-DISEASE
of	0
57	0
consecutively	I-DISEASE
diagnosed	0
cases	0
.	0

Sleep	I-DISEASE
2005;28:945–52	0
.	0

Lewy	I-DISEASE
AJ	0
,	I-DISEASE
Newsome	0
DA	I-DISEASE
.	0

Different	I-DISEASE
types	I-DISEASE
of	I-DISEASE
melatonin	B-DISEASE
circadian	0
secretory	0
rhythms	0
in	I-DISEASE
some	I-DISEASE
blind	0
subjects	0
.	0

J	I-DISEASE
Clin	0
Endocrinol	0
Metab	0
1983;56:1103–7	0
.	0

Lockley	I-DISEASE
SW	0
,	0
Arendt	I-DISEASE
J	0
,	0
Skene	0
DJ	I-DISEASE
.	0

Visual	I-DISEASE
impairment	0
and	0
circadian	I-DISEASE
rhythm	I-DISEASE
disorders	0
.	0

Dialogues	I-DISEASE
Clin	0
Neurosci	0
2007;9:301–14	B-DISEASE
.	0

Lockley	I-DISEASE
SW	I-DISEASE
,	0
Dijk	I-DISEASE
DJ	I-DISEASE
,	0
Kosti	0
O	I-DISEASE
,	I-DISEASE
Skene	0
DJ	I-DISEASE
,	0
Arendt	0
J.	0
Alertness	0
,	0
mood	I-DISEASE
and	0
performance	0
rhythm	I-DISEASE
disturbances	I-DISEASE
associated	0
with	I-DISEASE
circadian	0
sleep	0
disorders	0
in	0
the	0
blind	I-DISEASE
.	0

J	I-DISEASE
Sleep	0
Res	0
2008;17:207–16	0
.	0

Lockley	I-DISEASE
SW	I-DISEASE
,	0
Skene	I-DISEASE
DJ	0
,	0
Butler	0
LJ	0
,	I-DISEASE
Arendt	0
J.	0
Sleep	0
and	0
activity	0
rhythms	0
are	0
related	0
to	0
circadian	I-DISEASE
phase	0
in	I-DISEASE
the	I-DISEASE
blind	I-DISEASE
.	0

Sleep	I-DISEASE
1999;22:616–23	I-DISEASE
.	0

McArthur	I-DISEASE
A	0
,	I-DISEASE
Lewy	0
A	0
,	0
Sack	0
R.	I-DISEASE
Non-24	0
hour	0
sleep	0
-	I-DISEASE
wake	0
syndrome	I-DISEASE
in	I-DISEASE
a	0
sighted	I-DISEASE
man	0
:	I-DISEASE
circadian	0
rhythm	I-DISEASE
studies	I-DISEASE
and	0
efficacy	I-DISEASE
of	I-DISEASE
melatonin	0
treatment	I-DISEASE
.	0

Sleep	I-DISEASE
1996;19:544–53	0
.	0

Morgenthaler	I-DISEASE
TI	0
,	I-DISEASE
Lee	I-DISEASE
-	0
Chiong	0
T	0
,	I-DISEASE
Alessi	I-DISEASE
C	I-DISEASE
,	I-DISEASE
et	0
al	0
.	0

Practice	I-DISEASE
parameters	I-DISEASE
for	0
the	0
clinical	0
evaluation	I-DISEASE
and	0
treatment	I-DISEASE
of	I-DISEASE
circadian	0
rhythm	I-DISEASE
sleep	I-DISEASE
disorders	0
:	0
An	0
American	I-DISEASE
Academy	I-DISEASE
of	I-DISEASE
Sleep	0
Medicine	0
report	0
.	0

Sleep	I-DISEASE
2007;30:1445–59	I-DISEASE
.	0

Sack	I-DISEASE
RL	0
,	0
Lewy	0
AJ	I-DISEASE
,	0
Blood	0
ML	I-DISEASE
,	I-DISEASE
Keith	I-DISEASE
LD	0
,	I-DISEASE
Nakagawa	I-DISEASE
H.	I-DISEASE
Circadian	I-DISEASE
rhythm	0
abnormalities	I-DISEASE
in	I-DISEASE
totally	I-DISEASE
blind	I-DISEASE
people	0
:	I-DISEASE
incidence	0
and	0
clinical	I-DISEASE
significance	0
.	0

J	I-DISEASE
Clin	0
Endocrinol	0
Metab	0
1992;75:127–34	0
.	0

Uchiyama	I-DISEASE
M	I-DISEASE
,	0
Lockley	0
SW	I-DISEASE
.	0

Non-24	I-DISEASE
-	I-DISEASE
hour	0
sleep	0
-	0
wake	0
syndrome	0
in	0
sighted	I-DISEASE
and	0
blind	I-DISEASE
patients	I-DISEASE
.	0

Sleep	I-DISEASE
Med	I-DISEASE
Clin	I-DISEASE
2009;4:195–211	I-DISEASE
.	I-DISEASE

Uchiyama	I-DISEASE
M	I-DISEASE
,	0
Okawa	0
M	I-DISEASE
,	0
Shibui	0
K	I-DISEASE
,	I-DISEASE
et	0
al	I-DISEASE
.	0

Altered	I-DISEASE
phase	0
relation	I-DISEASE
between	0
sleep	0
timing	I-DISEASE
and	0
core	0
body	I-DISEASE
temperature	B-DISEASE
rhythm	I-DISEASE
in	I-DISEASE
delayed	I-DISEASE
sleep	0
phase	0
syndrome	I-DISEASE
and	0
non-24	0
-	0
hour	0
sleep	0
-	0
wake	0
syndrome	0
in	I-DISEASE
humans	0
.	0

Neurosci	0
Lett	0
2000;294:101–4	I-DISEASE
.	0

Uchiyama	I-DISEASE
M	I-DISEASE
,	0
Shibui	I-DISEASE
K	B-DISEASE
,	0
Hayakawa	0
T	0
,	0
et	0
al	I-DISEASE
.	I-DISEASE

Larger	I-DISEASE
phase	0
angle	0
between	0
sleep	0
propensity	I-DISEASE
and	0
melatonin	0
rhythms	0
in	0
sighted	I-DISEASE
humans	0
with	0
non-24	0
-	0
hour	0
sleep	0
-	I-DISEASE
wake	0
syndrome	I-DISEASE
.	0

Sleep	I-DISEASE
2002;25:83–8	I-DISEASE
.	0

Zaidi	I-DISEASE
FH	I-DISEASE
,	I-DISEASE
Hull	I-DISEASE
JT	0
,	0
Peirson	0
SN	I-DISEASE
,	I-DISEASE
et	0
al	I-DISEASE
.	0

Short	I-DISEASE
-	I-DISEASE
wavelength	0
light	0
sensitivity	I-DISEASE
of	I-DISEASE
circadian	0
,	0
pupillary	0
,	I-DISEASE
and	0
visual	I-DISEASE
awareness	0
in	I-DISEASE
humans	0
lacking	I-DISEASE
an	0
outer	0
retina	I-DISEASE
.	0

Curr	I-DISEASE
Biol	0
2007;17:2122–8	I-DISEASE
.	0

Shift	I-DISEASE
Work	0
Disorder	I-DISEASE
ICD-9	0
-	0
CM	0
code	0
:	0
327.36	0
Alternate	0
Names	I-DISEASE
Shift	I-DISEASE
work	I-DISEASE
sleep	0
disorder	I-DISEASE
.	0

Diagnostic	I-DISEASE
Criteria	0
Criteria	I-DISEASE
A	0
-	I-DISEASE
D	I-DISEASE
must	I-DISEASE
be	0
met	0
ICD-10	0
-	0
CM	0
code	0
:	0
G47.26	I-DISEASE
Circadian	I-DISEASE
Rhythm	0
Sleep	0
-	0
Wake	0
Disorders	0

A.	I-DISEASE

There	I-DISEASE
is	I-DISEASE
a	0
report	0
of	0
insomnia	I-DISEASE
and/or	0
excessive	0
sleepiness	I-DISEASE
,	0
accompanied	I-DISEASE
by	I-DISEASE
a	I-DISEASE
reduction	0
of	0
total	I-DISEASE
sleep	0
time	0
,	0
which	0
is	I-DISEASE
associated	0
with	I-DISEASE
a	0
recurring	I-DISEASE
work	I-DISEASE
schedule	B-DISEASE
that	0
overlaps	0
the	0
usual	I-DISEASE
time	0
for	I-DISEASE
sleep	0
.	0

B.	0
The	I-DISEASE
symptoms	I-DISEASE
have	0
been	I-DISEASE
present	I-DISEASE
and	0
associated	0
with	0
the	0
shift	0
work	I-DISEASE
schedule	I-DISEASE
for	0
at	I-DISEASE
least	B-DISEASE
three	I-DISEASE
months	0
.	0

C.	I-DISEASE
Sleep	0
log	0
and	0
actigraphy	0
monitoring	0
(	0
whenever	0
possible	0
and	0
preferably	0
with	0
concurrent	I-DISEASE
light	I-DISEASE
exposure	0
measurement	0
)	0
for	0
at	I-DISEASE
least	0
14	0
days	0
(	0
work	I-DISEASE
and	0
free	I-DISEASE
days	0
)	0
demonstrate	0
a	0
disturbed	0
sleep	0
and	0
wake	0
pattern	0
.	0

D.	I-DISEASE

The	I-DISEASE
sleep	0
and/or	0
wake	0
disturbance	I-DISEASE
are	I-DISEASE
not	0
better	0
explained	I-DISEASE
by	I-DISEASE
another	I-DISEASE
current	I-DISEASE
sleep	0
disorder	I-DISEASE
,	I-DISEASE
medical	I-DISEASE
or	0
neurological	0
disorder	I-DISEASE
,	0
mental	0
disorder	I-DISEASE
,	0
medication	0
use	0
,	I-DISEASE
poor	0
sleep	0
hygiene	0
,	I-DISEASE
or	0
substance	0
use	0
disorder	0
.	0

Essential	I-DISEASE
Features	I-DISEASE
Shift	0
work	I-DISEASE
disorder	I-DISEASE
is	I-DISEASE
characterized	0
by	B-DISEASE
complaints	0
of	I-DISEASE
insomnia	I-DISEASE
or	0
excessive	0
sleepi-	0
ness	0
that	0
occur	I-DISEASE
in	0
association	I-DISEASE
with	I-DISEASE
work	0
hours	I-DISEASE
that	0
occur	I-DISEASE
,	I-DISEASE
at	I-DISEASE
least	0
in	I-DISEASE
part	I-DISEASE
,	I-DISEASE
during	I-DISEASE
the	0
usual	I-DISEASE
sleep	0
episode	0
.	0

There	I-DISEASE
are	0
several	0
types	I-DISEASE
of	0
shift	0
-	I-DISEASE
work	I-DISEASE
schedules	I-DISEASE
,	0
including	0
evening	0
shifts	I-DISEASE
,	I-DISEASE
night	0
shifts	0
,	I-DISEASE
early	I-DISEASE
morning	0
shifts	0
,	I-DISEASE
rotating	I-DISEASE
shifts	0
,	I-DISEASE
split	I-DISEASE
shifts	B-DISEASE
,	0
on	0
-	0
call	I-DISEASE
overnight	I-DISEASE
duty	B-DISEASE
,	0
and	0
long	I-DISEASE
duration	0
work	I-DISEASE
shifts	0
that	0
include	I-DISEASE
work	I-DISEASE
hours	I-DISEASE
at	I-DISEASE
night	0
.	0

The	I-DISEASE
sleep	0
distur-	0
bance	I-DISEASE
is	0
most	0
commonly	0
reported	I-DISEASE
in	I-DISEASE
association	I-DISEASE
with	0
night	0
shifts	B-DISEASE
,	I-DISEASE
early	0
morning	0
shifts	B-DISEASE
,	0
and	0
rotating	I-DISEASE
shifts	0
.	0

Total	I-DISEASE
sleep	0
time	0
is	0
typically	0
curtailed	I-DISEASE
by	0
one	0
to	0
four	I-DISEASE
hours	I-DISEASE
,	I-DISEASE
and	0
sleep	0
quality	0
is	I-DISEASE
perceived	0
as	0
unsatisfactory	I-DISEASE
in	0
night	I-DISEASE
,	I-DISEASE
early	0
morning	0
,	I-DISEASE
and	0
rotating	I-DISEASE
shift	0
workers	0
as	0
well	0
as	0
in	0
those	0
who	I-DISEASE
work	0
long	0
-	0
duration	0
shifts	I-DISEASE
.	0

In	I-DISEASE
addition	0
to	0
impairment	0
of	I-DISEASE
performance	0
at	I-DISEASE
work	I-DISEASE
,	0
reduced	0
alertness	I-DISEASE
may	0
also	0
be	I-DISEASE
associated	0
with	0
consequences	0
for	I-DISEASE
safety	I-DISEASE
during	I-DISEASE
the	0
work	I-DISEASE
schedule	I-DISEASE
and	0
on	0
the	0
commute	I-DISEASE
to	0
and	0
from	I-DISEASE
work	I-DISEASE
.	0

The	I-DISEASE
sleep	0
disorder	0
occurs	0
despite	0
attempts	I-DISEASE
to	I-DISEASE
optimize	0
environmental	0
conditions	I-DISEASE
for	I-DISEASE
sleep	0
.	0

The	I-DISEASE
condition	0
usually	I-DISEASE
persists	I-DISEASE
only	0
for	I-DISEASE
the	0
duration	0
of	I-DISEASE
the	0
shift	I-DISEASE
work	I-DISEASE
schedule	I-DISEASE
.	0

However	I-DISEASE
,	I-DISEASE
in	I-DISEASE
some	I-DISEASE
individuals	I-DISEASE
,	I-DISEASE
the	0
sleep	0
disturbance	0
may	0
persist	I-DISEASE
beyond	I-DISEASE
the	0
duration	0
of	I-DISEASE
shift	0
work	I-DISEASE
.	0

Associated	I-DISEASE
Features	I-DISEASE
Early	0
morning	0
work	I-DISEASE
shifts	I-DISEASE
starting	I-DISEASE
between	0
4:00	0
a.m.	0
and	0
7:00	0
a.m.	0
can	0
also	0
be	I-DISEASE
asso-	0
ciated	I-DISEASE
with	B-DISEASE
complaints	0
of	I-DISEASE
difficulty	0
in	I-DISEASE
sleep	0
initiation	0
as	0
well	I-DISEASE
as	0
difficulty	0
awakening	0
.	0

Circadian	I-DISEASE
Rhythm	0
Sleep	I-DISEASE
-	I-DISEASE
Wake	I-DISEASE
Disorders	0
Permanent	0
evening	I-DISEASE
shifts	B-DISEASE
may	0
be	I-DISEASE
primarily	I-DISEASE
associated	0
with	0
sleep	0
maintenance	I-DISEASE
dif-	0
ficulty	I-DISEASE
.	0

Excessive	I-DISEASE
sleepiness	0
usually	I-DISEASE
occurs	0
during	I-DISEASE
work	I-DISEASE
shifts	0
(	I-DISEASE
mainly	0
night	I-DISEASE
,	I-DISEASE
early	0
morning	0
,	I-DISEASE
and	0
rotating	0
shifts	0
)	0
,	0
often	0
accompanied	0
by	I-DISEASE
the	I-DISEASE
need	0
to	I-DISEASE
nap	I-DISEASE
and	0
by	I-DISEASE
impaired	I-DISEASE
mental	0
ability	0
due	I-DISEASE
to	I-DISEASE
the	0
reduced	0
alertness	0
.	0

Reduced	I-DISEASE
alertness	I-DISEASE
and	0
increased	0
fatigue	I-DISEASE
throughout	0
the	0
waking	0
period	I-DISEASE
may	I-DISEASE
be	I-DISEASE
associated	0
with	0
reduced	0
performance	0
capacity	0
,	0
and	0
with	I-DISEASE
consequences	I-DISEASE
for	I-DISEASE
safety	I-DISEASE
.	0

Also	I-DISEASE
,	I-DISEASE
major	I-DISEASE
portions	I-DISEASE
of	I-DISEASE
free	I-DISEASE
time	I-DISEASE
may	I-DISEASE
have	0
to	0
be	I-DISEASE
used	0
for	I-DISEASE
recovery	I-DISEASE
of	I-DISEASE
sleep	0
,	I-DISEASE
resulting	I-DISEASE
in	0
adverse	0
social	I-DISEASE
consequences	I-DISEASE
.	0

When	I-DISEASE
compared	I-DISEASE
with	0
shift	0
workers	0
without	0
shift	0
work	I-DISEASE
disorder	0
,	0
patients	0
with	I-DISEASE
shift	I-DISEASE
work	I-DISEASE
disorder	0
report	0
greater	I-DISEASE
mood	I-DISEASE
problems	0
,	0
such	0
as	0
impatience	0
,	I-DISEASE
avoidance	0
of	I-DISEASE
interaction	0
with	I-DISEASE
coworkers	I-DISEASE
,	I-DISEASE
a	0
higher	0
risk	0
of	I-DISEASE
depression	0
,	0
impaired	0
social	0
functioning	0
,	I-DISEASE
and	0
lower	0
coping	I-DISEASE
skills	0
.	0

Patients	I-DISEASE
with	0
shift	0
work	I-DISEASE
disorder	I-DISEASE
also	0
have	I-DISEASE
a	0
higher	0
risk	0
of	I-DISEASE
subjective	I-DISEASE
health	I-DISEASE
complaints	0
,	I-DISEASE
ulcers	0
,	0
and	0
substance	I-DISEASE
abuse	I-DISEASE
.	0

Risk	I-DISEASE
for	I-DISEASE
sleepiness	0
-	0
related	0
errors	I-DISEASE
and	0
accidents	0
are	0
highest	0
at	I-DISEASE
night	I-DISEASE
,	I-DISEASE
especially	0
in	0
the	0
early	0
morning	0
hours	0
.	0

Drowsy	I-DISEASE
driving	0
accident	0
risk	0
is	I-DISEASE
highest	I-DISEASE
in	0
the	0
morning	0
hours	I-DISEASE
when	I-DISEASE
night	I-DISEASE
shift	0
workers	0
commute	I-DISEASE
home	0
and	0
early	0
morning	0
workers	0
commute	I-DISEASE
to	I-DISEASE
work	I-DISEASE
.	0

Clinical	I-DISEASE
and	0
Pathophysiological	I-DISEASE
Subtypes	I-DISEASE
There	0
are	I-DISEASE
substantial	I-DISEASE
individual	I-DISEASE
differences	I-DISEASE
in	I-DISEASE
the	0
ability	I-DISEASE
to	0
adjust	0
to	I-DISEASE
shift	0
work	I-DISEASE
.	0

However	I-DISEASE
,	I-DISEASE
mechanisms	0
underlying	0
these	0
individual	I-DISEASE
differences	I-DISEASE
are	I-DISEASE
not	0
known	0
.	0

Requirement	I-DISEASE
of	I-DISEASE
extended	0
work	I-DISEASE
hours	I-DISEASE
,	I-DISEASE
such	0
as	0
on	0
-	I-DISEASE
call	I-DISEASE
overnight	I-DISEASE
duty	0
and	0
long	I-DISEASE
-	I-DISEASE
duration	0
work	0
shifts	B-DISEASE
that	0
include	I-DISEASE
work	I-DISEASE
hours	I-DISEASE
at	I-DISEASE
night	0
,	I-DISEASE
represents	I-DISEASE
a	0
specific	I-DISEASE
clinical	0
subtype	I-DISEASE
.	0

In	I-DISEASE
addition	0
to	0
the	0
circadian	0
misalignment	0
(	0
having	0
to	I-DISEASE
work	I-DISEASE
during	I-DISEASE
the	0
night	0
)	0
,	I-DISEASE
sleep	0
loss	0
and	0
fatigue	I-DISEASE
associated	0
with	I-DISEASE
prolonged	0
continuous	I-DISEASE
work	0
may	I-DISEASE
increase	I-DISEASE
the	I-DISEASE
severity	0
of	I-DISEASE
excessive	0
sleepiness	0
and	0
performance	0
impairments	0
.	0

Demographics	I-DISEASE
The	I-DISEASE
prevalence	I-DISEASE
of	I-DISEASE
shift	0
work	I-DISEASE
disorder	0
depends	I-DISEASE
on	0
the	I-DISEASE
prevalence	I-DISEASE
of	I-DISEASE
shift	0
work	I-DISEASE
in	I-DISEASE
the	0
population	0
.	0

It	I-DISEASE
has	0
been	I-DISEASE
estimated	0
that	0
approximately	I-DISEASE
20	0
%	0
of	I-DISEASE
the	0
workforce	I-DISEASE
in	I-DISEASE
indus-	I-DISEASE
trialized	0
countries	I-DISEASE
is	0
employed	0
in	I-DISEASE
a	0
job	0
that	0
requires	I-DISEASE
shift	I-DISEASE
work	0
.	I-DISEASE

Although	I-DISEASE
the	0
actual	0
prevalence	I-DISEASE
of	0
clinically	0
significant	0
sleep	0
disturbance	0
and	0
excessive	0
daytime	I-DISEASE
sleepiness	0
due	0
to	I-DISEASE
work	I-DISEASE
schedules	0
is	0
unknown	I-DISEASE
,	0
the	0
total	0
number	0
of	I-DISEASE
night	0
-	I-DISEASE
shift	0
workers	I-DISEASE
suggests	I-DISEASE
that	0
an	0
estimated	0
prevalence	0
of	I-DISEASE
2	0
%	0
to	0
5	0
%	0
of	I-DISEASE
the	0
general	0
population	0
is	0
reasonable	I-DISEASE
.	0

The	I-DISEASE
prevalence	0
of	I-DISEASE
shift	0
work	I-DISEASE
disorder	I-DISEASE
among	0
rotating-	I-DISEASE
and	0
night	0
-	I-DISEASE
shift	I-DISEASE
workers	I-DISEASE
has	0
been	I-DISEASE
estimated	0
to	I-DISEASE
be	0
between	0
~10	0
%	0
and	0
38	0
%	0
.	0

These	0
figures	I-DISEASE
do	0
not	0
,	0
however	I-DISEASE
,	I-DISEASE
include	I-DISEASE
individuals	I-DISEASE
with	0
early	0
morning	I-DISEASE
or	I-DISEASE
split	I-DISEASE
shift	0
work	I-DISEASE
,	I-DISEASE
which	I-DISEASE
may	0
be	0
other	I-DISEASE
at	I-DISEASE
-	0
risk	0
groups	0
.	0

There	I-DISEASE
is	0
no	0
known	I-DISEASE
sex	0
or	I-DISEASE
racial	I-DISEASE
difference	I-DISEASE
in	0
vulnerability	I-DISEASE
.	0

Predisposing	I-DISEASE
and	0
Precipitating	I-DISEASE
Factors	0
Depending	I-DISEASE
on	0
the	B-DISEASE
type	I-DISEASE
of	I-DISEASE
shift	0
,	I-DISEASE
circadian	0
preference	0
may	0
influence	0
the	0
ability	0
to	I-DISEASE
adjust	0
to	I-DISEASE
or	0
tolerate	I-DISEASE
shift	0
work	I-DISEASE
.	0

For	I-DISEASE
example	0
,	0
individuals	I-DISEASE
described	0
as	0
morning	0
types	I-DISEASE
obtain	0
shorter	0
daytime	0
sleep	0
after	I-DISEASE
a	0
night	0
shift	0
.	0

Persons	I-DISEASE
with	I-DISEASE
comorbid	I-DISEASE
medical	0
,	0
psychiat-	0
ric	I-DISEASE
,	0
and	0
other	I-DISEASE
sleep	I-DISEASE
disorders	0
such	0
as	0
sleep	0
apnea	0
and	0
individuals	0
with	I-DISEASE
a	0
strong	I-DISEASE
need	0
for	I-DISEASE
stable	I-DISEASE
hours	I-DISEASE
of	I-DISEASE
sleep	0
may	0
be	0
at	I-DISEASE
particular	I-DISEASE
risk	0
.	0

Social	I-DISEASE
pressures	I-DISEASE
before	0
and	0
after	0
a	0
work	I-DISEASE
shift	0
also	0
contribute	0
to	0
short	0
sleep	I-DISEASE
durations	0
in	I-DISEASE
shift	0
workers	I-DISEASE
(	0
e.g.	0
,	0
social	0
inter-	I-DISEASE
actions	I-DISEASE
with	0
family	I-DISEASE
and	0
friends	0
,	0
domestic	0
obligations	0
,	0
a	0
second	I-DISEASE
job	0
,	0
and	0
leisure	0
activ-	0
ities	0
)	0
.	0

Social	I-DISEASE
pressures	I-DISEASE
also	0
diminish	0
the	0
desire	I-DISEASE
or	B-DISEASE
willingness	0
to	0
maintain	0
a	I-DISEASE
consis-	I-DISEASE
tent	I-DISEASE
daytime	I-DISEASE
sleep	0
schedule	0
on	0
days	0
off	I-DISEASE
,	I-DISEASE
thereby	I-DISEASE
reducing	I-DISEASE
the	0
likelihood	0
of	I-DISEASE
circadian	I-DISEASE
adjustment	B-DISEASE
.	0

Familial	I-DISEASE
Patterns	I-DISEASE
Not	I-DISEASE
applicable	0
or	B-DISEASE
known	0
.	0

Onset	I-DISEASE
,	0
Course	0
,	0
and	0
Complications	0

The	I-DISEASE
condition	0
is	0
closely	I-DISEASE
linked	0
to	0
work	I-DISEASE
schedules	I-DISEASE
and	0
typically	0
remits	0
when	I-DISEASE
the	0
major	I-DISEASE
sleep	0
episode	I-DISEASE
is	0
scheduled	0
at	I-DISEASE
a	0
conventional	I-DISEASE
time	0
.	0

Because	I-DISEASE
there	I-DISEASE
are	0
so	0
many	0
different	I-DISEASE
work	I-DISEASE
schedules	I-DISEASE
,	0
ranging	0
from	I-DISEASE
an	0
occasional	I-DISEASE
overnight	I-DISEASE
shift	0
to	I-DISEASE
regular	I-DISEASE
night	I-DISEASE
work	0
,	0
the	0
course	I-DISEASE
is	I-DISEASE
quite	0
variable	I-DISEASE
.	0

Because	I-DISEASE
shift	0
work	I-DISEASE
is	I-DISEASE
often	0
combined	0
with	I-DISEASE
extended	I-DISEASE
hours	I-DISEASE
of	I-DISEASE
duty	0
,	I-DISEASE
fatigue	I-DISEASE
can	0
be	0
a	0
complicating	I-DISEASE
factor	I-DISEASE
.	0

Circadian	I-DISEASE
adaptation	0
is	I-DISEASE
often	0
counteracted	I-DISEASE
by	I-DISEASE
exposure	0
to	I-DISEASE
light	0
at	I-DISEASE
the	0
wrong	I-DISEASE
time	I-DISEASE
of	0
the	0
day	I-DISEASE
and	0
the	0
tendency	0
of	I-DISEASE
most	I-DISEASE
workers	0
to	I-DISEASE
resume	0
full	I-DISEASE
daytime	I-DISEASE
activities	I-DISEASE
and	0
nighttime	0
sleep	0
during	I-DISEASE
weekends	0
and	0
vacations	0
.	0

It	I-DISEASE
has	0
been	I-DISEASE
hypothesized	I-DISEASE
that	0
in	0
some	I-DISEASE
individuals	I-DISEASE
,	I-DISEASE
the	I-DISEASE
condition	0
may	I-DISEASE
lead	0
to	I-DISEASE
chronic	0
sleep	0
disturbances	I-DISEASE
.	0

Complications	I-DISEASE
may	0
include	I-DISEASE
exacerbation	I-DISEASE
of	I-DISEASE
gastrointestinal	I-DISEASE
,	I-DISEASE
met-	0
abolic	0
,	0
reproductive	I-DISEASE
,	0
neoplastic	0
,	I-DISEASE
and	0
cardiovascular	I-DISEASE
disorders	0
.	0

Disruptions	I-DISEASE
of	0
social	I-DISEASE
and	0
family	I-DISEASE
life	0
are	0
frequent	I-DISEASE
.	0

Drug	I-DISEASE
and	0
alcohol	0
dependency	0
may	I-DISEASE
result	0
from	I-DISEASE
attempts	0
to	0
improve	0
the	0
sleep	I-DISEASE
and	0
wakefulness	0
disturbances	I-DISEASE
produced	0
by	0
shift	0
work	I-DISEASE
.	0

Fatigue	I-DISEASE
and	0
excessive	0
sleepiness	I-DISEASE
due	I-DISEASE
to	0
the	0
combination	I-DISEASE
of	I-DISEASE
sleep	I-DISEASE
loss	I-DISEASE
and	0
circadian	I-DISEASE
misalignment	I-DISEASE
pose	I-DISEASE
important	0
safety	I-DISEASE
concerns	I-DISEASE
.	0

The	I-DISEASE
level	0
of	I-DISEASE
alertness	I-DISEASE
required	I-DISEASE
of	I-DISEASE
the	I-DISEASE
worker	I-DISEASE
,	0
in	I-DISEASE
addi-	I-DISEASE
tion	0
to	I-DISEASE
the	I-DISEASE
intensity	0
of	I-DISEASE
symptoms	I-DISEASE
,	0
needs	I-DISEASE
to	0
be	0
taken	0
into	I-DISEASE
account	0
when	0
evaluating	0
the	0
disorder	B-DISEASE
.	0

For	I-DISEASE
example	0
,	0
the	0
threshold	0
for	0
intervention	0
may	I-DISEASE
be	0
lower	0
for	0
workers	0
whose	I-DISEASE
performance	0
is	0
critical	0
for	0
personal	I-DISEASE
or	0
public	0
safety	I-DISEASE
(	I-DISEASE
for	I-DISEASE
example	0
,	I-DISEASE
health	I-DISEASE
care	0
workers	0
or	0
nuclear	0
power	0
plant	0
or	0
public	0
transport	0
operators	0
)	0
.	0

Developmental	I-DISEASE
Issues	0
Not	I-DISEASE
applicable	0
or	I-DISEASE
known	I-DISEASE
.	0

Circadian	I-DISEASE
Rhythm	0
Sleep	I-DISEASE
-	I-DISEASE
Wake	I-DISEASE
Disorders	0
Circadian	0
Rhythm	0
Sleep	I-DISEASE
-	I-DISEASE
Wake	0
Disorders	0
Pathology	I-DISEASE
and	0
Pathophysiology	I-DISEASE

The	I-DISEASE
condition	I-DISEASE
is	0
thought	I-DISEASE
to	0
be	I-DISEASE
directly	I-DISEASE
related	B-DISEASE
to	0
circadian	0
misalignment	0
and	0
sleep	0
loss	I-DISEASE
.	I-DISEASE

The	I-DISEASE
sleep	0
disturbance	0
is	I-DISEASE
generated	0
by	I-DISEASE
a	0
circadian	0
alerting	0
process	0
that	I-DISEASE
corre-	I-DISEASE
sponds	0
with	0
the	0
time	0
that	0
the	0
worker	I-DISEASE
needs	I-DISEASE
to	0
sleep	0
.	0

The	I-DISEASE
excessive	0
sleepiness	0
during	I-DISEASE
the	0
night	0
and	0
early	0
morning	0
appears	0
to	I-DISEASE
be	I-DISEASE
partly	I-DISEASE
related	0
to	0
cumulative	I-DISEASE
sleep	I-DISEASE
loss	0
and	0
partly	I-DISEASE
due	0
to	0
a	0
decreased	I-DISEASE
circadian	I-DISEASE
alerting	I-DISEASE
signal	I-DISEASE
that	0
corresponds	I-DISEASE
with	I-DISEASE
the	0
work	I-DISEASE
time	0
and	0
the	0
commute	I-DISEASE
to	0
and	0
from	0
work	I-DISEASE
.	0

Tolerance	I-DISEASE
to	I-DISEASE
night	0
work	I-DISEASE
varies	I-DISEASE
considerably	0
and	0
may	0
involve	0
differences	I-DISEASE
in	I-DISEASE
the	0
degree	I-DISEASE
of	I-DISEASE
circadian	I-DISEASE
adaptation	0
(	0
“	I-DISEASE
clock	0
resetting	0
”	I-DISEASE
)	0
to	I-DISEASE
a	0
night	0
-	0
work	I-DISEASE
,	0
day	I-DISEASE
-	I-DISEASE
sleep	0
schedule	0
.	0

Alternatively	I-DISEASE
,	I-DISEASE
tolerance	0
may	I-DISEASE
be	0
related	B-DISEASE
to	I-DISEASE
individual	I-DISEASE
differences	I-DISEASE
in	0
response	0
to	I-DISEASE
circadian	I-DISEASE
and	0
homeostatic	I-DISEASE
influences	0
on	0
sleep	0
and	0
wakeful-	0
ness	0
regulation	I-DISEASE
.	0

Environmental	I-DISEASE
and	0
social	0
factors	I-DISEASE
may	0
exacerbate	I-DISEASE
sleep	0
loss	0
associated	0
with	I-DISEASE
shift	I-DISEASE
work	I-DISEASE
schedules	I-DISEASE
.	0

Objective	I-DISEASE
Findings	I-DISEASE

The	I-DISEASE
condition	I-DISEASE
can	0
usually	I-DISEASE
be	0
diagnosed	I-DISEASE
by	I-DISEASE
history	I-DISEASE
.	0

Sleep	I-DISEASE
logs	I-DISEASE
and	0
actigraphy	0
are	0
rec-	0
ommended	0
to	I-DISEASE
demonstrate	0
a	0
disrupted	I-DISEASE
sleep	I-DISEASE
-	0
wake	0
pattern	0
consistent	0
with	I-DISEASE
shift	0
work	I-DISEASE
disorder	I-DISEASE
.	0

Polysomnographic	I-DISEASE
recordings	I-DISEASE
,	0
while	I-DISEASE
not	0
required	0
for	0
the	0
diagnosis	I-DISEASE
,	I-DISEASE
are	0
useful	0
if	0
the	0
etiology	0
of	I-DISEASE
the	0
sleep	0
disturbance	I-DISEASE
is	0
in	I-DISEASE
question	0
(	I-DISEASE
for	0
example	0
to	I-DISEASE
rule	B-DISEASE
out	0
sleep	0
apnea	0
or	0
narcolepsy	0
)	0
.	0

Polysomnography	I-DISEASE
during	I-DISEASE
a	0
typical	0
daytime	0
sleep	0
episode	I-DISEASE
after	0
a	I-DISEASE
work	I-DISEASE
shift	0
also	0
can	0
be	I-DISEASE
useful	0
to	0
determine	0
the	0
severity	0
of	I-DISEASE
the	0
sleep	I-DISEASE
disruption	0
,	I-DISEASE
although	0
this	I-DISEASE
is	I-DISEASE
undertaken	0
almost	0
exclusively	B-DISEASE
for	I-DISEASE
research	I-DISEASE
studies	I-DISEASE
of	0
shift	0
work	I-DISEASE
disor-	0
der	0
.	0

Polysomnography	I-DISEASE
may	I-DISEASE
demonstrate	I-DISEASE
impaired	I-DISEASE
sleep	0
quality	0
,	0
with	I-DISEASE
prolonged	I-DISEASE
sleep	I-DISEASE
latency	I-DISEASE
,	I-DISEASE
sleep	I-DISEASE
maintenance	0
difficulty	0
,	I-DISEASE
or	0
shortened	0
total	I-DISEASE
sleep	0
time	I-DISEASE
,	0
depending	I-DISEASE
on	0
the	I-DISEASE
timing	I-DISEASE
of	I-DISEASE
the	0
sleep	0
episode	I-DISEASE
in	I-DISEASE
relation	0
to	0
the	0
underlying	0
phase	0
of	I-DISEASE
the	0
circadian	0
timing	I-DISEASE
system	I-DISEASE
.	0

The	I-DISEASE
sleep	0
episode	0
may	I-DISEASE
be	0
fragmented	I-DISEASE
,	I-DISEASE
with	0
frequent	0
arousals	0
and	0
awaken-	0
ings	0
.	0

The	I-DISEASE
Multiple	0
Sleep	0
Latency	0
Test	I-DISEASE
(	I-DISEASE
MSLT	I-DISEASE
)	0
may	I-DISEASE
demonstrate	I-DISEASE
excessive	I-DISEASE
sleepiness	I-DISEASE
during	I-DISEASE
the	0
time	I-DISEASE
of	I-DISEASE
the	0
work	I-DISEASE
shift	0
.	0

If	I-DISEASE
available	I-DISEASE
,	0
measures	0
of	0
the	0
unmasked	I-DISEASE
melatonin	0
rhythm	I-DISEASE
are	0
useful	0
to	I-DISEASE
indicate	I-DISEASE
the	0
degree	I-DISEASE
of	I-DISEASE
circadian	0
misalignment	0
.	0

Differential	I-DISEASE
Diagnosis	0

The	I-DISEASE
excessive	0
sleepiness	0
should	0
be	I-DISEASE
differentiated	0
from	I-DISEASE
that	0
caused	0
by	I-DISEASE
other	0
primary	I-DISEASE
sleep	0
disorders	0
such	0
as	0
obstructive	I-DISEASE
sleep	0
apnea	0
or	I-DISEASE
narcolepsy	0
.	0

Insufficient	I-DISEASE
sleep	0
related	B-DISEASE
to	I-DISEASE
conflicting	0
daytime	0
activities	I-DISEASE
(	I-DISEASE
for	0
example	I-DISEASE
,	I-DISEASE
child	0
care	I-DISEASE
)	0
or	I-DISEASE
from	0
environmental	0
interference	I-DISEASE
with	0
sleep	0
(	I-DISEASE
for	0
example	0
,	0
daytime	I-DISEASE
noise	0
)	0
often	0
contributes	0
to	0
sleepiness	0
.	0

Sometimes	I-DISEASE
patients	0
with	0
DSWPD	I-DISEASE
may	0
adopt	0
a	0
night	0
-	0
work	I-DISEASE
schedule	I-DISEASE
that	0
is	0
more	0
con-	0
gruent	0
with	0
their	0
sleep	0
preferences	0
.	0

Insomnia	I-DISEASE
and	0
excessive	0
sleepiness	0
may	0
also	0
suggest	I-DISEASE
other	0
persistent	I-DISEASE
circadian	I-DISEASE
rhythm	0
sleep	0
-	I-DISEASE
wake	0
disorders	0
.	0

However	I-DISEASE
,	I-DISEASE
historical	0
informa-	I-DISEASE
tion	0
on	0
the	0
relation	I-DISEASE
between	0
the	I-DISEASE
occurrence	0
of	I-DISEASE
disturbed	0
sleep	0
and	0
work	0
-	0
hour	I-DISEASE
distribu-	0
tion	0
should	0
provide	I-DISEASE
sufficient	I-DISEASE
information	B-DISEASE
to	0
indicate	I-DISEASE
the	I-DISEASE
correct	0
diagnosis	I-DISEASE
.	0

Increasing	I-DISEASE
frustration	I-DISEASE
,	0
negative	I-DISEASE
expectations	I-DISEASE
,	I-DISEASE
and	0
poor	0
sleep	0
hygiene	I-DISEASE
may	I-DISEASE
predispose	0
the	I-DISEASE
person	0
to	0
the	0
development	I-DISEASE
of	I-DISEASE
coexisting	B-DISEASE
chronic	I-DISEASE
insomnia	I-DISEASE
disorder	B-DISEASE
that	0
could	0
persist	I-DISEASE
beyond	0
the	0
shift	0
work	I-DISEASE
schedule	I-DISEASE
(	I-DISEASE
i.e.	0
,	I-DISEASE
shift	0
work	I-DISEASE
may	I-DISEASE
represent	0
a	0
precipitating	0
event	I-DISEASE
that	0
leads	0
to	I-DISEASE
chronic	0
problems	0
with	I-DISEASE
insomnia	I-DISEASE
)	0
.	0

Drug	I-DISEASE
and	0
alcohol	0
abuse	I-DISEASE
or	0
dependency	0
may	I-DISEASE
result	0
from	0
efforts	I-DISEASE
to	I-DISEASE
treat	I-DISEASE
the	0
sleep	0
disturbance	I-DISEASE
.	0

Unresolved	I-DISEASE
Issues	0
and	0
Further	I-DISEASE
Directions	0

Although	I-DISEASE
there	I-DISEASE
is	0
sufficient	I-DISEASE
information	0
regarding	0
the	0
prevalence	I-DISEASE
of	I-DISEASE
shift	0
work	I-DISEASE
in	I-DISEASE
indus-	I-DISEASE
trialized	0
populations	I-DISEASE
,	0
less	0
information	0
is	0
available	I-DISEASE
regarding	0
the	0
actual	I-DISEASE
prevalence	0
of	I-DISEASE
shift	0
work	I-DISEASE
disorder	0
and	0
its	I-DISEASE
impact	0
on	0
health	0
and	0
safety	0
.	0

Further	I-DISEASE
research	0
is	0
needed	0
to	0
improve	I-DISEASE
the	0
definition	I-DISEASE
of	I-DISEASE
what	0
constitutes	I-DISEASE
shift	0
work	I-DISEASE
disorder	I-DISEASE
,	0
to	I-DISEASE
develop	I-DISEASE
diagnostic	I-DISEASE
tools	0
for	0
shift	0
work	I-DISEASE
disorder	I-DISEASE
,	I-DISEASE
to	I-DISEASE
determine	I-DISEASE
the	0
prevalence	I-DISEASE
of	I-DISEASE
shift	0
work	I-DISEASE
disorder	B-DISEASE
using	I-DISEASE
diagnostic	0
criteria	I-DISEASE
,	I-DISEASE
to	I-DISEASE
elucidate	0
the	0
burden	I-DISEASE
of	0
shift	0
work	I-DISEASE
disorder	I-DISEASE
over	I-DISEASE
and	0
above	0
that	0
which	0
may	0
be	I-DISEASE
due	0
to	I-DISEASE
shift	0
work	I-DISEASE
in	0
general	0
,	0
to	0
investigate	I-DISEASE
mechanisms	I-DISEASE
underlying	0
the	0
health	I-DISEASE
and	0
safety	I-DISEASE
consequences	I-DISEASE
of	I-DISEASE
shift	0
work	I-DISEASE
disorder	I-DISEASE
,	I-DISEASE
and	0
to	0
determine	0
which	0
shift	0
workers	0
are	I-DISEASE
at	I-DISEASE
greatest	I-DISEASE
risk	0
of	I-DISEASE
shift	0
work	I-DISEASE
disorder	I-DISEASE
.	0

Furthermore	I-DISEASE
,	I-DISEASE
there	I-DISEASE
is	I-DISEASE
limited	I-DISEASE
information	0
on	0
the	I-DISEASE
role	0
of	I-DISEASE
age	I-DISEASE
,	I-DISEASE
sex	I-DISEASE
,	I-DISEASE
and	0
circadian	I-DISEASE
chronotype	I-DISEASE
on	0
the	0
vulnerability	I-DISEASE
to	0
shift	0
work	I-DISEASE
disorder	0
.	I-DISEASE

Bibliography	0
Akerstedt	0
T.	0
Shift	0
work	I-DISEASE
and	0
disturbed	0
sleep	0
/	0
wakefulness	0
.	0

Occup	I-DISEASE
Med	0
2003;53:89–94	0
.	I-DISEASE

Ancoli	0
-	I-DISEASE
Israel	0
S	I-DISEASE
,	I-DISEASE
Cole	I-DISEASE
R	I-DISEASE
,	0
Alessi	0
C	I-DISEASE
,	0
Chambers	0
M	I-DISEASE
,	I-DISEASE
Moorcroft	0
W	I-DISEASE
,	0
Pollak	0
C.	0

The	I-DISEASE
role	0
of	I-DISEASE
actigraphy	0
in	I-DISEASE
the	0
study	0
of	I-DISEASE
sleep	0
and	0
circadian	I-DISEASE
rhythms	0
.	0

Sleep	I-DISEASE
2003;26:342–92	0
.	0

Boggild	I-DISEASE
H	0
,	I-DISEASE
Knutsson	I-DISEASE
A.	0
Shift	I-DISEASE
work	I-DISEASE
,	0
risk	0
factors	I-DISEASE
and	0
cardiovascular	0
disease	I-DISEASE
.	0

Scand	I-DISEASE
J	0
Work	I-DISEASE
Environ	0
Health	0
1999;25:85–99	0
.	0

Costa	I-DISEASE
G.	I-DISEASE
Shift	I-DISEASE
work	I-DISEASE
and	0
occupational	I-DISEASE
medicine	0
:	0
an	0
overview	0
.	I-DISEASE

Occup	I-DISEASE
Med	0
2003;53:83–8	0
.	I-DISEASE

Drake	I-DISEASE
CL	I-DISEASE
,	I-DISEASE
Roehrs	I-DISEASE
T	0
,	0
Richardson	0
G	I-DISEASE
,	I-DISEASE
Walsh	I-DISEASE
JK	I-DISEASE
,	I-DISEASE
Roth	I-DISEASE
T.	0
Shift	0
work	I-DISEASE
sleep	0
disorder	I-DISEASE
:	0
prevalence	I-DISEASE
and	0
consequences	I-DISEASE
beyond	0
that	0
of	I-DISEASE
symptomatic	0
day	0
workers	0
.	0

Sleep	I-DISEASE
2004;27:1453–62	0
.	0

Drake	I-DISEASE
CL	I-DISEASE
,	I-DISEASE
Wright	0
KP	I-DISEASE
Jr.	I-DISEASE
Shift	0
work	I-DISEASE
,	I-DISEASE
shift	I-DISEASE
work	I-DISEASE
disorder	I-DISEASE
,	I-DISEASE
and	0
jet	0
lag	0
.	0

In	I-DISEASE
:	I-DISEASE
Kryger	0
MH	I-DISEASE
,	I-DISEASE
Roth	I-DISEASE
T	0
,	0
Dement	I-DISEASE
WC	I-DISEASE
,	0
eds	I-DISEASE
.	0

Principles	I-DISEASE
and	0
practice	0
of	I-DISEASE
sleep	0
medicine	0
,	I-DISEASE
5th	I-DISEASE
ed	0
.	0

Philadelphia	I-DISEASE
:	0
Elsevier	0
Saunders	0
,	0
2011:784–98	I-DISEASE
.	0

Flo	I-DISEASE
E	0
,	I-DISEASE
Pallesen	0
S	I-DISEASE
,	0
Magerøy	0
N	0
,	0
et	0
al	I-DISEASE
.	I-DISEASE

Shift	I-DISEASE
work	I-DISEASE
disorder	0
in	0
nurses	0
--	0
assessment	0
,	0
prevalence	0
and	0
related	I-DISEASE
health	I-DISEASE
problems	0
.	0

PLoS	0
One	0
2012;7	I-DISEASE
:	0
e33981	0
.	0

Folkard	I-DISEASE
S	I-DISEASE
,	I-DISEASE
Tucker	0
P.	I-DISEASE
Shift	I-DISEASE
work	I-DISEASE
,	I-DISEASE
safety	I-DISEASE
and	0
productivity	I-DISEASE
.	0

Occup	I-DISEASE
Med	0
2003;53:95–101	0
.	I-DISEASE

Horne	I-DISEASE
J	0
,	0
Reyner	I-DISEASE
L.	0
Vehicle	I-DISEASE
accidents	0
related	0
to	0
sleep	0
:	I-DISEASE
a	0
review	0
.	0

Occup	I-DISEASE
Environ	I-DISEASE
Med	0
1999;56:289–94	0
.	0

Knutsson	I-DISEASE
A.	0
Health	0
disorders	0
of	I-DISEASE
shift	0
workers	0
.	0

Occup	I-DISEASE
Environ	I-DISEASE
Med	0
2003;53:103–8	0
.	0

Swanson	I-DISEASE
LM	0
,	0
Arnedt	0
JT	0
,	0
Rosekind	I-DISEASE
MR	0
,	0
Belenky	0
G	0
,	0
Balkin	I-DISEASE
TJ	0
,	I-DISEASE
Drake	I-DISEASE
C.	I-DISEASE
Sleep	I-DISEASE
disorders	0
and	0
work	I-DISEASE
performance	0
:	I-DISEASE
findings	0
from	0
the	0
2008	I-DISEASE
National	0
Sleep	0
Foundation	I-DISEASE
Sleep	0
in	0
America	0
poll	I-DISEASE
.	I-DISEASE

J	I-DISEASE
Sleep	0
Res	0
2011;20:487–94	0
.	I-DISEASE

Waage	I-DISEASE
S	I-DISEASE
,	0
Moen	0
BE	0
,	0
Pallesen	0
S	I-DISEASE
,	0
et	0
al	I-DISEASE
.	I-DISEASE

Shift	I-DISEASE
work	I-DISEASE
disorder	0
among	0
oil	0
rig	0
workers	0
in	0
the	0
North	0
Sea	0
.	0

Sleep	I-DISEASE
2009;32:558–65	I-DISEASE
.	0

Wright	I-DISEASE
KP	0
Jr	I-DISEASE
,	0
Bogan	I-DISEASE
RK	I-DISEASE
,	0
Wyatt	0
JK	I-DISEASE
.	0

Shift	I-DISEASE
work	I-DISEASE
and	0
the	0
assessment	I-DISEASE
and	0
management	0
of	I-DISEASE
shift	0
work	I-DISEASE
disorder	I-DISEASE
(	I-DISEASE
SWD	I-DISEASE
)	0
.	0

Sleep	I-DISEASE
Med	I-DISEASE
Rev	I-DISEASE
2013;17:41–54	0
.	0

Circadian	I-DISEASE
Rhythm	0
Sleep	I-DISEASE
-	I-DISEASE
Wake	I-DISEASE
Disorders	0
Circadian	0
Rhythm	0
Sleep	I-DISEASE
-	I-DISEASE
Wake	0
Disorders	0
Jet	0
Lag	I-DISEASE
Disorder	I-DISEASE
Jet	0
lag	0
,	I-DISEASE
time	0
zone	I-DISEASE
change	I-DISEASE
syndrome	0
,	0
jet	0
lag	0
syndrome	0
,	I-DISEASE
jet	I-DISEASE
lag	0
type	I-DISEASE
.	I-DISEASE

ICD-9	I-DISEASE
-	0
CM	0
code	0
:	0
327.35	0
ICD-10	0
-	I-DISEASE
CM	0
code	0
:	0

G47.25	I-DISEASE
Alternate	0
Names	I-DISEASE
Diagnostic	I-DISEASE
Criteria	0
Criteria	I-DISEASE
A	0
-	I-DISEASE
C	0
must	0
be	I-DISEASE
met	0
A.	0

There	I-DISEASE
is	I-DISEASE
a	0
complaint	I-DISEASE
of	0
insomnia	I-DISEASE
or	B-DISEASE
excessive	0
daytime	0
sleepiness	0
,	I-DISEASE
accompanied	0
by	I-DISEASE
a	0
reduction	I-DISEASE
of	0
total	0
sleep	0
time	0
,	I-DISEASE
associated	0
with	I-DISEASE
transmeridian	0
jet	I-DISEASE
travel	I-DISEASE
across	I-DISEASE
at	I-DISEASE
least	0
two	0
time	I-DISEASE
zones	0
.	0

B.	0
There	0
is	I-DISEASE
associated	0
impairment	I-DISEASE
of	I-DISEASE
daytime	0
function	I-DISEASE
,	I-DISEASE
general	I-DISEASE
malaise	I-DISEASE
,	I-DISEASE
or	I-DISEASE
somatic	0
symptoms	I-DISEASE
(	I-DISEASE
e.g.	0
,	0
gastrointestinal	I-DISEASE
disturbance	I-DISEASE
)	0
within	I-DISEASE
one	0
to	I-DISEASE
two	0
days	0
after	0
travel	0
.	0

C.	I-DISEASE

The	I-DISEASE
sleep	0
disturbance	0
is	I-DISEASE
not	0
better	0
explained	I-DISEASE
by	I-DISEASE
another	I-DISEASE
current	0
sleep	0
disorder	0
,	I-DISEASE
medical	I-DISEASE
or	0
neurological	0
disorder	0
,	0
mental	0
disorder	0
,	I-DISEASE
medication	0
use	0
,	I-DISEASE
or	0
substance	I-DISEASE
use	0
disorder	I-DISEASE
.	0

Essential	I-DISEASE
Features	I-DISEASE
Jet	0
lag	0
disorder	I-DISEASE
is	0
characterized	0
by	0
a	0
temporary	0
mismatch	0
between	0
the	0
timing	I-DISEASE
of	I-DISEASE
the	0
sleep	0
and	0
wake	0
cycle	0
generated	0
by	I-DISEASE
the	0
endogenous	0
circadian	I-DISEASE
clock	I-DISEASE
and	0
that	0
of	I-DISEASE
the	0
sleep	0
and	0
wake	0
pattern	0
required	0
by	0
a	0
change	0
in	I-DISEASE
time	0
zone	I-DISEASE
.	0

Individuals	I-DISEASE
complain	I-DISEASE
of	I-DISEASE
disturbed	0
sleep	0
,	I-DISEASE
sleepiness	0
and	0
fatigue	I-DISEASE
,	0
and	0
impaired	I-DISEASE
daytime	I-DISEASE
function	0
.	0

The	I-DISEASE
severity	I-DISEASE
and	0
duration	0
of	0
symptoms	I-DISEASE
is	I-DISEASE
dependent	I-DISEASE
on	0
the	0
number	0
of	I-DISEASE
time	I-DISEASE
zones	I-DISEASE
traveled	0
,	I-DISEASE
the	0
ability	I-DISEASE
to	0
sleep	0
while	0
traveling	I-DISEASE
,	I-DISEASE
exposure	0
to	0
appropriate	I-DISEASE
circadian	0
times	0
cues	I-DISEASE
in	I-DISEASE
the	0
new	0
environment	0
,	I-DISEASE
tolerance	I-DISEASE
to	I-DISEASE
circadian	0
misalignment	0
when	0
awake	0
during	I-DISEASE
the	0
bio-	I-DISEASE
logical	I-DISEASE
night	0
,	0
and	0
the	0
direction	0
of	I-DISEASE
the	0
travel	I-DISEASE
.	0

Eastward	I-DISEASE
travel	0
(	I-DISEASE
requiring	0
advancing	I-DISEASE
circadian	I-DISEASE
rhythms	0
and	0
sleep	0
-	I-DISEASE
wake	I-DISEASE
hours	I-DISEASE
)	0
is	I-DISEASE
usually	I-DISEASE
more	I-DISEASE
difficult	0
to	0
adjust	I-DISEASE
to	I-DISEASE
than	I-DISEASE
westward	I-DISEASE
travel	I-DISEASE
.	I-DISEASE

Associated	I-DISEASE
Features	I-DISEASE

In	I-DISEASE
addition	0
to	0
sleep	0
disturbance	0
and	0
decreased	I-DISEASE
daytime	I-DISEASE
alertness	0
,	0
associated	0
features	I-DISEASE
may	I-DISEASE
include	0
general	0
malaise	I-DISEASE
and	0
gastrointestinal	I-DISEASE
symptoms	I-DISEASE
.	0

Numerous	I-DISEASE
other	I-DISEASE
variables	I-DISEASE
related	0
to	0
travel	0
,	I-DISEASE
such	I-DISEASE
as	0
sleep	0
loss	0
,	I-DISEASE
decreased	I-DISEASE
mobility	I-DISEASE
,	0
and	0
alcohol	I-DISEASE
and/or	0
caffeine	0
intake	0
,	I-DISEASE
contribute	0
to	0
the	I-DISEASE
overall	0
fatigue	I-DISEASE
.	0

Daytime	I-DISEASE
sleepiness	0
can	0
lead	0
to	I-DISEASE
memory	0
diffi-	0
culties	I-DISEASE
,	0
problems	0
concentrating	I-DISEASE
,	I-DISEASE
driving	0
and	0
flying	0
,	0
and	0
to	0
impaired	I-DISEASE
decision	I-DISEASE
-	0
making	0
.	0

Sleepiness	I-DISEASE
,	0
sleep	0
disturbance	0
and	0
circadian	0
misalignment	0
associated	0
with	I-DISEASE
jet	I-DISEASE
lag	0
may	I-DISEASE
also	I-DISEASE
impair	0
athletic	0
performance	0
.	0

Effects	I-DISEASE
of	I-DISEASE
jet	0
lag	0
not	0
only	I-DISEASE
affect	0
travelers	0
,	0
but	0
also	0
can	I-DISEASE
have	I-DISEASE
significant	0
consequences	I-DISEASE
for	I-DISEASE
airline	I-DISEASE
pilots	0
and	0
flight	0
attendants	I-DISEASE
.	0

Clinical	I-DISEASE
and	0
Pathophysiological	I-DISEASE
Subtypes	I-DISEASE
There	0
are	0
individual	I-DISEASE
differences	I-DISEASE
in	0
the	0
ability	0
to	I-DISEASE
adjust	0
to	0
rapid	I-DISEASE
shifts	0
in	I-DISEASE
time	0
zones	0
;	I-DISEASE
however	0
,	I-DISEASE
specific	I-DISEASE
clinical	0
subtypes	I-DISEASE
have	0
not	0
been	I-DISEASE
identified	0
.	0

Demographics	I-DISEASE
Jet	0
lag	0
affects	I-DISEASE
all	0
age	I-DISEASE
,	0
sex	0
,	I-DISEASE
and	0
racial	0
groups	0
.	0

Limited	I-DISEASE
available	I-DISEASE
data	0
suggest	I-DISEASE
that	0
older	0
individuals	I-DISEASE
may	0
experience	0
fewer	0
jet	I-DISEASE
lag	0
symptoms	I-DISEASE
compared	0
with	0
younger	0
individu-	I-DISEASE
als	I-DISEASE
.	0

However	I-DISEASE
,	I-DISEASE
the	0
data	I-DISEASE
have	0
limitations	I-DISEASE
and	0
further	I-DISEASE
research	0
is	0
needed	0
to	I-DISEASE
better	I-DISEASE
define	I-DISEASE
the	0
relationship	0
between	0
age	I-DISEASE
and	0
the	0
development	0
of	I-DISEASE
jet	I-DISEASE
lag	0
disorder	I-DISEASE
.	0

There	I-DISEASE
are	0
no	0
studies	I-DISEASE
on	0
the	0
prevalence	0
of	I-DISEASE
jet	0
lag	0
disorder	0
.	0

Predisposing	I-DISEASE
and	0
Precipitating	I-DISEASE
Factors	0
Disturbed	I-DISEASE
sleep	0
and/or	0
shortened	0
sleep	0
duration	0
before	0
and	0
during	I-DISEASE
travel	I-DISEASE
contribute	0
to	I-DISEASE
jet	I-DISEASE
lag	0
symptoms	I-DISEASE
.	0

Prolonged	I-DISEASE
uncomfortable	0
sitting	0
positions	0
,	I-DISEASE
air	I-DISEASE
quality	0
and	0
pressure	0
,	I-DISEASE
stress	I-DISEASE
,	I-DISEASE
and	0
excessive	0
caffeine	0
and	0
alcohol	I-DISEASE
consumption	I-DISEASE
may	I-DISEASE
increase	I-DISEASE
the	0
severity	I-DISEASE
of	0
insomnia	I-DISEASE
and	0
impaired	I-DISEASE
alertness	0
and	0
function	0
associated	0
with	0
transmeridian	I-DISEASE
travel	0
.	0

Eastward	I-DISEASE
travel	0
often	I-DISEASE
leads	0
to	I-DISEASE
difficulties	I-DISEASE
with	I-DISEASE
sleep	0
onset	0
as	0
attempts	I-DISEASE
to	I-DISEASE
sleep	0
are	0
made	0
at	I-DISEASE
an	I-DISEASE
earlier	0
internal	I-DISEASE
circadian	I-DISEASE
time	0
when	0
the	0
travelers	I-DISEASE
’	B-DISEASE
biological	I-DISEASE
clock	0
is	I-DISEASE
pro-	0
moting	0
alertness	I-DISEASE
(	I-DISEASE
i.e.	0
,	0
biological	I-DISEASE
day	0
)	0
.	0

Difficulty	I-DISEASE
awakening	0
and	0
daytime	0
sleepiness	0
and	0
fatigue	I-DISEASE
occur	I-DISEASE
because	0
wake	0
time	I-DISEASE
also	I-DISEASE
occurs	0
at	I-DISEASE
an	0
earlier	0
biological	I-DISEASE
time	0
when	0
the	I-DISEASE
circadian	0
clock	0
is	I-DISEASE
still	0
promoting	I-DISEASE
sleep	0
(	I-DISEASE
i.e.	I-DISEASE
,	I-DISEASE
during	I-DISEASE
the	0
travelers	I-DISEASE
’	0
biological	0
night	0
)	0
.	I-DISEASE

Westward	I-DISEASE
jet	0
travel	I-DISEASE
often	0
leads	0
to	I-DISEASE
sleepiness	0
and	0
fatigue	I-DISEASE
in	I-DISEASE
the	I-DISEASE
evening	I-DISEASE
hours	I-DISEASE
of	I-DISEASE
the	0
new	I-DISEASE
time	0
zone	0
as	0
the	0
internal	I-DISEASE
circadian	I-DISEASE
clock	I-DISEASE
of	0
the	I-DISEASE
traveler	0
is	I-DISEASE
promoting	I-DISEASE
sleep	0
(	I-DISEASE
i.e.	I-DISEASE
,	I-DISEASE
biological	I-DISEASE
night	0
)	0
.	0

Sleep	I-DISEASE
disturbance	I-DISEASE
in	0
the	0
new	0
time	I-DISEASE
zone	I-DISEASE
is	I-DISEASE
typically	0
manifest	0
as	0
a	0
sleep	I-DISEASE
maintenance	I-DISEASE
issue	0
with	0
early	0
morning	I-DISEASE
awakenings	0
and	0
difficulty	0
returning	I-DISEASE
to	0
sleep	I-DISEASE
because	0
the	0
internal	I-DISEASE
circadian	I-DISEASE
clock	I-DISEASE
of	I-DISEASE
the	0
traveler	I-DISEASE
is	0
promoting	0
wakefulness	0
during	0
the	0
sleep	0
episode	0
(	I-DISEASE
i.e.	I-DISEASE
,	0
biological	I-DISEASE
day	0
)	0
.	0

Basic	I-DISEASE
circadian	I-DISEASE
science	I-DISEASE
principles	0
suggest	I-DISEASE
that	0
inappropriately	0
timed	0
exposure	0
to	I-DISEASE
light	I-DISEASE
and	0
darkness	0
during	I-DISEASE
and	0
immediately	I-DISEASE
after	0
jet	0
travel	I-DISEASE
can	0
shift	0
the	0
circadian	0
clock	0
in	I-DISEASE
the	0
wrong	I-DISEASE
direction	0
,	I-DISEASE
thereby	I-DISEASE
increasing	I-DISEASE
the	I-DISEASE
duration	0
of	I-DISEASE
jet	0
lag	0
symptoms	I-DISEASE
.	0

Time	I-DISEASE
at	I-DISEASE
destina-	0
tion	0
upon	I-DISEASE
arrival	0
may	0
also	0
influence	0
jet	I-DISEASE
lag	0
symptoms	I-DISEASE
with	I-DISEASE
fewer	I-DISEASE
symptoms	0
reported	0
following	0
midday	I-DISEASE
arrivals	0
after	I-DISEASE
eastward	0
travel	I-DISEASE
.	0

An	I-DISEASE
individual	I-DISEASE
’s	B-DISEASE
innate	0
circadian	0
preference	0
may	0
also	0
confer	0
a	I-DISEASE
greater	I-DISEASE
or	I-DISEASE
lesser	I-DISEASE
ability	I-DISEASE
to	0
adjust	0
to	I-DISEASE
a	0
particular	I-DISEASE
time	0
shift	0
,	I-DISEASE
but	0
this	I-DISEASE
finding	I-DISEASE
has	0
not	0
been	I-DISEASE
systematically	I-DISEASE
assessed	I-DISEASE
.	0

Circadian	I-DISEASE
Rhythm	0
Sleep	I-DISEASE
-	I-DISEASE
Wake	I-DISEASE
Disorders	0
Circadian	I-DISEASE
Rhythm	0
Sleep	I-DISEASE
-	I-DISEASE
Wake	0
Disorders	0
Jet	0
lag	0
is	I-DISEASE
often	0
reported	I-DISEASE
to	0
be	I-DISEASE
worse	I-DISEASE
after	I-DISEASE
eastward	0
than	0
westward	I-DISEASE
travel	0
.	0

Westward	I-DISEASE
travel	0
may	I-DISEASE
generally	0
be	I-DISEASE
easier	I-DISEASE
because	0
the	0
genetically	0
determined	I-DISEASE
period	I-DISEASE
of	I-DISEASE
the	0
cir-	0
cadian	I-DISEASE
clock	0
in	I-DISEASE
humans	0
is	I-DISEASE
on	0
average	0
longer	I-DISEASE
than	0
24	0
hours	I-DISEASE
.	0

A	I-DISEASE
circadian	I-DISEASE
period	I-DISEASE
longer	0
than	I-DISEASE
24	0
hours	I-DISEASE
is	0
associated	0
with	I-DISEASE
a	0
circadian	I-DISEASE
drive	0
or	I-DISEASE
physiological	0
tendency	I-DISEASE
for	0
bed	0
and	0
wake	0
times	0
to	0
be	0
later	I-DISEASE
,	0
thus	I-DISEASE
making	0
it	I-DISEASE
easier	0
to	I-DISEASE
shift	0
the	0
circadian	I-DISEASE
clock	0
during	I-DISEASE
west-	I-DISEASE
ward	0
travel	0
to	0
more	0
delayed	I-DISEASE
sleep	0
and	0
wake	I-DISEASE
times	I-DISEASE
.	0

However	I-DISEASE
,	I-DISEASE
20	0
%	0
to	0
25	0
%	0
of	I-DISEASE
humans	0
have	0
circadian	0
periods	I-DISEASE
that	0
are	0
near	0
to	I-DISEASE
,	I-DISEASE
or	0
shorter	0
than	I-DISEASE
,	0
24	0
hours	I-DISEASE
,	I-DISEASE
and	0
these	0
individuals	I-DISEASE
may	I-DISEASE
find	I-DISEASE
it	I-DISEASE
easier	0
to	0
adapt	I-DISEASE
to	I-DISEASE
eastward	0
travel	0
.	0

Familial	I-DISEASE
Patterns	I-DISEASE
Not	I-DISEASE
applicable	0
or	B-DISEASE
known	0
.	0

Onset	I-DISEASE
,	0
Course	0
,	0
and	0
Complications	0
Jet	0
lag	0
is	I-DISEASE
usually	0
a	0
temporary	0
condition	I-DISEASE
.	0

Symptoms	I-DISEASE
begin	0
approximately	I-DISEASE
one	I-DISEASE
to	I-DISEASE
two	0
days	0
after	0
air	I-DISEASE
travel	I-DISEASE
across	I-DISEASE
at	I-DISEASE
least	0
two	I-DISEASE
time	I-DISEASE
zones	0
and	0
are	I-DISEASE
self	0
-	0
limited	I-DISEASE
.	0

The	I-DISEASE
severity	I-DISEASE
and	0
duration	0
of	0
symptoms	I-DISEASE
are	0
usually	I-DISEASE
in	0
proportion	I-DISEASE
to	0
the	0
number	I-DISEASE
of	I-DISEASE
time	0
zones	I-DISEASE
trav-	0
eled	I-DISEASE
and	0
the	0
direction	0
of	I-DISEASE
travel	0
.	I-DISEASE

It	I-DISEASE
is	I-DISEASE
estimated	0
that	0
it	0
takes	0
one	0
day	I-DISEASE
per	0
time	0
zone	0
for	0
circadian	I-DISEASE
rhythms	0
to	0
adjust	0
to	I-DISEASE
the	0
local	0
time	0
.	0

However	I-DISEASE
,	I-DISEASE
if	0
traveling	I-DISEASE
more	0
than	I-DISEASE
six	I-DISEASE
time	I-DISEASE
zones	0
,	0
circadian	0
rhythms	I-DISEASE
may	I-DISEASE
shift	0
in	I-DISEASE
the	0
opposite	0
direction	0
,	0
resulting	I-DISEASE
in	I-DISEASE
a	0
prolonged	0
period	0
of	I-DISEASE
adjustment	0
that	I-DISEASE
may	I-DISEASE
last	0
up	I-DISEASE
to	I-DISEASE
several	0
weeks	0
and	0
increased	0
severity	0
of	0
jet	I-DISEASE
-	0
lag	0
symptoms	0
.	0

Exposure	I-DISEASE
to	0
light	0
at	I-DISEASE
inappropriate	0
times	0
may	I-DISEASE
prolong	0
the	0
time	I-DISEASE
of	I-DISEASE
adjust-	0
ment	0
by	I-DISEASE
shifting	0
the	0
circadian	0
rhythms	0
in	0
the	0
opposite	0
direction	0
.	0

Menstrual	I-DISEASE
and	0
repro-	I-DISEASE
ductive	0
problems	0
have	I-DISEASE
been	I-DISEASE
associated	0
with	0
frequent	I-DISEASE
transmeridian	I-DISEASE
travel	I-DISEASE
in	I-DISEASE
female	I-DISEASE
airline	0
personnel	0
.	0

Poor	I-DISEASE
sleep	0
hygiene	0
practices	0
may	I-DISEASE
perpetuate	I-DISEASE
sleep	0
/	0
wake	0
complaints	I-DISEASE
,	I-DISEASE
and	0
repetitive	I-DISEASE
failed	I-DISEASE
attempts	I-DISEASE
to	0
initiate	0
or	I-DISEASE
maintain	0
sleep	0
at	I-DISEASE
desired	0
times	I-DISEASE
may	0
predis-	I-DISEASE
pose	0
to	B-DISEASE
the	0
development	B-DISEASE
of	I-DISEASE
insomnia	0
disorder	0
.	0

Developmental	I-DISEASE
Issues	0

The	I-DISEASE
effect	0
of	I-DISEASE
age	I-DISEASE
on	0
the	0
development	I-DISEASE
or	I-DISEASE
severity	0
of	I-DISEASE
jet	I-DISEASE
lag	0
disorder	I-DISEASE
symptoms	0
is	I-DISEASE
unknown	I-DISEASE
.	0

Pathology	I-DISEASE
and	0
Pathophysiology	I-DISEASE
The	I-DISEASE
symptoms	I-DISEASE
of	I-DISEASE
jet	I-DISEASE
lag	I-DISEASE
disorder	0
are	0
due	0
to	I-DISEASE
both	0
desynchronization	0
of	I-DISEASE
endogenous	I-DISEASE
circadian	0
rhythms	0
with	I-DISEASE
local	0
time	0
and	0
sleep	0
disturbance	I-DISEASE
.	0

The	I-DISEASE
severity	I-DISEASE
of	I-DISEASE
symptoms	I-DISEASE
can	0
be	I-DISEASE
influenced	I-DISEASE
by	I-DISEASE
the	0
environment	0
and	0
behaviors	I-DISEASE
of	I-DISEASE
the	I-DISEASE
traveler	0
.	0

Factors	I-DISEASE
inherent	0
to	I-DISEASE
jet	0
travel	0
,	0
including	0
prolonged	0
time	0
spent	I-DISEASE
sitting	I-DISEASE
in	I-DISEASE
a	I-DISEASE
confined	0
space	I-DISEASE
,	I-DISEASE
ability	I-DISEASE
to	0
sleep	0
on	0
long	0
-	0
haul	I-DISEASE
flights	I-DISEASE
,	I-DISEASE
decreased	0
physical	0
activity	0
,	I-DISEASE
and	0
a	I-DISEASE
low	0
oxygen	0
environment	0
,	0
may	0
influence	0
severity	0
.	0

Objective	I-DISEASE
Findings	I-DISEASE
Objective	I-DISEASE
laboratory	I-DISEASE
testing	0
usually	I-DISEASE
is	0
not	0
indicated	I-DISEASE
.	0

When	I-DISEASE
performed	0
,	0
polysomnogra-	0
phy	0
or	I-DISEASE
actigraphy	I-DISEASE
shows	I-DISEASE
disturbed	0
sleep	0
and	0
a	0
loss	0
of	I-DISEASE
a	0
normal	0
sleep	0
-	0
wake	0
pattern	0
or	I-DISEASE
a	0
mismatch	0
between	0
the	0
timing	0
of	0
sleep	0
and	0
wakefulness	0
with	0
the	0
desired	I-DISEASE
sleep	0
-	I-DISEASE
wake	0
pattern	0
of	I-DISEASE
the	0
local	0
time	0
.	0

Differential	I-DISEASE
Diagnosis	0
A	0
thorough	I-DISEASE
history	I-DISEASE
and	0
physical	0
examination	0
should	0
be	I-DISEASE
performed	I-DISEASE
to	0
exclude	0
other	I-DISEASE
mental	I-DISEASE
,	0
physical	0
,	0
or	0
sleep	0
disorders	0
.	0

Somatic	I-DISEASE
complaints	0
of	I-DISEASE
gastrointestinal	0
symptoms	I-DISEASE
may	I-DISEASE
indicate	I-DISEASE
an	I-DISEASE
underlying	0
medical	0
condition	0
.	0

When	I-DISEASE
jet	I-DISEASE
lag	0
symptoms	0
persist	I-DISEASE
,	I-DISEASE
increas-	0
ing	I-DISEASE
frustration	I-DISEASE
,	0
negative	I-DISEASE
expectations	I-DISEASE
,	I-DISEASE
and	0
poor	0
sleep	0
hygiene	0
may	I-DISEASE
predispose	0
the	I-DISEASE
indi-	I-DISEASE
vidual	0
to	I-DISEASE
the	0
development	B-DISEASE
of	0
chronic	I-DISEASE
insomnia	I-DISEASE
disorder	0
.	0

Unresolved	I-DISEASE
Issues	0
and	0
Further	I-DISEASE
Directions	0
Understanding	0
mechanisms	0
of	I-DISEASE
individual	I-DISEASE
differences	I-DISEASE
in	0
vulnerability	I-DISEASE
and	0
tolerance	I-DISEASE
to	0
disturbed	0
sleep	0
and	0
wakefulness	0
during	I-DISEASE
jet	I-DISEASE
lag	0
is	0
necessary	0
.	0

Development	I-DISEASE
of	I-DISEASE
effective	I-DISEASE
and	0
practical	0
strategies	0
to	I-DISEASE
combat	I-DISEASE
jet	0
-	0
lag	0
symptoms	I-DISEASE
and	0
improve	0
sleep	0
,	I-DISEASE
performance	0
and	0
safety	0
are	I-DISEASE
needed	0
.	0

It	I-DISEASE
is	0
unknown	0
how	0
expression	0
of	I-DISEASE
the	0
disorder	I-DISEASE
varies	B-DISEASE
across	I-DISEASE
the	0
life	0
span	I-DISEASE
.	0

Bibliography	0
Auger	I-DISEASE
RR	I-DISEASE
,	I-DISEASE
Morgenthaler	0
TI	0
.	0

Jet	I-DISEASE
lag	0
and	0
other	0
sleep	0
disorders	0
relevant	I-DISEASE
to	0
the	0
traveler	0
.	I-DISEASE

Travel	I-DISEASE
Med	I-DISEASE
Infect	I-DISEASE
Dis	I-DISEASE
2009;7:60–8	I-DISEASE
.	0

Burgess	I-DISEASE
HJ	I-DISEASE
,	I-DISEASE
Crowley	0
SJ	I-DISEASE
,	I-DISEASE
Gazda	I-DISEASE
CJ	0
,	I-DISEASE
Fogg	I-DISEASE
LF	0
.	0

Eastman	I-DISEASE
CI	I-DISEASE
.	I-DISEASE

Preflight	I-DISEASE
adjustment	0
to	0
eastward	I-DISEASE
travel	I-DISEASE
:	I-DISEASE
3	I-DISEASE
days	0
of	I-DISEASE
advancing	I-DISEASE
sleep	I-DISEASE
with	I-DISEASE
and	0
without	0
morning	0
bright	I-DISEASE
light	0
.	0

J	I-DISEASE
Biol	0
Rhythms	0
2003;18:318–28	0
.	0

Daan	I-DISEASE
S	I-DISEASE
,	I-DISEASE
Lewy	0
AJ	I-DISEASE
.	0

Scheduled	I-DISEASE
exposure	0
to	I-DISEASE
daylight	0
:	I-DISEASE
a	0
potential	I-DISEASE
strategy	0
to	0
reduce	I-DISEASE
“	0
jet	I-DISEASE
lag	0
”	I-DISEASE
following	0
transmeridian	I-DISEASE
flight	0
.	0

Psychopharmacol	I-DISEASE
Bull	I-DISEASE
1984;20:566–8	0
.	0

Dawson	I-DISEASE
D	I-DISEASE
,	0
Campbell	I-DISEASE
SS	0
.	0

Timed	I-DISEASE
exposure	0
to	I-DISEASE
bright	0
light	0
improves	0
sleep	0
and	0
alertness	0
during	I-DISEASE
simulated	I-DISEASE
night	0
shifts	0
.	0

Sleep	I-DISEASE
1991;14:511–6	0
.	0

Drake	I-DISEASE
CL	I-DISEASE
,	I-DISEASE
Wright	0
KP	I-DISEASE
Jr.	I-DISEASE
Shift	0
work	I-DISEASE
,	I-DISEASE
shift	I-DISEASE
work	I-DISEASE
disorder	I-DISEASE
,	I-DISEASE
and	0
jet	0
lag	0
.	0

In	I-DISEASE
:	I-DISEASE
Kryger	0
MH	I-DISEASE
,	I-DISEASE
Roth	I-DISEASE
T	0
,	0
Dement	I-DISEASE
WC	I-DISEASE
,	0
eds	I-DISEASE
.	0

Principles	I-DISEASE
and	0
practice	0
of	I-DISEASE
sleep	0
medicine	0
,	I-DISEASE
5th	I-DISEASE
ed	0
.	0

Philadelphia	I-DISEASE
:	0
Elsevier	0
Saunders	0
,	0
2011	I-DISEASE
;	0
784–98	0
.	0

Eastman	I-DISEASE
CI	I-DISEASE
,	I-DISEASE
Gazda	0
CJ	I-DISEASE
,	0
Burgess	0
HJ	I-DISEASE
,	I-DISEASE
Crowley	I-DISEASE
SJ	I-DISEASE
,	I-DISEASE
Fogg	0
LF	0
.	0

Advancing	I-DISEASE
circadian	I-DISEASE
rhythms	I-DISEASE
before	0
eastward	0
flight	0
:	0
a	0
strategy	I-DISEASE
to	I-DISEASE
prevent	I-DISEASE
or	0
reduce	I-DISEASE
jet	I-DISEASE
lag	I-DISEASE
.	0

Sleep	I-DISEASE
2005;28:33–44	I-DISEASE
.	0

Moline	I-DISEASE
ML	I-DISEASE
,	0
Pollak	0
CP	I-DISEASE
,	0
Monk	0
TH	0
,	I-DISEASE
et	0
al	0
.	0

Age	I-DISEASE
-	I-DISEASE
related	0
differences	I-DISEASE
in	0
recovery	I-DISEASE
from	0
simulated	I-DISEASE
jet	0
lag	0
.	0

Sleep	I-DISEASE
1992;15:28–40	I-DISEASE
.	0

Muhm	I-DISEASE
,	0
JM	0
,	I-DISEASE
Rock	0
PB	I-DISEASE
,	0
McMullin	I-DISEASE
DL	I-DISEASE
,	I-DISEASE
et	0
al	0
.	0

Effect	I-DISEASE
of	I-DISEASE
aircraft	0
-	I-DISEASE
cabin	0
altitude	0
on	0
passenger	I-DISEASE
discomfort	0
.	0

N	0
Engl	I-DISEASE
J	0
Med	I-DISEASE
2007;357:18–27	I-DISEASE
.	0

Sack	I-DISEASE
R	I-DISEASE
,	I-DISEASE
Auckley	0
D	I-DISEASE
,	0
Auger	I-DISEASE
RR	I-DISEASE
,	I-DISEASE
et	0
al	I-DISEASE
.	0

Circadian	I-DISEASE
rhythm	0
sleep	0
disorders	0
:	I-DISEASE
part	0
i	0
,	I-DISEASE
basic	0
principles	I-DISEASE
,	I-DISEASE
shift	0
work	I-DISEASE
and	0
jet	I-DISEASE
lag	0
:	I-DISEASE
An	0
American	0
Academy	0
of	I-DISEASE
Sleep	I-DISEASE
Medicine	0
Review	I-DISEASE
.	0

Sleep	I-DISEASE
2007;30:1456–79	I-DISEASE
.	0

Suhner	I-DISEASE
A	0
,	0
Schlagenhauf	0
P	0
,	I-DISEASE
Höfer	I-DISEASE
I	0
,	I-DISEASE
Johnson	I-DISEASE
R	I-DISEASE
,	0
Tschopp	0
A	0
,	I-DISEASE
Steffen	I-DISEASE
R.	0
Effectiveness	I-DISEASE
and	0
tolerability	I-DISEASE
of	0
melatonin	0
and	0
zolpidem	I-DISEASE
for	I-DISEASE
the	I-DISEASE
alleviation	0
of	0
jet	I-DISEASE
lag	0
.	0

Aviat	I-DISEASE
Space	0
Environ	0
Med	I-DISEASE
2001;72:638–46	I-DISEASE
.	0

Circadian	I-DISEASE
Rhythm	0
Sleep	I-DISEASE
-	I-DISEASE
Wake	I-DISEASE
Disorders	0
Circadian	0
Rhythm	0
Sleep	I-DISEASE
-	I-DISEASE
Wake	0
Disorders	0
Tresguerres	0
JA	0
,	I-DISEASE
Ariznavarreta	0
C	0
,	0
Granados	0
B	0
,	I-DISEASE
et	0
al	0
.	0

Circadian	I-DISEASE
urinary	0
6	0
-	0
sulphatoxymelatonin	0
,	I-DISEASE
cortisol	0
excretion	0
and	0
locomotor	0
activity	0
in	I-DISEASE
airline	0
pilots	I-DISEASE
during	I-DISEASE
transmeridian	0
flights	I-DISEASE
.	0

J	I-DISEASE
Pineal	0
Res	0
2001;31:16–22	I-DISEASE
.	0

Waterhouse	I-DISEASE
J	0
,	I-DISEASE
Edwards	0
B	0
,	I-DISEASE
Nevill	0
A	0
,	I-DISEASE
et	0
al	I-DISEASE
.	0

Identifying	I-DISEASE
some	I-DISEASE
determinants	0
of	I-DISEASE
“	0
jet	I-DISEASE
lag	0
”	I-DISEASE
and	0
its	I-DISEASE
symptoms	I-DISEASE
:	I-DISEASE
a	0
study	0
of	I-DISEASE
athletes	0
and	0
other	I-DISEASE
travellers	I-DISEASE
.	0

Br	0
J	0
Sports	I-DISEASE
Med	0
2002;36:54–60	I-DISEASE
.	0

Circadian	I-DISEASE
Sleep	0
-	0
Wake	I-DISEASE
Disorder	I-DISEASE
Not	I-DISEASE
Otherwise	0
Specified	I-DISEASE
(	I-DISEASE
NOS	I-DISEASE
)	0
ICD-9	0
-	0
CM	0
code	0
:	I-DISEASE
327.30	0
ICD-10	0
-	0
CM	0
code	0
:	0
G47.20	I-DISEASE
Patients	I-DISEASE
who	I-DISEASE
meet	0
all	0
of	I-DISEASE
the	0
general	0
diagnostic	0
criteria	0
for	0
a	0
CRSWD	0
but	0
do	0
not	0
meet	0
criteria	I-DISEASE
for	0
one	0
of	I-DISEASE
the	0
specific	I-DISEASE
types	I-DISEASE
of	I-DISEASE
circadian	0
rhythm	0
sleep	0
-	0
wake	0
disorders	0
are	0
clas-	I-DISEASE
sified	I-DISEASE
here	I-DISEASE
.	0

This	I-DISEASE
diagnosis	I-DISEASE
is	0
intended	I-DISEASE
primarily	0
for	I-DISEASE
patients	I-DISEASE
with	I-DISEASE
alterations	0
in	0
circa-	0
dian	I-DISEASE
sleep	0
-	I-DISEASE
wake	0
patterns	I-DISEASE
due	0
to	0
underlying	0
medical	0
,	0
neurologic	0
,	I-DISEASE
and	0
psychiatric	0
dis-	I-DISEASE
orders	I-DISEASE
.	0

The	I-DISEASE
underlying	0
neurological	0
,	I-DISEASE
psychiatric	I-DISEASE
,	I-DISEASE
or	B-DISEASE
medical	0
condition	0
is	I-DISEASE
typically	I-DISEASE
the	0
precipitating	0
factor	0
.	0

Patients	I-DISEASE
may	0
present	I-DISEASE
with	0
a	0
variety	I-DISEASE
of	I-DISEASE
symptoms	0
,	0
including	0
dis-	I-DISEASE
turbed	0
nocturnal	I-DISEASE
sleep	0
and	0
excessive	0
sleepiness	0
.	0

The	I-DISEASE
sleep	0
-	0
wake	0
pattern	0
may	I-DISEASE
range	I-DISEASE
from	I-DISEASE
alterations	0
in	0
the	0
phase	0
of	I-DISEASE
the	0
sleep	0
-	I-DISEASE
wake	0
cycle	I-DISEASE
to	0
irregular	0
sleep	0
-	0
wake	0
pattern	0
.	0

Recordings	I-DISEASE
of	I-DISEASE
sleep	0
logs	I-DISEASE
and	0
actigraphy	0
over	0
a	0
period	0
of	I-DISEASE
at	I-DISEASE
least	I-DISEASE
seven	0
days	0
,	I-DISEASE
preferably	I-DISEASE
for	0
14	0
days	0
or	0
longer	I-DISEASE
,	I-DISEASE
demonstrate	I-DISEASE
sleep	0
onsets	0
and	0
sleep	0
offsets	B-DISEASE
that	0
may	I-DISEASE
be	0
delayed	B-DISEASE
or	0
advanced	I-DISEASE
relative	I-DISEASE
to	0
conventional	0
times	0
,	0
irregular	I-DISEASE
or	I-DISEASE
non-24	I-DISEASE
-	0
hour	0
.	0

Sleep	I-DISEASE
-	I-DISEASE
wake	0
disturbances	I-DISEASE
are	0
common	I-DISEASE
in	I-DISEASE
patients	0
with	0
neurodegenerative	0
disorders	0
(	I-DISEASE
Alzheimer	I-DISEASE
disease	0
,	0
Parkinson	0
disease	I-DISEASE
,	0
Huntington	I-DISEASE
disease	I-DISEASE
)	0
,	0
as	0
well	I-DISEASE
as	0
neurodevelop-	0
mental	0
disorders	0
.	0

Sleep	I-DISEASE
-	I-DISEASE
wake	0
disturbances	I-DISEASE
associated	0
with	I-DISEASE
these	I-DISEASE
disorders	0
may	0
exhibit	0
some	I-DISEASE
features	I-DISEASE
of	I-DISEASE
irregular	0
sleep	0
-	I-DISEASE
wake	I-DISEASE
patterns	0
,	0
but	I-DISEASE
do	0
not	0
have	0
a	0
consistent	I-DISEASE
pattern	0
of	I-DISEASE
at	I-DISEASE
least	I-DISEASE
three	I-DISEASE
sleep	0
periods	0
per	I-DISEASE
day	I-DISEASE
.	0

The	I-DISEASE
particular	I-DISEASE
features	0
of	I-DISEASE
this	0
disorder	I-DISEASE
vary	I-DISEASE
with	I-DISEASE
the	0
type	I-DISEASE
of	I-DISEASE
underlying	0
medical	I-DISEASE
,	I-DISEASE
psychiatric	0
,	I-DISEASE
or	I-DISEASE
neurological	I-DISEASE
condition	I-DISEASE
.	0

The	I-DISEASE
disruption	I-DISEASE
of	I-DISEASE
the	0
sleep	0
-	I-DISEASE
wake	0
cycle	0
has	0
been	I-DISEASE
implicated	I-DISEASE
in	I-DISEASE
the	I-DISEASE
etiology	0
of	I-DISEASE
sundowning	I-DISEASE
and	0
noc-	0
turnal	0
wandering	I-DISEASE
in	0
older	0
adults	I-DISEASE
with	I-DISEASE
dementia	0
.	0

Patients	I-DISEASE
with	0
Parkinson	0
disease	0
may	I-DISEASE
exhibit	0
various	I-DISEASE
types	I-DISEASE
of	I-DISEASE
circadian	0
-	I-DISEASE
rhythm	I-DISEASE
alterations	0
.	0

In	I-DISEASE
addition	0
,	0
motor	I-DISEASE
fluctuations	0
can	I-DISEASE
exhibit	0
marked	0
diurnal	0
fluctuation	I-DISEASE
in	I-DISEASE
patients	I-DISEASE
with	0
Parkinson	0
disease	I-DISEASE
.	0

Parasomnias	I-DISEASE
NREM	0
-	0
Related	0
Parasomnias	I-DISEASE
Disorders	I-DISEASE
of	0
Arousal	0
(	I-DISEASE
From	I-DISEASE
NREM	0
Sleep)228	0

Confusional	0
Arousals229	0
Sleepwalking	0
229	I-DISEASE
Sleep	I-DISEASE
Terrors	I-DISEASE
230	I-DISEASE
Sleep	I-DISEASE
Related	I-DISEASE
Eating	0
Disorder	0
240	0
REM	I-DISEASE
-	I-DISEASE
Related	0
Parasomnias	I-DISEASE
REM	0
Sleep	0
Behavior	0
Disorder246	0

Recurrent	I-DISEASE
Isolated	0
Sleep	I-DISEASE
Paralysis	0
254	0
Nightmare	0
Disorder	0
257	I-DISEASE
Other	0
Parasomnias	0
Exploding	I-DISEASE
Head	0
Syndrome264	I-DISEASE
Sleep	0
Related	0
Hallucinations267	0
Sleep	0
Enuresis	0
270	0
Parasomnia	0
Due	I-DISEASE
to	0
a	0
Medical	0
Disorder276	0
Parasomnia	0

Due	I-DISEASE
to	I-DISEASE
a	0
Medication	I-DISEASE
or	I-DISEASE
Substance	I-DISEASE
276	0
Parasomnia	0
,	0
Unspecified	I-DISEASE
278	0
Isolated	I-DISEASE
Symptoms	0
and	0
Normal	0
Variants	I-DISEASE
Sleep	0
Talking	0
279	I-DISEASE
Parasomnias	0
are	0
undesirable	0
physical	0
events	I-DISEASE
or	0
experiences	I-DISEASE
that	0
occur	0
during	I-DISEASE
entry	0
into	I-DISEASE
sleep	0
,	0
within	I-DISEASE
sleep	0
,	0
or	I-DISEASE
during	I-DISEASE
arousal	0
from	I-DISEASE
sleep	I-DISEASE
.	0

Parasomnias	I-DISEASE
may	I-DISEASE
occur	I-DISEASE
during	I-DISEASE
non	B-DISEASE
-	0
rapid	I-DISEASE
eye	I-DISEASE
movement	I-DISEASE
sleep	0
(	0
NREM	0
)	0
,	0
rapid	I-DISEASE
eye	0
movement	I-DISEASE
sleep	0
(	I-DISEASE
REM	I-DISEASE
)	0
,	I-DISEASE
or	I-DISEASE
during	I-DISEASE
transitions	I-DISEASE
to	0
and	0
from	I-DISEASE
sleep	0
.	0

Parasomnias	I-DISEASE
encompass	I-DISEASE
abnormal	0
sleep	0
related	B-DISEASE
complex	0
movements	I-DISEASE
,	I-DISEASE
behaviors	0
,	I-DISEASE
emo-	I-DISEASE
tions	0
,	0
perceptions	0
,	I-DISEASE
dreams	I-DISEASE
,	0
and	0
autonomic	0
nervous	B-DISEASE
system	0
activity	0
.	0

Parasomnias	I-DISEASE
are	0
clinical	0
disorders	0
because	0
of	I-DISEASE
the	0
resulting	0
injuries	I-DISEASE
,	I-DISEASE
sleep	0
disruption	I-DISEASE
,	I-DISEASE
adverse	I-DISEASE
health	0
effects	0
,	I-DISEASE
and	0
untoward	0
psychosocial	0
effects	0
.	0

The	I-DISEASE
clinical	0
consequences	I-DISEASE
of	I-DISEASE
the	0
parasom-	I-DISEASE
nias	0
can	0
affect	I-DISEASE
the	0
patient	0
,	I-DISEASE
the	0
bed	I-DISEASE
partner	0
,	0
or	I-DISEASE
both	0
.	0

Human	I-DISEASE
consciousness	0
consists	I-DISEASE
of	I-DISEASE
three	0
essential	0
states	I-DISEASE
:	I-DISEASE
Wake	0
,	0
NREM	0
sleep	I-DISEASE
,	0
and	0
REM	I-DISEASE
sleep	0
.	0

The	I-DISEASE
three	0
states	0
are	I-DISEASE
modulated	0
by	I-DISEASE
a	0
host	0
of	I-DISEASE
influences	I-DISEASE
including	I-DISEASE
the	0
degree	I-DISEASE
of	I-DISEASE
ami-	I-DISEASE
nergic	0
and	0
cholinergic	I-DISEASE
neurochemical	0
bias	0
,	I-DISEASE
central	0
nervous	0
system	0
(	I-DISEASE
CNS	0
)	0
activation	0
,	0
Parasomnias	0
and	0
the	I-DISEASE
degree	I-DISEASE
of	I-DISEASE
endogenous	0
versus	0
exogenous	I-DISEASE
input	I-DISEASE
.	0

Under	I-DISEASE
normal	0
physiologic	0
conditions	I-DISEASE
,	0
which	0
include	0
homeostatic	I-DISEASE
drive	0
and	0
circadian	I-DISEASE
rhythmicity	0
,	0
the	0
process	0
of	I-DISEASE
state	B-DISEASE
declaration	0
is	0
maintained	0
in	0
a	0
stable	I-DISEASE
and	0
predictable	0
fashion	0
throughout	0
a	0
24	0
-	0
hour	0
period	0
.	0

However	I-DISEASE
,	I-DISEASE
as	0
the	0
sleep	0
-	0
wake	0
cycle	0
oscillates	0
,	I-DISEASE
the	0
normally	0
distinct	0
states	I-DISEASE
of	I-DISEASE
con-	0
sciousness	0
may	I-DISEASE
be	0
rendered	I-DISEASE
into	0
a	0
state	0
that	0
is	I-DISEASE
not	0
fully	I-DISEASE
declared	B-DISEASE
,	I-DISEASE
resulting	0
in	I-DISEASE
a	0
tempo-	I-DISEASE
rary	0
unstable	0
state	0
of	I-DISEASE
dissociation	I-DISEASE
.	0

Thus	I-DISEASE
,	I-DISEASE
sleep	0
and	0
wake	0
can	I-DISEASE
be	I-DISEASE
viewed	I-DISEASE
as	0
occurring	0
on	0
a	I-DISEASE
spectrum	I-DISEASE
rather	I-DISEASE
than	0
being	I-DISEASE
entirely	0
dichotomous	I-DISEASE
states	I-DISEASE
.	0

Parasomnias	I-DISEASE
are	0
the	0
result	0
of	0
such	0
state	B-DISEASE
dissociation	I-DISEASE
.	0

Recent	I-DISEASE
research	0
has	0
shown	I-DISEASE
that	0
com-	I-DISEASE
binations	I-DISEASE
of	I-DISEASE
one	0
or	I-DISEASE
more	I-DISEASE
of	I-DISEASE
these	0
states	0
do	I-DISEASE
occur	I-DISEASE
and	0
may	0
result	0
in	I-DISEASE
unstable	0
states	I-DISEASE
of	I-DISEASE
altered	I-DISEASE
consciousness	0
manifesting	I-DISEASE
as	0
parasomnias	I-DISEASE
.	0

Disorders	I-DISEASE
of	I-DISEASE
arousal	0
,	I-DISEASE
such	0
as	I-DISEASE
sleepwalking	0
,	I-DISEASE
sleep	I-DISEASE
terrors	I-DISEASE
,	I-DISEASE
and	0
confusional	I-DISEASE
arousals	0
are	0
an	0
admixture	0
of	I-DISEASE
wakefulness	0
and	0
NREM	B-DISEASE
sleep	0
.	0

Higher	I-DISEASE
cognitive	0
function	0
is	0
severely	0
impaired	I-DISEASE
,	0
if	I-DISEASE
not	0
absent	0
,	0
while	0
the	I-DISEASE
potential	I-DISEASE
for	0
motor	I-DISEASE
capacity	I-DISEASE
has	I-DISEASE
,	0
for	0
the	0
most	0
part	I-DISEASE
,	0
been	I-DISEASE
retained	0
.	0

REM	I-DISEASE
sleep	0
behavior	I-DISEASE
disorder	0
(	I-DISEASE
RBD	I-DISEASE
)	0
is	0
an	0
admixture	I-DISEASE
of	I-DISEASE
REM	I-DISEASE
sleep	0
coupled	0
with	I-DISEASE
waking	0
or	0
NREM	0
sleep	0
levels	I-DISEASE
of	I-DISEASE
tonic	I-DISEASE
EMG	0
activity	0
.	0

All	I-DISEASE
three	0
states	0
may	I-DISEASE
be	0
present	I-DISEASE
in	I-DISEASE
the	B-DISEASE
same	B-DISEASE
individual	0
as	B-DISEASE
an	0
overlap	I-DISEASE
of	I-DISEASE
disorders	0
.	0

The	I-DISEASE
comingling	I-DISEASE
of	I-DISEASE
basic	0
states	I-DISEASE
of	I-DISEASE
consciousness	I-DISEASE
is	0
the	0
result	0
of	I-DISEASE
different	I-DISEASE
forms	I-DISEASE
of	I-DISEASE
pathophysiology	I-DISEASE
.	0

In	I-DISEASE
disorders	0
of	I-DISEASE
arousal	0
,	0
no	0
identifiable	I-DISEASE
neuropathology	0
is	I-DISEASE
present	0
,	I-DISEASE
but	I-DISEASE
functional	I-DISEASE
changes	0
in	0
cerebral	0
activity	0
during	I-DISEASE
NREM	0
sleep	0
are	I-DISEASE
present	I-DISEASE
,	I-DISEASE
essentially	0
resulting	0
in	0
a	0
brain	I-DISEASE
in	I-DISEASE
which	0
certain	0
areas	0
are	0
deactivated	0
(	0
asleep	0
)	0
and	0
others	I-DISEASE
remain	I-DISEASE
activated	I-DISEASE
(	I-DISEASE
awake	0
)	0
.	0

This	I-DISEASE
CNS	0
activation	0
,	0
with	I-DISEASE
concomitant	0
skeletal	0
muscle	I-DISEASE
and	0
auto-	0
nomic	0
nervous	I-DISEASE
system	0
activation	0
,	I-DISEASE
is	0
believed	I-DISEASE
to	0
reflect	I-DISEASE
a	I-DISEASE
functional	0
disabling	I-DISEASE
of	I-DISEASE
,	I-DISEASE
or	0
damage	0
to	I-DISEASE
,	0
brain	0
areas	0
usually	I-DISEASE
responsible	0
for	0
the	0
inhibition	0
of	I-DISEASE
these	0
activities	I-DISEASE
during	I-DISEASE
sleep	I-DISEASE
.	0

Additionally	I-DISEASE
,	I-DISEASE
sleep	0
inertia	I-DISEASE
,	0
sleep	0
state	B-DISEASE
instability	0
,	0
and	0
locomotor	I-DISEASE
/	0
central	I-DISEASE
pattern	0
generators	0
are	I-DISEASE
thought	0
to	0
contribute	0
to	0
the	I-DISEASE
occurrence	0
of	I-DISEASE
NREM	0
parasomnias	I-DISEASE
.	0

NREM	I-DISEASE
disorders	0
of	I-DISEASE
arousal	0
frequently	I-DISEASE
appear	I-DISEASE
to	0
involve	0
the	0
disinhibition	I-DISEASE
of	I-DISEASE
“	I-DISEASE
basic	0
drive	I-DISEASE
states	0
”	I-DISEASE
such	0
as	0
feeding	I-DISEASE
,	I-DISEASE
sex	0
,	I-DISEASE
and	0
aggression	0
.	0

Here	I-DISEASE
,	I-DISEASE
it	0
has	I-DISEASE
been	0
postulated	I-DISEASE
that	I-DISEASE
central	0
pattern	0
generators	I-DISEASE
elicit	I-DISEASE
primal	I-DISEASE
fixed	0
action	I-DISEASE
patterns	I-DISEASE
that	0
would	0
otherwise	0
have	0
been	I-DISEASE
inhibited	I-DISEASE
by	I-DISEASE
the	I-DISEASE
prefrontal	0
cortex	I-DISEASE
during	I-DISEASE
wake	0
.	0

In	I-DISEASE
this	I-DISEASE
regard	0
,	I-DISEASE
aggression	0
is	I-DISEASE
typ-	0
ically	I-DISEASE
abrupt	I-DISEASE
in	0
onset	0
and	0
characterized	0
by	0
apparent	0
instinctual	I-DISEASE
defensive	0
posturing	B-DISEASE
as	0
opposed	0
to	I-DISEASE
behaviors	I-DISEASE
that	0
are	I-DISEASE
complex	B-DISEASE
and	0
procedural	0
.	0

These	0
can	0
emerge	0
in	I-DISEASE
pathologic	0
forms	0
with	0
the	0
parasomnias	I-DISEASE
,	I-DISEASE
as	0
seen	I-DISEASE
with	0
sleep	0
related	B-DISEASE
aggression	0
and	0
locomotion	0
,	0
sleep	0
related	0
eating	I-DISEASE
disorder	0
(	I-DISEASE
SRED	0
)	0
,	0
and	0
abnormal	0
sleep	0
related	0
sexual	0
behaviors	I-DISEASE
.	0

In	I-DISEASE
contrast	I-DISEASE
,	0
RBD	I-DISEASE
often	I-DISEASE
results	I-DISEASE
from	I-DISEASE
serious	0
neuropathology	0
.	0

Initially	I-DISEASE
,	I-DISEASE
this	0
neuropathology	0
affects	I-DISEASE
the	0
area	0
of	I-DISEASE
the	0
brain	I-DISEASE
responsible	I-DISEASE
for	0
inhibiting	I-DISEASE
muscle	0
tone	I-DISEASE
during	I-DISEASE
REM	I-DISEASE
sleep	0
.	0

As	I-DISEASE
a	I-DISEASE
result	0
,	I-DISEASE
dreams	0
may	I-DISEASE
be	I-DISEASE
enacted	I-DISEASE
.	0

In	I-DISEASE
the	0
case	I-DISEASE
of	I-DISEASE
REM	0
-	0
related	B-DISEASE
behaviors	I-DISEASE
,	0
the	0
experience	0
and	0
activity	0
reflect	I-DISEASE
the	0
actual	I-DISEASE
,	I-DISEASE
often	0
aggressive	0
content	0
of	I-DISEASE
a	0
dream	I-DISEASE
.	0

It	I-DISEASE
is	I-DISEASE
frequently	0
pos-	0
sible	0
to	0
correlate	0
observed	I-DISEASE
movements	0
with	0
later	0
descriptions	B-DISEASE
of	I-DISEASE
the	0
dream	I-DISEASE
.	0

The	I-DISEASE
initial	0
appearance	I-DISEASE
of	I-DISEASE
RBD	0
symptoms	I-DISEASE
is	I-DISEASE
often	0
followed	0
years	0
later	0
by	I-DISEASE
the	0
development	B-DISEASE
of	I-DISEASE
neu-	I-DISEASE
rodegenerative	0
disorders	0
,	I-DISEASE
particularly	0
Parkinson	0
disease	B-DISEASE
and	0
related	0
synucleinopathies	0
.	0

Abnormal	I-DISEASE
sleep	0
related	B-DISEASE
movements	0
comprise	I-DISEASE
a	0
separate	0
category	0
of	I-DISEASE
disorders	I-DISEASE
,	I-DISEASE
which	0
is	I-DISEASE
detailed	I-DISEASE
in	I-DISEASE
the	0
sleep	0
related	B-DISEASE
movement	I-DISEASE
disorders	0
section	0
.	0

Unlike	I-DISEASE
the	0
parasomnias	0
,	I-DISEASE
which	0
typ-	0
ically	I-DISEASE
entail	I-DISEASE
more	0
complex	0
movements	0
and	0
behavior	I-DISEASE
,	0
the	0
movement	I-DISEASE
disorders	0
encompass	I-DISEASE
a	0
broad	I-DISEASE
range	0
of	I-DISEASE
predominantly	I-DISEASE
simple	I-DISEASE
motoric	I-DISEASE
activities	I-DISEASE
:	0
myoclonic	0
,	0
repetitive	I-DISEASE
,	I-DISEASE
rocking	I-DISEASE
,	I-DISEASE
rhythmic	0
,	0
grinding	0
,	0
cramping	I-DISEASE
,	I-DISEASE
fragmentary	0
,	0
dystonic	0
,	I-DISEASE
or	0
dyskinetic	0
movements	0
or	I-DISEASE
tremors	0
,	I-DISEASE
which	0
are	0
not	0
usually	I-DISEASE
associated	0
with	I-DISEASE
dream	I-DISEASE
mentation	I-DISEASE
or	0
experiential	I-DISEASE
concomitants	0
.	0

Parasomnias	I-DISEASE
involve	0
sleep	0
related	0
behaviors	0
and	0
experiences	0
over	0
which	I-DISEASE
there	I-DISEASE
is	0
no	0
conscious	0
deliberate	I-DISEASE
control	0
.	0

There	I-DISEASE
are	I-DISEASE
ten	0
core	I-DISEASE
categories	0
of	I-DISEASE
parasomnias	I-DISEASE
listed	I-DISEASE
in	I-DISEASE
the	0
International	0
Classification	I-DISEASE
of	I-DISEASE
Sleep	I-DISEASE
Disorders	0
,	0
3rd	0
Edition	I-DISEASE
.	0

Only	I-DISEASE
one	0
of	I-DISEASE
the	0
core	0
cat-	I-DISEASE
egories	I-DISEASE
,	0
RBD	0
,	I-DISEASE
requires	I-DISEASE
video	0
-	I-DISEASE
polysomnographic	0
documentation	I-DISEASE
as	0
one	0
of	I-DISEASE
the	0
essen-	I-DISEASE
tial	0
diagnostic	0
criteria	0
.	0

However	I-DISEASE
,	I-DISEASE
for	0
most	0
of	0
the	0
other	I-DISEASE
parasomnias	I-DISEASE
,	I-DISEASE
polysomnographic	I-DISEASE
monitoring	0
can	0
provide	0
corroborative	0
documentation	B-DISEASE
in	I-DISEASE
support	0
of	I-DISEASE
the	0
clinical	0
diagnosis	0
.	0

Considerable	0
advances	0
have	I-DISEASE
taken	0
place	I-DISEASE
in	I-DISEASE
understanding	I-DISEASE
the	0
neurophysiologic	0
aspects	0
of	I-DISEASE
abnormal	I-DISEASE
arousals	0
from	I-DISEASE
slow	0
wave	I-DISEASE
sleep	0
associated	0
with	I-DISEASE
the	0
disorders	0
of	I-DISEASE
arousal	I-DISEASE
.	0

Advances	I-DISEASE
in	I-DISEASE
the	0
clinical	I-DISEASE
understanding	0
of	I-DISEASE
these	I-DISEASE
NREM	0
sleep	0
parasomnias	I-DISEASE
have	0
occurred	I-DISEASE
as	0
well	0
,	I-DISEASE
particularly	0
in	I-DISEASE
regard	0
to	0
their	I-DISEASE
prevalence	0
and	0
severity	0
in	I-DISEASE
adults	I-DISEASE
.	0

In	I-DISEASE
regard	0
to	0
RBD	I-DISEASE
,	I-DISEASE
long	I-DISEASE
-	I-DISEASE
term	0
delayed	0
emergence	I-DISEASE
of	I-DISEASE
neurodegeneration	I-DISEASE
has	I-DISEASE
frequently	0
been	I-DISEASE
found	I-DISEASE
in	I-DISEASE
middle	I-DISEASE
-	0
aged	I-DISEASE
and	0
older	0
adults	I-DISEASE
following	0
onset	I-DISEASE
of	I-DISEASE
RBD	I-DISEASE
.	B-DISEASE

When	I-DISEASE
combined	0
with	0
thorough	I-DISEASE
clinical	0
interviews	I-DISEASE
,	I-DISEASE
video	I-DISEASE
-	0
polysomnography	0
a	0
powerful	I-DISEASE
discriminating	I-DISEASE
tool	0
for	0
identifying	0
the	0
cause	I-DISEASE
of	I-DISEASE
sleep	0
related	0
injury	0
in	I-DISEASE
adults	I-DISEASE
.	0

Bibliography	0
Cramer	I-DISEASE
Bornemann	0
MA	0
,	0
Mahowald	0
MW	0
.	0

Sleep	I-DISEASE
forensics	0
.	I-DISEASE

In	I-DISEASE
:	I-DISEASE
Kryger	0
MH	I-DISEASE
,	I-DISEASE
Roth	I-DISEASE
T	0
,	0
Dement	I-DISEASE
WC	I-DISEASE
,	0
eds	I-DISEASE
.	0

Principles	I-DISEASE
and	0
practice	0
of	I-DISEASE
sleep	0
medicine	0
,	I-DISEASE
5th	I-DISEASE
ed	0
.	0

Philadelphia	I-DISEASE
:	I-DISEASE
Elsevier	0
Saunders	I-DISEASE
,	I-DISEASE
2010	I-DISEASE
.	0

Hobson	I-DISEASE
JA	0
.	0

REM	I-DISEASE
sleep	0
and	0
dreaming	0
:	I-DISEASE
towards	0
a	I-DISEASE
theory	0
of	I-DISEASE
protoconsciousness	0
.	0

Nat	I-DISEASE
Rev	I-DISEASE
Neurosci	0
2009;10:803–13	I-DISEASE
.	0

Ohayon	I-DISEASE
M	I-DISEASE
,	0
Caulet	I-DISEASE
M	I-DISEASE
,	0
Priest	I-DISEASE
R.	I-DISEASE
Violent	I-DISEASE
behavior	I-DISEASE
during	I-DISEASE
sleep	0
.	0

J	I-DISEASE
Clin	0
Psychiatry	0
1997;58:369–76	0
.	0

Ohayon	I-DISEASE
M	I-DISEASE
,	0
Mahowald	I-DISEASE
M	I-DISEASE
,	0
Dauvilliers	0
Y	0
,	I-DISEASE
Krystal	B-DISEASE
A	0
,	I-DISEASE
Leger	0
D.	I-DISEASE
Prevalence	I-DISEASE
and	0
comorbidity	0
of	I-DISEASE
nocturnal	0
wandering	0
in	I-DISEASE
the	0
US	I-DISEASE
adult	0
general	0
population	0
.	0

Neurology	0
2012;78:1583–9	I-DISEASE
.	0

Schenck	I-DISEASE
C	I-DISEASE
,	0
Milner	0
D	I-DISEASE
,	0
Hurwitz	0
T	I-DISEASE
,	I-DISEASE
Bundlie	0
S	I-DISEASE
,	0
Mahowald	0
M.	I-DISEASE
A	0
polysomnographic	0
and	0
clinical	0
report	0
on	0
sleep	0
related	0
injury	0
in	I-DISEASE
100	0
adult	0
patients	0
.	0

Am	I-DISEASE
J	0
Psychiatry	0
1989;146:1166–73	I-DISEASE
.	0

Siclari	I-DISEASE
F	I-DISEASE
,	I-DISEASE
Khatami	I-DISEASE
R	0
,	I-DISEASE
Urbaniok	I-DISEASE
F	I-DISEASE
,	I-DISEASE
et	0
al	I-DISEASE
.	0

Violence	I-DISEASE
in	I-DISEASE
sleep	0
.	I-DISEASE

Brain	0
2010;133:3494–509	0
.	0

Tassinari	I-DISEASE
C	I-DISEASE
,	0
Rubboli	I-DISEASE
G	0
,	0
Gardella	I-DISEASE
E	0
,	I-DISEASE
et	0
al	I-DISEASE
.	0

Central	I-DISEASE
pattern	0
generators	0
for	0
a	0
common	I-DISEASE
semiology	0
in	0
fronto-	0
limbic	I-DISEASE
seizures	0
and	0
in	I-DISEASE
parasomnias	0
.	0

A	I-DISEASE
neuroethologic	0
approach	I-DISEASE
.	0

Neurol	0
Sci	0
2005;26	I-DISEASE
:	0
s225–32	0
.	0

Parasomnias	I-DISEASE
Parasomnias	I-DISEASE
NREM	0
-	I-DISEASE
Related	0
Parasomnias	0
Disorders	0
of	I-DISEASE
Arousal	0
(	0
From	I-DISEASE
NREM	0
Sleep	0
)	0

This	I-DISEASE
group	I-DISEASE
of	I-DISEASE
NREM	0
-	I-DISEASE
related	B-DISEASE
disorders	0
,	0
which	0
includes	I-DISEASE
confusional	I-DISEASE
arousals	0
,	I-DISEASE
sleep-	I-DISEASE
walking	0
,	I-DISEASE
and	0
sleep	0
terrors	0
,	I-DISEASE
arise	I-DISEASE
as	0
a	0
result	0
of	I-DISEASE
incomplete	0
arousals	0
from	I-DISEASE
deep	0
sleep	0
.	0

The	I-DISEASE
conditions	I-DISEASE
share	0
:	I-DISEASE
(	0
1	0
)	0
similar	0
genetic	0
and	0
familial	0
patterns	I-DISEASE
;	0
(	0
2	0
)	0
similar	0
pathophysiology	0
of	I-DISEASE
partial	I-DISEASE
arousals	0
from	0
deep	0
sleep	0
;	I-DISEASE
and	0
(	0
3	I-DISEASE
)	0
similar	0
priming	0
by	0
sleep	0
deprivation	0
and	0
biopsychosocial	0
stressors	0
.	0

Disorders	I-DISEASE
of	I-DISEASE
arousal	0
are	0
:	I-DISEASE
(	I-DISEASE
1	0
)	0
not	0
secondary	0
to	I-DISEASE
psychiatric	I-DISEASE
disorders	0
;	I-DISEASE
(	I-DISEASE
2	I-DISEASE
)	0
not	0
generally	I-DISEASE
secondary	0
to	I-DISEASE
neuropathology	0
or	I-DISEASE
head	I-DISEASE
injury	I-DISEASE
;	I-DISEASE
(	I-DISEASE
3	0
)	0
associated	0
with	I-DISEASE
absent	I-DISEASE
or	0
minimal	I-DISEASE
cognitive	0
functioning	0
;	0
(	0
4	0
)	0
associated	0
with	I-DISEASE
amnesia	I-DISEASE
for	0
the	0
prior	0
episode	0
;	0
and	0
(	I-DISEASE
5	0
)	0
may	0
be	I-DISEASE
triggered	I-DISEASE
by	0
sound	I-DISEASE
,	I-DISEASE
touch	B-DISEASE
,	I-DISEASE
or	I-DISEASE
other	I-DISEASE
stimuli	I-DISEASE
.	0

General	I-DISEASE
Diagnostic	I-DISEASE
Criteria	I-DISEASE
for	0
Disorders	0
of	I-DISEASE
Arousal	0
Criteria	I-DISEASE
A	0
-	I-DISEASE
E	0
must	I-DISEASE
be	0
met	0
A.	0
Recurrent	I-DISEASE
episodes	I-DISEASE
of	I-DISEASE
incomplete	0
awakening	0
from	I-DISEASE
sleep.1	0
B.	0
Inappropriate	0
or	I-DISEASE
absent	I-DISEASE
responsiveness	0
to	0
efforts	0
of	I-DISEASE
others	I-DISEASE
to	I-DISEASE
intervene	0
or	I-DISEASE
redirect	I-DISEASE
the	I-DISEASE
person	0
during	I-DISEASE
the	0
episode	0
.	0

C.	I-DISEASE
Limited	0
(	I-DISEASE
e.g.	0
,	0
a	0
single	0
visual	I-DISEASE
scene	I-DISEASE
)	0
or	0
no	0
associated	0
cognition	I-DISEASE
or	0
dream	I-DISEASE
imagery	I-DISEASE
.	0

D.	I-DISEASE
Partial	I-DISEASE
or	0
complete	I-DISEASE
amnesia	I-DISEASE
for	0
the	0
episode	I-DISEASE
.	0

E.	I-DISEASE

The	I-DISEASE
disturbance	I-DISEASE
is	0
not	0
better	0
explained	I-DISEASE
by	I-DISEASE
another	I-DISEASE
sleep	0
disorder	0
,	I-DISEASE
mental	I-DISEASE
disorder	I-DISEASE
,	I-DISEASE
medical	0
condition	0
,	I-DISEASE
medication	I-DISEASE
,	0
or	0
substance	I-DISEASE
use	I-DISEASE
.	0

Notes	I-DISEASE
.	0

The	I-DISEASE
events	0
usually	I-DISEASE
occur	I-DISEASE
during	I-DISEASE
the	0
first	I-DISEASE
third	I-DISEASE
of	I-DISEASE
the	0
major	I-DISEASE
sleep	0
episode	I-DISEASE
.	0
.	0

The	I-DISEASE
individual	I-DISEASE
may	0
continue	0
to	0
appear	0
confused	I-DISEASE
and	0
disoriented	0
for	I-DISEASE
several	I-DISEASE
minutes	0
or	0
longer	I-DISEASE
following	0
the	0
episode	0
.	0

Confusional	I-DISEASE
Arousals	0
ICD-9	0
-	0
CM	0
code	0
:	0
327.41	0
Alternate	0
Names	I-DISEASE
Elpenor	0
syndrome	I-DISEASE
.	0

Diagnostic	I-DISEASE
Criteria	0
Criteria	I-DISEASE
A	0
-	I-DISEASE
C	I-DISEASE
must	I-DISEASE
be	0
met	0
ICD-10	0
-	0
CM	0
code	0
:	0

G47.51	I-DISEASE
Sleepwalking	0
ICD-9	I-DISEASE
-	I-DISEASE
CM	I-DISEASE
code	0
:	I-DISEASE
307.46	0
Alternate	0
Names	I-DISEASE
Somnambulism	0
.	0

Diagnostic	I-DISEASE
Criteria	0
Criteria	I-DISEASE
A	0
and	0
B	0
must	0
be	0
met	0
ICD-10	0
-	0
CM	0
code	0
:	0
F51.3	I-DISEASE
Parasomnias	I-DISEASE
A.	0
The	I-DISEASE
disorder	0
meets	0
general	0
criteria	0
for	0
NREM	0
disorders	0
of	I-DISEASE
arousal	0
.	0

B.	0
The	I-DISEASE
episodes	I-DISEASE
are	0
characterized	0
by	I-DISEASE
mental	0
confusion	0
or	0
confused	0
behavior	I-DISEASE
that	I-DISEASE
occurs	I-DISEASE
while	0
the	0
patient	I-DISEASE
is	I-DISEASE
in	0
bed	0
.	0

C.	I-DISEASE
There	0
is	I-DISEASE
an	0
absence	I-DISEASE
of	I-DISEASE
terror	I-DISEASE
or	B-DISEASE
ambulation	0
outside	I-DISEASE
of	I-DISEASE
the	0
bed	I-DISEASE
.	0

Notes	I-DISEASE
.	0

There	I-DISEASE
is	I-DISEASE
typically	0
a	0
lack	0
of	I-DISEASE
autonomic	0
arousal	0
such	0
as	0
mydriasis	I-DISEASE
,	I-DISEASE
tachycardia	I-DISEASE
,	0
tachypnea	0
,	0
and	0
diaphoresis	0
during	I-DISEASE
an	0
episode	I-DISEASE
.	0

A.	I-DISEASE

The	I-DISEASE
disorder	0
meets	0
general	I-DISEASE
criteria	0
for	I-DISEASE
NREM	0
disorders	0
of	I-DISEASE
arousal	0
.	I-DISEASE

B.	0
The	I-DISEASE
arousals	0
are	0
associated	0
with	I-DISEASE
ambulation	I-DISEASE
and	0
other	I-DISEASE
complex	B-DISEASE
behaviors	0
out	0
of	I-DISEASE
bed	I-DISEASE
.	0

Parasomnias	I-DISEASE
Sleep	I-DISEASE
Terrors	I-DISEASE
ICD-9	0
-	I-DISEASE
CM	I-DISEASE
code	0
:	I-DISEASE
307.46	I-DISEASE
Alternate	I-DISEASE
Names	I-DISEASE
Night	I-DISEASE
terrors	0
,	I-DISEASE
pavor	0
nocturnus	0
.	0

Diagnostic	I-DISEASE
Criteria	0
Criteria	I-DISEASE
A	0
-	I-DISEASE
C	I-DISEASE
must	I-DISEASE
be	0
met	0
ICD-10	0
-	0
CM	0
code	0
:	0

F51.4	I-DISEASE
A.	0
The	I-DISEASE
disorder	I-DISEASE
meets	0
general	0
criteria	I-DISEASE
for	0
NREM	I-DISEASE
disorders	0
of	I-DISEASE
arousal	I-DISEASE
.	0

B.	0
The	I-DISEASE
arousals	0
are	0
characterized	0
by	I-DISEASE
episodes	I-DISEASE
of	I-DISEASE
abrupt	I-DISEASE
terror	I-DISEASE
,	I-DISEASE
typically	I-DISEASE
beginning	B-DISEASE
with	0
an	0
alarming	I-DISEASE
vocalization	0
such	0
as	0
a	0
frightening	I-DISEASE
scream	I-DISEASE
.	0

C.	I-DISEASE
There	0
is	0
intense	0
fear	I-DISEASE
and	0
signs	0
of	I-DISEASE
autonomic	0
arousal	I-DISEASE
,	I-DISEASE
including	0
mydriasis	0
,	0
tachycardia	I-DISEASE
,	I-DISEASE
tachypnea	I-DISEASE
,	0
and	0
diaphoresis	I-DISEASE
during	I-DISEASE
an	0
episode	0
.	0

Essential	I-DISEASE
Features	I-DISEASE
Disorders	0
of	I-DISEASE
arousal	0
consist	I-DISEASE
of	I-DISEASE
complex	0
behaviors	I-DISEASE
that	0
are	I-DISEASE
usually	I-DISEASE
initiated	0
during	I-DISEASE
partial	I-DISEASE
arousals	I-DISEASE
from	0
slow	0
wave	I-DISEASE
(	I-DISEASE
N3	0
)	0
sleep	0
.	0

Most	I-DISEASE
episodes	I-DISEASE
are	0
brief	I-DISEASE
,	0
but	I-DISEASE
they	I-DISEASE
may	I-DISEASE
last	0
as	0
long	I-DISEASE
as	0
30	I-DISEASE
to	I-DISEASE
40	0
minutes	0
in	I-DISEASE
some	I-DISEASE
children	0
.	0

Sleep	I-DISEASE
talking	0
and	0
shouting	0
may	0
accompany	I-DISEASE
these	I-DISEASE
events	0
.	0

The	I-DISEASE
eyes	I-DISEASE
are	0
usually	I-DISEASE
open	0
during	I-DISEASE
an	0
episode	I-DISEASE
and	0
,	0
not	0
uncom-	I-DISEASE
monly	0
,	I-DISEASE
are	I-DISEASE
wide	0
open	0
with	I-DISEASE
a	0
confused	I-DISEASE
“	0
glassy	0
”	I-DISEASE
stare	0
.	0

The	I-DISEASE
patient	I-DISEASE
with	0
a	I-DISEASE
disorder	0
of	I-DISEASE
arousal	0
may	I-DISEASE
be	0
very	I-DISEASE
difficult	0
to	I-DISEASE
awaken	I-DISEASE
and	0
,	I-DISEASE
when	I-DISEASE
awakened	I-DISEASE
,	0
is	0
often	0
confused	I-DISEASE
.	0

There	I-DISEASE
is	I-DISEASE
usually	I-DISEASE
amnesia	I-DISEASE
for	I-DISEASE
these	I-DISEASE
episodes	I-DISEASE
,	0
although	0
adults	I-DISEASE
may	I-DISEASE
remember	I-DISEASE
fragments	I-DISEASE
of	I-DISEASE
episodes	I-DISEASE
.	0

Dream	I-DISEASE
-	I-DISEASE
like	0
mentation	I-DISEASE
is	I-DISEASE
sometimes	I-DISEASE
reported	I-DISEASE
in	0
adults	0
.	0

Other	I-DISEASE
high	I-DISEASE
-	0
level	0
cog-	0
nitive	I-DISEASE
functions	0
such	0
as	0
attention	I-DISEASE
,	I-DISEASE
planning	0
,	I-DISEASE
social	0
interaction	I-DISEASE
,	0
and	0
intent	I-DISEASE
are	0
absent	0
.	0

Because	I-DISEASE
disorders	0
of	I-DISEASE
arousal	0
usually	0
originate	I-DISEASE
from	0
slow	0
wave	B-DISEASE
sleep	0
,	I-DISEASE
they	I-DISEASE
most	I-DISEASE
often	I-DISEASE
emerge	0
in	I-DISEASE
the	0
first	I-DISEASE
third	0
or	0
first	I-DISEASE
half	0
of	I-DISEASE
the	0
typical	0
sleep	I-DISEASE
period	0
.	I-DISEASE

They	I-DISEASE
may	I-DISEASE
occur	0
during	I-DISEASE
other	0
times	0
of	I-DISEASE
increased	0
slow	0
wave	I-DISEASE
sleep	0
,	I-DISEASE
such	I-DISEASE
as	I-DISEASE
during	I-DISEASE
recovery	0
sleep	0
following	0
sleep	0
deprivation	0
.	0

They	I-DISEASE
rarely	I-DISEASE
arise	I-DISEASE
from	I-DISEASE
a	0
daytime	I-DISEASE
nap	I-DISEASE
.	0

Disorders	I-DISEASE
of	I-DISEASE
arousal	0
are	0
encountered	0
most	I-DISEASE
commonly	0
in	0
children	B-DISEASE
and	0
typically	I-DISEASE
resolve	I-DISEASE
by	B-DISEASE
puberty	0
but	I-DISEASE
may	0
persist	0
(	I-DISEASE
or	0
,	I-DISEASE
infrequently	I-DISEASE
,	I-DISEASE
arise	I-DISEASE
de	I-DISEASE
novo	0
)	0
in	I-DISEASE
adolescence	0
or	0
adulthood	0
.	0

Confusional	I-DISEASE
Arousals	0
:	I-DISEASE
Confusional	0
arousals	0
,	I-DISEASE
unlike	I-DISEASE
sleepwalking	0
,	I-DISEASE
occur	0
with	0
the	0
patient	I-DISEASE
in	I-DISEASE
bed	I-DISEASE
.	0

When	I-DISEASE
the	0
patient	I-DISEASE
leaves	0
the	0
bed	I-DISEASE
,	0
sleepwalking	0
has	0
been	I-DISEASE
initiated	I-DISEASE
.	0

Confusional	0
arousals	0
often	0
start	0
with	I-DISEASE
the	0
individual	0
sitting	I-DISEASE
up	0
in	I-DISEASE
bed	I-DISEASE
and	0
looking	0
about	0
in	I-DISEASE
a	0
confused	0
manner	0
.	0

Sleepwalking	I-DISEASE
:	I-DISEASE
Sleepwalking	0
episodes	I-DISEASE
typically	0
begin	0
as	0
confusional	I-DISEASE
arousals	I-DISEASE
.	0

Sleepwalking	I-DISEASE
episodes	I-DISEASE
can	0
also	I-DISEASE
begin	I-DISEASE
with	I-DISEASE
the	0
individual	I-DISEASE
immediately	I-DISEASE
leaving	I-DISEASE
the	I-DISEASE
bed	I-DISEASE
and	0
walking	I-DISEASE
or	I-DISEASE
even	I-DISEASE
“	0
bolting	0
”	I-DISEASE
from	I-DISEASE
the	0
bed	I-DISEASE
and	0
running	0
.	I-DISEASE

Highly	I-DISEASE
inappropriate	0
,	I-DISEASE
agitated	0
,	I-DISEASE
resistive	I-DISEASE
,	0
belligerent	0
,	I-DISEASE
or	I-DISEASE
violent	I-DISEASE
behavior	I-DISEASE
can	I-DISEASE
also	I-DISEASE
occur	0
.	0

Behaviors	I-DISEASE
can	0
be	0
simple	I-DISEASE
and	0
non	B-DISEASE
–	0
goal	0
-	I-DISEASE
directed	I-DISEASE
,	I-DISEASE
or	0
complex	0
and	0
protracted	0
,	0
and	0
may	0
involve	0
inappro-	0
priate	0
sexual	I-DISEASE
activity	0
with	0
oneself	I-DISEASE
or	0
an	0
individual	I-DISEASE
in	0
close	0
proximity	0
such	0
as	0
a	0
bed	I-DISEASE
partner	0
.	0

The	I-DISEASE
ambulation	I-DISEASE
may	0
terminate	I-DISEASE
spontaneously	I-DISEASE
,	0
at	I-DISEASE
times	0
in	I-DISEASE
inappropriate	I-DISEASE
places	I-DISEASE
,	0
or	I-DISEASE
the	0
sleepwalker	I-DISEASE
may	I-DISEASE
return	0
to	0
bed	I-DISEASE
,	I-DISEASE
lie	I-DISEASE
down	0
,	I-DISEASE
and	0
continue	0
to	0
sleep	0
without	0
reach-	0
ing	0
conscious	0
awareness	0
at	I-DISEASE
any	I-DISEASE
point	0
.	0

The	I-DISEASE
sleepwalking	0
individual	0
is	I-DISEASE
disoriented	I-DISEASE
in	0
time	0
and	0
place	I-DISEASE
,	0
with	0
slow	0
speech	I-DISEASE
,	0
with	0
severely	I-DISEASE
diminished	I-DISEASE
mentation	0
,	I-DISEASE
and	0
blunted	0
response	0
to	I-DISEASE
questions	0
or	B-DISEASE
requests	0
.	0

There	I-DISEASE
is	0
often	0
prominent	0
anterograde	0
and	0
retrograde	0
memory	0
impairment	I-DISEASE
.	0

Despite	I-DISEASE
diminished	I-DISEASE
external	0
perception	I-DISEASE
as	0
a	0
result	0
of	I-DISEASE
blockade	0
of	I-DISEASE
sensory	I-DISEASE
input	I-DISEASE
,	I-DISEASE
the	0
individual	0
may	I-DISEASE
appear	I-DISEASE
to	I-DISEASE
be	0
awake	0
during	I-DISEASE
some	I-DISEASE
or	0
most	0
of	I-DISEASE
a	I-DISEASE
disorder	0
of	I-DISEASE
arousal	0
with	I-DISEASE
reduced	0
vigilance	I-DISEASE
and	0
impaired	I-DISEASE
cognitive	0
response	0
.	0

Sleep	I-DISEASE
Terrors	I-DISEASE
:	I-DISEASE
Sleep	0
terrors	0
differ	I-DISEASE
from	0
other	0
disorders	0
of	I-DISEASE
arousal	I-DISEASE
in	I-DISEASE
that	0
the	0
events	0
are	I-DISEASE
often	0
accompanied	0
by	I-DISEASE
a	0
cry	0
or	0
piercing	0
scream	I-DISEASE
,	0
accompanied	I-DISEASE
by	0
autonomic	0
nervous	0
system	0
and	0
behavioral	0
manifestations	0
of	I-DISEASE
intense	0
fear	0
.	0

There	I-DISEASE
is	I-DISEASE
often	0
intense	I-DISEASE
autonomic	0
discharge	0
,	0
with	0
tachycardia	0
,	0
tachypnea	0
,	0
flushing	0
of	I-DISEASE
the	0
skin	0
,	I-DISEASE
diaphoresis	0
,	I-DISEASE
mydriasis	0
,	0
and	0
increased	0
muscle	0
tone	I-DISEASE
.	0

The	I-DISEASE
person	0
usually	I-DISEASE
sits	I-DISEASE
up	0
in	I-DISEASE
bed	I-DISEASE
;	I-DISEASE
is	0
unresponsive	0
to	0
exter-	I-DISEASE
nal	0
stimuli	0
;	0
and	0
,	0
if	0
awakened	I-DISEASE
,	0
is	I-DISEASE
confused	I-DISEASE
and	0
disoriented	0
.	0

However	I-DISEASE
,	I-DISEASE
bolting	0
out	0
of	I-DISEASE
bed	I-DISEASE
and	0
running	0
is	0
not	0
uncommon	0
in	I-DISEASE
adults	I-DISEASE
and	0
also	0
can	I-DISEASE
be	I-DISEASE
associated	0
with	0
violent	I-DISEASE
behav-	0
iors	I-DISEASE
,	I-DISEASE
particularly	0
if	0
attempts	I-DISEASE
are	I-DISEASE
made	0
to	I-DISEASE
block	I-DISEASE
or	0
restrain	0
the	0
individual	0
.	0

The	I-DISEASE
sleep	0
terror	0
episode	I-DISEASE
may	0
be	I-DISEASE
accompanied	0
by	I-DISEASE
incoherent	0
vocalizations	I-DISEASE
.	0

Sometimes	I-DISEASE
there	I-DISEASE
is	0
prolonged	0
inconsolability	0
associated	0
with	0
a	0
sleep	0
terror	I-DISEASE
in	I-DISEASE
children	0
or	0
adults	B-DISEASE
.	0

Associated	I-DISEASE
Features	I-DISEASE
Disorders	I-DISEASE
of	I-DISEASE
arousal	0
are	I-DISEASE
devoid	0
of	I-DISEASE
higher	0
cognitive	0
functions	I-DISEASE
such	I-DISEASE
as	0
planning	I-DISEASE
,	I-DISEASE
memory	I-DISEASE
from	0
before	0
an	0
incident	I-DISEASE
,	I-DISEASE
formation	0
of	I-DISEASE
a	I-DISEASE
memory	0
during	I-DISEASE
an	0
incident	I-DISEASE
,	I-DISEASE
true	B-DISEASE
social	0
inter-	I-DISEASE
action	I-DISEASE
,	0
or	0
recognition	I-DISEASE
of	I-DISEASE
others	0
.	0

Patients	I-DISEASE
exhibiting	I-DISEASE
disorders	0
of	I-DISEASE
arousal	I-DISEASE
are	0
not	I-DISEASE
con-	0
sciously	0
aware	I-DISEASE
and	0
behaviors	I-DISEASE
are	I-DISEASE
often	I-DISEASE
thought	0
to	0
be	I-DISEASE
“	I-DISEASE
automatic	I-DISEASE
”	I-DISEASE
in	I-DISEASE
nature	I-DISEASE
.	0

Self	I-DISEASE
-	I-DISEASE
injury	0
may	I-DISEASE
occur	0
as	0
well	I-DISEASE
as	B-DISEASE
injury	0
to	0
others	B-DISEASE
in	I-DISEASE
close	I-DISEASE
proximity	I-DISEASE
.	0

Disorders	I-DISEASE
of	I-DISEASE
arousal	0
,	I-DISEASE
in	I-DISEASE
particular	I-DISEASE
sleepwalking	0
,	I-DISEASE
can	I-DISEASE
involve	I-DISEASE
normal	B-DISEASE
,	I-DISEASE
routine	I-DISEASE
behav-	I-DISEASE
iors	I-DISEASE
that	0
are	I-DISEASE
inappropriate	0
only	0
in	I-DISEASE
regard	0
to	I-DISEASE
their	0
timing	I-DISEASE
.	0

More	I-DISEASE
often	0
,	0
however	I-DISEASE
,	0
sleep-	0
walking	I-DISEASE
involves	0
inappropriate	0
behaviors	I-DISEASE
,	I-DISEASE
such	I-DISEASE
as	0
urinating	0
in	I-DISEASE
a	0
wastebasket	0
,	0
moving	I-DISEASE
furniture	0
around	B-DISEASE
haphazardly	0
,	I-DISEASE
or	B-DISEASE
climbing	0
out	0
a	0
window	I-DISEASE
.	0

Sleepwalkers	I-DISEASE
are	I-DISEASE
sometimes	0
able	0
to	I-DISEASE
navigate	I-DISEASE
in	0
familiar	0
surroundings	0
,	I-DISEASE
but	I-DISEASE
are	I-DISEASE
prone	0
to	I-DISEASE
bumping	I-DISEASE
into	I-DISEASE
objects	I-DISEASE
or	I-DISEASE
falling	0
down	I-DISEASE
.	0

A	I-DISEASE
sudden	0
arousal	0
consistent	I-DISEASE
with	0
sleep	0
terrors	0
may	0
segue	I-DISEASE
rapidly	0
into	I-DISEASE
agitated	0
sleepwalking	0
and	0
panicky	0
running	0
and	0
other	I-DISEASE
potentially	0
dangerous	0
behav-	I-DISEASE
iors	I-DISEASE
.	B-DISEASE

Self	I-DISEASE
-	I-DISEASE
injury	0
is	I-DISEASE
not	0
unusual	I-DISEASE
and	0
when	I-DISEASE
resulting	0
in	0
death	0
has	0
been	I-DISEASE
given	0
the	0
term	0
of	I-DISEASE
Parasomnias	I-DISEASE
Parasomnias	0
“	I-DISEASE
parasomnia	I-DISEASE
pseudosuicide	0
.	0
”	0

Cuts	I-DISEASE
,	0
bruises	0
,	0
and	0
other	I-DISEASE
injuries	I-DISEASE
may	0
occur	0
—	I-DISEASE
often	I-DISEASE
to	I-DISEASE
the	0
surprise	0
of	I-DISEASE
the	0
sleepwalker	I-DISEASE
once	I-DISEASE
awake	0
.	0

Sleepwalkers	I-DISEASE
are	I-DISEASE
reported	0
to	I-DISEASE
have	0
a	I-DISEASE
high	I-DISEASE
tol-	0
erance	I-DISEASE
for	0
pain	0
.	0

Knife	I-DISEASE
cuts	0
,	I-DISEASE
burns	0
,	I-DISEASE
and	0
other	I-DISEASE
self	0
-	0
injury	I-DISEASE
sustained	0
during	I-DISEASE
sleepwalking	0
may	I-DISEASE
not	I-DISEASE
awaken	0
them	I-DISEASE
.	0

Violence	I-DISEASE
to	I-DISEASE
others	B-DISEASE
also	0
can	0
occur	I-DISEASE
with	I-DISEASE
adult	0
sleepwalking	0
,	I-DISEASE
especially	I-DISEASE
in	I-DISEASE
men	0
.	0

The	I-DISEASE
sleepwalker	0
does	0
not	0
generally	I-DISEASE
seek	I-DISEASE
out	0
the	0
eventual	I-DISEASE
victim	I-DISEASE
of	I-DISEASE
violence	I-DISEASE
.	0

More	I-DISEASE
typi-	I-DISEASE

cally	I-DISEASE
,	0
a	I-DISEASE
person	0
attempting	I-DISEASE
to	I-DISEASE
block	I-DISEASE
,	0
grab	I-DISEASE
,	0
restrain	I-DISEASE
,	I-DISEASE
redirect	0
or	I-DISEASE
awaken	0
a	0
sleepwalker	0
during	I-DISEASE
an	I-DISEASE
episode	0
may	I-DISEASE
be	0
violently	I-DISEASE
attacked	I-DISEASE
,	I-DISEASE
even	I-DISEASE
if	0
they	I-DISEASE
are	I-DISEASE
family	0
members	0
or	I-DISEASE
friends	0
.	0

This	I-DISEASE
may	I-DISEASE
result	0
in	I-DISEASE
a	0
form	I-DISEASE
of	I-DISEASE
primitive	I-DISEASE
defensive	B-DISEASE
aggression	0
including	0
pushing	0
,	I-DISEASE
hitting	I-DISEASE
,	0
kicking	0
,	I-DISEASE
or	I-DISEASE
throwing	0
objects	I-DISEASE
.	0

This	I-DISEASE
pattern	0
also	0
has	I-DISEASE
been	0
reported	I-DISEASE
in	I-DISEASE
the	I-DISEASE
sleep	0
laboratory	I-DISEASE
when	0
technical	I-DISEASE
personnel	I-DISEASE
have	I-DISEASE
attempted	I-DISEASE
to	I-DISEASE
return	I-DISEASE
sleepwalking	I-DISEASE
patients	I-DISEASE
to	0
bed	I-DISEASE
.	0

In	I-DISEASE
extreme	I-DISEASE
cases	0
,	I-DISEASE
victims	0
have	I-DISEASE
been	I-DISEASE
stabbed	0
with	0
knives	0
or	0
blunt	I-DISEASE
objects	I-DISEASE
.	0

Such	I-DISEASE
inappropriate	0
and	0
antisocial	0
behaviors	I-DISEASE
have	I-DISEASE
legal	0
and	0
forensic	0
implications	I-DISEASE
,	I-DISEASE
as	0
sleep-	0
walkers	I-DISEASE
have	0
been	0
arrested	0
and	0
charged	I-DISEASE
with	I-DISEASE
assault	0
and	0
battery	0
,	I-DISEASE
attempted	I-DISEASE
homicide	I-DISEASE
,	I-DISEASE
homicide	I-DISEASE
,	0
and	0
sexual	I-DISEASE
assault	0
with	I-DISEASE
indecency	0
.	0

The	I-DISEASE
child	0
with	0
calm	I-DISEASE
sleepwalking	0
may	I-DISEASE
quietly	0
walk	I-DISEASE
toward	I-DISEASE
a	0
light	I-DISEASE
or	I-DISEASE
to	0
the	0
parents	0
’	I-DISEASE
bedroom	0
.	0

Occasionally	0
,	I-DISEASE
children	0
will	0
walk	B-DISEASE
toward	I-DISEASE
a	0
window	I-DISEASE
or	0
door	0
or	0
even	I-DISEASE
go	I-DISEASE
outside	I-DISEASE
,	0
with	0
obvious	I-DISEASE
attendant	I-DISEASE
risk	0
.	0

Clinical	I-DISEASE
or	I-DISEASE
Pathophysiological	I-DISEASE
Subtypes	I-DISEASE
Sleep	0
related	I-DISEASE
abnormal	I-DISEASE
sexual	I-DISEASE
behaviors	0
are	0
primarily	I-DISEASE
classified	0
as	0
confusional	0
arous-	0
als	I-DISEASE
in	0
that	I-DISEASE
they	I-DISEASE
typically	0
occur	I-DISEASE
without	0
any	I-DISEASE
behaviors	I-DISEASE
outside	I-DISEASE
of	I-DISEASE
the	0
bed	0
(	I-DISEASE
or	0
chosen	0
sleep-	0
ing	0
accommodation	0
)	0
,	I-DISEASE
but	I-DISEASE
have	I-DISEASE
also	0
been	I-DISEASE
less	I-DISEASE
commonly	0
associated	0
with	0
sleepwalking	0
.	0

Other	I-DISEASE
terms	I-DISEASE
for	0
this	I-DISEASE
condition	0
include	I-DISEASE
“	I-DISEASE
atypical	I-DISEASE
sexual	I-DISEASE
behavior	I-DISEASE
during	I-DISEASE
sleep	0
,	0
”	I-DISEASE
“	I-DISEASE
sexsom-	I-DISEASE
nia	0
,	I-DISEASE
”	I-DISEASE
and	0
“	0
sleep	0
sex	0
.	0
”	I-DISEASE

Sleep	I-DISEASE
related	I-DISEASE
abnormal	0
sexual	I-DISEASE
behaviors	I-DISEASE
often	I-DISEASE
have	I-DISEASE
major	I-DISEASE
inter-	0
personal	I-DISEASE
,	I-DISEASE
clinical	I-DISEASE
,	I-DISEASE
and	0
occasional	I-DISEASE
criminal	I-DISEASE
consequences	I-DISEASE
.	0

The	I-DISEASE
set	I-DISEASE
of	I-DISEASE
abnormal	I-DISEASE
sexual	0
behaviors	I-DISEASE
during	I-DISEASE
disordered	I-DISEASE
arousals	0
includes	I-DISEASE
prolonged	I-DISEASE
or	I-DISEASE
violent	I-DISEASE
masturbation	0
,	0
sexual	0
molestation	0
and	0
assaults	I-DISEASE
(	I-DISEASE
of	0
minors	0
and	0
adults	I-DISEASE
)	0
,	I-DISEASE
initiation	I-DISEASE
of	I-DISEASE
sexual	I-DISEASE
intercourse	I-DISEASE
irre-	I-DISEASE
spective	0
of	0
the	0
menstrual	I-DISEASE
status	I-DISEASE
of	I-DISEASE
the	0
bed	I-DISEASE
partner	0
(	I-DISEASE
in	0
contrast	I-DISEASE
to	I-DISEASE
waking	0
intercourse	0
for	0
those	0
individuals	I-DISEASE
)	I-DISEASE
,	I-DISEASE
and	0
loud	I-DISEASE
(	I-DISEASE
sexual	0
)	0
vocalizations	0
during	I-DISEASE
sleep	0
—	I-DISEASE
followed	0
by	I-DISEASE
morning	0
amnesia	I-DISEASE
.	0

The	I-DISEASE
preponderance	I-DISEASE
of	I-DISEASE
patients	I-DISEASE
have	I-DISEASE
also	0
been	0
diagnosed	0
with	I-DISEASE
a	I-DISEASE
NREM	0
sleep	0
parasomnia	I-DISEASE
,	0
most	0
often	0
confusional	I-DISEASE
arousals	0
alone	I-DISEASE
but	I-DISEASE
on	0
occasion	I-DISEASE
with	0
sleepwalking	0
,	0
sleep	0
related	B-DISEASE
driving	0
,	0
or	0
sleep	0
related	0
eating	I-DISEASE
disorder	I-DISEASE
.	0

Obstructive	I-DISEASE
sleep	0
apnea	I-DISEASE
(	I-DISEASE
OSA	0
)	0
is	I-DISEASE
another	I-DISEASE
recognized	0
precipitant	I-DISEASE
of	0
sleep	0
related	0
abnormal	I-DISEASE
sexual	I-DISEASE
behaviors	I-DISEASE
.	0

The	I-DISEASE
presence	0
of	I-DISEASE
an	0
overlap	0
disorder	I-DISEASE
,	0
in	I-DISEASE
which	0
RBD	0
and	0
a	I-DISEASE
partial	I-DISEASE
arousal	0
disorder	I-DISEASE
(	I-DISEASE
sleepwalking	I-DISEASE
or	I-DISEASE
sleep	0
terrors	0
)	0
are	I-DISEASE
comorbid	0
in	I-DISEASE
a	0
patient	I-DISEASE
,	0
may	0
complicate	I-DISEASE
diagnosis	I-DISEASE
of	0
each	I-DISEASE
condition	0
.	0

Careful	I-DISEASE
review	0
of	I-DISEASE
history	I-DISEASE
and	0
use	0
of	I-DISEASE
polysomnography	0
may	0
facilitate	0
identification	0
of	I-DISEASE
this	0
presentation	0
.	0

Demographics	I-DISEASE
There	0
is	0
no	0
sex	0
difference	0
with	0
disorders	0
of	I-DISEASE
arousals	I-DISEASE
.	0

They	I-DISEASE
are	0
especially	0
prevalent	I-DISEASE
among	0
children	I-DISEASE
and	0
adults	I-DISEASE
younger	0
than	0
35	0
years	0
.	0

The	I-DISEASE
prevalence	0
rate	0
of	I-DISEASE
confusional	0
arousals	0
and	0
sleepwalking	0
are	I-DISEASE
similar	I-DISEASE
.	0

The	I-DISEASE
prevalence	0
of	I-DISEASE
confusional	I-DISEASE
arousals	0
in	I-DISEASE
children	0
three	0
to	0
13	0
years	I-DISEASE
of	I-DISEASE
age	I-DISEASE
in	I-DISEASE
a	0
large	I-DISEASE
population	0
-	0
based	I-DISEASE
study	0
was	0
17.3	0
%	0
.	0

Lifetime	I-DISEASE
prevalence	I-DISEASE
of	I-DISEASE
confusional	I-DISEASE
arousals	I-DISEASE
has	I-DISEASE
recently	0
been	I-DISEASE
reported	0
as	0
18.5	I-DISEASE
%	0
(	I-DISEASE
16.1	I-DISEASE
-	I-DISEASE
20.9	0
confidence	0
interval	I-DISEASE
)	0
.	I-DISEASE

The	I-DISEASE
prevalence	0
among	0
adults	I-DISEASE
older	0
than	0
15	0
years	I-DISEASE
is	0
2.9	0
%	0
to	I-DISEASE
4.2	0
%	0
.	0

The	I-DISEASE
lifetime	0
prevalence	0
of	I-DISEASE
sleepwalking	0
is	I-DISEASE
as	0
high	0
as	0
18.3	0
%	0
.	0

A	I-DISEASE
recent	I-DISEASE
study	0
of	I-DISEASE
“	0
noctur-	0
nal	0
wandering	0
”	I-DISEASE
that	0
likely	0
included	I-DISEASE
a	0
large	I-DISEASE
percentage	0
of	0
sleepwalkers	0
reported	0
a	0
life-	I-DISEASE
time	0
prevalence	0
of	I-DISEASE
29.2	I-DISEASE
%	0
.	0

A	I-DISEASE
Swedish	I-DISEASE
study	0
of	I-DISEASE
children	0
aged	I-DISEASE
6	0
-	0
16	0
years	0
found	I-DISEASE
the	0
inci-	I-DISEASE
dence	0
of	I-DISEASE
sleepwalking	0
to	0
be	I-DISEASE
40	0
%	0
.	0

Up	I-DISEASE
to	I-DISEASE
4.3	0
%	0
of	I-DISEASE
adults	I-DISEASE
sleepwalk	0
.	0

In	I-DISEASE
one	0
series	I-DISEASE
,	I-DISEASE
one	0
third	I-DISEASE
of	I-DISEASE
54	I-DISEASE
adult	0
patients	0
with	I-DISEASE
injurious	I-DISEASE
sleepwalking	0
(	I-DISEASE
with	0
or	0
without	0
night	0
terrors	0
)	0
began	I-DISEASE
sleepwalking	0
after	0
16	I-DISEASE
years	I-DISEASE
of	I-DISEASE
age	I-DISEASE
.	0

The	I-DISEASE
prevalence	0
of	I-DISEASE
sleep	0
terrors	0
has	0
not	0
been	I-DISEASE
studied	0
as	0
thoroughly	I-DISEASE
.	I-DISEASE

Prevalence	I-DISEASE
rates	0
of	I-DISEASE
1	0
%	0
to	I-DISEASE
6.5	0
%	0
in	I-DISEASE
children	I-DISEASE
and	0
2.2	0
%	0
in	0
adults	0
have	0
been	I-DISEASE
reported	0
,	0
with	0
a	I-DISEASE
virtually	0
constant	I-DISEASE
prevalence	0
rate	I-DISEASE
of	I-DISEASE
2.3	B-DISEASE
%	0
to	I-DISEASE
2.6	0
%	0
in	0
the	0
15	0
-	0
year	0
-	I-DISEASE
old	I-DISEASE
to	I-DISEASE
64	I-DISEASE
-	0
year	0
-	0
old	B-DISEASE
age	I-DISEASE
group	I-DISEASE
,	0
before	I-DISEASE
falling	0
to	0
1	0
%	0
in	0
the	I-DISEASE
older	I-DISEASE
than	I-DISEASE
65	0
years	0
age	I-DISEASE
group	I-DISEASE
.	0

Other	0
studies	I-DISEASE
have	0
reported	I-DISEASE
the	0
intermittent	I-DISEASE
appearance	I-DISEASE
of	I-DISEASE
sleep	0
terrors	0
in	I-DISEASE
25	I-DISEASE
%	0
of	0
children	0
younger	0
than	I-DISEASE
five	0
years	0
.	0

Predisposing	I-DISEASE
and	0
Precipitating	I-DISEASE
Factors	0
Disorders	I-DISEASE
of	I-DISEASE
arousal	0
are	I-DISEASE
most	I-DISEASE
often	0
evaluated	0
in	I-DISEASE
terms	I-DISEASE
of	I-DISEASE
predisposing	0
,	I-DISEASE
priming	0
,	I-DISEASE
and	0
precipitating	0
(	0
triggering	I-DISEASE
)	0
factors	0
.	0

Most	I-DISEASE
often	0
a	0
simultaneous	I-DISEASE
co	0
-	I-DISEASE
occurrence	0
of	I-DISEASE
these	I-DISEASE
factors	0
is	0
thought	0
necessary	I-DISEASE
in	I-DISEASE
order	0
for	0
a	0
disorder	I-DISEASE
of	0
arousal	0
occur	I-DISEASE
.	0

However	I-DISEASE
,	I-DISEASE
the	0
reason	0
a	0
disorder	I-DISEASE
of	I-DISEASE
arousal	I-DISEASE
occurs	0
on	0
one	0
night	0
and	0
not	0
others	B-DISEASE
is	I-DISEASE
not	0
fully	I-DISEASE
understood	0
.	0

A	I-DISEASE
genetic	I-DISEASE
predisposition	0
has	0
been	I-DISEASE
hypothesized	I-DISEASE
and	0
several	I-DISEASE
studies	I-DISEASE
have	0
identified	I-DISEASE
dif-	I-DISEASE
ferent	I-DISEASE
genetic	I-DISEASE
loci	0
and	0
modes	0
of	I-DISEASE
inheritance	I-DISEASE
(	I-DISEASE
see	I-DISEASE
Familial	I-DISEASE
Pattern	0
,	0
below	I-DISEASE
)	0
.	0

In	I-DISEASE
childhood	0
,	I-DISEASE
disorder	I-DISEASE
of	I-DISEASE
arousal	I-DISEASE
can	I-DISEASE
usually	I-DISEASE
be	0
considered	0
an	0
expected	I-DISEASE
and	0
normal	0
developmental	I-DISEASE
sleep	I-DISEASE
phenomenon	0
,	I-DISEASE
apart	0
from	0
those	I-DISEASE
cases	0
with	I-DISEASE
clinical	I-DISEASE
consequences	I-DISEASE
.	I-DISEASE

However	I-DISEASE
,	I-DISEASE
dis-	0
orders	I-DISEASE
of	I-DISEASE
arousal	I-DISEASE
that	0
persist	0
beyond	0
adolescence	I-DISEASE
or	I-DISEASE
begin	I-DISEASE
in	I-DISEASE
adulthood	0
can	0
often	0
be	0
problematic	I-DISEASE
and	0
may	I-DISEASE
require	I-DISEASE
clinical	0
attention	0
.	0

Parasomnias	I-DISEASE
Parasomnias	I-DISEASE
Many	0
priming	0
factors	B-DISEASE
for	0
disorders	0
of	I-DISEASE
arousal	0
,	0
in	I-DISEASE
particular	I-DISEASE
sleepwalking	0
,	I-DISEASE
have	0
been	I-DISEASE
identified	I-DISEASE
.	0

Sleep	I-DISEASE
deprivation	0
and	0
situational	I-DISEASE
stress	0
are	0
the	0
most	0
potent	I-DISEASE
factors	I-DISEASE
.	0

Hyperthyroidism	I-DISEASE
,	I-DISEASE
migraines	0
,	0
head	I-DISEASE
injury	0
,	I-DISEASE
encephalitis	I-DISEASE
,	0
stroke	0
,	I-DISEASE
and	0
other	I-DISEASE
conditions	I-DISEASE
have	I-DISEASE
also	0
been	0
reported	I-DISEASE
much	I-DISEASE
more	0
rarely	I-DISEASE
as	B-DISEASE
potential	0
priming	0
factors	0
.	0

OSA	I-DISEASE
and	0
other	I-DISEASE
sleep	0
related	0
respiratory	0
events	I-DISEASE
are	0
increasingly	0
recognized	0
precipitants	I-DISEASE
of	I-DISEASE
disorders	0
of	I-DISEASE
arousal	0
in	0
both	I-DISEASE
children	I-DISEASE
and	0
adults	B-DISEASE
.	0

Treatment	I-DISEASE
of	I-DISEASE
these	0
comorbid	I-DISEASE
con-	0
ditions	0
may	I-DISEASE
reduce	I-DISEASE
or	I-DISEASE
eliminate	I-DISEASE
the	0
occurrence	0
of	I-DISEASE
disorders	I-DISEASE
of	0
arousal	0
.	0

Disorders	I-DISEASE
of	I-DISEASE
arousal	0
may	I-DISEASE
also	0
be	I-DISEASE
triggered	0
by	I-DISEASE
environmental	I-DISEASE
stimuli	I-DISEASE
such	I-DISEASE
as	I-DISEASE
telephone	0
calls	0
,	I-DISEASE
pagers	I-DISEASE
,	0
messaging	I-DISEASE
from	I-DISEASE
electronic	0
devices	I-DISEASE
,	I-DISEASE
and	0
a	I-DISEASE
host	0
of	I-DISEASE
other	I-DISEASE
stimuli	I-DISEASE
.	0

It	I-DISEASE
is	I-DISEASE
clinically	0
important	0
to	I-DISEASE
note	0
that	0
first	0
responders	0
,	I-DISEASE
physicians	I-DISEASE
,	I-DISEASE
and	0
others	I-DISEASE
on	0
call	I-DISEASE
may	0
be	0
vulnerable	I-DISEASE
to	0
such	0
stimuli	0
,	I-DISEASE
increasing	I-DISEASE
the	0
potential	I-DISEASE
for	0
inappropriate	0
responses	I-DISEASE
and	0
behavior	I-DISEASE
.	0

Travel	I-DISEASE
,	I-DISEASE
sleeping	0
in	I-DISEASE
unfamiliar	0
surroundings	0
,	0
febrile	I-DISEASE
states	I-DISEASE
in	I-DISEASE
children	B-DISEASE
,	0
physical	0
or	I-DISEASE
emo-	I-DISEASE
tional	0
stress	I-DISEASE
in	0
adults	0
,	I-DISEASE
the	0
premenstrual	0
period	0
in	I-DISEASE
women	I-DISEASE
,	0
as	0
well	0
as	0
the	0
use	0
of	I-DISEASE
psycho-	0
tropic	I-DISEASE
medications	I-DISEASE
such	0
as	0
lithium	I-DISEASE
carbonate	0
,	0
phenothiazines	0
,	I-DISEASE
anticholinergic	I-DISEASE
agents	0
,	I-DISEASE
and	0
sedative	I-DISEASE
/	I-DISEASE
hypnotic	0
agents	0
have	0
been	I-DISEASE
associated	0
with	I-DISEASE
the	0
onset	0
of	I-DISEASE
sleepwalking	0
,	0
but	0
a	0
causal	0
relationship	0
has	0
yet	0
to	I-DISEASE
be	I-DISEASE
established	0
.	0

Alcohol	I-DISEASE
has	0
been	0
identified	I-DISEASE
in	I-DISEASE
previous	I-DISEASE
reports	0
as	0
a	0
potential	I-DISEASE
sleepwalking	I-DISEASE
trigger	I-DISEASE
.	0

However	I-DISEASE
,	I-DISEASE
the	0
amnesia	I-DISEASE
associated	0
with	I-DISEASE
dis-	I-DISEASE
orders	I-DISEASE
of	I-DISEASE
arousal	I-DISEASE
makes	I-DISEASE
these	0
reports	I-DISEASE
unreliable	I-DISEASE
.	0

More	0
recent	I-DISEASE
evidence	0
-	I-DISEASE
based	0
reviews	0
have	0
found	I-DISEASE
no	0
compelling	0
relationship	0
between	0
alcohol	I-DISEASE
and	0
disorders	0
of	I-DISEASE
arousal	0
.	0

Internal	I-DISEASE
stimuli	I-DISEASE
,	0
such	I-DISEASE
as	0
a	0
distended	I-DISEASE
bladder	I-DISEASE
,	I-DISEASE
or	I-DISEASE
external	I-DISEASE
stimuli	0
,	0
such	I-DISEASE
as	0
noise	I-DISEASE
or	0
light	0
,	I-DISEASE
can	0
also	0
precipitate	0
episodes	I-DISEASE
.	0

There	I-DISEASE
is	0
no	0
significant	0
association	0
between	0
childhood	0
disorders	0
of	0
arousal	0
and	0
psycho-	0
pathology	I-DISEASE
.	0

In	I-DISEASE
adult	0
sleepwalking	0
,	I-DISEASE
although	0
a	I-DISEASE
considerable	0
number	0
of	I-DISEASE
patients	I-DISEASE
may	I-DISEASE
have	I-DISEASE
a	0
past	I-DISEASE
or	I-DISEASE
current	I-DISEASE
history	I-DISEASE
of	0
nonpsychotic	I-DISEASE
depressive	0
and	0
anxiety	I-DISEASE
disorders	0
,	I-DISEASE
it	0
does	I-DISEASE
not	0
appear	I-DISEASE
that	0
the	0
psychiatric	0
disorder	0
and	0
sleepwalking	0
,	0
in	0
particular	I-DISEASE
,	0
are	I-DISEASE
tightly	I-DISEASE
linked	0
.	0

In	I-DISEASE
addition	0
,	0
when	I-DISEASE
the	0
two	I-DISEASE
conditions	I-DISEASE
emerge	I-DISEASE
in	0
close	0
temporal	0
proximity	I-DISEASE
,	I-DISEASE
control	I-DISEASE
of	I-DISEASE
the	0
psychiatric	I-DISEASE
disorder	I-DISEASE
often	0
does	0
not	0
control	0
the	0
parasomnia	I-DISEASE
,	I-DISEASE
for	0
which	I-DISEASE
separate	0
treatment	I-DISEASE
is	0
required	0
.	0

Familial	I-DISEASE
Pattern	I-DISEASE
Genetic	I-DISEASE
factors	I-DISEASE
appear	0
to	0
play	I-DISEASE
an	0
important	I-DISEASE
role	I-DISEASE
in	0
all	0
of	I-DISEASE
the	I-DISEASE
disorders	0
of	I-DISEASE
arousal	I-DISEASE
.	0

However	I-DISEASE
,	I-DISEASE
published	0
research	0
data	0
exist	I-DISEASE
primarily	I-DISEASE
for	I-DISEASE
patients	0
who	0
sleepwalk	0
.	I-DISEASE

Sleepwalking	I-DISEASE
has	0
a	0
familial	I-DISEASE
pattern	0
.	0

The	I-DISEASE
rate	0
of	I-DISEASE
childhood	0
sleepwalking	0
increases	0
in	0
relation	0
to	0
the	0
number	0
of	I-DISEASE
affected	0
parents	0
:	I-DISEASE
22	I-DISEASE
%	0
when	0
neither	B-DISEASE
parent	0
has	0
the	0
disor-	0
der	I-DISEASE
,	0
45	I-DISEASE
%	0
if	0
one	0
parent	0
is	0
affected	0
,	0
and	0
60	0
%	0
when	0
both	I-DISEASE
are	0
affected	0
.	0

Population	0
-	I-DISEASE
based	I-DISEASE
studies	I-DISEASE
of	0
monozygotic	I-DISEASE
and	0
dizygotic	I-DISEASE
twins	I-DISEASE
suggest	I-DISEASE
that	I-DISEASE
genetic	0
factors	0
play	I-DISEASE
a	0
role	0
in	I-DISEASE
65	0
%	0
of	0
cases	0
of	I-DISEASE
sleepwalking	0
.	0

Different	I-DISEASE
models	0
of	I-DISEASE
modes	0
of	0
inheritance	I-DISEASE
includ-	I-DISEASE
ing	0
multifactorial	I-DISEASE
,	I-DISEASE
recessive	I-DISEASE
with	I-DISEASE
incomplete	0
penetrance	0
,	I-DISEASE
and	0
autosomal	0
dominant	I-DISEASE
trait	0
with	I-DISEASE
reduced	0
penetrance	I-DISEASE
have	0
been	I-DISEASE
proposed	I-DISEASE
,	0
based	B-DISEASE
primarily	0
on	0
analysis	I-DISEASE
of	I-DISEASE
family	I-DISEASE
histories	I-DISEASE
.	0

However	I-DISEASE
,	I-DISEASE
these	I-DISEASE
finding	I-DISEASE
are	0
not	0
sufficiently	I-DISEASE
specific	I-DISEASE
to	0
be	0
used	0
for	I-DISEASE
diagnostic	I-DISEASE
testing	I-DISEASE
.	0

Further	I-DISEASE
,	I-DISEASE
the	0
mechanisms	I-DISEASE
by	0
which	0
a	0
genetic	I-DISEASE
predisposition	0
for	0
confusional	I-DISEASE
arousal	0
or	I-DISEASE
other	I-DISEASE
related	I-DISEASE
disorders	0
contributes	0
to	I-DISEASE
their	0
occurrence	0
are	0
not	0
known	I-DISEASE
.	0

Onset	I-DISEASE
,	0
Course	0
,	0
and	0
Complications	0
Confusional	0
arousals	I-DISEASE
most	0
often	0
appear	I-DISEASE
in	0
early	0
childhood	0
around	0
the	0
age	I-DISEASE
of	I-DISEASE
two	I-DISEASE
years	0
.	0

This	I-DISEASE
childhood	0
form	0
of	I-DISEASE
confusional	0
arousals	0
is	0
typically	0
benign	0
,	I-DISEASE
but	I-DISEASE
may	0
cause	I-DISEASE
concern	I-DISEASE
in	I-DISEASE
parents	0
.	0

Confusional	0
arousals	0
of	I-DISEASE
early	0
childhood	I-DISEASE
diminish	0
in	I-DISEASE
occurrence	I-DISEASE
after	I-DISEASE
the	0
age	I-DISEASE
of	I-DISEASE
five	I-DISEASE
years	0
.	0

Sleepwalking	I-DISEASE
can	I-DISEASE
begin	0
as	0
soon	I-DISEASE
as	I-DISEASE
a	0
child	0
is	0
able	0
to	I-DISEASE
walk	I-DISEASE
but	I-DISEASE
may	I-DISEASE
begin	I-DISEASE
at	I-DISEASE
almost	0
any	I-DISEASE
time	I-DISEASE
in	I-DISEASE
the	0
life	0
cycle	0
,	I-DISEASE
including	0
as	0
late	I-DISEASE
as	I-DISEASE
the	0
seventh	0
decade	0
.	B-DISEASE

Sleepwalking	I-DISEASE
is	0
often	0
preceded	I-DISEASE
by	I-DISEASE
confusional	I-DISEASE
arousals	0
.	0

Childhood	I-DISEASE
sleepwalking	0
usually	I-DISEASE
disappears	I-DISEASE
sponta-	I-DISEASE
neously	I-DISEASE
around	0
puberty	I-DISEASE
but	I-DISEASE
may	0
persist	0
into	I-DISEASE
adolescence	I-DISEASE
.	I-DISEASE

Episodes	I-DISEASE
can	0
occur	I-DISEASE
sporad-	0
ically	0
or	I-DISEASE
with	I-DISEASE
high	I-DISEASE
frequency	I-DISEASE
,	I-DISEASE
such	0
as	I-DISEASE
multiple	0
times	0
nightly	I-DISEASE
for	I-DISEASE
several	0
consecutive	I-DISEASE
nights	I-DISEASE
.	0

Sleepwalking	I-DISEASE
may	I-DISEASE
occur	0
for	0
the	0
first	I-DISEASE
time	0
in	0
adulthood	0
or	I-DISEASE
may	I-DISEASE
recur	B-DISEASE
in	I-DISEASE
adult-	0
hood	0
during	I-DISEASE
periods	0
of	I-DISEASE
sleep	0
deprivation	0
or	0
stress	I-DISEASE
.	0

Sleep	I-DISEASE
terrors	I-DISEASE
usually	I-DISEASE
emerge	0
in	I-DISEASE
children	I-DISEASE
aged	I-DISEASE
four	B-DISEASE
to	0
12	I-DISEASE
years	I-DISEASE
(	I-DISEASE
but	I-DISEASE
can	0
also	0
emerge	I-DISEASE
in	I-DISEASE
adulthood	0
)	0
and	0
tend	I-DISEASE
to	I-DISEASE
resolve	0
spontaneously	I-DISEASE
by	B-DISEASE
early	I-DISEASE
adolescence	0
,	I-DISEASE
as	0
does	I-DISEASE
sleep-	I-DISEASE
walking	0
.	0

Social	I-DISEASE
embarrassment	I-DISEASE
over	0
the	0
sleep	0
terrors	0
can	I-DISEASE
impair	0
social	0
relationships	I-DISEASE
in	I-DISEASE
children	I-DISEASE
and	0
adults	I-DISEASE
.	0

Serious	I-DISEASE
or	I-DISEASE
even	I-DISEASE
lethal	0
injuries	I-DISEASE
can	I-DISEASE
occur	I-DISEASE
.	0

Developmental	I-DISEASE
Issues	0
As	I-DISEASE
noted	0
above	0
,	I-DISEASE
disorders	0
of	I-DISEASE
arousal	0
most	0
often	I-DISEASE
occur	I-DISEASE
initially	I-DISEASE
in	0
childhood	0
and	0
decrease	I-DISEASE
in	0
occurrence	0
steadily	I-DISEASE
until	0
young	I-DISEASE
adulthood	0
.	0

However	I-DISEASE
,	I-DISEASE
they	0
may	I-DISEASE
occur	0
for	I-DISEASE
the	0
first	I-DISEASE
time	0
in	0
adulthood	0
or	I-DISEASE
reappear	I-DISEASE
after	0
many	0
asymptomatic	I-DISEASE
years	I-DISEASE
,	I-DISEASE
often	0
related	I-DISEASE
to	0
stress	I-DISEASE
,	I-DISEASE
sleep	0
deprivation	I-DISEASE
,	I-DISEASE
or	0
development	B-DISEASE
of	0
another	I-DISEASE
sleep	0
disorder	0
.	0

Pathology	I-DISEASE
and	0
Pathophysiology	I-DISEASE
The	I-DISEASE
overwhelming	0
majority	0
of	I-DISEASE
individuals	I-DISEASE
with	I-DISEASE
disorders	0
of	I-DISEASE
arousal	0
do	I-DISEASE
not	0
have	0
neuro-	I-DISEASE
logical	0
or	0
psychological	I-DISEASE
pathology	0
.	0

There	I-DISEASE
are	0
rare	I-DISEASE
reported	I-DISEASE
cases	0
of	I-DISEASE
confusional	I-DISEASE
arous-	0
als	I-DISEASE
associated	0
with	0
brain	I-DISEASE
lesions	0
in	I-DISEASE
areas	0
subserving	0
arousal	0
,	0
such	0
as	0
the	0
posterior	I-DISEASE
hypothalamus	I-DISEASE
,	0
midbrain	I-DISEASE
reticular	0
area	0
,	0
and	0
periventricular	0
gray	I-DISEASE
matter	0
.	0

However	I-DISEASE
,	I-DISEASE
data	0
from	I-DISEASE
a	0
single	0
patient	I-DISEASE
with	I-DISEASE
confusional	0
arousals	0
suggest	I-DISEASE
that	0
they	0
may	0
be	I-DISEASE
due	I-DISEASE
to	0
a	0
func-	0
tional	0
abnormality	I-DISEASE
in	I-DISEASE
the	0
brain	0
that	0
leaves	0
some	0
regions	0
,	0
such	0
as	0
hippocampus	0
and	0
Parasomnias	0
Parasomnias	I-DISEASE
frontal	0
associative	0
cortices	0
,	0
asleep	0
,	I-DISEASE
while	I-DISEASE
other	I-DISEASE
parts	0
of	I-DISEASE
the	0
brain	I-DISEASE
such	0
as	0
motor	I-DISEASE
,	I-DISEASE
cingu-	I-DISEASE
late	I-DISEASE
,	0
insular	0
,	I-DISEASE
amygdala	0
,	I-DISEASE
and	0
temporopolar	I-DISEASE
cortices	0
,	0
are	0
active	I-DISEASE
or	I-DISEASE
awake	0
.	0

It	I-DISEASE
is	I-DISEASE
generally	I-DISEASE
considered	I-DISEASE
that	0
disorders	0
of	I-DISEASE
arousal	I-DISEASE
represent	0
a	0
dissociation	0
of	I-DISEASE
different	0
regions	I-DISEASE
of	I-DISEASE
the	I-DISEASE
brain	0
in	0
addition	0
to	0
activation	I-DISEASE
of	I-DISEASE
locomotor	0
centers	0
/	0
central	0
pattern	0

gen-	I-DISEASE
erators	0
,	I-DISEASE
accompanied	I-DISEASE
by	I-DISEASE
sleep	0
inertia	I-DISEASE
and	0
sleep	I-DISEASE
state	B-DISEASE
instability	I-DISEASE
.	0

Objective	I-DISEASE
Findings	I-DISEASE

Although	I-DISEASE
not	0
routinely	0
indicated	I-DISEASE
for	0
the	0
evaluation	I-DISEASE
of	I-DISEASE
typical	0
,	0
uncomplicated	I-DISEASE
,	0
and	0
non-	I-DISEASE
injurious	0
parasomnias	I-DISEASE
,	0
polysomnographic	0
studies	I-DISEASE
demonstrate	I-DISEASE
that	0
disorders	0
of	0
arousal	0
typically	0
begin	0
after	0
an	0
arousal	0
from	0
slow	0
wave	I-DISEASE
sleep	0
,	I-DISEASE
most	0
commonly	0
toward	0
the	0
end	0
of	I-DISEASE
the	0
first	I-DISEASE
or	0
second	I-DISEASE
episode	0
of	I-DISEASE
slow	0
wave	I-DISEASE
sleep	I-DISEASE
.	0

Occasionally	I-DISEASE
,	I-DISEASE
disorders	0
of	I-DISEASE
arousal	0
can	I-DISEASE
emerge	I-DISEASE
from	I-DISEASE
stage	I-DISEASE
N2	0
sleep	0
.	I-DISEASE

Heart	I-DISEASE
rate	I-DISEASE
acceleration	0
,	I-DISEASE
increased	0
muscle	I-DISEASE
tone	I-DISEASE
,	I-DISEASE
and	0
muscle	0
twitching	I-DISEASE
may	I-DISEASE
rarely	I-DISEASE
be	0
observed	I-DISEASE
before	I-DISEASE
a	I-DISEASE
slow	0
wave	0
sleep	0
arousal	0
.	0

Diagnostic	I-DISEASE
polysomnography	0
may	I-DISEASE
note	0
high	I-DISEASE
-	I-DISEASE
amplitude	0
hypersynchronous	0
delta	I-DISEASE
waves	0
and	0
frequent	0
arousals	0
from	I-DISEASE
slow	0
wave	I-DISEASE
sleep	0
.	0

However	I-DISEASE
,	I-DISEASE
these	0
findings	0
have	0
a	0
low	0
spec-	0
ificity	0
and	0
have	0
been	I-DISEASE
reported	I-DISEASE
to	I-DISEASE
occur	0
in	0
other	I-DISEASE
disorders	0
such	0
as	0
OSA	0
and	0
in	I-DISEASE
asymp-	0
tomatic	0
individuals	I-DISEASE
.	0

On	I-DISEASE
rare	I-DISEASE
occasions	0
,	I-DISEASE
polysomnography	0
can	0
provide	I-DISEASE
support	I-DISEASE
for	I-DISEASE
the	0
clinical	0
diagnosis	I-DISEASE
by	I-DISEASE
documenting	0
arousals	0
from	0
slow	0
wave	I-DISEASE
sleep	0
accompanied	I-DISEASE
by	0
behaviors	I-DISEASE
typical	0
of	I-DISEASE
confusional	I-DISEASE
arousals	0
.	0

Out	I-DISEASE
-	I-DISEASE
of	I-DISEASE
-	I-DISEASE
bed	0
behaviors	I-DISEASE
are	0
very	I-DISEASE
rare	0
in	0
the	0
sleep	0
laboratory	I-DISEASE
.	0

Changes	I-DISEASE
between	0
the	0
home	I-DISEASE
and	0
sleep	0
laboratory	I-DISEASE
environment	0
,	0
timing	0
,	0
habits	I-DISEASE
,	I-DISEASE
and	0
other	0
factors	I-DISEASE
may	I-DISEASE
serve	I-DISEASE
to	0
decrease	0
the	0
likelihood	0
of	I-DISEASE
sleepwalking	0
in	0
the	0
laboratory	I-DISEASE
.	0

Time	I-DISEASE
-	I-DISEASE
synchronized	0
video	0
-	0
polysomnographic	0
(	0
vPSG	0
)	0
recording	0
is	0
essen-	0
tial	0
if	0
polysomnography	0
(	I-DISEASE
PSG	0
)	0
is	0
to	0
be	0
used	0
as	0
support	0
for	0
the	0
diagnosis	0
.	0

However	I-DISEASE
,	I-DISEASE
a	0
normal	0
PSG	0
does	I-DISEASE
not	0
rule	B-DISEASE
out	0
the	0
diagnosis	I-DISEASE
of	I-DISEASE
a	I-DISEASE
disorder	0
of	I-DISEASE
arousal	I-DISEASE
.	I-DISEASE

In	I-DISEASE
adults	I-DISEASE
in	I-DISEASE
whom	I-DISEASE
there	0
are	0
only	I-DISEASE
one	I-DISEASE
or	B-DISEASE
two	0
episodes	I-DISEASE
per	I-DISEASE
year	I-DISEASE
,	I-DISEASE
there	I-DISEASE
is	I-DISEASE
a	0
very	I-DISEASE
low	0
likelihood	0
of	I-DISEASE
occurrence	0
in	I-DISEASE
the	0
sleep	0
laboratory	I-DISEASE
.	0

However	I-DISEASE
,	I-DISEASE
the	0
sleep	0
study	0
may	I-DISEASE
assist	0
in	I-DISEASE
ruling	0
out	0
disorders	0
with	I-DISEASE
similar	I-DISEASE
presentations	I-DISEASE
,	0
such	0
as	0
RBD	I-DISEASE
or	0
nocturnal	0
epilepsy	0
.	0

PSG	I-DISEASE
may	0
further	I-DISEASE
be	0
useful	0
by	I-DISEASE
identifying	I-DISEASE
potential	0
triggers	0
,	I-DISEASE
such	I-DISEASE
as	0
sleep	0
related	0
breathing	I-DISEASE
disorder	I-DISEASE
or	0
peri-	0
odic	0
leg	I-DISEASE
movements	0
that	0
are	0
currently	0
present	I-DISEASE
.	0

Provocative	I-DISEASE
sleep	0
studies	I-DISEASE
using	0
sleep	0
deprivation	I-DISEASE
and	0
acoustic	0
stimuli	I-DISEASE
have	I-DISEASE
been	I-DISEASE
used	0
for	I-DISEASE
research	I-DISEASE
purposes	0
,	0
with	I-DISEASE
success	I-DISEASE
.	0

However	I-DISEASE
,	I-DISEASE
the	0
sensitivity	I-DISEASE
and	0
specificity	I-DISEASE
of	I-DISEASE
these	I-DISEASE
techniques	0
for	0
clinical	0
purposes	I-DISEASE
are	I-DISEASE
unknown	0
.	0

Postarousal	I-DISEASE
EEG	0
recordings	I-DISEASE
in	0
children	I-DISEASE
and	0
adults	0
with	I-DISEASE
sleepwalking	0
often	0
demon-	0

strate	I-DISEASE
a	0
partial	I-DISEASE
or	0
virtually	I-DISEASE
complete	0
persistence	I-DISEASE
of	I-DISEASE
sleep	0
,	I-DISEASE
with	I-DISEASE
diffuse	I-DISEASE
,	I-DISEASE
rhythmic	I-DISEASE
delta	0
activity	0
;	I-DISEASE
diffuse	0
delta	I-DISEASE
and	0
theta	0
activity	0
;	I-DISEASE
mixed	0
delta	I-DISEASE
,	0
theta	0
,	0
alpha	0
,	0
and	0
beta	0
activity	0
;	0
or	0
at	0
times	0
alpha	I-DISEASE
and	0
beta	0
activity	0
.	0

PSG	I-DISEASE
also	0
may	I-DISEASE
be	0
helpful	I-DISEASE
in	I-DISEASE
excluding	0
the	0
diagnosis	0
of	I-DISEASE
RBD	I-DISEASE
by	I-DISEASE
demonstration	0
of	I-DISEASE
normal	B-DISEASE
muscle	I-DISEASE
atonia	0
in	I-DISEASE
REM	0
sleep	0
(	I-DISEASE
assuming	I-DISEASE
adequate	0
amounts	I-DISEASE
of	I-DISEASE
REM	I-DISEASE
sleep	I-DISEASE
are	0
observed	I-DISEASE
)	0
.	B-DISEASE

Although	I-DISEASE
the	0
“	0
macrostructure	0
”	I-DISEASE
of	I-DISEASE
sleep	0
(	I-DISEASE
i.e.	I-DISEASE
,	I-DISEASE
the	0
cycling	I-DISEASE
of	0
various	0
NREM	0
and	0
REM	I-DISEASE
sleep	0
stages	I-DISEASE
and	0
the	I-DISEASE
relative	I-DISEASE
distributions	I-DISEASE
of	I-DISEASE
these	I-DISEASE
sleep	0
stages	0
)	0
is	0
generally	I-DISEASE
preserved	0
with	0
sleepwalking	0
,	I-DISEASE
the	0
“	I-DISEASE
microstructure	I-DISEASE
”	I-DISEASE
of	I-DISEASE
sleep	0
can	0
be	I-DISEASE
perturbed	0
.	0

Power	I-DISEASE
spectral	0
analyses	0
of	I-DISEASE
slow	0
wave	I-DISEASE
activity	0
in	I-DISEASE
adult	0
sleepwalkers	0
have	I-DISEASE
revealed	I-DISEASE
several	0
forms	0
of	I-DISEASE
slow	I-DISEASE
wave	0
sleep	0
dysregulation	0
,	I-DISEASE
including	0
high	I-DISEASE
amounts	0
of	I-DISEASE
slow	0
wave	B-DISEASE
sleep	0
fragmentation	B-DISEASE
(	I-DISEASE
particularly	0
during	0
the	0
first	0
NREM	0
-	0
REM	I-DISEASE
sleep	I-DISEASE
cycle	0
)	0
,	0
a	0
significant	0
increase	0
in	I-DISEASE
delta	I-DISEASE
power	0
just	I-DISEASE
prior	0
to	0
an	0
arousal	0
,	0
and	0
increased	I-DISEASE
slow	0
wave	I-DISEASE
activity	0
across	I-DISEASE
all	0
NREM	0
sleep	0
cycles	0
.	0

Differential	I-DISEASE
Diagnosis	0
Disorders	I-DISEASE
of	I-DISEASE
arousal	0
should	0
be	I-DISEASE
carefully	I-DISEASE
distinguished	I-DISEASE
from	0
other	I-DISEASE
disorders	0
with	I-DISEASE
similar	0
presentations	0
,	I-DISEASE
but	0
different	0
pathophysiologies	0
,	I-DISEASE
courses	I-DISEASE
,	I-DISEASE
and	0
treatments	0
.	0

Other	I-DISEASE
disorders	0
to	0
be	I-DISEASE
considered	0
include	I-DISEASE
RBD	I-DISEASE
,	0
sleep	0
related	B-DISEASE
epilepsy	I-DISEASE
,	0
sleep	0
related	B-DISEASE
dissocia-	I-DISEASE
tive	0
disorders	0
,	I-DISEASE
alcohol	I-DISEASE
and	0
drug	0
related	0
behaviors	I-DISEASE
,	I-DISEASE
and	0
OSA	0
.	0

RBD	I-DISEASE
typically	0
presents	0
as	0
dream	I-DISEASE
-	I-DISEASE
enacting	0
behaviors	I-DISEASE
during	I-DISEASE
the	I-DISEASE
second	I-DISEASE
half	0
of	I-DISEASE
the	0
night	I-DISEASE
and	0
usually	0
affects	I-DISEASE
middle	0
-	0
aged	I-DISEASE
men	0
,	I-DISEASE
but	0
also	0
can	0
affect	0
women	I-DISEASE
and	0
virtually	0
any	I-DISEASE
age	I-DISEASE
group	I-DISEASE
.	0

Because	I-DISEASE
sleepwalking	0
in	0
adults	I-DISEASE
can	0
also	0
present	I-DISEASE
as	0
dream	I-DISEASE
-	I-DISEASE
enacting	I-DISEASE
behaviors	I-DISEASE
that	0
emerge	I-DISEASE
during	I-DISEASE
any	I-DISEASE
time	0
of	I-DISEASE
the	0
night	B-DISEASE
,	I-DISEASE
vPSG	I-DISEASE
may	I-DISEASE
be	I-DISEASE
necessary	0
to	B-DISEASE
distinguish	0
sleep-	0
walking	0
from	0
RBD	0
.	0

In	I-DISEASE
contrast	I-DISEASE
to	0
disorders	0
of	0
arousal	0
,	I-DISEASE
signs	0
of	I-DISEASE
RBD	0
,	I-DISEASE
particularly	I-DISEASE
tonic	0
/	0
phasic	0
EMG	0
activity	0
during	I-DISEASE
REM	0
sleep	I-DISEASE
,	0
are	I-DISEASE
almost	I-DISEASE
always	0
present	I-DISEASE
during	I-DISEASE
sleep	0
studies	I-DISEASE
.	0

If	I-DISEASE
sleepwalking	0
(	0
or	I-DISEASE
sleep	0
terrors	0
)	0
occurs	0
with	I-DISEASE
RBD	I-DISEASE
in	0
the	0
same	B-DISEASE
patient	I-DISEASE
,	0
both	0
should	0
be	0
diagnosed	0
.	0

This	I-DISEASE
has	0
been	I-DISEASE
referred	I-DISEASE
to	0
as	0
a	0
parasomnia	I-DISEASE
overlap	0
disorder	I-DISEASE
.	0

Other	I-DISEASE
sleep	0
disorders	0
,	I-DISEASE
such	0
as	I-DISEASE
OSA	I-DISEASE
,	0
can	0
precipitate	0
disorders	0
of	I-DISEASE
arousal	0
.	I-DISEASE

Therefore	I-DISEASE
,	0
a	0
careful	0
history	I-DISEASE
must	I-DISEASE
be	0
obtained	0
to	0
identify	0
other	0
sleep	0
disorders	0
.	0

Sleep	I-DISEASE
related	B-DISEASE
epilepsy	0
can	0
manifest	0
with	I-DISEASE
wandering	0
behavior	0
or	0
with	I-DISEASE
frenzied	I-DISEASE
walking	0
or	I-DISEASE
running	0
.	0

In	I-DISEASE
adults	I-DISEASE
,	0
a	I-DISEASE
diagnosis	0
of	I-DISEASE
malingering	0
also	0
should	0
be	I-DISEASE
considered	I-DISEASE
.	0

If	I-DISEASE
a	0
neurologic	0
or	I-DISEASE
medical	I-DISEASE
disor-	0
der	I-DISEASE
is	I-DISEASE
identified	I-DISEASE
as	0
the	0
precipitant	0
of	I-DISEASE
a	0
disorder	I-DISEASE
of	I-DISEASE
arousal	0
,	I-DISEASE
then	0
the	0
sleepwalking	0
should	B-DISEASE
be	0
diagnosed	0
as	0
parasomnia	I-DISEASE
due	0
to	0
a	0
medical	0
disorder	0
.	0

Disorders	I-DISEASE
of	I-DISEASE
arousal	0
should	I-DISEASE
not	0
be	I-DISEASE
diagnosed	0
in	0
the	0
presence	0
of	I-DISEASE
alcohol	I-DISEASE
intoxication	I-DISEASE
.	I-DISEASE

The	I-DISEASE
behavior	I-DISEASE
of	I-DISEASE
the	0
alcohol	0
-	I-DISEASE
intoxicated	I-DISEASE
individual	0
may	I-DISEASE
superficially	0
resemble	I-DISEASE
that	0
of	I-DISEASE
the	0
sleepwalker	I-DISEASE
.	0

However	I-DISEASE
,	I-DISEASE
the	0
sleepwalker	0
is	I-DISEASE
typically	0
severely	0
cognitively	0
impaired	I-DISEASE
,	I-DISEASE
but	I-DISEASE
with	0
only	0
limited	I-DISEASE
motor	I-DISEASE
impairment	0
.	0

The	I-DISEASE
alcohol	I-DISEASE
-	0
intoxicated	I-DISEASE
individual	I-DISEASE
’s	I-DISEASE
level	0
of	I-DISEASE
cognitive	0
functioning	I-DISEASE
may	I-DISEASE
be	0
reduced	0
,	I-DISEASE
but	I-DISEASE
not	0
absent	0
,	I-DISEASE
whereas	0
motor	I-DISEASE
behavior	I-DISEASE
is	0
often	I-DISEASE
severely	0
impaired	I-DISEASE
.	0

In	I-DISEASE
alcoholic	I-DISEASE
blackouts	0
,	0
where	0
anterograde	0
amnesia	0
is	0
,	I-DISEASE
by	I-DISEASE
definition	0
,	I-DISEASE
Parasomnias	I-DISEASE
Parasomnias	0
the	0
cardinal	I-DISEASE
manifestation	0
,	I-DISEASE
it	0
is	0
important	B-DISEASE
to	I-DISEASE
note	0
that	0
outward	0
motor	I-DISEASE
behavior	I-DISEASE
and	0
cog-	0
nitive	0
function	I-DISEASE
may	I-DISEASE
not	0
be	0
impaired	0
and	0
may	0
be	0
perceived	0
as	0
normal	0
.	0

Thus	I-DISEASE
,	I-DISEASE
the	0
impor-	0
tance	I-DISEASE
of	I-DISEASE
appreciating	0
the	I-DISEASE
neuroscience	0
of	I-DISEASE
alcoholic	I-DISEASE
blackouts	0
and	0
its	I-DISEASE
potential	0
role	0
in	I-DISEASE
the	I-DISEASE
explanation	0
of	I-DISEASE
unusual	I-DISEASE
and	0
bizarre	I-DISEASE
nocturnal	B-DISEASE
behaviors	I-DISEASE
can	I-DISEASE
not	0
be	0
understated	0
because	0
these	I-DISEASE
can	0
mimic	0
parasomnias	I-DISEASE
.	0

The	I-DISEASE
former	0
are	0
exponentially	I-DISEASE
more	0
prevalent	0
and	0
thus	0
should	0
be	I-DISEASE
given	0
appropriate	B-DISEASE
weight	0
when	0
attributing	I-DISEASE
likely	I-DISEASE
causation	0
in	I-DISEASE
cases	0
with	I-DISEASE
criminal	I-DISEASE
allegations	0
.	0

Unresolved	I-DISEASE
Issues	0
and	0
Further	I-DISEASE
Directions	0
With	0
the	0
development	I-DISEASE
of	I-DISEASE
sophisticated	0
genetic	I-DISEASE
testing	0
and	0
neuroimaging	I-DISEASE
,	0
direct	0
research	0
into	I-DISEASE
the	I-DISEASE
causes	0
and	0
mechanisms	0
of	I-DISEASE
disorders	0
or	B-DISEASE
arousals	0
is	0
anticipated	0
.	0

Further	I-DISEASE
investigations	0
that	0
aid	I-DISEASE
in	0
the	0
characterization	0
of	I-DISEASE
the	0
pathophysiology	0
are	0
necessary	0
.	0

Further	I-DISEASE
development	I-DISEASE
of	I-DISEASE
sleep	0
laboratory	B-DISEASE
-	I-DISEASE
based	I-DISEASE
techniques	0
for	0
provoking	0
episodes	I-DISEASE
of	I-DISEASE
sleepwalking	I-DISEASE
would	I-DISEASE
improve	I-DISEASE
diagnostic	0
accuracy	0
.	0

Bibliography	0
Achermann	0
P	0
,	I-DISEASE
Werth	I-DISEASE
E	0
,	I-DISEASE
Dijk	I-DISEASE
DJ	0
,	I-DISEASE
Borbély	I-DISEASE
AA	0
.	0

Time	I-DISEASE
course	I-DISEASE
of	I-DISEASE
sleep	0
inertia	0
after	I-DISEASE
nighttime	0
and	0
daytime	0
sleep	I-DISEASE
episodes	I-DISEASE
.	0

Arch	I-DISEASE
Ital	I-DISEASE
Biol	0
1995;134:109–19	I-DISEASE
.	I-DISEASE

Broughton	I-DISEASE
RJ	I-DISEASE
.	0

Sleep	I-DISEASE
disorders	0
:	I-DISEASE
disorders	0
of	I-DISEASE
arousal	I-DISEASE
?	0

Science	I-DISEASE
1968;159:1070–8	0
.	0

Fisher	I-DISEASE
C	I-DISEASE
,	0
Kahn	I-DISEASE
E	0
,	I-DISEASE
Edwards	I-DISEASE
A	0
,	0
Davis	0
D	0
,	I-DISEASE
Fine	I-DISEASE
J.	I-DISEASE
A	0
psychophysiological	B-DISEASE
study	0
of	I-DISEASE
nightmares	0
and	0
night	0
terrors	I-DISEASE
.	0

III	I-DISEASE
.	0

Mental	I-DISEASE
content	0
and	0
recall	I-DISEASE
of	0
stage	0
4	0
night	0
terrors	0
.	0

J	I-DISEASE
Nerv	0
Ment	0
Dis	I-DISEASE
1974;158:174–88	0
.	0

Fisher	I-DISEASE
C	0
,	0
Kahn	I-DISEASE
E	0
,	I-DISEASE
Edwards	0
D	I-DISEASE
,	0
Davis	0
D.	0
A	I-DISEASE
psychophysiological	0
study	0
of	I-DISEASE
nightmares	0
and	0
night	0
terrors	0
:	0
physiological	0
aspects	0
of	I-DISEASE
the	0
stage	I-DISEASE
4	0
night	0
terror	I-DISEASE
.	0

J	I-DISEASE
Nerv	0
Ment	0
Dis	I-DISEASE
1973;157:75–98	0
.	0

Gastaut	I-DISEASE
H	I-DISEASE
,	0
Broughton	0
R.	I-DISEASE
A	0
clinical	0
and	0
polygraphic	I-DISEASE
study	I-DISEASE
of	I-DISEASE
episodic	0
phenomena	0
during	I-DISEASE
sleep	0
.	0

In	I-DISEASE
:	I-DISEASE
Wortis	I-DISEASE
J	I-DISEASE
,	I-DISEASE
ed	I-DISEASE
.	0

Recent	I-DISEASE
advances	I-DISEASE
in	0
biological	I-DISEASE
psychiatry	0
,	0
Volume	0
7	0
.	0

New	I-DISEASE
York	0
:	0
Plenum	0
Press	I-DISEASE
,	I-DISEASE
1965:197–223	0
.	0

Guilleminault	I-DISEASE
C	I-DISEASE
,	I-DISEASE
Moscovitch	I-DISEASE
A	0
,	I-DISEASE
Yuen	I-DISEASE
K	I-DISEASE
,	I-DISEASE
Poyares	I-DISEASE
D.	I-DISEASE
Atypical	0
sexual	I-DISEASE
behavior	I-DISEASE
during	I-DISEASE
sleep	0
.	0

Psychosom	I-DISEASE
Med	I-DISEASE
2002;64:328–36	I-DISEASE
.	0

Guilleminault	I-DISEASE
C	I-DISEASE
,	I-DISEASE
Silvestri	0
JM	0
.	I-DISEASE

Disorders	I-DISEASE
of	I-DISEASE
arousal	0
and	0
epilepsy	0
during	I-DISEASE
sleep	0
.	0

In	I-DISEASE
:	I-DISEASE
Sterman	0
M	0
,	I-DISEASE
Shouse	I-DISEASE
M	I-DISEASE
,	0
Passouant	0
P	I-DISEASE
,	0
eds	I-DISEASE
.	0

Sleep	I-DISEASE
and	0
epilepsy	0
.	0

New	I-DISEASE
York	0
:	0
Academic	I-DISEASE
Press	0
,	I-DISEASE
1983:513–31	0
.	0

Hublin	I-DISEASE
C	0
,	I-DISEASE
Kaprio	0
J	0
,	0
Partinen	0
M	I-DISEASE
,	I-DISEASE
Heikkila	0
K	I-DISEASE
,	0
Koskenvuo	0
M.	I-DISEASE
Parasomnias	0
:	B-DISEASE
co	0
-	0
occurrence	0
and	0
genetics	0
.	0

Psychiatr	0
Genet	0
2001;11:65–70	I-DISEASE
.	0

Hublin	I-DISEASE
C	0
,	I-DISEASE
Kaprio	0
J	0
,	0
Partinen	0
M	I-DISEASE
,	I-DISEASE
Heikkila	0
K	I-DISEASE
,	0
Koskenvuo	0
M.	I-DISEASE
Prevalence	0
and	0
genetics	0
of	I-DISEASE
sleepwalking	0
:	0
a	0
population	0
-	0
based	I-DISEASE
twin	0
study	0
.	0

Neurology	0
1997;48:177–81	0
.	0

Iranzo	I-DISEASE
A	0
,	I-DISEASE
Santamaria	0
J.	0
Severe	0
obstructive	0
sleep	0
apnea	0
/	0
hypopnea	I-DISEASE
mimicking	I-DISEASE
REM	0
sleep	0
behavior	I-DISEASE
disorder	0
.	0

Sleep	I-DISEASE
2005;28:203–6	0
.	0

Kales	I-DISEASE
A	0
,	I-DISEASE
Soldatos	0
C	I-DISEASE
,	0
Bixler	0
E	I-DISEASE
,	I-DISEASE
et	0
al	I-DISEASE
.	0

Hereditary	0
factors	0
in	0
sleepwalking	0
and	0
night	0
terrors	0
.	0

Br	0
J	0
Psychiatry	0
1980;137:111–8	I-DISEASE
.	0

Klackenberg	I-DISEASE
G.	0
Somnambulism	0
in	I-DISEASE
childhood	I-DISEASE
—	I-DISEASE
prevalence	0
,	I-DISEASE
course	I-DISEASE
and	0
behavioral	0
correlations	0
:	0
a	0
prospective	0
longitudinal	I-DISEASE
study	0
(	0
3	I-DISEASE
-	0
16	I-DISEASE
years	I-DISEASE
)	0
.	0

Acta	I-DISEASE
Paediatr	0
Scand	I-DISEASE
1982;71:495–9	I-DISEASE
.	0

Mahowald	I-DISEASE
M	I-DISEASE
,	0
Schenck	I-DISEASE
C	0
,	0
Goldner	0
M	I-DISEASE
,	I-DISEASE
Bachelder	0
V	I-DISEASE
,	0
Cramer	0
Bornemann	0
M.	I-DISEASE
Parasomnia	0
pseudo	I-DISEASE
-	I-DISEASE
suicide	I-DISEASE
.	0

J	I-DISEASE
Forensic	0
Sci	0
2003;48:1158–62	0
.	0

Nino	0
-	0
Murcia	I-DISEASE
G	I-DISEASE
,	I-DISEASE
Dement	I-DISEASE
W.	0
Psychophysiological	0
and	0
pharmacological	0
aspects	0
of	I-DISEASE
somnambulism	0
and	0
night	I-DISEASE
terrors	B-DISEASE
in	I-DISEASE
children	I-DISEASE

.	I-DISEASE

In	I-DISEASE
:	0
Meltzer	0
H	I-DISEASE
,	I-DISEASE
ed	I-DISEASE
.	0

Psychopharmacology	I-DISEASE
:	0
the	0
third	0
generation	0
of	I-DISEASE
progress	0
.	I-DISEASE

New	I-DISEASE
York	0
:	0
Raven	I-DISEASE
Press	0
,	I-DISEASE
1987:873–9	0
.	0

Ohayon	I-DISEASE
M	I-DISEASE
,	0
Guilleminault	I-DISEASE
C	0
,	I-DISEASE
Priest	I-DISEASE
R.	I-DISEASE
Night	I-DISEASE
terrors	0
,	0
sleepwalking	0
,	0
and	0
confusional	I-DISEASE
arousals	0
in	I-DISEASE
the	0
general	0
population	0
:	0
their	0
frequency	I-DISEASE
and	0
relationship	0
to	0
other	I-DISEASE
sleep	0
and	0
mental	0
disorders	0
.	0

J	I-DISEASE
Clin	0
Psychiatry	0
1999;60:268–76	I-DISEASE
.	0

Ohayon	I-DISEASE
M	I-DISEASE
,	0
Priest	I-DISEASE
R	I-DISEASE
,	I-DISEASE
Zulley	I-DISEASE
J	I-DISEASE
,	I-DISEASE
Smirne	I-DISEASE
S.	I-DISEASE

The	I-DISEASE
place	I-DISEASE
of	I-DISEASE
confusional	I-DISEASE
arousals	0
in	I-DISEASE
sleep	0
and	0
mental	0
disorders	0
:	I-DISEASE
findings	0
in	0
a	0
general	0
population	I-DISEASE
sample	0
of	0
13,057	0
subjects	0
.	0

J	I-DISEASE
Nerv	0
Ment	0
Dis	I-DISEASE
2000;188:340–8	0
.	0

Pilon	I-DISEASE
M	I-DISEASE
,	I-DISEASE
Zadra	0
A	0
,	0
Joncas	0
S	I-DISEASE
,	I-DISEASE
Montplaisir	I-DISEASE
J.	I-DISEASE
Hypersynchronous	0
delta	I-DISEASE
waves	0
and	0
somnambulism	0
:	I-DISEASE
brain	I-DISEASE
topography	0
and	0
effect	0
of	I-DISEASE
sleep	0
deprivation	0
.	0

Sleep	I-DISEASE
2006;29:77–84	0
.	0

Pressman	I-DISEASE
M	I-DISEASE
,	I-DISEASE
Mahowald	0
M	I-DISEASE
,	0
Schenck	0
C	I-DISEASE
,	I-DISEASE
Cramer	0
Bornemann	I-DISEASE
M.	0
Alcohol	0
-	0
induced	I-DISEASE
sleepwalking	0
or	I-DISEASE
confusional	I-DISEASE
arousal	0
as	0
a	0
defense	0
to	0
criminal	0
behavior	I-DISEASE
:	0
a	0
review	0
of	0
scientific	0
evidence	0
,	0
methods	I-DISEASE
and	0
forensic	0
considerations	0
.	0

J	I-DISEASE
Sleep	0
Rev	0
2007;16:198–212	I-DISEASE
.	0

Pressman	I-DISEASE
M.	I-DISEASE
Factors	0
that	0
predispose	I-DISEASE
,	0
prime	0
and	0
precipitate	I-DISEASE
NREM	0
parasomnias	I-DISEASE
in	I-DISEASE
adults	B-DISEASE
:	I-DISEASE
clinical	0
and	0
forensic	0
implications	I-DISEASE
.	0

Sleep	I-DISEASE
Med	I-DISEASE
Rev	0
2007;11:5–30	0
.	0

Pressman	I-DISEASE
MR	0
.	I-DISEASE

Hypersynchronous	I-DISEASE
delta	I-DISEASE
sleep	0
EEG	0
activity	0
and	0
sudden	I-DISEASE
arousals	I-DISEASE
from	0
slow	0
wave	I-DISEASE
sleep	0
in	0
adults	I-DISEASE
without	0
a	0
history	I-DISEASE
of	I-DISEASE
parasomnias	I-DISEASE
:	0
clinical	0
and	0
forensic	0
implications	I-DISEASE
.	0

Sleep	I-DISEASE
2004	0
;	0
27:706–10	I-DISEASE
.	0

Schenck	I-DISEASE
C	I-DISEASE
,	0
Arnulf	I-DISEASE
I	0
,	I-DISEASE
Mahowald	I-DISEASE
M.	I-DISEASE
Sleep	I-DISEASE
and	0
sex	I-DISEASE
:	0
what	0
can	0
go	I-DISEASE
wrong	I-DISEASE
?	B-DISEASE

A	I-DISEASE
review	0
of	I-DISEASE
the	0
literature	0
on	0
sleep	0
related	I-DISEASE
disorders	0
and	0
abnormal	I-DISEASE
sexual	I-DISEASE
behaviors	I-DISEASE
and	0
experiences	0
.	0

Sleep	I-DISEASE
2007;30:683–702	I-DISEASE
.	0

Schenck	I-DISEASE
C	I-DISEASE
,	0
Boyd	0
J	0
,	I-DISEASE
Mahowald	0
M.	I-DISEASE
A	0
parasomnia	0
overlap	0
disorder	0
involving	I-DISEASE
sleepwalking	0
,	I-DISEASE
sleep	I-DISEASE
terrors	0
,	0
and	0
REM	0
sleep	0
behavior	I-DISEASE
disorder	I-DISEASE
in	I-DISEASE
33	I-DISEASE
polysomnographically	0
confirmed	0
cases	0
.	0

Sleep	I-DISEASE
1997;20:972–81	I-DISEASE
.	0

Schenck	I-DISEASE
C	I-DISEASE
,	0
Mahowald	I-DISEASE
M.	I-DISEASE

On	I-DISEASE
the	0
reported	0
association	I-DISEASE
of	0
psychopathology	0
with	I-DISEASE
sleep	0
terrors	I-DISEASE
in	0
adults	I-DISEASE
.	0

Sleep	I-DISEASE
2000;23:448–9	I-DISEASE
.	0

Simonds	I-DISEASE
J	0
,	I-DISEASE
Parraga	0
H.	I-DISEASE
Prevalence	I-DISEASE
of	I-DISEASE
sleep	I-DISEASE
disorders	0
and	0
sleep	0
behaviors	I-DISEASE
in	I-DISEASE
children	0
and	0
adolescents	0
.	0

J	I-DISEASE
Am	I-DISEASE
Acad	0
Child	I-DISEASE
Adolesc	0
Psychiatry	0
1982;21:383–8	0
.	0

Zadra	I-DISEASE
A	0
,	0
Desautels	I-DISEASE
A	0
,	0
Petit	0
D	I-DISEASE
,	I-DISEASE
Montplaisir	0
J.	I-DISEASE
Somnambulism	0
:	0
clinical	I-DISEASE
aspects	0
and	0
pathophysiological	0
hypotheses	I-DISEASE
.	0

Lancet	0
Neurol	0
2013;12:285–94	0
.	0

Parasomnias	I-DISEASE
Parasomnias	0
Sleep	0
Related	0
Eating	I-DISEASE
Disorder	I-DISEASE
ICD-9	0
-	0
CM	0
code	0
:	0
327.40	0
Alternate	B-DISEASE
Names	I-DISEASE
Sleep	0
eating	I-DISEASE
Diagnostic	0
Criteria	0
Criteria	0

A	I-DISEASE
-	I-DISEASE
D	0
must	I-DISEASE
be	0
met	0
ICD-10	0
-	0
CM	0
code	0
:	0
G47.59	I-DISEASE
A.	0
Recurrent	0
episodes	I-DISEASE
of	I-DISEASE
dysfunctional	0
eating	I-DISEASE
that	0
occur	I-DISEASE
after	0
an	0
arousal	0
during	I-DISEASE
the	0
main	0
sleep	0
period	0
.	0

B.	0
The	I-DISEASE
presence	0
of	0
at	I-DISEASE
least	I-DISEASE
one	0
of	I-DISEASE
the	0
following	0
in	I-DISEASE
association	I-DISEASE
with	I-DISEASE
the	0
recurrent	0
episodes	I-DISEASE
of	0
involuntary	0
eating	I-DISEASE
:	0
.	0

Consumption	I-DISEASE
of	I-DISEASE
peculiar	I-DISEASE
forms	0
or	I-DISEASE
combinations	I-DISEASE
of	I-DISEASE
food	0
or	0
inedible	I-DISEASE
or	I-DISEASE
toxic	0
substances	0
.	0
.	I-DISEASE

Sleep	I-DISEASE
related	I-DISEASE
injurious	0
or	I-DISEASE
potentially	0
injurious	I-DISEASE
behaviors	I-DISEASE
performed	0
while	I-DISEASE
in	I-DISEASE
pursuit	I-DISEASE
of	I-DISEASE
food	0
or	I-DISEASE
while	0
cooking	0
food	0
.	0
.	0

Adverse	I-DISEASE
health	0
consequences	I-DISEASE
from	0
recurrent	0
nocturnal	0
eating	0
.	0

C.	I-DISEASE

There	I-DISEASE
is	I-DISEASE
partial	I-DISEASE
or	I-DISEASE
complete	0
loss	I-DISEASE
of	I-DISEASE
conscious	0
awareness	0
during	I-DISEASE
the	0
eating	I-DISEASE
episode	I-DISEASE
,	I-DISEASE
with	0
subsequent	0
impaired	I-DISEASE
recall	I-DISEASE
.	0

D.	I-DISEASE

The	I-DISEASE
disturbance	I-DISEASE
is	0
not	0
better	0
explained	I-DISEASE
by	I-DISEASE
another	I-DISEASE
sleep	0
disorder	0
,	I-DISEASE
mental	I-DISEASE
disorder	I-DISEASE
,	I-DISEASE
medical	0
disorder	I-DISEASE
,	I-DISEASE
medication	I-DISEASE
,	0
or	0
substance	I-DISEASE
use	I-DISEASE
.	0

Essential	I-DISEASE
Features	I-DISEASE
SRED	I-DISEASE
consists	0
of	I-DISEASE
recurrent	I-DISEASE
episodes	I-DISEASE
of	I-DISEASE
involuntary	I-DISEASE
eating	I-DISEASE
and	0
drinking	I-DISEASE
during	I-DISEASE
arous-	0
als	I-DISEASE
from	0
sleep	0
,	I-DISEASE
associated	0
with	I-DISEASE
diminished	I-DISEASE
levels	I-DISEASE
of	I-DISEASE
consciousness	0
and	0
subsequent	0
recall	I-DISEASE
,	I-DISEASE
with	I-DISEASE
problematic	0
consequences	I-DISEASE
.	0

The	I-DISEASE
episodes	I-DISEASE
of	I-DISEASE
eating	I-DISEASE
always	0
occur	I-DISEASE
in	I-DISEASE
an	0
involuntary	0
or	I-DISEASE
“	I-DISEASE
out	0
of	I-DISEASE
control	I-DISEASE
”	I-DISEASE
manner	0
after	0
an	0
interval	I-DISEASE
of	I-DISEASE
sleep	0
.	0

Typically	I-DISEASE
,	I-DISEASE
they	0
occur	I-DISEASE
during	I-DISEASE
partial	I-DISEASE
arousals	0
from	0
sleep	0
with	I-DISEASE
subsequent	0
partial	I-DISEASE
recall	I-DISEASE
.	0

On	I-DISEASE
the	0
one	0
hand	I-DISEASE
,	0
some	I-DISEASE
patients	I-DISEASE
can	I-DISEASE
not	0
be	0
easily	0
brought	I-DISEASE
to	I-DISEASE
full	0
consciousness	0
during	I-DISEASE
an	0
episode	I-DISEASE
of	0
eating	0
,	I-DISEASE
as	0
is	I-DISEASE
the	0
case	I-DISEASE
with	I-DISEASE
sleepwalking	0
,	I-DISEASE
and	0
may	I-DISEASE
have	0
no	0
recall	I-DISEASE
of	I-DISEASE
having	I-DISEASE
eaten	0
during	I-DISEASE
the	0
night	0
.	0

On	I-DISEASE
the	0
other	0
hand	I-DISEASE
,	0
some	I-DISEASE
patients	I-DISEASE
seemingly	I-DISEASE
have	0
considerable	0
alertness	I-DISEASE
during	I-DISEASE
an	I-DISEASE
episode	0
and	0
have	0
substantial	I-DISEASE
recall	0
in	0
the	0
morning	0
.	0

There	I-DISEASE
may	0
be	0
variability	I-DISEASE
of	I-DISEASE
awareness	0
and	0
subsequent	0
recall	0
within	I-DISEASE
one	0
night	I-DISEASE
,	I-DISEASE
and	0
across	I-DISEASE
the	0
evolution	I-DISEASE
of	0
the	0
disorder	I-DISEASE
in	I-DISEASE
individual	0
patients	0
.	0

The	I-DISEASE
recurrent	0
episodes	I-DISEASE
of	0
involuntary	I-DISEASE
eating	0
and	0
drinking	I-DISEASE
during	I-DISEASE
the	0
main	0
sleep	0
period	I-DISEASE
are	I-DISEASE
typically	0
associated	0
with	I-DISEASE
a	0
feeling	I-DISEASE
of	I-DISEASE
lack	I-DISEASE
of	I-DISEASE
control	0
over	I-DISEASE
eating	I-DISEASE
.	0

Problematic	I-DISEASE
features	0
of	I-DISEASE
the	0
recurrent	0
sleep	0
related	B-DISEASE
eating	0
include	I-DISEASE
the	0
following	0
:	I-DISEASE
con-	0
sumption	0
of	0
peculiar	0
forms	I-DISEASE
or	0
combinations	I-DISEASE
of	I-DISEASE
food	0
,	I-DISEASE
or	0
of	I-DISEASE
inedible	I-DISEASE
or	B-DISEASE
toxic	0
substances	B-DISEASE
(	I-DISEASE
e.g.	0
,	0
frozen	0
pizzas	0
,	0
raw	I-DISEASE
bacon	0
,	I-DISEASE
buttered	0
cigarettes	I-DISEASE
,	0
cat	0
food	0
and	0
salt	0
sandwiches	I-DISEASE
,	I-DISEASE
coffee	0
grounds	0
,	0
ammonia	0
cleaning	I-DISEASE
solutions	I-DISEASE
)	I-DISEASE
;	0
sleep	0
related	0
injury	I-DISEASE
(	I-DISEASE
e.g.	0
,	0
lacerations	I-DISEASE
from	I-DISEASE
care-	I-DISEASE
less	I-DISEASE
manipulation	0
of	I-DISEASE
kitchen	I-DISEASE
utensils	0
;	0
internal	I-DISEASE
or	I-DISEASE
external	I-DISEASE
burns	0
from	0
consuming	I-DISEASE
or	0
spilling	0
hot	0
foods	I-DISEASE
or	I-DISEASE
beverages	I-DISEASE
;	0
or	0
poisoning	I-DISEASE
and	0
internal	I-DISEASE
injuries	B-DISEASE
from	0
ingesting	I-DISEASE
toxic	I-DISEASE
substances	0
)	0
;	0
adverse	I-DISEASE
health	B-DISEASE
consequences	I-DISEASE
(	I-DISEASE
e.g.	0
,	I-DISEASE
dental	0
caries	I-DISEASE
and	0
tooth	0
chipping	I-DISEASE
from	0
biting	I-DISEASE
frozen	I-DISEASE
foods	0
)	0
;	0
weight	I-DISEASE
gain	0
;	0
obesity	0
(	I-DISEASE
including	I-DISEASE
morbid	I-DISEASE
obesity	0
resulting	0
in	0
bar-	0
iatric	0
surgery	0
)	0
;	0
various	0
metabolic	0
problems	0
,	0
such	0
as	B-DISEASE
destabilization	I-DISEASE
or	0
precipitation	0
of	I-DISEASE
diabetes	0
mellitus	B-DISEASE
,	I-DISEASE
hypertriglyceridemia	I-DISEASE
,	B-DISEASE
and	0
hypercholesterolemia	0
;	I-DISEASE
nonrestorative	I-DISEASE
sleep	0
from	I-DISEASE
sleep	0
disruption	I-DISEASE
;	I-DISEASE
morning	I-DISEASE
anorexia	0
and	0
abdominal	0
distention	0
.	0

SRED	I-DISEASE
carries	0
the	0
risk	0
of	I-DISEASE
consuming	0
foods	I-DISEASE
to	0
which	0
one	0
is	I-DISEASE
allergic	0
.	0

Also	I-DISEASE
,	I-DISEASE
overnight	I-DISEASE
fasting	0
prior	I-DISEASE
to	I-DISEASE
next	0
-	0
day	0
surgery	0
or	I-DISEASE
testing	I-DISEASE
can	I-DISEASE
be	0
compromised	I-DISEASE
.	0

Secondary	I-DISEASE
depressive	I-DISEASE
disorders	0
may	0
emerge	I-DISEASE
from	0
longstanding	I-DISEASE
personal	0
dejection	0
and	0
a	I-DISEASE
sense	0
of	I-DISEASE
failure	I-DISEASE
over	I-DISEASE
the	0
inability	0
to	I-DISEASE
control	0
the	0
nocturnal	0
eating	I-DISEASE
.	0

Secondary	I-DISEASE
food	0
restriction	0
,	I-DISEASE
prompted	I-DISEASE
by	I-DISEASE
despair	I-DISEASE
over	I-DISEASE
not	0
being	I-DISEASE
able	0
to	I-DISEASE
stop	I-DISEASE
the	0
nocturnal	0
eating	I-DISEASE
,	I-DISEASE
often	0
occurs	0
at	I-DISEASE
some	I-DISEASE
point	0
during	I-DISEASE
the	0
course	I-DISEASE
of	0
the	I-DISEASE
disorder	0
.	0

Patients	I-DISEASE
may	0
engage	0
in	0
potentially	I-DISEASE
hazardous	0
(	I-DISEASE
and	0
expensive	0
)	0
weight	0
-	I-DISEASE
loss	I-DISEASE
regimens	B-DISEASE
.	0

Insomnia	I-DISEASE
can	0
also	0
be	0
a	I-DISEASE
complication	0
.	0

Associated	I-DISEASE
Features	I-DISEASE
Nightly	I-DISEASE
eating	0
,	I-DISEASE
including	0
multiple	I-DISEASE
episodes	I-DISEASE
nightly	0
,	I-DISEASE
is	I-DISEASE
reported	I-DISEASE
by	B-DISEASE
a	0
majority	0
of	I-DISEASE
affected	0
individuals	0
.	0

The	I-DISEASE
episodes	I-DISEASE
of	I-DISEASE
eating	I-DISEASE
occur	0
during	I-DISEASE
any	I-DISEASE
time	I-DISEASE
in	0
the	0
sleep	0
cycle	0
.	I-DISEASE

High	I-DISEASE
-	0
caloric	0
foods	0
are	0
typically	0
preferred	0
.	0

The	I-DISEASE
foods	0
preferentially	0
consumed	I-DISEASE
during	I-DISEASE
sleep	0
related	B-DISEASE
eating	0
are	0
not	0
typically	I-DISEASE
consumed	I-DISEASE
with	0
preference	0
during	I-DISEASE
the	0
daytime	0
.	0

Paradoxically	I-DISEASE
,	I-DISEASE
to	0
the	0
extent	I-DISEASE
that	I-DISEASE
there	I-DISEASE
is	0
recall	I-DISEASE
,	I-DISEASE
hunger	I-DISEASE
and	0
thirst	0
are	0
notably	I-DISEASE
absent	I-DISEASE
during	I-DISEASE
episodes	I-DISEASE
of	I-DISEASE
compulsive	I-DISEASE
eating	I-DISEASE
with	I-DISEASE
SRED	0
.	0

The	I-DISEASE
episodes	I-DISEASE
of	I-DISEASE
eating	I-DISEASE
are	0
some-	I-DISEASE
times	I-DISEASE
experienced	0
as	0
food	0
-	I-DISEASE
related	I-DISEASE
enactment	I-DISEASE
of	I-DISEASE
a	I-DISEASE
dream	0
.	0

Simple	I-DISEASE
foods	0
or	0
entire	0
hot	0
or	I-DISEASE
cold	I-DISEASE
meals	0
may	0
be	0
prepared	0
and	0
consumed	I-DISEASE
.	0

Careless	I-DISEASE
food	0
handling	I-DISEASE
often	0
occurs	0
.	0

Alcoholic	I-DISEASE
beverages	0
are	0
almost	I-DISEASE
never	I-DISEASE
consumed	0
.	0

The	I-DISEASE
usual	I-DISEASE
response	0
to	I-DISEASE
interference	0
during	I-DISEASE
an	0
eating	I-DISEASE
episode	0
is	0
irritability	I-DISEASE
and	0
agitation	0
.	0

Clinical	I-DISEASE
or	I-DISEASE
Pathophysiological	I-DISEASE
Subtypes	I-DISEASE
None	I-DISEASE
known	I-DISEASE
.	I-DISEASE

Demographics	I-DISEASE
The	I-DISEASE
following	0
rates	I-DISEASE
of	I-DISEASE
SRED	0
,	0
as	0
determined	I-DISEASE
by	I-DISEASE
self	0
-	I-DISEASE
administered	0
questionnaire	I-DISEASE
,	0
have	0
been	I-DISEASE
reported	0
:	B-DISEASE
16.7	0
%	0
in	I-DISEASE
an	I-DISEASE
inpatient	I-DISEASE
eating	I-DISEASE
disorders	0
group	I-DISEASE
;	I-DISEASE
8.7	I-DISEASE
%	0
in	0
an	0
outpatient	0
eating	I-DISEASE
disorders	0
group	I-DISEASE
;	0
and	0
4.6	0
%	0
in	I-DISEASE
an	0
unselected	I-DISEASE
university	0
student	0
group	I-DISEASE
.	I-DISEASE

This	I-DISEASE
study	0
would	0
indicate	I-DISEASE
a	0
high	I-DISEASE
prevalence	0
of	I-DISEASE
SRED	0
,	0
although	0
confirmatory	I-DISEASE
studies	I-DISEASE
across	I-DISEASE
Parasomnias	0
Parasomnias	0
different	0
clinical	0
and	0
nonclinical	I-DISEASE
population	0
groups	0
are	0
needed	0
.	0

Females	I-DISEASE
comprise	I-DISEASE
60	0
%	0
to	0
83	I-DISEASE
%	0
of	I-DISEASE
patients	0
in	0
reported	0
series	I-DISEASE
.	I-DISEASE

Mean	I-DISEASE
age	I-DISEASE
of	I-DISEASE
onset	I-DISEASE
of	I-DISEASE
SRED	I-DISEASE
is	I-DISEASE
reported	0
to	0
be	0
22	I-DISEASE
-	I-DISEASE
39	I-DISEASE
years	I-DISEASE
.	0

In	I-DISEASE
the	I-DISEASE
reported	0
series	I-DISEASE
,	0
the	0
mean	I-DISEASE
duration	I-DISEASE
of	I-DISEASE
SRED	0
prior	I-DISEASE
to	I-DISEASE
clinical	I-DISEASE
presen-	0
tation	I-DISEASE
ranged	0
from	I-DISEASE
four	I-DISEASE
to	I-DISEASE
15	I-DISEASE
years	I-DISEASE
,	I-DISEASE
suggesting	0
that	I-DISEASE
SRED	I-DISEASE
often	0
is	I-DISEASE
a	0
chronic	I-DISEASE
disorder	I-DISEASE
.	0

Predisposing	I-DISEASE
and	0
Precipitating	I-DISEASE
Factors	0
SRED	I-DISEASE
can	0
be	0
idiopathic	0
,	0
but	0
it	0
appears	0
to	0
be	0
most	0
commonly	I-DISEASE
associated	0
with	I-DISEASE
a	0
primary	0
sleep	0
disorder	B-DISEASE
,	0
another	0
clinical	I-DISEASE
condition	0
,	0
or	0
use	I-DISEASE
of	I-DISEASE
a	0
sedative	I-DISEASE
-	0
hypnotic	I-DISEASE
medication	0
.	0

Sleepwalking	I-DISEASE
is	0
the	0
most	0
common	I-DISEASE
sleep	0
disorder	0
associated	0
with	I-DISEASE
sleep	0
related	I-DISEASE
eating	I-DISEASE
,	0
although	0
once	I-DISEASE
eating	I-DISEASE
becomes	0
part	0
of	I-DISEASE
the	0
behavioral	0
repertoire	I-DISEASE
,	I-DISEASE
it	I-DISEASE
quickly	0
becomes	I-DISEASE
the	0
predominant	0
,	I-DISEASE
if	0
not	0
the	0
exclusive	I-DISEASE
,	0
nocturnal	0
“	I-DISEASE
sleepwalking	0
”	0
behavior	0
.	0

This	I-DISEASE
would	0
indi-	0
cate	0
that	I-DISEASE
SRED	0
is	0
most	0
often	I-DISEASE
a	I-DISEASE
“	0
sleepwalking	0
variant	0
disorder	0
.	0
”	I-DISEASE

A	I-DISEASE
history	I-DISEASE
of	I-DISEASE
sleepwalk-	0
ing	I-DISEASE
during	I-DISEASE
childhood	0
appears	0
to	I-DISEASE
be	I-DISEASE
a	I-DISEASE
predisposing	I-DISEASE
factor	I-DISEASE
in	0
many	0
cases	0
.	0

A	I-DISEASE
recent	I-DISEASE
retro-	0
spective	0
controlled	0
study	0
of	I-DISEASE
SRED	I-DISEASE
patients	I-DISEASE
,	0
sleepwalking	0
patients	0
,	0
and	0
controls	0
found	I-DISEASE
that	0
SRED	I-DISEASE
patients	0
were	I-DISEASE
mainly	0
women	I-DISEASE
with	I-DISEASE
onset	I-DISEASE
of	I-DISEASE
the	0
disturbance	I-DISEASE
in	I-DISEASE
adulthood	0
.	0

They	I-DISEASE
typically	0
experienced	0
nightly	I-DISEASE
episodes	I-DISEASE
and	0
had	I-DISEASE
more	0
frequent	0
eating	I-DISEASE
problems	0
in	I-DISEASE
childhood	0
and	0
higher	0
current	I-DISEASE
anorexia	I-DISEASE
scores	I-DISEASE
than	0
sleepwalking	0
patients	I-DISEASE
or	0
controls	0
.	0

They	I-DISEASE
also	0
shared	0
commonalities	I-DISEASE
with	I-DISEASE
sleepwalking	0
patients	0
,	I-DISEASE
including	I-DISEASE
a	0
high	0
(	0
66	I-DISEASE
%	0
)	0
frequency	I-DISEASE
of	I-DISEASE
past	I-DISEASE
or	0
current	0
sleepwalking	0
,	I-DISEASE
a	0
similar	0
timing	I-DISEASE
of	I-DISEASE
parasomnia	I-DISEASE
episodes	I-DISEASE
(	0
in	I-DISEASE
the	0
first	0
half	0
of	0
the	0
night	0
)	0
,	I-DISEASE
and	0
numerous	I-DISEASE
arousals	0
from	0
stage	0
N3	0
.	0

On	I-DISEASE
video	I-DISEASE
-	0
polysom-	0
nography	0
,	0
eating	I-DISEASE
episodes	I-DISEASE
occurred	0
mostly	I-DISEASE
within	I-DISEASE
one	I-DISEASE
minute	I-DISEASE
after	0
awakening	0
from	0
stage	0
N2	0
or	I-DISEASE
N3	0
.	0

The	I-DISEASE
frequencies	I-DISEASE
of	I-DISEASE
RLS	I-DISEASE
,	I-DISEASE
PLMs	0
,	0
and	0
sleep	0
apnea	I-DISEASE
were	I-DISEASE
similar	0
across	I-DISEASE
the	0
three	0
groups	0
.	0

Other	I-DISEASE
sleep	0
disorders	0
that	0
can	0
be	I-DISEASE
closely	I-DISEASE
associated	0
with	0
SRED	0
include	I-DISEASE
:	I-DISEASE
RLS	I-DISEASE
,	I-DISEASE
PLMD	0
,	0
OSA	I-DISEASE
,	I-DISEASE
and	0
circadian	0
rhythm	0
sleep	0
-	I-DISEASE
wake	0
disorders	0
,	I-DISEASE
particularly	0
irregular	I-DISEASE
sleep/	0
wake	0
pattern	0
.	0

Multiple	I-DISEASE
sleep	0
disorders	0
in	I-DISEASE
the	0
same	0
patient	I-DISEASE
have	I-DISEASE
been	I-DISEASE
reported	0
with	I-DISEASE
SRED	I-DISEASE
,	I-DISEASE
including	0
sexsomnia	0
and	0
a	0
variant	I-DISEASE
of	I-DISEASE
confusional	I-DISEASE
arousals	0
and	0
sleepwalking	0
.	0

Medication	I-DISEASE
-	0
induced	I-DISEASE
SRED	0
has	0
been	I-DISEASE
reported	0
with	0
zolpidem	I-DISEASE
,	0
in	I-DISEASE
particular	I-DISEASE
,	I-DISEASE
but	0
also	0
with	I-DISEASE
a	0
broad	0
range	0
of	I-DISEASE
sedative	I-DISEASE
hypnotics	I-DISEASE
,	0
including	0
benzodiazepines	0
,	0
benzodiazepine	0
receptor	I-DISEASE
agonists	I-DISEASE
,	0
mirtazapine	0
,	I-DISEASE
risperidone	0
,	I-DISEASE
quetiapine	I-DISEASE
,	0
lithium	0
carbonate	0
,	I-DISEASE
anticholin-	0
ergics	0
,	I-DISEASE
and	0
various	0
other	0
psychotropic	I-DISEASE
agents	0
.	I-DISEASE

Onset	I-DISEASE
of	I-DISEASE
SRED	I-DISEASE
also	0
has	0
been	I-DISEASE
reported	0
with	0
cessation	I-DISEASE
of	I-DISEASE
cigarette	I-DISEASE
smoking	I-DISEASE
,	I-DISEASE
cessation	I-DISEASE
of	I-DISEASE
alcohol	0
and	0
substance	I-DISEASE
abuse	I-DISEASE
,	I-DISEASE
acute	0
stress	I-DISEASE
(	0
usually	I-DISEASE
involving	0
major	I-DISEASE
separation	0
reactions	I-DISEASE
)	0
,	I-DISEASE
after	0
daytime	0
dieting	I-DISEASE
,	0
and	0
with	0
onset	0
of	I-DISEASE
narcolepsy	0
,	0
autoimmune	0
hepatitis	I-DISEASE
,	I-DISEASE
encephalitis	0
,	I-DISEASE
and	0
other	0
conditions	I-DISEASE
.	0

SRED	I-DISEASE
can	0
also	0
be	0
associated	0
with	I-DISEASE
daytime	I-DISEASE
eating	I-DISEASE
disorders	0
,	I-DISEASE
and	0
with	I-DISEASE
nocturnal	I-DISEASE
dissocia-	I-DISEASE
tive	0
disorder	0
.	0

In	I-DISEASE
a	I-DISEASE
controlled	0
study	0
of	0
65	0
patients	I-DISEASE
with	I-DISEASE
narcolepsy	0
-	I-DISEASE
cataplexy	I-DISEASE
,	I-DISEASE
32	0
%	0
of	I-DISEASE
patients	0
had	I-DISEASE
SRED	0
vs.	I-DISEASE
2	I-DISEASE
%	0
of	I-DISEASE
controls	0
.	0

Nocturnal	I-DISEASE
smoking	0
was	0
present	0
in	I-DISEASE
33	I-DISEASE
%	0
of	I-DISEASE
SRED	0
-	I-DISEASE
narcolepsy	I-DISEASE
-	I-DISEASE
cataplexy	I-DISEASE
patients	0
and	0
in	I-DISEASE
16	I-DISEASE
%	0
of	0
narcolepsy	0
-	I-DISEASE
cataplexy	0
patients	0
without	0
SRED	I-DISEASE
.	0

(	I-DISEASE
A	0
link	0
between	0
SRED	0
and	0
nocturnal	0
smoking	0
had	0
previously	I-DISEASE
been	I-DISEASE
identified	I-DISEASE
when	0
nocturnal	0
smoking	I-DISEASE
was	0
first	0
reported	I-DISEASE
in	I-DISEASE
2008	I-DISEASE
)	0
.	0

A	I-DISEASE
study	I-DISEASE
of	I-DISEASE
88	I-DISEASE
patients	0
with	I-DISEASE
RLS	I-DISEASE
and	0
42	0
patients	0
with	I-DISEASE
insomnia	I-DISEASE
who	I-DISEASE
were	I-DISEASE
systematically	I-DISEASE
questioned	0
for	0
the	0
presence	0
of	I-DISEASE
SRED	0
or	I-DISEASE
other	0
nocturnal	0
eating	I-DISEASE
demonstrated	0
that	B-DISEASE
36	0
%	0
of	I-DISEASE
patients	I-DISEASE
with	I-DISEASE
RLS	0
versus	0
zero	0
patients	I-DISEASE
with	0
insomnia	0
had	I-DISEASE
SRED	I-DISEASE
,	I-DISEASE
and	0
the	0
very	I-DISEASE
significant	0
difference	0
was	0
not	0
related	0
to	0
arousal	0
frequency	I-DISEASE
.	0

In	I-DISEASE
that	I-DISEASE
study	0
,	I-DISEASE
patients	0
with	I-DISEASE
RLS	I-DISEASE
who	I-DISEASE
were	I-DISEASE
taking	0
hypnotic	I-DISEASE
medications	I-DISEASE
were	I-DISEASE
at	I-DISEASE
additional	0
risk	0
for	I-DISEASE
SRED	I-DISEASE
.	0

Familial	I-DISEASE
Pattern	I-DISEASE
A	0
familial	I-DISEASE
basis	0
for	0
SRED	I-DISEASE
is	I-DISEASE
not	0
uncommon	0
,	I-DISEASE
including	I-DISEASE
co	0
-	0
occurrence	0
in	I-DISEASE
fraternal	0
twins	I-DISEASE
,	0
although	I-DISEASE
detailed	0
genetic	I-DISEASE
studies	I-DISEASE
have	B-DISEASE
not	0
been	I-DISEASE
carried	0
out	0
.	0

Onset	I-DISEASE
,	0
Course	0
,	0
and	0
Complications	0
The	I-DISEASE
onset	I-DISEASE
of	I-DISEASE
SRED	I-DISEASE
can	0
be	I-DISEASE
insidious	I-DISEASE
and	0
sporadic	0
,	0
or	0
it	I-DISEASE
can	0
be	I-DISEASE
precipitous	0
and	0
fulmi-	0
nant	0
with	I-DISEASE
rapid	I-DISEASE
development	B-DISEASE
of	0
nightly	0
episodes	I-DISEASE
of	I-DISEASE
eating	I-DISEASE
,	I-DISEASE
related	0
or	0
unrelated	0
to	0
the	0
start	0
of	I-DISEASE
hypnotic	I-DISEASE
medication	0
therapy	I-DISEASE
of	I-DISEASE
insomnia	I-DISEASE
.	0

The	I-DISEASE
course	I-DISEASE
is	0
usually	I-DISEASE
unremitting	0
.	0

Fires	I-DISEASE
can	0
occur	I-DISEASE
when	0
the	0
individual	I-DISEASE
with	I-DISEASE
SRED	0
begins	I-DISEASE
to	I-DISEASE
cook	I-DISEASE
foods	I-DISEASE
on	0
the	0
stove	0
or	I-DISEASE
in	0
the	0
oven	0
,	0
and	0
then	0
abandons	I-DISEASE
them	I-DISEASE
.	I-DISEASE

A	I-DISEASE
variety	I-DISEASE
of	I-DISEASE
other	I-DISEASE
complications	0
have	I-DISEASE
been	I-DISEASE
described	I-DISEASE
previously	0
.	0

Developmental	I-DISEASE
Issues	0
SRED	I-DISEASE
can	I-DISEASE
emerge	I-DISEASE
in	I-DISEASE
childhood	0
,	I-DISEASE
either	I-DISEASE
associated	0
or	I-DISEASE
unassociated	I-DISEASE
with	I-DISEASE
a	0
family	0
history	I-DISEASE
of	I-DISEASE
SRED	I-DISEASE
.	0

Pathology	I-DISEASE
and	0
Pathophysiology	I-DISEASE
The	I-DISEASE
underlying	0
pathophysiology	0
of	I-DISEASE
SRED	I-DISEASE
is	0
unclear	0
.	0

Despite	I-DISEASE
the	0
broad	0
range	I-DISEASE
of	0
pre-	0
disposing	I-DISEASE
and	0
precipitating	I-DISEASE
factors	I-DISEASE
in	I-DISEASE
SRED	0
,	I-DISEASE
the	0
relatively	0
homogeneous	I-DISEASE
set	I-DISEASE
of	0
clinical	0
features	I-DISEASE
suggests	I-DISEASE
the	0
presence	0
of	I-DISEASE
a	0
“	I-DISEASE
final	I-DISEASE
common	I-DISEASE
pathway	0
”	I-DISEASE
that	0
can	0
be	0
accessed	0
by	0
a	0
variety	I-DISEASE
of	I-DISEASE
factors	0
.	0

Although	I-DISEASE
SRED	I-DISEASE
has	0
prominent	0
features	I-DISEASE
of	I-DISEASE
both	I-DISEASE
a	0
sleep	0
disorder	0
and	0
an	I-DISEASE
eating	I-DISEASE
disorder	0
,	I-DISEASE
its	I-DISEASE
relatively	0
homogeneous	0
presentation	0
supports	0
its	I-DISEASE
classification	I-DISEASE
as	0
a	I-DISEASE
separate	0
diagnostic	0
entity	0
.	0

More	I-DISEASE
than	I-DISEASE
half	0
of	I-DISEASE
patients	0
with	I-DISEASE
SRED	I-DISEASE
have	0
a	0
history	I-DISEASE
of	I-DISEASE
another	I-DISEASE
parasomnia	I-DISEASE
that	I-DISEASE
preceded	0
the	0
onset	I-DISEASE
of	I-DISEASE
nocturnal	0
eating	I-DISEASE
,	I-DISEASE
suggesting	0
that	0
the	0
presence	0
of	I-DISEASE
another	I-DISEASE
parasomnia	I-DISEASE
is	0
a	0
major	I-DISEASE
risk	0
factor	0
for	0
SRED	0
.	0

However	I-DISEASE
,	I-DISEASE
the	0
female	I-DISEASE
predominance	0
in	0
SRED	0
is	I-DISEASE
more	I-DISEASE
consistent	I-DISEASE
with	0
eating	I-DISEASE
disorders	0
,	I-DISEASE
which	0
are	0
female	I-DISEASE
pre-	0
dominant	I-DISEASE
,	I-DISEASE
than	I-DISEASE
with	0
sleepwalking	0
or	I-DISEASE
movement	I-DISEASE
disorders	0
(	I-DISEASE
RLS	I-DISEASE
/	0
PLMD	0
)	0
which	0
have	0
slight	0
to	I-DISEASE
no	0
female	I-DISEASE
bias	I-DISEASE
.	0

Thus	I-DISEASE
it	0
appears	0
that	I-DISEASE
two	0
basic	0
drive	0
states	I-DISEASE
—	I-DISEASE
sleeping	0
and	0
eating	I-DISEASE
—	I-DISEASE
are	I-DISEASE
pathologically	0
intertwined	I-DISEASE
in	0
SRED	I-DISEASE
.	0

Parasomnias	I-DISEASE
Parasomnias	I-DISEASE
Objective	0
Findings	I-DISEASE
Although	0
not	0
routinely	I-DISEASE
indicated	0
in	0
the	0
assessment	I-DISEASE
of	I-DISEASE
SRED	0
,	I-DISEASE
vPSG	0
evaluations	I-DISEASE
have	B-DISEASE
often	0
reported	0
positive	0
findings	0
.	0

The	I-DISEASE
most	0
common	I-DISEASE
finding	I-DISEASE
consists	0
of	I-DISEASE
multiple	I-DISEASE
confu-	I-DISEASE
sional	0
arousals	I-DISEASE
,	0
with	0
or	I-DISEASE
without	0
eating	0
,	0
arising	0
from	0
slow	0
wave	B-DISEASE
sleep	0
.	0

However	I-DISEASE
,	I-DISEASE
abnor-	0
mal	0
arousals	0
have	0
been	I-DISEASE
documented	I-DISEASE
from	I-DISEASE
all	0
stages	I-DISEASE
of	I-DISEASE
NREM	0
sleep	0
and	0
also	0
occasion-	0
ally	I-DISEASE
from	0
REM	I-DISEASE
sleep	0
.	0

The	I-DISEASE
level	0
of	I-DISEASE
consciousness	I-DISEASE
has	0
typically	I-DISEASE
spanned	I-DISEASE
the	I-DISEASE
range	0
from	0
virtual	I-DISEASE
unconsciousness	I-DISEASE
to	I-DISEASE
various	0
levels	I-DISEASE
of	I-DISEASE
partial	I-DISEASE
consciousness	0
despite	0
a	I-DISEASE
concurrent	0
EEG	0
pattern	0
that	0
is	0
often	I-DISEASE
predominantly	I-DISEASE
awake	0
,	I-DISEASE
suggesting	I-DISEASE
dissociation	I-DISEASE
between	0
the	0
EEG	0
and	0
the	0
level	0
of	0
consciousness	0
.	0

This	I-DISEASE
dissociation	I-DISEASE
also	0
can	0
be	I-DISEASE
found	I-DISEASE
in	0
adult	0
sleep-	0
walking	I-DISEASE
without	0
associated	0
eating	I-DISEASE
.	0

In	I-DISEASE
contrast	I-DISEASE
,	0
classic	I-DISEASE
sleepwalking	0
in	I-DISEASE
childhood	0
is	0
usually	I-DISEASE
associated	0
with	I-DISEASE
the	0
persistence	0
of	I-DISEASE
high	I-DISEASE
-	0
voltage	0
delta	I-DISEASE
waves	I-DISEASE
or	0
the	0
admixture	0
of	I-DISEASE
delta	I-DISEASE
,	I-DISEASE
theta	0
,	0
and	0
alpha	I-DISEASE
activity	0
.	0

A	I-DISEASE
predominant	0
wake	0
pattern	0
is	0
rare	I-DISEASE
in	I-DISEASE
childhood	I-DISEASE
sleep-	0
walking	0
.	0

PLMs	I-DISEASE
and	0
OSA	0
may	I-DISEASE
be	I-DISEASE
observed	I-DISEASE
in	0
polysomnographic	0
monitoring	0
of	I-DISEASE
SRED	0
patients	I-DISEASE
.	0

In	I-DISEASE
one	0
recent	I-DISEASE
study	0
that	0
addressed	I-DISEASE
the	0
boundaries	0
between	0
SRED	0
and	0
fully	I-DISEASE
conscious	0
abnormal	0
nocturnal	0
eating	I-DISEASE
,	0
22	0
of	I-DISEASE
35	0
patients	I-DISEASE
had	0
PLMs	0
,	I-DISEASE
5	0
of	I-DISEASE
35	0
had	I-DISEASE
RLS	0
,	I-DISEASE
and	0
29	0
of	0
35	0
had	0
recurring	0
chewing	0
and	0
swallowing	0
movements	0
during	I-DISEASE
sleep	I-DISEASE
that	0
were	I-DISEASE
associated	0
with	0
nearly	0
half	0
of	I-DISEASE
the	0
total	I-DISEASE
number	0
of	I-DISEASE
EEG	0
arousals	0
.	I-DISEASE

Differential	I-DISEASE
Diagnosis	0
SRED	I-DISEASE
must	I-DISEASE
be	0
distinguished	0
primarily	I-DISEASE
from	I-DISEASE
night	I-DISEASE
eating	I-DISEASE
syndrome	I-DISEASE
(	I-DISEASE
NES	I-DISEASE
)	0
,	0
which	0
is	0
characterized	0
by	B-DISEASE
excessive	0
eating	I-DISEASE
between	0
dinner	0
and	0
bedtime	I-DISEASE
and	0
during	I-DISEASE
full	0
awaken-	0
ings	0
during	I-DISEASE
the	0
sleep	0
period	0
.	0

In	I-DISEASE
contrast	I-DISEASE
to	0
daytime	I-DISEASE
eating	0
disorders	0
(	I-DISEASE
bulimia	0
nervosa	0
,	0
anorexia	0
nervosa	0
)	0
,	0
inappropriate	0
compensatory	I-DISEASE
behavior	I-DISEASE
,	I-DISEASE
such	B-DISEASE
as	0
self	0
-	0
induced	0
vom-	0
iting	0
,	0
enemas	0
,	0
misuse	I-DISEASE
of	I-DISEASE
laxatives	0
,	0
diuretics	0
,	I-DISEASE
or	0
other	0
medications	0
,	0
or	0
other	I-DISEASE
purging	0
activity	0
,	0
are	I-DISEASE
not	0
present	I-DISEASE
in	I-DISEASE
SRED	0
,	0
although	0
the	0
two	0
conditions	I-DISEASE
may	0
be	0
comorbid	I-DISEASE
.	0

A	I-DISEASE
person	0
with	0
a	I-DISEASE
daytime	0
eating	I-DISEASE
disorder	0
may	I-DISEASE
also	0
have	0
a	0
coexisting	0
SRED	I-DISEASE
that	I-DISEASE
is	0
asso-	0
ciated	I-DISEASE
with	I-DISEASE
confusional	I-DISEASE
arousals	0
but	I-DISEASE
not	0
associated	0
with	0
purging	0
behaviors	I-DISEASE
during	0
the	0
night	0
or	0
upon	0
arising	0
in	0
the	0
morning	0
.	0

Patients	I-DISEASE
with	0
longstanding	I-DISEASE
SRED	I-DISEASE
and	0
excessive	0
weight	0
gain	0
may	I-DISEASE
eventually	I-DISEASE
fast	0
during	I-DISEASE
the	0
daytime	I-DISEASE
and/or	0
engage	0
in	I-DISEASE
excessive	0
exer-	0
cise	0
to	0
prevent	I-DISEASE
obesity	0
from	0
the	0
SRED	I-DISEASE
.	0

Likewise	I-DISEASE
,	I-DISEASE
patients	0
who	I-DISEASE
otherwise	0
fulfill	I-DISEASE
crite-	I-DISEASE
ria	0
for	0
SRED	I-DISEASE
may	0
consciously	0
eat	I-DISEASE
during	I-DISEASE
the	0
prebedtime	0
period	0
in	0
a	0
futile	I-DISEASE
attempt	0
to	0
suppress	0
the	0
compulsion	I-DISEASE
to	I-DISEASE
eat	0
after	0
subsequently	I-DISEASE
falling	0
asleep	I-DISEASE
.	0

SRED	I-DISEASE
appears	0
to	I-DISEASE
be	0
considerably	0
more	0
female	I-DISEASE
predominant	0
that	0
NES	I-DISEASE
(	I-DISEASE
which	I-DISEASE
has	0
<	I-DISEASE
60	I-DISEASE
%	0
female	0
prevalence	0
)	0
,	0
and	0
mood	0
disorders	0
are	I-DISEASE
more	0
common	I-DISEASE
with	0
NES	I-DISEASE
than	I-DISEASE
with	I-DISEASE
SRED	I-DISEASE
.	0

Nevertheless	I-DISEASE
,	I-DISEASE
SRED	0
and	0
NES	I-DISEASE
share	I-DISEASE
a	0
considerable	0
number	0
of	I-DISEASE
overlapping	I-DISEASE
features	I-DISEASE
and	0
may	I-DISEASE
exist	I-DISEASE
along	I-DISEASE
a	0
common	0
spectrum	I-DISEASE
of	I-DISEASE
pathophysiology	0
.	I-DISEASE

SRED	I-DISEASE
should	0
also	0
be	0
distinguished	I-DISEASE
from	0
nocturnal	0
(	I-DISEASE
sleep	0
related	I-DISEASE
)	I-DISEASE
extensions	0
of	I-DISEASE
bulimia	0
nervosa	0
,	0
binge	0
-	I-DISEASE
eating	I-DISEASE
disorder	I-DISEASE
,	I-DISEASE
and	0
anorexia	I-DISEASE
nervosa	0
,	0
binge	0
/	0
purge	0
type	0
.	0

The	I-DISEASE
nocturnal	0
eating	I-DISEASE
(	0
drinking	I-DISEASE
)	0
syndrome	I-DISEASE
described	0
in	0
the	0
original	I-DISEASE
International	I-DISEASE
Classification	I-DISEASE
of	I-DISEASE
Sleep	0
Disorders	I-DISEASE
is	0
primarily	I-DISEASE
a	0
disorder	I-DISEASE
of	I-DISEASE
infancy	0
that	0
is	0
characterized	0
by	0
recurrent	I-DISEASE
awakenings	0
with	I-DISEASE
the	0
inability	0
to	0
resume	0
sleep	0
without	0
eating	I-DISEASE
or	0
drinking	0
.	0

Kleine	I-DISEASE
-	0
Levin	0
syndrome	0
(	I-DISEASE
periodic	I-DISEASE
hypersomnia	I-DISEASE
)	I-DISEASE
can	0
present	0
with	0
inappropriate	0
noctur-	I-DISEASE
nal	0
eating	0
,	I-DISEASE
but	I-DISEASE
its	0
predominance	0
in	I-DISEASE
adolescent	0
males	I-DISEASE
and	0
its	I-DISEASE
hallmark	0
symptom	0
complex	0
of	0
periodic	I-DISEASE
hypersomnia	0
,	0
hypersexuality	0
,	0
and	0
hyperphagia	0
lasting	0
days	I-DISEASE
to	I-DISEASE
weeks	I-DISEASE
should	0
easily	0
distinguish	0
it	0
from	I-DISEASE
SRED	I-DISEASE
.	0

Medical	I-DISEASE
and	0
neurologic	0
disorders	0
that	0
could	0
be	0
asso-	B-DISEASE
ciated	I-DISEASE
with	0
abnormal	I-DISEASE
recurrent	I-DISEASE
eating	0
during	I-DISEASE
the	0
main	0
sleep	0
period	0
(	I-DISEASE
usually	0
with	I-DISEASE
full	0
or	I-DISEASE
almost	I-DISEASE
full	0
alertness	0
)	0
should	0
also	0
be	0
excluded	0
.	0

These	0
include	I-DISEASE
:	0
hypoglycemic	I-DISEASE
states	0
,	0
peptic	0
ulcer	0
disease	B-DISEASE
,	I-DISEASE
reflux	0
esophagitis	0
,	0
and	0
Kluver	B-DISEASE
-	I-DISEASE
Bucy	0
syndrome	0
.	0

Unresolved	I-DISEASE
Issues	0
and	0
Future	0
Directions	0

The	I-DISEASE
extent	0
of	I-DISEASE
overlap	0
and	0
divergence	I-DISEASE
between	0
SRED	0
and	0
NES	I-DISEASE
needs	I-DISEASE
to	0
be	0
further	I-DISEASE
elucidated	I-DISEASE
.	0

Bibliography	0
Brion	0
A	0
,	0
Flamand	I-DISEASE
M	I-DISEASE
,	I-DISEASE
Oudiette	I-DISEASE
D	I-DISEASE
,	I-DISEASE
Voillery	I-DISEASE
D	I-DISEASE
,	0
Golmard	I-DISEASE
JL	0
,	I-DISEASE
Arnulf	0
I.	0
Sleep	0
related	B-DISEASE
eating	I-DISEASE
disorder	0
versus	0
sleepwalking	0
:	0
a	0
controlled	I-DISEASE
study	0
.	0

Sleep	I-DISEASE
Med	I-DISEASE
2012	I-DISEASE
;	0
3:1094–101	I-DISEASE
.	0

Howell	0
MJ	I-DISEASE
,	I-DISEASE
Schenck	0
CH	I-DISEASE
,	0
Crow	0
SJ	I-DISEASE
.	I-DISEASE

A	I-DISEASE
review	0
of	I-DISEASE
nighttime	0
eating	I-DISEASE
disorders	0
.	0

Sleep	I-DISEASE
Med	I-DISEASE
Rev	0
2009;13:23–-34	I-DISEASE
.	I-DISEASE

Howell	I-DISEASE
MJ	I-DISEASE
,	I-DISEASE
Schenck	0
CH	I-DISEASE
.	0

Restless	I-DISEASE
nocturnal	0
eating	0
:	I-DISEASE
a	0
common	I-DISEASE
feature	0
of	I-DISEASE
Willis	I-DISEASE
-	I-DISEASE
Ekbom	I-DISEASE
syndrome	I-DISEASE
(	I-DISEASE
RLS	0
)	0
.	0

J	I-DISEASE
Clin	0
Sleep	0
Med	0
2012;8:413–9	I-DISEASE
.	0

Palaia	I-DISEASE
V	I-DISEASE
,	0
Poli	0
F	I-DISEASE
,	0
Pizz	0
F	I-DISEASE
,	I-DISEASE
et	0
al	0
.	0

Narcolepsy	I-DISEASE
with	0
cataplexy	I-DISEASE
associated	0
with	I-DISEASE
nocturnal	0
compulsive	I-DISEASE
behaviors	I-DISEASE
:	I-DISEASE
a	0
case	0
-	I-DISEASE
control	0
study	0
.	0

Sleep	I-DISEASE
2011;34:1365–71	I-DISEASE
.	0

Schenck	I-DISEASE
CH	I-DISEASE
,	0
Hurwitz	I-DISEASE
TD	0
,	0
Bundlie	0
SR	I-DISEASE
,	I-DISEASE
Mahowald	I-DISEASE
MW	0
.	0

Sleep	I-DISEASE
-	I-DISEASE
related	0
eating	I-DISEASE
disorders	0
:	I-DISEASE
polysomnographic	0
correlates	I-DISEASE
of	I-DISEASE
a	0
heterogeneous	I-DISEASE
syndrome	0
distinct	0
from	0
daytime	I-DISEASE
eating	I-DISEASE
disorders	0
.	0

Sleep	I-DISEASE
1991;14:419–31	0
.	0

Schenck	I-DISEASE
CH	I-DISEASE
,	0
Hurwitz	I-DISEASE
TD	0
,	0
O’Connor	I-DISEASE
KA	I-DISEASE
,	I-DISEASE
Mahowald	I-DISEASE
MW	0
.	0

Additional	I-DISEASE
categories	I-DISEASE
of	I-DISEASE
sleep	0
-	0
related	0
eating	I-DISEASE
disorders	0
and	0
the	0
current	I-DISEASE
status	0
of	I-DISEASE
treatment	I-DISEASE
.	0

Sleep	I-DISEASE
1993;16:457–66	I-DISEASE
.	0

Vetrugno	I-DISEASE
R	0
,	I-DISEASE
Manconi	I-DISEASE
M	0
,	0
Ferini	I-DISEASE
-	I-DISEASE
Strambi	0
L	0
,	0
Provini	0
F	I-DISEASE
,	0
Plazzi	0
G	I-DISEASE
,	I-DISEASE
Montagna	0
P.	0
Nocturnal	0
eating	I-DISEASE
:	0
sleep	0
-	0
related	0
eating	I-DISEASE
disorder	0
or	0
night	0
eating	I-DISEASE
syndrome	I-DISEASE
?	0

A	I-DISEASE
videopolysomnographic	I-DISEASE
study	0
.	0

Sleep	I-DISEASE
2006;29:949–54	0
.	0

Vinai	I-DISEASE
P	0
,	I-DISEASE
Ferri	0
R	I-DISEASE
,	I-DISEASE
Ferini	I-DISEASE
-	I-DISEASE
Strambi	I-DISEASE
L	0
,	I-DISEASE
et	0
al	I-DISEASE
.	0

Defining	I-DISEASE
the	0
borders	0
between	0
sleep	0
-	0
related	B-DISEASE
eating	0
disorder	0
and	0
night	0
eating	I-DISEASE
syndrome	I-DISEASE
.	0

Sleep	I-DISEASE
Med	I-DISEASE
2012;13:686–90	I-DISEASE
.	0

Winkelman	I-DISEASE
JW	0
.	0

Clinical	I-DISEASE
and	0
polysomnographic	0
features	0
of	0
sleep	0
-	I-DISEASE
related	I-DISEASE
eating	I-DISEASE
disorder	0
.	0

J	I-DISEASE
Clin	0
Psychiatry	0
1998;59:14–9	0
.	0

Winkelman	I-DISEASE
JW	0
,	I-DISEASE
Herzog	I-DISEASE
DB	0
,	0
Fava	I-DISEASE
M.	I-DISEASE

The	I-DISEASE
prevalence	0
of	I-DISEASE
sleep	0
-	0
related	B-DISEASE
eating	I-DISEASE
disorder	I-DISEASE
in	0
psychiatric	0
and	0
non	0
-	I-DISEASE
psychiatric	I-DISEASE
populations	0
.	0

Psychol	I-DISEASE
Med	0
1999;29:1461–6	I-DISEASE
.	0

Winkelman	I-DISEASE
JW	0
.	0

Sleep	I-DISEASE
-	I-DISEASE
related	0
eating	I-DISEASE
disorder	0
and	0
night	0
eating	I-DISEASE
syndrome	0
:	0
sleep	0
disorders	0
,	I-DISEASE
eating	I-DISEASE
disorders	0
,	I-DISEASE
or	I-DISEASE
both	I-DISEASE
?	0

Sleep	I-DISEASE
2006;29:876–7	0
.	0

Parasomnias	I-DISEASE
Parasomnias	0
REM	0
-	I-DISEASE
Related	0
Parasomnias	0
REM	0
Sleep	0
Behavior	0
Disorder	0
ICD-9	0
-	0
CM	0
code	0
:	0
327.42	0
Alternate	0
Names	0
None	0
.	0

Diagnostic	I-DISEASE
Criteria	0
Criteria	I-DISEASE
A	0
-	I-DISEASE
D	I-DISEASE
must	0
be	0
met	0
ICD-10	0
-	0
CM	0
code	0
:	0
G47.52	I-DISEASE
A.	0
Repeated	I-DISEASE
episodes	I-DISEASE
of	I-DISEASE
sleep	0
related	0
vocalization	0
and/or	0
complex	0
motor	I-DISEASE

behaviors.1,2	I-DISEASE
B.	0

These	0
behaviors	I-DISEASE
are	0
documented	I-DISEASE
by	0
polysomnography	0
to	I-DISEASE
occur	I-DISEASE
during	I-DISEASE
REM	0
sleep	0
or	I-DISEASE
,	0
based	0
on	0
clinical	0
history	I-DISEASE
of	I-DISEASE
dream	I-DISEASE
enactment	I-DISEASE
,	I-DISEASE
are	I-DISEASE
presumed	I-DISEASE
to	I-DISEASE
occur	0
during	I-DISEASE
REM	I-DISEASE
sleep	0
.	0

C.	I-DISEASE
Polysomnographic	0
recording	0
demonstrates	I-DISEASE
REM	0
sleep	0
without	I-DISEASE
atonia	I-DISEASE
(	I-DISEASE
RWA)3	I-DISEASE
D.	0

The	I-DISEASE
disturbance	I-DISEASE
is	0
not	0
better	0
explained	I-DISEASE
by	I-DISEASE
another	I-DISEASE
sleep	0
disorder	0
,	0
mental	I-DISEASE
disorder	I-DISEASE
,	I-DISEASE
medication	0
,	I-DISEASE
or	I-DISEASE
substance	I-DISEASE
use	0
.	0

Notes	I-DISEASE
.	0

This	I-DISEASE
criterion	0
can	0
be	I-DISEASE
fulfilled	0
by	I-DISEASE
observation	I-DISEASE
of	I-DISEASE
repetitive	I-DISEASE
episodes	0
during	I-DISEASE
a	0
single	I-DISEASE
night	I-DISEASE
of	0
video	0
polysomnography	0
.	0
.	0

The	I-DISEASE
observed	I-DISEASE
vocalizations	0
or	0
behaviors	I-DISEASE
often	I-DISEASE
correlate	B-DISEASE
with	I-DISEASE
simultaneously	I-DISEASE
occurring	I-DISEASE
dream	I-DISEASE
mentation	0
,	I-DISEASE
leading	I-DISEASE
to	0
the	0
frequent	I-DISEASE
report	0
of	I-DISEASE
“	I-DISEASE
acting	I-DISEASE
out	0
one	0
’s	I-DISEASE
dreams	I-DISEASE
.	I-DISEASE
”	I-DISEASE
.	0

As	I-DISEASE
defined	I-DISEASE
by	I-DISEASE
the	0
guidelines	0
for	I-DISEASE
scoring	I-DISEASE
PSG	0
features	0
of	I-DISEASE
RBD	I-DISEASE
in	I-DISEASE
the	0
most	0
recent	I-DISEASE
version	I-DISEASE
of	0
the	0
American	I-DISEASE
Academy	0
of	I-DISEASE
Sleep	0
Medicine	I-DISEASE
(	I-DISEASE
AASM	0
)	0
Manual	I-DISEASE
for	I-DISEASE
the	B-DISEASE
Scoring	0
of	I-DISEASE
Sleep	0
and	0
Associated	0
Events	I-DISEASE
.	0
.	0

Upon	I-DISEASE
awakening	0
,	I-DISEASE
the	0
individual	I-DISEASE
is	I-DISEASE
typically	I-DISEASE
awake	0
,	0
alert	I-DISEASE
,	I-DISEASE
coherent	I-DISEASE
,	I-DISEASE
and	0
oriented	0
.	0
.	I-DISEASE

On	I-DISEASE
occasion	0
,	0
there	I-DISEASE
may	0
be	I-DISEASE
patients	I-DISEASE
with	I-DISEASE
a	0
typical	0
clinical	0
history	I-DISEASE
of	I-DISEASE
RBD	I-DISEASE
with	0
dream	I-DISEASE
-	I-DISEASE
enacting	0
behaviors	I-DISEASE
,	0
who	I-DISEASE
also	0
exhibit	0
typical	0
RBD	I-DISEASE
behaviors	I-DISEASE
during	I-DISEASE
vPSG	0
,	I-DISEASE
but	0
do	0
not	0
demonstrate	0
sufficient	0
RWA	0
,	0
based	0
on	0
the	0
current	I-DISEASE
evidence	0
-	I-DISEASE
based	I-DISEASE
data	I-DISEASE
,	0
to	0
satisfy	0
the	0
PSG	0
criteria	I-DISEASE
for	0
diagnosing	0
RBD	I-DISEASE
.	0

In	I-DISEASE
such	I-DISEASE
patients	0
,	I-DISEASE
RBD	0
may	I-DISEASE
be	I-DISEASE
provisionally	0
diagnosed	0
,	I-DISEASE
based	I-DISEASE
on	0
clinical	0
judgment	I-DISEASE
.	0

The	I-DISEASE
same	0
rule	0
applies	0
when	0
vPSG	I-DISEASE
is	0
not	0
readily	I-DISEASE
available	0
.	I-DISEASE

6	I-DISEASE
.	0

Medications	I-DISEASE
may	I-DISEASE
unmask	0
latent	I-DISEASE
RBD	0
with	I-DISEASE
preexisting	I-DISEASE
RWA	I-DISEASE
,	0
according	0
to	I-DISEASE
current	I-DISEASE
expert	0
opinion	0
.	0

Therefore	I-DISEASE
,	I-DISEASE
medication	0
-	I-DISEASE
induced	0
RBD	I-DISEASE
can	I-DISEASE
be	0
diagnosed	0
as	B-DISEASE
RBD	I-DISEASE
,	I-DISEASE
using	0
clinical	I-DISEASE
judgment	I-DISEASE
,	I-DISEASE
pending	0
future	0
longitudinal	I-DISEASE
studies	I-DISEASE
.	0

Essential	I-DISEASE
Features	I-DISEASE
RBD	0
is	0
characterized	0
by	I-DISEASE
abnormal	I-DISEASE
behaviors	I-DISEASE
emerging	I-DISEASE
during	I-DISEASE
REM	I-DISEASE
sleep	I-DISEASE
that	0
may	I-DISEASE
cause	I-DISEASE
injury	I-DISEASE
or	0
sleep	0
disruption	I-DISEASE
.	0

RBD	I-DISEASE
is	0
also	0
associated	0
with	I-DISEASE
EMG	0
abnormalities	0
during	I-DISEASE
REM	I-DISEASE
sleep	I-DISEASE
.	0

The	I-DISEASE
EMG	0
demonstrates	I-DISEASE
an	0
excess	0
of	I-DISEASE
muscle	I-DISEASE
tone	I-DISEASE
during	I-DISEASE
REM	0
sleep	I-DISEASE
,	I-DISEASE
and/or	0
an	I-DISEASE
excess	0
of	0
phasic	0
EMG	0
twitch	I-DISEASE
activity	0
during	I-DISEASE
REM	0
sleep	0
.	0

A	I-DISEASE
complaint	I-DISEASE
of	I-DISEASE
sleep	0
related	0
injury	0
is	I-DISEASE
common	I-DISEASE
with	0
RBD	0
,	I-DISEASE
which	I-DISEASE
usually	I-DISEASE
manifests	0
as	0
an	I-DISEASE
attempted	0
enactment	0
of	I-DISEASE
unpleasant	0
,	I-DISEASE
action	I-DISEASE
-	0
filled	0
,	I-DISEASE
and	0
violent	I-DISEASE
dreams	I-DISEASE
in	0
which	0
the	I-DISEASE
individual	I-DISEASE
is	0
being	0
confronted	0
,	0
attacked	0
,	0
or	0
chased	0
by	I-DISEASE
unfamiliar	I-DISEASE
people	I-DISEASE
or	I-DISEASE
animals	0
.	0

Typically	I-DISEASE
,	I-DISEASE
at	I-DISEASE
the	0
end	0
of	I-DISEASE
an	I-DISEASE
episode	I-DISEASE
,	0
the	0
individual	I-DISEASE
awakens	0
quickly	0
,	0
becomes	0
rapidly	I-DISEASE
alert	I-DISEASE
,	0
and	0
reports	I-DISEASE
a	0
dream	I-DISEASE
with	I-DISEASE
a	0
coherent	I-DISEASE
story	0
.	I-DISEASE

The	I-DISEASE
dream	I-DISEASE
action	0
corresponds	I-DISEASE
closely	0
to	I-DISEASE
the	0
observed	I-DISEASE
sleep	0
behaviors	I-DISEASE
.	0

Sleep	I-DISEASE
and	0
dream	I-DISEASE
-	I-DISEASE
related	0
behaviors	I-DISEASE
reported	0
by	I-DISEASE
history	I-DISEASE
and	0
documented	0
during	I-DISEASE
vPSG	I-DISEASE
include	I-DISEASE
both	I-DISEASE
violent	I-DISEASE
and	0
(	0
less	I-DISEASE
commonly	0
)	0
nonviolent	0
behaviors	0
:	I-DISEASE
talking	0
(	I-DISEASE
including	0
giving	I-DISEASE
speeches	0
)	0
,	I-DISEASE
smiling	I-DISEASE
,	0
laughing	0
,	I-DISEASE
singing	I-DISEASE
,	0
whistling	I-DISEASE
,	0
shouting	I-DISEASE
,	I-DISEASE
swearing	I-DISEASE
profan-	0
ities	0
,	0
crying	0
,	0
chewing	I-DISEASE
,	I-DISEASE
gesturing	0
,	0
reaching	0
,	0
grabbing	I-DISEASE
,	I-DISEASE
arm	I-DISEASE
flailing	0
,	0
clapping	I-DISEASE
,	I-DISEASE
slap-	I-DISEASE
ping	0
,	I-DISEASE
punching	0
,	0
kicking	0
,	I-DISEASE
sitting	I-DISEASE
up	I-DISEASE
,	0
leaping	0
from	0
bed	I-DISEASE
,	I-DISEASE
crawling	0
,	I-DISEASE
running	I-DISEASE
,	0
or	0
dancing	0
.	0

Walking	I-DISEASE
,	I-DISEASE
however	0
,	I-DISEASE
is	0
quite	I-DISEASE
uncommon	0
with	I-DISEASE
RBD	0
,	0
and	0
leaving	I-DISEASE
the	0
room	B-DISEASE
is	I-DISEASE
especially	0
rare	I-DISEASE
,	0
because	0
the	0
eyes	0
are	0
usually	I-DISEASE
closed	I-DISEASE
,	I-DISEASE
precluding	0
attention	0
to	I-DISEASE
the	0
environment	0
.	0

There	I-DISEASE
can	0
be	0
rare	I-DISEASE
occurrences	0
of	I-DISEASE
smoking	I-DISEASE
a	0
fictive	0
cigarette	I-DISEASE
,	I-DISEASE
masturbation	0
-	I-DISEASE
like	I-DISEASE
behav-	0
ior	I-DISEASE
,	I-DISEASE
pelvic	0
thrusting	0
,	I-DISEASE
and	0
mimics	B-DISEASE
of	I-DISEASE
eating	I-DISEASE
,	0
drinking	0
,	0
urinating	I-DISEASE
,	0
and	0
defecating	0
.	0

The	I-DISEASE
eyes	I-DISEASE
usually	I-DISEASE
remain	I-DISEASE
closed	0
during	I-DISEASE
an	0
RBD	I-DISEASE
episode	0
,	I-DISEASE
with	I-DISEASE
the	I-DISEASE
person	I-DISEASE
attending	I-DISEASE
to	I-DISEASE
the	0
dream	I-DISEASE
action	0
and	0
not	0
to	I-DISEASE
the	0
actual	I-DISEASE
environment	0
.	0

Medical	I-DISEASE
attention	I-DISEASE
is	0
usually	I-DISEASE
sought	0
after	0
sleep	0
related	B-DISEASE
injury	0
has	0
occurred	0
to	I-DISEASE
either	I-DISEASE
the	0
person	0
or	I-DISEASE
the	0
bed	I-DISEASE
partner	0
,	0
and	0
rarely	I-DISEASE
because	0
of	I-DISEASE
sleep	0
disruption	I-DISEASE
.	0

Because	I-DISEASE
RBD	I-DISEASE
occurs	0
during	I-DISEASE
REM	I-DISEASE
sleep	0
,	0
it	0
usually	I-DISEASE
appears	I-DISEASE
at	I-DISEASE
least	I-DISEASE
90	I-DISEASE
minutes	0
after	0
sleep	I-DISEASE
onset	0
,	0
unless	0
there	I-DISEASE
is	I-DISEASE
coexisting	B-DISEASE
narcolepsy	0
,	I-DISEASE
in	0
which	0
case	I-DISEASE
RBD	I-DISEASE
can	0
emerge	0
shortly	0
after	0
sleep	0
onset	0
during	I-DISEASE
a	0
sleep	0
onset	I-DISEASE
rapid	I-DISEASE
eye	I-DISEASE
movement	0
period	0
(	I-DISEASE
SOREMP	0
)	0
.	0

There	I-DISEASE
is	I-DISEASE
an	0
acute	I-DISEASE
form	0
of	I-DISEASE
RBD	I-DISEASE
that	0
emerges	0
during	I-DISEASE
intense	0
REM	I-DISEASE
sleep	0
rebound	0
states	I-DISEASE
,	0
such	0
as	0
during	I-DISEASE
withdrawal	0
from	0
alcohol	0
and	0
sedative	0
-	I-DISEASE
hypnotic	I-DISEASE
agents	I-DISEASE
,	0
or	0
in	I-DISEASE
association	0
with	0
certain	0
medication	0
use	0
,	I-DISEASE
drug	I-DISEASE
intoxication	I-DISEASE
,	0
or	0
relapsing	0
multiple	I-DISEASE
sclerosis	0
.	0

Parasomnias	I-DISEASE
Parasomnias	I-DISEASE
Associated	0
Features	I-DISEASE
PLMs	I-DISEASE
during	I-DISEASE
NREM	0
sleep	0
are	0
very	I-DISEASE
common	I-DISEASE
with	0
RBD	0
and	0
may	I-DISEASE
disturb	I-DISEASE
the	0
sleep	0
of	I-DISEASE
the	0
bed	I-DISEASE
partner	0
.	0

Daytime	I-DISEASE
tiredness	0
or	0
sleepiness	0
is	I-DISEASE
uncommon	0
,	0
unless	0
narcolepsy	0
is	I-DISEASE
also	0
present	I-DISEASE
.	0

There	I-DISEASE
is	I-DISEASE
typically	0
no	I-DISEASE
history	I-DISEASE
of	I-DISEASE
irritable	I-DISEASE
,	0
aggressive	0
,	I-DISEASE
or	I-DISEASE
violent	I-DISEASE
behav-	0
ior	0
during	I-DISEASE
the	0
day	I-DISEASE
.	0

There	I-DISEASE
may	I-DISEASE
be	0
a	I-DISEASE
longstanding	0
prodromal	0
history	I-DISEASE
of	I-DISEASE
sleep	I-DISEASE
talking	I-DISEASE
,	0
yelling	0
,	I-DISEASE
limb	I-DISEASE
twitching	0
,	I-DISEASE
and	0
jerking	0
during	I-DISEASE
sleep	0
that	0
may	0
or	I-DISEASE
may	I-DISEASE
not	0
be	0
dream	I-DISEASE
related	0
.	0

Clinical	I-DISEASE
or	I-DISEASE
Pathophysiological	0
Subtypes	I-DISEASE
Parasomnia	0
overlap	0
disorder	I-DISEASE
is	0
a	I-DISEASE
condition	0
in	0
which	0
patients	0
have	0
both	I-DISEASE
RBD	0
and	0
either	I-DISEASE
a	0
disorder	I-DISEASE
of	I-DISEASE
arousal	0
,	0
sleep	0
related	0
eating	I-DISEASE
disorder	I-DISEASE
,	0
sexsomnia	0
,	0
or	0
rhythmic	I-DISEASE
movement	0
disorder	I-DISEASE
.	0

This	I-DISEASE
condition	0
is	0
male	I-DISEASE
predominant	0
,	I-DISEASE
but	I-DISEASE
less	I-DISEASE
so	0
than	0
isolated	I-DISEASE
RBD	I-DISEASE
.	0

Most	I-DISEASE
cases	0
begin	0
during	I-DISEASE
childhood	0
or	I-DISEASE
adolescence	I-DISEASE
.	0

Virtually	I-DISEASE
all	0
age	I-DISEASE
groups	0
can	I-DISEASE
be	I-DISEASE
affected	I-DISEASE
.	0

It	I-DISEASE
can	0
be	0
idiopathic	I-DISEASE
or	I-DISEASE
symptomatic	0
of	I-DISEASE
a	0
broad	0
set	I-DISEASE
of	I-DISEASE
disorders	0
,	0
including	0
narcolepsy	0
,	I-DISEASE
mul-	I-DISEASE
tiple	I-DISEASE
sclerosis	0
,	0
brain	I-DISEASE
tumor	0
(	0
and	0
therapy	I-DISEASE
)	0
,	0
rhombencephalitis	0
(	I-DISEASE
right	0
pontine	0
tegmen-	I-DISEASE
tum	0
/	0
medulla	0
lesion	I-DISEASE
)	0
,	0
brain	0
trauma	0
,	0
congenital	0
Moebius	0
syndrome	I-DISEASE
,	0
agrypnia	0
excitata	0
,	0
Machado	0
-	I-DISEASE
Joseph	0
disease	0
,	0
various	I-DISEASE
psychiatric	0
disorders	0
and	0
their	I-DISEASE
pharmacotherapies	0
,	B-DISEASE
and	0
substance	I-DISEASE
abuse	0
disorders	0
and	0
withdrawal	0
states	0
.	0

Status	I-DISEASE
dissociatus	I-DISEASE
can	0
be	I-DISEASE
classified	0
as	0
a	0
subtype	I-DISEASE
of	I-DISEASE
RBD	I-DISEASE
that	0
manifests	0
as	0
an	0
extreme	I-DISEASE
form	I-DISEASE
of	I-DISEASE
state	B-DISEASE
dissociation	0
without	0
identifiable	I-DISEASE
sleep	0
stages	0
,	0
but	0
with	0
sleep	0
and	0
dream	I-DISEASE
-	0
related	0
behaviors	I-DISEASE
that	0
closely	0
resemble	I-DISEASE
RBD	I-DISEASE
.	0

Status	I-DISEASE
dissociatus	I-DISEASE
represents	I-DISEASE
a	0
major	I-DISEASE
breakdown	0
of	I-DISEASE
the	0
polysomnographic	0
markers	0
for	0
REM	0
sleep	0
,	0
NREM	0
sleep	0
,	I-DISEASE
and	0
wakefulness	0
,	I-DISEASE
with	I-DISEASE
admixtures	0
of	0
these	I-DISEASE
states	0
being	0
present	I-DISEASE
,	0
but	0
with	0
conventional	I-DISEASE
sleep	I-DISEASE
stages	I-DISEASE
not	0
being	I-DISEASE
identifiable	0
during	I-DISEASE
polysomnographic	0
monitoring	0
.	0

There	I-DISEASE
is	I-DISEASE
abnormal	I-DISEASE
behavioral	I-DISEASE
release	0
that	0
can	I-DISEASE
be	I-DISEASE
associated	0
with	0
disturbed	0
dreaming	0
,	I-DISEASE
strongly	I-DISEASE
suggestive	I-DISEASE
of	I-DISEASE
dream	I-DISEASE
-	0
enacting	0
behaviors	I-DISEASE
that	0
closely	I-DISEASE
resemble	I-DISEASE
RBD	0
.	0

Not	I-DISEASE
uncommonly	0
,	I-DISEASE
the	0
indi-	I-DISEASE
vidual	0
thinks	I-DISEASE
he	I-DISEASE
is	I-DISEASE
awake	0
when	I-DISEASE
observers	I-DISEASE
presume	I-DISEASE
he	0
is	I-DISEASE
asleep	I-DISEASE
and	0
attempting	B-DISEASE
to	I-DISEASE
act	I-DISEASE
out	0
a	I-DISEASE
dream	I-DISEASE
,	I-DISEASE
or	I-DISEASE
vice	I-DISEASE
versa	0
.	0

An	0
underlying	0
neurologic	0
or	I-DISEASE
medical	I-DISEASE
condition	0
,	0
spanning	I-DISEASE
a	0
broad	I-DISEASE
range	I-DISEASE
of	I-DISEASE
pathology	I-DISEASE
,	I-DISEASE
is	0
virtually	0
always	0
present	I-DISEASE
.	0

Dream	I-DISEASE
enactment	I-DISEASE
(	0
“	I-DISEASE
oneirism	0
”	I-DISEASE
)	0
that	0
is	I-DISEASE
REM	I-DISEASE
sleep	0
related	B-DISEASE
or	I-DISEASE
related	0
to	0
a	0
dissociated	0
REM	I-DISEASE
sleep	0
-	0
wakefulness	0
state	B-DISEASE
can	0
be	0
a	0
core	I-DISEASE
feature	0
of	0
a	0
pathologic	0
condition	0
called	0
agrypnia	0
excitata	0
that	0
is	0
characterized	0
by	I-DISEASE
generalized	0
motor	I-DISEASE
overactivity	0
,	0
impaired	I-DISEASE
ability	I-DISEASE
to	I-DISEASE
initiate	I-DISEASE
and	0
maintain	0
sleep	0
(	I-DISEASE
with	I-DISEASE
“	I-DISEASE
wakeful	0
dreaming	0
”	I-DISEASE
)	0
,	0
loss	0
of	I-DISEASE
slow	0
wave	I-DISEASE
sleep	0
,	I-DISEASE
and	0
marked	0
motor	I-DISEASE
and	0
autonomic	0
sympathetic	0
activation	0
.	0

Agrypnia	I-DISEASE
excitata	I-DISEASE
is	0
found	0
with	I-DISEASE
such	0
diverse	I-DISEASE
conditions	I-DISEASE
as	0
delirium	0
tremens	0
,	0
Morvan	0
syndrome	I-DISEASE
,	0
and	0
fatal	0
familial	I-DISEASE
insomnia	0
.	0

Thus	I-DISEASE
,	0
agrypnia	0
excitata	I-DISEASE
manifests	0
as	I-DISEASE
both	I-DISEASE
a	0
severe	0
parasomnia	I-DISEASE
and	0
a	0
severe	0
insomnia	0
.	0

Demographics	I-DISEASE
RBD	0
is	0
a	I-DISEASE
male	0
predominant	0
disorder	0
that	0
usually	I-DISEASE
emerges	0
after	0
age	I-DISEASE
50	0
years	I-DISEASE
.	0

Cases	I-DISEASE
of	I-DISEASE
RBD	I-DISEASE
from	I-DISEASE
early	0
childhood	I-DISEASE
up	0
to	0
age	I-DISEASE
88	I-DISEASE
years	I-DISEASE
have	I-DISEASE
been	I-DISEASE
reported	0
.	0

RBD	I-DISEASE
emerging	I-DISEASE
in	I-DISEASE
adults	B-DISEASE
before	I-DISEASE
age	I-DISEASE
50	0
years	0
tends	0
to	0
have	I-DISEASE
different	I-DISEASE
demographics	0
and	0
associated	0
features	I-DISEASE
,	0
including	0
greater	I-DISEASE
sex	0
parity	0
and	0
increased	0
rates	0
of	I-DISEASE
idiopathic	I-DISEASE
RBD	I-DISEASE
and	0
para-	I-DISEASE
somnia	0
overlap	0
disorder	0
(	I-DISEASE
POD	0
)	0
,	0
comorbid	I-DISEASE
narcolepsy	0
,	0
antidepressant	0
medication	0
use	0
,	0
and	0
possibly	I-DISEASE
autoimmune	0
diseases	0
.	0

In	I-DISEASE
addition	0
,	0
the	0
clinical	0
presentation	0
of	I-DISEASE
RBD	I-DISEASE
in	0
younger	0
adults	I-DISEASE
differs	I-DISEASE
from	I-DISEASE
that	0
in	I-DISEASE
older	0
adults	I-DISEASE
in	0
being	0
less	I-DISEASE
aggressive	0
and	0
violent	I-DISEASE
,	I-DISEASE
presumably	I-DISEASE
due	0
to	I-DISEASE
greater	I-DISEASE
female	I-DISEASE
representation	0
and	0
higher	0
rates	0
of	I-DISEASE
comorbid	I-DISEASE
narco-	0
lepsy	0
(	I-DISEASE
which	0
manifests	I-DISEASE
with	I-DISEASE
milder	0
RBD	0
behaviors	I-DISEASE
)	0
.	0

RBD	I-DISEASE
associated	0
with	I-DISEASE
neurologic	0
disorders	0
and	0
other	0
symptomatic	0
forms	0
of	I-DISEASE
RBD	0
are	I-DISEASE
as	0
male	I-DISEASE
predominant	0
as	0
idiopathic	B-DISEASE
RBD	I-DISEASE
,	I-DISEASE
with	I-DISEASE
the	0
exception	0
of	I-DISEASE
narcolepsy	0
(	I-DISEASE
as	0
described	0
below	0
)	0
and	0
multiple	I-DISEASE
system	I-DISEASE
atrophy	I-DISEASE
.	0

Of	0
note	0
,	0
RBD	I-DISEASE
may	I-DISEASE
not	0
be	I-DISEASE
the	0
presenting	0
com-	I-DISEASE
plaint	I-DISEASE
to	0
a	0
sleep	0
disorders	0
center	0
.	0

Therefore	I-DISEASE
,	I-DISEASE
systematic	0
questioning	I-DISEASE
for	0
RBD	I-DISEASE
should	I-DISEASE
be	0
included	0
for	0
all	0
newly	I-DISEASE
evaluated	0
patients	0
at	I-DISEASE
a	0
sleep	I-DISEASE
center	0
.	0

RBD	I-DISEASE
in	0
children	I-DISEASE
is	0
virtually	I-DISEASE
never	0
idiopathic	B-DISEASE
and	0
is	0
usually	I-DISEASE
associated	0
with	0
narcolepsy	0
(	0
at	I-DISEASE
times	0
emerging	I-DISEASE
months	0
before	0
the	0
emergence	0
of	I-DISEASE
narcoleptic	0
symptoms	0
)	0
,	0
brainstem	0
tumors	0
,	0
antidepressant	0
medications	0
,	I-DISEASE
neurodevelopmental	0
disorders	0
,	0
and	0
various	0
rare	I-DISEASE
conditions	I-DISEASE
.	0

The	I-DISEASE
prevalence	0
is	0
not	0
known	0
with	I-DISEASE
much	0
certainty	I-DISEASE
,	0
although	0
a	0
prevalence	0
of	I-DISEASE
0.38	I-DISEASE
%	0
to	I-DISEASE
0.5	0
%	0
is	I-DISEASE
reported	0
in	I-DISEASE
the	0
elderly	0
and	0
the	0
general	0
population	0
.	0

A	I-DISEASE
2.1	0
%	0
prevalence	I-DISEASE
of	I-DISEASE
current	I-DISEASE
sleep	0
related	0
violence	I-DISEASE
has	0
been	I-DISEASE
reported	I-DISEASE
;	0
38	0
%	0
of	I-DISEASE
these	0
events	0
have	0
associated	0
dream	I-DISEASE
enactment	0
,	0
suggesting	I-DISEASE
a	0
prevalence	I-DISEASE
of	I-DISEASE
RBD	I-DISEASE
as	0
high	I-DISEASE
as	0
0.8	I-DISEASE
%	0
.	0

Predisposing	I-DISEASE
and	0
Precipitating	0
Factors	0

The	I-DISEASE
major	I-DISEASE
predisposing	0
factors	I-DISEASE
are	I-DISEASE
male	0
sex	0
,	0
age	I-DISEASE
50	I-DISEASE
years	I-DISEASE
or	0
older	0
,	I-DISEASE
and	0
an	0
under-	0
lying	0
neurological	0
disorder	I-DISEASE
,	0
particularly	0
Parkinson	0
disease	I-DISEASE
,	I-DISEASE
multiple	I-DISEASE
system	0
atrophy	I-DISEASE
,	0
dementia	0
with	0
Lewy	0
bodies	0
,	I-DISEASE
narcolepsy	0
,	0
or	0
stroke	0
.	0

A	I-DISEASE
recent	I-DISEASE
multicenter	0
case	I-DISEASE
-	I-DISEASE
control	I-DISEASE
study	0
of	I-DISEASE
environmental	I-DISEASE
risk	0
factors	I-DISEASE
of	I-DISEASE
RBD	0
found	I-DISEASE
that	I-DISEASE
smoking	0
,	0
head	I-DISEASE
injury	0
,	I-DISEASE
pesticide	0
exposure	0
,	I-DISEASE
and	0
farming	I-DISEASE
were	I-DISEASE
significant	0
risk	0
factors	B-DISEASE
.	0

Medications	I-DISEASE
,	I-DISEASE
particularly	0
the	0
anti-	0
depressants	0
venlafaxine	I-DISEASE
,	I-DISEASE
serotonin	0
-	0
specific	I-DISEASE
reuptake	0
inhibitors	0
(	I-DISEASE
SSRIs	I-DISEASE
)	0
,	I-DISEASE
mirtazapine	0
,	0
and	0
other	0
antidepressant	0
agents	I-DISEASE
(	I-DISEASE
but	I-DISEASE
not	0
bupropion	0
)	0
are	0
an	0
increasingly	0
recognized	0
precipitating	0
factor	I-DISEASE
.	0

Beta	I-DISEASE
-	I-DISEASE
blockers	0
(	0
bisoprolol	0
,	0
atenolol	0
)	0
,	I-DISEASE
anticholinesterase	I-DISEASE
inhibitors	0
,	I-DISEASE
and	0
selegiline	0
can	0
also	0
trigger	0
RBD	0
.	0

Psychiatric	I-DISEASE
disorders	0
involving	I-DISEASE
depression	0
(	I-DISEASE
that	0
require	0
antidepressant	0
pharmacotherapy	0
)	0
may	0
comprise	0
a	0
predisposing	0
factor	I-DISEASE
,	I-DISEASE
particu-	I-DISEASE
larly	0
in	0
adults	B-DISEASE
younger	0
than	0
50	0
years	0
.	0

RBD	I-DISEASE
may	0
also	0
be	0
associated	0
with	I-DISEASE
posttraumatic	0
stress	I-DISEASE
disorder	I-DISEASE
.	I-DISEASE

Parasomnias	I-DISEASE
Parasomnias	I-DISEASE
Familial	I-DISEASE
Pattern	I-DISEASE
A	0
recent	I-DISEASE
multicenter	0
controlled	0
study	0
revealed	0
a	0
significantly	0
increased	0
positive	0
family	0
history	I-DISEASE
of	I-DISEASE
dream	I-DISEASE
enactment	0
,	I-DISEASE
raising	I-DISEASE
the	0
possibility	0
of	I-DISEASE
a	0
genetic	0
contribution	0
to	0
RBD	0
.	0

Onset	I-DISEASE
,	0
Course	0
,	0
and	0
Complications	I-DISEASE
Onset	0
of	I-DISEASE
chronic	I-DISEASE
RBD	0
can	I-DISEASE
be	I-DISEASE
gradual	0
or	0
rapid	I-DISEASE
,	0
and	0
the	0
course	I-DISEASE
is	I-DISEASE
often	0
progressive	0
.	0

Complications	I-DISEASE
include	0
sleep	0
related	0
injuries	I-DISEASE
to	0
self	0
and/or	0
bed	I-DISEASE
partner	0
that	0
at	I-DISEASE
times	I-DISEASE
are	0
life	0
threatening	I-DISEASE
,	0
and	0
disruption	B-DISEASE
of	I-DISEASE
the	I-DISEASE
bed	0
partner	0
’s	I-DISEASE
sleep	0
that	B-DISEASE
can	0
be	0
severe	I-DISEASE
.	0

Marital	I-DISEASE
discord	0
due	0
to	I-DISEASE
the	I-DISEASE
RBD	I-DISEASE
is	0
uncommon	0
but	I-DISEASE
can	I-DISEASE
be	I-DISEASE
severe	0
when	I-DISEASE
present	I-DISEASE
,	I-DISEASE
due	0
to	0
repeated	I-DISEASE
injury	I-DISEASE
and/or	0
disruption	I-DISEASE
of	0
the	I-DISEASE
bed	I-DISEASE
partner	0
’s	I-DISEASE
sleep	0
.	0

Delayed	I-DISEASE
emergence	I-DISEASE
of	0
a	0
neurodegenerative	0
disorder	0
,	I-DISEASE
often	I-DISEASE
more	0
than	0
a	0
decade	I-DISEASE
after	0
the	0
onset	I-DISEASE
of	I-DISEASE
idiopathic	I-DISEASE
RBD	I-DISEASE
,	I-DISEASE
is	0
very	I-DISEASE
common	I-DISEASE
in	I-DISEASE
men	0
50	0
years	I-DISEASE
of	I-DISEASE
age	I-DISEASE
and	0
older	0
.	0

These	0
dis-	I-DISEASE
orders	I-DISEASE
include	I-DISEASE
Parkinson	0
disease	I-DISEASE
(	I-DISEASE
PD	0
)	0
,	I-DISEASE
multiple	I-DISEASE
system	I-DISEASE
atrophy	I-DISEASE
(	I-DISEASE
MSA	I-DISEASE
)	0
,	0
and	0
dementia	0
with	0
Lewy	0
bodies	I-DISEASE
(	I-DISEASE
DLB	I-DISEASE
)	0
.	0

Two	I-DISEASE
recently	0
reported	0
series	I-DISEASE
found	0
81	I-DISEASE
%	0
and	0
82	0
%	0
eventual	I-DISEASE
conversion	0
rates	I-DISEASE
from	I-DISEASE
idiopathic	B-DISEASE
RBD	I-DISEASE
to	0
parkinsonism	I-DISEASE
/	0
dementia	0
(	0
and	0
also	0
mild	B-DISEASE
cog-	0
nitive	0
impairment	0
in	0
the	0
latter	0
study	0
)	0
.	0

Conversely	I-DISEASE
,	I-DISEASE
RBD	0
is	0
present	I-DISEASE
in	I-DISEASE
>	0
90	I-DISEASE
%	0
of	I-DISEASE
reported	I-DISEASE
cases	I-DISEASE
of	I-DISEASE
MSA	I-DISEASE
,	I-DISEASE
in	I-DISEASE
approximately	0
50	0
%	0
of	I-DISEASE
reported	0
cases	0
of	I-DISEASE
DLB	I-DISEASE
,	I-DISEASE
and	0
in	I-DISEASE
up	I-DISEASE
to	I-DISEASE
46	I-DISEASE
%	0
of	I-DISEASE
reported	I-DISEASE
patients	I-DISEASE
with	0
PD	I-DISEASE
.	0

Developmental	I-DISEASE
Issues	0
As	0
stated	0
previously	I-DISEASE
,	0
RBD	I-DISEASE
can	0
emerge	0
in	I-DISEASE
children	I-DISEASE
,	I-DISEASE
usually	I-DISEASE
in	I-DISEASE
association	B-DISEASE
with	I-DISEASE
narco-	0
lepsy	0
-	0
cataplexy	0
,	I-DISEASE
brainstem	0
tumors	0
,	0
or	I-DISEASE
antidepressant	0
medications	0
.	0

Pathology	I-DISEASE
and	0
Pathophysiology	I-DISEASE
Current	0
evidence	0
suggests	I-DISEASE
a	0
selective	I-DISEASE
association	I-DISEASE
between	0
RBD	I-DISEASE
and	0
neurodegenera-	0
tive	0
disorders	0
.	0

The	I-DISEASE
synucleinopathies	0
comprise	0
a	0
set	I-DISEASE
of	I-DISEASE
neurodegenerative	I-DISEASE
disorders	I-DISEASE
that	0
share	0
a	0
common	I-DISEASE
pathologic	0
lesion	0
composed	I-DISEASE
of	I-DISEASE
aggregates	I-DISEASE
of	I-DISEASE
insoluble	0
α	0
-	0
synu-	0
clein	0
protein	0
in	I-DISEASE
selectively	I-DISEASE
vulnerable	I-DISEASE
populations	0
of	I-DISEASE
neurons	0
and	0
glial	0
cells	0
.	0

These	0
pathologic	0
aggregates	0
appear	0
to	I-DISEASE
be	0
closely	0
linked	0
to	I-DISEASE
the	I-DISEASE
onset	I-DISEASE
and	0
progression	0
of	I-DISEASE
clin-	I-DISEASE
ical	I-DISEASE
symptoms	I-DISEASE
and	0
the	0
degeneration	I-DISEASE
of	I-DISEASE
affected	I-DISEASE
brain	I-DISEASE
regions	I-DISEASE
in	0
neurodegenerative	0
disorders	0
.	0

The	I-DISEASE
major	I-DISEASE
synucleinopathies	0
include	0
PD	I-DISEASE
,	I-DISEASE
DLB	I-DISEASE
,	0
and	0
MSA	I-DISEASE
.	0

RBD	I-DISEASE
can	0
be	I-DISEASE
strongly	0
linked	0
with	I-DISEASE
narcolepsy	0
(	I-DISEASE
almost	I-DISEASE
always	0
narcolepsy	0
type	0
1	0
)	0
,	0
rep-	0
resenting	I-DISEASE
another	I-DISEASE
form	I-DISEASE
of	I-DISEASE
REM	I-DISEASE
sleep	0
motor	I-DISEASE
-	0
behavioral	0
dyscontrol	0
.	0

The	I-DISEASE
RBD	I-DISEASE
may	I-DISEASE
be	0
precipitated	I-DISEASE
or	0
worsened	0
by	I-DISEASE
the	0
pharmacologic	0
treatment	I-DISEASE
of	I-DISEASE
cataplexy	0
.	0

RBD	I-DISEASE
associ-	0
ated	0
with	0
narcolepsy	0
is	I-DISEASE
now	I-DISEASE
considered	I-DISEASE
to	I-DISEASE
be	I-DISEASE
a	0
distinct	0
phenotype	0
of	I-DISEASE
RBD	0
,	0
character-	0
ized	I-DISEASE
by	B-DISEASE
lack	I-DISEASE
of	I-DISEASE
sex	0
predominance	0
,	0
less	I-DISEASE
complex	B-DISEASE
and	0
more	0
elementary	0
movements	0
in	I-DISEASE
REM	I-DISEASE
sleep	0
,	0
less	I-DISEASE
violent	0
behavior	I-DISEASE
in	0
REM	0
sleep	0
,	0
earlier	0
age	I-DISEASE
of	I-DISEASE
onset	I-DISEASE
,	I-DISEASE
and	0
hypocretin	0
deficiency	0
(	I-DISEASE
that	0
is	0
characteristic	0
of	I-DISEASE
narcolepsy	0
type	I-DISEASE
1	I-DISEASE
)	0
.	0

The	I-DISEASE
presence	0
of	I-DISEASE
RBD	I-DISEASE
in	I-DISEASE
pediat-	0
ric	0
patients	I-DISEASE
may	I-DISEASE
be	0
an	0
initial	I-DISEASE
manifestation	I-DISEASE
of	0
narcolepsy	0
type	I-DISEASE
1	I-DISEASE
.	0

Other	I-DISEASE
reported	0
etiologic	0
associations	I-DISEASE
of	I-DISEASE
RBD	0
with	I-DISEASE
neurologic	0
disorders	0
include	I-DISEASE
isch-	I-DISEASE
emic	I-DISEASE
or	0
hemorrhagic	0
cerebrovascular	I-DISEASE
disease	B-DISEASE
,	I-DISEASE
multiple	I-DISEASE
sclerosis	0
,	0
progressive	0
supranu-	0
clear	I-DISEASE
palsy	I-DISEASE
,	0
Guillain	I-DISEASE
-	0
Barré	B-DISEASE
syndrome	0
,	0
brainstem	0
neoplasms	0
(	I-DISEASE
including	0
cerebellopon-	I-DISEASE
tine	0
angle	0
tumors	0
)	0
,	0
Machado	0
-	0
Joseph	I-DISEASE
disease	0
(	0
spinocerebellar	I-DISEASE
ataxia	I-DISEASE
type	0
3	0
)	0
,	I-DISEASE
mitochon-	I-DISEASE
drial	I-DISEASE
encephalomyopathy	0
,	0
normal	0
pressure	0
hydrocephalus	0
,	0
Tourette	0
syndrome	I-DISEASE
,	0
group	I-DISEASE
A	0
xeroderma	0
,	0
and	0
autism	0
.	0

The	I-DISEASE
pathophysiology	I-DISEASE
of	I-DISEASE
human	0
RBD	0
is	0
presumed	0
to	I-DISEASE
correspond	0
to	0
the	0
findings	0
from	I-DISEASE
an	0
animal	0
model	I-DISEASE
of	I-DISEASE
RBD	0
with	I-DISEASE
respect	I-DISEASE
to	0
interruption	I-DISEASE
of	I-DISEASE
the	0
REM	I-DISEASE
atonia	I-DISEASE
pathway	0
and/	0
or	I-DISEASE
disinhibition	0
of	0
brainstem	0
motor	I-DISEASE
pattern	0
generators	I-DISEASE
.	0

Objective	I-DISEASE
Findings	I-DISEASE
Polysomnography	0
demonstrates	I-DISEASE
an	0
excessive	I-DISEASE
amount	I-DISEASE
of	0
sustained	0
or	I-DISEASE
intermittent	I-DISEASE
loss	0
of	0
REM	0
atonia	I-DISEASE
and/or	0
excessive	0
phasic	0
muscle	B-DISEASE
twitch	0
activity	0
of	I-DISEASE
the	0
submental	I-DISEASE
and/or	0
limb	0
EMGs	0
during	I-DISEASE
REM	I-DISEASE
sleep	I-DISEASE
.	0

Some	I-DISEASE
patients	0
have	0
almost	I-DISEASE
exclusively	B-DISEASE
arm	I-DISEASE
and	0
hand	I-DISEASE
behaviors	I-DISEASE
during	I-DISEASE
REM	0
sleep	I-DISEASE
,	I-DISEASE
indicating	0
the	0
need	I-DISEASE
for	I-DISEASE
both	0
upper	0
and	0
lower	0
extremity	0
EMG	I-DISEASE
monitoring	I-DISEASE
in	I-DISEASE
fully	I-DISEASE
evaluating	0
for	I-DISEASE
RBD	0
.	0

Some	I-DISEASE
patients	0
preserve	0
most	0
of	0
their	I-DISEASE
REM	I-DISEASE
atonia	I-DISEASE
but	0
have	I-DISEASE
excessive	I-DISEASE
EMG	I-DISEASE
twitching	I-DISEASE
during	I-DISEASE
REM	0
sleep	0
.	0

The	I-DISEASE
most	0
current	0
evidence	0
-	0
based	I-DISEASE
data	0
for	I-DISEASE
detecting	I-DISEASE
RWA	0
in	I-DISEASE
the	0
evaluation	0
of	I-DISEASE
RBD	I-DISEASE
indicate	0
that	0
any	I-DISEASE
(	I-DISEASE
tonic	0
/	0
phasic	0
)	0
chin	I-DISEASE
EMG	0
activity	0
combined	0
with	0
bilateral	0
phasic	0
activity	0
of	0
the	0
flexor	0
digitorum	0
superficialis	0
muscles	0
in	0
>	0
27	0
%	0
of	I-DISEASE
REM	0
sleep	0
(	0
scored	I-DISEASE
in	0
30	0
-	I-DISEASE
second	I-DISEASE
epochs	I-DISEASE
)	0
reliably	0
distinguishes	0
RBD	I-DISEASE
patients	0
from	0
controls	0
.	0

Autonomic	I-DISEASE
nervous	I-DISEASE
system	0
activa-	0
tion	0
(	I-DISEASE
such	0
as	I-DISEASE
tachycardia	0
)	0
is	0
uncommon	0
during	I-DISEASE
REM	0
sleep	0
motor	I-DISEASE
activation	I-DISEASE
in	0
RBD	I-DISEASE
,	I-DISEASE
in	I-DISEASE
contrast	I-DISEASE
to	0
the	0
disorders	0
of	I-DISEASE
arousal	0
.	0

Approximately	I-DISEASE
75	0
%	0
of	I-DISEASE
patients	0
have	I-DISEASE
PLMs	0
during	I-DISEASE
NREM	0
sleep	I-DISEASE
;	0
a	0
low	0
percentage	I-DISEASE
of	I-DISEASE
these	0
movements	I-DISEASE
is	0
associated	0
with	I-DISEASE
EEG	0
signs	0
of	I-DISEASE
arousal	0
.	0

Increased	I-DISEASE
percentages	0
of	0
slow	0
wave	I-DISEASE
sleep	0
and	0
increased	0
delta	I-DISEASE
power	0
in	I-DISEASE
RBD	I-DISEASE
have	0
been	I-DISEASE
found	I-DISEASE
in	0
controlled	0
and	0
uncontrolled	I-DISEASE
studies	I-DISEASE
,	0
but	I-DISEASE
this	0
can	0
be	0
a	I-DISEASE
highly	0
vari-	I-DISEASE
able	0
finding	0
in	I-DISEASE
RBD	0
,	0
depending	0
on	0
the	0
clinical	0
population	I-DISEASE
.	0

Sleep	I-DISEASE
architecture	I-DISEASE
and	0
the	0
customary	I-DISEASE
cycling	I-DISEASE
among	0
REM	I-DISEASE
and	0
NREM	0
sleep	I-DISEASE
stages	0
are	I-DISEASE
usually	I-DISEASE
preserved	I-DISEASE
in	0
RBD	0
,	I-DISEASE
although	0
some	I-DISEASE
patients	I-DISEASE
show	I-DISEASE
a	0
shift	I-DISEASE
toward	I-DISEASE
N1	0
sleep	I-DISEASE
.	0

Validated	I-DISEASE
RBD	0
screening	0
questionnaires	I-DISEASE
that	0
can	0
assist	0
in	I-DISEASE
the	I-DISEASE
process	I-DISEASE
of	I-DISEASE
diagnosing	I-DISEASE
RBD	0
are	0
currently	I-DISEASE
available	B-DISEASE
.	0

Parasomnias	I-DISEASE
Parasomnias	I-DISEASE
Differential	0
Diagnosis	I-DISEASE
RBD	I-DISEASE
is	I-DISEASE
one	0
of	0
several	I-DISEASE
disorders	0
that	0
can	0
manifest	0
as	0
complex	0
,	I-DISEASE
injurious	I-DISEASE
,	I-DISEASE
and	0
violent	I-DISEASE
sleep	0
related	B-DISEASE
and	0
dream	0
-	I-DISEASE
related	0
behaviors	0
in	I-DISEASE
adults	0
.	0

Other	I-DISEASE
disorders	0
that	0
can	I-DISEASE
mimic	B-DISEASE
RBD	I-DISEASE
in	I-DISEASE
adults	B-DISEASE
and/or	0
children	I-DISEASE
include	I-DISEASE
sleepwalking	0
,	I-DISEASE
sleep	0
terrors	0
,	0
OSA	0
,	I-DISEASE
nocturnal	0
seizures	I-DISEASE
(	I-DISEASE
nocturnal	0
frontal	0
lobe	0
epilepsy	0
;	0
nocturnal	0
complex	0
partial	I-DISEASE
seizures	0
)	0
;	0
rhyth-	I-DISEASE
mic	0
movement	0
disorders	0
;	0
sleep	0
related	0
dissociative	0
disorders	0
,	I-DISEASE
frightening	I-DISEASE
hypnopom-	I-DISEASE
pic	0
hallucinations	I-DISEASE
,	0
and	0
posttraumatic	0
stress	I-DISEASE
disorder	I-DISEASE
;	0
a	0
diagnosis	I-DISEASE
of	I-DISEASE
malingering	I-DISEASE
also	0
should	0
be	I-DISEASE
considered	0
.	0

In	I-DISEASE
general	I-DISEASE
,	0
RBD	I-DISEASE
involves	I-DISEASE
attempted	I-DISEASE
enactment	I-DISEASE
of	I-DISEASE
unpleasant	0
,	I-DISEASE
aggressive	I-DISEASE
dreams	0
that	0
usually	I-DISEASE
occurs	I-DISEASE
two	0
or	0
more	0
hours	I-DISEASE
after	I-DISEASE
sleep	0
onset	0
,	I-DISEASE
with	0
rapid	I-DISEASE
awakening	0
from	I-DISEASE
an	0
episode	I-DISEASE
.	0

In	I-DISEASE
contrast	I-DISEASE
,	0
sleepwalking	0
and	0
sleep	0
terror	0
episodes	0
often	0
emerge	0
within	I-DISEASE
two	I-DISEASE
hours	I-DISEASE
after	0
sleep	0
onset	I-DISEASE
,	0
are	0
not	0
usually	I-DISEASE
associated	0
with	I-DISEASE
rapid	I-DISEASE
alertness	I-DISEASE
,	I-DISEASE
and	0
are	0
rarely	I-DISEASE
associated	0
with	I-DISEASE
dreaming	0
in	I-DISEASE
children	I-DISEASE
.	0

Adults	I-DISEASE
can	I-DISEASE
have	I-DISEASE
dreams	I-DISEASE
associated	0
with	I-DISEASE
disor-	I-DISEASE
ders	0
of	I-DISEASE
arousal	I-DISEASE
,	I-DISEASE
but	I-DISEASE
they	I-DISEASE
are	I-DISEASE
usually	I-DISEASE
more	0
fragmentary	0
and	0
limited	I-DISEASE
than	0
RBD	I-DISEASE
dreams	0
.	I-DISEASE

Sleep	I-DISEASE
related	0
seizures	0
usually	0
present	I-DISEASE
with	I-DISEASE
repetitive	I-DISEASE
,	0
stereotypical	0
behaviors	I-DISEASE
.	0

Parasomnia	I-DISEASE
overlap	0
disorder	I-DISEASE
can	I-DISEASE
be	I-DISEASE
distinguished	0
from	0
status	0
dissociatus	I-DISEASE
in	I-DISEASE
several	I-DISEASE
ways	I-DISEASE
:	0
if	0
there	I-DISEASE
is	0
an	0
awakening	0
after	I-DISEASE
an	0
episode	I-DISEASE
of	I-DISEASE
RBD	I-DISEASE
,	I-DISEASE
sleepwalking	0
,	I-DISEASE
or	I-DISEASE
sleep	0
terror	0
,	0
there	0
is	0
the	0
realization	0
of	I-DISEASE
having	I-DISEASE
just	I-DISEASE
been	I-DISEASE
asleep	I-DISEASE
;	0
status	0
dissociatus	0
,	0
however	I-DISEASE
,	I-DISEASE
is	0
more	0
likely	0
to	0
manifest	I-DISEASE
with	I-DISEASE
confusion	I-DISEASE
over	I-DISEASE
whether	I-DISEASE
one	0
is	I-DISEASE
asleep	I-DISEASE
,	I-DISEASE
awake	0
,	I-DISEASE
or	I-DISEASE
dreaming	0
.	0

vPSG	I-DISEASE
in	I-DISEASE
overlap	0
conditions	I-DISEASE
shows	I-DISEASE
the	B-DISEASE
typical	0
findings	0
for	0
both	I-DISEASE
RBD	I-DISEASE
and	0
disorders	0
of	I-DISEASE
arousal	0
,	0
whereas	0
with	I-DISEASE
status	0
dissociatus	0
,	0
there	I-DISEASE
is	0
an	I-DISEASE
inability	I-DISEASE
to	I-DISEASE
discern	0
sleep	0
stages	0
.	0

Also	I-DISEASE
,	I-DISEASE
patients	0
with	I-DISEASE
status	0
dissociatus	I-DISEASE
do	0
not	0
walk	I-DISEASE
far	I-DISEASE
during	I-DISEASE
an	0
episode	I-DISEASE
,	I-DISEASE
and	0
their	0
behavioral	0
repertoire	I-DISEASE
more	0
closely	I-DISEASE
resembles	I-DISEASE
that	0
of	I-DISEASE
RBD	0
than	0
that	0
of	I-DISEASE
the	0
disorders	0
of	I-DISEASE
arousal	0
.	0

Unresolved	I-DISEASE
Issues	0
and	0
Future	0
Directions	0
Numerous	I-DISEASE
questions	0
related	I-DISEASE
to	I-DISEASE
the	0
vPSG	0
evaluation	I-DISEASE
of	0
RBD	0
remain	I-DISEASE
unresolved	I-DISEASE
.	0

These	0
include	I-DISEASE
issues	0
of	I-DISEASE
defining	I-DISEASE
and	0
quantifying	0
RWA	0
and	0
RBD	I-DISEASE
activity	0
such	0
as	0
:	I-DISEASE
(	0
1	0
)	0
What	0
is	I-DISEASE
the	0
minimum	0
REM	I-DISEASE
sleep	0
percentage	0
of	I-DISEASE
total	0
sleep	0
time	0
(	I-DISEASE
and	0
minimum	I-DISEASE
absolute	I-DISEASE
REM	0
sleep	0
time	0
)	0
needed	0
to	0
diagnose	0
RWA	I-DISEASE
or	I-DISEASE
rule	0
out	0
RWA	0
?	0

(	I-DISEASE
2	0
)	0
What	0
is	0
the	0
minimum	I-DISEASE
number	0
of	I-DISEASE
REM	0
sleep	0
epochs	I-DISEASE
and	0
minimum	I-DISEASE
duration	0
of	0
REM	0
sleep	0
epochs	0
necessary	0
to	0
diagnose	I-DISEASE
RWA	I-DISEASE
or	0
rule	B-DISEASE
out	0
RWA	0
?	0

(	I-DISEASE
3	I-DISEASE
)	0
What	0
guidelines	0
can	0
be	I-DISEASE
developed	I-DISEASE
for	0
diag-	0
nosing	I-DISEASE
or	0
ruling	0
out	0
RWA	I-DISEASE
in	0
the	0
setting	0
of	I-DISEASE
disrupted	B-DISEASE
REM	I-DISEASE
sleep	0
continuity	0
associated	0
with	I-DISEASE
conditions	I-DISEASE
such	B-DISEASE
as	0
obstructive	0
sleep	0
apnea	0
and	0
with	0
medications	0
?	0

(	I-DISEASE
4	0
)	0
What	0
are	0
the	0
minimal	I-DISEASE
amounts	I-DISEASE
of	I-DISEASE
true	0
RBD	0
behaviors	I-DISEASE
documented	I-DISEASE
by	B-DISEASE
vPSG	0
needed	0
to	0
identify	I-DISEASE
RBD	I-DISEASE
in	I-DISEASE
patients	I-DISEASE
without	0
sufficient	0
RWA	I-DISEASE
?	0

It	I-DISEASE
is	I-DISEASE
unclear	0
why	0
there	0
is	0
a	0
male	I-DISEASE
predominance	0
of	I-DISEASE
this	I-DISEASE
disorder	0
in	I-DISEASE
middle	I-DISEASE
-	I-DISEASE
aged	0
and	0
older	0
adults	I-DISEASE
.	0

It	I-DISEASE
is	I-DISEASE
unknown	0
if	I-DISEASE
RBD	0
subgroups	I-DISEASE
other	0
than	0
men	0
age	I-DISEASE
50	I-DISEASE
years	I-DISEASE
or	0
older	0
demon-	I-DISEASE
strate	0
increased	0
risk	0
for	I-DISEASE
development	B-DISEASE
of	I-DISEASE
parkinsonism	I-DISEASE
or	I-DISEASE
dementia	0
.	0

One	I-DISEASE
such	0
subgroup	0
comprises	I-DISEASE
patients	0
with	I-DISEASE
antidepressant	0
-	0
triggered	I-DISEASE
RBD	I-DISEASE
for	0
whom	0
the	0
potential	I-DISEASE
risk	0
for	0
future	0
parkinsonism	0
and	0
dementia	0
is	I-DISEASE
unclear	I-DISEASE
.	0

New	I-DISEASE
antidepressant	0
or	I-DISEASE
other	I-DISEASE
psychotro-	0
pic	I-DISEASE
agents	0
being	I-DISEASE
developed	B-DISEASE
for	I-DISEASE
clinical	0
use	0
should	0
be	0
assessed	I-DISEASE
for	0
their	0
immediate	0
and	0
long	I-DISEASE
-	0
term	0
effects	0
on	0
REM	0
atonia	I-DISEASE
,	0
REM	0
phasic	0
activity	0
,	0
REM	I-DISEASE
sleep	I-DISEASE
behavioral	I-DISEASE
release	I-DISEASE
,	0
and	0
proclivity	0
to	0
precipitate	0
dream	I-DISEASE
-	0
enacting	I-DISEASE
behaviors	I-DISEASE
.	0

Bibliography	0
Boeve	I-DISEASE
BF	0
.	I-DISEASE

REM	I-DISEASE
sleep	0
behavior	I-DISEASE
disorder	0
:	I-DISEASE
Updated	0
review	I-DISEASE
of	I-DISEASE
the	0
core	I-DISEASE
features	I-DISEASE
,	I-DISEASE
the	0
REM	0
sleep	0
behavior	I-DISEASE
disorder	0
-	0
neurodegenerative	0
disease	I-DISEASE
association	0
,	I-DISEASE
evolving	0
concepts	I-DISEASE
,	I-DISEASE
controversies	0
,	0
and	0
future	0
directions	0
.	0

Ann	I-DISEASE
N	0
Y	0
Acad	0
Sci	0
2010;1184:15–54	0
.	0

Dauvilliers	I-DISEASE
Y	0
,	I-DISEASE
Jennum	I-DISEASE
P	0
,	0
Plazzi	0
G.	I-DISEASE
REM	0
sleep	I-DISEASE
behaviour	0
disorder	0
and	0
REM	0
sleep	0
without	0
atonia	I-DISEASE
in	I-DISEASE
narcolepsy	0
.	0

Sleep	I-DISEASE
Med	I-DISEASE
2013;14:775–81	0
.	0

Frauscher	I-DISEASE
B	0
,	0
Gschliesser	I-DISEASE
V	I-DISEASE
,	0
Brandauer	0
E	I-DISEASE
,	0
et	0
al	I-DISEASE
.	I-DISEASE

REM	I-DISEASE
sleep	0
behavior	I-DISEASE
disorder	0
in	I-DISEASE
703	0
sleep	0
-	0
disorder	0
patients	I-DISEASE
:	I-DISEASE
the	0
importance	0
of	I-DISEASE
eliciting	I-DISEASE
a	0
comprehensive	I-DISEASE
sleep	0
history	I-DISEASE
.	0

Sleep	I-DISEASE
Med	I-DISEASE
2010;11:167–71	I-DISEASE
.	0

Frauscher	I-DISEASE
B	0
,	0
Iranzo	I-DISEASE
A	I-DISEASE
,	0
Gaig	I-DISEASE
C	I-DISEASE
,	I-DISEASE
et	0
al	I-DISEASE
.	0

Normative	I-DISEASE
EMG	0
values	I-DISEASE
during	I-DISEASE
REM	I-DISEASE
sleep	0
for	0
the	0
diagnosis	I-DISEASE
of	I-DISEASE
REM	I-DISEASE
sleep	0
behavior	I-DISEASE
disorder	I-DISEASE
.	0

Sleep	I-DISEASE
2012;35:835–47	I-DISEASE
.	0

Iranzo	I-DISEASE
A	0
,	I-DISEASE
Santamaria	0
J.	0
Severe	0
obstructive	0
sleep	0
apnea	0
/	0
hypopnea	I-DISEASE
mimicking	I-DISEASE
REM	0
sleep	0
behavior	I-DISEASE
disorder	0
.	0

Sleep	I-DISEASE
2005;28:203–6	0
.	0

Iranzo	I-DISEASE
A	0
,	I-DISEASE
Santamaria	0
J	0
,	0
Tolosa	0
E.	I-DISEASE

The	I-DISEASE
clinical	0
and	0
pathophysiological	0
relevance	0
of	I-DISEASE
REM	0
sleep	I-DISEASE
behavior	I-DISEASE
disorder	0
in	I-DISEASE
neurodegenerative	I-DISEASE
diseases	0
.	0

Sleep	I-DISEASE
Med	I-DISEASE
Rev	0
2009;13:385–401	I-DISEASE
.	0

Iranzo	I-DISEASE
A	0
,	I-DISEASE
Tolosa	I-DISEASE
E	I-DISEASE
,	0
Gelpi	I-DISEASE
E	I-DISEASE
,	I-DISEASE
et	0
al	I-DISEASE
.	0

Neurodegenerative	0
disease	I-DISEASE
status	0
and	0
post	0
-	0
mortem	0
pathology	I-DISEASE
in	0
isolated	0
rapid	I-DISEASE
-	0
eye	0
-	0
movement	0
sleep	0
behaviour	0
disorder	0
:	I-DISEASE
an	0
observational	I-DISEASE
cohort	0
study	0
.	0

Lancet	0
Neurol	0
2013;12:443–53	0
.	0

Ju	I-DISEASE
YE	I-DISEASE
.	I-DISEASE

Rapid	I-DISEASE
eye	0
movement	0
sleep	0
behavior	0
disorder	I-DISEASE
in	I-DISEASE
adults	I-DISEASE
younger	0
than	0
50	0
years	I-DISEASE
of	I-DISEASE
age	I-DISEASE
.	0

Sleep	I-DISEASE
Med	I-DISEASE
2013;14:768–74	0
.	0

Lloyd	I-DISEASE
R	I-DISEASE
,	0
Tippman	0
-	0
Peikert	0
M	I-DISEASE
,	I-DISEASE
Slocumb	0
N	0
,	0
Kotagal	I-DISEASE
S.	I-DISEASE
Characteristics	0
of	I-DISEASE
REM	0
sleep	0
behavior	I-DISEASE
disorder	0
in	I-DISEASE
childhood	0
.	0

J	I-DISEASE
Clin	0
Sleep	0
Med	0
2012:15:127–31	I-DISEASE
.	0

Olson	I-DISEASE
E	0
,	0
Boeve	I-DISEASE
B	0
,	I-DISEASE
Silber	0
M.	I-DISEASE
Rapid	I-DISEASE
eye	I-DISEASE
movement	0
sleep	0
behavior	I-DISEASE
disorder	I-DISEASE
:	0
demographic	0
,	I-DISEASE
clinical	0
,	I-DISEASE
and	0
laboratory	I-DISEASE
findings	0
in	0
93	I-DISEASE
cases	0
.	0

Brain	0
2000;123:331–9	I-DISEASE
.	0

Oudiette	I-DISEASE
D	I-DISEASE
,	0
De	0
Cock	I-DISEASE
VC	0
,	0
Lavault	I-DISEASE
S	I-DISEASE
,	0
Leu	0
S	I-DISEASE
,	0
Vidailhet	0
M	I-DISEASE
,	I-DISEASE
Arnulf	0
I.	I-DISEASE
Non	I-DISEASE
-	0
violent	I-DISEASE
elaborate	I-DISEASE
behaviors	I-DISEASE
may	I-DISEASE
also	0
occur	I-DISEASE
in	I-DISEASE
REM	0
sleep	0
behavior	0
disorder	I-DISEASE
.	0

Neurology	0
2009;72:551–7	I-DISEASE
.	0

Postuma	I-DISEASE
RB	0
,	I-DISEASE
Gagnon	0
JF	0
,	0
Vendette	I-DISEASE
M	I-DISEASE
,	0
Fantini	0
ML	0
,	I-DISEASE
Massicotte	0
-	0
Marquez	I-DISEASE
J	0
,	I-DISEASE
Montplaisir	I-DISEASE
J.	0
Quantifying	0
the	0
risk	0
of	0
neurodegenerative	0
disease	I-DISEASE
in	I-DISEASE
idiopathic	I-DISEASE
REM	0
sleep	0
behavior	0
disorder	I-DISEASE
.	0

Neurology	0
2009;72:1296–300	I-DISEASE
.	0

Schenck	I-DISEASE
CH	I-DISEASE
,	0
Mahowald	I-DISEASE
MW	0
.	0

REM	I-DISEASE
sleep	0
behavior	I-DISEASE
disorder	0
:	I-DISEASE
clinical	0
,	I-DISEASE
developmental	I-DISEASE
,	0
and	0
neuroscience	0
perspectives	0
16	I-DISEASE
years	I-DISEASE
after	I-DISEASE
its	0
formal	0
identification	0
in	I-DISEASE
SLEEP	I-DISEASE
.	0

Sleep	I-DISEASE
2002;25:120–38	I-DISEASE
.	0

Schenck	I-DISEASE
CH	I-DISEASE
,	0
Boeve	I-DISEASE
BF	0
,	0
Mahowald	I-DISEASE
MW	0
.	0

Delayed	I-DISEASE
emergence	I-DISEASE
of	0
a	0
parkinsonian	I-DISEASE
disorder	0
or	I-DISEASE
dementia	I-DISEASE
in	I-DISEASE
81	0
%	0
of	0
older	0
males	I-DISEASE
initially	I-DISEASE
diagnosed	0
with	I-DISEASE
idiopathic	I-DISEASE
REM	I-DISEASE
sleep	0
behavior	I-DISEASE
disorder	B-DISEASE
(	I-DISEASE
RBD	I-DISEASE
):	0
16	0
year	0
update	0
on	0
a	0
previously	0
reported	0
series	I-DISEASE
.	0

Sleep	I-DISEASE
Med	I-DISEASE
2013;14:744–8	0
.	0

Schenck	I-DISEASE
CH	I-DISEASE
,	0
Howell	0
MJ	I-DISEASE
.	0

Spectrum	I-DISEASE
of	I-DISEASE
RBD	0
(	0
overlap	0
between	0
RBD	I-DISEASE
and	0
other	0
parasomnias	I-DISEASE
)	0
.	0

Sleep	I-DISEASE
and	0
Biological	0
Rhythms	0
2013;11(Supplement	0
1):27–34	I-DISEASE
.	0

Parasomnias	I-DISEASE
Parasomnias	0
Recurrent	0
Isolated	I-DISEASE
Sleep	0
Paralysis	0
ICD-9	0
-	0
CM	0
code	0
:	0
327.43	0
ICD-10	0
-	0
CM	0
code	0
:	0
G47.53	0
Alternate	0
Names	I-DISEASE
Hypnagogic	I-DISEASE
and	0
hypnopompic	0
paralysis	0
,	I-DISEASE
predormital	I-DISEASE
and	0
postdormital	0
paralysis	I-DISEASE
,	0
kanashibari	0
(	I-DISEASE
Japan	0
)	0
.	0

Diagnostic	I-DISEASE
Criteria	0
Criteria	I-DISEASE
A	0
-	I-DISEASE
D	I-DISEASE
must	I-DISEASE
be	0
met	0
A.	0
A	0
recurrent	0
inability	0
to	0
move	0
the	0
trunk	0
and	0
all	0
of	I-DISEASE
the	I-DISEASE
limbs	0
at	I-DISEASE
sleep	0
onset	0
or	I-DISEASE
upon	I-DISEASE
awakening	0
from	I-DISEASE
sleep	0
.	0

B.	0
Each	0
episode	I-DISEASE
lasts	0
seconds	0
to	I-DISEASE
a	I-DISEASE
few	0
minutes	0
.	0

C.	I-DISEASE

The	I-DISEASE
episodes	I-DISEASE
cause	I-DISEASE
clinically	I-DISEASE
significant	0
distress	I-DISEASE
including	0
bedtime	I-DISEASE
anxiety	I-DISEASE
or	I-DISEASE
fear	I-DISEASE
of	I-DISEASE
sleep	0
.	0

D.	I-DISEASE
The	I-DISEASE
disturbance	I-DISEASE
is	0
not	0
better	0
explained	I-DISEASE
by	0
another	0
sleep	0
disorder	0
(	I-DISEASE
especially	0
narcolepsy	0
)	0
,	0
mental	0
disorder	I-DISEASE
,	0
medical	0
condition	0
,	I-DISEASE
medication	0
,	I-DISEASE
or	I-DISEASE
substance	I-DISEASE
use	0
.	0

Essential	I-DISEASE
Features	I-DISEASE
Recurrent	0
isolated	0
sleep	0
paralysis	I-DISEASE
is	0
characterized	0
by	I-DISEASE
an	0
inability	I-DISEASE
to	I-DISEASE
perform	0
voluntary	0
movements	0
at	I-DISEASE
sleep	0
onset	0
(	I-DISEASE
hypnagogic	0
or	I-DISEASE
predormital	0
form	0
)	0
or	I-DISEASE
on	0
waking	0
from	0
sleep	0
(	0
hypnopompic	0
or	0
postdormital	0
form	0
)	0
in	0
the	0
absence	I-DISEASE
of	I-DISEASE
a	0
diagnosis	0
of	0
narcolepsy	0
.	0

The	I-DISEASE
event	0
consists	0
of	I-DISEASE
an	0
inability	I-DISEASE
to	I-DISEASE
speak	I-DISEASE
or	B-DISEASE
to	0
move	0
the	0
limbs	I-DISEASE
,	I-DISEASE
trunk	0
,	I-DISEASE
and	0
head	I-DISEASE
.	0

Respiration	I-DISEASE
is	0
usually	I-DISEASE
unaffected	0
.	I-DISEASE

Consciousness	0
is	0
preserved	0
,	0
and	0
full	0
recall	0
is	0
present	I-DISEASE
.	0

An	I-DISEASE
episode	I-DISEASE
of	I-DISEASE
sleep	I-DISEASE
paralysis	0
lasts	I-DISEASE
seconds	I-DISEASE
to	0
minutes	0
.	0

It	I-DISEASE
usually	I-DISEASE
resolves	0
spontaneously	0
but	I-DISEASE
can	I-DISEASE
be	0
aborted	0
by	I-DISEASE
sensory	I-DISEASE
stimulation	0
,	I-DISEASE
such	0
as	I-DISEASE
being	0
touched	I-DISEASE
or	I-DISEASE
spoken	0
to	I-DISEASE
,	I-DISEASE
or	0
by	I-DISEASE
the	0
patient	I-DISEASE
making	0
intense	I-DISEASE
efforts	I-DISEASE
to	B-DISEASE
move	0
.	B-DISEASE

Associated	I-DISEASE
Features	I-DISEASE
At	0
least	0
during	I-DISEASE
the	0
initial	I-DISEASE
episodes	I-DISEASE
,	0
intense	0
anxiety	0
is	0
usually	I-DISEASE
present	I-DISEASE
.	0

Hallucinatory	I-DISEASE
experiences	0
accompany	I-DISEASE
the	0
paralysis	I-DISEASE
in	0
about	0
25	0
%	I-DISEASE
to	I-DISEASE
75	0
%	0
of	I-DISEASE
patients	I-DISEASE
.	0

These	0
may	I-DISEASE
include	I-DISEASE
auditory	I-DISEASE
,	I-DISEASE
visual	I-DISEASE
,	I-DISEASE
or	B-DISEASE
tactile	0
hallucinations	I-DISEASE
,	I-DISEASE
or	I-DISEASE
the	0
sense	0
of	I-DISEASE
a	0
presence	0
in	0
the	0
room	I-DISEASE
.	0

Some	I-DISEASE
patients	I-DISEASE
experience	0
predormital	I-DISEASE
or	I-DISEASE
postdormital	0
hallucinations	I-DISEASE
at	I-DISEASE
separate	I-DISEASE
times	0
from	0
episodes	I-DISEASE
of	I-DISEASE
sleep	0
paralysis	I-DISEASE
.	0

Clinical	I-DISEASE
or	I-DISEASE
Pathophysiological	I-DISEASE
Subtypes	I-DISEASE
A	0
familial	I-DISEASE
form	0
of	I-DISEASE
sleep	0
paralysis	I-DISEASE
has	0
been	I-DISEASE
described	0
(	I-DISEASE
see	I-DISEASE
below	I-DISEASE
)	0
.	0

Demographics	I-DISEASE
Estimates	0
of	I-DISEASE
the	0
prevalence	0
of	I-DISEASE
sleep	I-DISEASE
paralysis	I-DISEASE
vary	0
widely	0
due	I-DISEASE
to	0
differences	I-DISEASE
in	I-DISEASE
the	0
definition	I-DISEASE
used	0
,	I-DISEASE
the	I-DISEASE
age	0
of	I-DISEASE
the	0
population	0
sampled	I-DISEASE
,	I-DISEASE
and	0
possibly	I-DISEASE
cultural	I-DISEASE
and	0
ethnic	I-DISEASE
factors	0
.	0

Most	I-DISEASE
prevalence	0
studies	0
of	I-DISEASE
sleep	0
paralysis	I-DISEASE
(	I-DISEASE
usually	I-DISEASE
of	I-DISEASE
students	I-DISEASE
younger	0
than	I-DISEASE
30	I-DISEASE
years	0
)	0
have	0
investigated	I-DISEASE
the	0
occurrence	0
of	I-DISEASE
one	0
or	0
more	0
episodes	I-DISEASE
without	0
require-	0
ment	0
of	I-DISEASE
recurrence	B-DISEASE
or	I-DISEASE
distress	I-DISEASE
.	0

These	0
suggest	I-DISEASE
a	0
15	0
%	0
to	I-DISEASE
40	0
%	0
prevalence	0
of	I-DISEASE
at	I-DISEASE
least	0
one	I-DISEASE
episode	I-DISEASE
of	I-DISEASE
sleep	0
paralysis	I-DISEASE
.	0

Two	I-DISEASE
notable	0
exceptions	0
are	I-DISEASE
a	0
1962	I-DISEASE
study	0
of	I-DISEASE
mostly	I-DISEASE
college	0
students	I-DISEASE
that	0
reported	I-DISEASE
a	I-DISEASE
prevalence	0
of	I-DISEASE
5	0
%	0
,	0
and	0
a	0
1999	I-DISEASE
study	0
of	I-DISEASE
all	0
adult	0
ages	0
that	0
found	0
a	I-DISEASE
prevalence	0
of	I-DISEASE
6	0
%	0
.	0

No	I-DISEASE
consistent	I-DISEASE
sex	0
differences	I-DISEASE
have	0
emerged	I-DISEASE
from	0
multiple	I-DISEASE
studies	I-DISEASE
.	0

The	I-DISEASE
mean	I-DISEASE
age	I-DISEASE
of	I-DISEASE
onset	0
is	I-DISEASE
14	0
to	I-DISEASE
17	0
years	0
,	I-DISEASE
although	I-DISEASE
onset	I-DISEASE
earlier	I-DISEASE
and	0
later	0
in	I-DISEASE
life	I-DISEASE
has	0
been	I-DISEASE
reported	I-DISEASE
.	0

Predisposing	I-DISEASE
and	0
Precipitating	I-DISEASE
Factors	0
Sleep	0
deprivation	I-DISEASE
and	0
irregular	I-DISEASE
sleep	0
-	0
wake	0
schedules	I-DISEASE
have	0
been	I-DISEASE
identified	I-DISEASE
as	0
predis-	0
posing	0
factors	0
to	B-DISEASE
episodes	I-DISEASE
of	I-DISEASE
sleep	0
paralysis	I-DISEASE
.	0

Mental	I-DISEASE
stress	I-DISEASE
has	0
been	I-DISEASE
reported	0
as	0
a	0
precipitating	I-DISEASE
factor	I-DISEASE
in	I-DISEASE
some	I-DISEASE
but	0
not	0
other	I-DISEASE
studies	I-DISEASE
.	0

Sleep	I-DISEASE
paralysis	I-DISEASE
appears	I-DISEASE
to	0
be	I-DISEASE
more	0
common	I-DISEASE
with	0
sleep	0
in	I-DISEASE
the	0
supine	I-DISEASE
position	0
.	0

Personality	I-DISEASE
factors	0
have	I-DISEASE
not	0
been	I-DISEASE
shown	I-DISEASE
to	I-DISEASE
play	I-DISEASE
a	0
major	I-DISEASE
role	0
,	I-DISEASE
although	I-DISEASE
one	0
study	0
found	I-DISEASE
a	I-DISEASE
higher	0
score	I-DISEASE
on	0
the	0
paranoia	I-DISEASE
scale	I-DISEASE
of	0
the	I-DISEASE
Minnesota	0
Multiphasic	0
Personality	0
Inventory	I-DISEASE
in	I-DISEASE
patients	0
with	0
sleep	0
paralysis	0
com-	I-DISEASE
pared	0
to	I-DISEASE
controls	0
.	0

Other	I-DISEASE
factors	I-DISEASE
that	0
have	I-DISEASE
been	0
noted	0
on	0
regression	0
analysis	0
include	0
an	0
association	I-DISEASE
with	I-DISEASE
bipolar	0
disorder	I-DISEASE
,	0
the	0
use	I-DISEASE
of	I-DISEASE
anxiolytic	0
medication	0
,	I-DISEASE
and	0
sleep	0
related	0
leg	I-DISEASE
cramps	0
.	0

Familial	I-DISEASE
Pattern	I-DISEASE
Two	I-DISEASE
families	I-DISEASE
with	I-DISEASE
apparent	0
familial	0
sleep	I-DISEASE
paralysis	I-DISEASE
occurring	0
over	I-DISEASE
three	I-DISEASE
and	0
four	0
gen-	0
erations	0
have	I-DISEASE
been	0
reported	I-DISEASE
.	0

A	I-DISEASE
maternal	I-DISEASE
form	I-DISEASE
of	I-DISEASE
transmission	0
has	0
been	I-DISEASE
postulated	0
.	0

Onset	I-DISEASE
,	0
Course	0
,	0
and	0
Complications	0
Onset	0
is	I-DISEASE
usually	I-DISEASE
in	0
adolescence	0
.	0

Most	I-DISEASE
events	0
appear	0
to	I-DISEASE
occur	0
in	I-DISEASE
the	0
second	I-DISEASE
and	0
third	0
decades	0
,	I-DISEASE
but	I-DISEASE
may	I-DISEASE
continue	0
later	0
in	I-DISEASE
life	I-DISEASE
.	0

There	I-DISEASE
are	0
no	0
known	I-DISEASE
complications	0
,	I-DISEASE
apart	0
from	I-DISEASE
anxiety	0
over	0
the	0
episodes	I-DISEASE
.	0

Developmental	I-DISEASE
Issues	0
Though	0
sleep	0
paralysis	I-DISEASE
may	I-DISEASE
be	0
present	0
as	0
part	0
of	I-DISEASE
the	0
narcolepsy	0
tetrad	0
in	I-DISEASE
children	0
,	0
there	I-DISEASE
is	I-DISEASE
no	0
information	0
currently	0
available	0
about	0
childhood	0
presentation	0
of	I-DISEASE
recurrent	0
isolated	0
sleep	0
paralysis	I-DISEASE
.	0

Parasomnias	I-DISEASE
Parasomnias	I-DISEASE
Pathology	I-DISEASE
and	0
Pathophysiology	I-DISEASE
Episodes	0
of	I-DISEASE
sleep	0
paralysis	I-DISEASE
elicited	0
by	I-DISEASE
awakening	0
patients	I-DISEASE
from	I-DISEASE
nocturnal	0
sleep	0
appear	0
to	I-DISEASE
arise	I-DISEASE
from	I-DISEASE
REM	0
sleep	0
.	0

Sleep	I-DISEASE
paralysis	I-DISEASE
is	I-DISEASE
an	0
example	0
of	I-DISEASE
state	I-DISEASE
dissociation	0
with	I-DISEASE
ele-	I-DISEASE
ments	0
of	I-DISEASE
REM	0
sleep	0
persisting	I-DISEASE
into	I-DISEASE
wakefulness	0
.	I-DISEASE

Early	I-DISEASE
-	I-DISEASE
onset	0
REM	I-DISEASE
sleep	I-DISEASE
after	I-DISEASE
forced	I-DISEASE
awakenings	0
has	I-DISEASE
been	I-DISEASE
shown	I-DISEASE
to	I-DISEASE
predispose	I-DISEASE
an	0
individual	0
to	I-DISEASE
having	I-DISEASE
sleep	I-DISEASE
paralysis	I-DISEASE
.	I-DISEASE

It	I-DISEASE
may	0
be	0
that	0
subjects	0
with	I-DISEASE
less	I-DISEASE
tolerance	I-DISEASE
to	0
sleep	0
disruption	I-DISEASE
are	0
more	I-DISEASE
likely	I-DISEASE
to	0
experi-	I-DISEASE
ence	0
the	0
phenomenon	0
.	0

Objective	I-DISEASE
Findings	I-DISEASE
Analysis	I-DISEASE
of	I-DISEASE
sleep	0
paralysis	I-DISEASE
after	0
forced	I-DISEASE
awakenings	I-DISEASE
during	I-DISEASE
PSG	0
studies	0
reveals	0
the	0
event	0
to	0
be	0
a	0
dissociated	I-DISEASE
state	I-DISEASE
with	I-DISEASE
the	0
persistence	0
of	I-DISEASE
REM	0
-	0
related	B-DISEASE
electromyographic	0
atonia	I-DISEASE
into	I-DISEASE
conscious	0
wakefulness	I-DISEASE
.	0

Hallucinatory	I-DISEASE
experiences	0
may	I-DISEASE
be	I-DISEASE
present	I-DISEASE
but	0
are	0
not	0
essential	0
for	I-DISEASE
the	0
diagnosis	0
.	0

Differential	I-DISEASE
Diagnosis	0
Cataplexy	I-DISEASE
produces	0
similar	0
generalized	0
paralysis	I-DISEASE
of	I-DISEASE
skeletal	0
muscles	0
but	I-DISEASE
occurs	0
during	I-DISEASE
wakefulness	0
and	0
is	0
precipitated	0
by	0
emotion	I-DISEASE
.	0

Atonic	I-DISEASE
seizures	I-DISEASE
occur	0
during	I-DISEASE
wakefulness	0
.	0

Nocturnal	I-DISEASE
panic	0
attacks	I-DISEASE
are	0
not	0
usually	I-DISEASE
associated	0
with	0
paralysis	0
.	0

Familial	I-DISEASE
periodic	I-DISEASE
paralysis	0
syndromes	0
,	0
especially	0
hypokalemic	I-DISEASE
periodic	I-DISEASE
paralysis	I-DISEASE
,	0
may	I-DISEASE
occur	I-DISEASE
at	I-DISEASE
rest	B-DISEASE
and	0
on	0
awakening	0
.	0

However	I-DISEASE
,	I-DISEASE
the	0
episodes	I-DISEASE
usually	0
last	0
hours	I-DISEASE
,	I-DISEASE
may	0
be	0
associated	0
with	I-DISEASE
car-	I-DISEASE
bohydrate	0
intake	0
,	0
and	0
are	0
usually	I-DISEASE
accompanied	0
by	I-DISEASE
hypokalemia	I-DISEASE
.	0

There	I-DISEASE
are	0
also	0
hyper-	0
kalemic	0
and	0
normokalemic	0
periodic	0
paralysis	I-DISEASE
syndromes	I-DISEASE
.	0

Unresolved	I-DISEASE
Issues	0
and	0
Further	I-DISEASE
Directions	0
Not	0
applicable	0
or	I-DISEASE
known	I-DISEASE
.	0

Bibliography	0
Fukuda	I-DISEASE
K.	0
Sleep	0
paralysis	0
and	0
sleep	I-DISEASE
-	I-DISEASE
onset	0
REM	0
period	I-DISEASE
in	0
normal	0
individuals	I-DISEASE
.	0

In	I-DISEASE
:	I-DISEASE
Olgilvie	I-DISEASE
R	I-DISEASE
,	0
Harsh	0
J	I-DISEASE
,	I-DISEASE
eds	I-DISEASE
.	0

Sleep	I-DISEASE
onset	I-DISEASE
:	I-DISEASE
normal	0
and	0
abnormal	I-DISEASE
processes	0
.	I-DISEASE

Washington	I-DISEASE
:	0
American	0
Psychological	0
Association	0
,	I-DISEASE
1994:161–81	0
.	0

Goode	I-DISEASE
G.	I-DISEASE
Sleep	0
paralysis	I-DISEASE
.	0

Arch	I-DISEASE
Neurol	0
1962;6:228–34	0
.	0

Hishikawa	I-DISEASE
Y.	I-DISEASE
Sleep	I-DISEASE
paralysis	I-DISEASE
.	0

In	I-DISEASE
:	I-DISEASE
Guilleminault	I-DISEASE
C	I-DISEASE
,	0
Dement	0
W	I-DISEASE
,	I-DISEASE
Passouant	0
P	I-DISEASE
,	I-DISEASE
eds	0
.	0

Narcolepsy	I-DISEASE
.	0

New	I-DISEASE
York	0
:	0
Spectrum	0
,	0
1976:97–124	0
.	0

Ohayon	I-DISEASE
M	I-DISEASE
,	0
Zulley	I-DISEASE
J	0
,	0
Guilleminault	I-DISEASE
C	I-DISEASE
,	I-DISEASE
Smirne	I-DISEASE
S.	I-DISEASE
Prevalence	I-DISEASE
and	0
pathologic	I-DISEASE
associations	I-DISEASE
of	I-DISEASE
sleep	0
paralysis	I-DISEASE
in	I-DISEASE
the	I-DISEASE
general	0
population	0
.	0

Neurology	0
1999;52:1194–200	I-DISEASE
.	0

Takeuchi	0
T	0
,	I-DISEASE
Fukuda	0
K	B-DISEASE
,	0
Sasaki	0
Y	I-DISEASE
,	I-DISEASE
Inugami	I-DISEASE
M	I-DISEASE
,	I-DISEASE
Murphy	0
T.	0
Factors	0
related	B-DISEASE
to	0
the	I-DISEASE
occurrence	0
of	I-DISEASE
isolated	I-DISEASE
sleep	0
paralysis	I-DISEASE
elicited	0
during	I-DISEASE
a	0
multi	0
-	I-DISEASE
phasic	0
sleep	0
-	0
wake	0
schedule	I-DISEASE
.	0

Sleep	I-DISEASE
2002;25:89–96	I-DISEASE
.	0

Takeuchi	0
T	0
,	I-DISEASE
Miyasita	0
A	0
,	0
Sasaki	0
Y	I-DISEASE
,	I-DISEASE
Inugami	I-DISEASE
M	I-DISEASE
,	I-DISEASE
Fukuda	0
K.	0
Isolated	0
sleep	0
paralysis	I-DISEASE
elicited	I-DISEASE
by	0
sleep	0
interruption	I-DISEASE
.	0

Sleep	I-DISEASE
1992;15:217–25	I-DISEASE
.	0

Nightmare	I-DISEASE
Disorder	I-DISEASE
ICD-9	0
-	0
CM	0
code	0
:	I-DISEASE
307.47	0
ICD-10	0
-	I-DISEASE
CM	0
code	0
:	0

F51.5	I-DISEASE
Alternate	0
Names	I-DISEASE
Nightmares	I-DISEASE
,	0
REM	0
nightmares	0
,	I-DISEASE
recurrent	B-DISEASE
nightmares	0
,	I-DISEASE
dream	I-DISEASE
anxiety	0
disorder	0
,	I-DISEASE
anxiety	0
dreams	I-DISEASE
.	0

Diagnostic	I-DISEASE
Criteria	0
Criteria	I-DISEASE
A	0
-	I-DISEASE
C	I-DISEASE
must	I-DISEASE
be	0
met	0
A.	0
Repeated	0
occurrences	0
of	I-DISEASE
extended	0
,	I-DISEASE
extremely	0
dysphoric	0
,	0
and	0
well-	I-DISEASE
remembered	0
dreams	0
that	0
usually	I-DISEASE
involve	0
threats	0
to	0
survival	I-DISEASE
,	I-DISEASE
security	I-DISEASE
,	I-DISEASE
or	0
physical	0
integrity	0
.	0

B.	0
On	I-DISEASE
awakening	0
from	I-DISEASE
the	I-DISEASE
dysphoric	I-DISEASE
dreams	I-DISEASE
,	I-DISEASE
the	0
person	0
rapidly	I-DISEASE
becomes	I-DISEASE
oriented	0
and	0
alert	I-DISEASE
.	0

C.	I-DISEASE
The	I-DISEASE
dream	I-DISEASE
experience	0
,	I-DISEASE
or	I-DISEASE
the	B-DISEASE
sleep	0
disturbance	0
produced	0
by	I-DISEASE
awakening	I-DISEASE
from	0
it	0
,	I-DISEASE
causes	I-DISEASE
clinically	0
significant	0
distress	I-DISEASE
or	0
impairment	0
in	0
social	I-DISEASE
,	I-DISEASE
occupational	I-DISEASE
,	I-DISEASE
or	B-DISEASE
other	I-DISEASE
important	B-DISEASE
areas	I-DISEASE
of	I-DISEASE
functioning	I-DISEASE
as	0
indicated	I-DISEASE
by	I-DISEASE
the	0
report	0
of	0
at	I-DISEASE
least	I-DISEASE
one	I-DISEASE
of	I-DISEASE
the	I-DISEASE
following	0
:	0
.	0

Mood	I-DISEASE
disturbance	0
(	I-DISEASE
e.g.	0
,	0
persistence	0
of	I-DISEASE
nightmare	I-DISEASE
affect	0
,	0
anxiety	I-DISEASE
,	I-DISEASE
dysphoria	I-DISEASE
)	0
.	0
.	0

Sleep	I-DISEASE
resistance	I-DISEASE
(	I-DISEASE
e.g.	0
,	I-DISEASE
bedtime	I-DISEASE
anxiety	I-DISEASE
,	I-DISEASE
fear	I-DISEASE
of	I-DISEASE
sleep	0
/	0
subsequent	0
nightmares	I-DISEASE
)	0
.	0
.	0

Cognitive	I-DISEASE
impairments	0
(	I-DISEASE
e.g.	I-DISEASE
,	I-DISEASE
intrusive	I-DISEASE
nightmare	0
imagery	I-DISEASE
,	I-DISEASE
impaired	0
concentration	0
,	I-DISEASE
or	0
memory	0
)	0
.	0
.	0

Negative	I-DISEASE
impact	I-DISEASE
on	0
caregiver	I-DISEASE
or	B-DISEASE
family	0
functioning	I-DISEASE
(	I-DISEASE
e.g.	I-DISEASE
,	I-DISEASE
nighttime	I-DISEASE
disruption	I-DISEASE
)	0
.	0
.	0

Behavioral	I-DISEASE
problems	0
(	I-DISEASE
e.g.	0
,	0
bedtime	I-DISEASE
avoidance	0
,	I-DISEASE
fear	0
of	I-DISEASE
the	0
dark	0
)	0
.	0
.	0

Daytime	I-DISEASE
sleepiness	0
.	0
.	0

Fatigue	I-DISEASE
or	I-DISEASE
low	0
energy	I-DISEASE
.	0
.	I-DISEASE

Impaired	I-DISEASE
occupational	I-DISEASE
or	I-DISEASE
educational	I-DISEASE
function	I-DISEASE
.	0
.	0

Impaired	I-DISEASE
interpersonal	0
/	0
social	0
function	0
Notes	0
.	0

Nightmare	I-DISEASE
disorder	0
in	0
children	I-DISEASE
is	0
most	0
likely	0
to	I-DISEASE
occur	0
in	0
those	0
exposed	0
to	I-DISEASE
severe	I-DISEASE
psychosocial	0
stressors	0
.	0

Because	I-DISEASE
childhood	0
nightmares	0
often	I-DISEASE
resolve	0
spontaneously	I-DISEASE
,	I-DISEASE
the	0
diagnosis	0
should	0
be	I-DISEASE
given	I-DISEASE
only	I-DISEASE
if	0
there	I-DISEASE
is	0
persistent	I-DISEASE
distress	0
or	0
impairment	0
.	0

Parasomnias	I-DISEASE
Parasomnias	I-DISEASE
Essential	0
Features	I-DISEASE
Nightmare	I-DISEASE
disorder	I-DISEASE
is	0
characterized	0
by	I-DISEASE
recurrent	I-DISEASE
,	0
highly	I-DISEASE
dysphoric	0
dreams	0
,	I-DISEASE
which	0
are	I-DISEASE
disturbing	0
mental	0
experiences	0
that	0
generally	I-DISEASE
occur	0
during	I-DISEASE
REM	0
sleep	0
and	0
that	0
often	0
result	0
in	I-DISEASE
awakening	0
.	0

Given	I-DISEASE
that	I-DISEASE
these	0
experiences	0
are	0
most	0
often	0
associated	0
with	0
REM	0
sleep	0
,	I-DISEASE
the	0
episodes	I-DISEASE
have	0
a	0
greater	I-DISEASE
tendency	0
to	0
occur	I-DISEASE
during	I-DISEASE
the	0
second	I-DISEASE
half	0
of	I-DISEASE
the	0
major	I-DISEASE
sleep	0
episode	I-DISEASE
when	0
the	0
REM	0
pressure	0
is	0
most	0
pronounced	0
.	0

Nightmares	I-DISEASE
involve	0
an	0
internally	0
generated	0
conscious	0
experience	0
or	0
dream	I-DISEASE
sequence	0
that	0
seems	I-DISEASE
vivid	I-DISEASE
and	0
real	0
.	0

They	I-DISEASE
have	I-DISEASE
a	0
tendency	I-DISEASE
to	0
become	I-DISEASE
increasingly	0
more	0
disturbing	0
as	0
they	0
unfold	I-DISEASE
.	0

Emotions	I-DISEASE
are	I-DISEASE
characteristically	0
negative	I-DISEASE
and	0
most	0
frequently	0
involve	0
anxiety	0
,	I-DISEASE
fear	0
,	0
or	0
terror	0
but	I-DISEASE
may	0
also	0
involve	0
anger	0
,	0
rage	I-DISEASE
,	I-DISEASE
embarrassment	I-DISEASE
,	0
and	0
disgust	0
.	0

Nightmare	I-DISEASE
content	0
most	0
often	I-DISEASE
focuses	0
on	0
imminent	I-DISEASE
physical	0
danger	0
to	0
the	0
individual	I-DISEASE
but	I-DISEASE
may	I-DISEASE
also	0
involve	0
other	I-DISEASE
distressing	I-DISEASE
themes	0
.	0

Ability	I-DISEASE
to	0
detail	I-DISEASE
the	0
nightmare	0
’s	I-DISEASE
contents	0
upon	0
awakening	0
is	I-DISEASE
common	I-DISEASE
in	0
nightmare	0
disorder	I-DISEASE
.	0

Multiple	0
nightmares	0
within	0
a	0
single	0
sleep	0
episode	0
may	0
occur	0
and	0
may	0
bear	I-DISEASE
similar	I-DISEASE
themes	0
.	0

Because	I-DISEASE
nightmares	0
typically	0
arise	I-DISEASE
during	I-DISEASE
REM	I-DISEASE
sleep	0
,	0
they	0
may	I-DISEASE
occur	I-DISEASE
at	I-DISEASE
any	I-DISEASE
moment	I-DISEASE
that	0
REM	I-DISEASE
pressure	0
is	0
high	I-DISEASE
.	0

Nightmares	I-DISEASE
are	0
very	I-DISEASE
common	0
in	I-DISEASE
children	0
.	0

They	I-DISEASE
typically	0
occur	0
in	I-DISEASE
the	0
last	0
third	I-DISEASE
of	I-DISEASE
the	0
night	0
and	0
result	0
in	I-DISEASE
a	I-DISEASE
complete	0
awakening	0
,	I-DISEASE
after	0
which	0
the	0
child	0
can	0
often	0
provide	I-DISEASE
a	I-DISEASE
detailed	0
description	I-DISEASE
of	I-DISEASE
the	I-DISEASE
frightening	I-DISEASE
scenario	I-DISEASE
.	0

However	I-DISEASE
,	I-DISEASE
clear	I-DISEASE
distinction	0
from	0
con-	0
fusional	I-DISEASE
arousals	0
and	0
sleep	I-DISEASE
terrors	I-DISEASE
in	0
young	I-DISEASE
children	I-DISEASE
is	0
often	0
not	0
possible	0
.	0

Associated	I-DISEASE
Features	I-DISEASE
Postawakening	0
anxiety	I-DISEASE
and	0
difficulty	0
returning	0
to	0
sleep	0
may	0
be	I-DISEASE
present	I-DISEASE
.	0

Nightmares	I-DISEASE
are	0
more	0
common	0
in	I-DISEASE
those	0
with	I-DISEASE
higher	0
levels	0
of	I-DISEASE
anxiety	I-DISEASE
.	I-DISEASE

Additionally	I-DISEASE
,	I-DISEASE
nightmares	0
are	I-DISEASE
commonly	0
seen	I-DISEASE
in	I-DISEASE
those	I-DISEASE
who	I-DISEASE
have	0
been	I-DISEASE
physically	I-DISEASE
or	I-DISEASE
sexually	I-DISEASE
abused	I-DISEASE
and	0
in	I-DISEASE
those	I-DISEASE
suf-	0
fering	I-DISEASE
from	0
posttraumatic	0
stress	I-DISEASE
disorder	0
.	0

Nightmares	I-DISEASE
arising	0
either	I-DISEASE
immediately	0
following	0
a	0
trauma	0
(	I-DISEASE
acute	0
stress	I-DISEASE
disorder	0
[	I-DISEASE
ASD	I-DISEASE
]	0
)	0
or	I-DISEASE
one	0
month	0
or	I-DISEASE
more	0
after	0
a	0
trauma	0
(	I-DISEASE
posttraumatic	0
stress	I-DISEASE
disorder	0
[	0
PTSD	0
]	0
)	0
have	0
been	I-DISEASE
described	I-DISEASE
during	I-DISEASE
NREM	0
sleep	0
,	I-DISEASE
especially	0
N2	I-DISEASE
,	I-DISEASE
as	0
well	0
as	0
during	I-DISEASE
REM	0
sleep	0
and	0
at	I-DISEASE
sleep	0
onset	0
.	0

Posttraumatic	I-DISEASE
nightmares	0
may	0
take	I-DISEASE
the	0
form	I-DISEASE
of	I-DISEASE
a	0
realistic	0
reliving	0
of	I-DISEASE
a	0
traumatic	0
event	I-DISEASE
or	0
may	0
depict	I-DISEASE
only	0
some	I-DISEASE
of	I-DISEASE
its	I-DISEASE
elements	I-DISEASE
or	0
emotional	I-DISEASE
content	0
.	0

Clinical	I-DISEASE
or	I-DISEASE
Pathophysiological	I-DISEASE
Subtypes	I-DISEASE
None	I-DISEASE
known	I-DISEASE
.	I-DISEASE

Demographics	I-DISEASE
Occasional	0
nightmares	0
are	0
very	I-DISEASE
common	I-DISEASE
in	I-DISEASE
children	I-DISEASE
,	I-DISEASE
occurring	0
in	I-DISEASE
60	I-DISEASE
%	0
to	0
75	0
%	0
of	I-DISEASE
chil-	I-DISEASE
dren	0
,	I-DISEASE
beginning	I-DISEASE
as	0
young	I-DISEASE
as	B-DISEASE
2.5	0
years	I-DISEASE
of	I-DISEASE
age	0
.	0

The	I-DISEASE
occurrence	0
of	I-DISEASE
occasional	0
nightmares	0
in	I-DISEASE
children	I-DISEASE
does	I-DISEASE
not	0
constitute	I-DISEASE
a	0
nightmare	0
disorder	I-DISEASE
.	0

However	I-DISEASE
,	I-DISEASE
frequent	0
nightmares	0
are	0
uncommon	0
,	I-DISEASE
occurring	I-DISEASE
in	0
1	0
%	0
to	I-DISEASE
5	0
%	0
of	I-DISEASE
preadolescent	I-DISEASE
children	0
.	0

It	I-DISEASE
is	I-DISEASE
estimated	0
that	0
10	0
%	0
to	I-DISEASE
50	0
%	0
of	I-DISEASE
children	B-DISEASE
aged	I-DISEASE
three	I-DISEASE
to	I-DISEASE
five	0
years	0
have	0
at	I-DISEASE
least	0
occasional	0
nightmares	0
severe	0
enough	I-DISEASE
to	0
disturb	I-DISEASE
their	I-DISEASE
parents	0
.	0

Nightmares	I-DISEASE
appear	0
to	I-DISEASE
be	0
a	0
trait	0
-	0
like	0
characteristic	0
that	0
persists	0
over	0
time	0
during	I-DISEASE
childhood	0
.	0

The	I-DISEASE
best	0
predictor	0
of	0
recurrent	0
nightmares	I-DISEASE
at	I-DISEASE
an	0
older	0
age	I-DISEASE
is	I-DISEASE
recurrent	B-DISEASE
nightmares	0
in	I-DISEASE
childhood	0
.	0

Approximately	I-DISEASE
2	I-DISEASE
%	0
to	I-DISEASE
8	0
%	0
of	I-DISEASE
the	0
general	0
population	0
has	0
a	0
current	I-DISEASE
problem	I-DISEASE
with	0
nightmares	0
,	I-DISEASE
and	0
this	0
frequency	I-DISEASE
is	I-DISEASE
higher	0
in	I-DISEASE
clini-	I-DISEASE
cal	0
populations	0
.	0

Trauma	0
-	I-DISEASE
related	0
nightmares	0
are	0
the	0
most	0
consistent	0
problem	I-DISEASE
reported	I-DISEASE
by	I-DISEASE
patients	I-DISEASE
with	0
PTSD	0
.	0

Nightmares	I-DISEASE
beginning	I-DISEASE
within	I-DISEASE
three	0
months	0
of	I-DISEASE
a	I-DISEASE
trauma	0
are	0
present	I-DISEASE
in	I-DISEASE
up	I-DISEASE
to	I-DISEASE
80	0
%	0
of	I-DISEASE
patients	I-DISEASE
with	0
PTSD	0
.	0

Although	I-DISEASE
approximately	0
50	0
%	0
of	0
PTSD	I-DISEASE
cases	0
resolve	0
within	0
three	I-DISEASE
months	I-DISEASE
,	I-DISEASE
posttraumatic	I-DISEASE
nightmares	0
may	I-DISEASE
persist	0
throughout	0
life	0
.	0

Predisposing	I-DISEASE
and	0
Precipitating	I-DISEASE
Factors	0
Frequent	0
nightmares	0
are	0
associated	0
with	I-DISEASE
enduring	0
personality	0
characteristics	0
and	0
psy-	0
chopathologies	I-DISEASE
;	I-DISEASE
they	I-DISEASE
are	I-DISEASE
inversely	0
correlated	I-DISEASE
with	0
measures	0
of	0
well	I-DISEASE
-	0
being	0
.	0

Associations	I-DISEASE
with	0
psychopathology	0
have	0
been	0
identified	I-DISEASE
for	0
adults	I-DISEASE
and	0
adolescents	0
,	I-DISEASE
but	I-DISEASE
research	0
on	0
children	I-DISEASE
is	0
largely	I-DISEASE
absent	0
other	0
than	I-DISEASE
for	0
assessments	I-DISEASE
of	I-DISEASE
PTSD	I-DISEASE
.	0

Measures	I-DISEASE
of	I-DISEASE
nightmare	I-DISEASE
distress	0
are	0
much	I-DISEASE
more	I-DISEASE
robustly	0
associated	0
with	I-DISEASE
psychopathology	I-DISEASE
than	I-DISEASE
are	0
measures	0
of	I-DISEASE
nightmare	0
frequency	I-DISEASE
.	0

The	I-DISEASE
clinical	I-DISEASE
use	0
of	I-DISEASE
pharmacologic	0
agents	I-DISEASE
affecting	0
the	I-DISEASE
neurotransmitters	0
norepinephrine	0
,	I-DISEASE
serotonin	I-DISEASE
,	I-DISEASE
and	0
dopamine	I-DISEASE
is	0
associated	0
with	I-DISEASE
the	0
complaint	I-DISEASE
of	I-DISEASE
night-	0
mares	0
.	0

A	I-DISEASE
majority	0
of	I-DISEASE
these	I-DISEASE
agents	0
are	0
antidepressants	0
,	0
antihypertensives	I-DISEASE
,	I-DISEASE
and	0
dopa-	0
mine	0
-	0
receptor	I-DISEASE
agonists	I-DISEASE
.	I-DISEASE

Agents	I-DISEASE
affecting	0
the	0
neurotransmitters	0
gamma	0
-	0
aminobutyric	0
acid	I-DISEASE
(	I-DISEASE
GABA	I-DISEASE
)	0
,	0
acetylcholine	I-DISEASE
,	I-DISEASE
and	0
histamine	0
,	I-DISEASE
and	0
the	B-DISEASE
withdrawal	0
of	I-DISEASE
REM	I-DISEASE
sleep	0
sup-	0
pressive	0
agents	0
also	0
can	0
be	I-DISEASE
associated	0
with	I-DISEASE
the	I-DISEASE
complaint	0
of	I-DISEASE
nightmares	0
.	0

Of	I-DISEASE
note	I-DISEASE
,	0
nightmares	0
are	0
a	0
common	I-DISEASE
reaction	I-DISEASE
in	0
varenicline	I-DISEASE
,	I-DISEASE
which	0
is	0
an	0
agent	I-DISEASE
that	I-DISEASE
blocks	0
α-4	0
-	0
β-2	0
nicotinic	0
acetylcholine	I-DISEASE
receptors	0
.	0

Familial	I-DISEASE
Pattern	I-DISEASE
Twin	0
-	0
based	I-DISEASE
studies	I-DISEASE
have	0
identified	I-DISEASE
persistent	0
genetic	I-DISEASE
predisposition	I-DISEASE
to	I-DISEASE
nightmares	0
in	0
childhood	0
(	I-DISEASE
reported	0
retrospectively	0
by	I-DISEASE
adults	I-DISEASE
)	0
and	0
adulthood	0
as	0
well	I-DISEASE
as	B-DISEASE
genetic	0
influ-	I-DISEASE
ences	0
on	0
the	0
co	0
-	0
occurrence	0
of	I-DISEASE
nightmares	0
and	0
some	I-DISEASE
other	I-DISEASE
parasomnias	I-DISEASE
,	0
such	0
as	0
sleep	0
talking	0
(	I-DISEASE
somniloquy	0
)	0
.	0

Onset	I-DISEASE
,	0
Course	0
,	0
and	0
Complications	0
Nightmares	I-DISEASE
usually	I-DISEASE
start	0
between	0
ages	I-DISEASE
three	I-DISEASE
years	I-DISEASE
and	0
six	0
years	I-DISEASE
.	0

The	I-DISEASE
proportion	I-DISEASE
of	I-DISEASE
children	I-DISEASE
reporting	0
nightmares	0
reaches	I-DISEASE
a	I-DISEASE
peak	0
between	0
six	I-DISEASE
and	0
ten	I-DISEASE
years	I-DISEASE
of	I-DISEASE
age	I-DISEASE
and	0
decreases	0
thereafter	0
.	0

A	I-DISEASE
subgroup	I-DISEASE
of	I-DISEASE
children	I-DISEASE
continue	0
to	I-DISEASE
have	0
nightmares	0
into	I-DISEASE
Parasomnias	0
Parasomnias	0
adolescence	0
or	0
adulthood	0
and	0
may	I-DISEASE
become	I-DISEASE
lifelong	0
nightmare	0
sufferers	I-DISEASE
.	0

Nightmares	I-DISEASE
generally	0
diminish	0
in	I-DISEASE
frequency	I-DISEASE
and	0
intensity	0
over	0
the	0
course	I-DISEASE
of	I-DISEASE
decades	0
,	I-DISEASE
but	I-DISEASE
some	I-DISEASE
patients	0
still	0
describe	0
frequent	0
episodes	I-DISEASE
at	I-DISEASE
the	0
age	I-DISEASE
of	0
60	0
or	0
70	0
years	I-DISEASE
.	0

Nightmare	I-DISEASE
dis-	I-DISEASE
order	0
can	0
lead	0
to	I-DISEASE
sleep	0
avoidance	0
and	0
deprivation	I-DISEASE
,	I-DISEASE
and	0
thereby	0
to	0
more	0
intense	0
night-	0
mares	0
,	0
which	0
can	0
produce	0
insomnia	I-DISEASE
.	B-DISEASE

ASD	I-DISEASE
and	0
PTSD	I-DISEASE
associated	0
nightmares	0
can	I-DISEASE
develop	0
at	I-DISEASE
any	I-DISEASE
age	I-DISEASE
after	I-DISEASE
physical	0
or	0
emo-	I-DISEASE
tional	0
trauma	0
.	0

Individuals	I-DISEASE
with	0
PTSD	0
are	0
at	I-DISEASE
risk	0
for	I-DISEASE
developing	0
mood	0
disorders	0
and	0
depression	I-DISEASE
,	I-DISEASE
social	0
and	0
employment	I-DISEASE
consequences	I-DISEASE
,	0
self	0
-	0
destructive	I-DISEASE
and	0
impulsive	0
behavior	0
,	0
and	0
substance	I-DISEASE
abuse	0
;	I-DISEASE
it	0
is	0
not	0
known	I-DISEASE
to	0
what	0
extent	0
the	0
nightmares	0
symp-	0
tomatic	0
of	I-DISEASE
PTSD	I-DISEASE
contribute	0
to	0
these	0
complications	0
.	0

Developmental	I-DISEASE
Issues	0
As	I-DISEASE
stated	0
above	0
,	I-DISEASE
nightmares	I-DISEASE
are	0
very	I-DISEASE
common	I-DISEASE
in	I-DISEASE
children	I-DISEASE
but	I-DISEASE
the	0
occurrence	0
of	I-DISEASE
occa-	I-DISEASE
sional	0
nightmares	0
does	I-DISEASE
not	0
constitute	I-DISEASE
nightmare	0
disorder	I-DISEASE
.	0

Population	0
studies	I-DISEASE
have	0
revealed	I-DISEASE
that	0
the	0
prevalence	0
and	0
frequency	I-DISEASE
of	I-DISEASE
nightmares	0
increases	0
through	I-DISEASE
childhood	0
into	I-DISEASE
adolescence	0
.	0

For	I-DISEASE
example	0
,	0
preschoolers	I-DISEASE
seldom	0
report	0
“	0
bad	0
dreams	0
.	0
”	I-DISEASE

Furthermore	I-DISEASE
,	I-DISEASE
in	I-DISEASE
regard	0
to	0
the	0
prevalence	0
of	I-DISEASE
nightmares	0
,	0
children	I-DISEASE
appear	I-DISEASE
to	I-DISEASE
exhibit	0
a	0
sex	0
divergence	I-DISEASE
over	0
time	0
,	I-DISEASE
with	I-DISEASE
girls	I-DISEASE
demonstrating	0
higher	0
prevalence	I-DISEASE
by	0
late	I-DISEASE
adolescence	0
.	0

Pathology	I-DISEASE
and	0
Pathophysiology	I-DISEASE
Not	0
applicable	0
or	0
known	I-DISEASE
.	I-DISEASE

Objective	I-DISEASE
Findings	I-DISEASE
PSG	0
recordings	I-DISEASE
during	I-DISEASE
actual	0
nightmares	0
are	I-DISEASE
few	I-DISEASE
in	I-DISEASE
number	0
and	0
,	I-DISEASE
in	I-DISEASE
some	0
instances	0
,	I-DISEASE
have	0
shown	I-DISEASE
abrupt	I-DISEASE
awakenings	0
from	I-DISEASE
REM	0
sleep	0
preceded	I-DISEASE
by	0
accelerated	B-DISEASE
heart	0
and	0
respiratory	0
rates	0
.	0

Highly	I-DISEASE
disturbing	0
dream	I-DISEASE
content	0
frequently	I-DISEASE
contrasts	I-DISEASE
strikingly	I-DISEASE
with	0
relatively	0
minor	0
autonomic	I-DISEASE
changes	0
.	0

Distinctive	I-DISEASE
anomalies	0
in	I-DISEASE
nightly	0
sleep	0
architec-	0
ture	0
have	I-DISEASE
not	0
been	0
demonstrated	0
;	0
brainstem	0
and	0
auditory	I-DISEASE
-	0
evoked	0
potentials	0
appear	0
normal	0
.	0

Recordings	I-DISEASE
during	I-DISEASE
posttraumatic	0
nightmares	0
are	0
few	0
but	0
have	0
been	I-DISEASE
recorded	I-DISEASE
from	I-DISEASE
both	I-DISEASE
REM	0
and	0
NREM	0
sleep	0
.	0

PSG	I-DISEASE
recordings	0
of	I-DISEASE
sleep	0
in	I-DISEASE
patients	I-DISEASE
with	I-DISEASE
PTSD	0
have	0
provided	I-DISEASE
widely	I-DISEASE
variable	I-DISEASE
results	0
.	0

PSG	I-DISEASE
evaluation	0
is	I-DISEASE
not	0
routinely	0
performed	0
but	I-DISEASE
may	0
be	0
indicated	0
in	I-DISEASE
some	I-DISEASE
circumstances	0
to	0
exclude	0
other	I-DISEASE
parasomnias	I-DISEASE
such	0
as	0
disorders	0
of	I-DISEASE
arousal	0
and	0
sleep	0
-	I-DISEASE
associated	0
sei-	I-DISEASE
zures	I-DISEASE
.	0

A	I-DISEASE
PSG	0
is	0
particularly	0
appropriate	I-DISEASE
if	0
patients	I-DISEASE
report	0
nightmares	0
in	0
conjunction	I-DISEASE
with	I-DISEASE
sleep	0
behaviors	0
that	0
are	I-DISEASE
repetitive	I-DISEASE
or	0
stereotyped	0
or	0
are	0
injurious	I-DISEASE
to	I-DISEASE
self	0
or	I-DISEASE
others	I-DISEASE
.	0

Differential	I-DISEASE
Diagnosis	0
Nightmare	I-DISEASE
disorder	0
must	I-DISEASE
be	0
distinguished	0
from	I-DISEASE
dream	I-DISEASE
disturbances	I-DISEASE
associated	0
with	0
certain	0
other	I-DISEASE
neurological	0
and	0
sleep	0
disorders	0
.	0

Rare	I-DISEASE
cases	0
of	I-DISEASE
seizures	I-DISEASE
presenting	I-DISEASE
only	0
as	I-DISEASE
“	0
nightmares	0
”	I-DISEASE
have	I-DISEASE
been	I-DISEASE
reported	I-DISEASE
and	0
should	0
be	I-DISEASE
considered	I-DISEASE
in	0
the	0
differential	0
diagno-	0
sis	I-DISEASE
,	I-DISEASE
particularly	0
in	I-DISEASE
those	I-DISEASE
patients	I-DISEASE
who	I-DISEASE
present	I-DISEASE
with	I-DISEASE
a	0
history	I-DISEASE
of	0
central	0
nervous	0
system	0
disease	B-DISEASE
.	0

PSG	I-DISEASE
or	0
continuous	0
video	0
EEG	0
may	I-DISEASE
be	0
necessary	0
to	0
identify	0
nightmares	I-DISEASE
asso-	I-DISEASE
ciated	I-DISEASE
with	0
nocturnal	0
seizures	0
.	0

Nightmares	I-DISEASE
differ	0
from	I-DISEASE
sleep	0
terrors	0
in	I-DISEASE
having	0
detailed	0
recollection	0
of	I-DISEASE
dreaming	0
in	I-DISEASE
contrast	I-DISEASE
to	0
fragments	0
of	I-DISEASE
dreams	I-DISEASE
or	0
no	0
dream	I-DISEASE
recall	I-DISEASE
,	0
pre-	I-DISEASE
senting	I-DISEASE
no	0
or	0
minimal	I-DISEASE
overt	0
movement	I-DISEASE
or	0
autonomic	0
activity	0
,	0
occurring	0
late	I-DISEASE
in	I-DISEASE
the	I-DISEASE
night	0
,	I-DISEASE
being	I-DISEASE
followed	0
by	0
rapid	I-DISEASE
awakening	0
and	0
difficulty	0
returning	I-DISEASE
to	0
sleep	0
,	0
and	0
most	I-DISEASE
often	I-DISEASE
arising	0
from	0
REM	I-DISEASE
sleep	0
.	0

RBD	I-DISEASE
occurs	0
more	0
often	0
in	I-DISEASE
late	I-DISEASE
middle	I-DISEASE
-	0
aged	I-DISEASE
men	0
and	0
is	I-DISEASE
more	0
often	0
associated	0
with	I-DISEASE
violent	I-DISEASE
explosive	0
movements	0
and	0
a	0
history	I-DISEASE
of	I-DISEASE
nocturnal	0
injuries	0
.	I-DISEASE

The	I-DISEASE
dream	I-DISEASE
disturbance	0
of	I-DISEASE
RBD	0
usually	I-DISEASE
involves	0
being	0
threatened	0
or	0
attacked	I-DISEASE
by	I-DISEASE
unfamiliar	I-DISEASE
people	0
or	0
animals	0
and	0
is	0
controlled	0
in	I-DISEASE
tandem	0
with	I-DISEASE
the	0
sleep	0
behavioral	I-DISEASE
disturbance	0
by	I-DISEASE
appropriate	I-DISEASE
medication	0
.	0

Nightmares	I-DISEASE
occur	0
at	I-DISEASE
any	I-DISEASE
age	I-DISEASE
and	0
are	I-DISEASE
not	0
typ-	0
ically	I-DISEASE
associated	0
with	I-DISEASE
movements	0
,	0
overt	0
behaviors	I-DISEASE
,	0
or	0
injuries	I-DISEASE
.	0

Anxiety	0
may	I-DISEASE
accom-	0
pany	0
episodes	I-DISEASE
of	I-DISEASE
sleep	I-DISEASE
paralysis	I-DISEASE
occurring	0
either	I-DISEASE
at	I-DISEASE
sleep	0
onset	0
(	I-DISEASE
hypnagogic	0
)	0
or	0
offset	0
(	I-DISEASE
hypnopompic	I-DISEASE
)	0
,	0
when	0
the	0
individual	0
feels	0
conscious	0
but	I-DISEASE
unable	I-DISEASE
to	I-DISEASE
move	I-DISEASE
,	0
speak	0
,	0
and	0
,	0
at	I-DISEASE
times	0
,	I-DISEASE
breathe	0
properly	0
.	0

Anxiety	0
may	I-DISEASE
be	0
further	I-DISEASE
worsened	0
if	0
disturbing	0
hypnago-	0
gic	0
hallucinations	0
or	0
dream	I-DISEASE
sequences	I-DISEASE
accompany	I-DISEASE
the	0
paralysis	I-DISEASE
.	0

Nightmares	I-DISEASE
,	0
although	0
they	0
may	I-DISEASE
involve	0
some	I-DISEASE
degree	I-DISEASE
of	I-DISEASE
movement	0
inhibition	I-DISEASE
or	I-DISEASE
some	0
degree	I-DISEASE
of	I-DISEASE
apparent	I-DISEASE
wakefulness	0
,	0
are	0
usually	I-DISEASE
not	0
accompanied	0
by	I-DISEASE
feelings	0
of	I-DISEASE
either	0
total	I-DISEASE
paralysis	I-DISEASE
or	0
com-	I-DISEASE
plete	0
waking	0
consciousness	0
.	0

Patients	I-DISEASE
with	0
narcolepsy	0
often	0
report	0
nightmares	0
;	0
these	I-DISEASE
may	I-DISEASE
occur	I-DISEASE
at	I-DISEASE
sleep	0
onset	0
.	0

However	I-DISEASE
,	I-DISEASE
narcolepsy	0
and	0
nightmare	0
disorder	0
are	0
clearly	0
distinguishable	0
by	I-DISEASE
other	0
clinical	0
symptoms	I-DISEASE
.	0

Nocturnal	I-DISEASE
panic	0
attacks	I-DISEASE
occur	0
either	I-DISEASE
during	I-DISEASE
or	I-DISEASE
immediately	I-DISEASE
after	0
nocturnal	0
awakenings	I-DISEASE
from	0
NREM	0
sleep	0
,	0
usually	I-DISEASE
in	I-DISEASE
the	0
first	0
four	I-DISEASE
hours	I-DISEASE
of	I-DISEASE
the	0
sleep	0
episode	I-DISEASE
.	B-DISEASE

Although	I-DISEASE
frequency	I-DISEASE
of	I-DISEASE
panic	0
attacks	0
is	0
correlated	0
with	I-DISEASE
frequency	I-DISEASE
of	I-DISEASE
night-	0
mares	I-DISEASE
and	0
many	0
patients	0
report	0
that	0
dysphoric	0
dreams	0
precede	0
their	0
attacks	0
,	I-DISEASE
there	I-DISEASE
may	I-DISEASE
be	0
no	0
dream	I-DISEASE
recall	I-DISEASE
reported	0
on	0
awakening	0
with	0
a	0
panic	0
attack	0
.	0

Sleep	I-DISEASE
related	I-DISEASE
dissociative	0
disorders	0
comprise	I-DISEASE
a	0
sleep	0
related	B-DISEASE
variant	I-DISEASE
of	I-DISEASE
the	0
dissociative	0
disorders	0
as	0
defined	I-DISEASE
by	I-DISEASE
the	0
Diagnostic	0
and	0
Statistical	0
Manual	I-DISEASE
of	I-DISEASE
Mental	0
Disorders	I-DISEASE
,	I-DISEASE
Fifth	0
Edition	0
(	I-DISEASE
DSM	0
-	0
V	0
)	0
.	0

These	0
include	I-DISEASE
dissociative	0
identity	I-DISEASE
disorder	I-DISEASE
(	0
formerly	0
called	I-DISEASE
multi-	0
ple	0
personality	0
disorder	I-DISEASE
)	0
and	0
dissociative	0
fugue	0
,	0
in	I-DISEASE
which	0
individuals	I-DISEASE
meeting	I-DISEASE
waking	0
criteria	0
for	0
these	I-DISEASE
diagnoses	0
may	0
at	I-DISEASE
times	0
experience	0
the	0
recall	I-DISEASE
of	I-DISEASE
actual	I-DISEASE
physical	0
or	I-DISEASE
emotional	0
trauma	0
as	0
a	0
“	0
dream	I-DISEASE
”	I-DISEASE
during	I-DISEASE
periods	0
of	I-DISEASE
EEG	0
-	0
documented	I-DISEASE
nocturnal	I-DISEASE
waking	0
.	0

Parasomnias	I-DISEASE
Parasomnias	I-DISEASE
Nightmares	I-DISEASE
that	I-DISEASE
occur	I-DISEASE
intermittently	0
during	I-DISEASE
the	0
course	0
of	0
ASD	0
or	0
PTSD	0
are	I-DISEASE
an	0
expected	I-DISEASE
symptom	0
of	I-DISEASE
those	0
mental	I-DISEASE
disorders	0
and	0
do	0
not	0
always	0
require	0
independent	I-DISEASE
coding	0
as	0
nightmare	0
disorder	I-DISEASE
.	0

However	I-DISEASE
,	I-DISEASE
as	0
is	I-DISEASE
often	0
the	0
case	I-DISEASE
,	I-DISEASE
when	0
the	0
frequency	I-DISEASE
and/or	0
severity	0
of	I-DISEASE
posttraumatic	0
nightmares	0
is	I-DISEASE
such	0
that	0
they	0
require	I-DISEASE
independent	I-DISEASE
clinical	0
attention	0
,	I-DISEASE
then	0
a	0
diagnosis	I-DISEASE
of	I-DISEASE
nightmare	0
disorder	I-DISEASE
should	0
be	0
applied	0
.	0

In	I-DISEASE
some	I-DISEASE
cases	0
,	I-DISEASE
other	0
symp-	0
toms	0
of	I-DISEASE
PTSD	I-DISEASE
may	0
have	0
largely	I-DISEASE
resolved	0
while	0
the	0
nightmares	0
persist	0
.	0

Nightmare	I-DISEASE
disorder	0
should	0
be	I-DISEASE
coded	0
in	I-DISEASE
these	I-DISEASE
cases	0
as	0
well	0
.	0

It	I-DISEASE
is	I-DISEASE
clinically	0
important	0
to	I-DISEASE
establish	0
whether	I-DISEASE
nightmares	0
are	0
associated	0
with	I-DISEASE
PTSD	I-DISEASE
or	0
ASD	0
because	I-DISEASE
the	0
evaluation	0
,	0
course	I-DISEASE
,	0
complications	0
,	I-DISEASE
and	0
treatment	0
differ	I-DISEASE
significantly	0
for	I-DISEASE
these	I-DISEASE
groups	0
.	0

Unresolved	I-DISEASE
Issues	0
and	0
Further	I-DISEASE
Directions	0

Basic	I-DISEASE
pathophysiologic	0
studies	I-DISEASE
are	0
still	0
needed	0
,	I-DISEASE
especially	I-DISEASE
studies	I-DISEASE
contrasting	0
“	0
idio-	I-DISEASE
pathic	0
”	I-DISEASE
nightmare	0
disorder	I-DISEASE
and	0
nightmares	I-DISEASE
associated	0
with	I-DISEASE
PTSD	0
.	0

In	I-DISEASE
particular	I-DISEASE
,	0
deter-	I-DISEASE
mining	I-DISEASE
whether	I-DISEASE
posttraumatic	B-DISEASE
nightmares	0
arise	I-DISEASE
from	I-DISEASE
sleep	0
or	I-DISEASE
primarily	I-DISEASE
from	I-DISEASE
wakeful-	0
ness	0
would	I-DISEASE
be	0
an	I-DISEASE
important	0
distinguishing	I-DISEASE
feature	I-DISEASE
particularly	0
when	I-DISEASE
determining	0
effec-	I-DISEASE
tive	0
clinical	I-DISEASE
interventions	I-DISEASE
.	0

The	I-DISEASE
PSG	0
correlates	I-DISEASE
of	I-DISEASE
nightmare	0
disorder	0
and	0
posttraumatic	0
nightmares	I-DISEASE
as	0
well	I-DISEASE
as	0
the	I-DISEASE
variables	0
affecting	0
dream	I-DISEASE
mentation	0
and	0
recall	I-DISEASE
require	I-DISEASE
further	0
definition	I-DISEASE
and	0
delineation	I-DISEASE
.	0

The	I-DISEASE
distinction	0
between	0
nightmares	0
and	0
sleep	0
terrors	0
is	0
difficult	0
when	0
assessed	I-DISEASE
only	I-DISEASE
by	I-DISEASE
questionnaires	0
.	0

It	I-DISEASE
still	I-DISEASE
remains	0
unclear	I-DISEASE
to	0
what	0
degree	I-DISEASE
and	0
level	0
of	I-DISEASE
complexity	I-DISEASE
sleep	I-DISEASE
mentation	I-DISEASE
is	0
associated	0
with	I-DISEASE
sleep	I-DISEASE
terrors	0
.	0

The	I-DISEASE
topic	0
of	I-DISEASE
NREM	0
sleep	0
dream	I-DISEASE
distur-	0
bances	I-DISEASE
(	0
other	I-DISEASE
than	I-DISEASE
disturbed	0
mentation	0
that	0
may	0
occur	I-DISEASE
with	I-DISEASE
sleep	0
terrors	I-DISEASE
)	0
also	0
needs	I-DISEASE
formal	I-DISEASE
investigation	I-DISEASE
,	0
including	0
whether	I-DISEASE
or	0
not	0
the	0
term	0
NREM	0
sleep	0
nightmare	0
should	I-DISEASE
be	I-DISEASE
utilized	I-DISEASE
.	0

The	I-DISEASE
optimal	0
methods	0
for	I-DISEASE
assessing	0
nightmare	0
frequency	I-DISEASE
and	0
nightmare	0
distress	0
are	0
still	I-DISEASE
unclear	I-DISEASE
.	0

Standardized	I-DISEASE
scales	0
assessing	I-DISEASE
nightmare	0
distress	I-DISEASE
should	I-DISEASE
be	I-DISEASE
developed	0
and	0
utilized	I-DISEASE
.	0

Retrospective	I-DISEASE
questionnaire	I-DISEASE
-	I-DISEASE
based	I-DISEASE
evaluations	I-DISEASE
of	I-DISEASE
nightmares	0
are	I-DISEASE
problematic	I-DISEASE
inasmuch	I-DISEASE
as	I-DISEASE
they	0
underestimate	0
nightmare	0
frequencies	0
relative	I-DISEASE
to	I-DISEASE
home	0
logs	I-DISEASE
,	I-DISEASE
whereas	I-DISEASE
home	I-DISEASE
logs	B-DISEASE
may	0
selectively	I-DISEASE
increase	I-DISEASE
recall	I-DISEASE
of	I-DISEASE
nightmares	I-DISEASE
.	0

Bibliography	0
Germain	0
A	0
,	I-DISEASE
Nielsen	I-DISEASE
T.	0
Sleep	0
pathophysiology	0
in	I-DISEASE
posttraumatic	0
stress	0
disorder	I-DISEASE
and	0
idiopathic	I-DISEASE
nightmare	I-DISEASE
sufferers	0
.	0

Biol	0
Psychiatry	0
2003;54:1092–8	0
.	0

Hobson	I-DISEASE
J.	0
REM	0
sleep	0
and	0
dreaming	0
:	0
towards	0
a	0
theory	I-DISEASE
of	I-DISEASE
protoconsciousness	0
.	0

Nat	I-DISEASE
Rev	I-DISEASE
Neurosci	0
2009;10:803–13	I-DISEASE
.	0

Hublin	I-DISEASE
C	0
,	I-DISEASE
Kaprio	0
J	0
,	0
Partinen	0
M	I-DISEASE
,	I-DISEASE
Koskenvuo	0
M.	0
Nightmares	I-DISEASE
:	0
familial	0
aggregation	0
and	0
association	0
with	B-DISEASE
psychiatric	0
disorders	0
in	I-DISEASE
a	0
nationwide	I-DISEASE
twin	0
cohort	0
.	0

Am	I-DISEASE
J	0
Med	0
Genet	0
1999;88:329–36	I-DISEASE
.	0

Lavie	I-DISEASE
P.	0
Sleep	0
disturbances	I-DISEASE
in	I-DISEASE
the	0
wake	0
of	I-DISEASE
traumatic	0
events	I-DISEASE
.	0

N	0
Engl	I-DISEASE
J	0
Med	I-DISEASE
2001;345:1825–32	I-DISEASE
.	0

Levin	I-DISEASE
R	I-DISEASE
,	0
Fireman	I-DISEASE
G.	I-DISEASE
Nightmare	I-DISEASE
prevalence	0
,	0
nightmare	0
distress	I-DISEASE
,	I-DISEASE
and	0
self	0
-	I-DISEASE
reported	I-DISEASE
psychological	I-DISEASE
disturbance	0
.	0

Sleep	I-DISEASE
2002;25:205–12	I-DISEASE
.	0

Muzur	I-DISEASE
A	0
,	0
Pace	I-DISEASE
-	I-DISEASE
Schott	I-DISEASE
EF	0
,	I-DISEASE
Hobson	I-DISEASE
J.	0
The	I-DISEASE
prefrontal	0
cortex	0
in	I-DISEASE
sleep	0
.	0

Trends	0
Cogn	0
Sci	0
2002;6:475–81	I-DISEASE
.	0

Nielsen	I-DISEASE
T	0
,	0
Zadra	I-DISEASE
A.	0
Idiopathic	0
nightmares	0
and	0
dream	I-DISEASE
disturbances	0
associated	0
with	I-DISEASE
sleep	0
-	0
wake	0
transitions	I-DISEASE
.	0

In	I-DISEASE
:	I-DISEASE
Kryger	0
MH	I-DISEASE
,	I-DISEASE
Roth	I-DISEASE
T	0
,	0
Dement	I-DISEASE
WC	I-DISEASE
,	0
eds	I-DISEASE
.	0

Principles	I-DISEASE
and	0
practice	0
of	I-DISEASE
sleep	0
medicine	0
,	I-DISEASE
5th	I-DISEASE
ed	0
.	0

Philadelphia	I-DISEASE
:	0
Elsevier	0
Saunders	0
,	0
2010:1106–15	I-DISEASE
.	0

Pagel	I-DISEASE
J	0
,	I-DISEASE
Helfter	0
P.	0
Drug	0
induced	0
nightmares	0
—	I-DISEASE
an	I-DISEASE
etiology	0
based	I-DISEASE
review	I-DISEASE
.	0

Hum	I-DISEASE
Psychopharmacol	0
2003;18:59–67	0
.	0

Zadra	I-DISEASE
A	0
,	0
Donderi	0
D.	0
Nightmares	I-DISEASE
and	0
bad	I-DISEASE
dreams	0
:	0
their	0
prevalence	I-DISEASE
and	0
relationship	0
to	I-DISEASE
well	I-DISEASE
-	0
being	I-DISEASE
.	0

J	I-DISEASE
Abnorm	0
Psychol	0
2000;109:273–81	I-DISEASE
.	0

Parasomnias	I-DISEASE
Parasomnias	0
Other	0
Parasomnias	0
Exploding	I-DISEASE
Head	B-DISEASE
Syndrome	0
ICD-9	0
-	0
CM	I-DISEASE
code	B-DISEASE
:	0
327.49	0
Alternate	0
Names	I-DISEASE
Sensory	0
sleep	0
starts	0
,	0
sensory	0
sleep	I-DISEASE
shocks	I-DISEASE
.	0

Diagnostic	I-DISEASE
Criteria	0
Criteria	I-DISEASE
A	0
-	I-DISEASE
C	I-DISEASE
must	I-DISEASE
be	0
met	0
ICD-10	0
-	0
CM	0
code	0
:	0

G47.59	I-DISEASE
A.	0
There	0
is	I-DISEASE
a	0
complaint	0
of	I-DISEASE
a	0
sudden	I-DISEASE
loud	I-DISEASE
noise	0
or	0
sense	I-DISEASE
of	I-DISEASE
explosion	0
in	0
the	0
head	I-DISEASE
either	I-DISEASE
at	I-DISEASE
the	0
wake	0
-	0
sleep	0
transition	0
or	I-DISEASE
upon	0
waking	0
during	I-DISEASE
the	B-DISEASE
night	I-DISEASE
.	0

B.	0
The	I-DISEASE
individual	I-DISEASE
experiences	0
abrupt	I-DISEASE
arousal	0
following	0
the	0
event	0
,	I-DISEASE
often	I-DISEASE
with	I-DISEASE
a	I-DISEASE
sense	I-DISEASE
of	I-DISEASE
fright	I-DISEASE
.	0

C.	I-DISEASE

The	I-DISEASE
experience	0
is	0
not	0
associated	0
with	I-DISEASE
significant	0
complaints	0
of	I-DISEASE
pain	0
.	0

Essential	I-DISEASE
Features	I-DISEASE
Exploding	I-DISEASE
head	I-DISEASE
syndrome	I-DISEASE
is	0
characterized	0
by	I-DISEASE
a	0
sudden	I-DISEASE
,	I-DISEASE
loud	0
imagined	I-DISEASE
noise	0
or	I-DISEASE
sense	0
of	0
a	0
violent	I-DISEASE
explosion	0
in	0
the	0
head	I-DISEASE
occurring	0
as	0
the	0
patient	I-DISEASE
is	I-DISEASE
falling	0
asleep	0
or	0
waking	0
during	I-DISEASE
the	0
night	0
.	0

The	I-DISEASE
event	0
is	0
variously	I-DISEASE
described	0
as	0
a	0
painless	0
loud	0
bang	0
,	I-DISEASE
an	I-DISEASE
explosion	0
,	0
a	0
clash	I-DISEASE
of	I-DISEASE
cymbals	0
,	0
or	0
a	0
bomb	I-DISEASE
exploding	0
,	I-DISEASE
but	0
occasionally	0
may	0
be	I-DISEASE
a	0
less	B-DISEASE
alarming	0
sound	I-DISEASE
.	0

It	I-DISEASE
is	I-DISEASE
usually	I-DISEASE
associated	0
with	0
a	0
sense	I-DISEASE
of	I-DISEASE
fright	0
,	0
and	0
many	0
patients	I-DISEASE
believe	0
they	0
are	I-DISEASE
having	I-DISEASE
a	0
stroke	0
.	0

In	I-DISEASE
a	0
minority	0
of	I-DISEASE
cases	0
a	0
flash	I-DISEASE
of	I-DISEASE
light	0
or	0
myoclonic	0
jerk	0
may	I-DISEASE
accompany	I-DISEASE
the	I-DISEASE
event	0
.	0

The	I-DISEASE
abnormal	0
sensation	0
lasts	I-DISEASE
a	0
few	0
seconds	0
and	0
may	0
recur	0
during	I-DISEASE
further	I-DISEASE
attempts	0
at	I-DISEASE
sleeping	0
.	0

The	I-DISEASE
number	0
of	I-DISEASE
attacks	I-DISEASE
varies	B-DISEASE
—	I-DISEASE
from	0
many	0
on	0
a	0
single	I-DISEASE
night	0
to	I-DISEASE
infrequent	I-DISEASE
—	I-DISEASE
with	0
some	0
patients	I-DISEASE
reporting	I-DISEASE
clustering	0
of	I-DISEASE
attacks	I-DISEASE
over	0
several	0
nights	0
fol-	I-DISEASE
lowed	0
by	I-DISEASE
a	0
gap	I-DISEASE
of	0
weeks	I-DISEASE
to	I-DISEASE
months	0
.	0

A	I-DISEASE
high	I-DISEASE
level	0
of	I-DISEASE
clinical	0
distress	I-DISEASE
can	I-DISEASE
be	I-DISEASE
associated	0
with	0
recurrent	B-DISEASE
attacks	I-DISEASE
,	I-DISEASE
with	0
concern	I-DISEASE
about	0
their	I-DISEASE
underlying	0
cause	0
.	0

Associated	I-DISEASE
Features	I-DISEASE
A	0
flash	I-DISEASE
of	0
light	0
may	0
accompany	I-DISEASE
the	0
sound	0
,	0
and	0
a	I-DISEASE
myoclonic	0
jerk	0
may	0
sometimes	0
occur	I-DISEASE
.	0

Although	I-DISEASE
the	0
event	0
is	0
typically	0
painless	0
,	I-DISEASE
a	0
simultaneous	0
stab	I-DISEASE
of	I-DISEASE
pain	I-DISEASE
in	I-DISEASE
the	0
head	I-DISEASE
has	I-DISEASE
occasionally	I-DISEASE
been	0
reported	0
.	0

An	0
insomnia	I-DISEASE
complaint	0
may	I-DISEASE
develop	0
as	I-DISEASE
a	0
result	0
of	I-DISEASE
the	0
recurring	I-DISEASE
arousals	I-DISEASE
and	0
anxiety	I-DISEASE
regarding	I-DISEASE
the	0
events	0
.	0

Clinical	I-DISEASE
or	I-DISEASE
Pathophysiological	I-DISEASE
Subtypes	I-DISEASE
None	I-DISEASE
known	I-DISEASE
.	I-DISEASE

Demographics	I-DISEASE
The	I-DISEASE
prevalence	I-DISEASE
is	I-DISEASE
unknown	I-DISEASE
.	0

Exploding	I-DISEASE
head	0
syndrome	I-DISEASE
is	I-DISEASE
reported	I-DISEASE
to	0
be	0
more	0
common	I-DISEASE
in	I-DISEASE
women	I-DISEASE
than	0
in	I-DISEASE
men	I-DISEASE
.	0

The	I-DISEASE
median	I-DISEASE
age	I-DISEASE
of	I-DISEASE
onset	0
is	I-DISEASE
58	I-DISEASE
years	I-DISEASE
,	0
but	0
onset	0
at	I-DISEASE
all	I-DISEASE
ages	I-DISEASE
has	0
been	I-DISEASE
reported	I-DISEASE
,	I-DISEASE
including	0
the	0
first	I-DISEASE
and	0
eighth	I-DISEASE
decades	0
.	0

Predisposing	I-DISEASE
and	0
Precipitating	I-DISEASE
Factors	0
Most	I-DISEASE
patients	I-DISEASE
do	I-DISEASE
not	0
detect	I-DISEASE
precipitating	0
factors	I-DISEASE
,	0
but	0
some	0
report	0
increased	0
numbers	I-DISEASE
of	I-DISEASE
attacks	0
when	0
under	0
personal	0
stress	0
or	0
overtired	0
.	0

Familial	I-DISEASE
Pattern	I-DISEASE
Occasional	I-DISEASE
cases	0
of	I-DISEASE
exploding	0
head	I-DISEASE
syndrome	I-DISEASE
occurring	I-DISEASE
in	0
the	0
same	B-DISEASE
family	I-DISEASE
have	0
been	0
reported	I-DISEASE
,	0
although	0
it	0
is	0
not	0
clear	0
whether	I-DISEASE
this	0
represents	I-DISEASE
a	I-DISEASE
true	B-DISEASE
familial	0
pattern	0
.	0

Onset	I-DISEASE
,	0
Course	0
,	0
and	0
Complication	0
The	I-DISEASE
course	I-DISEASE
is	I-DISEASE
benign	I-DISEASE
with	0
no	0
reported	I-DISEASE
neurologic	I-DISEASE
sequelae	0
.	0

Frequent	I-DISEASE
events	0
on	0
a	0
single	0
night	I-DISEASE
can	0
result	0
in	0
insomnia	I-DISEASE
.	0

Clinical	I-DISEASE
levels	I-DISEASE
of	I-DISEASE
anxiety	I-DISEASE
may	0
result	0
from	0
patient	I-DISEASE
concern	I-DISEASE
about	0
a	0
serious	0
medical	I-DISEASE
basis	I-DISEASE
for	0
the	0
exploding	0
head	I-DISEASE
syndrome	0
.	0

The	I-DISEASE
condition	0
may	0
also	0
exacerbate	0
a	0
comorbid	0
migraine	I-DISEASE
disorder	I-DISEASE
.	0

In	I-DISEASE
many	0
patients	0
,	I-DISEASE
the	0
symptoms	I-DISEASE
appear	0
to	I-DISEASE
remit	0
spontaneously	I-DISEASE
over	I-DISEASE
some	I-DISEASE
years	0
.	0

Developmental	I-DISEASE
Issues	0
Not	I-DISEASE
known	0
or	I-DISEASE
applicable	0
.	I-DISEASE

Pathology	I-DISEASE
and	0
Pathophysiology	I-DISEASE
The	I-DISEASE
events	0
occur	0
most	0
frequently	I-DISEASE
during	I-DISEASE
a	0
period	0
of	I-DISEASE
drowsiness	I-DISEASE
preceding	I-DISEASE
sleep	0
.	0

Some	I-DISEASE
events	0
are	0
reported	I-DISEASE
to	0
occur	I-DISEASE
upon	I-DISEASE
waking	0
during	I-DISEASE
the	0
night	0
,	I-DISEASE
but	I-DISEASE
may	I-DISEASE
actually	B-DISEASE
be	0
occur-	I-DISEASE
ring	0
during	I-DISEASE
reinitiating	B-DISEASE
sleep	0
.	0

The	I-DISEASE
condition	0
appears	0
to	I-DISEASE
be	0
a	0
sensory	I-DISEASE
variant	I-DISEASE
of	I-DISEASE
the	0
better	0
-	I-DISEASE
known	I-DISEASE
transient	0
motor	I-DISEASE
phenomenon	0
of	I-DISEASE
sleep	0
starts	0
or	I-DISEASE
hypnic	0
jerks	0
occurring	0
at	I-DISEASE
wake	0
-	0
sleep	0
transition	0
.	B-DISEASE

The	I-DISEASE
neurophysiologic	I-DISEASE
mechanisms	I-DISEASE
underlying	0
these	0
hypnago-	0
gic	0
phenomena	0
are	0
unknown	I-DISEASE
.	0

Objective	I-DISEASE
Findings	I-DISEASE
VPSG	I-DISEASE
in	0
a	0
small	0
sample	0
of	I-DISEASE
patients	I-DISEASE
found	0
that	0
events	0
arose	0
from	0
early	0
drowsiness	0
with	I-DISEASE
predominant	0
alpha	I-DISEASE
rhythm	0
interspersed	I-DISEASE
with	I-DISEASE
some	I-DISEASE
theta	0
activity	0
.	0

In	I-DISEASE
one	0
patient	I-DISEASE
,	I-DISEASE
events	0
arose	0
during	I-DISEASE
transition	I-DISEASE
from	0
N1	0
sleep	0
,	I-DISEASE
in	I-DISEASE
another	I-DISEASE
patient	I-DISEASE
from	I-DISEASE
N1	0
sleep	0
to	I-DISEASE
wakeful-	0
ness	0
,	0
and	0
in	I-DISEASE
a	I-DISEASE
third	I-DISEASE
patient	I-DISEASE
from	0
N2	0
sleep	0
to	I-DISEASE
wakefulness	0
.	0

Events	I-DISEASE
occurring	0
in	0
the	0
N1/	0
Parasomnias	I-DISEASE
Parasomnias	I-DISEASE
N2	0
to	0
wake	0
transition	0
have	0
been	I-DISEASE
recorded	0
during	I-DISEASE
both	0
nocturnal	0
vPSG	I-DISEASE
and	0
MSLTs	I-DISEASE
.	0

Slow	I-DISEASE
eye	0
movements	0
were	I-DISEASE
present	0
in	I-DISEASE
the	0
only	I-DISEASE
tracing	0
reproduced	0
in	I-DISEASE
the	0
report	I-DISEASE
of	I-DISEASE
a	0
patient	I-DISEASE
with	I-DISEASE
exploding	I-DISEASE
head	0
syndrome	0
emerging	I-DISEASE
during	I-DISEASE
wake	0
to	0
N1	0
sleep	0
transition	I-DISEASE
.	0

Arousals	I-DISEASE
occurred	I-DISEASE
immediately	I-DISEASE
following	0
the	I-DISEASE
episodes	I-DISEASE
.	0

No	0
epileptiform	0
discharges	0
accompany	I-DISEASE
the	0
event	0
.	0

Differential	I-DISEASE
Diagnosis	0
Exploding	I-DISEASE
head	0
syndrome	I-DISEASE
should	I-DISEASE
be	I-DISEASE
distinguished	I-DISEASE
from	0
sudden	0
onset	0
-	I-DISEASE
headache	0
syn-	0
dromes	0
.	0

“	I-DISEASE
Idiopathic	0
stabbing	0
headache	I-DISEASE
”	I-DISEASE
(	I-DISEASE
ice	0
-	0
pick	0
headache	I-DISEASE
)	I-DISEASE
is	I-DISEASE
a	0
benign	I-DISEASE
syndrome	I-DISEASE
of	0
brief	I-DISEASE
stabs	I-DISEASE
of	I-DISEASE
pain	0
on	0
the	I-DISEASE
side	0
of	I-DISEASE
the	0
head	I-DISEASE
.	0

Although	I-DISEASE
they	I-DISEASE
can	0
occur	I-DISEASE
at	I-DISEASE
sleep	0
onset	I-DISEASE
,	I-DISEASE
they	B-DISEASE
are	0
more	0
common	I-DISEASE
during	I-DISEASE
wakefulness	0
.	0

“	I-DISEASE
Thunderclap	I-DISEASE
headache	0
”	I-DISEASE
is	I-DISEASE
a	I-DISEASE
very	I-DISEASE
severe	0
sudden	0
onset	I-DISEASE
headache	I-DISEASE
characteristic	I-DISEASE
of	I-DISEASE
subarachnoid	I-DISEASE
hemorrhage	I-DISEASE
but	0
also	0
resulting	0
from	I-DISEASE
other	0
causes	I-DISEASE
and	0
occasionally	0
occurring	0
as	0
a	0
benign	0
symptom	0
.	0

It	I-DISEASE
does	I-DISEASE
not	0
usually	I-DISEASE
occur	0
at	I-DISEASE
sleep	I-DISEASE
onset	I-DISEASE
.	0

“	I-DISEASE
Hypnic	I-DISEASE
headache	I-DISEASE
syndrome	0
”	I-DISEASE
affects	0
older	0
people	0
who	I-DISEASE
regularly	I-DISEASE
awaken	0
4	0
-	I-DISEASE
6	I-DISEASE
hours	I-DISEASE
after	0
sleep	0
onset	0
,	0
with	I-DISEASE
a	0
diffuse	I-DISEASE
headache	0
that	0
lasts	I-DISEASE
30	I-DISEASE
-	0
60	0
minutes	0
and	0
is	0
often	0
associated	0
with	I-DISEASE
nausea	0
but	0
no	0
autonomic	0
symptoms	I-DISEASE
.	0

Other	0
conditions	I-DISEASE
to	0
be	I-DISEASE
con-	0
sidered	0
include	0
sleep	0
related	B-DISEASE
migraines	0
,	0
cluster	0
headaches	0
,	0
and	0
nocturnal	0
paroxysmal	0
hemicrania	0
.	0

In	I-DISEASE
contrast	I-DISEASE
to	0
headache	I-DISEASE
syndromes	0
,	0
exploding	0
head	0
syndrome	0
is	0
usually	I-DISEASE
painless	I-DISEASE
.	0

Simple	I-DISEASE
partial	I-DISEASE
seizures	0
can	0
present	I-DISEASE
with	I-DISEASE
sensory	I-DISEASE
phenomena	0
but	0
do	I-DISEASE
not	0
usually	I-DISEASE
occur	I-DISEASE
predominantly	B-DISEASE
at	I-DISEASE
sleep	0
onset	I-DISEASE
.	0

Nocturnal	I-DISEASE
panic	0
attacks	I-DISEASE
can	0
waken	0
a	I-DISEASE
person	0
from	0
sleep	0
,	I-DISEASE
but	I-DISEASE
are	I-DISEASE
not	0
usually	I-DISEASE
associated	0
with	I-DISEASE
a	0
sense	0
of	I-DISEASE
noise	0
or	0
explosion	0
.	0

Recurrent	I-DISEASE
night-	0
mares	0
are	0
characterized	0
by	0
recall	0
of	I-DISEASE
more	0
complex	I-DISEASE
and	0
longer	0
-	0
lasting	0
visual	I-DISEASE
imagery	0
.	0

Sleep	I-DISEASE
starts	I-DISEASE
occur	0
at	I-DISEASE
wake	0
-	I-DISEASE
sleep	0
transition	I-DISEASE
but	0
are	0
predominantly	I-DISEASE
a	0
motor	I-DISEASE
phenomenon	0
with	0
sudden	0
myoclonic	0
jerks	0
rather	0
than	0
an	0
emphasis	I-DISEASE
on	0
sensory	0
symptoms	I-DISEASE
.	0

Unresolved	I-DISEASE
Issues	0
and	0
Future	0
Directions	0

The	I-DISEASE
neurophysiologic	0
basis	I-DISEASE
of	0
these	0
events	0
requires	I-DISEASE
further	I-DISEASE
study	0
.	0

Bibliography	0
Chakravarty	I-DISEASE
A.	0
Exploding	I-DISEASE
head	I-DISEASE
syndrome	0
:	0
report	0
of	I-DISEASE
two	0
new	0
cases	0
.	0

Cephalalgia	0
2008;28:399–400	0
.	0

Evans	I-DISEASE
RW	I-DISEASE
.	I-DISEASE

Exploding	I-DISEASE
head	0
syndrome	I-DISEASE
followed	0
by	I-DISEASE
sleep	0
paralysis	0
:	0
a	I-DISEASE
rare	I-DISEASE
migraine	0
aura	0
.	0

Headache	I-DISEASE
2006;46:682–3	0
.	0

Kallweit	I-DISEASE
U	0
,	I-DISEASE
Khatami	0
R	0
,	0
Bassetti	I-DISEASE
CL	I-DISEASE
.	0

Exploding	I-DISEASE
head	0
syndrome	I-DISEASE
-	0
more	0
than	0
“	0
snapping	I-DISEASE
of	I-DISEASE
the	I-DISEASE
brain	I-DISEASE
”	I-DISEASE
?	0

Sleep	I-DISEASE
Med	I-DISEASE
2008;9:589	I-DISEASE
.	0

Palikh	I-DISEASE
GM	I-DISEASE
,	0
Vaughn	I-DISEASE
BV	0
.	0

Topiramate	I-DISEASE
responsive	I-DISEASE
exploding	I-DISEASE
head	I-DISEASE
syndrome	0
.	0

J	I-DISEASE
Clin	0
Sleep	0
Med	0
2010;6:382–3	I-DISEASE
.	0

Pearce	I-DISEASE
JM	I-DISEASE
.	I-DISEASE

Clinical	I-DISEASE
features	I-DISEASE
of	I-DISEASE
the	0
exploding	0
head	I-DISEASE
syndrome	I-DISEASE
.	0

J	I-DISEASE
Neurol	0
Neurosurg	0
Psychiatry	0
1989;52:907–10	I-DISEASE
.	0

Sachs	I-DISEASE
C	I-DISEASE
,	0
Svanborg	I-DISEASE
E.	0

The	I-DISEASE
exploding	0
head	0
syndrome	I-DISEASE
:	0
polysomnographic	0
recordings	0
and	0
therapeutic	I-DISEASE
suggestions	0
.	0

Sleep	I-DISEASE
1991;14:263–6	0
.	0

Sleep	I-DISEASE
Related	0
Hallucinations	0
ICD-9	0
-	I-DISEASE
CM	I-DISEASE
code	0
:	0
368.16	I-DISEASE
ICD-10	0
-	0
CM	I-DISEASE
code	0
:	0

H53.16	I-DISEASE
Alternate	0
Names	I-DISEASE
Hypnagogic	I-DISEASE
hallucinations	I-DISEASE
,	I-DISEASE
hypnopompic	I-DISEASE
hallucinations	0
,	0
complex	0
nocturnal	0
visual	I-DISEASE
hallucinations	I-DISEASE
.	0

Diagnostic	I-DISEASE
Criteria	0
Criteria	I-DISEASE
A	0
-	I-DISEASE
C	I-DISEASE
must	I-DISEASE
be	0
met	0
A.	0

There	I-DISEASE
is	I-DISEASE
a	0
complaint	I-DISEASE
of	0
recurrent	I-DISEASE
hallucinations	I-DISEASE
that	0
are	I-DISEASE
experienced	I-DISEASE
just	I-DISEASE
prior	0
to	I-DISEASE
sleep	I-DISEASE
onset	0
or	0
upon	I-DISEASE
awakening	0
during	I-DISEASE
the	0
night	I-DISEASE
or	0
in	I-DISEASE
the	0
morning	0
.	0

B.	0
The	I-DISEASE
hallucinations	I-DISEASE
are	0
predominantly	B-DISEASE
visual	I-DISEASE
.	0

C.	I-DISEASE

The	I-DISEASE
disturbance	I-DISEASE
is	0
not	0
better	0
explained	I-DISEASE
by	I-DISEASE
another	I-DISEASE
sleep	0
disorder	0
(	I-DISEASE
especially	0
narcolepsy	I-DISEASE
)	0
,	I-DISEASE
mental	0
disorder	0
,	I-DISEASE
medical	0
disorder	I-DISEASE
,	0
medication	0
,	I-DISEASE
or	0
substance	I-DISEASE
use	0
.	0

Essential	I-DISEASE
Features	I-DISEASE
Sleep	I-DISEASE
related	I-DISEASE
hallucinations	0
are	0
hallucinatory	0
experiences	I-DISEASE
that	0
occur	I-DISEASE
at	I-DISEASE
sleep	I-DISEASE
onset	0
or	0
on	0
awakening	0
from	0
sleep	0
.	I-DISEASE

Sleep	I-DISEASE
related	I-DISEASE
hallucinations	0
are	0
predominantly	I-DISEASE
visual	0
but	0
may	I-DISEASE
include	I-DISEASE
auditory	I-DISEASE
,	0
tactile	0
,	0
or	0
kinetic	0
phenomena	0
.	0

Hallucinations	I-DISEASE
at	I-DISEASE
sleep	0
onset	I-DISEASE
(	I-DISEASE
hypnagogic	0
hallucinations	B-DISEASE
)	0
may	0
be	I-DISEASE
difficult	0
to	0
differentiate	B-DISEASE
from	I-DISEASE
sleep	I-DISEASE
onset	0
dream-	I-DISEASE
ing	0
.	0

Hallucinations	I-DISEASE
on	0
waking	0
in	I-DISEASE
the	B-DISEASE
morning	0
(	0
hypnopompic	0
hallucinations	I-DISEASE
)	0
may	0
arise	I-DISEASE
out	0
of	I-DISEASE
a	0
period	I-DISEASE
of	I-DISEASE
REM	I-DISEASE
sleep	0
,	0
and	0
patients	I-DISEASE
also	0
may	0
be	0
uncertain	0
whether	0
they	0
rep-	0
resent	0
waking	0
or	0
dream	I-DISEASE
-	0
related	0
experiences	0
.	0

Complex	I-DISEASE
nocturnal	0
visual	I-DISEASE
hallucinations	0
may	0
represent	0
a	0
distinct	0
form	I-DISEASE
of	I-DISEASE
sleep	0
related	0
hallucinations	I-DISEASE
.	0

They	I-DISEASE
typically	0
occur	0
fol-	I-DISEASE
lowing	0
a	0
sudden	0
awakening	0
,	I-DISEASE
without	0
recall	I-DISEASE
of	I-DISEASE
a	I-DISEASE
preceding	I-DISEASE
dream	0
.	0

They	I-DISEASE
usually	I-DISEASE
take	0
the	0
form	0
of	I-DISEASE
complex	0
,	I-DISEASE
vivid	0
,	0
relatively	0
immobile	I-DISEASE
images	I-DISEASE
of	I-DISEASE
people	0
or	I-DISEASE
animals	I-DISEASE
,	0
sometimes	0
distorted	I-DISEASE
in	I-DISEASE
shape	I-DISEASE
or	I-DISEASE
size	0
.	0

These	0
hallucinations	I-DISEASE
may	I-DISEASE
remain	0
present	I-DISEASE
for	0
many	0
minutes	0
but	I-DISEASE
usually	I-DISEASE
disappear	I-DISEASE
if	0
ambient	0
illumination	I-DISEASE
is	I-DISEASE
increased	0
.	0

Patients	I-DISEASE
are	0
clearly	I-DISEASE
awake	0
but	I-DISEASE
often	0
initially	I-DISEASE
perceive	0
the	0
hallucinations	I-DISEASE
as	0
real	I-DISEASE
and	0
frightening	I-DISEASE
.	0

Associated	I-DISEASE
Features	I-DISEASE
Sleep	0
related	0
hallucinations	0
may	0
be	0
associated	0
with	I-DISEASE
episodes	I-DISEASE
of	I-DISEASE
sleep	0
paralysis	I-DISEASE
,	I-DISEASE
either	0
at	I-DISEASE
the	0
same	0
time	0
or	B-DISEASE
on	0
different	I-DISEASE
nights	0
.	I-DISEASE

Patients	I-DISEASE
with	0
complex	B-DISEASE
nocturnal	0
visual	I-DISEASE
hal-	0
lucinations	0
may	0
jump	I-DISEASE
out	0
of	I-DISEASE
the	0
bed	0
in	I-DISEASE
terror	0
,	0
sometimes	0
injuring	I-DISEASE
themselves	I-DISEASE
.	0

Some	I-DISEASE
patients	0
may	0
experience	0
other	0
parasomnias	I-DISEASE
,	0
such	0
as	I-DISEASE
sleep	0
talking	0
or	0
sleepwalking	0
,	0
sep-	I-DISEASE
arate	0
from	I-DISEASE
the	0
hallucinations	I-DISEASE
;	I-DISEASE
some	0
patients	0
may	I-DISEASE
also	0
experience	0
similar	0
complex	0
hal-	0
lucinations	0
during	I-DISEASE
the	0
day	0
,	0
unassociated	0
with	0
sleep	0
.	0

Parasomnias	I-DISEASE
Parasomnias	0
Clinical	0
and	0
Pathophysiological	I-DISEASE
Subtypes	I-DISEASE
Dream	0
-	0
like	0
hypnagogic	0
and	0
hypnopompic	0
hallucinations	0
appear	0
to	0
differ	0
in	I-DISEASE
clini-	I-DISEASE
cal	0
features	0
and	0
pathogenesis	0
from	0
complex	0
nocturnal	0
visual	I-DISEASE
hallucinations	0
arising	0
in	I-DISEASE
wakefulness	0
after	0
sudden	0
arousals	0
during	I-DISEASE
the	0
night	0
.	0

Sleep	I-DISEASE
related	I-DISEASE
hallucinations	0
are	0
common	I-DISEASE
in	0
narcolepsy	0
and	0
also	0
occur	0
as	0
occasional	I-DISEASE
phenomena	0
in	0
a	0
high	I-DISEASE
per-	0
centage	0
of	0
the	0
general	0
population	0
.	0

In	I-DISEASE
contrast	I-DISEASE
,	0
complex	B-DISEASE
nocturnal	0
visual	I-DISEASE
hallucina-	I-DISEASE
tions	0
appear	I-DISEASE
to	0
be	0
rare	I-DISEASE
and	0
occur	0
in	0
the	0
setting	0
of	I-DISEASE
a	0
range	0
of	I-DISEASE
neurologic	0
and	0
visual	I-DISEASE
disorders	0
(	I-DISEASE
see	I-DISEASE
Differential	I-DISEASE
Diagnosis	0
)	0
as	0
well	0
as	0
in	I-DISEASE
an	0
idiopathic	I-DISEASE
form	0
.	0

However	I-DISEASE
,	I-DISEASE
further	0
work	I-DISEASE
is	0
needed	0
to	I-DISEASE
establish	I-DISEASE
whether	0
or	0
not	0
these	I-DISEASE
forms	I-DISEASE
of	I-DISEASE
hallucinations	0
represent	0
different	0
entities	0
.	0

Demographics	I-DISEASE
In	0
large	I-DISEASE
European	0
population	0
studies	I-DISEASE
,	0
sleep	0
related	0
hallucinations	I-DISEASE
have	0
been	I-DISEASE
reported	0
to	0
occur	I-DISEASE
with	0
a	0
prevalence	0
of	I-DISEASE
25	0
%	0
to	I-DISEASE
37	I-DISEASE
%	0
for	I-DISEASE
hypnagogic	I-DISEASE
hallucinations	0
,	0
whereas	0
the	0
equivalent	I-DISEASE
reported	I-DISEASE
prevalence	I-DISEASE
for	I-DISEASE
hypnopompic	I-DISEASE
hallucinations	I-DISEASE
is	0
7	0
%	0
to	I-DISEASE
13	0
%	0
.	0

Both	I-DISEASE
hypnagogic	I-DISEASE
and	0
hypnopompic	0
hallucinations	I-DISEASE
are	0
more	0
common	I-DISEASE
in	I-DISEASE
younger	0
persons	0
and	0
occur	0
slightly	I-DISEASE
more	0
frequently	I-DISEASE
in	I-DISEASE
women	I-DISEASE
than	0
in	I-DISEASE
men	0
.	0

Predisposing	I-DISEASE
and	0
Precipitating	I-DISEASE
Factors	0
Multivariate	0
analyses	0
in	I-DISEASE
large	I-DISEASE
population	0
studies	0
have	0
suggested	0
that	0
sleep	0
related	0
hal-	0
lucinations	0
are	I-DISEASE
associated	0
with	0
younger	0
age	I-DISEASE
,	0
current	0
drug	0
use	0
,	0
past	I-DISEASE
alcohol	0
use	0
,	I-DISEASE
anxiety	0
,	I-DISEASE
mood	0
disorder	I-DISEASE
,	0
sleep	0
onset	0
insomnia	0
,	0
and	0
perceived	0
insufficient	0
sleep	0
.	0

Familial	I-DISEASE
Pattern	I-DISEASE
Not	I-DISEASE
applicable	0
or	I-DISEASE
known	0
.	0

Onset	I-DISEASE
,	0
Course	0
,	0
and	0
Complications	0
Sleep	0
related	I-DISEASE
hallucinations	I-DISEASE
appear	I-DISEASE
to	I-DISEASE
be	0
more	0
common	I-DISEASE
in	I-DISEASE
adolescence	I-DISEASE
and	0
early	0
adult-	0
hood	I-DISEASE
.	0

In	I-DISEASE
many	0
patients	0
,	I-DISEASE
the	0
frequency	I-DISEASE
appears	0
to	I-DISEASE
decrease	0
with	0
age	I-DISEASE
.	0

The	I-DISEASE
natural	I-DISEASE
history	I-DISEASE
of	I-DISEASE
complex	0
nocturnal	0
visual	I-DISEASE
hallucinations	0
depends	I-DISEASE
on	0
the	0
underlying	0
cause	I-DISEASE
.	0

Developmental	I-DISEASE
Issues	0
Not	I-DISEASE
known	0
or	I-DISEASE
applicable	0
.	I-DISEASE

Pathology	I-DISEASE
and	0
Pathophysiology	I-DISEASE
It	0
is	0
presumed	0
that	0
most	I-DISEASE
sleep	I-DISEASE
related	0
hallucinations	I-DISEASE
are	0
due	I-DISEASE
to	0
dream	I-DISEASE
ideation	0
of	I-DISEASE
REM	0
sleep	0
intruding	I-DISEASE
into	I-DISEASE
wakefulness	0
,	I-DISEASE
but	I-DISEASE
this	0
has	0
not	0
been	0
firmly	I-DISEASE
established	0
.	0

Infrequent	I-DISEASE
hallucinations	0
of	I-DISEASE
this	0
type	I-DISEASE
may	I-DISEASE
be	I-DISEASE
within	I-DISEASE
the	0
limits	0
of	I-DISEASE
normal	0
sleep	0
-	0
wake	0
transition	0
.	0

Complex	I-DISEASE
nocturnal	0
visual	I-DISEASE
hallucinations	0
may	0
in	0
some	I-DISEASE
cases	0
be	I-DISEASE
release	I-DISEASE
phenomena	B-DISEASE
in	I-DISEASE
which	0
loss	I-DISEASE
of	0
visual	0
input	I-DISEASE
or	0
decreased	I-DISEASE
reticular	B-DISEASE
activating	0
system	0
activity	0
results	I-DISEASE
in	I-DISEASE
the	0
visual	I-DISEASE
cortex	I-DISEASE
generating	0
aberrant	0
images	0
.	0

Objective	I-DISEASE
Findings	I-DISEASE
Hypnagogic	I-DISEASE
hallucinations	I-DISEASE
appear	I-DISEASE
to	I-DISEASE
arise	I-DISEASE
predominantly	0
from	0
sleep	0
onset	I-DISEASE
REM	I-DISEASE
periods	I-DISEASE
.	0

However	I-DISEASE
,	I-DISEASE
the	0
very	I-DISEASE
few	0
reports	I-DISEASE
of	I-DISEASE
polysomnography	0
in	I-DISEASE
complex	0
nocturnal	0
visual	I-DISEASE
hallucinations	0
suggest	0
an	0
onset	0
from	I-DISEASE
NREM	0
sleep	0
.	0

MRI	I-DISEASE
scans	0
of	0
the	0
brain	0
,	I-DISEASE
PSG	0
,	0
EEG	0
,	I-DISEASE
and	0
neuropsychological	0
testing	0
may	0
help	0
in	I-DISEASE
the	0
differential	I-DISEASE
diagnosis	0
and	0
in	I-DISEASE
identifying	0
underlying	0
disorders	0
.	0

Differential	I-DISEASE
Diagnosis	0
Nightmares	I-DISEASE
are	I-DISEASE
frightening	I-DISEASE
dreams	0
awakening	0
the	I-DISEASE
patient	I-DISEASE
from	0
sleep	0
.	0

They	I-DISEASE
are	0
clearly	0
recognized	0
as	0
dreams	I-DISEASE
and	0
do	I-DISEASE
not	0
persist	0
into	I-DISEASE
wakefulness	I-DISEASE
.	0

Exploding	I-DISEASE
head	0
syndrome	I-DISEASE
consists	I-DISEASE
of	I-DISEASE
a	0
sudden	0
sensation	0
of	I-DISEASE
an	I-DISEASE
explosion	0
in	0
the	0
head	I-DISEASE
,	I-DISEASE
usually	0
at	I-DISEASE
sleep	0
onset	0
and	0
sometimes	0
accompanied	I-DISEASE
by	I-DISEASE
a	0
noise	0
or	0
flash	I-DISEASE
of	I-DISEASE
light	0
.	0

It	I-DISEASE
does	0
not	0
involve	0
complex	0
visual	I-DISEASE
imagery	I-DISEASE
and	0
lasts	0
only	0
seconds	0
.	0

In	I-DISEASE
RBD	I-DISEASE
,	I-DISEASE
the	0
patient	I-DISEASE
acts	I-DISEASE
out	0
dreams	0
during	I-DISEASE
REM	I-DISEASE
sleep	I-DISEASE
.	I-DISEASE

If	I-DISEASE
not	0
awakened	I-DISEASE
by	I-DISEASE
an	0
observer	0
,	I-DISEASE
the	B-DISEASE
person	0
usually	I-DISEASE
has	0
little	0
recollection	I-DISEASE
of	I-DISEASE
dream	I-DISEASE
content	0
.	0

Sleepwalking	I-DISEASE
may	I-DISEASE
occasionally	0
be	I-DISEASE
associated	0
with	I-DISEASE
dream	I-DISEASE
ideation	0
,	I-DISEASE
but	I-DISEASE
the	0
patient	I-DISEASE
recognizes	I-DISEASE
that	0
the	I-DISEASE
dream	0
occurred	0
during	I-DISEASE
sleep	0
.	0

Visual	I-DISEASE
hallucinations	I-DISEASE
can	0
be	I-DISEASE
due	I-DISEASE
to	0
epileptic	0
seizures	I-DISEASE
but	0
are	0
usually	I-DISEASE
brief	I-DISEASE
,	0
stereotyped	0
,	I-DISEASE
and	0
fragmentary	0
in	0
such	0
cases	0
.	0

Occasionally	I-DISEASE
,	I-DISEASE
complex	B-DISEASE
visual	I-DISEASE
hallucinations	0
may	0
be	0
associated	0
with	I-DISEASE
migraine	I-DISEASE
but	I-DISEASE
are	I-DISEASE
usually	I-DISEASE
followed	0
by	0
a	0
headache	0
.	0

Complex	I-DISEASE
nocturnal	0
visual	I-DISEASE
hallucinations	0
may	0
be	0
seen	I-DISEASE
in	I-DISEASE
patients	I-DISEASE
with	I-DISEASE
narcolepsy	0
,	0
PD	0
,	0
DLB	I-DISEASE
,	0
visual	I-DISEASE
loss	I-DISEASE
(	0
Charles	I-DISEASE
Bonnet	0
hallucinations	I-DISEASE
)	0
,	0
and	0
midbrain	0
and	0
diencephalic	I-DISEASE
pathology	0
(	I-DISEASE
peduncular	0
hallucinosis	0
)	0
,	I-DISEASE
as	0
well	I-DISEASE
as	0
with	0
the	I-DISEASE
use	I-DISEASE
of	I-DISEASE
β	0
-	0
adrenergic	0
receptor-	I-DISEASE
blocking	0
medications	0
.	0

Anxiety	0
disorders	0
have	0
been	I-DISEASE
noted	0
in	I-DISEASE
some	0
patients	0
.	0

Unresolved	I-DISEASE
Issues	0
and	0
Further	I-DISEASE
Directions	0

In	I-DISEASE
contrast	I-DISEASE
to	0
the	0
extensive	0
study	I-DISEASE
of	I-DISEASE
sleep	I-DISEASE
paralysis	I-DISEASE
,	I-DISEASE
little	0
work	I-DISEASE
has	I-DISEASE
been	I-DISEASE
reported	0
on	0
sleep	I-DISEASE
related	0
hallucinations	I-DISEASE
.	0

It	I-DISEASE
is	0
uncertain	0
whether	I-DISEASE
they	0
represent	0
normal	0
variants	0
or	0
pathologic	0
entities	I-DISEASE
.	0

It	I-DISEASE
is	I-DISEASE
unclear	0
whether	I-DISEASE
they	0
are	0
always	0
associated	0
with	0
REM	0
sleep	0
intruding	I-DISEASE
into	I-DISEASE
wakefulness	0
.	0

It	I-DISEASE
is	I-DISEASE
uncertain	0
how	0
frequently	0
complex	0
nocturnal	0
visual	0
hallucinations	0
are	I-DISEASE
an	0
independent	I-DISEASE
entity	I-DISEASE
,	I-DISEASE
as	0
opposed	0
to	I-DISEASE
representing	0
a	0
final	0
common	I-DISEASE
pathway	0
of	0
a	0
range	0
of	I-DISEASE
other	0
disorders	0
.	0

Further	I-DISEASE
work	I-DISEASE
is	0
needed	0
to	0
determine	0
from	0
which	0
stages	0
of	I-DISEASE
sleep	0
they	I-DISEASE
arise	I-DISEASE
.	0

Parasomnias	I-DISEASE
Parasomnias	0
Bibliography	0
Barnes	0
J	0
,	0
David	0
AS	I-DISEASE
.	0

Visual	I-DISEASE
hallucinations	I-DISEASE
in	I-DISEASE
Parkinson	0
’s	I-DISEASE
disease	0
:	0
a	0
review	I-DISEASE
and	0
phenomenological	0
survey	0
.	0

J	I-DISEASE
Neurol	0
Neurosurg	0
Psychiatry	0
2001;70:727–33	I-DISEASE
.	0

Kavey	I-DISEASE
N	0
,	I-DISEASE
Whyte	0
J.	0
Somnambulism	0
associated	0
with	0
hallucinations	I-DISEASE
.	0

Psychosomatics	0
1993;34:86–90	0
.	0

Mahowald	I-DISEASE
M	I-DISEASE
,	0
Woods	I-DISEASE
S	I-DISEASE
,	I-DISEASE
Schenck	0
C.	0
Sleeping	I-DISEASE
dreams	0
,	I-DISEASE
waking	0
hallucinations	I-DISEASE
,	0
and	0
the	0
central	0
nervous	I-DISEASE
system	0
.	I-DISEASE

Dreaming	I-DISEASE
1998;8:89–102	0
.	0

Manford	I-DISEASE
M	I-DISEASE
,	I-DISEASE
Andermann	0
F.	I-DISEASE
Complex	0
visual	I-DISEASE
hallucinations	I-DISEASE
.	0

Clinical	I-DISEASE
and	0
neurobiological	0
insights	0
.	0

Brain	0
1998;121:1819–40	0
.	0

Ohayon	I-DISEASE
M.	I-DISEASE
Prevalence	I-DISEASE
of	I-DISEASE
hallucinations	0
and	0
their	I-DISEASE
pathological	0
associations	I-DISEASE
in	I-DISEASE
the	0
general	0
population	0
.	0

Psychiatry	0
Res	0
2000;97:153–64	I-DISEASE
.	0

Ohayon	I-DISEASE
M	I-DISEASE
,	0
Priest	I-DISEASE
R	I-DISEASE
,	I-DISEASE
Caulet	0
M	I-DISEASE
,	I-DISEASE
Guilleminault	I-DISEASE
C.	0
Hypnagogic	I-DISEASE
and	0
hypnopompic	I-DISEASE
hallucinations	I-DISEASE
:	0
pathological	0
phenomena	0
?	0

Br	0
J	0
Psychiatry	0
1996;169:459–67	0
.	0

Silber	I-DISEASE
MH	I-DISEASE
,	I-DISEASE
Hansen	I-DISEASE
M	I-DISEASE
,	0
Girish	I-DISEASE
M.	I-DISEASE
Complex	0
nocturnal	0
visual	I-DISEASE
hallucinations	0
.	0

Sleep	I-DISEASE
Med	I-DISEASE
2005;6:363–6	I-DISEASE
.	0

Sleep	I-DISEASE
Enuresis	I-DISEASE
ICD-9	0
-	0
CM	0
code	0
:	I-DISEASE
788.36	0
ICD-10	I-DISEASE
-	0
CM	0
code	0
:	0

N39.44	0
Alternate	0
Names	I-DISEASE
Enuresis	I-DISEASE
nocturna	0
;	I-DISEASE
nocturnal	0
bedwetting	I-DISEASE
;	0
primary	0
,	0
familial	0
,	I-DISEASE
functional	0
,	0
idiopathic	0
,	I-DISEASE
monosymptomatic	0
,	0
or	0
essential	0
enuresis	0
;	0
night	0
wetting	0
;	0
sleep	0
related	0
enuresis	0
.	0

Diagnostic	I-DISEASE
Criteria	0
Primary	I-DISEASE
Sleep	0
Enuresis	0
–	I-DISEASE
Criteria	I-DISEASE
A	0
-	I-DISEASE
D	0
must	0
be	I-DISEASE
met	0
A.	0

The	I-DISEASE
patient	I-DISEASE
is	0
older	0
than	0
five	0
years	0
.	0

B.	0
The	I-DISEASE
patient	I-DISEASE
exhibits	0
recurrent	I-DISEASE
involuntary	I-DISEASE
voiding	I-DISEASE
during	I-DISEASE
sleep	0
,	I-DISEASE
occurring	0
at	I-DISEASE
least	0
twice	0
a	0
week	0
.	0

C.	I-DISEASE

The	I-DISEASE
condition	0
has	0
been	I-DISEASE
present	0
for	I-DISEASE
at	I-DISEASE
least	I-DISEASE
three	0
months	0
.	0

D.	I-DISEASE

The	I-DISEASE
patient	I-DISEASE
has	0
never	I-DISEASE
been	0
consistently	I-DISEASE
dry	0
during	I-DISEASE
sleep	0
.	0

Secondary	I-DISEASE
Sleep	0
Enuresis	0
–	0
Criteria	I-DISEASE
A	0
-	0
D	I-DISEASE
must	I-DISEASE
be	I-DISEASE
met	0
A.	0

The	I-DISEASE
patient	I-DISEASE
is	0
older	0
than	0
five	0
years	0
.	0

B.	0
The	I-DISEASE
patient	I-DISEASE
exhibits	0
recurrent	I-DISEASE
involuntary	I-DISEASE
voiding	I-DISEASE
during	I-DISEASE
sleep	0
,	I-DISEASE
occurring	0
at	I-DISEASE
least	0
twice	0
a	0
week	0
.	0

C.	I-DISEASE

The	I-DISEASE
condition	0
has	0
been	I-DISEASE
present	0
for	I-DISEASE
at	I-DISEASE
least	I-DISEASE
three	0
months	0
.	0

D.	I-DISEASE

The	I-DISEASE
patient	I-DISEASE
has	0
previously	I-DISEASE
been	0
consistently	I-DISEASE
dry	0
during	I-DISEASE
sleep	0
for	0
at	I-DISEASE
least	I-DISEASE
six	I-DISEASE
months	I-DISEASE
.	0

Essential	I-DISEASE
Features	I-DISEASE
Sleep	0
enuresis	0
(	I-DISEASE
SE	I-DISEASE
)	0
is	0
characterized	0
by	I-DISEASE
recurrent	I-DISEASE
involuntary	0
voiding	0
that	0
occurs	0
during	I-DISEASE
sleep	0
.	0

In	I-DISEASE
primary	0
SE	I-DISEASE
,	I-DISEASE
recurrent	0
involuntary	I-DISEASE
voiding	0
occurs	I-DISEASE
at	I-DISEASE
least	0
twice	0
a	0
week	0
during	0
sleep	0
after	0
five	0
years	I-DISEASE
of	I-DISEASE
age	I-DISEASE
in	I-DISEASE
a	0
patient	I-DISEASE
who	I-DISEASE
has	0
never	0
been	I-DISEASE
consistently	I-DISEASE
dry	0
during	I-DISEASE
sleep	0
for	0
six	0
consecutive	I-DISEASE
months	0
.	0

SE	I-DISEASE
is	I-DISEASE
considered	0
secondary	0
in	0
a	0
child	0
or	I-DISEASE
adult	0
who	0
had	0
previously	I-DISEASE
been	I-DISEASE
dry	I-DISEASE
for	0
six	0
consecutive	I-DISEASE
months	I-DISEASE
and	0
then	0
began	0
wetting	0
at	I-DISEASE
least	0
twice	0
a	0
week	0
.	0

Both	I-DISEASE
primary	0
and	0
secondary	0
enuresis	0
must	I-DISEASE
be	0
present	0
for	0
a	0
period	I-DISEASE
of	I-DISEASE
at	I-DISEASE
least	0
three	I-DISEASE
months	0
.	0

Though	I-DISEASE
primary	0
and	0
secondary	0
enuresis	0
share	I-DISEASE
the	0
common	I-DISEASE
symptom	0
of	I-DISEASE
voiding	0
during	I-DISEASE
sleep	0
,	0
they	I-DISEASE
are	0
understood	0
as	0
distinct	0
phenomena	0
with	0
different	I-DISEASE
etiologies	0
.	0

SE	I-DISEASE
is	I-DISEASE
associated	0
with	I-DISEASE
difficulty	0
arousing	0
from	0
sleep	0
in	I-DISEASE
response	0
to	I-DISEASE
an	I-DISEASE
urge	0
to	I-DISEASE
urinate	I-DISEASE
and	0
may	I-DISEASE
occur	I-DISEASE
during	I-DISEASE
any	I-DISEASE
sleep	0
stage	I-DISEASE
.	0

Sleep	I-DISEASE
disorders	0
that	0
fragment	I-DISEASE
sleep	0
such	I-DISEASE
as	0
sleep	0
apnea	0
are	0
associated	I-DISEASE
with	I-DISEASE
SE	I-DISEASE
,	I-DISEASE
and	0
treatment	I-DISEASE
of	0
these	0
disorders	0
may	0
cure	I-DISEASE
or	0
reduce	I-DISEASE
their	I-DISEASE
incidence	0
.	0

Associated	I-DISEASE
Features	I-DISEASE
Involuntary	0
voiding	I-DISEASE
during	I-DISEASE
wakefulness	0
may	I-DISEASE
be	I-DISEASE
associated	0
with	0
SE	I-DISEASE
and	0
,	I-DISEASE
if	0
present	0
,	0
generally	I-DISEASE
points	I-DISEASE
toward	I-DISEASE
a	0
physiological	I-DISEASE
etiology	0
.	0

Psychosocial	I-DISEASE
problems	0
are	0
consid-	I-DISEASE
ered	0
a	0
relatively	0
rare	I-DISEASE
cause	I-DISEASE
in	I-DISEASE
primary	0
SE	0
,	0
though	0
it	0
does	0
occur	0
more	0
commonly	0
in	I-DISEASE
children	0
with	I-DISEASE
attention	0
deficit	0
hyperactivity	0
disorder	I-DISEASE
and	0
in	I-DISEASE
children	0
living	0
in	I-DISEASE
disorga-	0
nized	I-DISEASE
families	I-DISEASE
.	0

Secondary	I-DISEASE
SE	I-DISEASE
is	0
seen	I-DISEASE
more	0
commonly	I-DISEASE
in	I-DISEASE
children	I-DISEASE
who	I-DISEASE
have	0
recently	0
experienced	0
a	I-DISEASE
significant	0
psychosocial	0
stress	0
,	0
such	0
as	0
parental	I-DISEASE
divorce	0
,	I-DISEASE
physical	0
or	0
sexual	I-DISEASE
abuse	I-DISEASE
,	I-DISEASE
or	I-DISEASE
neglect	0
.	0

Chronic	I-DISEASE
constipation	0
and	0
encopresis	0
(	I-DISEASE
fecal	I-DISEASE
soiling	0
)	0
often	0
occur	I-DISEASE
in	I-DISEASE
children	0
with	I-DISEASE
secondary	0
SE	I-DISEASE
.	0

SE	I-DISEASE
can	0
occur	0
in	I-DISEASE
association	0
with	I-DISEASE
diabetes	I-DISEASE
and	0
urinary	0
tract	I-DISEASE
infection	I-DISEASE
.	0

It	I-DISEASE
may	0
occur	0
in	I-DISEASE
individuals	0
with	I-DISEASE
nocturnal	0
epilepsy	0
.	0

Among	I-DISEASE
older	I-DISEASE
adults	B-DISEASE
,	I-DISEASE
SE	0
may	I-DISEASE
be	I-DISEASE
associated	0
with	I-DISEASE
symptoms	I-DISEASE
of	I-DISEASE
congestive	0
heart	0
failure	I-DISEASE
,	I-DISEASE
OSA	I-DISEASE
,	0
depression	I-DISEASE
,	0
and	0
dementia	0
.	0

SRBD	I-DISEASE
is	I-DISEASE
reported	0
in	I-DISEASE
8	I-DISEASE
%	0
to	0
47	0
%	0
of	I-DISEASE
children	I-DISEASE
with	I-DISEASE
enuresis	0
,	I-DISEASE
compared	0
to	0
an	0
overall	0
prev-	I-DISEASE
alence	I-DISEASE
of	I-DISEASE
1	I-DISEASE
%	0
to	I-DISEASE
2	B-DISEASE
%	0
.	B-DISEASE

PLMS	I-DISEASE
have	I-DISEASE
been	0
reported	I-DISEASE
in	I-DISEASE
patients	I-DISEASE
with	0
refractory	0
SE	I-DISEASE
.	0

A	I-DISEASE
large	I-DISEASE
epidemiology	0
study	0
of	I-DISEASE
children	B-DISEASE
aged	0
6	0
-	I-DISEASE
10	I-DISEASE
years	I-DISEASE
found	0
that	0
a	0
current	I-DISEASE
complaint	0
of	0
SE	I-DISEASE
was	0
significantly	0
associated	0
with	0
increased	0
ORs	0
(	0
2.7	0
-	0
3.4	I-DISEASE
)	0
for	0
subjectively	I-DISEASE
high	0
arousal	0
threshold	0
,	0
night	0
terrors	0
,	I-DISEASE
nocturia	0
,	0
and	0
confusion	I-DISEASE
when	0
awakened	I-DISEASE
from	I-DISEASE
sleep	0
.	0

Other	I-DISEASE
studies	I-DISEASE
have	0
found	I-DISEASE
mouth	0
breathing	I-DISEASE
,	I-DISEASE
nasal	I-DISEASE
congestion	0
,	0
snoring	0
,	I-DISEASE
and	0
restless	I-DISEASE
sleep	0
to	I-DISEASE
be	0
highly	0
related	I-DISEASE
to	I-DISEASE
enuresis	0
in	I-DISEASE
children	0
.	0

Parasomnias	I-DISEASE
Parasomnias	0
Clinical	0
and	0
Pathophysiological	I-DISEASE
Subtypes	I-DISEASE
The	I-DISEASE
most	0
important	0
distinction	0
is	0
between	0
primary	0
and	0
secondary	0
SE	I-DISEASE
.	0

Demographics	I-DISEASE
SE	0
occurs	0
in	I-DISEASE
15	I-DISEASE
%	0
to	0
20	0
%	0
of	I-DISEASE
5	0
-	0
year	0
-	I-DISEASE
olds	I-DISEASE
.	0

It	I-DISEASE
is	0
three	0
times	0
more	0
common	I-DISEASE
in	I-DISEASE
boys	I-DISEASE
than	0
in	0
girls	B-DISEASE
.	0

SE	I-DISEASE
is	I-DISEASE
reported	0
by	I-DISEASE
2.1	0
%	0
of	0
community	0
-	0
dwelling	0
older	I-DISEASE
adults	I-DISEASE
and	0
is	I-DISEASE
more	0
common	I-DISEASE
among	0
women	0
than	I-DISEASE
men	0
.	0

Predisposing	I-DISEASE
and	0
Precipitating	I-DISEASE
Factors	0
The	I-DISEASE
etiology	0
of	B-DISEASE
SE	I-DISEASE
is	0
complex	B-DISEASE
.	0

The	I-DISEASE
factors	0
that	0
precipitate	0
SE	I-DISEASE
on	0
a	0
particular	I-DISEASE
night	0
and	0
at	I-DISEASE
a	0
particular	I-DISEASE
time	I-DISEASE
remain	I-DISEASE
unknown	0
.	0

One	I-DISEASE
popular	0
model	0
hypothesizes	I-DISEASE
that	0
SE	I-DISEASE
consists	0
of	I-DISEASE
three	I-DISEASE
interrelated	I-DISEASE
factors	I-DISEASE
:	I-DISEASE
large	0
nocturnal	0
urine	0
volume	I-DISEASE
production	0
,	I-DISEASE
noc-	0
turnal	0
bladder	I-DISEASE
overactivity	I-DISEASE
,	I-DISEASE
and	0
difficulty	0
arousing	0
from	0
sleep	0
.	0

Several	0
studies	I-DISEASE
suggest	0
difficulty	0
arousing	0
from	I-DISEASE
sleep	0
is	0
most	0
important	0
in	I-DISEASE
primary	I-DISEASE
enuresis	0
,	I-DISEASE
whereas	0
bladder	0
instability	I-DISEASE
/	0
overactivity	0
is	I-DISEASE
more	0
important	0
in	I-DISEASE
secondary	0
enuresis	I-DISEASE
.	0

Children	I-DISEASE
with	I-DISEASE
enuresis	0
are	0
often	0
described	I-DISEASE
by	0
their	0
families	I-DISEASE
as	0
“	I-DISEASE
deep	0
sleepers	0
”	I-DISEASE
and	0
very	0
difficult	0
to	I-DISEASE
arouse	0
.	0

A	I-DISEASE
high	I-DISEASE
arousal	0
threshold	I-DISEASE
has	0
been	I-DISEASE
objectively	I-DISEASE
confirmed	0
in	0
these	I-DISEASE
children	I-DISEASE
.	I-DISEASE

It	I-DISEASE
has	0
been	I-DISEASE
reported	I-DISEASE
that	0
fragmentation	I-DISEASE
of	I-DISEASE
sleep	0
by	I-DISEASE
disorders	0
such	0
as	I-DISEASE
sleep	0
apnea	0
is	I-DISEASE
highly	0
correlated	0
with	I-DISEASE
SE	I-DISEASE
.	0

Sleep	I-DISEASE
fragmenting	0
disorders	0
such	0
as	0
sleep	0
apnea	I-DISEASE
and	0
PLMS	0
have	0
been	I-DISEASE
previously	I-DISEASE
reported	I-DISEASE
to	0
be	0
proximal	0
triggers	I-DISEASE
for	0
the	0
occurrence	0
of	I-DISEASE
disorders	0
of	I-DISEASE
arousal	0
—	I-DISEASE
sleepwalking	0
,	0
confusional	I-DISEASE
arousals	0
,	0
and	0
night	0
terrors	0
.	0

Successful	I-DISEASE
treatment	I-DISEASE
of	I-DISEASE
sleep	0
apnea	0
in	0
these	0
disorders	0
has	0
been	I-DISEASE
reported	I-DISEASE
to	0
result	0
in	I-DISEASE
reduction	I-DISEASE
or	0
elimination	0
of	I-DISEASE
disorders	0
of	I-DISEASE
arousal	0
.	0

Similarly	I-DISEASE
,	I-DISEASE
surgical	0
treatment	I-DISEASE
of	0
sleep	0
apneas	0
by	I-DISEASE
adenotonsillec-	I-DISEASE
tomy	I-DISEASE
has	0
been	I-DISEASE
reported	0
to	0
cure	I-DISEASE
nocturnal	0
enuresis	0
in	I-DISEASE
60	I-DISEASE
%	0
or	0
more	0
of	I-DISEASE
patients	I-DISEASE
,	0
although	0
this	0
is	0
not	0
a	0
consistent	0
result	0
.	0

Several	I-DISEASE
studies	I-DISEASE
have	0
noted	0
the	0
presence	0
of	I-DISEASE
sleep	0
related	B-DISEASE
breathing	0
disorder	0
in	I-DISEASE
>	I-DISEASE
40	I-DISEASE
%	0
of	I-DISEASE
enuresis	I-DISEASE
patients	0
studied	0
.	0

However	I-DISEASE
,	I-DISEASE
not	0
all	0
sleep	0
studies	I-DISEASE
have	0
noted	0
SRBD	0
in	I-DISEASE
patients	I-DISEASE
with	I-DISEASE
enuresis	0
.	0

Those	I-DISEASE
without	0
SRBD	0
were	I-DISEASE
still	0
found	I-DISEASE
to	0
have	0
high	I-DISEASE
arousal	0
threshold	I-DISEASE
from	I-DISEASE
sleep	0
.	0

Primary	I-DISEASE
SE	I-DISEASE
is	0
a	I-DISEASE
disorder	0
that	0
occurs	0
when	I-DISEASE
an	0
individual	0
fails	0
to	I-DISEASE
arouse	I-DISEASE
from	0
sleep	0
in	I-DISEASE
response	0
to	0
bladder	0
sensations	I-DISEASE
or	0
fails	0
to	0
inhibit	I-DISEASE
a	0
bladder	I-DISEASE
contraction	0
.	0

These	0
are	0
devel-	0
opmentally	0
acquired	0
skills	0
,	0
and	0
,	I-DISEASE
as	I-DISEASE
such	0
,	I-DISEASE
there	I-DISEASE
is	I-DISEASE
a	0
range	0
in	I-DISEASE
the	0
ages	I-DISEASE
of	I-DISEASE
their	0
acquisition	I-DISEASE
.	0

A	I-DISEASE
small	0
proportion	I-DISEASE
of	I-DISEASE
children	0
with	I-DISEASE
primary	0
SE	I-DISEASE
lack	I-DISEASE
the	0
normal	0
increase	I-DISEASE
in	I-DISEASE
vasopressin	I-DISEASE
release	0
during	I-DISEASE
sleep	0
,	0
leading	0
to	0
a	0
high	I-DISEASE
urinary	0
volume	I-DISEASE
that	0
exceeds	I-DISEASE
the	0
bladder	I-DISEASE
capac-	0
ity	0
.	0

If	I-DISEASE
these	I-DISEASE
children	0
do	0
not	0
arouse	0
to	I-DISEASE
the	0
sensation	0
of	I-DISEASE
a	0
full	I-DISEASE
bladder	I-DISEASE
,	0
primary	0
SE	I-DISEASE
is	I-DISEASE
the	0
result	0
.	0

Secondary	I-DISEASE
SE	I-DISEASE
can	0
be	I-DISEASE
caused	0
by	I-DISEASE
,	I-DISEASE
or	I-DISEASE
be	0
associated	0
with	I-DISEASE
,	I-DISEASE
any	I-DISEASE
one	I-DISEASE
of	I-DISEASE
the	0
following	0
identifiable	I-DISEASE
problems	I-DISEASE
:	I-DISEASE
(	I-DISEASE
1	0
)	0
an	I-DISEASE
inability	0
to	I-DISEASE
concentrate	0
urine	I-DISEASE
due	I-DISEASE
to	I-DISEASE
diabetes	I-DISEASE
mellitus	B-DISEASE
,	0
diabetes	I-DISEASE
insipidus	I-DISEASE
,	0
nephrogenic	0
diabetes	I-DISEASE
insipidus	I-DISEASE
(	0
idiopathic	I-DISEASE
or	I-DISEASE
pharmacologic	0

[	0
e.g.	0
,	I-DISEASE
secondary	0
to	I-DISEASE
the	0
use	0
of	I-DISEASE
lithium	I-DISEASE
carbonate	I-DISEASE
]	0
)	0
,	I-DISEASE
or	0
sickle	0
cell	0
disease	I-DISEASE
;	0
(	0
2	I-DISEASE
)	0
increased	0
urine	0
production	I-DISEASE
secondary	0
to	B-DISEASE
the	0
ingestion	0
of	I-DISEASE
caffeine	0
,	0
diuretics	0
,	I-DISEASE
or	0
other	I-DISEASE
agents	I-DISEASE
;	I-DISEASE
(	0
3	0
)	0
urinary	0
tract	I-DISEASE
pathology	I-DISEASE
,	0
such	0
as	0
urinary	0
tract	I-DISEASE
infections	0
,	0
irritable	0
bladder	I-DISEASE
,	I-DISEASE
malformations	0
of	I-DISEASE
the	0
genitourinary	0
tract	I-DISEASE
(	0
e.g.	0
,	I-DISEASE
ectopic	0
ureter	0
)	0
;	0
(	I-DISEASE
4	0
)	0
chronic	I-DISEASE
constipation	0
and	0
encopresis	0
;	0
(	0
5	0
)	0
neurologic	0
pathology	0
,	0
such	0
as	0
seizures	0
or	I-DISEASE
neurogenic	0
bladder	0
;	0
or	0
(	I-DISEASE
6	I-DISEASE
)	0
psychosocial	0
stressors	I-DISEASE
,	I-DISEASE
such	0
as	0
parental	I-DISEASE
divorce	0
,	0
neglect	0
,	0
physical	0
or	0
sexual	I-DISEASE
abuse	I-DISEASE
,	I-DISEASE
and	0
institution-	0
alization	0
.	0

The	I-DISEASE
mechanisms	0
by	0
which	0
secondary	0
SE	I-DISEASE
is	0
associated	0
with	0
these	0
problems	0
are	0
often	I-DISEASE
not	0
understood	0
.	0

Familial	I-DISEASE
Patterns	I-DISEASE
Hereditary	0
factors	0
are	0
suspected	0
in	I-DISEASE
children	B-DISEASE
with	0
primary	0
enuresis	I-DISEASE
.	0

There	I-DISEASE
is	I-DISEASE
often	0
a	0
high	0
prevalence	0
of	I-DISEASE
enuresis	0
among	0
the	0
parents	I-DISEASE
,	I-DISEASE
siblings	0
,	0
and	0
other	I-DISEASE
relatives	0
of	0
the	0
child	0
with	I-DISEASE
primary	0
enuresis	0
.	0

The	I-DISEASE
reported	0
prevalence	0
is	0
77	0
%	0
when	0
both	I-DISEASE
parents	0
were	0
enuretic	0
as	0
children	0
and	0
44	0
%	0
when	0
one	0
parent	0
has	0
a	0
history	I-DISEASE
of	I-DISEASE
enuresis	I-DISEASE
.	0

Recent	I-DISEASE
linkage	0
studies	I-DISEASE
support	0
the	0
hypothesis	I-DISEASE
of	I-DISEASE
genetic	0
and	0
phenotypic	0
heterogeneity	I-DISEASE
of	I-DISEASE
SE	0
.	0

A	I-DISEASE
putative	0
linkage	I-DISEASE
of	I-DISEASE
SE	I-DISEASE
to	I-DISEASE
a	0
region	0
on	0
chromosomes	I-DISEASE
22q	I-DISEASE
,	I-DISEASE
13q	I-DISEASE
,	0
and	0
12q	I-DISEASE
across	I-DISEASE
different	0
families	I-DISEASE
has	I-DISEASE
been	I-DISEASE
reported	I-DISEASE
.	0

Onset	I-DISEASE
,	0
Course	0
,	0
and	0
Complications	0
Voiding	I-DISEASE
is	I-DISEASE
a	0
spinal	I-DISEASE
reflex	0
during	I-DISEASE
wakefulness	0
and	0
sleep	0
during	I-DISEASE
infancy	0
,	I-DISEASE
until	0
about	0
18	I-DISEASE
months	0
of	I-DISEASE
age	I-DISEASE
.	0

Between	I-DISEASE
18	I-DISEASE
months	0
and	0
three	0
years	0
of	I-DISEASE
age	I-DISEASE
,	0
the	0
child	0
is	I-DISEASE
able	0
to	I-DISEASE
delay	0
voiding	0
with	I-DISEASE
a	0
full	0
bladder	I-DISEASE
,	0
first	I-DISEASE
during	I-DISEASE
wakefulness	0
and	0
at	I-DISEASE
a	0
later	0
age	I-DISEASE
during	I-DISEASE
sleep	0
.	0

The	I-DISEASE
primary	0
determinant	0
of	I-DISEASE
the	B-DISEASE
age	I-DISEASE
at	I-DISEASE
which	0
this	0
skill	I-DISEASE
is	I-DISEASE
acquired	0
is	I-DISEASE
developmental	I-DISEASE
matura-	I-DISEASE
tion	0
.	0

Somewhat	I-DISEASE
arbitrarily	0
,	0
primary	0
SE	I-DISEASE
is	0
defined	I-DISEASE
as	0
a	0
problem	0
if	0
it	I-DISEASE
persists	0
beyond	0
five	0
years	0
of	I-DISEASE
age	I-DISEASE
.	0

The	I-DISEASE
spontaneous	I-DISEASE
cure	I-DISEASE
rate	I-DISEASE
is	0
15	I-DISEASE
%	0
per	I-DISEASE
year	0
.	0

The	I-DISEASE
primary	0
complication	I-DISEASE
of	0
SE	I-DISEASE
is	0
to	I-DISEASE
the	0
child	0
’s	I-DISEASE
self	I-DISEASE
-	I-DISEASE
esteem	0
.	0

How	I-DISEASE
well	I-DISEASE
the	0
child	0
’s	I-DISEASE
family	0
deals	0
with	I-DISEASE
the	0
symptom	0
is	0
an	0
important	B-DISEASE
determinant	I-DISEASE
of	I-DISEASE
whether	0
complications	0
develop	0
.	0

Secondary	I-DISEASE
SE	I-DISEASE
can	0
occur	I-DISEASE
at	I-DISEASE
any	I-DISEASE
age	I-DISEASE
.	0

Complications	I-DISEASE
of	0
secondary	0
SE	I-DISEASE
are	I-DISEASE
determined	I-DISEASE
by	0
the	0
problem	0
leading	I-DISEASE
to	I-DISEASE
the	0
enuresis	0
.	0

Developmental	I-DISEASE
Issues	0
The	I-DISEASE
developmental	I-DISEASE
pattern	0
of	I-DISEASE
enuresis	0
is	0
similar	0
to	I-DISEASE
NREM	0
parasomnias	I-DISEASE
,	0
although	0
its	I-DISEASE
first	0
occurrence	0
in	0
adulthood	0
is	0
uncommon	0
.	0

Pathology	I-DISEASE
and	0
Pathophysiology	I-DISEASE
SE	I-DISEASE
is	0
a	0
heterogeneous	0
disorder	I-DISEASE
with	0
various	I-DISEASE
underlying	0
pathophysiological	0
mecha-	0
nisms	0
,	I-DISEASE
resulting	0
in	0
a	0
mismatch	0
between	0
nocturnal	0
bladder	0
capacity	B-DISEASE
and	0
the	0
amount	0
of	I-DISEASE
Parasomnias	I-DISEASE
Parasomnias	0
urine	0
produced	0
during	I-DISEASE
sleep	0
,	0
in	0
association	I-DISEASE
with	I-DISEASE
a	0
simultaneous	0
failure	0
of	I-DISEASE
arousal	0
from	0
sleep	0
in	I-DISEASE
response	0
to	I-DISEASE
the	0
sensation	0
of	0
bladder	0
fullness	0
.	0

SE	I-DISEASE
can	0
be	0
seen	I-DISEASE
in	0
association	I-DISEASE
with	I-DISEASE
sleep	0
fragmentation	0
disorders	0
including	0
SRBD	I-DISEASE
,	I-DISEASE
which	0
in	I-DISEASE
children	0
is	0
most	0
often	0
secondary	0
to	0
adenotonsillar	0
hypertrophy	I-DISEASE
.	0

Objective	I-DISEASE
Findings	I-DISEASE
In	I-DISEASE
primary	0
and	0
secondary	0
SE	0
,	0
enuretic	0
episodes	0
can	0
occur	0
in	I-DISEASE
all	0
sleep	0
stages	I-DISEASE
,	0
during	I-DISEASE
nocturnal	0
wakefulness	0
,	I-DISEASE
and	0
in	I-DISEASE
association	0
with	I-DISEASE
transient	0
arousals	0
.	0

Sleep	I-DISEASE
stages	I-DISEASE
have	0
not	0
been	0
found	I-DISEASE
to	I-DISEASE
be	I-DISEASE
different	0
on	0
nights	0
when	I-DISEASE
enuresis	I-DISEASE
occurs	0
versus	I-DISEASE
nights	I-DISEASE
on	0
which	0
it	0
does	I-DISEASE
not	0
occur	I-DISEASE
.	0

The	I-DISEASE
results	I-DISEASE
of	I-DISEASE
polysomnographic	0
studies	0
of	I-DISEASE
children	I-DISEASE
with	I-DISEASE
enuresis	I-DISEASE
com-	I-DISEASE
pared	0
to	I-DISEASE
normal	0
controls	0
have	0
been	I-DISEASE
inconsistent	I-DISEASE
.	0

A	I-DISEASE
computerized	I-DISEASE
power	I-DISEASE
analysis	0
of	I-DISEASE
sleep	0
data	I-DISEASE
suggested	0
an	0
increase	I-DISEASE
in	I-DISEASE
delta	I-DISEASE
power	I-DISEASE
,	0
whereas	I-DISEASE
the	0
majority	I-DISEASE
of	I-DISEASE
other	0
studies	I-DISEASE
have	0
reported	I-DISEASE
no	0
differences	I-DISEASE
.	0

However	I-DISEASE
,	I-DISEASE
a	0
recent	I-DISEASE
study	0
found	I-DISEASE
those	I-DISEASE
age	I-DISEASE
6	0
-	0
14	0
years	I-DISEASE
had	I-DISEASE
elevated	I-DISEASE
light	0
stage	0
N1	0
sleep	0
and	0
reduced	0
N3	0
sleep	0
and	0
REM	I-DISEASE
sleep	0
compared	I-DISEASE
to	I-DISEASE
normal	0
controls	0
.	0

The	I-DISEASE
population	0
with	0
enuresis	0
had	0
a	I-DISEASE
significantly	0
elevated	0
arousal	0
index	I-DISEASE
.	0

SRBD	I-DISEASE
has	0
been	0
reported	I-DISEASE
in	I-DISEASE
8	I-DISEASE
%	0
to	0
47	0
%	0
of	I-DISEASE
children	I-DISEASE
with	0
SE	I-DISEASE
.	0

SE	I-DISEASE
and	0
sleep	0
apnea	0
are	0
highly	I-DISEASE
correlated	0
with	0
an	0
increasing	I-DISEASE
prevalence	I-DISEASE
of	I-DISEASE
enuresis	0
as	I-DISEASE
the	0
respiratory	0
distur-	0
bance	I-DISEASE
index	0
(	I-DISEASE
RDI	0
)	0
increases	0
.	0

In	I-DISEASE
addition	0
to	0
SRBD	I-DISEASE
,	I-DISEASE
PLMS	0
(	I-DISEASE
range	I-DISEASE
of	I-DISEASE
3.9	I-DISEASE
to	I-DISEASE
38.6	I-DISEASE
per	I-DISEASE
hour	0
of	I-DISEASE
sleep	0
)	0
have	I-DISEASE
been	0
reported	I-DISEASE
in	I-DISEASE
a	I-DISEASE
group	I-DISEASE
of	I-DISEASE
children	0
with	I-DISEASE
treatment	I-DISEASE
-	I-DISEASE
resistant	0
SE	I-DISEASE
.	0

Recent	I-DISEASE
studies	I-DISEASE
have	0
demonstrated	I-DISEASE
that	0
patients	I-DISEASE
with	I-DISEASE
enuresis	I-DISEASE
are	I-DISEASE
subjectively	I-DISEASE
sleepier	I-DISEASE
than	I-DISEASE
normal	0
controls	0
.	0

This	I-DISEASE
has	0
been	I-DISEASE
hypothesized	I-DISEASE
to	0
result	0
from	I-DISEASE
fragmented	I-DISEASE
nocturnal	I-DISEASE
sleep	0
and	0
is	I-DISEASE
consistent	0
with	0
a	0
large	0
body	I-DISEASE
of	I-DISEASE
sleep	0
research	I-DISEASE
in	0
other	I-DISEASE
areas	0
.	0

Differential	I-DISEASE
Diagnosis	0
Enuresis	I-DISEASE
may	0
be	0
caused	0
by	I-DISEASE
a	I-DISEASE
variety	I-DISEASE
of	I-DISEASE
medical	0
or	I-DISEASE
neurological	I-DISEASE
disorders	0
such	0
as	0
diabetes	I-DISEASE
mellitus	0
,	I-DISEASE
diabetes	I-DISEASE
insipidus	I-DISEASE
,	0
epilepsy	0
,	0
sickle	0
cell	0
disease	0
,	0
bowel	0
or	I-DISEASE
bladder	I-DISEASE
dysfunction	0
,	0
anatomical	0
abnormalities	I-DISEASE
or	0
infection	I-DISEASE
of	I-DISEASE
the	0
urinary	0
tract	I-DISEASE
,	0
neurological/	0
developmental	I-DISEASE
disorders	0
or	0
other	I-DISEASE
sleep	0
disorders	0
,	0
especially	0
OSA	0
.	0

Organic	I-DISEASE
pathology	I-DISEASE
of	I-DISEASE
the	0
urinary	0
tract	I-DISEASE
is	0
more	0
prevalent	I-DISEASE
in	I-DISEASE
children	I-DISEASE
who	0
,	I-DISEASE
in	I-DISEASE
addition	0
to	0
sleep	0
enuresis	0
,	0
also	0
exhibit	0
daytime	0
enuresis	I-DISEASE
,	I-DISEASE
abnormalities	I-DISEASE
in	I-DISEASE
the	0
initiation	I-DISEASE
of	I-DISEASE
micturition	0
,	0
or	0
abnormal	0
urinary	0
flow	I-DISEASE
.	0

Evaluation	I-DISEASE
of	I-DISEASE
sleep	0
enuresis	0
should	I-DISEASE
include	I-DISEASE
complete	0
enuresis	0
history	I-DISEASE
,	I-DISEASE
sleep	0
history	I-DISEASE
,	I-DISEASE
physical	I-DISEASE
examination	0
and	0
laboratory	I-DISEASE
studies	I-DISEASE
(	0
as	0
indicated	0
)	0
to	0
exclude	0
these	I-DISEASE
etiol-	0
ogies	0
.	0

When	I-DISEASE
signs	I-DISEASE
and	0
symptoms	I-DISEASE
of	0
sleep	0
apnea	0
are	0
present	I-DISEASE
—	I-DISEASE
mouth	I-DISEASE
breathing	I-DISEASE
,	0
snoring	0
,	0
adenotonsillar	0
hypertrophy	0
,	I-DISEASE
daytime	I-DISEASE
sleepiness	0
,	0
hyperactivity	I-DISEASE
—	0
a	0
sleep	0
study	0
should	0
be	0
conducted	0
.	0

Unresolved	I-DISEASE
Issues	0
and	0
Further	I-DISEASE
Directions	0
Recent	0
advances	0
suggest	I-DISEASE
that	I-DISEASE
the	0
terms	I-DISEASE
primary	0
and	0
secondary	I-DISEASE
enuresis	0
may	0
be	0
overly	0
simplistic	0
.	0

Further	I-DISEASE
work	I-DISEASE
is	0
necessary	I-DISEASE
to	0
understand	I-DISEASE
the	0
genetic	I-DISEASE
and	0
clinical	0
aspects	0
of	I-DISEASE
SE	I-DISEASE
.	0

Other	0
sleep	0
disorders	0
are	I-DISEASE
common	0
in	I-DISEASE
children	0
with	0
SE	0
.	0

Though	0
it	0
may	0
be	I-DISEASE
possible	0
that	0
the	0
apneas	I-DISEASE
,	I-DISEASE
hypopneas	I-DISEASE
,	I-DISEASE
and	0
snoring	0
-	0
related	0
arousals	0
in	0
children	I-DISEASE
with	0
SRBD	I-DISEASE
could	0
be	0
the	0
trigger	0
of	I-DISEASE
SE	0
,	0
many	0
children	0
with	0
SE	0
do	0
not	0
have	I-DISEASE
a	I-DISEASE
sleep	0
disorder	I-DISEASE
.	0

In	I-DISEASE
such	0
cases	0
,	I-DISEASE
the	0
underlying	0
bladder	0
overactivity	I-DISEASE
may	I-DISEASE
be	I-DISEASE
the	I-DISEASE
stimulus	0
for	0
arousal	0
.	0

Studies	I-DISEASE
of	I-DISEASE
the	0
relationship	I-DISEASE
of	I-DISEASE
sleep	I-DISEASE
,	I-DISEASE
sleep	I-DISEASE
disorders	0
,	0
and	0
sleep	I-DISEASE
fragmentation	I-DISEASE
to	0
SE	I-DISEASE
performed	0
to	I-DISEASE
date	0
have	0
been	I-DISEASE
inconsistent	I-DISEASE
.	0

This	I-DISEASE
is	I-DISEASE
likely	0
due	I-DISEASE
to	0
differing	I-DISEASE
definitions	0
of	I-DISEASE
enuresis	0
and	0
varying	I-DISEASE
research	I-DISEASE
methodologies	0
.	0

Further	I-DISEASE
sophisticated	0
sleep	0
laboratory	I-DISEASE
studies	0
are	0
necessary	0
to	I-DISEASE
elucidate	0
the	I-DISEASE
relationship	I-DISEASE
.	0

In	I-DISEASE
particular	I-DISEASE
,	0
the	0
proximal	0
trigger	I-DISEASE
for	I-DISEASE
episodes	I-DISEASE
of	I-DISEASE
SE	I-DISEASE
has	0
not	I-DISEASE
been	I-DISEASE
determined	0
.	0

Some	I-DISEASE
studies	I-DISEASE
suggest	0
enuresis	I-DISEASE
is	I-DISEASE
sponta-	I-DISEASE
neous	I-DISEASE
,	I-DISEASE
whereas	0
others	I-DISEASE
suggest	I-DISEASE
a	I-DISEASE
relationship	0
to	0
sleep	0
disorders	0
that	0
result	0
in	I-DISEASE
arousals	0
—	I-DISEASE
similar	0
to	I-DISEASE
findings	0
in	I-DISEASE
disorders	0
of	I-DISEASE
arousal	0
.	0

Bibliography	0
Burgio	0
K	0
,	I-DISEASE
Locher	0
J	0
,	I-DISEASE
Ives	I-DISEASE
D	I-DISEASE
,	0
Hardin	0
J	I-DISEASE
,	0
Newman	0
A	0
,	0
Kuller	0
L.	0
Nocturnal	0
enuresis	0
in	I-DISEASE
community	0
-	I-DISEASE
dwelling	0
older	0
adults	B-DISEASE
.	0

J	I-DISEASE
Am	I-DISEASE
Geriatr	0
Soc	0
1996;44:139–43	0
.	0

Brooks	I-DISEASE
LJ	0
,	I-DISEASE
Topol	0
HI	I-DISEASE
.	0

Enuresis	I-DISEASE
in	I-DISEASE
children	0
with	I-DISEASE
sleep	0
apnea	I-DISEASE
.	0

J	I-DISEASE
Pediatr	0
2003;142:515–8	0
.	I-DISEASE

Chandra	I-DISEASE
M	I-DISEASE
,	0
Saharia	I-DISEASE
R	I-DISEASE
,	I-DISEASE
Hill	0
V	I-DISEASE
,	I-DISEASE
Shi	I-DISEASE
QH	I-DISEASE
.	0

Prevalence	I-DISEASE
of	I-DISEASE
diurnal	I-DISEASE
voiding	I-DISEASE
symptoms	I-DISEASE
and	0
difficult	0
arousal	0
from	I-DISEASE
sleep	0
in	0
children	0
with	I-DISEASE
nocturnal	I-DISEASE
enuresis	0
.	0

J	I-DISEASE
Urol	I-DISEASE
2004;172:311–6	0
.	0

Cohen	I-DISEASE
-	I-DISEASE
Zrubavel	0
V	I-DISEASE
,	0
Kushnir	I-DISEASE
B	0
,	I-DISEASE
Kushnir	0
J	0
,	I-DISEASE
Sadeh	I-DISEASE
A.	0
Sleep	0
and	0
sleepiness	0
in	I-DISEASE
children	0
with	I-DISEASE
nocturnal	0
enuresis	0
.	0

Sleep	I-DISEASE
2011;34:191–4	I-DISEASE
.	0

Dhondt	I-DISEASE
K	I-DISEASE
,	0
Raes	0
A	0
,	0
Hoebeke	0
P	0
,	0
Van	I-DISEASE
Laecke	I-DISEASE
E	0
,	0
Van	0
Herzeele	0
C	I-DISEASE
,	0
Vande	I-DISEASE
Walle	0
J.	B-DISEASE
Abnormal	0
sleep	0
architecture	I-DISEASE
and	0
refractory	0
nocturnal	0
enuresis	I-DISEASE
.	0

J	I-DISEASE
Urol	I-DISEASE
2009;182:1961–5	I-DISEASE
.	0

Jeyakumar	I-DISEASE
A	0
,	0
Rahman	I-DISEASE
SI	I-DISEASE
,	0
Armbrecht	0
ES	0
,	I-DISEASE
Mitchell	0
R.	0
The	I-DISEASE
association	0
between	0
sleep	0
-	0
disordered	0
breathing	0
and	0
enuresis	0
in	I-DISEASE
children	I-DISEASE
.	0

Laryngoscope	I-DISEASE
2012	0
Aug;122:1873–7	I-DISEASE
.	0

Neveus	0
T.	0
The	I-DISEASE
role	0
of	I-DISEASE
sleep	0
and	0
arousal	0
in	I-DISEASE
nocturnal	I-DISEASE
enuresis	0
.	0

Acta	I-DISEASE
Paediatr	0
2003;92:1118–23	0
.	0

Kalorin	I-DISEASE
CM	I-DISEASE
,	I-DISEASE
Mouzakes	0
J	0
,	I-DISEASE
Gavin	I-DISEASE
JP	I-DISEASE
,	I-DISEASE
et	0
al	I-DISEASE
.	0

Tonsillectomy	I-DISEASE
does	I-DISEASE
not	0
improve	I-DISEASE
bedwetting	I-DISEASE
:	I-DISEASE
results	I-DISEASE
of	I-DISEASE
a	0
prospective	0
controlled	I-DISEASE
trial	I-DISEASE
.	0

J	I-DISEASE
Urol	I-DISEASE
2010;184:2527	I-DISEASE
.	0

Neveus	I-DISEASE
T	0
,	0
Stenberg	I-DISEASE
A	0
,	0
Lackgren	0
G	I-DISEASE
,	I-DISEASE
Tuvemo	0
T	0
,	0
Hetta	0
J.	0
Sleep	0
of	I-DISEASE
children	I-DISEASE
with	0
enuresis	I-DISEASE
:	I-DISEASE
A	0
polysomnographic	0
study	0
.	0

Pediatrics	I-DISEASE
1999;103:1193–7	I-DISEASE
.	0

Norgaard	I-DISEASE
JP	0
,	I-DISEASE
Hansen	0
JH	I-DISEASE
,	I-DISEASE
Nielsen	0
JB	0
,	I-DISEASE
Petersen	I-DISEASE
BS	I-DISEASE
,	I-DISEASE
Knudsen	I-DISEASE
N	0
,	I-DISEASE
Djurhuus	I-DISEASE
JC	0
.	0

Simultaneous	I-DISEASE
registration	I-DISEASE
of	I-DISEASE
sleep	0
-	0
stages	0
and	0
bladder	I-DISEASE
activity	I-DISEASE
in	I-DISEASE
enuresis	0
.	I-DISEASE

Urology	I-DISEASE
1985;26:316–9	I-DISEASE
.	0

Sakellaropoulou	I-DISEASE
AV	0
,	0
Hatzistilianou	0
MN	0
,	I-DISEASE
Emporiadou	I-DISEASE
MN	I-DISEASE
,	I-DISEASE
et	0
al	0
.	0
Association	I-DISEASE
between	0
primary	0
nocturnal	0
enuresis	0
and	0
habitual	0
snoring	0
in	0
children	0
with	0
obstructive	0
sleep	0
apnoea	0
-	0
hypopnoea	0
syndrome	0
.	0

Arch	I-DISEASE
Med	0
Sci	0
2012;8:521–7	I-DISEASE
.	0

Stone	I-DISEASE
J	0
,	0
Malone	0
PS	0
,	I-DISEASE
Atwill	0
D	0
,	I-DISEASE
et	0
al	I-DISEASE
.	I-DISEASE

Symptoms	I-DISEASE
of	0
sleep	0
-	0
disordered	I-DISEASE
breathing	0
in	0
children	I-DISEASE
with	I-DISEASE
nocturnal	I-DISEASE
enuresis	0
.	0

J	I-DISEASE
Pediatr	0
Urol	0
2008;4:197	I-DISEASE
.	0

Parasomnias	I-DISEASE
Parasomnias	0
Weissbach	0
A	I-DISEASE
,	I-DISEASE
Leiberman	0
A	0
,	0
Tarasiuk	0
A	0
,	0
Goldbart	0
A	0
,	0
Tal	I-DISEASE
A.	0
Adenotonsillectomy	I-DISEASE
improves	0
enuresis	0
in	I-DISEASE
children	0
with	I-DISEASE
obstructive	0
sleep	0
apnea	0
syndrome	0
.	0

Int	I-DISEASE
J	0
Pediatr	0
Otorhinolaryngol	0
2006;70:1351–6	I-DISEASE
.	0

Wolfish	I-DISEASE
N.	0
Sleep	0
arousal	0
function	0
in	I-DISEASE
enuretic	0
males	I-DISEASE
.	I-DISEASE

Scand	I-DISEASE
J	0
Urol	I-DISEASE
Nephrol	0
Suppl	0
1999;202:24–6	I-DISEASE
.	0

Wolfish	I-DISEASE
NM	0
,	0
Pivik	I-DISEASE
RT	I-DISEASE
,	0
Busby	I-DISEASE
KA	I-DISEASE
.	0

Elevated	I-DISEASE
sleep	0
arousal	0
thresholds	0
in	I-DISEASE
enuretic	0
boys	0
:	I-DISEASE
clinical	0
implications	0
.	0

Acta	I-DISEASE
Paediatr	0
1997;86:381–4	I-DISEASE
.	0

Yeung	0
CK	0
,	0
Chiu	I-DISEASE
HN	I-DISEASE
,	0
Sit	0
FK	0
.	I-DISEASE

Sleep	I-DISEASE
disturbance	I-DISEASE
and	0
bladder	I-DISEASE
dysfunction	0
in	I-DISEASE
enuretic	0
children	I-DISEASE
with	I-DISEASE
treatment	I-DISEASE
failure	0
:	0
fact	I-DISEASE
or	I-DISEASE
fiction	0
?	0

Scand	I-DISEASE
J	0
Urol	I-DISEASE
Nephrol	0
Suppl	0
1999;202:20–3	I-DISEASE
.	0

Yeung	I-DISEASE
CK	0
,	0
Diao	I-DISEASE
M	I-DISEASE
,	0
Sreedhar	0
B.	0
Cortical	0
arousal	I-DISEASE
in	0
children	0
with	I-DISEASE
severe	I-DISEASE
enuresis	0
.	0

N	0
Engl	I-DISEASE
J	0
Med	I-DISEASE
2008;359;22–4	I-DISEASE
.	0

Parasomnia	I-DISEASE
Due	0
to	I-DISEASE
a	0
Medical	I-DISEASE
Disorder	0
ICD-9	0
-	I-DISEASE
CM	I-DISEASE
code	0
:	0
327.44	0
ICD-10	0
-	0
CM	I-DISEASE
code	B-DISEASE
:	0
G47.54	I-DISEASE
The	I-DISEASE
essential	0
feature	0
of	0
this	0
diagnosis	0
is	0
the	0
presence	0
of	I-DISEASE
a	0
parasomnia	I-DISEASE
that	0
is	0
attrib-	I-DISEASE
utable	0
to	0
an	0
underlying	0
neurological	0
or	I-DISEASE
medical	0
condition	0
.	0

RBD	I-DISEASE
is	0
the	0
parasomnia	0
most	0
commonly	0
associated	0
with	I-DISEASE
an	I-DISEASE
underlying	0
neurological	0
condition	I-DISEASE
(	0
“	0
symptomatic	0
RBD	I-DISEASE
”	I-DISEASE
)	0
.	0

However	I-DISEASE
,	I-DISEASE
when	0
diagnostic	0
criteria	0
for	I-DISEASE
RBD	I-DISEASE
are	0
met	0
,	0
the	0
more	I-DISEASE
specific	I-DISEASE
diagno-	0
sis	0
of	I-DISEASE
REM	0
sleep	0
behavior	I-DISEASE
disorder	I-DISEASE
should	0
be	I-DISEASE
made	0
.	0

Complex	I-DISEASE
nocturnal	0
sleep	0
related	0
(	I-DISEASE
hypnagogic	I-DISEASE
and	0
hypnopompic	I-DISEASE
)	0
visual	I-DISEASE
hallucina-	0
tions	0
can	0
occur	I-DISEASE
with	I-DISEASE
neurological	0
disorders	0
such	0
as	0
narcolepsy	0
,	0
PD	0
,	0
DLB	I-DISEASE
,	I-DISEASE
visual	I-DISEASE
loss	I-DISEASE
(	0
Charles	0
Bonnet	0
hallucinations	0
)	0
,	0
and	0
midbrain	0
and	0
diencephalic	I-DISEASE
pathology	I-DISEASE
(	I-DISEASE
pedun-	0
cular	0
hallucinosis	I-DISEASE
)	0
.	0

Dreaming	I-DISEASE
and	0
sleep	0
paralysis	0
may	0
or	I-DISEASE
may	0
not	0
be	0
associated	0
with	I-DISEASE
these	I-DISEASE
hallucinations	0
.	0

Parasomnia	I-DISEASE
Due	0
to	I-DISEASE
a	0
Medication	I-DISEASE
or	0
Substance	I-DISEASE
ICD-9	I-DISEASE
-	I-DISEASE
CM	I-DISEASE
code	0
:	I-DISEASE
292.85	0
(	I-DISEASE
drug	0
-	0
induced	0
)	0
;	0
291.82	0
(	I-DISEASE
alcohol	0
-	0
induced	0
)	0
ICD-10	0
-	0
CM	0
code	0
:	I-DISEASE
F11	0
-	0
F19	0
(	0
see	0
table	I-DISEASE
in	I-DISEASE
Appendix	0
B	0
for	I-DISEASE
detailed	I-DISEASE
coding	I-DISEASE
instructions	0
)	0

The	I-DISEASE
essential	0
feature	0
of	I-DISEASE
this	0
diagnosis	I-DISEASE
is	I-DISEASE
the	B-DISEASE
close	0
temporal	0
relationship	0
between	0
expo-	I-DISEASE
sure	0
to	I-DISEASE
a	I-DISEASE
drug	0
,	0
medication	0
,	0
or	0
biological	I-DISEASE
substance	0
and	0
the	0
onset	0
of	I-DISEASE
the	I-DISEASE
signs	0
and	0
symp-	0
toms	I-DISEASE
of	I-DISEASE
that	0
disorder	0
.	0

A	I-DISEASE
likely	I-DISEASE
causal	0
relationship	0
can	0
be	I-DISEASE
inferred	I-DISEASE
if	0
signs	0
and	0
symp-	I-DISEASE
toms	I-DISEASE
of	0
the	0
parasomnia	I-DISEASE
disappear	I-DISEASE
when	I-DISEASE
the	0
drug	0
or	0
substance	I-DISEASE
is	I-DISEASE
withdrawn	0
.	0

The	I-DISEASE
emergent	I-DISEASE
parasomnia	I-DISEASE
can	I-DISEASE
be	0
a	0
de	0
novo	0
parasomnia	I-DISEASE
,	I-DISEASE
the	0
aggravation	0
of	I-DISEASE
a	0
chronic	I-DISEASE
intermittent	0
parasomnia	I-DISEASE
,	I-DISEASE
or	0
the	0
reactivation	I-DISEASE
of	I-DISEASE
a	0
previous	0
parasomnia	0
.	0

As	I-DISEASE
discussed	I-DISEASE
previously	I-DISEASE
,	I-DISEASE
a	0
variety	I-DISEASE
of	I-DISEASE
medications	I-DISEASE
and	0
biological	0
substances	0
,	I-DISEASE
including	I-DISEASE
selective	I-DISEASE
serotonin	0
reuptake	0
inhibitors	0
,	0
venlafaxine	0
,	I-DISEASE
tricyclic	0
antidepressants	I-DISEASE
,	I-DISEASE
mono-	0
amine	0
oxidase	0
inhibitors	0
,	0
mirtazapine	0
,	0
bisoprolol	0
,	0
selegiline	I-DISEASE
,	0
or	0
cholinergic	I-DISEASE
treatment	I-DISEASE
for	0
Alzheimer	I-DISEASE
disease	0
,	I-DISEASE
have	0
been	I-DISEASE
reported	0
to	I-DISEASE
be	0
associated	0
with	0
acute	I-DISEASE
or	0
chronic	I-DISEASE
RBD	I-DISEASE
.	I-DISEASE

Acute	I-DISEASE
RBD	0
can	0
also	0
be	I-DISEASE
seen	I-DISEASE
during	I-DISEASE
states	0
of	I-DISEASE
withdrawal	0
from	I-DISEASE
cocaine	I-DISEASE
,	0
amphetamine	I-DISEASE
,	0
alcohol	0
,	I-DISEASE
barbiturate	0
,	I-DISEASE
and	0
meprobamate	I-DISEASE
abuse	I-DISEASE
.	B-DISEASE

Caffeine	I-DISEASE
and	0
chocolate	0
abuse	I-DISEASE
have	I-DISEASE
been	I-DISEASE
implicated	0
in	0
causing	0
or	I-DISEASE
unmasking	I-DISEASE
RBD	I-DISEASE
.	0

However	I-DISEASE
,	I-DISEASE
when	0
diagnostic	0
criteria	0
for	I-DISEASE
RBD	I-DISEASE
are	0
met	0
,	I-DISEASE
the	0
more	I-DISEASE
specific	I-DISEASE
diagnosis	I-DISEASE
of	I-DISEASE
REM	I-DISEASE
sleep	0
behavior	0
disorder	I-DISEASE
should	I-DISEASE
be	I-DISEASE
made	0
.	0

The	I-DISEASE
use	I-DISEASE
of	I-DISEASE
medications	I-DISEASE
such	0
as	0
β	0
-	I-DISEASE
adrenergic	0
receptor	I-DISEASE
-	I-DISEASE
blocking	0
agents	0
can	I-DISEASE
be	I-DISEASE
associ-	0
ated	0
with	I-DISEASE
sleep	I-DISEASE
related	0
hallucinations	I-DISEASE
.	B-DISEASE

When	I-DISEASE
the	0
clinical	0
presentation	0
suggests	0
a	0
direct	0
relationship	I-DISEASE
between	0
a	0
drug	0
or	I-DISEASE
substance	I-DISEASE
and	0
sleep	0
related	0
hallucinations	I-DISEASE
,	0
a	0
diagnosis	0
of	I-DISEASE
parasomnia	I-DISEASE
due	0
to	I-DISEASE
a	0
medication	0
or	0
substance	I-DISEASE
should	0
be	0
employed	0
.	0

Sedative	I-DISEASE
-	I-DISEASE
hypnotics	0
such	0
as	0
zolpidem	I-DISEASE
and	0
zopiclone	I-DISEASE
have	0
been	I-DISEASE
associated	0
with	I-DISEASE
apparent	0
NREM	0
parasomnias	I-DISEASE
including	0
SRED	I-DISEASE
and	0
sleep	0
driving	0
.	0

It	I-DISEASE
has	0
been	0
suggested	0
that	0
sleep	0
driving	0
is	I-DISEASE
an	0
overlap	0
behavior	I-DISEASE
in	I-DISEASE
which	I-DISEASE
the	0
sedative	0
-	I-DISEASE
hypnotic	0
increases	0
the	0
arousal	0
threshold	0
during	I-DISEASE
sleep	0
at	I-DISEASE
the	0
beginning	B-DISEASE
of	I-DISEASE
the	0
behavior	I-DISEASE
,	0
while	0
later	0
behavior	I-DISEASE
is	0
due	0
to	0
the	0
CNS	0
depressing	I-DISEASE
effects	0
of	I-DISEASE
the	0
drug	0
while	0
awake	0
.	0

It	I-DISEASE
has	0
not	0
been	I-DISEASE
determined	0
if	0
drug	0
-	0
re-	0
lated	I-DISEASE
NREM	I-DISEASE
parasomnias	I-DISEASE
are	0
associated	0
with	I-DISEASE
the	0
same	0
genetic	I-DISEASE
predisposition	0
,	I-DISEASE
priming	0
factors	0
,	I-DISEASE
and	0
triggers	I-DISEASE
observed	I-DISEASE
in	0
disorders	0
of	I-DISEASE
arousal	0
.	0

When	I-DISEASE
clinical	0
presentation	0
sug-	0
gests	0
a	0
direct	0
relationship	0
between	0
disorders	I-DISEASE
of	I-DISEASE
arousal	0
and	0
use	0
of	I-DISEASE
a	0
drug	0
or	0
substance	I-DISEASE
,	0
a	0
diagnosis	0
of	I-DISEASE
parasomnia	0
due	I-DISEASE
to	0
a	0
medication	0
or	I-DISEASE
substance	I-DISEASE
should	0
be	0
employed	0
.	0

Alcohol	I-DISEASE
has	0
often	0
appeared	I-DISEASE
on	0
lists	0
of	I-DISEASE
potential	0
sleepwalking	0
triggers	I-DISEASE
without	0
a	0
basis	I-DISEASE
in	0
reliable	0
empirical	0
scientific	0
research	I-DISEASE
.	0

Recent	I-DISEASE
evidence	0
-	0
based	I-DISEASE
reviews	0
have	I-DISEASE
found	I-DISEASE
no	0
relationship	0
between	0
alcohol	0
and	0
sleepwalking	I-DISEASE
.	0

The	I-DISEASE
behavior	I-DISEASE
of	I-DISEASE
the	0
alcohol	0
-	I-DISEASE
in-	I-DISEASE
toxicated	0
individual	I-DISEASE
may	I-DISEASE
superficially	I-DISEASE
resemble	0
that	0
of	I-DISEASE
the	I-DISEASE
sleepwalker	0
.	0

However	I-DISEASE
,	I-DISEASE
the	0
sleepwalker	0
is	I-DISEASE
typically	0
severely	0
cognitively	0
impaired	I-DISEASE
,	I-DISEASE
but	I-DISEASE
with	0
only	0
limited	I-DISEASE
motor	I-DISEASE
impairment	0
.	0

The	I-DISEASE
alcohol	I-DISEASE
-	0
intoxicated	I-DISEASE
individual	I-DISEASE
’s	I-DISEASE
level	0
of	I-DISEASE
cognitive	0
functioning	I-DISEASE
may	I-DISEASE
be	0
reduced	0
,	I-DISEASE
but	I-DISEASE
not	0
absent	0
,	I-DISEASE
whereas	0
motor	I-DISEASE
behavior	I-DISEASE
is	0
severely	I-DISEASE
impaired	0
.	0

Proponents	I-DISEASE
of	I-DISEASE
the	0
theory	0
of	I-DISEASE
alcohol	I-DISEASE
related	B-DISEASE
sleepwalking	0
suggest	I-DISEASE
that	I-DISEASE
the	0
effects	0
of	I-DISEASE
alcohol	I-DISEASE
are	I-DISEASE
similar	0
to	0
that	0
of	I-DISEASE
sleep	0
deprivation	0
—	I-DISEASE
that	0
is	I-DISEASE
,	I-DISEASE
alcohol	I-DISEASE
increases	0
deep	0
sleep	0
.	0

However	I-DISEASE
,	I-DISEASE
this	0
claim	0
in	0
not	0
substantiated	I-DISEASE
by	I-DISEASE
sleep	0
laboratory	I-DISEASE
-	I-DISEASE
based	I-DISEASE
studies	I-DISEASE
in	I-DISEASE
normal	B-DISEASE
controls	0
,	0
and	0
no	0
empirical	0
sleep	0
studies	I-DISEASE
of	I-DISEASE
alcohol	I-DISEASE
and	0
sleepwalking	0
have	I-DISEASE
ever	B-DISEASE
been	I-DISEASE
conducted	I-DISEASE
.	0

There	I-DISEASE
is	I-DISEASE
no	0
scientific	I-DISEASE
evidence	0
that	0
complex	0
behaviors	I-DISEASE
occurring	0
during	0
the	0
sleep	0
period	I-DISEASE
following	0
alcohol	0
ingestion	0
are	0
anything	0
other	I-DISEASE
than	0
the	0
nocturnal	0
wandering	I-DISEASE
of	0
Parasomnias	0
Parasomnias	0
an	0
alcohol	I-DISEASE
-	0
intoxicated	0
individual	0
.	0

Unconsciousness	I-DISEASE
,	I-DISEASE
intoxication	I-DISEASE
,	I-DISEASE
and	0
sleep	0
are	I-DISEASE
very	I-DISEASE
different	I-DISEASE
states	I-DISEASE
of	I-DISEASE
consciousness	0
.	0

Parasomnias	I-DISEASE
should	I-DISEASE
be	I-DISEASE
easily	0
distinguished	0
from	0
alcohol	I-DISEASE
intoxication	I-DISEASE
by	B-DISEASE
the	0
presence	0
of	I-DISEASE
significant	0
alcohol	0
ingestion	0
prior	0
to	0
bedtime	I-DISEASE
.	0

The	I-DISEASE
association	I-DISEASE
of	I-DISEASE
therapeutic	I-DISEASE
doses	0
of	I-DISEASE
sedative	I-DISEASE
hypnotic	0
drugs	0
and	0
apparent	0
para-	I-DISEASE
somnias	0
should	0
be	0
carefully	I-DISEASE
distinguished	0
from	I-DISEASE
the	0
expected	I-DISEASE
effects	0
of	I-DISEASE
drug	0
abuse	I-DISEASE
or	0
misuse	0
that	0
result	0
in	0
CNS	0
depression	0
.	0

Investigations	I-DISEASE
of	I-DISEASE
drivers	0
who	0
had	I-DISEASE
accidents	0
attributed	0
to	0
drug	0
-	0
related	0
sleep	I-DISEASE
driving	I-DISEASE
are	0
reported	0
to	I-DISEASE
show	I-DISEASE
that	0
(	0
1	0
)	0
blood	I-DISEASE
levels	0
of	I-DISEASE
prescribed	0
sedative	0
hypnotics	I-DISEASE
exceeded	0
therapeutic	I-DISEASE
ranges	0
;	0
(	0
2	0
)	0
the	0
individuals	0
failed	0
to	0
take	0
the	I-DISEASE
medication	0
at	I-DISEASE
the	0
correct	0
time	0
or	0
remain	0
in	0
bed	I-DISEASE
for	0
sufficient	I-DISEASE
time	0
follow-	I-DISEASE
ing	0
ingestion	I-DISEASE
;	0
and/or	0
(	0
3	I-DISEASE
)	0
the	0
individuals	I-DISEASE
combined	0
sedative	I-DISEASE
-	0
hypnotics	0
with	0
other	0
CNS	I-DISEASE
depressants	I-DISEASE
and/or	0
alcohol	0
.	0

Driving	I-DISEASE
with	I-DISEASE
a	0
high	I-DISEASE
blood	0
level	0
of	I-DISEASE
a	I-DISEASE
sedative	I-DISEASE
-	I-DISEASE
hypnotic	I-DISEASE
can	I-DISEASE
result	0
in	0
significant	0
cognitive	0
and	0
motor	I-DISEASE
impairment	0
.	0

Serious	I-DISEASE
accidents	0
can	I-DISEASE
result	0
.	0

Sleep	I-DISEASE
driving	I-DISEASE
and	0
other	I-DISEASE
complex	0
behaviors	I-DISEASE
in	I-DISEASE
this	0
population	0
are	0
more	0
likely	I-DISEASE
to	I-DISEASE
have	I-DISEASE
resulted	0
from	0
drug	0
misuse	I-DISEASE
and	0
abuse	I-DISEASE
rather	0
than	0
true	0
parasomnias	I-DISEASE
.	0

Parasomnia	I-DISEASE
,	0
Unspecified	I-DISEASE
ICD-9	0
-	0
CM	0
code	0
:	I-DISEASE
327.40	0
ICD-10	0
-	0
CM	I-DISEASE
code	0
:	0
G47.50	I-DISEASE
This	0
diagnosis	0
is	0
intended	0
for	0
parasomnias	0
that	0
can	I-DISEASE
not	0
be	0
classified	0
elsewhere	0
or	0
for	0
cases	0
in	0
which	0
the	0
physician	I-DISEASE
has	0
a	0
clinical	0
suspicion	0
of	I-DISEASE
a	I-DISEASE
parasomnia	I-DISEASE
but	0
is	I-DISEASE
unable	I-DISEASE
to	I-DISEASE
establish	0
a	0
specific	I-DISEASE
diagnosis	I-DISEASE
.	0

In	I-DISEASE
many	0
cases	0
,	I-DISEASE
“	0
parasomnia	I-DISEASE
,	0
unspecified	I-DISEASE
”	I-DISEASE
will	0
be	I-DISEASE
a	I-DISEASE
tem-	0
porary	0
diagnosis	0
.	0

However	I-DISEASE
,	I-DISEASE
in	0
other	I-DISEASE
patients	0
,	I-DISEASE
an	0
underlying	0
condition	0
may	0
not	0
ever	I-DISEASE
be	I-DISEASE
established	I-DISEASE
,	0
and	0
in	I-DISEASE
those	I-DISEASE
patients	0
,	0
“	I-DISEASE
parasomnia	I-DISEASE
,	I-DISEASE
unspecified	0
”	I-DISEASE
should	B-DISEASE
remain	0
an	0
ongoing	I-DISEASE
diagnosis	0
.	0

Isolated	I-DISEASE
Symptoms	I-DISEASE
and	0
Normal	0
Variants	0
Sleep	I-DISEASE
Talking	0
Alternate	0
Names	I-DISEASE
Somniloquy	0
.	0

The	I-DISEASE
essential	0
feature	0
is	I-DISEASE
talking	0
,	I-DISEASE
with	I-DISEASE
varying	0
degrees	0
of	I-DISEASE
comprehensibility	I-DISEASE
,	I-DISEASE
during	I-DISEASE
sleep	0
.	0

Sleep	I-DISEASE
talking	0
may	0
occur	I-DISEASE
during	I-DISEASE
REM	I-DISEASE
or	I-DISEASE
NREM	0
sleep	0
.	I-DISEASE

Sleep	I-DISEASE
talking	0
can	0
be	I-DISEASE
idiopathic	B-DISEASE
or	I-DISEASE
associated	0
with	0
parasomnias	I-DISEASE
such	0
as	0
RBD	I-DISEASE
or	0
disorders	0
of	I-DISEASE
arousal	0
such	0
as	0
confusional	I-DISEASE
arousal	0
.	0

Sleep	I-DISEASE
talking	0
may	0
follow	I-DISEASE
arousals	0
from	0
sleep	0
or	0
more	0
rarely	I-DISEASE
cause	I-DISEASE
them	I-DISEASE
.	0

Sleep	I-DISEASE
talking	0
is	0
highly	I-DISEASE
prevalent	0
.	0

A	I-DISEASE
recent	I-DISEASE
cross	0
-	I-DISEASE
sectional	0
epidemiologic	0
study	I-DISEASE
found	I-DISEASE
the	0
life-	0
time	I-DISEASE
prevalence	0
of	0
sleep	0
talking	0
to	0
be	0
66	I-DISEASE
%	0
and	0
current	I-DISEASE
prevalence	0
—	I-DISEASE
in	0
the	0
past	I-DISEASE
three	0
months	0
—	I-DISEASE
to	I-DISEASE
be	0
17	0
%	0
.	0

There	I-DISEASE
is	I-DISEASE
no	0
apparent	0
sex	0
difference	I-DISEASE
.	0

Onset	I-DISEASE
and	0
course	I-DISEASE
are	0
unknown	I-DISEASE
.	0

Complications	I-DISEASE
usually	0
arise	I-DISEASE
when	0
sleep	0
talking	0
is	0
very	I-DISEASE
frequent	0
or	I-DISEASE
loud	I-DISEASE
or	0
if	0
the	0
content	I-DISEASE
is	0
objectionable	0
to	0
others	I-DISEASE
.	0

Sleep	I-DISEASE
talking	0
is	0
usually	I-DISEASE
reported	0
by	I-DISEASE
the	0
bed	I-DISEASE
partner	0
or	0
someone	I-DISEASE
sleeping	I-DISEASE
in	I-DISEASE
the	0
same	0
room	I-DISEASE
or	I-DISEASE
sleeping	I-DISEASE
area	0
as	0
the	0
affected	I-DISEASE
individual	I-DISEASE
.	0

Sleep	I-DISEASE
talking	0
can	0
disrupt	I-DISEASE
the	0
sleep	0
of	I-DISEASE
a	I-DISEASE
bed	I-DISEASE
partner	0
,	0
roommate	0
,	I-DISEASE
or	I-DISEASE
others	B-DISEASE
in	I-DISEASE
a	0
group	I-DISEASE
-	0
sleeping	0
situation	I-DISEASE
(	I-DISEASE
such	0
as	0
college	0
dormitories	I-DISEASE
,	I-DISEASE
military	I-DISEASE
barracks	I-DISEASE
,	I-DISEASE
fire	0
stations	I-DISEASE
,	I-DISEASE
or	0
a	0
tent	0
while	I-DISEASE
camping	I-DISEASE
)	0
.	0

The	I-DISEASE
content	0
of	I-DISEASE
sleep	0
talking	0
has	0
not	0
been	I-DISEASE
shown	0
to	0
reflect	I-DISEASE
actual	I-DISEASE
prior	I-DISEASE
waking	0
behavior	I-DISEASE
or	I-DISEASE
memories	0
.	0

The	I-DISEASE
sleep	0
talker	0
is	0
rarely	I-DISEASE
aware	I-DISEASE
of	I-DISEASE
his	0
or	0
her	0
sleep	0
talking	I-DISEASE
.	0

Nocturnal	I-DISEASE
vocalization	0
,	0
including	0
frank	I-DISEASE
sleep	0
talking	0
,	0
is	I-DISEASE
often	I-DISEASE
seen	I-DISEASE
in	0
patients	I-DISEASE
with	I-DISEASE
RBD	I-DISEASE
and	0
subclinical	I-DISEASE
RBD	0
.	0

A	I-DISEASE
recent	I-DISEASE
report	0
notes	I-DISEASE
that	0
sleep	0
talking	0
may	I-DISEASE
be	0
a	0
useful	0
diagnostic	I-DISEASE
marker	I-DISEASE
for	I-DISEASE
differentiating	0
DLB	I-DISEASE
from	0
Alzheimer	0
disease	I-DISEASE
and	0
other	I-DISEASE
types	I-DISEASE
of	I-DISEASE
dementia	0
.	0

The	I-DISEASE
vocalizations	I-DISEASE
of	I-DISEASE
RBD	0
may	I-DISEASE
be	I-DISEASE
loud	I-DISEASE
,	0
emotional	I-DISEASE
,	I-DISEASE
profane	I-DISEASE
,	I-DISEASE
and	0
associated	0
with	0
behav-	0
iors	I-DISEASE
that	0
correlate	0
with	I-DISEASE
remembered	I-DISEASE
dream	I-DISEASE
mentation	0
.	0

Nocturnal	I-DISEASE
seizures	0
may	0
be	I-DISEASE
asso-	0
ciated	0
with	I-DISEASE
vocalization	I-DISEASE
that	0
tends	0
to	I-DISEASE
be	I-DISEASE
stereotypic	0
.	0

The	I-DISEASE
vocalizations	0
associated	0
with	0
sleep	0
terrors	0
are	0
emotionally	0
laden	I-DISEASE
and	0
associated	I-DISEASE
with	I-DISEASE
behaviors	0
of	I-DISEASE
intense	I-DISEASE
arousal	I-DISEASE
and	0
agitation	0
.	0

In	I-DISEASE
PTSD	I-DISEASE
,	I-DISEASE
increased	0
vocalizations	0
during	I-DISEASE
sleep	0
have	0
been	I-DISEASE
described	0
.	I-DISEASE

Bibliography	0
Arkin	I-DISEASE
AM	I-DISEASE
,	I-DISEASE
Toth	I-DISEASE
MF	I-DISEASE
,	I-DISEASE
Baker	I-DISEASE
J	I-DISEASE
,	0
Hastey	0
JM	0
.	0

The	I-DISEASE
frequency	I-DISEASE
of	I-DISEASE
sleep	0
talking	0
in	I-DISEASE
the	0
laboratory	I-DISEASE
among	0
chronic	0
sleep	0
talkers	0
and	0
good	0
dream	I-DISEASE
recallers	I-DISEASE
.	0

J	I-DISEASE
Nerv	0
Ment	0
Dis	I-DISEASE
1970;151:369–74	I-DISEASE
.	0

Bjorvatn	0
B	0
,	I-DISEASE
Grønli	I-DISEASE
J	I-DISEASE
,	I-DISEASE
Pallesen	0
S.	I-DISEASE
Prevalence	0
of	I-DISEASE
different	0
parasomnias	I-DISEASE
in	I-DISEASE
the	I-DISEASE
general	0
population	0
.	0

Sleep	I-DISEASE
Med	I-DISEASE
2010;11:1031–4	I-DISEASE
.	0

Parasomnias	I-DISEASE
Parasomnias	I-DISEASE
Honda	I-DISEASE
K	I-DISEASE
,	I-DISEASE
Hashimoto	I-DISEASE
M	I-DISEASE
,	I-DISEASE
Yatabe	0
Y	I-DISEASE
,	0
et	0
al	I-DISEASE
.	0

The	I-DISEASE
usefulness	0
of	I-DISEASE
monitoring	0
sleep	0
talking	0
for	I-DISEASE
the	0
diagnosis	0
of	I-DISEASE
Dementia	I-DISEASE
with	0
Lewy	0
bodies	I-DISEASE
.	0

Int	I-DISEASE
Psychogeriatr	0
2013;25:851–8	0
.	0

Hublin	I-DISEASE
C	0
,	I-DISEASE
Kaprio	0
J	0
,	0
Partinen	0
M	I-DISEASE
,	I-DISEASE
Koskenvuo	0
M.	0
Sleeptalking	0
in	0
twins	0
:	I-DISEASE
epidemiology	0
and	0
psychiatric	I-DISEASE
comorbidity	0
.	0

Behav	I-DISEASE
Genet	I-DISEASE
1998;28:289–98	0
.	0

Reimao	I-DISEASE
RN	I-DISEASE
,	I-DISEASE
Lefevre	0
AB	0
.	0

Prevalence	I-DISEASE
of	I-DISEASE
sleep	0
-	0
talking	0
in	I-DISEASE
childhood	I-DISEASE
.	0

Brain	0
Dev	I-DISEASE
1980;2:353–7	0
.	0

Sleep	I-DISEASE
Related	I-DISEASE
Movement	I-DISEASE
Disorders	0
Restless	I-DISEASE
Legs	0
Syndrome282	I-DISEASE
Periodic	I-DISEASE
Limb	0
Movement	0
Disorder	0
292	I-DISEASE
Sleep	0
Related	0
Leg	0
Cramps	I-DISEASE

299	I-DISEASE
Sleep	0
Related	I-DISEASE
Bruxism303	0
Sleep	0
Related	I-DISEASE
Rhythmic	0
Movement	0
Disorder312	I-DISEASE
Benign	0
Sleep	0
Myoclonus	I-DISEASE
of	I-DISEASE
Infancy	B-DISEASE
317	I-DISEASE
Propriospinal	B-DISEASE
Myoclonus	0
at	I-DISEASE
Sleep	0
Onset321	I-DISEASE
Sleep	0
Related	0
Movement	0
Disorder	0
Due	I-DISEASE
to	0
a	0
Medical	0
Disorder325	0
Sleep	0
Related	0
Movement	0
Disorder	I-DISEASE
Due	I-DISEASE
to	0
a	0
Medication	0
or	0
Substance	I-DISEASE
.....	0
326	0
Sleep	I-DISEASE
Related	I-DISEASE
Movement	0
Disorder	0
,	0
Unspecified327	I-DISEASE
Isolated	I-DISEASE
Symptoms	B-DISEASE
and	0
Normal	I-DISEASE
Variants	0
Excessive	I-DISEASE
Fragmentary	I-DISEASE
Myoclonus	0
328	0
Hypnagogic	0
Foot	0
Tremor	0
and	0
Alternating	0
Leg	0
Muscle	I-DISEASE
Activation	I-DISEASE
330	I-DISEASE
Sleep	0
Starts	0
(	0
Hypnic	0
Jerks)335	0

Sleep	I-DISEASE
related	I-DISEASE
movement	0
disorders	0
are	0
primarily	I-DISEASE
characterized	0
by	I-DISEASE
relatively	0
simple	I-DISEASE
,	I-DISEASE
usually	I-DISEASE
stereotyped	I-DISEASE
,	I-DISEASE
movements	I-DISEASE
that	I-DISEASE
disturb	I-DISEASE
sleep	0
or	I-DISEASE
its	I-DISEASE
onset	I-DISEASE
.	0

Restless	I-DISEASE
legs	0
syndrome	I-DISEASE
(	0
RLS	I-DISEASE
)	0
is	0
an	0
exception	0
in	I-DISEASE
that	I-DISEASE
patients	I-DISEASE
typically	0
engage	0
in	I-DISEASE
walking	I-DISEASE
or	0
nonstereotypic	0
limb	0
movement	I-DISEASE
to	0
reduce	I-DISEASE
leg	I-DISEASE
discomfort	I-DISEASE
.	0

However	I-DISEASE
,	I-DISEASE
RLS	0
is	0
closely	I-DISEASE
associated	0
with	I-DISEASE
periodic	0
limb	0
movements	0
(	I-DISEASE
PLMs	I-DISEASE
)	0
,	I-DISEASE
which	I-DISEASE
are	0
usually	0
simple	I-DISEASE
and	0
stereotyped	I-DISEASE
within	I-DISEASE
a	0
series	I-DISEASE
.	0

Nocturnal	I-DISEASE
sleep	0
disturbance	I-DISEASE
or	0
complaints	0
of	I-DISEASE
daytime	I-DISEASE
sleepiness	0
or	0
fatigue	I-DISEASE
are	I-DISEASE
a	I-DISEASE
prerequisite	0
for	I-DISEASE
a	0
diagnosis	0
of	I-DISEASE
a	0
sleep	0
related	B-DISEASE
movement	0
disorder	I-DISEASE
.	0

For	I-DISEASE
example	0
,	0
many	0
normal	0
sleepers	0
exhibit	0
episodes	I-DISEASE
of	I-DISEASE
periodic	I-DISEASE
limb	I-DISEASE
movements	I-DISEASE
of	I-DISEASE
sleep	0
(	I-DISEASE
PLMS	0
)	0
but	I-DISEASE
have	0
no	0
complaint	0
of	I-DISEASE
a	I-DISEASE
sleep	0
disturbance	I-DISEASE
,	I-DISEASE
nor	I-DISEASE
do	I-DISEASE
they	I-DISEASE
show	0
a	0
significant	0
objective	I-DISEASE
dis-	0
turbance	0
of	0
their	0
sleep	0
as	I-DISEASE
a	0
result	0
of	I-DISEASE
the	0
movements	0
.	0

Such	I-DISEASE
persons	I-DISEASE
should	0
not	0
be	0
classi-	I-DISEASE
fied	0
as	0
having	I-DISEASE
periodic	I-DISEASE
limb	I-DISEASE
movement	0
disorder	I-DISEASE
(	I-DISEASE
PLMD	I-DISEASE
)	0
,	0
but	I-DISEASE
instead	0
,	I-DISEASE
the	I-DISEASE
presence	0
of	I-DISEASE
PLMS	0
should	I-DISEASE
simply	0
be	0
noted	0
.	0

Similar	I-DISEASE
considerations	0
relate	I-DISEASE
to	I-DISEASE
the	0
distinction	I-DISEASE
between	0
rhythmic	I-DISEASE
movement	0
disorder	0
and	0
the	0
presence	I-DISEASE
of	I-DISEASE
rhythmic	B-DISEASE
movements	0
.	0

Body	I-DISEASE
movements	0
that	0
disturb	I-DISEASE
sleep	0
also	0
are	0
seen	I-DISEASE
in	0
many	0
other	0
sleep	0
disorder	I-DISEASE
categories	I-DISEASE
(	0
e.g.	0
,	0
in	I-DISEASE
parasomnias	I-DISEASE
such	0
as	0
sleepwalking	0
,	I-DISEASE
sleep	0
terrors	0
,	0
and	0
rapid	I-DISEASE
eye	0
movement	0
(	0
REM	0
)	0
sleep	0
behavior	I-DISEASE
disorder	I-DISEASE
(	I-DISEASE
RBD	I-DISEASE
)	0
)	0
.	0

However	I-DISEASE
,	I-DISEASE
these	0
parasomnias	I-DISEASE
differ	0
from	0
the	0
simple	I-DISEASE
ste-	I-DISEASE
reotyped	0
movements	0
categorized	I-DISEASE
as	0
sleep	0
related	I-DISEASE
movement	0
disorders	0
in	I-DISEASE
that	0
they	I-DISEASE
involve	0
complex	0
behaviors	I-DISEASE
during	I-DISEASE
the	0
sleep	0
period	I-DISEASE
.	0

Parasomnia	I-DISEASE
-	0
related	0
movements	0
may	I-DISEASE
appear	0
Sleep	0
Related	0
Movement	I-DISEASE
Disorders	I-DISEASE
purposeful	0
and	0
goal	0
directed	I-DISEASE
,	0
but	I-DISEASE
are	0
outside	I-DISEASE
the	I-DISEASE
conscious	0
awareness	I-DISEASE
of	I-DISEASE
the	0
individual	0
.	0

Parasomnias	I-DISEASE
are	0
listed	0
in	I-DISEASE
a	0
separate	0
section	I-DISEASE
from	I-DISEASE
the	I-DISEASE
sleep	0
related	0
movement	I-DISEASE
disorders	0
.	0

Although	I-DISEASE
the	0
history	I-DISEASE
may	I-DISEASE
be	0
diagnostic	0
,	0
polysomnography	0
is	I-DISEASE
sometimes	0
necessary	0
to	I-DISEASE
make	0
a	0
firm	0
diagnosis	0
of	I-DISEASE
sleep	0
related	0
movement	0
disorders	0
and	0
distinguish	0
them	I-DISEASE
from	I-DISEASE
parasomnias	I-DISEASE
.	0

In	I-DISEASE
these	I-DISEASE
cases	0
,	I-DISEASE
it	0
is	0
necessary	0
to	I-DISEASE
add	0
all	0
-	0
night	0
video	I-DISEASE
recording	I-DISEASE
to	0
the	0
poly-	0
somnographic	0
recording	0
and	0
to	I-DISEASE
correlate	0
the	I-DISEASE
documented	0
movements	0
with	I-DISEASE
the	0
techni-	0
cian	0
’s	I-DISEASE
description	0
of	0
the	0
patient	I-DISEASE
’s	I-DISEASE
behavior	I-DISEASE
and	0
level	0
of	I-DISEASE
consciousness	0
in	0
order	0
to	I-DISEASE
estab-	I-DISEASE
lish	0
a	0
diagnosis	0
.	I-DISEASE

There	I-DISEASE
are	0
some	0
movement	I-DISEASE
disorders	0
that	0
may	0
occur	I-DISEASE
during	I-DISEASE
both	0
sleep	0
and	0
wakefulness	I-DISEASE
.	0

If	I-DISEASE
the	0
presentation	0
during	I-DISEASE
sleep	0
is	I-DISEASE
significantly	0
different	I-DISEASE
from	0
that	0
during	I-DISEASE
wakefulness	0
,	I-DISEASE
or	0
if	0
the	0
movement	I-DISEASE
is	0
entirely	0
confined	0
to	0
sleep	0
,	0
then	0
the	I-DISEASE
move-	0
ment	0
disorder	0
is	0
classified	0
here	I-DISEASE
(	I-DISEASE
e.g.	0
,	0
the	0
occurrence	0
of	0
bruxism	0
exclusively	I-DISEASE
in	I-DISEASE
sleep	I-DISEASE
)	0
.	0

Restless	I-DISEASE
Legs	0
Syndrome	0
ICD-9	I-DISEASE
-	I-DISEASE
CM	I-DISEASE
code	0
:	0
333.94	0
Alternate	0
Names	I-DISEASE
Willis	I-DISEASE
-	0
Ekbom	0
disease	I-DISEASE
.	0

Diagnostic	I-DISEASE
Criteria	0
Criteria	I-DISEASE
A	0
-	I-DISEASE
C	I-DISEASE
must	I-DISEASE
be	0
met	0
ICD-10	0
-	0
CM	0
code	0
:	0

G25.81	I-DISEASE
A.	0
An	0
urge	0
to	0
move	0
the	0
legs	I-DISEASE
,	I-DISEASE
usually	I-DISEASE
accompanied	0
by	I-DISEASE
or	I-DISEASE
thought	I-DISEASE
to	0
be	0
caused	0
by	I-DISEASE
uncomfortable	0
and	0
unpleasant	0
sensations	I-DISEASE
in	0
the	I-DISEASE
legs.1,2	0
These	0
symptoms	I-DISEASE
must	I-DISEASE
:	I-DISEASE
.	0

Begin	I-DISEASE
or	0
worsen	0
during	I-DISEASE
periods	0
of	I-DISEASE
rest	0
or	0
inactivity	0
such	0
as	0
lying	0
down	B-DISEASE
or	I-DISEASE
sitting	0
;	0
.	0

Be	I-DISEASE
partially	0
or	0
totally	I-DISEASE
relieved	I-DISEASE
by	I-DISEASE
movement	I-DISEASE
,	I-DISEASE
such	0
as	0
walking	0
or	I-DISEASE
stretching	I-DISEASE
,	I-DISEASE
at	I-DISEASE
least	I-DISEASE
as	0
long	I-DISEASE
as	0
the	0
activity	0
continues;3	0
and	0
.	0

Occur	I-DISEASE
exclusively	I-DISEASE
or	0
predominantly	I-DISEASE
in	I-DISEASE
the	B-DISEASE
evening	0
or	0
night	0
rather	0
than	I-DISEASE
during	I-DISEASE
the	0
day.4	0
B.	0
The	I-DISEASE
above	0
features	I-DISEASE
are	0
not	0
solely	0
accounted	0
for	I-DISEASE
as	0
symptoms	I-DISEASE
of	I-DISEASE
another	I-DISEASE
medical	0
or	0
a	0
behavioral	0
condition	0
(	0
e.g.	0
,	0
leg	0
cramps	I-DISEASE
,	I-DISEASE
positional	I-DISEASE
discomfort	0
,	0
myalgia	0
,	0
venous	I-DISEASE
stasis	0
,	0
leg	I-DISEASE
edema	I-DISEASE
,	I-DISEASE
arthritis	0
,	I-DISEASE
habitual	0
foot	0
tapping	I-DISEASE
)	0
.	0

C.	I-DISEASE

The	I-DISEASE
symptoms	I-DISEASE
of	I-DISEASE
RLS	I-DISEASE
cause	I-DISEASE
concern	I-DISEASE
,	I-DISEASE
distress	I-DISEASE
,	0
sleep	0
disturbance	I-DISEASE
,	I-DISEASE
or	I-DISEASE
impairment	0
in	I-DISEASE
mental	0
,	0
physical	0
,	0
social	0
,	I-DISEASE
occupational	I-DISEASE
,	I-DISEASE
educational	0
,	I-DISEASE
behavioral	0
,	I-DISEASE
or	I-DISEASE
other	I-DISEASE
important	0
areas	B-DISEASE
of	I-DISEASE
functioning.5	I-DISEASE
Notes	0
.	0

Sometimes	I-DISEASE
the	0
urge	0
to	I-DISEASE
move	0
the	0
legs	I-DISEASE
is	I-DISEASE
present	I-DISEASE
without	0
the	0
uncomfortable	0
sensations	I-DISEASE
,	I-DISEASE
and	0
sometimes	0
the	0
arms	I-DISEASE
or	0
other	0
parts	I-DISEASE
of	I-DISEASE
the	0
body	I-DISEASE
are	I-DISEASE
involved	I-DISEASE
in	0
addition	0
to	0
the	I-DISEASE
legs	0
.	0
.	0

For	I-DISEASE
children	I-DISEASE
,	0
the	0
description	0
of	I-DISEASE
these	I-DISEASE
symptoms	I-DISEASE
should	0
be	0
in	I-DISEASE
the	0
child	I-DISEASE
’s	I-DISEASE
own	I-DISEASE
words	I-DISEASE
.	I-DISEASE
.	0

When	I-DISEASE
symptoms	I-DISEASE
are	0
very	I-DISEASE
severe	0
,	I-DISEASE
relief	0
by	I-DISEASE
activity	0
may	0
not	0
be	I-DISEASE
noticeable	I-DISEASE
but	I-DISEASE
must	0
have	0
been	I-DISEASE
previously	I-DISEASE
present	0
.	0
.	0

As	I-DISEASE
a	0
result	0
of	I-DISEASE
severity	0
,	I-DISEASE
treatment	I-DISEASE
intervention	I-DISEASE
,	0
or	0
treatment	I-DISEASE
-	I-DISEASE
induced	I-DISEASE
augmentation	0
,	I-DISEASE
the	0
worsening	0
in	I-DISEASE
the	0
evening	0
or	0
night	0
may	I-DISEASE
not	0
be	I-DISEASE
noticeable	0
but	I-DISEASE
must	0
have	B-DISEASE
been	I-DISEASE
previously	I-DISEASE
present	I-DISEASE
.	0
.	0

For	I-DISEASE
certain	0
research	0
applications	I-DISEASE
,	0
such	I-DISEASE
as	0
genetic	I-DISEASE
or	B-DISEASE
epidemiological	0
studies	I-DISEASE
,	I-DISEASE
it	I-DISEASE
may	I-DISEASE
be	0
appropriate	I-DISEASE
to	I-DISEASE
omit	0
criterion	0
C.	0

If	I-DISEASE
so	0
,	0
this	0
should	0
be	I-DISEASE
clearly	0
stated	0
in	0
the	0
research	0
report	0
.	I-DISEASE

Essential	I-DISEASE
Features	I-DISEASE
RLS	0
is	0
a	0
sensorimotor	I-DISEASE
disorder	0
characterized	0
by	I-DISEASE
a	I-DISEASE
complaint	I-DISEASE
of	I-DISEASE
a	0
strong	I-DISEASE
,	I-DISEASE
nearly	0
irresist-	0
ible	I-DISEASE
urge	0
to	0
move	I-DISEASE
the	0
limbs	0
.	0

This	I-DISEASE
urge	0
to	0
move	I-DISEASE
is	0
often	0
but	I-DISEASE
not	0
always	0
accompanied	0
by	I-DISEASE
other	0
uncomfortable	I-DISEASE
sensations	I-DISEASE
felt	0
deep	0
inside	I-DISEASE
the	I-DISEASE
limbs	0
or	0
by	I-DISEASE
a	0
feeling	I-DISEASE
that	0
is	0
simply	0
difficult	0
or	I-DISEASE
impossible	0
to	I-DISEASE
describe	0
.	0

Although	I-DISEASE
the	0
legs	0
are	I-DISEASE
most	0
prominently	0
affected	I-DISEASE
,	I-DISEASE
“	0
restless	I-DISEASE
legs	0
”	I-DISEASE
is	I-DISEASE
a	0
misnomer	0
,	0
in	0
that	0
21	0
%	0
to	0
57	0
%	0
of	0
individuals	I-DISEASE
with	0
RLS	I-DISEASE
describe	0
some	0
arm	B-DISEASE
sensations	0
.	0

The	I-DISEASE
most	0
common	I-DISEASE
adult	0
RLS	0
descriptors	I-DISEASE
in	0
English	I-DISEASE
are	I-DISEASE
“	I-DISEASE
rest-	I-DISEASE
less	I-DISEASE
,	I-DISEASE
”	I-DISEASE
“	0
uncomfortable	0
,	I-DISEASE
”	I-DISEASE
“	I-DISEASE
twitchy	0
,	I-DISEASE
”	I-DISEASE
“	I-DISEASE
need	0
to	I-DISEASE
stretch	0
,	I-DISEASE
”	I-DISEASE
“	I-DISEASE
urge	0
to	I-DISEASE
move	I-DISEASE
,	0
”	I-DISEASE
and	0
“	0
legs	0
want	I-DISEASE
to	0
move	I-DISEASE
on	0
their	I-DISEASE
own	I-DISEASE
.	0
”	I-DISEASE

About	I-DISEASE
half	0
express	0
their	0
RLS	0
sensations	0
as	I-DISEASE
painful	0
.	0

“	I-DISEASE
Numb	0
”	0
and	0
“	I-DISEASE
cold	I-DISEASE
”	I-DISEASE
are	0
very	I-DISEASE
uncommon	0
descriptors	I-DISEASE
for	0
RLS	I-DISEASE
.	0

Criteria	I-DISEASE
A1	I-DISEASE
-	0
3	I-DISEASE
specify	I-DISEASE
the	B-DISEASE
necessary	0
characteristics	0
of	I-DISEASE
the	0
RLS	I-DISEASE
sensations	0
:	I-DISEASE
worse	0
at	I-DISEASE
rest	0
,	0
better	0
with	I-DISEASE
movement	I-DISEASE
,	I-DISEASE
and	0
predominant	I-DISEASE
occurrence	0
in	I-DISEASE
the	0
evening	I-DISEASE
or	I-DISEASE
night	I-DISEASE
.	0

The	I-DISEASE
separation	0
of	I-DISEASE
worsening	I-DISEASE
at	I-DISEASE
rest	0
(	I-DISEASE
criterion	0
A1	0
)	0
from	I-DISEASE
worsening	I-DISEASE
in	0
the	0
evening/	0
night	0
(	0
criterion	0
A3	0
)	0
is	0
based	I-DISEASE
on	0
circadian	I-DISEASE
rhythm	I-DISEASE
studies	I-DISEASE
that	B-DISEASE
show	0
an	0
increase	I-DISEASE
at	I-DISEASE
night	0
,	0
independent	I-DISEASE
of	I-DISEASE
activity	0
level	0
.	0

RLS	I-DISEASE
must	I-DISEASE
be	I-DISEASE
differentiated	0
from	I-DISEASE
other	I-DISEASE
condi-	I-DISEASE
tions	0
that	I-DISEASE
can	I-DISEASE
mimic	B-DISEASE
RLS	0
(	I-DISEASE
criterion	0
B	0
)	0
.	0

Clinically	I-DISEASE
significant	0
RLS	I-DISEASE
is	I-DISEASE
defined	I-DISEASE
by	I-DISEASE
RLS	I-DISEASE
symptoms	I-DISEASE
causing	I-DISEASE
substantial	I-DISEASE
distress	I-DISEASE
,	0
sleep	0
disturbance	I-DISEASE
,	I-DISEASE
or	0
impairment	0
of	I-DISEASE
function	0
(	I-DISEASE
criterion	I-DISEASE
C	0
)	I-DISEASE
.	0

Associated	I-DISEASE
Features	I-DISEASE
Disturbed	0
sleep	0
is	I-DISEASE
a	0
common	I-DISEASE
,	I-DISEASE
prominent	0
,	I-DISEASE
and	0
distressing	I-DISEASE
aspect	0
of	I-DISEASE
RLS	0
.	0

Sleep	I-DISEASE
onset	0
and	0
maintenance	I-DISEASE
complaints	0
in	I-DISEASE
individuals	I-DISEASE
with	I-DISEASE
RLS	0
are	0
notably	I-DISEASE
higher	I-DISEASE
than	I-DISEASE
in	0
con-	0
trols	0
,	I-DISEASE
with	0
odds	I-DISEASE
ratios	B-DISEASE
(	0
OR	B-DISEASE
)	0
between	0
1.7	I-DISEASE
and	0
3.5	0
.	0

In	I-DISEASE
clinical	I-DISEASE
populations	0
,	I-DISEASE
disturbed	0
Sleep	I-DISEASE
Related	I-DISEASE
Movement	0
Disorders	0
Sleep	I-DISEASE
Related	0
Movement	0
Disorders	I-DISEASE
sleep	0
is	I-DISEASE
reported	0
in	I-DISEASE
60	0
%	0
to	I-DISEASE
90	I-DISEASE
%	0
of	I-DISEASE
individuals	I-DISEASE
with	I-DISEASE
RLS	I-DISEASE
,	I-DISEASE
is	0
typically	0
the	0
most	0
trou-	0
bling	0
symptom	0
,	I-DISEASE
and	0
is	0
often	0
the	0
primary	0
reason	I-DISEASE
for	0
seeking	I-DISEASE
medical	0
care	I-DISEASE
.	0

The	I-DISEASE
Medical	I-DISEASE
Outcomes	0
Study	I-DISEASE
Sleep	0
Questionnaire	I-DISEASE
scores	0
for	0
sleep	0
quantity	I-DISEASE
,	I-DISEASE
sleep	0
disturbance	I-DISEASE
,	I-DISEASE
sleep	I-DISEASE
adequacy	0
,	I-DISEASE
and	0
sleep	0
problems	I-DISEASE
are	0
significantly	0
worse	0
for	I-DISEASE
RLS	I-DISEASE
patients	0
than	0
con-	0
trols	0
.	0

Daytime	I-DISEASE
fatigue	I-DISEASE
and	0
daytime	0
sleepiness	0
are	I-DISEASE
also	0
common	I-DISEASE
complaints	0
;	I-DISEASE
however	I-DISEASE
,	I-DISEASE
the	0
sleepiness	0
is	I-DISEASE
not	0
as	0
severe	I-DISEASE
as	0
expected	0
for	0
the	0
degree	I-DISEASE
of	0
sleep	0
disruption	I-DISEASE
,	I-DISEASE
implying	0
hyperarousal	I-DISEASE
in	I-DISEASE
RLS	0
.	0

In	I-DISEASE
contrast	I-DISEASE
to	0
obstructive	0
sleep	0
apnea	0
,	I-DISEASE
Epworth	I-DISEASE
Sleepiness	0
Scale	I-DISEASE
scores	0
in	0
RLS	I-DISEASE
are	0
typically	0
in	I-DISEASE
the	I-DISEASE
normal	0
range	I-DISEASE
,	I-DISEASE
and	0
either	I-DISEASE
no	0
different	0
or	0
marginally	0
elevated	I-DISEASE
when	0
compared	I-DISEASE
to	I-DISEASE
normal	0
controls	0
.	0

Clinical	I-DISEASE
sleep	0
disturbance	I-DISEASE
correlates	I-DISEASE
with	I-DISEASE
both	I-DISEASE
severity	B-DISEASE
of	I-DISEASE
RLS	I-DISEASE
and	0
health	I-DISEASE
impact	I-DISEASE
of	I-DISEASE
RLS	I-DISEASE
.	0

Some	I-DISEASE
individuals	I-DISEASE
with	0
RLS	I-DISEASE
may	I-DISEASE
choose	0
to	I-DISEASE
work	I-DISEASE
at	I-DISEASE
night	0
,	I-DISEASE
thereby	I-DISEASE
shifting	I-DISEASE
quiet	0
activities	I-DISEASE
and	0
their	I-DISEASE
sleep	0
schedule	0
away	I-DISEASE
from	0
the	0
circadian	0
peak	0
of	0
their	0
RLS	0
symptoms	I-DISEASE
.	0

PLMs	I-DISEASE
,	I-DISEASE
a	0
family	I-DISEASE
history	I-DISEASE
of	I-DISEASE
RLS	I-DISEASE
,	I-DISEASE
and	0
response	0
to	I-DISEASE
dopaminergic	0
therapy	0
are	I-DISEASE
supportive	I-DISEASE
of	I-DISEASE
the	0
diagnosis	I-DISEASE
.	I-DISEASE

Periodic	I-DISEASE
limb	0
movements	I-DISEASE
can	0
occur	I-DISEASE
in	I-DISEASE
sleep	0
(	I-DISEASE
PLMS	0
)	I-DISEASE
or	I-DISEASE
wakeful-	0
ness	I-DISEASE
(	0
PLMW	0
)	0
.	0

PLMW	I-DISEASE
occur	I-DISEASE
during	I-DISEASE
quiet	I-DISEASE
rest	0
and	0
frequently	0
at	I-DISEASE
the	0
transition	I-DISEASE
between	I-DISEASE
waking	0
and	0
sleep	0
,	I-DISEASE
disrupting	I-DISEASE
sleep	0
onset	I-DISEASE
or	I-DISEASE
the	0
return	B-DISEASE
to	I-DISEASE
sleep	I-DISEASE
.	0

PLMS	I-DISEASE
are	I-DISEASE
frequently	0
associated	0
with	I-DISEASE
arousal	I-DISEASE
from	I-DISEASE
sleep	0
.	0

RLS	I-DISEASE
sensory	0
and	0
motor	0
features	I-DISEASE
respond	0
initially	I-DISEASE
to	0
treatment	I-DISEASE
with	I-DISEASE
dopaminergic	I-DISEASE
therapy	0
in	I-DISEASE
almost	0
all	0
cases	0
.	0

Multiple	I-DISEASE
clinic	I-DISEASE
-	0
based	I-DISEASE
and	0
population	0
-	I-DISEASE
based	I-DISEASE
studies	I-DISEASE
have	0
shown	I-DISEASE
an	0
increased	I-DISEASE
preva-	I-DISEASE
lence	I-DISEASE
of	0
mood	0
and	0
anxiety	0
disorders	0
in	0
individuals	I-DISEASE
with	I-DISEASE
RLS	0
.	0

Most	I-DISEASE
controlled	I-DISEASE
studies	0
using	I-DISEASE
validated	0
assessments	0
have	I-DISEASE
shown	0
significantly	0
increased	0
ORs	0
for	I-DISEASE
moderately	0
or	I-DISEASE
highly	I-DISEASE
elevated	I-DISEASE
depressive	0
symptoms	I-DISEASE
(	I-DISEASE
OR	0
1.95	0
and	0
3.67	I-DISEASE
)	0
,	I-DISEASE
major	I-DISEASE
depression	B-DISEASE
(	I-DISEASE
OR	B-DISEASE
2.6	0
)	0
,	0
major	0
depressive	0
disorder	I-DISEASE
(	I-DISEASE
OR	0
2.57	0
and	0
4.7	0
)	0
,	0
generalized	0
anxiety	0
disorder	0
(	I-DISEASE
OR	0
3.5	0
)	I-DISEASE
,	0
panic	I-DISEASE
disorder	I-DISEASE
(	I-DISEASE
OR	0
4.7	0
,	I-DISEASE
12.9	0
,	0
and	0
18.9	I-DISEASE
)	0
,	I-DISEASE
and	0
posttraumatic	0
stress	I-DISEASE
disorder	I-DISEASE
(	0
OR	0
3.76	0
)	0
.	0

In	I-DISEASE
addition	0
,	0
a	I-DISEASE
positive	0
correlation	I-DISEASE
has	0
been	I-DISEASE
found	0
between	0
the	0
severity	I-DISEASE
of	I-DISEASE
RLS	I-DISEASE
and	0
depression	I-DISEASE
/	I-DISEASE
anxiety	0
symptoms	0
.	0

Relevant	I-DISEASE
to	I-DISEASE
the	0
RLS	I-DISEASE
-	0
depression	B-DISEASE
relationship	0
is	0
the	0
emerging	I-DISEASE
evidence	0
that	0
treatment	I-DISEASE
of	I-DISEASE
RLS	I-DISEASE
improves	0
depressive	0
symptoms	I-DISEASE
.	0

Similarly	I-DISEASE
,	I-DISEASE
increased	0
rates	I-DISEASE
of	0
attention	0
deficit	I-DISEASE
hyperactivity	I-DISEASE
disorder	I-DISEASE
(	I-DISEASE
ADHD	I-DISEASE
)	0
have	0
been	I-DISEASE
found	0
in	0
RLS	I-DISEASE
,	I-DISEASE
both	I-DISEASE
in	I-DISEASE
pediatric	0
and	0
adult	0
studies	I-DISEASE
.	0

Emerging	I-DISEASE
data	0
indicate	I-DISEASE
that	0
about	0
one	I-DISEASE
fourth	I-DISEASE
of	I-DISEASE
individuals	I-DISEASE
with	I-DISEASE
RLS	I-DISEASE
have	I-DISEASE
ADHD	I-DISEASE
symptoms	I-DISEASE
,	I-DISEASE
and	0
conversely	0
,	0
that	0
12	I-DISEASE
%	0
to	0
35	0
%	0
of	I-DISEASE
those	I-DISEASE
with	I-DISEASE
ADHD	I-DISEASE
meet	0
criteria	0
for	0
RLS	0
.	0

Other	I-DISEASE
medical	I-DISEASE
condi-	0
tions	0
for	I-DISEASE
which	0
there	0
is	0
some	I-DISEASE
evidence	I-DISEASE
for	I-DISEASE
greater	I-DISEASE
-	I-DISEASE
than	I-DISEASE
-	I-DISEASE
chance	0
association	0
include	I-DISEASE
narcolepsy	0
,	I-DISEASE
migraine	0
,	I-DISEASE
chronic	I-DISEASE
obstructive	0
pulmonary	I-DISEASE
disease	I-DISEASE
,	0
Parkinson	0
disease	I-DISEASE
,	0
multiple	I-DISEASE
sclerosis	0
,	I-DISEASE
peripheral	I-DISEASE
neuropathy	0
,	0
obstructive	0
sleep	0
apnea	I-DISEASE
,	I-DISEASE
diabetes	I-DISEASE
melli-	0
tus	I-DISEASE
,	0
fibromyalgia	I-DISEASE
,	I-DISEASE
rheumatoid	I-DISEASE
arthritis	0
,	I-DISEASE
nocturnal	0
eating	I-DISEASE
,	I-DISEASE
obesity	0
,	I-DISEASE
thyroid	I-DISEASE
disease	0
,	0
and	0
heart	0
disease	0
.	0

Clinical	I-DISEASE
and	0
Pathophysiological	I-DISEASE
Subtypes	I-DISEASE
Evidence	0
in	I-DISEASE
the	I-DISEASE
literature	0
is	0
not	0
sufficient	I-DISEASE
to	I-DISEASE
support	0
well	0
-	I-DISEASE
defined	I-DISEASE
subtypes	I-DISEASE
of	I-DISEASE
RLS	0
.	0

Early	I-DISEASE
-	I-DISEASE
onset	0
RLS	I-DISEASE
(	I-DISEASE
prior	I-DISEASE
to	I-DISEASE
age	I-DISEASE
45	0
years	I-DISEASE
)	0
is	I-DISEASE
more	0
familial	0
and	0
associated	0
with	0
slower	0
progression	0
than	I-DISEASE
late	I-DISEASE
-	I-DISEASE
onset	I-DISEASE
RLS	0
.	0

In	I-DISEASE
addition	0
,	0
the	0
classification	0
of	I-DISEASE
“	I-DISEASE
secondary	0
”	I-DISEASE
RLS	0
has	0
been	I-DISEASE
suggested	I-DISEASE
when	0
the	0
condition	I-DISEASE
occurs	I-DISEASE
in	0
association	0
with	I-DISEASE
iron	0
deficiency	0
,	I-DISEASE
preg-	0
nancy	0
,	I-DISEASE
and	0
chronic	I-DISEASE
renal	0
failure	I-DISEASE
,	0
but	I-DISEASE
this	0
construct	0
has	0
been	0
challenged	0
based	0
on	0
patho-	0
physiological	I-DISEASE
,	I-DISEASE
family	0
history	I-DISEASE
,	0
genetic	0
,	0
and	0
clinical	I-DISEASE
course	I-DISEASE
data	I-DISEASE
.	0

Demographics	I-DISEASE
The	I-DISEASE
overall	0
prevalence	0
of	I-DISEASE
RLS	0
has	0
been	I-DISEASE
estimated	I-DISEASE
at	I-DISEASE
5	0
%	0
to	I-DISEASE
10	I-DISEASE
%	0
in	0
European	0
and	0
North	0
American	0
population	0
-	I-DISEASE
based	B-DISEASE
studies	I-DISEASE
.	0

However	I-DISEASE
,	0
in	0
Asian	0
countries	0
,	I-DISEASE
studies	I-DISEASE
thus	I-DISEASE
far	0
indicate	0
a	0
lower	0
prevalence	I-DISEASE
.	0

Prevalence	I-DISEASE
is	0
about	0
twice	0
as	0
high	I-DISEASE
in	I-DISEASE
women	0
than	0
in	0
men	0
.	I-DISEASE

In	I-DISEASE
most	0
studies	I-DISEASE
,	I-DISEASE
prevalence	0
increases	0
with	I-DISEASE
age	I-DISEASE
up	0
to	0
60	0
-	I-DISEASE
70	I-DISEASE
years	I-DISEASE
,	0
except	0
in	I-DISEASE
Asian	0
populations	0
where	0
an	0
age	I-DISEASE
-	0
related	0
increase	I-DISEASE
has	I-DISEASE
not	0
been	I-DISEASE
found	0
.	0

Various	I-DISEASE
measures	0
of	I-DISEASE
clinical	I-DISEASE
significance	0
such	I-DISEASE
as	0
frequency	I-DISEASE
(	I-DISEASE
1	0
-	0
2	I-DISEASE
times	I-DISEASE
/	I-DISEASE
week	0
)	0
,	I-DISEASE
severity	I-DISEASE
(	0
moderate	0
to	I-DISEASE
severe	0
distress	I-DISEASE
)	0
,	I-DISEASE
differential	I-DISEASE
diagnosis	0
,	I-DISEASE
and	0
impact	I-DISEASE
have	I-DISEASE
been	I-DISEASE
applied	0
to	I-DISEASE
population	0
-	0
based	B-DISEASE
studies	0
.	0

These	0
analyses	0
indicate	I-DISEASE
the	0
prevalence	0
of	I-DISEASE
clinically	0
significant	0
RLS	0
to	I-DISEASE
be	I-DISEASE
2	I-DISEASE
%	0
to	I-DISEASE
3	I-DISEASE
%	0
in	0
Europe	0
and	0
North	0
America	I-DISEASE
,	I-DISEASE
but	I-DISEASE
lower	0
in	0
Asia	I-DISEASE
.	0

Annual	I-DISEASE
incidence	0
rates	0
have	I-DISEASE
been	0
reported	I-DISEASE
as	I-DISEASE
0.8	I-DISEASE
%	0
to	I-DISEASE
2.2	I-DISEASE
%	0
.	0

Pediatric	I-DISEASE
prevalence	0
rates	0
are	0
2	0
%	0
to	I-DISEASE
4	0
%	0
in	I-DISEASE
UK	0
/	I-DISEASE
US	I-DISEASE
and	0
Turkish	0
studies	I-DISEASE
,	I-DISEASE
with	0
moderate	0
to	I-DISEASE
severe	0
RLS	0
in	I-DISEASE
about	0
0.5	0
%	0
to	I-DISEASE
1	B-DISEASE
%	0
.	0

Adolescents	I-DISEASE
are	0
more	0
likely	I-DISEASE
to	I-DISEASE
have	0
moderate	0
to	0
severe	I-DISEASE
RLS	I-DISEASE
symptoms	0
than	0
younger	0
children	I-DISEASE
—	0
one	0
half	0
of	I-DISEASE
12-	0
to	0
17	0
-	0
year	0
-	0
olds	0
com-	I-DISEASE
pared	0
to	I-DISEASE
one	0
fourth	0
of	0
8-	I-DISEASE
to	0
11	0
-	0
year	0
-	0
olds	0
with	I-DISEASE
RLS	I-DISEASE
.	0

Boys	I-DISEASE
are	I-DISEASE
affected	0
as	0
often	0
as	I-DISEASE
girls	I-DISEASE
,	I-DISEASE
with	I-DISEASE
the	0
sex	0
difference	I-DISEASE
not	I-DISEASE
emerging	I-DISEASE
until	0
the	0
late	I-DISEASE
teens	I-DISEASE
or	0
twenties	0
.	0

Predisposing	I-DISEASE
and	0
Precipitating	I-DISEASE
Factors	0
A	0
positive	I-DISEASE
family	0
history	B-DISEASE
of	I-DISEASE
RLS	I-DISEASE
,	0
the	0
genetic	I-DISEASE
variants	0
noted	0
below	I-DISEASE
,	I-DISEASE
and	0
female	I-DISEASE
sex	0
confer	0
increased	0
risk	0
for	0
RLS	0
.	0

The	I-DISEASE
best	0
characterized	0
precipitating	I-DISEASE
factors	I-DISEASE
are	0
iron	0
deficiency	0
,	I-DISEASE
certain	I-DISEASE
medications	I-DISEASE
,	0
pregnancy	0
,	I-DISEASE
chronic	I-DISEASE
renal	0
failure	I-DISEASE
,	0
and	0
prolonged	0
immo-	0
bility	I-DISEASE
.	0

Mild	I-DISEASE
iron	0
deficiency	0
,	0
characterized	0
by	I-DISEASE
serum	I-DISEASE
ferritin	0
below	I-DISEASE
50	0
μg	0
/	0
L	0
,	0
has	0
been	I-DISEASE
associated	0
with	I-DISEASE
increased	0
severity	I-DISEASE
of	I-DISEASE
RLS	0
,	I-DISEASE
and	0
repletion	I-DISEASE
of	I-DISEASE
iron	0
stores	0
from	0
below	I-DISEASE
50	0
-	0
75	0
μg	0
/	0
L	0
has	0
been	I-DISEASE
found	I-DISEASE
to	I-DISEASE
diminish	0
RLS	0
symptoms	I-DISEASE
.	0

Medications	I-DISEASE
that	0
may	0
precip-	0
itate	0
or	I-DISEASE
aggravate	I-DISEASE
RLS	I-DISEASE
and/or	0
PLMS	0
include	I-DISEASE
sedating	I-DISEASE
antihistamines	0
,	I-DISEASE
some	0
centrally	0
active	I-DISEASE
dopamine	0
receptor	0
antagonists	0
,	0
and	0
most	0
antidepressants	0
.	0

An	0
exception	I-DISEASE
is	0
the	0
antidepressant	0
bupropion	0
,	I-DISEASE
with	I-DISEASE
its	0
dopamine	0
-	0
promoting	0
activity	0
.	0

The	I-DISEASE
prevalence	0
of	I-DISEASE
RLS	I-DISEASE
during	I-DISEASE
pregnancy	0
is	I-DISEASE
two	0
to	0
three	0
times	0
greater	I-DISEASE
than	I-DISEASE
in	0
the	0
general	0
population	I-DISEASE
.	0

There	I-DISEASE
is	I-DISEASE
a	0
peak	0
in	0
the	0
number	0
of	I-DISEASE
women	0
affected	0
by	I-DISEASE
RLS	I-DISEASE
in	I-DISEASE
the	0
Sleep	0
Related	I-DISEASE
Movement	0
Disorders	0
Sleep	0
Related	0
Movement	I-DISEASE
Disorders	0
third	I-DISEASE
trimester	I-DISEASE
,	0
with	I-DISEASE
resolution	I-DISEASE
of	I-DISEASE
symptoms	0
for	0
most	0
,	0
but	0
not	0
all	0
,	0
by	I-DISEASE
one	0
month	I-DISEASE
after	0
delivery	0
.	0

Independent	0
predictors	I-DISEASE
of	I-DISEASE
RLS	0
during	I-DISEASE
pregnancy	I-DISEASE
are	0
a	0
family	0
history	I-DISEASE
of	I-DISEASE
RLS	I-DISEASE
(	I-DISEASE
OR	B-DISEASE
8.43	I-DISEASE
)	0
,	0
a	0
history	I-DISEASE
of	I-DISEASE
RLS	I-DISEASE
in	I-DISEASE
prior	I-DISEASE
pregnancy	0
(	I-DISEASE
OR	B-DISEASE
53.74	0
)	0
,	0
a	0
history	I-DISEASE
of	I-DISEASE
RLS	0
in	0
the	0
past	I-DISEASE
(	I-DISEASE
OR	0
12.91	I-DISEASE
)	0
,	0
and	0
hemoglobin	I-DISEASE
≤11	0
g	0
/	0
dL	0
(	I-DISEASE
OR	B-DISEASE
2.05	I-DISEASE
)	0
.	0

Parity	I-DISEASE
,	0
the	0
number	0
of	I-DISEASE
previous	I-DISEASE
pregnancies	I-DISEASE
,	0
appears	I-DISEASE
to	I-DISEASE
account	I-DISEASE
for	0
the	0
2:1	0
sex	0
difference	I-DISEASE
between	0
women	I-DISEASE
and	0
men	0
in	I-DISEASE
the	0
general	0
population	0
prevalence	I-DISEASE
of	I-DISEASE
RLS	I-DISEASE
.	0

In	I-DISEASE
chronic	I-DISEASE
renal	0
failure	0
patients	I-DISEASE
,	I-DISEASE
the	0
prevalence	0
of	I-DISEASE
RLS	0
is	I-DISEASE
two	I-DISEASE
to	0
five	0
times	I-DISEASE
greater	I-DISEASE
than	0
in	0
the	0
general	0
population	0
.	0

This	I-DISEASE
represents	I-DISEASE
prevalence	0
rates	0
of	0
11	0
%	0
to	I-DISEASE
58	B-DISEASE
%	0
in	0
US	I-DISEASE
and	0
European	0
chronic	0
renal	0
failure	I-DISEASE
clinics	0
.	0

Compared	I-DISEASE
to	I-DISEASE
patients	0
with	I-DISEASE
chronic	0
renal	I-DISEASE
failure	I-DISEASE
without	0
RLS	0
,	I-DISEASE
those	I-DISEASE
with	I-DISEASE
RLS	0
have	I-DISEASE
greater	I-DISEASE
sleep	0
disturbance	I-DISEASE
,	I-DISEASE
report	0
poorer	0
quality	0
of	I-DISEASE
life	0
,	I-DISEASE
and	0
more	I-DISEASE
frequently	I-DISEASE
discontinue	B-DISEASE
dialysis	I-DISEASE
prematurely	0
.	0

Typically	I-DISEASE
,	I-DISEASE
RLS	0
symptoms	0
improve	0
dramatically	I-DISEASE
within	I-DISEASE
one	0
month	0
after	0
kidney	I-DISEASE
transplantation	I-DISEASE
but	0
become	I-DISEASE
severe	I-DISEASE
again	I-DISEASE
with	0
transplant	0
failure	I-DISEASE
.	0

There	I-DISEASE
is	I-DISEASE
limited	I-DISEASE
or	I-DISEASE
contradictory	0
evidence	0
for	0
sleep	0
deprivation	0
,	I-DISEASE
peripheral	I-DISEASE
neuropathy	I-DISEASE
,	I-DISEASE
radiculopathy	0
,	0
pain	0
,	I-DISEASE
caffeine	I-DISEASE
,	0
tobacco	0
,	I-DISEASE
or	0
alcohol	I-DISEASE
as	0
exacerbating	I-DISEASE
factors	0
for	0
RLS	I-DISEASE
.	I-DISEASE

Familial	I-DISEASE
Patterns	I-DISEASE
Early	0
-	I-DISEASE
onset	0
RLS	0
is	I-DISEASE
highly	I-DISEASE
familial	I-DISEASE
,	I-DISEASE
with	I-DISEASE
40	0
%	0
to	I-DISEASE
92	0
%	0
of	I-DISEASE
cases	0
reporting	I-DISEASE
affected	0
family	I-DISEASE
members	I-DISEASE
.	0

High	I-DISEASE
concordance	0
rates	0
are	I-DISEASE
observed	I-DISEASE
in	I-DISEASE
monozygotic	0
twins	I-DISEASE
.	0

The	I-DISEASE
risk	0
of	I-DISEASE
RLS	I-DISEASE
is	I-DISEASE
two	I-DISEASE
to	I-DISEASE
six	I-DISEASE
times	0
greater	I-DISEASE
for	I-DISEASE
first	I-DISEASE
-	I-DISEASE
degree	I-DISEASE
relatives	I-DISEASE
of	I-DISEASE
patients	I-DISEASE
with	0
RLS	0
than	I-DISEASE
for	I-DISEASE
those	0
from	I-DISEASE
the	I-DISEASE
general	0
population	I-DISEASE
.	0

Although	I-DISEASE
an	0
autosomal	0
dominant	I-DISEASE
model	0
of	I-DISEASE
RLS	0
is	0
sug-	0
gested	0
by	I-DISEASE
many	0
family	0
studies	0
,	I-DISEASE
recent	0
genomewide	0
linkage	0
and	0
association	I-DISEASE
studies	I-DISEASE
suggest	I-DISEASE
a	I-DISEASE
more	0
complex	0
gene	0
-	I-DISEASE
environment	0
pattern	0
.	0

Linkage	I-DISEASE
analyses	0
have	I-DISEASE
reported	0
several	I-DISEASE
different	I-DISEASE
gene	I-DISEASE
loci	0
associated	0
with	I-DISEASE
RLS	I-DISEASE
but	I-DISEASE
,	I-DISEASE
to	I-DISEASE
date	I-DISEASE
,	0
no	0
single	I-DISEASE
causative	0
gene	0
.	I-DISEASE

However	I-DISEASE
,	I-DISEASE
genomewide	0
association	0
studies	I-DISEASE
have	0
identified	I-DISEASE
single	0
nucleotide	0
poly-	0
morphisms	0
in	I-DISEASE
RLS	0
,	0
four	I-DISEASE
of	I-DISEASE
which	0
have	I-DISEASE
been	I-DISEASE
replicated	I-DISEASE
:	B-DISEASE
BTBD9	0
,	0
MEIS1	0
,	0
MAP2K5/	0
LBXCOR	0
,	0
and	0
PTPRD	0
.	0

Nonetheless	I-DISEASE
,	I-DISEASE
the	0
relationship	I-DISEASE
between	0
familial	I-DISEASE
RLS	I-DISEASE
and	0
these	I-DISEASE
findings	0
remains	0
to	0
be	0
determined	I-DISEASE
.	I-DISEASE

Onset	I-DISEASE
,	0
Course	0
,	0
and	0
Complications	I-DISEASE
Onset	I-DISEASE
of	I-DISEASE
RLS	I-DISEASE
symptoms	I-DISEASE
occurs	0
at	I-DISEASE
all	0
ages	0
,	I-DISEASE
from	0
childhood	0
to	0
late	I-DISEASE
adult	0
life	0
.	0

Mean	I-DISEASE
age	I-DISEASE
of	I-DISEASE
onset	I-DISEASE
for	0
familial	I-DISEASE
RLS	0
is	0
in	I-DISEASE
the	I-DISEASE
third	I-DISEASE
or	0
fourth	I-DISEASE
decade	I-DISEASE
,	I-DISEASE
with	0
onset	0
prior	0
to	0
age	I-DISEASE
21	0
years	0
in	I-DISEASE
about	0
one	I-DISEASE
third	0
of	I-DISEASE
cases	0
.	B-DISEASE

The	I-DISEASE
clinical	I-DISEASE
course	0
of	I-DISEASE
RLS	0
differs	I-DISEASE
based	I-DISEASE
on	0
age	I-DISEASE
of	I-DISEASE
onset	I-DISEASE
.	I-DISEASE

In	I-DISEASE
early	0
-	0
onset	I-DISEASE
RLS	0
(	I-DISEASE
before	I-DISEASE
age	I-DISEASE
45	0
years	I-DISEASE
)	0
,	I-DISEASE
slow	I-DISEASE
progression	0
of	I-DISEASE
symptoms	I-DISEASE
is	I-DISEASE
found	0
in	0
about	0
two	I-DISEASE
thirds	I-DISEASE
of	I-DISEASE
cases	0
.	0

Most	I-DISEASE
of	I-DISEASE
the	0
remaining	I-DISEASE
one	0
third	I-DISEASE
report	0
stable	I-DISEASE
symp-	0
toms	I-DISEASE
over	0
time	0
,	I-DISEASE
although	I-DISEASE
remission	0
has	I-DISEASE
been	I-DISEASE
described	0
.	0

In	I-DISEASE
late	I-DISEASE
-	0
onset	I-DISEASE
RLS	0
,	0
rapid	I-DISEASE
pro-	0
gression	0
is	I-DISEASE
typical	0
and	0
aggravating	0
factors	I-DISEASE
are	0
common	I-DISEASE
.	0

Significant	I-DISEASE
impairment	0
of	I-DISEASE
health	0
-	I-DISEASE
related	B-DISEASE
quality	0
of	I-DISEASE
life	0
(	I-DISEASE
HRQoL	I-DISEASE
)	0
has	0
been	I-DISEASE
found	I-DISEASE
in	I-DISEASE
moderate	I-DISEASE
to	I-DISEASE
severe	I-DISEASE
RLS	0
.	0

Both	I-DISEASE
physical	0
health	0
and	0
mental	0
health	I-DISEASE
scores	I-DISEASE
have	I-DISEASE
consis-	0
tently	I-DISEASE
been	I-DISEASE
found	0
to	0
be	I-DISEASE
lower	0
for	0
individuals	0
with	I-DISEASE
RLS	0
,	0
using	I-DISEASE
standard	0
QoL	0
assess-	I-DISEASE
ment	I-DISEASE
tools	0
.	0

The	I-DISEASE
HRQoL	I-DISEASE
impairments	I-DISEASE
are	0
strongly	I-DISEASE
associated	0
with	I-DISEASE
severity	I-DISEASE
of	I-DISEASE
RLS	0
and	0
remain	0
after	0
controlling	0
for	0
age	I-DISEASE
,	I-DISEASE
sex	0
,	I-DISEASE
and	0
disease	I-DISEASE
comorbidity	I-DISEASE
.	0

In	I-DISEASE
addition	0
,	0
patients	I-DISEASE
with	0
cancer	0
,	I-DISEASE
type	I-DISEASE
2	0
diabetes	I-DISEASE
,	I-DISEASE
or	I-DISEASE
renal	I-DISEASE
failure	0
who	I-DISEASE
also	0
have	I-DISEASE
RLS	0
have	I-DISEASE
been	I-DISEASE
shown	I-DISEASE
to	0
have	I-DISEASE
poorer	I-DISEASE
quality	I-DISEASE
of	I-DISEASE
life	0
than	I-DISEASE
those	0
without	0
RLS	I-DISEASE
.	0

Overall	I-DISEASE
,	I-DISEASE
RLS	I-DISEASE
accounts	0
for	I-DISEASE
a	0
major	I-DISEASE
disease	B-DISEASE
burden	I-DISEASE
on	0
those	I-DISEASE
who	I-DISEASE
suffer	I-DISEASE
from	0
it	0
,	I-DISEASE
demonstrated	I-DISEASE
to	0
be	0
similar	0
to	0
or	0
worse	0
than	I-DISEASE
that	0
associated	0
with	I-DISEASE
osteoarthritis	0
,	I-DISEASE
congestive	0
heart	0
failure	0
,	0
depression	0
,	0
Parkinson	0
disease	I-DISEASE
,	I-DISEASE
or	I-DISEASE
stroke	0
.	0

Large	I-DISEASE
population	0
-	0
based	I-DISEASE
studies	0
have	I-DISEASE
found	I-DISEASE
positive	0
associations	0
between	0
RLS	0
and	0
cardiovascular	I-DISEASE
disease	I-DISEASE
,	I-DISEASE
including	I-DISEASE
coronary	0
heart	0
disease	I-DISEASE
and	0
stroke	0
.	0

Repetitive	I-DISEASE
surges	0
in	I-DISEASE
heart	0
rate	I-DISEASE
and	0
blood	I-DISEASE
pressure	0
associated	0
with	I-DISEASE
PLMS	0
are	I-DISEASE
a	I-DISEASE
potential	0
mediator	I-DISEASE
in	I-DISEASE
the	0
physiology	0
of	I-DISEASE
these	I-DISEASE
relationships	0
.	I-DISEASE

Only	I-DISEASE
limited	I-DISEASE
mortality	I-DISEASE
data	I-DISEASE
are	0
available	I-DISEASE
,	I-DISEASE
suggesting	I-DISEASE
increased	0
risk	0
of	I-DISEASE
mortality	I-DISEASE
in	I-DISEASE
women	I-DISEASE
and	0
in	I-DISEASE
chronic	I-DISEASE
renal	I-DISEASE
failure	0
patients	I-DISEASE
with	0
RLS	0
.	0

Developmental	I-DISEASE
Issues	0
The	I-DISEASE
accurate	0
diagnosis	I-DISEASE
of	I-DISEASE
RLS	I-DISEASE
in	0
children	I-DISEASE
and	0
adolescents	I-DISEASE
requires	0
understanding	I-DISEASE
of	I-DISEASE
developmental	I-DISEASE
language	0
and	0
cognitive	0
skills	0
.	0

Adequate	I-DISEASE
verbal	0
skills	0
are	0
needed	I-DISEASE
for	0
children	0
to	0
communicate	I-DISEASE
the	I-DISEASE
sensory	I-DISEASE
component	0
of	I-DISEASE
RLS	I-DISEASE
and	0
description	0
must	I-DISEASE
be	0
in	I-DISEASE
“	0
the	0
child	I-DISEASE
’s	I-DISEASE
own	0
words	I-DISEASE
,	I-DISEASE
”	I-DISEASE
rather	0
than	0
by	I-DISEASE
a	0
parent	0
or	0
caretaker	I-DISEASE
.	0

For	I-DISEASE
criterion	0
A	0
,	I-DISEASE
children	0
rarely	I-DISEASE
use	0
or	I-DISEASE
understand	0
the	0
word	I-DISEASE
“	I-DISEASE
urge	I-DISEASE
.	0
”	I-DISEASE

Instead	I-DISEASE
they	I-DISEASE
describe	0
that	0
their	0
legs	I-DISEASE
“	I-DISEASE
need	I-DISEASE
to	0
”	I-DISEASE
“	0
have	I-DISEASE
to	I-DISEASE
”	I-DISEASE
or	0
“	I-DISEASE
got	B-DISEASE
to	I-DISEASE
”	0
move	0
.	0

Descriptors	I-DISEASE
for	I-DISEASE
the	0
discomfort	0
include	I-DISEASE
:	I-DISEASE
bugs	I-DISEASE
,	0
ants	0
,	I-DISEASE
weird/	I-DISEASE
funny	0
feelings	0
,	I-DISEASE
tingle	0
,	0
wiggly	I-DISEASE
,	I-DISEASE
and	0
shaky	I-DISEASE
.	0

Younger	I-DISEASE
children	I-DISEASE
often	0
use	I-DISEASE
the	0
word	I-DISEASE
“	I-DISEASE
kick	I-DISEASE
”	I-DISEASE
rather	0
than	I-DISEASE
“	I-DISEASE
move	I-DISEASE
,	I-DISEASE
”	I-DISEASE
e.g.	0
,	0
“	I-DISEASE
my	0
legs	0
want	I-DISEASE
to	I-DISEASE
kick	I-DISEASE
.	0
”	I-DISEASE

Similar	I-DISEASE
to	0
adults	B-DISEASE
,	I-DISEASE
children	0
report	0
arm	0
involvement	I-DISEASE
in	0
almost	0
half	0
of	I-DISEASE
cases	0
.	0

Sitting	I-DISEASE
in	I-DISEASE
class	I-DISEASE
,	I-DISEASE
lying	0
in	I-DISEASE
bed	I-DISEASE
,	I-DISEASE
reading	0
a	0
book	I-DISEASE
,	I-DISEASE
and	0
riding	I-DISEASE
in	0
a	0
car	I-DISEASE
are	I-DISEASE
situations	0
where	0
children	I-DISEASE
report	0
onset	0
or	0
worsening	0
of	0
their	0
symp-	0
toms	0
.	0

Relief	I-DISEASE
is	I-DISEASE
typically	0
achieved	I-DISEASE
by	0
moving	I-DISEASE
around	0
,	I-DISEASE
walking	0
,	0
rubbing	B-DISEASE
,	I-DISEASE
kicking	I-DISEASE
,	I-DISEASE
or	0
distraction	0
.	0

Perhaps	I-DISEASE
as	0
a	0
result	0
of	0
prolonged	0
periods	I-DISEASE
of	I-DISEASE
sitting	0
in	0
class	I-DISEASE
,	I-DISEASE
two	I-DISEASE
thirds	I-DISEASE
of	I-DISEASE
children	I-DISEASE
and	0
adolescents	0
with	0
RLS	I-DISEASE
report	0
daytime	0
leg	I-DISEASE
sensations	0
.	0

Because	I-DISEASE
of	I-DISEASE
this	0
,	I-DISEASE
for	0
diagnostic	0
criterion	0
A3	0
(	0
worse	0
in	I-DISEASE
the	I-DISEASE
evening	I-DISEASE
/	0
night	0
)	0
,	I-DISEASE
it	0
is	0
important	0
to	0
compare	0
equal	0
duration	0
of	I-DISEASE
sitting	0
or	I-DISEASE
lying	0
down	I-DISEASE
in	I-DISEASE
the	B-DISEASE
day	0
to	I-DISEASE
sitting	I-DISEASE
or	0
lying	0
down	0
in	I-DISEASE
the	0
evening/	0
night	0
.	0

However	I-DISEASE
,	I-DISEASE
even	I-DISEASE
with	I-DISEASE
such	0
comparisons	I-DISEASE
,	0
a	I-DISEASE
significant	0
subset	0
of	I-DISEASE
children	I-DISEASE
do	I-DISEASE
not	0
report	0
worsening	0
at	I-DISEASE
evening	0
/	0
night	I-DISEASE
,	0
yet	0
meet	0
all	0
other	I-DISEASE
diagnostic	0
criteria	I-DISEASE
and	0
have	0
sup-	0
portive	0
features	I-DISEASE
for	0
RLS	0
,	0
including	0
a	0
positive	0
family	0
history	I-DISEASE
.	0

Children	I-DISEASE
who	I-DISEASE
are	0
age	I-DISEASE
six	0
years	I-DISEASE
or	I-DISEASE
older	0
and	0
developmentally	I-DISEASE
normal	0
have	I-DISEASE
been	I-DISEASE
shown	0
to	I-DISEASE
report	0
detailed	I-DISEASE
,	0
ade-	0
quate	0
descriptors	I-DISEASE
for	I-DISEASE
RLS	I-DISEASE
symptoms	I-DISEASE
.	B-DISEASE

For	I-DISEASE
children	I-DISEASE
who	I-DISEASE
are	I-DISEASE
too	0
young	I-DISEASE
to	I-DISEASE
adequately	B-DISEASE
describe	0
RLS	0
sensations	0
or	I-DISEASE
are	I-DISEASE
developmentally	I-DISEASE
delayed	I-DISEASE
,	I-DISEASE
a	0
PLMD	0
diagnosis	I-DISEASE
may	I-DISEASE
be	0
Sleep	I-DISEASE
Related	0
Movement	0
Disorders	I-DISEASE
Sleep	0
Related	0
Movement	I-DISEASE
Disorders	I-DISEASE
the	0
initial	0
diagnosis	0
,	0
with	0
full	0
RLS	I-DISEASE
symptomatology	0
evident	0
over	I-DISEASE
time	0
.	0

Diagnosis	I-DISEASE
by	I-DISEASE
observational	I-DISEASE
techniques	0
has	I-DISEASE
been	I-DISEASE
suggested	0
but	0
not	0
yet	I-DISEASE
validated	I-DISEASE
.	0

The	I-DISEASE
differential	I-DISEASE
diagnosis	0
of	I-DISEASE
pediatric	0
RLS	I-DISEASE
includes	I-DISEASE
positional	0
discomfort	0
,	I-DISEASE
sore	I-DISEASE
leg	I-DISEASE
muscles	0
,	I-DISEASE
joint	I-DISEASE
/	0
tendon	0
injury	I-DISEASE
,	I-DISEASE
and	0
bruises	0
,	I-DISEASE
all	0
of	I-DISEASE
which	0
are	I-DISEASE
common	I-DISEASE
mimics	B-DISEASE
.	0

In	I-DISEASE
child-	0
hood	0
,	0
RLS	I-DISEASE
is	I-DISEASE
frequently	0
misdiagnosed	0
as	0
“	0
growing	0
pains	I-DISEASE
.	0
”	I-DISEASE

Four	I-DISEASE
specific	I-DISEASE
domains	0
that	0
are	0
affected	I-DISEASE
in	I-DISEASE
pediatric	0
RLS	0
are	I-DISEASE
sleep	I-DISEASE
,	I-DISEASE
daily	I-DISEASE
activities	I-DISEASE
,	I-DISEASE
mood	I-DISEASE
,	0
and	0
energy	I-DISEASE
/	0
vital-	I-DISEASE
ity	0
.	0

Difficulties	I-DISEASE
with	I-DISEASE
sleep	0
onset	I-DISEASE
,	0
sleep	0
maintenance	I-DISEASE
,	I-DISEASE
and	0
sleep	I-DISEASE
quality	0
are	0
common	I-DISEASE
.	I-DISEASE

Negative	I-DISEASE
influence	0
of	0
RLS	I-DISEASE
on	0
waking	0
activities	I-DISEASE
includes	I-DISEASE
academic	I-DISEASE
impact	I-DISEASE
due	I-DISEASE
to	0
dis-	I-DISEASE
ruption	0
of	I-DISEASE
schoolwork	I-DISEASE
,	I-DISEASE
homework	I-DISEASE
,	0
and	0
ability	I-DISEASE
to	I-DISEASE
concentrate	0
.	0

Severity	I-DISEASE
assessment	I-DISEASE
of	0
pediatric	0
RLS	I-DISEASE
has	0
thus	0
far	I-DISEASE
been	I-DISEASE
limited	I-DISEASE
to	0
simple	I-DISEASE
measures	0
of	I-DISEASE
self	0
-	0
reported	I-DISEASE
frequency	I-DISEASE
and	0
intensity	0
.	0

Because	I-DISEASE
pediatric	0
RLS	I-DISEASE
is	I-DISEASE
highly	I-DISEASE
familial	I-DISEASE
,	I-DISEASE
the	0
presence	I-DISEASE
of	I-DISEASE
RLS	0
in	I-DISEASE
a	I-DISEASE
first	0
-	0
degree	I-DISEASE
rela-	0
tive	0
helps	0
to	I-DISEASE
increase	I-DISEASE
diagnostic	0
certainty	0
in	I-DISEASE
childhood	0
RLS	B-DISEASE
.	B-DISEASE

Similarly	I-DISEASE
,	I-DISEASE
the	0
presence	0
of	0
PLMS	0
or	B-DISEASE
a	0
history	I-DISEASE
of	I-DISEASE
PLMD	I-DISEASE
is	I-DISEASE
quite	I-DISEASE
helpful	I-DISEASE
in	0
supporting	0
an	0
RLS	0
diagnosis	0
in	I-DISEASE
chil-	I-DISEASE
dren	0
.	0

As	I-DISEASE
in	I-DISEASE
adults	B-DISEASE
,	I-DISEASE
approximately	0
70	0
%	0
of	I-DISEASE
children	0
with	0
RLS	0
demonstrate	I-DISEASE
PLMS	0
≥	0
5/	0
hour	0
on	0
a	0
single	I-DISEASE
night	0
and	0
nearly	0
90	0
%	0
when	0
multiple	I-DISEASE
nights	0
are	I-DISEASE
sampled	I-DISEASE
.	0

PLMS	I-DISEASE
≥	I-DISEASE
5/	0
hour	0
are	I-DISEASE
uncommon	0
in	0
pediatric	0
normative	0
samples	0
.	0

As	I-DISEASE
noted	0
above	0
,	I-DISEASE
pediatric	0
RLS	I-DISEASE
is	0
comorbid	0
with	I-DISEASE
ADHD	I-DISEASE
in	I-DISEASE
about	0
one	I-DISEASE
fourth	0
of	0
cases	0
,	0
and	0
,	I-DISEASE
as	0
in	I-DISEASE
adults	B-DISEASE
,	I-DISEASE
higher	0
rates	I-DISEASE
of	I-DISEASE
anxiety	I-DISEASE
and	0
depressive	I-DISEASE
symptoms	I-DISEASE
are	0
found	0
.	0

RLS	I-DISEASE
is	0
common	I-DISEASE
in	0
pediatric	0
chronic	I-DISEASE
kidney	0
disease	0
.	0

Prevalence	I-DISEASE
rates	0
of	I-DISEASE
RLS	0
increase	I-DISEASE
with	I-DISEASE
age	I-DISEASE
until	0
late	I-DISEASE
adulthood	0
then	I-DISEASE
stabilize	I-DISEASE
or	0
decrease	I-DISEASE
slightly	I-DISEASE
in	0
the	0
elderly	I-DISEASE
.	0

However	I-DISEASE
,	0
strong	0
associations	I-DISEASE
with	0
anxiety	I-DISEASE
,	0
mood	0
disorders	0
,	0
and	0
decreased	I-DISEASE
QoL	I-DISEASE
measures	0
remain	I-DISEASE
in	I-DISEASE
the	0
elderly	0
.	0

Diagnostic	I-DISEASE
criteria	0
for	I-DISEASE
RLS	I-DISEASE
in	0
the	0
cog-	0
nitive	I-DISEASE
-	I-DISEASE
impaired	I-DISEASE
elderly	I-DISEASE
have	0
been	0
suggested	0
but	0
not	0
validated	0
.	0

Pathology	I-DISEASE
and	0
Pathophysiology	I-DISEASE
Brain	0
iron	0
deficiency	0
,	I-DISEASE
central	I-DISEASE
nervous	I-DISEASE
system	0
dopamine	0
regulation	0
,	0
and	0
genetics	0
appear	I-DISEASE
to	0
be	0
primary	0
factors	0
in	I-DISEASE
the	0
pathophysiology	I-DISEASE
of	I-DISEASE
RLS	0
.	0

Iron	I-DISEASE
is	I-DISEASE
important	0
in	I-DISEASE
brain	0
dopa-	I-DISEASE
mine	0
production	0
and	0
synaptic	0
density	0
,	I-DISEASE
as	0
well	I-DISEASE
as	0
in	0
myelin	0
synthesis	0
and	0
energy	0
pro-	0
duction	I-DISEASE
.	0

A	I-DISEASE
connection	I-DISEASE
between	0
RLS	I-DISEASE
and	0
low	0
brain	I-DISEASE
iron	0
is	0
supported	0
by	I-DISEASE
autopsy	I-DISEASE
data	0
,	I-DISEASE
MRI	0
,	0
brain	0
sonography	0
,	I-DISEASE
and	0
cerebrospinal	I-DISEASE
fluid	0
analysis	I-DISEASE
.	0

Evidence	I-DISEASE
for	I-DISEASE
central	0
nervous	I-DISEASE
system	0
dopaminergic	I-DISEASE
system	0
involvement	I-DISEASE
comes	I-DISEASE
mainly	I-DISEASE
from	0
multiple	I-DISEASE
randomized	I-DISEASE
clinical	0
trials	0
that	0
have	0
clearly	0
demonstrated	0
the	0
effect	0
of	0
dopaminergic	I-DISEASE
drugs	I-DISEASE
for	0
RLS	I-DISEASE
and	0
PLMS	0
.	0

In	I-DISEASE
addition	0
,	0
an	0
altered	0
dopaminergic	I-DISEASE
profile	0
in	I-DISEASE
RLS	I-DISEASE
is	0
supported	0
by	I-DISEASE
func-	I-DISEASE
tional	0
MRI	0
,	I-DISEASE
positron	0
emission	0
tomography	I-DISEASE
,	0
and	0
autopsy	0
data	0
.	0

Association	I-DISEASE
of	I-DISEASE
gene	0
vari-	I-DISEASE
ants	0
BTBD9	I-DISEASE
,	I-DISEASE
MEIS1	I-DISEASE
,	I-DISEASE
MAP2K5	0
/	0
LBXCOR	0
,	I-DISEASE
and	0
PTPRD	I-DISEASE
with	0
RLS	0
has	0
been	I-DISEASE
replicated	0
,	0
indicating	0
a	0
genetic	0
substrate	0
upon	0
which	0
environmental	I-DISEASE
factors	0
might	0
act	0
.	0

BTBD9	I-DISEASE
is	0
estimated	0
to	I-DISEASE
confer	I-DISEASE
a	0
population	0
attributable	I-DISEASE
risk	0
(	I-DISEASE
PAR	I-DISEASE
)	0
of	I-DISEASE
50	0
%	0
for	0
RLS	I-DISEASE
.	0

Together	I-DISEASE
,	I-DISEASE
BTBD9	0
,	0
MEIS1	I-DISEASE
,	0
and	0
MAP2K5	I-DISEASE
/	I-DISEASE
LBXCOR	0
account	0
for	0
70	I-DISEASE
%	0
of	I-DISEASE
the	0
PAR	I-DISEASE
for	0
RLS	0
in	I-DISEASE
indi-	I-DISEASE
viduals	0
with	0
European	0
ancestry	0
.	0

Thus	I-DISEASE
far	I-DISEASE
,	0
two	I-DISEASE
of	0
the	0
variants	0
,	I-DISEASE
BTBD9	0
and	0
MEIS1	0
,	I-DISEASE
appear	I-DISEASE
to	0
influence	0
expression	I-DISEASE
of	I-DISEASE
PLMS	0
,	I-DISEASE
as	0
well	I-DISEASE
as	0
iron	I-DISEASE
homeostasis	I-DISEASE
.	0

However	I-DISEASE
,	I-DISEASE
the	0
full	I-DISEASE
role	0
of	I-DISEASE
RLS	I-DISEASE
gene	0
variants	0
has	I-DISEASE
not	0
been	I-DISEASE
adequately	B-DISEASE
defined	I-DISEASE
.	0

Objective	I-DISEASE
Findings	I-DISEASE

Although	I-DISEASE
polysomnography	0
is	I-DISEASE
not	0
routinely	0
indicated	0
in	I-DISEASE
the	I-DISEASE
evaluation	I-DISEASE
of	I-DISEASE
RLS	0
,	I-DISEASE
poly-	0
somnographic	0
studies	I-DISEASE
demonstrate	0
significant	0
objective	0
sleep	0
abnormalities	I-DISEASE
in	0
RLS	0
,	0
with	I-DISEASE
increased	0
latency	I-DISEASE
to	0
persistent	0
sleep	0
and	0
higher	0
arousal	0
index	I-DISEASE
as	0
the	0
most	0
consis-	0
tent	I-DISEASE
differences	I-DISEASE
in	I-DISEASE
sleep	0
architecture	0
.	0

PLMS	I-DISEASE
≥5	I-DISEASE
/	0
hour	0
occur	I-DISEASE
in	0
70	0
%	0
to	I-DISEASE
80	I-DISEASE
%	0
of	I-DISEASE
adults	I-DISEASE
with	I-DISEASE
RLS	I-DISEASE
on	0
single	I-DISEASE
-	0
night	0
testing	0
but	I-DISEASE
in	I-DISEASE
>	0
90	I-DISEASE
%	0
when	0
multiple	I-DISEASE
nights	I-DISEASE
are	0
sampled	I-DISEASE
.	0

In	I-DISEASE
adult	0
RLS	0
,	0
PLMS	0
are	0
more	0
prominent	0
during	I-DISEASE
the	I-DISEASE
first	I-DISEASE
half	0
of	I-DISEASE
the	0
night	I-DISEASE
and	0
vary	0
in	I-DISEASE
frequency	I-DISEASE
from	I-DISEASE
night	0
to	I-DISEASE
night	I-DISEASE
.	0

About	I-DISEASE
one	0
third	I-DISEASE
of	I-DISEASE
PLMS	0
are	I-DISEASE
associated	0
with	0
cortical	0
arousals	I-DISEASE
,	I-DISEASE
and	0
most	I-DISEASE
have	0
associated	0
autonomic	0
arousals	0
.	0

PLMS	I-DISEASE
are	I-DISEASE
not	0
influenced	I-DISEASE
by	I-DISEASE
placebo	0
effect	0
.	0

PLMS	I-DISEASE
arousals	0
contribute	0
to	I-DISEASE
the	0
primary	0
RLS	0
morbidity	I-DISEASE
of	I-DISEASE
sleep	0
dis-	I-DISEASE
turbance	0
.	0

Furthermore	I-DISEASE
,	I-DISEASE
RLS	I-DISEASE
sensory	0
symptoms	I-DISEASE
impair	I-DISEASE
return	0
to	0
sleep	0
,	I-DISEASE
and	0
thereby	I-DISEASE
result	0
in	I-DISEASE
more	0
prolonged	I-DISEASE
awakening	0
.	0

The	I-DISEASE
Suggested	I-DISEASE
Immobilization	0
Test	0
(	I-DISEASE
SIT	I-DISEASE
)	I-DISEASE
evaluates	I-DISEASE
PLMW	0
and	0
related	0
sensory	I-DISEASE
com-	I-DISEASE
ponents	0
of	0
RLS	I-DISEASE
during	I-DISEASE
resting	I-DISEASE
wakefulness	B-DISEASE
.	B-DISEASE

A	I-DISEASE
standard	0
polysomnogram	0
recording	0
without	0
respiratory	I-DISEASE
measures	0
is	I-DISEASE
used	0
for	0
one	0
hour	I-DISEASE
before	I-DISEASE
the	0
usual	I-DISEASE
bedtime	I-DISEASE
while	0
the	0
subject	I-DISEASE
sits	I-DISEASE
comfortably	0
awake	0
and	0
upright	I-DISEASE
in	I-DISEASE
bed	I-DISEASE
with	I-DISEASE
the	0
legs	0
outstretched	0
.	0

RLS	I-DISEASE
diagnosis	0
is	I-DISEASE
supported	0
by	I-DISEASE
a	0
finding	I-DISEASE
of	I-DISEASE
more	0
than	0
40	0
PLMW	I-DISEASE
/	0
hour	I-DISEASE
.	I-DISEASE

Activity	I-DISEASE
monitors	0
with	I-DISEASE
high	0
-	I-DISEASE
frequency	I-DISEASE
sampling	0
and	0
body	I-DISEASE
-	0
position	I-DISEASE
monitoring	I-DISEASE
may	I-DISEASE
be	0
attached	0
to	I-DISEASE
the	I-DISEASE
ankle	0
or	0
foot	0
to	0
provide	I-DISEASE
an	0
alternate	I-DISEASE
measure	0
of	0
PLMs	0
.	0

Recordings	I-DISEASE
assess	I-DISEASE
the	0
frequency	I-DISEASE
and	0
variability	I-DISEASE
of	I-DISEASE
PLMs	0
from	I-DISEASE
night	I-DISEASE
to	I-DISEASE
night	0
,	I-DISEASE
typically	0
over	I-DISEASE
three	0
to	0
five	0
nights	0
.	0

Differential	I-DISEASE
Diagnosis	0

The	I-DISEASE
differentiation	0
of	I-DISEASE
RLS	I-DISEASE
from	I-DISEASE
other	I-DISEASE
conditions	I-DISEASE
that	0
may	0
have	0
characteristics	I-DISEASE
of	I-DISEASE
RLS	I-DISEASE
is	I-DISEASE
essential	I-DISEASE
,	I-DISEASE
because	0
approximately	0
40	0
%	0
of	I-DISEASE
individuals	I-DISEASE
without	0
RLS	I-DISEASE
will	0
report	0
some	I-DISEASE
urge	0
or	B-DISEASE
need	0
to	I-DISEASE
move	I-DISEASE
the	0
legs	0
while	0
at	I-DISEASE
rest	0
.	0

Fulfilling	I-DISEASE
diagnostic	0
criteria	I-DISEASE
A2	0
(	I-DISEASE
better	0
with	0
movement	0
)	0
and	0
A3	0
(	I-DISEASE
worse	0
in	I-DISEASE
the	0
evening	0
/	0
night	0
)	0
improves	0
specificity	I-DISEASE
for	I-DISEASE
an	0
RLS	I-DISEASE
diagnosis	I-DISEASE
to	0
only	0
about	0
70	0
%	0
,	0
based	I-DISEASE
on	0
studies	0
that	0
have	0
used	0
structured	I-DISEASE
diagnostic	0
interviews	I-DISEASE
.	0

However	I-DISEASE
,	I-DISEASE
differentiating	0
RLS	0
from	0
leg	I-DISEASE
cramps	0
and	0
positional	I-DISEASE
discomfort	0
improves	I-DISEASE
specificity	I-DISEASE
to	0
94	I-DISEASE
%	0
,	I-DISEASE
emphasizing	I-DISEASE
the	0
importance	0
of	0
differential	I-DISEASE
diagnosis	0
.	0

The	I-DISEASE
Sleep	I-DISEASE
Related	0
Movement	0
Disorders	I-DISEASE
Sleep	0
Related	0
Movement	I-DISEASE
Disorders	I-DISEASE
most	0
important	B-DISEASE
“	I-DISEASE
mimics	0
”	I-DISEASE
of	I-DISEASE
RLS	0
are	0
leg	I-DISEASE
cramps	0
,	I-DISEASE
positional	I-DISEASE
discomfort	0
,	0
arthralgias/	0
arthritis	0
,	0
myalgias	0
,	I-DISEASE
leg	I-DISEASE
edema	0
,	0
peripheral	I-DISEASE
neuropathy	0
,	I-DISEASE
radiculopathy	0
,	I-DISEASE
and	0
habitual	0
foot	0
tapping	I-DISEASE
.	0

Not	I-DISEASE
characteristic	I-DISEASE
of	I-DISEASE
RLS	I-DISEASE
are	0
:	0
“	I-DISEASE
knotting	0
”	I-DISEASE
of	I-DISEASE
the	I-DISEASE
muscle	I-DISEASE
(	0
cramps	I-DISEASE
)	0
,	0
relief	I-DISEASE
with	0
a	0
single	0
postural	0
shift	0
(	I-DISEASE
positional	0
discomfort	0
)	0
,	0
limitation	I-DISEASE
to	I-DISEASE
joints	I-DISEASE
(	0
arthritis	0
)	0
,	0
sore-	0
ness	0
to	I-DISEASE
palpation	0
(	0
myalgias	0
)	0
,	I-DISEASE
and	0
other	0
abnormalities	I-DISEASE
on	0
physical	0
examination	0
.	0

Less	I-DISEASE
common	I-DISEASE
conditions	0
to	I-DISEASE
be	0
differentiated	0
from	0
RLS	I-DISEASE
include	0
neuroleptic	0
-	0
induced	I-DISEASE
akathi-	I-DISEASE

sia	I-DISEASE
,	0
myelopathy	0
,	0
symptomatic	I-DISEASE
venous	I-DISEASE
insufficiency	0
,	I-DISEASE
peripheral	0
artery	0
disease	I-DISEASE
,	0
eczema	0
,	I-DISEASE
orthopedic	0
problems	0
,	I-DISEASE
painful	0
legs	0
and	0
moving	I-DISEASE
toes	0
,	0
and	0
anxiety	0
-	0
induced	0
restlessness	I-DISEASE
.	0

Neuroleptic	I-DISEASE
-	0
induced	I-DISEASE
akathisia	I-DISEASE
differs	0
from	I-DISEASE
RLS	I-DISEASE
in	I-DISEASE
that	0
akathisia	I-DISEASE
is	0
associated	0
with	I-DISEASE
the	0
need	0
to	0
move	0
the	I-DISEASE
entire	0
body	I-DISEASE
and	0
occurs	0
in	I-DISEASE
association	B-DISEASE
with	I-DISEASE
use	0
of	I-DISEASE
dopamine	0
-	I-DISEASE
receptor	I-DISEASE
antagonists	0
.	0

Painful	I-DISEASE
legs	0
and	0
moving	I-DISEASE
toes	0
have	I-DISEASE
neither	B-DISEASE
a	0
clear	0
circadian	I-DISEASE
pattern	I-DISEASE
nor	I-DISEASE
the	0
sense	I-DISEASE
of	I-DISEASE
an	I-DISEASE
urge	0
to	0
move	I-DISEASE
.	0

Pain	I-DISEASE
involving	I-DISEASE
the	0
legs	I-DISEASE
occurs	0
with	I-DISEASE
numerous	0
conditions	I-DISEASE
,	0
including	0
arthritis	0
,	I-DISEASE
vascular	0
problems	0
,	I-DISEASE
sports	I-DISEASE
/	0
orthopedic	0
injuries	I-DISEASE
,	I-DISEASE
and	0
neuropathy	0
.	0

These	0
pains	I-DISEASE
can	0
have	I-DISEASE
a	0
nocturnal	0
presentation	0
and	0
may	0
be	0
worse	I-DISEASE
at	I-DISEASE
rest	I-DISEASE
,	0
but	I-DISEASE
improvement	0
with	I-DISEASE
movement	0
either	0
does	I-DISEASE
not	0
occur	I-DISEASE
or	I-DISEASE
entails	0
more	0
exercise	0
than	0
simple	I-DISEASE
movement	I-DISEASE
of	I-DISEASE
the	0
leg	I-DISEASE
.	0

The	I-DISEASE
urge	0
to	0
move	I-DISEASE
,	0
if	0
present	I-DISEASE
at	I-DISEASE
all	0
,	0
usually	I-DISEASE
stems	0
from	I-DISEASE
awareness	I-DISEASE
that	0
movement	I-DISEASE
produces	I-DISEASE
relief	I-DISEASE
rather	0
than	0
the	0
strong	0
primary	0
urgency	0
of	I-DISEASE
movement	I-DISEASE
felt	0
with	I-DISEASE
RLS	I-DISEASE
.	0

The	I-DISEASE
presence	I-DISEASE
of	I-DISEASE
pain	0
,	0
however	I-DISEASE
,	I-DISEASE
does	I-DISEASE
not	0
exclude	0
a	I-DISEASE
diagnosis	I-DISEASE
of	I-DISEASE
RLS	I-DISEASE
,	I-DISEASE
because	I-DISEASE
about	I-DISEASE
50	0
%	0
of	I-DISEASE
patients	I-DISEASE
with	I-DISEASE
RLS	I-DISEASE
report	0
their	0
RLS	I-DISEASE
symptoms	I-DISEASE
as	0
painful	B-DISEASE
.	0

Although	I-DISEASE
it	0
is	0
important	B-DISEASE
that	0
RLS	I-DISEASE
symptoms	I-DISEASE
not	0
be	0
attributable	I-DISEASE
solely	0
to	I-DISEASE
another	I-DISEASE
medical	I-DISEASE
or	0
behavioral	0
condition	0
,	0
it	0
should	0
also	0
be	I-DISEASE
appreciated	0
that	I-DISEASE
any	I-DISEASE
of	I-DISEASE
these	I-DISEASE
mimics	B-DISEASE
can	0
occur	I-DISEASE
in	I-DISEASE
an	0
individual	0
who	I-DISEASE
also	0
has	0
RLS	0
.	0

For	I-DISEASE
example	0
,	0
some	I-DISEASE
subjects	0
may	I-DISEASE
have	0
both	I-DISEASE
RLS	0
and	0
leg	I-DISEASE
cramps	I-DISEASE
.	0

When	I-DISEASE
the	0
diagnosis	0
of	I-DISEASE
RLS	0
is	I-DISEASE
not	0
certain	0
,	0
evaluation	0
for	0
the	I-DISEASE
supportive	I-DISEASE
features	0
such	0
as	0
the	I-DISEASE
presence	0
of	0
PLMS	0
or	0
a	0
family	I-DISEASE
history	I-DISEASE
of	I-DISEASE
RLS	I-DISEASE
may	I-DISEASE
be	I-DISEASE
helpful	0
.	0

Diagnostic	I-DISEASE
interviews	0
that	0
include	I-DISEASE
differential	I-DISEASE
diagnosis	0
have	0
been	I-DISEASE
validated	I-DISEASE
for	I-DISEASE
RLS	0
.	0

These	0
demonstrate	I-DISEASE
sensitivity	I-DISEASE
and	0
specificity	I-DISEASE
of	I-DISEASE
>	0
90	I-DISEASE
%	0
.	0

Unresolved	I-DISEASE
Issues	0
and	0
Further	I-DISEASE
Directions	0

The	I-DISEASE
diagnosis	I-DISEASE
of	I-DISEASE
RLS	I-DISEASE
relies	0
on	0
the	I-DISEASE
subjective	I-DISEASE
report	0
of	I-DISEASE
sensory	I-DISEASE
symptoms	I-DISEASE
that	I-DISEASE
lie	I-DISEASE
outside	I-DISEASE
the	0
range	I-DISEASE
of	I-DISEASE
common	I-DISEASE
sensory	I-DISEASE
experience	0
.	0

Many	I-DISEASE
patients	I-DISEASE
have	0
difficulty	0
describing	0
the	0
sensations	0
.	I-DISEASE

Further	I-DISEASE
studies	I-DISEASE
of	I-DISEASE
the	0
biological	I-DISEASE
bases	0
for	I-DISEASE
RLS	I-DISEASE
may	0
lead	0
to	I-DISEASE
better	I-DISEASE
classification	I-DISEASE
of	I-DISEASE
RLS	I-DISEASE
and	0
possibly	0
to	0
objective	I-DISEASE
tests	0
for	I-DISEASE
diagnosis	0
.	0

Iron	I-DISEASE
,	I-DISEASE
dopa-	0
mine	I-DISEASE
,	I-DISEASE
and	0
genetic	0
research	0
hold	0
particular	I-DISEASE
promise	I-DISEASE
.	0

Additional	I-DISEASE
epidemiological	0
and	0
genetic	I-DISEASE
studies	0
outside	0
the	0
US	I-DISEASE
and	0
Europe	0
are	0
needed	0
to	I-DISEASE
explore	I-DISEASE
apparent	0
population	0
differences	I-DISEASE
.	0

The	I-DISEASE
diagnostic	0
standards	0
and	0
severity	0
assessment	I-DISEASE
for	0
children	I-DISEASE
and	0
cogni-	0
tively	0
impaired	0
adults	0
require	I-DISEASE
further	I-DISEASE
development	0
.	0

Clarification	I-DISEASE
of	I-DISEASE
the	0
natural	0
course	0
and	0
potential	0
exacerbating	0
factors	I-DISEASE
is	0
needed	0
.	0

Better	I-DISEASE
understanding	I-DISEASE
of	I-DISEASE
RLS	I-DISEASE
with	I-DISEASE
comor-	I-DISEASE
bidities	0
such	I-DISEASE
as	I-DISEASE
mood	I-DISEASE
disorders	0
and	0
attention	I-DISEASE
deficit	I-DISEASE
hyperactivity	0
disorder	I-DISEASE
might	0
lead	0
to	I-DISEASE
improved	I-DISEASE
outcomes	I-DISEASE
in	I-DISEASE
those	0
disorders	0
.	B-DISEASE

Further	I-DISEASE
evaluation	I-DISEASE
of	I-DISEASE
long	I-DISEASE
-	0
term	0
complica-	I-DISEASE
tions	0
is	I-DISEASE
important	0
,	0
including	0
clarification	I-DISEASE
of	0
associations	0
with	0
hypertension	I-DISEASE
,	0
cardiovas-	I-DISEASE
cular	B-DISEASE
disease	B-DISEASE
,	I-DISEASE
and	0
stroke	0
.	0

Bibliography	0
Allen	I-DISEASE
R	0
,	I-DISEASE
Picchietti	0
D	0
,	0
Hening	0
W	I-DISEASE
,	0
et	0
al	I-DISEASE
.	I-DISEASE

Restless	I-DISEASE
legs	0
syndrome	I-DISEASE
:	0
diagnostic	I-DISEASE
criteria	I-DISEASE
,	I-DISEASE
special	I-DISEASE
considerations	0
,	I-DISEASE
and	0
epidemiology	I-DISEASE
.	0

A	I-DISEASE
report	0
from	0
the	0
restless	I-DISEASE
legs	I-DISEASE
syndrome	0
diagnosis	I-DISEASE
and	0
epidemiology	0
workshop	I-DISEASE
at	I-DISEASE
the	0
National	0
Institutes	I-DISEASE
of	0
Health	0
.	0

Sleep	I-DISEASE
Med	I-DISEASE
2003;4:101–19	0
.	0

Allen	I-DISEASE
RP	I-DISEASE
,	I-DISEASE
Stillman	0
P	0
,	I-DISEASE
Myers	0
AJ	0
.	0

Physician	I-DISEASE
-	0
diagnosed	I-DISEASE
restless	I-DISEASE
legs	I-DISEASE
syndrome	0
in	0
a	0
large	I-DISEASE
sample	I-DISEASE
of	I-DISEASE
primary	0
medical	0
care	I-DISEASE
patients	I-DISEASE
in	0
western	0
Europe	0
:	I-DISEASE
Prevalence	I-DISEASE
and	0
characteristics	I-DISEASE
.	0

Sleep	I-DISEASE
Med	I-DISEASE
2010;11:31–7	I-DISEASE
.	0

Dauvilliers	I-DISEASE
Y	I-DISEASE
,	I-DISEASE
Winkelmann	I-DISEASE
J.	0
Restless	I-DISEASE
legs	I-DISEASE
syndrome	I-DISEASE
:	I-DISEASE
update	I-DISEASE
on	0
pathogenesis	0
.	0

Curr	I-DISEASE
Opin	0
Pulm	0
med	0
2013;19:594	0
-	I-DISEASE
600	I-DISEASE
.	0

Earley	I-DISEASE
CJ	0
,	0
Silber	0
MH	I-DISEASE
.	0

Restless	I-DISEASE
legs	0
syndrome	I-DISEASE
:	0
Understanding	0
its	I-DISEASE
consequences	I-DISEASE
and	0
the	0
need	0
for	0
better	I-DISEASE
treatment	I-DISEASE
.	0

Sleep	I-DISEASE
Med	I-DISEASE
2010;11:807–15	I-DISEASE
.	0

Ekbom	I-DISEASE
K.	0
Restless	0
legs	0
:	0
a	0
clinical	0
study	I-DISEASE
.	0

Acta	I-DISEASE
Med	0
Scand	0
1945;158:1–122	0
.	0

Ferini	I-DISEASE
-	0
Strambi	I-DISEASE
L	0
,	I-DISEASE
Walters	0
AS	0
,	0
Sica	0
D.	I-DISEASE

The	I-DISEASE
relationship	I-DISEASE
among	0
restless	I-DISEASE
legs	0
syndrome	I-DISEASE
(	I-DISEASE
Willis	I-DISEASE
-	0
Ekbom	0
Disease	I-DISEASE
)	0
,	I-DISEASE
hypertension	I-DISEASE
,	I-DISEASE
cardiovascular	I-DISEASE
disease	B-DISEASE
,	I-DISEASE
and	0
cerebrovascular	0
disease	B-DISEASE
.	0

J	I-DISEASE
Neurol	0
2013	0

Aug	I-DISEASE
21	I-DISEASE
.	0

[	I-DISEASE
Epub	0
ahead	0
of	I-DISEASE
print	0
]	I-DISEASE
Hening	0
WA	B-DISEASE
,	I-DISEASE
Allen	I-DISEASE
RP	I-DISEASE
,	I-DISEASE
Washburn	I-DISEASE
M	I-DISEASE
,	I-DISEASE
Lesage	I-DISEASE
SR	0
,	I-DISEASE
Earley	I-DISEASE
CJ	I-DISEASE
.	0

The	I-DISEASE
four	I-DISEASE
diagnostic	0
criteria	I-DISEASE
for	0
Restless	0
Legs	0
Syndrome	0
are	I-DISEASE
unable	I-DISEASE
to	0
exclude	0
confounding	I-DISEASE
conditions	0
(	I-DISEASE
“	I-DISEASE
mimics	I-DISEASE
”	I-DISEASE
)	0
.	0

Sleep	I-DISEASE
Med	I-DISEASE
2009;10:976–81	I-DISEASE
.	0

Ohayon	I-DISEASE
MM	I-DISEASE
,	I-DISEASE
O’Hara	I-DISEASE
R	0
,	I-DISEASE
Vitiello	I-DISEASE
MV	B-DISEASE
.	0

Epidemiology	I-DISEASE
of	0
restless	I-DISEASE
legs	I-DISEASE
syndrome	I-DISEASE
:	0
A	0
synthesis	0
of	I-DISEASE
the	I-DISEASE
literature	0
.	0

Sleep	I-DISEASE
Med	I-DISEASE
Rev	0
2012;16:283–95	0
.	I-DISEASE

Picchietti	I-DISEASE
DL	I-DISEASE
,	0
Arbuckle	0
RA	0
,	0
Abetz	I-DISEASE
L	I-DISEASE
,	I-DISEASE
et	0
al	I-DISEASE
.	0

Pediatric	I-DISEASE
restless	I-DISEASE
legs	I-DISEASE
syndrome	0
:	I-DISEASE
analysis	I-DISEASE
of	I-DISEASE
symptom	0
descriptions	I-DISEASE
and	0
drawings	0
.	0

J	I-DISEASE
Child	I-DISEASE
Neurol	0
2011;26:1365–76	I-DISEASE
.	0

Picchietti	I-DISEASE
DL	I-DISEASE
,	0
Bruni	0
O	0
,	0
de	0
Weerd	I-DISEASE
A	0
,	0
et	0
al	I-DISEASE
.	I-DISEASE

Pediatric	I-DISEASE
restless	I-DISEASE
legs	I-DISEASE
syndrome	0
diagnostic	I-DISEASE
criteria	I-DISEASE
:	I-DISEASE
An	0
update	0
by	I-DISEASE
the	0
International	I-DISEASE
Restless	I-DISEASE
Legs	0
Syndrome	I-DISEASE
Study	0
Group	0
.	0

Sleep	I-DISEASE
Med	I-DISEASE
2013;14:1253	0
-	0
9	I-DISEASE
.	0

Sleep	I-DISEASE
Related	0
Movement	0
Disorders	0
Sleep	I-DISEASE
Related	0
Movement	0
Disorders	I-DISEASE
Periodic	0
Limb	0
Movement	0
Disorder	0
ICD-9	0
-	0
CM	I-DISEASE
code	0
:	0
327.51	0
ICD-10	0
-	0
CM	0
code	0
:	0
G47.61	I-DISEASE
Alternate	I-DISEASE
Names	I-DISEASE

Periodic	I-DISEASE
movement	0
disorder	I-DISEASE
of	0
sleep	0
,	I-DISEASE
sleep	0
myoclonus	0
syndrome	I-DISEASE
,	I-DISEASE
nocturnal	0
myoclo-	0
nus	I-DISEASE
syndrome	I-DISEASE
.	0

Diagnostic	I-DISEASE
Criteria	0
Criteria	I-DISEASE
A	0
-	I-DISEASE
D	I-DISEASE
must	I-DISEASE
be	0
met	0
A.	0
Polysomnography	0
demonstrates	I-DISEASE
PLMS	0
,	I-DISEASE
as	0
defined	I-DISEASE
in	I-DISEASE
the	0
most	0
recent	0
version	I-DISEASE
of	I-DISEASE
the	0
American	0
Academy	0
of	I-DISEASE
Sleep	0
Medicine	0
(	0
AASM	0
)	0

Manual	I-DISEASE
for	I-DISEASE
the	0
Scoring	I-DISEASE
of	I-DISEASE
Sleep	I-DISEASE
and	0
Associated	0
Events	I-DISEASE
.	0

B.	0
The	I-DISEASE
frequency	I-DISEASE
is	0
>	0
5	0
/	0
hour	0
in	0
children	B-DISEASE
or	I-DISEASE
>	I-DISEASE
15	I-DISEASE
/	0
hour	0
in	I-DISEASE
adults.1	I-DISEASE

C.	I-DISEASE
The	I-DISEASE
PLMS	0
cause	I-DISEASE
clinically	I-DISEASE
significant	0
sleep	0
disturbance	I-DISEASE
or	I-DISEASE
impairment	I-DISEASE
in	I-DISEASE
mental	I-DISEASE
,	0
physical	0
,	0
social	0
,	0
occupational	I-DISEASE
,	I-DISEASE
educational	I-DISEASE
,	0
behavioral	I-DISEASE
,	I-DISEASE
or	I-DISEASE
other	I-DISEASE
important	B-DISEASE
areas	0
of	I-DISEASE
functioning.2,3	I-DISEASE
D.	I-DISEASE
The	I-DISEASE
PLMS	0
and	0
the	I-DISEASE
symptoms	I-DISEASE
are	I-DISEASE
not	0
better	0
explained	I-DISEASE
by	I-DISEASE
another	I-DISEASE
current	0
sleep	0
disorder	I-DISEASE
,	I-DISEASE
medical	0
or	I-DISEASE
neurological	0
disorder	I-DISEASE
,	I-DISEASE
or	0
mental	0
disorder	0
(	I-DISEASE
e.g.	0
,	I-DISEASE
PLMS	0
occurring	0
with	I-DISEASE
apneas	0
or	I-DISEASE
hypopneas	0
should	I-DISEASE
not	0
be	0
scored).4,5	I-DISEASE
Notes	0
.	I-DISEASE

The	I-DISEASE
PLMS	0
Index	I-DISEASE
must	I-DISEASE
be	I-DISEASE
interpreted	I-DISEASE
in	0
the	0
context	I-DISEASE
of	I-DISEASE
a	I-DISEASE
patient	I-DISEASE
’s	B-DISEASE
sleep	0
related	I-DISEASE
complaint	0
.	0

In	I-DISEASE
adults	I-DISEASE
,	0
normative	0
values	I-DISEASE
greater	I-DISEASE
than	I-DISEASE
five	0
per	0
hour	0
have	I-DISEASE
been	I-DISEASE
found	I-DISEASE
in	0
studies	I-DISEASE
that	0
did	I-DISEASE
not	0
exclude	0
respiratory	I-DISEASE
event	0
-	0
related	0
arousals	0
(	0
using	I-DISEASE
sensitive	I-DISEASE
respiratory	I-DISEASE
monitoring	0
)	0
and	0
other	0
causes	I-DISEASE
for	0
PLMS	0
.	0

Data	I-DISEASE
suggest	I-DISEASE
a	0
partial	I-DISEASE
overlap	0
of	I-DISEASE
PLMS	0
Index	I-DISEASE
values	I-DISEASE
between	0
symptomatic	I-DISEASE
and	0
asymptomatic	0
individuals	I-DISEASE
,	I-DISEASE
emphasizing	I-DISEASE
the	0
importance	0
of	I-DISEASE
clinical	I-DISEASE
context	I-DISEASE
over	I-DISEASE
an	0
absolute	I-DISEASE
cutoff	I-DISEASE
value	0
.	0
.	0

If	I-DISEASE
PLMS	0
are	0
present	I-DISEASE
without	0
clinical	I-DISEASE
sleep	0
disturbance	0
or	0
daytime	0
impairment	I-DISEASE
,	I-DISEASE
the	0
PLMS	I-DISEASE
can	0
be	0
noted	0
as	0
a	0
polysomnographic	0
finding	I-DISEASE
,	0
but	0
criteria	I-DISEASE
are	0
not	0
met	0
for	I-DISEASE
a	0
diagnosis	0
of	I-DISEASE
PLMD	0
.	0
.	I-DISEASE

The	I-DISEASE
presence	0
of	I-DISEASE
insomnia	I-DISEASE
or	I-DISEASE
hypersomnia	I-DISEASE
with	I-DISEASE
PLMS	0
is	0
not	I-DISEASE
sufficient	0
to	0
establish	0
the	0
diagnosis	I-DISEASE
of	I-DISEASE
PLMD	0
.	0

Studies	I-DISEASE
have	I-DISEASE
shown	0
that	0
in	0
most	I-DISEASE
cases	0
the	0
cause	I-DISEASE
of	I-DISEASE
the	0
accompanying	I-DISEASE
insomnia	I-DISEASE
or	I-DISEASE
hypersomnia	I-DISEASE
is	0
something	0
other	I-DISEASE
than	I-DISEASE
the	I-DISEASE
PLMS	0
.	0

To	I-DISEASE
establish	0
the	0
diagnosis	I-DISEASE
of	0
PLMD	0
,	0
it	0
is	0
essential	0
to	I-DISEASE
establish	0
a	0
reasonable	0
cause	I-DISEASE
-	I-DISEASE
and	0
-	0
effect	0
relationship	0
between	0
the	0
insomnia	I-DISEASE
or	I-DISEASE
hypersomnia	0
and	0
the	0
PLMS	0
.	0

This	I-DISEASE
requires	I-DISEASE
that	0
other	I-DISEASE
causes	0
of	I-DISEASE
insomnia	0
such	0
as	0
anxiety	I-DISEASE
or	I-DISEASE
other	I-DISEASE
causes	0
of	I-DISEASE
hypersomnia	I-DISEASE
such	0
as	0
obstructive	0
sleep	0
apnea	0
or	B-DISEASE
narcolepsy	0
are	0
ruled	0
out	0
.	0

PLMS	I-DISEASE
are	I-DISEASE
common	0
,	I-DISEASE
but	0
PLMD	0
is	0
thought	0
to	I-DISEASE
be	I-DISEASE
rare	I-DISEASE
in	I-DISEASE
adults	B-DISEASE
.	0
.	0

PLMD	I-DISEASE
can	I-DISEASE
not	0
be	I-DISEASE
diagnosed	0
in	I-DISEASE
the	0
context	0
of	I-DISEASE
RLS	I-DISEASE
,	I-DISEASE
narcolepsy	0
,	0
untreated	0
obstructive	0
sleep	0
apnea	I-DISEASE
,	I-DISEASE
or	B-DISEASE
REM	0
sleep	0
behavior	I-DISEASE
disorder	I-DISEASE
;	0
PLMS	0
occur	I-DISEASE
commonly	0
in	0
these	I-DISEASE
conditions	I-DISEASE
but	I-DISEASE
the	I-DISEASE
sleep	I-DISEASE
complaint	0
is	0
more	0
readily	I-DISEASE
ascribed	0
to	I-DISEASE
the	0
accompanying	0
disorder	0
.	0

The	I-DISEASE
diagnosis	I-DISEASE
of	I-DISEASE
RLS	I-DISEASE
takes	I-DISEASE
precedence	I-DISEASE
over	I-DISEASE
that	0
of	I-DISEASE
PLMD	0
when	I-DISEASE
potentially	0
sleep-	0
disrupting	I-DISEASE
PLMS	0
occur	I-DISEASE
in	I-DISEASE
the	I-DISEASE
context	I-DISEASE
of	I-DISEASE
RLS	I-DISEASE
.	0

In	I-DISEASE
such	0
cases	0
,	I-DISEASE
the	0
diagnosis	I-DISEASE
of	I-DISEASE
RLS	I-DISEASE
is	0
made	0
and	0
the	I-DISEASE
PLMS	0
are	I-DISEASE
noted	I-DISEASE
.	0
.	0

When	I-DISEASE
it	I-DISEASE
is	0
reasonably	I-DISEASE
certain	0
that	0
the	0
PLMS	0
have	0
been	I-DISEASE
induced	I-DISEASE
by	I-DISEASE
medication	0
,	I-DISEASE
and	0
full	I-DISEASE
criteria	0
for	0
PLMD	0
are	0
met	0
,	I-DISEASE
it	0
is	I-DISEASE
preferred	0
that	0
the	0
more	0
specific	I-DISEASE
diagnosis	I-DISEASE
of	I-DISEASE
PLMD	0
be	I-DISEASE
used	0
,	0
rather	0
than	0
“	0
Sleep	0
related	0
movement	I-DISEASE
disorder	I-DISEASE
due	I-DISEASE
to	0
a	0
medication	0
or	0
substance	I-DISEASE
.	0
”	I-DISEASE

Essential	I-DISEASE
Features	I-DISEASE
PLMD	0
is	0
characterized	0
by	I-DISEASE
periodic	0
episodes	0
of	I-DISEASE
repetitive	I-DISEASE
,	I-DISEASE
highly	I-DISEASE
stereotyped	I-DISEASE
limb	I-DISEASE
movements	0
that	0
occur	I-DISEASE
during	I-DISEASE
sleep	0
(	I-DISEASE
PLMS	0
)	0
,	I-DISEASE
in	I-DISEASE
conjunction	I-DISEASE
with	I-DISEASE
clinical	0
sleep	0
dis-	I-DISEASE
turbance	0
or	0
fatigue	I-DISEASE
that	0
can	0
not	0
be	I-DISEASE
accounted	0
for	I-DISEASE
by	I-DISEASE
another	0
primary	0
sleep	0
disorder	0
or	0
other	I-DISEASE
etiology	0
.	0

PLMS	I-DISEASE
occur	I-DISEASE
most	0
frequently	I-DISEASE
in	0
the	0
lower	0
extremities	0
.	0

They	I-DISEASE
typically	0
involve	0
exten-	I-DISEASE
sion	0
of	I-DISEASE
the	0
big	0
toe	I-DISEASE
,	I-DISEASE
often	I-DISEASE
in	0
combination	I-DISEASE
with	I-DISEASE
partial	I-DISEASE
flexion	0
of	I-DISEASE
the	0
ankle	I-DISEASE
,	I-DISEASE
the	I-DISEASE
knee	0
,	I-DISEASE
and	0
sometimes	I-DISEASE
,	I-DISEASE
the	0
hip	0
.	0

Similar	I-DISEASE
movements	0
can	0
occur	I-DISEASE
in	0
the	I-DISEASE
upper	I-DISEASE
limbs	0
.	0

Individual	I-DISEASE
movements	0
may	0
be	I-DISEASE
associated	0
with	I-DISEASE
an	0
autonomic	0
arousal	0
,	I-DISEASE
a	I-DISEASE
cortical	I-DISEASE
arousal	0
,	I-DISEASE
or	0
an	0
awakening	0
.	0

Typically	I-DISEASE
,	I-DISEASE
the	0
patient	I-DISEASE
is	0
unaware	I-DISEASE
of	I-DISEASE
the	0
limb	B-DISEASE
movements	0
or	0
the	0
frequent	I-DISEASE
sleep	0
disruption	B-DISEASE
.	0

An	0
arousal	I-DISEASE
may	0
precede	I-DISEASE
,	I-DISEASE
coincide	I-DISEASE
with	I-DISEASE
,	0
or	0
follow	I-DISEASE
the	0
limb	I-DISEASE
movement	I-DISEASE
,	0
suggesting	I-DISEASE
that	0
a	I-DISEASE
central	0
generator	0
may	I-DISEASE
give	I-DISEASE
rise	0
to	0
both	I-DISEASE
the	I-DISEASE
periodic	0
movements	0
and	0
the	I-DISEASE
related	I-DISEASE
sleep	I-DISEASE
disturbance	I-DISEASE
.	0

A	I-DISEASE
clinical	I-DISEASE
history	I-DISEASE
of	I-DISEASE
sleep	0
onset	I-DISEASE
problems	I-DISEASE
,	I-DISEASE
sleep	0
maintenance	0
problems	0
,	I-DISEASE
or	I-DISEASE
unrefresh-	I-DISEASE
ing	0
sleep	0
attributable	I-DISEASE
to	0
the	I-DISEASE
PLMS	0
is	I-DISEASE
needed	0
for	I-DISEASE
a	0
diagnosis	I-DISEASE
of	I-DISEASE
PLMD	0
.	0

These	0
symp-	0
toms	I-DISEASE
have	I-DISEASE
most	0
consistently	0
been	I-DISEASE
associated	0
with	I-DISEASE
PLMS	0
,	I-DISEASE
and	0
the	0
presence	0
of	I-DISEASE
these	I-DISEASE
clinical	0
symptoms	I-DISEASE
differentiates	I-DISEASE
PLMD	0
from	I-DISEASE
asymptomatic	0
PLMS	0
.	0

Although	I-DISEASE
exces-	I-DISEASE
sive	0
daytime	0
sleepiness	0
has	0
been	I-DISEASE
reported	I-DISEASE
with	I-DISEASE
PLMD	0
in	I-DISEASE
the	0
past	0
,	0
newer	I-DISEASE
data	I-DISEASE
do	I-DISEASE
not	0
find	I-DISEASE
significantly	0
elevated	0
Epworth	I-DISEASE
Sleepiness	0
Scale	0
scores	0
or	I-DISEASE
Multiple	0
Sleep	0
Latency	0
Test	0
(	0
MSLT	I-DISEASE
)	0
values	I-DISEASE
in	I-DISEASE
subjects	I-DISEASE
with	I-DISEASE
PLMS	0
.	0

If	I-DISEASE
the	0
only	0
complaint	I-DISEASE
is	0
sleep	I-DISEASE
disruption	I-DISEASE
for	I-DISEASE
the	0
bed	I-DISEASE
partner	0
,	I-DISEASE
then	I-DISEASE
PLMD	I-DISEASE
should	I-DISEASE
not	I-DISEASE
be	0
diagnosed	0
but	I-DISEASE
the	0
sleep	0
disturbance	I-DISEASE
of	I-DISEASE
the	I-DISEASE
bed	0
partner	0
can	0
be	I-DISEASE
noted	0
.	B-DISEASE

Sleep	I-DISEASE
Related	0
Movement	I-DISEASE
Disorders	0
Sleep	I-DISEASE
Related	0
Movement	0
Disorders	I-DISEASE
The	I-DISEASE
PLMS	0
index	0
should	0
exceed	I-DISEASE
five	0
per	0
hour	0
in	I-DISEASE
children	I-DISEASE
and	0
15	I-DISEASE
per	0
hour	0
in	I-DISEASE
adult	0
cases	0
for	0
a	0
diagnosis	0
of	I-DISEASE
PLMD	0
.	0

This	I-DISEASE
is	0
based	I-DISEASE
on	0
substantial	0
normative	0
data	I-DISEASE
in	0
children	0
.	0

In	I-DISEASE
adults	I-DISEASE
,	0
there	I-DISEASE
is	0
a	0
significant	0
increase	I-DISEASE
in	0
sleep	0
disturbance	I-DISEASE
symptoms	I-DISEASE
with	I-DISEASE
PLMS	0
>	0
15	I-DISEASE
/	0
hour	0
.	0

The	I-DISEASE
PLMS	0
and	0
the	0
symptoms	I-DISEASE
of	I-DISEASE
sleep	0
disturbance	0
or	0
nonrestorative	I-DISEASE
sleep	0
should	I-DISEASE
not	I-DISEASE
be	0
better	0
explained	I-DISEASE
by	I-DISEASE
another	I-DISEASE
etiology	0
.	0

Most	I-DISEASE
important	0
in	I-DISEASE
the	0
differential	0
diagnosis	I-DISEASE
are	0
RLS	I-DISEASE
,	0
REM	0
sleep	I-DISEASE
behavior	I-DISEASE
disorder	0
(	I-DISEASE
RBD	I-DISEASE
)	0
,	0
and	0
narcolepsy	0
.	0

Research	I-DISEASE
studies	I-DISEASE
indicate	I-DISEASE
that	0
five	0
or	I-DISEASE
more	0
PLMS	0
per	I-DISEASE
hour	0
occur	I-DISEASE
in	I-DISEASE
80	0
%	0
to	I-DISEASE
90	I-DISEASE
%	0
of	0
patients	I-DISEASE
with	0
RLS	0
,	I-DISEASE
in	I-DISEASE
about	0
70	0
%	0
with	I-DISEASE
RBD	I-DISEASE
,	0
and	0
in	I-DISEASE
45	I-DISEASE
%	0
to	0
65	0
%	0
with	0
narcolepsy	0
.	0

In	I-DISEASE
RBD	I-DISEASE
,	I-DISEASE
PLMS	0
are	I-DISEASE
often	0
present	0
without	0
arousals	0
during	I-DISEASE
nonrapid	0
eye	I-DISEASE
movement	0
sleep	0
(	I-DISEASE
NREM	0
)	0
sleep	I-DISEASE
but	0
can	I-DISEASE
also	0
con-	I-DISEASE
tinue	0
into	I-DISEASE
REM	I-DISEASE
sleep	0
,	0
which	0
is	0
unusual	I-DISEASE
in	I-DISEASE
all	0
other	0
settings	I-DISEASE
.	0

If	I-DISEASE
significant	0
daytime	0
sleep-	0
iness	I-DISEASE
and	0
PLMS	0
are	0
present	I-DISEASE
,	I-DISEASE
a	0
diagnosis	I-DISEASE
of	I-DISEASE
narcolepsy	I-DISEASE
should	0
be	0
considered	I-DISEASE
.	0

PLMD	I-DISEASE
should	0
not	0
be	I-DISEASE
diagnosed	0
when	I-DISEASE
criteria	0
for	0
one	0
of	I-DISEASE
these	I-DISEASE
three	I-DISEASE
disorders	0
is	I-DISEASE
met	0
.	0

However	I-DISEASE
,	I-DISEASE
the	0
primary	0
disorder	0
“	I-DISEASE
with	I-DISEASE
PLMS	0
”	I-DISEASE
can	0
be	I-DISEASE
specified	I-DISEASE
(	0
e.g.	0
,	0
“	I-DISEASE
RLS	0
with	I-DISEASE
PLMS	0
”	I-DISEASE
)	0
.	0

A	I-DISEASE
sensitive	I-DISEASE
technique	0
,	I-DISEASE
such	0
as	0
pressure	0
transducer	0
airflow	0
monitoring	I-DISEASE
or	I-DISEASE
esophageal	I-DISEASE
manometry	0
,	0
should	0
be	0
used	0
to	I-DISEASE
monitor	0
breathing	I-DISEASE
during	I-DISEASE
polysomnography	0
to	I-DISEASE
rea-	0
sonably	0
exclude	0
sleep	0
related	0
breathing	0
disorders	0
(	I-DISEASE
SRBDs	I-DISEASE
)	0
as	0
the	0
direct	0
cause	0
of	I-DISEASE
the	0
PLMS	0
.	0

When	I-DISEASE
independent	I-DISEASE
PLMS	0
are	0
present	I-DISEASE
in	I-DISEASE
patients	0
with	0
SRBDs	0
,	I-DISEASE
a	0
separate	0
diag-	I-DISEASE
nosis	0
of	I-DISEASE
PLMD	0
may	I-DISEASE
be	0
considered	I-DISEASE
if	0
the	0
PLMS	0
persist	I-DISEASE
despite	0
adequate	0
treatment	0
of	I-DISEASE
the	0
SRBD	0
and	0
otherwise	0
unexplained	I-DISEASE
sleep	0
disturbance	0
remains	0
.	0

Ideally	I-DISEASE
,	I-DISEASE
polysom-	0
nography	0
for	0
the	I-DISEASE
diagnosis	I-DISEASE
of	I-DISEASE
PLMD	0
should	0
be	0
performed	0
after	0
the	0
biologic	0
effect	0
of	I-DISEASE
a	0
medication	0
or	I-DISEASE
substance	I-DISEASE
,	0
such	0
as	0
an	0
antidepressant	0
known	0
to	0
induce	0
or	0
aggravate	0
PLMS	0
,	0
has	0
ended	I-DISEASE
.	0

Associated	I-DISEASE
Features	I-DISEASE
Higher	0
rates	0
of	0
mood	0
disorders	0
,	I-DISEASE
anxiety	0
,	0
attention	0
deficits	I-DISEASE
,	I-DISEASE
oppositional	0
behaviors	I-DISEASE
,	I-DISEASE
and	0
parasomnias	0
have	I-DISEASE
been	I-DISEASE
reported	0
in	I-DISEASE
some	I-DISEASE
studies	I-DISEASE
of	I-DISEASE
patients	I-DISEASE
with	I-DISEASE
PLMD	0
.	0

In	I-DISEASE
children	I-DISEASE
with	0
PLMD	0
,	I-DISEASE
a	I-DISEASE
family	0
history	I-DISEASE
of	I-DISEASE
RLS	I-DISEASE
is	I-DISEASE
common	I-DISEASE
.	0

A	I-DISEASE
sustained	0
clinical	0
response	0
to	0
dopa-	I-DISEASE
minergic	0
therapy	0
is	I-DISEASE
supportive	I-DISEASE
of	I-DISEASE
the	0
diagnosis	I-DISEASE
of	I-DISEASE
PLMD	0
.	0

Although	I-DISEASE
PLMD	0
symptoms	0
may	I-DISEASE
be	I-DISEASE
responsive	I-DISEASE
to	I-DISEASE
benzodiazepines	I-DISEASE
,	0
benzodiazepine	0
responsiveness	0
is	I-DISEASE
not	0
support-	I-DISEASE
i	B-DISEASE
ve	I-DISEASE
of	I-DISEASE
the	0
diagnosis	0
due	I-DISEASE
to	I-DISEASE
the	0
nonspecific	0
effect	0
of	I-DISEASE
benzodiazepines	I-DISEASE
on	0
sleep	0
.	0

Clinical	I-DISEASE
and	0
Pathophysiological	0
Subtypes	I-DISEASE
Not	I-DISEASE
applicable	0
or	I-DISEASE
known	I-DISEASE
.	0

Demographics	I-DISEASE
Although	0
PLMD	0
is	0
thought	0
to	0
be	I-DISEASE
rare	I-DISEASE
,	I-DISEASE
the	0
exact	0
prevalence	I-DISEASE
is	I-DISEASE
not	0
known	0
.	0

PLMD	I-DISEASE
has	0
been	0
reported	I-DISEASE
in	I-DISEASE
both	I-DISEASE
children	B-DISEASE
and	0
adults	B-DISEASE
.	0

PLMS	I-DISEASE
>	0
5	0
/	0
hour	I-DISEASE
are	I-DISEASE
very	I-DISEASE
uncommon	0
in	I-DISEASE
children	I-DISEASE
and	0
adults	I-DISEASE
younger	0
than	0
the	0
age	I-DISEASE
of	0
40	0
years	I-DISEASE
,	0
but	I-DISEASE
then	0
increase	I-DISEASE
markedly	I-DISEASE
with	I-DISEASE
advancing	I-DISEASE
age	I-DISEASE
,	I-DISEASE
occurring	0
in	0
over	0
45	I-DISEASE
%	0
of	I-DISEASE
the	0
elderly	I-DISEASE
.	0

The	I-DISEASE
population	0
prevalence	0
of	I-DISEASE
PLMS	0
>	0
15	0
/	0
hour	0
has	0
been	I-DISEASE
estimated	0
at	I-DISEASE
7.6	0
%	0
of	0
18-	I-DISEASE
to	0
65	0
-	0
year	I-DISEASE
-	0
olds	I-DISEASE
,	I-DISEASE
with	I-DISEASE
4.5	0
%	0
of	I-DISEASE
the	0
total	0
population	0
also	0
reporting	I-DISEASE
sleep	0
disturbance	I-DISEASE
or	0
excessive	0
sleepiness	0
.	I-DISEASE

However	I-DISEASE
,	I-DISEASE
RLS	0
and	0
medication	0
-	I-DISEASE
induced	I-DISEASE
PLMS	0
were	I-DISEASE
not	I-DISEASE
exclusionary	I-DISEASE
criteria	I-DISEASE
in	I-DISEASE
this	I-DISEASE
popula-	I-DISEASE
tion	0
,	0
suggesting	I-DISEASE
much	I-DISEASE
lower	0
rates	I-DISEASE
for	0
PLMD	I-DISEASE
.	0

The	I-DISEASE
increase	I-DISEASE
in	I-DISEASE
PLMS	0
with	I-DISEASE
age	I-DISEASE
may	0
occur	0
as	0
a	0
partial	I-DISEASE
expression	I-DISEASE
of	I-DISEASE
familial	I-DISEASE
or	0
genetic	0
factors	I-DISEASE
associated	0
with	I-DISEASE
RLS	0
,	I-DISEASE
based	B-DISEASE
on	0
data	I-DISEASE
that	0
show	0
very	I-DISEASE
little	0
increase	I-DISEASE
in	I-DISEASE
PLMS	0
with	I-DISEASE
age	I-DISEASE
when	0
individuals	I-DISEASE
who	0
have	0
RLS	I-DISEASE
or	I-DISEASE
first	I-DISEASE
-	I-DISEASE
degree	I-DISEASE
relatives	I-DISEASE
with	0
RLS	0
are	0
excluded	0
.	0

PLMS	I-DISEASE
are	I-DISEASE
less	I-DISEASE
common	I-DISEASE
in	0
black	I-DISEASE
adults	0
and	0
children	0
than	0
in	I-DISEASE
whites	0
.	0

No	I-DISEASE
sex	0
difference	0
has	0
been	0
described	0
for	0
PLMS	0
or	0
PLMD	0
.	0

Predisposing	I-DISEASE
and	0
Precipitating	I-DISEASE
Factors	0
A	0
positive	I-DISEASE
family	0
history	B-DISEASE
of	I-DISEASE
RLS	I-DISEASE
confers	0
increased	0
risk	0
for	I-DISEASE
PLMS	0
and	0
PLMD	0
.	0

The	I-DISEASE
genetic	I-DISEASE
variants	0
noted	0
below	0
may	I-DISEASE
be	I-DISEASE
a	I-DISEASE
mediator	I-DISEASE
of	I-DISEASE
this	I-DISEASE
risk	0
.	0

Precipitation	I-DISEASE
or	0
aggrava-	0
tion	0
of	I-DISEASE
PLMS	I-DISEASE
has	I-DISEASE
been	I-DISEASE
reported	0
with	0
the	0
use	I-DISEASE
of	I-DISEASE
several	0
medications	I-DISEASE
.	0

Selective	I-DISEASE
sero-	0
tonin	0
reuptake	I-DISEASE
inhibitor	0
antidepressants	I-DISEASE
,	I-DISEASE
tricyclic	0
antidepressants	0
,	I-DISEASE
lithium	I-DISEASE
,	0
and	0
dopa-	0
mine	I-DISEASE
receptor	0
antagonists	0
have	0
most	0
often	0
been	I-DISEASE
associated	0
with	0
this	0
effect	0
.	0

Low	I-DISEASE
brain	I-DISEASE
iron	0
,	I-DISEASE
as	0
reflected	I-DISEASE
by	I-DISEASE
serum	I-DISEASE
ferritin	I-DISEASE
level	I-DISEASE
,	I-DISEASE
may	0
worsen	0
PLMS	I-DISEASE
via	I-DISEASE
the	0
role	0
of	I-DISEASE
iron	0
in	I-DISEASE
dopamine	0
function	I-DISEASE
.	0

Less	I-DISEASE
evidence	I-DISEASE
is	0
available	I-DISEASE
for	0
obstructive	0
sleep	0
apnea	0
(	I-DISEASE
OSA	0
)	0
,	I-DISEASE
alcohol	0
,	0
pain	0
,	0
and	0
sleep	0
deprivation	0
as	0
factors	I-DISEASE
that	0
worsen	0
PLMS	0
.	0

Familial	I-DISEASE
Patterns	I-DISEASE

The	I-DISEASE
familial	I-DISEASE
pattern	0
of	I-DISEASE
PLMD	0
has	0
not	0
been	I-DISEASE
studied	I-DISEASE
in	I-DISEASE
detail	0
.	0

Families	0
with	I-DISEASE
RLS	0
have	0
been	I-DISEASE
found	I-DISEASE
to	I-DISEASE
include	0
first	0
-	0
degree	I-DISEASE
relatives	I-DISEASE
without	0
RLS	0
but	I-DISEASE
with	I-DISEASE
increased	0
rates	0
of	I-DISEASE
PLMS	0
or	I-DISEASE
PLMD	I-DISEASE
,	I-DISEASE
raising	I-DISEASE
the	0
possibility	I-DISEASE
that	0
PLMD	0
is	0
an	0
attenuated	I-DISEASE
manifestation	0
or	0
a	0
precursor	I-DISEASE
to	I-DISEASE
RLS	I-DISEASE
.	0

The	I-DISEASE
gene	0
variants	0
BTBD9	I-DISEASE
and	0
MEIS1	0
,	I-DISEASE
which	I-DISEASE
were	I-DISEASE
found	0
in	I-DISEASE
genome-	0
wide	0
studies	0
of	I-DISEASE
RLS	0
,	0
appear	0
to	I-DISEASE
influence	0
the	I-DISEASE
expression	0
of	I-DISEASE
PLMS	0
.	0

Onset	I-DISEASE
,	0
Course	0
,	0
and	0
Complications	0
Although	0
the	0
typical	I-DISEASE
age	I-DISEASE
of	I-DISEASE
onset	0
is	0
not	I-DISEASE
known	0
,	0
PLMD	0
occurs	0
in	I-DISEASE
both	I-DISEASE
children	0
and	0
adults	I-DISEASE
,	I-DISEASE
with	I-DISEASE
onset	I-DISEASE
as	0
early	0
as	0
infancy	0
.	0

The	I-DISEASE
natural	I-DISEASE
history	I-DISEASE
has	I-DISEASE
not	0
been	I-DISEASE
described	I-DISEASE
in	I-DISEASE
detail	0
,	0
but	0
some	I-DISEASE
pediatric	I-DISEASE
cases	0
of	I-DISEASE
PLMD	0
progress	0
to	I-DISEASE
RLS	I-DISEASE
.	0

Incidence	I-DISEASE
and	0
remission	0
rates	I-DISEASE
are	I-DISEASE
unknown	0
.	0

Impaired	I-DISEASE
performance	0
in	I-DISEASE
a	0
simulated	I-DISEASE
driving	0
task	0
has	0
been	I-DISEASE
found	I-DISEASE
in	I-DISEASE
patients	0
with	0
PLMD	0
.	0

Increased	I-DISEASE
PLMS	0
have	I-DISEASE
been	I-DISEASE
associated	0
with	I-DISEASE
a	0
higher	0
risk	0
of	I-DISEASE
cardiovascular	I-DISEASE
disease	I-DISEASE
,	I-DISEASE
stroke	I-DISEASE
,	0
and	0
mortality	I-DISEASE
in	I-DISEASE
some	I-DISEASE
studies	I-DISEASE
.	0

PLMS	I-DISEASE
-	I-DISEASE
related	B-DISEASE
overac-	I-DISEASE
tivity	0
of	I-DISEASE
the	0
sympathetic	I-DISEASE
nervous	I-DISEASE
system	0
is	I-DISEASE
postulated	B-DISEASE
to	0
be	0
a	0
potential	0
mechanism	0
for	0
these	0
associations	I-DISEASE
.	0

Sleep	I-DISEASE
Related	I-DISEASE
Movement	I-DISEASE
Disorders	0
Sleep	I-DISEASE
Related	0
Movement	I-DISEASE
Disorders	I-DISEASE
Developmental	0
Issues	0
Given	I-DISEASE
the	0
low	0
background	0
rates	0
of	I-DISEASE
PLMS	0
in	0
children	I-DISEASE
,	I-DISEASE
PLMD	I-DISEASE
has	0
emerged	I-DISEASE
as	0
a	0
useful	0
diagnostic	0
category	I-DISEASE
in	I-DISEASE
pediatric	0
sleep	0
medicine	0
.	0

Pediatric	I-DISEASE
PLMD	0
has	I-DISEASE
important	0

clini-	I-DISEASE

cal	I-DISEASE

and	0
polysomnographic	0
correlates	B-DISEASE
that	0
are	0
comparable	I-DISEASE
in	I-DISEASE
severity	0
to	0
pediatric	0
OSA	0
.	0

However	I-DISEASE
,	I-DISEASE
PLMS	0
and	0
PLMD	0
normative	0
data	I-DISEASE
remain	I-DISEASE
sparse	0
for	0
children	I-DISEASE
younger	0
than	I-DISEASE
two	0
years	0
.	0

In	I-DISEASE
the	0
elderly	I-DISEASE
,	I-DISEASE
frequent	0
occurrence	0
of	I-DISEASE
other	I-DISEASE
conditions	0
that	0
can	0
account	0
for	I-DISEASE
sleep	I-DISEASE
dis-	0

turbance	I-DISEASE
and	0
fatigue	I-DISEASE
makes	I-DISEASE
application	0
of	I-DISEASE
PLMD	0
criteria	I-DISEASE
difficult	I-DISEASE
,	0
even	I-DISEASE
though	0
PLMS	I-DISEASE
are	I-DISEASE
common	I-DISEASE
.	0

Pathology	I-DISEASE
and	0
Pathophysiology	I-DISEASE
Dopaminergic	I-DISEASE
impairment	I-DISEASE
has	0
been	I-DISEASE
implicated	0
in	0
the	0
pathophysiology	0
of	0
PLMS	0
and	0
PLMD	0
.	0

The	I-DISEASE
study	I-DISEASE
of	I-DISEASE
PLMS	0
in	I-DISEASE
RLS	I-DISEASE
and	0
in	I-DISEASE
children	I-DISEASE
also	I-DISEASE
suggests	I-DISEASE
genetic	I-DISEASE
diathesis	I-DISEASE
and	0
iron	0
status	I-DISEASE
as	0
factors	0
.	0

Cyclic	I-DISEASE
alternating	I-DISEASE
pattern	0
,	I-DISEASE
a	0
marker	I-DISEASE
of	I-DISEASE
nonrestorative	0
sleep	0
,	0
is	I-DISEASE
increased	0
in	I-DISEASE
individuals	0
with	0
PLMS	0
and	0
may	0
influence	0
the	0
periodicity	I-DISEASE
of	I-DISEASE
PLMS	0
.	0

Cortical	I-DISEASE
arousals	0
can	I-DISEASE
precede	I-DISEASE
,	0
coincide	0
with	I-DISEASE
,	I-DISEASE
or	I-DISEASE
follow	I-DISEASE
PLMS	0
,	I-DISEASE
indicating	0
that	0
PLMS	0
do	I-DISEASE
not	0
cause	I-DISEASE
the	0
arousals	0
.	0

In	I-DISEASE
addition	0
,	0
PLMS	0
can	I-DISEASE
be	I-DISEASE
dissociated	0
from	I-DISEASE
arousals	I-DISEASE
pharma-	0
cologically	0
,	I-DISEASE
suggesting	0
an	0
indirect	I-DISEASE
relation	0
,	I-DISEASE
possibly	I-DISEASE
mediated	0
by	I-DISEASE
a	I-DISEASE
central	0
generator	0
.	0

The	I-DISEASE
autonomic	0
arousals	0
associated	0
with	I-DISEASE
PLMS	0
are	0
characterized	0
by	I-DISEASE
significant	0
heart	0
rate	I-DISEASE
and	0
blood	0
pressure	0
surges	I-DISEASE
,	0
a	0
mechanism	0
for	I-DISEASE
possible	0
increased	0
cardiovascular	I-DISEASE
and	0
cerebrovascular	I-DISEASE
disease	0
risk	0
.	0

Objective	I-DISEASE
Findings	I-DISEASE
PLMS	0
can	0
appear	0
immediately	I-DISEASE
with	I-DISEASE
the	I-DISEASE
onset	I-DISEASE
of	I-DISEASE
stage	0
N1	0
sleep	0
,	0
are	I-DISEASE
frequent	0
during	I-DISEASE
stage	I-DISEASE
N2	0
sleep	0
,	I-DISEASE
decrease	I-DISEASE
in	I-DISEASE
frequency	I-DISEASE
in	I-DISEASE
stage	I-DISEASE
N3	0
,	0
and	0
are	0
usually	I-DISEASE
absent	I-DISEASE
during	0
stage	I-DISEASE
R	0
sleep	0
.	0

PLMS	I-DISEASE
typically	0
occur	0
in	I-DISEASE
discrete	0
episodes	I-DISEASE
that	0
last	0
from	I-DISEASE
a	0
few	I-DISEASE
minutes	0
to	0
an	0
hour	I-DISEASE
.	I-DISEASE

Both	I-DISEASE
lower	0
limbs	0
should	0
be	0
monitored	0
for	0
the	0
presence	0
of	I-DISEASE
limb	0
movements	0
.	I-DISEASE

Movements	I-DISEASE
of	I-DISEASE
the	0
upper	0
limbs	0
may	0
be	I-DISEASE
sampled	I-DISEASE
if	0
clinically	0
indicated	I-DISEASE
.	0

The	I-DISEASE
anterior	I-DISEASE
tibialis	0
electro-	I-DISEASE
myogram	I-DISEASE
(	0
EMG	0
)	I-DISEASE
shows	I-DISEASE
repetitive	I-DISEASE
contractions	I-DISEASE
,	I-DISEASE
each	0
lasting	0
0.5	I-DISEASE
to	0
10	0
seconds	I-DISEASE
.	0

The	I-DISEASE
movements	0
may	0
affect	0
one	0
or	I-DISEASE
,	0
more	0
typically	0
,	0
both	I-DISEASE
of	I-DISEASE
the	I-DISEASE
lower	0
limbs	0
,	I-DISEASE
but	I-DISEASE
not	I-DISEASE
neces-	0
sarily	I-DISEASE
in	I-DISEASE
a	0
symmetric	0
or	0
simultaneous	I-DISEASE
pattern	0
.	0

Specific	I-DISEASE
scoring	0
criteria	I-DISEASE
for	0
PLMS	I-DISEASE
are	0
described	0
in	I-DISEASE
the	0
AASM	I-DISEASE
Manual	I-DISEASE
for	0
the	0
Scoring	I-DISEASE
of	0
Sleep	0
and	0
Associated	I-DISEASE
Events	I-DISEASE
.	0

Self	I-DISEASE
-	I-DISEASE
reports	0
,	I-DISEASE
bed	0
partner	0
observations	I-DISEASE
,	I-DISEASE
or	B-DISEASE
parental	I-DISEASE
reports	0
for	0
children	I-DISEASE
have	I-DISEASE
not	0
been	I-DISEASE
found	I-DISEASE
to	I-DISEASE
have	0
sufficient	0
specificity	I-DISEASE
or	0
sensitivity	I-DISEASE
to	I-DISEASE
replace	I-DISEASE
objective	B-DISEASE
testing	0
for	0
PLMS	I-DISEASE
.	0

Care	I-DISEASE
must	I-DISEASE
be	0
taken	0
to	0
discriminate	0
PLMS	0
from	I-DISEASE
other	I-DISEASE
movements	0
such	0
as	0
a	0
simple	I-DISEASE
change	0
in	0
body	I-DISEASE
position	0
,	0
stretching	0
of	I-DISEASE
a	I-DISEASE
limb	0
,	I-DISEASE
or	0
a	0
muscle	I-DISEASE
cramp	I-DISEASE
.	0

PLMS	I-DISEASE
are	I-DISEASE
longer	0
in	I-DISEASE
duration	0
than	I-DISEASE
myoclonic	0
jerks	I-DISEASE
,	0
which	0
,	I-DISEASE
by	I-DISEASE
definition	0
,	0
are	I-DISEASE
typically	0
50	0
to	0
150	I-DISEASE
millisec-	I-DISEASE
onds	0
long	I-DISEASE
.	0

Movements	I-DISEASE
associated	0
with	I-DISEASE
respiratory	0
events	0
,	0
hypnagogic	I-DISEASE
foot	0
tremor	0
,	I-DISEASE
or	0
alternating	0
leg	I-DISEASE
muscle	0
activation	0
during	I-DISEASE
sleep	0
(	I-DISEASE
ALMA	0
)	0
should	I-DISEASE
not	0
be	I-DISEASE
included	0
in	I-DISEASE
the	0
PLMS	0
index	I-DISEASE
.	0

PLMS	I-DISEASE
may	I-DISEASE
be	0
associated	0
with	I-DISEASE
electroencephalographic	I-DISEASE
(	I-DISEASE
cortical	I-DISEASE
)	0
arousals	I-DISEASE
or	0
with	I-DISEASE
awakenings	0
.	0

Autonomic	I-DISEASE
arousals	0
—	I-DISEASE
measured	0
by	I-DISEASE
a	0
change	0
in	I-DISEASE
heart	0
rate	I-DISEASE
,	I-DISEASE
blood	0
pressure	0
,	I-DISEASE
or	I-DISEASE
pulse	0
transit	0
time	I-DISEASE
—	I-DISEASE
have	0
been	I-DISEASE
shown	I-DISEASE
to	I-DISEASE
be	0
more	0
frequent	I-DISEASE
than	I-DISEASE
cortical	0
arousals	0
.	0

In	I-DISEASE
some	I-DISEASE
cases	0
,	I-DISEASE
periodic	0
arousals	0
may	I-DISEASE
persist	0
even	I-DISEASE
though	0
the	I-DISEASE
PLMS	0
have	0
subsided	I-DISEASE
.	0

The	I-DISEASE
arousals	0
are	I-DISEASE
typically	0
more	0
difficult	0
to	I-DISEASE
measure	0
than	0
are	0
the	0
PLMS	I-DISEASE
,	I-DISEASE
and	0
their	I-DISEASE
clinical	0
significance	0
is	I-DISEASE
a	0
topic	0
of	I-DISEASE
ongoing	I-DISEASE
debate	I-DISEASE
.	0

As	I-DISEASE
with	I-DISEASE
obstructive	0
sleep	0
apnea	I-DISEASE
,	0
the	0
associated	I-DISEASE
cortical	I-DISEASE
arousal	0
index	I-DISEASE
has	0
not	0
proven	0
more	0
useful	0
than	0
the	0
PLMS	I-DISEASE
index	0
in	I-DISEASE
making	0
clini-	I-DISEASE
cal	0
decisions	I-DISEASE
.	0

Although	I-DISEASE
a	0
subjective	0
report	0
of	0
excessive	0
daytime	0
sleepiness	0
is	0
present	I-DISEASE
in	I-DISEASE
some	I-DISEASE
patients	I-DISEASE
with	0
PLMD	0
,	0
mean	0
sleep	0
latency	I-DISEASE
measured	0
by	I-DISEASE
MSLT	I-DISEASE
has	0
not	0
been	I-DISEASE
found	0
to	0
be	0
consistently	I-DISEASE
abnormal	I-DISEASE
or	0
to	I-DISEASE
correlate	0
with	0
the	0
PLMS	0
cortical	0
arousal	0
index	I-DISEASE
.	0

The	I-DISEASE
movements	0
should	0
be	I-DISEASE
reported	0
as	0
an	0
index	I-DISEASE
of	I-DISEASE
total	0
sleep	0
time	I-DISEASE
,	I-DISEASE
called	I-DISEASE
the	0
PLMS	0
index	0
.	0

The	I-DISEASE
PLMS	0
index	0
is	I-DISEASE
the	0
number	0
of	I-DISEASE
periodic	I-DISEASE
limb	0
movements	0
per	I-DISEASE
hour	I-DISEASE
of	I-DISEASE
total	I-DISEASE
sleep	0
time	I-DISEASE
,	0
as	0
determined	I-DISEASE
by	I-DISEASE
polysomnography	0
.	0

The	I-DISEASE
PLMS	0
arousal	0
index	I-DISEASE
is	I-DISEASE
the	0
number	0
of	I-DISEASE
PLMS	0
associated	0
with	0
a	0
cortical	B-DISEASE
arousal	0
,	I-DISEASE
expressed	I-DISEASE
per	0
hour	0
of	I-DISEASE
total	I-DISEASE
sleep	0
time	0
.	0

Other	I-DISEASE
parameters	I-DISEASE
for	0
the	0
description	0
of	I-DISEASE
PLMS	0
include	0
periodicity	0
index	I-DISEASE
,	I-DISEASE
intermove-	0
ment	0
interval	I-DISEASE
distribution	I-DISEASE
,	0
and	0
time	0
of	I-DISEASE
night	0
distribution	I-DISEASE
.	0

These	0
features	I-DISEASE
have	0
been	I-DISEASE
shown	0
to	I-DISEASE
help	I-DISEASE
differentiate	I-DISEASE
PLMS	0
patterns	0
in	I-DISEASE
different	I-DISEASE
conditions	0
(	I-DISEASE
e.g.	I-DISEASE
,	I-DISEASE
a	0
finding	I-DISEASE
of	I-DISEASE
the	0
highest	I-DISEASE
periodicity	0
indices	I-DISEASE
in	I-DISEASE
adult	0
RLS	0
and	0
PLMD	0
)	0
.	0

Leg	I-DISEASE
actigraphy	0
has	0
been	I-DISEASE
validated	I-DISEASE
against	0
PSG	0
for	I-DISEASE
the	0
measurement	0
of	I-DISEASE
PLMS	0
and	0
provides	I-DISEASE
a	0
methodology	0
to	0
assess	0
PLMS	I-DISEASE
in	I-DISEASE
large	I-DISEASE
populations	0
,	I-DISEASE
as	0
well	B-DISEASE
as	0
night	0
-	0
to	0
-	I-DISEASE
night	0
variability	0
.	0

Differential	I-DISEASE
Diagnosis	0
As	0
described	0
in	I-DISEASE
the	0
essential	0
features	0
section	I-DISEASE
,	I-DISEASE
PLMD	0
is	0
a	I-DISEASE
diagnosis	0
of	0
exclusion	I-DISEASE
and	0
it	0
is	0
important	0
to	I-DISEASE
differentiate	0
it	0
from	0
other	I-DISEASE
conditions	I-DISEASE
in	I-DISEASE
which	0
PLMS	0
occur	I-DISEASE
,	0
particularly	0
RLS	0
,	0
RBD	0
,	I-DISEASE
narcolepsy	0
,	0
and	0
SRBDs	0
.	0

Increased	I-DISEASE
rates	0
of	I-DISEASE
PLMS	0
have	I-DISEASE
also	0
been	I-DISEASE
reported	0
in	I-DISEASE
multiple	I-DISEASE
system	I-DISEASE
atrophy	I-DISEASE
,	I-DISEASE
dopa	0
-	I-DISEASE
responsive	0
dystonia	0
,	I-DISEASE
sleep	0
related	B-DISEASE
eating	I-DISEASE
disorder	I-DISEASE
,	I-DISEASE
spinal	I-DISEASE
cord	I-DISEASE
injury	0
,	I-DISEASE
end	0
-	0
stage	I-DISEASE
renal	0
disease	I-DISEASE
,	I-DISEASE
congestive	I-DISEASE
heart	0
failure	0
,	0
Parkinson	0
disease	0
,	0
sickle	0
cell	0
disease	0
,	I-DISEASE
posttraumatic	0
stress	I-DISEASE
disorder	I-DISEASE
,	I-DISEASE
Asperger	0
syndrome	I-DISEASE
,	I-DISEASE
Williams	I-DISEASE
syn-	0
drome	0
,	0
and	0
multiple	I-DISEASE
sclerosis	0
.	I-DISEASE

Dopaminergic	I-DISEASE
impairment	I-DISEASE
and/or	0
diminished	I-DISEASE
inhibition	I-DISEASE
of	I-DISEASE
the	0
central	0
pattern	0
generator	0
for	0
PLMS	0
have	0
been	I-DISEASE
proposed	I-DISEASE
as	0
common	I-DISEASE
factors	0
linking	I-DISEASE
various	0
disorders	0
and	0
PLMS	0
.	0

Sleep	I-DISEASE
Related	I-DISEASE
Movement	I-DISEASE
Disorders	0
Sleep	I-DISEASE
Related	0
Movement	I-DISEASE
Disorders	I-DISEASE
Sleep	0
starts	0
(	I-DISEASE
hypnic	I-DISEASE
jerks	0
)	0
need	I-DISEASE
to	I-DISEASE
be	0
differentiated	I-DISEASE
from	0
PLMS	I-DISEASE
.	0

Sleep	I-DISEASE
starts	I-DISEASE
typically	0
are	I-DISEASE
limited	0
to	I-DISEASE
the	0
transition	I-DISEASE
from	0
wakefulness	0
to	I-DISEASE
sleep	I-DISEASE
,	I-DISEASE
are	0
not	0
periodic	I-DISEASE
,	I-DISEASE
and	0
are	0
briefer	I-DISEASE
(	I-DISEASE
20	0
to	I-DISEASE
100	0
milliseconds	I-DISEASE
)	0
than	I-DISEASE
PLMS	0
.	0

Normal	I-DISEASE
phasic	0
REM	0
activity	0
is	I-DISEASE
limited	I-DISEASE
to	0
REM	0
sleep	I-DISEASE
,	I-DISEASE
typically	0
occurs	0
in	I-DISEASE
5-	0
to	0
15	I-DISEASE
-	0
second	I-DISEASE
clusters	I-DISEASE
,	I-DISEASE
and	0
is	0
usually	I-DISEASE
associated	0
with	I-DISEASE
bursts	I-DISEASE
of	I-DISEASE
REMs	0
.	0

Phasic	I-DISEASE
REM	I-DISEASE
EMG	I-DISEASE
twitches	I-DISEASE
are	0
more	0
variable	I-DISEASE
in	I-DISEASE
duration	0
and	0
do	0
not	0
have	I-DISEASE
the	0
periodicity	0
of	I-DISEASE
PLMS	0
.	0

Fragmentary	I-DISEASE
myoclonus	0
is	I-DISEASE
characterized	0
by	I-DISEASE
EMG	0
activity	I-DISEASE
that	0
is	0
briefer	I-DISEASE
(	I-DISEASE
75	0
to	0
150	I-DISEASE
milliseconds	I-DISEASE
)	I-DISEASE
,	0
more	0
variable	I-DISEASE
in	I-DISEASE
duration	0
,	I-DISEASE
less	I-DISEASE
periodic	I-DISEASE
than	I-DISEASE
PLMS	0
,	I-DISEASE
and	0
has	0
little	0
or	0
no	0
associated	0
visible	0
movement	I-DISEASE
.	0

Also	I-DISEASE
,	I-DISEASE
PLMS	0
must	I-DISEASE
be	0
differentiated	I-DISEASE
from	0
movements	0
associated	0
with	I-DISEASE
nocturnal	I-DISEASE
epileptic	0
seizures	I-DISEASE
and	0
myoclonic	0
epilepsy	0
and	0
from	0
a	0
number	0
of	I-DISEASE
forms	0
of	I-DISEASE
myoclonus	0
seen	I-DISEASE
while	0
awake	0
,	0
such	0
as	0
in	I-DISEASE
Alzheimer	I-DISEASE
disease	I-DISEASE
,	I-DISEASE
Creutzfeldt	I-DISEASE
-	0
Jakob	0
disease	0
,	I-DISEASE
and	0
other	0
neuropathologic	0
conditions	I-DISEASE
.	0

However	I-DISEASE
,	I-DISEASE
in	0
these	I-DISEASE
disorders	0
,	I-DISEASE
the	0
involuntary	I-DISEASE
movements	0
are	I-DISEASE
prominent	0
during	0
the	0
daytime	I-DISEASE
,	I-DISEASE
often	0
do	0
not	0
disappear	0
with	I-DISEASE
activity	0
,	I-DISEASE
are	I-DISEASE
prominent	0
in	I-DISEASE
the	0
arms	I-DISEASE
and	0
other	I-DISEASE
body	I-DISEASE
parts	0
in	I-DISEASE
addition	0
to	0
the	0
legs	0
,	0
and	0
do	0
not	0
display	0
the	0
periodicity	I-DISEASE
seen	I-DISEASE
with	I-DISEASE
PLMS	0
.	0

Unresolved	I-DISEASE
Issues	0
and	0
Further	I-DISEASE
Directions	0

There	I-DISEASE
has	0
been	I-DISEASE
controversy	I-DISEASE
over	0
the	0
clinical	0
significance	I-DISEASE
of	0
PLMS	0
.	I-DISEASE

To	I-DISEASE
date	0
,	0
the	0
inter-	0
pretation	0
of	B-DISEASE
most	0
studies	I-DISEASE
has	0
been	I-DISEASE
confounded	I-DISEASE
by	I-DISEASE
multiple	I-DISEASE
factors	I-DISEASE
that	0
include	0
:	I-DISEASE
impre-	0
cise	I-DISEASE
diagnostic	0
criteria	I-DISEASE
;	0
confusion	I-DISEASE
between	0
PLMS	0
and	0
PLMD	0
;	0
inadequate	0
monitoring	0
for	0
subtle	0
SRBDs	0
;	I-DISEASE
a	0
lack	I-DISEASE
of	I-DISEASE
consideration	I-DISEASE
of	I-DISEASE
medications	0
known	0
to	0
induce	0
,	I-DISEASE
worsen	0
,	0
or	0
suppress	0
PLMS	I-DISEASE
;	0
and	0
inadequate	0
measurement	0
of	I-DISEASE
the	0
known	I-DISEASE
night	0
-	I-DISEASE
to	0
-	0
night	0
vari-	I-DISEASE
ability	0
of	I-DISEASE
PLMS	0
.	0

Newer	I-DISEASE
respiratory	0
monitoring	0
techniques	0
for	I-DISEASE
polysomnography	0
and	0
the	0
use	0
of	I-DISEASE
actigraphy	0
monitors	0
over	0
several	0
nights	0
should	0
help	0
address	I-DISEASE
a	0
number	0
of	I-DISEASE
these	I-DISEASE
issues	0
.	0

The	I-DISEASE
role	0
of	I-DISEASE
associated	0
arousals	0
in	I-DISEASE
relation	I-DISEASE
to	0
clinical	0
symptoms	I-DISEASE
is	I-DISEASE
yet	I-DISEASE
to	I-DISEASE
be	0
determined	I-DISEASE
,	I-DISEASE
but	I-DISEASE
the	0
appreciation	0
of	I-DISEASE
autonomic	0
arousals	0
as	0
well	I-DISEASE
as	0
cortical	0
arousals	0
might	I-DISEASE
be	0
critical	0
.	0

It	I-DISEASE
is	I-DISEASE
possible	0
that	0
PLMS	0
are	I-DISEASE
a	0
measurable	0
marker	I-DISEASE
of	I-DISEASE
unstable	0
sleep	0
,	I-DISEASE
related	I-DISEASE
to	0
genetic	0
diathesis	I-DISEASE
and	0
dopaminergic	I-DISEASE
impairment	0
.	0

Bibliography	0
Ferri	I-DISEASE
R.	I-DISEASE
The	I-DISEASE
time	0
structure	0
of	I-DISEASE
leg	I-DISEASE
movement	I-DISEASE
activity	0
during	I-DISEASE
sleep	0
:	I-DISEASE
The	I-DISEASE
theory	0
behind	0
the	0
practice	I-DISEASE
.	0

Sleep	I-DISEASE
Med	I-DISEASE
2012;13:433–41	I-DISEASE
.	0

Gingras	I-DISEASE
JL	0
,	I-DISEASE
Gaultney	I-DISEASE
JF	0
,	I-DISEASE
Picchietti	I-DISEASE
DL	I-DISEASE
.	0

Pediatric	I-DISEASE
periodic	I-DISEASE
limb	I-DISEASE
movement	0
disorder	I-DISEASE
:	I-DISEASE
sleep	0
symptom	0
and	0
polysomnographic	I-DISEASE
correlates	0
compared	I-DISEASE
to	0
obstructive	0
sleep	0
apnea	I-DISEASE
.	0

J	I-DISEASE
Clin	0
Sleep	0
Med	0
2011;7:603–9	I-DISEASE
.	0

Hornyak	I-DISEASE
M	I-DISEASE
,	0
Feige	I-DISEASE
B	0
,	0
Riemann	0
D	I-DISEASE
,	I-DISEASE
Voderholzer	I-DISEASE
U.	0
Periodic	0
leg	I-DISEASE
movements	0
in	I-DISEASE
sleep	0
and	0
periodic	I-DISEASE
limb	I-DISEASE
movement	I-DISEASE
disorder	B-DISEASE
:	0
prevalence	0
,	I-DISEASE
clinical	0
significance	I-DISEASE
and	0
treatment	I-DISEASE
.	0

Sleep	I-DISEASE
Med	I-DISEASE
Rev	I-DISEASE
2006;10:169–77	0
.	0

Koo	I-DISEASE
BB	0
,	0
Blackwell	I-DISEASE
T	0
,	I-DISEASE
Ancoli	0
-	I-DISEASE
Israel	I-DISEASE
S	I-DISEASE
,	0
Stone	0
KL	B-DISEASE
,	0
Stefanick	0
ML	I-DISEASE
,	0
Redline	0
S.	0
Association	I-DISEASE
of	I-DISEASE
incident	I-DISEASE
cardiovascular	I-DISEASE
disease	B-DISEASE
with	I-DISEASE
periodic	I-DISEASE
limb	0
movements	0
during	I-DISEASE
sleep	0
in	0
older	0
men	0
:	0
Outcomes	0
of	I-DISEASE
Sleep	0
Disorders	I-DISEASE
in	0
Older	0
Men	0
(	I-DISEASE
MrOS	I-DISEASE
)	0
Study	0
.	0

Circulation	I-DISEASE
2011;124:1223–31	0
.	0

Pennestri	I-DISEASE
MH	I-DISEASE
,	I-DISEASE
Whittom	0
S	0
,	0
Adam	0
B	0
,	I-DISEASE
Petit	0
D	I-DISEASE
,	I-DISEASE
Carrier	I-DISEASE
J	0
,	0
Montplaisir	I-DISEASE
J.	0
PLMS	0
and	0
PLMW	0
in	I-DISEASE
healthy	I-DISEASE
subjects	0
as	0
a	0
function	0
of	I-DISEASE
age	0
:	0
prevalence	0
and	0
interval	I-DISEASE
distribution	I-DISEASE
.	I-DISEASE

Sleep	I-DISEASE
2006;29:1183–7	0
.	0

Picchietti	I-DISEASE
DL	I-DISEASE
,	0
Rajendran	I-DISEASE
RR	0
,	0
Wilson	0
MP	I-DISEASE
,	I-DISEASE
Picchietti	0
MA	I-DISEASE
.	0

Pediatric	I-DISEASE
restless	I-DISEASE
legs	I-DISEASE
syndrome	0
and	0
periodic	I-DISEASE
limb	I-DISEASE
movement	0
disorder	0
:	0
parent	0
-	I-DISEASE
child	I-DISEASE
pairs	0
.	0

Sleep	I-DISEASE
Med	I-DISEASE
2009;10:925–31	I-DISEASE
.	0

Picchietti	I-DISEASE
D.	I-DISEASE
Periodic	I-DISEASE
limb	I-DISEASE
movements	0
in	0
sleep	0
:	I-DISEASE
irrelevant	I-DISEASE
epiphenomenon	I-DISEASE
,	0
marker	0
for	0
a	0
potential	0
problem	0
,	I-DISEASE
or	0
a	I-DISEASE
disorder	0
?	0

J	I-DISEASE
Clin	0
Sleep	0
Med	0
2006;2:446–7	0
.	0

Scofield	I-DISEASE
H	I-DISEASE
,	0
Roth	I-DISEASE
T	0
,	I-DISEASE
Drake	I-DISEASE
C.	0
Periodic	I-DISEASE
limb	I-DISEASE
movements	0
during	I-DISEASE
sleep	0
:	I-DISEASE
population	0
prevalence	0
,	I-DISEASE
clinical	0
correlates	0
,	I-DISEASE
and	0
racial	I-DISEASE
differences	I-DISEASE
.	0

Sleep	I-DISEASE
2008;31:1221–7	I-DISEASE
.	0

Stefansson	I-DISEASE
H	I-DISEASE
,	I-DISEASE
Rye	0
DB	I-DISEASE
,	I-DISEASE
Hicks	I-DISEASE
A	0
,	I-DISEASE
et	0
al	I-DISEASE
.	0

A	I-DISEASE
genetic	I-DISEASE
risk	0
factor	I-DISEASE
for	0
periodic	I-DISEASE
limb	I-DISEASE
movements	I-DISEASE
in	0
sleep	0
.	0

N	0
Engl	I-DISEASE
J	0
Med	I-DISEASE
2007;357:639–47	I-DISEASE
.	0

Walters	I-DISEASE
AS	I-DISEASE
,	I-DISEASE
Rye	I-DISEASE
DB	I-DISEASE
.	0

Review	I-DISEASE
of	I-DISEASE
the	0
relationship	I-DISEASE
of	I-DISEASE
restless	I-DISEASE
legs	I-DISEASE
syndrome	I-DISEASE
and	0
periodic	I-DISEASE
limb	0
movements	0
in	I-DISEASE
sleep	I-DISEASE
to	0
hypertension	I-DISEASE
,	0
heart	0
disease	I-DISEASE
,	I-DISEASE
and	0
stroke	I-DISEASE
.	0

Sleep	I-DISEASE
2009;32:589–97	I-DISEASE
.	0

Sleep	I-DISEASE
Related	0
Leg	0
Cramps	0
ICD-9	0
-	I-DISEASE
CM	I-DISEASE
code	0
:	I-DISEASE
327.52	I-DISEASE
Alternate	0
names	0
Leg	0
cramps	I-DISEASE
,	I-DISEASE
“	I-DISEASE
charley	I-DISEASE
horse	0
,	I-DISEASE
”	I-DISEASE
nocturnal	0
leg	I-DISEASE
cramps	0
.	0

Diagnostic	I-DISEASE
Criteria	0
Criteria	I-DISEASE
A	0
-	I-DISEASE
C	I-DISEASE
must	I-DISEASE
be	0
met	0
ICD-10	0
-	I-DISEASE
CM	0
code	0
:	0
G47.62	I-DISEASE
Sleep	I-DISEASE
Related	0
Movement	0

Disorders	I-DISEASE
A.	I-DISEASE

A	I-DISEASE
painful	0
sensation	0
in	I-DISEASE
the	0
leg	I-DISEASE
or	I-DISEASE
foot	I-DISEASE
associated	0
with	0
sudden	0
,	I-DISEASE
involuntary	I-DISEASE
muscle	I-DISEASE
hardness	I-DISEASE
or	0
tightness	0
,	0
indicating	0
a	0
strong	0
muscle	I-DISEASE
contraction	0
.	0

B.	0
The	I-DISEASE
painful	0
muscle	0
contractions	I-DISEASE
occur	I-DISEASE
during	I-DISEASE
the	0
time	0
in	I-DISEASE
bed	I-DISEASE
,	I-DISEASE
although	0
they	I-DISEASE
may	I-DISEASE
arise	I-DISEASE
from	0
either	0
wakefulness	0
or	0
sleep	0
.	0

C.	I-DISEASE

The	I-DISEASE
pain	0
is	0
relieved	I-DISEASE
by	0
forceful	I-DISEASE
stretching	I-DISEASE
of	0
the	0
affected	0
muscles	0
,	I-DISEASE
thus	I-DISEASE
releasing	0
the	0
contraction	I-DISEASE
.	0

Essential	I-DISEASE
Features	I-DISEASE
Sleep	0
related	0
leg	0
cramps	I-DISEASE
are	0
painful	0
sensations	0
caused	0
by	I-DISEASE
sudden	0
and	0
intense	0
involun-	I-DISEASE
tary	0
contractions	0
of	I-DISEASE
muscles	0
or	I-DISEASE
muscle	0
groups	0
during	I-DISEASE
which	0
there	I-DISEASE
is	0
muscle	0
spasm	0
and	0
hardness	0
for	0
several	0
seconds	0
.	0

These	0
painful	0
sensations	0
are	I-DISEASE
usually	0
in	I-DISEASE
the	0
calf	I-DISEASE
or	0
small	0
muscle	0
of	I-DISEASE
the	I-DISEASE
foot	0
.	0

Occurring	I-DISEASE
during	I-DISEASE
the	0
time	I-DISEASE
in	I-DISEASE
bed	I-DISEASE
,	0
sleep	0
related	0
leg	I-DISEASE
cramps	I-DISEASE
may	I-DISEASE
arise	I-DISEASE
from	0
either	0
wakefulness	0
or	0
sleep	0
.	0

Sleep	I-DISEASE
related	0
leg	I-DISEASE
cramps	I-DISEASE
usually	I-DISEASE
start	0
abruptly	0
but	0
may	0
in	I-DISEASE
some	I-DISEASE
cases	0
be	0
preceded	I-DISEASE
by	I-DISEASE
a	I-DISEASE
less	0
painful	0
warning	0
sensation	0
.	0

The	I-DISEASE
muscle	0
contractions	0
last	0
for	0
a	0
few	0
seconds	0
up	0
to	0
several	0
minutes	0
and	0
then	0
remit	0
spontaneously	I-DISEASE
.	0

The	I-DISEASE
frequency	I-DISEASE
of	I-DISEASE
sleep	0
related	0
leg	I-DISEASE
cramps	I-DISEASE
varies	0
considerably	0
from	I-DISEASE
less	I-DISEASE
than	I-DISEASE
yearly	0
to	I-DISEASE
multiple	I-DISEASE
episodes	I-DISEASE
every	0
night	0
.	0

Sleep	I-DISEASE
Related	I-DISEASE
Movement	I-DISEASE
Disorders	0

The	I-DISEASE
cramps	I-DISEASE
can	0
be	I-DISEASE
relieved	I-DISEASE
by	I-DISEASE
strongly	I-DISEASE
stretching	0
the	0
affected	I-DISEASE
muscle	I-DISEASE
and	0
sometimes	0
also	0
by	I-DISEASE
local	I-DISEASE
massage	0
,	0
application	0
of	I-DISEASE
heat	I-DISEASE
,	I-DISEASE
or	I-DISEASE
movement	I-DISEASE
of	0
the	I-DISEASE
affected	0
limb	I-DISEASE
.	0

Leg	I-DISEASE
cramps	0
can	0
be	0
present	I-DISEASE
primarily	I-DISEASE
during	I-DISEASE
the	0
daytime	0
.	I-DISEASE

Associated	I-DISEASE
Features	I-DISEASE
The	I-DISEASE
muscle	I-DISEASE
cramp	0
affects	I-DISEASE
sleep	0
.	0

The	I-DISEASE
pain	0
from	0
the	0
cramp	0
itself	I-DISEASE
and	0
from	0
the	0
activities	I-DISEASE
used	I-DISEASE
to	I-DISEASE
relieve	I-DISEASE
it	0
commonly	I-DISEASE
disturb	I-DISEASE
sleep	0
onset	0
or	I-DISEASE
cause	I-DISEASE
an	0
awakening	0
from	I-DISEASE
sleep	0
.	I-DISEASE

Often	I-DISEASE
the	0
presenting	0
complaint	I-DISEASE
is	0
insomnia	I-DISEASE
,	0
at	I-DISEASE
times	0
severe	I-DISEASE
.	0

Tenderness	0
and	0
discomfort	0
in	I-DISEASE
the	0
muscle	I-DISEASE
may	0
persist	0
for	0
several	I-DISEASE
hours	I-DISEASE
after	0
the	0
cramp-	I-DISEASE
ing	0
.	0

Persisting	I-DISEASE
discomfort	0
after	0
the	0
cramping	I-DISEASE
episode	0
often	0
delays	I-DISEASE
subsequent	0
return	I-DISEASE
to	0
sleep	0
.	0

Clinical	I-DISEASE
and	0
Pathophysiological	I-DISEASE
Subtypes	I-DISEASE
Sleep	0
related	0
leg	I-DISEASE
cramps	I-DISEASE
are	I-DISEASE
known	I-DISEASE
to	0
be	0
either	I-DISEASE
idiopathic	I-DISEASE
or	0
secondary	0
to	0
other	I-DISEASE
medical	0
conditions	I-DISEASE
,	I-DISEASE
but	I-DISEASE
there	I-DISEASE
have	0
been	I-DISEASE
no	0
indications	0
of	I-DISEASE
significant	0
differences	0
in	I-DISEASE
the	0
clinical	0
features	I-DISEASE
of	I-DISEASE
the	I-DISEASE
disorder	I-DISEASE
related	0
to	0
the	0
cause	0
.	0

Demographics	I-DISEASE
Sleep	0
related	B-DISEASE
leg	I-DISEASE
cramps	I-DISEASE
are	0
common	I-DISEASE
.	0

It	I-DISEASE
has	0
been	I-DISEASE
suggested	I-DISEASE
that	0
nearly	0
every	0
adult	0
older	0
than	0
50	0
years	I-DISEASE
has	I-DISEASE
experienced	I-DISEASE
sleep	0
related	0
leg	I-DISEASE
cramps	I-DISEASE
at	I-DISEASE
least	0
once	I-DISEASE
.	0

Both	I-DISEASE
the	0
prevalence	0
and	0
the	0
frequency	I-DISEASE
of	I-DISEASE
the	0
events	0
increase	0
with	I-DISEASE
age	I-DISEASE
.	I-DISEASE

Sleep	I-DISEASE
related	I-DISEASE
leg	I-DISEASE
cramps	I-DISEASE
have	0
been	I-DISEASE
reported	0
to	0
occur	0
at	I-DISEASE
least	I-DISEASE
occasionally	0
in	0
about	0
7	0
%	0
of	0
children	0
and	0
adoles-	0
cents	I-DISEASE
,	0
33	I-DISEASE
%	0
in	I-DISEASE
adults	I-DISEASE
older	0
than	0
60	0
years	I-DISEASE
,	0
and	0
50	0
%	0
in	0
adults	0
older	0
than	0
80	0
years	I-DISEASE
,	0
with	I-DISEASE
both	I-DISEASE
older	0
groups	0
reporting	I-DISEASE
a	0
symptom	0
frequency	I-DISEASE
of	I-DISEASE
at	I-DISEASE
least	0
once	0
every	0
two	I-DISEASE
months	I-DISEASE
.	0

Nightly	I-DISEASE
leg	I-DISEASE
cramps	I-DISEASE
have	0
been	I-DISEASE
reported	0
in	0
6	0
%	0
of	I-DISEASE
adults	I-DISEASE
older	0
than	0
60	I-DISEASE
years	I-DISEASE
.	0

No	I-DISEASE
defin-	0
itive	0
sex	0
information	I-DISEASE
has	0
been	I-DISEASE
reported	0
,	I-DISEASE
though	I-DISEASE
a	I-DISEASE
single	I-DISEASE
study	0
reported	I-DISEASE
a	I-DISEASE
higher	0
prev-	0
alence	I-DISEASE
in	I-DISEASE
women	I-DISEASE
.	0

Predisposing	I-DISEASE
and	0
Precipitating	I-DISEASE
Factors	0
Predisposing	I-DISEASE
factors	I-DISEASE
include	I-DISEASE
diabetes	I-DISEASE
mellitus	0
,	0
amyotrophic	I-DISEASE
lateral	0
sclerosis	0
,	I-DISEASE
cramp	B-DISEASE
fasciculation	I-DISEASE
syndrome	0
,	0
peripheral	0
vascular	0
disease	0
,	I-DISEASE
hypokalemia	I-DISEASE
,	0
hypocalcemia	0
,	I-DISEASE
hypomagnesemia	0
,	0
and	0
metabolic	0
disorders	0
.	0

The	I-DISEASE
disorder	I-DISEASE
can	0
be	I-DISEASE
associated	0
with	I-DISEASE
prior	0
vigorous	I-DISEASE
exercise	0
,	0
prolonged	0
standing	0
at	I-DISEASE
work	I-DISEASE
,	0
dehydration	0
,	0
fluid	0
and	0
electrolyte	I-DISEASE
distur-	I-DISEASE
bances	I-DISEASE
,	I-DISEASE
endocrine	0
disorders	0
,	0
neuromuscular	0
disorders	0
,	0
disorders	0
of	I-DISEASE
reduced	0
mobility	I-DISEASE
,	I-DISEASE
vascular	I-DISEASE
disease	0
,	0
cirrhosis	0
,	I-DISEASE
and	0
hemodialysis	0
.	I-DISEASE

Medications	I-DISEASE
that	0
have	0
been	I-DISEASE
associated	0
with	I-DISEASE
sleep	0
related	0
leg	I-DISEASE
cramps	I-DISEASE
include	0
oral	0
contraceptives	0
,	0
intravenous	I-DISEASE
iron	I-DISEASE
sucrose	0
,	I-DISEASE
teriparatide	I-DISEASE
,	I-DISEASE
raloxifene	0
,	0
diuretics	0
,	I-DISEASE
long	I-DISEASE
-	I-DISEASE
acting	I-DISEASE
β	0
-	0
agonists	0
,	0
and	0
statins	0
.	0

Sleep	I-DISEASE
related	0
leg	I-DISEASE
cramps	I-DISEASE
occur	I-DISEASE
in	I-DISEASE
about	0
40	0
%	0
of	I-DISEASE
pregnant	I-DISEASE
women	I-DISEASE
and	0
generally	I-DISEASE
resolve	0
after	I-DISEASE
delivery	0
.	0

Familial	I-DISEASE
Pattern	I-DISEASE
Not	I-DISEASE
known	I-DISEASE
.	0

Onset	I-DISEASE
,	0
Course	0
and	0
Complications	I-DISEASE
Sleep	0
related	B-DISEASE
leg	I-DISEASE
cramps	I-DISEASE
have	0
not	0
been	I-DISEASE
reported	0
in	0
infancy	0
,	0
nor	0
in	0
children	0
younger	I-DISEASE
than	0
eight	0
years	I-DISEASE
.	0

The	I-DISEASE
peak	0
onset	0
is	0
usually	0
in	I-DISEASE
adulthood	0
,	I-DISEASE
but	0
the	0
condition	0
may	I-DISEASE
be	I-DISEASE
seen	I-DISEASE
for	0
the	0
first	I-DISEASE
time	I-DISEASE
in	0
old	0
age	I-DISEASE
.	0

The	I-DISEASE
natural	I-DISEASE
history	I-DISEASE
of	I-DISEASE
leg	0
cramps	I-DISEASE
is	0
not	0
well	B-DISEASE
under-	0
stood	I-DISEASE
.	0

Many	0
patients	0
describe	0
a	0
waxing	0
and	0
waning	I-DISEASE
course	0
of	I-DISEASE
many	0
years	I-DISEASE
’	I-DISEASE
duration	0
.	0

Complications	I-DISEASE
include	0
muscle	I-DISEASE
tenderness	0
,	0
insomnia	0
,	I-DISEASE
and	0
occasional	0
daytime	I-DISEASE
fatigue	I-DISEASE
due	I-DISEASE
to	0
interrupted	0
sleep	0
.	0

No	I-DISEASE
marked	0
mental	0
or	I-DISEASE
social	0
dysfunction	0
has	0
been	I-DISEASE
described	0
due	0
to	I-DISEASE
sleep	0
related	B-DISEASE
leg	I-DISEASE
cramps	I-DISEASE
alone	0
.	0

Pathology	I-DISEASE
and	0
Pathophysiology	I-DISEASE
Many	0
sleep	0
related	B-DISEASE
leg	I-DISEASE
cramps	I-DISEASE
appear	0
to	I-DISEASE
be	I-DISEASE
idiopathic	0
.	0

Although	I-DISEASE
leg	I-DISEASE
cramps	0
involve	0
abnormal	I-DISEASE
muscle	I-DISEASE
tone	I-DISEASE
,	0
they	0
are	0
generally	I-DISEASE
considered	I-DISEASE
not	0
to	0
involve	0
agonist	I-DISEASE
-	0
antagonist	0
co	0
-	0
contractions	0
and	0
,	0
thus	0
,	0
are	0
not	0
classified	0
as	0
dystonias	0
.	0

Some	I-DISEASE
nocturnal	0
leg	I-DISEASE
cramps	0
,	I-DISEASE
particularly	0
those	0
in	0
the	0
feet	I-DISEASE
,	I-DISEASE
may	0
resemble	I-DISEASE
dystonias	0
but	I-DISEASE
,	0
unlike	0
classic	I-DISEASE
dystonias	0
,	0
sleep	0
related	0
leg	B-DISEASE
and	0
foot	0
cramps	I-DISEASE
are	0
relieved	I-DISEASE
by	0
stretching	0
the	0
affected	0
muscle	0
or	I-DISEASE
muscles	0
.	0

Electrophysiologic	I-DISEASE
recordings	I-DISEASE
show	0
that	0
the	0
cramps	I-DISEASE
typically	0
start	0
with	I-DISEASE
spontaneous	I-DISEASE
firing	0
of	0
anterior	I-DISEASE
horn	I-DISEASE
cells	I-DISEASE
followed	0
by	I-DISEASE
motor	I-DISEASE
unit	B-DISEASE
discharges	0
for	I-DISEASE
contractions	0
at	I-DISEASE
rates	0
up	0
to	I-DISEASE
300	0
Hz	0
(	0
considerably	0
more	0
than	0
with	0
voluntary	0
muscle	I-DISEASE
contractions	I-DISEASE
)	0
.	0

The	I-DISEASE
pain	0
may	0
result	0
from	0
local	0
metabolite	0
accumulations	0
or	I-DISEASE
from	I-DISEASE
local	0
ischemia	0
.	0

Muscle	I-DISEASE
and	0
tendon	B-DISEASE
shortening	0
due	0
to	0
age	I-DISEASE
or	I-DISEASE
lack	I-DISEASE
of	I-DISEASE
stretching	B-DISEASE
exercise	0
is	0
thought	I-DISEASE
to	0
contribute	0
to	I-DISEASE
the	0
development	I-DISEASE
of	I-DISEASE
sleep	0
related	I-DISEASE
leg	0
cramps	I-DISEASE
.	0

Exercise	I-DISEASE
involving	I-DISEASE
stretch-	0
ing	0
the	0
affected	0
muscles	0
is	0
thought	0
to	I-DISEASE
help	0
prevent	0
or	0
reduce	I-DISEASE
the	0
occurrence	0
of	0
sleep	0
related	0
leg	I-DISEASE
cramps	B-DISEASE
.	0

Objective	I-DISEASE
Findings	I-DISEASE
Polysomnographic	0
studies	I-DISEASE
of	I-DISEASE
patients	I-DISEASE
with	I-DISEASE
chronic	0
sleep	0
related	B-DISEASE
leg	I-DISEASE
cramps	0
reveal	0
non-	0
periodic	I-DISEASE
bursts	I-DISEASE
of	0
gastrocnemius	I-DISEASE
EMG	0
activity	0
.	0

Episodes	I-DISEASE
arise	I-DISEASE
from	I-DISEASE
sleep	0
without	0
any	I-DISEASE
specific	I-DISEASE
preceding	I-DISEASE
physiologic	0
changes	0
during	I-DISEASE
sleep	0
.	I-DISEASE

Differential	I-DISEASE
Diagnosis	0
Sleep	I-DISEASE
related	0
leg	I-DISEASE
cramps	0
are	I-DISEASE
common	I-DISEASE
in	I-DISEASE
chronic	0
myelopathy	0
,	0
peripheral	0
neuropathy	0
,	I-DISEASE
muscular	0
pain	0
fasciculation	0
syndrome	I-DISEASE
,	0
and	0
disorders	0
of	I-DISEASE
calcium	I-DISEASE
metabolism	0
.	0

These	0
causes	0
should	0
be	I-DISEASE
differentiated	0
by	I-DISEASE
clinical	0
history	I-DISEASE
and	0
physical	0
examination	0
.	0

RLS	I-DISEASE
is	0
Sleep	0
Related	0
Movement	0
Disorders	I-DISEASE
Sleep	0
Related	0
Movement	I-DISEASE
Disorders	0
sometimes	I-DISEASE
confused	0
with	0
sleep	0
related	0
leg	I-DISEASE
cramps	B-DISEASE
because	0
both	I-DISEASE
can	0
present	I-DISEASE
with	I-DISEASE
leg	I-DISEASE
discomfort	0
during	I-DISEASE
the	0
sleep	0
period	0
and	0
RLS	0
patients	0
sometimes	0
complain	0
of	0
a	0
cramping	I-DISEASE
sensation	0
.	0

However	I-DISEASE
,	I-DISEASE
if	0
patients	I-DISEASE
meet	0
the	0
diagnostic	0
criteria	I-DISEASE
for	0
RLS	0
and	0
do	I-DISEASE
not	0
describe	0
an	0
actual	I-DISEASE
cramp	I-DISEASE
or	I-DISEASE
hardening	I-DISEASE
of	I-DISEASE
the	0
muscle	I-DISEASE
,	0
the	I-DISEASE
diagnosis	0
should	I-DISEASE
be	0
RLS	I-DISEASE
.	0

Because	I-DISEASE
leg	I-DISEASE
cramps	0
can	0
mimic	I-DISEASE
RLS	I-DISEASE
and	0
meet	0
all	0
the	I-DISEASE
criteria	I-DISEASE
for	0
RLS	0
,	I-DISEASE
the	0
description	0
of	I-DISEASE
an	0
actual	0
spasm	0
or	I-DISEASE
hardening	B-DISEASE
of	I-DISEASE
the	I-DISEASE
muscle	I-DISEASE
is	0
a	0
critical	0
differentiating	I-DISEASE
factor	0
.	0

A	I-DISEASE
leg	I-DISEASE
cramp	I-DISEASE
is	I-DISEASE
also	0
a	I-DISEASE
much	0
briefer	I-DISEASE
event	0
than	I-DISEASE
the	0
typical	0
symptoms	I-DISEASE
of	I-DISEASE
RLS	I-DISEASE
,	0
which	0
can	0
persist	0
for	0
hours	I-DISEASE
.	0

However	I-DISEASE
,	I-DISEASE
RLS	0
and	0
leg	I-DISEASE
cramps	I-DISEASE
may	0
sometimes	0
be	I-DISEASE
seen	I-DISEASE
in	I-DISEASE
the	0
same	0
individual	I-DISEASE
.	0

Dystonia	I-DISEASE
is	0
ongoing	0
daily	I-DISEASE
spasm	0
of	I-DISEASE
muscles	0
and	0
is	I-DISEASE
distinguished	I-DISEASE
electrophysiologi-	0
cally	0
from	0
leg	B-DISEASE
cramps	I-DISEASE
by	I-DISEASE
ongoing	0
co	0
-	0
contraction	I-DISEASE
of	I-DISEASE
agonist	0
and	0
antagonist	0
muscles	0
.	0

Dystonia	I-DISEASE
can	0
be	I-DISEASE
focal	0
,	I-DISEASE
as	0
in	I-DISEASE
the	0
case	I-DISEASE
of	I-DISEASE
muscles	0
of	I-DISEASE
the	0
neck	I-DISEASE
(	I-DISEASE
torticollis	0
)	0
or	B-DISEASE
hand	0
(	I-DISEASE
writer	0
’s	I-DISEASE
cramp	I-DISEASE
)	0
,	I-DISEASE
or	I-DISEASE
generalized	0
as	0
in	0
the	0
case	I-DISEASE
of	0
torsion	0
dystonia	0
.	0

Unresolved	I-DISEASE
Issues	0
and	0
Further	I-DISEASE
Directions	0
Sleep	0
related	B-DISEASE
leg	I-DISEASE
cramps	I-DISEASE
are	0
common	I-DISEASE
and	0
can	0
affect	0
sleep	0
.	0

Their	I-DISEASE
association	I-DISEASE
with	0
other	I-DISEASE
disorders	0
and	0
different	0
medications	I-DISEASE
hinder	0
accurate	0
epidemiological	0
data	I-DISEASE
and	0
under-	0
estimate	0
their	0
effect	0
on	0
sleep	0
and	0
on	0
quality	0
of	I-DISEASE
life	0
.	0

Instruments	I-DISEASE
to	I-DISEASE
quantify	0
the	0
sever-	I-DISEASE
ity	0
of	I-DISEASE
the	I-DISEASE
disorder	I-DISEASE
and	0
its	I-DISEASE
impact	I-DISEASE
are	I-DISEASE
needed	0
to	0
adequately	B-DISEASE
address	0
clinical	0
relevance	0
,	I-DISEASE
treatment	I-DISEASE
,	0
and	0
the	0
potential	I-DISEASE
occupational	I-DISEASE
hazards	I-DISEASE
.	0

Effective	I-DISEASE
treatments	0
for	I-DISEASE
sleep	0
related	B-DISEASE
leg	I-DISEASE
cramps	I-DISEASE
have	0
yet	0
to	I-DISEASE
be	I-DISEASE
developed	0
.	0

The	I-DISEASE
prophylactic	I-DISEASE
benefits	0
of	I-DISEASE
stretching	0
exercises	0
remain	0
to	0
be	0
adequately	B-DISEASE
validated	I-DISEASE
.	0

Bibliography	0
Allen	I-DISEASE
RE	0
,	I-DISEASE
Kirby	I-DISEASE
KA	0
.	0

Nocturnal	I-DISEASE
leg	I-DISEASE
cramps	I-DISEASE
.	0

Am	I-DISEASE
Fam	I-DISEASE
Physician	0
2012;86:350–5	I-DISEASE
.	0

Bahk	I-DISEASE
JW	0
,	I-DISEASE
Kim	0
H	I-DISEASE
,	0
Jung	0
-	0
Choi	I-DISEASE
K	I-DISEASE
,	I-DISEASE
Jung	0
MC	I-DISEASE
,	I-DISEASE
Lee	I-DISEASE
I.	0
Relationship	0
between	0
prolonged	0
standing	0
and	0
symptoms	0
of	I-DISEASE
varicose	I-DISEASE
veins	I-DISEASE
and	0
nocturnal	0
leg	I-DISEASE
cramps	I-DISEASE
among	0
women	0
and	0
men	0
.	0

Ergonomics	I-DISEASE
2012;55:133–9	0
.	0

Butler	0
J	0
,	0
Mulkerrin	I-DISEASE
E	I-DISEASE
,	0
O’Keeffe	0
S.	0
Nocturnal	0
leg	0
cramps	0
in	I-DISEASE
older	0
people	0
.	0

Postgrad	I-DISEASE
Med	0
J	0
2002;78:596–8	I-DISEASE
.	0

Garrison	I-DISEASE
SR	I-DISEASE
,	0
Dormuth	I-DISEASE
CR	I-DISEASE
,	I-DISEASE
Morrow	0
RL	0
,	I-DISEASE
Carney	I-DISEASE
GA	0
,	I-DISEASE
Khan	I-DISEASE
KM	I-DISEASE
.	0

Nocturnal	0
leg	I-DISEASE
cramps	I-DISEASE
and	0
prescription	I-DISEASE
use	0
that	0
precedes	0
them	I-DISEASE
:	0
a	0
sequence	0
symmetry	I-DISEASE
analysis	0
.	0

Arch	I-DISEASE
Intern	0
Med	0
2012;172:120–6	I-DISEASE
.	0

Hawke	I-DISEASE
F	I-DISEASE
,	0
Chuter	0
V	I-DISEASE
,	0
Burns	I-DISEASE
J.	0
Factors	0
associated	I-DISEASE
with	I-DISEASE
night	0
-	0
time	I-DISEASE
calf	I-DISEASE
muscle	0
cramps	0
;	0
a	0
case	I-DISEASE
control	I-DISEASE
study	0
.	0

Muscle	I-DISEASE
Nerve	0
2013;47:339–43	0
.	0

Hawke	I-DISEASE
F	I-DISEASE
,	0
Chuter	I-DISEASE
V	I-DISEASE
,	I-DISEASE
Burns	I-DISEASE
J.	0
Impact	0
of	I-DISEASE
nocturnal	I-DISEASE
calf	0
cramping	I-DISEASE
on	0
quality	0
of	I-DISEASE
sleep	0
and	0
health	0
-	0
related	I-DISEASE
quality	0
of	I-DISEASE
life	0
.	0

Qual	I-DISEASE
Life	0
Res	I-DISEASE
2013;22:1281–6	0
.	0

Heimisdottir	I-DISEASE
F	I-DISEASE
,	I-DISEASE
Guddnason	0
V	I-DISEASE
,	I-DISEASE
Sigurdsson	0
G	0
,	0
Benediktsson	0
R.	I-DISEASE
[	0
Foot	0
disease	I-DISEASE
in	I-DISEASE
Icelandic	I-DISEASE
patients	0
with	I-DISEASE
established	I-DISEASE
type	I-DISEASE
2	0
diabetes	0
]	0
.	0

Laeknabladid	I-DISEASE
2008;94:109–14	I-DISEASE
.	0

Hudson	I-DISEASE
AJ	I-DISEASE
,	0
Brown	I-DISEASE
WF	0
,	I-DISEASE
Gilbert	I-DISEASE
JJ	0
.	0

The	I-DISEASE
muscular	0
pain	0
-	I-DISEASE
fasciculation	0
syndrome	0
.	0

Neurology	0
1978;28:1105–9	0
.	0

Jacobsen	I-DISEASE
J	0
,	I-DISEASE
Rosenberg	0
R	I-DISEASE
,	I-DISEASE
Huttenlocher	I-DISEASE
P	0
,	I-DISEASE
Spire	I-DISEASE
J.	0
Familial	I-DISEASE
nocturnal	0
cramping	I-DISEASE
.	0

Sleep	I-DISEASE
1986;9:54–60	I-DISEASE
.	0

Kleopa	I-DISEASE
KA	I-DISEASE
,	I-DISEASE
Zamba	I-DISEASE
-	0
Papanicolaou	I-DISEASE
E	0
,	I-DISEASE
Kyriakides	B-DISEASE
T.	0
Compressive	0
lumbar	0
myelopathy	0
presenting	0
as	0
segmental	I-DISEASE
motor	0
neuron	0
disease	0
.	0

Muscle	I-DISEASE
Nerve	0
2003;28:69–73	0
.	0

Leung	0
AK	0
,	I-DISEASE
Wong	0
BE	0
,	I-DISEASE
Chan	0
PY	0
,	I-DISEASE
Cho	I-DISEASE
HY	I-DISEASE
.	0

Nocturnal	0
leg	I-DISEASE
cramps	I-DISEASE
in	0
children	I-DISEASE
:	0
incidence	0
and	0
clinical	0
characteristics	I-DISEASE
.	0

J	I-DISEASE
Natl	I-DISEASE
Med	I-DISEASE
Assoc	0
1999;91:329–32	0
.	0

Matsumoto	I-DISEASE
M	I-DISEASE
,	0
Watanabe	I-DISEASE
K	0
,	0
Tsuji	0
T	0
,	I-DISEASE
et	0
al	I-DISEASE
.	0

Nocturnal	0
leg	I-DISEASE
cramps	I-DISEASE
:	0
a	I-DISEASE
common	I-DISEASE
complaint	0
in	0
patients	0
with	I-DISEASE
lumbar	B-DISEASE
spinal	B-DISEASE
canal	0
stenosis	0
.	0

Spine	I-DISEASE
(	0
Phila	0
Pa	0
1976	0
)	0
2009;34	I-DISEASE
:	0
E189–94	I-DISEASE
.	0

Norris	I-DISEASE
FJ	I-DISEASE
,	I-DISEASE
Gasteiger	0
E	I-DISEASE
,	0
Chatfield	0
P.	I-DISEASE

An	0
electromyographic	I-DISEASE
study	0
of	I-DISEASE
induced	I-DISEASE
and	0
spontaneous	0
muscle	0
cramps	I-DISEASE
.	0

Electroencephalogr	I-DISEASE
Clin	I-DISEASE
Neurophysiol	0
1957;9:139–47	0
.	0

Parisi	I-DISEASE
L	0
,	I-DISEASE
Serrao	0
M	I-DISEASE
,	I-DISEASE
Rossi	I-DISEASE
P	0
,	I-DISEASE
et	0
al	I-DISEASE
.	0

Afterdischarge	I-DISEASE
activity	0
in	I-DISEASE
neuropathic	0
patients	0
with	I-DISEASE
frequent	0
muscle	I-DISEASE
cramps	I-DISEASE
.	0

Acta	I-DISEASE
Neurol	0
Scand	0
2000;102:359–62	I-DISEASE
.	0

Pitkin	I-DISEASE
RM	I-DISEASE
.	0

Endocrine	I-DISEASE
regulation	I-DISEASE
of	0
calcium	I-DISEASE
homeostasis	I-DISEASE
during	I-DISEASE
pregnancy	0
.	0

Clin	I-DISEASE
Perinatol	0
1983;10:575–92	0
.	0

Saskin	I-DISEASE
P	0
,	I-DISEASE
Whelton	0
C	I-DISEASE
,	0
Moldofsky	0
H	I-DISEASE
,	0
Akin	0
F.	I-DISEASE
Sleep	0
and	0
nocturnal	0
leg	I-DISEASE
cramps	I-DISEASE
.	0

Sleep	I-DISEASE
1988;11:307–8	I-DISEASE
.	0

Weiner	I-DISEASE
I	0
,	I-DISEASE
Weiner	0
H.	I-DISEASE
Nocturnal	0
leg	I-DISEASE
muscle	I-DISEASE
cramps	I-DISEASE
.	0

JAMA	I-DISEASE
1980;244:2332–3	I-DISEASE
.	0

Sleep	I-DISEASE
Related	0
Bruxism	0
ICD-9	0
-	I-DISEASE
CM	I-DISEASE
code	0
:	0
327.53	0
ICD-10	0
-	0
CM	I-DISEASE
code	0
:	0
G47.63	I-DISEASE
Alternate	0
Names	I-DISEASE
Nocturnal	0
bruxism	0
,	0
nocturnal	0
tooth	0
grinding	0
,	0
tooth	I-DISEASE
clenching	I-DISEASE
.	0

Diagnostic	I-DISEASE
Criteria	0
Criteria	I-DISEASE
A	0
and	0
B	0
must	I-DISEASE
be	0
met	0
A.	0

The	I-DISEASE
presence	0
of	I-DISEASE
regular	I-DISEASE
or	0
frequent	I-DISEASE
tooth	I-DISEASE
grinding	0
sounds	0
occurring	0
during	I-DISEASE
sleep	0
.	I-DISEASE

B.	0
The	I-DISEASE
presence	0
of	0
one	I-DISEASE
or	I-DISEASE
more	0
of	I-DISEASE
the	0
following	0
clinical	0
signs	I-DISEASE
:	I-DISEASE
.	0

Abnormal	I-DISEASE
tooth	0
wear	I-DISEASE
consistent	I-DISEASE
with	I-DISEASE
above	0
reports	0
of	I-DISEASE
tooth	I-DISEASE
grinding	I-DISEASE
during	I-DISEASE
sleep	0
.	0
.	0

Transient	I-DISEASE
morning	0
jaw	0
muscle	0
pain	0
or	I-DISEASE
fatigue	I-DISEASE
;	0
and/or	0
temporal	I-DISEASE
headache	I-DISEASE
;	0
and/or	0
jaw	0
locking	0
upon	I-DISEASE
awakening	0
consistent	0
with	I-DISEASE
above	0
reports	0
of	I-DISEASE
tooth	I-DISEASE
grinding	0
during	I-DISEASE
sleep	0
.	0

Notes	I-DISEASE
.	0

Although	I-DISEASE
polysomnography	0
is	I-DISEASE
not	0
required	0
for	0
the	0
diagnosis	I-DISEASE
,	I-DISEASE
sleep	0
bruxism	0
,	0
as	0
described	0
in	I-DISEASE
the	0
most	0
recent	0
version	I-DISEASE
of	0
the	I-DISEASE
AASM	I-DISEASE
Manual	I-DISEASE
for	I-DISEASE
the	0
Scoring	0
of	I-DISEASE
Sleep	0
and	0
Associated	I-DISEASE
Events	I-DISEASE
,	0
is	0
ideally	0
recorded	0
with	I-DISEASE
masseter	I-DISEASE
muscle	I-DISEASE
activity	0
with	0
audio	0
-	0
video	0
signal	I-DISEASE
to	I-DISEASE
increase	I-DISEASE
diagnostic	0
reliability	0
.	0

Essential	I-DISEASE
Features	I-DISEASE
Bruxism	0
is	I-DISEASE
defined	I-DISEASE
as	0
a	0
repetitive	I-DISEASE
jaw	0
-	I-DISEASE
muscle	I-DISEASE
activity	0
characterized	0
by	I-DISEASE
clenching	I-DISEASE
or	0
grinding	0
of	I-DISEASE
the	0
teeth	I-DISEASE
and/or	0
by	I-DISEASE
bracing	0
or	I-DISEASE
thrusting	0
of	I-DISEASE
the	0
mandible	0
.	0

Bruxism	0
Sleep	0
Related	I-DISEASE
Movement	I-DISEASE
Disorders	0
Sleep	0
Related	I-DISEASE
Movement	0
Disorders	I-DISEASE
has	0
been	0
divided	0
into	I-DISEASE
its	I-DISEASE
two	0
distinct	0
circadian	I-DISEASE
manifestations	I-DISEASE
:	I-DISEASE
sleep	0
bruxism	0
and	0
awake	0
bruxism	0
.	0

In	I-DISEASE
sleep	0
,	0
jaw	0
muscle	0
contractions	I-DISEASE
are	I-DISEASE
frequently	0
repeated	0
over	0
time	I-DISEASE
and	0
are	I-DISEASE
termed	I-DISEASE
rhythmic	0
masticatory	0
muscle	0
activity	0
(	I-DISEASE
RMMA	I-DISEASE
)	0
.	0

These	0
contractions	0
can	0
take	0
two	I-DISEASE
forms	0
on	0
electromyographic	0
traces	0
:	I-DISEASE
a	0
series	0
of	I-DISEASE
repetitive	I-DISEASE
activity	0
(	0
phasic	0
muscle	0
contractions	0
)	0
or	0
isolated	I-DISEASE
sustained	0
jaw	0
clenching	I-DISEASE
(	0
tonic	0
contractions	I-DISEASE
)	0
.	0

These	0
contractions	I-DISEASE
during	I-DISEASE
sleep	0
produce	0
tooth	I-DISEASE
-	0
grinding	0
sounds	0
and	0
are	0
referred	I-DISEASE
to	I-DISEASE
as	0
sleep	0
related	B-DISEASE
bruxism	I-DISEASE
.	0

Sleep	I-DISEASE
related	I-DISEASE
bruxism	0
can	0
lead	0
to	I-DISEASE
abnormal	0
tooth	0
wear	I-DISEASE
,	I-DISEASE
tooth	I-DISEASE
pain	0
,	0
jaw	0
muscle	I-DISEASE
pain	0
,	0
and	0
temporal	I-DISEASE
headache	0
.	0

Severe	I-DISEASE
sleep	0
related	0
bruxism	0
may	I-DISEASE
also	0
result	0
in	0
sleep	0
dis-	I-DISEASE
ruption	0
.	0

This	I-DISEASE
may	0
involve	0
not	0
only	0
the	0
individual	I-DISEASE
affected	I-DISEASE
,	0
but	0
also	0
the	0
bed	I-DISEASE
partner	0
,	0
because	0
the	0
sounds	I-DISEASE
made	0
by	0
the	0
friction	0
of	I-DISEASE
the	0
teeth	I-DISEASE
are	I-DISEASE
usually	0
perceived	0
as	0
being	I-DISEASE
unpleasant	0
and	0
can	0
be	0
quite	I-DISEASE
loud	I-DISEASE
and	0
disturbing	0
to	0
those	0
nearby	0
.	0

The	I-DISEASE
disorder	I-DISEASE
is	0
typically	0
brought	0
to	I-DISEASE
dental	I-DISEASE
or	I-DISEASE
medical	0
attention	0
because	0
of	I-DISEASE
the	I-DISEASE
tooth	I-DISEASE
damage	0
,	I-DISEASE
pain	0
,	I-DISEASE
or	0
disturbing	0
sounds	I-DISEASE
.	0

Less	I-DISEASE
commonly	I-DISEASE
,	0
it	0
may	0
present	I-DISEASE
as	0
a	I-DISEASE
cause	0
of	I-DISEASE
dis-	0
turbed	0
sleep	0
.	0

Young	I-DISEASE
and	0
otherwise	0
healthy	I-DISEASE
individuals	I-DISEASE
with	I-DISEASE
sleep	0
related	B-DISEASE
bruxism	0
appear	0
to	I-DISEASE
have	I-DISEASE
normal	0
sleep	0
structure	0
and	0
homeostasis	0
.	0

The	I-DISEASE
majority	0
of	I-DISEASE
RMMA	I-DISEASE
epi-	0
sodes	0
during	I-DISEASE
sleep	I-DISEASE
occur	I-DISEASE
in	0
association	I-DISEASE
with	I-DISEASE
sleep	I-DISEASE
arousal	0
.	0

Jaw	I-DISEASE
muscle	0
pain	0
,	0
tenderness	0
in	I-DISEASE
the	0
masseter	0
and	0
temporalis	I-DISEASE
muscle	0
regions	I-DISEASE
,	I-DISEASE
morning	I-DISEASE
headache	0
,	0
or	I-DISEASE
fatigue	I-DISEASE
can	0
arise	I-DISEASE
due	0
to	I-DISEASE
sleep	0
related	I-DISEASE
bruxism	0
.	0

Associated	I-DISEASE
Features	I-DISEASE
Additional	I-DISEASE
symptoms	I-DISEASE
include	0
a	0
variety	I-DISEASE
of	I-DISEASE
unpleasant	0
muscle	0
and	0
tooth	I-DISEASE
sensations	I-DISEASE
,	I-DISEASE
lim-	0
itation	I-DISEASE
of	0
jaw	0
movements	0
,	0
orofacial	0
pain	0
,	I-DISEASE
and	0
temporal	0
/	0
tension	0
headaches	0
.	0

Tooth	I-DISEASE
wear	0
,	I-DISEASE
fractured	0
teeth	I-DISEASE
,	0
and	0
buccal	0
lacerations	I-DISEASE
also	0
can	0
occur	0
.	0

These	0
symptoms	I-DISEASE
may	0
be	I-DISEASE
induced	0
by	I-DISEASE
sleep	0
related	B-DISEASE
bruxism	0
,	I-DISEASE
but	I-DISEASE
the	0
connection	0
may	I-DISEASE
not	0
be	I-DISEASE
apparent	0
to	0
the	0
affected	I-DISEASE
indi-	I-DISEASE
vidual	I-DISEASE
and	0
diagnostic	0
discrimination	I-DISEASE
is	I-DISEASE
weak	0
.	0

Headaches	I-DISEASE
are	I-DISEASE
frequently	0
reported	0
by	I-DISEASE
both	I-DISEASE
adults	0
and	0
children	I-DISEASE
with	I-DISEASE
sleep	I-DISEASE
related	I-DISEASE
bruxism	0
.	0

The	I-DISEASE
headache	0
usually	I-DISEASE
involves	0
the	0
temporal	I-DISEASE
regions	I-DISEASE
and	0
it	0
has	0
the	0
charac-	I-DISEASE
teristics	I-DISEASE
of	0
a	0
tension	0
headache	0
.	0

It	I-DISEASE
is	I-DISEASE
reported	0
either	I-DISEASE
in	0
the	0
morning	0
(	I-DISEASE
more	0
frequently	0
)	0
or	I-DISEASE
during	I-DISEASE
the	0
day	0
(	I-DISEASE
with	I-DISEASE
wake	I-DISEASE
bruxism	0
)	0
.	0

The	I-DISEASE
estimated	0
OR	0
for	I-DISEASE
headache	0
in	I-DISEASE
individuals	I-DISEASE
with	I-DISEASE
sleep	0
related	0
bruxism	0
is	I-DISEASE
>	0
4	0
compared	0
to	I-DISEASE
controls	0
.	0

There	I-DISEASE
is	I-DISEASE
high	0
individual	I-DISEASE
variability	0
in	I-DISEASE
the	0
intensity	0
and	0
duration	0
of	I-DISEASE
sleep	I-DISEASE
related	I-DISEASE
bruxism	0
,	I-DISEASE
but	0
in	0
the	0
most	0
severe	I-DISEASE
cases	0
,	I-DISEASE
hundreds	0
of	0
events	0
can	0
occur	I-DISEASE
during	I-DISEASE
a	I-DISEASE
night	0
of	I-DISEASE
sleep	0
.	0

However	I-DISEASE
,	I-DISEASE
no	0
direct	0
relationship	0
has	0
been	I-DISEASE
observed	I-DISEASE
between	0
the	0
severity	0
of	I-DISEASE
sleep	I-DISEASE
related	I-DISEASE
bruxism	0
and	0
the	0
appearance	I-DISEASE
of	I-DISEASE
clinical	0
signs	0
and	0
symptoms	I-DISEASE
.	0

Indeed	I-DISEASE
,	I-DISEASE
indi-	I-DISEASE
viduals	I-DISEASE
with	0
a	0
mild	0
to	I-DISEASE
moderate	I-DISEASE
index	0
of	I-DISEASE
sleep	0
bruxism	I-DISEASE
(	I-DISEASE
2	0
to	0
4	0
RMMA	I-DISEASE
episodes	I-DISEASE
/	0
hour	I-DISEASE
of	I-DISEASE
sleep	0
)	0
have	0
a	0
higher	0
risk	0
of	I-DISEASE
reporting	I-DISEASE
painful	0
jaw	0
upon	0
awakening	0
(	I-DISEASE
OR	0
3.9	I-DISEASE
)	0
,	0
and	0
masticatory	0
muscle	0
fatigue	I-DISEASE
(	I-DISEASE
OR	0
5.1	0
)	I-DISEASE
compared	I-DISEASE
to	I-DISEASE
individuals	I-DISEASE
with	0
severe	I-DISEASE
sleep	0
related	I-DISEASE
bruxism	0
(	I-DISEASE
>	0
4	0
RMMA	0
episodes	I-DISEASE
/	0
hour	I-DISEASE
of	I-DISEASE
sleep	I-DISEASE
)	0
.	0

Psychosocial	I-DISEASE
components	I-DISEASE
may	0
also	0
be	0
linked	0
to	0
sleep	0
related	I-DISEASE
bruxism	I-DISEASE
.	0

The	I-DISEASE
psycholog-	0
ical	0
assessment	0
of	I-DISEASE
otherwise	0
healthy	0
adults	I-DISEASE
with	I-DISEASE
sleep	0
related	0
bruxism	0
suggests	0
a	0
cor-	0
relation	0
(	I-DISEASE
not	0
yet	0
proven	0
as	0
a	0
causality	0
)	0
between	0
bruxism	0
and	0
stress	0
/	0
anxiety	0
.	0

Moreover	I-DISEASE
,	I-DISEASE
both	0
children	I-DISEASE
and	0
adults	I-DISEASE
with	I-DISEASE
sleep	0
related	B-DISEASE
bruxism	0
seem	I-DISEASE
to	I-DISEASE
have	0
higher	0
scores	0
in	I-DISEASE
stress	0
,	0
anxiety	I-DISEASE
,	0
and	0
psychiatric	0
scales	0
compared	I-DISEASE
to	0
control	0
individuals	I-DISEASE
.	0

Clinical	I-DISEASE
and	0
Pathophysiological	I-DISEASE
Subtypes	I-DISEASE
Sleep	0
related	0
bruxism	I-DISEASE
without	0
clear	I-DISEASE
cause	I-DISEASE
is	0
termed	0
primary	0
or	0
idiopathic	I-DISEASE
.	0

Forms	I-DISEASE
of	I-DISEASE
sleep	0
related	0
bruxism	0
associated	0
with	0
the	0
use	I-DISEASE
of	I-DISEASE
psychoactive	B-DISEASE
medications	I-DISEASE
,	0
recreational	I-DISEASE
drugs	I-DISEASE
,	0
or	0
a	0
variety	I-DISEASE
of	I-DISEASE
medical	0
disorders	0
(	0
e.g.	I-DISEASE
,	0
Parkinson	0
disease	I-DISEASE
,	0
RBD	0
,	0
Down	I-DISEASE
syndrome	0
)	0
are	0
defined	I-DISEASE
as	0
secondary	I-DISEASE
sleep	0
related	I-DISEASE
bruxism	0
.	0

Treatment	I-DISEASE
-	I-DISEASE
induced	0
sleep	0
related	0
bruxism	0
is	0
also	0
termed	I-DISEASE
iatrogenic	I-DISEASE
.	0

Although	I-DISEASE
the	0
primary	0
form	I-DISEASE
of	0
sleep	0
related	0
bruxism	0
is	0
most	0
often	I-DISEASE
reported	I-DISEASE
in	0
healthy	0
children	I-DISEASE
and	0
adults	0
,	0
secondary	0
sleep	0
related	0
bruxism	0
is	0
observed	I-DISEASE
in	0
children	I-DISEASE
with	I-DISEASE
cere-	B-DISEASE
bral	0
palsy	0
and	0
mental	0
retardation	0
and	0
in	I-DISEASE
adult	0
patients	0
with	I-DISEASE
abnormal	0
movements	0
such	0
as	0
in	I-DISEASE
oromandibular	0
myoclonus	0
/	I-DISEASE
facio	I-DISEASE
-	0
mandibular	0
myoclonus	0
or	0
with	0
sleep	0
related	B-DISEASE
breathing	0
disorders	0
.	0

OSA	I-DISEASE
and	0
sleep	0
related	B-DISEASE
bruxism	0
commonly	0
co	0
-	0
occur	I-DISEASE
.	I-DISEASE

Tooth	I-DISEASE
grinding	0
and	0
clenching	0
also	0
can	I-DISEASE
occur	0
during	I-DISEASE
wakefulness	0
,	I-DISEASE
as	I-DISEASE
an	0
oral	0
parafunc-	I-DISEASE
tional	0
activity	0
known	I-DISEASE
as	0
awake	0
bruxism	0
.	0

Awake	I-DISEASE
bruxism	0
is	I-DISEASE
considered	I-DISEASE
a	0
different	0
dis-	0
order	0
,	0
probably	0
with	I-DISEASE
different	I-DISEASE
diagnostic	0
criteria	0
and	0
pathophysiology	0
;	0
its	I-DISEASE
association	0
with	I-DISEASE
sleep	0
bruxism	0
is	0
still	0
under	0
debate	0
.	0

However	I-DISEASE
,	I-DISEASE
the	0
two	0
oral	0
activities	I-DISEASE
may	0
coexist	B-DISEASE
in	0
the	0
same	0
individual	I-DISEASE
.	0

Demographics	I-DISEASE
The	I-DISEASE
prevalence	I-DISEASE
of	I-DISEASE
sleep	0
related	B-DISEASE
bruxism	0
,	I-DISEASE
based	I-DISEASE
on	0
reports	I-DISEASE
from	I-DISEASE
parents	I-DISEASE
or	0
sleep	0
partner	0
,	0
is	I-DISEASE
highest	0
in	I-DISEASE
childhood	0
(	0
approximately	I-DISEASE
14	0
%	0
to	I-DISEASE
17	0
%	0
)	0
and	0
then	0
decreases	0
over	0
the	0
life	0
span	0
.	0

In	I-DISEASE
teenagers	I-DISEASE
to	0
young	I-DISEASE
adults	0
,	I-DISEASE
prevalence	0
is	I-DISEASE
in	0
the	0
12	0
%	0
range	I-DISEASE
.	0

In	I-DISEASE
young	I-DISEASE
to	0
middle	I-DISEASE
-	0
aged	I-DISEASE
adults	I-DISEASE
,	I-DISEASE
it	0
is	0
approximately	0
8	I-DISEASE
%	I-DISEASE
but	I-DISEASE
as	0
little	0
as	0
3	I-DISEASE
%	0
in	0
older	0
persons	0
.	0

The	I-DISEASE
reported	I-DISEASE
reduction	0
in	I-DISEASE
tooth	0
grinding	0
in	I-DISEASE
the	0
elderly	0
probably	0
overestimates	0
the	0
actual	I-DISEASE
Sleep	I-DISEASE
Related	I-DISEASE
Movement	0
Disorders	I-DISEASE
Sleep	0
Related	0
Movement	0
Disorders	I-DISEASE
reduction	0
,	I-DISEASE
because	0
edentulism	0
,	0
use	I-DISEASE
of	I-DISEASE
dentures	0
,	0
and	0
changes	0
in	I-DISEASE
sleeping	I-DISEASE
behaviors	I-DISEASE
(	I-DISEASE
i.e.	I-DISEASE
,	0
in	0
isolation	0
)	0
may	I-DISEASE
influence	0
reporting	I-DISEASE
.	0

There	I-DISEASE
is	I-DISEASE
no	0
reported	I-DISEASE
sex	0
difference	I-DISEASE
for	0
the	0
prev-	0
alence	I-DISEASE
of	I-DISEASE
sleep	0
related	0
bruxism	0
.	0

Predisposing	I-DISEASE
and	0
Precipitating	I-DISEASE
Factors	0
Predisposing	I-DISEASE
factors	0
include	I-DISEASE
personality	I-DISEASE
types	0
;	0
for	0
example	0
,	0
individuals	I-DISEASE
who	0
are	I-DISEASE
highly	0
motivated	0
or	0
characteristically	0
maintain	0
high	0
vigilance	0
may	0
have	0
an	0
increased	0
preva-	0
lence	0
of	I-DISEASE
sleep	I-DISEASE
related	0
bruxism	0
.	0

Genetic	I-DISEASE
predisposition	0
is	I-DISEASE
plausible	0
but	I-DISEASE
still	0
under	0
investigation	0
.	0

As	I-DISEASE
described	0
below	0
,	I-DISEASE
there	0
is	0
some	I-DISEASE
familial	I-DISEASE
predisposition	0
due	I-DISEASE
to	0
environmental	I-DISEASE
or	I-DISEASE
shared	I-DISEASE
genetic	0
factors	0
.	0

Recently	I-DISEASE
,	I-DISEASE
a	0
serotonin	I-DISEASE
gene	I-DISEASE
was	0
described	0
in	I-DISEASE
bruxism	0
patients	0
but	I-DISEASE
the	0
absence	I-DISEASE
of	0
distinction	0
between	0
the	0
wake	0
and	0
sleep	0
forms	I-DISEASE
in	0
this	I-DISEASE
report	0
preclude	I-DISEASE
firm	I-DISEASE
conclusions	I-DISEASE
.	0

Precipitating	I-DISEASE
factors	0
can	0
include	I-DISEASE
anxiety	I-DISEASE
related	B-DISEASE
to	0
current	I-DISEASE
life	0
events	I-DISEASE
,	I-DISEASE
tasks	I-DISEASE
requir-	I-DISEASE
ing	0
high	I-DISEASE
levels	0
of	I-DISEASE
performance	0
,	I-DISEASE
and	0
repetitive	I-DISEASE
tasks	I-DISEASE
with	0
short	0
deadlines	I-DISEASE
.	0

The	I-DISEASE
use	I-DISEASE
of	I-DISEASE
cigarettes	I-DISEASE
or	0
caffeine	0
in	0
the	0
hours	I-DISEASE
before	I-DISEASE
sleep	I-DISEASE
also	I-DISEASE
can	0
contribute	0
to	I-DISEASE
the	I-DISEASE
occur-	0
rence	I-DISEASE
of	I-DISEASE
sleep	0
related	0
bruxism	I-DISEASE
(	I-DISEASE
probably	I-DISEASE
due	I-DISEASE
to	B-DISEASE
the	0
increased	0
arousals	I-DISEASE
and	0
sleep	0
instability	I-DISEASE
)	0
.	0

The	I-DISEASE
role	0
of	I-DISEASE
dental	I-DISEASE
morphologic	0
“	0
defects	0
”	I-DISEASE
(	I-DISEASE
occlusal	0
interferences	I-DISEASE
)	0
remains	0
controver-	0
sial	I-DISEASE
in	I-DISEASE
the	0
etiology	0
of	I-DISEASE
sleep	0
related	B-DISEASE
bruxism	I-DISEASE
.	0

Tooth	I-DISEASE
contacts	0
do	I-DISEASE
not	0
usually	I-DISEASE
set	I-DISEASE
in	I-DISEASE
motion	0
a	0
bruxism	0
episode	I-DISEASE
;	0
they	0
are	I-DISEASE
usually	I-DISEASE
late	0
in	0
the	0
series	I-DISEASE
of	I-DISEASE
events	0
occurring	0
during	I-DISEASE
sleep	0
related	0
bruxism	0
/	0

tooth	I-DISEASE
grinding	I-DISEASE
.	0

Hence	I-DISEASE
,	I-DISEASE
the	0
causality	0
link	0
between	0
tooth	0
contact	0
and	0
sleep	0
related	I-DISEASE
bruxism	I-DISEASE
is	0
not	I-DISEASE
supported	0
by	0
the	0
temporal	0
sequence	0
.	0

Familial	I-DISEASE
Patterns	I-DISEASE
Sleep	0
related	B-DISEASE
bruxism	0
tends	0
to	I-DISEASE
occur	I-DISEASE
in	0
families	I-DISEASE
;	I-DISEASE
approximately	I-DISEASE
20	0
%	0
to	I-DISEASE
50	0
%	0
of	I-DISEASE
affected	0
individuals	I-DISEASE
have	0
at	I-DISEASE
least	0
one	I-DISEASE
direct	0
family	B-DISEASE
member	I-DISEASE
with	I-DISEASE
a	0
history	I-DISEASE
of	I-DISEASE
tooth	0
grinding	0
,	0
and	0
childhood	0
sleep	0
related	0
bruxism	0
appears	I-DISEASE
to	I-DISEASE
persist	0
into	I-DISEASE
adulthood	0
in	I-DISEASE
two	0
thirds	0
of	I-DISEASE
reported	I-DISEASE
cases	0
.	0

However	I-DISEASE
,	I-DISEASE
no	0
genetic	I-DISEASE
variants	0
or	I-DISEASE
genetic	I-DISEASE
inheritance	I-DISEASE
patterns	0
so	0
far	I-DISEASE
have	I-DISEASE
been	I-DISEASE
associated	0
with	0
sleep	0
related	B-DISEASE
bruxism	I-DISEASE
.	0

Onset	I-DISEASE
,	0
Course	0
,	0
and	0
Complications	I-DISEASE
The	I-DISEASE
onset	I-DISEASE
of	I-DISEASE
sleep	0
related	0
bruxism	0
may	0
occur	0
during	I-DISEASE
childhood	0
,	I-DISEASE
adolescence	0
,	0
or	I-DISEASE
adulthood	0
.	0

It	I-DISEASE
is	I-DISEASE
difficult	0
to	I-DISEASE
establish	0
the	0
time	I-DISEASE
of	I-DISEASE
onset	0
with	0
precision	I-DISEASE
because	0
it	I-DISEASE
is	I-DISEASE
mainly	0
based	I-DISEASE
on	0
the	I-DISEASE
awareness	0
of	0
the	0
individual	0
or	0

his	0
/	0
her	0
family	I-DISEASE
members	0
who	I-DISEASE
report	0
the	0
disorder	0
.	0

Sleep	I-DISEASE
related	I-DISEASE
bruxism	0
in	I-DISEASE
childhood	0
has	I-DISEASE
been	I-DISEASE
reported	0
by	I-DISEASE
parents	0
to	I-DISEASE
begin	I-DISEASE
as	0
soon	I-DISEASE
as	0
both	I-DISEASE
upper	0
and	0
lower	0
teeth	I-DISEASE
have	0
erupted	0
.	0

Secondary	I-DISEASE
sleep	0
related	0
bruxism	0
may	0
occur	I-DISEASE
at	I-DISEASE
any	I-DISEASE
age	I-DISEASE
,	I-DISEASE
but	I-DISEASE
is	I-DISEASE
more	0
common	I-DISEASE
in	I-DISEASE
younger	I-DISEASE
and	0
middle	0
-	I-DISEASE
aged	I-DISEASE
adults	I-DISEASE
.	0

Even	I-DISEASE
without	0
a	0
tooth	I-DISEASE
grinding	0
history	I-DISEASE
or	I-DISEASE
complaints	0
,	0
RMMA	0
may	I-DISEASE
be	I-DISEASE
observed	I-DISEASE
in	I-DISEASE
most	0
normal	0
sleepers	0
(	I-DISEASE
on	0
average	I-DISEASE
,	I-DISEASE
one	0
episode	I-DISEASE
per	0
hour	I-DISEASE
of	I-DISEASE
sleep	0
)	0
across	I-DISEASE
the	0
life	0
span	I-DISEASE
.	0

However	I-DISEASE
,	I-DISEASE
in	0
individuals	I-DISEASE
with	0
sleep	0
related	0
bruxism	I-DISEASE
,	0
jaw	0
-	I-DISEASE
muscle	I-DISEASE
contractions	0
are	I-DISEASE
more	0
frequent	0
and	0
more	0
intense	0
.	0

This	I-DISEASE
may	0
explain	0
the	0
secondary	0
tooth	I-DISEASE
damage	0
and	0
the	0
occurrence	0
of	I-DISEASE
pain	0
and	0
other	I-DISEASE
symptoms	0
.	0

The	I-DISEASE
night	I-DISEASE
-	0
to	I-DISEASE
-	0
night	I-DISEASE
variability	I-DISEASE
in	0
episodes	0
of	I-DISEASE
audible	0
tooth	I-DISEASE
grinding	0
sounds	0
is	I-DISEASE
large	I-DISEASE
(	I-DISEASE
greater	0
than	0
50	0
%	0
coefficient	I-DISEASE
of	I-DISEASE
variation	0
)	0
.	0

In	I-DISEASE
-	I-DISEASE
laboratory	I-DISEASE
polysomnographic	0
record-	0
ings	0
indicate	I-DISEASE
that	0
the	0
corresponding	I-DISEASE
variability	I-DISEASE
in	0
frequency	I-DISEASE
of	I-DISEASE
RMMA	I-DISEASE
is	I-DISEASE
smaller	I-DISEASE
(	I-DISEASE
approximately	0
25	I-DISEASE
%	0
)	0
,	0
although	0
ambulatory	I-DISEASE
recording	0
has	0
suggested	0
somewhat	I-DISEASE
higher	0
RMMA	0
variability	I-DISEASE
.	0

First	I-DISEASE
-	I-DISEASE
night	0
effect	0
on	0
RMMA	I-DISEASE
index	0
is	0
minimal	I-DISEASE
.	0

Dental	I-DISEASE
damage	0
and	0
abnormal	I-DISEASE
tooth	0
wear	I-DISEASE
are	0
the	0
most	0
frequent	0
signs	0
of	I-DISEASE
the	I-DISEASE
disorder	I-DISEASE
.	0

However	I-DISEASE
,	I-DISEASE
they	0
are	I-DISEASE
not	0
a	0
direct	0
proof	0
of	I-DISEASE
current	0
sleep	0
related	0
bruxism	I-DISEASE
and	0
many	0
contrib-	I-DISEASE
uting	0
factors	0
have	I-DISEASE
to	I-DISEASE
be	0
ruled	I-DISEASE
out	0
(	I-DISEASE
e.g.	0
,	I-DISEASE
type	I-DISEASE
of	I-DISEASE
diet	0
in	I-DISEASE
the	0
occurrence	0
of	I-DISEASE
abnormal	0
tooth	0
wear	I-DISEASE
)	0
.	0

Diagnostic	I-DISEASE
discriminative	0
strength	0
of	I-DISEASE
these	I-DISEASE
dental	0
findings	0
is	I-DISEASE
weak	0
;	I-DISEASE
severity	I-DISEASE
of	I-DISEASE
wear	0
can	0
not	0
account	0
for	I-DISEASE
the	0
index	0
(	I-DISEASE
i.e.	0
,	I-DISEASE
frequency	I-DISEASE
of	I-DISEASE
RMMA	0
)	0
.	0

Sleep	I-DISEASE
related	I-DISEASE
bruxism	0
could	0
lead	0
to	I-DISEASE
temporomandibular	0
joint	I-DISEASE
disorders	0
(	I-DISEASE
e.g.	I-DISEASE
,	I-DISEASE
pain	0
,	0
joint	I-DISEASE
sound	0
[	0
click	0
]	I-DISEASE
,	I-DISEASE
or	I-DISEASE
jaw	0
movement	I-DISEASE
limitations	I-DISEASE
)	0
,	I-DISEASE
although	0
recent	0
evidence	0
does	I-DISEASE
not	0
support	0
this	0
association	0
.	0

Transient	I-DISEASE
morning	0
orofacial	I-DISEASE
pain	I-DISEASE
,	0
including	0
temporal	0
headaches	I-DISEASE
,	I-DISEASE
is	0
not	0
uncommon	0
,	I-DISEASE
as	0
described	0
above	0
.	0

Hypertrophy	I-DISEASE
of	0
the	0
masseter	0
and	0
temporalis	0
muscles	0
can	I-DISEASE
occur	I-DISEASE
,	0
but	I-DISEASE
the	0
diagnostic	I-DISEASE
specificity	0
of	I-DISEASE
this	0
finding	I-DISEASE
for	I-DISEASE
sleep	0
related	I-DISEASE
bruxism	0
is	I-DISEASE
also	0
weak	I-DISEASE
.	0

The	I-DISEASE
natural	I-DISEASE
course	0
of	I-DISEASE
this	0
sleep	0
disorder	I-DISEASE
is	I-DISEASE
usually	I-DISEASE
benign	0
.	0

Many	0
individuals	I-DISEASE
with	0
sleep	0
related	0
bruxism	0
remain	0
asymptomatic	0
for	0
most	0
of	I-DISEASE
their	I-DISEASE
lives	0
.	0

Others	I-DISEASE
can	0
experi-	0
ence	0
associated	0
symptoms	0
(	I-DISEASE
i.e.	I-DISEASE
,	I-DISEASE
pain	0
)	I-DISEASE
that	0
may	0
interfere	I-DISEASE
with	0
their	0
quality	0
of	I-DISEASE
life	I-DISEASE
and/	0
or	0
sleep	0
and	0
may	I-DISEASE
require	0
treatments	0
.	0

Further	I-DISEASE
diagnostic	0
investigations	0
and	0
assessment	0
are	0
recommended	I-DISEASE
if	I-DISEASE
sleep	0
related	0
bruxism	0
is	I-DISEASE
associated	0
with	0
other	I-DISEASE
more	0
severe	0
sleep	0
or	I-DISEASE
medical	0
disorders	0
(	I-DISEASE
e.g.	0
,	I-DISEASE
SRBD	I-DISEASE
,	0
RBD	0
,	0
epilepsy	0
)	0
.	0

Developmental	I-DISEASE
Issues	0
Sleep	0
related	B-DISEASE
bruxism	0
is	0
frequently	0
reported	0
in	I-DISEASE
childhood	I-DISEASE
but	I-DISEASE
decreases	0
with	0
age	I-DISEASE
.	I-DISEASE

However	I-DISEASE
,	0
some	0
individuals	I-DISEASE
may	0
experience	0
it	0
every	0
night	0
for	0
most	0
of	I-DISEASE
their	I-DISEASE
lives	0
.	0

Sleep	I-DISEASE
Related	I-DISEASE
Movement	I-DISEASE
Disorders	0
Sleep	I-DISEASE
Related	0
Movement	I-DISEASE
Disorders	I-DISEASE
Conceptualizations	I-DISEASE
of	I-DISEASE
sleep	0
related	0
bruxism	I-DISEASE
in	I-DISEASE
children	I-DISEASE
vary	I-DISEASE
.	0

Some	I-DISEASE
consider	0
this	0
a	0
physiological	0
oral	0
parafunction	I-DISEASE
while	0
teeth	0
are	0
erupting	0
or	0
exfoliating	0
,	0
whereas	0
others	B-DISEASE
view	0
this	0
as	0
a	0
sleep	0
disorder	0
with	I-DISEASE
many	0
associated	0
signs	0
and	0
symptoms	0
.	0

Sleep	I-DISEASE
related	I-DISEASE
bruxism	0
,	I-DISEASE
especially	0
in	I-DISEASE
children	0
,	0
has	0
been	I-DISEASE
associated	I-DISEASE
with	I-DISEASE
attention	0
deficit	0
hyperactivity	I-DISEASE
disorder	I-DISEASE
,	0
parasomnias	I-DISEASE
,	I-DISEASE
SRBD	I-DISEASE
,	I-DISEASE
snoring	0
,	I-DISEASE
and	0
many	0
psychological	I-DISEASE
and	0
medical	0
conditions	I-DISEASE
.	0

In	I-DISEASE
the	0
elderly	I-DISEASE
,	I-DISEASE
sleep	0
related	B-DISEASE
bruxism	I-DISEASE
has	0
been	I-DISEASE
observed	I-DISEASE
in	I-DISEASE
association	I-DISEASE
with	0
movement	I-DISEASE
disorders	0
(	I-DISEASE
e.g.	0
,	I-DISEASE
Parkinson	0
disease	I-DISEASE
or	I-DISEASE
oral	0
tardive	0
dyskinesia	0
persisting	I-DISEASE
during	I-DISEASE
sleep	0
)	0
,	I-DISEASE
RBD	0
,	I-DISEASE
and	0
dementia	I-DISEASE
.	0

Pathology	I-DISEASE
and	0
Pathophysiology	I-DISEASE
The	I-DISEASE
majority	0
of	I-DISEASE
RMMA	I-DISEASE
episodes	I-DISEASE
during	I-DISEASE
sleep	0
(	I-DISEASE
up	0
to	0
80	I-DISEASE
%	0
)	0
occur	I-DISEASE
in	I-DISEASE
association	I-DISEASE
with	0
sleep	0
arousals	0
.	0

Sleep	I-DISEASE
related	I-DISEASE
bruxism	0
episodes	I-DISEASE
typically	0
follow	I-DISEASE
a	0
clear	0
arousal	0
sequence	I-DISEASE
,	I-DISEASE
starting	I-DISEASE
with	0
increased	0
sympathetic	I-DISEASE
-	I-DISEASE
cardiac	0
activity	0
and	0
fast	0
electroenceph-	I-DISEASE
alographic	0
(	0
EEG	0
)	0
waves	0
in	I-DISEASE
the	I-DISEASE
minutes	0
to	I-DISEASE
seconds	0
preceding	I-DISEASE
the	0
onset	0
of	I-DISEASE
an	0
RMMA	0
episode	I-DISEASE
.	0

The	I-DISEASE
jaw	0
muscle	0
contractions	I-DISEASE
are	0
then	0
followed	0
by	B-DISEASE
,	0
or	0
are	I-DISEASE
concomitant	I-DISEASE
with	I-DISEASE
,	I-DISEASE
an	0
increase	0
in	I-DISEASE
blood	I-DISEASE
pressure	0
and	0
ventilation	0
.	0

RMMA	I-DISEASE
episodes	I-DISEASE
sometimes	0
conclude	I-DISEASE
with	I-DISEASE
swallowing	I-DISEASE
.	0

Other	I-DISEASE
causes	I-DISEASE
of	I-DISEASE
sleep	0
bruxism	0
onset	I-DISEASE
are	0
unknown	0
,	0
although	I-DISEASE
potential	I-DISEASE
candidates	I-DISEASE
include	I-DISEASE
airway	I-DISEASE
resistance	I-DISEASE
and	0
oropharyngeal	0
dryness	I-DISEASE
.	I-DISEASE

In	I-DISEASE
the	0
majority	0
of	I-DISEASE
individuals	I-DISEASE
with	I-DISEASE
sleep	0
related	B-DISEASE
bruxism	0
,	I-DISEASE
the	I-DISEASE
frequency	I-DISEASE
of	I-DISEASE
sleep	0
arous-	0
als	0
is	0
within	I-DISEASE
the	0
normal	0
range	I-DISEASE
.	0

However	I-DISEASE
,	I-DISEASE
they	B-DISEASE
may	I-DISEASE
have	0
an	I-DISEASE
exaggerated	I-DISEASE
responsiveness	0
to	I-DISEASE
ongoing	I-DISEASE
sleep	0
arousals	0
or	I-DISEASE
an	0
increased	0
magnitude	I-DISEASE
of	I-DISEASE
arousal	0
.	0

Individuals	I-DISEASE
with	I-DISEASE
sleep	0
related	0
bruxism	0
show	I-DISEASE
more	0
CAP	0
phase	0
A3	I-DISEASE
(	0
as	0
described	I-DISEASE
by	I-DISEASE
the	0
scoring	0
and	0
analysis	I-DISEASE
of	I-DISEASE
cyclic	I-DISEASE
alternating	I-DISEASE
pattern	0
(	I-DISEASE
CAP	0
)	0
during	I-DISEASE
sleep	0
)	0
than	I-DISEASE
controls	0
,	0
an	0
expression	I-DISEASE
of	I-DISEASE
increased	0
arousal	0
pressure	0
and	0
increased	0
sleep	0
instability	I-DISEASE
.	0

This	I-DISEASE
increased	0
sleep	0
instability	I-DISEASE
seems	I-DISEASE
to	I-DISEASE
be	I-DISEASE
the	I-DISEASE
“	0
permissive	0
window	I-DISEASE
”	I-DISEASE
for	0
occurrence	0
of	I-DISEASE
RMMA	I-DISEASE
during	I-DISEASE
sleep	0
.	0

Objective	I-DISEASE
Findings	I-DISEASE
Polysomnographic	0
(	I-DISEASE
PSG	0
)	0
monitoring	0
of	I-DISEASE
individuals	I-DISEASE
with	I-DISEASE
sleep	0
related	0
bruxism	0
demonstrates	I-DISEASE
increased	0
masseter	0
and	0
temporalis	0
muscle	I-DISEASE
activity	0
during	I-DISEASE
sleep	0
,	I-DISEASE
along	I-DISEASE
with	I-DISEASE
grinding	0
sounds	I-DISEASE
.	0

RMMA	I-DISEASE
episodes	I-DISEASE
can	0
occur	I-DISEASE
during	I-DISEASE
all	0
sleep	0
stages	0
,	I-DISEASE
but	I-DISEASE
are	I-DISEASE
most	I-DISEASE
common	I-DISEASE
in	I-DISEASE
sleep	0
stages	I-DISEASE
N1	0
and	0
N2	0
(	I-DISEASE
more	0
than	I-DISEASE
80	0
%	0
of	I-DISEASE
episodes	I-DISEASE
)	0
,	I-DISEASE
whereas	I-DISEASE
fewer	I-DISEASE
than	I-DISEASE
10	0
%	0
of	I-DISEASE
RMMA	I-DISEASE
episodes	I-DISEASE
occur	0
during	I-DISEASE
REM	I-DISEASE
sleep	I-DISEASE
.	0

However	I-DISEASE
,	I-DISEASE
in	0
some	I-DISEASE
individuals	I-DISEASE
,	I-DISEASE
sleep	0
related	B-DISEASE
bruxism	0
occurs	0
predominantly	I-DISEASE
in	I-DISEASE
REM	0
sleep	0
.	I-DISEASE

As	I-DISEASE
described	I-DISEASE
above	0
,	I-DISEASE
the	0
majority	0
of	I-DISEASE
sleep	0
related	B-DISEASE
bruxism	0
episodes	I-DISEASE
are	I-DISEASE
temporally	0
associated	0
with	I-DISEASE
sleep	0
arousal	0
and	0
are	0
preceded	0
by	I-DISEASE
signs	0
of	I-DISEASE
autonomic	0
/	0
cardiac	I-DISEASE
activa-	0
tion	0
(	I-DISEASE
e.g.	0
,	0
increased	0
heart	0
rate	0
and	0
blood	I-DISEASE
pressure	0
)	0
.	0

Three	I-DISEASE
subtypes	I-DISEASE
of	0
the	0
EMG	0
pattern	0
of	I-DISEASE
sleep	0
related	0
bruxism	I-DISEASE
have	0
been	I-DISEASE
described	I-DISEASE
:	0
phasic	0
activity	0
at	I-DISEASE
1	0
Hz	0
frequency	0
with	I-DISEASE
EMG	0
bursts	0
lasting	0
0.25	0
to	I-DISEASE
2	0
seconds	0
;	0
sustained	0
tonic	0
activity	0
lasting	0
longer	I-DISEASE
than	0
2	I-DISEASE
seconds	0
;	I-DISEASE
or	0
a	0
mixed	0
pattern	0
.	0

An	0
episode	0
begins	0
after	0
at	I-DISEASE
least	0
a	0
three	0
-	0
second	0
interval	0
with	I-DISEASE
no	I-DISEASE
muscle	I-DISEASE
activity	0
.	0

Polysomnography	0
is	0
not	0
usually	I-DISEASE
performed	0
in	0
otherwise	0
healthy	0
individuals	I-DISEASE
with	I-DISEASE
sleep	0
related	0
bruxism	0
in	0
routine	0
clinical	0
settings	I-DISEASE
.	0

However	I-DISEASE
,	I-DISEASE
PSG	0
may	0
be	I-DISEASE
indicated	0
to	I-DISEASE
demon-	0
strate	0
the	I-DISEASE
disorder	I-DISEASE
and	0
to	0
rule	I-DISEASE
out	0
associated	0
respiratory	0
disturbances	I-DISEASE
,	0
gastroesophageal	I-DISEASE
reflux	I-DISEASE
,	0
RBD	0
,	0
night	0
terrors	0
,	0
faciomandibular	0
myoclonus	I-DISEASE
,	0
or	0
epilepsy	0
.	0

The	I-DISEASE
sensitivity	I-DISEASE
of	I-DISEASE
polysomnographic	0
study	0
in	0
detecting	I-DISEASE
sleep	0
related	0
bruxism	0
in	0
severe	0
cases	0
is	0
moderate	I-DISEASE
to	0
high	I-DISEASE
;	I-DISEASE
in	0
milder	0
cases	0
,	I-DISEASE
however	I-DISEASE
,	0
it	0
may	I-DISEASE
be	0
low	0
due	0
to	0
the	0
night	0
-	0
to	0
-	0
night	0
variability	I-DISEASE
in	I-DISEASE
RMMA	I-DISEASE
and	0
tooth	0
grinding	0
.	0

Ambulatory	I-DISEASE
home	I-DISEASE
monitoring	0
may	I-DISEASE
be	I-DISEASE
used	0
for	0
screening	0
,	0
diagnosis	I-DISEASE
,	I-DISEASE
and	0
treatment	B-DISEASE
outcome	0
assessment	I-DISEASE
by	I-DISEASE
studying	0
the	0
individual	I-DISEASE
in	I-DISEASE
his	0
/	0
her	0
usual	I-DISEASE
environment	0
,	I-DISEASE
but	0
it	I-DISEASE
is	I-DISEASE
characterized	0
by	0
lower	B-DISEASE
diagnostic	0
specificity	I-DISEASE
due	0
to	0
the	0
absence	0
of	I-DISEASE
audiovisual	0
record-	0
ings	0
(	0
i.e.	0
,	0
20	0
%	0
overestimation	0
in	0
RMMA	0
frequency	I-DISEASE
is	0
expected	0
due	0
to	I-DISEASE
poor	0
capacity	I-DISEASE
to	I-DISEASE
exclude	0
concomitant	I-DISEASE
nonspecific	0
activities	I-DISEASE
)	0
.	0

To	I-DISEASE
record	0
and	0
score	I-DISEASE
sleep	0
related	B-DISEASE
bruxism	I-DISEASE
activity	0
(	I-DISEASE
i.e.	I-DISEASE
,	I-DISEASE
RMMA	I-DISEASE
)	0

,	I-DISEASE
there	I-DISEASE
must	I-DISEASE
be	I-DISEASE
a	0
minimum	I-DISEASE
of	I-DISEASE
one	I-DISEASE
masseter	0
muscle	I-DISEASE
monitor	0
,	I-DISEASE
ideally	0
with	0
audiovisual	I-DISEASE
recording	0
,	I-DISEASE
to	I-DISEASE
associate	0
muscular	0
activity	0
with	I-DISEASE
grinding	0
sound	I-DISEASE
production	I-DISEASE
.	0

Video	0
monitoring	0
helps	0
distinguish	0
bruxism	0
from	I-DISEASE
other	0
orofacial	0
and	0
masticatory	0
movements	0
that	0
normally	0
occur	I-DISEASE
during	I-DISEASE
sleep	0
(	I-DISEASE
e.g.	0
,	I-DISEASE
swallowing	I-DISEASE
,	I-DISEASE
coughing	I-DISEASE
)	0
and	0
from	I-DISEASE
specific	I-DISEASE
movement	I-DISEASE
disorders	0
(	I-DISEASE
RBD	I-DISEASE
,	0
epilepsy	0
and	0
tooth	I-DISEASE
tapping	0
,	I-DISEASE
oromandibular	I-DISEASE
myoclonus	0
)	0
.	0

For	I-DISEASE
the	0
best	0
level	0
of	I-DISEASE
diagnostic	I-DISEASE
specificity	I-DISEASE
and	0
sensitivity	0
,	I-DISEASE
bilateral	I-DISEASE
masseter	I-DISEASE
and	0
tem-	I-DISEASE
poralis	0
muscle	I-DISEASE
EMG	0
recordings	I-DISEASE
,	I-DISEASE
referenced	0
to	I-DISEASE
ear	I-DISEASE
,	I-DISEASE
mastoid	0
,	0
or	I-DISEASE
zygomatic	I-DISEASE
bone	I-DISEASE
,	0
are	0
advisable	0
.	0

Differential	I-DISEASE
Diagnosis	0

The	I-DISEASE
disorder	I-DISEASE
seldom	0
poses	I-DISEASE
diagnostic	0
problems	I-DISEASE
.	0

Evaluation	I-DISEASE
for	I-DISEASE
temporomandibular	0
disorders	0
and	0
damage	0
to	0
dentition	0
is	0
indicated	0
.	0

Sleep	I-DISEASE
related	I-DISEASE
bruxism	0
needs	I-DISEASE
to	I-DISEASE
be	I-DISEASE
differentiated	0
from	0
other	0
faciomandibular	0
activities	I-DISEASE
occurring	0
during	I-DISEASE
sleep	0
,	0
such	0
as	0
faciomandibular	0
myoclonus	0
,	I-DISEASE
SRBD	I-DISEASE
,	0
RBD	0
,	0
abnormal	0
swallowing	0
,	I-DISEASE
gastro	I-DISEASE
-	I-DISEASE
esophageal	I-DISEASE
reflux	0
,	0
night	I-DISEASE
terrors	0
,	0
confusional	0
arousals	0
,	I-DISEASE
dyskinetic	0
jaw	0
movements	0
persisting	I-DISEASE
in	0
sleep	0
(	0
dystonia	0
,	I-DISEASE
tremor	0
,	0
chorea	I-DISEASE
,	I-DISEASE
dyskinesia	0
)	0
,	0
and	0
,	I-DISEASE
rarely	I-DISEASE
,	0
sleep	0
related	B-DISEASE
epilepsy	0
.	0

Sleep	I-DISEASE
Related	I-DISEASE
Movement	I-DISEASE
Disorders	0
Sleep	I-DISEASE
Related	0
Movement	0
Disorders	I-DISEASE
Oromandibular	0
or	0
faciomandibular	0
myoclonus	I-DISEASE
has	0
been	I-DISEASE
observed	I-DISEASE
in	0
approximately	0
10	0
%	0
of	I-DISEASE
individuals	0
with	I-DISEASE
severe	0
sleep	0
related	0
bruxism	0
,	I-DISEASE
but	I-DISEASE
it	0
can	0
also	0
occur	0
in	I-DISEASE
indi-	0
viduals	0
without	0
abnormally	0
increased	0
RMMA	I-DISEASE
events	0
.	0

As	I-DISEASE
opposed	I-DISEASE
to	0
sleep	0
related	0
bruxism	0
,	0
faciomandibular	0
myoclonus	0
consists	0
of	I-DISEASE
EMG	0
bursts	0
of	I-DISEASE
brief	I-DISEASE
duration	0
(	I-DISEASE
less	I-DISEASE
than	I-DISEASE
250	I-DISEASE
milliseconds	I-DISEASE
in	I-DISEASE
length	0
)	0
in	I-DISEASE
the	0
facial	0
muscles	0
;	0
these	0
can	0
occur	I-DISEASE
either	I-DISEASE
as	0
isolated	I-DISEASE
bursts	0
or	0
as	0
a	0
cluster	0
of	I-DISEASE
regularly	0
or	I-DISEASE
irregularly	I-DISEASE
occurring	0
brief	I-DISEASE
bursts	0
.	I-DISEASE

A	I-DISEASE
high	I-DISEASE
index	I-DISEASE
of	I-DISEASE
oromandibular	0
myoclonus	0
in	I-DISEASE
sleep	0
has	0
been	I-DISEASE
observed	I-DISEASE
in	0
idiopathic	0
RBD	I-DISEASE
patients	I-DISEASE
.	0

Rhythmic	0
jaw	0
movements	I-DISEASE
also	0
have	I-DISEASE
been	I-DISEASE
observed	I-DISEASE
in	0
association	0
with	I-DISEASE
partial	I-DISEASE
complex	I-DISEASE
or	I-DISEASE
generalized	0
seizure	I-DISEASE
disorders	0
.	I-DISEASE

Epilepsy	I-DISEASE
needs	I-DISEASE
to	0
be	I-DISEASE
considered	I-DISEASE
in	I-DISEASE
the	0
differential	0
diagnosis	0
,	I-DISEASE
although	I-DISEASE
the	0
presentation	0
of	I-DISEASE
epilepsy	I-DISEASE
as	0
relatively	0
isolated	0
sleep	0
related	0
bruxism	0
is	I-DISEASE
very	I-DISEASE
rare	I-DISEASE
.	0

Unresolved	I-DISEASE
Issues	0
and	0
Further	I-DISEASE
Directions	0

An	I-DISEASE
expert	0
bruxism	0
international	I-DISEASE
group	I-DISEASE
has	I-DISEASE
proposed	0
a	0
diagnostic	0
grading	I-DISEASE
system	I-DISEASE
of	I-DISEASE
“	0
possible	0
,	I-DISEASE
”	0
“	0
probable	0
,	0
”	I-DISEASE
and	0
“	0
definite	I-DISEASE
”	I-DISEASE
for	I-DISEASE
both	I-DISEASE
sleep	0
and	0
awake	0
bruxism	0
.	0

Such	I-DISEASE
a	0
clinical	0
tool	0
will	0
help	I-DISEASE
to	I-DISEASE
discriminate	I-DISEASE
sleep	0
bruxism	0
from	0
awake	0
bruxism	0
,	0
although	I-DISEASE
further	I-DISEASE
validation	I-DISEASE
is	0
required	I-DISEASE
for	0
clinical	0
and	0
research	0
purposes	0
in	I-DISEASE
all	0
relevant	I-DISEASE
dental	I-DISEASE
and	0
medical	0
domains	0
.	0

In	I-DISEASE
summary	I-DISEASE
,	0
this	0
group	I-DISEASE
suggests	I-DISEASE
that	0
a	I-DISEASE
rating	0
of	0
:	0
(	I-DISEASE
1	I-DISEASE
)	0
“	0
possible	0
”	I-DISEASE
is	I-DISEASE
given	0
if	0
based	I-DISEASE
on	0
self	0
-	0
report	0
,	I-DISEASE
by	0
means	0
of	I-DISEASE
questionnaires	I-DISEASE
,	0
and/or	0
the	0
anamnestic	0
part	0
of	0
a	0
clinical	0
examination	0
;	I-DISEASE
(	I-DISEASE
2	0
)	0
“	0
probable	0
”	0
sleep	0
or	B-DISEASE
awake	0
bruxism	0
is	0
given	0
if	0
based	I-DISEASE
on	0
self	0
-	0
report	0
and	0
supportive	I-DISEASE
physical	0
findings	0
;	I-DISEASE
(	0
3	I-DISEASE
)	0
“	0
definite	0
”	I-DISEASE
sleep	0
bruxism	0
if	0
based	I-DISEASE
on	0
self	0
-	0
report	0
,	I-DISEASE
physical	I-DISEASE
findings	0
,	0
and	0
a	0
polysomnographic	0
recording	0
,	0
preferably	I-DISEASE
with	0
audiovisual	0
recordings	0
.	0

The	I-DISEASE
clinical	0
relevance	0
of	I-DISEASE
sleep	0
related	0
bruxism	I-DISEASE
in	0
cases	0
of	I-DISEASE
comorbidity	I-DISEASE
with	I-DISEASE
other	I-DISEASE
medical	0
problems	0
such	0
as	0
snoring	0
,	I-DISEASE
sleep	0
related	0
breathing	0
disorder	I-DISEASE
,	I-DISEASE
RBD	I-DISEASE
,	0
attention	0
deficit	0
hyperactivity	I-DISEASE
disorder	0
,	0
headache	0
,	0
and	0
orofacial	I-DISEASE
pain	0
needs	0
to	0
be	0
assessed	I-DISEASE
in	0
order	0
to	I-DISEASE
distinguish	0
primary	0
benign	0
forms	0
of	I-DISEASE
sleep	I-DISEASE
related	B-DISEASE
bruxism	0
from	I-DISEASE
those	I-DISEASE
that	0
rep-	0
resent	0
an	0
epiphenomenon	0
of	I-DISEASE
other	0
more	0
severe	I-DISEASE
sleep	0
and	0
medical	I-DISEASE
disorders	0
.	0

Sleep	I-DISEASE
related	I-DISEASE
bruxism	0
may	I-DISEASE
be	I-DISEASE
concomitant	I-DISEASE
to	I-DISEASE
breathing	I-DISEASE
disorders	0
,	0
including	0
any	I-DISEASE
level	0
of	0
severity	0
of	I-DISEASE
OSA	0
;	I-DISEASE
further	I-DISEASE
research	I-DISEASE
is	0
in	I-DISEASE
progress	0
to	I-DISEASE
assess	I-DISEASE
the	0
specificity	I-DISEASE
and	0
validity	I-DISEASE
of	I-DISEASE
this	0
association	I-DISEASE
.	0

There	I-DISEASE
is	I-DISEASE
currently	0
no	0
evidence	0
supporting	0
the	0
possibility	I-DISEASE
that	0
patients	0
with	I-DISEASE
sleep	0
related	I-DISEASE
bruxism	I-DISEASE
,	I-DISEASE
in	I-DISEASE
its	0
primary	0
form	I-DISEASE
,	0
are	0
at	I-DISEASE
increased	0
risk	0
of	0
neurological	0
disorders	0
;	I-DISEASE
such	0
a	0
risk	0
factor	I-DISEASE
assessment	I-DISEASE
needs	0
long-	I-DISEASE
term	0
study	0
before	0
any	0
conclusion	I-DISEASE
can	0
be	I-DISEASE
drawn	I-DISEASE
.	0

Investigation	I-DISEASE
of	I-DISEASE
genetic	I-DISEASE
associations	I-DISEASE
to	0
sleep	0
related	0
bruxism	0
require	I-DISEASE
large	I-DISEASE
sample	I-DISEASE
sizes	I-DISEASE
,	0
using	I-DISEASE
valid	I-DISEASE
tools	I-DISEASE
to	0
assess	0
the	0
specificity	I-DISEASE
of	I-DISEASE
RMMA	I-DISEASE
versus	0
other	0
oromandibular	I-DISEASE
activities	I-DISEASE
and	0
to	I-DISEASE
discriminate	0
gene	0
candidates	0
specific	0
for	0
bruxism	0
from	I-DISEASE
those	I-DISEASE
related	0
to	0
its	I-DISEASE
comorbidities	0
such	I-DISEASE
as	0
stress	0
or	I-DISEASE
other	0
related	0
triggers	I-DISEASE
of	I-DISEASE
RMMA	0
.	0

Bibliography	0
Abe	I-DISEASE
S	0
,	I-DISEASE
Yamaguchi	I-DISEASE
T	0
,	I-DISEASE
Rompré	I-DISEASE
PH	0
,	0
De	0
Grandmont	I-DISEASE
P	0
,	I-DISEASE
Chen	0
YJ	I-DISEASE
,	I-DISEASE
Lavigne	I-DISEASE
GJ	I-DISEASE
.	0

Tooth	I-DISEASE
wear	0
in	I-DISEASE
young	0
subjects	I-DISEASE
:	0
a	I-DISEASE
discriminator	0
between	0
sleep	I-DISEASE
bruxers	I-DISEASE
and	0
controls	0
?	0

Int	I-DISEASE
J	0
Prosthodont	I-DISEASE
2009;22:342–50	I-DISEASE
.	0

Carra	I-DISEASE
MC	0
,	I-DISEASE
Macaluso	0
GM	B-DISEASE
,	0
Rompre	I-DISEASE
PH	0
,	I-DISEASE
et	0
al	0
.	0

Clonidine	I-DISEASE
has	0
a	0
paradoxical	I-DISEASE
effect	0
on	0
cyclic	I-DISEASE
arousal	I-DISEASE
and	0
sleep	0
bruxism	0
during	I-DISEASE
NREM	0
sleep	0
.	0

Sleep	I-DISEASE
2010;33:1711–6	I-DISEASE
.	0

Hublin	I-DISEASE
C	0
,	I-DISEASE
Kaprio	0
J	0
,	0
Partinen	0
M	I-DISEASE
,	I-DISEASE
Koskenvuo	0
M.	0
Sleep	0
bruxism	0
based	0
on	0
self	0
-	0
report	0
in	I-DISEASE
a	0
nationwide	0
twin	0
cohort	B-DISEASE
.	0

J	I-DISEASE
Sleep	0
Res	0
1998;7:61–7	0
.	0

Lavigne	I-DISEASE
G	I-DISEASE
,	0
Guitard	I-DISEASE
F	I-DISEASE
,	0
Rompre	0
P	0
,	0
Montplaisir	0
J.	0
Variability	I-DISEASE
in	I-DISEASE
sleep	I-DISEASE
bruxism	0
activity	I-DISEASE
over	0
time	I-DISEASE
.	0

J	I-DISEASE
Sleep	0
Res	0
2001;10:237–44	I-DISEASE
.	0

Lavigne	I-DISEASE
G	I-DISEASE
,	0
Manzini	I-DISEASE
C	0
,	0
Huynh	I-DISEASE
NT	0
.	0

Sleep	I-DISEASE
bruxism	I-DISEASE
.	0

In	I-DISEASE
:	I-DISEASE
Kryger	0
MH	I-DISEASE
,	I-DISEASE
Roth	I-DISEASE
T	0
,	0
Dement	I-DISEASE
WC	I-DISEASE
,	0
eds	I-DISEASE
.	0

Principles	I-DISEASE
and	0
practice	0
of	I-DISEASE
sleep	0
medicine	0
,	I-DISEASE
5th	I-DISEASE
ed	0
.	0

St.	I-DISEASE
Louis	0
:	0
Elsevier	0
Saunders	0
,	0
2011:1129–39	0
.	0

Lobbezoo	I-DISEASE
F	I-DISEASE
,	I-DISEASE
Ahlberg	0
J	0
,	0
Glaros	I-DISEASE
AG	I-DISEASE
,	0
et	0
al	I-DISEASE
.	I-DISEASE

Bruxism	0
defined	0
and	0
graded	I-DISEASE
:	I-DISEASE
An	0
international	0
consensus	0
.	0

J	I-DISEASE
Oral	0
Rehab	0
2013;40:2–4	0
.	0

Ohayon	I-DISEASE
M	I-DISEASE
,	0
Li	I-DISEASE
K	I-DISEASE
,	I-DISEASE
Guilleminault	I-DISEASE
C.	I-DISEASE
Risk	I-DISEASE
factors	I-DISEASE
for	I-DISEASE
sleep	0
bruxism	0
in	I-DISEASE
the	0
general	0
population	0
.	0

Chest	I-DISEASE
2001;119:53–61	I-DISEASE
.	0

Rompre	I-DISEASE
PH	0
,	I-DISEASE
Daigle	I-DISEASE
-	0
Landry	I-DISEASE
D	I-DISEASE
,	I-DISEASE
Guitard	0
F	I-DISEASE
,	I-DISEASE
Montplaisir	0
JY	0
,	I-DISEASE
Lavigne	I-DISEASE
GJ	I-DISEASE
.	0

Identification	I-DISEASE
of	I-DISEASE
a	0
sleep	0
bruxism	I-DISEASE
subgroup	0
with	I-DISEASE
a	0
higher	I-DISEASE
risk	0
of	I-DISEASE
pain	0
.	0

J	I-DISEASE
Dent	0
Res	0
2007;86:837–42	B-DISEASE
.	0

Vetrugno	I-DISEASE
R	0
,	I-DISEASE
Provini	0
F	0
,	0
Plazzi	0
G	I-DISEASE
,	I-DISEASE
et	0
al	I-DISEASE
.	0

Familial	I-DISEASE
nocturnal	I-DISEASE
facio	I-DISEASE
-	0
mandibular	0
myoclonus	0
mimicking	I-DISEASE
sleep	0
bruxism	0
.	0

Neurology	0
2002;58:644–7	I-DISEASE
.	0

Sleep	I-DISEASE
Related	0
Movement	0
Disorders	0
Sleep	I-DISEASE
Related	0
Movement	0
Disorders	I-DISEASE
Sleep	0
Related	0
Rhythmic	0
Movement	0
Disorder	0
ICD-9	0
-	0
CM	0
code	0
:	B-DISEASE
327.59	0
ICD-10	0
-	0
CM	0
code	0
:	I-DISEASE
G47.69	I-DISEASE
Alternate	0
Names	I-DISEASE
Body	I-DISEASE
rocking	0
,	0
head	I-DISEASE
banging	0
,	I-DISEASE
head	I-DISEASE
rolling	0
,	0
body	I-DISEASE
rolling	0
,	I-DISEASE
jactatio	I-DISEASE
capitis	0
nocturna	0
,	I-DISEASE
jac-	0
tatio	0
corporis	0
nocturna	I-DISEASE
,	I-DISEASE
rhythmie	I-DISEASE
du	0
sommeil	0
.	0

Diagnostic	I-DISEASE
Criteria	0
Criteria	I-DISEASE
A	0
-	I-DISEASE
D	I-DISEASE
must	0
be	0
met	0
A.	0

The	I-DISEASE
patient	I-DISEASE
exhibits	0
repetitive	I-DISEASE
,	0
stereotyped	I-DISEASE
,	0
and	0
rhythmic	I-DISEASE
motor	I-DISEASE
behaviors	I-DISEASE
involving	I-DISEASE
large	0
muscle	I-DISEASE
groups	0
.	0

B.	0
The	I-DISEASE
movements	I-DISEASE
are	0
predominantly	I-DISEASE
sleep	0
related	B-DISEASE
,	0
occurring	0
near	0
nap	I-DISEASE
or	I-DISEASE
bedtime	I-DISEASE
,	I-DISEASE
or	I-DISEASE
when	I-DISEASE
the	0
individual	0
appears	I-DISEASE
drowsy	0
or	I-DISEASE
asleep	I-DISEASE
.	0

C.	I-DISEASE

The	I-DISEASE
behaviors	I-DISEASE
result	0
in	I-DISEASE
a	0
significant	0
complaint	I-DISEASE
as	I-DISEASE
manifest	0
by	I-DISEASE
at	I-DISEASE
least	0
one	I-DISEASE
of	I-DISEASE
the	0
following:1	0
.	0

Interference	I-DISEASE
with	0
normal	0
sleep	0
.	0
.	0

Significant	I-DISEASE
impairment	0
in	I-DISEASE
daytime	0
function	0
.	0
.	0

Self	I-DISEASE
-	I-DISEASE
inflicted	0
bodily	0
injury	0
or	I-DISEASE
likelihood	0
of	I-DISEASE
injury	0
if	0
preventive	I-DISEASE
measures	I-DISEASE
are	I-DISEASE
not	0
used	0
.	0

D.	I-DISEASE

The	I-DISEASE
rhythmic	I-DISEASE
movements	0
are	I-DISEASE
not	0
better	0
explained	I-DISEASE
by	I-DISEASE
another	0
movement	0
disorder	0
or	I-DISEASE
epilepsy	I-DISEASE
.	0

Notes	I-DISEASE
.	0

When	I-DISEASE
there	I-DISEASE
are	0
no	I-DISEASE
clinical	0
consequences	I-DISEASE
of	I-DISEASE
the	0
rhythmic	0
movements	0
,	0
the	0
rhythmic	I-DISEASE
movements	0
are	0
simply	0
noted	0
but	I-DISEASE
the	0
term	0
rhythmic	I-DISEASE
movement	0
disorder	I-DISEASE
is	0
not	0
employed	0
.	0

Essential	I-DISEASE
Features	I-DISEASE
Sleep	0
related	0
rhythmic	0
movement	I-DISEASE
disorder	I-DISEASE
(	I-DISEASE
RMD	0
)	0
is	I-DISEASE
characterized	0
by	I-DISEASE
repetitive	I-DISEASE
,	I-DISEASE
ste-	0
reotyped	0
,	0
and	0
rhythmic	0
motor	I-DISEASE
behaviors	0
(	I-DISEASE
not	0
tremors	I-DISEASE
)	0
that	0
occur	I-DISEASE
predominantly	I-DISEASE
during	I-DISEASE
drowsiness	0
or	0
sleep	0
and	0
involve	0
large	I-DISEASE
muscle	I-DISEASE
groups	I-DISEASE
.	0

The	I-DISEASE
occurrence	0
of	I-DISEASE
significant	I-DISEASE
clinical	0
consequences	I-DISEASE
differentiates	I-DISEASE
RMD	I-DISEASE
from	I-DISEASE
developmentally	I-DISEASE
normal	0
sleep	0
related	I-DISEASE
movements	I-DISEASE
.	I-DISEASE

Typically	I-DISEASE
seen	I-DISEASE
in	0
infants	0
and	0
children	I-DISEASE
,	0
but	I-DISEASE
also	0
in	0
adults	B-DISEASE
,	I-DISEASE
RMD	I-DISEASE
comprises	B-DISEASE
several	0
sub-	I-DISEASE
types	0
.	0

Body	I-DISEASE
rocking	I-DISEASE
may	0
involve	0
the	0
entire	0
body	I-DISEASE
,	I-DISEASE
with	0
the	0
individual	I-DISEASE
on	0
hands	I-DISEASE
and	0
knees	0
,	I-DISEASE
or	I-DISEASE
it	I-DISEASE
may	0
be	0
limited	I-DISEASE
to	0
the	0
torso	0
,	I-DISEASE
with	I-DISEASE
the	0
individual	I-DISEASE
sitting	I-DISEASE
.	0

Head	I-DISEASE
banging	0
often	0
occurs	0
with	0
the	0
person	0
prone	0
,	0
repeatedly	0
lifting	0
the	0
head	I-DISEASE
or	I-DISEASE
entire	0
upper	0
torso	0
,	I-DISEASE
and	0
forc-	0
ibly	I-DISEASE
banging	0
the	I-DISEASE
head	0
back	I-DISEASE
down	I-DISEASE
into	I-DISEASE
the	0
pillow	B-DISEASE
or	0
mattress	0
.	0

Alternately	I-DISEASE
,	0
the	0
individual	0
may	I-DISEASE
sit	I-DISEASE
with	I-DISEASE
the	0
back	0
of	I-DISEASE
the	0
head	I-DISEASE
against	I-DISEASE
the	0
headboard	I-DISEASE
or	I-DISEASE
wall	0
,	0
repeatedly	I-DISEASE
banging	0
the	0
occiput	0
.	0

Combining	I-DISEASE
head	I-DISEASE
banging	0
and	0
body	I-DISEASE
rocking	I-DISEASE
,	0
they	0
may	I-DISEASE
rock	I-DISEASE
on	0
hands	0
and	0
knees	0
,	I-DISEASE
banging	0
the	0
vertex	0
or	I-DISEASE
frontal	0
region	I-DISEASE
of	I-DISEASE
the	0
head	I-DISEASE
into	0
the	I-DISEASE
headboard	I-DISEASE
or	I-DISEASE
wall	I-DISEASE
.	0

Head	I-DISEASE
rolling	I-DISEASE
consists	0
of	I-DISEASE
side	0
-	I-DISEASE
to	I-DISEASE
-	0
side	0
head	0
movements	0
,	I-DISEASE
usually	I-DISEASE
with	I-DISEASE
the	0
child	0
(	I-DISEASE
or	I-DISEASE
adult	0
)	0
in	I-DISEASE
the	0
supine	0
position	0
.	0

Less	I-DISEASE
common	I-DISEASE
rhythmic	0
movement	I-DISEASE
forms	0
include	I-DISEASE
body	I-DISEASE
rolling	I-DISEASE
,	0
leg	I-DISEASE
banging	0
,	I-DISEASE
or	I-DISEASE
leg	I-DISEASE
rolling	0
.	0

Rhythmic	0
humming	I-DISEASE
or	I-DISEASE
inarticulate	0
sounds	I-DISEASE
often	0
accompany	0
the	0
body	I-DISEASE
,	I-DISEASE
head	I-DISEASE
,	0
or	0
limb	0
movements	0
and	0
may	0
be	I-DISEASE
quite	0
loud	0
.	0

Episodes	I-DISEASE
often	0
occur	I-DISEASE
near	0
sleep	0
onset	0
,	I-DISEASE
although	0
they	0
also	0
may	I-DISEASE
occur	I-DISEASE
at	I-DISEASE
any	I-DISEASE
time	0
during	I-DISEASE
the	0
night	0
and	0
even	I-DISEASE
during	I-DISEASE
quiet	0
wakeful	0
activities	I-DISEASE
,	0
such	0
as	0
listening	I-DISEASE
to	I-DISEASE
music	0
or	0
trav-	0
eling	0
in	0
vehicles	0
.	0

The	I-DISEASE
movement	I-DISEASE
frequency	I-DISEASE
can	I-DISEASE
vary	0
,	I-DISEASE
but	I-DISEASE
the	0
rate	0
is	0
usually	I-DISEASE
between	0
0.5	I-DISEASE
per	I-DISEASE
second	I-DISEASE
and	0
two	0
per	0
second	I-DISEASE
.	0

Duration	I-DISEASE
of	I-DISEASE
the	0
individual	0
movement	I-DISEASE
clusters	I-DISEASE
also	I-DISEASE
varies	B-DISEASE
but	0
generally	I-DISEASE
is	I-DISEASE
less	I-DISEASE
than	I-DISEASE
15	0
minutes	0
.	0

Cessation	0
of	I-DISEASE
movements	0
may	I-DISEASE
occur	I-DISEASE
fol-	I-DISEASE
lowing	0
environmental	I-DISEASE
disturbance	I-DISEASE
or	0
being	I-DISEASE
spoken	0
to	I-DISEASE
.	0

Children	I-DISEASE
who	I-DISEASE
have	0
sufficient	I-DISEASE
language	0
development	I-DISEASE
to	I-DISEASE
be	I-DISEASE
asked	0
about	0
event	0
recall	I-DISEASE
in	I-DISEASE
the	0
morning	0
are	0
typically	0
amnestic	I-DISEASE
for	I-DISEASE
the	0
episodes	I-DISEASE
.	0

Rarely	I-DISEASE
,	0
adults	I-DISEASE
will	0
report	0
a	0
volitional	I-DISEASE
component	I-DISEASE
.	0

Sleep	I-DISEASE
related	0
rhythmic	0
movements	0
are	0
common	I-DISEASE
in	0
normal	0
infants	0
and	0
children	0
.	0

Without	I-DISEASE
evidence	0
for	0
significant	0
consequences	0
,	I-DISEASE
the	0
movements	I-DISEASE
alone	I-DISEASE
should	0
not	0
be	I-DISEASE
considered	I-DISEASE
a	I-DISEASE
disorder	0
.	0

Sleep	I-DISEASE
related	B-DISEASE
rhythmic	0
movements	I-DISEASE
should	0
be	I-DISEASE
considered	I-DISEASE
a	I-DISEASE
disorder	0
only	0
if	0
the	0
behaviors	I-DISEASE
significantly	0
interfere	B-DISEASE
with	0
normal	B-DISEASE
sleep	0
,	0
cause	0
significant	0
impairment	0
in	I-DISEASE
daytime	I-DISEASE
function	0
,	I-DISEASE
or	0
result	0
in	0
self	0
-	0
inflicted	0
bodily	0
injury	0
(	0
or	0
would	I-DISEASE
result	0
in	0
injury	0
if	0
preventive	0
measures	0
are	I-DISEASE
not	0
used	0
)	0
.	0

Associated	I-DISEASE
Features	I-DISEASE
The	I-DISEASE
vast	I-DISEASE
majority	0
of	I-DISEASE
infants	0
and	0
children	B-DISEASE
with	0
sleep	0
related	I-DISEASE
rhythmic	I-DISEASE
movements	0
are	0
otherwise	0
developmentally	I-DISEASE
and	0
intellectually	0
normal	0
,	I-DISEASE
as	0
are	0
most	I-DISEASE
adolescents	0
and	0
adults	I-DISEASE
.	0

Clinical	I-DISEASE
and	0
Pathophysiological	0
Subtypes	I-DISEASE
Body	0
Rocking	0
:	I-DISEASE
The	I-DISEASE
whole	0
body	I-DISEASE
is	I-DISEASE
rocked	0
while	0
on	0
the	0
hands	0
and	0
knees	0
.	0

Head	I-DISEASE
Banging	0
:	0
The	0
head	I-DISEASE
is	0
forcibly	I-DISEASE
moved	0
,	0
striking	0
an	0
object	I-DISEASE
.	0

Head	I-DISEASE
Rolling	I-DISEASE
:	0
The	I-DISEASE
head	0
is	0
moved	0
laterally	I-DISEASE
,	0
typically	0
while	0
in	I-DISEASE
a	0
supine	0
position	0
.	0

Other	0
:	0
Includes	0
body	I-DISEASE
rolling	0
,	0
leg	I-DISEASE
rolling	0
,	0
and	0
leg	I-DISEASE
banging	0
.	0

Combined	I-DISEASE
:	0
Involves	0
two	I-DISEASE
or	I-DISEASE
more	0
of	I-DISEASE
the	0
individual	I-DISEASE
types	I-DISEASE
.	I-DISEASE

Sleep	I-DISEASE
Related	0
Movement	I-DISEASE
Disorders	0
Sleep	I-DISEASE
Related	0
Movement	0
Disorders	I-DISEASE
Demographics	0

At	I-DISEASE
nine	0
months	0
of	I-DISEASE
age	0
,	I-DISEASE
59	0
%	0
of	I-DISEASE
all	0
infants	0
have	I-DISEASE
been	I-DISEASE
reported	I-DISEASE
to	0
exhibit	0
one	I-DISEASE
or	I-DISEASE
more	0
of	0
the	0
following	0
sleep	0
related	B-DISEASE
rhythmic	0
movements	0
:	0
body	I-DISEASE
rocking	0
(	I-DISEASE
43	0
%	0
)	0
,	0
head	I-DISEASE
banging	0
(	I-DISEASE
22	0
%	0
)	0
,	0
or	I-DISEASE
head	0
rolling	0
(	I-DISEASE
24	0
%	I-DISEASE
)	0
.	0

At	I-DISEASE
18	I-DISEASE
months	0
,	I-DISEASE
the	0
overall	0
prevalence	0
has	I-DISEASE
been	I-DISEASE
reported	0
to	0
decline	0
to	I-DISEASE
33	I-DISEASE
%	0
,	I-DISEASE
and	0
by	I-DISEASE
five	0
years	0
,	I-DISEASE
to	I-DISEASE
only	0
5	0
%	0
.	0

Most	I-DISEASE
pediatric	0
studies	I-DISEASE
have	0
found	I-DISEASE
no	0
sex	0
difference	I-DISEASE
.	0

Over	I-DISEASE
50	0
cases	0
of	I-DISEASE
RMD	0
have	0
been	I-DISEASE
reported	0
in	0
adolescents	0
and	0
adults	I-DISEASE
,	0
with	0
a	0
male	I-DISEASE
pre-	0
ponderance	I-DISEASE
found	0
in	I-DISEASE
adults	I-DISEASE
.	0

Predisposing	I-DISEASE
and	0
Precipitating	I-DISEASE
Factors	0
The	I-DISEASE
soothing	I-DISEASE
effect	0
of	I-DISEASE
vestibular	I-DISEASE
stimulation	0
has	0
been	I-DISEASE
proposed	I-DISEASE
as	0
the	0
initiating	I-DISEASE
factor	I-DISEASE
in	I-DISEASE
infants	I-DISEASE
and	0
toddlers	B-DISEASE
.	0

Environmental	I-DISEASE
stress	I-DISEASE
and	0
lack	I-DISEASE
of	0
environmental	I-DISEASE
stimulation	I-DISEASE
have	I-DISEASE
also	0
been	I-DISEASE
proposed	I-DISEASE
as	0
factors	I-DISEASE
.	0

One	I-DISEASE
study	0
found	0
higher	0
anxiety	0
scores	0
in	0
children	I-DISEASE
with	0
body	I-DISEASE
rocking	0
than	I-DISEASE
in	I-DISEASE
controls	0
.	0

Self	I-DISEASE
-	I-DISEASE
stimulation	0
has	0
been	0
suggested	0
as	0
a	I-DISEASE
factor	I-DISEASE
,	0
particularly	0
in	I-DISEASE
intellectually	I-DISEASE
disabled	I-DISEASE
,	I-DISEASE
autistic	0
,	0
and	0
emotionally	I-DISEASE
disturbed	0
children	B-DISEASE
.	0

Rhythmic	0
movements	0
have	I-DISEASE
been	0
postulated	I-DISEASE
to	I-DISEASE
be	0
a	0
calming	0
technique	0
employed	I-DISEASE
by	I-DISEASE
children	0
to	I-DISEASE
combat	I-DISEASE
insomnia	I-DISEASE
.	0

Rhythmic	0
movements	0
have	I-DISEASE
been	0
reported	I-DISEASE
in	I-DISEASE
association	I-DISEASE
with	I-DISEASE
RLS	0
,	I-DISEASE
OSA	I-DISEASE
,	I-DISEASE
narcolepsy	0
,	0
RBD	I-DISEASE
,	I-DISEASE
and	0
ADHD	I-DISEASE
.	0

Rhythmic	0
movements	0
may	I-DISEASE
be	0
used	0
as	I-DISEASE
a	I-DISEASE
conscious	0
strategy	0
to	I-DISEASE
relieve	I-DISEASE
the	I-DISEASE
urge	0
to	0
move	I-DISEASE
or	I-DISEASE
the	I-DISEASE
uncomfortable	0
sensations	0
associated	0
with	I-DISEASE
RLS	I-DISEASE
.	0
OSA-	I-DISEASE

associated	0
RMD	I-DISEASE
often	I-DISEASE
improves	0
with	I-DISEASE
positive	0
airway	0
pressure	0
.	0

Individuals	I-DISEASE
with	0
narco-	0
lepsy	0
may	0
initiate	0
rhythmic	B-DISEASE
movements	0
to	I-DISEASE
terminate	I-DISEASE
episodes	0
of	I-DISEASE
sleep	0
paralysis	I-DISEASE
.	0

In	I-DISEASE
older	0
children	0
or	I-DISEASE
adults	B-DISEASE
,	I-DISEASE
stereotypic	I-DISEASE
movements	0
may	I-DISEASE
be	I-DISEASE
associated	I-DISEASE
with	I-DISEASE
intellectual	0
disability	0
or	I-DISEASE
autism	I-DISEASE
spectrum	0
disorder	0
.	0

However	I-DISEASE
,	I-DISEASE
in	I-DISEASE
most	0
of	0
these	I-DISEASE
cases	0
,	I-DISEASE
the	0
movements	0
are	I-DISEASE
not	0
predominantly	I-DISEASE
sleep	I-DISEASE
related	0
,	I-DISEASE
and	0
an	I-DISEASE
additional	0
diagnosis	0
of	I-DISEASE
RMD	I-DISEASE
is	0
not	0
indicated	I-DISEASE
.	0

Familial	I-DISEASE
Patterns	I-DISEASE

A	I-DISEASE
familial	I-DISEASE
pattern	0
has	0
been	I-DISEASE
reported	I-DISEASE
rarely	I-DISEASE
,	0
as	0
has	I-DISEASE
occurrence	I-DISEASE
in	I-DISEASE
identical	0
twins	I-DISEASE
.	0

Onset	I-DISEASE
,	0
Course	0
,	0
and	0
Complications	0
The	I-DISEASE
onset	I-DISEASE
of	I-DISEASE
sleep	0
related	0
rhythmic	0
movements	0
is	I-DISEASE
typically	0
in	0
early	0
childhood	0
.	0

Body	I-DISEASE
rocking	I-DISEASE
has	0
a	I-DISEASE
mean	0
age	I-DISEASE
of	I-DISEASE
onset	I-DISEASE
of	I-DISEASE
six	0
months	0
,	I-DISEASE
head	I-DISEASE
banging	0
of	I-DISEASE
nine	0
months	I-DISEASE
,	I-DISEASE
and	0
head	I-DISEASE
rolling	I-DISEASE
of	I-DISEASE
ten	0
months	0
.	0

The	I-DISEASE
condition	0
may	0
rarely	I-DISEASE
present	0
at	I-DISEASE
an	0
older	0
age	I-DISEASE
following	0
central	0
nervous	0
system	I-DISEASE
trauma	0
.	0

Sleep	I-DISEASE
related	0
rhythmic	0
movements	I-DISEASE
commonly	0
resolve	I-DISEASE
in	I-DISEASE
the	0
second	I-DISEASE
or	0
third	0
year	0
of	I-DISEASE
life	0
.	0

Persistence	I-DISEASE
at	I-DISEASE
five	0
years	0
of	I-DISEASE
age	I-DISEASE
occurs	0
in	0
about	0
5	0
%	0
of	I-DISEASE
children	B-DISEASE
.	0

Sleep	I-DISEASE
related	I-DISEASE
movements	0
rarely	I-DISEASE
continue	0
into	I-DISEASE
adolescence	0
and	0
adulthood	0
.	0

Worsening	I-DISEASE
or	I-DISEASE
spontaneous	0
onset	I-DISEASE
in	I-DISEASE
adults	I-DISEASE
is	0
very	I-DISEASE
rare	I-DISEASE
.	0

In	I-DISEASE
some	I-DISEASE
adult	0
cases	0
the	0
chief	I-DISEASE
concern	I-DISEASE
is	I-DISEASE
disturbance	0
of	I-DISEASE
the	0
bed	I-DISEASE
partner	I-DISEASE
’s	I-DISEASE
sleep	0
.	0

Most	I-DISEASE
adolescents	0
and	0
adults	B-DISEASE
have	I-DISEASE
one	I-DISEASE
form	I-DISEASE
of	I-DISEASE
RMD	0
,	I-DISEASE
although	I-DISEASE
some	I-DISEASE
have	0
two	I-DISEASE
or	I-DISEASE
more	I-DISEASE
.	0

Head	I-DISEASE
banging	0
is	0
the	0
most	0
disturbing	0
form	0
of	I-DISEASE
the	0
problem	0
.	0

Typical	I-DISEASE
cases	0
in	0
infants	0
and	0
toddlers	I-DISEASE
pose	0
little	0
risk	0
of	I-DISEASE
serious	I-DISEASE
injury	I-DISEASE
.	0

Vigorous	I-DISEASE
rhythmic	I-DISEASE
movements	0
can	0
produce	0
loud	I-DISEASE
noises	I-DISEASE
when	0
the	0
patient	I-DISEASE
hits	I-DISEASE
the	0
bed	I-DISEASE
frame	0
or	I-DISEASE
when	I-DISEASE
the	0
bed	0
bangs	0
against	I-DISEASE
the	0
wall	I-DISEASE
or	I-DISEASE
floor	0
.	0

The	I-DISEASE
noises	I-DISEASE
can	0
be	I-DISEASE
very	0
disturbing	I-DISEASE
to	I-DISEASE
other	I-DISEASE
family	0
members	0
.	0

Parental	I-DISEASE
concern	I-DISEASE
is	0
common	I-DISEASE
,	0
and	0
psychosocial	0
consequences	I-DISEASE
in	I-DISEASE
the	0
older	0
individual	I-DISEASE
can	I-DISEASE
be	0
distressing	0
.	0

It	I-DISEASE
is	I-DISEASE
important	0
to	I-DISEASE
discuss	0
appropriate	I-DISEASE
safety	I-DISEASE
precautions	I-DISEASE
with	I-DISEASE
the	I-DISEASE
patient	I-DISEASE
’s	B-DISEASE
caretak-	I-DISEASE
ers	0
.	0

Under	I-DISEASE
extraordinary	I-DISEASE
circumstances	0
,	I-DISEASE
particularly	0
in	I-DISEASE
the	I-DISEASE
developmentally	I-DISEASE
disabled	0
,	I-DISEASE
injury	I-DISEASE
to	I-DISEASE
soft	I-DISEASE
tissues	I-DISEASE
or	I-DISEASE
bone	I-DISEASE
has	I-DISEASE
been	I-DISEASE
reported	0
.	0

Developmental	I-DISEASE
Issues	0
Because	I-DISEASE
age	I-DISEASE
-	I-DISEASE
related	0
factors	I-DISEASE
are	0
a	0
critical	0
dimension	I-DISEASE
for	I-DISEASE
RMD	I-DISEASE
,	I-DISEASE
developmental	I-DISEASE
issues	I-DISEASE
are	0
discussed	0
under	0
Essential	0
Features	I-DISEASE
and	0
other	0
sections	0
.	0

Pathology	I-DISEASE
and	0
Pathophysiology	I-DISEASE
In	0
infants	0
and	0
young	I-DISEASE
children	I-DISEASE
,	I-DISEASE
rhythmic	0
movements	0
have	0
been	I-DISEASE
hypothesized	0
to	0
promote	I-DISEASE
motor	I-DISEASE
development	B-DISEASE
by	I-DISEASE
stimulation	0
of	I-DISEASE
the	0
vestibular	I-DISEASE
system	0
.	0

More	I-DISEASE
recently	0
,	0
the	0
role	0
of	I-DISEASE
inhibitory	0
control	0
on	0
the	0
central	0
motor	I-DISEASE
pattern	0
generator	0
has	0
been	I-DISEASE
sug-	I-DISEASE
gested	0
as	0
a	0
physiologic	0
mechanism	0
to	I-DISEASE
explain	B-DISEASE
both	0
pediatric	0
and	0
adult	0
forms	0
of	I-DISEASE
sleep	0
related	0
rhythmic	I-DISEASE
movements	0
.	0

Objective	I-DISEASE
Findings	I-DISEASE
Polysomnographic	0
scoring	0
rules	I-DISEASE
for	I-DISEASE
RMD	I-DISEASE
are	I-DISEASE
defined	I-DISEASE
in	I-DISEASE
the	0
AASM	0
Manual	I-DISEASE
for	I-DISEASE
the	0
Scoring	0
of	0
Sleep	I-DISEASE
and	0
Associated	I-DISEASE
Events	I-DISEASE
.	0

Video	0
-	I-DISEASE
polysomnographic	0
studies	I-DISEASE
have	0
shown	0
rhythmic	I-DISEASE
movements	I-DISEASE
to	I-DISEASE
occur	0
most	0
often	0
in	I-DISEASE
association	0
with	0
stages	0
N1	0
and	0
N2	0
sleep	0
;	I-DISEASE
46	I-DISEASE
%	0
occur	I-DISEASE
while	B-DISEASE
falling	0
asleep	I-DISEASE
or	I-DISEASE
during	I-DISEASE
NREM	0
sleep	0
;	0
30	0
%	0
during	I-DISEASE
both	I-DISEASE
NREM	0
and	0
REM	0
sleep	0
;	0
and	0
24	0
%	0
only	I-DISEASE
during	I-DISEASE
REM	0
sleep	0
.	0

The	I-DISEASE
exclusively	I-DISEASE
REM	0
-	0
related	B-DISEASE
rhythmic	I-DISEASE
movements	I-DISEASE
occur	0
more	0
frequently	I-DISEASE
in	I-DISEASE
adults	I-DISEASE
.	0

Although	I-DISEASE
an	0
epileptic	0
etiology	0
has	I-DISEASE
been	I-DISEASE
reported	0
in	I-DISEASE
one	0
individual	I-DISEASE
,	I-DISEASE
most	0
EEG	0
studies	I-DISEASE
have	0
shown	0
normal	0
activity	0
between	0
epi-	0
sodes	0
of	I-DISEASE
rhythmic	I-DISEASE
behavior	I-DISEASE
.	0

Differential	I-DISEASE
Diagnosis	0
RMD	I-DISEASE
must	I-DISEASE
be	0
distinguished	0
from	I-DISEASE
other	0
repetitive	I-DISEASE
movements	0
involving	0
restricted	0
small	0
muscle	I-DISEASE
groups	0
,	0
such	0
as	0
sleep	0
related	0
bruxism	0
,	I-DISEASE
thumb	I-DISEASE
sucking	I-DISEASE
,	I-DISEASE
and	0
rhythmic	0
sucking	0
of	I-DISEASE
a	0
pacifier	0
or	0
the	0
lips	0
,	0
as	0
well	I-DISEASE
as	0
other	I-DISEASE
specifically	I-DISEASE
defined	I-DISEASE
rhythmic	0
movements	0
of	I-DISEASE
sleep	0
,	0
such	0
as	0
hypnagogic	I-DISEASE
foot	0
tremor	I-DISEASE
.	0

Sleep	I-DISEASE
Related	I-DISEASE
Movement	I-DISEASE
Disorders	0
Sleep	I-DISEASE
Related	0
Movement	I-DISEASE
Disorders	I-DISEASE
In	0
adults	I-DISEASE
,	I-DISEASE
RMD	I-DISEASE
can	0
be	I-DISEASE
misdiagnosed	0
as	0
RBD	I-DISEASE
or	I-DISEASE
be	0
comorbid	I-DISEASE
with	I-DISEASE
RBD	I-DISEASE
.	0

Video	0
poly-	0
somnography	0
is	0
particularly	0
helpful	0
in	I-DISEASE
these	I-DISEASE
cases	0
.	0

Rhythmic	0
movements	0
may	I-DISEASE
occur	0
as	0
a	0
conscious	0
or	B-DISEASE
unconscious	I-DISEASE
strategy	I-DISEASE
to	I-DISEASE
relieve	I-DISEASE
RLS	I-DISEASE
symptoms	I-DISEASE
.	0

If	I-DISEASE
the	0
rhythmic	0
move-	I-DISEASE
ments	I-DISEASE
are	I-DISEASE
clearly	0
in	0
response	0
to	I-DISEASE
RLS	I-DISEASE
sensations	0
,	I-DISEASE
then	0
a	I-DISEASE
separate	0
diagnosis	0
of	I-DISEASE
RMD	0
is	0
not	0
needed	I-DISEASE
.	0

However	I-DISEASE
,	I-DISEASE
RMD	0
may	0
be	I-DISEASE
diagnosed	I-DISEASE
if	I-DISEASE
RMD	I-DISEASE
criteria	I-DISEASE
are	I-DISEASE
met	I-DISEASE
and	0
RLS	0
does	I-DISEASE
not	I-DISEASE
adequately	0
explain	0
the	0
presence	0
or	0
extent	0
of	I-DISEASE
rhythmic	I-DISEASE
movements	0
.	I-DISEASE

Children	I-DISEASE
with	I-DISEASE
autism	0
spectrum	I-DISEASE
disorder	0
often	0
exhibit	0
repetitive	I-DISEASE
behaviors	I-DISEASE
,	0
but	0
these	I-DISEASE
movements	I-DISEASE
typically	I-DISEASE
occur	0
during	I-DISEASE
wakefulness	0
and	0
are	0
not	0
predominantly	I-DISEASE
sleep	0
related	0
.	0

Stereotypic	I-DISEASE
movement	I-DISEASE
disorder	0
is	0
a	0
Diagnostic	I-DISEASE
and	0
Statistical	I-DISEASE
Manual	I-DISEASE
of	I-DISEASE
Mental	0
Disorders	I-DISEASE
(	0
DSM	I-DISEASE
)	0
diagnosis	0
that	0
is	I-DISEASE
typically	0
seen	I-DISEASE
with	0
intellectual	I-DISEASE
disability	0
and	0
is	0
not	0
predominantly	I-DISEASE
sleep	0
related	0
.	0

In	I-DISEASE
children	I-DISEASE
with	0
autism	0
spectrum	0
disorder	I-DISEASE
or	I-DISEASE
intellectual	I-DISEASE
disability	0
,	0
an	0
additional	0
diagnosis	I-DISEASE
of	I-DISEASE
RMD	0
should	I-DISEASE
be	I-DISEASE
made	0
only	0
if	I-DISEASE
the	0
movements	0
are	0
predominantly	I-DISEASE
sleep	I-DISEASE
related	0
.	0

Akathisia	I-DISEASE
is	0
seen	I-DISEASE
as	0
a	I-DISEASE
complication	0
of	I-DISEASE
neuroleptic	0
medi-	0
cation	0
and	0
is	0
not	0
predominantly	B-DISEASE
sleep	0
related	I-DISEASE
.	0

Autoerotic	I-DISEASE
or	I-DISEASE
masturbatory	0
behaviors	I-DISEASE
may	0
involve	0
body	I-DISEASE
rocking	I-DISEASE
or	I-DISEASE
other	0
repetitive	I-DISEASE
body	I-DISEASE
movements	0
,	0
but	0
the	0
primary	0
focus	I-DISEASE
is	0
genital	0
stimulation	0
as	0
is	I-DISEASE
evident	I-DISEASE
by	B-DISEASE
direct	0
genital	0
contact	I-DISEASE
.	0

Rarely	I-DISEASE
,	0
RMD	I-DISEASE
needs	I-DISEASE
to	I-DISEASE
be	I-DISEASE
differentiated	0
from	0
epilepsy	0
,	I-DISEASE
tic	0
disorders	0
,	I-DISEASE
or	0
involuntary	0
movements	0
associated	0
with	I-DISEASE
other	0
neurological	0
conditions	I-DISEASE
.	0

Unresolved	I-DISEASE
Issues	0
and	0
Further	I-DISEASE
Directions	0

There	I-DISEASE
is	I-DISEASE
controversy	0
about	0
the	0
classification	I-DISEASE
of	I-DISEASE
hypnagogic	I-DISEASE
foot	0
tremor	0
as	I-DISEASE
a	0
separate	0
entity	I-DISEASE
or	0
as	0
a	0
subtype	I-DISEASE
of	0
sleep	0
related	0
rhythmic	I-DISEASE
movements	0
.	0

Many	0
aspects	0
of	I-DISEASE
sleep	0
related	0
rhythmic	I-DISEASE
movements	0
deserve	I-DISEASE
further	I-DISEASE
study	0
,	0
including	0
the	I-DISEASE
relationship	I-DISEASE
of	I-DISEASE
the	0
typical	0
form	I-DISEASE
seen	0
in	0
otherwise	0
normal	0
infants	0
and	0
young	I-DISEASE
children	I-DISEASE
to	0
the	I-DISEASE
rhythmic	0
movements	0
seen	I-DISEASE
in	I-DISEASE
children	0
with	I-DISEASE
intellectual	I-DISEASE
disability	0
and	0
autism	0
spectrum	0
disorder	0
.	0

The	I-DISEASE
pathophysiology	I-DISEASE
of	I-DISEASE
persistent	0
RMD	I-DISEASE
is	0
poorly	I-DISEASE
understood	I-DISEASE
,	I-DISEASE
as	0
is	I-DISEASE
the	0
association	I-DISEASE
with	0
other	0
sleep	0
disorders	0
in	I-DISEASE
adults	B-DISEASE
.	0

Bibliography	0
Dyken	0
M	I-DISEASE
,	0
Lin	B-DISEASE
-	0
Dyken	0
D	I-DISEASE
,	I-DISEASE
Yamada	I-DISEASE
T.	0
Diagnosing	I-DISEASE
rhythmic	0
movement	0
disorder	I-DISEASE
with	I-DISEASE
video	I-DISEASE
-	0
polysomnography	0
.	0

Pediatr	I-DISEASE
Neurol	0
1997;16:37–41	0
.	0

Kohyama	I-DISEASE
J	0
,	0
Matsukura	I-DISEASE
F	I-DISEASE
,	0
Kimura	0
K	I-DISEASE
,	I-DISEASE
Tachibana	I-DISEASE
N.	0
Rhythmic	0
movement	0
disorder	0
:	0
polysomnographic	0
study	0
and	0
summary	0
of	I-DISEASE
reported	I-DISEASE
cases	0
.	0

Brain	0
Dev	I-DISEASE
2002;24:33–8	0
.	0

Laberge	I-DISEASE
L	0
,	0
Tremblay	0
R	0
,	0
Vitaro	0
F	I-DISEASE
,	0
Montplaisir	0
J.	0
Development	0
of	I-DISEASE
parasomnias	I-DISEASE
from	0
childhood	0
to	I-DISEASE
early	B-DISEASE
adolescence	0
.	0

Pediatrics	I-DISEASE
2000;106:67–74	I-DISEASE
.	0

Manni	I-DISEASE
R	0
,	I-DISEASE
Terzaghi	0
M.	I-DISEASE
Rhythmic	0
movements	I-DISEASE
during	I-DISEASE
sleep	0
:	0
a	0
physiological	I-DISEASE
and	0
pathological	0
profile	0
.	0

Neurol	0
Sci	0
2005;26	I-DISEASE
:	0
s181–5	0
.	0

Mayer	I-DISEASE
G	I-DISEASE
,	0
Wilde	0
-	0
Frenz	I-DISEASE
J	0
,	I-DISEASE
Kurella	0
B.	0
Sleep	0
related	I-DISEASE
rhythmic	I-DISEASE
movement	I-DISEASE
disorder	0
revisited	0
.	0

J	I-DISEASE
Sleep	0
Res	0
2007;16:110–6	0
.	0

Benign	I-DISEASE
Sleep	0
Myoclonus	0
of	I-DISEASE
Infancy	0
ICD-9	0
-	I-DISEASE
CM	I-DISEASE
code	0
:	0
327.59	0
Alternate	0
Names	I-DISEASE
Benign	0
neonatal	I-DISEASE
sleep	0
myoclonus	0
.	0

Diagnostic	I-DISEASE
Criteria	0
Criteria	0

A	I-DISEASE
-	I-DISEASE
E	0
must	I-DISEASE
be	0
met	0
ICD-10	0
-	0
CM	0
code	0
:	0
G47.69	I-DISEASE
Sleep	0
Related	0
Movement	0
Disorders	0
A.	0
Observation	0
of	I-DISEASE
repetitive	I-DISEASE
myoclonic	0
jerks	0
that	0
involve	0
the	0
limbs	0
,	I-DISEASE
trunk	0
,	I-DISEASE
or	0
whole	I-DISEASE
body	I-DISEASE
.	0

B.	0
The	I-DISEASE
movements	I-DISEASE
occur	0
in	I-DISEASE
early	0
infancy	I-DISEASE
,	0
typically	0
from	I-DISEASE
birth	I-DISEASE
to	I-DISEASE
six	I-DISEASE
months	0
of	I-DISEASE
age	I-DISEASE
.	I-DISEASE

C.	I-DISEASE

The	I-DISEASE
movements	0
occur	0
only	I-DISEASE
during	I-DISEASE
sleep	0
.	0

D.	I-DISEASE

The	I-DISEASE
movements	0
stop	0
abruptly	I-DISEASE
and	0
consistently	I-DISEASE
when	0
the	0
infant	0
is	0
aroused	0
.	0

E.	I-DISEASE

The	I-DISEASE
disorder	I-DISEASE
is	0
not	0
better	0
explained	I-DISEASE
by	I-DISEASE
another	I-DISEASE
sleep	0
disorder	0
,	0
medical	I-DISEASE
or	I-DISEASE
neurological	0
disorder	I-DISEASE
,	I-DISEASE
or	0
medication	0
use	I-DISEASE
.	0

Essential	I-DISEASE
Features	I-DISEASE
Benign	0
sleep	0
myoclonus	0
of	I-DISEASE
infancy	0
(	I-DISEASE
BSMI	I-DISEASE
)	0
is	I-DISEASE
characterized	0
by	I-DISEASE
repetitive	I-DISEASE
myoclonic	0
jerks	0
that	0
occur	0
during	I-DISEASE
sleep	0
in	I-DISEASE
neonates	I-DISEASE
and	0
infants	0
.	0

Although	I-DISEASE
BSMI	0
is	0
benign	0
and	0
relatively	0
rare	0
,	0
it	0
is	I-DISEASE
included	I-DISEASE
in	I-DISEASE
the	0
sleep	0
related	B-DISEASE
movement	I-DISEASE
disorders	0
section	0
because	0
it	0
is	I-DISEASE
commonly	I-DISEASE
confused	I-DISEASE
with	I-DISEASE
epilepsy	0
.	0

However	I-DISEASE
,	I-DISEASE
unlike	0
the	0
jerks	0
of	I-DISEASE
myoclonic	I-DISEASE
seizures	I-DISEASE
and	0
myoclonic	0
encephalopathy	0
,	0
the	0
jerks	0
of	I-DISEASE
BSMI	0
occur	I-DISEASE
exclusively	B-DISEASE
during	I-DISEASE
sleep	0
.	0

The	I-DISEASE
jerks	0
are	I-DISEASE
often	0
bilateral	0
and	0
massive	0
,	0
typically	0
involving	0
large	I-DISEASE
muscle	I-DISEASE
groups	0
.	0

The	I-DISEASE
movements	0
can	0
occur	I-DISEASE
in	0
the	0
whole	0
body	I-DISEASE
or	B-DISEASE
exclusively	B-DISEASE
in	0
the	0
limbs	I-DISEASE
,	I-DISEASE
the	0
trunk	0
,	I-DISEASE
or	I-DISEASE
rarely	0
,	0
the	0
face	0
.	0

Associated	I-DISEASE
Features	I-DISEASE
Not	0
applicable	0
or	0
known	I-DISEASE
.	0

Clinical	I-DISEASE
and	0
Pathophysiological	I-DISEASE
Subtypes	I-DISEASE
Most	I-DISEASE
infants	0
with	I-DISEASE
BSMI	I-DISEASE
are	0
neurologically	I-DISEASE
normal	0
,	0
born	0
to	0
mothers	I-DISEASE
with	I-DISEASE
no	0
history	I-DISEASE
of	I-DISEASE
illicit	I-DISEASE
drug	0
use	0
.	0

However	I-DISEASE
,	I-DISEASE
BSMI	0
has	0
been	I-DISEASE
described	I-DISEASE
in	I-DISEASE
more	0
than	0
half	0
of	I-DISEASE
infants	I-DISEASE
with	I-DISEASE
neonatal	0
opioid	I-DISEASE
withdrawal	0
syndrome	0
,	I-DISEASE
suggesting	0
a	0
subtype	I-DISEASE
with	I-DISEASE
this	0
specific	I-DISEASE
etiology	0
.	0

It	I-DISEASE
must	I-DISEASE
be	0
stressed	I-DISEASE
,	0
however	I-DISEASE
,	I-DISEASE
that	I-DISEASE
some	I-DISEASE
cases	0
of	I-DISEASE
neonatal	I-DISEASE
abstinence	0
syndrome	0
do	0
not	0
follow	I-DISEASE
a	0
benign	0
clinical	I-DISEASE
course	0
.	I-DISEASE

Whether	I-DISEASE
such	I-DISEASE
cases	0
should	0
be	0
included	I-DISEASE
with	I-DISEASE
those	I-DISEASE
of	B-DISEASE
BSMI	0
is	I-DISEASE
an	I-DISEASE
unresolved	I-DISEASE
matter	I-DISEASE
.	0

Sleep	I-DISEASE
Related	0
Movement	I-DISEASE
Disorders	0
Demographics	I-DISEASE

The	I-DISEASE
prevalence	I-DISEASE
is	0
unknown	I-DISEASE
.	0

The	I-DISEASE
incidence	0
has	0
been	I-DISEASE
estimated	0
at	I-DISEASE
3.7	I-DISEASE
per	0
10,000	0
live	I-DISEASE
births	I-DISEASE
.	0

More	I-DISEASE
than	I-DISEASE
200	0
cases	0
have	0
been	I-DISEASE
described	0
in	I-DISEASE
the	0
literature	0
.	0

Males	I-DISEASE
are	0
affected	0
more	0
than	0
females	0
by	I-DISEASE
a	I-DISEASE
ratio	I-DISEASE
of	I-DISEASE
about	0
2:1	0
.	0

The	I-DISEASE
typical	0
age	I-DISEASE
range	I-DISEASE
is	0
birth	I-DISEASE
to	I-DISEASE
six	I-DISEASE
months	0
of	I-DISEASE
age	I-DISEASE
.	0

Predisposing	I-DISEASE
and	0
Precipitating	I-DISEASE
Factors	0
Predisposing	I-DISEASE
factors	I-DISEASE
have	0
not	I-DISEASE
been	0
delineated	0
.	0

Rocking	0
or	0
repetitive	I-DISEASE
noises	0
may	I-DISEASE
pre-	0
cipitate	0
individual	I-DISEASE
episodes	I-DISEASE
of	I-DISEASE
BSMI	0
.	0

Familial	I-DISEASE
Patterns	I-DISEASE
Familial	I-DISEASE
occurrence	0
has	0
been	I-DISEASE
described	I-DISEASE
.	0

Onset	I-DISEASE
,	0
Course	0
,	0
and	0
Complications	0
Onset	0
is	I-DISEASE
usually	I-DISEASE
noted	0
between	0
birth	I-DISEASE
and	0
one	0
month	0
of	I-DISEASE
age	I-DISEASE
in	I-DISEASE
a	0
neurologically	0
normal	0
infant	0
.	0

The	I-DISEASE
course	I-DISEASE
is	0
self	0
-	0
limited	I-DISEASE
and	0
benign	0
.	0

The	I-DISEASE
disorder	0
may	0
be	0
present	0
for	0
only	0
a	I-DISEASE
few	0
days	0
or	0
may	0
last	0
for	I-DISEASE
several	0
months	0
.	0

Maximum	I-DISEASE
expression	0
is	0
typically	0
between	0
15	I-DISEASE
and	0
35	0
days	0
of	I-DISEASE
age	I-DISEASE
.	0

BSMI	I-DISEASE
resolves	0
by	0
three	I-DISEASE
months	0
of	I-DISEASE
age	I-DISEASE
in	0
64	0
%	0
of	I-DISEASE
affected	I-DISEASE
infants	0
,	I-DISEASE
by	I-DISEASE
six	I-DISEASE
months	0
in	0
95	0
%	0
,	I-DISEASE
and	0
by	I-DISEASE
12	I-DISEASE
months	0
in	I-DISEASE
97	0
%	0
with	I-DISEASE
persistence	I-DISEASE
rarely	I-DISEASE
into	I-DISEASE
the	0
second	I-DISEASE
year	0
of	I-DISEASE
life	0
or	0
later	0
.	0

There	I-DISEASE
are	0
no	0
known	I-DISEASE
complications	0
.	0

Long	I-DISEASE
-	I-DISEASE
term	0
follow	I-DISEASE
-	0
up	I-DISEASE
in	I-DISEASE
a	I-DISEASE
limited	I-DISEASE
number	0
of	I-DISEASE
children	I-DISEASE
has	I-DISEASE
shown	I-DISEASE
normal	0
psychomotor	0
development	0
and	0
normal	0
cognitive	0
function	0
at	I-DISEASE
five	I-DISEASE
to	0
10	I-DISEASE
years	I-DISEASE
of	I-DISEASE
age	I-DISEASE
.	0

There	I-DISEASE
is	I-DISEASE
no	0
evidence	0
for	0
an	I-DISEASE
increased	0
risk	0
of	0
seizures	0
.	0

Developmental	I-DISEASE
Issues	0
Because	I-DISEASE
age	I-DISEASE
-	I-DISEASE
related	0
factors	I-DISEASE
are	0
a	0
critical	0
dimension	I-DISEASE
for	I-DISEASE
BSMI	I-DISEASE
,	I-DISEASE
developmental	I-DISEASE
issues	I-DISEASE
are	0
discussed	0
throughout	0
this	0
section	I-DISEASE
.	0

Pathology	I-DISEASE
and	0
Pathophysiology	I-DISEASE
The	I-DISEASE
presence	0
of	I-DISEASE
a	0
generator	I-DISEASE
in	I-DISEASE
the	0
cervical	I-DISEASE
spinal	0
cord	0
that	0
is	I-DISEASE
not	0
adequately	0
inhibited	I-DISEASE
due	0
to	I-DISEASE
immature	0
myelination	0
of	I-DISEASE
descending	0
pathways	I-DISEASE
has	0
been	0
hypothesized	I-DISEASE
.	I-DISEASE

Objective	I-DISEASE
Findings	I-DISEASE
Video	0
-	I-DISEASE
polysomnographic	0
EEG	I-DISEASE
and	0
EMG	0
monitoring	0
has	0
demonstrated	0
paroxysmal	0
muscle	I-DISEASE
activity	0
,	I-DISEASE
without	0
ictal	I-DISEASE
or	0
interictal	0
EEG	0
abnormalities	I-DISEASE
.	0

BSMI	I-DISEASE
occurs	0
predom-	I-DISEASE
inantly	I-DISEASE
during	I-DISEASE
quiet	0
sleep	0
but	I-DISEASE
also	I-DISEASE
may	I-DISEASE
be	0
present	I-DISEASE
during	I-DISEASE
active	I-DISEASE
sleep	0
.	0

The	I-DISEASE
muscle	0
jerks	0
are	0
usually	I-DISEASE
seen	I-DISEASE
in	I-DISEASE
clusters	0
of	I-DISEASE
four	B-DISEASE
or	I-DISEASE
five	I-DISEASE
jerks	0
per	I-DISEASE
second	I-DISEASE
,	I-DISEASE
each	0
jerk	0
lasting	0
40	0
to	0
300	I-DISEASE
milliseconds	I-DISEASE
.	0

BSMI	I-DISEASE
clusters	0
typically	0
repeat	0
in	I-DISEASE
irregular	0
series	I-DISEASE
for	0
one	0
to	0
15	I-DISEASE
minutes	0
,	I-DISEASE
but	0
,	I-DISEASE
in	I-DISEASE
some	I-DISEASE
cases	0
,	0
the	0
clusters	I-DISEASE
may	0
recur	B-DISEASE
for	0
up	0
to	0
60	0
minutes	0
or	B-DISEASE
longer	0
and	0
be	I-DISEASE
mistaken	I-DISEASE
for	0
status	0
epilepticus	0
.	0

One	I-DISEASE
study	0
showed	0
30	0
%	0
of	I-DISEASE
the	0
jerks	0
to	0
involve	0
the	0
whole	I-DISEASE
body	I-DISEASE
,	0
20	0
%	0
to	I-DISEASE
involve	0
the	0
abdominal	I-DISEASE
or	0
proximal	0
muscles	0
,	I-DISEASE
and	0
50	0
%	0
to	I-DISEASE
involve	0
only	0
the	0
arms	0
or	0
the	0
legs	0
.	0

The	I-DISEASE
arms	I-DISEASE
are	0
usually	I-DISEASE
more	0
involved	I-DISEASE
than	0
the	0
legs	0
.	0

Activity	I-DISEASE
is	0
symmetrical	I-DISEASE
in	0
over	I-DISEASE
90	I-DISEASE
%	0
of	I-DISEASE
cases	0
but	0
can	0
be	I-DISEASE
lateralized	I-DISEASE
.	0

The	I-DISEASE
myoclonus	0
is	0
not	0
associ-	0
ated	0
with	I-DISEASE
arousals	0
,	I-DISEASE
awakenings	0
,	0
or	0
sleep	0
stage	I-DISEASE
transitions	I-DISEASE
.	0

Spontaneous	I-DISEASE
or	I-DISEASE
provoked	0
awakening	0
of	I-DISEASE
the	0
infant	0
leads	0
to	I-DISEASE
prompt	I-DISEASE
,	0
abrupt	I-DISEASE
,	I-DISEASE
and	0
consis-	0
tent	I-DISEASE
cessation	I-DISEASE
of	I-DISEASE
the	0
movements	0
.	0

Gentle	I-DISEASE
rocking	0
of	I-DISEASE
the	0
infant	0
or	I-DISEASE
the	I-DISEASE
infant	0
’s	I-DISEASE
crib	I-DISEASE
has	0
been	I-DISEASE
shown	I-DISEASE
to	I-DISEASE
provoke	0
the	0
myoclonus	0
.	0

This	I-DISEASE
may	0
be	0
a	0
useful	0
maneuver	0
during	I-DISEASE
EEG	I-DISEASE
monitoring	0
when	0
differentiation	0
from	I-DISEASE
seizures	I-DISEASE
is	I-DISEASE
of	I-DISEASE
concern	I-DISEASE
.	0

In	I-DISEASE
contrast	I-DISEASE
to	0
jitteriness	0
and	0
other	I-DISEASE
nonepileptic	0
etiologies	0
,	0
BSMI	0
will	0
often	0
increase	0
rather	0
than	0
be	0
suppressed	0
by	I-DISEASE
gentle	0
restraint	0
.	0

Neuroimaging	I-DISEASE
studies	0
are	I-DISEASE
normal	0
.	0

Differential	I-DISEASE
Diagnosis	0
BSMI	0
should	I-DISEASE
be	0
distinguished	0
from	I-DISEASE
myoclonic	0
seizures	I-DISEASE
;	I-DISEASE
misdiagnosis	0
may	0
lead	0
to	I-DISEASE
unnecessary	0
diagnostic	0
testing	0
or	I-DISEASE
medication	0
use	0
.	0

The	I-DISEASE
absence	I-DISEASE
of	I-DISEASE
episodes	I-DISEASE
while	0
awake	0
in	I-DISEASE
infants	0
with	0
BSMI	0
is	I-DISEASE
the	I-DISEASE
single	I-DISEASE
most	0
helpful	0
clinical	I-DISEASE
feature	I-DISEASE
.	0

In	I-DISEASE
addition	0
,	0
BSMI	0
will	0
stop	0
abruptly	I-DISEASE
and	0
consistently	0
when	0
the	0
infant	I-DISEASE
is	I-DISEASE
aroused	0
.	0

Neonatal	I-DISEASE
sei-	I-DISEASE
zures	0
are	0
often	0
seen	I-DISEASE
in	I-DISEASE
the	I-DISEASE
context	I-DISEASE
of	I-DISEASE
perinatal	I-DISEASE
disorders	0
such	0
as	0
hypoxic	0
-	I-DISEASE
ischemic	0
encephalopathy	I-DISEASE
,	I-DISEASE
infection	I-DISEASE
,	0
or	0
metabolic	0
abnormalities	0
,	0
whereas	0
BSMI	0
is	0
typically	0
present	I-DISEASE
in	I-DISEASE
neurologically	0
normal	0
infants	0
.	0

Infantile	I-DISEASE
spasms	0
(	I-DISEASE
West	I-DISEASE
syndrome	0
)	0
are	0
most	0
often	I-DISEASE
seen	I-DISEASE
after	0
the	0
first	I-DISEASE
month	I-DISEASE
of	0
life	0
but	I-DISEASE
sometimes	0
occur	I-DISEASE
earlier	0
.	0

Infantile	I-DISEASE
spasms	0
are	0
usually	I-DISEASE
manifest	0
by	0
sudden	0
head	I-DISEASE
flexion	I-DISEASE
with	0
arm	I-DISEASE
extension	I-DISEASE
and	0
lower	0
extremity	I-DISEASE
flexion	0
.	0

They	I-DISEASE
are	0
usually	I-DISEASE
associated	0
with	0
a	0
hypsarrhythmic	I-DISEASE
EEG	0
pattern	0
.	0

Pyridoxine-	I-DISEASE
dependency	0
seizures	0
are	0
responsive	0
to	I-DISEASE
treatment	I-DISEASE
with	I-DISEASE
vitamin	0
B6	0
.	0

In	I-DISEASE
cases	0
that	0
are	I-DISEASE
dif-	0
ficult	I-DISEASE
to	0
differentiate	I-DISEASE
,	I-DISEASE
an	I-DISEASE
EEG	0
obtained	0
during	I-DISEASE
sleep	0
will	0
show	I-DISEASE
normal	0
patterns	I-DISEASE
when	0
BSMI	0
is	0
elicited	I-DISEASE
by	I-DISEASE
gentle	0
rocking	0
.	0

Anticonvulsant	I-DISEASE
medications	I-DISEASE
are	0
ineffective	0
and	0
unnecessary	0
in	I-DISEASE
BSMI	0
.	0

BSMI	I-DISEASE
also	0
should	0
be	0
distinguished	I-DISEASE
from	0
other	I-DISEASE
disorders	0
that	0
occur	I-DISEASE
during	I-DISEASE
wakeful-	I-DISEASE
ness	0
,	I-DISEASE
including	0
myoclonic	0
encephalopathies	0
,	I-DISEASE
hyperekplexia	I-DISEASE
(	I-DISEASE
startle	0
disease	I-DISEASE
)	0
,	0
drug	0
withdrawal	0
,	0
and	0
jitteriness	0
.	0

Benign	I-DISEASE
myoclonus	0
of	I-DISEASE
early	I-DISEASE
infancy	0
usually	I-DISEASE
occurs	0
after	0
the	I-DISEASE
third	I-DISEASE
month	0
of	I-DISEASE
life	0
and	0
only	0
occurs	0
during	I-DISEASE
wakefulness	0
.	0

PLMD	I-DISEASE
can	I-DISEASE
occur	0
in	I-DISEASE
infants	0
but	I-DISEASE
typically	0
has	0
a	0
distinctly	0
different	I-DISEASE
duration	0
and	0
fre-	I-DISEASE
quency	0
.	0

The	I-DISEASE
muscle	0
activity	0
is	I-DISEASE
of	0
longer	I-DISEASE
duration	0
(	I-DISEASE
0.5	0
to	I-DISEASE
10	I-DISEASE
seconds	I-DISEASE
)	0
and	0
recurs	I-DISEASE
at	I-DISEASE
a	0
more	0
regular	I-DISEASE
and	0
longer	I-DISEASE
interval	I-DISEASE
(	0
typically	0
20	0
to	I-DISEASE
40	0
seconds	B-DISEASE
)	0
.	0

PLMD	I-DISEASE
can	I-DISEASE
be	0
associated	0
with	I-DISEASE
EEG	I-DISEASE
arousals	0
,	I-DISEASE
whereas	I-DISEASE
BSMI	I-DISEASE
is	I-DISEASE
not	0
.	I-DISEASE

BSMI	I-DISEASE
is	0
more	0
often	0
seen	I-DISEASE
in	I-DISEASE
the	I-DISEASE
arms	0
than	0
the	0
legs	I-DISEASE
,	I-DISEASE
whereas	I-DISEASE
PLMD	0
predominantly	I-DISEASE
occurs	0
in	0
the	0
lower	0
limbs	I-DISEASE
.	0

Sleep	I-DISEASE
Related	0
Movement	I-DISEASE
Disorders	0
Sleep	I-DISEASE
Related	0
Movement	0
Disorders	I-DISEASE
Phasic	0
-	I-DISEASE
REM	0
muscle	I-DISEASE
activity	0
typically	0
involves	0
smaller	I-DISEASE
muscle	I-DISEASE
groups	0
and	0
can	0
be	I-DISEASE
linked	0
to	I-DISEASE
observable	0
eye	0
movements	0
.	0

Sleep	I-DISEASE
starts	0
occur	0
at	I-DISEASE
the	0
wake	0
-	I-DISEASE
sleep	0
transition	0
and	0
typ-	0
ically	0
are	I-DISEASE
not	0
repetitive	I-DISEASE
.	0

Propriospinal	I-DISEASE
myoclonus	0
at	0
sleep	0
onset	0
is	I-DISEASE
a	0
rare	0
disorder	I-DISEASE
that	0
has	I-DISEASE
not	0
been	0
reported	0
in	I-DISEASE
children	0
and	0
is	0
characterized	0
by	0
jerks	0
involving	I-DISEASE
the	0
abdominal	I-DISEASE
and	0
truncal	0
muscles	0
at	0
the	0
transition	0
from	0
wakefulness	0
to	0
sleep	0
.	0

Fragmentary	I-DISEASE
myoclo-	0
nus	I-DISEASE
has	0
been	I-DISEASE
described	0
in	I-DISEASE
adults	I-DISEASE
and	0
is	I-DISEASE
primarily	I-DISEASE
a	I-DISEASE
nonspecific	0
EMG	0
finding	I-DISEASE
with	I-DISEASE
little	0
or	I-DISEASE
no	0
visible	I-DISEASE
movement	I-DISEASE
.	0

Unresolved	I-DISEASE
Issues	0
and	0
Further	I-DISEASE
Directions	0

The	I-DISEASE
prevalence	0
,	0
incidence	0
,	0
and	0
pathophysiology	0
of	I-DISEASE
BSMI	I-DISEASE
warrant	I-DISEASE
further	I-DISEASE
study	I-DISEASE
.	I-DISEASE

Bibliography	0
Alfonso	I-DISEASE
I	0
,	I-DISEASE
Papazian	I-DISEASE
O	0
,	0
Aicardi	I-DISEASE
J	0
,	I-DISEASE
Jeffries	0
HE	0
.	0

A	I-DISEASE
simple	I-DISEASE
maneuver	0
to	I-DISEASE
provoke	0
benign	I-DISEASE
neonatal	0
sleep	0
myoclonus	I-DISEASE
.	0

Pediatrics	I-DISEASE
1995;96:1161–3	I-DISEASE
.	0

Di	I-DISEASE
Capua	0
M	I-DISEASE
,	0
Fusco	0
L	0
,	0
Ricci	0
S	I-DISEASE
,	I-DISEASE
Vigevano	B-DISEASE
F.	0
Benign	0
neonatal	I-DISEASE
sleep	I-DISEASE
myoclonus	0
:	0
clinical	0
features	0
and	0
video-	I-DISEASE
polygraphic	0
recordings	0
.	0

Mov	I-DISEASE
Disord	0
1993;8:191–4	B-DISEASE
.	I-DISEASE

Held	I-DISEASE
-	I-DISEASE
Egli	0
K	0
,	I-DISEASE
Rüegger	I-DISEASE
C	I-DISEASE
,	0
Das	I-DISEASE
-	0
Kundu	0
S	0
,	I-DISEASE
Schmitt	I-DISEASE
B	0
,	I-DISEASE
Bucher	0
HU	I-DISEASE
.	0

Benign	I-DISEASE
neonatal	0
sleep	0
myoclonus	0
in	I-DISEASE
newborn	I-DISEASE
infants	I-DISEASE
of	I-DISEASE
opioid	0
dependent	I-DISEASE
mothers	0
.	0

Acta	I-DISEASE
Paediatrica	0
2009;98:69–73	I-DISEASE
.	I-DISEASE

Hrastovec	I-DISEASE
A	0
,	I-DISEASE
Hostnik	0
T	0
,	0
Neubauer	0
D.	0
Benign	0
convulsions	0
in	I-DISEASE
newborns	I-DISEASE
and	0
infants	0
:	I-DISEASE
Occurrence	0
,	0
clinical	I-DISEASE
course	I-DISEASE
and	0
prognosis	0
.	0

Eur	I-DISEASE
J	0
Paediatr	0
Neurol	0
2012;16:64–73	0
.	0

Maurer	I-DISEASE
VO	I-DISEASE
,	0
Rizzi	I-DISEASE
M	I-DISEASE
,	0
Bianchetti	0
MG	I-DISEASE
,	I-DISEASE
Ramelli	0
GP	0
.	0

Benign	I-DISEASE
neonatal	0
sleep	0
myoclonus	0
:	0
a	0
review	I-DISEASE
of	I-DISEASE
the	0
literature	0
.	0

Pediatrics	I-DISEASE
2010;125	I-DISEASE
:	0
e919–24	0
.	0

Propriospinal	I-DISEASE
Myoclonus	0
at	0
Sleep	0
Onset	I-DISEASE
ICD-9	0
-	I-DISEASE
CM	0
code	0
:	0
327.59	0
ICD-10	0
-	0
CM	0
code	0
:	0
G47.69	I-DISEASE
Alternate	0
Names	I-DISEASE

Spinal	I-DISEASE
myoclonus	0
,	I-DISEASE
plurisegmental	0
myoclonus	I-DISEASE
,	I-DISEASE
intersegmental	I-DISEASE
myoclonus	0
,	I-DISEASE
axial	0
myoclonus	0
.	0

Diagnostic	I-DISEASE
Criteria	0
Criteria	0

A	I-DISEASE
-	I-DISEASE
E	0
must	I-DISEASE
be	0
met	0
A.	0

The	I-DISEASE
patient	I-DISEASE
complains	0
of	0
sudden	0
jerks	0
,	0
mainly	0
of	I-DISEASE
the	0
abdomen	I-DISEASE
,	I-DISEASE
trunk	0
,	I-DISEASE
and	0
neck	I-DISEASE
.	0

B.	0
The	I-DISEASE
jerks	0
appear	I-DISEASE
during	I-DISEASE
relaxed	0
wakefulness	0
and	0
drowsiness	0
,	0
as	0
the	0
patient	I-DISEASE
attempts	0
to	0
fall	I-DISEASE
asleep	I-DISEASE
.	0

C.	I-DISEASE

The	I-DISEASE
jerks	0
disappear	I-DISEASE
upon	0
mental	0
activation	0
and	0
with	0
onset	0
of	I-DISEASE
a	0
stable	I-DISEASE
sleep	0
stage	0
.	0

D.	I-DISEASE
The	I-DISEASE
jerks	0
result	0
in	0
difficulty	0
initiating	0
sleep	0
.	0

E.	I-DISEASE

The	I-DISEASE
disorder	I-DISEASE
is	0
not	0
better	0
explained	I-DISEASE
by	I-DISEASE
another	I-DISEASE
sleep	0
disorder	0
,	0
medical	I-DISEASE
or	I-DISEASE
neurological	0
disorder	I-DISEASE
,	I-DISEASE
mental	0
disorder	0
,	I-DISEASE
medication	0
use	I-DISEASE
,	I-DISEASE
or	I-DISEASE
substance	I-DISEASE
use	0
disorder	I-DISEASE
.	0

Notes	I-DISEASE
.	0

Although	I-DISEASE
there	I-DISEASE
is	0
no	0
current	0
definitive	0
evidence	0
that	0
propriospinal	B-DISEASE
myoclonus	I-DISEASE
confined	B-DISEASE
to	I-DISEASE
sleep	0
onset	0
is	I-DISEASE
associated	0
with	I-DISEASE
significant	0
structural	0
lesions	0
of	0
the	I-DISEASE
spinal	0
cord	I-DISEASE
,	I-DISEASE
propriospinal	I-DISEASE
myoclonus	0
that	0
is	0
persistent	0
during	I-DISEASE
the	0
day	0
has	0
been	I-DISEASE
linked	0
to	I-DISEASE
structural	0
spinal	I-DISEASE
cord	0
pathology	0
in	0
16	0
%	0
to	0
20	0
%	0
of	I-DISEASE
cases	0
.	I-DISEASE

Essential	I-DISEASE
Features	I-DISEASE
Propriospinal	0
myoclonus	I-DISEASE
at	I-DISEASE
sleep	I-DISEASE
onset	I-DISEASE
(	0
PSM	0
)	I-DISEASE
consists	0
of	0
sudden	0
myoclonic	0
jerks	0
occurring	0
in	I-DISEASE
the	I-DISEASE
transition	0
from	I-DISEASE
wakefulness	0
to	I-DISEASE
sleep	0
and	0
,	0
rarely	I-DISEASE
,	0
during	I-DISEASE
intrasleep	I-DISEASE
wakefulness	0
and	0
upon	I-DISEASE
awakening	0
in	0
the	0
morning	0
.	0

The	I-DISEASE
jerks	0
arise	I-DISEASE
mainly	0
in	I-DISEASE
the	0
axial	I-DISEASE
muscles	0
and	0
spread	I-DISEASE
rostrally	I-DISEASE
and	0
caudally	I-DISEASE
according	0
to	0
propriospinal	I-DISEASE
propagation	0
.	0

The	I-DISEASE
jerks	0
may	I-DISEASE
be	0
of	I-DISEASE
variable	I-DISEASE
intensity	0
;	0
they	0
are	0
isolated	I-DISEASE
,	I-DISEASE
recurring	I-DISEASE
in	0
quasi	0
-	I-DISEASE
periodic	I-DISEASE
fashion	0
for	0
variable	I-DISEASE
durations	0
,	0
or	0
may	I-DISEASE
be	0
repeated	I-DISEASE
in	0
brief	I-DISEASE
clusters	I-DISEASE
of	I-DISEASE
a	0
few	0
movements	0
,	0
sepa-	I-DISEASE
rated	I-DISEASE
by	0
longer	0
intervals	0
.	0

Jerks	I-DISEASE
involve	0
the	0
abdominal	0
and	0
truncal	0
muscles	0
first	0
and	0
are	I-DISEASE
then	0
propagated	I-DISEASE
to	I-DISEASE
proximal	0
muscles	0
of	I-DISEASE
the	0
limbs	0
and	0
the	0
neck	0
.	0

The	I-DISEASE
pattern	0
of	I-DISEASE
move-	I-DISEASE
ment	0
is	I-DISEASE
usually	I-DISEASE
flexor	0
but	I-DISEASE
may	I-DISEASE
be	0
an	0
extension	I-DISEASE
of	I-DISEASE
the	0
trunk	0
.	0

Vocalization	I-DISEASE
rarely	I-DISEASE
occurs	I-DISEASE
.	0

The	I-DISEASE
jerks	0
are	I-DISEASE
most	0
often	0
spontaneous	I-DISEASE
but	I-DISEASE
,	0
in	0
some	I-DISEASE
cases	0
,	I-DISEASE
can	0
be	0
evoked	0
by	I-DISEASE
external	0
stimulations	0
.	0

The	I-DISEASE
jerks	0
appear	I-DISEASE
to	0
be	I-DISEASE
related	0
to	I-DISEASE
the	0
recumbent	0
position	I-DISEASE
and	0
a	0
state	0
of	I-DISEASE
Sleep	I-DISEASE
Related	0
Movement	0
Disorders	0
Sleep	0
Related	I-DISEASE
Movement	I-DISEASE
Disorders	0
relaxed	B-DISEASE
wakefulness	0
,	I-DISEASE
particularly	0
when	0
the	0
patient	I-DISEASE
tries	0
to	0
fall	0
asleep	0
.	0

Any	0
mental	0
acti-	0
vation	0
makes	I-DISEASE
the	0
jerks	0
disappear	0
.	0

The	I-DISEASE
jerks	0
eventually	I-DISEASE
disappear	0
at	I-DISEASE
sleep	0
onset	I-DISEASE
and	0
remain	0
absent	0
throughout	0
all	I-DISEASE
stages	I-DISEASE
of	I-DISEASE
sleep	0
,	I-DISEASE
even	I-DISEASE
though	0
they	0
sometimes	0
reappear	0
during	I-DISEASE
intrasleep	I-DISEASE
wakefulness	0
.	0

Associated	I-DISEASE
Features	I-DISEASE
PSM	0
often	0
is	I-DISEASE
associated	0
with	I-DISEASE
severe	0
sleep	0
-	I-DISEASE
onset	I-DISEASE
insomnia	I-DISEASE
due	I-DISEASE
to	I-DISEASE
the	I-DISEASE
inability	0
of	I-DISEASE
the	0
patient	I-DISEASE
to	I-DISEASE
fall	I-DISEASE
asleep	I-DISEASE
because	I-DISEASE
of	0
the	I-DISEASE
recurrent	0
disturbing	I-DISEASE
muscular	I-DISEASE
activity	0
.	B-DISEASE

Clinical	I-DISEASE
and	0
Pathophysiological	I-DISEASE
Subtypes	I-DISEASE
PSM	0
may	I-DISEASE
be	I-DISEASE
considered	0
a	0
variant	I-DISEASE
of	I-DISEASE
the	0
more	0
generally	I-DISEASE
described	0
propriospinal	I-DISEASE
myoc-	0
lonus	I-DISEASE
seen	I-DISEASE
during	I-DISEASE
the	0
daytime	I-DISEASE
.	0

In	I-DISEASE
daytime	I-DISEASE
PSM	0
,	0
myoclonic	0
jerks	0
involve	I-DISEASE
the	I-DISEASE
thoracoab-	0
dominal	0
/	0
paraspinal	0
or	I-DISEASE
cervical	0
muscles	0
and	0
spread	0
caudally	0
or	0
rostrally	0
to	0
the	0
other	0
myotomes	0
.	0

The	I-DISEASE
jerks	0
are	I-DISEASE
provoked	0
or	I-DISEASE
worsened	0
by	0
the	0
recumbent	0
position	I-DISEASE
and	0
can	0
not	0
be	I-DISEASE
voluntarily	0
suppressed	0
.	0

They	I-DISEASE
are	0
often	0
preceded	I-DISEASE
by	0
premonitory	I-DISEASE
sensations	0
,	0
are	0
stable	I-DISEASE
over	I-DISEASE
time	0
,	I-DISEASE
and	0
respond	B-DISEASE
unpredictably	0
to	0
drug	0
treatment	I-DISEASE
.	0

The	I-DISEASE
frequent	I-DISEASE
presleep	0
worsening	0
of	I-DISEASE
daytime	0
PSM	0
(	I-DISEASE
around	I-DISEASE
50	0
%	0
of	I-DISEASE
the	0
cases	0
)	0
suggests	0
that	0
patients	0
with	I-DISEASE
PSM	0
may	I-DISEASE
have	0
a	0
milder	0
or	I-DISEASE
variant	I-DISEASE
form	I-DISEASE
of	I-DISEASE
a	0
single	I-DISEASE
clinical	0
and	0
neurophysiologic	0
entity	I-DISEASE
.	0

Demographics	I-DISEASE
Epidemiologic	0
data	0
are	0
lacking	I-DISEASE
.	0

PSM	I-DISEASE
is	0
probably	I-DISEASE
a	0
rare	I-DISEASE
condition	0
.	I-DISEASE

A	I-DISEASE
higher	0
prevalence	0
in	I-DISEASE
men	0
is	I-DISEASE
reported	0
.	0

The	I-DISEASE
disorder	I-DISEASE
affects	0
adults	I-DISEASE
and	0
has	0
not	0
been	I-DISEASE
reported	0
in	0
children	I-DISEASE
.	0

Predisposing	I-DISEASE
and	0
Precipitating	I-DISEASE
Factors	0
Not	0
applicable	I-DISEASE
or	I-DISEASE
known	0
.	0

Familial	I-DISEASE
Patterns	I-DISEASE
Not	I-DISEASE
applicable	0
or	B-DISEASE
known	0
.	0

Onset	I-DISEASE
,	0
Course	0
,	0
and	0
Complications	0
PSM	0
arises	0
in	I-DISEASE
adulthood	0
and	0
is	I-DISEASE
usually	I-DISEASE
a	0
chronic	0
,	I-DISEASE
unremitting	I-DISEASE
condition	0
.	0

Patients	I-DISEASE
may	0
develop	0
a	0
fear	I-DISEASE
of	I-DISEASE
falling	0
asleep	0
,	0
anxiety	0
,	I-DISEASE
and	0
depression	I-DISEASE
.	0

Intense	I-DISEASE
myoclonic	0
jerks	0
may	0
cause	I-DISEASE
injury	0
to	I-DISEASE
the	0
patient	0
or	0
the	0
bed	I-DISEASE
partner	0
.	0

Pathology	I-DISEASE
and	0
Pathophysiology	I-DISEASE
The	I-DISEASE
pathophysiology	0
of	I-DISEASE
PSM	0
is	I-DISEASE
unknown	0
.	0

PSM	I-DISEASE
is	0
thought	I-DISEASE
to	0
originate	I-DISEASE
from	0
a	I-DISEASE
focal	0
spinal	0
pattern	0
generator	0
,	I-DISEASE
set	I-DISEASE
into	I-DISEASE
motion	0
by	I-DISEASE
supraspinal	I-DISEASE
dysfacilitatory	0
influences	I-DISEASE
typical	0
of	I-DISEASE
the	0
state	B-DISEASE
of	I-DISEASE
relaxed	0
wakefulness	0
and	0
drowsiness	0
.	0

PSM	I-DISEASE
is	0
presumed	0
to	0
propagate	I-DISEASE
up	0
and	0
down	I-DISEASE
the	0
spinal	I-DISEASE
cord	I-DISEASE
via	0
slowly	I-DISEASE
conducting	B-DISEASE
,	I-DISEASE
long	0
propriospinal	0
(	I-DISEASE
intersegmental	I-DISEASE
)	0
pathways	I-DISEASE
.	0

A	I-DISEASE
focal	0
spinal	0
generator	0
thus	0
is	I-DISEASE
able	0
to	I-DISEASE
recruit	0
muscles	0
from	I-DISEASE
multiple	I-DISEASE
segments	I-DISEASE
.	0

Objective	I-DISEASE
Findings	I-DISEASE
Polysomnography	0
demonstrates	I-DISEASE
brief	I-DISEASE
myoclonic	I-DISEASE
EMG	0
bursts	0
recurring	0
nonperiodi-	0
cally	I-DISEASE
with	I-DISEASE
alpha	0
activity	0
present	I-DISEASE
on	0
the	0
EEG	0
and	0
,	0
in	0
particular	I-DISEASE
,	0
when	0
alpha	0
activity	0
spreads	0
from	0
the	0
posterior	I-DISEASE
to	I-DISEASE
the	0
anterior	I-DISEASE
brain	0
regions	0
.	0

Epileptic	I-DISEASE
EEG	0
discharges	0
are	0
not	0
observed	0
in	0
PSM	0
.	0

Jerks	I-DISEASE
disappear	0
either	I-DISEASE
with	0
EEG	I-DISEASE
desynchronization	I-DISEASE
,	I-DISEASE
due	I-DISEASE
to	0
mental	0
activation	0
,	I-DISEASE
or	0
with	0
appearance	I-DISEASE
of	I-DISEASE
sleep	0
spindles	0
and	0
K	0
-	0
complexes	I-DISEASE
.	0

Jerks	I-DISEASE
remain	0
absent	I-DISEASE
throughout	0
sleep	0
but	0
may	I-DISEASE
occasionally	0
reappear	0
upon	I-DISEASE
awakening	0
and	0
during	I-DISEASE
intrasleep	I-DISEASE
wakefulness	0
.	0

Polysomnography	I-DISEASE
with	I-DISEASE
extended	0
EMG	I-DISEASE
recording	0
demonstrates	I-DISEASE
that	0
the	I-DISEASE
jerks	0
arise	I-DISEASE
first	I-DISEASE
in	I-DISEASE
spinal	0
innervated	0
muscles	0
and	0
then	0
propagate	I-DISEASE
to	I-DISEASE
more	0
caudal	0
and	0
rostral	0
muscles	0
according	0
to	0
a	0
propriospinal	0
pattern	0
of	I-DISEASE
propagation	I-DISEASE
.	0

Detailed	I-DISEASE
analysis	0
of	I-DISEASE
the	0
jerks	0
shows	I-DISEASE
that	0
the	0
EMG	0
activity	I-DISEASE
originates	I-DISEASE
in	0
muscles	0
innervated	I-DISEASE
by	0
thoracic	0
or	0
cervical	I-DISEASE
spinal	0
segments	I-DISEASE
(	I-DISEASE
sternocleidomastoid	B-DISEASE
,	0
paraspinalis	0
,	0
rectus	0
abdominis	I-DISEASE
)	0
and	0
then	0
spreads	0
to	0
more	0
rostrally	0
and	0
caudally	0
innervated	I-DISEASE
muscles	0
at	I-DISEASE
a	0
slow	0
velocity	I-DISEASE
(	I-DISEASE
2	0
to	0
16	I-DISEASE
milliseconds	0
;	I-DISEASE
around	0
5	0
milliseconds	I-DISEASE
on	0
average	I-DISEASE
)	I-DISEASE
.	0

Back	I-DISEASE
-	I-DISEASE
averaging	0
of	I-DISEASE
the	0
EEG	0
does	I-DISEASE
not	0
show	0
any	I-DISEASE
jerk	0
-	I-DISEASE
locked	I-DISEASE
cortical	0
activity	I-DISEASE
.	0

MRI	I-DISEASE
of	I-DISEASE
the	0
brain	0
is	I-DISEASE
normal	0
.	I-DISEASE

In	I-DISEASE
a	0
recent	0
review	0
of	0
PSM	0
,	I-DISEASE
only	0
one	0
patient	I-DISEASE
with	I-DISEASE
exacerbation	I-DISEASE
at	I-DISEASE
sleep	0
onset	0
had	0
a	0
hypersignal	0
at	I-DISEASE
T10	0
-	0
T11	0
and	0
a	0
nonspecific	0
medullary	0
cone	I-DISEASE
lesion	0
.	0

The	I-DISEASE
remaining	I-DISEASE
patients	0
had	I-DISEASE
no	0
signs	I-DISEASE
on	0
spinal	I-DISEASE
cord	0
MRI	0
at	I-DISEASE
sleep	I-DISEASE
onset	I-DISEASE
.	0

MRI	I-DISEASE
of	I-DISEASE
the	0
spine	0
is	I-DISEASE
usually	I-DISEASE
normal	0
but	0
demonstrates	0
a	0
focal	0
lesion	I-DISEASE
in	0
around	0
20	0
%	0
of	0
the	0
cases	0
.	0

The	I-DISEASE
causal	0
relationship	I-DISEASE
of	0
PSM	0
with	I-DISEASE
these	I-DISEASE
spinal	I-DISEASE
lesions	0
is	I-DISEASE
unclear	I-DISEASE
,	I-DISEASE
although	0
magnetic	0
resonance	I-DISEASE
diffusion	I-DISEASE
tensor	0
imaging	0
with	I-DISEASE
fiber	0
tracking	I-DISEASE
may	I-DISEASE
demonstrate	I-DISEASE
spinal	I-DISEASE
tract	0
disorganization	I-DISEASE
.	0

Differential	I-DISEASE
Diagnosis	0
PSM	0
shows	I-DISEASE
features	0
similar	0
to	0
those	0
of	I-DISEASE
the	0
syndrome	I-DISEASE
of	I-DISEASE
intensified	I-DISEASE
sleep	I-DISEASE
starts	0
.	0

However	I-DISEASE
,	I-DISEASE
sleep	0
starts	I-DISEASE
(	0
hypnic	I-DISEASE
jerks	0
)	0
usually	I-DISEASE
appear	I-DISEASE
during	0
the	0
transition	0
between	0
wakefulness	0
and	0
sleep	0
and	0
during	I-DISEASE
light	0
NREM	0
sleep	0
,	I-DISEASE
whereas	0
PSM	0
may	0
sometimes	0
be	0
present	I-DISEASE
during	I-DISEASE
relaxed	0
wakefulness	0
.	0

Unlike	I-DISEASE
PSM	0
,	I-DISEASE
sleep	0
starts	0
(	I-DISEASE
hypnic	I-DISEASE
jerks	0
)	0
some-	0
times	0
affect	0
only	0
one	0
or	0
a	0
few	0
body	I-DISEASE
segments	0
;	0
propriospinal	0
propagation	0
is	0
not	0
present	I-DISEASE
in	I-DISEASE
neurophysiological	0
studies	0
of	B-DISEASE
sleep	0
starts	0
.	0

Phasic	I-DISEASE
REM	I-DISEASE
twitches	I-DISEASE
,	I-DISEASE
which	0
are	0
a	0
normal	0
phenomenon	0
during	I-DISEASE
REM	0
sleep	0
,	I-DISEASE
involve	0
the	0
distal	I-DISEASE
muscles	0
of	I-DISEASE
the	0
hands	I-DISEASE
and	0
face	I-DISEASE
,	I-DISEASE
often	0
without	0
displacement	0
of	I-DISEASE
the	0
body	I-DISEASE
segment	I-DISEASE
.	0

Fragmentary	I-DISEASE
myoclonus	0
resembles	I-DISEASE
physiological	0
hypnic	0
myoclonus	0
,	I-DISEASE
but	0
in	0
an	0
enhanced	0
form	I-DISEASE
,	I-DISEASE
and	0
persists	I-DISEASE
throughout	0
all	0
stages	I-DISEASE
of	I-DISEASE
NREM	0
and	0
REM	0
sleep	0
.	0

Both	I-DISEASE
physiological	I-DISEASE
hypnic	0
myoclonus	0
and	0
frag-	0
mentary	0
myoclonus	0
are	I-DISEASE
EMG	0
findings	0
not	0
associated	0
with	0
overt	0
muscular	0
activity	0
and	0
Sleep	0
Related	0
Movement	0
Disorders	0
Sleep	0
Related	0
Movement	0
Disorders	0
do	I-DISEASE
not	0
involve	0
muscles	0
acting	0
across	I-DISEASE
large	0
joints	0
.	0

Epileptic	I-DISEASE
myoclonus	0
is	I-DISEASE
not	0
confined	0
to	0
relaxed	0
wakefulness	I-DISEASE
and	0
may	0
be	I-DISEASE
associated	0
with	0
epileptic	0
discharges	0
on	0
the	0
EEG	0
.	0

PLMS	I-DISEASE
are	I-DISEASE
longer	0
in	I-DISEASE
duration	0
,	I-DISEASE
involve	0
mainly	0
the	0
lower	0
limbs	I-DISEASE
,	I-DISEASE
and	0
usually	I-DISEASE
spare	I-DISEASE
truncal	0
and	0
abdominal	I-DISEASE
muscles	0
.	0

PLMs	I-DISEASE
may	I-DISEASE
begin	0
during	I-DISEASE
presleep	I-DISEASE
wakefulness	0
but	I-DISEASE
generally	I-DISEASE
occur	I-DISEASE
during	I-DISEASE
NREM	0
sleep	0
.	0

Some	I-DISEASE
patients	0
with	0
RLS	I-DISEASE
may	I-DISEASE
have	0
prominent	0
PLMs	0
in	I-DISEASE
wakefulness	I-DISEASE
while	0
sitting	I-DISEASE
or	I-DISEASE
lying	I-DISEASE
down	0
.	0

However	I-DISEASE
,	0
prominent	0
leg	I-DISEASE
discomfort	0
is	0
usually	I-DISEASE
present	I-DISEASE
in	0
these	0
patients	0
.	0

Occasionally	I-DISEASE
PSM	0
may	I-DISEASE
be	0
present	I-DISEASE
in	I-DISEASE
RLS	I-DISEASE
/	0
PLMS	0
patients	I-DISEASE
in	0
wake	0
before	I-DISEASE
sleep	I-DISEASE
,	0
but	0
the	0
EMG	0
morphology	0
is	0
different	I-DISEASE
.	0

In	I-DISEASE
addition	0
,	0
when	0
myoclonic	0
jerks	0
involving	0
leg	I-DISEASE
muscles	0
appear	I-DISEASE
,	0
the	0
PSM	0
disappears	0
.	0

Psychogenic	I-DISEASE
myoclonus	0
may	0
simulate	0
PSM	I-DISEASE
but	0
the	0
muscle	I-DISEASE
recruitment	I-DISEASE
pattern	0
,	0
the	0
spread	0
velocity	I-DISEASE
,	0
and	0
the	0
record-	0
ing	0
of	I-DISEASE
cortical	0
premovement	0
activity	0
observed	I-DISEASE
before	0
voluntary	0
movements	0
may	0
be	0
useful	0
to	I-DISEASE
differentiate	I-DISEASE
the	0
two	I-DISEASE
types	I-DISEASE
of	I-DISEASE
jerks	0
.	0

Unresolved	I-DISEASE
Issues	0
and	0
Further	I-DISEASE
Directions	0
Future	0
studies	I-DISEASE
are	0
needed	I-DISEASE
to	I-DISEASE
better	0
define	0
the	0
distinctions	I-DISEASE
between	0
PSM	0
and	0
related	B-DISEASE
conditions	0
such	I-DISEASE
as	0
sleep	0
starts	0
(	I-DISEASE
hypnic	I-DISEASE
jerks	0
)	0
and	0
,	0
in	0
particular	0
,	0
the	0
syndrome	0
of	I-DISEASE
inten-	I-DISEASE
sified	0
sleep	0
starts	0
.	0

Also	I-DISEASE
,	I-DISEASE
neuroimaging	0
and	0
possibly	I-DISEASE
postmortem	0
studies	I-DISEASE
may	I-DISEASE
detect	I-DISEASE
the	0
neural	0
structures	I-DISEASE
responsible	I-DISEASE
for	0
the	0
initiation	I-DISEASE
of	I-DISEASE
the	0
myoclonic	0
jerks	0
.	0

Bibliography	0
Montagna	0
P	0
,	I-DISEASE
Provini	0
F	I-DISEASE
,	I-DISEASE
Plazzi	0
G	I-DISEASE
,	I-DISEASE
Liguori	0
R	0
,	0
Lugaresi	I-DISEASE
E.	0
Propriospinal	0
myoclonus	0
upon	0
relaxation	0
and	0
drowsiness	0
:	0
a	0
cause	I-DISEASE
of	I-DISEASE
severe	I-DISEASE
insomnia	I-DISEASE
.	0

Mov	I-DISEASE
Disord	0
1997;12:66–72	I-DISEASE
.	I-DISEASE

Montagna	I-DISEASE
P	0
,	0
Provini	0
F	I-DISEASE
,	0
Vetrugno	I-DISEASE
R.	0
Propriospinal	B-DISEASE
myoclonus	0
at	I-DISEASE
sleep	0
onset	I-DISEASE
.	0

Neurophysiologique	0
clinique	I-DISEASE
2006;36:351–5	0
.	0

Roze	I-DISEASE
E	0
,	0
Bounolleau	I-DISEASE
P	0
,	I-DISEASE
Ducreux	I-DISEASE
D	I-DISEASE
,	I-DISEASE
et	0
al	I-DISEASE
.	0

Propriospinal	I-DISEASE
myclonusmyoclonus	0
revisited	0
.	0

Clinical	I-DISEASE
,	0
neurophysiologic	0
,	0
and	0
neuroradiologic	0
findings	0
.	0

Neurology	0
2009;72:1301–9	I-DISEASE
.	0

Tison	0
F	0
,	I-DISEASE
Arne	0
P	0
,	I-DISEASE
Dousset	0
V	I-DISEASE
,	I-DISEASE
Paty	I-DISEASE
J	0
,	I-DISEASE
Henry	I-DISEASE
P.	0
Propriospinal	I-DISEASE
myoclonus	0
induced	0
by	I-DISEASE
relaxation	0
and	0
drowsiness	0
.	0

Rev	I-DISEASE
Neurol	0
(	0
Paris	0
)	0
1998;154:423–5	0
.	0

Vetrugno	I-DISEASE
R	0
,	I-DISEASE
Provini	0
F	0
,	0
Meletti	0
S	I-DISEASE
,	0
et	0
al	I-DISEASE
.	0

Propriospinal	I-DISEASE
myoclonus	0
at	I-DISEASE
the	0
sleep	0
-	I-DISEASE
wake	0
transition	0
:	0
a	0
new	I-DISEASE
type	0
of	0
parasomnia	I-DISEASE
.	0

Sleep	I-DISEASE
2001;24:835–43	I-DISEASE
.	0

Sleep	I-DISEASE
Related	0
Movement	0
Disorder	0
Due	I-DISEASE
to	0
a	0
Medical	I-DISEASE
Disorder	I-DISEASE
ICD-9	0
-	0
CM	0
code	0
:	0
327.59	0
ICD-10	0
-	0
CM	0
code	0
:	0
G47.69	I-DISEASE
Diagnostic	0
Criteria	0

Criteria	I-DISEASE
A	0
-	0
C	0
must	0
be	I-DISEASE
met	0
A.	0

The	I-DISEASE
patient	I-DISEASE
manifests	0
sleep	0
related	B-DISEASE
movements	0
that	0
disturb	0
sleep	0
or	0
its	I-DISEASE
onset	I-DISEASE
.	0

B.	0
The	I-DISEASE
movement	I-DISEASE
disorder	0
occurs	0
as	0
a	I-DISEASE
consequence	0
of	I-DISEASE
a	0
significant	I-DISEASE
underlying	I-DISEASE
medical	I-DISEASE
or	0
neurological	0
condition	0
.	0

C.	I-DISEASE

The	I-DISEASE
symptoms	I-DISEASE
are	0
not	0
better	0
explained	I-DISEASE
by	I-DISEASE
another	I-DISEASE
sleep	0
related	0
movement	0
disorder	0
,	I-DISEASE
other	I-DISEASE
untreated	0
sleep	I-DISEASE
disorder	0
,	0
substance	I-DISEASE
use	I-DISEASE
,	0
or	I-DISEASE
mental	0
disorder	I-DISEASE
.	0

This	I-DISEASE
diagnosis	I-DISEASE
is	0
intended	I-DISEASE
for	0
sleep	0
related	0
movement	I-DISEASE
disorders	0
due	0
to	0
an	0
underlying	I-DISEASE
medical	I-DISEASE
or	0
neurologic	0
condition	0
that	0
do	I-DISEASE
not	0
meet	0
criteria	I-DISEASE
for	I-DISEASE
another	0
specific	I-DISEASE
movement	I-DISEASE
disorder	I-DISEASE
.	0

Many	I-DISEASE
neurological	I-DISEASE
conditions	0
may	I-DISEASE
be	I-DISEASE
associated	0
with	0
movement	0
abnormali-	I-DISEASE
ties	I-DISEASE
that	0
are	0
evident	I-DISEASE
in	I-DISEASE
wake	0
and	0
sleep	0
.	0

In	I-DISEASE
some	I-DISEASE
cases	0
,	I-DISEASE
the	0
nocturnal	0
manifestations	I-DISEASE
of	I-DISEASE
the	0
movement	I-DISEASE
abnormalities	I-DISEASE
may	0
be	I-DISEASE
apparent	0
before	I-DISEASE
establishment	0
of	0
a	0
firm	I-DISEASE
neurolog-	0
ical	0
diagnosis	0
.	0

Thus	I-DISEASE
,	I-DISEASE
in	I-DISEASE
some	I-DISEASE
cases	0
,	I-DISEASE
“	I-DISEASE
sleep	0
related	B-DISEASE
movement	0
disorder	0
due	I-DISEASE
to	I-DISEASE
a	I-DISEASE
medical	0
disorder	I-DISEASE
”	I-DISEASE
is	I-DISEASE
a	0
temporary	0
diagnosis	I-DISEASE
,	0
given	0
when	0
a	0
sleep	I-DISEASE
diagnosis	0
is	I-DISEASE
required	0
before	I-DISEASE
the	0
underlying	0
medical	0
or	I-DISEASE
neurological	0
condition	0
can	0
be	0
fully	0
diagnosed	0
.	0

Once	I-DISEASE
the	0
pres-	0
ence	I-DISEASE
of	I-DISEASE
a	0
medical	0
or	0
neurological	0
condition	0
is	I-DISEASE
clearly	0
established	I-DISEASE
,	0
that	0
becomes	0
the	0
sole	0
diagnosis	0
unless	0
the	I-DISEASE
sleep	0
complaint	I-DISEASE
is	0
the	I-DISEASE
focus	I-DISEASE
of	I-DISEASE
independent	I-DISEASE
clinical	0
attention	0
.	0

When	I-DISEASE
a	I-DISEASE
movement	0
disorder	I-DISEASE
that	0
is	I-DISEASE
listed	0
elsewhere	I-DISEASE
in	0
the	0
sleep	0
related	I-DISEASE
movement	I-DISEASE
disorder	I-DISEASE
section	0
of	I-DISEASE
the	0
International	B-DISEASE
Classification	0
of	0
Sleep	0
Disorders	0
,	I-DISEASE
3rd	0
Edition	0
is	I-DISEASE
caused	0
or	I-DISEASE
exacerbated	I-DISEASE
by	I-DISEASE
a	0
medical	0
or	0
neurological	0
condition	0
(	0
e.g.	0
,	I-DISEASE
restless	I-DISEASE
legs	0
syn-	0
drome	0
)	0
,	I-DISEASE
it	0
is	0
preferred	0
that	0
the	0
more	I-DISEASE
specific	I-DISEASE
diagnosis	I-DISEASE
(	I-DISEASE
e.g.	0
,	I-DISEASE
RLS	I-DISEASE
)	0
be	0
used	0
rather	0
than	0
“	I-DISEASE
sleep	0
related	0
movement	I-DISEASE
due	I-DISEASE
to	I-DISEASE
a	0
medical	0
disorder	I-DISEASE
,	I-DISEASE
”	I-DISEASE
with	I-DISEASE
annotation	0
of	I-DISEASE
the	0
relation-	0
ship	I-DISEASE
to	I-DISEASE
the	I-DISEASE
medical	0
or	0
neurological	I-DISEASE
disorder	B-DISEASE
.	0

Sleep	I-DISEASE
Related	0
Movement	0
Disorders	0
Sleep	I-DISEASE
Related	0
Movement	0
Disorders	I-DISEASE
Sleep	0
Related	0
Movement	I-DISEASE
Disorder	0
Due	0
to	0
a	0
Medication	0
or	0
Substance	I-DISEASE
ICD-9	0
-	I-DISEASE
CM	I-DISEASE
code	0
:	0
292.85	I-DISEASE
(	0
drug	0
-	0
induced	I-DISEASE
)	I-DISEASE
;	0
291.82	I-DISEASE
(	0
alcohol	I-DISEASE
-	0
induced	I-DISEASE
)	0
ICD-10	0
-	0
CM	I-DISEASE
code	0
:	0
F11	I-DISEASE
-	I-DISEASE
F19	I-DISEASE
(	I-DISEASE
see	I-DISEASE
table	0
in	I-DISEASE
Appendix	0
B	0
for	I-DISEASE
detailed	I-DISEASE
coding	0
instructions	0
)	0

Diagnostic	I-DISEASE
Criteria	0
Criteria	I-DISEASE
A	0
-	I-DISEASE
C	I-DISEASE
must	I-DISEASE
be	0
met	0
A.	0

The	I-DISEASE
patient	I-DISEASE
manifests	0
sleep	0
related	B-DISEASE
movements	0
that	0
disturb	0
sleep	0
or	0
its	I-DISEASE
onset	I-DISEASE
.	0

B.	0
The	I-DISEASE
movement	I-DISEASE
disorder	0
occurs	0
as	0
a	I-DISEASE
consequence	0
of	I-DISEASE
current	I-DISEASE
medication	0
or	I-DISEASE
substance	I-DISEASE
use	0
or	I-DISEASE
withdrawal	0
from	I-DISEASE
a	0
wake	0
-	I-DISEASE
promoting	I-DISEASE
medication	0
or	I-DISEASE
substance	0
.	0

C.	I-DISEASE

The	I-DISEASE
symptoms	I-DISEASE
are	0
not	0
better	0
explained	I-DISEASE
by	I-DISEASE
another	I-DISEASE
sleep	0
related	0
movement	0
disorder	I-DISEASE
,	I-DISEASE
other	I-DISEASE
untreated	0
sleep	I-DISEASE
disorder	0
,	0
or	I-DISEASE
medical	0
,	0
neurological	0
,	0
or	I-DISEASE
mental	0
disorder	I-DISEASE
.	0

This	I-DISEASE
diagnosis	I-DISEASE
is	0
intended	I-DISEASE
for	0
sleep	0
related	0
movement	I-DISEASE
disorders	0
due	0
to	0
a	0
medication	I-DISEASE
or	I-DISEASE
substance	0
(	I-DISEASE
toxin	I-DISEASE
or	0
other	0
bioactive	0
substance	I-DISEASE
)	0
that	0
do	I-DISEASE
not	0
meet	0
criteria	0
for	I-DISEASE
another	I-DISEASE
spe-	0
cific	I-DISEASE
movement	I-DISEASE
disorder	0
.	0

Many	I-DISEASE
substances	I-DISEASE
may	0
be	I-DISEASE
associated	0
with	I-DISEASE
movement	0
abnor-	I-DISEASE
malities	0
that	0
are	0
evident	I-DISEASE
in	I-DISEASE
wake	I-DISEASE
and	0
sleep	0
.	0

To	I-DISEASE
the	0
extent	0
that	0
the	0
movement	I-DISEASE
abnormal-	I-DISEASE
ity	0
is	0
an	0
expected	I-DISEASE
complication	I-DISEASE
of	I-DISEASE
the	0
substance(s	I-DISEASE
)	0
involved	0
(	I-DISEASE
e.g.	0
,	I-DISEASE
tardive	0
dyskinesia	0
or	0
akathisia	0
associated	0
with	0
neuroleptic	0
usage	I-DISEASE
)	0
,	I-DISEASE
this	0
diagnosis	0
is	0
unnecessary	0
unless	0
the	0
sleep	0
related	0
aspects	0
of	I-DISEASE
the	0
movement	0
abnormality	0
or	I-DISEASE
its	I-DISEASE
sequelae	0
,	0
are	I-DISEASE
the	0
focus	I-DISEASE
of	I-DISEASE
independent	I-DISEASE
clinical	I-DISEASE
attention	0
.	0

When	I-DISEASE
a	I-DISEASE
movement	0
disorder	I-DISEASE
that	0
is	I-DISEASE
listed	0
elsewhere	I-DISEASE
in	0
the	0
sleep	0
related	I-DISEASE
movement	I-DISEASE
disorder	I-DISEASE
section	0
of	I-DISEASE
the	0
International	0
Classification	0
of	0
Sleep	0
Disorders	0
,	I-DISEASE
3rd	0
Edition	0
is	I-DISEASE
caused	0
or	I-DISEASE
exacerbated	I-DISEASE
by	I-DISEASE
drugs	I-DISEASE
or	0
substances	0
(	I-DISEASE
e.g.	0
,	0
restless	I-DISEASE
legs	0
syndrome	I-DISEASE
)	0
,	I-DISEASE
it	0
is	0
pre-	0
ferred	I-DISEASE
that	0
the	0
more	0
specific	I-DISEASE
diagnosis	0
(	0
e.g.	I-DISEASE
,	I-DISEASE
RLS	0
)	0
be	I-DISEASE
used	0
rather	0
than	I-DISEASE
“	0
Sleep	I-DISEASE
related	0
movement	0
disorder	0
due	I-DISEASE
to	I-DISEASE
a	I-DISEASE
medication	0
or	I-DISEASE
substance	0
,	I-DISEASE
”	I-DISEASE
with	I-DISEASE
annotation	I-DISEASE
of	0
the	0
relation-	I-DISEASE
ship	0
to	0
drug	I-DISEASE
or	I-DISEASE
substance	I-DISEASE
.	0

Sleep	I-DISEASE
Related	0
Movement	0
Disorder	0
,	I-DISEASE
Unspecified	I-DISEASE
ICD-9	I-DISEASE
-	I-DISEASE
CM	I-DISEASE
code	0
:	I-DISEASE
327.59	0
ICD-10	I-DISEASE
-	I-DISEASE
CM	I-DISEASE
code	0
:	B-DISEASE
G47.69	I-DISEASE
This	0
diagnosis	0
is	0
assigned	0
when	0
patients	0
have	0
a	0
sleep	I-DISEASE
related	0
movement	I-DISEASE
disorder	0
that	0
can	0
not	0
be	0
classified	0
elsewhere	I-DISEASE
or	I-DISEASE
is	0
suspected	0
to	I-DISEASE
be	0
associated	0
with	I-DISEASE
an	I-DISEASE
underlying	0
psy-	0
chiatric	I-DISEASE
condition	I-DISEASE
.	0

In	I-DISEASE
some	I-DISEASE
cases	0
,	I-DISEASE
“	0
sleep	0
related	0
movement	I-DISEASE
disorder	0
,	0
unspecified	I-DISEASE
”	I-DISEASE
is	I-DISEASE
a	0
temporary	0
diagnosis	0
prior	0
to	I-DISEASE
establishment	0
of	I-DISEASE
an	0
underlying	0
psychiatric	I-DISEASE
condition	0
that	I-DISEASE
may	I-DISEASE
explain	I-DISEASE
the	0
sleep	0
related	0
movement	0
(	I-DISEASE
e.g.	0
,	0
movements	0
associated	0
with	0
posttrau-	0
matic	I-DISEASE
stress	I-DISEASE
disorder	0
nightmares	0
prior	0
to	0
firm	0
establishment	0
of	I-DISEASE
the	0
psychiatric	0
diag-	0
nosis	I-DISEASE
)	I-DISEASE
.	0

Once	I-DISEASE
the	I-DISEASE
psychiatric	0
diagnosis	I-DISEASE
is	0
established	I-DISEASE
,	I-DISEASE
that	I-DISEASE
becomes	0
the	0
sole	0
diagnosis	I-DISEASE
unless	I-DISEASE
the	0
sleep	0
complaint	I-DISEASE
is	I-DISEASE
the	I-DISEASE
focus	0
of	I-DISEASE
independent	I-DISEASE
clinical	0
attention	0
.	0

Sleep	I-DISEASE
Related	0
Movement	0
Disorders	0
Sleep	I-DISEASE
Related	0
Movement	0
Disorders	I-DISEASE
Isolated	0
Symptoms	I-DISEASE
and	0
Normal	I-DISEASE
Variants	I-DISEASE
Excessive	I-DISEASE
Fragmentary	I-DISEASE
Myoclonus	0
Excessive	I-DISEASE
fragmentary	0
myoclonus	0
(	I-DISEASE
EFM	I-DISEASE
)	0
is	0
a	0
largely	I-DISEASE
incidental	0
polysomnographic	0
finding	0
on	0
EMG	I-DISEASE
,	I-DISEASE
characterized	0
by	I-DISEASE
small	0
movements	0
of	I-DISEASE
the	0
corners	0
of	I-DISEASE
the	0
mouth	0
,	I-DISEASE
fingers	0
,	0
or	0
toes	0
,	0
or	I-DISEASE
by	I-DISEASE
no	I-DISEASE
visible	0
movement	0
at	I-DISEASE
all	0
.	I-DISEASE

The	I-DISEASE
finding	I-DISEASE
is	0
associated	0
with	0
no	0
known	I-DISEASE
clinical	I-DISEASE
consequence	0
.	0

Large	I-DISEASE
limb	0
movements	0
across	I-DISEASE
large	0
joint	I-DISEASE
spaces	I-DISEASE
are	I-DISEASE
not	0
characteristic	0
of	I-DISEASE
EFM	0
and	0
,	0
if	0
present	I-DISEASE
,	I-DISEASE
should	0
exclude	0
the	0
diagnosis	0
of	I-DISEASE
EFM	0
.	0

Scoring	I-DISEASE
of	I-DISEASE
EFM	0
is	I-DISEASE
described	I-DISEASE
in	I-DISEASE
the	0
most	0
recent	0
version	I-DISEASE
of	I-DISEASE
the	0
AASM	0
Manual	I-DISEASE
for	I-DISEASE
the	0
Scoring	0
of	I-DISEASE
Sleep	0
and	0
Associated	0
Events	I-DISEASE
.	0

The	I-DISEASE
condition	0
is	0
a	0
NREM	0
phenomenon	0
and	0
the	0
move-	0
ments	I-DISEASE
resemble	0
the	0
phasic	0
twitches	0
seen	0
in	I-DISEASE
normal	B-DISEASE
REM	0
sleep	0
except	0
that	0
they	I-DISEASE
are	0
more	0
universally	0
dispersed	0
throughout	0
a	0
sleep	0
epoch	0
than	0
phasic	0
REM	I-DISEASE
twitches	I-DISEASE
,	0
which	0
are	0
generally	0
clustered	0
within	B-DISEASE
small	0
groups	0
in	I-DISEASE
a	0
sleep	0
epoch	0
.	I-DISEASE

Its	I-DISEASE
importance	0
lies	0
in	I-DISEASE
that	0
it	I-DISEASE
is	I-DISEASE
within	I-DISEASE
the	0
differential	0
diagnosis	I-DISEASE
of	I-DISEASE
other	I-DISEASE
sleep	I-DISEASE
related	0
movement	I-DISEASE
disorders	0
.	I-DISEASE

Patients	I-DISEASE
usually	I-DISEASE
are	I-DISEASE
not	0
aware	0
of	I-DISEASE
the	0
twitch	0
-	0
like	0
movements	0
.	I-DISEASE

Patients	I-DISEASE
may	0
have	I-DISEASE
other	0
coexistent	0
sleep	0
disorders	0
,	I-DISEASE
but	I-DISEASE
EFM	I-DISEASE
does	I-DISEASE
not	0
appear	I-DISEASE
to	0
contribute	0
to	I-DISEASE
the	0
symptoms	I-DISEASE
of	I-DISEASE
these	I-DISEASE
sleep	I-DISEASE
disorders	0
.	0

EFM	I-DISEASE
,	0
a	I-DISEASE
NREM	0
phenomenon	0
,	0
is	0
less	I-DISEASE
common	I-DISEASE
than	I-DISEASE
phasic	I-DISEASE
REM	I-DISEASE
twitches	0
,	0
which	0
occur	I-DISEASE
in	0
REM	I-DISEASE
sleep	0
in	I-DISEASE
normal	0
individuals	I-DISEASE
without	0
sleep	0
complaints	0
.	0

Most	I-DISEASE
cases	0
have	I-DISEASE
been	I-DISEASE
reported	0
in	I-DISEASE
adults	I-DISEASE
.	I-DISEASE

EFM	I-DISEASE
is	0
predominantly	I-DISEASE
found	0
in	I-DISEASE
males	I-DISEASE
.	0

A	I-DISEASE
recent	I-DISEASE
study	0
found	I-DISEASE
EFM	0
in	I-DISEASE
100	0
%	0
of	I-DISEASE
62	I-DISEASE
patients	I-DISEASE
with	I-DISEASE
a	I-DISEASE
variety	0
of	I-DISEASE
sleep	0
disorders	I-DISEASE
,	0
bringing	0
into	I-DISEASE
question	0
the	0
specificity	I-DISEASE
of	I-DISEASE
EFM	0
.	0

Numerous	I-DISEASE
causes	0
of	I-DISEASE
chronic	I-DISEASE
sleep	0
fragmentation	I-DISEASE
may	I-DISEASE
be	0
associated	0
with	I-DISEASE
EFM	0
.	0

The	I-DISEASE
condition	0
has	0
been	I-DISEASE
described	0
with	I-DISEASE
obstructive	0
sleep	0
apnea	0
and	0
primary	0
central	0
sleep	0
apnea	0
,	0
sleep	0
related	0
hypoxemic	0
/	0
hypoventilation	I-DISEASE
syndromes	0
,	0
narcolepsy	0
,	0
PLMD	0
,	I-DISEASE
and	0
various	0
causes	0
of	I-DISEASE
insomnia	0
.	0

In	I-DISEASE
apneic	0
patients	I-DISEASE
,	0
the	0
twitching	0
intensifies	I-DISEASE
during	I-DISEASE
periods	0
of	I-DISEASE
increased	0
hypoxemia	I-DISEASE
.	0

One	I-DISEASE
report	0
has	0
found	I-DISEASE
excessive	0
fragmentary	I-DISEASE
myoclonus	I-DISEASE
to	I-DISEASE
be	I-DISEASE
very	I-DISEASE
common	I-DISEASE
in	I-DISEASE
children	I-DISEASE
with	I-DISEASE
Niemann	0
-	I-DISEASE
Pick	0
disease	I-DISEASE
,	I-DISEASE
type	I-DISEASE
C.	I-DISEASE
No	0
specific	I-DISEASE
precipitating	I-DISEASE
factors	B-DISEASE
have	I-DISEASE
been	I-DISEASE
reported	0
.	0

The	I-DISEASE
contribution	0
of	I-DISEASE
EFM	I-DISEASE
to	I-DISEASE
the	I-DISEASE
symptomatology	I-DISEASE
of	I-DISEASE
any	I-DISEASE
of	I-DISEASE
these	I-DISEASE
disorders	0
is	I-DISEASE
unknown	0
.	0

The	I-DISEASE
course	I-DISEASE
is	0
not	0
well	B-DISEASE
studied	0
but	I-DISEASE
appears	I-DISEASE
to	B-DISEASE
be	0
benign	I-DISEASE
and	0
non	I-DISEASE
-	0
progressive	0
.	0

The	I-DISEASE
dis-	I-DISEASE
order	0
may	I-DISEASE
be	0
the	0
sole	0
abnormality	0
in	I-DISEASE
some	I-DISEASE
cases	0
of	0
excessive	0
daytime	I-DISEASE
sleepiness	0
,	0
but	I-DISEASE
causality	0
is	0
questionable	I-DISEASE
.	0

No	I-DISEASE
other	I-DISEASE
serious	0
consequences	I-DISEASE
of	0
the	0
disorder	I-DISEASE
have	I-DISEASE
been	I-DISEASE
described	0
when	0
it	0
occurs	I-DISEASE
in	I-DISEASE
isolation	0
.	0

In	I-DISEASE
some	0
cases	0
,	I-DISEASE
EFM	0
is	0
present	I-DISEASE
in	0
normal	0
individuals	I-DISEASE
.	0

Its	I-DISEASE
relatively	0
benign	0
course	0
sug-	0
gests	0
that	0
it	0
is	I-DISEASE
not	0
associated	0
with	0
a	0
neurodegenerative	I-DISEASE
process	0
.	0

In	I-DISEASE
most	0
reported	0
cases	0
,	0
there	I-DISEASE
have	I-DISEASE
been	I-DISEASE
associated	0
sleep	0
abnormalities	I-DISEASE
and	0
sleep	I-DISEASE
disruption	B-DISEASE
,	I-DISEASE
suggesting	I-DISEASE
that	I-DISEASE
EFM	0
may	I-DISEASE
be	0
due	I-DISEASE
to	0
disruptions	I-DISEASE
of	0
normal	0
motor	I-DISEASE
-	I-DISEASE
control	I-DISEASE
mechanisms	I-DISEASE
during	I-DISEASE
sleep	0
.	0

Whether	I-DISEASE
there	I-DISEASE
is	0
a	I-DISEASE
genetic	0
or	I-DISEASE
other	0
basis	I-DISEASE
predisposing	0
individuals	I-DISEASE
to	I-DISEASE
develop	0
the	0
condi-	I-DISEASE
tion	0
is	0
unknown	I-DISEASE
.	0

In	I-DISEASE
any	I-DISEASE
case	I-DISEASE
,	I-DISEASE
it	0
would	I-DISEASE
appear	0
to	I-DISEASE
result	0
from	0
intensification	I-DISEASE
of	I-DISEASE
an	0
other-	I-DISEASE
wise	I-DISEASE
normal	0
motor	0
phenomenon	0
.	0

The	I-DISEASE
predominant	0
topographic	0
distribution	0
of	I-DISEASE
EFM	0
in	0
distal	0
and	0
facial	I-DISEASE
muscles	0
suggests	I-DISEASE
that	0
cortical	B-DISEASE
motor	0
centers	I-DISEASE
participate	0
in	I-DISEASE
its	I-DISEASE
generation	0
.	0

EFM	I-DISEASE
is	0
detected	0
as	0
isolated	I-DISEASE
,	0
very	I-DISEASE
brief	I-DISEASE
(	0
usually	I-DISEASE
75	0
to	I-DISEASE
150	I-DISEASE
milliseconds	0
)	0
,	0
asymmetrical	0
,	I-DISEASE
asynchronous	0
EMG	0
potentials	0
in	I-DISEASE
various	0
muscles	0
of	0
the	0
face	0
,	0
trunk	0
,	0
arms	0
,	I-DISEASE
and	0
legs	I-DISEASE
.	0

The	I-DISEASE
amplitude	0
varies	0
from	I-DISEASE
approximately	0
50	0
to	I-DISEASE
several	I-DISEASE
hundred	0
microvolts	0
;	I-DISEASE
the	0
taller	0
amplitudes	0
are	I-DISEASE
often	0
associated	0
with	I-DISEASE
visible	0
movement	I-DISEASE
of	I-DISEASE
the	0
fingers	I-DISEASE
,	0
toes	0
,	I-DISEASE
or	I-DISEASE
corners	0
of	I-DISEASE
the	0
mouth	0
,	I-DISEASE
whereas	I-DISEASE
the	0
smaller	I-DISEASE
ones	I-DISEASE
may	0
resemble	0
fasciculation	0
potentials	I-DISEASE
and	0
be	I-DISEASE
without	0
overt	0
movement	0
.	0

Large	I-DISEASE
movements	0
across	I-DISEASE
large	I-DISEASE
joint	0
spaces	0
preclude	0
a	0
diag-	0
nosis	I-DISEASE
of	I-DISEASE
EFM	0
.	0

Small	I-DISEASE
twitch	I-DISEASE
-	0
like	0
movements	0
may	I-DISEASE
be	0
observed	I-DISEASE
on	0
video	0
recording	0
.	0

Episodes	I-DISEASE
of	I-DISEASE
these	I-DISEASE
myoclonic	0
potentials	0
typically	0
last	0
from	I-DISEASE
10	0
minutes	0
to	0
several	I-DISEASE
hours	I-DISEASE
.	0

They	I-DISEASE
often	0
appear	0
at	I-DISEASE
sleep	0
onset	I-DISEASE
and	0
continue	0
through	0
the	0
NREM	0
sleep	I-DISEASE
stages	0
,	I-DISEASE
includ-	I-DISEASE
ing	0
slow	0
wave	B-DISEASE
sleep	0
.	0

The	I-DISEASE
presence	0
of	I-DISEASE
EFM	0
in	I-DISEASE
REM	I-DISEASE
is	0
difficult	0
to	0
determine	0
because	I-DISEASE
it	I-DISEASE
is	0
superimposed	0
on	0
the	0
normal	0
phasic	0
clusters	I-DISEASE
of	I-DISEASE
physiological	0
phasic	0
REM	I-DISEASE
twitches	0
.	0

EFM	I-DISEASE
is	0
electromyographically	I-DISEASE
similar	0
to	0
the	0
latter	0
.	0

Occasionally	I-DISEASE
,	I-DISEASE
the	0
EMG	0
activity	0
also	0
persists	I-DISEASE
during	I-DISEASE
EEG	0
periods	I-DISEASE
of	I-DISEASE
wakefulness	0
within	I-DISEASE
the	0
sleep	0
period	I-DISEASE
or	0
is	I-DISEASE
present	I-DISEASE
in	I-DISEASE
drowsiness	0
prior	0
to	I-DISEASE
sleep	0
onset	I-DISEASE
.	0

The	I-DISEASE
EEG	0
usually	I-DISEASE
shows	0
no	0
changes	0
at	I-DISEASE
the	0
time	0
of	I-DISEASE
the	0
movements	I-DISEASE
,	I-DISEASE
although	0
high	I-DISEASE
-	I-DISEASE
amplitude	0
EMG	0
potentials	I-DISEASE
may	0
be	0
associated	0
with	I-DISEASE
a	0
K	I-DISEASE
complex	0
or	I-DISEASE
even	I-DISEASE
with	I-DISEASE
transient	0
EEG	0
arousal	0
.	0

There	I-DISEASE
are	0
no	0
ocular	0
or	I-DISEASE
autonomic	0
accom-	0
paniments	I-DISEASE
.	0

It	I-DISEASE
seems	I-DISEASE
possible	0
that	0
,	0
depending	I-DISEASE
on	0
the	I-DISEASE
digitalization	I-DISEASE
rates	0
,	I-DISEASE
digital	I-DISEASE
systems	I-DISEASE
may	0
record	0
less	I-DISEASE
fragmentary	I-DISEASE
myoclonus	0
than	0
earlier	0
paper	I-DISEASE
records	0
.	I-DISEASE

No	I-DISEASE
laboratory	I-DISEASE
tests	0
other	I-DISEASE
than	0
polysomnography	0
(	I-DISEASE
optimally	I-DISEASE
with	0
multiple	I-DISEASE
EMG	0
leads	0
)	0
have	0
been	I-DISEASE
reported	0
to	0
be	0
helpful	I-DISEASE
in	0
assessing	I-DISEASE
EFM	0
.	0

EFM	I-DISEASE
generally	0
has	0
a	0
maximum	I-DISEASE
burst	I-DISEASE
duration	I-DISEASE
of	0
only	0
150	I-DISEASE
milliseconds	I-DISEASE
and	0
does	I-DISEASE
not	I-DISEASE
recur	0
periodically	0
.	0

It	I-DISEASE
can	0
be	0
distinguished	I-DISEASE
from	0
PLMS	0
because	0
PLMS	0
are	I-DISEASE
character-	I-DISEASE
ized	I-DISEASE
by	I-DISEASE
a	0
longer	0
burst	I-DISEASE
duration	0
(	0
typically	0
0.5	0
to	I-DISEASE
10	0
seconds	0
)	0
and	0
a	0
long	0
period	I-DISEASE
between	0
bursts	0
(	0
5	0
-	0
90	0
seconds	0
)	0
.	0

EFM	I-DISEASE
,	0
which	0
occurs	0
in	I-DISEASE
NREM	0
,	0
must	0
also	0
be	I-DISEASE
differentiated	0
from	0
normal	0
physiological	0
phasic	0
REM	0
twitches	I-DISEASE
,	I-DISEASE
which	0
have	0
a	0
similar	0
burst	I-DISEASE
duration	0
but	0
are	0
limited	I-DISEASE
to	0
the	0
REM	0
state	B-DISEASE
and	0
tend	0
to	0
occur	0
in	0
clusters	I-DISEASE
within	I-DISEASE
an	I-DISEASE
epoch	0
,	0
as	0
opposed	0
to	0
EFM	0
in	I-DISEASE
which	0
bursts	0
tend	I-DISEASE
not	0
to	0
cluster	0
within	I-DISEASE
a	0
particular	I-DISEASE
epoch	0
.	0

Larger	I-DISEASE
body	I-DISEASE
move-	I-DISEASE

ments	I-DISEASE
across	I-DISEASE
the	0
large	0
joints	I-DISEASE
are	0
not	0
a	0
feature	0
of	I-DISEASE
excessive	0
fragmentary	I-DISEASE
myoclonus	0
.	0

The	I-DISEASE
presence	0
of	I-DISEASE
such	I-DISEASE
movements	0
suggests	I-DISEASE
other	I-DISEASE
disorders	0
.	0

Sleep	I-DISEASE
Related	0
Movement	0
Disorders	0
Sleep	I-DISEASE
Related	0
Movement	0
Disorders	I-DISEASE
Further	0
investigation	0
is	0
necessary	0
to	0
determine	0
whether	0
EFM	0
occurs	0
as	0
a	I-DISEASE
consequence	0
of	I-DISEASE
sleep	0
disruption	I-DISEASE
or	I-DISEASE
whether	0
it	0
is	0
an	0
independent	I-DISEASE
cause	0
of	0
sleep	0
disruption	0
and	0
daytime	0
symptoms	0
in	0
its	I-DISEASE
own	0
right	0
.	0

It	I-DISEASE
must	I-DISEASE
also	0
be	I-DISEASE
determined	0
whether	0
there	I-DISEASE
are	I-DISEASE
any	0
physiolog-	0
ical	0
differences	I-DISEASE
that	I-DISEASE
distinguish	0
fragmentary	0
myoclonus	0
seen	I-DISEASE
in	0
many	0
normal	0
individu-	I-DISEASE
als	I-DISEASE
from	0
EFM	0
.	0

It	I-DISEASE
is	I-DISEASE
not	0
known	I-DISEASE
whether	0
some	I-DISEASE
additional	0
pathophysiological	0
element	I-DISEASE
is	I-DISEASE
required	0
to	0
increase	I-DISEASE
fragmentary	I-DISEASE
myoclonus	0
into	I-DISEASE
an	0
abnormal	I-DISEASE
range	0
.	0

The	I-DISEASE
current	I-DISEASE
thresh-	0
old	I-DISEASE
for	0
the	0
diagnosis	0
of	I-DISEASE
EFM	0
should	I-DISEASE
be	I-DISEASE
further	I-DISEASE
investigated	0
because	0
the	I-DISEASE
scoring	0
criteria	0
lack	I-DISEASE
specificity	I-DISEASE
.	0

The	I-DISEASE
apparent	0
strong	0
predominance	I-DISEASE
in	I-DISEASE
males	0
also	0
remains	0
unexplained	I-DISEASE
.	0

Bibliography	0
Broughton	0
R.	I-DISEASE
Pathological	I-DISEASE
fragmentary	0
myoclonus	I-DISEASE
,	I-DISEASE
intensified	I-DISEASE
sleep	0
starts	0
and	0
hypnagogic	0
foot	I-DISEASE
tremor	0
:	B-DISEASE
three	0
unusual	I-DISEASE
sleep	0
-	0
related	0
disorders	0
.	0

In	I-DISEASE
:	0
Koella	0
WP	0
,	I-DISEASE
Schulz	I-DISEASE
OF	I-DISEASE
,	I-DISEASE
Visser	I-DISEASE
P	0
,	I-DISEASE
eds	I-DISEASE
.	0

Sleep	I-DISEASE
1986	I-DISEASE
.	0

Stuttgart	I-DISEASE
:	I-DISEASE

Fischer	I-DISEASE
-	0
Verlag	0
,	I-DISEASE
1988:240–3	0
.	0

Broughton	0
R	I-DISEASE
,	0
Tolentino	I-DISEASE
MA	I-DISEASE
.	0

Fragmentary	I-DISEASE
pathological	I-DISEASE
myoclonus	0
in	0
NREM	0
sleep	0
.	0

Electroencephalogr	I-DISEASE
Clin	I-DISEASE
Neurophysiol	0
1984;57:303–9	I-DISEASE
.	0

Broughton	0
R	I-DISEASE
,	0
Tolentino	I-DISEASE
MA	0
,	0
Krelina	B-DISEASE
M.	I-DISEASE
Excessive	I-DISEASE
fragmentary	0
myoclonus	0
in	I-DISEASE
NREM	0
sleep	0
:	I-DISEASE
a	I-DISEASE
report	0
of	I-DISEASE
38	0
cases	0
.	0

Electroencephalogr	I-DISEASE
Clin	I-DISEASE
Neurophysiol	0
1985;61:123–33	I-DISEASE
.	0

Frauscher	I-DISEASE
B	0
,	0
Kunz	0
A	0
,	0
Brandauer	0
E	0
,	I-DISEASE
Ulmer	I-DISEASE
H	I-DISEASE
,	I-DISEASE
Poewe	0
W	0
,	I-DISEASE
Hogl	0
B.	0
Fragmentary	0
myoclonus	0
in	I-DISEASE
sleep	0
revisited	I-DISEASE
:	0
A	0
polysomnographic	0
study	I-DISEASE
in	I-DISEASE
62	I-DISEASE
patients	0
.	0

Sleep	I-DISEASE
Med	I-DISEASE
2011;12:410–5	I-DISEASE
.	0

Goyal	I-DISEASE
MK	I-DISEASE
,	0
Kumar	I-DISEASE
G	I-DISEASE
,	I-DISEASE
Sivaraman	0
M.	I-DISEASE
Sahota	I-DISEASE
P.	0
Teaching	0
neuroimages	0
:	0
excessive	0
fragmentary	I-DISEASE
hypnic	I-DISEASE
myoclonus	0
.	0

Neurology	0
2011;77	0
:	0
e59	0
–	0
e60	0
.	0

Lins	I-DISEASE
O	0
,	I-DISEASE
Castonguay	0
M	I-DISEASE
,	0
Dunham	I-DISEASE
W	I-DISEASE
,	I-DISEASE
Nevsimalova	0
S	0
,	0
Broughton	0
R.	0
Excessive	I-DISEASE
fragmentary	I-DISEASE
myoclonus	0
:	I-DISEASE
time	0
of	I-DISEASE
night	0
and	0
sleep	0
stage	0
distributions	I-DISEASE
.	0

Can	I-DISEASE
J	0
Neurol	0
Sci	0
1993;20:142–6	I-DISEASE
.	0

Vankova	I-DISEASE
J	0
,	I-DISEASE
Stepanova	0
I	I-DISEASE
,	0
Jech	0
R	I-DISEASE
,	I-DISEASE
et	0
al	I-DISEASE
.	0

Sleep	I-DISEASE
disturbances	I-DISEASE
and	0
hypocretin	0
deficiency	0
in	I-DISEASE
Niemann	0
-	I-DISEASE
Pick	0
disease	I-DISEASE
type	I-DISEASE
C.	I-DISEASE
Sleep	0
2003;26:427–30	I-DISEASE
.	0

Vetrugno	I-DISEASE
R	0
,	I-DISEASE
Plazzi	0
G	0
,	0
Provini	I-DISEASE
F	0
,	I-DISEASE
Liguori	I-DISEASE
R	0
,	0
Lugaresi	0
E	0
,	I-DISEASE
Montagna	0
P.	I-DISEASE
Excessive	B-DISEASE
fragmentary	0
hypnic	I-DISEASE
myoclonus	0
:	I-DISEASE
clinical	0
and	0
neurophysiological	0
findings	0
.	0

Sleep	I-DISEASE
Med	I-DISEASE
2002;3:73–6	I-DISEASE
.	0

Montagna	I-DISEASE
P	I-DISEASE
,	0
Liguori	I-DISEASE
R	I-DISEASE

et	I-DISEASE
al	I-DISEASE
.	0

Physiological	0
hypnic	0
myoclonus	0
Electroencephalogr	I-DISEASE
Clin	0
Neurophysiol	0
1988;70:172–6	0
.	0

Hypnagogic	I-DISEASE
Foot	0
Tremor	0
and	0
Alternating	I-DISEASE
Leg	0
Muscle	I-DISEASE
Activation	0
Hypnagogic	I-DISEASE
foot	I-DISEASE
tremor	0
(	I-DISEASE
HFT	I-DISEASE
)	0
is	0
rhythmic	0
movement	0
of	I-DISEASE
the	0
feet	0
or	0
toes	0
that	0
occurs	0
at	I-DISEASE
the	I-DISEASE
transition	0
between	0
wake	0
and	0
sleep	0
or	0
during	I-DISEASE
light	0
NREM	0
sleep	0
(	I-DISEASE
stages	0
N1	0
and	0
N2	0
)	0
.	0

Alternating	I-DISEASE
leg	I-DISEASE
muscle	0
activation	0
(	I-DISEASE
ALMA	I-DISEASE
)	0
consists	0
of	I-DISEASE
brief	I-DISEASE
activation	I-DISEASE
of	0
the	0
ante-	0
rior	0
tibialis	0
in	I-DISEASE
one	I-DISEASE
leg	0
in	I-DISEASE
alternation	0
with	I-DISEASE
similar	0
activation	0
in	I-DISEASE
the	0
other	I-DISEASE
leg	I-DISEASE
during	0
sleep	0
or	0
arousals	0
from	0
sleep	0
.	0

HFT	I-DISEASE
may	0
be	I-DISEASE
a	0
relatively	0
common	I-DISEASE
and	0
normal	0
finding	0
.	0

Affected	I-DISEASE
individuals	I-DISEASE
move	0
the	0
feet	0
or	I-DISEASE
the	0
toes	0
rhythmically	B-DISEASE
for	I-DISEASE
seconds	I-DISEASE
to	0
minutes	0
during	I-DISEASE
drowsy	I-DISEASE
wakefulness	0
or	0
lighter	0
stages	0
of	I-DISEASE
sleep	0
.	0

It	I-DISEASE
can	0
be	0
pathologically	0
exagger-	I-DISEASE
ated	0
in	I-DISEASE
some	I-DISEASE
patients	I-DISEASE
.	0

ALMA	I-DISEASE
is	0
defined	I-DISEASE
by	0
a	0
polysomnographic	0
pattern	0
with	I-DISEASE
unknown	0
clinical	0
manifestations	0
,	0
but	0
frequency	I-DISEASE
of	I-DISEASE
muscle	0
activations	0
,	I-DISEASE
length	0
of	I-DISEASE
activations	0
,	I-DISEASE
and	0
occurrence	0
primarily	0
with	I-DISEASE
arousals	0
suggest	0
that	0
ALMA	0
may	0
be	0
similar	0
to	0
HFT	I-DISEASE
or	0
rep-	0
resent	0
an	0
EMG	0
manifestation	0
of	I-DISEASE
some	I-DISEASE
episodes	I-DISEASE
of	0
HFT	I-DISEASE
.	0

The	I-DISEASE
original	I-DISEASE
case	I-DISEASE
series	I-DISEASE
that	0
described	0
ALMA	0
did	0
not	0
link	0
it	0
with	I-DISEASE
movement	I-DISEASE
of	I-DISEASE
the	0
lower	0
extremity	I-DISEASE
,	I-DISEASE
but	0
a	0
subse-	I-DISEASE
quent	0
report	0
did	I-DISEASE
.	0

HFT	I-DISEASE
and	0
ALMA	I-DISEASE
are	0
considered	I-DISEASE
together	I-DISEASE
because	0
the	0
relationship	0
between	0
them	I-DISEASE
remains	0
to	0
be	0
clarified	I-DISEASE
,	I-DISEASE
and	0
the	0
similarity	I-DISEASE
in	I-DISEASE
a	0
number	0
of	I-DISEASE
their	I-DISEASE
features	0
suggests	I-DISEASE
they	I-DISEASE
may	I-DISEASE
not	0
be	I-DISEASE
fully	I-DISEASE
independent	I-DISEASE
entities	0
.	0

Associated	I-DISEASE
features	I-DISEASE
of	I-DISEASE
HFT	I-DISEASE
and	0
ALMA	0
are	0
similar	0
.	0

Most	I-DISEASE
cases	0
of	I-DISEASE
HFT	I-DISEASE
have	I-DISEASE
been	I-DISEASE
reported	I-DISEASE
in	0
persons	0
with	I-DISEASE
other	I-DISEASE
sleep	I-DISEASE
disorders	0
,	0
such	0
as	0
RLS	I-DISEASE
or	0
SRBDs	I-DISEASE
.	0

ALMA	I-DISEASE
has	0
been	I-DISEASE
identified	0
mainly	0
in	I-DISEASE
patients	I-DISEASE
with	0
SRBD	0
or	I-DISEASE
PLMs	0
.	0

Seventy	I-DISEASE
-	0
five	0
percent	0
of	I-DISEASE
patients	I-DISEASE
with	I-DISEASE
ALMA	0
in	0
the	0
original	I-DISEASE
series	I-DISEASE
used	0
antidepressant	0
medication	0
.	0

In	I-DISEASE
that	I-DISEASE
study	0
,	I-DISEASE
patients	0
with	I-DISEASE
ALMA	0
complained	0
of	I-DISEASE
sleepiness	0
,	I-DISEASE
insomnia	I-DISEASE
,	I-DISEASE
or	I-DISEASE
restless	0
of	0
the	0
legs	0
,	I-DISEASE
but	0
only	I-DISEASE
one	I-DISEASE
reported	0
patient	I-DISEASE
had	0
more	I-DISEASE
specific	I-DISEASE
complaints	0
of	I-DISEASE
sudden	0
nocturnal	0
muscle	I-DISEASE
contractions	0
in	I-DISEASE
his	0
legs	0
and	0
a	0
sensation	0
that	0
his	I-DISEASE
legs	I-DISEASE
were	I-DISEASE
vibrating	0
.	0

A	I-DISEASE
separately	I-DISEASE
reported	0
case	I-DISEASE
of	0
a	0
patient	I-DISEASE
with	I-DISEASE
ALMA	0
documented	0
absence	I-DISEASE
of	I-DISEASE
any	I-DISEASE
SRBD	0
,	I-DISEASE
PLMs	0
,	0
or	0
use	0
of	I-DISEASE
antidepressant	I-DISEASE
medication	0
.	0

This	I-DISEASE
patient	I-DISEASE
complained	I-DISEASE
of	I-DISEASE
frequent	0
and	0
easily	0
provoked	0
awakenings	0
,	I-DISEASE
as	I-DISEASE
well	I-DISEASE
as	0
excessive	0
daytime	I-DISEASE
sleepiness	I-DISEASE
.	0

The	I-DISEASE
ALMA	I-DISEASE
and	0
symptoms	0
responded	0
to	I-DISEASE
treat-	0
ment	0
with	I-DISEASE
pramipexole	I-DISEASE
.	0

The	I-DISEASE
single	I-DISEASE
series	I-DISEASE
in	I-DISEASE
which	0
HFT	I-DISEASE
was	I-DISEASE
studied	0
found	0
that	0
it	0
occurs	I-DISEASE
in	I-DISEASE
7.5	0
%	0
of	0
patients	0
in	I-DISEASE
whom	0
a	0
polysomnogram	0
was	I-DISEASE
performed	0
for	I-DISEASE
other	0
reasons	I-DISEASE
.	0

Affected	I-DISEASE
individuals	I-DISEASE
range	0
in	I-DISEASE
age	I-DISEASE
from	I-DISEASE
14	0
to	0
72	0
years	I-DISEASE
,	I-DISEASE
with	I-DISEASE
a	0
majority	0
in	I-DISEASE
the	I-DISEASE
middle	0
-	0
age	I-DISEASE
range	0
(	I-DISEASE
40	0
to	0
65	0
years	0
)	0
.	0

Men	I-DISEASE
and	0
women	I-DISEASE
are	I-DISEASE
equally	0
affected	I-DISEASE
.	0

It	I-DISEASE
is	I-DISEASE
possible	0
that	0
the	0
frequency	I-DISEASE
of	I-DISEASE
these	I-DISEASE
move-	0
ments	0
may	I-DISEASE
be	I-DISEASE
increased	0
in	I-DISEASE
individuals	I-DISEASE
with	I-DISEASE
disorders	0
such	0
as	0
RLS	0
or	B-DISEASE
SRBD	0
,	I-DISEASE
but	0
it	I-DISEASE
can	I-DISEASE
occur	I-DISEASE
in	0
individuals	I-DISEASE
with	I-DISEASE
otherwise	0
normal	B-DISEASE
sleep	0
.	0

The	I-DISEASE
prevalence	0
of	I-DISEASE
the	0
condition	0
in	I-DISEASE
the	0
general	I-DISEASE
population	0
and	0
its	I-DISEASE
frequency	I-DISEASE
in	I-DISEASE
affected	I-DISEASE
individuals	I-DISEASE
remains	0
uncertain	0
.	I-DISEASE

The	I-DISEASE
initial	0
series	I-DISEASE
reporting	I-DISEASE
ALMA	0
found	I-DISEASE
that	I-DISEASE
it	0
occurs	0
in	I-DISEASE
1.1	I-DISEASE
%	0
of	I-DISEASE
unselected	I-DISEASE
studies	I-DISEASE
from	I-DISEASE
a	0
sleep	0
disorder	0
center	0
.	0

Patients	I-DISEASE
with	0
ALMA	I-DISEASE
were	I-DISEASE
mostly	I-DISEASE
male	I-DISEASE
(	0
11:5	0
)	I-DISEASE
and	0
ranged	0
in	I-DISEASE
age	I-DISEASE
from	I-DISEASE
12	0
to	0
70	0
years	0
,	0
with	I-DISEASE
most	0
aged	I-DISEASE
35	0
to	I-DISEASE
55	0
years	I-DISEASE
(	I-DISEASE
mean	I-DISEASE
age	I-DISEASE
41	0
years	I-DISEASE
)	0
.	0

Therefore	I-DISEASE
,	0
the	0
age	I-DISEASE
ranges	0
of	I-DISEASE
both	I-DISEASE
conditions	I-DISEASE
are	0
similar	0
,	0
with	I-DISEASE
both	I-DISEASE
males	I-DISEASE
and	0
females	0
affected	I-DISEASE
.	0

These	0
distributions	I-DISEASE
may	0
be	I-DISEASE
due	0
to	I-DISEASE
the	0
incidental	I-DISEASE
discovery	0
of	I-DISEASE
both	I-DISEASE
entities	I-DISEASE
during	I-DISEASE
routine	0
sleep	0
studies	I-DISEASE
for	I-DISEASE
other	0
sleep	0
complaints	0
.	0

No	I-DISEASE
predisposing	I-DISEASE
factors	0
are	0
known	I-DISEASE
for	0
HFT	0
.	0

The	I-DISEASE
use	0
of	I-DISEASE
antidepressant	I-DISEASE
medication	0
may	0
increase	0
risk	0
for	0
ALMA	I-DISEASE
.	0

No	I-DISEASE
longitudinal	I-DISEASE
studies	I-DISEASE
have	I-DISEASE
been	0
performed	0
for	0
either	I-DISEASE
entity	0
.	0

In	I-DISEASE
some	I-DISEASE
individuals	I-DISEASE
,	I-DISEASE
HFT	0
is	I-DISEASE
an	0
occasional	0
finding	0
,	0
but	I-DISEASE
others	I-DISEASE
appear	I-DISEASE
to	0
manifest	0
the	0
rhythmic	I-DISEASE
movements	0
Sleep	0
Related	0
Movement	0
Disorders	0
Sleep	0
Related	0
Movement	I-DISEASE
Disorders	I-DISEASE
on	0
many	0
nights	0
and	0
over	0
a	0
span	0
of	0
at	I-DISEASE
least	0
months	0
.	0

ALMA	I-DISEASE
showed	0
some	I-DISEASE
tendency	0
to	I-DISEASE
persist	I-DISEASE
between	0
two	0
different	0
recordings	I-DISEASE
in	I-DISEASE
the	0
originally	0
reported	0
series	I-DISEASE
.	0

Because	I-DISEASE
most	0
individuals	I-DISEASE
are	I-DISEASE
unaware	0
of	I-DISEASE
the	0
presence	0
of	0
the	0
HFT	I-DISEASE
movements	I-DISEASE
,	I-DISEASE
and	0
patients	I-DISEASE
with	I-DISEASE
ALMA	I-DISEASE
may	0
have	0
no	0
associated	0
complaint	0
or	0
awareness	0
of	0
the	0
phenomenon	0
,	I-DISEASE
the	0
evo-	0
lution	I-DISEASE
of	I-DISEASE
HFT	0
and	0
ALMA	0
may	0
be	0
difficult	0
to	I-DISEASE
follow	I-DISEASE
except	0
in	I-DISEASE
the	0
sleep	0
laboratory	I-DISEASE
or	0
with	0
home	0
monitoring	0
.	0

Although	I-DISEASE
usually	I-DISEASE
an	0
incidental	I-DISEASE
and	0
benign	I-DISEASE
finding	0
,	0
HFT	I-DISEASE
may	I-DISEASE
cause	I-DISEASE
sleep	0
disruption	I-DISEASE
and	0
sleep	I-DISEASE
-	0
onset	0
insomnia	I-DISEASE
if	0
sufficiently	I-DISEASE
prolonged	0
or	0
severe	I-DISEASE
.	0

In	I-DISEASE
HFT	I-DISEASE
,	I-DISEASE
the	0
patient	I-DISEASE
typically	0
reports	I-DISEASE
foot	0
movements	0
(	I-DISEASE
directly	I-DISEASE
experienced	I-DISEASE
or	I-DISEASE
observed	I-DISEASE
by	I-DISEASE
others	B-DISEASE
)	I-DISEASE
that	0
occur	0
at	I-DISEASE
the	0
transition	I-DISEASE
between	0
wake	0
and	0
sleep	0
or	I-DISEASE
during	I-DISEASE
light	0
sleep	0
.	0

On	I-DISEASE
occasion	0
,	0
movement	I-DISEASE
has	0
not	0
been	I-DISEASE
observed	I-DISEASE
but	0
HFT	0
is	I-DISEASE
seen	I-DISEASE
as	I-DISEASE
an	0
incidental	I-DISEASE
finding	I-DISEASE
on	0
sleep	0
study	0
conducted	I-DISEASE
for	I-DISEASE
other	I-DISEASE
indications	I-DISEASE
.	0

Polysomnography	I-DISEASE
demonstrates	I-DISEASE
a	0
pattern	0
of	0
brief	0
,	0
repeated	I-DISEASE
activation	I-DISEASE
of	I-DISEASE
the	0
anterior	I-DISEASE
tibialis	0
in	0
one	0
leg	I-DISEASE
.	0

The	I-DISEASE
minimum	I-DISEASE
frequency	I-DISEASE
is	0
0.3	0
Hz	0
;	0
the	0
maximum	0
4.0	0
Hz	0
.	0

Multiple	0
leg	I-DISEASE
activations	0
in	0
a	0
single	0
leg	I-DISEASE
occur	0
in	0
a	0
train	0
of	I-DISEASE
at	I-DISEASE
least	0
four	0
movements	0
.	0

EMG	I-DISEASE
recordings	0
of	I-DISEASE
the	0
foot	0
or	I-DISEASE
leg	I-DISEASE
muscles	0
or	0
video	0
record-	0
ings	I-DISEASE
of	I-DISEASE
movement	I-DISEASE
may	I-DISEASE
show	0
trains	0
of	I-DISEASE
recurrent	0
1	0
-	0
Hz	0
to	0
2	I-DISEASE
-	0
Hz	0
EMG	0
potentials	I-DISEASE
or	I-DISEASE
move-	I-DISEASE
ments	0
.	0

Typical	I-DISEASE
associated	0
EMG	0
bursts	0
are	I-DISEASE
300	I-DISEASE
to	I-DISEASE
700	0
milliseconds	I-DISEASE
in	I-DISEASE
duration	0
,	I-DISEASE
and	0
the	I-DISEASE
typical	0
duration	0
of	I-DISEASE
trains	0
is	I-DISEASE
10	0
to	I-DISEASE
15	I-DISEASE
seconds	0
,	I-DISEASE
although	0
longer	I-DISEASE
bursts	I-DISEASE
and	0
trains	0
have	0
been	I-DISEASE
reported	I-DISEASE
.	0

In	I-DISEASE
morbid	0
conditions	0
,	I-DISEASE
trains	0
may	I-DISEASE
persist	0
much	0
longer	I-DISEASE
.	0

Events	I-DISEASE
are	0
recorded	0
at	I-DISEASE
the	0
transition	I-DISEASE
into	I-DISEASE
sleep	0
and	0
during	I-DISEASE
stages	0
N1	0
and	0
N2	0
sleep	0
.	I-DISEASE

Distribution	I-DISEASE
over	0
the	0
night	0
has	0
not	0
been	I-DISEASE
fully	I-DISEASE
investigated	0
.	0

Persistent	I-DISEASE
HFT	I-DISEASE
has	0
been	I-DISEASE
found	I-DISEASE
in	0
about	0
half	0
of	I-DISEASE
the	I-DISEASE
indi-	I-DISEASE
viduals	I-DISEASE
who	I-DISEASE
have	0
had	I-DISEASE
multiple	I-DISEASE
studies	I-DISEASE
.	0

Alternation	I-DISEASE
between	0
legs	0
has	0
not	0
been	I-DISEASE
described	I-DISEASE
,	0
but	0
its	I-DISEASE
potential	I-DISEASE
occurrence	I-DISEASE
is	0
suggested	I-DISEASE
in	I-DISEASE
two	I-DISEASE
published	0
studies	I-DISEASE
of	I-DISEASE
HFT	I-DISEASE
.	0

In	I-DISEASE
ALMA	I-DISEASE
,	I-DISEASE
polysomnography	0
demonstrates	I-DISEASE
a	0
pattern	0
of	I-DISEASE
brief	I-DISEASE
,	I-DISEASE
repeated	I-DISEASE
activation	I-DISEASE
of	0
the	0
anterior	I-DISEASE
tibialis	0
in	I-DISEASE
one	I-DISEASE
leg	0
alternating	I-DISEASE
with	0
similar	0
activation	0
in	I-DISEASE
the	0
other	0
leg	I-DISEASE
.	0

At	I-DISEASE
a	0
minimum	0
,	I-DISEASE
a	0
single	0
leg	I-DISEASE
muscle	I-DISEASE
activation	0
in	0
one	0
leg	I-DISEASE
is	I-DISEASE
followed	0
sequentially	0
by	I-DISEASE
a	0
similar	0
single	I-DISEASE
activation	0
in	I-DISEASE
the	0
other	0
leg	I-DISEASE
,	0
reactivation	I-DISEASE
in	I-DISEASE
the	0
original	I-DISEASE
leg	I-DISEASE
,	0
and	0
then	0
reactivation	I-DISEASE
in	I-DISEASE
the	0
alternate	0
leg	I-DISEASE
,	0
with	0
some	I-DISEASE
continued	0
alternation	I-DISEASE
beyond	0
this	0
minimal	0
sequence	0
in	0
most	0
instances	0
.	0

The	I-DISEASE
minimum	I-DISEASE
frequency	I-DISEASE
of	I-DISEASE
alternating	0
EMG	I-DISEASE
bursts	I-DISEASE
is	0
0.5	0
Hz	0
,	I-DISEASE
and	0
the	0
maximum	I-DISEASE
frequency	I-DISEASE
is	0
3.0	0
Hz	0
.	0

The	I-DISEASE
patient	I-DISEASE
may	0
report	0
foot	0
movements	0
(	I-DISEASE
directly	I-DISEASE
experi-	0
enced	I-DISEASE
or	0
observed	I-DISEASE
by	I-DISEASE
others	I-DISEASE
)	0
that	0
occur	I-DISEASE
at	I-DISEASE
the	0
transition	0
between	0
wake	0
and	0
sleep	0
or	0
during	I-DISEASE
light	0
sleep	0
.	0

As	I-DISEASE
noted	0
above	0
,	I-DISEASE
there	0
is	I-DISEASE
frequently	I-DISEASE
no	0
observation	I-DISEASE
of	I-DISEASE
movement	0
reported	I-DISEASE
but	I-DISEASE
alternating	I-DISEASE
leg	I-DISEASE
muscle	0
activation	0
is	I-DISEASE
recorded	0
as	0
an	0
incidental	I-DISEASE
finding	0
on	0
polysomnography	0
.	0

ALMA	I-DISEASE
can	0
be	I-DISEASE
demonstrated	0
by	I-DISEASE
polysomnography	0
if	I-DISEASE
the	0
surface	0
EMG	0
is	I-DISEASE
recorded	0
inde-	0
pendently	0
from	I-DISEASE
both	0
right	0
and	0
left	0
anterior	I-DISEASE
tibialis	0
muscles	0
.	0

A	I-DISEASE
sequence	I-DISEASE
of	I-DISEASE
ALMA	I-DISEASE
may	I-DISEASE
begin	0
with	I-DISEASE
one	0
to	0
several	0
lengthy	I-DISEASE
activations	I-DISEASE
(	0
one	0
to	I-DISEASE
two	I-DISEASE
seconds	0
)	0
in	I-DISEASE
one	0
or	0
both	I-DISEASE
legs	I-DISEASE
.	0

Some	I-DISEASE
patients	I-DISEASE
show	0
unilateral	I-DISEASE
activity	0
at	I-DISEASE
times	0
.	0

ALMA	I-DISEASE
usually	I-DISEASE
closely	I-DISEASE
precedes	0
or	I-DISEASE
follows	0
an	0
arousal	0
or	I-DISEASE
awakening	I-DISEASE
and	0
gradually	0
diminishes	0
as	0
sleep	0
returns	0
.	0

However	I-DISEASE
,	I-DISEASE
ALMA	0
can	0
also	0
emerge	I-DISEASE
without	0
arousals	0
from	I-DISEASE
any	I-DISEASE
sleep	I-DISEASE
stage	I-DISEASE
.	0

Proclivity	I-DISEASE
for	0
any	I-DISEASE
spe-	0
cific	0
portion	0
of	I-DISEASE
the	0
nocturnal	0
sleep	0
cycle	I-DISEASE
has	0
not	0
been	I-DISEASE
identified	0
.	0

Leg	I-DISEASE
muscle	0
activa-	I-DISEASE
tions	0
during	I-DISEASE
REM	0
sleep	0
,	I-DISEASE
in	I-DISEASE
comparison	0
to	I-DISEASE
NREM	0
sleep	0
,	I-DISEASE
are	0
often	I-DISEASE
briefer	I-DISEASE
and	0
some-	0

what	I-DISEASE
less	I-DISEASE
regular	I-DISEASE
.	I-DISEASE

Sequences	I-DISEASE
of	I-DISEASE
ALMA	0
sometimes	0
recur	0
at	I-DISEASE
intervals	0
similar	I-DISEASE
to	I-DISEASE
those	0
of	I-DISEASE
PLMs	0
.	0

Extensor	I-DISEASE
forearm	0
EMG	0
study	0
may	I-DISEASE
suggest	I-DISEASE
alternating	0
muscle	0
activity	0
in	I-DISEASE
the	0
upper	0
extremities	I-DISEASE
,	0
though	0
it	0
is	I-DISEASE
less	I-DISEASE
prominent	0
than	I-DISEASE
activation	0
in	I-DISEASE
the	0
legs	I-DISEASE
.	0

ALMA	I-DISEASE
shows	I-DISEASE
some	I-DISEASE
night	0
-	I-DISEASE
to	I-DISEASE
-	0
night	0
consistency	0
.	0

Repeat	I-DISEASE
studies	I-DISEASE
are	I-DISEASE
likely	0
to	I-DISEASE
show	I-DISEASE
persistent	0
ALMA	0
.	0

The	I-DISEASE
number	0
of	I-DISEASE
sequences	I-DISEASE
recorded	0
,	I-DISEASE
on	0
average	I-DISEASE
,	0
and	0
the	0
timing	I-DISEASE
of	I-DISEASE
ALMA	I-DISEASE
with	I-DISEASE
respect	I-DISEASE
to	I-DISEASE
arousals	0
tends	0
to	I-DISEASE
remain	I-DISEASE
constant	0
.	0

The	I-DISEASE
specific	I-DISEASE
polysomnographic	0
criteria	0
for	0
HFT	I-DISEASE
during	I-DISEASE
sleep	0
and	0
ALMA	0
are	I-DISEASE
defined	0
in	0
the	0
most	0
recent	0
version	0
of	I-DISEASE
the	I-DISEASE
AASM	0
Manual	I-DISEASE
for	I-DISEASE
the	0
Scoring	I-DISEASE
of	I-DISEASE
Sleep	0
and	0
Associated	I-DISEASE
Events	0
.	0

Presentation	I-DISEASE
of	I-DISEASE
HFT	I-DISEASE
or	I-DISEASE
ALMA	0
with	0
other	0
concurrent	0
sleep	0
disorders	0
is	I-DISEASE
common	I-DISEASE
.	0

Because	I-DISEASE
of	I-DISEASE
the	0
similar	I-DISEASE
frequency	0
,	I-DISEASE
duration	0
,	I-DISEASE
and	0
body	I-DISEASE
part	I-DISEASE
involvement	I-DISEASE
of	I-DISEASE
the	0
move-	0
ments	I-DISEASE
,	0
HFT	0
and	0
ALMA	I-DISEASE
may	I-DISEASE
represent	0
variants	0
of	I-DISEASE
the	0
same	0
disorder	I-DISEASE
.	0

Insufficient	I-DISEASE
sci-	0

entific	I-DISEASE
evidence	0
has	0
accumulated	I-DISEASE
to	0
make	0
this	0
a	0
certainty	0
.	0

Thus	I-DISEASE
,	I-DISEASE
these	0
entities	0
are	0
listed	0
sequentially	I-DISEASE
but	0
separately	I-DISEASE
.	0

Of	I-DISEASE
note	I-DISEASE
,	0
some	I-DISEASE
have	0
questioned	I-DISEASE
whether	I-DISEASE
HFT	I-DISEASE
and	0
ALMA	0
might	I-DISEASE
represent	0
a	0
variant	I-DISEASE
of	I-DISEASE
rhythmic	I-DISEASE
movement	0
disorder	0
in	I-DISEASE
which	0
movements	0
are	0
confined	0
to	I-DISEASE
the	0
legs	I-DISEASE
and	0
an	I-DISEASE
older	0
population	0
is	0
affected	0
.	0

HFT	I-DISEASE
and	0
ALMA	I-DISEASE
should	I-DISEASE
be	I-DISEASE
distinguished	I-DISEASE
from	0
other	0
sleep	0
-	I-DISEASE
onset	I-DISEASE
movements	0
:	0
PLMD	0
(	0
especially	0
the	0
polyclonic	0
form	0
)	0
,	I-DISEASE
PSM	0
,	I-DISEASE
and	0
sleep	0
related	0
RMD	0
.	0

Movement	I-DISEASE
disorders	0
that	0
should	0
be	0
distinguished	I-DISEASE
from	0
HFT	I-DISEASE
and	0
ALMA	0
include	I-DISEASE
dyskinetic	I-DISEASE
movements	0
of	0
the	0
foot	0
,	0
such	0
as	0
painful	0
legs	I-DISEASE
and	0
moving	I-DISEASE
toes	0
;	I-DISEASE
tremors	0
or	0
rhythmic	I-DISEASE
movements	0
of	I-DISEASE
other	0
cause	I-DISEASE
(	0
Parkinson	0
disease	B-DISEASE
,	0
clonus	0
)	I-DISEASE
;	0
and	0
neuroleptic	0
-	0
induced	0
akathisia	I-DISEASE
.	0

None	I-DISEASE
of	I-DISEASE
these	0
conditions	I-DISEASE
involves	0
regular	I-DISEASE
alternation	0
between	0
sides	0
,	0
as	0
seen	I-DISEASE
in	I-DISEASE
ALMA	0
,	I-DISEASE
or	I-DISEASE
an	0
associ-	0
ation	I-DISEASE
with	I-DISEASE
the	0
use	I-DISEASE
of	I-DISEASE
antidepressant	I-DISEASE
medication	0
.	0

Whether	I-DISEASE
HFT	I-DISEASE
should	0
be	0
distinguished	I-DISEASE
from	0
ALMA	I-DISEASE
is	0
not	0
known	I-DISEASE
.	I-DISEASE

Potential	I-DISEASE
differences	I-DISEASE
based	B-DISEASE
on	0
existing	I-DISEASE
reports	I-DISEASE
include	I-DISEASE
the	0
presence	0
of	I-DISEASE
clear	I-DISEASE
movement	I-DISEASE
in	I-DISEASE
HFT	I-DISEASE
as	I-DISEASE
opposed	0
to	0
some	I-DISEASE
uncertainty	0
whether	I-DISEASE
ALMA	I-DISEASE
must	I-DISEASE
involve	0
movement	I-DISEASE
.	0

ALMA	I-DISEASE
,	0
in	I-DISEASE
contrast	0
to	I-DISEASE
HFT	I-DISEASE
,	0
alternates	I-DISEASE
between	0
sides	I-DISEASE
,	I-DISEASE
occurs	0
in	I-DISEASE
any	I-DISEASE
sleep	I-DISEASE
stage	0
,	0
can	0
occur	I-DISEASE
without	0
arousal	0
,	I-DISEASE
and	0
is	0
associated	0
with	0
the	I-DISEASE
use	I-DISEASE
of	I-DISEASE
antidepressants	0
.	0

Sleep	I-DISEASE
Related	0
Movement	0
Disorders	0
Sleep	I-DISEASE
Related	0
Movement	0
Disorders	I-DISEASE
High	0
-	0
frequency	I-DISEASE
leg	I-DISEASE
movements	0
(	0
HFLM	I-DISEASE
)	0
also	0
have	I-DISEASE
been	0
described	I-DISEASE
as	0
a	I-DISEASE
repetitive	I-DISEASE
ante-	B-DISEASE
rior	0
tibialis	0
,	0
polysomnographic	0
activation	I-DISEASE
phenomenon	0
,	I-DISEASE
possibly	I-DISEASE
showing	I-DISEASE
some	0
asso-	0
ciation	I-DISEASE
with	0
RLS	0
,	0
and	0
with	I-DISEASE
potential	I-DISEASE
overlap	0
with	0
HFT	I-DISEASE
and	0
ALMA	I-DISEASE
.	0

In	I-DISEASE
contrast	I-DISEASE
to	I-DISEASE
HFT	I-DISEASE
,	I-DISEASE
however	I-DISEASE
,	I-DISEASE
HFLM	I-DISEASE
occur	I-DISEASE
in	I-DISEASE
all	0
sleep	0
stages	I-DISEASE
,	I-DISEASE
and	0
are	0
mostly	I-DISEASE
unilateral	I-DISEASE
rather	0
than	I-DISEASE
bilateral	I-DISEASE
.	0

In	I-DISEASE
contrast	I-DISEASE
to	0
ALMA	I-DISEASE
,	I-DISEASE
HFLM	I-DISEASE
are	0
mostly	I-DISEASE
unilateral	I-DISEASE
rather	0
than	I-DISEASE
alternating	I-DISEASE
,	I-DISEASE
and	0
often	0
show	I-DISEASE
sequences	I-DISEASE
that	0
last	0
longer	I-DISEASE
than	I-DISEASE
those	0
reported	I-DISEASE
for	I-DISEASE
ALMA	I-DISEASE
.	B-DISEASE

The	I-DISEASE
reported	I-DISEASE
HFLM	I-DISEASE
may	I-DISEASE
be	I-DISEASE
more	0
common	I-DISEASE
than	0
ALMA	0
,	I-DISEASE
and	0
the	0
possibility	I-DISEASE
exists	I-DISEASE
that	I-DISEASE
ALMA	0
rep-	I-DISEASE
resents	B-DISEASE
a	0
subtype	I-DISEASE
of	I-DISEASE
HFLM	I-DISEASE
in	I-DISEASE
which	0
leg	I-DISEASE
alternation	0
occurs	0
.	0

The	I-DISEASE
degree	I-DISEASE
to	0
which	0
these	0
movements	0
are	0
quasi	B-DISEASE
-	0
voluntary	0
remains	0
to	I-DISEASE
be	I-DISEASE
determined	I-DISEASE
because	0
some	I-DISEASE
are	I-DISEASE
suppressible	0
.	0

Whether	0
HFT	I-DISEASE
and	0
ALMA	0
are	0
merely	0
alternate	I-DISEASE
forms	0
of	I-DISEASE
the	0
same	I-DISEASE
underlying	0
motor	0
mechanism	0
is	0
also	I-DISEASE
unclear	0
.	0

As	I-DISEASE
reports	0
of	I-DISEASE
these	I-DISEASE
move-	0
ments	0
have	0
arisen	I-DISEASE
from	I-DISEASE
reviews	0
of	I-DISEASE
sleep	0
center	0
records	I-DISEASE
,	I-DISEASE
nothing	0
is	0
known	I-DISEASE
about	0
their	I-DISEASE
manifestation	0
in	I-DISEASE
the	0
general	0
population	0
.	0

The	I-DISEASE
associations	I-DISEASE
noted	0
may	I-DISEASE
be	0
due	I-DISEASE
to	I-DISEASE
biased	I-DISEASE
sampling	0
caused	0
by	I-DISEASE
a	I-DISEASE
skewing	0
of	I-DISEASE
the	I-DISEASE
population	0
toward	0
those	I-DISEASE
with	I-DISEASE
sleep	0
disorders	0
,	I-DISEASE
especially	I-DISEASE
respiratory	0
disorders	0
.	0

The	I-DISEASE
degree	I-DISEASE
to	0
which	0
HFT	0
and	0
ALMA	I-DISEASE
have	0
clinical	0
significance	I-DISEASE
remains	I-DISEASE
uncertain	0
.	0

Bibliography	0
Berry	0
RB	0
.	0

A	I-DISEASE
woman	I-DISEASE
with	0
rhythmic	I-DISEASE
foot	0
movements	0
.	0

J	I-DISEASE
Clin	0
Sleep	0
Med	0
2007;3:749–51	I-DISEASE
.	0

Broughton	0
R.	I-DISEASE
Pathological	I-DISEASE
fragmentary	I-DISEASE
myoclonus	0
,	I-DISEASE
intensified	0
sleep	0
starts	0
and	0
hypnagogic	0
foot	0
tremor	0
:	0
three	0
unusual	I-DISEASE
sleep	0
-	0
related	B-DISEASE
disorders	0
.	0

In	I-DISEASE
:	0
Koella	0
WP	0
,	I-DISEASE
Schulz	I-DISEASE
OF	I-DISEASE
,	I-DISEASE
Visser	I-DISEASE
P	0
,	I-DISEASE
eds	I-DISEASE
.	0

Sleep	I-DISEASE
1986	I-DISEASE
.	0

Stuttgart	I-DISEASE
:	I-DISEASE

Fischer	I-DISEASE
-	0
Verlag	0
,	I-DISEASE
1988:240–3	0
.	0

Chervin	I-DISEASE
RD	I-DISEASE
,	I-DISEASE
Consens	0
FB	0
,	I-DISEASE
Kutluay	0
E.	0
Alternating	I-DISEASE
leg	I-DISEASE
muscle	0
activation	I-DISEASE
during	I-DISEASE
sleep	0
and	0
arousals	0
:	0
a	0
new	I-DISEASE
sleep	0
-	0
related	B-DISEASE
motor	I-DISEASE
phenomenon	0
?	0

Mov	I-DISEASE
Disord	0
2003;18:551–9	0
.	0

Consentino	0
FI	I-DISEASE
,	I-DISEASE
Iero	0
I	0
,	0
Lanuzza	I-DISEASE
B	0
,	0
Tripodi	0
M	0
,	0
Ferri	I-DISEASE
R.	I-DISEASE
The	I-DISEASE
neurophysiology	0
of	I-DISEASE
the	0
alternating	0
leg	I-DISEASE
muscle	I-DISEASE
activation	0
(	I-DISEASE
ALMA	0
)	0
during	I-DISEASE
sleep	0
:	0
Study	0
of	I-DISEASE
one	0
patient	I-DISEASE
before	0
and	0
after	0
treatment	I-DISEASE
with	0
pramipexole	0
.	0

Sleep	I-DISEASE
Med	I-DISEASE
2006;7:63–71	0
.	0

Cunningham	I-DISEASE
SL	I-DISEASE
,	0
Winkelman	I-DISEASE
JW	0
,	0
Dorsey	0
CM	0
,	I-DISEASE
et	0
al	I-DISEASE
.	0

An	I-DISEASE
electromyographic	I-DISEASE
marker	0
for	I-DISEASE
neuroleptic	0
-	0
induced	I-DISEASE
akathisia	I-DISEASE
:	I-DISEASE
preliminary	I-DISEASE
measures	I-DISEASE
of	0
sensitivity	0
and	0
specificity	I-DISEASE
.	0

Clin	I-DISEASE
Neuropharmacol	0
1996;19:321–32	0
.	0

Wichniak	I-DISEASE
A	0
,	I-DISEASE
Tracik	0
F	0
,	0
Geisler	I-DISEASE
P	0
,	I-DISEASE
Ebersbach	0
G	0
,	I-DISEASE
Morrissey	0
SP	0
,	I-DISEASE
Zulley	I-DISEASE
J.	0
Rhythmic	0
feet	0
movements	0
while	I-DISEASE
falling	0
asleep	I-DISEASE
.	0

Mov	I-DISEASE
Disord	0
2001;16:1164–70	I-DISEASE
.	0

Yang	I-DISEASE
C	0
,	0
Winkelman	I-DISEASE
JW	0
,	0
White	0
DP	0
.	I-DISEASE

The	I-DISEASE
effects	0
of	I-DISEASE
antidepressants	I-DISEASE
on	0
leg	I-DISEASE
movements	0
(	I-DISEASE
abstract	I-DISEASE
)	I-DISEASE
Sleep	I-DISEASE
2004;27(Abst	0
Suppl):A311–2	0
.	B-DISEASE

Yang	I-DISEASE
C	0
,	0
Winkelman	I-DISEASE
JW	0
.	0

Clinical	I-DISEASE
and	0
polysomnographic	0
characteristics	0
of	0
high	0
frequency	I-DISEASE
leg	I-DISEASE
movements	0
.	0

J	I-DISEASE
Clin	0
Sleep	0
Med	0
2010;6:431–8	I-DISEASE
.	0

Sleep	I-DISEASE
Starts	I-DISEASE
(	I-DISEASE
Hypnic	0
Jerks	0
)	0

Sleep	I-DISEASE
starts	I-DISEASE
,	0
also	0
known	0
as	0
hypnic	I-DISEASE
jerks	0
,	I-DISEASE
are	I-DISEASE
sudden	0
,	I-DISEASE
brief	I-DISEASE
,	I-DISEASE
simultaneous	0
contractions	0
of	I-DISEASE
the	0
body	I-DISEASE
or	I-DISEASE
one	I-DISEASE
or	0
more	0
body	I-DISEASE
segments	I-DISEASE
occurring	0
at	I-DISEASE
sleep	0
onset	0
.	0

Sleep	I-DISEASE
starts	0
(	0
or	I-DISEASE
hypnic	0
jerks	0
)	0
usually	I-DISEASE
consist	I-DISEASE
of	I-DISEASE
a	0
single	I-DISEASE
contraction	I-DISEASE
that	I-DISEASE
often	0
affects	I-DISEASE
the	0
body	I-DISEASE
asymmetrically	0
.	0

The	I-DISEASE
jerks	0
may	I-DISEASE
be	0
either	0
spontaneous	I-DISEASE
or	I-DISEASE
induced	0
by	0
stimuli	0
.	0

The	I-DISEASE
motor	I-DISEASE
activity	0
is	0
often	0
associated	0
with	I-DISEASE
a	I-DISEASE
sensory	0
component	0
,	0
which	0
may	I-DISEASE
be	I-DISEASE
somesthetic	0
,	I-DISEASE
often	0
an	0
impression	I-DISEASE
of	I-DISEASE
falling	0
or	0
less	I-DISEASE
commonly	I-DISEASE
pain	0
or	I-DISEASE
tingling	I-DISEASE
;	I-DISEASE
auditory	I-DISEASE
,	0
such	0
as	0
banging	0
,	0
snapping	0
or	I-DISEASE
crackling	I-DISEASE
noises	I-DISEASE
;	0
or	0
visual	I-DISEASE
,	0
including	I-DISEASE
flashing	I-DISEASE
lights	I-DISEASE
,	0
hypnagogic	0
dreams	I-DISEASE
,	I-DISEASE
or	0
hallucina-	0
tions	I-DISEASE
.	0

A	I-DISEASE
sharp	I-DISEASE
cry	0
may	I-DISEASE
occur	0
.	0

The	I-DISEASE
patient	I-DISEASE
may	0
not	0
recall	I-DISEASE
a	0
jerk	0
that	I-DISEASE
was	0
noted	0
by	I-DISEASE
a	0
bed	I-DISEASE
partner	0
if	0
the	0
sleep	0
start	I-DISEASE
does	0
not	0
cause	I-DISEASE
awakening	0
.	0

Multiple	0
jerks	0
occasionally	0
occur	0
in	I-DISEASE
succession	0
,	I-DISEASE
usually	I-DISEASE
early	0
in	0
the	0
sleep	I-DISEASE
period	I-DISEASE
.	0

When	I-DISEASE
sleep	0
starts	0
or	I-DISEASE
hypnic	0
jerks	0
are	0
frequent	I-DISEASE
,	I-DISEASE
intense	I-DISEASE
,	0
or	I-DISEASE
repetitive	I-DISEASE
,	I-DISEASE
they	0
may	0
lead	0
to	0
sleep	0
-	0
onset	0
insomnia	I-DISEASE
.	0

Purely	I-DISEASE
sensory	0
sleep	I-DISEASE
starts	0
are	I-DISEASE
subjective	I-DISEASE
,	I-DISEASE
localized	0
,	0
sensory	I-DISEASE
impressions	I-DISEASE
that	I-DISEASE
occur	I-DISEASE
at	I-DISEASE
sleep	0
onset	0
and	0
are	0
not	0
associated	0
with	I-DISEASE
motor	I-DISEASE
activity	0
.	0

The	I-DISEASE
term	0
“	0
Intensified	I-DISEASE
sleep	0
starts	I-DISEASE
”	I-DISEASE
has	0
been	I-DISEASE
applied	0
to	I-DISEASE
both	I-DISEASE
the	0
motor	I-DISEASE
and	0
purely	I-DISEASE
sensory	0
forms	0
when	0
a	0
complaint	I-DISEASE
of	I-DISEASE
difficulty	0
falling	I-DISEASE
asleep	0
as	0
a	0
result	0
of	I-DISEASE
the	0
starts	0
is	0
present	I-DISEASE
.	0

A	I-DISEASE
prevalence	0
of	I-DISEASE
60	I-DISEASE
%	0
to	I-DISEASE
70	0
%	0
has	0
been	I-DISEASE
reported	0
,	I-DISEASE
but	I-DISEASE
with	I-DISEASE
a	0
highly	I-DISEASE
sporadic	I-DISEASE
occurrence	0
.	0

Sleep	I-DISEASE
starts	0
affect	0
all	0
ages	0
and	0
both	I-DISEASE
sexes	I-DISEASE
.	0

Excessive	I-DISEASE
caffeine	0
or	I-DISEASE
other	I-DISEASE
stimulant	0
intake	I-DISEASE
,	I-DISEASE
prior	0
intense	0
physical	0
work	I-DISEASE
or	0
exercise	0
,	0
sleep	0
deprivation	0
,	0
and	0
emotional	0
stress	I-DISEASE
can	0
increase	I-DISEASE
the	0
frequency	I-DISEASE
and	0
severity	I-DISEASE
of	I-DISEASE
sleep	0
starts	I-DISEASE
.	0

Sleep	I-DISEASE
starts	I-DISEASE
are	0
an	0
essentially	0
universal	I-DISEASE
component	I-DISEASE
of	I-DISEASE
the	0
sleep	0
-	I-DISEASE
onset	I-DISEASE
process	I-DISEASE
,	I-DISEASE
although	0
they	I-DISEASE
are	I-DISEASE
often	I-DISEASE
not	0
recalled	0
.	0

Hypnic	I-DISEASE
jerks	0
may	0
occur	I-DISEASE
at	I-DISEASE
any	0
age	I-DISEASE
,	I-DISEASE
as	I-DISEASE
a	I-DISEASE
subjective	I-DISEASE
com-	I-DISEASE
plaint	I-DISEASE
;	0
however	I-DISEASE
,	0
they	I-DISEASE
are	0
usually	I-DISEASE
encountered	0
in	0
adulthood	0
.	0

The	I-DISEASE
course	I-DISEASE
is	0
usually	I-DISEASE
benign	0
.	0

Intensified	I-DISEASE
sleep	0
starts	0
may	I-DISEASE
lead	0
to	I-DISEASE
avoidance	0
/	0
delay	I-DISEASE
of	I-DISEASE
sleep	0
,	0
a	0
fear	0
of	I-DISEASE
falling	0
asleep	0
and	0
chronic	I-DISEASE
anxiety	I-DISEASE
.	0

As	I-DISEASE
a	0
result	0
,	I-DISEASE
acute	0
and	0
chronic	I-DISEASE
sleep	0
deprivation	0
may	I-DISEASE
occur	I-DISEASE
.	0

Sleep	I-DISEASE
-	I-DISEASE
onset	0
insomnia	I-DISEASE
may	I-DISEASE
result	I-DISEASE
either	0
from	0
repeated	I-DISEASE
awakenings	0
induced	0
by	I-DISEASE
the	0
starts	I-DISEASE
or	0
from	0
anxiety	I-DISEASE
about	0
falling	0
asleep	I-DISEASE
.	0

Injury	I-DISEASE
,	I-DISEASE
such	0
as	0
bruising	I-DISEASE
a	0
foot	0
against	I-DISEASE
a	I-DISEASE
bedstead	I-DISEASE
or	I-DISEASE
kicking	0
a	I-DISEASE
sleeping	0
companion	0
,	I-DISEASE
may	0
occasionally	0
occur	I-DISEASE
.	0

The	I-DISEASE
physiological	I-DISEASE
mechanisms	0
underlying	0
sleep	0
starts	I-DISEASE
are	0
uncertain	0
.	0

No	I-DISEASE
pathologic	0
finding	0
has	0
been	I-DISEASE
described	I-DISEASE
except	0
for	0
a	0
single	I-DISEASE
case	I-DISEASE
of	I-DISEASE
auditory	0
sleep	0
starts	I-DISEASE
associated	0
with	0
a	0
brainstem	0
lesion	0
.	0

Hypnic	I-DISEASE
jerks	0
are	0
hypothetically	I-DISEASE
caused	I-DISEASE
by	I-DISEASE
sudden	0
descending	0
volleys	0
originating	0
in	I-DISEASE
the	0
brainstem	0
reticular	0
formation	0
activated	I-DISEASE
by	I-DISEASE
the	0
system	0
insta-	0
bility	0
at	0
the	0
transition	0
between	0
wake	0
and	0
sleep	0
.	0

However	I-DISEASE
,	I-DISEASE
the	0
similarity	0
between	0
sleep	0
starts	0
and	0
the	0
startle	0
response	0
has	I-DISEASE
led	I-DISEASE
some	0
to	0
postulate	0
that	0
abnormalities	0
of	I-DISEASE
sensory	0
Sleep	0
Related	0
Movement	0
Disorders	I-DISEASE
Sleep	0
Related	I-DISEASE
Movement	0
Disorders	I-DISEASE
processing	0
are	0
primary	0
,	0
with	0
secondary	0
motor	0
manifestations	0
involving	I-DISEASE
the	I-DISEASE
reticulo-	0
spinal	I-DISEASE
tract	I-DISEASE
.	0

Sleep	I-DISEASE
starts	I-DISEASE
are	0
a	I-DISEASE
prominent	0
symptom	0
in	I-DISEASE
hereditary	0
hyperekplexia	I-DISEASE
,	I-DISEASE
some	I-DISEASE
cases	0
of	I-DISEASE
which	0
are	0
caused	I-DISEASE
by	I-DISEASE
mutations	0
in	I-DISEASE
the	0
glycine	I-DISEASE
receptor	I-DISEASE
.	0

It	I-DISEASE
has	0
also	0
been	I-DISEASE
postu-	0
lated	I-DISEASE
that	0
sleep	0
starts	I-DISEASE
are	I-DISEASE
a	I-DISEASE
response	0
to	I-DISEASE
hypnagogic	I-DISEASE
imagery	I-DISEASE
.	0

Polysomnographic	I-DISEASE
monitoring	0
shows	I-DISEASE
that	0
hypnic	0
jerks	I-DISEASE
occur	0
during	I-DISEASE
transitions	I-DISEASE
from	I-DISEASE
wakefulness	0
to	I-DISEASE
sleep	0
,	0
mainly	0
at	I-DISEASE
the	I-DISEASE
beginning	0
of	I-DISEASE
the	0
sleep	0
episode	I-DISEASE
.	0

Superficial	I-DISEASE
EMG	0
recordings	I-DISEASE
of	I-DISEASE
the	B-DISEASE
involved	0
muscles	0
show	I-DISEASE
brief	I-DISEASE
(	I-DISEASE
generally	I-DISEASE
75	0
-	I-DISEASE
millisecond	I-DISEASE
to	I-DISEASE
250	0
-	0
mil-	0
lisecond	0
)	0
high	I-DISEASE
-	0
amplitude	0
potentials	0
,	0
either	0
singly	0
or	0
in	I-DISEASE
succession	0
.	0

The	I-DISEASE
EEG	0
typically	0
shows	0
drowsiness	0
or	0
stage	0
N1	0
sleep	I-DISEASE
patterns	I-DISEASE
,	0
sometimes	0
with	0
a	I-DISEASE
negative	0
-	0
vertex	I-DISEASE
sharp	0
wave	I-DISEASE
occurring	0
at	I-DISEASE
the	0
time	0
of	I-DISEASE
the	0
jerk	0
.	0

Autonomic	I-DISEASE
activation	0
,	0
including	0
tachycardia	0
,	0
tachypnea	0
or	0
irregular	I-DISEASE
breathing	I-DISEASE
,	0
and	0
sudomotor	0
activation	0
may	I-DISEASE
follow	0
an	0
intense	0
jerk	0
.	0

After	I-DISEASE
the	0
jerk	0
,	I-DISEASE
a	0
brief	I-DISEASE
arousal	0
or	I-DISEASE
a	0
return	0
to	0
sustained	0
wakefulness	I-DISEASE
may	0
occur	I-DISEASE
.	0

Physical	I-DISEASE
and	0
neurological	0
examinations	I-DISEASE
and	0
routine	I-DISEASE
laboratory	B-DISEASE
tests	0
are	0
otherwise	0
normal	0
.	0

Although	I-DISEASE
polysomnography	0
is	I-DISEASE
not	0
necessary	0
for	0
diagnosis	I-DISEASE
in	I-DISEASE
most	0
individuals	I-DISEASE
,	I-DISEASE
it	0
may	I-DISEASE
be	0
indicated	0
in	I-DISEASE
occasional	0
cases	0
with	I-DISEASE
complaints	0
of	I-DISEASE
insomnia	0
and	0
frequent	I-DISEASE
movements	0
.	0

Hypnic	I-DISEASE
jerks	0
must	0
be	I-DISEASE
differentiated	0
from	0
a	0
number	0
of	I-DISEASE
physiological	I-DISEASE
or	0
pathologic	I-DISEASE
movements	0
that	0
occur	I-DISEASE
at	I-DISEASE
sleep	0
onset	0
or	0
during	I-DISEASE
sleep	0
.	0

Physiological	0
partial	I-DISEASE
hypnic	0
myoclonus	0
consists	I-DISEASE
of	0
small	0
,	I-DISEASE
isolated	I-DISEASE
contractions	0
of	I-DISEASE
a	0
muscle	0
or	0
part	I-DISEASE
thereof	I-DISEASE
,	0
occur-	I-DISEASE
ring	I-DISEASE
sporadically	0
in	0
distal	0
muscles	0
and	0
resembling	I-DISEASE
fasciculation	0
potentials	I-DISEASE
.	0

The	I-DISEASE
con-	0
tractions	I-DISEASE
are	0
particularly	0
evident	I-DISEASE
during	I-DISEASE
stage	0
N1	0
and	0
REM	I-DISEASE
sleep	0
.	0

Fragmentary	I-DISEASE
myoclonus	0
consists	I-DISEASE
of	I-DISEASE
profuse	0
,	I-DISEASE
brief	I-DISEASE
,	I-DISEASE
small	0
-	I-DISEASE
amplitude	0
muscle	I-DISEASE
twitches	0
that	0
occur	I-DISEASE
in	I-DISEASE
an	0
asynchronous	0
,	I-DISEASE
symmetrical	I-DISEASE
,	I-DISEASE
and	0
bilateral	0
manner	0
,	0
especially	0
in	0
distal	0
muscles	0
.	0

Fragmentary	I-DISEASE
myoclonus	0
occurs	I-DISEASE
at	I-DISEASE
sleep	0
onset	0
as	0
well	I-DISEASE
as	I-DISEASE
within	B-DISEASE
all	0
sleep	0
stages	I-DISEASE
.	0

Contrary	0
to	I-DISEASE
the	0
massive	0
jerks	0
of	0
the	0
sleep	0
starts	0
or	I-DISEASE
hypnic	I-DISEASE
jerks	0
,	0
the	0
small	0
muscle	0
twitches	0
of	I-DISEASE
physiological	0
partial	I-DISEASE
hypnic	0
myoclonus	0
and	0
of	0
fragmentary	0
myoclonus	0
often	0
represent	0
only	I-DISEASE
an	0
EMG	0
finding	0
and	0
are	0
not	0
associated	0
with	0
overt	I-DISEASE
movements	0
at	I-DISEASE
the	0
joints	0
.	I-DISEASE

Normal	I-DISEASE
body	I-DISEASE
movements	0
are	I-DISEASE
complex	0
,	I-DISEASE
with	I-DISEASE
body	I-DISEASE
postural	0
shifts	B-DISEASE
usually	I-DISEASE
at	I-DISEASE
the	0
transition	0
between	0
one	0
sleep	0
stage	0
and	0
another	I-DISEASE
.	0

Benign	I-DISEASE
sleep	0
myoclonus	0
of	I-DISEASE
infancy	0
consists	0
of	I-DISEASE
myoclonic	0
jerks	0
at	I-DISEASE
the	0
elbow	0
,	I-DISEASE
fingers	0
,	0
toes	0
,	I-DISEASE
and	0
face	0
during	I-DISEASE
sleep	0
in	I-DISEASE
infants	0
.	0

PSM	I-DISEASE
is	0
characterized	0
by	0
jerks	0
,	I-DISEASE
usually	I-DISEASE
spontaneous	0
,	0
but	I-DISEASE
sometimes	I-DISEASE
also	0
evoked	0
,	I-DISEASE
arising	I-DISEASE
first	0
in	0
spinal	0
innervated	0
axial	0
muscles	0
of	0
the	0
trunk	0
,	I-DISEASE
neck	0
,	I-DISEASE
or	0
abdomen	0
and	0
then	0
prop-	I-DISEASE
agated	0
at	I-DISEASE
slow	0
velocity	0
to	0
more	0
rostral	I-DISEASE
and	0
caudal	0
muscles	0
.	0

PSM	I-DISEASE
is	0
present	I-DISEASE
during	I-DISEASE
relaxed	0
wakefulness	0
,	0
characterized	0
by	I-DISEASE
diffuse	I-DISEASE
EEG	0
alpha	I-DISEASE
activity	I-DISEASE
,	0
and	0
disappears	I-DISEASE
with	I-DISEASE
sleep	0
onset	0
or	0
mental	I-DISEASE
activation	0
.	0

PSM	I-DISEASE
is	0
usually	I-DISEASE
a	0
chronic	I-DISEASE
condition	0
associated	0
with	0
sleep	0
-	0
onset	I-DISEASE
insomnia	I-DISEASE
.	0

Excessive	I-DISEASE
startling	0
and	0
hypnic	I-DISEASE
jerks	0
may	I-DISEASE
occur	I-DISEASE
as	0
part	0
of	I-DISEASE
the	0
hyperekplexia	I-DISEASE
syndrome	I-DISEASE
,	0
in	I-DISEASE
which	I-DISEASE
generalized	0
myoclonus	0
is	0
readily	I-DISEASE
elicited	0
by	I-DISEASE
stimuli	0
during	I-DISEASE
either	0
wakeful-	0
ness	0
or	I-DISEASE
sleep	I-DISEASE
.	0

The	I-DISEASE
major	I-DISEASE
form	0
of	I-DISEASE
this	0
condition	0
is	I-DISEASE
also	0
characterized	0
by	I-DISEASE
stiffness	0
and	0
falls	I-DISEASE
.	0

Brief	0
epileptic	0
myoclonus	0
can	0
be	0
differentiated	0
by	I-DISEASE
coexistent	I-DISEASE
EEG	I-DISEASE
discharge	0
,	0
the	0
presence	0
of	I-DISEASE
other	0
features	I-DISEASE
of	0
epileptic	0
seizures	I-DISEASE
,	0
and	0
the	0
occurrence	0
of	I-DISEASE
the	0
myoclonus	0
in	0
both	0
wakefulness	0
and	0
during	I-DISEASE
sleep	I-DISEASE
rather	0
than	0
only	0
at	0
sleep	0
onset	0
.	0

The	I-DISEASE
muscle	0
contractions	0
of	0
PLMD	0
are	0
much	0
longer	0
in	I-DISEASE
duration	I-DISEASE
,	I-DISEASE
involve	0
mainly	0
the	0
feet	I-DISEASE
and	0
lower	0
legs	0
,	0
show	I-DISEASE
periodicity	I-DISEASE
,	I-DISEASE
and	0
occur	I-DISEASE
within	I-DISEASE
sleep	0
.	0

RLS	I-DISEASE
consists	0
of	I-DISEASE
slower	0
and	0
repetitive	I-DISEASE
semivoluntary	0
movements	0
at	I-DISEASE
sleep	I-DISEASE
onset	0
that	0
are	I-DISEASE
associated	0
with	0
deep	0
,	I-DISEASE
unpleasant	0
,	0
and	0
sometimes	0
unbearable	I-DISEASE
sensations	I-DISEASE
,	I-DISEASE
which	I-DISEASE
are	I-DISEASE
temporarily	I-DISEASE
relieved	I-DISEASE
by	B-DISEASE
getting	I-DISEASE
up	0
and	0
exercising	0
.	0

Bibliography	0
Broughton	0
R.	I-DISEASE
Pathological	I-DISEASE
fragmentary	0
myoclonus	I-DISEASE
,	I-DISEASE
intensified	I-DISEASE
sleep	0
starts	0
and	0
hypnagogic	0
foot	I-DISEASE
tremor	0
:	B-DISEASE
three	0
unusual	I-DISEASE
sleep	0
-	0
related	0
disorders	0
.	0

In	I-DISEASE
:	0
Koella	0
WP	0
,	I-DISEASE
Schulz	I-DISEASE
OF	I-DISEASE
,	I-DISEASE
Visser	I-DISEASE
P	0
,	I-DISEASE
eds	I-DISEASE
.	0

Sleep	I-DISEASE
1986	I-DISEASE
.	0

Stuttgart	I-DISEASE
:	0
Fisher	0
Verlag	0
;	0
1988:240–3	0
.	0

Kennard	0
MA	0
,	I-DISEASE
Schwartzman	0
AE	0
,	0
Millar	0
TP	0
.	0

Sleep	I-DISEASE
,	I-DISEASE
consciousness	0
,	I-DISEASE
and	0
the	I-DISEASE
alpha	I-DISEASE
electroencephalographic	I-DISEASE
rhythm	I-DISEASE
.	0

Arch	I-DISEASE
Neurol	0
Psychiatry	0
1958;79:328–35	0
.	0

Montagna	I-DISEASE
P	0
,	0
Liguori	I-DISEASE
R	I-DISEASE
,	0
Zucconi	I-DISEASE
M	I-DISEASE
,	I-DISEASE
et	0
al	I-DISEASE
.	0

Physiological	0
hypnic	0
myoclonus	0
.	I-DISEASE

Electroencephalgr	I-DISEASE
Clin	0
Neurophysiol	0
1988;70:172–6	0
.	0

Oswald	I-DISEASE
I.	0
Sudden	I-DISEASE
bodily	0
jerks	0
on	0
falling	0
asleep	I-DISEASE
.	0

Brain	0
1959;82:92–103	0
.	0

Salih	I-DISEASE
F	I-DISEASE
,	I-DISEASE
Klingebiel	0
R	0
,	0
Zschenderlein	I-DISEASE
R	0
,	I-DISEASE
et	0
al	I-DISEASE
.	0

Acoustic	I-DISEASE
sleep	0
starts	0
with	I-DISEASE
sleep	0
-	0
onset	0
insomnia	I-DISEASE
related	B-DISEASE
to	I-DISEASE
a	I-DISEASE
brainstem	B-DISEASE
lesion	0
.	0

Neurology	0
2008;70:1935–7	I-DISEASE
.	0

Sander	I-DISEASE
HW	I-DISEASE
,	0
Geisse	I-DISEASE
H	I-DISEASE
,	0
Quinto	I-DISEASE
C	I-DISEASE
,	0
Sachdeo	I-DISEASE
R	0
,	I-DISEASE
Chokroverty	0
S.	0
Sensory	I-DISEASE
sleep	I-DISEASE
starts	0
.	0

J	I-DISEASE
Neurol	0
Neurosurg	0
Psychiatry	0
1998;64:690	I-DISEASE
.	0

Vetrugno	I-DISEASE
R	0
,	I-DISEASE
Montagna	0
P.	0
Sleep	I-DISEASE
-	I-DISEASE
to	I-DISEASE
-	0
wake	0
transition	I-DISEASE
movement	I-DISEASE
disorders	0
.	0

Sleep	I-DISEASE
Med	I-DISEASE
2011;12	I-DISEASE
:	0
S11–6	I-DISEASE
.	0

Sleep	I-DISEASE
Related	0
Movement	0
Disorders	0
Other	I-DISEASE
Sleep	0
Disorder	0
ICD-9	I-DISEASE
-	I-DISEASE
CM	I-DISEASE
code	0
:	I-DISEASE
327.8	0
ICD-10	I-DISEASE
-	I-DISEASE
CM	I-DISEASE
code	0
:	0

G47.8	I-DISEASE
Sleep	0
disorders	0
that	0
can	I-DISEASE
not	0
be	0
classified	0
elsewhere	I-DISEASE
in	I-DISEASE
the	0
International	0
Classification	I-DISEASE
of	I-DISEASE
Sleep	I-DISEASE
Disorders	0
,	0
3rd	0
Edition	I-DISEASE
are	I-DISEASE
listed	I-DISEASE
here	0
.	I-DISEASE

This	I-DISEASE
may	I-DISEASE
be	0
due	I-DISEASE
to	0
the	0
fact	I-DISEASE
that	I-DISEASE
the	0
sleep	0
disorder	0
overlaps	0
more	0
than	0
one	0
category	I-DISEASE
or	I-DISEASE
,	0
more	0
often	0
,	0
when	I-DISEASE
insufficient	0
data	I-DISEASE
have	I-DISEASE
been	I-DISEASE
collected	I-DISEASE
to	0
firmly	I-DISEASE
establish	I-DISEASE
another	I-DISEASE
diagnosis	I-DISEASE
.	0

It	I-DISEASE
is	I-DISEASE
also	0
possible	I-DISEASE
that	0
new	I-DISEASE
sleep	0
disorders	0
that	0
do	0
not	0
fall	I-DISEASE
within	I-DISEASE
any	I-DISEASE
of	I-DISEASE
the	0
current	I-DISEASE
major	I-DISEASE
categories	0
will	0
be	I-DISEASE
dis-	0
covered	0
during	I-DISEASE
the	0
lifetime	0
of	I-DISEASE
the	I-DISEASE
International	0
Classification	I-DISEASE
of	I-DISEASE
Sleep	0
Disorders	I-DISEASE
,	0
3rd	0
Edition	0
.	0

When	I-DISEASE
a	0
specific	I-DISEASE
diagnosis	I-DISEASE
can	0
not	0
yet	0
be	I-DISEASE
determined	I-DISEASE
but	0
the	0
presenting	0
problem	I-DISEASE
clearly	B-DISEASE
falls	0
into	I-DISEASE
a	0
specific	I-DISEASE
category	0
(	0
e.g.	0
,	I-DISEASE
a	I-DISEASE
circadian	0
rhythm	0
sleep	0
-	0
wake	B-DISEASE
dis-	0
order	0
)	0
,	0
the	0
“	0
unspecified	0
”	I-DISEASE
diagnosis	I-DISEASE
within	I-DISEASE
that	0
category	0
(	I-DISEASE
e.g.	0
,	0
circadian	0
rhythm	I-DISEASE
sleep-	0
wake	0
disorder	0
,	I-DISEASE
unspecified	I-DISEASE
)	0
is	I-DISEASE
preferred	0
.	0

The	I-DISEASE
International	0
Classification	I-DISEASE
of	I-DISEASE
Sleep	0
Disorders	I-DISEASE
,	0
2nd	0
Edition	I-DISEASE
included	I-DISEASE
a	I-DISEASE
specific	I-DISEASE
diagnosis	I-DISEASE
of	I-DISEASE
environmental	I-DISEASE
sleep	I-DISEASE
disorder	0
within	0
this	0
section	0
.	0

This	I-DISEASE
diagnosis	I-DISEASE
is	0
infre-	I-DISEASE
quently	I-DISEASE
employed	0
in	I-DISEASE
the	0
clinical	I-DISEASE
setting	0
and	0
significant	0
controversy	I-DISEASE
exists	I-DISEASE
regarding	0
whether	0
environmentally	I-DISEASE
induced	I-DISEASE
sleep	0
disturbance	I-DISEASE
represents	I-DISEASE
a	0
clinical	0
disorder	0
per	I-DISEASE
se	I-DISEASE
.	0

The	I-DISEASE
condition	0
is	0
typically	0
characterized	0
by	I-DISEASE
complaints	0
of	I-DISEASE
sleep	0
initiation	I-DISEASE
and/or	0
maintenance	I-DISEASE
that	0
are	0
the	0
direct	I-DISEASE
result	0
of	0
an	0
environmental	I-DISEASE
factor	I-DISEASE
.	0

Associated	I-DISEASE
daytime	I-DISEASE
symptoms	I-DISEASE
such	0
as	0
sleepiness	0
,	I-DISEASE
fatigue	I-DISEASE
,	0
or	0
cognitive	0
or	I-DISEASE
emotional	I-DISEASE
disturbance	0
may	0
be	I-DISEASE
present	I-DISEASE
.	0

The	I-DISEASE
environmental	I-DISEASE
disturbance	0
may	I-DISEASE
be	0
a	0
physical	0
stimulus	0
such	0
as	0
noise	0
(	I-DISEASE
e.g.	I-DISEASE
,	I-DISEASE
vehicular	I-DISEASE
traffic	0
,	0
aircraft	0
,	I-DISEASE
bed	I-DISEASE
partner	0
snoring	0
)	0
,	I-DISEASE
light	0
,	0
temperature	B-DISEASE
,	I-DISEASE
movement	I-DISEASE
(	I-DISEASE
e.g.	0
,	0
bed	0
partner	0
movement	I-DISEASE
disorder	I-DISEASE
or	I-DISEASE
parasomnia	I-DISEASE
)	0
,	0
an	0
emotional	0
stimulus	0
such	I-DISEASE
as	0
environ-	0
mental	I-DISEASE
danger	I-DISEASE
(	I-DISEASE
e.g.	0
,	I-DISEASE
combat	I-DISEASE
setting	0
or	0
disaster	0
area	0
)	0
,	0
or	0
an	0
environmental	I-DISEASE
requirement	0
(	I-DISEASE
such	0
as	I-DISEASE
caring	0
for	0
an	I-DISEASE
infant	0
or	I-DISEASE
elderly	I-DISEASE
family	0
member	0
)	0
.	B-DISEASE

Hospitalization	I-DISEASE
is	0
often	I-DISEASE
cited	0
as	0
a	0
precipitant	I-DISEASE
of	I-DISEASE
environmental	I-DISEASE
sleep	0
disturbance	0
although	0
many	0
additional	0
factors	0
(	0
e.g.	0
,	I-DISEASE
anxiety	I-DISEASE
or	0
pain	0
)	0
may	I-DISEASE
also	0
contribute	0
to	0
sleep	0
disturbance	I-DISEASE
in	I-DISEASE
this	0
setting	0
.	0

If	I-DISEASE
the	0
clinician	0
determines	0
that	0
an	0
environmental	I-DISEASE
factor	I-DISEASE
is	0
the	0
primary	0
cause	I-DISEASE
of	I-DISEASE
a	0
sleep	0
distur-	I-DISEASE
bance	I-DISEASE
,	I-DISEASE
a	0
diagnosis	0
of	I-DISEASE
Other	0
Sleep	I-DISEASE
Disorder	0
may	I-DISEASE
be	0
employed	0
.	0

It	I-DISEASE
is	I-DISEASE
the	0
physical	0
aspects	0
of	I-DISEASE
the	0
environment	0
,	0
rather	0
than	I-DISEASE
their	I-DISEASE
psychological	I-DISEASE
meaning	I-DISEASE
,	0
which	0
account	0
for	I-DISEASE
the	0
sleep	0
complaint	I-DISEASE
.	0

Unlike	I-DISEASE
insomnia	I-DISEASE
disorder	0
,	I-DISEASE
the	0
sleep	0
disturbance	0
is	0
dependent	0
on	0
the	I-DISEASE
presence	0
of	I-DISEASE
the	0
environmental	I-DISEASE
factor	I-DISEASE
.	0

In	I-DISEASE
the	0
absence	I-DISEASE
of	I-DISEASE
the	0
stimu-	0
lus	0
,	I-DISEASE
sleep	I-DISEASE
is	I-DISEASE
normal	0
.	0

The	I-DISEASE
prevalence	0
of	I-DISEASE
environmentally	I-DISEASE
induced	I-DISEASE
sleep	0
disturbances	I-DISEASE
is	0
not	0
known	I-DISEASE
although	I-DISEASE
,	I-DISEASE
as	0
noted	0
,	I-DISEASE
the	I-DISEASE
diagnosis	0
is	0
not	0
commonly	I-DISEASE
reported	0
in	0
sleep	0
centers	I-DISEASE
.	0

Some	I-DISEASE
individuals	I-DISEASE
Other	0
Sleep	0
Disorder	0
may	I-DISEASE
be	0
more	0
susceptible	0
to	I-DISEASE
environmental	I-DISEASE
disturbances	I-DISEASE
but	I-DISEASE
little	0
is	I-DISEASE
known	0
about	0
spe-	0
cific	B-DISEASE
characteristics	I-DISEASE
that	0
might	I-DISEASE
predispose	0
to	B-DISEASE
this	0
condition	0
.	0

Although	I-DISEASE
environmental	I-DISEASE
factors	0
may	I-DISEASE
play	0
a	0
contributing	0
role	0
in	0
some	I-DISEASE
cases	0
of	I-DISEASE
chronic	I-DISEASE
insomnia	I-DISEASE
disorder	I-DISEASE
,	I-DISEASE
multiple	0
other	0
factors	I-DISEASE
account	0
for	I-DISEASE
that	0
condition	0
,	I-DISEASE
which	0
is	I-DISEASE
typically	0
evident	I-DISEASE
even	I-DISEASE
in	I-DISEASE
the	0
absence	I-DISEASE
of	I-DISEASE
the	0
offending	I-DISEASE
environmental	I-DISEASE
stimulus	0
.	0

Distinguishing	I-DISEASE
an	0
insomnia	I-DISEASE
disorder	0
from	0
an	0
environmentally	I-DISEASE
induced	I-DISEASE
sleep	0
disturbance	I-DISEASE
may	I-DISEASE
pose	I-DISEASE
a	0
challenge	0
in	I-DISEASE
certain	0
clinical	0
encounters	I-DISEASE
and	0
providers	I-DISEASE
must	0
use	I-DISEASE
clinical	0
judgment	I-DISEASE
in	I-DISEASE
establishing	B-DISEASE
the	0
diagnosis	I-DISEASE
.	0

In	I-DISEASE
behavioral	0
insomnia	0
of	I-DISEASE
childhood	0
,	I-DISEASE
the	0
child	0
may	0
require	I-DISEASE
certain	I-DISEASE
environmental	I-DISEASE
cir-	0
cumstances	I-DISEASE
in	I-DISEASE
order	0
to	0
sleep	0
(	0
e.g.	I-DISEASE
,	I-DISEASE
a	0
pacifier	0
,	0
music	0
,	0
lights	I-DISEASE
,	0
television	0
,	0
or	0
a	0
parent	0
)	0
.	0

It	I-DISEASE
is	I-DISEASE
the	0
absence	I-DISEASE
of	0
these	I-DISEASE
circumstances	0
that	0
results	0
in	0
sleep	0
initiation	I-DISEASE
or	I-DISEASE
maintenance	I-DISEASE
prob-	0
lems	I-DISEASE
.	0

In	I-DISEASE
such	I-DISEASE
cases	0
,	I-DISEASE
a	0
diagnosis	I-DISEASE
of	I-DISEASE
chronic	I-DISEASE
insomnia	I-DISEASE
disorder	0
(	I-DISEASE
behavioral	I-DISEASE
insomnia	0
of	I-DISEASE
childhood	0
–	0
sleep	I-DISEASE
-	I-DISEASE
onset	I-DISEASE
association	B-DISEASE
type	I-DISEASE
)	I-DISEASE
is	0
indicated	I-DISEASE
.	0

Bibliography	0
Basner	0
M	I-DISEASE
,	0
Griefahn	I-DISEASE
B	0
,	I-DISEASE
Berg	I-DISEASE
MV	0
.	0

Aircraft	I-DISEASE
noise	0
effects	0
on	0
sleep	0
:	I-DISEASE
mechanisms	I-DISEASE
,	I-DISEASE
mitigation	0
and	0
research	I-DISEASE
needs	I-DISEASE
.	0

Noise	I-DISEASE
Health	0
2010;12:95–109	0
.	0

Hume	I-DISEASE
KI	0
,	I-DISEASE
Brink	0
M	I-DISEASE
,	0
Basner	0
M.	I-DISEASE
Effects	0
of	I-DISEASE
environmental	I-DISEASE
noise	0
on	0
sleep	0
.	0

Noise	I-DISEASE
Health	I-DISEASE
.	0

2012;14:297–302	I-DISEASE
.	0

Thiessen	I-DISEASE
G	I-DISEASE
,	I-DISEASE
Lapointe	I-DISEASE
A.	0
Effect	I-DISEASE
of	I-DISEASE
continuous	I-DISEASE
traffic	0
noise	0
on	0
percentage	I-DISEASE
of	I-DISEASE
deep	0
sleep	I-DISEASE
,	I-DISEASE
waking	0
,	I-DISEASE
and	0
sleep	I-DISEASE
latency	0
.	0

J	I-DISEASE
Acoust	0
Soc	0
Amer	I-DISEASE
1983;73:225–9	0
.	0

Yilmaz	I-DISEASE
M	I-DISEASE
,	0
Sayin	I-DISEASE
Y	I-DISEASE
,	I-DISEASE
Gurler	I-DISEASE
H.	I-DISEASE
Sleep	0
quality	0
of	I-DISEASE
hospitalized	I-DISEASE
patients	0
in	I-DISEASE
surgical	0
units	I-DISEASE
.	0

Nurs	0
Forum	0
2012;47:183–92	I-DISEASE
.	0

Appendix	I-DISEASE
A	0
:	I-DISEASE
Sleep	0
Related	0
Medical	0
and	0
Neurological	0
Disorders	0
Fatal	I-DISEASE
Familial	0
Insomnia342	I-DISEASE
Sleep	0
Related	I-DISEASE
Epilepsy	0
345	0
Sleep	0
Related	0
Headaches350	B-DISEASE
Sleep	0
Related	0
Laryngospasm	I-DISEASE
355	0
Sleep	0
Related	0
Gastroesophageal	0
Reflux	0
358	0
Sleep	0
Related	I-DISEASE
Myocardial	I-DISEASE
Ischemia	0
363	I-DISEASE
The	I-DISEASE
disorders	0
presented	I-DISEASE
in	0
this	I-DISEASE
section	0
may	0
have	I-DISEASE
a	0
unique	I-DISEASE
presentation	0
during	I-DISEASE
the	0
sleep	0
period	I-DISEASE
or	0
may	0
present	0
exclusively	I-DISEASE
in	I-DISEASE
association	I-DISEASE
with	0
sleep	0
.	I-DISEASE

Some	I-DISEASE
of	I-DISEASE
these	I-DISEASE
disorders	0
(	0
e.g.	0
,	0
sleep	0
related	I-DISEASE
epilepsy	I-DISEASE
and	0
sleep	0
related	I-DISEASE
headache	0
)	0
may	I-DISEASE
be	0
encountered	0
during	I-DISEASE
evaluation	0
for	I-DISEASE
other	0
sleep	0
disorders	0
.	0

In	I-DISEASE
addition	0
,	0
some	I-DISEASE
of	0
these	I-DISEASE
disorders	0
are	I-DISEASE
in	0
the	0
dif-	I-DISEASE
ferential	I-DISEASE
diagnosis	I-DISEASE
of	I-DISEASE
other	0
sleep	0
-	I-DISEASE
wake	0
disorders	0
.	0

Sleep	I-DISEASE
related	I-DISEASE
epilepsy	0
must	I-DISEASE
be	0
con-	I-DISEASE
sidered	0
in	I-DISEASE
the	I-DISEASE
differential	I-DISEASE
diagnosis	0
of	I-DISEASE
certain	0
movement	I-DISEASE
disorders	0
and	0
parasomnias	I-DISEASE
.	0

Sleep	I-DISEASE
related	I-DISEASE
headaches	0
may	0
be	I-DISEASE
a	0
clue	I-DISEASE
to	0
the	0
presence	0
of	I-DISEASE
sleep	I-DISEASE
apnea	I-DISEASE
.	0

Sleep	I-DISEASE
related	0
gastroesophageal	0
reflux	0
may	I-DISEASE
either	I-DISEASE
be	I-DISEASE
a	0
precipitant	0
of	0
a	0
sleep	0
apnea	0
episode	I-DISEASE
or	0
be	I-DISEASE
trig-	0
gered	0
by	B-DISEASE
sleep	0
apnea	0
with	I-DISEASE
aspiration	0
pneumonia	I-DISEASE
as	0
its	0
most	0
serious	0
consequence	0
.	0

Sleep	I-DISEASE
related	0
myocardial	0
ischemia	0
is	0
an	0
important	0
consideration	I-DISEASE
because	0
myocardial	0
infarc-	0
tion	0
has	0
a	I-DISEASE
predilection	0
for	I-DISEASE
the	0
early	0
morning	0
hours	I-DISEASE
during	I-DISEASE
the	0
latter	0
phase	0
of	I-DISEASE
the	0
sleep	0
period	0
and	0
may	I-DISEASE
be	I-DISEASE
precipitated	I-DISEASE
by	I-DISEASE
episodes	I-DISEASE
of	0
sleep	0
apnea	0
.	0

It	I-DISEASE
is	I-DISEASE
important	0
to	I-DISEASE
be	0
aware	I-DISEASE
of	I-DISEASE
sleep	0
related	B-DISEASE
laryngospasm	0
as	0
a	0
potentially	I-DISEASE
life	I-DISEASE
-	0
threatening	0
consequence	0
of	I-DISEASE
neurode-	0
generative	0
diseases	0
such	0
as	0
multiple	I-DISEASE
system	0
atrophy	I-DISEASE
.	0

Fatal	I-DISEASE
familial	0
insomnia	I-DISEASE
,	0
although	0
rare	I-DISEASE
,	I-DISEASE
presents	I-DISEASE
with	I-DISEASE
severe	0
insomnia	I-DISEASE
and	0
has	0
a	0
well	I-DISEASE
-	0
understood	0
neuropathology	0
.	0

Appendix	I-DISEASE
A	0
:	I-DISEASE
Sleep	0
Related	0
Medical	0
and	0
Neurological	0
Disorders	0
Fatal	I-DISEASE
Familial	0
Insomnia	I-DISEASE
Alternate	0
Names	I-DISEASE
Fatal	0
progressive	0
insomnia	I-DISEASE
with	I-DISEASE
dysautonomia	0
,	0
familial	0
thalamic	0
degeneration	I-DISEASE
of	I-DISEASE
the	0
anterior	0
and	0
dorsomedial	0
thalamic	0
nuclei	0
,	I-DISEASE
thalamic	I-DISEASE
insomnia	0
.	0

Essential	I-DISEASE
Features	I-DISEASE
Fatal	0
familial	0
insomnia	I-DISEASE
is	0
a	0
very	I-DISEASE
rare	I-DISEASE
,	0
progressive	0
disorder	I-DISEASE
characterized	0
by	0
initial	0
dif-	0
ficulties	I-DISEASE
in	I-DISEASE
falling	0
asleep	I-DISEASE
and	0
maintaining	B-DISEASE
sleep	0
,	0
spontaneous	I-DISEASE
lapses	0
from	0
quiet	0
wake-	0
fulness	0
into	I-DISEASE
a	0
sleep	I-DISEASE
state	I-DISEASE
with	I-DISEASE
enacted	I-DISEASE
dreams	0
(	I-DISEASE
oneiric	0
stupor	0
)	0
,	0
and	0
loss	0
of	I-DISEASE
slow	0
wave	I-DISEASE
sleep	0
features	I-DISEASE
.	0

In	I-DISEASE
later	0
stages	0
of	I-DISEASE
the	0
disease	I-DISEASE
,	I-DISEASE
it	I-DISEASE
may	0
not	0
be	0
possible	0
to	I-DISEASE
identify	I-DISEASE
any	I-DISEASE
dis-	I-DISEASE
tinct	0
sleep	0
stages	0
.	0

Although	I-DISEASE
loss	0
of	I-DISEASE
temporal	I-DISEASE
and	0
spatial	I-DISEASE
orientation	I-DISEASE
develops	0
,	0
cognitive	0
function	0
is	I-DISEASE
retained	0
until	0
impaired	0
alertness	I-DISEASE
makes	I-DISEASE
testing	0
impossible	0
.	0

The	I-DISEASE
disorder	I-DISEASE
progresses	I-DISEASE
to	I-DISEASE
unarousable	0
coma	0
,	0
and	0
finally	I-DISEASE
,	I-DISEASE
death	0
.	0

Associated	I-DISEASE
Features	I-DISEASE
Bronchopulmonary	0
and	0
other	0
infections	0
may	I-DISEASE
also	0
be	0
present	I-DISEASE
.	0

There	I-DISEASE
is	0
a	0
loss	0
of	0
the	0
circadian	0
rhythmicity	0
of	I-DISEASE
endocrine	0
rhythms	0
.	0

Autonomic	I-DISEASE
hyperactivity	I-DISEASE
(	I-DISEASE
e.g.	0
,	I-DISEASE
pyrexia	0
,	I-DISEASE
salivation	I-DISEASE
,	0
hyperhidrosis	0
,	0
tachycardia	0
,	I-DISEASE
tachypnea	0
,	0
and	0
dyspnea	0
)	0
is	0
present	I-DISEASE
.	0

The	I-DISEASE
disor-	I-DISEASE
der	0
includes	I-DISEASE
somatomotor	0
disturbances	0
,	I-DISEASE
with	I-DISEASE
dysarthria	0
,	0
dysphagia	0
,	I-DISEASE
tremor	0
,	I-DISEASE
sponta-	0
neous	I-DISEASE
and	0
reflex	0
myoclonus	0
,	0
dystonic	0
posturing	I-DISEASE
,	I-DISEASE
ataxia	I-DISEASE
,	0
and	0
a	0
positive	0
Babinski	0
sign	0
.	0

Hallucinations	I-DISEASE
may	0
be	I-DISEASE
present	I-DISEASE
.	0

Clinical	I-DISEASE
and	0
Pathologic	0
Subtypes	I-DISEASE
None	0
.	0

Demographics	I-DISEASE
Age	0
of	I-DISEASE
onset	I-DISEASE
is	I-DISEASE
usually	I-DISEASE
in	0
adulthood	0
,	I-DISEASE
between	I-DISEASE
36	I-DISEASE
and	0
62	I-DISEASE
years	I-DISEASE
of	I-DISEASE
age	0
.	0

The	I-DISEASE
disorder	I-DISEASE
is	0
rare	I-DISEASE
.	0

There	I-DISEASE
are	0
no	0
sex	0
differences	I-DISEASE
.	0

Predisposing	I-DISEASE
and	0
Precipitating	I-DISEASE
Factors	0
Not	0
known	I-DISEASE
or	I-DISEASE
applicable	0
.	0

Familial	I-DISEASE
Patterns	I-DISEASE
Fatal	I-DISEASE
familial	I-DISEASE
insomnia	I-DISEASE
(	0
FFI	0
)	I-DISEASE
is	0
transmitted	0
according	I-DISEASE
to	0
an	0
autosomal	0
dominant	0
pattern	0
.	0

Patients	I-DISEASE
harbor	0
a	I-DISEASE
missense	0
GAC	I-DISEASE
to	0
AAC	0
mutation	0
at	I-DISEASE
codon	I-DISEASE
178	I-DISEASE
of	I-DISEASE
the	I-DISEASE
prion	0
protein	I-DISEASE
gene	0
PRNP	I-DISEASE
located	0
on	0
chromosome	0
20	0
,	I-DISEASE
cosegregating	0
with	I-DISEASE
the	0
methionine	0
Appendix	0
A	0
:	I-DISEASE
Sleep	I-DISEASE
Related	0
Medical	I-DISEASE
and	0
Neurological	0
Disorders	0
polymorphism	0
at	I-DISEASE
codon	I-DISEASE
129	0
of	I-DISEASE
the	0
same	0
gene	0
on	0
the	0
mutated	I-DISEASE
allele	0
(	0
D178N	0
129	0
M	I-DISEASE
)	I-DISEASE
.	0

The	I-DISEASE
clinical	0
syndrome	0
varies	I-DISEASE
by	0
the	0
M129V	0
genotype	0
.	I-DISEASE

Patients	I-DISEASE
who	I-DISEASE
are	I-DISEASE
methionine	0
homozygous	0
at	I-DISEASE
the	0
129	0
codon	B-DISEASE
are	0
younger	0
and	0
display	0
a	0
shorter	B-DISEASE
disease	I-DISEASE
course	I-DISEASE
than	0
do	I-DISEASE
patients	I-DISEASE
who	I-DISEASE
are	I-DISEASE
methionine	B-DISEASE
-	I-DISEASE
valine	0
heterozygous	0
at	I-DISEASE
codon	0
129	0
.	0

Onset	I-DISEASE
,	0
Course	0
,	0
and	0
Complications	0

The	I-DISEASE
disorder	I-DISEASE
is	0
always	0
fatal	0
,	I-DISEASE
usually	I-DISEASE
within	I-DISEASE
eight	0
to	0
72	0
months	0
.	I-DISEASE

The	I-DISEASE
course	I-DISEASE
is	0
one	I-DISEASE
of	0
relentless	I-DISEASE
worsening	0
of	I-DISEASE
symptoms	I-DISEASE
.	0

Patients	I-DISEASE
may	0
die	I-DISEASE
after	0
a	0
short	0
(	I-DISEASE
less	I-DISEASE
than	0
12	I-DISEASE
months	I-DISEASE
)	I-DISEASE
or	I-DISEASE
long	0
(	I-DISEASE
12	I-DISEASE
to	I-DISEASE
72	0
months	0
)	0
disease	I-DISEASE
course	I-DISEASE
.	0

The	I-DISEASE
younger	I-DISEASE
age	I-DISEASE
at	I-DISEASE
disease	0
onset	I-DISEASE
and	0
,	I-DISEASE
conse-	0
quently	I-DISEASE
,	I-DISEASE
a	0
lower	0
rate	I-DISEASE
of	I-DISEASE
comorbidity	0
,	I-DISEASE
may	I-DISEASE
explain	0
the	I-DISEASE
generally	0
more	0
prolonged	0
disease	I-DISEASE
course	I-DISEASE
in	I-DISEASE
FFI	0
in	I-DISEASE
comparison	0
to	I-DISEASE
other	0
prion	0
diseases	0
.	0

Complications	I-DISEASE
include	0
infections	I-DISEASE
(	I-DISEASE
in	I-DISEASE
particular	I-DISEASE
of	I-DISEASE
the	0
lungs	I-DISEASE
and	0
bladder	I-DISEASE
)	0
that	0
develop	0
during	I-DISEASE
the	0
course	0
of	I-DISEASE
the	0
disease	I-DISEASE
,	I-DISEASE
especially	0
in	I-DISEASE
the	0
late	I-DISEASE
stages	0
,	I-DISEASE
and	0
represent	0
the	0
usual	I-DISEASE
cause	I-DISEASE
of	I-DISEASE
death	0
.	0

Other	0
frequent	0
com-	I-DISEASE
plications	0
include	I-DISEASE
skin	0
ulcers	0
when	I-DISEASE
patients	I-DISEASE
become	0
bedridden	I-DISEASE
and	0
aspiration	0
of	I-DISEASE
food	0
due	0
to	0
the	0
severe	0
dysphagia	0
;	I-DISEASE
the	0
latter	0
may	0
require	0
nasogastric	0
or	0
gastrostomy	I-DISEASE
feeding	0
.	0

Pathology	I-DISEASE
and	0
Pathophysiology	I-DISEASE
Severe	B-DISEASE
bilateral	0
loss	I-DISEASE
of	I-DISEASE
neurons	I-DISEASE
,	0
with	0
reactive	I-DISEASE
gliosis	I-DISEASE
of	I-DISEASE
the	0
anterior	I-DISEASE
and	0
dorsomedial	I-DISEASE
thalamic	0
nuclei	0
and	0
severe	0
neuronal	0
loss	0
and	0
reactive	0
astrogliosis	0
in	I-DISEASE
the	0
inferior	I-DISEASE
olives	0
,	0
are	0
found	0
.	0

Spongiform	I-DISEASE
changes	0
in	I-DISEASE
cortical	0
layers	0
in	0
cases	0
with	I-DISEASE
a	0
prolonged	0
course	0
have	0
been	I-DISEASE
described	0
.	0

Deposition	I-DISEASE
of	I-DISEASE
proteinase	I-DISEASE
K	0
-	0
resistant	I-DISEASE
prion	0
protein	0
type	I-DISEASE
2	I-DISEASE
in	I-DISEASE
the	0
grey	0
matter	0
but	I-DISEASE
not	0
the	0
white	0
matter	0
occurs	0
in	0
both	I-DISEASE
familial	I-DISEASE
and	0
sporadic	0
fatal	I-DISEASE
insomnia	0
.	0

Both	I-DISEASE
familial	I-DISEASE
and	0
sporadic	0
fatal	I-DISEASE
insomnia	0
have	I-DISEASE
been	I-DISEASE
transmitted	I-DISEASE
to	0
transgenic	0
animals	0
by	0
intracerebral	0
inoculum	I-DISEASE
of	I-DISEASE
brain	0
homogenates	I-DISEASE
.	0

Objective	I-DISEASE
Findings	I-DISEASE

In	I-DISEASE
early	0
stages	0
of	I-DISEASE
FFI	0
,	0
periods	I-DISEASE
of	0
relaxed	0
wakefulness	0
alternate	I-DISEASE
with	I-DISEASE
episodes	0
of	I-DISEASE
elec-	I-DISEASE
troencephalographic	0
(	I-DISEASE
EEG	0
)	0
desynchronization	I-DISEASE
,	I-DISEASE
rapid	I-DISEASE
eye	0
movement	0
(	0
REM	0
)	0
bursts	0
,	0
loss	0
of	I-DISEASE
antigravity	I-DISEASE
muscle	0
tone	I-DISEASE
,	0
and	0
irregular	0
myoclonic	0
and	0
tremor	0
-	I-DISEASE
like	I-DISEASE
limb	B-DISEASE
-	0
muscle	0
activities	I-DISEASE
associated	0
with	0
vivid	I-DISEASE
dreams	I-DISEASE
(	I-DISEASE
oneiric	I-DISEASE
stupor	0
)	0
.	0

Sleep	I-DISEASE
spindles	I-DISEASE
and	0
features	0
of	I-DISEASE
slow	0
wave	I-DISEASE
sleep	0
are	0
absent	0
or	I-DISEASE
progressively	I-DISEASE
lost	I-DISEASE
throughout	0
the	0
course	I-DISEASE
of	I-DISEASE
the	0
illness	0
.	0

In	I-DISEASE
the	0
final	0
stages	I-DISEASE
of	0
the	0
disorder	I-DISEASE
,	I-DISEASE
the	0
EEG	0
becomes	I-DISEASE
unreactive	I-DISEASE
and	0
progressively	0
flattens	I-DISEASE
until	0
death	0
occurs	0
;	I-DISEASE
it	0
may	I-DISEASE
display	I-DISEASE
periodic	0
spike	0
discharges	0
.	0

Positron	I-DISEASE
emission	0
tomography	0
(	I-DISEASE
PET	0
)	0
with	I-DISEASE
(	I-DISEASE
18F)-2	I-DISEASE
-	0
fluorodeoxy	0
-	0
d	0
-	0
glucose	0
shows	I-DISEASE
tha-	I-DISEASE
lamic	0
hypometabolism	0
.	0

Magnetic	I-DISEASE
resonance	0
spectroscopy	0
with	I-DISEASE
multisequences	0
can	I-DISEASE
detect	I-DISEASE
prion	0
-	I-DISEASE
induced	I-DISEASE
gliosis	0
in	I-DISEASE
vivo	I-DISEASE
.	0

Circadian	I-DISEASE
rhythms	0
of	I-DISEASE
body	I-DISEASE
temperature	I-DISEASE
,	0
systemic	0
blood	I-DISEASE
pressure	0
,	I-DISEASE
and	0
heart	0
and	0
respiratory	I-DISEASE
rate	I-DISEASE
and	0
endocrine	0
rhythms	0
of	I-DISEASE
growth	0
hormone	0
,	0
prolactin	0
,	I-DISEASE
luteinizing	0
hormone	0
,	0
follicle	I-DISEASE
-	0
stimulating	0
hormone	0
,	I-DISEASE
and	0
adrenocorticotropic	0
Appendix	0
A	0
:	0
Sleep	0
Related	I-DISEASE
Medical	I-DISEASE
and	0
Neurological	0
Disorders	I-DISEASE
hormone	0
may	I-DISEASE
be	0
lost	0
.	0

Serum	I-DISEASE
catecholamine	0
and	0
cortisol	B-DISEASE
values	I-DISEASE
are	I-DISEASE
elevated	I-DISEASE
,	0
with	0
low	0
or	I-DISEASE
undetectable	0
adrenocorticotropic	I-DISEASE
hormone	0
levels	0
.	0

Pathologic	I-DISEASE
examination	0
demon-	0
strates	0
degeneration	0
of	I-DISEASE
the	0
anterior	I-DISEASE
and	0
dorsomedial	I-DISEASE
thalamic	I-DISEASE
nuclei	0
and	0
atrophy	I-DISEASE
of	I-DISEASE
the	I-DISEASE
inferior	I-DISEASE
olivary	0
nucleus	0
.	0

Deposition	I-DISEASE
of	I-DISEASE
proteinase	I-DISEASE
K	0
-	0
resistant	I-DISEASE
prion	0
protein	0
type	I-DISEASE
2	I-DISEASE
is	I-DISEASE
found	0
in	I-DISEASE
the	0
brain	I-DISEASE
.	0

Differential	I-DISEASE
Diagnosis	0

This	I-DISEASE
disorder	I-DISEASE
must	0
be	I-DISEASE
differentiated	0
from	I-DISEASE
REM	I-DISEASE
sleep	0
behavior	0
disorder	0
(	I-DISEASE
RBD	I-DISEASE
)	0
,	I-DISEASE
which	0
is	I-DISEASE
not	0
associated	0
with	I-DISEASE
autonomic	0
hyperactivity	0
or	I-DISEASE
a	I-DISEASE
familial	I-DISEASE
pattern	0
.	0

The	I-DISEASE
differential	0
diagnosis	0
includes	I-DISEASE
dementia	0
,	I-DISEASE
familial	0
Creutzfeldt	0
-	I-DISEASE
Jakob	I-DISEASE
disease	0
with	0
the	0
178	0
codon	0
mutation	0
in	I-DISEASE
the	0
PRNP	I-DISEASE
cosegregating	0
with	I-DISEASE
the	0
valine	0
polymorphism	0
at	0
codon	0
129	I-DISEASE
on	0
the	I-DISEASE
mutated	0
allele	0
,	0
Morvan	0
fibrillary	0
chorea	I-DISEASE
,	0
delirium	0
tremens	0
,	I-DISEASE
or	0
even	0
schizophrenia	0
.	0

A	I-DISEASE
sporadic	0
form	I-DISEASE
of	0
fatal	I-DISEASE
insomnia	I-DISEASE
has	0
also	0
been	I-DISEASE
reported	I-DISEASE
.	I-DISEASE

Unresolved	I-DISEASE
Issues	0
and	0
Future	0
Directions	0
Not	0
applicable	0
or	I-DISEASE
known	I-DISEASE
.	0

Bibliography	0
Cortelli	I-DISEASE
P	0
,	I-DISEASE
Perani	0
D	I-DISEASE
,	I-DISEASE
Parchi	I-DISEASE
P	0
,	I-DISEASE
et	0
al	0
.	0

Cerebral	0
metabolism	0
in	I-DISEASE
fatal	I-DISEASE
familial	I-DISEASE
insomnia	I-DISEASE
:	I-DISEASE
relation	0
to	I-DISEASE
duration	0
,	I-DISEASE
neuropathology	0
,	I-DISEASE
and	0
distribution	0
of	I-DISEASE
protease	0
-	I-DISEASE
resistant	I-DISEASE
prion	0
protein	I-DISEASE
.	0

Neurology	0
1997;49:126–33	0
.	0

Goldfarb	I-DISEASE
L	0
,	0
Petersen	I-DISEASE
R	I-DISEASE
,	I-DISEASE
Tabaton	I-DISEASE
M	I-DISEASE
,	I-DISEASE
et	0
al	0
.	0

Fatal	I-DISEASE
familial	0
insomnia	I-DISEASE
and	0
familial	0
Creutzfeldt	I-DISEASE
-	I-DISEASE
Jakob	0
disease	0
:	I-DISEASE
disease	0
phenotype	0
determined	I-DISEASE
by	0
a	0
DNA	0
polymorphism	0
.	0

Science	0
1992;258:806–8	I-DISEASE
.	0

Haik	I-DISEASE
S	I-DISEASE
,	I-DISEASE
Galanaud	0
D	I-DISEASE
,	0
Linguraru	0
MG	I-DISEASE
,	I-DISEASE
et	0
al	I-DISEASE
.	0

In	I-DISEASE
vivo	I-DISEASE
detection	0
of	0
thalamic	I-DISEASE
gliosis	0
.	0

A	I-DISEASE
pathoradiologic	0
demonstration	I-DISEASE
in	I-DISEASE
familial	0
fatal	0
insomnia	I-DISEASE
.	0

Arch	I-DISEASE
Neurol	0
2008;65:545–9	0
.	0

Krasnianski	I-DISEASE
A	0
,	I-DISEASE
Bartl	0
M	I-DISEASE
,	0
Sanchez	B-DISEASE
Juan	I-DISEASE
PJ	I-DISEASE
,	0
et	0
al	I-DISEASE
.	0

Fatal	I-DISEASE
familial	0
insomnia	I-DISEASE
:	0
clinical	0
features	0
and	0
early	I-DISEASE
identification	0
.	0

Ann	I-DISEASE
Neurol	0
2008;63:658–61	0
.	0

Lugaresi	I-DISEASE
E	0
,	0
Medori	I-DISEASE
R	I-DISEASE
,	0
Montagna	0
P	I-DISEASE
,	0
et	0
al	I-DISEASE
.	I-DISEASE

Fatal	I-DISEASE
familial	0
insomnia	I-DISEASE
and	0
dysautonomia	0
with	0
selective	I-DISEASE
degeneration	0
of	0
thalamic	I-DISEASE
nuclei	0
.	0

N	0
Engl	I-DISEASE
J	0
Med	I-DISEASE
1986;315:997–1003	I-DISEASE
.	0

Monari	I-DISEASE
L	0
,	I-DISEASE
Chen	0
S	I-DISEASE
,	I-DISEASE
Brown	I-DISEASE
P	0
,	0
et	0
al	I-DISEASE
.	I-DISEASE

Fatal	I-DISEASE
familial	0
insomnia	I-DISEASE
and	0
familial	0
Creutzfeldt	I-DISEASE
-	I-DISEASE
Jakob	0
disease	0
:	I-DISEASE
different	0
prion	0
proteins	I-DISEASE
determined	I-DISEASE
by	0
a	0
DNA	0
polymorphism	0
.	0

Proc	I-DISEASE
Natl	I-DISEASE
Acad	0
Sci	0
U	0
S	I-DISEASE
A	0
1994;91:2839–42	0
.	0

Montagna	I-DISEASE
P	0
,	0
Cortelli	I-DISEASE
P	0
,	0
Gambetti	I-DISEASE
P	0
,	I-DISEASE
Lugaresi	I-DISEASE
E.	0
Fatal	0
familial	0
insomnia	0
:	I-DISEASE
sleep	0
,	I-DISEASE
neuroendocrine	0
and	0
vegetative	I-DISEASE
alterations	0
.	0

Adv	I-DISEASE
Neuroimmunol	0
1995;5:13–21	I-DISEASE
.	0

Montagna	I-DISEASE
P	0
,	0
Gambetti	I-DISEASE
P	0
,	0
Cortelli	0
P	0
,	I-DISEASE
Lugaresi	I-DISEASE
E.	0
Familial	I-DISEASE
and	0
sporadic	0
fatal	I-DISEASE
insomnia	I-DISEASE
.	0

Lancet	0
Neurol	0
2003;2:167–76	0
.	0

Sforza	I-DISEASE
E	0
,	I-DISEASE
Montagna	0
P	0
,	I-DISEASE
Tinuper	I-DISEASE
P	0
,	I-DISEASE
et	0
al	I-DISEASE
.	0

Sleep	I-DISEASE
-	I-DISEASE
wake	0
cycle	0
abnormalities	0
in	I-DISEASE
fatal	I-DISEASE
familial	0
insomnia	I-DISEASE
.	0

Evidence	I-DISEASE
of	I-DISEASE
the	0
role	0
of	0
the	I-DISEASE
thalamus	0
in	0
sleep	0
regulation	I-DISEASE
.	I-DISEASE

Electroencephalogr	I-DISEASE
Clin	I-DISEASE
Neurophysiol	0
1995;94:398–405	I-DISEASE
.	0

Telling	I-DISEASE
G	I-DISEASE
,	I-DISEASE
Parchi	0
P	I-DISEASE
,	0
DeArmond	0
S	I-DISEASE
,	I-DISEASE
et	0
al	I-DISEASE
.	I-DISEASE

Evidence	I-DISEASE
for	I-DISEASE
the	0
conformation	0
of	I-DISEASE
the	0
pathologic	0
isoform	0
of	I-DISEASE
the	0
prion	0
protein	I-DISEASE
enciphering	0
and	0
propagating	I-DISEASE
prion	0
diversity	0
.	0

Science	0
1996;274:2079–82	0
.	0

Appendix	I-DISEASE
A	0
:	I-DISEASE
Sleep	0
Related	0
Medical	0
and	0
Neurological	0
Disorders	0
Sleep	I-DISEASE
Related	0
Epilepsy	0
Alternate	B-DISEASE
Names	I-DISEASE
Sleep	I-DISEASE
epilepsy	0
,	I-DISEASE
nocturnal	0
seizure	0
,	0
sleep	0
related	0
seizures	I-DISEASE
.	0

Essential	I-DISEASE
Features	I-DISEASE
A	0
seizure	I-DISEASE
is	0
a	0
paroxysmal	0
event	0
resulting	0
from	I-DISEASE
a	I-DISEASE
sudden	0
excessive	0
discharge	0
of	I-DISEASE
the	0
neurons	0
of	I-DISEASE
the	0
cerebral	0
cortex	0
,	I-DISEASE
whereas	I-DISEASE
epilepsy	0
is	I-DISEASE
a	0
condition	0
of	I-DISEASE
recurrent	B-DISEASE
unpro-	0
voked	0
seizures	0
.	0

Sleep	I-DISEASE
facilitates	0
epileptic	0
activity	0
and	0
seizures	0
.	0

The	I-DISEASE
characteristics	0
of	I-DISEASE
specific	I-DISEASE
subtypes	0
of	I-DISEASE
sleep	0
related	0
epilepsy	0
are	I-DISEASE
discussed	0
in	0
the	0
Clinical	I-DISEASE
and	0
Pathologic	0
Subtypes	I-DISEASE
section	I-DISEASE
below	0
.	0

Associated	I-DISEASE
Features	I-DISEASE
The	I-DISEASE
different	0
types	0
of	I-DISEASE
nocturnal	0
frontal	0
lobe	0
epilepsy	0
(	I-DISEASE
NFLE	I-DISEASE
)	0
may	I-DISEASE
cause	0
severe	0
sleep	0
disruption	I-DISEASE
,	0
affecting	0
both	I-DISEASE
macrostructure	0
and	0
microstructure	I-DISEASE
of	I-DISEASE
sleep	0
,	I-DISEASE
resulting	0
in	I-DISEASE
poor	0
sleep	0
quality	0
,	0
daytime	0
fatigue	0
,	0
and	0
sleepiness	0
in	I-DISEASE
some	I-DISEASE
patients	0
.	0

The	I-DISEASE
movements	0
also	0
may	I-DISEASE
be	0
so	I-DISEASE
severe	I-DISEASE
that	I-DISEASE
injuries	B-DISEASE
can	0
occur	I-DISEASE
.	0

From	I-DISEASE
one	0
third	0
to	I-DISEASE
one	0
half	0
of	I-DISEASE
patients	I-DISEASE
with	0
sleep	0
related	B-DISEASE
epilepsy	0
also	0
have	0
occasional	0
attacks	I-DISEASE
during	0
the	0
day	I-DISEASE
,	0
although	0
these	I-DISEASE
are	0
not	0
necessarily	0
of	I-DISEASE
the	0
same	0
type	I-DISEASE
as	B-DISEASE
those	0
occurring	0
at	I-DISEASE
night	0
.	0

Neurocognitive	I-DISEASE
impairment	I-DISEASE
is	0
typically	0
diagnosed	I-DISEASE
in	I-DISEASE
almost	I-DISEASE
all	0
cases	0
of	I-DISEASE
continuous	I-DISEASE
spike	0
waves	0
during	I-DISEASE
NREM	0
sleep	0
(	I-DISEASE
CSWS	0
)	0
.	0

Motor	I-DISEASE
impairment	0
in	0
the	0
form	I-DISEASE
of	I-DISEASE
a	0
unilat-	0
eral	0
deficit	0
is	I-DISEASE
sometimes	I-DISEASE
seen	0
as	0
an	0
associated	0
feature	I-DISEASE
of	I-DISEASE
CSWS	0
.	0

Clinical	I-DISEASE
and	0
Pathologic	0
Subtypes	I-DISEASE
Clinical	0
and	0
EEG	0
criteria	I-DISEASE
are	I-DISEASE
used	0
to	0
define	0
a	I-DISEASE
variety	0
of	0
sleep	0
related	0
epilepsy	0
subtypes	I-DISEASE
.	0

Several	0
types	I-DISEASE
of	I-DISEASE
epileptic	0
syndromes	0
have	0
a	0
marked	0
tendency	I-DISEASE
to	I-DISEASE
manifest	I-DISEASE
only	0
or	I-DISEASE
pre-	0
dominantly	0
during	I-DISEASE
sleep	0
,	0
or	B-DISEASE
after	0
arousal	I-DISEASE
from	0
sleep	0
.	0

These	0
include	I-DISEASE
NFLE	0
,	0
benign	0
epilepsy	I-DISEASE
of	I-DISEASE
childhood	0
with	I-DISEASE
centrotemporal	0
spikes	0
(	0
BECT	0
)	0
,	0
benign	0
epilepsy	0
with	I-DISEASE
occip-	0
ital	0
paroxysms	0
(	0
BEOP	0
)	0
,	0
early	I-DISEASE
-	I-DISEASE
onset	I-DISEASE
or	I-DISEASE
late	I-DISEASE
-	0
onset	0
childhood	0
occipital	0
epilepsy	0
,	0
juvenile	I-DISEASE
myoclonic	I-DISEASE
epilepsy	0
(	I-DISEASE
JME	0
)	0
,	0
generalized	0
tonic	0
-	0
clonic	0
seizures	0
on	0
awakening	0
,	I-DISEASE
certain	I-DISEASE
forms	I-DISEASE
of	I-DISEASE
temporal	0
lobe	0
epilepsy	I-DISEASE
,	0
tonic	0
seizure	I-DISEASE
(	I-DISEASE
as	0
a	I-DISEASE
component	I-DISEASE
of	I-DISEASE
Lennox	0
-	0
Gastaut	0
syndrome	I-DISEASE
)	0
,	I-DISEASE
Landau	0
-	0
Kleffner	0
syndrome	0
,	0
and	0
continuous	0
spike	0
waves	0
during	I-DISEASE
NREM	0
sleep	0
(	I-DISEASE
CSWS	0
)	0
.	0

NFLE	I-DISEASE
may	0
present	I-DISEASE
in	0
three	I-DISEASE
distinct	0
ways	I-DISEASE
:	0
(	0
1	0
)	0
nocturnal	I-DISEASE
paroxysmal	0
arousal	0
,	0
(	I-DISEASE
2	0
)	0
noc-	0
turnal	0
paroxysmal	0
dystonia	0
,	0
or	0
(	0
3	0
)	0
episodic	0
nocturnal	0
wanderings	0
.	0

Appendix	I-DISEASE
A	0
:	I-DISEASE
Sleep	0
Related	0
Medical	0
and	0
Neurological	0
Disorders	0
BECT	0
can	0
present	I-DISEASE
with	I-DISEASE
focal	0
clonic	I-DISEASE
facial	I-DISEASE
twitching	0
that	0
is	0
often	0
preceded	I-DISEASE
by	I-DISEASE
perioral	I-DISEASE
numbness	0
.	0

These	0
seizures	I-DISEASE
are	I-DISEASE
more	0
often	0
seen	I-DISEASE
in	I-DISEASE
drowsiness	0
and	0
sleep	I-DISEASE
than	I-DISEASE
wakeful-	0
ness	I-DISEASE
.	0

The	I-DISEASE
clinical	I-DISEASE
course	0
is	I-DISEASE
often	0
benign	I-DISEASE
with	I-DISEASE
disappearance	0
of	I-DISEASE
the	0
seizures	I-DISEASE
in	I-DISEASE
adulthood	0
.	0

BEOP	0
is	I-DISEASE
characterized	0
by	I-DISEASE
focal	0
seizures	I-DISEASE
marked	0
by	I-DISEASE
deviation	0
of	I-DISEASE
the	0
eyes	0
and	0
vom-	I-DISEASE
iting	0
.	0

Sleep	I-DISEASE
is	I-DISEASE
the	0
main	I-DISEASE
precipitating	0
factor	I-DISEASE
,	0
with	I-DISEASE
most	0
of	I-DISEASE
the	0
seizures	0
occurring	I-DISEASE
soon	I-DISEASE
after	0
sleep	0
onset	I-DISEASE
or	0
in	I-DISEASE
the	0
early	0
hours	I-DISEASE
of	0
the	I-DISEASE
morning	0
.	0

There	I-DISEASE
is	0
frequent	0
evolution	0
to	0
secondary	0
generalized	0
attacks	I-DISEASE
.	0

The	I-DISEASE
clinical	0
evolution	0
of	I-DISEASE
the	0
early	0
-	I-DISEASE
onset	I-DISEASE
type	I-DISEASE
is	0
benign	0
,	I-DISEASE
whereas	I-DISEASE
in	0
the	0
late	I-DISEASE
-	I-DISEASE
onset	0
type	0
with	I-DISEASE
visual	I-DISEASE
seizures	I-DISEASE
,	I-DISEASE
the	I-DISEASE
prognosis	0
is	I-DISEASE
uncertain	0
.	0

JME	I-DISEASE
is	0
characterized	0
by	0
massive	0
bilaterally	0
synchronous	0
myoclonic	0
jerks	0
,	0
which	0
are	0
most	0
frequently	0
noted	0
on	0
awakening	0
.	0

CSWS	I-DISEASE
(	0
formerly	0
known	0
as	0
electrical	I-DISEASE
status	B-DISEASE
epilepticus	0
of	I-DISEASE
sleep	0
[	0
ESES	0
]	0
)	0
is	0
charac-	I-DISEASE
terized	I-DISEASE
by	0
continuous	I-DISEASE
and	0
diffuse	I-DISEASE
slow	0
spike	0
-	0
and	0
-	0
wave	I-DISEASE
complexes	I-DISEASE
persisting	0
through	0
NREM	0
sleep	I-DISEASE
(	0
at	I-DISEASE
least	0
85	0
%	0
of	I-DISEASE
the	0
duration	0
)	0
,	0
as	0
well	0
as	0
neuropsychological	I-DISEASE
and	0
motor	I-DISEASE
impairment	0
.	0

Despite	I-DISEASE
the	0
continuous	0
presence	0
of	0
epileptic	0
spike	0
-	0
wave	I-DISEASE
activity	0
on	0
EEG	I-DISEASE
in	I-DISEASE
sleep	0
,	I-DISEASE
there	0
may	0
be	I-DISEASE
no	0
associated	0
visible	0
sleep	0
related	I-DISEASE
movement	0
.	0

However	I-DISEASE
,	0
clinical	0
epileptic	0
seizures	0
are	0
sometimes	0
seen	0
in	0
the	I-DISEASE
daytime	I-DISEASE
.	0

Demographics	I-DISEASE
There	0
is	0
no	0
significant	0
sex	0
predominance	0
.	0

Predisposing	I-DISEASE
and	0
Participating	I-DISEASE
Factors	0
Stress	0
,	I-DISEASE
sleep	0
deprivation	0
,	0
irregularities	0
of	I-DISEASE
the	0
sleep	0
-	0
wake	0
rhythm	0
,	I-DISEASE
other	0
sleep	0
patholo-	I-DISEASE
gies	0
,	0
and	0
the	0
use	I-DISEASE
of	I-DISEASE
stimulant	0
drugs	I-DISEASE
or	I-DISEASE
other	I-DISEASE
drugs	I-DISEASE
that	0
modify	0
sleep	0
architecture	0
may	0
predispose	0
an	I-DISEASE
individual	I-DISEASE
to	0
having	I-DISEASE
seizures	0
.	I-DISEASE

Perinatal	I-DISEASE
or	I-DISEASE
prenatal	0
problems	I-DISEASE
,	0
congenital	0
hemiparesis	I-DISEASE
,	I-DISEASE
and	0
prior	0
encephalopathy	0
may	0
be	I-DISEASE
considered	0
antecedents	I-DISEASE
of	I-DISEASE
the	0
syndrome	0
of	I-DISEASE
CSWS	0
.	0

OSA	I-DISEASE
may	0
exacerbate	I-DISEASE
sleep	0
related	B-DISEASE
seizures	0
and	0
complicate	I-DISEASE
their	0
treatment	I-DISEASE
.	0

Familial	I-DISEASE
Patterns	I-DISEASE

The	I-DISEASE
idiopathic	I-DISEASE
generalized	0
epilepsies	0
form	0
the	0
largest	0
category	I-DISEASE
of	I-DISEASE
epilepsies	0
that	0
appear	0
to	I-DISEASE
be	0
heritable	0
but	I-DISEASE
show	0
no	0
clear	I-DISEASE
mendelian	I-DISEASE
mode	0
of	I-DISEASE
transmission	I-DISEASE
.	0

Juvenile	I-DISEASE
myoclonic	0
epilepsy	I-DISEASE
and	0
idiopathic	I-DISEASE
generalized	0
epilepsy	0
with	0
adolescent	0
onset	I-DISEASE
appear	0
to	0
be	0
genet-	0
ically	I-DISEASE
heterogeneous	I-DISEASE
.	0

Among	I-DISEASE
the	0
partial	I-DISEASE
epilepsies	0
,	I-DISEASE
BECT	0
shows	I-DISEASE
a	I-DISEASE
familial	I-DISEASE
pattern	0
.	0

A	I-DISEASE
form	I-DISEASE
of	I-DISEASE
autosomal	I-DISEASE
dominant	I-DISEASE
NFLE	I-DISEASE
with	0
70	0
%	0
to	I-DISEASE
80	0
%	0
penetrance	I-DISEASE
has	0
been	0
reported	I-DISEASE
in	I-DISEASE
many	0
countries	B-DISEASE
,	I-DISEASE
and	0
a	0
genetic	I-DISEASE
heterogeneity	I-DISEASE
also	0
has	0
been	I-DISEASE
reported	0
.	0

Genetic	I-DISEASE
factors	0
have	I-DISEASE
not	0
been	I-DISEASE
established	0
in	I-DISEASE
CSWS	0
and	0
seem	I-DISEASE
to	I-DISEASE
play	I-DISEASE
a	0
minor	I-DISEASE
role	0
.	0

Familial	I-DISEASE
anteced-	I-DISEASE
ents	0
of	I-DISEASE
epilepsy	0
(	I-DISEASE
including	0
febrile	I-DISEASE
convulsions	0
)	0
have	I-DISEASE
been	I-DISEASE
found	0
in	I-DISEASE
15	0
%	0
of	I-DISEASE
cases	0
.	0

Appendix	0
A	0
:	I-DISEASE
Sleep	0
Related	0
Medical	0
and	0
Neurological	0
Disorders	0
Onset	I-DISEASE
,	0
Course	0
,	0
and	0
Complications	0
Idiopathic	0
generalized	0
epilepsies	0
and	0
partial	I-DISEASE
epilepsy	0
may	0
start	0
at	0
any	0
age	I-DISEASE
.	0

The	I-DISEASE
onset	0
of	I-DISEASE
benign	I-DISEASE
epilepsies	0
of	I-DISEASE
childhood	0
with	I-DISEASE
centrotemporal	I-DISEASE
or	I-DISEASE
occipital	I-DISEASE
spikes	0
is	I-DISEASE
between	0
4	0
and	0
12	0
years	I-DISEASE
of	I-DISEASE
age	I-DISEASE
.	0

The	I-DISEASE
onset	0
of	I-DISEASE
NFLE	I-DISEASE
is	I-DISEASE
generally	I-DISEASE
from	I-DISEASE
age	I-DISEASE
10	0
to	0
16	I-DISEASE
years	I-DISEASE
,	I-DISEASE
mostly	I-DISEASE
before	I-DISEASE
the	0
age	I-DISEASE
of	0
20	0
years	I-DISEASE
.	0

The	I-DISEASE
average	I-DISEASE
age	I-DISEASE
of	I-DISEASE
recognition	0
of	I-DISEASE
CSWS	0
is	0
between	0
4	0
and	0
14	0
years	I-DISEASE
,	0
but	I-DISEASE
the	0
appearance	I-DISEASE
of	0
the	0
first	I-DISEASE
seizure	I-DISEASE
is	I-DISEASE
early	0
,	I-DISEASE
typically	0
between	0
two	I-DISEASE
months	0
and	0
12	0
years	I-DISEASE
of	I-DISEASE
age	I-DISEASE
.	0

Most	I-DISEASE
patients	0
with	0
recurrent	0
sleep	0
related	0
epilepsy	0
continue	0
to	I-DISEASE
have	I-DISEASE
seizures	I-DISEASE
restricted	0
to	I-DISEASE
sleep	0
.	0

In	I-DISEASE
some	0
cases	0
,	I-DISEASE
they	0
may	I-DISEASE
have	0
seizures	I-DISEASE
during	0
both	I-DISEASE
sleep	0
and	0
wakefulness	0
.	0

For	I-DISEASE
focal	0
epilepsies	0
(	I-DISEASE
excluding	0
BECT	0
and	0
the	I-DISEASE
early	0
-	0
onset	0
type	I-DISEASE
of	I-DISEASE
BEOP	0
)	0
,	0
the	0
prognosis	0
is	I-DISEASE
less	I-DISEASE
favorable	I-DISEASE
compared	I-DISEASE
to	I-DISEASE
generalized	0
epilepsies	0
.	0

At	I-DISEASE
least	I-DISEASE
35	0
%	0
of	0
the	0
focal	0
seizures	I-DISEASE
confined	0
to	0
sleep	0
are	I-DISEASE
resistant	I-DISEASE
to	0
antiepileptic	0
drugs	0
.	0

Definitive	I-DISEASE
data	I-DISEASE
on	0
the	0
natural	I-DISEASE
history	I-DISEASE
of	I-DISEASE
NFLE	I-DISEASE
are	I-DISEASE
not	I-DISEASE
available	I-DISEASE
,	0
although	0
a	0
high	I-DISEASE
prev-	0
alence	0
of	I-DISEASE
parasomnias	I-DISEASE
has	0
been	I-DISEASE
documented	I-DISEASE
in	0
NFLE	I-DISEASE
patients	I-DISEASE
.	0

CSWS	I-DISEASE
resolves	0
in	0
many	0
cases	0
within	I-DISEASE
three	0
years	0
after	0
onset	I-DISEASE
,	I-DISEASE
and	0
in	0
almost	0
all	0
cases	0
by	0
the	0
mid	I-DISEASE
-	0
teen	I-DISEASE
years	0
.	0

Despite	I-DISEASE
normalization	0
of	I-DISEASE
the	0
EEG	I-DISEASE
and	0
elimination	0
of	I-DISEASE
seizures	I-DISEASE
,	I-DISEASE
neuropsychological	0
impairment	0
may	0
persist	0
.	0

Interictal	I-DISEASE
paroxysmal	0
activity	0
may	0
induce	0
prolonged	0
cognitive	0
and	0
motor	I-DISEASE
impairment	0
.	0

Hyperkinesias	I-DISEASE
,	I-DISEASE
aggressiveness	0
,	0
and	0
psy-	B-DISEASE
chotic	I-DISEASE
states	0
may	I-DISEASE
appear	I-DISEASE
.	0

OSA	I-DISEASE
may	0
exacerbate	I-DISEASE
sleep	0
related	B-DISEASE
seizures	0
and	0
complicate	I-DISEASE
their	0
treatment	I-DISEASE
.	0

Pathology	I-DISEASE
and	0
Pathophysiology	I-DISEASE
In	0
idiopathic	0
generalized	I-DISEASE
epilepsy	I-DISEASE
,	I-DISEASE
genetic	I-DISEASE
factors	0
are	0
contributory	0
.	0

Pathogenic	I-DISEASE
markers	0
,	I-DISEASE
associated	0
neurologic	0
deficits	0
,	I-DISEASE
or	I-DISEASE
characteristic	I-DISEASE
brain	0
imaging	0
findings	0
have	I-DISEASE
not	0
been	0
identified	I-DISEASE
.	0

However	I-DISEASE
,	I-DISEASE
microdysgenesis	I-DISEASE
has	0
been	I-DISEASE
described	0
in	0
some	I-DISEASE
forms	0
of	I-DISEASE
idiopathic	I-DISEASE
generalized	0
epilepsy	I-DISEASE
.	0

EEG	I-DISEASE
recordings	0
with	I-DISEASE
sphenoidal	0
or	0
zygomatic	I-DISEASE
leads	0
may	0
show	0
epileptic	0
activity	0
over	0
the	0
mesiotemporal	0
regions	0
in	0
partial	I-DISEASE
complex	0
seizures	I-DISEASE
.	0

Video	0
-	I-DISEASE
polysomnographic	0
(	0
vPSG	0
)	I-DISEASE
analysis	I-DISEASE
confirms	0
that	0
the	0
motor	I-DISEASE
pattern	0
of	0
NFLE	I-DISEASE
resembles	0
that	0
noted	0
in	I-DISEASE
orbital	0
and	0
mesial	0
frontal	0
seizures	0
.	0

Nocturnal	I-DISEASE
frontal	0
lobe	0
sei-	0

zures	I-DISEASE
involve	0
a	I-DISEASE
large	0
neuronal	0
network	0
,	0
and	0
some	I-DISEASE
of	I-DISEASE
their	I-DISEASE
clinical	0
expressions	0
are	I-DISEASE
pos-	0
sible	0
consequences	I-DISEASE
of	I-DISEASE
disinhibition	0
of	I-DISEASE
innate	0
motor	I-DISEASE
patterns	B-DISEASE
produced	0
by	B-DISEASE
the	0
central	0
pattern	0
generator	0
.	0

Recent	I-DISEASE
reports	0
derived	0
from	I-DISEASE
stereo	0
-	0
EEG	0
studies	0
seem	0
to	0
show	I-DISEASE
that	I-DISEASE
in	I-DISEASE
some	0
cases	0
,	I-DISEASE
the	0
seizures	0
(	I-DISEASE
in	I-DISEASE
particular	I-DISEASE
nocturnal	0
wanderings	I-DISEASE
)	0
may	0
arise	I-DISEASE
from	0
temporal	0
or	0
insular	0
regions	0
(	0
rather	0
than	I-DISEASE
frontal	0
regions	0
)	0
with	0
a	0
secondary	0
spread	0
to	I-DISEASE
the	0
cingulate	I-DISEASE
regions	0
.	0

They	I-DISEASE
may	0
sometimes	0
mimic	I-DISEASE
parasomnias	0
.	0

Appendix	I-DISEASE
A	0
:	I-DISEASE
Sleep	I-DISEASE
Related	0
Medical	I-DISEASE
and	0
Neurological	0
Disorders	0
Secondary	I-DISEASE
bilateral	0
synchrony	0
is	0
the	0
mechanism	I-DISEASE
generating	0
CSWS	I-DISEASE
.	0

This	I-DISEASE
hypothesis	I-DISEASE
is	0
supported	0
by	0
EEG	0
,	I-DISEASE
intracranial	0
recordings	I-DISEASE
,	0
EEG	0
with	I-DISEASE
coherence	0
computer	I-DISEASE
-	0
assisted	0
analysis	I-DISEASE
,	I-DISEASE
and	0
metabolic	0
(	I-DISEASE
positron	0
emission	0
tomography	I-DISEASE

[	0
PET	0
]	0
and	0
single	0
-	0
photon	0
emis-	I-DISEASE
sion	I-DISEASE
computed	0
tomography	I-DISEASE
[	0
SPECT	0
]	0
)	0
studies	I-DISEASE
.	0

CSWS	I-DISEASE
associated	0
with	I-DISEASE
Landau	0
-	I-DISEASE
Kleffner	B-DISEASE
syndrome	I-DISEASE
(	I-DISEASE
an	I-DISEASE
acquired	0
epileptic	0
aphasia	0
)	0
is	I-DISEASE
probably	0
secondary	0
to	I-DISEASE
an	0
alteration	I-DISEASE
of	I-DISEASE
function	0
over	I-DISEASE
the	0
temporal	0
area	I-DISEASE
.	0

Objective	I-DISEASE
Findings	I-DISEASE
Patients	I-DISEASE
with	I-DISEASE
suspected	0
sleep	0
related	B-DISEASE
epilepsy	I-DISEASE
often	0
need	0
to	I-DISEASE
be	I-DISEASE
evaluated	0
in	0
the	0
sleep	0
laboratory	I-DISEASE
with	I-DISEASE
video	0
and	0
full	0
-	I-DISEASE
head	I-DISEASE
EEG	0
monitoring	0
in	0
order	0
to	I-DISEASE
obtain	I-DISEASE
the	0
correct	0
diagnosis	I-DISEASE
.	0

The	I-DISEASE
characteristic	I-DISEASE
interictal	0
epileptiform	0
activity	0
in	I-DISEASE
idiopathic	I-DISEASE
general-	0
ized	I-DISEASE
epilepsies	0
usually	I-DISEASE
increases	0
during	I-DISEASE
NREM	0
sleep	0
,	I-DISEASE
whereas	0
it	0
decreases	0
during	I-DISEASE
REM	I-DISEASE
sleep	0
and	0
wakefulness	0
.	0

Interictal	I-DISEASE
epileptiform	0
activity	0
may	0
be	0
associated	0
with	I-DISEASE
phasic	I-DISEASE
arousals	0
.	0

In	I-DISEASE
partial	I-DISEASE
epilepsies	0
,	0
the	0
interictal	0
epileptiform	0
activity	0
occurs	0
in	I-DISEASE
a	0
localized	0
distribu-	0
tion	0
with	I-DISEASE
an	0
increase	I-DISEASE
in	I-DISEASE
spike	B-DISEASE
frequency	I-DISEASE
in	I-DISEASE
stages	0
N2	0
and	0
N3	0
compared	0
to	0
REM	0
sleep	0
.	0

Most	I-DISEASE
of	I-DISEASE
the	0
seizures	I-DISEASE
are	0
activated	I-DISEASE
in	I-DISEASE
stage	0
N2	0
sleep	0
.	I-DISEASE

Monitoring	I-DISEASE
may	0
also	0
detect	0
tran-	0
sient	0
autonomic	0
alterations	I-DISEASE
in	0
cardiac	I-DISEASE
rhythm	I-DISEASE
,	I-DISEASE
blood	0
pressure	0
,	I-DISEASE
and	0
respiration	0
during	I-DISEASE
seizures	I-DISEASE
.	I-DISEASE

If	I-DISEASE
epilepsy	I-DISEASE
is	0
suspected	I-DISEASE
,	0
a	I-DISEASE
standard	0
daytime	0
16	0
-	I-DISEASE
channel	I-DISEASE
to	I-DISEASE
20	0
-	0
channel	0
EEG	I-DISEASE
(	0
with	0
partial	I-DISEASE
or	0
total	0
sleep	0
deprivation	I-DISEASE
the	0
night	0
before	I-DISEASE
,	0
as	0
indicated	0
)	0
should	0
be	0
per-	I-DISEASE
formed	0
.	0

Ambulatory	I-DISEASE
24	0
-	0
hour	0
EEG	0
recordings	0
may	0
be	0
useful	0
to	I-DISEASE
detect	I-DISEASE
distribution	0
of	I-DISEASE
interictal	I-DISEASE
epileptiform	0
activity	0
during	I-DISEASE
the	0
sleep	0
-	0
wake	0
cycle	0
.	0

Nocturnal	I-DISEASE
vPSG	0
is	0
the	0
gold	I-DISEASE
standard	0
test	0
for	0
NFLE	I-DISEASE
.	0

Most	I-DISEASE
of	I-DISEASE
the	0
seizures	I-DISEASE
appear	I-DISEASE
during	I-DISEASE
NREM	0
sleep	0
,	I-DISEASE
with	I-DISEASE
preponderance	I-DISEASE
in	I-DISEASE
NREM	0
stages	0
N1	0
and	0
N2	0
(	I-DISEASE
greater	I-DISEASE
than	I-DISEASE
60	I-DISEASE
%	B-DISEASE
)	0
.	0

Rarely	I-DISEASE
do	I-DISEASE
they	I-DISEASE
emerge	0
from	I-DISEASE
REM	I-DISEASE
sleep	0
.	0

In	I-DISEASE
some	I-DISEASE
cases	0
,	I-DISEASE
particularly	0
in	I-DISEASE
paroxysmal	0
arousals	0
,	I-DISEASE
the	0
motor	0
attacks	0
may	I-DISEASE
show	I-DISEASE
a	0
periodicity	0
(	I-DISEASE
every	0
20	0
seconds	0
to	I-DISEASE
two	0
minutes	0
)	0
.	0

Due	I-DISEASE
to	0
the	0
fact	I-DISEASE
that	0
the	0
discharges	0
originate	0
deep	0
in	0
the	0
frontal	0
lobe	0
and	0
are	0
not	0
visible	I-DISEASE
using	0
scalp	0
EEG	0
,	0
the	0
EEG	0
during	I-DISEASE
the	0
attacks	0
is	I-DISEASE
uninformative	I-DISEASE
in	I-DISEASE
almost	I-DISEASE
half	0
of	0
the	0
cases	0
.	0

In	I-DISEASE
a	0
few	0
cases	0
,	0
recording	0
using	I-DISEASE
intracranial	I-DISEASE
or	I-DISEASE
depth	0
electrodes	0
confirms	I-DISEASE
the	0
paroxysms	0
during	I-DISEASE
or	0
preceding	I-DISEASE
the	I-DISEASE
motor	0
components	0
.	0

The	I-DISEASE
interictal	I-DISEASE
sleep	0
EEG	I-DISEASE
is	I-DISEASE
generally	0
normal	0
,	0
but	I-DISEASE
in	I-DISEASE
30	I-DISEASE
%	0
to	I-DISEASE
40	0
%	0
of	0
subjects	0
,	I-DISEASE
focal	0
epileptic	0
abnormalities	I-DISEASE
are	I-DISEASE
seen	I-DISEASE
,	I-DISEASE
predominantly	I-DISEASE
in	I-DISEASE
the	0
anterior	I-DISEASE
regions	I-DISEASE
.	0

The	I-DISEASE
video	I-DISEASE
recording	0
of	I-DISEASE
the	0
different	I-DISEASE
types	I-DISEASE
of	I-DISEASE
attacks	0
in	0
NFLE	I-DISEASE
permits	I-DISEASE
categorization	0
of	I-DISEASE
the	0
seizures	0
and	0
characterization	0
of	I-DISEASE
the	0
main	I-DISEASE
features	0
.	0

During	I-DISEASE
CSWS	I-DISEASE
,	I-DISEASE
diffuse	0
spike	0
waves	0
at	I-DISEASE
two	I-DISEASE
to	I-DISEASE
2.5	I-DISEASE
Hz	0
occur	I-DISEASE
in	I-DISEASE
bursts	0
,	0
with	I-DISEASE
or	0
without	0
clinical	0
manifestations	0
.	0

The	I-DISEASE
discharges	0
are	I-DISEASE
continuous	0
and	0
occupy	0
from	I-DISEASE
85	0
%	0
to	0
100	0
%	I-DISEASE
Appendix	0
A	I-DISEASE
:	0
Sleep	0
Related	0
Medical	I-DISEASE
and	0
Neurological	0
Disorders	I-DISEASE
of	I-DISEASE
NREM	B-DISEASE
sleep	0
stages	0
.	0

Abnormalities	I-DISEASE
arise	I-DISEASE
as	0
soon	I-DISEASE
as	0
the	0
patients	0
fall	I-DISEASE
asleep	I-DISEASE
and	0
dis-	0
appear	I-DISEASE
abruptly	0
on	0
awakening	0
.	0

REM	I-DISEASE
sleep	0
is	I-DISEASE
typically	0
preserved	0
,	I-DISEASE
and	0
the	0
frequency	I-DISEASE
of	I-DISEASE
spike	0
-	I-DISEASE
wave	I-DISEASE
discharges	0
significantly	0
decreases	I-DISEASE
but	0
the	0
frontal	0
predominance	0
of	I-DISEASE
the	0
infrequent	I-DISEASE
bursts	I-DISEASE
may	0
become	I-DISEASE
more	0
prominent	0
.	0

In	I-DISEASE
general	I-DISEASE
,	0
EEG	0
patterns	I-DISEASE
during	I-DISEASE
REM	I-DISEASE
sleep	0
are	I-DISEASE
similar	0
to	I-DISEASE
those	I-DISEASE
in	I-DISEASE
the	0
awake	0
records	I-DISEASE
.	0

The	I-DISEASE
sleep	0
structure	0
is	I-DISEASE
normal	0
,	I-DISEASE
but	0
the	B-DISEASE
presence	0
of	I-DISEASE
almost	I-DISEASE
continuous	0
spike	I-DISEASE
-	I-DISEASE
wave	B-DISEASE
discharges	0
makes	I-DISEASE
the	0
recognition	0
of	I-DISEASE
normal	0
NREM	0
sleep	I-DISEASE
EEG	0
elements	0
(	I-DISEASE
such	0
as	B-DISEASE
K	0
complexes	I-DISEASE
,	I-DISEASE
spindles	0
,	0
or	I-DISEASE
vertex	0
sharp	0
transients	0
)	0
difficult	0
.	0

Differential	I-DISEASE
Diagnosis	0
NFLE	I-DISEASE
may	I-DISEASE
be	0
mistaken	0
for	0
a	0
disorder	I-DISEASE
of	I-DISEASE
arousal	0
from	0
NREM	0
such	0
as	0
sleepwalking	0
,	I-DISEASE
confusional	I-DISEASE
arousal	0
,	I-DISEASE
or	I-DISEASE
sleep	0
terror	B-DISEASE
.	0

Ictal	I-DISEASE
and	0
interictal	0
EEGs	I-DISEASE
are	0
often	I-DISEASE
normal	I-DISEASE
because	0
the	0
focus	I-DISEASE
for	0
the	0
epileptic	0
discharge	0
may	0
be	0
deep	0
in	I-DISEASE
the	0
brain	I-DISEASE
.	0

Disorders	I-DISEASE
of	I-DISEASE
arousal	0
show	I-DISEASE
a	0
different	I-DISEASE
pattern	0
of	I-DISEASE
episodes	I-DISEASE
in	I-DISEASE
that	I-DISEASE
they	I-DISEASE
occur	0
out	0
of	I-DISEASE
stage	I-DISEASE
N3	0
sleep	I-DISEASE
,	0
are	0
not	0
ste-	0
reotyped	I-DISEASE
,	I-DISEASE
often	I-DISEASE
have	0
a	0
sustained	0
autonomic	0
component	I-DISEASE
,	0
and	0
are	0
frequently	0
seen	0
during	I-DISEASE
the	0
first	I-DISEASE
part	I-DISEASE
of	I-DISEASE
the	0
night	0
.	0

Partial	I-DISEASE
arousal	0
disorders	0
tend	B-DISEASE
to	I-DISEASE
disappear	I-DISEASE
or	I-DISEASE
decrease	I-DISEASE
in	0
fre-	I-DISEASE
quency	I-DISEASE
after	0
adolescence	I-DISEASE
.	0

VPSG	I-DISEASE
is	I-DISEASE
often	0
useful	0
.	0

Sleep	I-DISEASE
talking	0
,	0
bruxism	0
,	I-DISEASE
and	0
rhythmic	0
movement	0
disorders	0
can	0
be	I-DISEASE
differentiated	I-DISEASE
from	0
nocturnal	0
seizures	I-DISEASE
by	0
history	I-DISEASE
and	0
vPSG	I-DISEASE
recordings	I-DISEASE
.	0

Benign	I-DISEASE
neonatal	0
sleep	0
myoclonus	0
may	0
be	0
confused	I-DISEASE
with	I-DISEASE
clonic	0
or	I-DISEASE
myoc-	0
lonic	0
seizures	0
during	I-DISEASE
sleep	0
.	0

In	I-DISEASE
the	0
elderly	I-DISEASE
(	I-DISEASE
older	0
than	I-DISEASE
60	0
years	I-DISEASE
)	0
,	0
the	0
main	0
differentiation	0
from	I-DISEASE
RBD	0
is	I-DISEASE
by	I-DISEASE
vPSG	0
recording	0
.	0

PLMD	I-DISEASE
,	I-DISEASE
sleep	0
starts	I-DISEASE
,	0
and	0
propriospinal	0
myoclonus	I-DISEASE
at	I-DISEASE
sleep	0
onset	0
do	0
not	0
show	0
EEG	0
epileptiform	0
activity	0
and	0
belong	I-DISEASE
in	I-DISEASE
the	0
category	0
of	I-DISEASE
move-	I-DISEASE
ment	0
disorders	0
during	0
sleep	0
.	0

Jerks	I-DISEASE
,	0
dyskinesias	0
,	0
or	0
arousal	0
on	0
resumption	I-DISEASE
of	I-DISEASE
breathing	I-DISEASE
in	I-DISEASE
patients	I-DISEASE
with	0
OSA	0
also	0
enter	I-DISEASE
into	I-DISEASE
the	0
differential	I-DISEASE
diagnosis	0
of	I-DISEASE
sleep	0
related	0
epilepsy	0
.	0

Rare	I-DISEASE
cases	0
of	I-DISEASE
anoxic	0
syncope	0
with	0
some	I-DISEASE
clonic	I-DISEASE
jerks	0
at	I-DISEASE
the	I-DISEASE
end	0
of	0
a	0
prolonged	0
(	I-DISEASE
longer	I-DISEASE
than	I-DISEASE
two	I-DISEASE
minutes	0
)	0
obstructive	0
event	0
have	0
been	I-DISEASE
described	0
.	0

Unresolved	I-DISEASE
Issues	0
and	0
Further	I-DISEASE
Directions	0
Not	0
applicable	0
or	I-DISEASE
known	I-DISEASE
.	0

Bilbliography	0
Bazil	0
C	I-DISEASE
,	0
Malow	0
B	0
,	I-DISEASE
Sammaritano	I-DISEASE
M.	I-DISEASE
Sleep	0
and	0
epilepsy	0
:	0
the	0
clinical	0
spectrum	0
.	0

Amsterdam	I-DISEASE
:	0
Elsevier	0
Science	0
;	0
2002	I-DISEASE
.	0

Dinner	I-DISEASE
D	I-DISEASE
,	0
Luders	I-DISEASE
H.	I-DISEASE
Relationship	0
of	I-DISEASE
epilepsy	0
and	0
sleep	0
:	0
an	0
overview	I-DISEASE
.	0

In	I-DISEASE
:	0
Dinner	0
D	I-DISEASE
,	0
Luders	I-DISEASE
H	I-DISEASE
,	0
eds	I-DISEASE
.	0

Epilepsy	I-DISEASE
and	0
sleep	0
:	I-DISEASE
physiological	0
and	0
clinical	0
relationships	0
.	0

San	0
Diego	I-DISEASE
:	0
Academic	I-DISEASE
Press	0
,	I-DISEASE
2001:2–18	I-DISEASE
.	0

Malow	I-DISEASE
B.	0
Paroxysmal	0
events	0
in	0
sleep	0
.	0

J	I-DISEASE
Clin	0
Neurophysiol	0
2002;19:522–34	0
.	0

Nobili	I-DISEASE
L	0
,	0
Cossu	I-DISEASE
M	I-DISEASE
,	0
Mai	I-DISEASE
R.	I-DISEASE
Sleep	I-DISEASE
-	0
related	0
hyperkinetic	I-DISEASE
seizures	I-DISEASE
of	I-DISEASE
temporal	0
lobe	0
origin	I-DISEASE
.	0

Neurology	0
2004;62:482–5	0
.	0

Oldani	I-DISEASE
A	0
,	I-DISEASE
Zucconi	0
M	I-DISEASE
,	0
Ferini	I-DISEASE
-	I-DISEASE
Strambi	I-DISEASE
L	0
,	I-DISEASE
Bizzozero	0
D	I-DISEASE
,	I-DISEASE
Smirne	I-DISEASE
S.	0
Autosomal	I-DISEASE
dominant	I-DISEASE
nocturnal	0
frontal	0
lobe	0
epilepsy	0
:	0
electroclinical	0
picture	I-DISEASE
.	0

Epilepsia	I-DISEASE
1996;37:964–76	0
.	0

Appendix	I-DISEASE
A	0
:	I-DISEASE
Sleep	0
Related	0
Medical	0
and	0
Neurological	0
Disorders	0
Provini	I-DISEASE
F	I-DISEASE
,	0
Plazzi	0
G	I-DISEASE
,	0
Tinuper	I-DISEASE
P	0
,	I-DISEASE
Vandi	0
S	I-DISEASE
,	0
Lugaresi	I-DISEASE
E	0
,	0
Montagna	0
P.	0
Nocturnal	I-DISEASE
frontal	0
lobe	0
epilepsy	0
.	0

A	I-DISEASE
clinical	0
and	0
polygraphic	0
overview	I-DISEASE
of	I-DISEASE
100	0
consecutive	0
cases	0
.	0

Brain	0
1999;122:1017–31	I-DISEASE
.	0

Scheffer	I-DISEASE
I	0
,	0
Bhatia	0
K	B-DISEASE
,	0
Lopes	0
-	I-DISEASE
Cendes	0
I	0
,	I-DISEASE
et	0
al	0
.	0

Autosomal	I-DISEASE
dominant	I-DISEASE
nocturnal	0
frontal	0
lobe	0
epilepsy	0
.	0

A	I-DISEASE
distinctive	I-DISEASE
clinical	0
disorder	I-DISEASE
.	0

Brain	0
1995;118:61–73	I-DISEASE
.	0

Shouse	I-DISEASE
M	I-DISEASE
,	I-DISEASE
Martins	0
da	0
Silva	I-DISEASE
A	0
,	0
Sammaritano	I-DISEASE
M.	I-DISEASE
Circadian	I-DISEASE
rhythm	0
,	I-DISEASE
sleep	0
,	I-DISEASE
and	0
epilepsy	0
.	I-DISEASE

J	I-DISEASE
Clin	0
Neurophysiol	0
1996;13:32–50	0
.	0

Tassinari	I-DISEASE
C	I-DISEASE
,	0
Dravet	0
C	0
,	0
Roger	0
J.	0
CSWS	I-DISEASE
:	0

Encephalography	I-DISEASE
related	0
to	I-DISEASE
electrical	I-DISEASE
status	0
epilepticus	0
during	I-DISEASE
slow	0
sleep	0
.	0

Electroencephalogr	I-DISEASE
Clin	I-DISEASE
Neurophysiol	0
1977;43:529–30	0
.	0

Tinuper	I-DISEASE
P	0
,	0
Provini	B-DISEASE
F	I-DISEASE
,	0
Bisulli	0
F	0
,	I-DISEASE
et	0
al	I-DISEASE
.	0

Movements	I-DISEASE
disorders	0
in	I-DISEASE
sleep	0
:	I-DISEASE
guideline	0
for	0
differentiating	0
epileptic	0
from	0
non	0
-	I-DISEASE
epileptic	I-DISEASE
motor	I-DISEASE
phenomena	0
arising	0
from	0
sleep	0
.	0

Sleep	I-DISEASE
Med	I-DISEASE
Rev	I-DISEASE
2007;11:255–67	0
.	0

Zucconi	I-DISEASE
M.	0
Sleep	0
-	0
related	B-DISEASE
epilepsy	0
.	I-DISEASE

Handb	0
Clin	0
Neurol	0
2011;99:1109–37	I-DISEASE
.	0

Sleep	I-DISEASE
Related	0
Headaches	I-DISEASE
Alternate	0
Names	I-DISEASE
Various	0
(	0
see	I-DISEASE
Clinical	0
and	0
Pathologic	I-DISEASE
Subtypes	I-DISEASE
)	0
.	0

Essential	I-DISEASE
Features	I-DISEASE
Sleep	0
related	B-DISEASE
headaches	0
are	0
a	I-DISEASE
group	I-DISEASE
of	I-DISEASE
unilateral	I-DISEASE
or	I-DISEASE
bilateral	0
cephalalgias	I-DISEASE
of	I-DISEASE
varying	0
severity	0
and	0
duration	0
that	0
occur	I-DISEASE
during	I-DISEASE
sleep	0
or	I-DISEASE
upon	B-DISEASE
awakening	0
from	I-DISEASE
sleep	0
.	0

It	I-DISEASE
is	I-DISEASE
a	0
heterogenous	I-DISEASE
group	I-DISEASE
of	I-DISEASE
different	0
headache	I-DISEASE
entities	0
with	I-DISEASE
the	0
common	I-DISEASE
feature	0
of	I-DISEASE
occur-	I-DISEASE
rence	0
during	I-DISEASE
sleep	0
or	I-DISEASE
upon	0
awakening	0
.	I-DISEASE

The	I-DISEASE
characteristics	I-DISEASE
of	I-DISEASE
specific	I-DISEASE
subtypes	0
of	I-DISEASE
sleep	0
related	0
headache	0
are	I-DISEASE
discussed	I-DISEASE
in	I-DISEASE
the	0
Clinical	0
and	0
Pathologic	I-DISEASE
Subtypes	I-DISEASE
section	0
below	I-DISEASE
.	0

Associated	I-DISEASE
Features	I-DISEASE
Individual	0
features	I-DISEASE
associated	0
with	I-DISEASE
specific	I-DISEASE
sleep	0
related	B-DISEASE
headache	0
types	I-DISEASE
are	I-DISEASE
discussed	I-DISEASE
in	I-DISEASE
the	0
following	0
section	I-DISEASE
.	I-DISEASE

Clinical	I-DISEASE
and	0
Pathologic	I-DISEASE
Subtypes	I-DISEASE
Most	0
sleep	0
related	B-DISEASE
headaches	I-DISEASE
are	I-DISEASE
daytime	0
headache	0
conditions	I-DISEASE
that	I-DISEASE
also	0
may	0
occur	I-DISEASE
during	I-DISEASE
sleep	0
.	0

These	0
include	I-DISEASE
the	0
primary	0
headaches	0
such	0
as	I-DISEASE
migraine	0
,	I-DISEASE
cluster	0
head-	I-DISEASE
ache	0
,	I-DISEASE
and	0
chronic	0
paroxysmal	0
hemicrania	0
.	0

There	I-DISEASE
are	0
other	0
primary	0
headaches	0
that	0
occur	I-DISEASE
solely	0
with	0
sleep	0
;	I-DISEASE
for	I-DISEASE
example	0
,	0
hypnic	I-DISEASE
headaches	0
.	0

In	I-DISEASE
addition	0
,	0
secondary	0
head-	0
aches	0
related	B-DISEASE
to	0
medical	0
,	I-DISEASE
neurological	I-DISEASE
,	I-DISEASE
psychiatric	I-DISEASE
,	I-DISEASE
and	0
sleep	0
disorders	0
can	0
cause	I-DISEASE
sleep	0
related	0
headaches	I-DISEASE
.	I-DISEASE

Migraines	I-DISEASE
are	I-DISEASE
common	0
recurrent	0
headaches	I-DISEASE
of	I-DISEASE
moderate	0
to	I-DISEASE
severe	I-DISEASE
intensity	0
that	0
last	0
between	0
four	I-DISEASE
and	0
72	0
hours	I-DISEASE
.	0

Pain	0
is	I-DISEASE
typically	0
unilateral	I-DISEASE
and	0
pulsating	0
,	0
aggra-	0
vated	0
by	I-DISEASE
routine	0
physical	0
activity	0
and	0
associated	0
with	0
nausea	0
,	I-DISEASE
and/or	0
photophobia	0
Appendix	0
A	0
:	0
Sleep	0
Related	0
Medical	I-DISEASE
and	0
Neurological	0
Disorders	I-DISEASE
or	0
phonophobia	0
.	0

They	I-DISEASE
occur	I-DISEASE
during	I-DISEASE
the	0
day	0
or	I-DISEASE
during	I-DISEASE
sleep	0
;	0
approximately	0
50	0
%	0
of	I-DISEASE
migraine	I-DISEASE
attacks	I-DISEASE
occur	I-DISEASE
between	0
4:00	0
a.m.	0
and	0
9:00	I-DISEASE
a.m.	0

Migraine	I-DISEASE
headaches	I-DISEASE
do	I-DISEASE
not	0
have	I-DISEASE
a	0
fixed	0
association	0
with	I-DISEASE
a	I-DISEASE
particular	I-DISEASE
sleep	0
stage	0
.	0

The	I-DISEASE
patient	I-DISEASE
may	0
awaken	0
with	I-DISEASE
a	0
migraine	I-DISEASE
out	0
of	I-DISEASE
REM	I-DISEASE
sleep	0
,	I-DISEASE
or	I-DISEASE
the	I-DISEASE
headaches	0
may	I-DISEASE
occur	I-DISEASE
in	I-DISEASE
relationship	0
to	I-DISEASE
stage	I-DISEASE
N3	0
sleep	0
.	0

A	I-DISEASE
“	I-DISEASE
classic	0
migraine	0
”	I-DISEASE
headache	I-DISEASE
is	0
preceded	0
by	I-DISEASE
an	0
aura	I-DISEASE
(	I-DISEASE
if	0
the	0
patient	I-DISEASE
is	I-DISEASE
awake	0
)	0
,	I-DISEASE
which	0
usually	I-DISEASE
lasts	0
four	I-DISEASE
to	I-DISEASE
60	0
minutes	0
and	0
typically	0
consists	I-DISEASE
of	I-DISEASE
homonymous	I-DISEASE
visual	I-DISEASE
field	0
defects	0
and	0
scintillating	0
scotomas	0
.	0

In	I-DISEASE
some	I-DISEASE
patients	0
,	I-DISEASE
the	0
aura	0
may	I-DISEASE
continue	0
or	0
even	0
begin	I-DISEASE
during	I-DISEASE
the	I-DISEASE
headache	I-DISEASE
phase	0
.	0

In	I-DISEASE
contrast	I-DISEASE
,	0
“	I-DISEASE
common	I-DISEASE
migraine	0
”	I-DISEASE
does	0
not	0
start	0
with	I-DISEASE
an	I-DISEASE
aura	0
.	0

Other	I-DISEASE
signs	I-DISEASE
of	I-DISEASE
neurological	0
dysfunction	0
may	0
include	I-DISEASE
unilateral	I-DISEASE
paresthesias	0
,	0
weakness	0
,	I-DISEASE
and	0
aphasia	0
.	0

Features	I-DISEASE
of	I-DISEASE
brainstem	0
involvement	0
may	I-DISEASE
include	I-DISEASE
vertigo	I-DISEASE
,	0
tinni-	0
tus	0
,	I-DISEASE
dysarthria	I-DISEASE
,	I-DISEASE
decreased	I-DISEASE
hearing	I-DISEASE
,	I-DISEASE
diplopia	0
,	I-DISEASE
ataxia	I-DISEASE
,	0
bilateral	I-DISEASE
paresthesias	0
,	0
and	0
impaired	I-DISEASE
level	0
of	0
consciousness	0
.	0

A	I-DISEASE
familial	I-DISEASE
syndrome	0
with	I-DISEASE
hemiplegia	0
is	0
well	I-DISEASE
described	I-DISEASE
.	0

The	I-DISEASE
hemiplegia	I-DISEASE
is	I-DISEASE
ipsilateral	I-DISEASE
or	I-DISEASE
contralateral	I-DISEASE
to	I-DISEASE
the	0
side	I-DISEASE
of	0
the	0
headache	I-DISEASE
.	0

Cluster	I-DISEASE
headaches	0
are	0
severe	I-DISEASE
,	I-DISEASE
unilateral	I-DISEASE
,	0
periorbital	I-DISEASE
or	I-DISEASE
temporal	I-DISEASE
headaches	I-DISEASE
that	0
start	0
quickly	0
and	0
peak	0
within	I-DISEASE
10	I-DISEASE
to	0
15	I-DISEASE
minutes	0
.	0

They	I-DISEASE
have	I-DISEASE
a	0
relatively	0
shorter	0
duration	0
,	0
usually	I-DISEASE
lasting	0
15	0
minutes	0
to	I-DISEASE
three	I-DISEASE
hours	I-DISEASE
(	0
mean	I-DISEASE
,	I-DISEASE
60	I-DISEASE
minutes	0
)	0
.	0

The	I-DISEASE
headaches	I-DISEASE
occur	I-DISEASE
daily	0
during	I-DISEASE
cluster	0
periods	I-DISEASE
—	I-DISEASE
usually	I-DISEASE
one	0
to	I-DISEASE
three	I-DISEASE
attacks	I-DISEASE
per	0
day	0
over	I-DISEASE
a	I-DISEASE
period	0
of	0
one	0
to	0
two	I-DISEASE
months	0
.	0

Most	I-DISEASE
patients	0
have	0
one	I-DISEASE
cluster	0
period	I-DISEASE
per	I-DISEASE
year	0
,	0
though	0
this	0
can	0
vary	I-DISEASE
from	I-DISEASE
patient	0
to	I-DISEASE
patient	I-DISEASE
.	I-DISEASE

The	I-DISEASE
headaches	I-DISEASE
tend	I-DISEASE
to	0
occur	I-DISEASE
at	I-DISEASE
the	B-DISEASE
same	0
hour	0
each	0
day	0
,	I-DISEASE
with	I-DISEASE
75	0
%	0
of	I-DISEASE
cluster	I-DISEASE
episodes	0
reported	0
to	I-DISEASE
occur	I-DISEASE
between	0
9:00	I-DISEASE
p.m.	0
and	0
10:00	B-DISEASE
a.m.	0

One	I-DISEASE
or	I-DISEASE
more	0
cranial	I-DISEASE
autonomic	0
features	0
(	I-DISEASE
e.g.	0
,	I-DISEASE
ipsilateral	I-DISEASE
conjunctival	I-DISEASE
injection	0
,	I-DISEASE
lacrimation	0
,	I-DISEASE
nasal	0
congestion	I-DISEASE
,	0
rhinorrhea	0
,	0
forehead	I-DISEASE
and	0
facial	0
sweating	0
,	0
miosis	0
,	0
ptosis	I-DISEASE
,	I-DISEASE
or	I-DISEASE
eyelid	0
edema	0
)	0
invariably	I-DISEASE
accompany	0
attacks	0
of	I-DISEASE
cluster	0
headaches	I-DISEASE
.	0

A	I-DISEASE
strong	I-DISEASE
predilection	0
for	I-DISEASE
attacks	I-DISEASE
to	0
occur	0
during	I-DISEASE
sleep	0
is	I-DISEASE
well	I-DISEASE
recognized	0
,	I-DISEASE
and	0
these	I-DISEASE
attacks	0
are	0
strongly	I-DISEASE
related	0
to	I-DISEASE
REM	I-DISEASE
sleep	I-DISEASE
.	0

Chronic	I-DISEASE
paroxysmal	0
hemicrania	I-DISEASE
closely	I-DISEASE
resembles	I-DISEASE
cluster	0
headaches	I-DISEASE
and	0
consists	I-DISEASE
of	I-DISEASE
severe	0
unilateral	0
orbital	I-DISEASE
,	0
supraorbital	0
,	I-DISEASE
or	I-DISEASE
temporal	0
pain	0
associated	0
with	I-DISEASE
one	0
or	0
more	0
cranial	I-DISEASE
autonomic	0
features	I-DISEASE
.	0

However	I-DISEASE
,	I-DISEASE
the	0
attacks	I-DISEASE
are	0
usually	I-DISEASE
of	I-DISEASE
shorter	0
duration	0
(	I-DISEASE
lasting	0
two	I-DISEASE
to	I-DISEASE
30	I-DISEASE
minutes	0
)	0
and	0
occur	I-DISEASE
more	0
frequently	0
,	I-DISEASE
most	I-DISEASE
often	I-DISEASE
at	I-DISEASE
a	0
frequency	I-DISEASE
of	0
more	0
than	0
five	I-DISEASE
per	I-DISEASE
day	I-DISEASE
.	0

In	I-DISEASE
contrast	I-DISEASE
to	0
cluster	0
headaches	0
,	0
chronic	I-DISEASE
paroxysmal	0
hemicrania	I-DISEASE
is	0
exqui-	I-DISEASE
sitely	0
sensitive	I-DISEASE
to	0
indomethacin	I-DISEASE
.	0

Attacks	I-DISEASE
are	0
also	0
strongly	0
associated	0
with	I-DISEASE
REM	I-DISEASE
sleep	0
.	0

Hypnic	I-DISEASE
headaches	0
are	0
an	0
uncommon	0
type	I-DISEASE
of	I-DISEASE
headache	I-DISEASE
that	I-DISEASE
awakens	0
the	0
patient	I-DISEASE
from	I-DISEASE
sleep	0
with	0
a	0
generalized	0
or	0
lateralized	0
headache	I-DISEASE
that	0
lasts	I-DISEASE
at	I-DISEASE
least	I-DISEASE
15	I-DISEASE
minutes	0
(	I-DISEASE
range	0
,	I-DISEASE
one	0
to	I-DISEASE
180	0
minutes	0
)	0
with	0
a	0
frequency	I-DISEASE
of	0
at	I-DISEASE
least	I-DISEASE
15	I-DISEASE
times	I-DISEASE
per	I-DISEASE
month	0
.	0

Onset	I-DISEASE
is	0
typically	0
after	0
the	0
age	I-DISEASE
of	I-DISEASE
50	0
,	0
although	0
similar	0
headaches	I-DISEASE
are	0
described	I-DISEASE
rarely	I-DISEASE
in	I-DISEASE
younger	0
indi-	0
viduals	0
,	0
including	I-DISEASE
children	0
.	0

In	I-DISEASE
comparison	0
to	0
cluster	0
headaches	0
,	0
hypnic	I-DISEASE
headaches	I-DISEASE
are	I-DISEASE
Appendix	0
A	0
:	0
Sleep	0
Related	0
Medical	I-DISEASE
and	0
Neurological	0
Disorders	0
less	B-DISEASE
severe	0
,	0
often	I-DISEASE
bilateral	0
and	0
not	0
associated	0
with	I-DISEASE
cranial	0
autonomic	0
features	I-DISEASE
.	0

Isolated	I-DISEASE
nausea	I-DISEASE
,	0
photophobia	0
,	0
or	0
phonophobia	0
may	0
be	I-DISEASE
present	I-DISEASE
.	0

They	I-DISEASE
may	0
occur	0
one	0
to	0
three	I-DISEASE
times	0
during	I-DISEASE
the	0
night	0
,	0
with	I-DISEASE
many	I-DISEASE
patients	I-DISEASE
reporting	0
that	0
the	0
headaches	I-DISEASE
occur	0
at	I-DISEASE
the	0
same	0
time	0
of	I-DISEASE
the	I-DISEASE
night	0
.	I-DISEASE

The	I-DISEASE
headaches	I-DISEASE
tend	I-DISEASE
to	0
occur	I-DISEASE
during	I-DISEASE
REM	I-DISEASE
sleep	0
.	0

However	I-DISEASE
,	I-DISEASE
they	I-DISEASE
also	0
have	0
been	I-DISEASE
reported	0
to	I-DISEASE
occur	0
during	I-DISEASE
stage	I-DISEASE
N3	0
sleep	I-DISEASE
.	0

A	I-DISEASE
positive	0
therapeutic	0
response	0
to	0
lithium	I-DISEASE
,	I-DISEASE
indomethacin	0
,	I-DISEASE
and	0
caffeine	0
has	0
been	I-DISEASE
reported	I-DISEASE
in	I-DISEASE
many	0
patients	0
.	0

Other	I-DISEASE
medical	I-DISEASE
(	0
e.g.	0
,	I-DISEASE
hypertension	0
)	I-DISEASE
,	I-DISEASE
neurologic	0
(	0
e.g.	0
,	I-DISEASE
brain	I-DISEASE
tumors	I-DISEASE
,	0
arteriovenous	0
mal-	0
formations	0
,	0
cerebral	0
venous	0
thrombosis	0
and	0
trauma	0
)	0
,	I-DISEASE
psychiatric	I-DISEASE
(	I-DISEASE
e.g.	0
,	0
depression	B-DISEASE
)	0
,	I-DISEASE
and	0
sleep	0
disorders	0
(	0
e.g.	0
,	I-DISEASE
snoring	0
and	0
OSA	I-DISEASE
)	0
also	0
can	0
give	I-DISEASE
rise	0
to	I-DISEASE
headaches	0
that	0
may	I-DISEASE
occur	I-DISEASE
during	I-DISEASE
sleep	0
or	0
upon	I-DISEASE
awakening	0
from	I-DISEASE
sleep	0
.	0

Patients	I-DISEASE
with	0
increased	0
intracranial	0
pressure	0
(	I-DISEASE
due	I-DISEASE
,	I-DISEASE
for	I-DISEASE
example	0
,	I-DISEASE
to	I-DISEASE
brain	I-DISEASE
tumor	0
,	0
hematoma	I-DISEASE
,	0
arteriovenous	0
malformations	0
,	0
or	0
cerebral	0
venous	I-DISEASE
thrombosis	0
)	0
may	0
complain	0
of	I-DISEASE
headache	I-DISEASE
in	I-DISEASE
the	I-DISEASE
morning	0
or	I-DISEASE
head-	I-DISEASE
ache	0
that	0
starts	0
after	0
recumbence	0
and	0
improves	0
after	I-DISEASE
the	0
patient	I-DISEASE
is	0
up	0
for	I-DISEASE
30	I-DISEASE
to	I-DISEASE
60	I-DISEASE
minutes	0
.	0

Nausea	I-DISEASE
,	I-DISEASE
vomiting	0
,	0
signs	0
of	I-DISEASE
focal	0
neurological	0
deficits	I-DISEASE
,	I-DISEASE
and	0
papilledema	0
may	0
be	0
present	I-DISEASE
.	0

The	I-DISEASE
headache	I-DISEASE
may	0
worsen	0
with	I-DISEASE
bending	0
down	I-DISEASE
or	B-DISEASE
sneezing	0
or	I-DISEASE
with	I-DISEASE
other	0
activities	I-DISEASE
that	0
may	I-DISEASE
cause	0
further	0
increase	I-DISEASE
in	I-DISEASE
intracranial	I-DISEASE
pressure	0
.	0

Sleep	I-DISEASE
related	I-DISEASE
headaches	0
can	0
disrupt	I-DISEASE
nocturnal	0
sleep	0
,	0
although	0
the	0
exact	I-DISEASE
prevalence	I-DISEASE
of	I-DISEASE
this	I-DISEASE
complication	I-DISEASE
is	0
unknown	0
.	0

Demographics	I-DISEASE
The	0
exact	0
prevalence	0
of	I-DISEASE
sleep	0
related	0
headaches	0
is	I-DISEASE
not	0
known	0
.	0

One	I-DISEASE
study	I-DISEASE
from	0
a	I-DISEASE
head-	0
ache	0
clinic	I-DISEASE
suggested	0
that	0
17	0
%	0
of	I-DISEASE
all	0
headache	I-DISEASE
patients	I-DISEASE
complain	I-DISEASE
of	I-DISEASE
nocturnal	0
or	I-DISEASE
early	0
morning	0
headaches	0
,	I-DISEASE
and	0
roughly	I-DISEASE
half	0
of	I-DISEASE
these	I-DISEASE
were	I-DISEASE
related	0
to	I-DISEASE
an	0
identifiable	I-DISEASE
sleep	0
disorder	0
.	0

However	I-DISEASE
,	I-DISEASE
many	0
primary	0
headache	0
disorders	0
can	I-DISEASE
occur	I-DISEASE
during	I-DISEASE
sleep	0
as	0
well	I-DISEASE
.	I-DISEASE

Sleep	I-DISEASE
related	I-DISEASE
migraines	0
have	I-DISEASE
been	I-DISEASE
reported	I-DISEASE
to	0
increase	0
in	I-DISEASE
frequency	I-DISEASE
with	I-DISEASE
age	I-DISEASE
.	0

Predisposing	I-DISEASE
and	0
Precipitating	I-DISEASE
Factors	0
Migraine	I-DISEASE
headaches	B-DISEASE
have	0
several	I-DISEASE
predisposing	0
factors	0
that	0
vary	0
from	I-DISEASE
patient	0
to	I-DISEASE
patient	I-DISEASE
.	0

However	I-DISEASE
,	I-DISEASE
stress	0
,	I-DISEASE
relaxation	0
,	I-DISEASE
changes	0
in	I-DISEASE
weather	0
and	0
barometric	0
pressure	I-DISEASE
,	I-DISEASE
changes	0
in	I-DISEASE
sleep	0
pattern	0
,	0
hypoglycemia	0
,	I-DISEASE
and	0
specific	I-DISEASE
foods	0
(	I-DISEASE
e.g.	0
,	I-DISEASE
chocolate	0
,	0
Chinese	0
food	0
,	0
alcohol	0
)	0
have	0
been	0
known	I-DISEASE
to	I-DISEASE
trigger	I-DISEASE
migraine	0
headaches	0
.	0

Alcohol	I-DISEASE
can	I-DISEASE
also	0
predispose	I-DISEASE
an	0
indi-	I-DISEASE
vidual	I-DISEASE
to	I-DISEASE
having	I-DISEASE
cluster	I-DISEASE
headache	0
and	0
chronic	I-DISEASE
paroxysmal	0
hemicrania	I-DISEASE
.	0

OSA	I-DISEASE
and	0
atten-	I-DISEASE
dant	0
hypoxia	0
have	I-DISEASE
been	I-DISEASE
reported	0
to	I-DISEASE
be	I-DISEASE
a	I-DISEASE
trigger	0
for	0
cluster	0
headache	0
.	0

However	I-DISEASE
,	I-DISEASE
sleep	0
apnea	I-DISEASE
may	I-DISEASE
also	0
predispose	0
a	0
person	I-DISEASE
to	I-DISEASE
having	0
other	I-DISEASE
types	I-DISEASE
of	I-DISEASE
headache	0
and	0
may	I-DISEASE
inde-	I-DISEASE
pendently	0
lead	0
to	0
morning	0
headaches	I-DISEASE
.	0

Change	I-DISEASE
of	I-DISEASE
sleep	0
pattern	0
and	0
insomnia	I-DISEASE
can	0
pre-	0
dispose	I-DISEASE
the	0
patient	I-DISEASE
to	I-DISEASE
developing	I-DISEASE
headaches	0
.	0

Appendix	I-DISEASE
A	0
:	I-DISEASE
Sleep	0
Related	0
Medical	0
and	0
Neurological	0
Disorders	0
Familial	I-DISEASE
Patterns	0
There	0
is	0
a	I-DISEASE
positive	0
family	0
history	I-DISEASE
for	I-DISEASE
migraine	0
in	I-DISEASE
up	0
to	I-DISEASE
80	0
%	0
of	I-DISEASE
patients	0
with	0
this	0
disor-	0
der	0
.	0

Familial	I-DISEASE
hemiplegic	I-DISEASE
migraine	0
is	0
inherited	I-DISEASE
in	I-DISEASE
an	I-DISEASE
autosomal	0
dominant	I-DISEASE
pattern	0
with	0
a	0
variety	I-DISEASE
of	I-DISEASE
genetic	I-DISEASE
mutations	0
identified	I-DISEASE
on	0
chromosomes	I-DISEASE
1	I-DISEASE
and	0
19	B-DISEASE
.	0

Cluster	I-DISEASE
headache	0
does	I-DISEASE
not	0
have	I-DISEASE
as	0
strong	I-DISEASE
of	I-DISEASE
a	0
familial	I-DISEASE
disposition	I-DISEASE
as	0
migraine	0
headache	0
,	0
but	I-DISEASE
first	I-DISEASE
-	0
degree	I-DISEASE
relatives	I-DISEASE
of	I-DISEASE
probands	0
with	I-DISEASE
cluster	0
headache	B-DISEASE
are	0
seven	0
times	0
more	0
likely	I-DISEASE
to	0
develop	0
cluster	0
headaches	0
,	0
and	0
the	0
concordance	0
rates	I-DISEASE
in	I-DISEASE
monozygotic	0
twins	I-DISEASE
is	0
100	0
%	0
.	0

The	I-DISEASE
inheritance	I-DISEASE
patterns	0
of	I-DISEASE
hypnic	0
headache	0
are	0
not	0
known	I-DISEASE
.	I-DISEASE

Onset	I-DISEASE
,	0
Course	0
,	0
and	0
Complications	0
Migraine	0
headache	I-DISEASE
usually	I-DISEASE
starts	0
in	I-DISEASE
the	0
second	0
or	0
third	I-DISEASE
decade	I-DISEASE
of	I-DISEASE
life	0
,	I-DISEASE
with	I-DISEASE
a	0
slightly	I-DISEASE
earlier	0
onset	I-DISEASE
in	I-DISEASE
men	I-DISEASE
than	0
in	I-DISEASE
women	I-DISEASE
.	0

The	I-DISEASE
mean	I-DISEASE
age	I-DISEASE
of	I-DISEASE
onset	0
of	I-DISEASE
cluster	0
headache	I-DISEASE
is	0
28	0
years	I-DISEASE
.	0

Chronic	I-DISEASE
paroxysmal	0
hemicrania	I-DISEASE
has	0
a	0
wide	I-DISEASE
range	I-DISEASE
of	I-DISEASE
onset	0
,	I-DISEASE
from	I-DISEASE
childhood	0
to	0
old	I-DISEASE
age	I-DISEASE
.	0

Most	I-DISEASE
patients	I-DISEASE
with	0
hypnic	I-DISEASE
headache	I-DISEASE
are	0
elderly	0
,	0
with	I-DISEASE
the	I-DISEASE
age	I-DISEASE
of	I-DISEASE
onset	0
from	I-DISEASE
40	I-DISEASE
to	0
82	0
years	I-DISEASE
.	0

Brain	0
tumors	0
are	0
more	0
prevalent	0
in	I-DISEASE
the	0
elderly	I-DISEASE
,	0
most	0
occurring	0
from	I-DISEASE
the	I-DISEASE
fifth	I-DISEASE
decade	0
to	I-DISEASE
late	I-DISEASE
life	I-DISEASE
.	0

Most	I-DISEASE
sleep	0
related	0
headaches	I-DISEASE
are	0
benign	I-DISEASE
and	0
tend	0
to	0
decrease	I-DISEASE
in	I-DISEASE
frequency	I-DISEASE
with	0
age	I-DISEASE
.	0

There	I-DISEASE
may	0
be	0
spontaneous	I-DISEASE
remissions	0
that	0
last	0
from	0
months	0
to	I-DISEASE
years	I-DISEASE
.	0

Pregnancy	I-DISEASE
has	0
a	0
variable	I-DISEASE
effect	0
on	0
these	0
headaches	0
.	0

Migraines	I-DISEASE
tend	I-DISEASE
to	0
decrease	I-DISEASE
with	I-DISEASE
age	I-DISEASE
and	0
,	0
in	0
women	I-DISEASE
,	I-DISEASE
may	I-DISEASE
stop	0
after	0
menopause	I-DISEASE
.	0

Cluster	I-DISEASE
headaches	0
,	0
as	0
the	0
name	I-DISEASE
suggests	I-DISEASE
,	0
occur	I-DISEASE
in	I-DISEASE
clusters	I-DISEASE
and	0
are	0
accompanied	I-DISEASE
by	I-DISEASE
pain	0
-	0
free	0
intervals	I-DISEASE
lasting	0
months	0
to	0
a	0
couple	I-DISEASE
of	0
years	I-DISEASE
.	0

They	I-DISEASE
also	0
tend	B-DISEASE
to	I-DISEASE
decrease	0
with	I-DISEASE
age	I-DISEASE
.	0

Hypnic	I-DISEASE
headache	0
occurs	0
infrequently	I-DISEASE
.	0

Headaches	I-DISEASE
in	I-DISEASE
patients	0
with	I-DISEASE
brain	0
tumors	I-DISEASE
are	0
related	0
to	0
an	0
increase	I-DISEASE
in	I-DISEASE
intracranial	0
pressure	0
and	0
tend	I-DISEASE
to	0
improve	0
with	0
treatment	I-DISEASE
of	0
the	0
primary	0
lesion	0
and	0
a	0
decrease	0
in	I-DISEASE
intracranial	I-DISEASE
pres-	0
sure	0
.	0

Some	I-DISEASE
patients	0
with	0
OSA	I-DISEASE
report	0
improvement	0
of	I-DISEASE
the	0
headache	0
after	0
treatment	I-DISEASE
of	I-DISEASE
the	0
apnea	0
.	I-DISEASE

The	I-DISEASE
sleep	0
related	0
headaches	I-DISEASE
can	0
cause	I-DISEASE
sleep	0
disruption	0
and	0
insomnia	I-DISEASE
with	I-DISEASE
decreased	I-DISEASE
sleep	0
efficiency	I-DISEASE
.	0

Cluster	I-DISEASE
headaches	0
occurring	0
regularly	I-DISEASE
in	I-DISEASE
sleep	0
can	0
also	0
lead	0
to	I-DISEASE
tran-	I-DISEASE
sient	0
situational	I-DISEASE
insomnia	0
that	0
may	I-DISEASE
resolve	0
after	I-DISEASE
the	0
remission	I-DISEASE
or	I-DISEASE
the	0
treatment	B-DISEASE
of	I-DISEASE
the	0
cluster	0
headache	I-DISEASE
.	0

Depending	I-DISEASE
on	0
the	0
etiology	0
of	I-DISEASE
the	I-DISEASE
sleep	0
related	B-DISEASE
headache	0
(	I-DISEASE
e.g.	I-DISEASE
,	I-DISEASE
brain	I-DISEASE
tumor	I-DISEASE
)	0
,	0
other	I-DISEASE
complications	0
may	I-DISEASE
occur	I-DISEASE
.	0

Developmental	I-DISEASE
Issues	0
Not	I-DISEASE
applicable	0
or	I-DISEASE
known	I-DISEASE
.	0

Appendix	I-DISEASE
A	0
:	I-DISEASE
Sleep	0
Related	0
Medical	0
and	0
Neurological	0
Disorders	0
Pathology	I-DISEASE
and	0
Pathophysiology	I-DISEASE
Several	0
anatomic	0
areas	0
are	0
common	I-DISEASE
to	0
the	0
physiology	I-DISEASE
of	I-DISEASE
both	0
sleep	0
and	0
headaches	0
;	0
these	0
include	0
the	0
brainstem	0
and	0
diencephalon	I-DISEASE
,	0
specifically	I-DISEASE
the	0
ventrolateral	0
periaque-	0
ductal	I-DISEASE
gray	I-DISEASE
and	0
the	0
posterior	I-DISEASE
hypothalamus	I-DISEASE
.	0

From	I-DISEASE
a	0
neurochemical	0
perspective	I-DISEASE
,	0
ade-	I-DISEASE
nosine	0
,	I-DISEASE
melatonin	B-DISEASE
,	0
and	0
orexin	I-DISEASE
also	0
are	0
involved	0
in	I-DISEASE
both	0
the	0
regulation	I-DISEASE
of	I-DISEASE
sleep	0
and	0
the	0
evolution	0
of	I-DISEASE
headaches	0
.	0

Dysfunction	I-DISEASE
of	I-DISEASE
REM	0
sleep	0
and	0
arousal	0
mechanisms	0
are	I-DISEASE
common	I-DISEASE
to	I-DISEASE
many	I-DISEASE
headache	I-DISEASE
disorders	0
.	0

Data	I-DISEASE
from	I-DISEASE
transgenic	0
models	0
indicate	I-DISEASE
that	0
dis-	I-DISEASE
ruption	0
of	I-DISEASE
sleep	0
occurs	I-DISEASE
in	I-DISEASE
two	I-DISEASE
forms	0
of	0
familial	I-DISEASE
migraine	0
.	0

However	I-DISEASE
,	I-DISEASE
current	0
mechanis-	B-DISEASE
tic	I-DISEASE
explanations	0
of	I-DISEASE
the	0
relationship	I-DISEASE
between	0
sleep	0
and	0
headache	I-DISEASE
are	I-DISEASE
speculative	0
.	0

Objective	I-DISEASE
Findings	I-DISEASE
Polysomnographic	0
aspects	0
of	I-DISEASE
sleep	I-DISEASE
related	I-DISEASE
headaches	I-DISEASE
need	I-DISEASE
to	I-DISEASE
be	0
better	0
defined	I-DISEASE
.	0

Migraine	I-DISEASE
headache	I-DISEASE
is	0
reported	I-DISEASE
to	I-DISEASE
occur	I-DISEASE
in	0
association	0
with	I-DISEASE
REM	I-DISEASE
sleep	0
or	0
stage	0
N3	0
sleep	0
.	0

An	I-DISEASE
excess	I-DISEASE
of	I-DISEASE
stage	I-DISEASE
N3	0
sleep	0
also	I-DISEASE
has	0
been	I-DISEASE
reported	0
in	I-DISEASE
patients	I-DISEASE
with	I-DISEASE
migraine	0
.	I-DISEASE

However	I-DISEASE
,	I-DISEASE
large	I-DISEASE
controlled	I-DISEASE
studies	0
are	I-DISEASE
not	0
available	I-DISEASE
.	0

Fifty	I-DISEASE
percent	I-DISEASE
of	I-DISEASE
cluster	0
headaches	0
and	0
a	I-DISEASE
majority	0
of	I-DISEASE
chronic	I-DISEASE
paroxysmal	0
hemicrania	I-DISEASE
are	0
associated	0
with	I-DISEASE
REM	I-DISEASE
sleep	0
.	0

OSA	I-DISEASE
and	0
hypoxia	I-DISEASE
during	I-DISEASE
sleep	0
may	0
aggravate	0
other	0
sleep	0
related	B-DISEASE
headaches	I-DISEASE
or	0
may	I-DISEASE
be	0
an	0
independent	I-DISEASE
cause	I-DISEASE
of	I-DISEASE
headache	0
.	I-DISEASE

Hypnic	I-DISEASE
headache	0
occurs	0
during	I-DISEASE
sleep	I-DISEASE
,	0
with	0
recent	I-DISEASE
reports	I-DISEASE
of	I-DISEASE
headache	I-DISEASE
during	I-DISEASE
REM	I-DISEASE
sleep	I-DISEASE
and	0
uncommonly	0
during	I-DISEASE
stage	I-DISEASE
N3	0
sleep	I-DISEASE
.	0

Thus	I-DISEASE
,	I-DISEASE
the	0
majority	0
of	0
sleep	0
related	0
headaches	I-DISEASE
seem	0
to	0
have	I-DISEASE
some	I-DISEASE
relationship	I-DISEASE
with	0
REM	0
sleep	0
,	0
but	0
there	I-DISEASE
are	0
no	0
defining	I-DISEASE
or	0
pathognomonic	I-DISEASE
polysomnographic	0
aspects	0
of	0
indi-	I-DISEASE
vidual	0
headache	I-DISEASE
syndromes	I-DISEASE
.	0

Neuroimaging	I-DISEASE
studies	0
(	I-DISEASE
computed	I-DISEASE
tomography	0
or	I-DISEASE
magnetic	I-DISEASE
resonance	I-DISEASE
imaging	0
head	I-DISEASE
scans	I-DISEASE
or	0
angiography	0
)	0
may	I-DISEASE
be	0
performed	0
to	0
rule	I-DISEASE
out	0
structural	I-DISEASE
,	I-DISEASE
vascular	B-DISEASE
,	0
or	I-DISEASE
infectious	I-DISEASE
disease	I-DISEASE
processes	0
that	0
may	0
cause	0
headaches	0
.	0

Differential	I-DISEASE
Diagnosis	0
Sleep	I-DISEASE
related	0
headaches	I-DISEASE
are	0
a	0
heterogeneous	I-DISEASE
group	I-DISEASE
of	I-DISEASE
different	I-DISEASE
headache	0
entities	0
with	I-DISEASE
a	0
common	I-DISEASE
expression	0
of	I-DISEASE
occurrence	0
during	I-DISEASE
sleep	0
.	0

They	I-DISEASE
need	0
to	0
be	I-DISEASE
differentiated	0
from	0
other	0
headache	I-DISEASE
conditions	0
that	0
are	0
not	0
sleep	I-DISEASE
related	B-DISEASE
.	0

These	0
include	I-DISEASE
tension	0
-	I-DISEASE
type	I-DISEASE
head-	I-DISEASE
aches	0
and	0
headaches	B-DISEASE
associated	I-DISEASE
with	I-DISEASE
paranasal	0
sinus	I-DISEASE
inflammation	0
,	I-DISEASE
tooth	0
infection	I-DISEASE
,	0
ear	0
infection	I-DISEASE
,	0
febrile	I-DISEASE
illness	0
,	0
benign	0
intracranial	I-DISEASE
hypertension	0
,	I-DISEASE
intracranial	I-DISEASE
hypoten-	0
sion	0
,	I-DISEASE
vasculitis	0
,	I-DISEASE
head	I-DISEASE
trauma	0
,	0
alcohol	0
intoxication	I-DISEASE
,	I-DISEASE
or	0
bruxism	0
.	0

Although	I-DISEASE
the	0
initial	0
presentation	0
may	0
be	I-DISEASE
one	I-DISEASE
of	I-DISEASE
headache	0
,	0
detailed	0
history	I-DISEASE
and	0
examination	0
will	0
identify	0
one	I-DISEASE
of	I-DISEASE
these	0
contributing	0
conditions	I-DISEASE
.	0

Tension	0
-	0
type	I-DISEASE
headaches	0
are	0
bilateral	I-DISEASE
headaches	B-DISEASE
with	I-DISEASE
a	0
feeling	I-DISEASE
of	I-DISEASE
a	0
band	0
-	I-DISEASE
like	I-DISEASE
tighten-	0
ing	0
sensation	0
around	0
the	0
head	0
.	0

In	I-DISEASE
patients	0
older	0
than	I-DISEASE
50	0
years	0
,	I-DISEASE
giant	I-DISEASE
cell	0
arteritis	0
may	I-DISEASE
Appendix	0
A	0
:	0
Sleep	0
Related	0
Medical	I-DISEASE
and	0
Neurological	0
Disorders	I-DISEASE
present	I-DISEASE
with	I-DISEASE
lateralized	0
or	I-DISEASE
bilateral	0
headache	0
with	0
tenderness	I-DISEASE
over	0
the	0
temporal	0
area	0
,	I-DISEASE
accompanied	I-DISEASE
by	I-DISEASE
polymyalgia	0
rheumatica	0
and	0
visual	I-DISEASE
problems	0
,	0
including	0
loss	0
of	I-DISEASE
vision	B-DISEASE
.	0

Exploding	I-DISEASE
head	0
syndrome	I-DISEASE
is	I-DISEASE
in	I-DISEASE
the	0
differential	0
diagnosis	0
of	I-DISEASE
headache	I-DISEASE
because	0
it	0
may	0
occur	I-DISEASE
in	I-DISEASE
association	0
with	0
the	0
sleep	0
period	I-DISEASE
.	0

Patients	I-DISEASE
report	0
hearing	I-DISEASE
an	0
explosion	0
in	0
the	B-DISEASE
head	0
which	0
is	0
unaccompanied	0
by	I-DISEASE
pain	0
.	0

Unresolved	I-DISEASE
Issues	0
and	0
Further	I-DISEASE
Directions	0
Not	0
applicable	0
or	I-DISEASE
known	I-DISEASE
.	0

Bibliography	0
Brennan	I-DISEASE
KC	0
,	I-DISEASE
Charles	I-DISEASE
A.	0
Sleep	0
and	0
headache	I-DISEASE
.	I-DISEASE

Semin	0
Neurol	0
2009;29:406–17	I-DISEASE
.	0

Sleep	I-DISEASE
Related	I-DISEASE
Laryngospasm	I-DISEASE
Alternate	0
Names	I-DISEASE
Stridor	I-DISEASE
,	I-DISEASE
laryngeal	0
dysfunction	0
.	0

Essential	I-DISEASE
Features	I-DISEASE
Sleep	0
related	0
laryngospasm	0
is	0
a	0
disorder	0
in	I-DISEASE
which	0
tracheal	0
muscle	0
dysfunction	0
or	0
para-	I-DISEASE
tracheal	0
soft	0
-	0
tissue	I-DISEASE
swelling	0
causes	0
stridor	0
or	0
interruption	I-DISEASE
of	0
airflow	0
,	0
with	0
associated	0
awakening	0
from	I-DISEASE
sleep	0
.	0

Patients	I-DISEASE
may	0
have	0
total	0
or	I-DISEASE
near	0
-	0
total	0
cessation	0
of	I-DISEASE
airflow	0
while	0
asleep	I-DISEASE
,	I-DISEASE
and	0
suddenly	I-DISEASE
arouse	0
.	0

This	I-DISEASE
brief	I-DISEASE
respiratory	0
blockage	I-DISEASE
(	I-DISEASE
lasting	0
an	0
estimated	0
five	0
to	0
45	I-DISEASE
seconds	I-DISEASE
)	I-DISEASE
is	0
often	0
followed	0
by	I-DISEASE
a	0
period	0
of	I-DISEASE
stridor	0
that	0
lasts	I-DISEASE
several	0
minutes	0
and	0
gradually	I-DISEASE
evolves	0
to	0
normal	0
breathing	I-DISEASE
.	0

Episodes	I-DISEASE
are	0
associated	0
with	0
panic	I-DISEASE
and	0
fear	0
of	0
suffocation	0
;	I-DISEASE
cyanosis	0
may	I-DISEASE
be	0
observed	0
.	0

In	I-DISEASE
some	I-DISEASE
cases	0
of	I-DISEASE
laryngospasm	0
during	I-DISEASE
sleep	0
,	I-DISEASE
patients	I-DISEASE
may	I-DISEASE
have	0
frequent	I-DISEASE
laryngeal	0
stridor	0
(	I-DISEASE
which	0
may	I-DISEASE
be	0
difficult	I-DISEASE
for	0
families	I-DISEASE
to	I-DISEASE
dif-	I-DISEASE
ferentiate	I-DISEASE
from	I-DISEASE
snoring	0
)	0
,	0
associated	0
tachypnea	0
,	0
and	0
intermittent	0
upper	0
airway	0
blockage	I-DISEASE
.	0

Associated	I-DISEASE
Features	I-DISEASE
Fear	0
and	0
panic	0
upon	I-DISEASE
awakening	0
often	0
accompany	0
events	0
and	0
may	I-DISEASE
,	I-DISEASE
at	I-DISEASE
times	0
,	I-DISEASE
lead	I-DISEASE
to	0
insomnia	0
.	0

In	I-DISEASE
some	I-DISEASE
cases	0
of	I-DISEASE
sleep	0
related	B-DISEASE
laryngospasm	0
,	I-DISEASE
gastroesophageal	I-DISEASE
reflux	0
has	0
been	I-DISEASE
identified	I-DISEASE
.	0

Less	I-DISEASE
commonly	I-DISEASE
,	0
sleep	I-DISEASE
related	B-DISEASE
laryngospasm	0
has	I-DISEASE
been	I-DISEASE
related	I-DISEASE
to	I-DISEASE
underlying	0
OSA	I-DISEASE
.	I-DISEASE

Clinical	I-DISEASE
and	0
Pathophysiological	I-DISEASE
Subtypes	I-DISEASE
Sleep	0
related	I-DISEASE
laryngospasm	I-DISEASE
may	I-DISEASE
be	0
associated	0
with	I-DISEASE
multisystem	0
atrophy	I-DISEASE
,	I-DISEASE
a	I-DISEASE
neurode-	0
generative	I-DISEASE
disorder	I-DISEASE
.	0

Appendix	I-DISEASE
A	0
:	I-DISEASE
Sleep	I-DISEASE
Related	0
Medical	I-DISEASE
and	0
Neurological	0
Disorders	0
Demographics	I-DISEASE
Prevalence	0
data	0
do	I-DISEASE
not	0
exist	0
.	0

Typical	I-DISEASE
age	I-DISEASE
of	I-DISEASE
onset	I-DISEASE
is	0
unknown	I-DISEASE
,	I-DISEASE
although	I-DISEASE
when	0
the	0
con-	0
dition	I-DISEASE
is	0
due	0
to	I-DISEASE
multisystem	I-DISEASE
atrophy	I-DISEASE
,	I-DISEASE
affected	I-DISEASE
individuals	I-DISEASE
are	I-DISEASE
typically	0
older	0
.	0

Predisposing	I-DISEASE
and	0
Precipitating	I-DISEASE
Factors	0
Sleep	0
related	I-DISEASE
laryngospasm	0
may	0
be	0
associated	0
with	0
gastroesophageal	I-DISEASE
reflux	0
.	B-DISEASE

Laryngeal	I-DISEASE
dysfunction	0
seen	I-DISEASE
in	0
other	0
disorders	0
,	I-DISEASE
including	I-DISEASE
laryngeal	0
tumors	I-DISEASE
and	0
multisystem	0
atrophy	I-DISEASE
,	0
may	I-DISEASE
cause	I-DISEASE
sleep	0
related	I-DISEASE
stridor	0
and	0
intermittent	0
laryngospasm	0
.	0

Precipitating	I-DISEASE
factors	0
include	I-DISEASE
use	0
of	I-DISEASE
hypnotic	0
or	I-DISEASE
other	0
central	0
nervous	I-DISEASE
system	I-DISEASE
depressant	0
medications	0
.	0

Tonic	0
-	0
clonic	I-DISEASE
seizures	I-DISEASE
may	0
be	0
a	0
rare	I-DISEASE
cause	I-DISEASE
of	I-DISEASE
sleep	0
related	0
laryngospasm	0
in	I-DISEASE
children	0
.	0

Familial	I-DISEASE
Patterns	I-DISEASE
Not	I-DISEASE
applicable	0
or	B-DISEASE
known	0
.	0

Onset	I-DISEASE
,	0
Course	0
,	0
and	0
Complications	0
Laryngospasm	I-DISEASE
is	I-DISEASE
a	0
common	I-DISEASE
cause	0
of	0
death	0
in	I-DISEASE
multiple	I-DISEASE
system	0
atrophy	I-DISEASE
.	0

Developmental	I-DISEASE
Issues	0
Not	I-DISEASE
known	0
.	0

Pathology	I-DISEASE
and	0
Pathophysiology	I-DISEASE
When	0
not	0
associated	0
with	I-DISEASE
neurodegenerative	I-DISEASE
disorders	0
of	0
known	0
pathology	0
(	0
e.g.	0
,	I-DISEASE
mul-	0
tisystem	0
atrophy	I-DISEASE
)	0
,	0
the	0
pathology	0
and	0
pathophysiology	0
is	0
uncertain	0
.	0

Sleep	I-DISEASE
related	I-DISEASE
laryn-	0
gospasm	0
can	0
be	0
related	0
to	I-DISEASE
tracheal	0
muscle	I-DISEASE
dysfunction	0
,	0
postnasal	0
drip	0
,	I-DISEASE
or	0
reflux	0
of	I-DISEASE
gas-	0
troesophageal	0
contents	0
causing	0
irritation	0
of	I-DISEASE
soft	0
tissue	I-DISEASE
in	I-DISEASE
the	I-DISEASE
upper	0
airway	0
.	0

Laryngeal	I-DISEASE
tumors	0
and	0
multisystem	0
atrophy	I-DISEASE
can	0
cause	0
laryngeal	0
dysfunction	0
,	I-DISEASE
resulting	0
in	I-DISEASE
sleep	I-DISEASE
related	0
laryngospasm	0
.	0

Objective	I-DISEASE
Findings	I-DISEASE
Sleep	I-DISEASE
related	0
laryngospasm	0
may	I-DISEASE
be	I-DISEASE
observed	I-DISEASE
on	0
PSG	0
with	0
accompanying	0
audio	I-DISEASE
record-	0
ing	0
.	0

It	I-DISEASE
is	I-DISEASE
seen	0
in	I-DISEASE
all	0
stages	I-DISEASE
of	I-DISEASE
sleep	0
but	0
is	0
most	0
severe	I-DISEASE
in	I-DISEASE
REM	I-DISEASE
sleep	0
.	0

Laryngospasm	I-DISEASE
can	0
appear	0
to	I-DISEASE
be	0
similar	0
to	0
snoring	0
on	0
the	0
polysomnographic	0
snoring	0
channel	I-DISEASE
,	0
but	I-DISEASE
the	0
audio	I-DISEASE
recording	0
will	0
confirm	0
the	0
high	I-DISEASE
-	I-DISEASE
pitched	0
inspiratory	0
sound	0
as	0
laryngospasm	0
.	0

OSA	I-DISEASE
has	0
also	0
been	0
detected	0
in	I-DISEASE
some	I-DISEASE
cases	0
.	0

Patients	I-DISEASE
or	0
family	I-DISEASE
members	0
may	I-DISEASE
mistake	I-DISEASE
laryngospasm	0
for	I-DISEASE
snoring	0
or	I-DISEASE
sleep	I-DISEASE
apnea	0
.	0

PSG	I-DISEASE
evaluation	0
may	I-DISEASE
be	0
necessary	0
to	I-DISEASE
distin-	I-DISEASE
guish	I-DISEASE
these	0
disorders	0
.	0

In	I-DISEASE
children	I-DISEASE
,	0
PSG	0
or	I-DISEASE
sleep	0
-	0
deprived	0
EEG	0
may	I-DISEASE
demonstrate	I-DISEASE
sei-	I-DISEASE
zures	I-DISEASE
that	0
manifest	0
solely	0
as	0
nocturnal	0
laryngospasm	0
.	0

Endoscopy	I-DISEASE
of	I-DISEASE
the	0
upper	0
airway	I-DISEASE
is	0
necessary	0
to	0
examine	I-DISEASE
vocal	I-DISEASE
cord	I-DISEASE
function	0
and	0
to	I-DISEASE
exclude	I-DISEASE
upper	0
airway	0
pathology	0
.	0

Gastroesophageal	I-DISEASE
studies	I-DISEASE
may	I-DISEASE
reveal	0
evidence	0
of	I-DISEASE
reflux	0
.	0

Appendix	I-DISEASE
A	0
:	I-DISEASE
Sleep	0
Related	0
Medical	0
and	0
Neurological	0
Disorders	0
Differential	I-DISEASE
Diagnosis	0
OSA	0
may	0
cause	I-DISEASE
awakenings	0
,	I-DISEASE
with	I-DISEASE
choking	0
or	0
gasping	I-DISEASE
for	I-DISEASE
air	0
,	0
excessive	0
daytime	I-DISEASE
som-	0
nolence	0
,	0
restlessness	I-DISEASE
,	I-DISEASE
or	I-DISEASE
insomnia	0
.	0

If	I-DISEASE
OSA	0
is	0
a	0
diagnostic	0
consideration	I-DISEASE
,	I-DISEASE
sleep	0
study	0
is	0
warranted	I-DISEASE
.	0

Sleep	I-DISEASE
related	I-DISEASE
gastroesophageal	I-DISEASE
reflux	B-DISEASE
may	I-DISEASE
result	I-DISEASE
in	I-DISEASE
coughing	0
or	I-DISEASE
choking	0
episodes	I-DISEASE
during	I-DISEASE
the	0
night	I-DISEASE
without	0
true	I-DISEASE
laryngospasm	0
.	0

However	I-DISEASE
,	I-DISEASE
these	0
episodes	I-DISEASE
usually	0
are	0
described	0
in	I-DISEASE
the	0
setting	0
of	I-DISEASE
chest	I-DISEASE
pain	I-DISEASE
or	I-DISEASE
“	0
heartburn	0
.	I-DISEASE
”	0

One	I-DISEASE
possible	0
cause	I-DISEASE
of	I-DISEASE
sleep	0
related	B-DISEASE
laryngospasm	0
may	I-DISEASE
be	I-DISEASE
occult	0
acid	I-DISEASE
reflux	I-DISEASE
into	I-DISEASE
the	0
upper	I-DISEASE
airway	0
,	I-DISEASE
causing	0
irritation	I-DISEASE
or	I-DISEASE
swelling	I-DISEASE
.	0

Sleep	I-DISEASE
terrors	I-DISEASE
may	I-DISEASE
be	0
associated	0
with	I-DISEASE
sensations	I-DISEASE
of	I-DISEASE
impaired	0
breathing	B-DISEASE
or	I-DISEASE
choking	I-DISEASE
,	I-DISEASE
rapid	I-DISEASE
heartbeat	0
,	I-DISEASE
and	0
agitation	0
.	0

However	I-DISEASE
,	I-DISEASE
sleep	0
terrors	I-DISEASE
are	0
most	0
common	I-DISEASE
in	0
children	0
,	0
and	0
most	I-DISEASE
patients	I-DISEASE
do	0
not	0
focus	I-DISEASE
on	0
upper	0
airway	0
choking	0
.	0

Panic	I-DISEASE
disorder	I-DISEASE
can	0
involve	I-DISEASE
abrupt	I-DISEASE
awakening	0
with	I-DISEASE
respiratory	0
distress	I-DISEASE
,	I-DISEASE
signs	I-DISEASE
of	I-DISEASE
sympathetic	I-DISEASE
activity	0
,	I-DISEASE
and	0
fear	I-DISEASE
of	I-DISEASE
dying	0
.	0

However	I-DISEASE
,	I-DISEASE
most	0
patients	I-DISEASE
also	0
have	I-DISEASE
daytime	0
episodes	I-DISEASE
of	0
panic	0
.	0

Nocturnal	I-DISEASE
asthma	0
can	I-DISEASE
result	0
in	I-DISEASE
sleep	0
related	0
coughing	0
,	I-DISEASE
wheezing	I-DISEASE
,	I-DISEASE
or	I-DISEASE
shortness	I-DISEASE
of	0
breath	I-DISEASE
.	0

REM	I-DISEASE
sleep	0
behavior	I-DISEASE
disorder	0
(	I-DISEASE
RBD	I-DISEASE
)	0
may	0
be	0
in	I-DISEASE
the	I-DISEASE
differential	I-DISEASE
diagnosis	0
of	I-DISEASE
laryngospasm	0
,	0
but	I-DISEASE
is	0
generally	I-DISEASE
recognizable	I-DISEASE
by	0
polysomnographic	0
features	I-DISEASE
of	I-DISEASE
RBD	I-DISEASE
and	0
a	0
history	I-DISEASE
of	0
dream	I-DISEASE
enactment	0
.	0

Unresolved	I-DISEASE
Issues	0
and	0
Further	I-DISEASE
Directions	0
Published	0
reports	0
generally	I-DISEASE
have	I-DISEASE
been	I-DISEASE
limited	I-DISEASE
to	I-DISEASE
case	I-DISEASE
series	I-DISEASE
.	0

Clarification	I-DISEASE
of	I-DISEASE
the	0
rela-	0
tionship	0
between	0
laryngospasm	I-DISEASE
,	I-DISEASE
sleep	0
related	0
breathing	0
disorders	0
,	0
and	0
gastroesopha-	0
geal	0
reflux	0
is	0
needed	0
.	0

Bibliography	0
Aloe	0
F	I-DISEASE
,	I-DISEASE
Thorpy	I-DISEASE
M.	0
Sleep	I-DISEASE
-	I-DISEASE
related	B-DISEASE
laryngospasm	0
.	0

Arq	I-DISEASE
Neuropsiquiatr	0
1995;53:46–52	I-DISEASE
.	I-DISEASE

Campbell	I-DISEASE
A	0
,	0
Pierce	B-DISEASE
R.	0
Brief	0
upper	0
airway	0
dysfunction	0
.	0

Respir	I-DISEASE
Med	I-DISEASE
1994;88:125–9	0
.	I-DISEASE

Guilleminault	I-DISEASE
C	I-DISEASE
,	I-DISEASE
Eldridge	0
F	I-DISEASE
,	I-DISEASE
Phillips	0
J	I-DISEASE
,	I-DISEASE
Dement	0
W.	I-DISEASE
Two	0
occult	0
causes	I-DISEASE
of	I-DISEASE
insomnia	I-DISEASE
and	0
their	I-DISEASE
therapeutic	I-DISEASE
problems	0
.	0

Arch	I-DISEASE
Gen	0
Psychiatry	0
1976;33:1241–5	0
.	0

Iriarte	I-DISEASE
J	0
,	0
Urrestarazu	I-DISEASE
E	0
,	I-DISEASE
Alegre	I-DISEASE
M	0
,	I-DISEASE
Goni	I-DISEASE
C	0
,	0
Viteri	I-DISEASE
C	0
,	I-DISEASE
Artieda	0
J.	0
Sleep	0
-	0
related	B-DISEASE
laryngospasm	0
:	0
A	0
video	0
polysomnographic	0
recording	I-DISEASE
.	0

Epileptic	I-DISEASE
Disord	I-DISEASE
2006;8:70–2	0
.	0

Kavey	I-DISEASE
N	0
,	I-DISEASE
Whyte	0
J	0
,	I-DISEASE
Blitzer	0
A	0
,	I-DISEASE
Gidro	I-DISEASE
-	I-DISEASE
Frank	I-DISEASE
S.	0
Sleep	0
-	0
related	I-DISEASE
laryngeal	0
obstruction	0
presenting	I-DISEASE
as	B-DISEASE
snoring	0
or	0
sleep	0
apnea	0
.	0

Laryngoscope	I-DISEASE
1989;99:851–4	B-DISEASE
.	I-DISEASE

Roland	I-DISEASE
MM	I-DISEASE
,	I-DISEASE
Baran	0
AS	0
,	I-DISEASE
Richert	0
AC	0
.	0

Sleep	I-DISEASE
related	I-DISEASE
laryngospasm	0
caused	0
by	0
gastroesophageal	0
reflux	0
.	0

Sleep	I-DISEASE
Med	I-DISEASE
2008;9:451–3	I-DISEASE
.	0

Thorpy	I-DISEASE
M	I-DISEASE
,	I-DISEASE
Aloe	0
F.	I-DISEASE
Choking	0
during	I-DISEASE
sleep	0
.	I-DISEASE

Sleep	I-DISEASE
Res	0
1989;18:314	I-DISEASE
.	0

Thorpy	I-DISEASE
M	I-DISEASE
,	I-DISEASE
Aloe	0
F.	I-DISEASE
Sleep	0
related	0
laryngospasm	0
.	0

Sleep	I-DISEASE
Res	0
1989;18:313	I-DISEASE
.	0

Thurnheer	0
R	0
,	I-DISEASE
Henz	0
S	I-DISEASE
,	0
Knoblauch	B-DISEASE
A.	0
Sleep	I-DISEASE
-	I-DISEASE
related	0
laryngospasm	0
.	0

Eur	I-DISEASE
Respir	0
J	0
1997;10:2084–6	0
.	0

Appendix	I-DISEASE
A	0
:	I-DISEASE
Sleep	0
Related	0
Medical	0
and	0
Neurological	0
Disorders	0
Sleep	I-DISEASE
Related	0
Gastroesophageal	0
Reflux	0
Alternative	I-DISEASE
Names	I-DISEASE
Gastroesophageal	0
reflux	0
,	0
nocturnal	0
gastroesophageal	0
reflux	0
,	0
supine	0
gastroesophageal	0
reflux	0
,	I-DISEASE
nocturnal	0
heartburn	0
,	0
reflux	0
esophagitis	I-DISEASE
,	0
esophagitis	I-DISEASE
,	0
heartburn	0
.	0

Essential	I-DISEASE
Features	I-DISEASE
Sleep	0
related	0
gastroesophageal	0
reflux	0
(	I-DISEASE
GER	0
)	0
occurs	I-DISEASE
when	0
gastric	0
contents	0
cross	0
the	0
lower	0
esophageal	I-DISEASE
sphincter	0
(	I-DISEASE
LES	0
)	0
into	0
the	0
esophagus	I-DISEASE
and	0
,	I-DISEASE
potentially	0
,	I-DISEASE
into	I-DISEASE
more	0
prox-	0
imal	0
sites	0
during	I-DISEASE
sleep	0
time	0
.	0

Symptoms	I-DISEASE
are	0
usually	I-DISEASE
noticed	0
during	I-DISEASE
arousals	0
or	0
awak-	0
enings	0
.	0

Symptoms	I-DISEASE
may	0
include	I-DISEASE
heartburn	0
,	0
substernal	0
burning	I-DISEASE
,	I-DISEASE
chest	0
discomfort	0
,	I-DISEASE
a	I-DISEASE
sour	0
or	0
bitter	0
taste	0
in	I-DISEASE
the	0
mouth	0
,	I-DISEASE
regurgitation	0
,	I-DISEASE
water	I-DISEASE
brash	0
,	I-DISEASE
coughing	I-DISEASE
,	0
choking	0
,	I-DISEASE
or	I-DISEASE
unex-	0
plained	0
excessive	0
daytime	I-DISEASE
sleepiness	0
,	0
even	I-DISEASE
in	I-DISEASE
the	0
absence	I-DISEASE
of	I-DISEASE
typical	0
reflux	0
symptoms	I-DISEASE
.	0

Sleep	I-DISEASE
related	I-DISEASE
GER	0
is	0
associated	0
with	I-DISEASE
sleep	0
onset	0
and	0
sleep	0
maintenance	I-DISEASE
insomnia	I-DISEASE
,	I-DISEASE
early	0
morning	I-DISEASE
awakenings	0
,	0
sleep	0
disturbances	I-DISEASE
,	I-DISEASE
arousals	0
,	I-DISEASE
unrefreshing	I-DISEASE
sleep	0
,	I-DISEASE
daytime	0
functioning	I-DISEASE
difficulties	0
,	I-DISEASE
and	0
excessive	0
daytime	0
sleepiness	0
.	0

GER	I-DISEASE
is	0
a	I-DISEASE
potential	0
asthma	0
trigger	I-DISEASE
,	0
predisposes	0
to	0
aspiration	0
,	I-DISEASE
and	0
is	0
a	0
cause	I-DISEASE
of	I-DISEASE
cough	0
.	0

GER	I-DISEASE
commonly	0
coexists	I-DISEASE
in	I-DISEASE
patients	I-DISEASE
with	0
chronic	0
obstructive	0
pulmonary	0
disease	0
,	I-DISEASE
cystic	I-DISEASE
fibrosis	I-DISEASE
,	0
idiopathic	I-DISEASE
pulmo-	0
nary	B-DISEASE
fibrosis	I-DISEASE
,	0
and	0
bronchiolitis	0
obliterans	0
syndrome	I-DISEASE
in	I-DISEASE
lung	0
transplant	0
recipients	0
.	0

Sleep	I-DISEASE
related	I-DISEASE
GER	0
is	0
associated	0
with	I-DISEASE
sleep	0
related	B-DISEASE
laryngospasm	0
and	0
is	I-DISEASE
prevalent	I-DISEASE
in	I-DISEASE
patients	0
with	0
OSA	I-DISEASE
.	0

Associated	I-DISEASE
Features	I-DISEASE
Associated	0
features	I-DISEASE
of	0
this	0
disorder	I-DISEASE
include	I-DISEASE
dysphagia	0
,	I-DISEASE
odynophagia	0
,	0
laryngopharyn-	0
gitis	I-DISEASE
,	I-DISEASE
laryngospasm	0
,	0
epigastric	0
burning	I-DISEASE
,	0
chronic	0
cough	0
,	0
wheezing	0
,	I-DISEASE
or	I-DISEASE
chest	I-DISEASE
pain	0
that	0
may	0
mimic	0
angina	0
.	0

Other	I-DISEASE
associated	0
features	0
of	I-DISEASE
sleep	0
related	0
GER	0
include	0
sleep	0
onset	0
and	0
sleep	I-DISEASE
maintenance	I-DISEASE
insomnia	0
,	I-DISEASE
excessive	0
daytime	0
sleepiness	0
,	0
daytime	0
fatigue	I-DISEASE
,	I-DISEASE
poor	0
daytime	I-DISEASE
functioning	I-DISEASE
,	I-DISEASE
and	0
reduced	0
work	I-DISEASE
productivity	I-DISEASE
.	0

Patients	I-DISEASE
with	0
sleep	0
related	B-DISEASE
GER	I-DISEASE
also	0
have	0
a	0
decrease	I-DISEASE
in	I-DISEASE
health	I-DISEASE
-	I-DISEASE
related	B-DISEASE
quality	0
of	I-DISEASE
life	I-DISEASE
and	0
more	0
health	0
care	I-DISEASE
visits	I-DISEASE
.	0

Clinical	I-DISEASE
and	0
Pathological	0
Subtypes	0
Not	I-DISEASE
applicable	0
or	0
known	0
.	0

Demographics	I-DISEASE
GER	0
symptoms	I-DISEASE
affect	0
up	0
to	0
44	0
%	0
of	I-DISEASE
adults	I-DISEASE
in	I-DISEASE
the	0
United	I-DISEASE
States	I-DISEASE
monthly	0
,	0
and	0
20	0
%	0
weekly	0
.	0

Among	I-DISEASE
patients	0
with	0
weekly	0
heartburn	0
,	0
79	I-DISEASE
%	0
report	0
GER	0
symptoms	I-DISEASE
during	I-DISEASE
sleep	0
time	0
,	I-DISEASE
57	I-DISEASE
%	0
report	0
waking	0
up	0
during	I-DISEASE
sleep	0
,	I-DISEASE
and	0
40	0
%	0
report	0
that	0
GER	I-DISEASE
during	I-DISEASE
sleep	0
time	0
affected	I-DISEASE
their	0
ability	0
to	0
work	I-DISEASE
the	0
next	0
day	0
.	0

Among	I-DISEASE
the	0
15,315	0
subjects	I-DISEASE
of	I-DISEASE
the	I-DISEASE
Sleep	0
Heart	I-DISEASE
Health	0
Study	I-DISEASE
,	I-DISEASE
25	I-DISEASE
%	0
reported	0
heartburn	0
during	I-DISEASE
sleep	0
.	0

In	I-DISEASE
a	0
review	0
of	I-DISEASE
5	0
large	I-DISEASE
Appendix	0
A	0
:	I-DISEASE
Sleep	I-DISEASE
Related	0
Medical	I-DISEASE
and	0
Neurological	0
Disorders	I-DISEASE
population	0
studies	I-DISEASE
,	I-DISEASE
the	0
mean	I-DISEASE
prevalence	0
of	I-DISEASE
heartburn	0
during	I-DISEASE
sleep	0
time	I-DISEASE
was	0
54	I-DISEASE
%	0
±	I-DISEASE
22	I-DISEASE
%	0
(	I-DISEASE
standard	0
deviation	0
)	0
.	I-DISEASE

In	I-DISEASE
patients	I-DISEASE
with	0
OSA	I-DISEASE
,	I-DISEASE
sleep	0
related	B-DISEASE
reflux	0
symptoms	I-DISEASE
are	I-DISEASE
present	I-DISEASE
in	I-DISEASE
up	I-DISEASE
to	I-DISEASE
62	I-DISEASE
%	0
.	0

Furthermore	I-DISEASE
,	I-DISEASE
in	I-DISEASE
a	I-DISEASE
trial	0
examining	0
consecutive	I-DISEASE
asthmatics	I-DISEASE
,	I-DISEASE
50	I-DISEASE
%	0
had	0
awakenings	0
from	0
sleep	0
because	0
of	I-DISEASE
heartburn	0
.	0

Thus	I-DISEASE
,	I-DISEASE
GER	0
symptoms	0
during	I-DISEASE
sleep	0
time	I-DISEASE
are	0
common	I-DISEASE
.	0

There	I-DISEASE
is	0
no	0
known	I-DISEASE
predilection	0
for	0
men	0
or	0
women	I-DISEASE
.	0

However	I-DISEASE
,	I-DISEASE
men	0
are	I-DISEASE
more	0
likely	I-DISEASE
than	I-DISEASE
women	I-DISEASE
to	0
develop	0
Barrett	0
esophagus	I-DISEASE
.	0

Predisposing	I-DISEASE
and	0
Precipitating	I-DISEASE
Factors	0
Predisposing	I-DISEASE
factors	I-DISEASE
for	0
sleep	0
related	0
GER	0
include	0
eating	I-DISEASE
within	B-DISEASE
two	0
hours	I-DISEASE
of	0
bedtime	I-DISEASE
,	I-DISEASE
an	0
elevated	I-DISEASE
body	I-DISEASE
mass	0
index	I-DISEASE
,	0
erosive	0
esophagitis	I-DISEASE
,	I-DISEASE
and	0
hiatal	I-DISEASE
hernia	0
.	0

Predictors	I-DISEASE
of	I-DISEASE
heart-	0
burn	I-DISEASE
during	I-DISEASE
sleep	0
include	0
consumption	I-DISEASE
of	I-DISEASE
alcohol	I-DISEASE
or	I-DISEASE
carbonated	0
beverages	I-DISEASE
,	I-DISEASE
or	0
the	0
use	I-DISEASE
of	I-DISEASE
benzodiazepines	I-DISEASE
before	0
sleep	0
time	I-DISEASE
.	B-DISEASE

Other	I-DISEASE
predictors	I-DISEASE
of	I-DISEASE
heartburn	0
during	I-DISEASE
sleep	0
include	0
the	0
presence	0
of	I-DISEASE
insomnia	I-DISEASE
,	I-DISEASE
hypertension	I-DISEASE
,	I-DISEASE
asthma	0
,	I-DISEASE
snoring	0
,	I-DISEASE
or	I-DISEASE
daytime	I-DISEASE
sleepiness	0
.	B-DISEASE

The	I-DISEASE
relationship	0
between	0
GER	0
and	0
sleep	0
disturbance	I-DISEASE
is	0
bidirectional	0
.	0

Sleep	I-DISEASE
related	I-DISEASE
GER	0
is	0
associated	0
with	I-DISEASE
short	0
sleep	0
duration	0
,	0
difficulty	0
falling	I-DISEASE
asleep	I-DISEASE
,	0
arousals	0
,	I-DISEASE
poor	0
sleep	0
quality	0
,	0
and	0
early	0
morning	0
awakenings	0
.	0

Conversely	I-DISEASE
,	I-DISEASE
sleep	0
deprivation	0
induces	0
a	0
state	B-DISEASE
of	I-DISEASE
esophageal	I-DISEASE
hyperalgesia	I-DISEASE
to	0
acid	I-DISEASE
,	0
thus	0
worsening	I-DISEASE
heartburn	0
symptoms	I-DISEASE
.	0

Familial	I-DISEASE
Patterns	I-DISEASE
Not	I-DISEASE
applicable	0
or	B-DISEASE
known	0
.	0

Onset	I-DISEASE
,	0
Course	0
,	0
and	0
Complications	0
GER	B-DISEASE
occurs	I-DISEASE
in	I-DISEASE
all	0
age	I-DISEASE
groups	0
,	I-DISEASE
including	0
infants	0
and	0
children	I-DISEASE
.	0

Sleep	I-DISEASE
disruption	I-DISEASE
occurs	0
more	0
frequently	0
in	I-DISEASE
infants	0
and	0
children	0
with	0
GER	B-DISEASE
,	I-DISEASE
compared	I-DISEASE
to	0
infants	0
and	0
children	I-DISEASE
without	0
GER	0
.	0

The	I-DISEASE
incidence	0
of	I-DISEASE
GER	I-DISEASE
increases	0
with	I-DISEASE
age	I-DISEASE
.	0

GER	I-DISEASE
may	0
be	I-DISEASE
more	0
severe	I-DISEASE
and	0
is	I-DISEASE
associated	0
with	0
more	0
complications	0
in	I-DISEASE
older	0
adults	B-DISEASE
.	0

GER	I-DISEASE
is	0
a	I-DISEASE
chronic	0
disease	I-DISEASE
which	0
is	I-DISEASE
rarely	I-DISEASE
cured	0
,	I-DISEASE
but	I-DISEASE
it	I-DISEASE
may	I-DISEASE
be	0
controlled	0
with	I-DISEASE
lifestyle	I-DISEASE
,	0
and	0
medical	I-DISEASE
and/or	0
surgical	0
therapies	I-DISEASE
.	0

In	I-DISEASE
patients	0
with	0
sleep	0
related	0
GER	I-DISEASE
,	I-DISEASE
medical	0
GER	0
therapy	0
improved	I-DISEASE
sleep	0
disturbances	0
and	0
daytime	I-DISEASE
functioning	0
in	0
placebo	0
-	0
con-	0
trolled	I-DISEASE
trials	I-DISEASE
.	0

Long	I-DISEASE
-	I-DISEASE
term	0
outcome	0
data	0
are	I-DISEASE
currently	I-DISEASE
lacking	I-DISEASE
.	0

If	I-DISEASE
GER	I-DISEASE
is	I-DISEASE
left	0
untreated	I-DISEASE
,	0
the	0
disease	B-DISEASE
generally	I-DISEASE
progresses	I-DISEASE
and	0
can	0
be	0
associated	0
with	I-DISEASE
many	0
complications	0
.	0

Esophageal	I-DISEASE
complications	0
include	I-DISEASE
esophagitis	I-DISEASE
,	I-DISEASE
esophageal	I-DISEASE
erosions	I-DISEASE
,	0
esophageal	I-DISEASE
stric-	0
ture	0
,	I-DISEASE
ulcerations	0
with	I-DISEASE
stricture	0
,	0
and	0
Barrett	0
esophagus	I-DISEASE
,	0
which	0
is	0
thought	I-DISEASE
to	I-DISEASE
be	I-DISEASE
a	0
precur-	0
sor	0
to	I-DISEASE
esophageal	I-DISEASE
adenocarcinoma	0
.	0

Reflux	I-DISEASE
can	I-DISEASE
also	0
result	0
in	I-DISEASE
dysphagia	I-DISEASE
,	I-DISEASE
weight	I-DISEASE
loss	I-DISEASE
,	0
and	0
upper	0
gastrointestinal	I-DISEASE
bleeding	I-DISEASE
.	0

Sleep	I-DISEASE
related	I-DISEASE
GER	0
is	0
more	0
commonly	I-DISEASE
associated	0
with	0
erosive	0
esophagitis	I-DISEASE
,	I-DISEASE
stricture	0
,	I-DISEASE
Barrett	0
esophagitis	I-DISEASE
,	I-DISEASE
and	0
esophageal	I-DISEASE
adenocarci-	0
noma	0
,	0
compared	I-DISEASE
to	0
diurnal	0
reflux	I-DISEASE
.	0

Extraesophageal	I-DISEASE
complications	0
include	I-DISEASE
pulmonary	I-DISEASE
complications	0
previously	0
discussed	0
in	I-DISEASE
the	I-DISEASE
Essential	I-DISEASE
Features	I-DISEASE
section	0
.	0

Appendix	I-DISEASE
A	0
:	I-DISEASE
Sleep	I-DISEASE
Related	0
Medical	I-DISEASE
and	0
Neurological	0
Disorders	0
Pathology	I-DISEASE
and	0
Pathophysiology	I-DISEASE
Two	I-DISEASE
major	0
pathophysiologic	0
mechanisms	0
cause	I-DISEASE
individual	I-DISEASE
reflux	0
episodes	I-DISEASE
.	0

Transient	I-DISEASE
LES	0
relaxations	0
(	I-DISEASE
LES	0
relaxations	0
occurring	0
without	I-DISEASE
esophageal	I-DISEASE
contractions	I-DISEASE
)	0
account	0
for	0
53	0
%	0
to	I-DISEASE
74	I-DISEASE
%	0
of	I-DISEASE
GER	0
episodes	I-DISEASE
.	B-DISEASE

Transient	I-DISEASE
LES	0
relaxations	0
decrease	I-DISEASE
the	0
LES	0
pres-	0
sure	0
to	0
the	0
gastric	I-DISEASE
pressure	0
gradient	0
,	0
facilitating	0
the	0
retrograde	I-DISEASE
flow	0
of	I-DISEASE
gastric	0
contents	0
.	0

An	0
LES	0
pressure	0
of	0
10	0
mm	0
Hg	I-DISEASE
or	0
less	I-DISEASE
is	0
the	I-DISEASE
second	I-DISEASE
mechanism	0
by	I-DISEASE
which	0
intra	I-DISEASE
-	0
abdom-	0
inal	I-DISEASE
pressure	0
overcomes	0
the	0
LES	0
pressure	0
,	0
resulting	0
in	I-DISEASE
the	0
retrograde	0
flow	0
of	I-DISEASE
gastric	0
contents	0
into	I-DISEASE
the	I-DISEASE
esophagus	I-DISEASE
.	0

Pathophysiology	I-DISEASE
of	I-DISEASE
sleep	0
related	B-DISEASE
GER	0
is	0
similar	0
to	I-DISEASE
diurnal	I-DISEASE
GER	I-DISEASE
(	0
i.e.	0
,	0
transient	0
LES	0
relaxations	0
and	0
a	I-DISEASE
low	0
LES	0
pressure	0
)	0
.	0

However	I-DISEASE
,	I-DISEASE
sleep	0
impacts	0
esophageal	0
physiology	0
through	0
the	0
impairment	I-DISEASE
of	I-DISEASE
esophageal	I-DISEASE
acid	0
clearance	0
mechanisms	0
when	I-DISEASE
GER	0
events	I-DISEASE
occur	0
.	I-DISEASE

With	I-DISEASE
sleep	0
onset	0
,	I-DISEASE
the	0
upper	0
esophageal	I-DISEASE
sphincter	0
(	0
UES	0
)	I-DISEASE
pressure	0
decreases	0
and	0
is	0
lowest	I-DISEASE
during	I-DISEASE
N3	0
sleep	0
,	I-DISEASE
thus	I-DISEASE
predisposing	I-DISEASE
to	I-DISEASE
aspiration	0
.	0

The	I-DISEASE
UES	I-DISEASE
contractile	I-DISEASE
reflex	I-DISEASE
remains	I-DISEASE
intact	0
during	I-DISEASE
sleep	0
,	I-DISEASE
including	I-DISEASE
REM	I-DISEASE
sleep	0
.	0

Lower	I-DISEASE
esophageal	I-DISEASE
sphincter	0
(	I-DISEASE
LES	0
)	I-DISEASE
pressure	I-DISEASE
remains	0
unchanged	0
during	I-DISEASE
sleep	I-DISEASE
.	0

Sleep	I-DISEASE
increases	0
the	0
vagal	0
threshold	I-DISEASE
for	I-DISEASE
trig-	0
gering	0
transient	0
LES	0
relaxations	I-DISEASE
,	0
so	I-DISEASE
they	I-DISEASE
usually	I-DISEASE
do	I-DISEASE
not	0
occur	I-DISEASE
during	I-DISEASE
stable	I-DISEASE
sleep	0
and	0
are	0
usually	I-DISEASE
confined	0
to	I-DISEASE
arousals	0
.	0

When	I-DISEASE
GER	I-DISEASE
events	0
occur	0
during	I-DISEASE
sleep	0
,	I-DISEASE
esophageal	I-DISEASE
refluxate	I-DISEASE
clearance	0
is	I-DISEASE
prolonged	0
and	0
an	0
arousal	0
is	I-DISEASE
required	0
.	0

Sleep	I-DISEASE
facilitates	0
proxi-	0
mal	0
refluxate	B-DISEASE
migration	I-DISEASE
toward	I-DISEASE
the	0
UES	0
.	0

Saliva	I-DISEASE
secretion	0
,	0
with	I-DISEASE
its	I-DISEASE
acid	I-DISEASE
-	0
neutralizing	I-DISEASE
bicarbonate	0
,	I-DISEASE
ceases	I-DISEASE
during	I-DISEASE
sleep	0
.	0

Swallowing	I-DISEASE
,	I-DISEASE
required	0
for	I-DISEASE
esophageal	I-DISEASE
peristalsis	I-DISEASE
and	0
refluxate	I-DISEASE
clearance	0
,	I-DISEASE
does	I-DISEASE
not	0
occur	I-DISEASE
during	I-DISEASE
sleep	I-DISEASE
and	0
is	I-DISEASE
dependent	0
on	0
an	I-DISEASE
arousal	I-DISEASE
.	0

Sleep	I-DISEASE
also	0
delays	0
gastric	I-DISEASE
emptying	I-DISEASE
by	I-DISEASE
disrupting	I-DISEASE
gastromyoelectric	I-DISEASE
function	0
.	I-DISEASE

Events	I-DISEASE
causing	0
arousals	0
,	0
including	0
periodic	I-DISEASE
limb	I-DISEASE
movements	0
and	0
apneas	0
,	0
could	0
trigger	I-DISEASE
transient	I-DISEASE
LES	0
relaxations	0
and	0
thus	0
GER	I-DISEASE
events	0
.	0

Because	I-DISEASE
refluxate	0
clearance	0
requires	I-DISEASE
an	0
arousal	0
,	0
medications	0
decreasing	I-DISEASE
the	I-DISEASE
arousal	I-DISEASE
response	0
(	I-DISEASE
including	0
benzodiazepines	I-DISEASE
and	0
zolp-	I-DISEASE
idem	I-DISEASE
)	0
may	I-DISEASE
prolong	0
refluxate	I-DISEASE
clearance	0
and	0
increase	I-DISEASE
the	0
risk	0
of	0
aspiration	0
during	I-DISEASE
sleep	0
.	0

The	I-DISEASE
pathology	I-DISEASE
of	I-DISEASE
GER	0
includes	I-DISEASE
abnormal	I-DISEASE
esophageal	I-DISEASE
manometry	I-DISEASE
,	I-DISEASE
endoscopy	I-DISEASE
,	0
and	0
esophageal	0
biopsy	I-DISEASE
findings	0
.	0

Esophageal	I-DISEASE
manometry	0
findings	0
include	0
an	0
increased	0
frequency	I-DISEASE
of	I-DISEASE
transient	0
LES	0
relaxations	0
,	0
altered	0
or	0
decreased	I-DISEASE
esophageal	I-DISEASE
peristaltic	I-DISEASE
contraction	I-DISEASE
amplitude	0
,	I-DISEASE
and	0
a	0
decrease	0
in	I-DISEASE
LES	0
pressure	0
.	0

Endoscopic	I-DISEASE
findings	0
include	0
changes	0
ranging	0
from	I-DISEASE
mild	0
erythema	0
,	I-DISEASE
erosions	0
,	I-DISEASE
and	0
ulcerations	0
to	0
severe	I-DISEASE
erosions	0
with	I-DISEASE
stricture	0
.	0

Barrett	I-DISEASE
esophagus	I-DISEASE
is	I-DISEASE
identified	I-DISEASE
when	I-DISEASE
columnar	0
tissue	I-DISEASE
replaces	I-DISEASE
the	I-DISEASE
normal	0
squamous	0
epithelium	I-DISEASE
of	I-DISEASE
the	0
distal	0
esophagus	I-DISEASE
.	0

Objective	I-DISEASE
Findings	I-DISEASE
Diagnostic	I-DISEASE
testing	0
is	0
not	0
required	I-DISEASE
for	I-DISEASE
sleep	0
related	0
GER	I-DISEASE
.	0

The	I-DISEASE
diagnosis	I-DISEASE
can	0
be	I-DISEASE
made	0
if	0
typical	0
symptoms	I-DISEASE
of	I-DISEASE
heartburn	0
and/or	0
regurgitation	0
are	0
present	0
during	I-DISEASE
sleep	0
time	0
.	0

Appendix	I-DISEASE
A	0
:	I-DISEASE
Sleep	I-DISEASE
Related	0
Medical	I-DISEASE
and	0
Neurological	0
Disorders	0
PSG	0
is	0
not	0
indicated	0
.	0

Esophageal	I-DISEASE
pH	0
monitoring	0
,	I-DISEASE
which	0
may	0
be	0
combined	0
with	I-DISEASE
esophageal	I-DISEASE
impedance	I-DISEASE
,	0
objectively	I-DISEASE
measures	0
individual	I-DISEASE
GER	I-DISEASE
events	0
.	0

Esophageal	I-DISEASE
monitoring	0
is	I-DISEASE
recommended	I-DISEASE
in	0
difficult	0
,	0
refractory	0
cases	0
,	I-DISEASE
or	I-DISEASE
when	0
symptoms	0
continue	0
despite	0
therapy	0
.	0

Sleep	I-DISEASE
related	I-DISEASE
GER	0
is	0
more	0
likely	I-DISEASE
to	I-DISEASE
occur	0
during	I-DISEASE
the	0
first	I-DISEASE
two	I-DISEASE
hours	I-DISEASE
of	I-DISEASE
sleep	0
time	I-DISEASE
.	I-DISEASE

Furthermore	I-DISEASE
,	I-DISEASE
in	I-DISEASE
studies	I-DISEASE
using	0
combined	0
esophageal	I-DISEASE
pH	0
monitoring	0
with	I-DISEASE
actigraphy	I-DISEASE
,	I-DISEASE
acid	I-DISEASE
reflux	0
events	0
occurred	0
primarily	I-DISEASE
during	I-DISEASE
the	I-DISEASE
recumbent	0
-	I-DISEASE
awake	0
period	I-DISEASE
,	0
versus	0
the	0
recumbent	I-DISEASE
-	I-DISEASE
asleep	0
period	0
.	0

Reflux	I-DISEASE
events	I-DISEASE
are	0
more	0
likely	I-DISEASE
to	I-DISEASE
occur	0
in	0
the	0
right	0
side	I-DISEASE
down	I-DISEASE
and	0
supine	0
positions	I-DISEASE
than	0
in	0
the	0
left	0
side	0
down	I-DISEASE
position	0
.	0

PSG	I-DISEASE
without	0
esophageal	I-DISEASE
pH	0
or	B-DISEASE
impedance	0
monitoring	I-DISEASE
reveals	I-DISEASE
arousals	0
that	0
are	I-DISEASE
often	0
associated	0
with	I-DISEASE
swallows	0
and	0
a	0
notable	0
increase	0
in	I-DISEASE
chin	I-DISEASE
EMG	0
tone	I-DISEASE
.	0

Esophageal	I-DISEASE
pH	0
monitoring	0
detects	I-DISEASE
acid	0
reflux	0
events	0
and	0
can	0
be	I-DISEASE
integrated	I-DISEASE
with	0
PSG	0
.	0

Esophageal	I-DISEASE
pH	0
monitoring	0
should	I-DISEASE
be	0
performed	0
over	0
a	0
24	I-DISEASE
-	I-DISEASE
hour	0
period	0
to	I-DISEASE
improve	I-DISEASE
the	0
test	0
’s	I-DISEASE
sensitiv-	I-DISEASE
ity	0
and	0
specificity	I-DISEASE
,	0
which	0
approximate	I-DISEASE
90	I-DISEASE
%	0
.	0

The	I-DISEASE
distal	I-DISEASE
pH	0
probe	0
is	0
placed	0
5	0
cm	I-DISEASE
above	0
the	0
LES	0
.	0

A	0
proximal	0
pH	0
probe	0
is	0
often	0
placed	0
near	0
the	0
UES	0
.	I-DISEASE

An	I-DISEASE
acid	I-DISEASE
reflux	0
event	0
is	I-DISEASE
defined	I-DISEASE
when	0
the	0
pH	0
drops	I-DISEASE
to	I-DISEASE
less	I-DISEASE
than	0
4.0	0
,	0
and	0
this	0
variable	I-DISEASE
is	I-DISEASE
reported	0
as	0
time	I-DISEASE
(	0
%	0
)	0
where	0
pH	0
is	I-DISEASE
less	I-DISEASE
than	0
4.0	0
.	0

The	I-DISEASE
percent	I-DISEASE
time	0
where	0
pH	0
is	0
less	I-DISEASE
than	I-DISEASE
4	0
is	0
reported	0
over	I-DISEASE
the	I-DISEASE
total	I-DISEASE
recording	0
time	0
,	I-DISEASE
upright	I-DISEASE
time	0
and	0
supine	0
time	0
.	0

Note	I-DISEASE
that	0
supine	0
(	0
in	I-DISEASE
this	0
testing	0
)	0
is	0
defined	I-DISEASE
as	0
the	I-DISEASE
period	I-DISEASE
of	I-DISEASE
time	I-DISEASE
that	0
the	I-DISEASE
patient	0
is	0
in	I-DISEASE
bed	I-DISEASE
.	0

Symptom	I-DISEASE
correlation	0
is	0
also	0
helpful	0
using	0
the	0
event	0
marker	I-DISEASE
on	0
the	0
device	0
or	0
diaries	I-DISEASE
.	0

Normal	I-DISEASE
esophageal	I-DISEASE
pH	0
times	0
during	I-DISEASE
the	0
“	0
supine	0
”	I-DISEASE
or	I-DISEASE
sleep	0
period	0
are	I-DISEASE
:	I-DISEASE
1	0
)	0
distal	0
pH	0
<	I-DISEASE
4	0
-	I-DISEASE
less	0
than	I-DISEASE
3.5	0
%	0
of	I-DISEASE
the	0
time	0
;	0
and	0
2	0
)	0
proximal	0
pH	I-DISEASE
<	0
4	0
-	0
less	I-DISEASE
than	I-DISEASE
0.6	I-DISEASE
%	0
of	I-DISEASE
the	0
time	0
.	0

If	I-DISEASE
esophageal	I-DISEASE
pH	0
monitoring	0
is	I-DISEASE
integrated	0
with	0
polysomnography	0
,	I-DISEASE
esophageal	I-DISEASE
acid	I-DISEASE
events	0
can	0
be	0
cor-	I-DISEASE
related	0
with	I-DISEASE
sleep	0
events	0
,	0
including	0
arousals	0
,	0
apneas	0
,	0
laryngospasm	0
,	I-DISEASE
and	0
increased	0
chin	0
EMG	0
tone	I-DISEASE
.	0

Esophageal	I-DISEASE
pH	0
monitoring	0
also	0
can	0
be	0
performed	0
simultaneously	I-DISEASE
with	I-DISEASE
actigraphy	I-DISEASE
to	I-DISEASE
correlate	I-DISEASE
acid	I-DISEASE
reflux	0
events	0
with	I-DISEASE
sleep	0
and	0
wake	0
periods	I-DISEASE
.	0

Catheter-	I-DISEASE
free	0
wireless	0
pH	I-DISEASE
systems	0
are	0
also	0
available	I-DISEASE
and	0
are	I-DISEASE
deployed	I-DISEASE
into	I-DISEASE
the	0
esophagus	I-DISEASE
,	I-DISEASE
usually	I-DISEASE
by	I-DISEASE
endoscopy	0
.	0

Esophageal	I-DISEASE
impedance	I-DISEASE
monitoring	0
can	0
be	0
combined	0
with	I-DISEASE
pH	I-DISEASE
probes	0
detecting	I-DISEASE
liquid	0
,	0
gas	I-DISEASE
,	0
or	0
liquid	0
gas	0
in	I-DISEASE
the	0
esophagus	I-DISEASE
,	I-DISEASE
and	0
can	0
assess	I-DISEASE
both	I-DISEASE
acid	I-DISEASE
and	0
nonacid	I-DISEASE
reflux	0
events	0
.	0

Use	I-DISEASE
of	I-DISEASE
esophageal	0
impedance	I-DISEASE
monitoring	0
is	0
often	I-DISEASE
performed	I-DISEASE
in	I-DISEASE
esophageal	I-DISEASE
centers	0
,	0
and	0
this	0
technique	I-DISEASE
would	0
be	0
difficult	I-DISEASE
to	0
integrate	0
with	0
polysomnography	0
.	0

Other	I-DISEASE
objective	I-DISEASE
measures	0
include	I-DISEASE
esophageal	0
endoscopy	0
with	I-DISEASE
or	I-DISEASE
without	0
biopsy	0
in	I-DISEASE
order	0
to	0
evaluate	0
for	I-DISEASE
esophagitis	0
and	0
other	I-DISEASE
esophageal	I-DISEASE
complications	0
.	0

A	I-DISEASE
histologic	0
evaluation	I-DISEASE
is	I-DISEASE
required	I-DISEASE
to	0
establish	0
a	0
diagnosis	I-DISEASE
of	I-DISEASE
Barrett	0
esophagus	I-DISEASE
.	0

Appendix	I-DISEASE
A	0
:	I-DISEASE
Sleep	0
Related	0
Medical	0
and	0
Neurological	0
Disorders	0
Differential	I-DISEASE
Diagnosis	0
The	I-DISEASE
differential	0
diagnosis	0
is	I-DISEASE
primarily	0
with	I-DISEASE
peptic	0
ulcer	0
disease	B-DISEASE
and	0
angina	0
.	0

The	I-DISEASE
chest	I-DISEASE
pain	0
associated	0
with	0
GER	I-DISEASE
is	I-DISEASE
sometimes	0
indistinguishable	0
from	0
that	0
of	I-DISEASE
angina	0
.	0

Duodenal	I-DISEASE
ulcer	0
disease	I-DISEASE
is	I-DISEASE
commonly	I-DISEASE
associated	0
with	0
a	0
burning	I-DISEASE
epigastric	I-DISEASE
pain	0
,	I-DISEASE
and	0
this	0
can	0
sometimes	0
be	0
similar	0
to	I-DISEASE
the	I-DISEASE
pain	0
experienced	I-DISEASE
by	0
patients	I-DISEASE
with	I-DISEASE
GER	B-DISEASE
.	0

Other	I-DISEASE
conditions	I-DISEASE
that	0
may	I-DISEASE
be	0
associated	0
with	I-DISEASE
GER	I-DISEASE
include	0
OSA	I-DISEASE
,	I-DISEASE
sleep	I-DISEASE
related	B-DISEASE
abnormal	I-DISEASE
swallowing	I-DISEASE
,	I-DISEASE
and	0
sleep	0
related	B-DISEASE
laryngospasm	0
.	0

PSG	I-DISEASE
evaluation	0
with	I-DISEASE
respiratory	0
and	0
pH	0
monitoring	0
can	0
differentiate	0
these	I-DISEASE
disorders	0
.	I-DISEASE

Unresolved	I-DISEASE
Issues	0
and	0
Further	I-DISEASE
Directions	0
Not	0
applicable	0
or	I-DISEASE
known	I-DISEASE
.	0

Bibliography	0
Allen	I-DISEASE
L	0
,	I-DISEASE
Poh	0
CH	0
,	0
Gasiorowska	0
A	0
,	I-DISEASE
et	0
al	I-DISEASE
.	0

Increased	I-DISEASE
oesophageal	0
acid	I-DISEASE
exposure	0
at	I-DISEASE
the	0
beginning	I-DISEASE
of	I-DISEASE
the	0
recumbent	0
period	I-DISEASE
is	0
primarily	0
a	0
recumbent	0
-	0
awake	0
phenomenon	0
.	I-DISEASE

Aliment	I-DISEASE
Pharmacol	0
Ther	I-DISEASE
2010;32:787–94	0
.	0

Bajaj	I-DISEASE
JS	0
,	0
Bajaj	I-DISEASE
S	I-DISEASE
,	0
Dua	I-DISEASE
KS	I-DISEASE
,	I-DISEASE
et	0
al	I-DISEASE
.	0

Influence	I-DISEASE
of	0
sleep	0
stages	I-DISEASE
on	0
esophago	I-DISEASE
-	I-DISEASE
upper	I-DISEASE
esophageal	I-DISEASE
sphincter	0
contractile	0
reflex	0
and	0
secondary	0
esophageal	I-DISEASE
peristalsis	I-DISEASE
.	0

Gastroenterology	I-DISEASE
2006;130:17–25	0
.	0

Fass	I-DISEASE
R	I-DISEASE
,	I-DISEASE
Johnson	0
DA	I-DISEASE
,	I-DISEASE
Orr	0
WC	I-DISEASE
,	I-DISEASE
et	I-DISEASE
al	I-DISEASE
.	0

The	I-DISEASE
effect	0
of	I-DISEASE
dexlansoprazole	I-DISEASE
MR	0
on	0
nocturnal	I-DISEASE
heartburn	0
and	0
GERD-	I-DISEASE
related	B-DISEASE
sleep	0
disturbances	I-DISEASE
in	I-DISEASE
patients	I-DISEASE
with	0
symptomatic	0
GERD	0
.	0

Am	I-DISEASE
J	0
Gastroenterol	0
2011;106:421–31	0
.	0

Fass	I-DISEASE
R	I-DISEASE
,	I-DISEASE
Quan	0
SF	0
,	I-DISEASE
O’Connor	B-DISEASE
GT	I-DISEASE
,	I-DISEASE
et	I-DISEASE
al	I-DISEASE
.	0

Predictors	I-DISEASE
of	I-DISEASE
heartburn	0
during	I-DISEASE
sleep	0
in	0
a	0
large	I-DISEASE
prospective	0
cohort	I-DISEASE
study	0
.	0

Chest	I-DISEASE
2005;127:1654–66	0
.	0

Fujiwara	I-DISEASE
Y	I-DISEASE
,	I-DISEASE
Arakawa	0
T	0
,	I-DISEASE
Fass	I-DISEASE
R.	I-DISEASE
Gastroesophageal	I-DISEASE
reflux	0
disease	I-DISEASE
and	0
sleep	0
disturbances	I-DISEASE
.	0

J	I-DISEASE
Gastroenterol	0
2012;47:760–9	I-DISEASE
.	I-DISEASE

Gagliardi	I-DISEASE
GS	0
,	I-DISEASE
Shah	I-DISEASE
AP	0
,	0
Goldstein	0
M	I-DISEASE
,	I-DISEASE
et	0
al	I-DISEASE
.	0

Effect	I-DISEASE
of	I-DISEASE
zolpidem	I-DISEASE
on	0
the	B-DISEASE
sleep	0
arousal	0
response	0
to	I-DISEASE
nocturnal	I-DISEASE
esophageal	I-DISEASE
acid	0
exposure	0
.	0

Clin	I-DISEASE
Gastroenterol	0
Hepatol	0
2009;7:948–52	I-DISEASE
.	0

Gerson	I-DISEASE
LB	0
,	0
Fass	I-DISEASE
R.	I-DISEASE
A	0
systematic	0
review	I-DISEASE
of	I-DISEASE
definitions	I-DISEASE
,	0
prevalence	0
,	I-DISEASE
and	0
response	0
to	0
treatment	I-DISEASE
of	I-DISEASE
nocturnal	0
gastroesophageal	I-DISEASE
reflux	I-DISEASE
disease	B-DISEASE
.	0

Clin	I-DISEASE
Gastroenterol	0
Hepatol	0
2009;7:372–8	I-DISEASE
.	0

Ghaem	I-DISEASE
M	I-DISEASE
,	0
Armstrong	I-DISEASE
KL	0
,	0
Trocki	0
O	I-DISEASE
,	I-DISEASE
et	0
al	I-DISEASE
.	0

The	I-DISEASE
sleep	0
patterns	0
of	I-DISEASE
infants	0
and	0
young	I-DISEASE
children	I-DISEASE
with	0
gastro-	0
oesophageal	I-DISEASE
reflux	I-DISEASE
.	0

J	I-DISEASE
Paediatr	0
Child	0
Health	0
1998;34:160–3	0
.	0

Green	I-DISEASE
BT	I-DISEASE
,	0
Broughton	0
WA	0
,	I-DISEASE
O’Connor	B-DISEASE
JB	I-DISEASE
.	0

Marked	I-DISEASE
improvement	0
in	I-DISEASE
nocturnal	0
gastroesophageal	I-DISEASE
reflux	I-DISEASE
in	I-DISEASE
a	0
large	I-DISEASE
cohort	0
of	I-DISEASE
patients	0
with	I-DISEASE
obstructive	0
sleep	0
apnea	0
treated	0
with	I-DISEASE
continuous	0
positive	0
airway	0
pressure	0
.	0

Arch	I-DISEASE
Intern	0
Med	0
2003;163:41–5	0
.	0

Harding	I-DISEASE
SM	I-DISEASE
,	0
Richter	0
JE	0
,	I-DISEASE
Guzzo	I-DISEASE
MR	0
,	I-DISEASE
et	I-DISEASE
al	I-DISEASE
.	0

Asthma	I-DISEASE
and	0
gastroesophageal	0
reflux	0
:	I-DISEASE
acid	I-DISEASE
suppressive	0
therapy	I-DISEASE
improves	0
asthma	0
outcome	0
.	0

Am	I-DISEASE
J	0
Med	0
1996;100:395–405	0
.	0

Harding	I-DISEASE
SM	I-DISEASE
.	0

Gastroesophageal	I-DISEASE
reflux	I-DISEASE
during	I-DISEASE
sleep	0
.	0

Sleep	I-DISEASE
Med	I-DISEASE
Clin	I-DISEASE
2007;2:41–50	I-DISEASE
.	I-DISEASE

Locke	I-DISEASE
GR	I-DISEASE
3rd	0
,	0
Talley	I-DISEASE
NJ	I-DISEASE
,	0
Fett	0
SL	I-DISEASE
,	I-DISEASE
et	0
al	0
.	0

Prevalence	I-DISEASE
and	0
clinical	I-DISEASE
spectrum	0
of	I-DISEASE
gastroesophageal	I-DISEASE
reflux	I-DISEASE
:	0
a	0
population	I-DISEASE
-	0
based	0
study	0
in	I-DISEASE
Olmstead	I-DISEASE
County	0
,	0
Minnesota	I-DISEASE
.	0

Gastroenterology	I-DISEASE
1997;112:1448–56	0
.	0

Mainie	I-DISEASE
I	0
,	I-DISEASE
Tutuian	0
R	I-DISEASE
,	0
Shay	I-DISEASE
S	I-DISEASE
,	I-DISEASE
et	I-DISEASE
al	I-DISEASE
.	0

Acid	I-DISEASE
and	0
non	0
-	0
acid	I-DISEASE
reflux	I-DISEASE
in	0
patients	0
with	I-DISEASE
persistent	I-DISEASE
symptoms	I-DISEASE
despite	0
acid	I-DISEASE
suppressive	0
therapy	0
:	0
a	0
multicentre	0
study	0
using	I-DISEASE
combined	0
ambulatory	I-DISEASE
impedance	0
pH	0
monitoring	I-DISEASE
.	0

Gut	I-DISEASE
2006;55:1398–402	0
.	0

Appendix	I-DISEASE
A	0
:	I-DISEASE
Sleep	I-DISEASE
Related	0
Medical	I-DISEASE
and	0
Neurological	0
Disorders	0
Schey	I-DISEASE
R	0
,	I-DISEASE
Dickman	0
R	I-DISEASE
,	I-DISEASE
Parthasarathy	I-DISEASE
S	I-DISEASE
,	I-DISEASE
et	0
al	I-DISEASE
.	0

Sleep	I-DISEASE
deprivation	I-DISEASE
is	0
hyperalgesic	I-DISEASE
in	I-DISEASE
patients	I-DISEASE
with	I-DISEASE
gastroesophageal	0
reflux	I-DISEASE
disease	B-DISEASE
.	0

Gastroenterology	I-DISEASE
2007;133:1787–95	0
.	0

Shaheen	I-DISEASE
NJ	0
,	I-DISEASE
Weinberg	0
DS	0
,	I-DISEASE
Denberg	0
TD	0
,	I-DISEASE
et	0
al	I-DISEASE
.	0

Upper	I-DISEASE
endoscopy	I-DISEASE
for	0
gastroesophageal	I-DISEASE
reflux	0
disease	0
:	0
Best	I-DISEASE
Practice	I-DISEASE
Advice	0
from	I-DISEASE
the	0
Clinical	0
Guidelines	I-DISEASE
Committee	I-DISEASE
of	0
the	I-DISEASE
American	0
College	0
of	I-DISEASE
Physicians	0
.	0

Ann	I-DISEASE
Intern	0
Med	0
2012;157:808–16	I-DISEASE
.	0

Shaker	I-DISEASE
R.	I-DISEASE
Castell	0
DO	I-DISEASE
,	0
Schoenfeld	0
PS	0
,	0
et	0
al	I-DISEASE
.	I-DISEASE

Nighttime	I-DISEASE
heartburn	0
is	0
an	I-DISEASE
under	0
-	0
appreciated	0
clinical	0
problem	I-DISEASE
that	0
impacts	I-DISEASE
sleep	0
and	0
daytime	I-DISEASE
function	0
:	I-DISEASE
the	0
results	0
of	I-DISEASE
a	0
Gallup	I-DISEASE
survey	I-DISEASE
conducted	0
on	0
behalf	I-DISEASE
of	I-DISEASE
the	0
American	0
Gastroenterological	0
Association	B-DISEASE
.	0

Am	I-DISEASE
J	0
Gastroenterol	0
2003;98:1487–93	0
.	0

Sontag	I-DISEASE
SJ	I-DISEASE
,	0
O’Connell	I-DISEASE
S	I-DISEASE
,	0
Miller	0
TQ	0
,	I-DISEASE
et	0
al	I-DISEASE
.	0

Asthmatics	I-DISEASE
have	0
more	0
nocturnal	0
gasping	0
and	0
reflux	0
symptoms	I-DISEASE
than	0
nonasthmatics	0
,	I-DISEASE
and	0
they	I-DISEASE
are	0
related	0
to	I-DISEASE
bedtime	0
eating	I-DISEASE
.	0

Am	I-DISEASE
J	0
Gastroenterol	0
2004;99:789–96	0
.	0

Sleep	I-DISEASE
Related	0
Myocardial	0
Ischemia	I-DISEASE
Alternate	0
Names	I-DISEASE
Unstable	I-DISEASE
angina	0
,	I-DISEASE
coronary	0
insufficiency	0
-	0
acute	I-DISEASE
,	0
nocturnal	0
angina	0
,	0
angina	0
decubitus	0
,	0
variant	0
angina	0
,	0
Prinzmetal	I-DISEASE
angina	0
,	0
vasospastic	0
angina	0
,	I-DISEASE
angina	0
pectoris	0
,	0
atherosclerotic	I-DISEASE
heart	0
disease	I-DISEASE
,	0
asymptomatic	0
cardiac	0
ischemia	0
,	I-DISEASE
silent	0
ischemia	0
.	0

Essential	I-DISEASE
Features	I-DISEASE
Sleep	0
related	0
myocardial	0
ischemia	0
is	I-DISEASE
characterized	0
by	I-DISEASE
nocturnal	0
reduction	0
of	I-DISEASE
blood	0
flow	0
to	I-DISEASE
the	0
myocardium	0
,	0
typically	0
during	I-DISEASE
sleep	0
.	0

The	I-DISEASE
symptoms	I-DISEASE
of	I-DISEASE
sleep	0
related	0
myo-	0
cardial	0
ischemia	0
are	I-DISEASE
very	I-DISEASE
similar	0
to	I-DISEASE
those	I-DISEASE
that	0
characterize	0
episodes	I-DISEASE
of	I-DISEASE
cardiac	0
isch-	0
emia	I-DISEASE
during	I-DISEASE
the	0
daytime	I-DISEASE
.	0

Classically	I-DISEASE
,	0
there	I-DISEASE
is	0
a	0
feeling	I-DISEASE
of	I-DISEASE
chest	0
pressure	0
or	0
pain	0
that	I-DISEASE
awakens	0
the	0
patient	I-DISEASE
from	I-DISEASE
sleep	0
and	0
may	I-DISEASE
be	0
described	0
as	0
a	0
“	I-DISEASE
viselike	0
”	I-DISEASE
discomfort	0
.	0

The	I-DISEASE
discomfort	0
may	0
radiate	I-DISEASE
to	I-DISEASE
the	0
chin	0
and	0
jaw	0
and	0
to	I-DISEASE
the	0
arm	B-DISEASE
,	I-DISEASE
especially	0
the	I-DISEASE
left	0
arm	0
.	0

Associated	I-DISEASE
Features	I-DISEASE
Acute	0
episodes	0
of	I-DISEASE
sleep	0
related	B-DISEASE
myocardial	0
ischemia	I-DISEASE
sometimes	0
elicit	I-DISEASE
atrial	0
or	0
ventric-	0
ular	0
arrhythmias	0
.	0

Other	I-DISEASE
associated	0
presentations	I-DISEASE
include	I-DISEASE
acute	0
onset	I-DISEASE
of	I-DISEASE
shortness	0
of	I-DISEASE
breath	0
that	0
wakes	I-DISEASE
the	0
patient	0
from	0
sleep	0
and	0
that	0
may	0
be	I-DISEASE
secondary	0
to	I-DISEASE
left	0
ventricular	0
diastolic	I-DISEASE
dysfunction	0
or	I-DISEASE
ischemic	I-DISEASE
mitral	0
regurgitation	0
.	0

Other	0
related	0
features	0
depend	0
on	0
the	0
trigger	0
for	0
the	0
cardiac	0
ischemia	0
.	0

Ischemic	I-DISEASE
events	0
related	0
to	0
OSA	0
may	0
present	0
during	I-DISEASE
those	0
times	I-DISEASE
of	I-DISEASE
sleep	0
when	0
nocturnal	0
desaturation	0
is	0
most	0
severe	0
.	0

Cardiac	0
isch-	0
emia	I-DISEASE
related	B-DISEASE
to	0
hemodynamic	0
changes	I-DISEASE
or	0
vasospasm	0
occurring	0
during	I-DISEASE
REM	I-DISEASE
sleep	0
may	I-DISEASE
present	0
in	I-DISEASE
the	0
early	0
hours	I-DISEASE
of	I-DISEASE
the	0
morning	0
,	I-DISEASE
around	B-DISEASE
the	0
time	0
of	I-DISEASE
waking	0
,	0
when	0
REM	0
sleep	0
is	0
most	I-DISEASE
likely	I-DISEASE
to	I-DISEASE
occur	0
.	0

Ischemia	I-DISEASE
associated	0
with	0
nocturnal	0
hypotension	I-DISEASE
is	I-DISEASE
most	0
likely	0
to	0
occur	0
during	I-DISEASE
slow	0
wave	0
(	I-DISEASE
N3	0
)	0
sleep	0
,	I-DISEASE
when	0
blood	I-DISEASE
pressure	0
is	I-DISEASE
lowest	I-DISEASE
.	B-DISEASE

Clinical	I-DISEASE
and	0
Pathophysiologic	0
Subtypes	0
None	I-DISEASE
known	I-DISEASE
.	0

Appendix	I-DISEASE
A	0
:	I-DISEASE
Sleep	0
Related	0
Medical	0
and	0
Neurological	0
Disorders	0
Demographics	I-DISEASE

The	I-DISEASE
specifics	I-DISEASE
of	I-DISEASE
prevalence	0
,	I-DISEASE
sex	0
ratios	I-DISEASE
,	0
and	0
age	I-DISEASE
ranges	I-DISEASE
have	I-DISEASE
not	0
been	I-DISEASE
comprehensively	I-DISEASE
evaluated	0
.	0

Some	I-DISEASE
insights	I-DISEASE
into	I-DISEASE
demographics	0
can	0
be	I-DISEASE
extrapolated	I-DISEASE
,	0
depending	I-DISEASE
on	0
the	0
cause	0
of	I-DISEASE
nocturnal	0
angina	0
.	0

For	I-DISEASE
sleep	0
related	0
myocardial	0
ischemia	I-DISEASE
triggered	0
by	I-DISEASE
OSA	I-DISEASE
,	0
the	0
preponderance	I-DISEASE
of	I-DISEASE
OSA	0
in	0
men	0
suggests	I-DISEASE
that	0
middle	I-DISEASE
-	0
aged	I-DISEASE
men	I-DISEASE
with	I-DISEASE
severe	0
OSA	0
are	0
more	0
likely	0
to	0
experience	0
nocturnal	0
angina	0
,	I-DISEASE
particularly	I-DISEASE
if	0
they	I-DISEASE
have	0
more	0
severe	0
coronary	0
artery	0
disease	I-DISEASE
.	0

Variant	I-DISEASE
angina	0
(	I-DISEASE
also	0
referred	I-DISEASE
to	0
as	0
vasospastic	0
or	I-DISEASE
Prinzmetal	I-DISEASE
angina	0
)	0
more	0
commonly	I-DISEASE
affects	I-DISEASE
younger	I-DISEASE
populations	0
,	I-DISEASE
particularly	0
women	I-DISEASE
and	0
those	0
of	I-DISEASE
Asian	0
descent	0
.	0

Cardiac	0
ischemia	0
secondary	0
to	I-DISEASE
nocturnal	0
hypotension	0
is	0
more	0
com-	I-DISEASE
monly	0
manifested	0
in	I-DISEASE
older	0
individuals	I-DISEASE
,	I-DISEASE
particularly	0
those	I-DISEASE
with	0
severe	I-DISEASE
vasculopathy	0
who	I-DISEASE
are	0
taking	0
multiple	I-DISEASE
antihypertensive	0
medications	0
,	0
and	0
especially	0
those	I-DISEASE
in	I-DISEASE
whom	0
autonomic	0
dysfunction	0
(	I-DISEASE
related	0
to	I-DISEASE
either	0
age	I-DISEASE
or	I-DISEASE
diabetes	I-DISEASE
)	0
may	0
impair	0
blood	I-DISEASE
pressure	0
homeostatic	0
mechanisms	I-DISEASE
.	0

Predisposing	I-DISEASE
and	0
Precipitating	I-DISEASE
Factors	0
Predisposing	I-DISEASE
factors	I-DISEASE
include	I-DISEASE
established	I-DISEASE
coronary	0
artery	0
disease	I-DISEASE
or	B-DISEASE
valvular	0
disease	0
such	0
as	0
aortic	I-DISEASE
stenosis	0
.	0

Because	I-DISEASE
coronary	0
filling	0
occurs	0
during	I-DISEASE
diastole	I-DISEASE
,	0
conditions	I-DISEASE
associated	I-DISEASE
with	I-DISEASE
reduced	0
diastolic	I-DISEASE
blood	0
pressure	0
,	0
such	0
as	0
severe	0
aortic	0
regurgita-	I-DISEASE
tion	0
,	I-DISEASE
may	0
elicit	0
nocturnal	0
angina	0
,	0
particularly	0
in	I-DISEASE
the	I-DISEASE
presence	0
of	I-DISEASE
preexisting	0
coro-	0

nary	I-DISEASE
artery	0
disease	I-DISEASE
.	0

Similarly	I-DISEASE
,	I-DISEASE
any	I-DISEASE
predisposition	I-DISEASE
to	I-DISEASE
hypotension	I-DISEASE
,	I-DISEASE
which	I-DISEASE
is	0
most	0
likely	I-DISEASE
to	I-DISEASE
occur	0
during	I-DISEASE
slow	0
wave	I-DISEASE
(	I-DISEASE
N3	0
)	0
sleep	0
,	I-DISEASE
may	I-DISEASE
heighten	I-DISEASE
risk	0
.	0

Usual	I-DISEASE
risk	0
factors	I-DISEASE
for	0
coronary	0
artery	0
disease	0
that	0
predispose	0
an	0
individual	I-DISEASE
to	I-DISEASE
the	0
development	0
of	0
sleep	0
related	0
myocardial	0
ischemia	0
include	I-DISEASE
hypertension	I-DISEASE
,	I-DISEASE
diabetes	I-DISEASE
mellitus	0
,	0
cigarette	0
smoking	0
,	0
and	0
hyperlipidemia	I-DISEASE
.	0

Retrospective	I-DISEASE
and	0
prospective	0
studies	I-DISEASE
suggest	I-DISEASE
that	I-DISEASE
OSA	0
may	I-DISEASE
be	I-DISEASE
a	I-DISEASE
trigger	I-DISEASE
for	0
myo-	0
cardial	0
infarction	I-DISEASE
and	0
sudden	0
death	0
that	0
occurs	0
at	I-DISEASE
night	I-DISEASE
.	0

Deeper	I-DISEASE
oxyhemoglobin	0
desaturations	0
,	I-DISEASE
which	0
may	0
be	0
encountered	0
in	I-DISEASE
REM	0
,	0
particularly	0
with	I-DISEASE
coexisting	B-DISEASE
pulmonary	I-DISEASE
disease	0
or	I-DISEASE
truncal	0
-	I-DISEASE
abdominal	I-DISEASE
obesity	0
,	0
are	0
more	0
likely	0
to	0
trigger	0
cardiac	0
ischemia	0
.	0

In	I-DISEASE
patients	I-DISEASE
with	0
vasospastic	I-DISEASE
angina	0
,	I-DISEASE
use	I-DISEASE
of	I-DISEASE
nonselective	0
β	0
-	0
adrenergic	0
receptor	I-DISEASE
-	I-DISEASE
blocking	0
agents	I-DISEASE
may	I-DISEASE
theoretically	I-DISEASE
increase	I-DISEASE
the	0
likelihood	0
of	I-DISEASE
vasospasm	I-DISEASE
.	0

In	I-DISEASE
patients	0
with	0
nocturnal	I-DISEASE
angina	I-DISEASE
secondary	0
to	0
hypotension	I-DISEASE
,	I-DISEASE
an	0
excess	I-DISEASE
of	0
antihy-	0
pertensive	0
medications	0
,	I-DISEASE
as	0
well	I-DISEASE
as	0
long	I-DISEASE
-	0
acting	I-DISEASE
nitroglycerin	0
administered	0
prior	0
to	I-DISEASE
sleep	0
,	I-DISEASE
may	0
contribute	0
.	0

Finally	I-DISEASE
,	I-DISEASE
in	0
the	0
proper	0
clinical	0
context	I-DISEASE
,	I-DISEASE
abuse	0
of	I-DISEASE
drugs	I-DISEASE
such	I-DISEASE
as	I-DISEASE
amphetamine	I-DISEASE
,	I-DISEASE
cocaine	I-DISEASE
,	0
and	0
other	I-DISEASE
stimulants	0
,	I-DISEASE
needs	0
to	I-DISEASE
be	0
considered	I-DISEASE
in	I-DISEASE
the	0
evaluation	0
of	I-DISEASE
myocardial	0
ischemia	0
.	0

Familial	I-DISEASE
Patterns	I-DISEASE
Familial	I-DISEASE
patterns	0
reflect	I-DISEASE
those	0
of	I-DISEASE
the	0
underlying	0
disease	0
process	0
.	0

Appendix	I-DISEASE
A	0
:	I-DISEASE
Sleep	0
Related	0
Medical	0
and	0
Neurological	0
Disorders	0
Onset	I-DISEASE
,	0
Course	0
,	0
and	0
Complications	0
For	I-DISEASE
angina	0
related	B-DISEASE
to	0
OSA	0
,	0
the	0
first	0
presentation	0
of	I-DISEASE
nocturnal	0
angina	0
may	0
occur	I-DISEASE
only	I-DISEASE
when	0
the	0
severity	0
of	I-DISEASE
both	0
the	0
sleep	0
apnea	0
and	0
the	0
coronary	0
artery	I-DISEASE
disease	B-DISEASE
are	0
suffi-	0
cient	I-DISEASE
to	0
elicit	I-DISEASE
sleep	0
related	0
myocardial	0
ischemia	I-DISEASE
.	0

This	I-DISEASE
is	I-DISEASE
likely	0
to	I-DISEASE
be	0
most	0
common	I-DISEASE
in	I-DISEASE
middle	0
-	0
aged	I-DISEASE
to	I-DISEASE
older	I-DISEASE
men	I-DISEASE
,	0
particularly	0
those	I-DISEASE
who	I-DISEASE
are	0
overweight	0
,	0
although	0
several	0
studies	I-DISEASE
have	I-DISEASE
documented	0
life	0
-	0
threatening	I-DISEASE
OSA	I-DISEASE
related	0
cardiac	0
ischemia	0
in	0
women	0
.	0

It	I-DISEASE
is	I-DISEASE
notable	0
that	0
several	0
studies	I-DISEASE
have	0
reported	I-DISEASE
cardiac	0
ischemia	0
in	I-DISEASE
patients	I-DISEASE
with	0
OSA	I-DISEASE
even	I-DISEASE
in	0
the	0
absence	I-DISEASE
of	I-DISEASE
severe	I-DISEASE
coronary	B-DISEASE
artery	0
stenosis	0
.	0

ST	I-DISEASE
segment	I-DISEASE
changes	0
occur-	I-DISEASE
ring	I-DISEASE
as	I-DISEASE
a	I-DISEASE
result	0
of	I-DISEASE
OSA	I-DISEASE
would	I-DISEASE
be	I-DISEASE
expected	0
to	I-DISEASE
resolve	I-DISEASE
with	I-DISEASE
treatment	0
of	I-DISEASE
the	0
OSA	I-DISEASE
.	0

Regardless	I-DISEASE
of	I-DISEASE
the	0
underlying	0
etiology	0
,	0
potential	I-DISEASE
complications	0
of	I-DISEASE
sleep	0
related	0
myo-	I-DISEASE
cardial	0
ischemia	I-DISEASE
include	I-DISEASE
acute	0
left	0
ventricular	0
dysfunction	0
,	I-DISEASE
ischemic	I-DISEASE
mitral	I-DISEASE
regur-	0
gitation	0
and	0
pulmonary	0
edema	0
,	0
arrhythmias	I-DISEASE
,	0
and	0
even	I-DISEASE
progression	0
to	I-DISEASE
myocardial	0
infarction	0
and	0
death	0
.	0

Pathology	I-DISEASE
and	0
Pathophysiology	I-DISEASE
For	0
sleep	0
related	B-DISEASE
myocardial	0
ischemia	I-DISEASE
related	0
to	0
OSA	I-DISEASE
,	0
the	0
apnea	0
-	0
related	0
hypoxemia	I-DISEASE
and	0
surges	0
in	I-DISEASE
blood	0
pressure	0
and	0
heart	0
rate	I-DISEASE
at	I-DISEASE
termination	0
of	I-DISEASE
apnea	0
may	I-DISEASE
all	0
result	0
in	0
rel-	0
ative	I-DISEASE
myocardial	0
oxygen	0
deficiency	I-DISEASE
.	I-DISEASE

A	I-DISEASE
substrate	0
of	I-DISEASE
preexisting	I-DISEASE
severe	I-DISEASE
coronary	0
artery	0
disease	I-DISEASE
is	I-DISEASE
expected	0
to	0
exacerbate	I-DISEASE
this	0
problem	0
.	0

Variant	I-DISEASE
angina	0
may	I-DISEASE
be	I-DISEASE
more	0
likely	0
to	0
occur	I-DISEASE
during	I-DISEASE
sleep	I-DISEASE
because	0
of	I-DISEASE
the	0
significant	0
and	0
abrupt	I-DISEASE
fluctuations	I-DISEASE
in	I-DISEASE
cardiovascular	0
neural	0
control	I-DISEASE
during	I-DISEASE
REM	I-DISEASE
sleep	I-DISEASE
.	0

For	I-DISEASE
nocturnal	0
angina	0
related	0
to	I-DISEASE
hypotension	0
,	I-DISEASE
perfu-	0
sion	I-DISEASE
of	0
the	0
coronary	0
arteries	0
during	I-DISEASE
diastole	I-DISEASE
makes	I-DISEASE
maintenance	I-DISEASE
of	I-DISEASE
diastolic	0
pressures	I-DISEASE
during	0
sleep	0
important	0
for	0
adequate	0
myocardial	0
perfusion	I-DISEASE
.	0

Autonomic	I-DISEASE
insufficiency	I-DISEASE
due	I-DISEASE
to	I-DISEASE
old	B-DISEASE
age	I-DISEASE
,	0
diabetes	I-DISEASE
,	I-DISEASE
and	0
medication	0
effects	0
blunts	I-DISEASE
the	0
ability	0
of	I-DISEASE
the	0
cardiovascular	I-DISEASE
system	0
to	I-DISEASE
maintain	0
adequate	0
blood	I-DISEASE
pressure	0
.	0

Objective	I-DISEASE
Findings	I-DISEASE
Electrocardiographic	0
monitoring	I-DISEASE
during	I-DISEASE
sleep	I-DISEASE
reveals	0
horizontal	I-DISEASE
or	I-DISEASE
downsloping	I-DISEASE
ST	I-DISEASE
segment	I-DISEASE
depression	I-DISEASE
of	I-DISEASE
greater	I-DISEASE
than	I-DISEASE
or	0
equal	I-DISEASE
to	0
1	I-DISEASE
mm	I-DISEASE
,	I-DISEASE
or	0
ST	B-DISEASE
segment	I-DISEASE
elevation	0
of	I-DISEASE
1	0
mm	0
or	I-DISEASE
more	0
.	0

The	I-DISEASE
electrocardiographic	I-DISEASE
evidence	0
of	I-DISEASE
sleep	0
related	B-DISEASE
coronary	0
artery	I-DISEASE
ischemia	0
is	0
sometimes	I-DISEASE
unaccompanied	0
by	B-DISEASE
chest	0
discomfort	0
or	0
other	0
symptoms	I-DISEASE
(	I-DISEASE
silent	0
ischemia	0
)	0
and	0
may	0
be	0
incidentally	I-DISEASE
noted	0
on	0
either	0
Holter	0
monitoring	0
or	I-DISEASE
telemetry	I-DISEASE
.	0

In	I-DISEASE
general	I-DISEASE
,	0
ST	I-DISEASE
segment	I-DISEASE
abnormalities	I-DISEASE
indicative	I-DISEASE
of	I-DISEASE
myocardial	0
ischemia	0
are	I-DISEASE
1	0
mm	0
or	I-DISEASE
more	0
horizontal	I-DISEASE
or	B-DISEASE
down	I-DISEASE
-	I-DISEASE
sloping	0
depression	I-DISEASE
or	I-DISEASE
ST	I-DISEASE
segment	I-DISEASE
elevation	0
,	0
which	0
may	0
be	0
detected	0
on	0
the	0
single	0
lead	0
electrocardiogram	0
(	I-DISEASE
ECG	0
)	0
employed	0
in	I-DISEASE
most	0
sleep	0
labo-	B-DISEASE
ratories	0
.	0

However	I-DISEASE
,	I-DISEASE
because	0
the	0
sensitivity	0
of	I-DISEASE
single	0
-	0
lead	0
ECG	0
in	I-DISEASE
detecting	I-DISEASE
ischemic	0
changes	I-DISEASE
is	0
poor	0
,	0
the	0
patient	I-DISEASE
with	0
symptoms	I-DISEASE
compatible	I-DISEASE
with	0
angina	0
with	I-DISEASE
a	0
normal	0
-	0
ap-	0
pearing	0
single	0
ECG	0
channel	0
should	0
be	0
further	I-DISEASE
evaluated	0
with	I-DISEASE
multichannel	0
ECG	0
.	0

Appendix	I-DISEASE
A	0
:	I-DISEASE
Sleep	0
Related	0
Medical	0
and	0
Neurological	0
Disorders	0
Sleep	I-DISEASE
related	0
myocardial	0
ischemia	0
in	0
patients	I-DISEASE
without	0
sleep	0
related	0
breathing	B-DISEASE
disor-	0
ders	0
may	0
be	0
associated	0
with	0
REM	0
sleep	0
.	0

Slow	I-DISEASE
wave	I-DISEASE
sleep	0
with	I-DISEASE
a	0
fall	I-DISEASE
in	I-DISEASE
blood	I-DISEASE
pressure	0
and	0
heart	0
rate	I-DISEASE
can	I-DISEASE
be	I-DISEASE
associated	0
with	0
ischemia	0
.	0

Sleep	I-DISEASE
related	I-DISEASE
breathing	0
disorders	0
,	0
par-	0
ticularly	I-DISEASE
OSA	I-DISEASE
,	I-DISEASE
may	I-DISEASE
elicit	0
oxygen	I-DISEASE
desaturation	I-DISEASE
and	0
consequent	0
sleep	0
related	I-DISEASE
myocar-	0
dial	I-DISEASE
ischemia	I-DISEASE
.	0

The	I-DISEASE
presence	0
of	0
cardiac	I-DISEASE
arrhythmias	0
should	0
prompt	0
an	0
evaluation	0
for	0
nocturnal	0
ischemia	0
.	0

Differential	I-DISEASE
Diagnosis	0
Sleep	I-DISEASE
related	0
myocardial	I-DISEASE
ischemia	0
must	0
be	0
differentiated	0
from	I-DISEASE
gastroesophageal	0
reflux	0
,	I-DISEASE
which	0
may	I-DISEASE
also	0
be	I-DISEASE
associated	0
with	I-DISEASE
chest	0
discomfort	0
.	0

The	I-DISEASE
nature	I-DISEASE
of	I-DISEASE
the	0
pain	0
,	I-DISEASE
associated	0
symptoms	I-DISEASE
and	0
prior	0
history	I-DISEASE
are	0
helpful	I-DISEASE
in	I-DISEASE
making	0
a	0
distinction	I-DISEASE
,	I-DISEASE
although	0
12	0
-	I-DISEASE
lead	0
ECG	0
may	I-DISEASE
be	I-DISEASE
necessary	0
in	I-DISEASE
some	I-DISEASE
cases	0
.	0

Nocturnal	0
panic	0
attacks	0
may	0
be	0
asso-	0
ciated	0
with	I-DISEASE
chest	I-DISEASE
wall	I-DISEASE
pain	0
and	0
respiratory	B-DISEASE
distress	I-DISEASE
.	0

Although	I-DISEASE
the	0
majority	0
of	I-DISEASE
patients	0
with	I-DISEASE
nocturnal	0
panic	0
will	0
have	0
a	0
history	I-DISEASE
of	I-DISEASE
daytime	0
panic	0
attacks	I-DISEASE
,	I-DISEASE
a	0
small	0
percentage	0
have	0
only	0
nocturnal	0
events	0
.	0

Nocturnal	I-DISEASE
panic	0
attacks	I-DISEASE
typically	0
occur	I-DISEASE
during	I-DISEASE
transition	I-DISEASE
from	0
N2	0
to	I-DISEASE
N3	I-DISEASE
sleep	0
.	0

Other	I-DISEASE
causes	0
of	I-DISEASE
nocturnal	0
respiratory	I-DISEASE
distress	I-DISEASE
,	I-DISEASE
including	0
heart	0
failure	0
and	0
pulmonary	I-DISEASE
disease	I-DISEASE
,	0
may	0
be	I-DISEASE
confused	I-DISEASE
with	0
myocardial	0
ischemic	0
episodes	0
,	I-DISEASE
although	0
typical	0
anginal	0
chest	0
pain	0
is	0
not	0
evident	0
in	I-DISEASE
these	0
cases	0
.	0

Chest	I-DISEASE
pain	0
due	I-DISEASE
to	0
thoracic	0
mass	0
,	0
pleuritic	0
pain	0
,	I-DISEASE
aortic	I-DISEASE
aneurysm	0
,	I-DISEASE
or	I-DISEASE
other	0
thoracic	0
disease	I-DISEASE
should	0
be	0
considered	I-DISEASE
in	I-DISEASE
the	0
differential	0
diagnosis	I-DISEASE
.	0

Chest	I-DISEASE
wall	I-DISEASE
pain	0
may	0
be	I-DISEASE
sec-	I-DISEASE
ondary	0
to	I-DISEASE
a	I-DISEASE
variety	I-DISEASE
of	I-DISEASE
causes	I-DISEASE
such	I-DISEASE
as	0
trauma	0
,	I-DISEASE
muscle	I-DISEASE
spasm	0
,	I-DISEASE
or	I-DISEASE
immobility	0
.	0

Unresolved	I-DISEASE
Issues	0
and	0
Further	I-DISEASE
Directions	0

More	I-DISEASE
comprehensive	I-DISEASE
data	0
are	I-DISEASE
needed	0
to	I-DISEASE
identify	0
the	0
prevalence	0
and	0
demographics	0
of	I-DISEASE
the	0
various	0
causes	0
of	I-DISEASE
sleep	I-DISEASE
related	0
myocardial	0
ischemia	0
.	0

Further	I-DISEASE
information	0
is	0
also	0
needed	0
to	I-DISEASE
explore	0
the	0
relationship	0
between	0
sleep	0
related	0
myocardial	I-DISEASE
ischemia	0
and	0
the	0
circadian	0
variation	0
in	I-DISEASE
myocardial	0
infarction	I-DISEASE
and	0
sudden	0
death	0
,	0
particularly	0
the	0
role	0
of	I-DISEASE
treatment	0
on	0
outcomes	0
.	0

Bibliography	0
Caples	0
S	I-DISEASE
,	I-DISEASE
Rosen	I-DISEASE
C	0
,	0
Shen	I-DISEASE
W	I-DISEASE
,	I-DISEASE
et	0
al	0
.	0

The	I-DISEASE
scoring	I-DISEASE
of	I-DISEASE
cardiac	I-DISEASE
events	0
during	I-DISEASE
sleep	I-DISEASE
.	I-DISEASE

J	I-DISEASE
Clin	0
Sleep	0
Med	0
2007;15:147–54	I-DISEASE
.	0

Franklin	I-DISEASE
K	0
,	0
Nilsson	0
J	0
,	0
Sahlin	I-DISEASE
C	0
,	I-DISEASE
Naslund	I-DISEASE
U.	0
Sleep	I-DISEASE
apnoea	0
and	0
nocturnal	0
angina	I-DISEASE
.	0

Lancet	I-DISEASE
1995;345:1085–7	0
.	0

Gami	I-DISEASE
A	0
,	I-DISEASE
Howard	0
D	I-DISEASE
,	I-DISEASE
Olson	I-DISEASE
E	0
,	0
Somers	0
V.	I-DISEASE
Day	I-DISEASE
-	I-DISEASE
night	I-DISEASE
pattern	I-DISEASE
of	I-DISEASE
sudden	0
death	0
in	I-DISEASE
obstructive	0
sleep	0
apnea	I-DISEASE
.	0

New	I-DISEASE
Engl	I-DISEASE
J	0
Med	I-DISEASE
2005;352:1206–14	I-DISEASE
.	0

Appendix	I-DISEASE
A	0
:	I-DISEASE
Sleep	I-DISEASE
Related	0
Medical	I-DISEASE
and	0
Neurological	0
Disorders	0
Muller	I-DISEASE
J	0
,	0
Ludmer	I-DISEASE
P	0
,	I-DISEASE
Willich	I-DISEASE
S	I-DISEASE
,	I-DISEASE
et	0
al	I-DISEASE
.	0

Circadian	I-DISEASE
variation	0
and	0
the	0
frequency	I-DISEASE
of	I-DISEASE
sudden	0
cardiac	I-DISEASE
death	0
.	I-DISEASE

Circulation	I-DISEASE
1987;75:131–8	0
.	0

Nowlin	I-DISEASE
J	0
,	I-DISEASE
Troyer	0
WJ	I-DISEASE
,	0
Collins	I-DISEASE
W	I-DISEASE
,	I-DISEASE
et	I-DISEASE
al	I-DISEASE
.	0

The	I-DISEASE
association	I-DISEASE
of	I-DISEASE
nocturnal	0
angina	0
pectoris	0
with	I-DISEASE
dreaming	I-DISEASE
.	0

Ann	I-DISEASE
Intern	0
Med	0
1965;63:1040–6	0
.	0

Schroeder	I-DISEASE
J	0
,	I-DISEASE
Motta	0
J	0
,	0
Guilleminault	I-DISEASE
C.	I-DISEASE
Hemodynamic	I-DISEASE
studies	I-DISEASE
in	I-DISEASE
sleep	0
apnea	0
.	0

In	I-DISEASE
:	I-DISEASE
Guilleminault	I-DISEASE
C	I-DISEASE
,	0
Dement	0
W	I-DISEASE
,	I-DISEASE
eds	I-DISEASE
.	0

Sleep	I-DISEASE
Apnea	0
Syndromes	0
.	0

New	I-DISEASE
York	I-DISEASE
:	0

Alan	I-DISEASE
R.	I-DISEASE
Liss	0
,	I-DISEASE
1978:177–96	0
.	0

Sert	I-DISEASE
Kuniyoshi	0
F	I-DISEASE
,	I-DISEASE
Garcia	I-DISEASE
-	0
Touchard	0
A	0
,	I-DISEASE
Gami	I-DISEASE
A	0
,	I-DISEASE
et	0
al	0
.	0

Day	I-DISEASE
-	I-DISEASE
night	0
variation	I-DISEASE
of	0
acute	I-DISEASE
myocardial	0
infarction	I-DISEASE
in	I-DISEASE
obstructive	0
sleep	0
apnea	0
.	0

J	I-DISEASE
Amer	0
Coll	I-DISEASE
Cardiol	0
2008;52:343–6	I-DISEASE
.	0

Verrier	I-DISEASE
R	I-DISEASE
,	0
Muller	0
J	0
,	I-DISEASE
Hobson	0
J.	0
Sleep	I-DISEASE
,	I-DISEASE
dreams	0
,	I-DISEASE
and	0
sudden	I-DISEASE
death	0
:	0
the	0
case	I-DISEASE
for	I-DISEASE
sleep	0
as	0
an	I-DISEASE
autonomic	0
stress	I-DISEASE
test	I-DISEASE
for	I-DISEASE
the	0
heart	0
.	0

Cardiovasc	0
Res	0
1996;31:181	0
-	0
211	0
.	0

Appendix	I-DISEASE
B	0
:	I-DISEASE
ICD-10	0
-	0
CM	0
Coding	I-DISEASE
for	0
Substance-	I-DISEASE
Induced	0
Sleep	0
Disorders	0
ICD-10	I-DISEASE
-	I-DISEASE
CM	I-DISEASE
coding	I-DISEASE
for	0
substance	I-DISEASE
-	0
induced	0
disorders	0
is	0
more	0
complex	0
than	0
ICD-9	0
-	I-DISEASE
CM	I-DISEASE
coding	I-DISEASE
.	0

The	I-DISEASE
series	I-DISEASE
F10.xxx-F19.xxx	0
(	I-DISEASE
which	0
is	I-DISEASE
the	0
general	0
section	I-DISEASE
for	0
substance	I-DISEASE
-	0
in-	I-DISEASE
duced	0
mental	0
and	0
behavioral	I-DISEASE
disorders	0
in	0
ICD-10	0
-	0
CM	I-DISEASE
)	0
contains	0
the	0
pertinent	0
codes	0
for	I-DISEASE
substance	I-DISEASE
-	I-DISEASE
induced	0
sleep	0
disorders	0
.	0

There	I-DISEASE
are	0
specific	I-DISEASE
codes	0
for	0
sleep	0
disorders	0
induced	I-DISEASE
by	0
alcohol	0
,	0
opioids	0
,	0
sedatives	I-DISEASE
,	0
cocaine	0
,	0
other	I-DISEASE
stimulants	0
and	0
other	I-DISEASE
psychoactive	0
sub-	I-DISEASE
stances	0
.	0

However	I-DISEASE
,	I-DISEASE
in	I-DISEASE
the	0
case	I-DISEASE
of	I-DISEASE
cannabis	0
,	I-DISEASE
hallucinogens	0
,	I-DISEASE
nicotine	I-DISEASE
and	0
inhalants	I-DISEASE
,	I-DISEASE
there	I-DISEASE
are	0
no	0
sleep	0
-	I-DISEASE
specific	I-DISEASE
codes	I-DISEASE
.	0

In	I-DISEASE
these	I-DISEASE
instances	0
,	I-DISEASE
the	0
coder	0
must	I-DISEASE
use	0
an	0
“	0
unspecified	I-DISEASE
”	I-DISEASE
or	I-DISEASE
“	I-DISEASE
other	0
”	I-DISEASE
code	0
.	0

A	I-DISEASE
detailed	I-DISEASE
list	0
of	I-DISEASE
the	0
appropriate	I-DISEASE
codes	0
for	I-DISEASE
substance	0
-	0
induced	0
sleep	0
dis-	I-DISEASE
orders	I-DISEASE
is	0
included	I-DISEASE
in	0
the	0
table	I-DISEASE
below	I-DISEASE
.	0

Substance	I-DISEASE
Relevant	0
ICD-10	I-DISEASE
-	0
CM	0
Codes	I-DISEASE
Alcohol	0
F10.182	I-DISEASE
Alcohol	0
abuse	I-DISEASE
with	I-DISEASE
alcohol	0
-	0
induced	0
sleep	0
disorder	0
F10.282	B-DISEASE
Alcohol	0
dependence	0
with	0
alcohol	0
-	0
induced	0
sleep	0
disorder	I-DISEASE
F10.982	I-DISEASE
Alcohol	0
use	0
,	0
unspecified	I-DISEASE
with	0
alcohol	0
-	I-DISEASE
induced	I-DISEASE
sleep	0
disorder	0
Opioid	0
F11.182	I-DISEASE
Opioid	0
abuse	0
with	0
opioid	0
-	I-DISEASE
induced	0
sleep	I-DISEASE
disorder	0
F11.282	0
Opioid	0
dependence	0
with	0
opioid	0
-	I-DISEASE
induced	I-DISEASE
sleep	0
disorder	0
F11.982	I-DISEASE
Opioid	0
use	I-DISEASE
,	0
unspecified	I-DISEASE
with	0
opioid	0
-	0
induced	0
sleep	0
disorder	0
Cannabis	0
F12.188	0
Cannabis	I-DISEASE
abuse	0
with	I-DISEASE
other	I-DISEASE
cannabis	0
-	0
induced	I-DISEASE
disorder	I-DISEASE
F12.288	0
Cannabis	0
dependence	0
with	0
other	0
cannabis	0
-	0
induced	0
disorder	I-DISEASE
F12.988	I-DISEASE
Cannabis	0
use	0
,	I-DISEASE
unspecified	0
with	0
other	I-DISEASE
cannabis	0
-	0
induced	B-DISEASE
disorder	0
Sedative	I-DISEASE
,	0
Hypnotic	0
or	0
Anxiolytic	0
F13.182	0
Sedative	I-DISEASE
,	I-DISEASE
hypnotic	0
or	I-DISEASE
anxiolytic	0
abuse	0
with	0
sedative	I-DISEASE
,	I-DISEASE
hypnotic	0
or	0
anxiolytic	0
-	0
induced	0
sleep	0
disorder	0
F13.282	0
Sedative	B-DISEASE
,	I-DISEASE
hypnotic	0
or	I-DISEASE
anxiolytic	0
dependence	0
with	I-DISEASE
sedative	0
,	I-DISEASE
hypnotic	0
or	0
anxiolytic	0
-	0
induced	I-DISEASE
sleep	I-DISEASE
disorder	0
F13.982	0
Sedative	0
,	0
hypnotic	0
or	0
anxiolytic	I-DISEASE
use	0
,	0
unspecified	I-DISEASE
with	0
sedative	0
,	0
hypnotic	I-DISEASE
or	0
anxiolytic	0
-	0
induced	0
sleep	0
disorder	I-DISEASE
Appendix	0
B	0
:	I-DISEASE
ICD-10	0
-	I-DISEASE
CM	0
Coding	0
for	I-DISEASE
Substance	0
-	0
Induced	I-DISEASE
Sleep	I-DISEASE
Disorders	I-DISEASE
Substance	I-DISEASE

Relevant	I-DISEASE
ICD-10	0
-	I-DISEASE
CM	0
Codes	B-DISEASE
Cocaine	I-DISEASE
F14.182	0
Cocaine	0
abuse	I-DISEASE
with	0
cocaine	I-DISEASE
-	0
induced	0
sleep	I-DISEASE
disorder	0
F14.282	I-DISEASE
Cocaine	0
dependence	0
with	0
cocaine	I-DISEASE
-	0
induced	I-DISEASE
sleep	0
disorder	0
F14.982	I-DISEASE
Cocaine	I-DISEASE
use	I-DISEASE
,	I-DISEASE
unspecified	I-DISEASE
with	0
cocaine	I-DISEASE
-	I-DISEASE
induced	I-DISEASE
sleep	0
disorder	I-DISEASE
Other	0
Stimulant	0
(	I-DISEASE
includes	I-DISEASE
amphetamine	I-DISEASE
and	0
caffeine	I-DISEASE
)	0

F15.182	I-DISEASE
Other	0
stimulant	0
abuse	0
with	I-DISEASE
stimulant	0
-	I-DISEASE
induced	I-DISEASE
sleep	0
disorder	0
F15.282	0
Other	0
stimulant	0
dependence	0
with	I-DISEASE
stimulant	0
-	0
induced	0
sleep	0
disorder	I-DISEASE
F15.982	0
Other	0
stimulant	0
use	0
,	0
unspecified	0
with	0
stimulant	0
-	0
induced	0
sleep	0
disorder	I-DISEASE
Hallucinogen	I-DISEASE
(	I-DISEASE
includes	I-DISEASE
ecstasy	I-DISEASE
,	I-DISEASE
PCP	0
,	0
phencyclidine	0
)	0

F16.188	I-DISEASE
Hallucinogen	0
abuse	0
with	0
other	0
hallucinogen	I-DISEASE
-	I-DISEASE
induced	I-DISEASE
disorder	I-DISEASE
F16.288	0
Hallucinogen	I-DISEASE
dependence	0
with	I-DISEASE
other	0
hallucinogen	I-DISEASE
-	I-DISEASE
induced	I-DISEASE
disorder	I-DISEASE
F16.988	0
Hallucinogen	0
use	0
,	I-DISEASE
unspecified	I-DISEASE
with	0
other	0
hallucinogen-	I-DISEASE
induced	0
disorder	I-DISEASE
Nicotine	0
F17.208	I-DISEASE
Nicotine	0
dependence	0
,	0
unspecified	I-DISEASE
,	0
with	I-DISEASE
other	0
nicotine-	0
induced	I-DISEASE
disorders	0
F17.218	I-DISEASE
Nicotine	0
dependence	I-DISEASE
,	0
cigarettes	0
,	0
with	I-DISEASE
other	0
nicotine	0
-	I-DISEASE
induced	I-DISEASE
disorders	0
F17.228	0
Nicotine	B-DISEASE
dependence	0
,	0
chewing	0
tobacco	I-DISEASE
,	0
with	I-DISEASE
other	0
nicotine-	0
induced	0
disorders	0
F17.298	0
Nicotine	0
dependence	0
,	I-DISEASE
other	0
tobacco	0
product	0
,	0
with	0
other	0
nicotine	I-DISEASE
-	0
induced	I-DISEASE
disorders	0
Inhalant	B-DISEASE
(	0
includes	I-DISEASE
volatile	0
solvents	0
)	0

F18.188	I-DISEASE
Inhalant	0
abuse	I-DISEASE
with	0
other	0
inhalant	0
-	0
induced	0
disorder	I-DISEASE
F18.288	I-DISEASE
Inhalant	0
dependence	0
with	0
other	I-DISEASE
inhalant	0
-	I-DISEASE
induced	0
disorder	B-DISEASE
F18.988	0
Inhalant	0
use	0
,	0
unspecified	0
with	I-DISEASE
other	0
inhalant	I-DISEASE
-	0
induced	0
disorder	0
Other	0
Psychoactive	0
Substance	0
(	0
includes	I-DISEASE
polysubstance	0
drug	0
use	0
)	0

F19.182	I-DISEASE
Other	0
psychoactive	0
substance	0
abuse	I-DISEASE
with	I-DISEASE
psychoactive	I-DISEASE
substance	I-DISEASE
-	I-DISEASE
induced	0
sleep	0
disorder	I-DISEASE
F19.282	0
Other	0
psychoactive	0
substance	I-DISEASE
dependence	0
with	0
psychoactive	0
substance	I-DISEASE
-	0
induced	0
sleep	0
disorder	0
F19.982	0
Other	0
psychoactive	0
substance	I-DISEASE
use	0
,	0
unspecified	I-DISEASE
with	0
psychoactive	0
substance	I-DISEASE
-	0
induced	0
sleep	0
disorder	I-DISEASE
Glossary	I-DISEASE
Actigraphy	I-DISEASE
:	0
A	0
measurement	0
of	I-DISEASE
physical	0
activity	0
,	0
typically	0
via	0
a	0
wrist	0
-	0
worn	I-DISEASE
movement	I-DISEASE
sensor	0
,	0
employed	0
to	I-DISEASE
estimate	0
sleep	0
and	0
wakefulness	0
based	I-DISEASE
on	0
relative	0
levels	I-DISEASE
of	I-DISEASE
physical	0
inactivity	0
and	0
activity	0
.	0

Alveolar	I-DISEASE
Hypoventilation	I-DISEASE
:	0
A	0
condition	0
in	I-DISEASE
which	I-DISEASE
ventilation	0
of	B-DISEASE
the	0
lung	I-DISEASE
gas	I-DISEASE
exchanging	0
units	I-DISEASE
is	0
decreased	I-DISEASE
relative	0
to	0
the	0
carbon	0
dioxide	I-DISEASE
production	0
(	I-DISEASE
excretion	I-DISEASE
)	0
such	0
that	0
the	0
arterial	0
partial	I-DISEASE
pressure	0
of	I-DISEASE
carbon	0
dioxide	0
is	0
increased	0
.	0

Alveolar	I-DISEASE
ventilation	0
is	0
equal	I-DISEASE
to	I-DISEASE
the	B-DISEASE
minute	0
ventilation	0
(	I-DISEASE
tidal	0
volume	I-DISEASE
×	0
respiratory	B-DISEASE
rate	I-DISEASE
)	0
minus	I-DISEASE
the	0
dead	0
space	I-DISEASE
ventilation	0
.	0

Apneic	I-DISEASE
Threshold	0
:	0

The	I-DISEASE
value	0
of	I-DISEASE
PaCO2	0
below	I-DISEASE
which	0
central	0
apnea	0
occurs	I-DISEASE
during	I-DISEASE
NREM	0
sleep	I-DISEASE
.	0

Ataxic	I-DISEASE
Breathing	0
:	I-DISEASE
A	0
breathing	B-DISEASE
pattern	0
consisting	0
of	I-DISEASE
irregular	I-DISEASE
variation	I-DISEASE
in	0
tidal	0
volume	I-DISEASE
and	0
respiratory	0
rate	0
,	I-DISEASE
characteristic	0
of	I-DISEASE
the	0
effects	0
of	I-DISEASE
opioids	0
on	0
breathing	I-DISEASE
.	B-DISEASE

Autonomic	I-DISEASE
Arousal	0
:	I-DISEASE
An	0
abrupt	I-DISEASE
shift	0
in	I-DISEASE
autonomic	0
nervous	0
system	0
activity	0
during	I-DISEASE
sleep	0
characterized	0
by	I-DISEASE
an	0
increase	I-DISEASE
in	I-DISEASE
sympathetic	I-DISEASE
activity	I-DISEASE
,	0
including	I-DISEASE
heart	0
rate	I-DISEASE
and	0
blood	I-DISEASE
pressure	0
.	0

Biological	I-DISEASE
Day	I-DISEASE
/	0
Night	I-DISEASE
:	0
In	I-DISEASE
humans	0
,	I-DISEASE
biological	I-DISEASE
day	0
refers	0
to	I-DISEASE
the	I-DISEASE
internal	I-DISEASE
circadian	0
time	I-DISEASE
when	I-DISEASE
wakefulness	0
and	0
associated	0
functions	0
are	0
promoted	0
(	I-DISEASE
e.g.	0
,	I-DISEASE
when	0
endogenous	0
melatonin	0
levels	0
are	0
low	0
)	0
.	0

Biological	I-DISEASE
night	I-DISEASE
refers	0
to	I-DISEASE
the	0
internal	I-DISEASE
circadian	0
time	0
when	0
sleep	0
and	0
associated	I-DISEASE
functions	0
are	0
promoted	0
(	I-DISEASE
e.g.	I-DISEASE
,	0
when	0
endogenous	0
melatonin	0
levels	0
are	I-DISEASE
high	I-DISEASE
)	0
.	0

Cataplexy	I-DISEASE
:	0

More	I-DISEASE
than	I-DISEASE
one	0
episode	I-DISEASE
of	I-DISEASE
generally	I-DISEASE
brief	I-DISEASE
(	I-DISEASE
<	I-DISEASE
2	0
minutes	0
)	0
,	I-DISEASE
usually	I-DISEASE
bilaterally	0
symmetrical	I-DISEASE
sudden	I-DISEASE
loss	0
of	I-DISEASE
muscle	I-DISEASE
tone	I-DISEASE
with	I-DISEASE
retained	0
consciousness	0
.	I-DISEASE

The	I-DISEASE
episodes	I-DISEASE
are	0
precipitated	I-DISEASE
by	I-DISEASE
strong	0
emotions	0
,	0
usually	I-DISEASE
positive	I-DISEASE
,	I-DISEASE
with	0
almost	I-DISEASE
all	0
patients	I-DISEASE
reporting	0
some	0
episodes	I-DISEASE
precipitated	0
by	I-DISEASE
emotions	0
associated	0
with	0
laughter	I-DISEASE
.	0

Chemosensitivity	I-DISEASE
:	I-DISEASE
The	I-DISEASE
sensitivity	I-DISEASE
of	I-DISEASE
the	0
chemoreceptors	I-DISEASE
to	I-DISEASE
increases	I-DISEASE
in	0
PCO2	0
or	0
decreases	0
in	I-DISEASE
PO2	I-DISEASE
.	0

In	I-DISEASE
humans	0
this	0
is	0
measured	0
by	I-DISEASE
increases	0
in	I-DISEASE
ventilation	0
associated	0
with	I-DISEASE
these	I-DISEASE
stimuli	I-DISEASE
.	0

Chronotype	I-DISEASE
:	I-DISEASE
Individual	0
timing	I-DISEASE
preference	0
for	I-DISEASE
various	0
physical	0
and	0
mental	0
activities	I-DISEASE
,	I-DISEASE
and	0
sleep	0
and	0
wakefulness	I-DISEASE
,	0
over	0
the	0
course	I-DISEASE
of	I-DISEASE
a	0
day	I-DISEASE
.	0

“	I-DISEASE
Morningness	I-DISEASE
”	I-DISEASE
refers	0
to	I-DISEASE
preference	0
for	I-DISEASE
earlier	0
timing	0
of	I-DISEASE
activities	I-DISEASE
and	0
sleep	I-DISEASE
initiation	0
;	I-DISEASE
“	I-DISEASE
eveningness	I-DISEASE
”	I-DISEASE
refers	0
to	0
preference	0
for	0
later	0
timing	I-DISEASE
of	0
activities	I-DISEASE
and	0
sleep	0
initiation	I-DISEASE
.	0

Glossary	I-DISEASE
Circadian	I-DISEASE
Misalignment	I-DISEASE
:	0

Incorrect	I-DISEASE
or	0
inappropriate	0
timing	I-DISEASE
of	I-DISEASE
sleep	0
and	0
wakefulness	0
with	I-DISEASE
respect	I-DISEASE
to	0
internal	I-DISEASE
circadian	I-DISEASE
timing	0
(	0
e.g.	0
,	I-DISEASE
the	I-DISEASE
wake	0
episode	I-DISEASE
occurring	0
entirely	0
or	I-DISEASE
partially	0
during	I-DISEASE
the	0
biological	I-DISEASE
night	0
and/or	0
the	0
major	0
sleep	0
episode	0
occurring	0
entirely	0
or	0
partially	I-DISEASE
during	I-DISEASE
the	0
biological	I-DISEASE
day	0
)	0
.	0

Circadian	I-DISEASE
Period	0
(	I-DISEASE
tau	0
):	0
The	I-DISEASE
time	0
it	I-DISEASE
takes	0
to	0
complete	0
one	I-DISEASE
circadian	I-DISEASE
cycle	0
(	I-DISEASE
e.g.	0
,	I-DISEASE
time	0
from	I-DISEASE
one	0
circadian	I-DISEASE
phase	0
on	0
day	I-DISEASE
1	0
to	I-DISEASE
the	0
same	0
circadian	0
phase	0
on	0
day	0
2	0
)	0
.	0

Circadian	I-DISEASE
Phase	0
:	I-DISEASE
The	I-DISEASE
time	I-DISEASE
at	I-DISEASE
which	0
a	0
particular	I-DISEASE
event	I-DISEASE
occurs	I-DISEASE
within	B-DISEASE
the	0
circadian	I-DISEASE
cycle	0
(	0
e.g.	I-DISEASE
,	I-DISEASE
onset	I-DISEASE
,	0
offset	0
,	I-DISEASE
trough	I-DISEASE
,	I-DISEASE
peak	0
)	0
.	0

Circadian	I-DISEASE
Rhythm	0
:	I-DISEASE
Biological	0
oscillation	0
,	I-DISEASE
with	I-DISEASE
a	0
periodicity	0
near	0
24	0
hours	I-DISEASE
,	0
which	0
is	0
clock-	0
driven	0
(	I-DISEASE
i.e.	0
,	I-DISEASE
not	0
caused	0
by	B-DISEASE
external	I-DISEASE
or	0
non	0
-	0
circadian	0
clock	0
factors	0
)	0
.	0

Comorbid	I-DISEASE
Insomnia	I-DISEASE
:	I-DISEASE
An	0
insomnia	0
syndrome	I-DISEASE
thought	I-DISEASE
to	0
have	0
partial	I-DISEASE
or	I-DISEASE
total	0
independence	0
from	I-DISEASE
a	0
co	0
-	0
occurring	0
sleep	I-DISEASE
disorder	0
or	I-DISEASE
sleep	0
-	I-DISEASE
disruptive	I-DISEASE
medical	0
,	0
psychiatric	I-DISEASE
,	I-DISEASE
substance	I-DISEASE
dependence	0
/	0
abuse	I-DISEASE
disorder	0
.	0

Conditioned	0
Arousal	0
:	0
An	0
arousal	0
response	0
developed	0
by	I-DISEASE
the	I-DISEASE
repeated	I-DISEASE
association	0
of	I-DISEASE
a	0
specific	I-DISEASE
setting	0
such	0
as	0
the	0
bedroom	I-DISEASE
with	I-DISEASE
unsuccessful	0
sleep	I-DISEASE
attempts	0
.	0

Cortical	I-DISEASE
Arousal	0
:	I-DISEASE
An	0
abrupt	I-DISEASE
shift	0
of	I-DISEASE
EEG	0
frequency	I-DISEASE
to	0
a	0
faster	0
frequency	I-DISEASE
lasting	0
at	I-DISEASE
least	I-DISEASE
3	I-DISEASE
seconds	0
,	I-DISEASE
indicating	0
cortical	I-DISEASE
activation	0
.	0

Cyclic	I-DISEASE
Alternating	0
Pattern	0
(	0
CAP	0
):	0
The	I-DISEASE
occurrence	0
in	I-DISEASE
NREM	0
sleep	0
of	I-DISEASE
transient	0
EEG	0
events	0
(	0
phase	0
A	0
,	I-DISEASE
subtypes	I-DISEASE
A1	I-DISEASE
,	I-DISEASE
A2	I-DISEASE
and	0
A3	0
)	0
interrupting	0
the	0
background	0
activity	0
(	I-DISEASE
phase	0
B	0
)	0
.	0

CAP	I-DISEASE
is	0
a	I-DISEASE
sensitive	0
marker	0
of	I-DISEASE
sleep	0
instability	I-DISEASE
,	0
usually	I-DISEASE
increased	0
in	I-DISEASE
sleep	I-DISEASE
disorders	0
that	0
adversely	I-DISEASE
affect	0
sleep	0
continuity	0
.	0

Dim	I-DISEASE
Light	0
Melatonin	0
Onset	I-DISEASE
(	0
DLMO	I-DISEASE
):	0
A	0
marker	0
of	I-DISEASE
internal	I-DISEASE
circadian	I-DISEASE
phase	0
designated	I-DISEASE
by	I-DISEASE
the	0
rise	0
in	I-DISEASE
melatonin	B-DISEASE
above	0
low	0
daytime	I-DISEASE
levels	0
,	0
typically	0
assessed	I-DISEASE
via	I-DISEASE
blood	0
or	I-DISEASE
salivary	I-DISEASE
melatonin	0
levels	I-DISEASE
.	0

Melatonin	I-DISEASE
levels	I-DISEASE
are	0
reduced	0
by	I-DISEASE
exposure	0
to	0
light	0
and	0
thus	I-DISEASE
need	I-DISEASE
to	I-DISEASE
be	0
assessed	I-DISEASE
in	I-DISEASE
dim	0
light	0
to	0
be	I-DISEASE
accurate	0
.	0

Dopaminergic	I-DISEASE
:	I-DISEASE

Related	I-DISEASE
to	0
the	0
neurotransmitter	0
dopamine	I-DISEASE
.	0

Dystonia	I-DISEASE
:	0
Involuntary	I-DISEASE
muscle	0
contractions	0
that	I-DISEASE
result	0
in	0
slow	0
repetitive	I-DISEASE
movements	0
or	0
abnormal	0
postures	0
.	0

Early	I-DISEASE
Morning	I-DISEASE
Awakening	0
:	I-DISEASE
The	I-DISEASE
termination	0
of	I-DISEASE
sleep	0
at	I-DISEASE
least	0
30	I-DISEASE
minutes	0
before	0
the	0
desired	I-DISEASE
rising	I-DISEASE
time	0
with	0
a	0
concomitant	0
reduced	0
total	0
sleep	0
time	0
compared	I-DISEASE
to	0
the	0
usual	I-DISEASE
premorbid	0
sleep	0
pattern	0
.	0

Electromyogram	I-DISEASE
(	I-DISEASE
EMG	0
):	0
Physiological	0
recording	0
of	I-DISEASE
muscle	I-DISEASE
activity	I-DISEASE
,	0
based	0
on	0
electrical	0
activity	0
that	0
accompanies	0
muscle	I-DISEASE
contraction	0
.	0

For	I-DISEASE
sleep	0
monitoring	0
purposes	I-DISEASE
,	0
EMG	I-DISEASE
is	I-DISEASE
typically	0
recorded	0
from	I-DISEASE
skin	I-DISEASE
surface	I-DISEASE
rather	I-DISEASE
than	0
intramuscular	I-DISEASE
electrodes	0
.	0

Entrained	I-DISEASE
/	I-DISEASE
Entrainment	0
:	0
The	I-DISEASE
successful	B-DISEASE
end	0
result	I-DISEASE
(	I-DISEASE
entrained	0
)	I-DISEASE
or	0
process	0
of	I-DISEASE
(	I-DISEASE
entrainment	0
)	0
synchronization	0
of	I-DISEASE
an	0
internal	I-DISEASE
circadian	0
clock	0
to	0
the	0
environment	0
(	I-DISEASE
e.g.	0
,	I-DISEASE
light	0
dark	0
cycle	0
)	0
,	0
producing	0
a	0
stable	I-DISEASE
phase	0
relationship	0
between	0
the	0
circadian	I-DISEASE
clock	0
and	0
environmental	I-DISEASE
time	I-DISEASE
.	0

Fatigue	I-DISEASE
:	I-DISEASE
A	0
lack	I-DISEASE
of	I-DISEASE
energy	I-DISEASE
,	0
accompanied	0
by	I-DISEASE
a	0
desire	I-DISEASE
to	I-DISEASE
reduce	I-DISEASE
or	I-DISEASE
limit	I-DISEASE
activity	I-DISEASE
levels	0
.	0

This	I-DISEASE
symptom	0
should	I-DISEASE
be	I-DISEASE
differentiated	I-DISEASE
from	I-DISEASE
reports	0
of	I-DISEASE
subjective	I-DISEASE
sleepiness	I-DISEASE
as	0
well	I-DISEASE
as	0
from	I-DISEASE
unintended	0
sleep	0
episodes	I-DISEASE
.	0

Homeostasis	I-DISEASE
:	I-DISEASE

The	I-DISEASE
tendency	I-DISEASE
of	I-DISEASE
a	I-DISEASE
living	0
organism	I-DISEASE
to	I-DISEASE
maintain	0
internal	I-DISEASE
equilibrium	0
by	I-DISEASE
adjusting	I-DISEASE
and	0
regulating	I-DISEASE
its	I-DISEASE
physiological	0
processes	0
.	I-DISEASE

Hypercapnia	I-DISEASE
:	0
Elevation	0
of	I-DISEASE
the	0
arterial	0
partial	I-DISEASE
pressure	I-DISEASE
of	I-DISEASE
carbon	0
dioxide	I-DISEASE
(	I-DISEASE
PaCO2	0
)	0
to	I-DISEASE
a	0
level	0
>	0
45	0
mm	0

Hg	I-DISEASE
during	I-DISEASE
wakefulness	0
.	0

Hypersomnolence	I-DISEASE
:	I-DISEASE
Excessive	I-DISEASE
sleepiness	0
during	I-DISEASE
the	0
normal	0
wake	0
period	I-DISEASE
.	0

Hypersomnia	I-DISEASE
:	I-DISEASE
A	0
disorder	I-DISEASE
characterized	0
by	I-DISEASE
excessive	0
sleepiness	0
(	I-DISEASE
e.g.	0
idiopathic	0
hypersomnia	I-DISEASE
)	0
.	0

Hypnagogic	I-DISEASE
Hallucinations	0
:	0

Vivid	I-DISEASE
dreamlike	I-DISEASE
experiences	I-DISEASE
occurring	I-DISEASE
at	I-DISEASE
the	0
transition	0
from	I-DISEASE
wake	I-DISEASE
to	I-DISEASE
sleep	I-DISEASE
.	0

Hypnopompic	I-DISEASE
Hallucinations	0
:	0

Vivid	I-DISEASE
dreamlike	I-DISEASE
experiences	I-DISEASE
occurring	I-DISEASE
at	I-DISEASE
the	0
transition	0
from	I-DISEASE
sleep	0
to	I-DISEASE
wake	0
.	0

Myalgia	I-DISEASE
:	0
Muscle	0
pain	0
.	0

Nonrestorative	I-DISEASE
Sleep	0
:	I-DISEASE
Sleep	I-DISEASE
that	I-DISEASE
is	0
perceived	0
to	I-DISEASE
be	I-DISEASE
poor	I-DISEASE
in	I-DISEASE
quality	0
and	0
unrefreshing	I-DISEASE
,	I-DISEASE
resulting	0
in	I-DISEASE
a	0
sense	I-DISEASE
of	I-DISEASE
feeling	0
unrested	I-DISEASE
upon	I-DISEASE
awakening	0
.	0

Glossary	I-DISEASE
Glossary	I-DISEASE
Odds	I-DISEASE
Ratio	0
:	0

A	I-DISEASE
statistical	I-DISEASE
term	0
that	I-DISEASE
provides	0
a	0
measure	0
of	I-DISEASE
the	0
strength	0
of	I-DISEASE
relationship	I-DISEASE
between	I-DISEASE
two	I-DISEASE
variables	I-DISEASE
;	I-DISEASE
the	0
odds	I-DISEASE
of	0
an	0
event	0
occurring	0
in	I-DISEASE
one	0
group	I-DISEASE
compared	I-DISEASE
to	0
the	I-DISEASE
odds	I-DISEASE
of	I-DISEASE
it	I-DISEASE
occurring	0
in	0
another	I-DISEASE
group	I-DISEASE
.	0

Oneirism	I-DISEASE
:	I-DISEASE
Acting	0
-	I-DISEASE
out	0
of	I-DISEASE
dreams	0
,	0
usually	I-DISEASE
from	I-DISEASE
REM	I-DISEASE
sleep	0
.	0

Out	I-DISEASE
of	I-DISEASE
Center	0
Sleep	I-DISEASE
Testing	0
:	I-DISEASE
A	0
sleep	0
study	0
performed	0
outside	I-DISEASE
of	I-DISEASE
the	I-DISEASE
sleep	I-DISEASE
center	0
,	I-DISEASE
usually	I-DISEASE
at	I-DISEASE
a	0
patient	I-DISEASE
’s	I-DISEASE
home	I-DISEASE
and	0
with	I-DISEASE
limited	I-DISEASE
(	0
typically	0
respiratory	I-DISEASE
related	0
)	0
channels	B-DISEASE
(	I-DISEASE
parameters	I-DISEASE
)	0
recorded	0
.	0

Parasomnia	I-DISEASE
Pseudo	0
-	I-DISEASE
Suicide	0
:	0
A	0
death	0
,	I-DISEASE
erroneously	I-DISEASE
attributed	0
by	I-DISEASE
authorities	0
to	0
suicide	I-DISEASE
,	0
which	0
results	I-DISEASE
from	I-DISEASE
complex	B-DISEASE
parasomnia	0
,	I-DISEASE
usually	I-DISEASE
from	0
NREM	0
sleep	0
.	0

Parkinson	I-DISEASE
Disease	I-DISEASE
:	0
A	0
neurodegenerative	0
movement	0
disorder	0
which	0
may	I-DISEASE
result	0
in	0
bradykinesia	0
,	I-DISEASE
rigidity	0
,	I-DISEASE
tremor	0
,	I-DISEASE
and/or	0
postural	0
instability	I-DISEASE
,	I-DISEASE
and	0
eventually	0
cognitive	0
decline	0
.	0

Phase	I-DISEASE
Advance	I-DISEASE
/	0
Delay	I-DISEASE
:	I-DISEASE
A	0
shift	0
in	0
the	0
timing	I-DISEASE
of	I-DISEASE
the	I-DISEASE
internal	I-DISEASE
circadian	0
clock	I-DISEASE
in	I-DISEASE
which	0
circadian	0
phase	0
is	I-DISEASE
moved	0
earlier	0
(	I-DISEASE
advance	0
,	I-DISEASE
such	0
as	0
required	0
for	I-DISEASE
eastward	0
jet	I-DISEASE
travel	I-DISEASE
or	0
to	I-DISEASE
assume	0
an	0
earlier	0
sleep	0
schedule	I-DISEASE
)	0
or	0
later	0
(	I-DISEASE
delay	I-DISEASE
,	I-DISEASE
such	0
as	0
required	0
for	0
westward	0
jet	I-DISEASE
travel	0
or	0
to	I-DISEASE
assume	I-DISEASE
a	0
later	0
sleep	0
schedule	I-DISEASE
)	0
.	I-DISEASE

Phase	I-DISEASE
Response	I-DISEASE
Curve	0
:	I-DISEASE
Graphic	0
representation	B-DISEASE
that	0
describes	0
the	0
circadian	I-DISEASE
phase	0
shifting	0
response	0
to	I-DISEASE
a	I-DISEASE
time	0
cue	0
(	I-DISEASE
e.g.	0
,	I-DISEASE
light	0
)	0
as	0
a	I-DISEASE
function	0
of	I-DISEASE
the	0
internal	I-DISEASE
circadian	I-DISEASE
time	0
at	I-DISEASE
which	0
the	0
cue	0
is	0
presented	0
.	0

Phase	I-DISEASE
Tolerance	I-DISEASE
:	0

The	I-DISEASE
ability	0
to	0
be	I-DISEASE
awake	0
or	I-DISEASE
asleep	I-DISEASE
at	I-DISEASE
an	0
inappropriate	0
internal	I-DISEASE
circadian	I-DISEASE
time	I-DISEASE
.	0

Physiological	I-DISEASE
Hyperarousal	0
:	0
A	0
state	B-DISEASE
of	I-DISEASE
chronic	I-DISEASE
physiologic	0
arousal	0
as	0
reflected	I-DISEASE
by	I-DISEASE
measures	0
such	0
as	0
increased	0
mean	0
latency	I-DISEASE
on	0
MSLT	I-DISEASE
,	0
increased	0
metabolic	0
rate	0
and	0
glucose	0
metabolism	0
in	0
the	0
CNS	0
(	0
PET	0
scan	I-DISEASE
)	0
,	I-DISEASE
decreased	I-DISEASE
heart	0
rate	0
variability	0
and	0
increased	0
heart	0
rate	0
.	0

PHOX2B	I-DISEASE
:	I-DISEASE

A	I-DISEASE
paired	I-DISEASE
-	0
like	I-DISEASE
homobox	0
gene	I-DISEASE
,	0
mutation	0
of	I-DISEASE
which	I-DISEASE
is	I-DISEASE
the	0
defining	I-DISEASE
abnormality	I-DISEASE
of	I-DISEASE
Congenital	0
Central	I-DISEASE
Hypoventilation	I-DISEASE
Syndrome	I-DISEASE
.	0

Prevalence	I-DISEASE
:	I-DISEASE

The	I-DISEASE
proportion	I-DISEASE
of	I-DISEASE
the	0
population	0
affected	I-DISEASE
by	I-DISEASE
a	I-DISEASE
disease	B-DISEASE
or	0
condition	0
at	I-DISEASE
a	I-DISEASE
given	0
time	0
;	0
prevalence	I-DISEASE
indicates	I-DISEASE
how	0
widespread	0
a	0
disease	0
or	0
condition	0
is	0
,	I-DISEASE
thereby	0
serving	I-DISEASE
as	0
a	I-DISEASE
measure	0
of	I-DISEASE
its	I-DISEASE
burden	I-DISEASE
on	0
society	0
.	0

REM	I-DISEASE
Sleep	0
without	0
Atonia	0
,	I-DISEASE
REM	I-DISEASE
-	0
without	0
Atonia	0
:	I-DISEASE
The	I-DISEASE
intermittent	0
or	I-DISEASE
continuous	I-DISEASE
loss	0
of	0
the	0
normal	0
muscle	I-DISEASE
atonia	I-DISEASE
of	I-DISEASE
REM	0
sleep	0
.	0

Reverse	I-DISEASE
First	0
Night	I-DISEASE
Effect	0
:	I-DISEASE
A	0
propensity	I-DISEASE
to	0
sleep	0
better	I-DISEASE
than	I-DISEASE
usual	I-DISEASE
on	0
the	0
first	I-DISEASE
night	0
in	0
the	0
sleep	0
laboratory	I-DISEASE
.	0

Sleep	I-DISEASE
Attacks	I-DISEASE
:	I-DISEASE
Inappropriate	0
falling	0
asleep	I-DISEASE
with	I-DISEASE
few	0
or	0
no	0
prodromal	0
symptoms	I-DISEASE
of	I-DISEASE
sleepiness	0
.	0

Sleep	I-DISEASE
Diary	I-DISEASE
(	I-DISEASE
sleep	0
log	0
):	0
An	0
instrument	0
used	0
by	I-DISEASE
individuals	I-DISEASE
to	I-DISEASE
keep	I-DISEASE
records	I-DISEASE
of	I-DISEASE
their	0
nightly	I-DISEASE
sleep	0
duration	0
and	0
quality	0
over	0
a	0
period	I-DISEASE
of	0
days	0
to	0
weeks	I-DISEASE
.	0

Sleep	I-DISEASE
Drunkenness	0
(	I-DISEASE
prolonged	0
sleep	0
inertia	0
):	0
Prolonged	I-DISEASE
difficulty	0
waking	0
up	0
after	0
a	0
night	0
’s	I-DISEASE
sleep	0
or	I-DISEASE
a	0
nap	I-DISEASE
with	0
repeated	I-DISEASE
returns	0
to	I-DISEASE
sleep	0
,	0
irritability	I-DISEASE
,	0
automatic	0
behavior	0
and	0
confusion	0
.	0

Sleep	I-DISEASE
Homeostasis	0
:	0
A	I-DISEASE
process	0
which	I-DISEASE
describes	0
the	0
propensity	I-DISEASE
for	I-DISEASE
sleep	0
driven	I-DISEASE
by	I-DISEASE
duration	0
of	0
prior	0
time	I-DISEASE
awake	0
and	0
sleep	0
history	I-DISEASE
.	0

Sleep	I-DISEASE
Hygiene	I-DISEASE
:	I-DISEASE
A	0
set	I-DISEASE
of	I-DISEASE
rules	I-DISEASE
/	0
instructions	0
about	0
lifestyle	I-DISEASE
(	I-DISEASE
caffeine	0
intake	0
,	I-DISEASE
alcohol	0
and	0
tobacco	0
use	I-DISEASE
,	I-DISEASE
diet	0
,	I-DISEASE
etc	0
.	0
)	0

and	0
environmental	I-DISEASE
factors	0
(	I-DISEASE
light	0
,	I-DISEASE
noise	0
,	I-DISEASE
temperature	B-DISEASE
)	0
that	0
affect	0
overall	I-DISEASE
sleep	0
duration	0
and	0
quality	0
.	I-DISEASE

Sleep	I-DISEASE
Onset	I-DISEASE
REM	I-DISEASE
Period	I-DISEASE
(	I-DISEASE
SOREMP	I-DISEASE
):	0
REM	I-DISEASE
sleep	0
occurring	I-DISEASE
within	I-DISEASE
15	0
minutes	0
of	I-DISEASE
sleep	0
onset	I-DISEASE
on	0
a	0
multiple	I-DISEASE
sleep	0
latency	I-DISEASE
test	I-DISEASE
or	I-DISEASE
overnight	I-DISEASE
polysomnogram	0
.	0

Sleep	I-DISEASE
Related	I-DISEASE
Abnormal	0
Sexual	I-DISEASE
Behaviors	0
:	I-DISEASE
Any	I-DISEASE
of	I-DISEASE
a	0
spectrum	I-DISEASE
of	I-DISEASE
sexualized	0
behaviors	I-DISEASE
which	0
arise	I-DISEASE
from	0
sleep	0
,	I-DISEASE
typically	0
NREM	0
sleep	0
.	B-DISEASE

Sleep	I-DISEASE
Related	0
Violence	I-DISEASE
:	0
Violent	I-DISEASE
behavior	0
which	0
is	0
associated	0
with	I-DISEASE
a	0
NREM	0
parasomnia	I-DISEASE
when	0
the	0
affected	0
individual	I-DISEASE
is	I-DISEASE
accidentally	0
provoked	0
by	0
another	I-DISEASE
person	0
in	I-DISEASE
close	0
proximity	0
–	I-DISEASE
usually	I-DISEASE
a	0
family	0
member	I-DISEASE
.	0

Suggested	I-DISEASE
Immobilization	0
Test	I-DISEASE
:	0
A	0
procedure	I-DISEASE
for	I-DISEASE
evaluation	I-DISEASE
of	I-DISEASE
periodic	I-DISEASE
leg	I-DISEASE
movements	I-DISEASE
and	0
related	0
sensory	0
components	I-DISEASE
of	I-DISEASE
RLS	I-DISEASE
during	I-DISEASE
resting	I-DISEASE
wakefulness	0
.	0

A	I-DISEASE
standard	0
polysomnogram	0
recording	0
without	0
respiratory	I-DISEASE
measures	0
is	I-DISEASE
used	0
for	0
one	0
hour	I-DISEASE
while	I-DISEASE
the	0
subject	0
sits	0
quietly	0
awake	0
and	0
upright	I-DISEASE
in	I-DISEASE
bed	0
with	I-DISEASE
the	0
legs	I-DISEASE
outstretched	I-DISEASE
.	0

Glossary	I-DISEASE
Index	I-DISEASE
A	0
Actigraphy	I-DISEASE
35	0
,	0
144	0
,	I-DISEASE
152	0
,	I-DISEASE
159	I-DISEASE
,	I-DISEASE
161–163	I-DISEASE
,	0
165	0
,	0
182	I-DISEASE
,	I-DISEASE
185	I-DISEASE
,	I-DISEASE
187	0
,	I-DISEASE
189	I-DISEASE
,	I-DISEASE
191	0
,	I-DISEASE
196	0
,	0
199	0
,	0
204	I-DISEASE
,	0
207	I-DISEASE
,	0
209	0
,	I-DISEASE
213	I-DISEASE
,	0
215	I-DISEASE
,	I-DISEASE
218	I-DISEASE
,	I-DISEASE
223	I-DISEASE
,	I-DISEASE
224	I-DISEASE
,	0
297	0
,	0
298	0
,	I-DISEASE
361	0
Adenotonsillar	0
hypertrophy	I-DISEASE
65	0
,	I-DISEASE
66	I-DISEASE
,	I-DISEASE
139	0
,	I-DISEASE
274	I-DISEASE
Advanced	0
sleep	0
-	0
wake	0
phase	0
disorder	0
198–203	0
Agrypnia	0
excitata	0
248	0
Akathisia	0
290	I-DISEASE
,	0
316	I-DISEASE
,	I-DISEASE
326	0
,	0
333	0
Alcohol	0
27	I-DISEASE
,	0
31	I-DISEASE
,	0
43	0
,	0
54	I-DISEASE
,	0
57	0
,	0
110	0
,	0
122	0
,	0
125	I-DISEASE
,	0
,	0
139	0
,	I-DISEASE
167	0
,	0
168	I-DISEASE
,	0
175	0
,	0
176	0
,	I-DISEASE
192	I-DISEASE
,	I-DISEASE
194	0
,	I-DISEASE
200	I-DISEASE
,	I-DISEASE
212	I-DISEASE
,	I-DISEASE
217	0
,	I-DISEASE
219	I-DISEASE
,	0
220	0
,	I-DISEASE
221	0
,	0
234	0
,	I-DISEASE
237	I-DISEASE
,	I-DISEASE
238	I-DISEASE
,	0
241	0
,	0
242	0
,	0
247	I-DISEASE
,	I-DISEASE
268	0
,	0
276–278	0
,	I-DISEASE
286	I-DISEASE
,	0
295	I-DISEASE
,	I-DISEASE
326	0
,	0
352	0
,	0
354	0
,	0
359	I-DISEASE
,	I-DISEASE
369	I-DISEASE
Alpha-1	I-DISEASE
antitrypsin	I-DISEASE
129	I-DISEASE
,	0
130	0
,	I-DISEASE
136	0
Alternating	0
leg	I-DISEASE
muscle	0
activation	0
330–334	I-DISEASE
Alzheimer	0
disease	0
204	I-DISEASE
,	0
205	I-DISEASE
,	I-DISEASE
224	I-DISEASE
,	0
277	0
,	I-DISEASE
279	I-DISEASE
,	0
Amyotrophic	0
lateral	0
sclerosis	0
300	I-DISEASE
Angina	0
61	0
,	I-DISEASE
358	0
,	I-DISEASE
362–366	0
Antidepressant	0
148	0
,	0
153	I-DISEASE
,	0
176	0
,	0
249	0
,	0
250	0
,	0
,	0
259	I-DISEASE
,	0
277	0
,	0
285	0
,	I-DISEASE
294	0
,	I-DISEASE
295	0
,	0
331	I-DISEASE
,	0
333	I-DISEASE
Anxiety	0
disorder	0
26	I-DISEASE
,	0
28	0
,	I-DISEASE
31	I-DISEASE
,	I-DISEASE
38	0
,	0
148	0
,	0
192	0
,	I-DISEASE
,	I-DISEASE
257	0
,	0
269	0
,	0
284	0
Anxiolytic	0
110	0
,	I-DISEASE
122	0
,	I-DISEASE
130	0
,	0
255	I-DISEASE
,	I-DISEASE
369	I-DISEASE
Apneic	I-DISEASE
threshold	I-DISEASE
72	0
,	I-DISEASE
73	I-DISEASE
,	0
82	I-DISEASE
,	0
91	I-DISEASE
,	I-DISEASE
92	I-DISEASE
Apparent	0
life	I-DISEASE
-	0
threatening	0
event	0
(	0
ALTE	I-DISEASE
)	0
94	I-DISEASE
,	I-DISEASE
,	I-DISEASE
97	I-DISEASE
,	0
114	I-DISEASE
,	0
117	I-DISEASE
Arrhythmia	0
58	I-DISEASE
,	I-DISEASE
65	0
,	I-DISEASE
101	0
,	I-DISEASE
110	0
,	0
122	0
,	0
126	I-DISEASE
,	I-DISEASE
,	I-DISEASE
136	0
,	0
363	I-DISEASE
,	I-DISEASE
365	I-DISEASE
,	I-DISEASE
366	I-DISEASE
Asperger	0
syndrome	0
206	0
,	0
297	0
Asthma	0
61	0
,	0
357–359	0
Ataxic	I-DISEASE
breathing	I-DISEASE
74	I-DISEASE
,	I-DISEASE
76	0
,	0
85	0
,	I-DISEASE
87	0
,	I-DISEASE
88	B-DISEASE
,	I-DISEASE
105	0
,	0
,	0
125	I-DISEASE
,	I-DISEASE
127	I-DISEASE
,	0
128	I-DISEASE
Atrial	0
fibrillation	I-DISEASE
53	0
,	I-DISEASE
55	0
,	I-DISEASE
58	I-DISEASE
,	I-DISEASE
69	I-DISEASE
,	0
71	I-DISEASE
,	0
139	0
Attention	0
deficit	I-DISEASE
hyperactivity	0
disorder	0
66	I-DISEASE
,	0
192	0
,	0
193	0
,	I-DISEASE
195	0
,	0
271	0
,	I-DISEASE
284	0
,	I-DISEASE
288	0
,	I-DISEASE
291	I-DISEASE
,	I-DISEASE
308	0
,	0
310	0
,	0
314	0
Augmentation	I-DISEASE
59	0
,	I-DISEASE
283	0
Autism	0
(	0
see	I-DISEASE
also	0
pervasive	0
developmental	I-DISEASE
disorder	0
)	0
119	I-DISEASE
,	0
195	0
,	I-DISEASE
200	0
,	0
206	0
,	0
211	0
,	I-DISEASE
251	0
,	I-DISEASE
314	I-DISEASE
,	0
316	I-DISEASE
B	0
Barrett	0
esophagus	I-DISEASE
359–361	0
Behavioral	O
insomnia	O
of	O
childhood	O
(	O
see	O
also	O
limit	O
-	O
setting	O
sleep	O
disorder	O
and	O
sleep-	O
onset	O
association	O
disorder	O
)	O
21	O
,	O
27	O
,	O
29	O
,	O
340	O
Benign	O
epilepsy	O
of	O
childhood	O
with	O
centrotemporal	O
spikes	O
(	O
BECT	O
)	O
345–347	O
Benign	O
epilepsy	O
with	O
occipital	O
paroxysms	O
(	O
BEOP	O
)	O
345–347	O
Benign	O
sleep	O
myoclonus	O
of	O
infancy	O
317–320	O
Biot	O
breathing	O
87	O
Blindness	O
202	O
,	O
209–213	O
Body	O
rocking	O
312–314	O
,	O
316	O
Breathing	O
disorders	O
(	O
see	O
sleep	O
related	O
breathing	O
disorders	O
)	O
Bruxism	O
(	O
see	O
sleep	O
related	O
bruxism	O
)	O
C	O
Cataplexy	O
141	O
,	O
145–162	O
,	O
171	O
,	O
242	O
,	O
250	O
,	O
256	O
Catathrenia	O
141	O
Central	O
disorders	O
of	O
hypersomnolence	O
–	O
188	O
Central	O
sleep	O
apnea	O
due	O
to	O
a	O
medical	O
disorder	O
without	O
Cheyne	O
-	O
Stokes	O
breathing	O
75–79	O
Index	O
Central	O
sleep	O
apnea	O
due	O
to	O
a	O
medication	O
or	O
substance	O
85–89	O
Central	O
sleep	O
apnea	O
syndromes	O

69–107	I-DISEASE
Central	I-DISEASE
sleep	0
apnea	0
with	0
Cheyne	0
-	I-DISEASE
Stokes	0
breathing	0
69–75	I-DISEASE
Cerebrovascular	0
accident	0
(	0
see	I-DISEASE
also	0
stroke	I-DISEASE
)	0
,	I-DISEASE
78	0
,	I-DISEASE
93	0
Charley	0
horse	I-DISEASE
299	0
Chemoresponsiveness	0
80	0
,	0
81	I-DISEASE
,	I-DISEASE
91	0
,	0
92	0
,	0
121	0
,	0
,	0
129	0
Chemosensitivity	I-DISEASE
111	I-DISEASE
,	I-DISEASE
123	0
,	I-DISEASE
126	0
,	0
130	I-DISEASE
,	I-DISEASE
131	I-DISEASE
,	I-DISEASE
Chiari	0
malformation	0
76–78	0
,	I-DISEASE
93	0
,	I-DISEASE
116	0
Children	0
’s	I-DISEASE
Chronotype	I-DISEASE
Questionnaire	0
196	I-DISEASE
Choking	0
(	0
see	I-DISEASE
also	0
sleep	I-DISEASE
related	B-DISEASE
laryngospasm	0
)	0
53	0
,	0
54	I-DISEASE
,	I-DISEASE
96	0
,	I-DISEASE
357	0
,	0
358	0
Chronic	I-DISEASE
bronchitis	0
129	0
Chronic	0
fatigue	I-DISEASE
syndrome	I-DISEASE
39	0
,	0
154	I-DISEASE
,	0
160	I-DISEASE
,	0
,	I-DISEASE
181	I-DISEASE
,	I-DISEASE
206	0
Chronic	I-DISEASE
insomnia	I-DISEASE
disorder	0
21–41	0
Chronic	I-DISEASE
obstructive	0
pulmonary	I-DISEASE
disease	I-DISEASE
(	I-DISEASE
see	I-DISEASE
also	0
lower	0
airway	0
)	0
55	0
,	I-DISEASE
56	0
,	0
129	0
,	0
131	I-DISEASE
,	I-DISEASE
,	0
138	I-DISEASE
,	0
284	0
,	I-DISEASE
358	0
Chronic	0
pain	0
22	0
,	0
31	0
,	0
86	I-DISEASE
,	I-DISEASE
87	I-DISEASE
Chronic	I-DISEASE
renal	0
failure	I-DISEASE
285	0
,	0
286	I-DISEASE
,	0
287	0
Chronotype	I-DISEASE
184	I-DISEASE
,	0
189–193	I-DISEASE
,	0
195–197	0
,	0
199	0
,	0
,	0
219	I-DISEASE
Circadian	0
period	0
195	0
,	I-DISEASE
197	I-DISEASE
,	I-DISEASE
201	0
,	0
209	0
,	I-DISEASE
212	0
,	I-DISEASE
,	0
222	0
Circadian	I-DISEASE
phase	0
191–196	0
,	I-DISEASE
199	I-DISEASE
,	0
200	0
Circadian	0
rhythm	0
sleep	0
-	I-DISEASE
wake	0
disorders	0
–	I-DISEASE
224	0
Circadian	0
sleep	0
-	0
wake	0
disorder	I-DISEASE
not	I-DISEASE
otherwise	0
specified	0
224	I-DISEASE
Cluster	0
headache	I-DISEASE
266	0
,	I-DISEASE
350–354	0
Comorbid	0
insomnia	I-DISEASE
21	0
Complex	0
nocturnal	0
visual	I-DISEASE
hallucinations	I-DISEASE
–	0
269	0
Complex	0
sleep	0
apnea	0
(	0
see	I-DISEASE
also	0
treatment-	I-DISEASE
emergent	0
central	0
sleep	0
apnea	0
)	0

102	I-DISEASE
Conditioned	0
arousal	0
20	0
,	I-DISEASE
23	I-DISEASE
,	0
26	0
,	0
28	0
Confusional	0
arousal	0

228–239	I-DISEASE
Congenital	0
central	0
alveolar	I-DISEASE
hypoventilation	I-DISEASE
syndrome	I-DISEASE
113–117	I-DISEASE
Congestive	0
heart	0
failure	I-DISEASE
50	0
,	I-DISEASE
53	0
,	I-DISEASE
55	0
,	I-DISEASE
58	I-DISEASE
,	I-DISEASE
61	0
,	0
,	I-DISEASE
71	I-DISEASE
,	0
72	0
,	I-DISEASE
93	0
,	0
271	0
,	0
287	0
,	I-DISEASE
297	I-DISEASE
Continuous	0
spike	0
and	0
wave	I-DISEASE
in	0
sleep	0
(	I-DISEASE
CSWS	0
)	0
,	0
346	0
,	I-DISEASE
347	0
,	0
348	0
Coronary	0
artery	0
disease	I-DISEASE
(	I-DISEASE
see	I-DISEASE
also	0
angina	0
)	0
,	I-DISEASE
55	0
,	I-DISEASE
58	0
,	I-DISEASE
61	0
,	I-DISEASE
139	0
,	I-DISEASE
364	0
,	0
365	I-DISEASE
Cor	0
pulmonale	0
55	0
,	0
66	I-DISEASE
,	I-DISEASE
77	0
,	0
91	0
,	I-DISEASE
109	0
,	I-DISEASE
110	0
,	0
,	I-DISEASE
115	0
,	I-DISEASE
117	0
,	0
119	I-DISEASE
,	0
122	0
,	0
125	0
,	I-DISEASE
129	0
,	0
135	0
Cyclic	0
alternating	0
pattern	0
296	I-DISEASE
,	0
308	0
Cystic	I-DISEASE
fibrosis	I-DISEASE
129	I-DISEASE
,	I-DISEASE
130	I-DISEASE
,	I-DISEASE
136	0
,	I-DISEASE
358	0
D	0
Delayed	0
sleep	0
-	0
wake	0
phase	0
disorder	I-DISEASE
191–198	0
Dementia	0
with	0
Lewy	0
bodies	I-DISEASE
249	0
,	0
250	0
Diabetes	I-DISEASE
53	0
,	0
55	0
,	I-DISEASE
58	0
,	0
62	0
,	0
118	I-DISEASE
,	0
119	0
,	0
187	0
,	I-DISEASE
241	0
,	I-DISEASE
,	0
273	0
,	I-DISEASE
274	I-DISEASE
,	0
284	0
,	I-DISEASE
287	0
,	I-DISEASE
300	I-DISEASE
,	I-DISEASE
364	I-DISEASE
,	0
365	I-DISEASE
Diagnostic	0
and	0
statistical	I-DISEASE
manual	0
26	0
,	0
28	0
,	0
,	0
261	I-DISEASE
,	0
316	0
Dim	I-DISEASE
-	I-DISEASE
light	0
melatonin	0
onset	I-DISEASE
196	0
,	0
199	I-DISEASE
,	0
209	0
Disorders	I-DISEASE
of	I-DISEASE
arousal	0
(	I-DISEASE
from	I-DISEASE
NREM	0
sleep	0
)	0
–	0
239	0
Dopamine	I-DISEASE
172	0
,	I-DISEASE
176	0
,	0
259	0
,	0
284	0
,	0
285	I-DISEASE
,	I-DISEASE
288	0
,	0
,	I-DISEASE
294–298	0
Down	I-DISEASE
syndrome	0
57	0
,	I-DISEASE
65	0
,	0
305	I-DISEASE
Dystonia	0
297	0
,	0
301	I-DISEASE
,	I-DISEASE
302	I-DISEASE
,	0
309	0
,	0
345	0
E	0
Early	0
morning	0
awakening	0
24	0
,	0
33	I-DISEASE
,	I-DISEASE
37	0
,	I-DISEASE
45	0
,	0
195	0
,	I-DISEASE
202	0
,	I-DISEASE
221	0
,	0
358	0
,	0
359	0
Electromyogram	0
(	I-DISEASE
EMG	0
)	0
60	0
,	I-DISEASE
226	0
,	I-DISEASE
237	I-DISEASE
,	I-DISEASE
247	0
,	I-DISEASE
251	0
,	0
296	0
,	0
298	0
,	I-DISEASE
301	I-DISEASE
,	I-DISEASE
309	I-DISEASE
,	I-DISEASE
310	0
,	I-DISEASE
318	0
,	I-DISEASE
320	0
,	0
323	0
,	0
324	0
,	I-DISEASE
328	0
,	0
329	0
,	I-DISEASE
331–333	I-DISEASE
,	0
336	I-DISEASE
,	I-DISEASE
361	I-DISEASE
Emphysema	0
(	0
see	0
also	0
chronic	0
obstructive	0
pulmonary	0
disease	0
)	0
129	0
,	I-DISEASE
130	0
,	I-DISEASE
136	I-DISEASE
Entrainment	0
189	I-DISEASE
,	0
197	0
,	I-DISEASE
206	0
,	I-DISEASE
210–213	0
Environmental	I-DISEASE
sleep	0
disorder	I-DISEASE
339	I-DISEASE
Epilepsy	0
(	0
see	I-DISEASE
also	0
sleep	0
related	0
epilepsy	0
and	0
seizure	I-DISEASE
)	0
68	I-DISEASE
,	0
236	0
,	0
237	0
,	0
252	I-DISEASE
,	0
271	I-DISEASE
,	0
274	0
,	0
298	0
,	0
307	0
,	0
309	I-DISEASE
,	0
310	0
,	I-DISEASE
312	0
,	0
316	I-DISEASE
,	I-DISEASE
317	I-DISEASE
,	I-DISEASE
341	0
,	0
345–349	0
Epworth	I-DISEASE
Sleepiness	0
Scale	I-DISEASE
55	0
,	I-DISEASE
86	0
,	0
144	0
,	I-DISEASE
163	I-DISEASE
,	0
173	0
,	0
181	0
,	I-DISEASE
196	0
,	0
284	0
,	0
293	0
Esophageal	0
manometry	0
60	I-DISEASE
,	0
294	I-DISEASE
,	0
360	0
Esophageal	0
pH	O
361	O
Excessive	O
fragmentary	O
myoclonus	O
328–330	O
Excessive	O
time	O
in	O
bed	O
47	O

Exploding	I-DISEASE
head	0
syndrome	I-DISEASE
264–266	0
F	I-DISEASE
Fatal	0
familial	I-DISEASE
insomnia	I-DISEASE
342–344	0
Ferritin	0
285	0
,	0
295	I-DISEASE
Fibromyalgia	0
39	I-DISEASE
,	0
284	0
Free	0
-	0
running	0
(	0
see	0
non-24	0
-	I-DISEASE
hour	0
sleep	0
-	0
wake	0
rhythm	0
disorder	0
)	0

G	I-DISEASE
Gastroesophageal	0
reflux	I-DISEASE
(	I-DISEASE
see	I-DISEASE
also	I-DISEASE
sleep	0
related	0
gastroesophageal	I-DISEASE
reflux	0
)	0
22	I-DISEASE
,	0
23	I-DISEASE
,	I-DISEASE
31	I-DISEASE
,	I-DISEASE
33	I-DISEASE
,	0
38	0
,	I-DISEASE
55	0
,	0
61	0
,	I-DISEASE
99	I-DISEASE
,	0
101	0
,	0
117	0
,	I-DISEASE
309	I-DISEASE
,	I-DISEASE
341	I-DISEASE
,	0
355–358	0
,	I-DISEASE
362	I-DISEASE
,	I-DISEASE
363	0
,	I-DISEASE
366	I-DISEASE
H	I-DISEASE
Hcrt	I-DISEASE
149	I-DISEASE
,	I-DISEASE
156–160	I-DISEASE
,	0
171	I-DISEASE
Headaches	0
(	I-DISEASE
see	I-DISEASE
sleep	I-DISEASE
related	0
headaches	I-DISEASE
)	0
Head	I-DISEASE
banging	0
312–315	I-DISEASE
Head	0
trauma	0
149	I-DISEASE
,	0
156	0
,	0
157	0
,	I-DISEASE
168	I-DISEASE
,	0
170	0
,	I-DISEASE
172	0
,	0
High	0
-	0
altitude	0
periodic	0
breathing	0
79–84	I-DISEASE
hPer2	0
(	I-DISEASE
clock	0
gene	0
)	0
201	0
hPer3	I-DISEASE
(	0
clock	0
gene	I-DISEASE
)	0
193	0
,	I-DISEASE
194	0
Human	0
leukocyte	0
antigen	0
149	I-DISEASE
,	I-DISEASE
150	I-DISEASE
,	I-DISEASE
152	0
,	I-DISEASE
153	0
,	I-DISEASE
157–160	0
,	0
164	0
,	0
168	I-DISEASE
,	I-DISEASE
169	I-DISEASE
,	I-DISEASE
194	0
Huntington	I-DISEASE
disease	0
205	I-DISEASE
,	0
224	I-DISEASE
Hypernychthemeral	I-DISEASE
209	0
Hypersomnia	0
associated	0
with	0
psychiatric	0
disorders	0
179–182	0
Hypersomnia	I-DISEASE
due	I-DISEASE
to	0
a	0
medical	0
disorder	I-DISEASE
–	I-DISEASE
175	0
Hypersomnia	I-DISEASE
due	0
to	I-DISEASE
a	I-DISEASE
medication	0
or	I-DISEASE
substance	I-DISEASE
175–178	I-DISEASE
Hypertension	I-DISEASE
32	0
,	0
53	0
,	0
55	0
,	I-DISEASE
56	0
,	0
58	0
,	I-DISEASE
60	0
,	I-DISEASE
61	0
,	0
66	I-DISEASE
,	I-DISEASE
,	0
91	0
,	0
110	0
,	I-DISEASE
112	0
,	I-DISEASE
116	I-DISEASE
,	I-DISEASE
120	0
,	0
122–126	0
,	0
128–132	0
,	0
134–137	0
,	I-DISEASE
139	0
,	0
140	I-DISEASE
,	0
291	0
,	0
352	0
,	0
354	0
,	I-DISEASE
359	0
,	I-DISEASE
364	0
Hyperthyroidism	I-DISEASE
234	0
Hypnagogic	I-DISEASE
foot	0
tremor	0
330–334	I-DISEASE
Hypnagogic	I-DISEASE
hallucination	I-DISEASE
148	0
,	I-DISEASE
150	I-DISEASE
,	I-DISEASE
151	0
,	I-DISEASE
,	I-DISEASE
158	0
,	0
163	I-DISEASE
,	I-DISEASE
171	I-DISEASE
,	I-DISEASE
183	0
,	0
261	0
,	I-DISEASE
267–269	0
,	0
Hypnic	I-DISEASE
headache	0
266	0
,	I-DISEASE
350	0
,	I-DISEASE
351	0
,	0
353	0
,	0
354	0
Hypnic	I-DISEASE
jerks	0
(	I-DISEASE
see	0
also	I-DISEASE
sleep	0
starts	I-DISEASE
)	0
335–337	0
Hypnopompic	I-DISEASE
hallucination	0
148	I-DISEASE
,	I-DISEASE
252	0
,	I-DISEASE
267	0
,	0
,	I-DISEASE
276	I-DISEASE
Hypnotic	I-DISEASE
22	0
,	0
33	I-DISEASE
,	0
110	0
,	0
122	I-DISEASE
,	I-DISEASE
130	0
,	0
176	0
,	I-DISEASE
178	0
,	I-DISEASE
,	0
194	0
,	I-DISEASE
212	0
,	I-DISEASE
234	0
,	I-DISEASE
242	0
,	0
243	0
,	I-DISEASE
247	I-DISEASE
,	I-DISEASE
277	B-DISEASE
,	0
,	0
356	0
,	I-DISEASE
369	I-DISEASE
Hypocretin	I-DISEASE
145	0
,	0
146	0
,	I-DISEASE
149–156	0
,	I-DISEASE
158–160	I-DISEASE
,	0
,	0
169	I-DISEASE
,	I-DISEASE
172	0
,	I-DISEASE
250	I-DISEASE
Hypothyroidism	I-DISEASE
57	0
,	0
112	0
,	I-DISEASE
118	I-DISEASE
,	0
123	0
,	I-DISEASE
127	0
,	0
173	I-DISEASE
Hypoventilation	I-DISEASE
(	I-DISEASE
see	I-DISEASE
sleep	0
related	0
hypoventilation	0
disorders	0
)	0

I	I-DISEASE
Idiopathic	0
central	0
alveolar	I-DISEASE
hypoventilation	0

121–124	I-DISEASE
Idiopathic	0
hypersomnia	I-DISEASE
161–166	I-DISEASE
Idiopathic	0
insomnia	I-DISEASE
20	0
,	0
27	I-DISEASE
Inadequate	B-DISEASE
sleep	0
hygiene	I-DISEASE
20	0
,	I-DISEASE
27	I-DISEASE
,	0
197	I-DISEASE
Insomnia	I-DISEASE
19–48	0
Index	I-DISEASE
Index	I-DISEASE
Insomnia	I-DISEASE
due	I-DISEASE
to	0
(	0
a	0
)	0
medical	0
condition	0
28	0
Insomnia	I-DISEASE
due	0
to	0
(	I-DISEASE
another	I-DISEASE
)	I-DISEASE
mental	0
disorder	I-DISEASE
Insomnia	0
due	I-DISEASE
to	0
drug	I-DISEASE
or	0
substance	I-DISEASE
28	0
Insomnia	I-DISEASE
with	I-DISEASE
objectively	I-DISEASE
short	0
sleep	0
duration	0
29	I-DISEASE

Insufficient	I-DISEASE
sleep	0
syndrome	I-DISEASE
182–186	0
Iron	0
deficiency	0
285	0
,	I-DISEASE
288	I-DISEASE
Irregular	0
sleep	0
-	0
wake	0
rhythm	I-DISEASE
disorder	I-DISEASE
–	0
208	0
J	0
Jet	0
lag	0
disorder	I-DISEASE
220–224	I-DISEASE
Juvenile	0
myoclonic	0
epilepsy	0
(	0
JME	0
)	I-DISEASE
345	I-DISEASE
,	I-DISEASE
K	0
Kleine	I-DISEASE
-	0
Levin	0
syndrome	0
166–170	I-DISEASE
L	0
Laryngospasm	I-DISEASE
(	I-DISEASE
see	I-DISEASE
sleep	0
related	0
laryngospasm	0
)	0

Late	I-DISEASE
-	I-DISEASE
onset	0
central	0
hypoventilation	0
with	0
hypothalamic	0
dysfunction	0
118–120	0
Leg	0
cramps	B-DISEASE
(	0
see	I-DISEASE
sleep	0
related	B-DISEASE
leg	I-DISEASE
cramps	B-DISEASE
)	0

Limit	I-DISEASE
-	0
setting	0
sleep	0
disorder	I-DISEASE
21	I-DISEASE
Long	0
sleeper	0
187–188	I-DISEASE
Lower	0
airway	0
(	I-DISEASE
lung	I-DISEASE
disease	0
)	0
(	I-DISEASE
see	I-DISEASE
also	0
chronic	I-DISEASE
obstructive	0
pulmonary	I-DISEASE
disease	I-DISEASE
,	I-DISEASE
emphysema	I-DISEASE
and	0
chronic	I-DISEASE
bronchitis	0
)	0
52	0
,	0
129	0
,	0
135	0
M	I-DISEASE
Major	0
depression	0
(	0
see	I-DISEASE
also	0
mood	0
disorder	0
)	0

180	I-DISEASE
,	I-DISEASE
193	0
,	I-DISEASE
284	0
Melatonin	0
(	I-DISEASE
see	I-DISEASE
also	0
dim	0
-	I-DISEASE
light	0
melatonin	0
onset	0
)	0

173	I-DISEASE
,	I-DISEASE
176	0
,	I-DISEASE
189	0
,	I-DISEASE
191	0
,	I-DISEASE
195	0
,	0
196	0
,	I-DISEASE
200	I-DISEASE
,	I-DISEASE
201	0
,	I-DISEASE
206	0
,	I-DISEASE
207	0
,	0
209	0
,	0
213	I-DISEASE
,	0
218	I-DISEASE
,	I-DISEASE
354	0
Menopause	0
57	0
,	0
353	0
Menstrual	0
-	0
related	0
Kleine	0
-	0
Levin	I-DISEASE
syndrome	I-DISEASE
167	0
Methadone	0
(	I-DISEASE
see	0
also	0
opioid	0
)	0
86	0
,	0
87	0
,	0
105	I-DISEASE
,	I-DISEASE
126	I-DISEASE
Migraine	0
170	0
,	I-DISEASE
234	0
,	I-DISEASE
265	I-DISEASE
,	I-DISEASE
266	0
,	0
269	0
,	I-DISEASE
284	0
,	0
350–354	0
Mood	0
disorder	I-DISEASE
(	0
see	0
also	0
major	I-DISEASE
depression	0
)	0
28	0
,	I-DISEASE
53	0
,	I-DISEASE
168	0
,	0
179	I-DISEASE
,	I-DISEASE
192	0
,	0
193	0
,	I-DISEASE
212	0
,	I-DISEASE
244	I-DISEASE
,	0
260	0
,	0
268	0
,	0
288	I-DISEASE
,	0
291	0
,	0
294	I-DISEASE
Morningness	0
-	0
eveningness	0
questionnaire	0
189	I-DISEASE
,	0
190	0
,	0
196	0
Movement	I-DISEASE
disorders	0
(	I-DISEASE
see	I-DISEASE
sleep	I-DISEASE
related	B-DISEASE
movement	I-DISEASE
disorders	0
)	0

Multiple	0
sclerosis	0
34	0
,	I-DISEASE
156	0
,	I-DISEASE
170	0
,	0
247	0
,	I-DISEASE
248	I-DISEASE
,	I-DISEASE
251	0
,	I-DISEASE
284	0
,	0
297	0
Multiple	0
sleep	0
latency	I-DISEASE
test	0
35	0
,	I-DISEASE
55	0
,	I-DISEASE
61	0
,	I-DISEASE
144	0
,	0
146	0
,	0
151–165	0
,	0
169	0
,	0
171–174	0
,	0
177	I-DISEASE
,	I-DISEASE
179	I-DISEASE
,	0
181	0
,	0
185	0
,	0
188	0
,	0
218	I-DISEASE
,	I-DISEASE
266	0
,	0
293	0
,	I-DISEASE
297	I-DISEASE
Multisystem	0
atrophy	I-DISEASE
355	0
,	I-DISEASE
356	0
Munich	0
Chronotype	I-DISEASE
Questionnaire	I-DISEASE
190	0
,	I-DISEASE
196	I-DISEASE
Muscular	0
dystrophy	0
67	0
,	0
117	0
Myocardial	I-DISEASE
ischemia	0
(	0
see	0
sleep	0
related	B-DISEASE
myocardial	0
ischemia	0
)	0

Myotonic	I-DISEASE
dystrophy	0
57	I-DISEASE
,	0
156	0
,	0
172	0
,	I-DISEASE
175	0
N	0
Narcolepsy	0
type	0
1	0
146–155	0
Narcolepsy	0
type	I-DISEASE
2	0
155–161	I-DISEASE
Negative	0
expectations	I-DISEASE
23	0
,	I-DISEASE
219	I-DISEASE
,	0
223	0
Neuromuscular	0
(	I-DISEASE
disease	I-DISEASE
/	0
disorder	0
)	0
52	0
,	0
64	0
,	0
,	I-DISEASE
66	I-DISEASE
,	0
67	I-DISEASE
,	0
93	0
,	I-DISEASE
112	I-DISEASE
,	I-DISEASE
121	0
,	0
123	0
,	I-DISEASE
126–131	0
,	I-DISEASE
–	0
137	0
,	I-DISEASE
153	0
,	0
300	I-DISEASE
Night	I-DISEASE
eating	I-DISEASE
syndrome	I-DISEASE
244	I-DISEASE
,	I-DISEASE
245	0
Nightmare	0
disorder	I-DISEASE
257–263	0
Nocturnal	0
frontal	I-DISEASE
lobe	0
epilepsy	0
(	I-DISEASE
NFLE	I-DISEASE
)	0
,	I-DISEASE
345–349	0
Nocturnal	0
paroxysmal	0
hemicrania	0
266	I-DISEASE
Non-24	0
-	0
hour	0
sleep	0
-	0
wake	0
rhythm	0
disorder	I-DISEASE
–	0
214	0
Nonrestorative	I-DISEASE
sleep	0
23	I-DISEASE
,	0
33	I-DISEASE
,	I-DISEASE
39	I-DISEASE
,	I-DISEASE
43	I-DISEASE
,	I-DISEASE
53	0
,	I-DISEASE
69	I-DISEASE
,	I-DISEASE
75	0
,	0
79	0
,	0
85	0
,	0
89	I-DISEASE
,	I-DISEASE
241	0
,	I-DISEASE
294	0
,	0
296	0

O	I-DISEASE

Obesity	I-DISEASE
51	0
,	I-DISEASE
53	0
,	I-DISEASE
55	0
,	I-DISEASE
57	0
,	0
58	0
,	I-DISEASE
61	I-DISEASE
,	I-DISEASE
65	0
,	I-DISEASE
66	I-DISEASE
,	I-DISEASE
68	0
,	0
108–111	I-DISEASE
,	I-DISEASE
116	0
,	I-DISEASE
118–121	0
,	I-DISEASE
123	0
,	I-DISEASE
124	0
,	0
126	I-DISEASE
,	0
128	I-DISEASE
,	0
139	0
,	0
148	0
,	I-DISEASE
151	0
,	0
173	0
,	I-DISEASE
241	I-DISEASE
,	I-DISEASE
244	I-DISEASE
,	I-DISEASE
284	0
,	0
364	I-DISEASE
Obesity	0
hypoventilation	0
syndrome	I-DISEASE
108–113	I-DISEASE
Obstructive	I-DISEASE
sleep	0
apnea	0
,	0
adult	0
53–62	0
Obstructive	I-DISEASE
sleep	I-DISEASE
apnea	0
disorders	0
53–68	I-DISEASE
Obstructive	0
sleep	0
apnea	0
,	I-DISEASE
pediatric	0
63–68	I-DISEASE
Oneirism	B-DISEASE
248	0
Opioid	0
(	I-DISEASE
see	0
also	0
methadone	0
)	0
51	B-DISEASE
,	0
69	I-DISEASE
,	I-DISEASE
74	0
,	0
85–88	0
,	I-DISEASE
93	0
,	0
103	I-DISEASE
,	0
126	0
,	0
176	0
,	I-DISEASE
317	I-DISEASE
,	I-DISEASE
369	I-DISEASE
Opioid	I-DISEASE
withdrawal	0
88	0
,	I-DISEASE
317	0
Other	0
insomnia	0
disorder	I-DISEASE
46	I-DISEASE
Other	0
parasomnias	I-DISEASE
264–278	0
Other	0
sleep	0
disorder	0
339–340	0
Out	0
-	0
of	0
-	I-DISEASE
center	0
sleep	0
testing	0
(	0
OCST	0
)	0
50	0
,	0
53	0
,	I-DISEASE
,	I-DISEASE
60	0
,	0
61	0
,	I-DISEASE
134	I-DISEASE
,	I-DISEASE
137	0
,	I-DISEASE
139	0
P	0
Paradoxical	0
insomnia	I-DISEASE
20	0
,	I-DISEASE
27	0
,	0
35	0
Parasomnia	0
due	0
to	0
a	0
medical	0
disorder	0
276	I-DISEASE
Parasomnia	0
due	0
to	0
a	0
medication	0
or	0
substance	I-DISEASE
–	0
278	0
Parasomnia	I-DISEASE
overlap	I-DISEASE
disorder	I-DISEASE
237	0
,	0
248	I-DISEASE
,	I-DISEASE
249	0
,	0
Parasomnias	0
225–280	I-DISEASE
Parasomnia	0
,	0
unspecified	0
278	0
Parenchymal	0
(	I-DISEASE
lung	0
disease	I-DISEASE
)	0
52	0
,	I-DISEASE
93	0
,	0
109	0
,	I-DISEASE
,	0
121	0
,	I-DISEASE
123	0
,	I-DISEASE
124	0
,	0
127–131	0
,	I-DISEASE
134–137	0
Parkinson	0
disease	0
156	0
,	0
172	0
,	I-DISEASE
205	0
,	0
224	B-DISEASE
,	I-DISEASE
227	0
,	I-DISEASE
249	I-DISEASE
,	I-DISEASE
250	I-DISEASE
,	0
284	0
,	I-DISEASE
287	0
,	I-DISEASE
297	0
,	I-DISEASE
305	I-DISEASE
,	0
308	0
,	I-DISEASE
333	0
Performance	I-DISEASE
anxiety	0
26	I-DISEASE
Periodic	I-DISEASE
breathing	B-DISEASE
50	0
,	I-DISEASE
74	0
,	I-DISEASE
78–83	0
,	I-DISEASE
87	0
,	I-DISEASE
92	0
,	I-DISEASE
,	I-DISEASE
95	0
,	I-DISEASE
98	I-DISEASE
,	0
101	0
Periodic	0
limb	I-DISEASE
movement	0
disorder	I-DISEASE
292–299	0
Periodic	I-DISEASE
limb	B-DISEASE
movements	0
of	I-DISEASE
sleep	0
148	I-DISEASE
,	I-DISEASE
271	0
,	0
272	0
,	I-DISEASE
274	I-DISEASE
,	I-DISEASE
281	0
,	I-DISEASE
284	0
,	I-DISEASE
285	I-DISEASE
,	I-DISEASE
287–290	0
,	0
292–298	0
,	0
324	I-DISEASE
,	0
329	0
Periodic	0
limb	I-DISEASE
movements	0
of	I-DISEASE
wake	I-DISEASE
284	0
,	I-DISEASE
289	0
Pervasive	0
developmental	I-DISEASE
disorder	I-DISEASE
(	I-DISEASE
see	I-DISEASE
also	0
autism	0
)	0
206	0
Phase	I-DISEASE
response	0
curve	I-DISEASE
193	0
,	I-DISEASE
201	0
PHOX2B	0
113	0
,	I-DISEASE
114	0
,	I-DISEASE
116	I-DISEASE
,	I-DISEASE
118–120	I-DISEASE
,	0
123	0
Physiological	0
hyperarousal	0
33	I-DISEASE
,	0
35	0
Posttraumatic	0
stress	I-DISEASE
disorder	I-DISEASE
249	0
,	I-DISEASE
252	0
,	I-DISEASE
258	0
,	I-DISEASE
,	I-DISEASE
260	0
,	I-DISEASE
262	I-DISEASE
,	0
279	I-DISEASE
,	0
284	0
,	0
297	I-DISEASE
,	I-DISEASE
327	0
Prader	0
-	0
Willi	0
syndrome	I-DISEASE
120	0
,	0
156	0
,	0
172	0
Pramipexole	0
176	0
,	0
331	I-DISEASE
Pregnancy	B-DISEASE
139	I-DISEASE
,	0
140	0
,	I-DISEASE
285	I-DISEASE
,	0
286	I-DISEASE
,	0
353	0
Prematurity	I-DISEASE
91	O
,	O
98–101	O
Primary	O
central	O
sleep	O
apnea	O
89–94	O
Primary	O
central	O
sleep	O
apnea	O
of	O
infancy	O
–	O
98	O
Primary	O
central	O
sleep	O
apnea	O
of	O
prematurity	O
–	O
102	O
Primary	O
insomnia	O
20	O
,	O
21	O
,	O
26	O
,	O
28	O
,	O
29	O
Prion	O
protein	O
342–344	O
Propriospinal	O
myoclonus	O
at	O
sleep	O
onset	O
–	O
324	O
Psychophysiological	O
insomnia	O
20	O
,	O
26	O
Pulmonary	O
hypertension	O
55	O
,	O
56	O
,	O
66	O
,	O
77	O
,	O
91	O
,	O
110	O
,	O
112	O
,	O
113	O
,	O
116	O
,	O
120	O
,	O
122–124	O
,	O
126	O
,	O
128	O
,	O
130–132	O
,	O
134	O
,	O
136	O
,	O
137	O
R	O
Recurrent	O
hypersomnia	O
145	O
,	O
166	O
Recurrent	O
isolated	O
sleep	O
paralysis	O
254–256	O
REM	O
-	O
related	O
parasomnias	O
246–263	O
REM	O
sleep	O
behavior	O
disorder	O
246–253	O

REM	I-DISEASE
sleep	0
without	0
atonia	I-DISEASE
151	0
,	I-DISEASE
152	0
,	0
159	0
,	I-DISEASE
,	I-DISEASE
247	I-DISEASE
,	0
251	I-DISEASE
,	I-DISEASE
252	I-DISEASE
Renal	0
failure	I-DISEASE
70–74	0
,	I-DISEASE
285–287	0
Residual	0
hypersomnia	0
173	0
Index	I-DISEASE
Index	I-DISEASE
Respiratory	0
depressant	I-DISEASE
51	I-DISEASE
,	I-DISEASE
85	0
,	0
121	0
,	0
125–127	I-DISEASE
Respiratory	I-DISEASE
effort	I-DISEASE
related	0
arousal	0
(	I-DISEASE
RERA	I-DISEASE
)	0
53	I-DISEASE
,	I-DISEASE
54	I-DISEASE
,	I-DISEASE
56	0
,	I-DISEASE
60	0
,	I-DISEASE
61	0
,	0
65	0
,	I-DISEASE
102	I-DISEASE
,	I-DISEASE
139	0
,	I-DISEASE
164	0
Restless	0
legs	0
syndrome	I-DISEASE
282–291	0
Reverse	0
first	0
-	I-DISEASE
night	I-DISEASE
effect	0
34	0
Rhythmic	0
masticatory	0
muscle	0
activity	0
304	0
,	I-DISEASE
,	I-DISEASE
307–311	0
S	I-DISEASE
Secondary	I-DISEASE
insomnia	0
20	0
,	0
21	0
,	I-DISEASE
28	0
,	0
29	0
Sedating	0
medication	0
54	I-DISEASE
,	0
57	I-DISEASE
,	0
165	0
,	0
176	0
,	I-DISEASE
177	0
Sedative	0
86	0
,	I-DISEASE
125	I-DISEASE
,	I-DISEASE
175–178	0
,	0
192	0
,	I-DISEASE
194	0
,	0
200	0
,	I-DISEASE
,	I-DISEASE
234	0
,	I-DISEASE
242	0
,	0
247	0
,	0
277	0
,	I-DISEASE
278	0
,	0
369	0
Seizures	I-DISEASE
(	0
see	I-DISEASE
also	0
epilepsy	I-DISEASE
)	0
55	0
,	0
66	I-DISEASE
,	0
68	B-DISEASE
,	0
,	0
101	I-DISEASE
,	I-DISEASE
115	0
,	0
153	0
,	I-DISEASE
170	0
,	I-DISEASE
176	0
,	0
252	0
,	0
256	I-DISEASE
,	0
260	0
,	I-DISEASE
261	I-DISEASE
,	0
266	I-DISEASE
,	I-DISEASE
269	0
,	I-DISEASE
273	0
,	I-DISEASE
279	0
,	0
298	0
,	I-DISEASE
310	0
,	0
317–319	0
,	0
337	I-DISEASE
,	0
345–349	0
,	0
356	0
Sexsomnia	I-DISEASE
232	0
,	I-DISEASE
242	0
,	0
248	0
Shift	I-DISEASE
work	0
disorder	0
215–219	I-DISEASE
Short	0
sleeper	I-DISEASE
47–48	0
Short	0
-	0
term	0
insomnia	0
disorder	0
41–45	0
Sleep	0
attack	I-DISEASE
143	0
,	I-DISEASE
147	I-DISEASE
Sleep	0
drunkenness	0
154	I-DISEASE
,	0
160	I-DISEASE
,	0
162	I-DISEASE
,	I-DISEASE
163	I-DISEASE
Sleep	0
enuresis	0
270–276	I-DISEASE
Sleep	0
inertia	0
162	0
,	0
192	0
,	B-DISEASE
197	I-DISEASE
,	0
226	0
,	I-DISEASE
236	0
Sleep	0
log	0
144	0
,	0
152	0
,	0
159	I-DISEASE
,	0
162	0
,	I-DISEASE
182	I-DISEASE
,	0
187	I-DISEASE
,	I-DISEASE
189	I-DISEASE
,	I-DISEASE
,	0
196	I-DISEASE
,	I-DISEASE
199	I-DISEASE
,	I-DISEASE
204	0
,	I-DISEASE
207	0
,	I-DISEASE
209	0
,	I-DISEASE
213	I-DISEASE
,	I-DISEASE
215	0
,	I-DISEASE
,	I-DISEASE
224	I-DISEASE
Sleep	0
-	0
onset	I-DISEASE
association	0
disorder	0
21	I-DISEASE

Sleep	I-DISEASE
onset	I-DISEASE
REM	I-DISEASE
period	0
144	0
,	I-DISEASE
146	0
,	0
152	0
,	I-DISEASE
–	I-DISEASE
162	I-DISEASE
,	I-DISEASE
164	0
,	I-DISEASE
165	0
,	I-DISEASE
169	0
,	0
171	I-DISEASE
,	0
174	0
,	I-DISEASE
177	0
,	I-DISEASE
,	0
247	I-DISEASE
,	I-DISEASE
269	I-DISEASE
Sleep	0
paralysis	I-DISEASE
148	I-DISEASE
,	I-DISEASE
150	I-DISEASE
,	0
151	0
,	0
153	0
,	I-DISEASE
156	0
,	0
,	I-DISEASE
163	I-DISEASE
,	I-DISEASE
171	I-DISEASE
,	I-DISEASE
183	I-DISEASE
,	0
254–256	0
,	0
261	I-DISEASE
,	I-DISEASE
266	0
,	I-DISEASE
,	0
269	0
,	I-DISEASE
276	I-DISEASE
,	I-DISEASE
314	I-DISEASE
Sleep	0
related	B-DISEASE
abnormal	I-DISEASE
sexual	I-DISEASE
behaviors	I-DISEASE
Sleep	0
related	I-DISEASE
breathing	0
disorders	0
49–141	0
Sleep	I-DISEASE
related	0
Sleep	I-DISEASE
related	0
Sleep	0
related	I-DISEASE
Sleep	0
related	I-DISEASE
–	I-DISEASE
363	0
Sleep	0
related	B-DISEASE
Sleep	0
related	0
Sleep	0
related	I-DISEASE
–	0
133	I-DISEASE
Sleep	0
related	B-DISEASE
bruxism	I-DISEASE
303–311	0
eating	0
disorder	0
240–245	0
epilepsy	0
345–350	0
gastroesophageal	0
reflux	0
hallucinations	I-DISEASE
267–270	0
headaches	I-DISEASE
350–355	0
hypoventilation	I-DISEASE
disorders	0
hypoventilation	0
due	0
to	I-DISEASE
a	0
medical	I-DISEASE
disorder	I-DISEASE
128–133	I-DISEASE
Sleep	0
related	0
hypoventilation	0
due	0
to	0
a	0
medication	0
or	I-DISEASE
substance	I-DISEASE
124–128	0
Sleep	0
related	B-DISEASE
hypoxemia	0

134–138	I-DISEASE
Sleep	0
related	B-DISEASE
injury	0
227	0
,	I-DISEASE
241	0
,	0
247	0
,	I-DISEASE
250	I-DISEASE
Sleep	I-DISEASE
related	B-DISEASE
laryngospasm	0
355–357	0
Sleep	I-DISEASE
related	0
leg	I-DISEASE
cramps	I-DISEASE
299–303	0
Sleep	0
related	B-DISEASE
medical	0
and	0
neurological	0
disorders	0
341–367	0
Sleep	0
related	0
movement	0
disorder	I-DISEASE
due	0
to	0
a	0
medical	0
disorder	I-DISEASE
325	0
Sleep	0
related	0
movement	0
disorder	0
due	I-DISEASE
to	I-DISEASE
a	I-DISEASE
medication	0
or	I-DISEASE
substance	I-DISEASE
326	0
Sleep	0
related	B-DISEASE
movement	I-DISEASE
disorders	0
281–337	0
Sleep	0
related	B-DISEASE
movement	I-DISEASE
disorder	I-DISEASE
,	0
unspecified	I-DISEASE
327	0
Sleep	I-DISEASE
related	0
myocardial	0
ischemia	0
363–367	I-DISEASE
Sleep	0
related	0
rhythmic	B-DISEASE
movement	0
disorder	I-DISEASE
–	0
316	0
Sleep	I-DISEASE
starts	0
(	I-DISEASE
see	0
also	0
hypnic	0
jerks	0
)	0

335–337	I-DISEASE
Sleep	0
talking	0
279–280	I-DISEASE
Sleep	0
terrors	I-DISEASE
228–239	I-DISEASE
Sleepwalking	I-DISEASE
228–239	0
Smith	0
-	0
Magenis	0
syndrome	I-DISEASE
173	0
,	I-DISEASE
200	I-DISEASE
,	I-DISEASE
206	0
Snoring	B-DISEASE
139–140	0

Status	I-DISEASE
cataplecticus	I-DISEASE
148	0
Status	0
dissociatus	I-DISEASE
248	I-DISEASE
,	I-DISEASE
252	I-DISEASE
Stroke	0
(	I-DISEASE
see	I-DISEASE
also	0
cerebrovascular	0
accident	0
)	0
34	0
,	I-DISEASE
50	0
,	I-DISEASE
53	0
,	I-DISEASE
55	0
,	0
58	I-DISEASE
,	0
61	0
,	0
70–74	0
,	0
76	0
,	0
140	0
,	I-DISEASE
172	I-DISEASE
,	I-DISEASE
173	I-DISEASE
,	0
234	0
,	0
249	0
,	0
264	0
,	0
287	0
,	I-DISEASE
291	0
,	0
295	0
Sudden	I-DISEASE
infant	0
death	0
syndrome	0
(	0
SIDS	I-DISEASE
)	0
94	0
,	I-DISEASE
97	0
,	I-DISEASE
98	I-DISEASE
Suggested	0
immobilization	0
test	0
289	0
Synucleinopathies	I-DISEASE
(	0
see	0
also	0
Parkinson	0
disease	I-DISEASE
and	0
multisystem	0
atrophy	I-DISEASE
)	0
227	0
,	I-DISEASE
250	I-DISEASE
T	0
Treatment	I-DISEASE
-	0
emergent	0
central	0
sleep	0
apnea	0
102–107	I-DISEASE
V	I-DISEASE
Ventilatory	0
drive	0
50	0
,	I-DISEASE
59	0
,	0
66	0
,	I-DISEASE
72	0
,	I-DISEASE
74	I-DISEASE
,	I-DISEASE
87	0
,	I-DISEASE
90	I-DISEASE
,	I-DISEASE
92	0
,	I-DISEASE
122	0
,	I-DISEASE
124	0
,	0
125	I-DISEASE
Violence	I-DISEASE
(	0
in	0
sleep	0
)	0
232	I-DISEASE
,	I-DISEASE
249	0
W	0
Willis	0
-	0
Ekbom	0
disease	I-DISEASE
282	0
Index	I-DISEASE

